Citrus Sinensis ID: 011945
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 474 | 2.2.26 [Sep-21-2011] | |||||||
| P42158 | 450 | Casein kinase I isoform d | no | no | 0.945 | 0.995 | 0.709 | 0.0 | |
| Q5BP74 | 415 | Casein kinase I isoform d | N/A | no | 0.628 | 0.718 | 0.771 | 1e-145 | |
| P48730 | 415 | Casein kinase I isoform d | yes | no | 0.628 | 0.718 | 0.775 | 1e-145 | |
| P35508 | 415 | Casein kinase I isoform d | yes | no | 0.628 | 0.718 | 0.775 | 1e-145 | |
| Q06486 | 415 | Casein kinase I isoform d | yes | no | 0.628 | 0.718 | 0.775 | 1e-145 | |
| Q9DC28 | 415 | Casein kinase I isoform d | yes | no | 0.628 | 0.718 | 0.775 | 1e-145 | |
| Q5ZLL1 | 416 | Casein kinase I isoform e | no | no | 0.622 | 0.709 | 0.779 | 1e-145 | |
| Q6P647 | 415 | Casein kinase I isoform d | no | no | 0.622 | 0.710 | 0.776 | 1e-145 | |
| Q9JMK2 | 416 | Casein kinase I isoform e | no | no | 0.622 | 0.709 | 0.776 | 1e-145 | |
| Q7T2E3 | 403 | Casein kinase I isoform d | yes | no | 0.622 | 0.732 | 0.779 | 1e-145 |
| >sp|P42158|KC1D_ARATH Casein kinase I isoform delta-like OS=Arabidopsis thaliana GN=At4g26100 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 683 bits (1762), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 337/475 (70%), Positives = 388/475 (81%), Gaps = 27/475 (5%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNI TNEE+AIKLENVKTKHPQL YE+KLY+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIHTNEELAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTG+PN++WFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVEF H
Sbjct: 61 GGTGVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFFH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SKSFLHRD+KPDNFLMGLGRRANQVYIIDFGLAK+YRD+ THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDSTTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGY+LMYFL+GSLPWQGLKAGTKKQKYE+ISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
CRGYP+EFASYFHYCRSLRFDDKPDYAYLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 ST-PARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 359
+ P+RA+ P G S+ +PP +N+DR +G EEGR + SRRR SG L NS N+S
Sbjct: 301 TAPPSRALNPAVGTSAALPPGISNIDRYTGEEEGR----PHMESSRRRVSGALDNSGNIS 356
Query: 360 KQKSPMANDPAFSKDAMMSSYNLL-RSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDAS 418
Q + + ++D+M+ S +L +S+GSSRRV + GS+ R RT D S
Sbjct: 357 NQPTSSS-----ARDSMIPSSSLFAQSAGSSRRVTAVSGSRDNFPGSEELLQRSRTGDVS 411
Query: 419 PGAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVH 473
G + S G+ +G+ST +++ES ++GI++L ++ H
Sbjct: 412 RGVIPRNSPGE--------------AGKSTR--RHYESVVKGIDNLQVSDEHHPH 450
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. It can phosphorylate a large number of proteins. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q5BP74|KC1D_XENLA Casein kinase I isoform delta OS=Xenopus laevis GN=csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 516 bits (1330), Expect = e-145, Method: Compositional matrix adjust.
Identities = 230/298 (77%), Positives = 272/298 (91%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I +EEVAIKLE VKTKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAASEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP ++W G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 298
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+ S
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Isoform 1 can phosphorylate a large number of proteins. Isoform 2 has no kinase activity. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P48730|KC1D_HUMAN Casein kinase I isoform delta OS=Homo sapiens GN=CSNK1D PE=1 SV=2 | Back alignment and function description |
|---|
Score = 516 bits (1329), Expect = e-145, Method: Compositional matrix adjust.
Identities = 231/298 (77%), Positives = 271/298 (90%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 298
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+ S
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|P35508|KC1D_BOVIN Casein kinase I isoform delta OS=Bos taurus GN=CSNK1D PE=2 SV=2 | Back alignment and function description |
|---|
Score = 516 bits (1329), Expect = e-145, Method: Compositional matrix adjust.
Identities = 231/298 (77%), Positives = 271/298 (90%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 298
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+ S
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q06486|KC1D_RAT Casein kinase I isoform delta OS=Rattus norvegicus GN=Csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 516 bits (1329), Expect = e-145, Method: Compositional matrix adjust.
Identities = 231/298 (77%), Positives = 271/298 (90%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 298
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+ S
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q9DC28|KC1D_MOUSE Casein kinase I isoform delta OS=Mus musculus GN=Csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 516 bits (1329), Expect = e-145, Method: Compositional matrix adjust.
Identities = 231/298 (77%), Positives = 271/298 (90%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 298
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+ S
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGAS 298
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q5ZLL1|KC1E_CHICK Casein kinase I isoform epsilon OS=Gallus gallus GN=CSNK1E PE=2 SV=2 | Back alignment and function description |
|---|
Score = 515 bits (1327), Expect = e-145, Method: Compositional matrix adjust.
Identities = 230/295 (77%), Positives = 270/295 (91%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
ME RVGNK+RLGRKIGSGSFG+IYLG NI T EEVAIKLE VKTKHPQL E+K YK++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIATGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP+++W G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 295
C+GYP+EF++Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P647|KC1D_XENTR Casein kinase I isoform delta OS=Xenopus tropicalis GN=csnk1d PE=2 SV=1 | Back alignment and function description |
|---|
Score = 515 bits (1326), Expect = e-145, Method: Compositional matrix adjust.
Identities = 229/295 (77%), Positives = 270/295 (91%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAAEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP ++W G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 295
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9JMK2|KC1E_MOUSE Casein kinase I isoform epsilon OS=Mus musculus GN=Csnk1e PE=1 SV=2 | Back alignment and function description |
|---|
Score = 514 bits (1325), Expect = e-145, Method: Compositional matrix adjust.
Identities = 229/295 (77%), Positives = 270/295 (91%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
ME RVGNK+RLGRKIGSGSFG+IYLG NI + EEVAIKLE VKTKHPQL E+K YK++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP+++W G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 295
C+GYP+EF++Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Inhibits cytokine-induced granuloytic differentiation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T2E3|KC1DA_DANRE Casein kinase I isoform delta-A OS=Danio rerio GN=csnk1da PE=2 SV=1 | Back alignment and function description |
|---|
Score = 514 bits (1325), Expect = e-145, Method: Compositional matrix adjust.
Identities = 230/295 (77%), Positives = 271/295 (91%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I T EEVAIKLE VKTKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDITTGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP ++W G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 295
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKF 295
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 474 | ||||||
| 255560729 | 472 | casein kinase, putative [Ricinus communi | 0.993 | 0.997 | 0.858 | 0.0 | |
| 359482807 | 471 | PREDICTED: casein kinase I isoform delta | 0.989 | 0.995 | 0.844 | 0.0 | |
| 357454569 | 475 | Casein kinase I isoform delta-like prote | 0.995 | 0.993 | 0.819 | 0.0 | |
| 359484471 | 474 | PREDICTED: casein kinase I isoform delta | 0.991 | 0.991 | 0.843 | 0.0 | |
| 363807148 | 471 | uncharacterized protein LOC100795570 [Gl | 0.993 | 1.0 | 0.814 | 0.0 | |
| 356550412 | 472 | PREDICTED: casein kinase I isoform delta | 0.993 | 0.997 | 0.806 | 0.0 | |
| 121501708 | 473 | casein kinase [Beta vulgaris] | 0.993 | 0.995 | 0.814 | 0.0 | |
| 125527438 | 472 | hypothetical protein OsI_03457 [Oryza sa | 0.989 | 0.993 | 0.807 | 0.0 | |
| 224128674 | 470 | predicted protein [Populus trichocarpa] | 0.987 | 0.995 | 0.829 | 0.0 | |
| 392311590 | 483 | Chain A, Crystal Structure Of Casein Kin | 0.991 | 0.973 | 0.802 | 0.0 |
| >gi|255560729|ref|XP_002521378.1| casein kinase, putative [Ricinus communis] gi|223539456|gb|EEF41046.1| casein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 851 bits (2198), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/475 (85%), Positives = 440/475 (92%), Gaps = 4/475 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL YE+KLYKILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYKILQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPN+RWFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK+YRDT+THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 301 ST-PARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 359
+ P RA+GPGAGPSSGMPP+ AN+DRQ G EEGR T W S DP+RRRNSGP+ +S N S
Sbjct: 301 ANPPTRALGPGAGPSSGMPPSGANIDRQPGGEEGRPT-WPSMDPTRRRNSGPITSSVNFS 359
Query: 360 KQKSPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDASP 419
KQK P+AND SKDA +SS N LRSSG+SRR A+ +SR+AA+ G+++DP+ RTTDASP
Sbjct: 360 KQKGPVANDLPLSKDAKLSSTNFLRSSGTSRRPAISSSRDAALTGNESDPTWSRTTDASP 419
Query: 420 GAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 474
KIS GQRSSP+VS+E +H +SGR+T+NIK FESTLRGIESLHFNN+ERV +
Sbjct: 420 AV--KISGGQRSSPIVSAEQKHLSSGRNTTNIKTFESTLRGIESLHFNNDERVQY 472
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482807|ref|XP_002277513.2| PREDICTED: casein kinase I isoform delta-like [Vitis vinifera] gi|297743045|emb|CBI35912.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 828 bits (2140), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 402/476 (84%), Positives = 440/476 (92%), Gaps = 7/476 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL YE+KLYKILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYKILQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPN++WFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVY+IDFGLAK+YRD++THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYVIDFGLAKKYRDSSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 301 S-TPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 359
S P+RA+GPGAGPS G+PPA AN+DRQSG E+GR +GWSSADPSRRR + P N +L
Sbjct: 301 SGPPSRALGPGAGPSHGIPPAVANMDRQSGGEDGRPSGWSSADPSRRRTTVPALNLGSL- 359
Query: 360 KQKSPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDASP 419
KQKSP+AND +KD++ ++ +R+SGSSRR AV +SR+A +VG ++DPSR R DASP
Sbjct: 360 KQKSPVANDSTMAKDSLSAN---VRASGSSRRGAVSSSRDAVIVGGESDPSRSR-ADASP 415
Query: 420 GAFQKISSGQRSSPVVSSENRHTTSGRST-SNIKNFESTLRGIESLHFNNNERVHH 474
GA +KISSGQR SPV SSE++ +SGR+T SNIKNFESTL+GIESLHFNN ERV +
Sbjct: 416 GALRKISSGQRGSPVHSSEHKRISSGRNTSSNIKNFESTLKGIESLHFNNEERVQY 471
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357454569|ref|XP_003597565.1| Casein kinase I isoform delta-like protein [Medicago truncatula] gi|355486613|gb|AES67816.1| Casein kinase I isoform delta-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 815 bits (2106), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 391/477 (81%), Positives = 435/477 (91%), Gaps = 5/477 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPR+GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN+KTKHPQL YE+KLYK+LQ
Sbjct: 1 MEPRIGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENIKTKHPQLLYESKLYKVLQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPN+RWFGVEG+YNVLV+DLLGPSLEDLF+FCSRKLSLKTVLMLADQMINRVE++H
Sbjct: 61 GGTGIPNVRWFGVEGEYNVLVMDLLGPSLEDLFSFCSRKLSLKTVLMLADQMINRVEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVY IDFGLAK+YRDT+THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYAIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE+L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIESL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
CRGYP+EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 301 STP-ARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 359
+TP ARAIG GAGPSSG+PPA + +R SG E+GRH GWSS+DP+RRRNSGP+ N NLS
Sbjct: 301 ATPSARAIGSGAGPSSGLPPAVVSAERPSGGEDGRHAGWSSSDPARRRNSGPIANDGNLS 360
Query: 360 KQKSPMANDPAFSKDAMMSSYNLLRSSGSSRRV-AVPNSREAAVVGSDTDPSRPRTTDAS 418
+QK+P+ +D SK+ M+SS N R SGS+RRV AV NSR+ AVV S+ +PS P D S
Sbjct: 361 RQKAPVPSDSNGSKEVMLSSSNFFRPSGSTRRVGAVSNSRD-AVVSSEIEPSLPLARDGS 419
Query: 419 PGAFQKISSGQRSSPVVSSENRHTT-SGRSTSNIKNFESTLRGIESLHFNNNERVHH 474
PGA K S QR+SP+ SSE++ TT SGR+TSN+KNFEST+RGIESL+F N+E+V +
Sbjct: 420 PGALLKTSGAQRNSPITSSEHKATTSSGRNTSNMKNFESTIRGIESLNF-NDEKVQY 475
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359484471|ref|XP_002281345.2| PREDICTED: casein kinase I isoform delta-like [Vitis vinifera] gi|147859066|emb|CAN80417.1| hypothetical protein VITISV_024542 [Vitis vinifera] gi|297738643|emb|CBI27888.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 802 bits (2071), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/478 (84%), Positives = 443/478 (92%), Gaps = 8/478 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL YE+KLY+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPN+RWFGVEG+YNVLV+DLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVRWFGVEGEYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK+YRDTATHQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTATHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE+KVSTSIE L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISERKVSTSIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 ST-PARAIGPGAGPSSGM-PPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANL 358
+T P+R +GPGAG SSG+ PPA AN DRQSG EEGR G SS DPSRRR S G+ L
Sbjct: 301 ATPPSRVLGPGAGTSSGLPPPAVANADRQSG-EEGRPAGLSSMDPSRRRIS---GDGGGL 356
Query: 359 SKQKSPMANDPAFSKDAMMSSYNLL-RSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDA 417
SKQKSP+A+D A SKDAM+SS + L RSSGSSRR AV +SR+AA++GS++DPSR TT+A
Sbjct: 357 SKQKSPVASDLAVSKDAMLSSSHFLGRSSGSSRRAAVSSSRDAAIMGSESDPSRAHTTEA 416
Query: 418 SPG-AFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 474
SPG A ++ISSGQRSSPV SS+ + T+SGR+ +NIKN+EST+RGIE+L+F+N+ERVH+
Sbjct: 417 SPGAAVRRISSGQRSSPVGSSDPKRTSSGRNITNIKNYESTIRGIENLNFDNDERVHY 474
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|363807148|ref|NP_001242599.1| uncharacterized protein LOC100795570 [Glycine max] gi|255641648|gb|ACU21096.1| unknown [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 794 bits (2051), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 386/474 (81%), Positives = 430/474 (90%), Gaps = 3/474 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRV NKFRLGRKIGSGS EIYLGTN QTNEEVAIKLENVKTKHPQL YE+KLYKILQ
Sbjct: 1 MEPRVANKFRLGRKIGSGSSCEIYLGTNTQTNEEVAIKLENVKTKHPQLLYESKLYKILQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPN+RWFG+EGDYNVLV+DLLGPSLEDLFNFC+RKLSLKTVLMLADQMINRVEF+H
Sbjct: 61 GGTGIPNVRWFGIEGDYNVLVMDLLGPSLEDLFNFCTRKLSLKTVLMLADQMINRVEFIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVY IDFGLAK+YRDT+THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYAIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLG+VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE+L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGFVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIESL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
CRGYP+EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 301 STPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSK 360
+TP R I P AG SSG+PPA N DRQ+G RHTGWSS+DP+RRRNSGP+ N S+
Sbjct: 301 ATPVRVIVPTAGQSSGLPPAVVNADRQTGGVNSRHTGWSSSDPARRRNSGPIANDGMSSR 360
Query: 361 QKSPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDASPG 420
QK+P+ +D SKD M+SS + RSSGS+RR AV +SR+AA VG++T+PS P T DASPG
Sbjct: 361 QKAPVPSDSTGSKDVMLSS-SNFRSSGSTRRGAVSSSRDAA-VGNETEPSHPLTMDASPG 418
Query: 421 AFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 474
A +KIS+ QRSSP++S E+ T+SGR+TSN+KN+ESTLRGIE+L+F N+ER+ +
Sbjct: 419 ALRKISNAQRSSPIMSFEHNRTSSGRNTSNMKNYESTLRGIETLNF-NDERLQY 471
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356550412|ref|XP_003543581.1| PREDICTED: casein kinase I isoform delta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 794 bits (2050), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/475 (80%), Positives = 428/475 (90%), Gaps = 4/475 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRV NKFRLGRKIGSGSFGEIYLGTN QTNEEVA+KLENVKTKHPQL YE+KLYKILQ
Sbjct: 1 MEPRVANKFRLGRKIGSGSFGEIYLGTNTQTNEEVAVKLENVKTKHPQLLYESKLYKILQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPN+RWFGVEGDYNVLV+DLLGPSLEDLFNFC+RKLSLKTVLMLADQMINRVEF+H
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCTRKLSLKTVLMLADQMINRVEFIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVY IDFGLAK++RDT+THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYAIDFGLAKKHRDTSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLG+VLMYFLRGSLPWQGLKAGTKKQKYE+ISEKKVSTSIE+L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGFVLMYFLRGSLPWQGLKAGTKKQKYERISEKKVSTSIESL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
CR YP+EFASYFHYCRSL+FDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRSYPSEFASYFHYCRSLQFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 301 ST-PARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 359
+T PARAIGP AGPSSG+PPA N DRQ+G E RHTGWSS+DP+RRRNSGP+ N LS
Sbjct: 301 ATPPARAIGPAAGPSSGLPPAVVNADRQTGGENSRHTGWSSSDPARRRNSGPIANDGMLS 360
Query: 360 KQKSPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDASP 419
+QK+P +D SKD M+SS N S S+RR V +SR+ A VG++T+PS P T DAS
Sbjct: 361 RQKAPFPSDSTRSKDVMLSSSNFRSSG-STRRGVVSSSRD-ATVGNETEPSHPLTVDASQ 418
Query: 420 GAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 474
GA +KIS QRSSP++ E+ T+SGR+TSN+KN+EST+RGIE+L+F N+ER+ +
Sbjct: 419 GALRKISGAQRSSPIMPFEHNRTSSGRNTSNMKNYESTIRGIETLNF-NDERLQY 472
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|121501708|gb|ABM55249.1| casein kinase [Beta vulgaris] | Back alignment and taxonomy information |
|---|
Score = 793 bits (2049), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/475 (81%), Positives = 422/475 (88%), Gaps = 4/475 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRVGNK+RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL YE+KLY+ILQ
Sbjct: 1 MEPRVGNKYRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPN+RWFGVEGDYNVLV+DLLGPSLEDLFNFCSRK SLKTVLMLADQMINR+EFVH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKFSLKTVLMLADQMINRIEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVY+IDFGLAK+YRDT THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYVIDFGLAKKYRDTTTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR++RDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRIYRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 STPARAIGPGAGPSSGMP-PAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 359
+ P G GAG S+G+P P AN +R+ G EEGR G S+ D RRR SG L NS +L
Sbjct: 301 AAPPARTGAGAGTSAGVPTPPVANPERKLGEEEGRAGGLSTGDGLRRRMSGSLLNSGSLL 360
Query: 360 KQKSPMANDPAFSKDAMMSSYNLL-RSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDAS 418
KQKSP+ANDP SKD +SS NL RSSG +R A+P+SREA G+++DPSR RT +AS
Sbjct: 361 KQKSPLANDPTVSKDPTLSSTNLTGRSSGFLKRAAIPSSREAVTGGNESDPSRSRTAEAS 420
Query: 419 PGAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVH 473
P Q+ SSGQRSSPV SS+ + +SGR TS IKN+ESTL+GIESLHF ++ERVH
Sbjct: 421 PSTMQRFSSGQRSSPVGSSDAKQQSSGRITS-IKNYESTLKGIESLHF-DDERVH 473
|
Source: Beta vulgaris Species: Beta vulgaris Genus: Beta Family: Amaranthaceae Order: Caryophyllales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|125527438|gb|EAY75552.1| hypothetical protein OsI_03457 [Oryza sativa Indica Group] | Back alignment and taxonomy information |
|---|
Score = 789 bits (2037), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/477 (80%), Positives = 429/477 (89%), Gaps = 8/477 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL YE+K+Y+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPN+RWFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK+YRDT+THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV+TSIEAL
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
CRGYPTEFASYFHYCRSLRFDDKPDY+YLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 301 -STPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 359
S P RA+G GAGPS PPA N DRQSG +EGR +GWSS D RRR P+ + L+
Sbjct: 301 ASAPPRAVGHGAGPSGLAPPALQN-DRQSGVDEGRTSGWSSMD--RRRAPPPIASVGTLA 357
Query: 360 KQKSPMANDPAFSKDAMMSSYNLL-RSSGSSRRVAVPNSREAAVVGSDT-DPSRPRTTDA 417
KQK+P+ ND +FSK+ ++S+ N L RSSGSSRR AV +SR+ V+ +DT +PSR R TDA
Sbjct: 358 KQKAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSRD--VMPTDTSEPSRTRATDA 415
Query: 418 SPGAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 474
SPGAF++ S Q+SSPV S+E +H++S R +SN+KN+ES L+GIE L+F+ +ERV +
Sbjct: 416 SPGAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESALKGIEGLNFDGDERVQY 472
|
Source: Oryza sativa Indica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224128674|ref|XP_002329062.1| predicted protein [Populus trichocarpa] gi|222839733|gb|EEE78056.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 788 bits (2036), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/476 (82%), Positives = 423/476 (88%), Gaps = 8/476 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLG NIQTNEEVAIKLENVKT+HPQL YE+KLYK+LQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGANIQTNEEVAIKLENVKTRHPQLLYESKLYKMLQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPN++WFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVY IDFGLAK+YRDT+THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYAIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 301 STP-ARAIGPGAGPSSGMPPAAA-NVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANL 358
+ P RA GPGAGPSSG+PP A N DRQSG EEG S D +RRRNSGP+ NS NL
Sbjct: 301 ANPTTRAHGPGAGPSSGIPPPGANNADRQSGGEEGGPGW-PSIDHARRRNSGPIVNSGNL 359
Query: 359 SKQKSPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDAS 418
SKQKSP+ ND + SKDA +SS N LRS SSR V +SR AA G+D+DPSRPRTTDAS
Sbjct: 360 SKQKSPVTNDLSLSKDATLSSSNFLRSIVSSRNPVVSSSRGAA-FGNDSDPSRPRTTDAS 418
Query: 419 PGAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 474
F + +GQRSS +SSE +H++SGR+T NIK ESTL+GIESLH N R+HH
Sbjct: 419 ---FAVLQNGQRSSAALSSEQKHSSSGRNT-NIKTLESTLKGIESLHVNIEGRLHH 470
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|392311590|pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant | Back alignment and taxonomy information |
|---|
Score = 788 bits (2036), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/476 (80%), Positives = 427/476 (89%), Gaps = 6/476 (1%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL YE+K+Y+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPN+RWFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK+YRDT+THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV+TSIEAL
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
CRGYPTEFASYFHYCRSLRFDDKPDY+YLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 301 -STPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 359
S P RA+G GAGPS PPA N DRQSG +EGR +GWSS D RRR P+ + L+
Sbjct: 301 ASAPPRAVGHGAGPSGLAPPALQN-DRQSGVDEGRTSGWSSMD--RRRAPPPIASVGTLA 357
Query: 360 KQKSPMANDPAFSKDAMMSSYNLL-RSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDAS 418
KQK+P+ ND +FSK+ ++S+ N L RSSGSSRR AV +SR+ + + ++PSR R TDAS
Sbjct: 358 KQKAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSRDVMPIDT-SEPSRTRATDAS 416
Query: 419 PGAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 474
PGAF++ S Q+SSPV S+E +H++S R +SN+KN+ES L+GIE L+F+ +ERV +
Sbjct: 417 PGAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESALKGIEGLNFDGDERVQY 472
|
Source: Oryza sativa Japonica Group Species: Oryza sativa Genus: Oryza Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 474 | ||||||
| TAIR|locus:2030170 | 465 | CKL2 "casein kinase 1-like pro | 0.976 | 0.995 | 0.702 | 9.6e-176 | |
| TAIR|locus:2120765 | 450 | CK1 "casein kinase 1" [Arabido | 0.875 | 0.922 | 0.711 | 7.7e-159 | |
| TAIR|locus:504954933 | 435 | ckl12 "casein kinase I-like 12 | 0.784 | 0.855 | 0.758 | 1.4e-157 | |
| TAIR|locus:2050409 | 433 | ckl5 "casein kinase I-like 5" | 0.630 | 0.690 | 0.822 | 3.4e-143 | |
| TAIR|locus:2024147 | 471 | ADK1 "dual specificity kinase | 0.959 | 0.966 | 0.565 | 2.3e-135 | |
| TAIR|locus:2167634 | 476 | ckl7 "casein kinase I-like 7" | 0.879 | 0.876 | 0.602 | 2.3e-135 | |
| UNIPROTKB|Q6K9N1 | 463 | OJ1234_B11.27 "Os02g0622100 pr | 0.966 | 0.989 | 0.551 | 5e-131 | |
| TAIR|locus:2090875 | 442 | ckl10 "casein kinase I-like 10 | 0.628 | 0.674 | 0.771 | 5e-131 | |
| UNIPROTKB|Q70YQ4 | 463 | Q70YQ4 "Putative casein kinase | 0.966 | 0.989 | 0.549 | 4.5e-130 | |
| TAIR|locus:2121338 | 479 | CKL6 "casein kinase I-like 6" | 0.628 | 0.622 | 0.758 | 7.6e-128 |
| TAIR|locus:2030170 CKL2 "casein kinase 1-like protein 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1707 (606.0 bits), Expect = 9.6e-176, P = 9.6e-176
Identities = 329/468 (70%), Positives = 374/468 (79%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRVGNKFRLGRKIG GSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL YE+KLYK+LQ
Sbjct: 1 MEPRVGNKFRLGRKIGGGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYKVLQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTG+PN++W+GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR+EFVH
Sbjct: 61 GGTGVPNVKWYGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRIEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
KSFLHRDIKPDNFLMGLGRRANQVY+IDFGLAK+YRD+ HQHIPYRENKNLTGTARYA
Sbjct: 121 QKSFLHRDIKPDNFLMGLGRRANQVYVIDFGLAKKYRDS-NHQHIPYRENKNLTGTARYA 179
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
SMNTHLGIEQSRRDDLESLG+VLMYFL+GSLPWQGLKAG VSTSIEAL
Sbjct: 180 SMNTHLGIEQSRRDDLESLGFVLMYFLKGSLPWQGLKAGNKKQKYEKISEKKVSTSIEAL 239
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
CRGYP+EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 240 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 299
Query: 301 STXXXXXXXXXXXXXXXXX-XXXNVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 359
ST + +R SG +E R +GWSS P RRNSG + NS +L+
Sbjct: 300 STPPPRHHGPVVGPSSALPPAITSAERPSGGDEARPSGWSSGIP--RRNSGQIFNSGSLA 357
Query: 360 KQKSPMANDPAFSKDAMMXXXXXXXXXXXXXXVAVPNSREAAVVGSDTDPSRPRTTDASP 419
KQK+P+++DPA SKD ++ AV +SREAAV+G+D++PS P+ +A
Sbjct: 358 KQKAPVSSDPAISKDVVLSSSSFLRATGSSRRAAVSSSREAAVLGTDSEPSNPQIVEAGS 417
Query: 420 GAFQKIXXXXXXXXXXXXENRHTTSGRSTSNI-KNFESTLRGIESLHF 466
G+ KI N+ ++ R+T+++ KN+E+ L+GIESLHF
Sbjct: 418 GSNSKIPVSRNSPIVSSEINKLSSPSRATTSVMKNYEANLKGIESLHF 465
|
|
| TAIR|locus:2120765 CK1 "casein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1521 (540.5 bits), Expect = 7.7e-159, Sum P(2) = 7.7e-159
Identities = 303/426 (71%), Positives = 329/426 (77%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNI TNEE+AIKLENVKTKHPQL YE+KLY+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIHTNEELAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTG+PN++WFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVEF H
Sbjct: 61 GGTGVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFFH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SKSFLHRD+KPDNFLMGLGRRANQVYIIDFGLAK+YRD+ THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDSTTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGY+LMYFL+GSLPWQGLKAGT VSTSIEAL
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
CRGYP+EFASYFHYCRSLRFDDKPDYAYLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 STXXXXXXXXXXXXXXXXX-XXXNVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 359
+ N+DR +G EEGR + SRRR SG L NS N+S
Sbjct: 301 TAPPSRALNPAVGTSAALPPGISNIDRYTGEEEGR----PHMESSRRRVSGALDNSGNIS 356
Query: 360 KQK-SPMANDPAFSKDAMMXXXXXXXXXXXXXXVAVPNSREAAVVGSDTDPSRPRTTDAS 418
Q S A D ++ AV SR+ GS+ R RT D S
Sbjct: 357 NQPTSSSARDSMIPSSSLFAQSAGSSRRVT----AVSGSRDN-FPGSEELLQRSRTGDVS 411
Query: 419 PGAFQK 424
G +
Sbjct: 412 RGVIPR 417
|
|
| TAIR|locus:504954933 ckl12 "casein kinase I-like 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1489 (529.2 bits), Expect = 1.4e-157, Sum P(2) = 1.4e-157
Identities = 286/377 (75%), Positives = 312/377 (82%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRVGNK+RLGRKIGSGSFGEIYLGT+IQTNEEVAIKLENVKTKHPQL YE+KLY+ILQ
Sbjct: 1 MEPRVGNKYRLGRKIGSGSFGEIYLGTHIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTG+PN++WFGVEGDYN LV+DLLGPSLEDLFNFCSRKLSLK+VLMLADQMINRVE+ H
Sbjct: 61 GGTGVPNIKWFGVEGDYNTLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEYFH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SKSFLHRD+KPDNFLMGLGRRANQV+IIDFGLAK+YRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDLKPDNFLMGLGRRANQVHIIDFGLAKKYRDNTTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
SMNTHLGIEQSRRDDLESLGY+LMYFL+GSLPWQGLKAGT VSTSIE+L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIESL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
CRGYP+EFASYFHYCRSLRFDDKPDY YLKR+FRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYGYLKRIFRDLFIREGFQFDYVFDWTILKYQQSQL 300
Query: 301 STXXXXXXXXXXXXXXXXX--XXXNVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANL 358
+ ++DR G EEG G D SRRR SG L NS NL
Sbjct: 301 TAPPSRGLVSPAVGTSAGLPPGLTSIDRYGGEEEG---GRPPMDSSRRRMSGALENSGNL 357
Query: 359 SKQKSPMANDPAFSKDA 375
S + M + F++ A
Sbjct: 358 SSRGPMMPSSSLFAQSA 374
|
|
| TAIR|locus:2050409 ckl5 "casein kinase I-like 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1363 (484.9 bits), Expect = 3.4e-143, Sum P(2) = 3.4e-143
Identities = 246/299 (82%), Positives = 278/299 (92%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGT++QTNEEVAIKLE+VKT HPQL YE+++Y++LQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTDVQTNEEVAIKLESVKTAHPQLSYESRIYRVLQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPN++W+GVEGDYNVLV+DLLGPSLEDLF++C R+ SLKTVLMLADQMINR+EF+H
Sbjct: 61 GGTGIPNMKWYGVEGDYNVLVMDLLGPSLEDLFSYCKRQFSLKTVLMLADQMINRLEFIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SKS+LHRDIKPDNFLMGLGRRANQVYIID+GLAK+YRD++TH+HIPYRENK+L GT RYA
Sbjct: 121 SKSYLHRDIKPDNFLMGLGRRANQVYIIDYGLAKKYRDSSTHRHIPYRENKSLIGTPRYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
S+NTHLGIEQSRRDD+ESLGY+LMYFL+GSLPWQGLKAG VSTSIE L
Sbjct: 181 SLNTHLGIEQSRRDDIESLGYILMYFLKGSLPWQGLKAGNKKQKYDKISEKKVSTSIETL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 299
CRG+PTEFASYFHYCRSLRFDDKPDYAYLKRLFR+LFIREGFQFD+VFDWT+ KYQQSQ
Sbjct: 241 CRGHPTEFASYFHYCRSLRFDDKPDYAYLKRLFRNLFIREGFQFDFVFDWTVYKYQQSQ 299
|
|
| TAIR|locus:2024147 ADK1 "dual specificity kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1326 (471.8 bits), Expect = 2.3e-135, P = 2.3e-135
Identities = 263/465 (56%), Positives = 313/465 (67%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
M+ +G KF+LGRKIGSGSFGE+YLG N+QT EEVA+KLE+VKTKHPQL YE+KLY +LQ
Sbjct: 1 MDLVIGGKFKLGRKIGSGSFGELYLGINVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTG+PNL+W+GVEGDYNV+VIDLLGPSLEDLFN+C+RKLSLKTVLMLADQ+INRVEF+H
Sbjct: 61 GGTGVPNLKWYGVEGDYNVMVIDLLGPSLEDLFNYCNRKLSLKTVLMLADQLINRVEFMH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
++ FLHRDIKPDNFLMGLGR+ANQVYIIDFGL K+YRD TH+HIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDLQTHRHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
S+NTHLG+EQSRRDDLE+LGYVLMYFL+GSLPWQGLKAGT V+T IE L
Sbjct: 181 SVNTHLGVEQSRRDDLEALGYVLMYFLKGSLPWQGLKAGTKKQKYDRISEKKVATPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
C+ P+EF SYF YCRSLRFDDKPDY+YLKRLFRDLFIREG+QFDYVFDWT+LKY Q
Sbjct: 241 CKNQPSEFVSYFRYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQIGS 300
Query: 301 STXXXXXXXXXXXXXXXXXXXXNVDRQS--GAEEGRHTGWSSADP--SRRR--NSGPLGN 354
S+ ++++Q +E R +S A SRR S
Sbjct: 301 SSGSSSRTRNHTTANPGLTAGASLEKQERIAGKETRENRFSGAVEAFSRRHPATSTTRDR 360
Query: 355 SANLSKQKSPMANDPAFSKDAMMXXXXXXXXXXXXXXVAVPNSREAAVVGSDTDPSRPRT 414
SA+ + P++ P + A+P+S + G +D
Sbjct: 361 SASRNSVDGPLSKHPPGDSERPRSSSRYGSSSRR----AIPSSSRPSSAGGPSDSRSSSR 416
Query: 415 TDASPGAFQKIXXXXXXXXXXXXENRHTTSGRSTSNIKNFESTLR 459
S G + N TS S + E LR
Sbjct: 417 LVTSTGGVGTVSNRASTSQRIQAGNESRTSSFSRAARNTREDPLR 461
|
|
| TAIR|locus:2167634 ckl7 "casein kinase I-like 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1326 (471.8 bits), Expect = 2.3e-135, P = 2.3e-135
Identities = 258/428 (60%), Positives = 308/428 (71%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
M+ +G KF+LG+KIGSGSFGE+YLG N+QT EEVA+KLENVKTKHPQL YE+KLY +LQ
Sbjct: 1 MDLVIGGKFKLGKKIGSGSFGELYLGVNVQTGEEVAVKLENVKTKHPQLHYESKLYMLLQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG+GIPN++WFGVEGDY+V+VIDLLGPSLEDLFN+C+RKL+LKTVLMLADQ++NRVEF+H
Sbjct: 61 GGSGIPNIKWFGVEGDYSVMVIDLLGPSLEDLFNYCNRKLTLKTVLMLADQLLNRVEFMH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
++ FLHRDIKPDNFLMGLGR+ANQVYIIDFGL K+YRD TH+HIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
S+NTHLG+EQSRRDDLESLGYVLMYFL+GSLPWQGLKAGT VST IE L
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLKGSLPWQGLKAGTKKQKYDRISEKKVSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
C+ P+EF SYFHYCRSLRFDDKPDY+YLKRLFRDLFIREG+QFDYVFDWT+LKY Q
Sbjct: 241 CKNQPSEFVSYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGYQFDYVFDWTVLKYPQIG- 299
Query: 301 STXXXXXXXXXXXXXXXXXXXXNVDRQS---GAEEGRHTGWSSADPSRRRNSGPLGNSAN 357
S+ ++RQ G E R+ + + RR+ P S+
Sbjct: 300 SSSGSSSRTRHHTTAKPGFNADPIERQERILGKETTRYKIPGAVEAFSRRH--PTTTSSP 357
Query: 358 LSKQKSPMANDPAFSKDA-----MMXXXXXXXXXXXXXXVAVPNSREAAVVGSDTDPSRP 412
+ +S ++D FSK VA +SR ++ G +
Sbjct: 358 RDRSRSRNSDDGPFSKQTHGDSERANSSSRYRASSSRKAVAASSSRPSSAGGPSESRTSS 417
Query: 413 RTTDASPG 420
R +S G
Sbjct: 418 RLVSSSGG 425
|
|
| UNIPROTKB|Q6K9N1 OJ1234_B11.27 "Os02g0622100 protein" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1285 (457.4 bits), Expect = 5.0e-131, P = 5.0e-131
Identities = 262/475 (55%), Positives = 323/475 (68%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
ME +G KF+LGRKIGSGSFGE+YLG NIQ++EEVAIKLE+VK++HPQL YE+KLY +LQ
Sbjct: 1 MEHVIGGKFKLGRKIGSGSFGELYLGVNIQSSEEVAIKLESVKSRHPQLHYESKLYMLLQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIP+L+WFGVEG+YNV+VIDLLGPSLEDLFN+C+RK SLKTVLMLADQMINRVE++H
Sbjct: 61 GGTGIPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQMINRVEYMH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
++ FLHRDIKPDNFLMGLGR+A+QVY+ID+GLAK+YRD TH+HIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKASQVYVIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
S+NTHLG+EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT + T +E L
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPVEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
C+ YPTEF SYFHYCRSLRF+DKPDY+YLKRLFRDLFIREG+Q DY+FDWT K Q S+
Sbjct: 241 CKSYPTEFISYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQLDYIFDWT--K-QGSES 297
Query: 301 STXXXXXXXXXXXXXXXXXXXXNVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSK 360
+ RQ + R +G + DP RR G+ +K
Sbjct: 298 NRLRSSGRTSGLVGPSAERTERAAARQDVPD--RFSG--TVDPFARRTGSGSGHYGEHTK 353
Query: 361 QK----SPMANDPAFSKDAMMXXXXXXXXXXXXXXVAVPNSREAAVVGSDTDPSRPRTTD 416
+ S +A A D + + +SR ++ G DP+R
Sbjct: 354 HRNILDSLLAPKTAVDLDKRRPTSSSRNGSTSRKAL-LSSSRPSS--GDPIDPNRSNLIP 410
Query: 417 ASPGAFQKIXXXXXXXXXXXXENRHTTSGRSTSNIKNFESTLRGIESLHFNNNER 471
S G+ + E R + + ++ N+ + + TLR E L + + R
Sbjct: 411 TSSGS-SRPSTMQRLHQSTGLETRSSLT-KTARNVHD-DPTLRTFERLSISADRR 462
|
|
| TAIR|locus:2090875 ckl10 "casein kinase I-like 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1285 (457.4 bits), Expect = 5.0e-131, P = 5.0e-131
Identities = 230/298 (77%), Positives = 265/298 (88%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
M+ +G KF+LGRKIGSGSFGE+Y+G N+QT EEVA+KLE VKTKHPQL YE+K+Y +LQ
Sbjct: 1 MDHVIGGKFKLGRKIGSGSFGELYIGINVQTGEEVALKLEPVKTKHPQLHYESKVYMLLQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTG+P+++WFGVEG+YN + IDLLGPSLEDLFN+C+R SLKTVLMLADQ+INRVE++H
Sbjct: 61 GGTGVPHIKWFGVEGNYNCMAIDLLGPSLEDLFNYCTRSFSLKTVLMLADQLINRVEYMH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
S+ FLHRDIKPDNFLMGLGR+ANQVYIID+GLAK+YRD TH+HIPYRENKNLTGTARYA
Sbjct: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF+RGSLPWQGLKAGT + T +E L
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFIRGSLPWQGLKAGTKKQKYEKISEKKMLTPVEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 298
C+ YP+EF SYFHYCRSLRF+DKPDY+YLKRLFRDLFIREG+QFDYVFDWTILKY QS
Sbjct: 241 CKSYPSEFTSYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTILKYPQS 298
|
|
| UNIPROTKB|Q70YQ4 Q70YQ4 "Putative casein kinase I" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1276 (454.2 bits), Expect = 4.5e-130, P = 4.5e-130
Identities = 261/475 (54%), Positives = 322/475 (67%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
ME +G KF+LGRKIGSGSFGE+YLG NIQ++EEVAIKLE+VK++HPQL YE+KLY +LQ
Sbjct: 1 MEHVIGGKFKLGRKIGSGSFGELYLGVNIQSSEEVAIKLESVKSRHPQLHYESKLYMLLQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIP+L+WFGVEG+YNV+VIDLLGPSLEDLFN+C+RK SLKTVLMLADQMINRVE++H
Sbjct: 61 GGTGIPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQMINRVEYMH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
++ FLHRDIKPDNFLMGLGR+A+QVY+ID+ LAK+YRD TH+HIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKASQVYVIDYVLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
S+NTHLG+EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT + T +E L
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPVEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
C+ YPTEF SYFHYCRSLRF+DKPDY+YLKRLFRDLFIREG+Q DY+FDWT K Q S+
Sbjct: 241 CKSYPTEFISYFHYCRSLRFEDKPDYSYLKRLFRDLFIREGYQLDYIFDWT--K-QGSES 297
Query: 301 STXXXXXXXXXXXXXXXXXXXXNVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSK 360
+ RQ + R +G + DP RR G+ +K
Sbjct: 298 NRLRSSGRTSGLVGPSAERTERAAARQDVPD--RFSG--TVDPFARRTGSGSGHYGEHTK 353
Query: 361 QK----SPMANDPAFSKDAMMXXXXXXXXXXXXXXVAVPNSREAAVVGSDTDPSRPRTTD 416
+ S +A A D + + +SR ++ G DP+R
Sbjct: 354 HRNILDSLLAPKTAVDLDKRRPTSSSRNGSTSRKAL-LSSSRPSS--GDPIDPNRSNLIP 410
Query: 417 ASPGAFQKIXXXXXXXXXXXXENRHTTSGRSTSNIKNFESTLRGIESLHFNNNER 471
S G+ + E R + + ++ N+ + + TLR E L + + R
Sbjct: 411 TSSGS-SRPSTMQRLHQSTGLETRSSLT-KTARNVHD-DPTLRTFERLSISADRR 462
|
|
| TAIR|locus:2121338 CKL6 "casein kinase I-like 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1255 (446.8 bits), Expect = 7.6e-128, P = 7.6e-128
Identities = 226/298 (75%), Positives = 261/298 (87%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
M+ +G KF+LGRKIG GSFGE++L ++QT EE A+KLE KTKHPQL YE+K+Y +LQ
Sbjct: 5 MDNVIGGKFKLGRKIGGGSFGELFLAVSLQTGEEAAVKLEPAKTKHPQLHYESKIYMLLQ 64
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG+GIP+L+WFGV+GDYN +VIDLLGPSLEDLFN+C+R+L+LK VLMLADQ+I+RVE++H
Sbjct: 65 GGSGIPSLKWFGVQGDYNAMVIDLLGPSLEDLFNYCNRRLTLKAVLMLADQLISRVEYMH 124
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
S+ FLHRDIKPDNFLMGLGR+ANQVYIIDFGLAK+YRD TH+HIPYRENKNLTGTARYA
Sbjct: 125 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDLQTHRHIPYRENKNLTGTARYA 184
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTXXXXXXXXXXXXVSTSIEAL 240
S+NTHLG+EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT VST IE L
Sbjct: 185 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDRISEKKVSTPIEVL 244
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 298
C+ YP EF SYF YCRSLRF+DKPDY+YLKRLFRDLFIREG+QFDYVFDWT LK+ QS
Sbjct: 245 CKSYPPEFVSYFQYCRSLRFEDKPDYSYLKRLFRDLFIREGYQFDYVFDWTALKHPQS 302
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P42158 | KC1D_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7094 | 0.9451 | 0.9955 | no | no |
| Q556Y4 | KC1_DICDI | 2, ., 7, ., 1, 1, ., 1 | 0.7074 | 0.6202 | 0.6901 | yes | no |
| P48730 | KC1D_HUMAN | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7751 | 0.6286 | 0.7180 | yes | no |
| Q6QNM1 | KC1_TOXGO | 2, ., 7, ., 1, 1, ., 1 | 0.7263 | 0.6476 | 0.9475 | N/A | no |
| P35508 | KC1D_BOVIN | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7751 | 0.6286 | 0.7180 | yes | no |
| Q7T2E3 | KC1DA_DANRE | 2, ., 7, ., 1, 1, ., 1 | 0.7796 | 0.6223 | 0.7320 | yes | no |
| Q9DC28 | KC1D_MOUSE | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7751 | 0.6286 | 0.7180 | yes | no |
| Q5RC72 | KC1D_PONAB | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7684 | 0.6286 | 0.7180 | yes | no |
| P29295 | HRR25_YEAST | 2, ., 7, ., 1, 1, ., 1 | 0.6666 | 0.6329 | 0.6072 | yes | no |
| P40235 | HHP1_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.7671 | 0.6160 | 0.8 | yes | no |
| Q06486 | KC1D_RAT | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7751 | 0.6286 | 0.7180 | yes | no |
| O76324 | DCO_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.7220 | 0.6223 | 0.6704 | yes | no |
| Q8IHZ9 | KC1_PLAF7 | 2, ., 7, ., 1, 1, ., 1 | 0.6894 | 0.6181 | 0.9071 | yes | no |
| Q20471 | KIN20_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.7389 | 0.6202 | 0.5915 | yes | no |
| Q6QNL9 | KC1_EIMTE | 2, ., 7, ., 1, 1, ., 1 | 0.7073 | 0.6561 | 0.9283 | N/A | no |
| Q5BP74 | KC1D_XENLA | 2, ., 7, ., 1, 1, ., 1 | 0.7718 | 0.6286 | 0.7180 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00034133001 | SubName- Full=Chromosome chr9 scaffold_7, whole genome shotgun sequence; (471 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 474 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-34 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-33 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-21 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-20 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-19 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-13 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-13 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-13 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-13 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-12 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-12 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-12 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 8e-12 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-11 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-11 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-11 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-11 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-11 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-10 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-10 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-10 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-10 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-09 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-09 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-09 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-09 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-09 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-08 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-08 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-08 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-08 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-08 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-08 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-08 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-08 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 9e-08 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 9e-08 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 9e-08 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-08 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-07 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-07 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-07 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-07 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-07 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-07 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-07 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-07 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-06 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-06 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-06 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-06 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-06 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-06 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-06 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-06 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-06 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 5e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-06 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-06 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-06 | |
| COG2112 | 201 | COG2112, COG2112, Predicted Ser/Thr protein kinase | 8e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 8e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-06 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 9e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-05 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-05 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-05 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-05 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-05 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-05 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-05 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-05 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 5e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-05 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-05 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-04 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-04 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-04 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-04 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-04 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-04 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-04 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-04 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-04 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-04 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-04 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-04 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-04 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-04 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-04 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 4e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-04 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-04 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-04 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 6e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-04 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-04 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-04 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-04 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-04 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 0.001 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.001 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 0.001 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.001 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 0.001 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.001 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.001 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 0.002 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 0.002 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 0.002 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 0.002 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 0.002 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.003 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.003 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 4e-47
Identities = 68/260 (26%), Positives = 109/260 (41%), Gaps = 23/260 (8%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY----EAKLYKILQGGTG 64
+ L RK+GSGSFG +Y + T + VA+K+ +++ + E ++ + L
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 65 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSK 122
+ + F + D+ LV++ DLF++ SR LS +A Q++ +E++HS
Sbjct: 61 VRLIDAF-EDKDHLYLVMEYCEGG--DLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
+HRD+KP+N L+ V I DFGLAK+ GT Y +
Sbjct: 118 GIIHRDLKPENILLD---ENGVVKIADFGLAKK-------LLKSSSSLTTFVGTPWYMAP 167
Query: 183 NTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241
L G + D+ SLG +L L G P+ G + Q +I +
Sbjct: 168 EVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWS 227
Query: 242 RGYPTEFASYFHYCRSLRFD 261
G E C L D
Sbjct: 228 SGSE-EAKDLIKKC--LNKD 244
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 5e-34
Identities = 61/198 (30%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGTGIPNLRWF 71
+G G FG +YL + +T ++VAIK E+ + +L E ++ K L I L
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH-PNIVKLYGV 59
Query: 72 GVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
+ ++ LV++ G SL+DL KLS +L + Q++ +E++HS +HRD+K
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119
Query: 131 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-E 189
P+N L L +V + DFGL+K K + GT Y + LG
Sbjct: 120 PENIL--LDSDNGKVKLADFGLSKLLTS-------DKSLLKTIVGTPAYMAPEVLLGKGY 170
Query: 190 QSRRDDLESLGYVLMYFL 207
S + D+ SLG V++Y L
Sbjct: 171 YSEKSDIWSLG-VILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 1e-33
Identities = 77/238 (32%), Positives = 118/238 (49%), Gaps = 11/238 (4%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTN--EEVAIKLENVKTKHPQLQYEAKLYKILQGGTGI 65
+R+ RK+G GSFGE+YL + + + +A KLE+ + + E ++ L I
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 66 PNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSK 122
L F + LV++ + G SLEDL R LS L + Q+++ +E++HSK
Sbjct: 61 VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
+HRDIKP+N L L R V +IDFGLAK D + IP + ++ GT Y +
Sbjct: 121 GIIHRDIKPENIL--LDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV-GTPGYMAP 177
Query: 183 NTHLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237
LG+ S D+ SLG L L G P++G K + + KI + + S+
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
|
Length = 384 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 66/235 (28%), Positives = 107/235 (45%), Gaps = 29/235 (12%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGTGI 65
+ + K+G GSFG++YL + +T + VAIK + +K ++ E K+ K L+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKH---- 56
Query: 66 PN----LRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
PN F + D LV++ G L DL +LS Q+++ +E++H
Sbjct: 57 PNIVRLYDVF-EDEDKLYLVMEYCEGGDLFDLLKKR-GRLSEDEARFYLRQILSALEYLH 114
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SK +HRD+KP+N L+ V + DFGLA++ GT Y
Sbjct: 115 SKGIVHRDLKPENILLD---EDGHVKLADFGLARQLDPGEKL--------TTFVGTPEYM 163
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
+ LG + D+ SLG V++Y L G P+ G + ++KI + K
Sbjct: 164 APEVLLGKGYGKAVDIWSLG-VILYELLTGKPPFPG--DDQLLELFKKIGKPKPP 215
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 9e-21
Identities = 61/221 (27%), Positives = 107/221 (48%), Gaps = 24/221 (10%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTK-HPQLQYEAKLYKILQGGT 63
+++ G KIG G+FG++Y N+ T E +A I++++ K ++ E K+ ++L+
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH-- 58
Query: 64 GIPNL-RWFGVEGDYNVLVIDL---LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
PNL +++GVE + I + G +LE+L R L + + Q++ + ++
Sbjct: 59 --PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYL 115
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN-KNLTGTAR 178
HS +HRDIKP N + + + DFG A + ++ T E ++L GT
Sbjct: 116 HSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVKLKNNTT----TMGEEVQSLAGTPA 168
Query: 179 YASMNTHLGIEQS---RRDDLESLGYVLMYFLRGSLPWQGL 216
Y + G + R D+ SLG V++ G PW L
Sbjct: 169 YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 8e-20
Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQGGT 63
++ G +G GSFG +YL + T E +A+K + L+ E ++ LQ
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQH-- 58
Query: 64 GIPNL-RWFGVEGDYNVLVIDLL-----GPSLEDLF-NFCSRKLSLKTVLMLADQMINRV 116
PN+ R++G E D +++ G SL L F KL + Q++ +
Sbjct: 59 --PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGL 114
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
++HS +HRDIK N L+ + DFG AKR D T + ++ GT
Sbjct: 115 AYLHSNGIVHRDIKGANILVDSDGVVK---LADFGCAKRLGDIETGE-----GTGSVRGT 166
Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
+ + G E R D+ SLG ++ G PW
Sbjct: 167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPW 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 78/299 (26%), Positives = 137/299 (45%), Gaps = 47/299 (15%)
Query: 6 GNKFRLGRKIGSGSFGEIY---LGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKI- 58
G ++++ + IG G FG +Y ++ N + K+EN++ + L Y +Y I
Sbjct: 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNN-IYDID 69
Query: 59 -LQGGTGIPNLRWFGVEGDYNV------------LVIDLLGPSLEDLFN--FCSRKLSLK 103
+ I N+ G+ Y ++++ L + +++F C K +K
Sbjct: 70 KIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIK 129
Query: 104 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163
++ M+ +E++H H DIKP+N ++ R YIID+G+A + +
Sbjct: 130 NIMK---DMLTTLEYIHEHGISHGDIKPENIMVDGNNRG---YIIDYGIASHF--IIHGK 181
Query: 164 HIPY-RENKNL-TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT- 220
HI Y +E K+L GT YA ++ H G +RR DLESLGY ++ + LPW+G
Sbjct: 182 HIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241
Query: 221 -----KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRS-LRFDDKPDYAYLKRLF 273
K +++ E K+ +F F C + L +++KPDY L ++F
Sbjct: 242 LIHAAKCDFIKRLHEGKIKIK-------NANKFIYDFIECVTKLSYEEKPDYDALIKIF 293
|
Length = 294 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 69/288 (23%), Positives = 117/288 (40%), Gaps = 48/288 (16%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKI-------- 58
+ F+ G+ IG GSF + L +TN+E AIK+ + + QL E K+ +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR----QLIKEKKVKYVKIEKEVLT 56
Query: 59 -LQGGTGIPNLRWFGVEGDYNV-LVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
L G GI L ++ + + N+ V++ G L+ + + S L K A +++
Sbjct: 57 RLNGHPGIIKL-YYTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILL 113
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK-------------RYRDTAT 161
+E++HSK +HRD+KP+N L+ + + I DFG AK + +
Sbjct: 114 ALEYLHSKGIIHRDLKPENILLD---KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221
R + GTA Y S + DL +LG ++ L G P++G +
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG---SNE 227
Query: 222 KQKYEKISE----------KKVSTSIEALCRGYPTEFASYFHYCRSLR 259
++KI + IE L P + L+
Sbjct: 228 YLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 1e-18
Identities = 50/180 (27%), Positives = 92/180 (51%), Gaps = 21/180 (11%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQGGTGI 65
F + KIG G FGE+Y + +T +EVAIK+ K K ++ E ++ K +
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKH---- 56
Query: 66 PN-LRWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
PN ++++G ++ D +V++ G SL+DL ++ L+ + + +++ +E++HS
Sbjct: 57 PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
+HRDIK N L+ +V +IDFGL+ + DT + + GT + +
Sbjct: 117 NGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLSDT--------KARNTMVGTPYWMA 165
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 51/225 (22%), Positives = 90/225 (40%), Gaps = 49/225 (21%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----------------QLQY 51
++++ +IG G+ G ++ + +T E VA+K ++ Q Y
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 52 EAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
KL + G+G VLV++ + L ++ R L V
Sbjct: 61 VVKLLDVFPHGSGF-------------VLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRM 107
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA----THQHIP- 166
++ V ++H+ +HRD+KP N L+ + I DFGLA+ + + +HQ
Sbjct: 108 LLKGVAYMHANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQVATR 164
Query: 167 -YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGS 210
YR + L G +Y G+ DL ++G + L GS
Sbjct: 165 WYRAPELLYGARKYDP-----GV------DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (192), Expect = 6e-16
Identities = 39/165 (23%), Positives = 67/165 (40%), Gaps = 38/165 (23%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKT----------------KHPQL 49
+ K+G G++G +Y + +T E VA+K L+N + KHP +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60
Query: 50 QYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA 109
KL ++ + LV + L+ + LS + +
Sbjct: 61 ---VKLLDVIHTERKL-------------YLVFEYCDMDLKKYLDKRPGPLSPNLIKSIM 104
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
Q++ + + HS LHRD+KP N L+ R + + DFGLA+
Sbjct: 105 YQLLRGLAYCHSHRILHRDLKPQNILIN---RDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 50/184 (27%), Positives = 81/184 (44%), Gaps = 38/184 (20%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----------HPQLQYEAKLY 56
++ G+K+G G++ +Y + +T VAIK K K + E KL
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIK----KIKLGERKEAKDGINFTALREIKLL 56
Query: 57 KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD------ 110
+ L+ I L FG + + N LV + + LE + VL AD
Sbjct: 57 QELKHPNIIGLLDVFGHKSNIN-LVFEFMETDLEKVIK------DKSIVLTPADIKSYML 109
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRY---RDTATHQHIP 166
+ +E++HS LHRD+KP+N L+ ++ + + DFGLA+ + THQ +
Sbjct: 110 MTLRGLEYLHSNWILHRDLKPNNLLIA----SDGVLKLADFGLARSFGSPNRKMTHQVVT 165
Query: 167 --YR 168
YR
Sbjct: 166 RWYR 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 8e-14
Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 35/229 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-------QLQYEAKLYKIL 59
+R G+ +G G+FG +YL ++ T E+A+K P L+ E +L K L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 60 QGGTGIPNLRWFGVEGDYNVLVI---DLLGPSLED-------LFNFCSRKLSLKTVLMLA 109
Q + +++G D L I + G S++D L +RK +
Sbjct: 62 QHERIV---QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR------- 111
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 169
Q++ VE++HS +HRDIK N L A V + DFG +KR + +
Sbjct: 112 -QILEGVEYLHSNMIVHRDIKGANILRDS---AGNVKLGDFGASKRLQTICSSG----TG 163
Query: 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
K++TGT + S G R+ D+ S+G ++ L PW +A
Sbjct: 164 MKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 68/255 (26%), Positives = 98/255 (38%), Gaps = 58/255 (22%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTKHPQLQ------YEAK 54
+ I G+FG +YL T + AIK + NVK + + Y AK
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 55 LYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMI 113
LY Q DY LV++ L G L L +++
Sbjct: 62 LYYSFQ-------------SKDYLYLVMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVV 107
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 173
VE +H + +HRDIKP+N L+ + + + DFGL++ ENK
Sbjct: 108 LGVEDLHQRGIIHRDIKPENLLID---QTGHLKLTDFGLSRN-----------GLENKKF 153
Query: 174 TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI----- 228
GT Y + T LG+ + D SLG V+ FL G P+ A T ++ I
Sbjct: 154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH---AETPDAVFDNILSRRI 210
Query: 229 ---SEKKVSTSIEAL 240
E K S EA+
Sbjct: 211 NWPEEVKEFCSPEAV 225
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 3e-13
Identities = 43/166 (25%), Positives = 71/166 (42%), Gaps = 39/166 (23%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--------------LENVK-----TKHPQL 49
+++ +++G G+FG +YL N +T E VAIK L VK +HP +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 50 QYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLF-NFCSRKLSLKTVLML 108
KL ++ E D V + + +L L + + S + +
Sbjct: 61 ---VKLKEVF-------------RENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSI 104
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
Q++ + +H F HRD+KP+N L+ V I DFGLA+
Sbjct: 105 IYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (167), Expect = 6e-13
Identities = 65/255 (25%), Positives = 103/255 (40%), Gaps = 79/255 (30%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT--------KHP---QLQY 51
+G GSFG++ L T + A+K +E+ T HP +L Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 52 ----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSL 102
E KLY +L+ GG +LF+ S+ + S
Sbjct: 61 AFQTEEKLYLVLEYAPGG----------------------------ELFSHLSKEGRFSE 92
Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR--YRDTA 160
+ A +++ +E++HS ++RD+KP+N L L + + + DFGLAK +
Sbjct: 93 ERARFYAAEIVLALEYLHSLGIIYRDLKPENIL--LDADGH-IKLTDFGLAKELSSEGSR 149
Query: 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAG 219
T+ GT Y + LG + D SLG VL+Y L G P+ A
Sbjct: 150 TNT---------FCGTPEYLAPEVLLGKGYGKAVDWWSLG-VLLYEMLTGKPPFY---AE 196
Query: 220 TKKQKYEKISEKKVS 234
+K+ YEKI + +
Sbjct: 197 DRKEIYEKILKDPLR 211
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 7e-13
Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 26/176 (14%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVKTKHPQLQY-----EAKLYKILQ 60
LG+K+G G+FGE+Y G EVA+K +K + Q EA++ + L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT--LKEDASEQQIEEFLREARIMRKLD 59
Query: 61 GGTGIPN-LRWFGV-EGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINRV 116
PN ++ GV + + ++ L KLSL +L A Q+ +
Sbjct: 60 H----PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT----ATHQHIPYR 168
E++ SK+F+HRD+ N L+G V I DFGL++ D +P R
Sbjct: 116 EYLESKNFIHRDLAARNCLVGEN---LVVKISDFGLSRDLYDDDYYRKRGGKLPIR 168
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 9e-13
Identities = 48/160 (30%), Positives = 68/160 (42%), Gaps = 15/160 (9%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY------EAKLYKILQGGTGIP 66
KIG G++G +Y + T E VAIK +K + E KL K L I
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIK--KIKLRFESEGIPKTALREIKLLKELNHPNIIK 62
Query: 67 NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
L F +GD LV + + L L R L + Q++ + F HS LH
Sbjct: 63 LLDVFRHKGDL-YLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILH 121
Query: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQ 163
RD+KP+N L+ + + DFGLA+ + TH
Sbjct: 122 RDLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYTHY 158
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 45/154 (29%), Positives = 76/154 (49%), Gaps = 30/154 (19%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY-EAKLYKILQGGTGIPN-LRWF 71
KIG G+ GE+Y T+ T +EVAIK ++ ++ +L E + K + PN + ++
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKH----PNIVDYY 81
Query: 72 G--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV--------EFVH 120
+ GD +V++ + G SL D+ +++ + I V E++H
Sbjct: 82 DSYLVGDELWVVMEYMDGGSLTDIITQNFVRMN--------EPQIAYVCREVLQGLEYLH 133
Query: 121 SKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGLA 153
S++ +HRDIK DN L+ G V + DFG A
Sbjct: 134 SQNVIHRDIKSDNILLSKDGS----VKLADFGFA 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 2e-12
Identities = 73/270 (27%), Positives = 111/270 (41%), Gaps = 54/270 (20%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKILQGGTGIPN 67
R IG G GE+YL + + VA+K L + EAK+ L +P
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP- 66
Query: 68 LRWFGVEGD-----YNVLVIDLLGPSLEDLFNFCSRKLSL----------KTVLMLADQM 112
+ + D Y + I+ G +L+ L +K SL L + ++
Sbjct: 67 --VYSICSDGDPVYYTMPYIE--GYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKI 122
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK---RYRDTATHQHIPYRE 169
+E+VHSK LHRD+KPDN L+GL +V I+D+G A + + R
Sbjct: 123 CATIEYVHSKGVLHRDLKPDNILLGL---FGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 170 N--KNLT------GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221
++T GT Y + LG+ S D+ +LG +L L S P+ +
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY-------R 232
Query: 222 KQKYEKISEKKVSTSIEALCRGYPTEFASY 251
++K KIS + V S P E A Y
Sbjct: 233 RKKGRKISYRDVILS--------PIEVAPY 254
|
Length = 932 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 2e-12
Identities = 52/161 (32%), Positives = 80/161 (49%), Gaps = 26/161 (16%)
Query: 9 FRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTKHPQLQ---YEAKLYKILQG 61
LG+K+G G+FGE+Y GT T +VA+K + + EA + K L
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 62 GTGIPNL-RWFGV--EGDYNVLVIDL--LGPSLEDLFNF---CSRKLSLKTVLMLADQMI 113
PN+ R GV +G+ +V + G DL +F KL+LK +L +A Q+
Sbjct: 61 ----PNIVRLLGVCTQGEPLYIVTEYMPGG----DLLDFLRKHGEKLTLKDLLQMALQIA 112
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+E++ SK+F+HRD+ N L+ V I DFGL++
Sbjct: 113 KGMEYLESKNFVHRDLAARNCLVT---ENLVVKISDFGLSR 150
|
Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 5e-12
Identities = 48/162 (29%), Positives = 75/162 (46%), Gaps = 22/162 (13%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTK-HPQLQYEAKLYKILQGGT 63
++LG IG G+FG +Y G N++T + VAIK LE +K + + E L K L+
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKH-- 58
Query: 64 GIPNL-RWFGVEGDYNVLVIDL---LGPSLEDL---FNFCSRKLSLKTVLMLADQMINRV 116
PN+ ++ G + L I L SL + F L V Q++ +
Sbjct: 59 --PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVY----QVLQGL 112
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
++H + +HRDIK N L + V + DFG+A + D
Sbjct: 113 AYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLND 151
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 8e-12
Identities = 47/159 (29%), Positives = 78/159 (49%), Gaps = 21/159 (13%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKLENVKTKH--PQLQYEAKLYKILQ 60
++R G +GSGSFG +Y G N+ + EV++ + + QL+ E L LQ
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 61 GGTGIPNL-RWFGVEGDYNVLVIDL---LGPSLEDLF-NFCSRKLSLKTVLMLADQMINR 115
PN+ ++ G E + + L I L G SL L + S + + + Q++
Sbjct: 61 H----PNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPV--IRLYTRQILLG 114
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+E++H ++ +HRDIK N L+ V + DFG+AK
Sbjct: 115 LEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 64.9 bits (159), Expect = 1e-11
Identities = 53/188 (28%), Positives = 82/188 (43%), Gaps = 49/188 (26%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTN----EEVAIK--LENVKTKHPQ-LQYEAKLYKILQGG 62
LG+K+G G+FGE+Y GT EVA+K E+ + + EA++ + L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH- 60
Query: 63 TGIPN-LRWFGV-EGDYNVLVI-------DLL---------GPSLEDLFNFCSRKLSLKT 104
PN ++ GV + ++++ DLL SL DL +F
Sbjct: 61 ---PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFA-------- 109
Query: 105 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD----TA 160
L +A M E++ SK+F+HRD+ N L+G V I DFGL++ D
Sbjct: 110 -LQIARGM----EYLESKNFIHRDLAARNCLVGEN---LVVKISDFGLSRDLYDDDYYKV 161
Query: 161 THQHIPYR 168
+P R
Sbjct: 162 KGGKLPIR 169
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 38/155 (24%), Positives = 75/155 (48%), Gaps = 11/155 (7%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPN- 67
F + K+G GS+G +Y + +T + VAIK+ V+ ++ E + K P
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDS----PYI 60
Query: 68 LRWFG---VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
++++G D +++ S+ D+ ++ L+ + + + Q + +E++HS
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKK 120
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
+HRDIK N L+ Q + DFG++ + DT
Sbjct: 121 IHRDIKAGNILLN---EEGQAKLADFGVSGQLTDT 152
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 2e-11
Identities = 43/164 (26%), Positives = 72/164 (43%), Gaps = 20/164 (12%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLQYEAKLYKILQGGT 63
K+ + ++IG GSFG++YL + +K L N+ K E K+ K L
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNH-- 58
Query: 64 GIPNL-RWFG--VEGDYNVLVIDLL-GPSLEDLF---NFCSRKLSLKTVLMLADQMINRV 116
PN+ +++ E +V++ G L + + +L Q+ +
Sbjct: 59 --PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 117 EFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDT 159
+++HS+ LHRDIKP N FL V + DFG++K T
Sbjct: 117 KYLHSRKILHRDIKPQNIFLT----SNGLVKLGDFGISKVLSST 156
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 2e-11
Identities = 77/291 (26%), Positives = 123/291 (42%), Gaps = 69/291 (23%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQY-EAKLYKILQGGTGIPN- 67
+IG G++G++Y N +T E VA+K +EN K P E KL + L+ PN
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR----HPNI 60
Query: 68 LRWFGV---EGDYNVLVI------DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
+R + +G ++ ++ DL G L + K + + Q++ +++
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTG-----LLDSPEVKFTESQIKCYMKQLLEGLQY 115
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP----------YR 168
+HS LHRDIK N L+ + + DFGLA+ Y T ++ YR
Sbjct: 116 LHSNGILHRDIKGSNILIN---NDGVLKLADFGLARPY----TKRNSADYTNRVITLWYR 168
Query: 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228
+ L G RY + D+ S+G +L G +QG T+ ++ EKI
Sbjct: 169 PPELLLGATRYGP-----EV------DMWSVGCILAELFLGKPIFQG---STELEQLEKI 214
Query: 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRF--DDKPDYAYLKRLFRDLF 277
E LC G PT+ + L + + KP Y KR R+ F
Sbjct: 215 FE---------LC-GSPTD--ENWPGVSKLPWFENLKPKKPY-KRRLREFF 252
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 3e-11
Identities = 71/246 (28%), Positives = 105/246 (42%), Gaps = 55/246 (22%)
Query: 13 RKIGSGSFGEIYLGT---NIQTNEEVAIKLENVKTKHPQLQY-----EAKLYKILQGGTG 64
+K+G G+FGE+Y G EVA+K +K + + EA++ K L G
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT--LKEDASEEERKDFLKEARVMKKL----G 54
Query: 65 IPN-LRWFGV--EGDYNVLVI------DLLG---PSLEDLFNFCSRKLSLKTVLMLADQM 112
PN +R GV E + LV+ DLL S + LSLK +L A Q+
Sbjct: 55 HPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQI 114
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-----YRDTATHQHIPY 167
+E++ SK F+HRD+ N L+G V I DFGL++ Y T +P
Sbjct: 115 AKGMEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPI 171
Query: 168 R----ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTK 221
R E S+ + +S D+ S G VL++ F G+ P+ GL
Sbjct: 172 RWMAPE-----------SLKDGIFTSKS---DVWSFG-VLLWEIFTLGATPYPGLSNEEV 216
Query: 222 KQKYEK 227
+ K
Sbjct: 217 LEYLRK 222
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 50/194 (25%), Positives = 77/194 (39%), Gaps = 37/194 (19%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-QLQYEAKLYKILQGGTG 64
+ + K+G G+FGE+Y I+T VA+K + N K P E K+ K L+
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV 69
Query: 65 IPNLRWFGVEGD---------YNVL---VIDLLG----PSLEDLFNFCSRKLSLKTVLML 108
+P + D Y V DL G PS++ K +
Sbjct: 70 VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK--LTESQIKCYML----- 122
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 168
Q++ + ++H LHRDIK N L+ + I DFGLA+ Y P
Sbjct: 123 --QLLEGINYLHENHILHRDIKAANILID---NQGILKIADFGLARPYDGP-----PPNP 172
Query: 169 ENKNLTGTARYASM 182
+ GT +Y ++
Sbjct: 173 KGGGGGGTRKYTNL 186
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-10
Identities = 68/281 (24%), Positives = 123/281 (43%), Gaps = 52/281 (18%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQGGTGIP 66
F L RK+GSG FGE++ G + VAIK+ + K Q E + K L+ I
Sbjct: 8 FTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI- 65
Query: 67 NLRWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
F V G+ ++ +L+ G L L + + L + +++ +A Q+ + ++ +
Sbjct: 66 --SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TATHQHIPYRENKNLTGTARY 179
+ +HRD+ N L+G + DFGLA+ ++ ++ + IPY+ TA
Sbjct: 124 NSIHRDLAARNILVGEDLVCK---VADFGLARLIKEDVYLSSDKKIPYK------WTAPE 174
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237
A+ + S + D+ S G +L+Y F G +P+ G+ + Y++I+
Sbjct: 175 AASHGTF----STKSDVWSFG-ILLYEMFTYGQVPYPGM---NNHEVYDQIT-------- 218
Query: 238 EALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLK 270
GY P E C + +D+P + L+
Sbjct: 219 ----AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALR 255
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 56/203 (27%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQL--QYEAKLYKILQGGT 63
K+ R +G G+FG ++L + V IK V+ TK +L Q E ++ K+L
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 64 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHSK 122
I F + +++ G +L + C+ L T+L Q++ + VH+K
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT--GTARYA 180
LHRD+K N L+ + V I DFG++K I ++K T GT Y
Sbjct: 121 LILHRDLKTQNILL--DKHKMVVKIGDFGISK----------ILSSKSKAYTVVGTPCYI 168
Query: 181 SMNTHLGIEQSRRDDLESLGYVL 203
S G +++ D+ +LG VL
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 43/169 (25%), Positives = 69/169 (40%), Gaps = 45/169 (26%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT----------------------KHPQLQYE 52
IG G++G +Y ++ T VA+K V +HP +
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI--- 63
Query: 53 AKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLE-DLFNFCSR----KLSLKTVLM 107
+L + G L + L+ ++ DL + S+ L +T+
Sbjct: 64 VRLLDVCHGPR------------TDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKD 111
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
L Q++ V+F+HS +HRD+KP N L+ QV I DFGLA+ Y
Sbjct: 112 LMRQLLRGVDFLHSHRIVHRDLKPQNILVT---SDGQVKIADFGLARIY 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 63/216 (29%), Positives = 92/216 (42%), Gaps = 25/216 (11%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYK---ILQGGTG- 64
F L R IG G+FG++ + T + A+K N K K + + ILQ
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMN-KQKCVEKGSVRNVLNERRILQELNHP 60
Query: 65 -IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLK--TVLMLADQMINRVEFVHS 121
+ NL + + + LV+DLL DL S+K+ V +++ +E++HS
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGG--DLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS 118
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT-GTARYA 180
K +HRDIKPDN L+ V+I DF +A + T GT Y
Sbjct: 119 KGIIHRDIKPDNILLD---EQGHVHITDFNIAT---------KVTPDTLTTSTSGTPGYM 166
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 215
+ S D SLG V Y LRG P++G
Sbjct: 167 APEVLCRQGYSVAVDWWSLG-VTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 48/170 (28%), Positives = 77/170 (45%), Gaps = 37/170 (21%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGI----- 65
G +G G++G++ + T + VAIK K K ++ + + L G GI
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIK----KVKIIEISNDVTKDRQLVGMCGIHFTTL 68
Query: 66 -----------PN---LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL----KTVLM 107
N L VEGD+ LV+D++ L+ + + RK+ L ++
Sbjct: 69 RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVD---RKIRLTESQVKCIL 125
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRY 156
L Q++N + +H F+HRD+ P N F+ G I DFGLA+RY
Sbjct: 126 L--QILNGLNVLHKWYFMHRDLSPANIFINSKG----ICKIADFGLARRY 169
|
Length = 335 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 58/257 (22%), Positives = 96/257 (37%), Gaps = 38/257 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN----VKTKHPQLQYEAKLYKILQGG 62
+ F + + IG G+FGE++L + T + A+K+ +K +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 63 TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVH 120
I L + + ++ LV++ + DL N RK +T +++ ++ VH
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGG--DLMNLLIRKDVFPEETARFYIAELVLALDSVH 118
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT-----------------HQ 163
F+HRDIKPDN L+ + + DFGL K+
Sbjct: 119 KLGFIHRDIKPDNILID---ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 164 HIPYRENKN-----LTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLK 217
+ + GT Y + G D SLG V++Y L G P
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLG-VILYEMLYGFPP---FY 231
Query: 218 AGTKKQKYEKISEKKVS 234
+ T ++ Y KI K S
Sbjct: 232 SDTLQETYNKIINWKES 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 8e-10
Identities = 63/241 (26%), Positives = 103/241 (42%), Gaps = 45/241 (18%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTK-----HPQLQYEAKLYK 57
I G++G ++L T + AIK ++ V T+ Q Y KLY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 58 ILQGGTGIPNLRWFGVE----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
QG NL + +E GD L ++ +G ED+ +++
Sbjct: 61 SFQGKK---NL-YLVMEYLPGGDLASL-LENVGSLDEDVARIYIA------------EIV 103
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-YRDTATHQHIPYRENKN 172
+E++HS +HRD+KPDN L+ + + DFGL+K + + +E+K
Sbjct: 104 LALEYLHSNGIIHRDLKPDNILID---SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160
Query: 173 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232
+ GT Y + LG S+ D SLG +L FL G P+ G T ++ ++ I K
Sbjct: 161 IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG---ETPEEIFQNILNGK 217
Query: 233 V 233
+
Sbjct: 218 I 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 51/164 (31%), Positives = 86/164 (52%), Gaps = 20/164 (12%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKIL 59
PR +L RK+G+G FGE+++GT N T +VA+K T P+ LQ EA++ K L
Sbjct: 4 PR--ESLKLERKLGAGQFGEVWMGTWNGTT--KVAVKTLKPGTMSPEAFLQ-EAQIMKKL 58
Query: 60 QGGTGIPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
+ L + + V E + +V + + G L+ L + +KL L ++ +A Q+
Sbjct: 59 RH----DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAE 114
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
+ ++ S++++HRD+ N L+G I DFGLA+ D
Sbjct: 115 GMAYLESRNYIHRDLAARNILVGEN---LVCKIADFGLARLIED 155
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 2e-09
Identities = 45/150 (30%), Positives = 72/150 (48%), Gaps = 13/150 (8%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----QGGT 63
K+ KIG G+ G +Y ++ T +EVAIK N++ Q + E + +IL
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHP 76
Query: 64 GIPN-LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
I N L + V + V++ L G SL D+ + + + + + +EF+HS
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSN 134
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152
+HRDIK DN L+G+ V + DFG
Sbjct: 135 QVIHRDIKSDNILLGMD---GSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 33/238 (13%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG-IPNLR- 69
G IGSGSFG +YLG N + E +A+K V+ + + +L I L+
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVK--QVELPSVSASSKDRKRSMLDALAREIALLKE 62
Query: 70 --------WFGVEGDYNVLVIDLL---GPSLEDLFN-FCSRKLSLKTVLMLADQMINRVE 117
+ G D + L I L G S+ L N + + + +L V Q++ +
Sbjct: 63 LQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETL--VRNFVRQILKGLN 120
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR----DTATHQHIPYRENKNL 173
++H++ +HRDIK N L+ + I DFG++K+ T T+ P +L
Sbjct: 121 YLHNRGIIHRDIKGANILVD---NKGGIKISDFGISKKLEANSLSTKTNGARP-----SL 172
Query: 174 TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231
G+ + + +R+ D+ SLG +++ L G P+ T+ Q KI E
Sbjct: 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC---TQLQAIFKIGEN 227
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 54/181 (29%), Positives = 86/181 (47%), Gaps = 19/181 (10%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLQY-EAKLYKILQGGTGIPNLR 69
KIG G++G +Y + TNE +A I+LE P E L K +Q G I L+
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN-IVRLQ 67
Query: 70 WFGVEGDYNV-LVIDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFL 125
V + + LV + L L+ + ++ L + Q++ + + HS L
Sbjct: 68 DV-VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLY--QILRGIAYCHSHRVL 124
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQHIP--YRENKNLTGTARYA 180
HRD+KP N L + RR N + + DFGLA+ + T TH+ + YR + L G+ Y+
Sbjct: 125 HRDLKPQNLL--IDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYS 182
Query: 181 S 181
+
Sbjct: 183 T 183
|
Length = 294 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 3e-09
Identities = 68/277 (24%), Positives = 117/277 (42%), Gaps = 25/277 (9%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQG 61
PR RL K+G G FGE+++GT T + VAIK T P+ EA++ K L+
Sbjct: 4 PR--ESLRLDVKLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRH 60
Query: 62 GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
+P E Y V G L+ L + L L ++ +A Q+ + + ++
Sbjct: 61 DKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER 120
Query: 122 KSFLHRDIKPDNFLMGLGRRANQV-YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
+++HRD++ N L+G N V I DFGLA+ D Y + ++
Sbjct: 121 MNYIHRDLRAANILVG----DNLVCKIADFGLARLIEDNE------YTARQGAKFPIKWT 170
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
+ L + + D+ S G +L + +G +P+ G+ ++ E +V
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM---VNREVLE-----QVERGYRM 222
Query: 240 LC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 275
C +G P C D++P + Y++ D
Sbjct: 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 3e-09
Identities = 38/153 (24%), Positives = 60/153 (39%), Gaps = 32/153 (20%)
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGLAK---RYRDTATHQHIP 166
++ E++H++ ++RD+KP+N L+ G V ++DFG AK + T T
Sbjct: 101 CVVLAFEYLHNRGIIYRDLKPENLLLDSNGY----VKLVDFGFAKKLKSGQKTWT----- 151
Query: 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKA------- 218
GT Y + L D SLG +L+Y L G P+
Sbjct: 152 ------FCGTPEYVAPEIILNKGYDFSVDYWSLG-ILLYELLTGRPPFGEDDEDPMEIYN 204
Query: 219 ----GTKKQKYEKISEKKVSTSIEALCRGYPTE 247
G K ++ +K I+ L R P E
Sbjct: 205 DILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEE 237
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 4e-09
Identities = 57/221 (25%), Positives = 95/221 (42%), Gaps = 25/221 (11%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK---TKHPQLQYEAKLYKILQGGTGI 65
+ +G GS G +Y + T + A+K +V QL E K L+
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELK---TLRS-CES 58
Query: 66 PNL-RWFGV---EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
P + + +G EG+ + +V++ + G SL DL K+ + +A Q++ ++++H
Sbjct: 59 PYVVKCYGAFYKEGEIS-IVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLH 116
Query: 121 SKS-FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
+K +HRDIKP N L+ +V I DFG++K +T + GT Y
Sbjct: 117 TKRHIIHRDIKPSNLLIN---SKGEVKIADFGISKVLENTLD-------QCNTFVGTVTY 166
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220
S G S D+ SLG L+ G P+ +
Sbjct: 167 MSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 5e-09
Identities = 48/173 (27%), Positives = 79/173 (45%), Gaps = 48/173 (27%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIP 66
++ L + IGSG++G + + +T +VAIK + NV AK +IL+ I
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-FDDLID---AK--RILRE---IK 51
Query: 67 NLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD--------------- 110
LR E N++ ++D+L P + FN + + T LM D
Sbjct: 52 LLRHLRHE---NIIGLLDILRPPSPEDFN----DVYIVTELMETDLHKVIKSPQPLTDDH 104
Query: 111 ------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN---QVYIIDFGLAK 154
Q++ ++++HS + +HRD+KP N L N + I DFGLA+
Sbjct: 105 IQYFLYQILRGLKYLHSANVIHRDLKPSNIL------VNSNCDLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 7e-09
Identities = 50/200 (25%), Positives = 88/200 (44%), Gaps = 23/200 (11%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY----EAKLYKILQGGTGIPNL 68
R +G G+FGE L + + V K N+ + + E + +LQ PN+
Sbjct: 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH----PNI 61
Query: 69 -RWFGVEGDYNVLVIDLL---GPSLEDLFNFCSRKL-SLKTVLMLADQMINRVEFVHSKS 123
++ D N L+I++ G +L D +L + VL Q+++ V ++H
Sbjct: 62 IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG 121
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
LHRDIK N + +A + + DFG++K + + + GT Y S
Sbjct: 122 ILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEYSMA-------ETVVGTPYYMSPE 171
Query: 184 THLGIEQSRRDDLESLGYVL 203
G++ + + D+ +LG VL
Sbjct: 172 LCQGVKYNFKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 7e-09
Identities = 43/162 (26%), Positives = 79/162 (48%), Gaps = 20/162 (12%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKL-YKILQGGTG 64
F L IG G++G++Y + +T + VAIK+ ++ + E K Y IL+ +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII---EDEEEEIKEEYNILRKYSN 61
Query: 65 IPNL-RWFGV--------EGDYNVLVIDLL-GPSLEDLFN---FCSRKLSLKTVLMLADQ 111
PN+ ++G D LV++L G S+ DL ++L + + + +
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
+ + ++H +HRDIK N L L + A +V ++DFG++
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNIL--LTKNA-EVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 9e-09
Identities = 62/230 (26%), Positives = 99/230 (43%), Gaps = 41/230 (17%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKT---KHPQLQY--------EAKLYKIL 59
G IG G++G +YL N+ T E +A+K +E T +H Q E + K L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 60 QGGTGIPNL-RWFGVEGDYNVLVIDL---LGPSLEDLFNFCSR---KLSLKTVLMLADQM 112
N+ ++ G E L I L G S+ C R + + V +Q+
Sbjct: 66 DH----LNIVQYLGFETTEEYLSIFLEYVPGGSIGS----CLRTYGRFEEQLVRFFTEQV 117
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 172
+ + ++HSK LHRD+K DN L+ I DFG++K+ D + +N +
Sbjct: 118 LEGLAYLHSKGILHRDLKADNLLVDA---DGICKISDFGISKKSDDIYDND-----QNMS 169
Query: 173 LTGT----ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
+ G+ A + G S + D+ SLG V++ G PW +A
Sbjct: 170 MQGSVFWMAPEVIHSYSQGY--SAKVDIWSLGCVVLEMFAGRRPWSDEEA 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 26/167 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-----------QLQYE 52
+K+ KIG G+FGE++ + +T + VA+K +EN K P L++E
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHE 71
Query: 53 --AKLYKILQG-GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA 109
L +I + T + G + LV + L L + + K +L + +
Sbjct: 72 NVVNLIEICRTKATPYNRYK-----GSF-YLVFEFCEHDLAGLLSNKNVKFTLSEIKKVM 125
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
++N + ++H LHRD+K N L+ + + + DFGLA+ +
Sbjct: 126 KMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLADFGLARAF 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 1e-08
Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 20/211 (9%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY---EAKLYKILQGGTG 64
K+ KIG G+ G ++ ++ T +EVAIK N++ K P+ + E + K L+
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQ-KQPKKELIINEILVMKELKNPNI 78
Query: 65 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHSKS 123
+ L F V + V++ L G SL D+ C + + V + + +EF+H+
Sbjct: 79 VNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CRECLQALEFLHANQ 135
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN-LTGTARYASM 182
+HRDIK DN L+G+ V + DFG Q P + ++ + GT + +
Sbjct: 136 VIHRDIKSDNVLLGM---DGSVKLTDFGFCA--------QITPEQSKRSTMVGTPYWMAP 184
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
+ D+ SLG + + + G P+
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 70/281 (24%), Positives = 114/281 (40%), Gaps = 28/281 (9%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQ-LQYEAKLYKILQGGT 63
F++ +KIG G F E+Y T + + VA+K E + K Q E L K L
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 64 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL---KTVLMLADQMINRVEFVH 120
I L F + + N+++ L + + ++ L +TV Q+ + VE +H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 121 SKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
S+ +HRDIKP N F+ G V + D GL + + T H +L GT Y
Sbjct: 124 SRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAH-------SLVGTPYY 172
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG--TKKQKYEKISEKKVSTSI 237
S + + D+ SLG +L P+ G K + QK E+ + T
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPT-- 230
Query: 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278
Y + C D +PD Y+ ++ + + +
Sbjct: 231 ----EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMHV 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 56/222 (25%), Positives = 97/222 (43%), Gaps = 23/222 (10%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-------LQYEAKLYKILQG 61
+RLG+ +G G+FG +YL + T E+A+K + P+ L+ E +L K L
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 62 GTGIPNLRWFGV-----EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
+ +++G E ++ + + G S++D L+ Q++ V
Sbjct: 64 ERIV---QYYGCLRDPMERTLSIFMEHMPGGSIKDQLK-SYGALTENVTRKYTRQILEGV 119
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
++HS +HRDIK N L V + DFG +KR + + K++TGT
Sbjct: 120 SYLHSNMIVHRDIKGANILRD---SVGNVKLGDFGASKRLQTIC----LSGTGMKSVTGT 172
Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
+ S G R+ D+ S+G ++ L PW +A
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 40/156 (25%), Positives = 74/156 (47%), Gaps = 21/156 (13%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGI-- 65
+ L ++IGSG++G++Y +I T E VAIK+ ++ ++I+Q +
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE--------PGDDFEIIQQEISMLK 55
Query: 66 ----PNL-RWFGVEGDYNVLVIDLL---GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
PN+ +FG + L I + G SL+D++ LS + + + + +
Sbjct: 56 ECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLA 115
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
++H +HRDIK N L+ V + DFG++
Sbjct: 116 YLHETGKIHRDIKGANILL---TEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 2e-08
Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 21/209 (10%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFG- 72
+IG GSFGE+Y G + +T E VAIK+ +++ +++ + +L R++G
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 73 -VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
++G ++++ L G S DL L + + +++ ++++HS+ +HRDIK
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIK 128
Query: 131 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ 190
N L+ V + DFG+A + DT ++ GT + + I+Q
Sbjct: 129 AANVLLS---EQGDVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMAPEV---IKQ 175
Query: 191 SRRD---DLESLGYVLMYFLRGSLPWQGL 216
S D D+ SLG + +G P L
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 2e-08
Identities = 44/165 (26%), Positives = 75/165 (45%), Gaps = 22/165 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGT 63
F L IG GSFGE+Y + +TN+ VAIK LE + + +Q E + +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR--- 57
Query: 64 GIPNL-RWFG-VEGDYNVLVI--DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
P + +++G + +I G S DL KL + + +++ +E++
Sbjct: 58 -SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK--PGKLDETYIAFILREVLLGLEYL 114
Query: 120 HSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKRYRDTAT 161
H + +HRDIK N L+ G V + DFG++ + T +
Sbjct: 115 HEEGKIHRDIKAANILLSEEG------DVKLADFGVSGQLTSTMS 153
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 55/191 (28%), Positives = 85/191 (44%), Gaps = 41/191 (21%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLQY-EAKLYKILQGGTGIPNLR 69
KIG G++G +Y G N +T + VA I+LE+ + P E L K LQ PN+
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH----PNI- 61
Query: 70 WFGVEGDYNVLVIDLL--GPSLEDLFNFCS-------------RKLSLKTVLMLADQMIN 114
V + D+L L +F F S + + + V Q++
Sbjct: 62 ---------VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQ 112
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQHIP--YRE 169
+ F HS+ LHRD+KP N L+ + + DFGLA+ + TH+ + YR
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLID---NKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRA 169
Query: 170 NKNLTGTARYA 180
+ L G+ RY+
Sbjct: 170 PEVLLGSPRYS 180
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 38/162 (23%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKL-------ENVKT------------KHPQLQYEAK 54
KIG G++G ++ N +T+E VA+K E V + KH + +
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI---VR 63
Query: 55 LYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
LY +L + LV + L+ F+ C+ + + V Q++
Sbjct: 64 LYDVLHSDKKL-------------TLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLK 110
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
+ F HS + LHRD+KP N L+ + ++ + DFGLA+ +
Sbjct: 111 GLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 23/222 (10%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-------LENVKTKHPQLQYEAKLYKILQG 61
+RLG+ +G G+FGE+YL + T E+A+K + + L+ E +L K L+
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63
Query: 62 GTGIPNLRWFGV-----EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
+ +++G E ++ V + G S++D L+ Q++ V
Sbjct: 64 DRIV---QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLK-AYGALTENVTRRYTRQILQGV 119
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
++HS +HRDIK N L A V + DFG +KR + + K++TGT
Sbjct: 120 SYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRIQTI----CMSGTGIKSVTGT 172
Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
+ S G R+ D+ S+ ++ L PW +A
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 73/287 (25%), Positives = 119/287 (41%), Gaps = 41/287 (14%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQ 60
PR RL K+G G FGE+++GT T VAIK T P+ LQ EA++ K L+
Sbjct: 4 PR--ESLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQ-EAQVMKKLR 59
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
+ E Y V G L+ L + L L ++ +A Q+ + + +V
Sbjct: 60 HEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 119
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQV-YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
+++HRD++ N L+G N V + DFGLA+ D Y + ++
Sbjct: 120 RMNYVHRDLRAANILVG----ENLVCKVADFGLARLIEDNE------YTARQGAKFPIKW 169
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238
+ L + + D+ S G +L +G +P+ G+ ++V +E
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM------------VNREVLDQVE 217
Query: 239 ALCRGY----PTEFASYFH----YCRSLRFDDKPDYAYLKRLFRDLF 277
RGY P E H C +++P + YL+ D F
Sbjct: 218 ---RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 37/151 (24%), Positives = 70/151 (46%), Gaps = 12/151 (7%)
Query: 13 RKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTKHPQ---LQYEAKLYKILQGGTGI 65
+++G G FG++ L T E+VA+K N + + E ++ + L +
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 66 PNLRWFGVEGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
G ++ +I P SL D +++LK +L+ + Q+ ++++ S+
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR 129
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
++HRD+ N L+ + V I DFGLAK
Sbjct: 130 YIHRDLAARNILV---ESEDLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 4e-08
Identities = 45/158 (28%), Positives = 70/158 (44%), Gaps = 7/158 (4%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLQYEAKLYKILQGGTGIPNLRWF 71
+IG GSFG +Y TN TNE VA+K + K + + Q K K LQ + +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 72 G--VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
G ++ LV++ S DL + L + + + + ++HS + +HRDI
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147
Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167
K N L+ QV + DFG A + + PY
Sbjct: 148 KAGNILL---TEPGQVKLADFGSASKSSPANSFVGTPY 182
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 4e-08
Identities = 44/181 (24%), Positives = 72/181 (39%), Gaps = 44/181 (24%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--------LENVK-----------TKHPQ- 48
+++ KIG G+F E+ + +T + AIK LE V + HP
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 49 LQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLML 108
L+ L+ G L LV +L+ +L +L R L K V
Sbjct: 61 LRLIEVLFDRKTG-----RL----------ALVFELMDMNLYELIKGRKRPLPEKRVKSY 105
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 168
Q++ ++ +H HRDIKP+N L+ + + + + DFG + + PY
Sbjct: 106 MYQLLKSLDHMHRNGIFHRDIKPENILI----KDDILKLADFGSCR-----GIYSKPPYT 156
Query: 169 E 169
E
Sbjct: 157 E 157
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 6e-08
Identities = 57/198 (28%), Positives = 87/198 (43%), Gaps = 34/198 (17%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQY-EAKLYKILQGG 62
+KF + +IG G++G++Y + T E VA+K L+N K P E K+ + L
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNH- 65
Query: 63 TGIPNLRWFGVEGDYNV----------LVI-----DLLGPSLEDLFNFCSRKLSLKTVLM 107
I NL+ + + LV DL+G L +F S +
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHF-----SEDHIKS 120
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY----RDTATHQ 163
Q++ + + H K+FLHRDIK N L+ Q+ + DFGLA+ Y T++
Sbjct: 121 FMKQLLEGLNYCHKKNFLHRDIKCSNILLN---NKGQIKLADFGLARLYNSEESRPYTNK 177
Query: 164 HIP--YRENKNLTGTARY 179
I YR + L G RY
Sbjct: 178 VITLWYRPPELLLGEERY 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 6e-08
Identities = 41/160 (25%), Positives = 78/160 (48%), Gaps = 23/160 (14%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAK-----------LYKILQGGT 63
+GSG+FG +Y + N + + L+ + +P + + I++
Sbjct: 8 LGSGAFGCVY-KVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 64 GIPNL-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRK---LSLKTVLMLADQMINRV 116
PN+ R++ +E D +V+DL+ G L + FN K + + + + QM+ +
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 117 EFVH-SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
++H K +HRD+ P+N ++G ++V I DFGLAK+
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLG---EDDKVTITDFGLAKQ 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 9e-08
Identities = 47/156 (30%), Positives = 80/156 (51%), Gaps = 18/156 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGT 63
+L RK+G+G FGE++ G N T VA+K T P+ L EA++ K L+
Sbjct: 6 TSIQLLRKLGAGQFGEVWEGLWNNTT--PVAVKTLKPGTMDPKDFLA-EAQIMKKLRH-- 60
Query: 64 GIPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
P L + + V + +V +L+ G LE L R L L ++ +A Q+ + + +
Sbjct: 61 --PKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAY 118
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ +++++HRD+ N L+G N + DFGLA+
Sbjct: 119 LEAQNYIHRDLAARNVLVG---ENNICKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 9e-08
Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 14/155 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------ENVKTKHPQLQYEAKLYKIL 59
NK+ + +G G++G + N T E VAIK E+VK E K+ + L
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKT---ALREVKVLRQL 57
Query: 60 QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
+ + F +G LV + + +L +L L V Q++ + +
Sbjct: 58 RHENIVNLKEAFRRKGRL-YLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
HS + +HRDIKP+N L+ + + + DFG A+
Sbjct: 117 HSHNIIHRDIKPENILV---SESGVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 9e-08
Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 22/212 (10%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----QGGT 63
K+ KIG G+ G +Y ++ T +EVAI+ N++ Q + E + +IL
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNP 77
Query: 64 GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
I N + GD +V++ L G SL D+ + + + + + +EF+HS
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN-LTGTARYAS 181
+HRDIK DN L+G+ V + DFG Q P + ++ + GT + +
Sbjct: 136 QVIHRDIKSDNILLGMD---GSVKLTDFGFCA--------QITPEQSKRSTMVGTPYWMA 184
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
+ D+ SLG + + + G P+
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 9e-08
Identities = 53/182 (29%), Positives = 82/182 (45%), Gaps = 22/182 (12%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLQY-EAKLYKILQGGTGIPNL- 68
KIG G++G +Y + T E VA I+LE P E L K L PN+
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNH----PNIV 61
Query: 69 RWFGV-EGDYNV-LVIDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFL 125
R V + + LV + L L+ + L + Q++ + + HS L
Sbjct: 62 RLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVL 121
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRY----RDTATHQHIP--YRENKNLTGTARY 179
HRD+KP N L+ R + + DFGLA+ + R T TH+ + YR + L G+ +Y
Sbjct: 122 HRDLKPQNLLID---REGALKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILLGSRQY 177
Query: 180 AS 181
++
Sbjct: 178 ST 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 9e-08
Identities = 41/155 (26%), Positives = 69/155 (44%), Gaps = 31/155 (20%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNL-RW 70
IG G++G +Y G ++ T VA+K+ N+ T +Q E L L+ PN+ ++
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQ-PPNITKY 67
Query: 71 FGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR------------VEF 118
+G L GP L + + S++T LM A + + +++
Sbjct: 68 YGSY---------LKGPRLWIIMEYAEGG-SVRT-LMKAGPIAEKYISVIIREVLVALKY 116
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
+H +HRDIK N L+ V + DFG+A
Sbjct: 117 IHKVGVIHRDIKAANILV---TNTGNVKLCDFGVA 148
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 9e-08
Identities = 50/200 (25%), Positives = 75/200 (37%), Gaps = 58/200 (29%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIK-------LENVKT------------KHPQL----- 49
KIG G++G +Y N T E VA+K E V + HP +
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 50 --QYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVL 106
E KLY LV + L L+ + + L +
Sbjct: 67 VIHTENKLY-----------------------LVFEFLHQDLKKFMDASPLSGIPLPLIK 103
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY---RDTATHQ 163
Q++ + F HS LHRD+KP N L+ + + DFGLA+ + T TH+
Sbjct: 104 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHE 160
Query: 164 HIP--YRENKNLTGTARYAS 181
+ YR + L G Y++
Sbjct: 161 VVTLWYRAPEILLGCKYYST 180
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 37/213 (17%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKL-------YKILQGGT 63
KIG GSFGE++ G + +T + VAIK LE + + +Q E + Y G+
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 64 GIPNLR-WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
+ + + W +E +DLL P D + + T+L +++ ++++HS+
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLEPGPLD-------ETQIATILR---EILKGLDYLHSE 120
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
+HRDIK N L+ +V + DFG+A + DT ++ GT + +
Sbjct: 121 KKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMAP 170
Query: 183 NTHLGIEQSRRD---DLESLGYVLMYFLRGSLP 212
I+QS D D+ SLG + +G P
Sbjct: 171 EV---IKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 26/161 (16%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQ--LQYEAKLYKILQGG 62
K+ +G GS+G + + +T + VAIK LE+ K + E ++ K L+
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR-H 59
Query: 63 TGIPNL--------RWFGVEGDYNVLVIDLLGPS-LEDLFNFCSRKLSLKTVLMLADQMI 113
+ NL R + LV + + + L+DL + + L V Q++
Sbjct: 60 ENLVNLIEVFRRKKRLY--------LVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQIL 110
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+EF HS + +HRDIKP+N L+ ++ V + DFG A+
Sbjct: 111 RGIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 55/212 (25%), Positives = 94/212 (44%), Gaps = 22/212 (10%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL----QGGT 63
K+ KIG G+ G +Y +I T +EVAIK N++ Q + E + +IL
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKNP 76
Query: 64 GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
I N + GD +V++ L G SL D+ + + + + + ++F+HS
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALDFLHSN 134
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN-LTGTARYAS 181
+HRDIK DN L+G+ V + DFG Q P + ++ + GT + +
Sbjct: 135 QVIHRDIKSDNILLGMD---GSVKLTDFGFCA--------QITPEQSKRSTMVGTPYWMA 183
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
+ D+ SLG + + + G P+
Sbjct: 184 PEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 44/159 (27%), Positives = 71/159 (44%), Gaps = 7/159 (4%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYE--AKLYKILQGGTGIPNLRW 70
R+IG GSFG +Y +++TNE VAIK + K +++ K K LQ ++ +
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 71 FG--VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 128
G + LV++ S DL + L + + + + ++HS + +HRD
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 129 IKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167
IK N L+ QV + DFG A + PY
Sbjct: 151 IKAGNILL---TEPGQVKLADFGSASIASPANSFVGTPY 186
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 44/159 (27%), Positives = 82/159 (51%), Gaps = 16/159 (10%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKILQGGTGIPNL 68
+GSG++G + + + ++VA+K + + H + Y E +L K ++ I L
Sbjct: 21 TPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 69 RWF----GVEGDYN--VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
F +E ++N LV +L+G L ++ +KLS + V L Q++ ++++HS
Sbjct: 81 DVFTPATSIE-NFNEVYLVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSA 137
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
+HRD+KP N + ++ I+DFGLA++ D T
Sbjct: 138 GIIHRDLKPSNVAVN---EDCELRILDFGLARQADDEMT 173
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-07
Identities = 27/149 (18%), Positives = 61/149 (40%), Gaps = 18/149 (12%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQG-GTGIPNLRWF 71
+ + G +YL +E+ +K+ + K + E + ++L G +P +
Sbjct: 4 KLLKGGLTNRVYLLGT--KDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 72 GVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---KSFLHR 127
G ++ L+++ + G +L+ ++S + +A+Q+ + +H H
Sbjct: 62 GESDGWSYLLMEWIEGETLD--------EVSEEEKEDIAEQLAELLAKLHQLPLLVLCHG 113
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
D+ P N L+ + IID+ A
Sbjct: 114 DLHPGNILV---DDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 23/222 (10%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-------LQYEAKLYKILQG 61
+R G+ +G G+FG +YL ++ T E+A K + P+ L+ E +L K LQ
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 62 GTGIPNLRWFGVEGDYNVLVIDLL-----GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
+ +++G D + + G S++D L+ Q++ +
Sbjct: 64 ERIV---QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLK-AYGALTESVTRKYTRQILEGM 119
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
++HS +HRDIK N L A V + DFG +KR + + +++TGT
Sbjct: 120 SYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRLQTIC----MSGTGIRSVTGT 172
Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
+ S G R+ D+ SLG ++ L PW +A
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 49/168 (29%), Positives = 73/168 (43%), Gaps = 52/168 (30%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKILQGGTGIPNLR 69
IG G++G + N +TNE+VAIK +N L+ E KL LR
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKL------------LR 59
Query: 70 WFGVEGDYNVLVI-DLLGPSLEDLFNFCSRKLSLKTVLMLAD------------------ 110
E NV+ I D++ P + FN + + LM D
Sbjct: 60 HLDHE---NVIAIKDIMPPPHREAFN----DVYIVYELMDTDLHQIIRSSQTLSDDHCQY 112
Query: 111 ---QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAK 154
Q++ ++++HS + LHRD+KP N L+ AN + I DFGLA+
Sbjct: 113 FLYQLLRGLKYIHSANVLHRDLKPSNLLLN----ANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 47/162 (29%), Positives = 77/162 (47%), Gaps = 15/162 (9%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQG 61
PR +L +K+G+G FGE+++G + +VAIK + P+ EA L K LQ
Sbjct: 4 PR--ETLKLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH 60
Query: 62 GTGIPNL-RWFGVEGDYNVLVID--LLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVE 117
P L R + V + +I + SL D KL++ ++ +A Q+ +
Sbjct: 61 ----PRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
F+ K+++HRD++ N L+ I DFGLA+ D
Sbjct: 117 FIERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDN 155
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 2e-07
Identities = 39/159 (24%), Positives = 65/159 (40%), Gaps = 30/159 (18%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHP-----------QLQYEAKLYKIL 59
+I G++G +Y + +T E VA +K+E K P +LQ+
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHP------- 64
Query: 60 QGGTGIPNLR--WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
I ++ G D +V++ + L+ L + V L Q+++ V
Sbjct: 65 ----NIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVA 120
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
+H LHRD+K N L+ + I DFGLA+ Y
Sbjct: 121 HLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREY 156
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 50/206 (24%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFG- 72
+IG GSFGE++ G + +T + VAIK+ +++ +++ + +L +++G
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 73 -VEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
++G ++++ L G +L+ L + + T+L +++ ++++HS+ +HRDI
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATML---KEILKGLDYLHSEKKIHRDI 127
Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE 189
K N L+ V + DFG+A + DT + GT + + I+
Sbjct: 128 KAANVLLS---EQGDVKLADFGVAGQLTDTQI-------KRNTFVGTPFWMAPEV---IQ 174
Query: 190 QSRRD---DLESLGYVLMYFLRGSLP 212
QS D D+ SLG + +G P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 2e-07
Identities = 69/263 (26%), Positives = 112/263 (42%), Gaps = 50/263 (19%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN----VKTKHPQLQYEAKLYKILQGGTG 64
F + +G+GSFG + L + + + A+K+ + VK K Q+++ +ILQ
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLK--QVEHVLNEKRILQS-IR 59
Query: 65 IPNL--RWFGVEGDYNV-LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
P L + + D N+ LV++ + G L + A Q++ +E++H
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLH 118
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD-TATHQHIPYRENKNLTGTARY 179
S ++RD+KP+N L+ + I DFG AKR + T T L GT Y
Sbjct: 119 SLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGRTYT-----------LCGTPEY 164
Query: 180 AS--MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236
+ + G ++ D +LG +L+Y L G P+ Q YEKI E KV
Sbjct: 165 LAPEIILSKGYGKAV--DWWALG-ILIYEMLAGYPPF---FDDNPIQIYEKILEGKV--- 215
Query: 237 IEALCRGYPTEFASYFHY-CRSL 258
F S+F + L
Sbjct: 216 ----------RFPSFFSPDAKDL 228
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 62/237 (26%), Positives = 106/237 (44%), Gaps = 50/237 (21%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGI-----PN 67
KIG G+FG++Y G ++ N EVA+K ++ P K LQ + PN
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVK--TCRSTLPPDLKR----KFLQEAEILKQYDHPN 53
Query: 68 L-RWFGVEGD-YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSK 122
+ + GV + ++ L P L F +K L++K +L ++ +E++ SK
Sbjct: 54 IVKLIGVCVQKQPIYIVMELVPG-GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK 112
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-----YRDTATHQHIPYR----ENKNL 173
+ +HRD+ N L+G N + I DFG+++ Y + + IP + E N
Sbjct: 113 NCIHRDLAARNCLVGEN---NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALN- 168
Query: 174 TGTARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKI 228
RY S + D+ S G +L++ F G P+ G+ + +Q E+I
Sbjct: 169 --YGRYTSES-----------DVWSYG-ILLWETFSLGDTPYPGM---SNQQTRERI 208
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 56/232 (24%), Positives = 102/232 (43%), Gaps = 26/232 (11%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG-- 64
+ +G+G+FG ++L + + A+K+ + + Q Q+ ++L+ +
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 65 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSK 122
I L W + ++ P E LF++ S + S T L A +++ +E++HSK
Sbjct: 63 IIRLFW-TEHDQRFLYMLMEYVPGGE-LFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD-TATHQHIPYRENKNLTGTARYAS 181
++RD+KP+N L+ + + + DFG AK+ RD T T L GT Y +
Sbjct: 121 EIVYRDLKPENILLD---KEGHIKLTDFGFAKKLRDRTWT-----------LCGTPEYLA 166
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233
++ D +LG ++ L G P+ YEKI K+
Sbjct: 167 PEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD---DNPFGIYEKILAGKL 215
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 66/283 (23%), Positives = 118/283 (41%), Gaps = 37/283 (13%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQG 61
PR +L +K+G+G FGE+++GT N +VA+K T P+ EA++ K L+
Sbjct: 4 PR--ESLQLIKKLGNGQFGEVWMGT-WNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRH 60
Query: 62 GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
+ E Y V G L+ L + R L L ++ +A Q+ + ++
Sbjct: 61 DKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER 120
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
+++HRD++ N L+G G I DFGLA+ D Y + ++ +
Sbjct: 121 MNYIHRDLRSANILVGDGLVCK---IADFGLARLIEDNE------YTARQGAKFPIKWTA 171
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
L + + D+ S G +L + +G +P+ G+ + ++V +E
Sbjct: 172 PEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM------------NNREVLEQVE-- 217
Query: 241 CRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 275
RGY P C +++P + YL+ D
Sbjct: 218 -RGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 45/156 (28%), Positives = 72/156 (46%), Gaps = 17/156 (10%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY----EAKLYKILQGGTGIPNL- 68
+IG G++G +Y + + VA+K V+T L E L K L+ PN+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH-PNIV 65
Query: 69 RWFGV----EGDYNVLVIDLLGPSLEDLFNFCSR----KLSLKTVLMLADQMINRVEFVH 120
R V D V + +DL + + L +T+ L Q + ++F+H
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
+ +HRD+KP+N L+ G QV + DFGLA+ Y
Sbjct: 126 ANCIVHRDLKPENILVTSG---GQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 42/150 (28%), Positives = 68/150 (45%), Gaps = 12/150 (8%)
Query: 13 RKIGSGSFGEI----YLGTNIQTNEEVAIKL---ENVKTKHPQLQYEAKLYKILQGGTGI 65
R +G G FG++ Y N T E VA+K E + + E + K L +
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 66 PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSF 124
+G + +I P L L ++ + KL+L +L+ A Q+ + ++HS+ +
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVP-LGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHY 128
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+HRD+ N L+ V I DFGLAK
Sbjct: 129 IHRDLAARNVLL---DNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 45/150 (30%), Positives = 71/150 (47%), Gaps = 15/150 (10%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
LG IG G FG++ LG ++VA+K L++ T EA + L+ PNL
Sbjct: 10 LGATIGKGEFGDVMLGD--YRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRH----PNLV 63
Query: 69 RWFGV--EGDYNVLVIDLLGP-SLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSF 124
+ GV +G+ +V + + SL D R ++L L A + +E++ K+F
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF 123
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+HRD+ N L+ + DFGLAK
Sbjct: 124 VHRDLAARNVLVS---EDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 8e-07
Identities = 60/219 (27%), Positives = 92/219 (42%), Gaps = 22/219 (10%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQGG 62
FR+ +KIG G F E+Y T + VA+K L + K + ++ E L K L
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIK-EIDLLKQLNHP 62
Query: 63 TGIPNLRWFGVEGDYNVLVIDLLGPSLEDL---FNFCSRKLSLKTVLMLADQMINRVEFV 119
I F + + N+++ L + F R + KTV Q+ + +E +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 120 HSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
HS+ +HRDIKP N F+ G V + D GL + + T H +L GT
Sbjct: 123 HSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAH-------SLVGTPY 171
Query: 179 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217
Y S + + D+ SLG +L P+ G K
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 46/159 (28%), Positives = 80/159 (50%), Gaps = 20/159 (12%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTGIP 66
++LG IG+GSFG +Y I T+E+VAIK L++ + K+ +L L I I
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHI-----NII 122
Query: 67 NLR-WFGVE----GDYNV---LVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINR 115
L+ ++ E + N+ +V++ + ++ +R L L V + + Q+
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRA 182
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ ++HSK HRD+KP N L + + + + DFG AK
Sbjct: 183 LAYIHSKFICHRDLKPQNLL--IDPNTHTLKLCDFGSAK 219
|
Length = 440 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 45/173 (26%), Positives = 76/173 (43%), Gaps = 27/173 (15%)
Query: 14 KIGSGSFGEIYLGTNIQTNEE---VAIKLENVKTKHPQ------LQYEAKLYKILQGGTG 64
K+G GSFG + G + + VA+K +K+ L+ A ++ +
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKC--LKSDKLSDIMDDFLKEAAIMHSLDH---- 55
Query: 65 IPNL-RWFGVEGDYNV-LVIDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
NL R +GV + + +V +L LG L+ L + T+ A Q+ N + ++
Sbjct: 56 -ENLIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE 114
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 173
SK F+HRD+ N L+ ++V I DFGL + H Y ++L
Sbjct: 115 SKRFIHRDLAARNILLA---SDDKVKIGDFGLMRALPQNEDH----YVMEEHL 160
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-06
Identities = 39/159 (24%), Positives = 68/159 (42%), Gaps = 7/159 (4%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYE--AKLYKILQGGTGIPNLRW 70
R+IG GSFG +Y +++ +E VAIK + K +++ K + LQ +++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 71 FG--VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 128
G + LV++ S DL + L + + + + ++HS + +HRD
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 129 IKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167
+K N L+ V + DFG A PY
Sbjct: 141 VKAGNILL---SEPGLVKLGDFGSASIMAPANXFVGTPY 176
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 58/211 (27%), Positives = 87/211 (41%), Gaps = 30/211 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQ--LQYEAKLYKILQ 60
F++ +KIG G F +Y + VA+K E + K Q L+ E L K L
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQLD 60
Query: 61 GGTGIPN-LRWFGVEGDYNVLVIDLLGPSLEDL------FNFCSRKLSLKTVLMLADQMI 113
PN +++ + N L I L DL F R + +T+ Q+
Sbjct: 61 H----PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTATHQHIPYRENKN 172
+ +E +HSK +HRDIKP N + A V + D GL + + T H +
Sbjct: 117 SALEHMHSKRIMHRDIKPANVFIT----ATGVVKLGDLGLGRFFSSKTTAAH-------S 165
Query: 173 LTGTARYASMNTHLGIEQSRRDDLESLGYVL 203
L GT Y S + + D+ SLG +L
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLL 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 38/145 (26%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQ-LQYEAKLYKILQGGTGIPNLRWFG 72
+G G++G +Y ++ T +AIK + +++ Q L E L+ L+ + L
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 73 VEGDYNVLVIDLLGPSLEDLF--NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
G + + + + G SL L + K + +T++ Q++ ++++H +HRDIK
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIK 135
Query: 131 PDNFLMGLGRRANQVYIIDFGLAKR 155
DN L + + V I DFG +KR
Sbjct: 136 GDNVL--VNTYSGVVKISDFGTSKR 158
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 70/284 (24%), Positives = 125/284 (44%), Gaps = 49/284 (17%)
Query: 14 KIGSGSFGEIYLG--TNIQTNEEVAIKLENVKTKHPQLQYEA-KLYKILQGGTGIPNLRW 70
++GSG+FG + G ++ + VA+K+ P L+ E + ++Q +R
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 71 FGV-EGDYNVLVIDL--LGPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFL 125
G+ E + +LV++L LGP L F ++ ++ K + L Q+ ++++ +F+
Sbjct: 62 IGICEAESWMLVMELAELGP----LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFV 117
Query: 126 HRDIKPDNFLMGLGRRANQVY--IIDFGLAK------RYRDTATHQHIPYRENKNLTGTA 177
HRD+ N L+ Q Y I DFGL+K Y TH P +
Sbjct: 118 HRDLAARNVLL-----VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK--------- 163
Query: 178 RYAS--MNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKV 233
YA MN + + S + D+ S G VLM+ F G P++G+K Q E +++
Sbjct: 164 WYAPECMNYY---KFSSKSDVWSFG-VLMWEAFSYGQKPYKGMKGNEVTQMIES--GERM 217
Query: 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
+ P E C + D++P +A ++ R+ +
Sbjct: 218 ECP-----QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 48/172 (27%), Positives = 73/172 (42%), Gaps = 35/172 (20%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVK---TKHPQLQYEAK 54
PR N G+ +G+G+FG++ T +VA+K+ ++ L E K
Sbjct: 33 PR--NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK 90
Query: 55 LYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSL--------EDLFNFCSRK----LSL 102
+ L I NL G GP L DL NF RK L+L
Sbjct: 91 IMSHLGNHENIVNLLGACTIG----------GPILVITEYCCYGDLLNFLRRKRESFLTL 140
Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ +L + Q+ + F+ SK+ +HRD+ N L+ G+ I DFGLA+
Sbjct: 141 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVK---ICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 40/156 (25%), Positives = 68/156 (43%), Gaps = 30/156 (19%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQ----YEAKLYKILQGGTGIPNLR 69
KIG GS+G ++ N +T + VAIK P ++ E ++ K L+ PNL
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH----PNL- 62
Query: 70 WFGVEGDYNVLVIDLLGPSLEDLFNFCS-----------RKLSLKTVLMLADQMINRVEF 118
N++ + L +F +C R + + + Q + V F
Sbjct: 63 -------VNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNF 115
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
H + +HRD+KP+N L+ + Q+ + DFG A+
Sbjct: 116 CHKHNCIHRDVKPENILI---TKQGQIKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 51/182 (28%), Positives = 80/182 (43%), Gaps = 25/182 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGT 63
+ + L IG G+ +Y + NE+VAIK LE +T +L+ E +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNH-- 58
Query: 64 GIPNL-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRK-----LSLKTVLMLADQMIN 114
PN+ +++ V GD LV+ L G SL D+ + + TVL +++
Sbjct: 59 --PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL---KEVLK 113
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 174
+E++HS +HRDIK N L+G V I DFG++ D + K
Sbjct: 114 GLEYLHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSASLADGGDRTR---KVRKTFV 167
Query: 175 GT 176
GT
Sbjct: 168 GT 169
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 72/281 (25%), Positives = 121/281 (43%), Gaps = 45/281 (16%)
Query: 13 RKIGSGSFGEIYLGTNIQTNE---EVAIKL---ENVKTKHPQLQYEAKLYKILQGGTGIP 66
+++G G+FG + G + + EVA+K E++ + EA + L P
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDH----P 56
Query: 67 NL-RWFGV-EGDYNVLVIDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
+ R GV +G+ +LV++L LGP L+ L R++ + + LA Q+ + ++ SK
Sbjct: 57 CIVRLIGVCKGEPLMLVMELAPLGPLLKYLKK--RREIPVSDLKELAHQVAMGMAYLESK 114
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK------RYRDTATHQHIPYRENKNLTGT 176
F+HRD+ N L L R +Q I DFG+++ Y T P +
Sbjct: 115 HFVHRDLAARNVL--LVNR-HQAKISDFGMSRALGAGSDYYRATTAGRWPLK-------- 163
Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
YA + G S + D+ S G V ++ F G+ P+ +K + + E
Sbjct: 164 -WYAPECINYGK-FSSKSDVWSYG-VTLWEAFSYGAKPYGEMKG----AEVIAMLESGER 216
Query: 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 275
C P E S C R +D+P ++ L+ FR
Sbjct: 217 LPRPEEC---PQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 41/172 (23%), Positives = 71/172 (41%), Gaps = 37/172 (21%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-----------QLQYE--A 53
+L R IG G++G +Y + + E VA+K ++N + P L++
Sbjct: 11 KLNR-IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIV 69
Query: 54 KLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
+L +++ G D LV++ L L + S V L Q++
Sbjct: 70 ELKEVVVGK-----------HLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLL 118
Query: 114 NRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKRYRDTATH 162
++++H +HRD+K N L+ G + I DFGLA+ Y A
Sbjct: 119 RGLQYLHENFIIHRDLKVSNLLLTDKGC------LKIADFGLARTYGLPAKP 164
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 41/155 (26%), Positives = 78/155 (50%), Gaps = 10/155 (6%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
F L ++IGSG++G++Y N+ T E AIK+ ++ + ++ I+ N+
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEI--IMMKDCKHSNI 68
Query: 69 -RWFGVEGDYNVLVIDLL---GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
+FG + L I + G SL+D+++ + LS + ++ + + + ++HSK
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYH-VTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
+HRDIK N L+ V + DFG++ + T
Sbjct: 128 MHRDIKGANILL---TDNGHVKLADFGVSAQITAT 159
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 53/233 (22%), Positives = 85/233 (36%), Gaps = 57/233 (24%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--------------------TKH 46
F++ ++G G +G+++L T E VA+K TK
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 47 PQLQYEAKLYKILQGGTGIPNLRWFGVE----GDYNVLVIDLLGPSLEDLFNFCSRKLSL 102
L KL Q + +E GD+ L+ +L LS
Sbjct: 61 EWL---VKLLYAFQD----DEYLYLAMEYVPGGDFRTLLNNL-------------GVLSE 100
Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162
+M V+ +H ++HRD+KP+NFL+ + + + DFGL+K A
Sbjct: 101 DHARFYMAEMFEAVDALHELGYIHRDLKPENFLID---ASGHIKLTDFGLSKGIVTYA-- 155
Query: 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
++ G+ Y + G D SLG +L FL G P+ G
Sbjct: 156 --------NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSG 200
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 3e-06
Identities = 21/67 (31%), Positives = 35/67 (52%), Gaps = 4/67 (5%)
Query: 91 DLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148
DLF+ KLS V + Q++ + +H + +H DIK +N L R +++Y+
Sbjct: 95 DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL--YDRAKDRIYLC 152
Query: 149 DFGLAKR 155
D+GL K
Sbjct: 153 DYGLCKI 159
|
Length = 267 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 45/158 (28%), Positives = 81/158 (51%), Gaps = 16/158 (10%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQGGTGIPNL-RW 70
K+G G +GE+Y G + + VA+K E+ L+ EA + K ++ PNL +
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMKEIKH----PNLVQL 67
Query: 71 FGV---EGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLH 126
GV E + ++ + +L D C+R+ ++ +L +A Q+ + +E++ K+F+H
Sbjct: 68 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 127
Query: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYR-DTATHQ 163
RD+ N L+G + V + DFGL++ DT T
Sbjct: 128 RDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 162
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 62/218 (28%), Positives = 95/218 (43%), Gaps = 24/218 (11%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEA-KLYKILQGGTGIP 66
++ + +KIG GSFG+IYL +E IK ++ TK P + EA K IL P
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDL-TKMPVKEKEASKKEVILLAKMKHP 59
Query: 67 NL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN-------RVEF 118
N+ +F + L I + DL +R+ + VL DQ+++ ++
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQ---RGVLFSEDQILSWFVQISLGLKH 116
Query: 119 VHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
+H + LHRDIK N FL G A + DFG+A++ D+ GT
Sbjct: 117 IHDRKILHRDIKSQNIFLSKNGMVAK---LGDFGIARQLNDSMELA-------YTCVGTP 166
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
Y S + + D+ SLG VL P++G
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 50/217 (23%), Positives = 93/217 (42%), Gaps = 25/217 (11%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKI-LQGGTGIPN 67
F++ +K+G GS+G +Y + N+ A+K ++ + Q + E + +I + PN
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPN 60
Query: 68 LRWFGVEG--DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVL------MLADQMINRVEFV 119
+ + E D N L I + DL S++ + ++ + Q++ ++ +
Sbjct: 61 IISYK-EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYII-DFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
H + LHRD+K N L AN + I D G++K + K GT
Sbjct: 120 HEQKILHRDLKSANIL----LVANDLVKIGDLGISKVLKKNMA---------KTQIGTPH 166
Query: 179 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
Y + G S + D+ SLG +L + P++
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 43/154 (27%), Positives = 77/154 (50%), Gaps = 20/154 (12%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQY-EAKLYKILQGGTGIP 66
+GSG++G++ + +T +VAIK ++ H + Y E +L K + I
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYRELRLLKHMDHENVIG 78
Query: 67 NLRWF----GVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
L F +E +V LV L+G L ++ +KLS + L Q++ ++++HS
Sbjct: 79 LLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK--CQKLSDDHIQFLVYQILRGLKYIHS 136
Query: 122 KSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAK 154
+HRD+KP N + + ++ I+DFGLA+
Sbjct: 137 AGIIHRDLKPSN----IAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 4e-06
Identities = 45/176 (25%), Positives = 80/176 (45%), Gaps = 12/176 (6%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
K+G G++ ++ G + T VA I+LE+ + E L K L+ I L
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN-IVTLHD 71
Query: 71 FGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
LV + L L+ + C +S+ V + Q++ + + H + LHRD+K
Sbjct: 72 IVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLK 131
Query: 131 PDNFLMGLGRRANQVYIIDFGLAK-RYRDTATHQH----IPYRENKNLTGTARYAS 181
P N L+ ++ + DFGLA+ + T T+ + + YR L G++ Y++
Sbjct: 132 PQNLLIN---ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 18/203 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHPQLQYEAKLYKILQG 61
NKF + +G G++G + + +T E VAIK EN + K L+ E K+ + L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQ 59
Query: 62 GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
+ F G LV + + ++ +L + + V Q+I + + H
Sbjct: 60 ENIVELKEAFRRRGKL-YLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK 118
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
+HRDIKP+N L+ N V + DFG A+ + + + Y T Y
Sbjct: 119 NDIVHRDIKPENLLIS----HNDVLKLCDFGFARNLSEGSNANYTEY------VATRWYR 168
Query: 181 SMNTHLGIEQSRRDDLESLGYVL 203
S LG + D+ S+G +L
Sbjct: 169 SPELLLGAPYGKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 56/229 (24%), Positives = 105/229 (45%), Gaps = 37/229 (16%)
Query: 11 LGRKIGSGSFGEIYLGT--NIQ-TNEEVAIKLENVK----TKHPQLQYEAKLYKILQGGT 63
L R++G G+FG+++L N+ T +++ + ++ +K Q EA+L LQ
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 64 GIPNLRWFGV--EGDYNVLVIDLL------------GPSLEDLFNFCSRK----LSLKTV 105
+ +++GV +GD ++V + + GP L + R+ L L +
Sbjct: 69 IV---KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 165
L +A Q+ + + ++ S+ F+HRD+ N L+G V I DFG++ RD + +
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANL---LVKIGDFGMS---RDVYSTDY- 178
Query: 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPW 213
YR + R+ + + + + D+ S G +L F G PW
Sbjct: 179 -YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 37/162 (22%), Positives = 77/162 (47%), Gaps = 19/162 (11%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKI 58
VG++++ IGSG++G + + ++ ++VAIK + L+ E K+ +
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRH 60
Query: 59 LQGGTGIPNLRWF---GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
+ I G + +V+DL+ L + + L+ + + Q++
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHII-HSDQPLTEEHIRYFLYQLLRG 119
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQ---VYIIDFGLAK 154
++++HS + +HRD+KP N L+ N+ + I DFG+A+
Sbjct: 120 LKYIHSANVIHRDLKPSNLLV------NEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 6e-06
Identities = 42/148 (28%), Positives = 67/148 (45%), Gaps = 13/148 (8%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYE--AKLYKILQGGTGIPNLRW 70
R+IG GSFG +Y +++TNE VAIK + K +++ K + LQ PN
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH-PNTIE 79
Query: 71 FGVEGDY-----NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
+ +G Y LV++ S D+ + L + + + + ++HS +
Sbjct: 80 Y--KGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERI 137
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLA 153
HRDIK N L+ V + DFG A
Sbjct: 138 HRDIKAGNILL---TEPGTVKLADFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 6e-06
Identities = 21/49 (42%), Positives = 29/49 (59%), Gaps = 1/49 (2%)
Query: 111 QMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRD 158
Q++N V ++HS LHRD+KP N +MG G V I D GLA+ +
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 45/177 (25%), Positives = 82/177 (46%), Gaps = 14/177 (7%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
K+G G++ ++ G + T VA I+LE+ + E L K L+ I L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHAN-IVTLHD 70
Query: 71 FGVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
+ + + LV + L L+ + C +S+ V + Q++ + + H + LHRD+
Sbjct: 71 I-IHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDL 129
Query: 130 KPDNFLMGLGRRANQVYIIDFGLAK-RYRDTATHQH----IPYRENKNLTGTARYAS 181
KP N L+ ++ + DFGLA+ + T T+ + + YR L G+ Y++
Sbjct: 130 KPQNLLIN---EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|225023 COG2112, COG2112, Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 8e-06
Identities = 44/192 (22%), Positives = 71/192 (36%), Gaps = 38/192 (19%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFG 72
+++ G+ +YLG EVA+K+ + L+ EAK+ +IL G P + ++G
Sbjct: 28 KELAKGTTSVVYLGE--WRGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYG 85
Query: 73 VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTV---LMLADQMINRVEFVHSKSFLHRDI 129
+ + + + G L L RK L+ + L I E + +
Sbjct: 86 ED---FIRMEYIDGRPLGKLEIGGDRKHLLRVLEKAYKLDRLGIEHGELSRPWKNV---L 139
Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE 189
D VYIIDF D+AT + P +N+T L E
Sbjct: 140 VND----------RDVYIIDF-------DSATFKKKP----RNVTQALSL------LFRE 172
Query: 190 QSRRDDLESLGY 201
R + GY
Sbjct: 173 GLRIEKTILRGY 184
|
Length = 201 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 44/176 (25%), Positives = 80/176 (45%), Gaps = 12/176 (6%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
K+G G++ +Y G + T+ VA I+LE+ + E L K L+ +
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 71 FGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130
E LV + L L+ + C +++ V + Q++ + + H + LHRD+K
Sbjct: 73 IHTEKSLT-LVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLK 131
Query: 131 PDNFLMGLGRRANQVYIIDFGLAK-RYRDTATHQH----IPYRENKNLTGTARYAS 181
P N L+ ++ + DFGLA+ + T T+ + + YR L G+ Y++
Sbjct: 132 PQNLLIN---ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 8e-06
Identities = 45/150 (30%), Positives = 70/150 (46%), Gaps = 17/150 (11%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-QLQYEAK-------LYKILQGGTGIP 66
+GSG++G + + +T E+VAIK K P Q + AK L K +Q I
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIK----KLSRPFQSEIFAKRAYRELTLLKHMQHENVIG 78
Query: 67 NLRWFGVEGDYNVLV-IDLLGPSLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
L F + L+ P ++ DL LS V L QM+ ++++HS
Sbjct: 79 LLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGI 138
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+HRD+KP N + ++ I+DFGLA+
Sbjct: 139 IHRDLKPGNLAVN---EDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 57/191 (29%), Positives = 80/191 (41%), Gaps = 47/191 (24%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTKHPQL-----QYEAKL 55
+ IG G+FGE+ L + TN A+K +VK + L ++ KL
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 56 YKILQGGTGIPNLRWFGVE----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
Y Q NL +F ++ GD L+I L G EDL F +L+
Sbjct: 67 YYSFQDKD---NL-YFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCA-------- 113
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
+E VH F+HRDIKPDN L+ R + + DFGL +R TH Y++
Sbjct: 114 ----IESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFR--WTHDSKYYQKG- 163
Query: 172 NLTGTARYASM 182
R SM
Sbjct: 164 ---DHHRQDSM 171
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 52/203 (25%), Positives = 82/203 (40%), Gaps = 58/203 (28%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP----NL 68
R IG G+FG ++ T+ + + VA+K K+ + Q L
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKRVALK---------------KMPNVFQNLVSCKRVFREL 50
Query: 69 RWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD----------------- 110
+ NVL +D+L P D F ++ + T LM +D
Sbjct: 51 KMLCFFKHDNVLSALDILQPPHIDPF----EEIYVVTELMQSDLHKIIVSPQPLSSDHVK 106
Query: 111 ----QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTATHQHI 165
Q++ ++++HS LHRDIKP N L+ +N + I DFGLA R + +H+
Sbjct: 107 VFLYQILRGLKYLHSAGILHRDIKPGNLLVN----SNCVLKICDFGLA-RVEEPDESKHM 161
Query: 166 P-------YRENKNLTGTARYAS 181
YR + L G+ Y S
Sbjct: 162 TQEVVTQYYRAPEILMGSRHYTS 184
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 8e-06
Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 19/158 (12%)
Query: 11 LGRKIGSGSFGEIYLGTNI-QTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
LGR IG G FG++Y G + NE++A+ ++ K E K LQ +
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVRE----KFLQEAYIMRQFD 65
Query: 69 -----RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVH 120
+ GV + V ++ L P L +L ++ L L ++++ + Q+ + ++
Sbjct: 66 HPHIVKLIGVITENPVWIVMELAP-LGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE 124
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
SK F+HRDI N L+ + V + DFGL+ RY +
Sbjct: 125 SKRFVHRDIAARNVLVS---SPDCVKLGDFGLS-RYLE 158
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 9e-06
Identities = 65/245 (26%), Positives = 101/245 (41%), Gaps = 52/245 (21%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQGGTG 64
F +G +G+GSFG + + + T E AIK E +K K Q+Q+ A+ IL
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMK--QVQHVAQEKSILM---- 73
Query: 65 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKL---SLKTVLMLADQMINRV----- 116
E + +V + E+ F + L T L A + N V
Sbjct: 74 ---------ELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYH 124
Query: 117 -------EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD-TATHQHIPYR 168
E++HSK ++RD+KP+N L L + + V + DFG AK+ D T T
Sbjct: 125 AELVLAFEYLHSKDIIYRDLKPENLL--LDNKGH-VKVTDFGFAKKVPDRTFT------- 174
Query: 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228
L GT Y + + D ++G +L F+ G P+ T + YEKI
Sbjct: 175 ----LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD---DTPFRIYEKI 227
Query: 229 SEKKV 233
++
Sbjct: 228 LAGRL 232
|
Length = 329 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 9e-06
Identities = 36/158 (22%), Positives = 54/158 (34%), Gaps = 8/158 (5%)
Query: 296 QQSQVSTPARAIGPGAGPSSGMP-PAAANVDRQSGAEEGRHTGWSSADPSRRRNSGP--- 351
S S+ + + G G GP + P P A + + E S+ P +S
Sbjct: 234 ASSSDSSSSESSGCGWGPENECPLPRPAPITLPTRIWEASGWNGPSSRPGPASSSSSPRE 293
Query: 352 LGNSANLSKQKSPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSR 411
S + S S A + + SS R S SS + S A V PSR
Sbjct: 294 RSPSPSPSSPGSGPAPSSPRASSSSSSS----RESSSSSTSSSSESSRGAAVSPGPSPSR 349
Query: 412 PRTTDASPGAFQKISSGQRSSPVVSSENRHTTSGRSTS 449
+ P S +R P + + ++GR T
Sbjct: 350 SPSPSRPPPPADPSSPRKRPRPSRAPSSPAASAGRPTR 387
|
Length = 1352 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 9e-06
Identities = 50/213 (23%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLQYEAKLYKI-LQGGTGIP 66
G+++G+G+F Y +++T +A+K + N ++ ++ EA +I L P
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEV-VEALRKEIRLMARLNHP 63
Query: 67 NL-RWFGV---EGDYNVLVIDLLGPSLEDLF-NFCSRKLSLKTVLMLADQMINRVEFVHS 121
++ R G + +N+ V + G S+ L + + K ++ ++ +Q++ + ++H
Sbjct: 64 HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAV--IINYTEQLLRGLSYLHE 121
Query: 122 KSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
+HRD+K N L+ G+R + I DFG A R T L GT +
Sbjct: 122 NQIIHRDVKGANLLIDSTGQR---LRIADFGAAARLAAKGTGAG---EFQGQLLGTIAFM 175
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
+ G + R D+ S+G V++ PW
Sbjct: 176 APEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 45/164 (27%), Positives = 69/164 (42%), Gaps = 33/164 (20%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTKHPQL-----QYEAKL 55
+ +G G+FGE+ L + T A+K + +VK + L ++ +L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 56 YKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
Y Q + + + GD L+I + G EDL F ++
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRM-GIFPEDLARF------------YIAELTCA 113
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
VE VH F+HRDIKPDN L+ R + + DFGL +R T
Sbjct: 114 VESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFRWT 154
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 43/146 (29%), Positives = 67/146 (45%), Gaps = 9/146 (6%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTK--HPQLQYEAKLYKILQGGTGIPNL 68
+ +G G+FG + + T + VAIK ++ T + E KL K L+ I
Sbjct: 16 QPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLS 75
Query: 69 RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRD 128
F + V +LLG L L SR L + + Q++ +++VHS +HRD
Sbjct: 76 DIFISPLEDIYFVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRD 133
Query: 129 IKPDNFLMGLGRRANQVYIIDFGLAK 154
+KP N L+ + I DFGLA+
Sbjct: 134 LKPSNILIN---ENCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 43/164 (26%), Positives = 79/164 (48%), Gaps = 22/164 (13%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP--------QLQYEAKLY 56
V +++R +++GSG++G + + +T +VAIK K P + E +L
Sbjct: 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIK----KLYRPFQSELFAKRAYRELRLL 68
Query: 57 KILQGGTGIPNLRWFGVE---GDYN--VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
K ++ I L F + ++ LV+ +G L L KLS + L Q
Sbjct: 69 KHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQ 126
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
M+ ++++H+ +HRD+KP N + ++ I+DFGLA++
Sbjct: 127 MLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQ 167
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 44/172 (25%), Positives = 78/172 (45%), Gaps = 42/172 (24%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEE--VAIK-LENVKTKHPQLQYEAKLYKILQGGTGI 65
+ L +++G G++G + N +T+EE VAIK + NV +K + + K+L+ G
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 66 PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD--------------- 110
N+ + D ++ +F +L L LM AD
Sbjct: 62 KNITC----------LYD-----MDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAH 106
Query: 111 ------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
Q++ ++++HS + LHRD+KP N L+ ++ I DFGLA+ +
Sbjct: 107 FQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNAD---CELKICDFGLARGF 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 65/272 (23%), Positives = 115/272 (42%), Gaps = 43/272 (15%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----LQYEAKLYKILQGGTGIPNL- 68
+G G+FGE++ GT ++ VA+K K PQ EA++ K PN+
Sbjct: 3 LGKGNFGEVFKGT-LKDKTPVAVK--TCKEDLPQELKIKFLSEARILKQYDH----PNIV 55
Query: 69 RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFL 125
+ GV + I + D +F +K L K ++ A + ++ SK+ +
Sbjct: 56 KLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCI 115
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD----TATHQHIPYR-ENKNLTGTARYA 180
HRD+ N L+G N + I DFG++++ D ++ + IP + RY+
Sbjct: 116 HRDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 181 SMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
S D+ S G +L F G P+ G+ T +Q E++ EK S
Sbjct: 173 S-----------ESDVWSYGILLWETFSLGVCPYPGM---TNQQAREQV-EKGYRMSCPQ 217
Query: 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271
C P + C + +++P ++ L++
Sbjct: 218 KC---PDDVYKVMQRCWDYKPENRPKFSELQK 246
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 47/202 (23%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTGIPNLRWF 71
KIG GS G + + + +VA+K+ +++ + + L E + + Q + + +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 72 GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 131
V + VL+ L G +L D+ + +L+ + + + + ++ + ++HS+ +HRDIK
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145
Query: 132 DNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQS 191
D+ L+ L R V + DFG + + +P R K+L GT + +
Sbjct: 146 DSILLTLDGR---VKLSDFGFCAQ-----ISKDVPKR--KSLVGTPYWMAPEVISRTPYG 195
Query: 192 RRDDLESLGYVLMYFLRGSLPW 213
D+ SLG +++ + G P+
Sbjct: 196 TEVDIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 71/281 (25%), Positives = 120/281 (42%), Gaps = 53/281 (18%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
+++GSG FG ++LG + +VAIK+ E ++ ++ EAK+ L PNL
Sbjct: 8 FLKELGSGQFGVVHLG-KWRGKIDVAIKMIREGAMSEDDFIE-EAKVMMKLSH----PNL 61
Query: 69 -RWFGVEGDYNVLVIDLLGPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSKSF 124
+ +GV + I + L N+ KL + +L + + +E++ S F
Sbjct: 62 VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGF 121
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT---ARYAS 181
+HRD+ N L+G N V + DFGLA+ D + + GT ++A
Sbjct: 122 IHRDLAARNCLVG---EDNVVKVSDFGLARYVLDD---------QYTSSQGTKFPVKWAP 169
Query: 182 MNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
S + D+ S G VLM+ F G +P YE+ S +V +E+
Sbjct: 170 PEVFDYSRFSSKSDVWSFG-VLMWEVFSEGKMP------------YERFSNSEV---VES 213
Query: 240 LCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRL 272
+ GY PTE + + C + +D+P + L
Sbjct: 214 VSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 67/251 (26%), Positives = 106/251 (42%), Gaps = 48/251 (19%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK---TKHPQLQYEAKLYKILQGGTG 64
K LG IG G FG + G T ++VA+K N+K T L+ A + K+
Sbjct: 7 KLTLGEIIGEGEFGAVLQGE--YTGQKVAVK--NIKCDVTAQAFLEETAVMTKLHH---- 58
Query: 65 IPNL-RWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRK----LSLKTVLMLADQMINRV 116
NL R GV G Y +V++L+ S +L NF + +S+ +L + + +
Sbjct: 59 -KNLVRLLGVILHNGLY--IVMELM--SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
E++ SK +HRD+ N L+ + DFGLA+ + +P + T
Sbjct: 114 EYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGSMGVDNSKLPVK------WT 164
Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236
A A + S + D+ S G +L W+ G + Y K+S K+V
Sbjct: 165 APEALKHKKF----SSKSDVWSYGVLL---------WEVFSYG--RAPYPKMSLKEVKEC 209
Query: 237 IEALCRGYPTE 247
+E R P E
Sbjct: 210 VEKGYRMEPPE 220
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-05
Identities = 49/161 (30%), Positives = 75/161 (46%), Gaps = 37/161 (22%)
Query: 15 IGSGSFGEI----Y--LGTNIQTNEEVAIK-LENVKTKHPQ-LQYEAKLYKILQG----- 61
+G G+FG + Y L N T E VA+K L++ +H + + E ++ K LQ
Sbjct: 12 LGKGNFGSVELCRYDPLQDN--TGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 62 ------GTGIPNLRWFGVEGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMI 113
G NLR LV++ L P SL D +L + +L+ A Q+
Sbjct: 70 YKGVCYSAGRRNLR----------LVMEYL-PYGSLRDYLQKHRERLDHRKLLLYASQIC 118
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+E++ SK ++HRD+ N L+ N+V I DFGL K
Sbjct: 119 KGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTK 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 42/158 (26%), Positives = 78/158 (49%), Gaps = 14/158 (8%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIP 66
+ L +++GSG++G++Y N+ T E A+K+ ++ +Q E + K + +
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVA 70
Query: 67 NLRWFGVEGDYNVLVIDLL---GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
+FG L I + G SL+D+++ + LS + + + + + ++HSK
Sbjct: 71 ---YFGSYLSREKLWICMEYCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
+HRDIK N L+ V + DFG+A + TAT
Sbjct: 127 KMHRDIKGANILL---TDNGDVKLADFGVAAKI--TAT 159
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 3e-05
Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 14/156 (8%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQY-EAKLYKILQGGTGIPNLRW 70
+GSG++G + + +T VA+K + + H + Y E +L K ++ I L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 71 FGVEGDYN-----VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
F LV L+G L ++ +KL+ V L Q++ ++++HS +
Sbjct: 85 FTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADII 142
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
HRD+KP N + ++ I+DFGLA+ D T
Sbjct: 143 HRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT 175
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 70/288 (24%), Positives = 114/288 (39%), Gaps = 61/288 (21%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LEN----VKTKHPQLQ 50
++ L ++IGSG FG ++LG +VAIK +E +K HP+L
Sbjct: 4 SELTLVQEIGSGQFGLVWLGY-WLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKL- 61
Query: 51 YEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLA 109
+LY + + I LV + + L D K S +T+L +
Sbjct: 62 --VQLYGVCTERSPI-------------CLVFEFMEHGCLSDYLRAQRGKFSQETLLGMC 106
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKRYRDTATHQHIPYR 168
+ + ++ S + +HRD+ N L+G NQV + DFG+ + D Y
Sbjct: 107 LDVCEGMAYLESSNVIHRDLAARNCLVG----ENQVVKVSDFGMTRFVLDDQ------YT 156
Query: 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228
+ +++S + S + D+ S G VLM W+ G K YE
Sbjct: 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFG-VLM--------WEVFSEG--KTPYENR 205
Query: 229 SEKKVSTSIEALCRGYPTEFAS-----YFHYCRSLRFDDKPDYAYLKR 271
S +V +I A R Y AS +C R +D+P ++ L
Sbjct: 206 SNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLH 253
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 58/236 (24%), Positives = 98/236 (41%), Gaps = 56/236 (23%)
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 168
A +++ ++F+HSK ++RD+K DN ++ R + I DFG+ K +++ +
Sbjct: 102 AAEIVCGLQFLHSKGIIYRDLKLDNVMLD---RDGHIKIADFGMCK--------ENV-FG 149
Query: 169 ENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 226
+N+ T GT Y + G++ + D S G +L L G P+ G + + +E
Sbjct: 150 DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG---DDEDELFE 206
Query: 227 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF-RDLFIREGF--- 282
I +V T HY R + + K L++LF RD R G
Sbjct: 207 SI---RVDTP----------------HYPRWITKESKD---ILEKLFERDPTRRLGVVGN 244
Query: 283 ----QFDYVFDWTILKYQQSQVSTPARAIGPGAGPSSGMPPAAANVDRQSGAEEGR 334
F +WT L+ R + P P P +N DR+ +E+ R
Sbjct: 245 IRGHPFFKTINWTALE---------KRELDPPFKPKVKSPSDYSNFDREFLSEKPR 291
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 32/144 (22%), Positives = 69/144 (47%), Gaps = 5/144 (3%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY--EAKLYKILQGGTGIPNLRWF 71
++G G+FG++Y N +T A K+ K++ Y E ++ + L F
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 72 GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 131
+G +++ G +++ + R L+ + ++ QM+ ++++HS +HRD+K
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKA 138
Query: 132 DNFLMGLGRRANQVYIIDFGLAKR 155
N L+ L + + DFG++ +
Sbjct: 139 GNVLLTLD---GDIKLADFGVSAK 159
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 39/170 (22%), Positives = 82/170 (48%), Gaps = 19/170 (11%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQG 61
P + + + IG G++G+++ N + + A+K L+ + +++ E Y IL+
Sbjct: 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAE---YNILKA 70
Query: 62 GTGIPNL-RWFG-------VEGDYNVLVIDLL-GPSLEDLFN-FCSR--KLSLKTVLMLA 109
+ PN+ +++G GD LV++L G S+ DL F R ++ + +
Sbjct: 71 LSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYIL 130
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
+ + ++ +H +HRD+K +N L+ V ++DFG++ + T
Sbjct: 131 HEALMGLQHLHVNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQLTST 177
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 60/228 (26%), Positives = 103/228 (45%), Gaps = 36/228 (15%)
Query: 14 KIGSGSFGEIYLG--TNIQTNEE---VAIKL--ENVKTKHPQLQYEAKLYKILQGGTGIP 66
++G G+FG+++L N+ ++ VA+K E ++ Q EA+L +LQ +
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIV- 70
Query: 67 NLRWFGV--EGDYNVLVIDLL------------GPS---LEDLFNFCSRKLSLKTVLMLA 109
R++GV EG ++V + + GP L + +L+L +L +A
Sbjct: 71 --RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 169
Q+ + + ++ S F+HRD+ N L+G G V I DFG++ RD + + YR
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGL---VVKIGDFGMS---RDIYSTDY--YRV 180
Query: 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPWQGL 216
R+ + L + + D+ S G VL F G PW L
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 38/138 (27%), Positives = 67/138 (48%), Gaps = 18/138 (13%)
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI--PYR 168
QM+ ++ +HS +HRD+KP N ++ + + I+DFGLA+ TA + PY
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR----TACTNFMMTPY- 182
Query: 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228
T Y + LG+ D+ S+G ++ ++GS+ +QG ++ K+
Sbjct: 183 -----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD---HIDQWNKV 234
Query: 229 SEKKVSTSIEALCRGYPT 246
E+ + S E + R PT
Sbjct: 235 IEQLGTPSAEFMNRLQPT 252
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 69/284 (24%), Positives = 116/284 (40%), Gaps = 48/284 (16%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGIPNL 68
+L +K+G+G FGE+++G + +VA+K T Q EA L K LQ +
Sbjct: 9 KLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLV--- 64
Query: 69 RWFGV----EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
R + V E Y + G L+ L + K+ L ++ + Q+ + ++ K++
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN--LTGTARYASM 182
+HRD++ N L+ + I DFGLA+ D RE + TA A
Sbjct: 125 IHRDLRAANVLVS---ESLMCKIADFGLARVIED----NEYTAREGAKFPIKWTAPEAIN 177
Query: 183 NTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
I + D+ S G +L+Y G +P+ G+ S + AL
Sbjct: 178 FGSFTI----KSDVWSFG-ILLYEIVTYGKIPYPGMSN---------------SDVMSAL 217
Query: 241 CRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276
RGY P E C + +++P + YL+ + D
Sbjct: 218 QRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 47/171 (27%), Positives = 81/171 (47%), Gaps = 29/171 (16%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKILQGG 62
++++ IG GS+G + + T E+VAIK E+V L+ E KL ++L+
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHP 59
Query: 63 TGI--------PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
+ P+ R F D V V +L+ L + + L+ + Q++
Sbjct: 60 DIVEIKHIMLPPSRREFK---DIYV-VFELMESDLHQVIK-ANDDLTPEHHQFFLYQLLR 114
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRAN---QVYIIDFGLAK-RYRDTAT 161
++++H+ + HRD+KP N L AN ++ I DFGLA+ + DT T
Sbjct: 115 ALKYIHTANVFHRDLKPKNIL------ANADCKLKICDFGLARVAFNDTPT 159
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 41/153 (26%), Positives = 64/153 (41%), Gaps = 11/153 (7%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTKHPQLQYEAKLYKILQGGTG 64
+ +GSG+FG +Y G I E VAIK+ +T P+ E +
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVD 67
Query: 65 IPNL-RWFGVEGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
P++ R G+ V +I L P L D + + +L Q+ + ++
Sbjct: 68 HPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE 127
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
K +HRD+ N L+ + V I DFGLAK
Sbjct: 128 KRLVHRDLAARNVLV---KTPQHVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 39/168 (23%), Positives = 61/168 (36%), Gaps = 53/168 (31%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKL-------------------------ENVKTKHPQ 48
K+G G++ +Y G N T E VA+K EN+ H
Sbjct: 7 KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66
Query: 49 LQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLF--NFCSRKLSLKTVL 106
+ E KL +LV + + L+ + L TV
Sbjct: 67 IHTENKL-----------------------MLVFEYMDKDLKKYMDTHGVRGALDPNTVK 103
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
Q++ + F H LHRD+KP N L+ + ++ + DFGLA+
Sbjct: 104 SFTYQLLKGIAFCHENRVLHRDLKPQNLLIN---KRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 30/113 (26%), Positives = 54/113 (47%), Gaps = 21/113 (18%)
Query: 116 VEFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAK------------RYRDTATH 162
+E++H+ +HRD+KPDN L+ +G + + DFGL+K + + T
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMG----HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169
Query: 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+ + +K + GT Y + L + D ++G +L FL G +P+ G
Sbjct: 170 EFL----DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 63/288 (21%)
Query: 14 KIGSGSFGEIYLGTNIQTNEE--VAIKL---ENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
++GSG+FG + G ++ VAIK+ EN K+ ++ EA++ L P +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDN----PYI 57
Query: 69 -RWFGV-EGDYNVLVIDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFVHS 121
R GV E + +LV+++ GP L F S K +++ V+ L Q+ ++++
Sbjct: 58 VRMIGVCEAEALMLVMEMASGGP----LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG 113
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVY--IIDFGLAK------RYRDTATHQHIPYRENKNL 173
K+F+HRD+ N L+ NQ Y I DFGL+K Y + P +
Sbjct: 114 KNFVHRDLAARNVLL-----VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK----- 163
Query: 174 TGTARYAS--MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231
YA +N + S R D+ S G + W+ G K Y+K+
Sbjct: 164 ----WYAPECINFR---KFSSRSDVWSYGITM---------WEAFSYGQK--PYKKMKGP 205
Query: 232 KVSTSIEALCR-----GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 274
+V + IE R P E + C +++D+P++A ++ R
Sbjct: 206 EVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMR 253
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 7e-05
Identities = 33/112 (29%), Positives = 52/112 (46%), Gaps = 19/112 (16%)
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167
+A Q+++ + ++H + +HRDIKP N L+ + V I DFG+++ T P
Sbjct: 173 VARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN---VKIADFGVSRILAQTMD----PC 225
Query: 168 RENKNLTGTARYAS---MNTHLGIEQSRRD----DLESLGYVLMYFLRGSLP 212
+ GT Y S +NT L D D+ SLG ++ F G P
Sbjct: 226 NSS---VGTIAYMSPERINTDL--NHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 52/211 (24%), Positives = 87/211 (41%), Gaps = 31/211 (14%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN---VKTKHPQLQYEAKLYKILQGGTG 64
++ L +++G GSFG +YL + + E +K+ V +P +A L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 65 IPNLRWFG---VEGDYNVLVIDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVE 117
P + F +E D ++ + G L+ + LS V Q++ V
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQHIPYRENKNLT 174
++H + LHRD+K N + + N + I DFG+++ D AT T
Sbjct: 121 YMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLMGSCDLAT----------TFT 166
Query: 175 GTARYASMN--THLGIEQSRRDDLESLGYVL 203
GT Y S H G + + D+ SLG +L
Sbjct: 167 GTPYYMSPEALKHQGYDS--KSDIWSLGCIL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 8e-05
Identities = 39/168 (23%), Positives = 69/168 (41%), Gaps = 47/168 (27%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----------------KHPQLQ--YEAKL 55
+G G+FG++Y + +T A K+ +++ KHP + YEA
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 56 YKILQGGTGIPNLRWFGVE----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
Y+ L W +E G + ++++L E + R Q
Sbjct: 73 YE--------NKL-WILIEFCDGGALDSIMLELERGLTEPQIRYVCR------------Q 111
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
M+ + F+HS +HRD+K N L+ L V + DFG++ + + T
Sbjct: 112 MLEALNFLHSHKVIHRDLKAGNILLTL---DGDVKLADFGVSAKNKST 156
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 9e-05
Identities = 49/191 (25%), Positives = 80/191 (41%), Gaps = 56/191 (29%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLY------- 56
VG +++ IG G++G + T+ T +VAIK K P +E + +
Sbjct: 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK------KISP---FEHQTFCQRTLRE 53
Query: 57 -KILQGGTGIPNLRWFGVEGDYNVLVI-DLLGPSLEDLFN----------------FCSR 98
KIL R F E N++ I D++ P + FN ++
Sbjct: 54 IKIL---------RRFKHE---NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQ 101
Query: 99 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYR 157
LS + Q++ ++++HS + LHRD+KP N L+ N + I DFGLA+
Sbjct: 102 HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN----TNCDLKICDFGLAR--- 154
Query: 158 DTATHQHIPYR 168
A +H
Sbjct: 155 -IADPEHDHTG 164
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 60/222 (27%), Positives = 93/222 (41%), Gaps = 23/222 (10%)
Query: 2 EPRVGNK-----FRLGRKIGSGSFGEIYLGTNIQTN-EEVAIK-LENVKT-KHPQLQYEA 53
EP+ NK F R +G+GSFG + L T + VAIK E K K Q+ +
Sbjct: 20 EPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF 79
Query: 54 KLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVL--MLADQ 111
KIL + +G D + L + L + F F R + A Q
Sbjct: 80 SERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQ 139
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
++ E++ S + ++RD+KP+N L+ + + + DFG AK DT T+
Sbjct: 140 IVLIFEYLQSLNIVYRDLKPENLLLD---KDGFIKMTDFGFAK-VVDTRTY--------- 186
Query: 172 NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
L GT Y + L + + D +LG + L G P+
Sbjct: 187 TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 45/164 (27%), Positives = 70/164 (42%), Gaps = 33/164 (20%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTKHPQL-----QYEAKL 55
+ +G G+FGE+ L + T+ A+K + +VK + L ++ KL
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 56 YKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
Y Q + + + GD L+I + E L F +L+L
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLA------------ 113
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
+E VH F+HRDIKPDN L+ L + + DFGL +R T
Sbjct: 114 IESVHKMGFIHRDIKPDNILIDLD---GHIKLTDFGLCTGFRWT 154
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 58/227 (25%), Positives = 93/227 (40%), Gaps = 57/227 (25%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK-------LEN--------------VKTKHPQLQYEA 53
+G GSFG++ L TNE AIK LE+ + +HP L +
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH-- 60
Query: 54 KLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQ 111
L+ Q ++ V++ L G L +F+ S + A +
Sbjct: 61 -LFCTFQ-------------TKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFYAAE 104
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
+I ++F+H K ++RD+K DN L+ + + I DFG+ K +++ E K
Sbjct: 105 IICGLQFLHKKGIIYRDLKLDNVLLD---KDGHIKIADFGMCK--------ENM-NGEGK 152
Query: 172 NLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 215
T GT Y + G + + D S G VL+Y L G P+ G
Sbjct: 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFG-VLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 40/170 (23%), Positives = 78/170 (45%), Gaps = 29/170 (17%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHP--------QLQYE 52
+G+++ R +G GS G ++ + ++ VA+K + KH +L ++
Sbjct: 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHD 62
Query: 53 --AKLYKILQGGTGIPNLRWFGVEGDYNVLVI--DLLGPSLEDLFNFCSRKLSLKTVLML 108
K+Y++L G +G G + N + I + + L ++ LS + +
Sbjct: 63 NIVKVYEVL-GPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLF 119
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ----VYIIDFGLAK 154
Q++ ++++HS + LHRD+KP N + N + I DFGLA+
Sbjct: 120 MYQLLRGLKYIHSANVLHRDLKPANVFI------NTEDLVLKIGDFGLAR 163
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 38/155 (24%), Positives = 65/155 (41%), Gaps = 10/155 (6%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLQYEAKLYKILQGGT 63
F + +G G FGE+ + T + A+K+ + + +E + IL
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEE-RDILSISN 59
Query: 64 G--IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
IP L++ + D LV++ G L L N + +++ + VH
Sbjct: 60 SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH 119
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
++HRDIKP+N L+ R + + DFG A R
Sbjct: 120 QMGYVHRDIKPENVLID---RTGHIKLADFGSAAR 151
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 46/170 (27%), Positives = 73/170 (42%), Gaps = 29/170 (17%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTNEE-----VAIK-LENVKTKHPQLQY--EAKLYKILQG 61
L R +G G+FGE+Y G + + VA+K L ++ + + EA ++
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEA----LIMS 64
Query: 62 GTGIPNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFC---------SRKLSLKTVLMLADQ 111
N+ R GV + I L + DL +F L++K +L A
Sbjct: 65 KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKR-YR 157
+ +++ F+HRDI N L+ G GR A I DFG+A+ YR
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK---IADFGMARDIYR 171
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 63/285 (22%), Positives = 115/285 (40%), Gaps = 49/285 (17%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY---EAKLYKILQGGTGI 65
+L +K+G+G FGE+++ T N+ + ++ +K ++ EA + K LQ +
Sbjct: 8 LKLEKKLGAGQFGEVWMAT---YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLV 64
Query: 66 PNLRWFGVEGDYNVLVIDLL---GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
+ V + +I G L+ L + K L ++ + Q+ + F+ +
Sbjct: 65 ---KLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 121
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN--LTGTARYA 180
+++HRD++ N L+ + I DFGLA+ D RE + TA A
Sbjct: 122 NYIHRDLRAANILVS---ASLVCKIADFGLARVIED----NEYTAREGAKFPIKWTAPEA 174
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
I + D+ S G +LM + G +P+ G+ I A
Sbjct: 175 INFGSFTI----KSDVWSFGILLMEIVTYGRIPYPGMSN---------------PEVIRA 215
Query: 240 LCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276
L RGY P E + C R +++P + Y++ + D
Sbjct: 216 LERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 57/235 (24%), Positives = 95/235 (40%), Gaps = 24/235 (10%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN----VKTKHPQLQYEAKLYKILQGGTG 64
F + + IG G+FGE+ + ++ A+K+ N +K E + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 65 IPNLRWFGVEGDYNV-LVIDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
I L + + + N+ LV+D +G L L + +L +M+ ++ VH
Sbjct: 63 ITTLH-YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
++HRDIKPDN LM + + + DFG + + T Q + GT Y S
Sbjct: 122 HYVHRDIKPDNILMDMN---GHIRLADFGSCLKLMEDGTVQ------SSVAVGTPDYISP 172
Query: 183 NTHLGIEQSR-----RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232
+E + D SLG + L G P+ A + + Y KI K
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY---AESLVETYGKIMNHK 224
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 46/209 (22%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGTGIPNL- 68
++G+G+ G + + T + +A+K LE + Q+ E IL P +
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRE---LDILHKCNS-PYIV 62
Query: 69 RWFG---VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SF 124
++G GD ++ + + G SL+ + ++ + + +A ++ + ++H K
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKI 122
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
+HRD+KP N L+ Q+ + DFG++ + ++ K GT+ Y +
Sbjct: 123 IHRDVKPSNILVN---SRGQIKLCDFGVSGQLVNSLA---------KTFVGTSSYMAPER 170
Query: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
G + S + D+ SLG L+ G P+
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 53/224 (23%), Positives = 93/224 (41%), Gaps = 42/224 (18%)
Query: 12 GRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVKT---KHPQLQYEAKLYKILQG--- 61
G +G G++G +Y G Q ++V + NV ++ +LQ E L K L+
Sbjct: 5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 62 ----GT----GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
GT ++ V G +++ GP E +F ++ Q++
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK------------QIL 112
Query: 114 NRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRY---RDTATHQHIPYRE 169
+ V ++H+ +HRDIK +N LM G + +IDFG A+R TH ++
Sbjct: 113 DGVAYLHNNCVVHRDIKGNNVMLMPNG----IIKLIDFGCARRLAWVGLHGTHSNML--- 165
Query: 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
K++ GT + + R+ D+ S+G + G P
Sbjct: 166 -KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 42/157 (26%), Positives = 76/157 (48%), Gaps = 16/157 (10%)
Query: 13 RKIGSGSFGEIYL------GTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
R +G G FG++ L G N T E+VA+K ++ + K +IL+
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDN--TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 67
Query: 67 NLRWFGV---EGDYNV-LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
+++ G+ +G + L+++ L SL++ K++LK L A Q+ ++++ S
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
+ ++HRD+ N L+ +QV I DFGL K
Sbjct: 128 RQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIET 161
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 48/188 (25%), Positives = 83/188 (44%), Gaps = 24/188 (12%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLR 69
KIG G++G++Y + T + VA+K ++ P E L ++L I +R
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI--VR 65
Query: 70 WFGVE------GDYNV-LVIDLLGPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEF 118
VE G ++ LV + L L+ + R L KT+ Q++ V
Sbjct: 66 LLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQHIP--YRENKNL 173
H +HRD+KP N L + ++ + I D GL + + + TH+ + YR + L
Sbjct: 126 CHKHGVMHRDLKPQNLL--VDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVL 183
Query: 174 TGTARYAS 181
G+ Y++
Sbjct: 184 LGSTHYST 191
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 58/217 (26%), Positives = 89/217 (41%), Gaps = 24/217 (11%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQG--GTG----IPN 67
IG G FGE+Y T + A+K L+ + K Q + A +I+ TG I
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 68 LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFL 125
+ + D ++DL+ DL S+ S + A ++I +E +H++ +
Sbjct: 62 MSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVV 119
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY-ASMNT 184
+RD+KP N L+ V I D GLA + H + GT Y A
Sbjct: 120 YRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGYMAPEVL 167
Query: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221
G+ D SLG +L LRG P++ K K
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 48/206 (23%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTGIPNL-RW 70
KIG GS G + + T+ T +VA+K +++ + + L E + + Q PN+
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQH----PNIVEM 81
Query: 71 FG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127
+ + GD +V++ L G +L D+ +++ + + + ++ + F+H++ +HR
Sbjct: 82 YSSYLVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIATVCLAVLKALSFLHAQGVIHR 139
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG 187
DIK D+ L+ +V + DFG + + +P R K+L GT + +
Sbjct: 140 DIKSDSILL---TSDGRVKLSDFGFCAQ-----VSKEVPRR--KSLVGTPYWMAPEVISR 189
Query: 188 IEQSRRDDLESLGYVLMYFLRGSLPW 213
+ D+ SLG +++ + G P+
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 19/158 (12%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIPN-LRWFG 72
IG G++G++Y TN + A+K L+ + +++ E Y ILQ PN ++++G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAE---YNILQSLPNHPNVVKFYG 86
Query: 73 V--EGDYNV-----LVIDLL-GPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVHS 121
+ + D V LV++L G S+ +L C ++L + + + ++ +H+
Sbjct: 87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN 146
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
+HRD+K +N L+ V ++DFG++ + T
Sbjct: 147 NRIIHRDVKGNNILL---TTEGGVKLVDFGVSAQLTST 181
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 14/39 (35%), Positives = 22/39 (56%), Gaps = 3/39 (7%)
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
++ +H ++HRDIKPDN L+ + + DFGL
Sbjct: 114 IDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 17/209 (8%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQGGTGIPNLR 69
K+G GS+ +Y G + + VA+K+ E T ++ EA L K L+ I L
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHAN-IVLLH 69
Query: 70 WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
+ LV + + L + L + V + Q++ + ++H + LHRD+
Sbjct: 70 DIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDL 129
Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-I 188
KP N L+ ++ + DFGLA+ + +P N T Y + LG
Sbjct: 130 KPQNLLIS---DTGELKLADFGLARA-------KSVPSHTYSNEVVTLWYRPPDVLLGST 179
Query: 189 EQSRRDDLESLGYVLMYFLRGSLPWQGLK 217
E S D+ +G + + ++G + G+K
Sbjct: 180 EYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 36/148 (24%), Positives = 68/148 (45%), Gaps = 10/148 (6%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQGGTG 64
+ + + IG G+FGE+ L + T + A+KL E +K +E +
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 65 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS 123
+ L + + Y +V++ + DL N S + K +++ ++ +HS
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGG--DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG 162
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFG 151
F+HRD+KPDN L+ ++ + + DFG
Sbjct: 163 FIHRDVKPDNMLLD---KSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 38/162 (23%), Positives = 77/162 (47%), Gaps = 16/162 (9%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQLQYEAKLYKILQGGTGIPN 67
F L +G+G++G++Y G +++T + AIK+ +V + + +++ E + K I
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 68 LRWFGV--------EGDYNVLVIDLLGP-SLEDLF-NFCSRKLSLKTVLMLADQMINRVE 117
++G D LV++ G S+ DL N L + + +++ +
Sbjct: 78 --YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
+H+ +HRDIK N L+ +V ++DFG++ + T
Sbjct: 136 HLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRT 174
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 3e-04
Identities = 38/162 (23%), Positives = 76/162 (46%), Gaps = 16/162 (9%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLQYEAKLYKILQGGTGIPN 67
F L +G+G++G++Y G +++T + AIK+ +V + +++ E + K I
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 68 LRWFGV--------EGDYNVLVIDLLGP-SLEDLF-NFCSRKLSLKTVLMLADQMINRVE 117
++G D LV++ G S+ DL N L + + + +++ +
Sbjct: 68 --YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 125
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
+H +HRDIK N L+ +V ++DFG++ + T
Sbjct: 126 HLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRT 164
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 53/219 (24%), Positives = 85/219 (38%), Gaps = 27/219 (12%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN----VKTKHPQLQYEAKLYKILQGGTG 64
F + + IG G+FGE+ + T A+K+ N +K E + +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 65 IPNLRWFGVEGDYNVLVIDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
I L + + +Y LV+D +G L L + +L +M+ + +H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
++HRDIKPDN L+ + + + DFG + T Q + GT Y S
Sbjct: 123 YVHRDIKPDNVLLDMN---GHIRLADFGSCLKMNQDGTVQ------SSVAVGTPDYISPE 173
Query: 184 THLGIEQSRRD---------DLESLGYVLMYFLRGSLPW 213
I Q+ D D SLG + L G P+
Sbjct: 174 ----ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 60/258 (23%), Positives = 97/258 (37%), Gaps = 79/258 (30%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEE-----VAIK-----------------LENVKT- 44
+ LG+ +G G+FG++ + + VA+K +E +K
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMI 72
Query: 45 -KHPQL-------QYEAKLYKIL----QGGTGIPNLRWF-----GVEGDYNVLVIDLLGP 87
KH + E LY ++ G NLR F +
Sbjct: 73 GKHKNIINLLGVCTQEGPLYVVVEYAAHG-----NLRDFLRARRPPGEYASPDDPRPPEE 127
Query: 88 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 147
L+ K ++ A Q+ +EF+ SK +HRD+ N L+ + + I
Sbjct: 128 -----------TLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED---HVMKI 173
Query: 148 IDFGLAKR------YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY 201
DFGLA+ YR T T+ +P K + A + + TH QS D+ S G
Sbjct: 174 ADFGLARDIHHIDYYRKT-TNGRLPV---KWMAPEALFDRVYTH----QS---DVWSFG- 221
Query: 202 VLMY--FLRGSLPWQGLK 217
VL++ F G P+ G+
Sbjct: 222 VLLWEIFTLGGSPYPGIP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 33/117 (28%), Positives = 46/117 (39%), Gaps = 19/117 (16%)
Query: 121 SKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTA--THQHIPYRENKNLTGTA 177
+ LHRD+KP N FL N V + DFGLAK + ++ GT
Sbjct: 128 GNTVLHRDLKPANIFLDA----NNNVKLGDFGLAKILGHDSSFAKTYV---------GTP 174
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
Y S + + D+ SLG ++ S P+ A + Q KI E K
Sbjct: 175 YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT---ARNQLQLASKIKEGKFR 228
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 30/110 (27%), Positives = 51/110 (46%), Gaps = 12/110 (10%)
Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162
K + +A+ ++ + ++HS+ +HRDIKP N L+ R QV + DFG++ ++
Sbjct: 105 KVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELVNSLA- 160
Query: 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
TGT+ Y + G S D+ SLG L+ + P
Sbjct: 161 --------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 18/46 (39%), Positives = 29/46 (63%), Gaps = 3/46 (6%)
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
Q++ ++F+HS +HRD+KP N L+ Q+ + DFGLA+ Y
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 4e-04
Identities = 42/169 (24%), Positives = 75/169 (44%), Gaps = 28/169 (16%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQY---------EAK-LYKILQGGT 63
I G+ EIYLG + + IK K +HP+L EA+ + + + G
Sbjct: 4 IKRGAEAEIYLGDFL--GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGV 61
Query: 64 GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
+P + + E ++V++ + G L+DL N S + + +++ ++ HS
Sbjct: 62 NVPAVYFVDPENF--IIVMEYIEGEPLKDLIN--SNGMEELELSREIGRLVGKL---HSA 114
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA---KRYRDTATHQHIPYR 168
+H D+ N ++ ++Y+IDFGLA K D A H+ R
Sbjct: 115 GIIHGDLTTSNMIL----SGGKIYLIDFGLAEFSKDLEDRAVDLHVLLR 159
|
Length = 211 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 32/117 (27%), Positives = 50/117 (42%), Gaps = 10/117 (8%)
Query: 99 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
K L A ++I ++F+HSK ++RD+K DN L+ + I DFG+ K
Sbjct: 92 KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD---TDGHIKIADFGMCK---- 144
Query: 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+ + GT Y + LG + + D S G +L L G P+ G
Sbjct: 145 ---ENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 4e-04
Identities = 61/247 (24%), Positives = 93/247 (37%), Gaps = 64/247 (25%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT--NIQTNE---EVAIKLENVK-TKHPQLQY--EAKLYKI 58
K L R++G GSFG +Y G + E VAIK N + ++++ EA + K
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65
Query: 59 LQGGTGIPNL-RWFGVEGDYN-VLVI-------DLLG-----------------PSLEDL 92
++ R GV LV+ DL P+L+
Sbjct: 66 FN----CHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121
Query: 93 FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152
+ +AD M ++ +K F+HRD+ N ++ V I DFG+
Sbjct: 122 IQMAAE---------IADGM----AYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGM 165
Query: 153 AKRYRDTATHQHIPYR-ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVL--MYFLRG 209
RD + YR K L A + G+ + + D+ S G VL M L
Sbjct: 166 T---RDIYETDY--YRKGGKGLLPVRWMAPESLKDGVFTT-KSDVWSFGVVLWEMATL-A 218
Query: 210 SLPWQGL 216
P+QGL
Sbjct: 219 EQPYQGL 225
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 34/100 (34%), Positives = 47/100 (47%), Gaps = 15/100 (15%)
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167
Q++ V VHSK +HRDIK N L+ GL V + DFG +K Y T +
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGL------VKLGDFGFSKMYAATVSDD---- 200
Query: 168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 207
+ GT Y + S++ D+ SLG VL+Y L
Sbjct: 201 -VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLG-VLLYEL 238
|
Length = 496 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 34/146 (23%), Positives = 68/146 (46%), Gaps = 9/146 (6%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPN----LR 69
++G G+FG++Y N +T A K+ + K++ Y ++ IL PN L
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEI-DIL-ASCDHPNIVKLLD 69
Query: 70 WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129
F E + +L+ G +++ + R L+ + ++ Q + + ++H +HRD+
Sbjct: 70 AFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDL 129
Query: 130 KPDNFLMGLGRRANQVYIIDFGLAKR 155
K N L L + + DFG++ +
Sbjct: 130 KAGNILFTLD---GDIKLADFGVSAK 152
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 65/269 (24%), Positives = 110/269 (40%), Gaps = 41/269 (15%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQ----YEAKLYKILQGGTGIPNL- 68
+IG G+FGE++ G N VA+K +T P L+ EA++ K PN+
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVK-SCRETLPPDLKAKFLQEARILKQYSH----PNIV 56
Query: 69 RWFGV--EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
R GV + +V++L+ G +L +K ++ + + +E++ SK +
Sbjct: 57 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCI 116
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKR-----YRDTATHQHIPYR-ENKNLTGTARY 179
HRD+ N L+ N + I DFG+++ Y T + IP + RY
Sbjct: 117 HRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238
+S D+ S G +L F G++P+ L + +Q E I E+ V
Sbjct: 174 SS-----------ESDVWSFGILLWEAFSLGAVPYANL---SNQQTREAI-EQGVRLPCP 218
Query: 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYA 267
LC P C +P ++
Sbjct: 219 ELC---PDAVYRLMERCWEYDPGQRPSFS 244
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 58/219 (26%), Positives = 90/219 (41%), Gaps = 24/219 (10%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQG--GTG----IPN 67
IG G FGE+Y T + A+K L+ + K Q + A +I+ TG I
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 68 LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFL 125
+ + D ++DL+ DL S+ S K + A ++I +E +H++ +
Sbjct: 62 MTYAFHTPDKLCFILDLMNGG--DLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT- 184
+RD+KP N L+ V I D GLA + H + GT Y +
Sbjct: 120 YRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGYMAPEVL 167
Query: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 223
G D SLG +L LRG P++ K K +
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 41/147 (27%), Positives = 68/147 (46%), Gaps = 11/147 (7%)
Query: 15 IGSGSFGEIYLGTNIQTNEE----VAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL-R 69
+GSG+FG +Y G + E VAIK+ N +T P+ E ++ P+L R
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 70 WFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLML--ADQMINRVEFVHSKSFLHR 127
GV + ++ L P L K ++ + L+L Q+ + ++ + +HR
Sbjct: 74 LLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHR 133
Query: 128 DIKPDNFLMGLGRRANQVYIIDFGLAK 154
D+ N L+ + N V I DFGLA+
Sbjct: 134 DLAARNVLV---KSPNHVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 44/202 (21%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENV-KTKHPQLQYEAKLYKILQGGTGIPNLRWFG 72
KIG GS G + + T T ++VA+K ++ K + +L + + + ++
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 73 VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP 131
+ GD +V++ L G +L D+ +++ + + + ++ + ++H++ +HRDIK
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146
Query: 132 DNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQS 191
D+ L+ R + + DFG + + +P R K+L GT + + +
Sbjct: 147 DSILLTSDGR---IKLSDFGFCAQ-----VSKEVPKR--KSLVGTPYWMAPEVISRLPYG 196
Query: 192 RRDDLESLGYVLMYFLRGSLPW 213
D+ SLG +++ + G P+
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 19/153 (12%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQY-EAKLYKILQGGTGIP 66
+ IGSG+ G + + T + VAIK +NV H + Y E L K++ I
Sbjct: 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVT--HAKRAYRELVLMKLVNHKNIIG 79
Query: 67 NLRWFGVEGDYN-----VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
L F + LV++L+ +L + L + + L QM+ ++ +HS
Sbjct: 80 LLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MDLDHERMSYLLYQMLCGIKHLHS 136
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+HRD+KP N ++ + + I+DFGLA+
Sbjct: 137 AGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 32/110 (29%), Positives = 54/110 (49%), Gaps = 10/110 (9%)
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 165
+L Q++ ++ VHS+ +HRD+K N FLM G + + DFG +K+Y D+ +
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG----IIKLGDFGFSKQYSDS-----V 223
Query: 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+ GT Y + S++ D+ SLG +L L P++G
Sbjct: 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 62/269 (23%), Positives = 96/269 (35%), Gaps = 22/269 (8%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY----EAKLYKILQGGTG 64
F + KIG GSFG ++ A+K ++ + + + EA++ L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 65 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHSKS 123
I F +G N+++ L L R L V Q++ + +HSK
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
LHRDIK N + + V I D G+AK D + GT Y S
Sbjct: 122 ILHRDIKSLNLFLDAY---DNVKIGDLGVAKLLSDNTNFA-------NTIVGTPYYLSPE 171
Query: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243
+ + D+ +LG VL G P+ G K + VS +
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVS-------QM 224
Query: 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRL 272
Y + A C + + +PD L R
Sbjct: 225 YSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 37/165 (22%), Positives = 74/165 (44%), Gaps = 37/165 (22%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL------------ENVKTKHPQL-----QY 51
F + + I G+FG++YLG ++ A+K+ V+ + L +
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 52 EAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
LY LQ + + + + GD SL ++ + ++++K + +
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVK---------SLLHIYGYFDEEMAVKYI----SE 112
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI--IDFGLAK 154
+ ++++H +HRD+KPDN L+ +N+ +I DFGL+K
Sbjct: 113 VALALDYLHRHGIIHRDLKPDNMLI-----SNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 59/231 (25%), Positives = 97/231 (41%), Gaps = 38/231 (16%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------KHPQLQYEAKLYKILQGGT 63
L R++G G+FG+++L E L VKT EA+L LQ
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 64 GIPNLRWFGV--EGDYNVLVIDLLGPSLEDLFNFCS---------------RKLSLKTVL 106
+ +++GV EGD ++V + + DL F +L+ +L
Sbjct: 69 IV---KFYGVCVEGDPLIMVFEYMKHG--DLNKFLRAHGPDAVLMAEGNRPAELTQSQML 123
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166
+A Q+ + ++ S+ F+HRD+ N L+G V I DFG++ RD + +
Sbjct: 124 HIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMS---RDVYSTDY-- 175
Query: 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM-YFLRGSLPWQGL 216
YR + R+ + + + + D+ SLG VL F G PW L
Sbjct: 176 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 41/157 (26%), Positives = 68/157 (43%), Gaps = 12/157 (7%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQ--YEAKLYKILQGGTGIPNLR 69
G K+G G++G +Y +E L+ ++ + E L + L+ I +
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQK 65
Query: 70 WFGVEGDYNV-LVIDLLGPSLEDLFNF--CSR------KLSLKTVLMLADQMINRVEFVH 120
F D V L+ D L + F S+ +L V L Q+++ + ++H
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 121 SKSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKRY 156
+ LHRD+KP N L MG G +V I D G A+ +
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 45/164 (27%), Positives = 65/164 (39%), Gaps = 33/164 (20%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKTKHPQLQ---- 50
F + IG G+FGE+ L T + A+K L +VK + L
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 51 -YEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA 109
+ LY Q + + F GD ++I S ED+ F + L
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFS-EDVTRFYMAECVLA------ 113
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
+E VH F+HRDIKPDN L+ R + + DFGL+
Sbjct: 114 ------IEAVHKLGFIHRDIKPDNILID---RGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 43/167 (25%), Positives = 71/167 (42%), Gaps = 25/167 (14%)
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 170
Q+I+ +E +H + ++RD+KP+N L+ V I D GLA +D + +
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLD---NDGNVRISDLGLAVELKDGQS-------KT 154
Query: 171 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230
K GT + + G E D +LG L + P+ + + EK+
Sbjct: 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF--------RARGEKVEN 206
Query: 231 KKVSTSIEALCRGYPTEF-ASYFHYCRSLRFDDKPDYAYLKRL-FRD 275
K++ I YP +F + +C +L P+ KRL FRD
Sbjct: 207 KELKQRILNDSVTYPDKFSPASKSFCEAL-LAKDPE----KRLGFRD 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 49/192 (25%), Positives = 84/192 (43%), Gaps = 24/192 (12%)
Query: 15 IGSGSFGEIYLGTNIQTNEEVAIK-------LENVKTKHPQLQYEAKLYKILQGGTGIPN 67
IG G+FGE+ L T A+K LE + H + + + IL +
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERD-----ILVEADSLWV 63
Query: 68 LRWF-GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSL---KTVLMLADQMINRVEFVHSKS 123
++ F + N+ +I P D+ +K +L +T +A+ ++ ++ +H
Sbjct: 64 VKMFYSFQDKLNLYLIMEFLPG-GDMMTLLMKKDTLTEEETQFYIAETVL-AIDSIHQLG 121
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE-NKNLTGTARYASM 182
F+HRDIKPDN L+ V + DFGL + H+ YR N +L + +M
Sbjct: 122 FIHRDIKPDNLLLD---SKGHVKLSDFGLCTGLKK--AHRTEFYRNLNHSLPSDFTFQNM 176
Query: 183 NTHLGIEQSRRD 194
N+ E +R+
Sbjct: 177 NSKRKAETWKRN 188
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 41/160 (25%), Positives = 69/160 (43%), Gaps = 8/160 (5%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN----VKTKHPQLQYEAKLYKILQGGTG 64
F + + IG G+FGE+ + T + A+K+ N +K E + +
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 65 IPNLRWFGVEGDYNVLVIDL-LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
I NL + + + LV+D +G L L + +L +M+ ++ VH
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163
++HRDIKPDN L+ + + + DFG R T Q
Sbjct: 123 YVHRDIKPDNVLLD---KNGHIRLADFGSCLRLLADGTVQ 159
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 0.002
Identities = 16/44 (36%), Positives = 29/44 (65%), Gaps = 3/44 (6%)
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
Q++ ++++HS + +HRD+KP N L+ +V + DFGLA+
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLN---SDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 41/149 (27%), Positives = 65/149 (43%), Gaps = 11/149 (7%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEE----VAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
+ +GSG+FG +Y G I E VAIK+ T P+ E + G G P +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-PKANKEILDEAYVMAGVGSPYV 71
Query: 69 -RWFGVEGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
R G+ V ++ L P L D ++ + +L Q+ + ++ +
Sbjct: 72 CRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLV 131
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
HRD+ N L+ + N V I DFGLA+
Sbjct: 132 HRDLAARNVLV---KSPNHVKITDFGLAR 157
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.002
Identities = 29/128 (22%), Positives = 47/128 (36%), Gaps = 11/128 (8%)
Query: 297 QSQVSTPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADP------SRRRNSG 350
+ + P G + P+S PP AA A T + D SR
Sbjct: 464 DERDAQPPADSGSASAPASDAPPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPA 523
Query: 351 PLGNSANLSKQKSPMANDPAFSKDAMMSSYNLLRSSG----SSR-RVAVPNSREAAVVGS 405
A ++ +P A PA ++ ++LR++G S R A ++ AA +
Sbjct: 524 AAAPPAPEARPPTPAAAAPAARAGGAAAALDVLRNAGMRVSSDRGARAAAAAKPAAAPAA 583
Query: 406 DTDPSRPR 413
P+ PR
Sbjct: 584 APKPAAPR 591
|
Length = 830 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 12/101 (11%)
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 175
++ +HS ++RD+KP+N L+ + + DFGL+K D H+ Y + G
Sbjct: 111 LDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESID---HEKKAY----SFCG 160
Query: 176 TARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 215
T Y + ++ D S G VLM+ L GSLP+QG
Sbjct: 161 TVEYMAPEVVNRRGHTQSADWWSFG-VLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 53/243 (21%), Positives = 103/243 (42%), Gaps = 47/243 (19%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE-------VAIKL--ENVKTKH-PQLQYEAKLY 56
+K LG+ +G G FG++ + + +++ VA+K+ ++ K L E ++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 57 KILQGGTGIPNLRWFGVEGDYNVLVIDLLG-------------PSLE---DLFNFCSRKL 100
K++ I NL + ++++ P +E D+ ++
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 101 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK-----R 155
+ K ++ Q+ +E++ S+ +HRD+ N L+ N + I DFGLA+
Sbjct: 135 TFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDVNNID 191
Query: 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPW 213
Y T+ +P K + A + + TH + D+ S G VLM+ F G P+
Sbjct: 192 YYKKTTNGRLPV---KWMAPEALFDRVYTH-------QSDVWSFG-VLMWEIFTLGGSPY 240
Query: 214 QGL 216
G+
Sbjct: 241 PGI 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 15/49 (30%), Positives = 30/49 (61%), Gaps = 3/49 (6%)
Query: 91 DLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 136
DL+ + + L L V +A Q+++ ++++H + +HRDIK +N L+
Sbjct: 245 DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV 293
|
Length = 461 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.003
Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 12/157 (7%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQ--YEAKLYKILQGGTGIPNLR 69
G K+G G++G +Y ++ L+ ++ + E L + L+ I +
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQK 65
Query: 70 WFGVEGDYNV-LVIDLLGPSLEDLFNFC-SRKLSLKTVLM-------LADQMINRVEFVH 120
F D V L+ D L + F + K + K V + L Q+++ + ++H
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 121 SKSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKRY 156
+ LHRD+KP N L MG G +V I D G A+ +
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 29/104 (27%), Positives = 49/104 (47%), Gaps = 12/104 (11%)
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR-YRDTATHQHIPYRE 169
++++ +E++HS+ ++RDIK +N ++ + + I DFGL K D AT
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGATM------- 152
Query: 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
K GT Y + + R D LG V+ + G LP+
Sbjct: 153 -KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 474 | |||
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.64 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.61 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.53 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.45 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.44 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.43 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.31 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.28 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.15 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.07 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.05 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.97 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.97 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.89 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.76 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.72 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.72 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.66 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.62 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.58 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.53 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.52 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.49 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.42 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.36 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.19 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.18 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.12 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.12 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.04 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.88 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.87 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.79 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.79 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.76 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.69 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.58 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.53 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.52 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.51 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.46 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.34 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.34 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.32 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.26 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.25 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.21 | |
| PLN02236 | 344 | choline kinase | 96.95 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.8 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.72 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.42 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.32 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.11 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.96 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.78 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.64 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.54 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.52 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.41 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.09 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.76 | |
| PTZ00296 | 442 | choline kinase; Provisional | 93.97 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 93.6 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.57 |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-59 Score=423.72 Aligned_cols=295 Identities=71% Similarity=1.242 Sum_probs=288.3
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.+++++|+++++||+|+||.+|+|....+|+.||||++..+..++++..|.++++.|++..+|+.+.+|+.+..+.++||
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 46789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 83 e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
|++|++|+++++.|.+.|+.++++.++.||+..|+|+|.+++|||||||+|+|++.+.....+.|+|||+|+.+.+..+.
T Consensus 91 dLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 91 DLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred eccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 99999999999999999999999999999999999999999999999999999999888899999999999999999999
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhc
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (474)
.|+||++...++||.+|++...+.+.++++++|+.|+|++|+++..|.+||++..+.++.+++++|.+++...+++.+|+
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~ 250 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCK 250 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccccccc
Q 011945 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQ 297 (474)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~ 297 (474)
++|.||.-++.+|..+.+++.|++..|.++|+-+|...++++|+.|||+.++.+.
T Consensus 251 G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkqk~ 305 (341)
T KOG1163|consen 251 GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQKS 305 (341)
T ss_pred CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHHHh
Confidence 9999999999999999999999999999999999999999999999999987543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-57 Score=431.88 Aligned_cols=291 Identities=61% Similarity=1.044 Sum_probs=283.6
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
+|+-.|+++++||+|+||++++|++..+++.||||.+..+...+++..|.+.++.|.+..+|+.+++|+.++.+.+||||
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 67889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeC--CCCCeEEEEecCCccccccCCC
Q 011945 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 84 ~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~--~~~~~vkL~DFGla~~~~~~~~ 161 (474)
++|+||+|+++.|+++|+.+++++|+.||+.-++|+|++.+|+|||||+|+||+.. .+...|.|+|||+|+.+.++.+
T Consensus 105 LLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 105 LLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred hhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 99999999999999999999999999999999999999999999999999999852 3456799999999999999999
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
++|+||++.+.+.||.+||+...++|.++++++|+.|||-|++++|.|.+||+++++.+.+++|++|.+++..++++.+|
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc 264 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLC 264 (449)
T ss_pred cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccccc
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 294 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 294 (474)
.++|.+|..++.+...+++++-|+|+.+..+|.++|.+.|..+|+.|||..+.
T Consensus 265 ~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ln 317 (449)
T KOG1165|consen 265 EGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMGLN 317 (449)
T ss_pred hcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccccC
Confidence 99999999999999999999999999999999999999999999999999875
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=382.35 Aligned_cols=254 Identities=22% Similarity=0.341 Sum_probs=214.7
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
.+.+.++.||+|..|+||+|.++.+++.+|+|++.... ...++.+|+++++.++++.+|..+..|...+....|+||
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE 158 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME 158 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence 36778899999999999999999999999999884432 356799999999999755555555555544446899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs-~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
|| +|+|++++... +++++..+-.|+.+|++||.|||+ ++||||||||+|||| +..|.|||||||.++.+.+..
T Consensus 159 YMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvnS~- 233 (364)
T KOG0581|consen 159 YMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVNSI- 233 (364)
T ss_pred hcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee---ccCCCEEeccccccHHhhhhh-
Confidence 99 99999999854 679999999999999999999996 999999999999999 589999999999999887753
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CcCcHHHHHHHHhhccccchHHH
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL--KAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~--~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
.++++||..|||||.+.+..|+.++||||||++|+||++|++||... ......+.+..|..... +.
T Consensus 234 --------a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp----P~ 301 (364)
T KOG0581|consen 234 --------ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP----PR 301 (364)
T ss_pred --------cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC----CC
Confidence 36789999999999999999999999999999999999999999763 23456666666665443 33
Q ss_pred HhcC-CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 240 LCRG-YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 240 l~~~-~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
++.+ ++++|++||..||.+||.+||++.+| +.+.|.+.
T Consensus 302 lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qL---l~Hpfi~~ 340 (364)
T KOG0581|consen 302 LPEGEFSPEFRSFVSCCLRKDPSERPSAKQL---LQHPFIKK 340 (364)
T ss_pred CCcccCCHHHHHHHHHHhcCCcccCCCHHHH---hcCHHHhh
Confidence 4454 89999999999999999999997665 66777654
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=385.20 Aligned_cols=260 Identities=24% Similarity=0.339 Sum_probs=213.2
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC---------CchHHHHHHHHHHHhcCCCCCceeEEEeEe
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---------KHPQLQYEAKLYKILQGGTGIPNLRWFGVE 74 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---------~~~~l~~E~~il~~l~~~~~i~~l~~~~~~ 74 (474)
.+.+.|.+.+.||+|+||.|-+|..+.+|+.||||+++... ....+.+|++||++|+| |+|+.+..+.+.
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~H-P~IV~~~d~f~~ 247 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSH-PNIVRIKDFFEV 247 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCC-CCEEEEeeeeec
Confidence 35678999999999999999999999999999999986532 12236799999999995 555566666677
Q ss_pred CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCc
Q 011945 75 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (474)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (474)
.++.||||||+ ||.|.+.+- .++.+.+.....++.||+.||.|||++||+||||||+|||+..+..+..+||+|||+|
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv-~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVV-ANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred CCceEEEEEEecCccHHHHHH-hccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchh
Confidence 77889999999 999999886 3567899999999999999999999999999999999999987767789999999999
Q ss_pred cccccCCCccccccccCCCCccCccccccccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhh
Q 011945 154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (474)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~---~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (474)
+...... ..+++|||+.|.|||++.+.. +..++|||||||+||-+|+|.+||.+.... ....+.|..
T Consensus 327 K~~g~~s--------fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~--~sl~eQI~~ 396 (475)
T KOG0615|consen 327 KVSGEGS--------FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD--PSLKEQILK 396 (475)
T ss_pred hccccce--------ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--ccHHHHHhc
Confidence 9776432 246789999999999998765 345889999999999999999999875432 223445555
Q ss_pred ccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
.+... .+..+..++++..+||.+||..||++||+++++ |++.+.+
T Consensus 397 G~y~f-~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~ea---L~hpW~~ 441 (475)
T KOG0615|consen 397 GRYAF-GPLQWDRISEEALDLINWMLVVDPENRPSADEA---LNHPWFK 441 (475)
T ss_pred Ccccc-cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHH---hcChhhh
Confidence 55432 234457789999999999999999999997765 5565543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-48 Score=387.55 Aligned_cols=270 Identities=24% Similarity=0.364 Sum_probs=228.9
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
-.++|++++.||.|+|++||+|+++.+++.||||++.+. ...+-+..|-.+|.+|.+|++|..++..+.++...|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 356899999999999999999999999999999986543 344558889999999999999999999999999999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
+|+||+ +|.|.++|+.. +.|++..+..++.||+.||+|||++|||||||||+|||| +.++++||+|||.|+.+..
T Consensus 151 FvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCCh
Confidence 999999 99999999854 689999999999999999999999999999999999999 6899999999999998876
Q ss_pred CCCcccc----cccc--CCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc
Q 011945 159 TATHQHI----PYRE--NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (474)
Q Consensus 159 ~~~~~~~----~~~~--~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (474)
....+.- .+.. ...++||..|.+||++.....+..+|||+||||||+|+.|.+||.+.+.... +++|+...
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli---FqkI~~l~ 303 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI---FQKIQALD 303 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH---HHHHHHhc
Confidence 5433111 1111 2569999999999999999999999999999999999999999988655433 44444333
Q ss_pred ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccccccc
Q 011945 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 296 (474)
Q Consensus 233 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 296 (474)
. .+..++|+.+.+||+++|..||.+|++.++|.+ +.|...+||.-+..+
T Consensus 304 y-----~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~----------HpFF~~Vdw~nlw~~ 352 (604)
T KOG0592|consen 304 Y-----EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA----------HPFFEGVDWENLWQQ 352 (604)
T ss_pred c-----cCCCCCCHHHHHHHHHHHccCccccccHHHHhh----------CcccccCChhhhhhc
Confidence 2 345789999999999999999999999876643 356677888875443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-48 Score=391.27 Aligned_cols=256 Identities=24% Similarity=0.373 Sum_probs=222.4
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
.+|+..+.||+|||+.||.+++..+|+.||+|++... ...+.+.+|++|.+.|+ |++|+.++.|+++.++.|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCCceEEE
Confidence 5799999999999999999999999999999987652 34556999999999999 55667777788999999999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
+|+| .++|..+++ ..+.+++.+++.++.||+.||.|||+++|||||||..|||| +++.+|||+|||||..+..+.
T Consensus 97 LELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 97 LELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeecCcc
Confidence 9999 889999988 56789999999999999999999999999999999999999 588899999999999887553
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
. ...+.|||+.|+|||++.....+..+||||+|||||-||.|++||+. .+.++.|.+|.......
T Consensus 173 E-------rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet---k~vkety~~Ik~~~Y~~----- 237 (592)
T KOG0575|consen 173 E-------RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET---KTVKETYNKIKLNEYSM----- 237 (592)
T ss_pred c-------ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc---chHHHHHHHHHhcCccc-----
Confidence 2 23678999999999999999999999999999999999999999986 45567777776655432
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCC
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 285 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~ 285 (474)
+..++.+.++||..+|..||.+||++++| |++-|-..|+...
T Consensus 238 P~~ls~~A~dLI~~lL~~~P~~Rpsl~~v---L~h~Ff~~g~~p~ 279 (592)
T KOG0575|consen 238 PSHLSAEAKDLIRKLLRPNPSERPSLDEV---LDHPFFKSGFTPA 279 (592)
T ss_pred ccccCHHHHHHHHHHhcCCcccCCCHHHH---hcCHhhhCCCcCC
Confidence 34778999999999999999999997766 6676666665443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-48 Score=374.48 Aligned_cols=266 Identities=21% Similarity=0.285 Sum_probs=223.8
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
.++|+++++||+|+||+||+++.+.+++.||+|++++.. .......|..||..++ |+.|+.+.+.++..+..||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecccCCeEEE
Confidence 578999999999999999999999999999999876543 2345889999999977 5666667667778888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
|+||+ ||.|...++ ..+.|++..+..++.+|+.||.|||++|||||||||+|||| +..|+++|+|||||+.....
T Consensus 103 Vld~~~GGeLf~hL~-~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQ-REGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EEeccCCccHHHHHH-hcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhcccC
Confidence 99999 889999998 46689999999999999999999999999999999999999 58999999999999966554
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
... ..+++||+.|||||++.+..|+..+|+||||+++|||++|..||.+ .+..+.+++|...+...
T Consensus 179 ~~~-------t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~---~~~~~~~~~I~~~k~~~---- 244 (357)
T KOG0598|consen 179 GDA-------TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA---EDVKKMYDKILKGKLPL---- 244 (357)
T ss_pred CCc-------cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC---ccHHHHHHHHhcCcCCC----
Confidence 332 3568999999999999999999999999999999999999999987 45567777777766322
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCC----HHHHHHHHHHHHHHcCCCCCCcccccccccccccc
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPD----YAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt----~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~~ 300 (474)
...-++.+.++++..+|..||++|-. +.+ -....+....+|+.+.....++
T Consensus 245 ~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~----------ik~HpfF~~inW~~l~~k~l~P 299 (357)
T KOG0598|consen 245 PPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEE----------IKRHPFFKGINWEKLLAKKLSP 299 (357)
T ss_pred CCccCCHHHHHHHHHHhccCHHHhcCCCCChHH----------hhcCcccccCCHHHHHhcCCCC
Confidence 22337899999999999999999953 333 2345677789999887655544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=377.91 Aligned_cols=251 Identities=25% Similarity=0.356 Sum_probs=209.3
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
....++|.+.++||.|+||+||+|+++.++..||||.+..+. ..+.+..|+.+|+.|+ |++|+.+..+...+++.
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~~i 84 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDDFI 84 (429)
T ss_pred ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCCeE
Confidence 345678999999999999999999999999999999887654 2345789999999999 56666777788888899
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCC---CeEEEEecCCcc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA---NQVYIIDFGLAK 154 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~---~~vkL~DFGla~ 154 (474)
||||||| ||+|.+++.. .+.+++.+++.++.||+.||++||+++||||||||+||||+..... -.+||+|||+|+
T Consensus 85 ~lVMEyC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EEEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999 8999999984 4589999999999999999999999999999999999999864233 679999999999
Q ss_pred ccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (474)
.+..... ..+++|++.|||||++..+.|+.|+|+||+|+|||+|++|+.||...+. .+.+..+....
T Consensus 164 ~L~~~~~--------a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~---~eL~~~~~k~~-- 230 (429)
T KOG0595|consen 164 FLQPGSM--------AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP---KELLLYIKKGN-- 230 (429)
T ss_pred hCCchhH--------HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH---HHHHHHHhccc--
Confidence 8875432 3578999999999999999999999999999999999999999987443 34333332222
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 268 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~ 268 (474)
..++.+...++..+.+++...+..++.+|-++.+
T Consensus 231 ~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~ 264 (429)
T KOG0595|consen 231 EIVPVLPAELSNPLRELLISLLQRNPKDRISFED 264 (429)
T ss_pred cccCchhhhccCchhhhhhHHHhcCccccCchHH
Confidence 2233334455677789999999999999988654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-48 Score=360.62 Aligned_cols=243 Identities=25% Similarity=0.326 Sum_probs=208.0
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeE-EEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLR-WFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~-~~~~~~~~~~lv 81 (474)
.+|+|+++||.|+||+||++.+..+|..||.|.+..... .+.+..|+.+|++|+|+|+|.++. .+..+.+..+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 359999999999999999999999999999997664432 345889999999999999888887 445566668999
Q ss_pred EecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHH--CC--ccccCCCCCcEEeeeCCCCCeEEEEecCCc
Q 011945 82 IDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHS--KS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (474)
Q Consensus 82 ~e~~-g~sL~~li~~---~~~~l~~~~~~~i~~qi~~gL~yLHs--~g--IiHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (474)
||+| +|+|.++++. ..+.+++.++|.++.|++.||..+|+ .. |+||||||.||+|+ .+|.|||+||||+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~---~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLT---ANGVVKLGDFGLG 175 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEc---CCCceeeccchhH
Confidence 9999 8999999863 34569999999999999999999999 45 99999999999994 8899999999999
Q ss_pred cccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc
Q 011945 154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (474)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (474)
+.+....+. ..+++||+.||+||.+.+.+|+.|+||||+||++|||+.-..||.+. ...+.-.+|.....
T Consensus 176 r~l~s~~tf-------A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n~~~L~~KI~qgd~ 245 (375)
T KOG0591|consen 176 RFLSSKTTF-------AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---NLLSLCKKIEQGDY 245 (375)
T ss_pred hHhcchhHH-------HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---cHHHHHHHHHcCCC
Confidence 998876553 34679999999999999999999999999999999999999999985 44455555555544
Q ss_pred cchHHHHh-cCCcHHHHHHHHHHhcCCCCCCCCH
Q 011945 234 STSIEALC-RGYPTEFASYFHYCRSLRFDDKPDY 266 (474)
Q Consensus 234 ~~~~~~l~-~~~p~~l~~li~~cl~~dp~~RPt~ 266 (474)
++ ++ ..++.++..||..|+..|++.||+.
T Consensus 246 ~~----~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 246 PP----LPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred CC----CcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 32 22 3568899999999999999999984
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=371.24 Aligned_cols=256 Identities=23% Similarity=0.358 Sum_probs=209.2
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeE-EEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE-VAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~-vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
....+.+.||.|+||+||+|.+. |.. ||||++..... ...|.+|+.+|.+|+|+|+|..+..+.......+||
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iV 118 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIV 118 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEE
Confidence 34566778999999999999964 555 99998865432 347999999999999777776555444443378999
Q ss_pred EecC-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCCCcEEeeeCCCCC-eEEEEecCCccccc
Q 011945 82 IDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKS-FLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYR 157 (474)
Q Consensus 82 ~e~~-g~sL~~li~~-~~~~l~~~~~~~i~~qi~~gL~yLHs~g-IiHrDIKP~NILl~~~~~~~-~vkL~DFGla~~~~ 157 (474)
|||+ +|+|.+++.. ....+++..++.|+.||+.||.|||+++ ||||||||+|||++ ..+ ++||+|||+++...
T Consensus 119 tEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~---~~~~~~KI~DFGlsr~~~ 195 (362)
T KOG0192|consen 119 TEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVD---LKGKTLKIADFGLSREKV 195 (362)
T ss_pred EEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEc---CCCCEEEECCCccceeec
Confidence 9999 9999999986 3778999999999999999999999999 99999999999994 665 99999999998765
Q ss_pred cCCCccccccccCCCCccCcccccccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccc
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHL--GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~--~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
.... ..+...||+.|||||++. ...|+.|+||||||++||||+||+.||.+... .+....+.......
T Consensus 196 ~~~~-------~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~---~~~~~~v~~~~~Rp 265 (362)
T KOG0192|consen 196 ISKT-------SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP---VQVASAVVVGGLRP 265 (362)
T ss_pred cccc-------cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcCCCC
Confidence 4321 123468999999999999 55899999999999999999999999998764 23333333333222
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
.+...+|+.+..+|..||..||+.||++.+|...|+.+....
T Consensus 266 ---~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 266 ---PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred ---CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 334558999999999999999999999999999999987644
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=350.35 Aligned_cols=253 Identities=20% Similarity=0.274 Sum_probs=207.4
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCch----HHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
++|+.+.++|+|+||+||+|+++.||+.||||.+......+ -..+|+++|++|+|.|.|..+. ++......+||+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiE-VFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIE-VFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHH-HHHhcceeEEEe
Confidence 57999999999999999999999999999999876554433 3688999999999776665554 445666789999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 83 e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
|||..++.+.+......++.+.+..++.|++.|+.|+|+++||||||||+||||+ ..+.+||||||+|+.+..+..
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit---~~gvvKLCDFGFAR~L~~pgd- 156 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT---QNGVVKLCDFGFARTLSAPGD- 156 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe---cCCcEEeccchhhHhhcCCcc-
Confidence 9999999998887777799999999999999999999999999999999999996 889999999999998875332
Q ss_pred cccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc--------
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------- 233 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 233 (474)
.-+.++.|.+|.|||.+.| .+|+..+||||+||++.||++|...|.+..+-+....+.+......
T Consensus 157 ------~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 157 ------NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred ------hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence 1145688999999999998 6799999999999999999999999998765444444433322111
Q ss_pred ---------------cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 234 ---------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 234 ---------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
..+++.-...++.-+.+|++.||..||++|++.++++
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 1122222334456789999999999999999988874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-46 Score=368.27 Aligned_cols=259 Identities=23% Similarity=0.304 Sum_probs=218.5
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCch----HHHHHHHHHHHhcCCCCCceeEEEeEe-CCE
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQGGTGIPNLRWFGVE-GDY 77 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~l~~E~~il~~l~~~~~i~~l~~~~~~-~~~ 77 (474)
++-.+.|+.+++||+|.||.||+|++..+|+.||+|.+..+...+ ...+|+.||++|.|+++|.....+... ...
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 345567999999999999999999999999999999877655333 468999999999988777776666555 578
Q ss_pred EEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 78 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 78 ~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
+|||+|||..+|..++....-+|++.++..|+.||+.||+|||++||+|||||.+|||| |.+|.+||+|||||+.+.
T Consensus 193 iYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 193 IYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccceeecc
Confidence 99999999999999998777789999999999999999999999999999999999999 689999999999999887
Q ss_pred cCCCccccccccCCCCccCccccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc---
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--- 233 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--- 233 (474)
...... .+..+-|..|.|||.++|.. |+..+|+||.||||.||++|++.|++.+..+...++.+++...-
T Consensus 270 ~~~~~~------~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~ 343 (560)
T KOG0600|consen 270 PSGSAP------YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDY 343 (560)
T ss_pred CCCCcc------cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhc
Confidence 654321 24567899999999999865 99999999999999999999999999766555555555542111
Q ss_pred ------------------cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 234 ------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 234 ------------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
...+.+.+..+|....+|+..+|.+||++|.|+.+++
T Consensus 344 W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 344 WPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred cccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 1123344567789999999999999999999988764
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=370.38 Aligned_cols=264 Identities=23% Similarity=0.313 Sum_probs=213.3
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc-hH--HHHHHHHHHHhcCCCCCcee-EEEeEeCCEEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQ--LQYEAKLYKILQGGTGIPNL-RWFGVEGDYNV 79 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-~~--l~~E~~il~~l~~~~~i~~l-~~~~~~~~~~~ 79 (474)
.+-++|.++++||.|+||.||+|+.+.+++.||||.++.+-.. ++ -.+|++.|++|+.|++|..+ ..+.+.+...+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 3457899999999999999999999999999999987655332 22 47899999999955555555 44444444999
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 80 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 80 lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
+|||||..+|+++++..++.|++..+..|+.||++||+|+|.+|+.||||||+|||+. ....|||+|||+|+.....
T Consensus 87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~---~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS---GNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec---ccceeEecccccccccccC
Confidence 9999999999999998888899999999999999999999999999999999999994 5889999999999987654
Q ss_pred CCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc------
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------ 232 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~------ 232 (474)
. || +.++.|..|.|||+++. .-|+.+.|||++|||++|+.+-+..|.|....+...++-.+....
T Consensus 164 p-----PY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 164 P-----PY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred C-----Cc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 3 23 45789999999999886 458999999999999999999999999865544333333322111
Q ss_pred ----------------ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011945 233 ----------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281 (474)
Q Consensus 233 ----------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 281 (474)
....+..+...++.++.++|..|+.+||++|||++++ |+..|-+.+
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~a---l~~pffq~~ 297 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQA---LQHPFFQVG 297 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHH---hcCcccccc
Confidence 1223445556678999999999999999999998877 445544443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=344.67 Aligned_cols=270 Identities=21% Similarity=0.293 Sum_probs=229.4
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
-.++|++++.||.|+||.|.+++.+.+|..+|+|+++.... .+...+|..+|+.+. ++.+..+.+.+.+..+.+
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCeEE
Confidence 35689999999999999999999999999999999876532 234788999999998 677778888888999999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
|||||. ||-|..+++.+ ++|++..++.++.||+.||+|||+++|++|||||+|||| +.+|.+||+|||+|+....
T Consensus 121 mvmeyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EEEeccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEecC
Confidence 999999 89999999854 589999999999999999999999999999999999999 6899999999999998776
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
.. -+.|||+.|+|||++...+++..+|.|+|||++|||+.|..||...+. .+.|++|.+.+..
T Consensus 197 rT----------~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~iY~KI~~~~v~---- 259 (355)
T KOG0616|consen 197 RT----------WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQIYEKILEGKVK---- 259 (355)
T ss_pred cE----------EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HHHHHHHHhCccc----
Confidence 43 357999999999999999999999999999999999999999987543 7888888887764
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccccccccccCC
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVST 302 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~~~~ 302 (474)
++..+++++++|+..+|+.|-.+|- ..+..--+++ .+.++....+|.....+..+.+.
T Consensus 260 -fP~~fs~~~kdLl~~LL~vD~t~R~--gnlknG~~dI---k~H~wF~~v~W~~i~~r~ie~P~ 317 (355)
T KOG0616|consen 260 -FPSYFSSDAKDLLKKLLQVDLTKRF--GNLKNGVEDI---KNHPWFKGVDWEAILQRKIEPPF 317 (355)
T ss_pred -CCcccCHHHHHHHHHHHhhhhHhhh--cCcCCCcccc---ccCcccccccHHHHhhccccCCC
Confidence 3466789999999999999999982 1122122222 34567778999988766555544
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=360.85 Aligned_cols=260 Identities=24% Similarity=0.395 Sum_probs=207.4
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeEeCC-EEEEEEe
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD-YNVLVID 83 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~-~~~lv~e 83 (474)
.+|...+.||+|+||.||++.+..+|+.+|||.+..... .+.+.+|+.+|..|+|+++|..+........ .++|.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 458889999999999999999999999999998765411 3458999999999995555555443334343 7899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCC-CCeEEEEecCCccccccCCC
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~-~~~vkL~DFGla~~~~~~~~ 161 (474)
|+ +++|.+++...+.+|++..+..++.||+.||+|||++|||||||||+|||++ . ++.+||+|||+++.......
T Consensus 97 y~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~---~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD---PSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe---CCCCeEEeccCccccccccccc
Confidence 99 9999999987665899999999999999999999999999999999999995 5 68999999999987764111
Q ss_pred ccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
. ......+.||+.|||||++.+ ....+++|||||||++.||+||+.||.+. ......+..+.... ..+.+
T Consensus 174 ~----~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~---~~P~i 244 (313)
T KOG0198|consen 174 K----SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGRED---SLPEI 244 (313)
T ss_pred c----ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccC---CCCCC
Confidence 1 112345789999999999995 34556999999999999999999999874 22223333333322 22356
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 281 (474)
+..++++.++||..|+..||++|||+++| |++.|....
T Consensus 245 p~~ls~~a~~Fl~~C~~~~p~~Rpta~eL---L~hpf~~~~ 282 (313)
T KOG0198|consen 245 PDSLSDEAKDFLRKCFKRDPEKRPTAEEL---LEHPFLKQN 282 (313)
T ss_pred CcccCHHHHHHHHHHhhcCcccCcCHHHH---hhChhhhcc
Confidence 67799999999999999999999998776 667765553
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=364.33 Aligned_cols=247 Identities=26% Similarity=0.335 Sum_probs=210.1
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-------CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCC
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 76 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-------~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (474)
...++|++++.||+|+||.|++|.+..+++.||||+++.+ ...+.+.+|+.+++.+.+|++|..+..+.....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457899999999999999999999999999999987664 234567789999999996767777777777777
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCC-CeEEEEecCCcc
Q 011945 77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA-NQVYIIDFGLAK 154 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~-~~vkL~DFGla~ 154 (474)
..++||||+ ||.|.+++.. .+++.+..+..++.||+.|++|||++||+||||||+|||++ .+ +.+||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld---~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLD---GNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEec---CCCCCEEEecccccc
Confidence 799999999 7799999986 78899999999999999999999999999999999999995 55 999999999998
Q ss_pred ccc-cCCCccccccccCCCCccCccccccccccCCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc
Q 011945 155 RYR-DTATHQHIPYRENKNLTGTARYASMNTHLGIE-QS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (474)
Q Consensus 155 ~~~-~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s-~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (474)
... ... ...+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|.+||.+. +....+.+|...
T Consensus 170 ~~~~~~~--------~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~---~~~~l~~ki~~~ 238 (370)
T KOG0583|consen 170 ISPGEDG--------LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS---NVPNLYRKIRKG 238 (370)
T ss_pred ccCCCCC--------cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc---cHHHHHHHHhcC
Confidence 774 221 236789999999999999987 75 8999999999999999999999873 344455555444
Q ss_pred cccchHHHHhcCC-cHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 232 KVSTSIEALCRGY-PTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 232 ~~~~~~~~l~~~~-p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.+. ++..+ ++++..|+.+||..||.+|+++.+|.
T Consensus 239 ~~~-----~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 239 EFK-----IPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred Ccc-----CCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 432 23445 89999999999999999999977775
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=362.25 Aligned_cols=273 Identities=21% Similarity=0.303 Sum_probs=217.1
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
.++|++++.||+|+||+||+|+.+.||+.+|+|++++... ...+..|-.+|.. ...+.|+.+++.+++.++.||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~-~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAE-VDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhh-cCCCcEEEEEEEecCCCeeEE
Confidence 4689999999999999999999999999999999876543 2347889999988 557888888888999999999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
+|||+ ||++..++.. .+.|++..+..++.+++.||+.||+.|||||||||+|+|| +..|++||+|||||..+...
T Consensus 219 iMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccchhhhh
Confidence 99999 9999999973 5689999999999999999999999999999999999999 69999999999999754321
Q ss_pred CCc------------------ccccc----c------------------cCCCCccCccccccccccCCCCCchhhHHHH
Q 011945 160 ATH------------------QHIPY----R------------------ENKNLTGTARYASMNTHLGIEQSRRDDLESL 199 (474)
Q Consensus 160 ~~~------------------~~~~~----~------------------~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSl 199 (474)
... ...+. + -....+|||.|||||++.+..|+..+|+|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 000 00010 0 1234689999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 200 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 200 Gvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
||||||||.|.+||.+.+. .+.+.+|..-+..-..+ -...++++.++||.+|+. ||++|-...-+.++
T Consensus 375 G~ImyEmLvGyPPF~s~tp---~~T~rkI~nwr~~l~fP-~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EI------- 442 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETP---QETYRKIVNWRETLKFP-EEVDLSDEAKDLITRLLC-DPENRLGSKGAEEI------- 442 (550)
T ss_pred HHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhhhccCC-CcCcccHHHHHHHHHHhc-CHHHhcCcccHHHH-------
Confidence 9999999999999988544 44555554322111110 013456999999999999 99999763222222
Q ss_pred cCCCCCCccccccccc
Q 011945 280 EGFQFDYVFDWTILKY 295 (474)
Q Consensus 280 ~~~~~~~~~dw~~~~~ 295 (474)
...++...++|+-+..
T Consensus 443 K~HPfF~~v~W~~l~~ 458 (550)
T KOG0605|consen 443 KKHPFFKGVDWDHLRE 458 (550)
T ss_pred hcCCccccCCcchhhc
Confidence 2347778899998754
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=362.83 Aligned_cols=253 Identities=24% Similarity=0.356 Sum_probs=208.9
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-C
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 86 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (474)
+++++.||+|.||+||+|.+. ....||+|.++..... ..|.+|+++|++|+|.+ |+.+++++..++..+|||||+ .
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~-lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEK-LVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHhcCCccceEEEEEEc-CCCcccceEEeccccChhHHHHHHHHHHhCcccC-eEEEEEEEecCCceEEEEEeccc
Confidence 456789999999999999973 3448999988775544 67899999999999655 455555566666899999999 8
Q ss_pred CCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccc
Q 011945 87 PSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 165 (474)
Q Consensus 87 ~sL~~li~~-~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (474)
|+|.+++.. ....+...+.+.++.|||+||+||+++++|||||-..||||+ ++..+||+|||||+...++...
T Consensus 286 GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~---~~~~vKIsDFGLAr~~~d~~Y~--- 359 (468)
T KOG0197|consen 286 GSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVD---EDLVVKISDFGLARLIGDDEYT--- 359 (468)
T ss_pred CcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeec---cCceEEEcccccccccCCCcee---
Confidence 999999986 456799999999999999999999999999999999999994 7889999999999965554432
Q ss_pred ccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCC
Q 011945 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (474)
Q Consensus 166 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (474)
......-...|.|||.+....++.|||||||||+||||+| |+.||.++... +.++.+..... -..+..|
T Consensus 360 ---~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~---ev~~~le~GyR----lp~P~~C 429 (468)
T KOG0197|consen 360 ---ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE---EVLELLERGYR----LPRPEGC 429 (468)
T ss_pred ---ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH---HHHHHHhccCc----CCCCCCC
Confidence 2223344678999999999999999999999999999999 99999986553 33333333222 1224679
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 245 PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 245 p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
|+++.++|..||..+|++||||+.+...|++++..
T Consensus 430 P~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 430 PDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 99999999999999999999999999999998754
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=366.55 Aligned_cols=272 Identities=22% Similarity=0.284 Sum_probs=228.3
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
-.++|.++++||+|+||+|+++..+.+++.+|||++++.. ..+.+..|.+|+.....|+.+..++.+++..++.|
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~ 445 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF 445 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence 3578999999999999999999999999999999887653 34568899999999999999999999999999999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
+||||+ ||++..+. ..+.|++..+..++..|+.||+|||++||||||||.+|||+ |..|++||+|||+++....
T Consensus 446 fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 446 FVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccccCC
Confidence 999999 66633333 25689999999999999999999999999999999999999 6899999999999997553
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
... ...+++||+.|||||++.+..|+..+|+|||||+|||||.|..||.+.+ ..+.+..|.......
T Consensus 521 ~g~-------~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd---Eee~FdsI~~d~~~y--- 587 (694)
T KOG0694|consen 521 QGD-------RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD---EEEVFDSIVNDEVRY--- 587 (694)
T ss_pred CCC-------ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHhcCCCCC---
Confidence 222 2467899999999999999999999999999999999999999999854 345555555544332
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCH-----HHHHHHHHHHHHHcCCCCCCccccccccccccccCCCCCc
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDY-----AYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVSTPARA 306 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~-----~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~~~~p~~~ 306 (474)
+..++.+..++|+.+|..+|++|-.+ ++|. . ..+....||+.+...+.+++..+..
T Consensus 588 --P~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~---~-------hpFFr~i~w~~L~~r~i~PPf~P~i 648 (694)
T KOG0694|consen 588 --PRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIK---K-------HPFFRSIDWDDLLNRRIKPPFVPTI 648 (694)
T ss_pred --CCcccHHHHHHHHHHhccCcccccCCCCCCchhhh---h-------CCccccCCHHHHhhccCCCCCCccc
Confidence 35678999999999999999999765 2222 1 2556678999998887777665443
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=357.41 Aligned_cols=261 Identities=18% Similarity=0.316 Sum_probs=203.3
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEc-----CCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCcee-EEEeEeC
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNL-RWFGVEG 75 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l-~~~~~~~ 75 (474)
-.++|++.++||+|+||.||+|.+. .+++.||||++..... ...+..|+.++..+.+|++|..+ ..+...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 4578999999999999999999752 3457899998864332 24588899999999545555555 4444455
Q ss_pred CEEEEEEecC-CCCHHHHHHHcC---------------------------------------------------------
Q 011945 76 DYNVLVIDLL-GPSLEDLFNFCS--------------------------------------------------------- 97 (474)
Q Consensus 76 ~~~~lv~e~~-g~sL~~li~~~~--------------------------------------------------------- 97 (474)
...+++|||+ +++|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 6688999999 899999986421
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccccccCCCC
Q 011945 98 ----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 173 (474)
Q Consensus 98 ----~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 173 (474)
..+++.+++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++........ ......
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~---~~~~~kl~DfG~a~~~~~~~~~-----~~~~~~ 236 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDY-----VRKGSA 236 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEc---CCCcEEEeecccccccccCcch-----hcccCC
Confidence 2478889999999999999999999999999999999994 6789999999999865432211 112334
Q ss_pred ccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHH
Q 011945 174 TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYF 252 (474)
Q Consensus 174 ~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li 252 (474)
.++..|+|||++.+..++.++|||||||+||||++ |..||.+..... .....+..... ......+++++.+++
T Consensus 237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~~~----~~~~~~~~~~l~~li 310 (338)
T cd05102 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQRLKDGTR----MRAPENATPEIYRIM 310 (338)
T ss_pred CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHHHhcCCC----CCCCCCCCHHHHHHH
Confidence 56789999999999999999999999999999997 999998754321 11122221111 112356789999999
Q ss_pred HHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 253 HYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 253 ~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
..||..||++||++.+|++.|++++.+
T Consensus 311 ~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 311 LACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=358.89 Aligned_cols=253 Identities=21% Similarity=0.355 Sum_probs=210.9
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
..|....+||+|+.|.||.+....+++.||||.++... ..+-+..|+.+|+.++|.|+|.++..|... +..|+||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-deLWVVMEy 351 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-DELWVVMEY 351 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-ceeEEEEee
Confidence 56888999999999999999999999999999876543 345589999999999988888888666555 678999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 85 ~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
+ |++|.|++.. ..+++.++..|+.+++.||+|||.+||||||||.+|||++ .++.+||+|||+|..+......
T Consensus 352 m~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~---~~g~vKltDFGFcaqi~~~~~K- 425 (550)
T KOG0578|consen 352 MEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT---MDGSVKLTDFGFCAQISEEQSK- 425 (550)
T ss_pred cCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec---cCCcEEEeeeeeeeccccccCc-
Confidence 9 9999999973 3599999999999999999999999999999999999995 7788999999999988776542
Q ss_pred ccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcC
Q 011945 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (474)
..+.+||+.|||||+.....|++|+||||||+|++||+.|++||-..+. .+.+..|..... +.-.....
T Consensus 426 ------R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P---lrAlyLIa~ng~--P~lk~~~k 494 (550)
T KOG0578|consen 426 ------RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP---LRALYLIATNGT--PKLKNPEK 494 (550)
T ss_pred ------cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh---HHHHHHHhhcCC--CCcCCccc
Confidence 2578999999999999999999999999999999999999999976333 222222222111 11122356
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
++++|++|+.+||..|+++|+++.+| |++-|.+.
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eL---L~HpFl~~ 528 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKEL---LEHPFLKM 528 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHH---hcChhhhh
Confidence 88999999999999999999997766 66666543
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=339.34 Aligned_cols=268 Identities=17% Similarity=0.215 Sum_probs=205.8
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.++..+.|++++ .+..+...+...+++|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv-~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVV-SLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEE-EEEEEEccCCeEEEEE
Confidence 4889999999999999999999999999999875432 123467899999999865544 4555556677889999
Q ss_pred ecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 83 e~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCC
Confidence 998 78998887643 3469999999999999999999999999999999999999 477899999999998654322
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
. .....||..|+|||++.+..++.++|||||||++|||++|+.||...........+..... .....+
T Consensus 157 ~--------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~----~~~~~~ 224 (285)
T cd05631 157 T--------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK----EDQEEY 224 (285)
T ss_pred e--------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh----cccccC
Confidence 1 1235789999999999999999999999999999999999999987544322222222111 111223
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHH--HHHHHHHHHHHcCCCCCCcccccccccccc
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAY--LKRLFRDLFIREGFQFDYVFDWTILKYQQS 298 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~--l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~ 298 (474)
...+++++.+|+..||+.||++||++.+ +.+++++.+ ....+|..+...+.
T Consensus 225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~-------~~~~~~~~~~~~~~ 277 (285)
T cd05631 225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPI-------FKNINFKRLEANML 277 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHh-------hcCCCHHHHHhCcC
Confidence 4568899999999999999999997321 223344433 33456776654433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=354.97 Aligned_cols=252 Identities=22% Similarity=0.332 Sum_probs=214.1
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
++|.+.+.||+|+||.||+|+.+.+.+.||||.+.+.... ..+.+|++|++.|+|+++|..+.+|.. ....|+|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt-~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET-SAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc-cceEEEEe
Confidence 5799999999999999999999999999999987654322 348999999999998888877777654 45679999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 83 e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
||+-++|..++. .+++++++.+..|+.|++.||.|||+.+|+|||+||.|||+ +..+.+|+||||+|+.+.....
T Consensus 81 e~a~g~L~~il~-~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~- 155 (808)
T KOG0597|consen 81 EYAVGDLFTILE-QDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTS- 155 (808)
T ss_pred hhhhhhHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCce-
Confidence 999779999998 46789999999999999999999999999999999999999 5899999999999998765332
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhc
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (474)
......||+.|||||+..+.+|+..+|+||||||+||++.|++||.. ....+....|.......+ .
T Consensus 156 ------vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a---~si~~Lv~~I~~d~v~~p-----~ 221 (808)
T KOG0597|consen 156 ------VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA---RSITQLVKSILKDPVKPP-----S 221 (808)
T ss_pred ------eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH---HHHHHHHHHHhcCCCCCc-----c
Confidence 12456899999999999999999999999999999999999999975 455666666665544432 2
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011945 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281 (474)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 281 (474)
..+..|..|++.+|.+||..|.+..++ +.+.|.+..
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~L---l~HpF~k~~ 257 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTDL---LGHPFWKGK 257 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHHH---hcChHHhhh
Confidence 567899999999999999999997665 556665543
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=338.26 Aligned_cols=253 Identities=19% Similarity=0.245 Sum_probs=199.9
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
++|++.++||.|+||.||+|.+..+++.||+|++.... ....+.+|+.+++.++|+++ ..+..+.......++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI-VTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCE-eeEEEEEcCCCeEEEEEe
Confidence 57999999999999999999999999999999876432 23457899999999986554 455555666778999999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 84 ~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
|+.++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 84 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~~-- 158 (288)
T cd07871 84 YLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPTK-- 158 (288)
T ss_pred CCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeeccCCCc--
Confidence 99889999998666678999999999999999999999999999999999999 4778999999999976433221
Q ss_pred ccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc--------
Q 011945 164 HIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS-------- 234 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-------- 234 (474)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+.........
T Consensus 159 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 159 -----TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred -----cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence 1133478999999999876 46899999999999999999999999875432222222111110000
Q ss_pred --------------chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 235 --------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 235 --------------~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.........++.++.+||..||.+||.+|||+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l 283 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAAL 283 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 001112235678899999999999999999988875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=344.17 Aligned_cols=240 Identities=20% Similarity=0.256 Sum_probs=201.4
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
+|++++.||+|+||.||+|.+..+++.||||++... .....+..|..++..+.+++++..+..+....+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999987643 123457789999999998888988888888888999999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~---~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD---AEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEc---CCCCEEEeecCcceecCCCCC
Confidence 999 8899988874 45789999999999999999999999999999999999994 678999999999875332211
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
......||..|+|||++.+..++.++|||||||++|||++|+.||.+.. ....+..+..... .+.
T Consensus 157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~---~~~~~~~i~~~~~-----~~~ 221 (324)
T cd05587 157 -------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED---EDELFQSIMEHNV-----SYP 221 (324)
T ss_pred -------ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCC-----CCC
Confidence 1134579999999999999999999999999999999999999998643 3344444443322 223
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDY 266 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~ 266 (474)
..+++++.+++..||..||.+|++.
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 222 KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 5678999999999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=352.22 Aligned_cols=254 Identities=21% Similarity=0.327 Sum_probs=212.0
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
...|..++.||+|+||.||+|.+..+++.||||++..+... +.++.|+.+|..+++ ++|..++.....+...+++|
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~-~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDS-PNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCc-chHHhhhhheeecccHHHHH
Confidence 45688899999999999999999999999999998876544 458899999999986 55656666667888899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
||| ||++.++++. +..+.+..+..|+.+++.||.|||.++.+|||||+.|||+. ..+.|||+|||++..+.....
T Consensus 91 ey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s---~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS---ESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe---ccCcEEEEecceeeeeechhh
Confidence 999 8999999983 44569999999999999999999999999999999999996 559999999999987766543
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
...+++||+.|||||++.+..|+.|+||||||++.+||++|.+||..+.+... .........+.+.
T Consensus 167 -------rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-------lflIpk~~PP~L~ 232 (467)
T KOG0201|consen 167 -------RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV-------LFLIPKSAPPRLD 232 (467)
T ss_pred -------ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE-------EEeccCCCCCccc
Confidence 12678999999999999988999999999999999999999999998766211 1111122223344
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 281 (474)
..+++.|++||..||++||+.||++.+| |.+-|++..
T Consensus 233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~L---LKh~FIk~a 269 (467)
T KOG0201|consen 233 GDFSPPFKEFVEACLDKNPEFRPSAKEL---LKHKFIKRA 269 (467)
T ss_pred cccCHHHHHHHHHHhhcCcccCcCHHHH---hhhHHHHhc
Confidence 5788999999999999999999998776 555565553
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=356.70 Aligned_cols=252 Identities=20% Similarity=0.294 Sum_probs=213.0
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
-+.|++++.||.|+-|.|-+|++..||+.+|||++..... ...+.+|+.||+.|.|+|++..+ .......++|+
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~Ly-dVwe~~~~lyl 89 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLY-DVWENKQHLYL 89 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeee-eeeccCceEEE
Confidence 4679999999999999999999999999999999876522 23589999999999966655554 44556667777
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
|.||+ ||-|.+++- ..+++++.++..++.||+.|+.|+|..+|+||||||+|+||+ ..+.+||+|||+|..-...
T Consensus 90 vlEyv~gGELFdylv-~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd---~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLV-RKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLD---VKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EEEecCCchhHHHHH-hhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhh---cccCEeeeccceeecccCC
Confidence 78877 899999887 367899999999999999999999999999999999999994 6667999999999865544
Q ss_pred CCccccccccCCCCccCccccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
.. ..+.||++.|+|||++.|.+| +.++||||+|||||.||+|++||.+ ++....+.++....+.
T Consensus 166 kl--------LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD---dNir~LLlKV~~G~f~---- 230 (786)
T KOG0588|consen 166 KL--------LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD---DNIRVLLLKVQRGVFE---- 230 (786)
T ss_pred cc--------ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC---ccHHHHHHHHHcCccc----
Confidence 32 356799999999999999997 6899999999999999999999985 4566777777776664
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 281 (474)
++..+|.+.++||.+||..||+.|.|.++| |.+.|....
T Consensus 231 -MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI---~kHP~l~g~ 269 (786)
T KOG0588|consen 231 -MPSNISSEAQDLLRRMLDVDPSTRITTEEI---LKHPFLSGY 269 (786)
T ss_pred -CCCcCCHHHHHHHHHHhccCccccccHHHH---hhCchhhcC
Confidence 347899999999999999999999997766 666665443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=337.34 Aligned_cols=266 Identities=20% Similarity=0.303 Sum_probs=213.8
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
.-.+.|++...||.|..++||+|+.+.+++.||||+++.+.. .+.+.+|+..+..+.|+| |..++..+..+...|+
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPN-Iv~~~~sFvv~~~LWv 101 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPN-IVTYHCSFVVDSELWV 101 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCC-cceEEEEEEecceeEE
Confidence 346789999999999999999999999999999999876543 356899999999888555 5555556677778899
Q ss_pred EEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 81 VIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
||.|| +|++.++++.. ...|++..+..|+.++++||.|||.+|.||||||+.|||| +.+|.|||+|||.+..+.+
T Consensus 102 VmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 102 VMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSASLFD 178 (516)
T ss_pred eehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeeeecc
Confidence 99999 99999999743 4459999999999999999999999999999999999999 5899999999999877766
Q ss_pred CCCccccccccCCCCccCccccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc--
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS-- 234 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-- 234 (474)
....+ .++. +.++||+.|||||++.. ..|+.|+||||||++..||.+|..||..+.+ .+..+.++......
T Consensus 179 ~G~R~--~~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP--mkvLl~tLqn~pp~~~ 253 (516)
T KOG0582|consen 179 SGDRQ--VTRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP--MKVLLLTLQNDPPTLL 253 (516)
T ss_pred cCcee--eEee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh--HHHHHHHhcCCCCCcc
Confidence 54322 2333 78899999999999654 3599999999999999999999999988754 23333343332221
Q ss_pred --chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011945 235 --TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281 (474)
Q Consensus 235 --~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 281 (474)
.......+.++..|.+++..||.+||.+||+++++ |.+.|-+..
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskL---lkh~FFk~~ 299 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKL---LKHAFFKKA 299 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHH---hccHHHhhc
Confidence 11122235678899999999999999999998876 555555444
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=344.72 Aligned_cols=238 Identities=20% Similarity=0.297 Sum_probs=198.5
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
.++|++.+.||+|+||.||+|++..+++.||||++.... ....+..|+.+++.++|++++..+ .+...+...++
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~-~~~~~~~~~~l 95 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMM-CSFQDENRVYF 95 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEE-EEEEcCCEEEE
Confidence 478999999999999999999999999999999876431 234578999999999866555544 45567778999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
+|||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 96 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 96 LLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEcCCC
Confidence 99998 8899999874 4578999999999999999999999999999999999999 47889999999999866432
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
. ....||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+......
T Consensus 172 ~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~----- 233 (329)
T PTZ00263 172 T----------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT---PFRIYEKILAGRLK----- 233 (329)
T ss_pred c----------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC---HHHHHHHHhcCCcC-----
Confidence 2 23579999999999999999999999999999999999999997643 33444444443321
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDY 266 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~ 266 (474)
+...++..+.+||..||..||.+||+.
T Consensus 234 ~p~~~~~~~~~li~~~L~~dP~~R~~~ 260 (329)
T PTZ00263 234 FPNWFDGRARDLVKGLLQTDHTKRLGT 260 (329)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 234578899999999999999999973
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=332.24 Aligned_cols=253 Identities=19% Similarity=0.232 Sum_probs=206.6
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCch----HHHHHHHHHHHhcCCCCCceeEE--EeEeCCEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQGGTGIPNLRW--FGVEGDYNVL 80 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~l~~E~~il~~l~~~~~i~~l~~--~~~~~~~~~l 80 (474)
+.|+.+.+|++|+||.||+|+|+.|++.||+|.++.+.... .-.+|+.+|.+++| ++|+.+.. .+..-+..||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H-~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARH-PNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCC-CCeeeeEEEEeccccceeee
Confidence 56899999999999999999999999999999887765433 36899999999994 55555533 3556677999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 81 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 81 v~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||||..+|..+++....+|...++..++.|++.||+|||.+.|+||||||+|+|++ ..|.+||+|||+|+.+..+.
T Consensus 155 VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~---~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 155 VMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS---HKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec---cCCcEEecccchhhhhcCCc
Confidence 999999999999998888999999999999999999999999999999999999994 88999999999999987753
Q ss_pred CccccccccCCCCccCccccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc----cc-
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK----VS- 234 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~----~~- 234 (474)
. ..+..+-|..|.|||.++|.. |+...|+||+|||+.||+++++.|.+....+...++.++.... ++
T Consensus 232 k-------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 232 K-------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred c-------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence 2 224567899999999999865 9999999999999999999999999866554444444433211 00
Q ss_pred --------------chHHHHh---c--CCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 235 --------------TSIEALC---R--GYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 235 --------------~~~~~l~---~--~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.+...+. . ++++.-.+|+..+|.+||.+|.|+++.+
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L 359 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGL 359 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhh
Confidence 0001111 1 1347778999999999999999988763
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=339.67 Aligned_cols=236 Identities=22% Similarity=0.346 Sum_probs=196.6
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.|++++ .+..+..+....+++
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv-~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFII-RLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHh-hhHhhhccCCeEEEE
Confidence 47999999999999999999999999999999875432 234578899999999865554 444556677889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 80 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 80 MEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhccCCc
Confidence 9998 8899999874 4579999999999999999999999999999999999999 467899999999998664321
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
....||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ....+..+..... .+
T Consensus 156 ----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~-----~~ 217 (291)
T cd05612 156 ----------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN---PFGIYEKILAGKL-----EF 217 (291)
T ss_pred ----------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCc-----CC
Confidence 23579999999999999999999999999999999999999998743 3334444443332 12
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCC
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPD 265 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt 265 (474)
...++..+.++|.+||+.||.+||+
T Consensus 218 ~~~~~~~~~~li~~~l~~dp~~R~~ 242 (291)
T cd05612 218 PRHLDLYAKDLIKKLLVVDRTRRLG 242 (291)
T ss_pred CccCCHHHHHHHHHHcCCCHHHccC
Confidence 3456889999999999999999995
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=321.81 Aligned_cols=253 Identities=19% Similarity=0.226 Sum_probs=207.1
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.+|...++||+|.||.||+|++..+|+.||||.++..... -...+|++.|+.++|.++|..++ ++......-||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD-~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELID-VFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhh-hccCCCceEEEE
Confidence 5789999999999999999999999999999988765433 35899999999999666555554 455666678999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 83 e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
||+..+|+.+++.....++...+..++.+++.||+|||++.|+||||||.|+||+ .++.+||+|||+|+.+......
T Consensus 81 Efm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis---~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 81 EFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS---SDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred EeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc---CCCcEEeecccchhccCCCCcc
Confidence 9999999999998788899999999999999999999999999999999999995 8899999999999998765542
Q ss_pred cccccccCCCCccCccccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc-------
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS------- 234 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~------- 234 (474)
. ...+-|..|.|||.+.|.. |+..+||||.|||+.||+.|.+-|.|..+-+....+..+......
T Consensus 158 ~-------~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 158 Q-------THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred c-------ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccc
Confidence 2 1226799999999999854 899999999999999999999999886654444333333221111
Q ss_pred -------------chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 235 -------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 235 -------------~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.....+....+.+..+|+..||.+||.+|.++.+++
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL 279 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQAL 279 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHh
Confidence 111223345567889999999999999999987764
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=342.92 Aligned_cols=255 Identities=18% Similarity=0.233 Sum_probs=197.3
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEe----CCEEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVE----GDYNV 79 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~----~~~~~ 79 (474)
+|++.++||+|+||.||+|.+..+++.||||.+.... ....+.+|+.+++.++|++++..+..+... ....|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 6999999999999999999999999999999876421 223578899999999977766655544322 23579
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 80 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 80 lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
++|||++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 81 lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 81 VVFELMESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEecCCCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCccccccccc
Confidence 9999999999999874 4569999999999999999999999999999999999999 47889999999999865432
Q ss_pred CCccccccccCCCCccCccccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHH---------
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI--------- 228 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i--------- 228 (474)
.... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+...
T Consensus 157 ~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 157 TPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cCcc----ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 2111 01134579999999999876 57899999999999999999999999764422111111110
Q ss_pred --------------hhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 229 --------------SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 229 --------------~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
...............+++++.+++.+||..||++||++++++
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l 288 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEAL 288 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHh
Confidence 011111122223346788999999999999999999987774
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=334.92 Aligned_cols=254 Identities=19% Similarity=0.208 Sum_probs=198.9
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.++|++++.. ..+.......++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~-~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVEL-KEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccch-hhhEecCCEEEEEE
Confidence 57999999999999999999999999999999876432 23457889999999987665554 44556677899999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 83 e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
||+.+++.+.+......+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS---HNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEEeeccCcccccccccc
Confidence 9997676666655556799999999999999999999999999999999999994 7789999999999876432211
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc--------
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS-------- 234 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-------- 234 (474)
......||..|+|||++.+..++.++|||||||++|||++|+.||.+.........+..+......
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07848 157 ------NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS 230 (287)
T ss_pred ------cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence 112457899999999999989999999999999999999999999875432222222211100000
Q ss_pred ----------------chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 235 ----------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 235 ----------------~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.........++.++.+||.+||..||++||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l 282 (287)
T cd07848 231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCL 282 (287)
T ss_pred cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000111234678899999999999999999988765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=356.23 Aligned_cols=210 Identities=24% Similarity=0.342 Sum_probs=180.7
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhc-----CCCCCceeEEEeEeCCE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQ-----GGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~-----~~~~i~~l~~~~~~~~~ 77 (474)
.+..+|.|++.||+|+||.|.+|.+..|++.||||+++.+. ...+-..|+.+|..|+ +..++..+..++....+
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 34568999999999999999999999999999999987654 3466788999999998 23467777888899999
Q ss_pred EEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 78 NVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 78 ~~lv~e~~g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
.|||+|++..+|+++++..+ ..|+...+..|+.||+.||.+||+.||||+||||+||||..- ....|||+|||.|...
T Consensus 263 lciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~-~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP-KRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC-CcCceeEEeccccccc
Confidence 99999999999999998543 459999999999999999999999999999999999999643 3348999999999866
Q ss_pred ccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHH
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~ 224 (474)
.+... .++.+..|.|||+++|.+|+.+.||||||||+.||++|.+.|.|....+....
T Consensus 342 ~q~vy----------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~ 399 (586)
T KOG0667|consen 342 SQRVY----------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLAR 399 (586)
T ss_pred CCcce----------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHH
Confidence 54322 45778999999999999999999999999999999999999988655443333
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=335.21 Aligned_cols=252 Identities=20% Similarity=0.259 Sum_probs=197.4
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.++|++.++||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+.|++++ .+..+...+...++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV-LLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcC-eEEEEEecCCeEEEEE
Confidence 4689999999999999999999999999999998764322 23577899999999866554 5555566778899999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 83 e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
||++++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +..+.+||+|||+++.......
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~- 158 (303)
T cd07869 83 EYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVPSH- 158 (303)
T ss_pred ECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceeccCCCc-
Confidence 999999999987666679999999999999999999999999999999999999 4778999999999975432211
Q ss_pred cccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc--------
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------- 233 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 233 (474)
......||..|+|||++.+. .++.++|||||||++|||++|..||.+... ....+..+.....
T Consensus 159 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (303)
T cd07869 159 ------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWP 230 (303)
T ss_pred ------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhcc
Confidence 11335789999999998764 589999999999999999999999987543 2222222211000
Q ss_pred -----------------cchHHHHh--cCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 234 -----------------STSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 234 -----------------~~~~~~l~--~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
........ ..+++.+.+|+..||+.||++||++.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l 286 (303)
T cd07869 231 GVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL 286 (303)
T ss_pred chhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHh
Confidence 00000001 12457889999999999999999977663
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=345.78 Aligned_cols=246 Identities=21% Similarity=0.315 Sum_probs=199.1
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++|+++++||+|+||.||+|++..+++.||||++.... ....+..|+.++..+.| ++|..+..+.......|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS-EWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCC-CCCccEEEEEEcCCEEEEE
Confidence 57999999999999999999999999999999876432 23457889999999985 4555555666778889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||++......
T Consensus 80 ~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~~- 154 (333)
T cd05600 80 MEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVTY- 154 (333)
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCcccccc-
Confidence 9999 8899999974 4579999999999999999999999999999999999999 47789999999999865431
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc---cchH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV---STSI 237 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~---~~~~ 237 (474)
.....||+.|+|||++.+..++.++|||||||+||||++|..||.+.... +.+..+..... ....
T Consensus 155 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~~~~~~ 222 (333)
T cd05600 155 ---------ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN---ETWENLKYWKETLQRPVY 222 (333)
T ss_pred ---------cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH---HHHHHHHhccccccCCCC
Confidence 23457999999999999999999999999999999999999999875432 22222221110 0100
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
......+++++.++|..||..+|++||++.+++
T Consensus 223 ~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll 255 (333)
T cd05600 223 DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIK 255 (333)
T ss_pred CccccccCHHHHHHHHHHhhChhhhcCCHHHHH
Confidence 001125689999999999999999999976664
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=337.59 Aligned_cols=261 Identities=18% Similarity=0.268 Sum_probs=199.0
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcC----------------CCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCC
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQ----------------TNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGI 65 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~----------------~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i 65 (474)
..++|++.++||+|+||.||+|.+.. ++..||||++..... ...+.+|+.++..++|++ |
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-i 81 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPN-I 81 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCC-e
Confidence 45789999999999999999998532 345799998865432 235889999999998655 4
Q ss_pred ceeEEEeEeCCEEEEEEecC-CCCHHHHHHHcC------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 011945 66 PNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS------------------RKLSLKTVLMLADQMINRVEFVHSKSFLH 126 (474)
Q Consensus 66 ~~l~~~~~~~~~~~lv~e~~-g~sL~~li~~~~------------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiH 126 (474)
..+..++......+++|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 45555556667789999998 889999986421 23678899999999999999999999999
Q ss_pred cCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHH
Q 011945 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYF 206 (474)
Q Consensus 127 rDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~el 206 (474)
|||||+|||++ .++.+||+|||+++.+..... +.......++..|+|||++.+..++.++|||||||++|||
T Consensus 162 ~dlkp~Nill~---~~~~~kl~DfG~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 233 (304)
T cd05096 162 RDLATRNCLVG---ENLTIKIADFGMSRNLYAGDY-----YRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233 (304)
T ss_pred cCcchhheEEc---CCccEEECCCccceecccCce-----eEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHH
Confidence 99999999994 678999999999986543321 1112334568899999999988999999999999999999
Q ss_pred Hh--CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011945 207 LR--GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 274 (474)
Q Consensus 207 lt--G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (474)
++ +..||.+............................+|..+.+|+.+||..||++||++.+|.+.|+
T Consensus 234 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 234 LMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 86 678888754332222221111111111111123467899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=353.72 Aligned_cols=254 Identities=20% Similarity=0.267 Sum_probs=197.2
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeE-------eCCE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV-------EGDY 77 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~-------~~~~ 77 (474)
..++|+++++||+|+||.||+|.+..+++.||||++... .....+|+.+++.++|++++..+..+.. ...+
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~--~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD--PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC--cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 356899999999999999999999999999999987543 2345689999999998777776554432 1235
Q ss_pred EEEEEecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 78 NVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 78 ~~lv~e~~g~sL~~li~~---~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
.++||||++++|.+++.. ....+++..++.++.||+.||.|||++|||||||||+||||+ ...+.+||+|||+|+
T Consensus 142 l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~--~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 142 LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGSAK 219 (440)
T ss_pred EEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEc--CCCCceeeeccccch
Confidence 779999999999888753 345699999999999999999999999999999999999995 234579999999998
Q ss_pred ccccCCCccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc-
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK- 232 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~- 232 (474)
.+..... .....||+.|+|||++.+. .++.++|||||||+||||++|.+||.+.........+..+....
T Consensus 220 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~ 291 (440)
T PTZ00036 220 NLLAGQR--------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT 291 (440)
T ss_pred hccCCCC--------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 7643221 1245789999999998765 58999999999999999999999998754322222221111000
Q ss_pred --------------------ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 233 --------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 233 --------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.......++...|+++.+||.+||..||.+||++.+++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 00011122345788999999999999999999988764
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=333.05 Aligned_cols=262 Identities=19% Similarity=0.243 Sum_probs=211.0
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEec----cCCCchHHHHHHHHHHHhcCCCCCceeEEEeE----eCC
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN----VKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV----EGD 76 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~----~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~----~~~ 76 (474)
+..+|..++.||.|+||.|+.+.++.+|+.||||.+. .....+...+|+++|+.++|.|+|..+..+.. .-.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 4567888899999999999999999999999999765 22344568899999999998888877777655 345
Q ss_pred EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 77 YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 77 ~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
..|+|+|+|+.+|.++++ .+..++...+..++.||+.||.|+|+.+|+||||||.|+|+ +.+..+||||||+|+..
T Consensus 100 DvYiV~elMetDL~~iik-~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~---n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 100 DVYLVFELMETDLHQIIK-SQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL---NADCDLKICDFGLARYL 175 (359)
T ss_pred eeEEehhHHhhHHHHHHH-cCccccHHHHHHHHHHHHHhcchhhcccccccccchhheee---ccCCCEEeccccceeec
Confidence 679999999999999998 34459999999999999999999999999999999999999 57888999999999987
Q ss_pred ccCCCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHH-------
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI------- 228 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i------- 228 (474)
...... ...+.++-|..|.|||++.. ..|+...||||+||||.||++|+..|.|.+.-...+.+..+
T Consensus 176 ~~~~~~-----~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 176 DKFFED-----GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred cccCcc-----cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 643111 12356788999999998775 56999999999999999999999999885433222222111
Q ss_pred -----h-----------hccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 229 -----S-----------EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 229 -----~-----------~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
. ......+...+..+.++...+|+++||.+||.+|+|+++. |.+.+-
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eA---L~hPYl 313 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEA---LAHPYL 313 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHH---hcChhh
Confidence 1 1222334455566788999999999999999999997765 555543
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=355.06 Aligned_cols=257 Identities=22% Similarity=0.332 Sum_probs=207.4
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
.+.+.+...||+|.||+||+|+|. | .||||+++.+.-. +.|.+|+.+|++-+|.|++.. .+++....+ .||
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh--G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLF-MG~~~~p~~-AIi 465 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH--G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLF-MGACMNPPL-AII 465 (678)
T ss_pred HHHhhccceeccccccceeecccc--c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheee-ehhhcCCce-eee
Confidence 456778999999999999999974 3 5999999876543 348999999999986655544 445555555 778
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
.-+| |.+|+.++.-...+|...+.+.|+.||++||.|||.++|||||||..||++ .++++|||+||||+..-.--.
T Consensus 466 TqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 466 TQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred ehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccceeeeeeec
Confidence 8888 889999998777889999999999999999999999999999999999999 466999999999996533221
Q ss_pred CccccccccCCCCccCccccccccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~---~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
..+. .....|...|||||++..+ +|++.+||||||||+|||++|.+||... ...+.+..+.........
T Consensus 543 g~~q-----~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~---~~dqIifmVGrG~l~pd~ 614 (678)
T KOG0193|consen 543 GEQQ-----LEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ---NRDQIIFMVGRGYLMPDL 614 (678)
T ss_pred cccc-----cCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC---ChhheEEEecccccCccc
Confidence 1111 1334788999999999854 5899999999999999999999999843 233444444444444555
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
......+|.++++|+..||.+++++||.+.+|+..|+.++.
T Consensus 615 s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 615 SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 56667899999999999999999999999999998888764
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=332.77 Aligned_cols=254 Identities=19% Similarity=0.247 Sum_probs=196.1
Q ss_pred CcEEEeeeeeecCceEEEEEEEcC-CCeEEEEEEeccCCC----chHHHHHHHHHHHhc---CCCCCceeEEEe----Ee
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKTK----HPQLQYEAKLYKILQ---GGTGIPNLRWFG----VE 74 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~-~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~---~~~~i~~l~~~~----~~ 74 (474)
++|++.+.||+|+||.||+|++.. +++.||||++..... ...+.+|+.+++.+. |++++..+..+. ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999854 468899998764322 235677888888774 444444444332 23
Q ss_pred CCEEEEEEecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCc
Q 011945 75 GDYNVLVIDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (474)
Q Consensus 75 ~~~~~lv~e~~g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (474)
....+++||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~---~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEc---CCCCEEEccccce
Confidence 4568999999999999998743 34589999999999999999999999999999999999994 6789999999999
Q ss_pred cccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhh---
Q 011945 154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE--- 230 (474)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~--- 230 (474)
+...... ......||..|+|||++.+..++.++|||||||++|||++|..||.+....+....+.....
T Consensus 158 ~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~ 229 (290)
T cd07862 158 RIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 229 (290)
T ss_pred EeccCCc--------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence 8654321 12345789999999999998999999999999999999999999987543222222211110
Q ss_pred ----------------ccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 231 ----------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 231 ----------------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.......+.+...+++.+.+++.+||+.||++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 01111233344567889999999999999999999888753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=332.96 Aligned_cols=261 Identities=25% Similarity=0.458 Sum_probs=191.1
Q ss_pred CCccCCcEEEeeeeeecCceEEEEEEEcCC---CeEEEEEEeccCCCchHH----------HHHHH---HHHHhcCCCCC
Q 011945 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKHPQL----------QYEAK---LYKILQGGTGI 65 (474)
Q Consensus 2 ~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAvK~~~~~~~~~~l----------~~E~~---il~~l~~~~~i 65 (474)
....+++|++.++||+|+||.||+|.+..+ +..+|+|+.......... ..++. .+..+.| .++
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h-~~i 85 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDH-LGI 85 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCC-CCC
Confidence 345678999999999999999999998777 677888875433221100 11122 2223343 344
Q ss_pred ceeEEEeEeC----CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCC
Q 011945 66 PNLRWFGVEG----DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (474)
Q Consensus 66 ~~l~~~~~~~----~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~ 141 (474)
+.+..++... .+.+++++++..++.+++... ..+++..++.|+.||+.||.|||+++|+||||||+|||++ .
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~---~ 161 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVD---G 161 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehhccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---C
Confidence 4444443322 255788898888998888743 3468889999999999999999999999999999999994 6
Q ss_pred CCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcH
Q 011945 142 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221 (474)
Q Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~ 221 (474)
.+.++|+|||+|+.+..................||+.|+|||++.+..++.++|||||||+||||++|+.||.+......
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 78899999999987754322111111122345799999999999999999999999999999999999999987643222
Q ss_pred HHH------HHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011945 222 KQK------YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 273 (474)
Q Consensus 222 ~~~------~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (474)
... +..+...+ .....+|+++.+++..||..+|++||++++|++.|
T Consensus 242 ~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 242 LIHAAKCDFIKRLHEGK------IKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHhHHHHHHHhhhhh------hccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111 11111111 12356789999999999999999999999999876
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=340.60 Aligned_cols=252 Identities=19% Similarity=0.276 Sum_probs=199.6
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-C
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 86 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (474)
+.||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.+.|++ |..+..++..+...|+||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~-i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPF-LTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCC-CCCEEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999876432 1234678999999998655 455555666778899999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccc
Q 011945 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166 (474)
Q Consensus 87 ~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (474)
++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~----- 150 (323)
T cd05571 80 GELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGA----- 150 (323)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCC-----
Confidence 899888874 4579999999999999999999999999999999999999 4778999999999975432211
Q ss_pred cccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcH
Q 011945 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (474)
Q Consensus 167 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (474)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ....+..+..... .+...+++
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~~~~~~~-----~~p~~~~~ 220 (323)
T cd05571 151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILMEEI-----RFPRTLSP 220 (323)
T ss_pred --cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC---HHHHHHHHHcCCC-----CCCCCCCH
Confidence 1234579999999999999999999999999999999999999997633 2333333332222 23456889
Q ss_pred HHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCcccccccc
Q 011945 247 EFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILK 294 (474)
Q Consensus 247 ~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 294 (474)
++.++|..||..||++|| ++.+|+ ++ .+....+|....
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll---~h-------~~f~~~~~~~~~ 263 (323)
T cd05571 221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIM---EH-------RFFASINWQDVV 263 (323)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHH---cC-------CCcCCCCHHHHH
Confidence 999999999999999999 655553 32 334445676543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=340.32 Aligned_cols=263 Identities=20% Similarity=0.260 Sum_probs=210.6
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
+|.+++.||+|+||.||+|.+..+++.||||++.... ....+..|..++..+.+++++..+..+....+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5899999999999999999999999999999876432 12246678888888888899998888888889999999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCCCCC
Confidence 999 8899988864 4579999999999999999999999999999999999999 4778999999999975432221
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ...+..+...... ++
T Consensus 157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~~~~~~-----~p 221 (323)
T cd05616 157 -------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIMEHNVA-----YP 221 (323)
T ss_pred -------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCC-----CC
Confidence 12345799999999999999999999999999999999999999987433 3444444433321 23
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHH--HHHHHHHHHHHcCCCCCCcccccccccc
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAY--LKRLFRDLFIREGFQFDYVFDWTILKYQ 296 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~--l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 296 (474)
..++.++.+++..||..||++|++... ..++++ ..+....+|......
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~-------h~~~~~~~~~~~~~~ 271 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE-------HAFFRYIDWEKLERK 271 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc-------CCCcCCCCHHHHHhC
Confidence 567899999999999999999998521 112222 233445678765543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=339.33 Aligned_cols=253 Identities=18% Similarity=0.252 Sum_probs=200.3
Q ss_pred cEEEeeeeeecCceEEEEEEEc---CCCeEEEEEEeccCC------CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAvK~~~~~~------~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
+|+++++||+|+||.||++++. .+++.||+|++.... ....+..|+.+++.+.++++|..+..+.......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 478999999875321 2235778999999998888888888888888899
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
+++|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.+.
T Consensus 81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~---~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD---SEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEEC---CCCCEEEeeCcCCcccc
Confidence 9999999 8899998863 45799999999999999999999999999999999999994 67899999999998654
Q ss_pred cCCCccccccccCCCCccCccccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcH-HHHHHHHhhccccc
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVST 235 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~ 235 (474)
...... .....||..|+|||++.+.. ++.++|||||||+||||++|..||........ ......+....
T Consensus 157 ~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--- 227 (332)
T cd05614 157 SEEKER------TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD--- 227 (332)
T ss_pred ccCCCc------cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC---
Confidence 332211 12457999999999998754 78999999999999999999999975433222 22222222211
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHH
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRD 275 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~--~l~~~L~~ 275 (474)
..+...+++.+.+++..||..||++||++. .+.+++++
T Consensus 228 --~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 228 --PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 122346789999999999999999999543 33344444
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=356.62 Aligned_cols=254 Identities=18% Similarity=0.245 Sum_probs=192.3
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-CCchHHHHHHHHHHHhcCCCC-----Cce-eEEEeEeCCEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLQYEAKLYKILQGGTG-----IPN-LRWFGVEGDYN 78 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-~~~~~l~~E~~il~~l~~~~~-----i~~-l~~~~~~~~~~ 78 (474)
.++|+++++||+|+||+||+|.+..+++.||||+++.. .....+..|+.+++.+.+.+. +.. +.++.......
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 47899999999999999999999999999999998643 223456778899888875432 333 34444556788
Q ss_pred EEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEeeeCC-------------CCCe
Q 011945 79 VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGR-------------RANQ 144 (474)
Q Consensus 79 ~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs-~gIiHrDIKP~NILl~~~~-------------~~~~ 144 (474)
||||+++|++|.+++.. .+.+++..++.|+.||+.||.|||+ .|||||||||+|||++.++ +...
T Consensus 208 ~iv~~~~g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~ 286 (467)
T PTZ00284 208 CIVMPKYGPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR 286 (467)
T ss_pred EEEEeccCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCce
Confidence 99999999999998874 4579999999999999999999998 5999999999999996322 1225
Q ss_pred EEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHH
Q 011945 145 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224 (474)
Q Consensus 145 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~ 224 (474)
+||+|||++...... ....+||..|+|||++.+..++.++|||||||+||||++|+.||.+.........
T Consensus 287 vkl~DfG~~~~~~~~----------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 287 VRICDLGGCCDERHS----------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred EEECCCCccccCccc----------cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 999999988643221 2346899999999999999999999999999999999999999987543322222
Q ss_pred HHHHhhcccc---------------------------chHHHHhc-------CCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 225 YEKISEKKVS---------------------------TSIEALCR-------GYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 225 ~~~i~~~~~~---------------------------~~~~~l~~-------~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
+.++...... ..+..+.. ...+.+.+||..||.+||++||++++++
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 2221110000 00000000 0135678999999999999999988774
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=348.02 Aligned_cols=250 Identities=21% Similarity=0.256 Sum_probs=218.9
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
.++|.++++||+|+||.+++++++..+..|++|.+..... ......|+.+++++.|+++|.+...|..++.+.+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 4689999999999999999999999999999998876542 235789999999999888888888888888889999
Q ss_pred EecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 82 IDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
|+|| ||+|.+.++..+ ..|+++.++.|+.||+.||.|||+++|+|||||+.||+++ +++.|||.|||+|+.+...
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt---k~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT---KDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc---ccCceeecchhhhhhcCCc
Confidence 9999 999999998655 5699999999999999999999999999999999999995 7778899999999988776
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
.. ...+++||+.||+||++.+.+|+.|+|||||||++|||++-+.+|... +....+.+|..... ..
T Consensus 160 ~~-------~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~---~m~~Li~ki~~~~~----~P 225 (426)
T KOG0589|consen 160 DS-------LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS---NMSELILKINRGLY----SP 225 (426)
T ss_pred hh-------hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc---chHHHHHHHhhccC----CC
Confidence 42 235689999999999999999999999999999999999999999874 44555556555442 33
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL 272 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~ 272 (474)
+...++.+++.+|..||..+|+.||++.+|+..
T Consensus 226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 557789999999999999999999999888654
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=345.65 Aligned_cols=257 Identities=21% Similarity=0.338 Sum_probs=202.7
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCC-----CeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
++|++.+.||+|+||.||+|.+... ++.||||++..... ...+.+|+.+++.+..|++|..+..++......
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 4699999999999999999986544 35799998865432 235788999999995566666666677777889
Q ss_pred EEEEecC-CCCHHHHHHHcC------------------------------------------------------------
Q 011945 79 VLVIDLL-GPSLEDLFNFCS------------------------------------------------------------ 97 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~------------------------------------------------------------ 97 (474)
+++|||+ +++|.+++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 9999999 889999885321
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccccc
Q 011945 98 ---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 168 (474)
Q Consensus 98 ---------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 168 (474)
..+++..++.|+.||+.||.|||++||+||||||+|||++ +++.+||+|||+++.+...... .
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~---~~~~~kL~DfGla~~~~~~~~~-----~ 269 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT---DGRVAKICDFGLARDIMNDSNY-----V 269 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEe---CCCeEEEeeceeeeeccCCcce-----e
Confidence 2478889999999999999999999999999999999995 6788999999999865443211 1
Q ss_pred cCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHH
Q 011945 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 247 (474)
Q Consensus 169 ~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 247 (474)
......++..|||||++.+..++.++|||||||++|||++ |+.||....... .+.......... .....+|++
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~~~~~~~~~~~---~~~~~~~~~ 343 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KFYKMVKRGYQM---SRPDFAPPE 343 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HHHHHHHcccCc---cCCCCCCHH
Confidence 1123345678999999999899999999999999999997 999998754322 122221111111 122346899
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 248 FASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 248 l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
+.+++..||+.||++||++.+|.++|++++
T Consensus 344 l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 344 IYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=337.27 Aligned_cols=264 Identities=20% Similarity=0.253 Sum_probs=211.4
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
+|.+.+.||+|+||.||+|.+..+++.||||++.... ....+..|..++..+.+++++..+..+....+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4789999999999999999999999999999876431 22346788899999988999988888888888999999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
||+ +++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCCCCc
Confidence 999 8899998874 4579999999999999999999999999999999999999 4778999999999975432221
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
......||..|+|||++.+..++.++|||||||++|||++|..||.+... ...+..+...... +.
T Consensus 157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i~~~~~~-----~p 221 (323)
T cd05615 157 -------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQSIMEHNVS-----YP 221 (323)
T ss_pred -------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCC-----CC
Confidence 12345799999999999999999999999999999999999999987532 3344444433321 23
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccccc
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 295 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 295 (474)
..++.++.+++..||..+|.+|++..+. ..+++. ..++...++|.....
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~R~~~~~~--~~~~i~---~h~~f~~~~~~~~~~ 270 (323)
T cd05615 222 KSLSKEAVSICKGLMTKHPSKRLGCGPE--GERDIR---EHAFFRRIDWDKLEN 270 (323)
T ss_pred ccCCHHHHHHHHHHcccCHhhCCCCCCC--CHHHHh---cCcccCCCCHHHHhc
Confidence 5678999999999999999999985321 112221 234455678876543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=332.80 Aligned_cols=269 Identities=22% Similarity=0.333 Sum_probs=219.1
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
+.|++++.||.|.-|+||+|+...++..+|+|++.... ...+.+.|.+||..+. |+.++.++..++..++.|++
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD-HPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD-HPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC-CCccchhhheeeccceeEEE
Confidence 46889999999999999999999999999999987643 2235778999999988 77888998899999999999
Q ss_pred EecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 82 IDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
|||| ||+|..+.+.. ++.|++..+..++.+|+.||+|||-.|||+|||||+|||| .++|+|.|+||.|+....-.
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccCCCC
Confidence 9999 99999998754 4569999999999999999999999999999999999999 58999999999998654210
Q ss_pred CCcc------------------------------c------------------cc-cccCCCCccCccccccccccCCCC
Q 011945 160 ATHQ------------------------------H------------------IP-YRENKNLTGTARYASMNTHLGIEQ 190 (474)
Q Consensus 160 ~~~~------------------------------~------------------~~-~~~~~~~~GT~~Y~APE~~~~~~~ 190 (474)
.+.. . .| -.....++||..|+|||++.|...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0000 0 00 012456789999999999999999
Q ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCC----H
Q 011945 191 SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD----Y 266 (474)
Q Consensus 191 s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt----~ 266 (474)
+.++|+|+|||+|||||.|..||.+.+. .+.+..|.......+-. ..++..+++||+.+|.+||.+|.. +
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~---~~Tl~NIv~~~l~Fp~~---~~vs~~akDLIr~LLvKdP~kRlg~~rGA 386 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNN---KETLRNIVGQPLKFPEE---PEVSSAAKDLIRKLLVKDPSKRLGSKRGA 386 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCc---hhhHHHHhcCCCcCCCC---CcchhHHHHHHHHHhccChhhhhccccch
Confidence 9999999999999999999999998543 45555555544332211 245689999999999999999987 5
Q ss_pred HHHHHHHHHHHHHcCCCCCCccccccccc
Q 011945 267 AYLKRLFRDLFIREGFQFDYVFDWTILKY 295 (474)
Q Consensus 267 ~~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 295 (474)
.+|++ ..+...++|...+.
T Consensus 387 ~eIK~----------HpFF~gVnWaLir~ 405 (459)
T KOG0610|consen 387 AEIKR----------HPFFEGVNWALIRC 405 (459)
T ss_pred HHhhc----------CccccCCChhheec
Confidence 55533 46777889996654
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=334.39 Aligned_cols=232 Identities=20% Similarity=0.289 Sum_probs=188.4
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-C
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 86 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (474)
+.||+|+||.||++.+..+|+.||+|++.... ....+..|+.+++.+.|++ |..+..++......|+||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF-LTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCC-CcceeeEEecCCEEEEEEeCCCC
Confidence 47999999999999999999999999876431 2234678999999998655 445555566777899999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccc
Q 011945 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166 (474)
Q Consensus 87 ~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (474)
++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~----- 150 (323)
T cd05595 80 GELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA----- 150 (323)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCC-----
Confidence 899888863 4579999999999999999999999999999999999999 4778999999999875432211
Q ss_pred cccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcH
Q 011945 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (474)
Q Consensus 167 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (474)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...+..+..... .+...+++
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~---~~~~~~~~~~~~-----~~p~~~~~ 220 (323)
T cd05595 151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELILMEEI-----RFPRTLSP 220 (323)
T ss_pred --ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCC-----CCCCCCCH
Confidence 11345799999999999999999999999999999999999999976432 333333332222 13356889
Q ss_pred HHHHHHHHHhcCCCCCCC
Q 011945 247 EFASYFHYCRSLRFDDKP 264 (474)
Q Consensus 247 ~l~~li~~cl~~dp~~RP 264 (474)
++.++|..||..||++|+
T Consensus 221 ~~~~li~~~L~~dP~~R~ 238 (323)
T cd05595 221 EAKSLLAGLLKKDPKQRL 238 (323)
T ss_pred HHHHHHHHHccCCHHHhC
Confidence 999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=334.72 Aligned_cols=236 Identities=21% Similarity=0.271 Sum_probs=193.0
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-C
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 86 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (474)
+.||+|+||.||+|.+..+++.||||++.... ....+..|..++..+.+|++|..+..+...+...++||||+ |
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999876431 22345667777777666777777777777888999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccc
Q 011945 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166 (474)
Q Consensus 87 ~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (474)
++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~----- 151 (316)
T cd05592 81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEG----- 151 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCC-----
Confidence 899998874 4579999999999999999999999999999999999999 4778999999999976433221
Q ss_pred cccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcH
Q 011945 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (474)
Q Consensus 167 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (474)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+... .+.+..+.... ..+...++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~~~i~~~~-----~~~~~~~~~ 221 (316)
T cd05592 152 --KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELFDSILNDR-----PHFPRWISK 221 (316)
T ss_pred --ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCC-----CCCCCCCCH
Confidence 12345799999999999999999999999999999999999999987543 33333333221 122355789
Q ss_pred HHHHHHHHHhcCCCCCCCCHH
Q 011945 247 EFASYFHYCRSLRFDDKPDYA 267 (474)
Q Consensus 247 ~l~~li~~cl~~dp~~RPt~~ 267 (474)
++.++|..||..||++||++.
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~ 242 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVD 242 (316)
T ss_pred HHHHHHHHHccCCHHHcCCCh
Confidence 999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=333.59 Aligned_cols=239 Identities=21% Similarity=0.267 Sum_probs=192.9
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhc--CCCCCceeEEEeEeCCEEEEE
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQ--GGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~--~~~~i~~l~~~~~~~~~~~lv 81 (474)
|++++.||+|+||.||+|.+..+++.||||++.... ....+..|++++..+. .|++|..+..+.......|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 789999999999999999999999999999886431 2245677777766543 255666666667788899999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ +++|..++. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCC
Confidence 9999 788888775 4579999999999999999999999999999999999999 477899999999987543221
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+... .+.+..+...... +
T Consensus 156 ~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~---~~~~~~i~~~~~~-----~ 220 (324)
T cd05589 156 D-------RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE---EEVFDSIVNDEVR-----Y 220 (324)
T ss_pred C-------cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCC-----C
Confidence 1 12346799999999999999999999999999999999999999986432 3333333332221 2
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHH
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYA 267 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~ 267 (474)
...+++++.++|.+||..||++||+..
T Consensus 221 p~~~~~~~~~li~~~L~~dP~~R~~~~ 247 (324)
T cd05589 221 PRFLSREAISIMRRLLRRNPERRLGSG 247 (324)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCC
Confidence 356789999999999999999999543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=338.85 Aligned_cols=254 Identities=20% Similarity=0.274 Sum_probs=200.3
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----------------chHHHHHHHHHHHhcCCCCCce
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------------HPQLQYEAKLYKILQGGTGIPN 67 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----------------~~~l~~E~~il~~l~~~~~i~~ 67 (474)
...++|++++.||+|.||.|-+|++..+++.||||++..... .+...+|+.||++|.|.++|..
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 456899999999999999999999999999999998765321 1357899999999998555555
Q ss_pred eEEEe-EeCCEEEEEEecC-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCe
Q 011945 68 LRWFG-VEGDYNVLVIDLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 144 (474)
Q Consensus 68 l~~~~-~~~~~~~lv~e~~-g~sL~~li~~~~~~-l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~ 144 (474)
+.... ...+..|||+||| .|.+... . +... +++.+++.|+.+++.||+|||.+|||||||||+|+||+ .+++
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~-p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~---~~g~ 248 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC-P-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS---SDGT 248 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC-C-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc---CCCc
Confidence 54443 3567899999999 4433222 1 2344 99999999999999999999999999999999999995 7799
Q ss_pred EEEEecCCccccccCCCccccccccCCCCccCccccccccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCcCc
Q 011945 145 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220 (474)
Q Consensus 145 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~----~s~ksDIwSlGvil~elltG~~Pf~~~~~~~ 220 (474)
|||+|||.+..+........ .......+||+.|+|||...++. .+.+.||||+||+||.|+.|++||.+ ..
T Consensus 249 VKIsDFGVs~~~~~~~~~~~--d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~---~~ 323 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGS--DDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD---DF 323 (576)
T ss_pred EEeeccceeeecccCCcccc--HHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc---ch
Confidence 99999999987633211100 01123368999999999988743 36889999999999999999999977 45
Q ss_pred HHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
..+.+.+|....+..+.. ..+.+.+++||.+||.+||+.|.+..+|+
T Consensus 324 ~~~l~~KIvn~pL~fP~~---pe~~e~~kDli~~lL~KdP~~Ri~l~~ik 370 (576)
T KOG0585|consen 324 ELELFDKIVNDPLEFPEN---PEINEDLKDLIKRLLEKDPEQRITLPDIK 370 (576)
T ss_pred HHHHHHHHhcCcccCCCc---ccccHHHHHHHHHHhhcChhheeehhhhe
Confidence 567777777665543322 24568999999999999999999976664
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=344.32 Aligned_cols=250 Identities=16% Similarity=0.185 Sum_probs=194.7
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 85 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (474)
.++|+++++||+|+||.||+|.+..+++.||||... ...+.+|+++++.|+|++++. +..++..+...+++||++
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----~~~~~~E~~il~~l~HpnIv~-~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----RGGTATEAHILRAINHPSIIQ-LKGTFTYNKFTCLILPRY 165 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----hhhhHHHHHHHHhCCCCCCCC-EeEEEEECCeeEEEEecC
Confidence 367999999999999999999999999999999753 345789999999999765555 445556778889999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccc
Q 011945 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 165 (474)
Q Consensus 86 g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (474)
+++|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+|||++ ..+.+||+|||+|+........
T Consensus 166 ~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~---~~~~vkL~DFG~a~~~~~~~~~--- 238 (391)
T PHA03212 166 KTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN---HPGDVCLGDFGAACFPVDINAN--- 238 (391)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEc---CCCCEEEEeCCccccccccccc---
Confidence 9999988864 45789999999999999999999999999999999999994 7788999999999754332211
Q ss_pred ccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcC----cHHHHHHHHhhcc---------
Q 011945 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG----TKKQKYEKISEKK--------- 232 (474)
Q Consensus 166 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~----~~~~~~~~i~~~~--------- 232 (474)
......||+.|+|||++.+..++.++|||||||+||||++|..||...... .....+..+....
T Consensus 239 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 239 ---KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred ---ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 123458999999999999999999999999999999999999887542210 0011111111000
Q ss_pred -----------------c----cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 233 -----------------V----STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 233 -----------------~----~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
. ..........+|.++.+||.+||++||++||++.+++
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL 374 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALL 374 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHh
Confidence 0 0000001124577899999999999999999988774
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=326.93 Aligned_cols=254 Identities=14% Similarity=0.222 Sum_probs=202.9
Q ss_pred CCcEEEeeeeeecCceEEEEEEEc---CCCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
.++|++.+.||+|+||.||+|.+. ..+..||+|.++..... ..+..|+.++..++|+ ++..+..+...+...+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHS-NIVRLEGVITRGNTMM 82 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCC-CcCeEEEEEecCCCcE
Confidence 457999999999999999999865 34678999987754322 3578899999999755 5555556666778899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
+||||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||.+.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCcccccccc
Confidence 999999 778999987656679999999999999999999999999999999999999 4678999999998765432
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
.... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+.... ..+..+......
T Consensus 160 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~~~~~~--- 227 (266)
T cd05064 160 EAIY------TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ---DVIKAVEDGFRL--- 227 (266)
T ss_pred cchh------cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH---HHHHHHHCCCCC---
Confidence 2110 1112345678999999999999999999999999999775 99999875432 223333322211
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
.....+|..+.+++..||+.+|++||++++|.+.|..+
T Consensus 228 -~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 -PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 12456899999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=338.46 Aligned_cols=243 Identities=20% Similarity=0.287 Sum_probs=197.9
Q ss_pred eeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-CCC
Q 011945 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS 88 (474)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~s 88 (474)
||+|+||.||+|.+..+++.||||++... .....+..|+.+++.++|++++. +..+.......++||||+ +++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVP-LKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEec-eeeEEecCCeEEEEEcCCCCCc
Confidence 79999999999999999999999987542 12235778999999998665555 445556778899999999 889
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccccc
Q 011945 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 168 (474)
Q Consensus 89 L~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 168 (474)
|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~------- 148 (312)
T cd05585 80 LFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDD------- 148 (312)
T ss_pred HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCC-------
Confidence 9999874 4579999999999999999999999999999999999999 4778999999999975433221
Q ss_pred cCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHH
Q 011945 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF 248 (474)
Q Consensus 169 ~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l 248 (474)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+..... .+...+++++
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~---~~~~~~~~~~~~~-----~~~~~~~~~~ 220 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN---VNEMYRKILQEPL-----RFPDGFDRDA 220 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC---HHHHHHHHHcCCC-----CCCCcCCHHH
Confidence 1234579999999999999999999999999999999999999998643 3344444433222 2335688999
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 249 ASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 249 ~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
.++|..||..||++||++..+.++|.+.+
T Consensus 221 ~~li~~~L~~dp~~R~~~~~~~e~l~hp~ 249 (312)
T cd05585 221 KDLLIGLLSRDPTRRLGYNGAQEIKNHPF 249 (312)
T ss_pred HHHHHHHcCCCHHHcCCCCCHHHHHcCCC
Confidence 99999999999999998766777776654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=340.38 Aligned_cols=253 Identities=21% Similarity=0.241 Sum_probs=195.9
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeC----
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEG---- 75 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~---- 75 (474)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++|++++..+..+....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 35689999999999999999999999999999999875432 2345778999999999877777666554322
Q ss_pred -CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 76 -DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 76 -~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
...|++|||++++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 98 FQDVYLVMELMDANLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 171 (359)
T ss_pred cceeEEEEeCCCcCHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEecCCCcc
Confidence 3579999999988888775 358999999999999999999999999999999999999 478899999999997
Q ss_pred ccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc---
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--- 231 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~--- 231 (474)
....... .....||..|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......
T Consensus 172 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 243 (359)
T cd07876 172 TACTNFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSA 243 (359)
T ss_pred ccccCcc--------CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcH
Confidence 5433211 13357899999999999999999999999999999999999999875432111111100000
Q ss_pred ----------------cc---cchHHHH------------hcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 232 ----------------KV---STSIEAL------------CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 232 ----------------~~---~~~~~~l------------~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.. ......+ ....++++.+||.+||..||++||++.+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 313 (359)
T cd07876 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEAL 313 (359)
T ss_pred HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHh
Confidence 00 0000000 112357889999999999999999987774
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=330.34 Aligned_cols=254 Identities=19% Similarity=0.248 Sum_probs=200.0
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.++|.+.++||+|+||.||+|++..+++.||||.+.... ....+.+|+.+++.++|++++ .+..+...+...+++|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV-TLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcc-eEEEEEeeCCeEEEEE
Confidence 367999999999999999999999999999999876432 233577899999999865555 4555566777899999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 83 e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
||+.++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||+++.......
T Consensus 84 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~- 159 (309)
T cd07872 84 EYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSVPTK- 159 (309)
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceecCCCcc-
Confidence 999989999987666678999999999999999999999999999999999999 4778999999999976433221
Q ss_pred cccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc-------
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS------- 234 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~------- 234 (474)
......+|..|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+.........
T Consensus 160 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 160 ------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred ------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence 1123467899999999876 45899999999999999999999999875543332222221111000
Q ss_pred ---------------chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 235 ---------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 235 ---------------~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.........+++++.++|.+||..||.+||++.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 284 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAM 284 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHh
Confidence 001112235688999999999999999999987774
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=340.01 Aligned_cols=269 Identities=19% Similarity=0.284 Sum_probs=203.1
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++|+++++||+|+||+||+|.+..+++.||||++.... ....+..|+.++..++|++ |..+.....+....++|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~-iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW-VVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCC-cceEEEEEecCCeEEEE
Confidence 57999999999999999999999999999999986421 2235778999999998654 55555556677889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ |++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||||+ .++.+||+|||+++.+....
T Consensus 80 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~---~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 80 MEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD---SKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC---CCCCEEEeeccCcccccccc
Confidence 9999 8899999874 45799999999999999999999999999999999999994 67899999999998654321
Q ss_pred Ccc-------ccc---------------------cccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 011945 161 THQ-------HIP---------------------YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212 (474)
Q Consensus 161 ~~~-------~~~---------------------~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~P 212 (474)
... ..+ .......+||+.|+|||++.+..++.++|||||||+||||++|..|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 100 000 0011245899999999999999999999999999999999999999
Q ss_pred CCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCC---CCCCHHHHHHHHHHHHHHcCCCCCCccc
Q 011945 213 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFD---DKPDYAYLKRLFRDLFIREGFQFDYVFD 289 (474)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~---~RPt~~~l~~~L~~l~~~~~~~~~~~~d 289 (474)
|.+.. ....+.++.........+. ...+++++.++|.+++. +|+ .||++++|+ + .++....+
T Consensus 236 f~~~~---~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~---~-------hp~f~~~~ 300 (363)
T cd05628 236 FCSET---PQETYKKVMNWKETLIFPP-EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIK---T-------NPFFEGVD 300 (363)
T ss_pred CCCCC---HHHHHHHHHcCcCcccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh---C-------CCCCCCCC
Confidence 98643 3344444443221111111 12367899999998664 444 457866663 2 24555678
Q ss_pred cccccc
Q 011945 290 WTILKY 295 (474)
Q Consensus 290 w~~~~~ 295 (474)
|.....
T Consensus 301 ~~~~~~ 306 (363)
T cd05628 301 WEHIRE 306 (363)
T ss_pred HHHHHh
Confidence 887543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=335.77 Aligned_cols=260 Identities=20% Similarity=0.238 Sum_probs=203.3
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-C
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 86 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (474)
++||+|+||.||+|++..+++.||||++.... ....+..|.+++..+.+|++|..+..+.......|+||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999876431 22346778889888877888888888888888999999999 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccc
Q 011945 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166 (474)
Q Consensus 87 ~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (474)
++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~----- 151 (321)
T cd05591 81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGV----- 151 (321)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCc-----
Confidence 899888864 4579999999999999999999999999999999999999 4778999999999975433221
Q ss_pred cccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcH
Q 011945 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (474)
Q Consensus 167 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (474)
......||..|+|||++.+..++.++|||||||++|||++|+.||.... ....+..+...... ....++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~---~~~~~~~i~~~~~~-----~p~~~~~ 221 (321)
T cd05591 152 --TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN---EDDLFESILHDDVL-----YPVWLSK 221 (321)
T ss_pred --cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCC-----CCCCCCH
Confidence 1234579999999999999999999999999999999999999998743 33444444433221 2235689
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccccc
Q 011945 247 EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 294 (474)
Q Consensus 247 ~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 294 (474)
++.++|..||..||++||+........++++ ..++...++|....
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~---~hp~~~~~~~~~~~ 266 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIK---QHPFFKEIDWVLLE 266 (321)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCCHHHHh---cCCccCCCCHHHHH
Confidence 9999999999999999994322111112221 12334556787653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=335.61 Aligned_cols=260 Identities=18% Similarity=0.242 Sum_probs=204.4
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-C
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 86 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (474)
+.||+|+||.||+|++..+++.||||++... .....+..|..++..+.+|++|..+..+.......|+||||+ +
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999987642 122346778888888877788888877788888999999999 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccc
Q 011945 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166 (474)
Q Consensus 87 ~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (474)
++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~----- 151 (320)
T cd05590 81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGK----- 151 (320)
T ss_pred chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCC-----
Confidence 899988874 4579999999999999999999999999999999999999 4778999999999875432211
Q ss_pred cccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcH
Q 011945 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (474)
Q Consensus 167 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (474)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ....+..+..... .+...++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~---~~~~~~~i~~~~~-----~~~~~~~~ 221 (320)
T cd05590 152 --TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN---EDDLFEAILNDEV-----VYPTWLSQ 221 (320)
T ss_pred --cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHHhcCCC-----CCCCCCCH
Confidence 1234579999999999999999999999999999999999999998743 3334444433222 12345789
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccccc
Q 011945 247 EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 295 (474)
Q Consensus 247 ~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 295 (474)
++.++|..||..||++||++.++. -.++++ ..++...++|.....
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~-~~~~~~---~h~~f~~~~~~~~~~ 266 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGSLTLG-GEEAIL---RHPFFKELDWEKLNR 266 (320)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCC-CHHHHH---cCCCcCCCCHHHHHh
Confidence 999999999999999999974431 112221 234444567776543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=333.66 Aligned_cols=236 Identities=20% Similarity=0.261 Sum_probs=192.5
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-C
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 86 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (474)
++||+|+||.||+|++..+++.||||+++.. .....+..|..++..+.+++++..+..+.......|+||||+ +
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999987643 223446778888887766777777777777888999999999 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccc
Q 011945 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166 (474)
Q Consensus 87 ~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (474)
++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~----- 151 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDN----- 151 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCC-----
Confidence 899988874 4579999999999999999999999999999999999999 4778999999999874322111
Q ss_pred cccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcH
Q 011945 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (474)
Q Consensus 167 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (474)
......||..|+|||++.+..++.++|||||||++|||++|..||.+... .+.+..+.... ..+...++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~~~~~~~-----~~~~~~~~~ 221 (316)
T cd05620 152 --RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFESIRVDT-----PHYPRWITK 221 (316)
T ss_pred --ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCC-----CCCCCCCCH
Confidence 12346799999999999999999999999999999999999999976432 33333332221 122345788
Q ss_pred HHHHHHHHHhcCCCCCCCCHH
Q 011945 247 EFASYFHYCRSLRFDDKPDYA 267 (474)
Q Consensus 247 ~l~~li~~cl~~dp~~RPt~~ 267 (474)
++.++|..||..||++||++.
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~ 242 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVV 242 (316)
T ss_pred HHHHHHHHHccCCHHHcCCCh
Confidence 999999999999999999963
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=337.44 Aligned_cols=257 Identities=22% Similarity=0.305 Sum_probs=205.2
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCC-eEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~-~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
.++|++.++||+|+||.||+|.+..++ ..||||++... .....+..|+.+++.+.|++++ .+..+.......+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv-~~~~~~~~~~~~~ 107 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCV-NLYGSFKDESYLY 107 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCc-ceEEEEEeCCEEE
Confidence 467999999999999999999876654 68999987532 2234578899999999865555 5555567778899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
++|||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 108 lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCCCeecCC
Confidence 999999 8899999974 4579999999999999999999999999999999999999 4788999999999986543
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
.. ....||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ....+..+.....
T Consensus 184 ~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~---~~~~~~~i~~~~~----- 245 (340)
T PTZ00426 184 RT----------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE---PLLIYQKILEGII----- 245 (340)
T ss_pred Cc----------ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC---HHHHHHHHhcCCC-----
Confidence 21 24579999999999999889999999999999999999999998643 3334444443322
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccccc
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILKY 295 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 295 (474)
.+...+++++.++|.+||+.||++|+ ++++++ + .++...++|.....
T Consensus 246 ~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~---~-------hp~f~~~~~~~~~~ 297 (340)
T PTZ00426 246 YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVK---E-------HPWFGNIDWVSLLH 297 (340)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHH---c-------CCCcCCCCHHHHHh
Confidence 12356788999999999999999996 555442 2 23444567876443
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=335.67 Aligned_cols=271 Identities=18% Similarity=0.273 Sum_probs=206.8
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
..++|++.++||.|+||.||++.+..++..||+|++..... ...+.+|+++++.++|++++. +..++..+...+++
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~-~~~~~~~~~~~~lv 81 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG-FYGAFYSDGEISIC 81 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccc-eeEEEEECCEEEEE
Confidence 45789999999999999999999999999999998765432 245889999999998655554 55555667889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~-gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
|||+ +++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||++..+...
T Consensus 82 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~---~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 82 MEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred EecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc---CCCCEEEeeCCcchhhhhh
Confidence 9999 8899999974 45689999999999999999999985 799999999999994 6788999999999765432
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHH-------------
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE------------- 226 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~------------- 226 (474)
.. ....||..|+|||++.+..++.++|||||||++|||++|+.||...........+.
T Consensus 158 ~~---------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (333)
T cd06650 158 MA---------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETS 228 (333)
T ss_pred cc---------ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccC
Confidence 21 33578999999999999899999999999999999999999997543211111000
Q ss_pred ------------------------HHhhccccchHHHHh-cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011945 227 ------------------------KISEKKVSTSIEALC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281 (474)
Q Consensus 227 ------------------------~i~~~~~~~~~~~l~-~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 281 (474)
.+.........+.+. ..++.++.+||.+||.+||++||++.+| |.+.|.+..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~el---l~h~~~~~~ 305 (333)
T cd06650 229 PRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQL---MVHAFIKRS 305 (333)
T ss_pred cccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHH---hhCHHHhcC
Confidence 000000000000011 1357889999999999999999998877 444544443
Q ss_pred -CCCCCcccccc
Q 011945 282 -FQFDYVFDWTI 292 (474)
Q Consensus 282 -~~~~~~~dw~~ 292 (474)
....+.+.|..
T Consensus 306 ~~~~~~~~~~~~ 317 (333)
T cd06650 306 EAEEVDFAGWLC 317 (333)
T ss_pred ccccccHHHHHH
Confidence 34445667753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=329.01 Aligned_cols=251 Identities=22% Similarity=0.297 Sum_probs=203.3
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeC----CEEEEEEe
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEG----DYNVLVID 83 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~----~~~~lv~e 83 (474)
.|.-.+++|.|+||.||.|....+++.||||..-.+.. --.+|+++|+.+.|+|+|..++.|.... -+..+|||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r--~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVle 102 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR--YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLE 102 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC--cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHH
Confidence 58889999999999999999999999999997544332 3367999999999888777776665422 25678999
Q ss_pred cCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 84 LLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 84 ~~g~sL~~li~~~---~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|+..+|.++++.. +.+++...+.-+..||++||.|||+.||+||||||.|+|++ .+.+.+||||||.|+.+....
T Consensus 103 ymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 103 YMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred hchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEeccCCcceeeccCC
Confidence 9999999999842 67799999999999999999999999999999999999997 567999999999999887654
Q ss_pred CccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH--
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI-- 237 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-- 237 (474)
. +..+..|..|.|||.+.|. +|+.+.||||.|||+.||+.|++-|.|....+....+.++....-...+
T Consensus 181 p--------niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 181 P--------NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred C--------ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 3 3456889999999999985 4999999999999999999999999996554444333333221111000
Q ss_pred -------------------HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 238 -------------------EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 238 -------------------~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
..+....+++..+|+.++|.++|.+|.++.++.
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l 304 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEAL 304 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHh
Confidence 113345689999999999999999999977663
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=325.14 Aligned_cols=252 Identities=19% Similarity=0.243 Sum_probs=195.6
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhc---CCCCCceeEEEeE----eCC
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQ---GGTGIPNLRWFGV----EGD 76 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~---~~~~i~~l~~~~~----~~~ 76 (474)
+|++.+.||+|+||+||+|.+..+++.||||.+..... ...+.+|+.+++.+. |++++..+..+.. ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 59999999999999999999999999999998765322 235678888888774 4444444433322 245
Q ss_pred EEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 77 YNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 77 ~~~lv~e~~g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
..+++||++.++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~---~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVT---SGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEECccCcccc
Confidence 679999999889999887543 3589999999999999999999999999999999999994 778999999999986
Q ss_pred cccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc----
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---- 231 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~---- 231 (474)
+..... .....||..|+|||++.+..++.++|||||||++|||++|..||.+.........+......
T Consensus 158 ~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07863 158 YSCQMA--------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 229 (288)
T ss_pred ccCccc--------CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChh
Confidence 643221 12357899999999999989999999999999999999999999765432222222211100
Q ss_pred ---------------cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 232 ---------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 232 ---------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
........+...++.++.+++.+||..||++||++.+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l 283 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRAL 283 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHh
Confidence 001112233456788999999999999999999988775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=352.91 Aligned_cols=253 Identities=22% Similarity=0.261 Sum_probs=202.8
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeEeC----
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEG---- 75 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~~~---- 75 (474)
...++|++.++||+|+||+||+|.+..+++.||||++...... ..+..|+.++..+.|.+++.....+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 3568999999999999999999999999999999998654322 34678888888888776665544433221
Q ss_pred ---CEEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEE
Q 011945 76 ---DYNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148 (474)
Q Consensus 76 ---~~~~lv~e~~-g~sL~~li~~~---~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~ 148 (474)
...++||||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~---~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLC---SNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEe---CCCCEEEE
Confidence 2468999999 88999998642 34699999999999999999999999999999999999994 67899999
Q ss_pred ecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHH
Q 011945 149 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (474)
Q Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i 228 (474)
|||+++.+....... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.+.. ....+..+
T Consensus 186 DFGls~~~~~~~~~~-----~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~---~~~~~~~~ 257 (496)
T PTZ00283 186 DFGFSKMYAATVSDD-----VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN---MEEVMHKT 257 (496)
T ss_pred ecccCeecccccccc-----ccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHH
Confidence 999998765432111 1234689999999999999999999999999999999999999997643 23333333
Q ss_pred hhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
..... ..+...+++++.+++..||..||++||++.++++
T Consensus 258 ~~~~~----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 258 LAGRY----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred hcCCC----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 33222 2244678899999999999999999999998764
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=341.70 Aligned_cols=255 Identities=22% Similarity=0.304 Sum_probs=201.2
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++|.+.++||+|+||+||+|.+..+++.||||++... .....+..|+.++..+.|.+ +..+..+..++...++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~-i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW-IVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCC-ccchhhheecCCeEEEE
Confidence 5799999999999999999999999999999987643 22345788999999998554 44555556677889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++..+....
T Consensus 80 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 80 MEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCcccC
Confidence 9999 88999999754 679999999999999999999999999999999999999 477899999999998765433
Q ss_pred Ccc----------------------ccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 011945 161 THQ----------------------HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (474)
Q Consensus 161 ~~~----------------------~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~ 218 (474)
... ...........||+.|+|||++.+..++.++|||||||+||||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 000 0000112345799999999999999999999999999999999999999987542
Q ss_pred CcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCC-HHHHHH
Q 011945 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD-YAYLKR 271 (474)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt-~~~l~~ 271 (474)
...+..+.........+ ....+++++.++|..||. ||.+||+ ++++++
T Consensus 236 ---~~~~~~i~~~~~~~~~p-~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 236 ---QETYNKIINWKESLRFP-PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred ---HHHHHHHhccCCcccCC-CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 33333333311111111 112368999999999997 9999999 887743
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=343.61 Aligned_cols=251 Identities=21% Similarity=0.303 Sum_probs=201.2
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
+..|+++++||+||.+.||++.. .+...||+|.+...... ..+..|+.+|.+|+++..|..++.|...+.+.|||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 55699999999999999999996 44456677754433222 34899999999999999999999999999999999
Q ss_pred EecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 82 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 82 ~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
||+-..+|..+++.....++.-.+..+..||+.++.++|.+||||.||||.|||+ -.|.+||+|||+|..+..+.+
T Consensus 439 mE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl----VkG~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 439 MECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL----VKGRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred eecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE----EeeeEEeeeechhcccCcccc
Confidence 9999999999998666556655899999999999999999999999999999999 479999999999998877654
Q ss_pred ccccccccCCCCccCccccccccccCCC-----------CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIE-----------QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~-----------~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (474)
... ....+||+.||+||.+.... .++++||||||||||+|+.|+.||.... ....++..|..
T Consensus 515 sI~-----kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI~~ 587 (677)
T KOG0596|consen 515 SIV-----KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAITD 587 (677)
T ss_pred cee-----eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhhcC
Confidence 321 24569999999999987432 4689999999999999999999997643 22334444444
Q ss_pred ccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.......+.+.. +.++.++++.||.+||++||+..+|+
T Consensus 588 P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLL 625 (677)
T KOG0596|consen 588 PNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELL 625 (677)
T ss_pred CCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHh
Confidence 322222222222 23499999999999999999976653
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=341.75 Aligned_cols=256 Identities=21% Similarity=0.317 Sum_probs=202.3
Q ss_pred CcEEEeeeeeecCceEEEEEEE-----cCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTN-----IQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~-----~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
++|++.++||+|+||.||+|++ ..++..||||+++.... .+.+.+|+.++..+.+|++|..+..++..+...
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4799999999999999999974 34567899998864332 245788999999996677777777777888889
Q ss_pred EEEEecC-CCCHHHHHHHcC------------------------------------------------------------
Q 011945 79 VLVIDLL-GPSLEDLFNFCS------------------------------------------------------------ 97 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~------------------------------------------------------------ 97 (474)
+++|||+ +++|.+++....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 9999999 889999886321
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 98 --------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 98 --------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
..+++..++.|+.||+.||.|||++||+||||||+|||++ ..+.+||+|||+++........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~---~~~~~kl~DfG~a~~~~~~~~~- 270 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIRNDSNY- 270 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE---CCCcEEEecCccceeccCcccc-
Confidence 1478889999999999999999999999999999999995 6778999999999866443211
Q ss_pred ccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhc
Q 011945 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (474)
.......++..|+|||++.+..++.++|||||||+||||++ |..||....... ..+..+.... .. ....
T Consensus 271 ----~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~~~-~~---~~~~ 340 (375)
T cd05104 271 ----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIKEGY-RM---LSPE 340 (375)
T ss_pred ----cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHHhCc-cC---CCCC
Confidence 11123345678999999999999999999999999999998 899997754322 1222222111 11 1223
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
..|.++.+|+..||..||++||++.+|++.|++.
T Consensus 341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 4678999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=336.53 Aligned_cols=248 Identities=21% Similarity=0.296 Sum_probs=198.2
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++|.+.++||+|+||+||+|.+..+++.||||+++... ....+..|+.+++.+.| ++|..+..+.......++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~-~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS-PWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCcceeeEEecCCeEEEE
Confidence 47999999999999999999999999999999876532 22347788888888775 5555555566677889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||++..+....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECCCCC
Confidence 9999 899999998766789999999999999999999999999999999999999 478899999999998765432
Q ss_pred CccccccccCCCCccCcccccccccc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHL------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~------~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (474)
.. ......||+.|+|||++. +..++.++|||||||++|||++|..||..... ...+..+......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~~~i~~~~~~ 227 (330)
T cd05601 157 MV------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS---AKTYNNIMNFQRF 227 (330)
T ss_pred ce------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH---HHHHHHHHcCCCc
Confidence 21 112347899999999987 45678999999999999999999999976432 3333333322111
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 269 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (474)
...+ ....++.++.+|+..||. +|++||+++++
T Consensus 228 ~~~~-~~~~~~~~~~~li~~ll~-~p~~R~t~~~l 260 (330)
T cd05601 228 LKFP-EDPKVSSDFLDLIQSLLC-GQKERLGYEGL 260 (330)
T ss_pred cCCC-CCCCCCHHHHHHHHHHcc-ChhhCCCHHHH
Confidence 1111 113578999999999998 99999997765
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=334.55 Aligned_cols=238 Identities=19% Similarity=0.280 Sum_probs=192.3
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-C
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 86 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (474)
+.||+|+||.||++.+..+++.||||++.... ....+..|+.+++.+.|+ +|..+..+.......++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHP-FLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCC-CCcceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999886432 223577899999999865 4555556667778899999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccc
Q 011945 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166 (474)
Q Consensus 87 ~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (474)
++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~----- 150 (328)
T cd05593 80 GELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAA----- 150 (328)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCccc-----
Confidence 899888863 4579999999999999999999999999999999999999 4778999999999975432211
Q ss_pred cccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcH
Q 011945 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (474)
Q Consensus 167 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (474)
......||+.|+|||++.+..++.++|||||||+||||++|..||.+... .+.+..+..... .+...+++
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~---~~~~~~~~~~~~-----~~p~~~~~ 220 (328)
T cd05593 151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEDI-----KFPRTLSA 220 (328)
T ss_pred --ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH---HHHHHHhccCCc-----cCCCCCCH
Confidence 11345799999999999999999999999999999999999999976432 223333322211 23456889
Q ss_pred HHHHHHHHHhcCCCCCCC-----CHHHHH
Q 011945 247 EFASYFHYCRSLRFDDKP-----DYAYLK 270 (474)
Q Consensus 247 ~l~~li~~cl~~dp~~RP-----t~~~l~ 270 (474)
++.++|..||..||++|+ ++.+++
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~il 249 (328)
T cd05593 221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIM 249 (328)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHh
Confidence 999999999999999997 666553
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=336.38 Aligned_cols=264 Identities=20% Similarity=0.270 Sum_probs=206.6
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-C
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 86 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (474)
+.||+|+||.||+|.+..+++.||||++.... ....+..|+.++..+.++++|..+..+.......++||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999986532 12347789999999988888888888888888999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccc
Q 011945 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166 (474)
Q Consensus 87 ~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (474)
++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~---~~~~~kl~Dfg~~~~~~~~~~----- 151 (327)
T cd05617 81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLD---ADGHIKLTDYGMCKEGLGPGD----- 151 (327)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEe---CCCCEEEeccccceeccCCCC-----
Confidence 899888863 45799999999999999999999999999999999999994 778899999999975332211
Q ss_pred cccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcC----cHHHHHHHHhhccccchHHHHhc
Q 011945 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG----TKKQKYEKISEKKVSTSIEALCR 242 (474)
Q Consensus 167 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~----~~~~~~~~i~~~~~~~~~~~l~~ 242 (474)
.....+||+.|+|||++.+..++.++|||||||+||||++|..||...... .....+..+..... .++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~p~ 224 (327)
T cd05617 152 --TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI-----RIPR 224 (327)
T ss_pred --ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC-----CCCC
Confidence 113457999999999999999999999999999999999999999643221 11222222222211 1345
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccccccc
Q 011945 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 296 (474)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 296 (474)
.++.++.+++.+||..||++|+++... ..++++. ..++....+|+.....
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~~~~-~~~~~i~---~h~~f~~~~~~~~~~~ 274 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGCQPQ-TGFSDIK---SHTFFRSIDWDLLEKK 274 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCC-CCHHHHH---cCCCCCCCCHHHHHhC
Confidence 678999999999999999999985421 1122221 3355566788876543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=334.72 Aligned_cols=257 Identities=21% Similarity=0.275 Sum_probs=198.1
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHH-HHHHhcCCCCCceeEEEeEeCCEEEEEEecC-
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAK-LYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 85 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~-il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (474)
+.||+|+||+||+|++..+++.||+|++.... ....+..|.. +++.+.| ++|..+..++...+..+++|||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h-~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH-PFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCC-CCCCceeEEEEcCCeEEEEEeCCC
Confidence 47999999999999999999999999876432 1123444444 3555665 45555666667778899999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccc
Q 011945 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 165 (474)
Q Consensus 86 g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (474)
+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~---- 151 (325)
T cd05602 80 GGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNG---- 151 (325)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCC----
Confidence 7899998874 4578999999999999999999999999999999999999 4778999999999975433221
Q ss_pred ccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCc
Q 011945 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245 (474)
Q Consensus 166 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 245 (474)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+..... .+...++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~-----~~~~~~~ 220 (325)
T cd05602 152 ---TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN---TAEMYDNILNKPL-----QLKPNIT 220 (325)
T ss_pred ---CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC---HHHHHHHHHhCCc-----CCCCCCC
Confidence 1234679999999999999999999999999999999999999998643 3334444433222 1234688
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccccc
Q 011945 246 TEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 295 (474)
Q Consensus 246 ~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 295 (474)
.++.++|..||..||.+||++.+. +.++. +..+...++|.....
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~---~~~i~---~~~~~~~~~~~~~~~ 264 (325)
T cd05602 221 NSARHLLEGLLQKDRTKRLGAKDD---FMEIK---NHIFFSPINWDDLIN 264 (325)
T ss_pred HHHHHHHHHHcccCHHHCCCCCCC---HHHHh---cCcccCCCCHHHHHh
Confidence 999999999999999999997643 22222 223445678876643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=333.60 Aligned_cols=259 Identities=18% Similarity=0.279 Sum_probs=201.0
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
..++|+++++||+|+||.||++++..++..||+|++..... ...+.+|+++++.++|++++.. ..+...+...++|
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~-~~~~~~~~~~~lv 81 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGF-YGAFYSDGEISIC 81 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeE-EEEEEECCEEEEE
Confidence 35789999999999999999999999999999998865432 2458899999999986655554 4455667788999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~-gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
|||+ +++|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++......
T Consensus 82 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 82 MEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred eecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEc---CCCcEEEccCccccccccc
Confidence 9999 7899999974 44689999999999999999999986 699999999999994 6788999999999765432
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHH------------
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK------------ 227 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~------------ 227 (474)
.. ....||..|+|||++.+..++.++|||||||+||||++|+.||...........+..
T Consensus 158 ~~---------~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (331)
T cd06649 158 MA---------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHS 228 (331)
T ss_pred cc---------ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccc
Confidence 21 345799999999999999999999999999999999999999975432111110000
Q ss_pred ---------------------------HhhccccchHHHH-hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 228 ---------------------------ISEKKVSTSIEAL-CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 228 ---------------------------i~~~~~~~~~~~l-~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
..........+.. ...+++++.+||.+||.+||++||++.+| |++.|.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~el---l~h~~~~ 305 (331)
T cd06649 229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKML---MNHTFIK 305 (331)
T ss_pred cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHH---hcChHHh
Confidence 0000000000000 12467899999999999999999998877 5555544
Q ss_pred c
Q 011945 280 E 280 (474)
Q Consensus 280 ~ 280 (474)
.
T Consensus 306 ~ 306 (331)
T cd06649 306 R 306 (331)
T ss_pred h
Confidence 3
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=333.88 Aligned_cols=264 Identities=19% Similarity=0.278 Sum_probs=203.0
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-C
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 86 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (474)
+.||+|+||.||+|.+..+++.||+|++.... ....+..|+.++..+.+|++|..+..+.......++||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999876532 12346788888888866777777777778888999999999 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccc
Q 011945 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166 (474)
Q Consensus 87 ~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (474)
++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~----- 151 (329)
T cd05618 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGD----- 151 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCC-----
Confidence 899888763 4579999999999999999999999999999999999999 4778999999999975432221
Q ss_pred cccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcC------cHHHHHHHHhhccccchHHHH
Q 011945 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG------TKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 167 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~------~~~~~~~~i~~~~~~~~~~~l 240 (474)
......||..|+|||++.+..++.++|||||||++|||++|..||...... .....+..+..... .+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-----~~ 224 (329)
T cd05618 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-----RI 224 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-----CC
Confidence 123457999999999999999999999999999999999999999632211 11122222222221 23
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccccccc
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 296 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 296 (474)
+..++.++.++|.+||..||++||++.... .+.+++ ..++...++|......
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~-~~~~i~---~hp~f~~~~~~~~~~~ 276 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLGCHPQT-GFADIQ---GHPFFRNVDWDLMEQK 276 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCCCCCCC-CHHHHh---cCCCCCCCCHHHHHcC
Confidence 456789999999999999999999842110 011121 2355566788866543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=353.14 Aligned_cols=262 Identities=19% Similarity=0.265 Sum_probs=202.9
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--CchHHHHHHHHHHHhcCCCCCceeEE-EeE-----e-CCE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRW-FGV-----E-GDY 77 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~l~~E~~il~~l~~~~~i~~l~~-~~~-----~-~~~ 77 (474)
.+++|.+.|.+|||+.||+|.+...+..||+|.+-... ....+.+|+.+|+.|++|++|+.|.. ... . .-.
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 46889999999999999999998887999999754442 23458899999999998877777655 211 1 245
Q ss_pred EEEEEecC-CCCHHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEeeeCCCCCeEEEEecCCc
Q 011945 78 NVLVIDLL-GPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~-~~~~~l~~~~~~~i~~qi~~gL~yLHs~g--IiHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (474)
++|.|||| |++|-|+++ +....|++.++++|+.|+++|+.+||..+ |||||||-+||||+ .++.+||||||.|
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls---~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS---ADGNYKLCDFGSA 193 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc---CCCCEEeCccccc
Confidence 68999999 589999997 33456999999999999999999999987 99999999999995 7889999999998
Q ss_pred cccccCC-Ccccccc-ccCCCCccCcccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHH
Q 011945 154 KRYRDTA-THQHIPY-RENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (474)
Q Consensus 154 ~~~~~~~-~~~~~~~-~~~~~~~GT~~Y~APE~~~---~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i 228 (474)
....... ....+.+ ...-....|+.|.|||++. |.+.++|+|||+|||+||.||....||.+... ..|
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------laI 266 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------LAI 266 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------eeE
Confidence 6433322 1111100 0111234699999999865 77899999999999999999999999987421 123
Q ss_pred hhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011945 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281 (474)
Q Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 281 (474)
...++..+. ...++..|.+||..||+.||++||++.++...+.++.....
T Consensus 267 lng~Y~~P~---~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 267 LNGNYSFPP---FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred EeccccCCC---CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 333322211 14678999999999999999999998888777777765544
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=341.17 Aligned_cols=270 Identities=20% Similarity=0.291 Sum_probs=204.2
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++|+++++||.|+||+||+|++..+++.||||++.... ....+..|+.+++.++| ++|..+..++..+...++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN-PWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCcceEEEEEcCCeEEEE
Confidence 47999999999999999999999999999999886431 22346789999999985 4555555666778889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ +++|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 80 ~E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 80 MEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred ECCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceeccccc
Confidence 9999 8899999874 4579999999999999999999999999999999999999 478899999999997654321
Q ss_pred Ccccc-----------------cc--------------ccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 011945 161 THQHI-----------------PY--------------RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG 209 (474)
Q Consensus 161 ~~~~~-----------------~~--------------~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG 209 (474)
..... +. ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 10000 00 001134799999999999999999999999999999999999
Q ss_pred CCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccc
Q 011945 210 SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFD 289 (474)
Q Consensus 210 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~d 289 (474)
..||.+... .+.+..+.........+. ...+++++.++|..|+. +|.+|++...+.++|.+. +...++
T Consensus 236 ~~Pf~~~~~---~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~-------~~~~~~ 303 (364)
T cd05599 236 YPPFCSDNP---QETYRKIINWKETLQFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHP-------FFKGVD 303 (364)
T ss_pred CCCCCCCCH---HHHHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCC-------CcCCCC
Confidence 999987432 333333332211111110 12468899999999996 999999843344444443 333456
Q ss_pred cccc
Q 011945 290 WTIL 293 (474)
Q Consensus 290 w~~~ 293 (474)
|...
T Consensus 304 ~~~~ 307 (364)
T cd05599 304 WEHI 307 (364)
T ss_pred HHHH
Confidence 7643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=335.59 Aligned_cols=260 Identities=19% Similarity=0.304 Sum_probs=202.7
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcC-----CCeEEEEEEeccCCC---chHHHHHHHHHHHhcCC-CCCceeEEEeEeCC
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTK---HPQLQYEAKLYKILQGG-TGIPNLRWFGVEGD 76 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~-~~i~~l~~~~~~~~ 76 (474)
.++|++.+.||.|+||.||+|.+.. +++.||+|++..... .+.+..|+.++..+.+| +++..+..+...+.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 4689999999999999999997543 457899998865432 23577899999999544 55555555555667
Q ss_pred EEEEEEecC-CCCHHHHHHHcC----------------------------------------------------------
Q 011945 77 YNVLVIDLL-GPSLEDLFNFCS---------------------------------------------------------- 97 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~~---------------------------------------------------------- 97 (474)
..+++|||+ +++|.+++....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 788999999 889999885321
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccccccCCCCcc
Q 011945 98 --RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 175 (474)
Q Consensus 98 --~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~G 175 (474)
..+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||++..+...... .......+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~---~~~~vkL~DfG~a~~~~~~~~~-----~~~~~~~~ 237 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDY-----VRKGDARL 237 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe---CCCcEEEeccccchhcccCcch-----hhccCCCC
Confidence 2578999999999999999999999999999999999995 6788999999999876432211 11233456
Q ss_pred CccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHH
Q 011945 176 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHY 254 (474)
Q Consensus 176 T~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~ 254 (474)
+..|+|||++.+..++.++|||||||+||||++ |..||.+...... ....+.... . ......+++++.+++..
T Consensus 238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~~~~~~~-~---~~~~~~~~~~~~~l~~~ 311 (337)
T cd05054 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCRRLKEGT-R---MRAPEYATPEIYSIMLD 311 (337)
T ss_pred CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHHHHhccC-C---CCCCccCCHHHHHHHHH
Confidence 788999999999999999999999999999998 9999987433221 111111111 1 11234567899999999
Q ss_pred HhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 255 CRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 255 cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
||+.+|++||++.+|++.|++++..
T Consensus 312 cl~~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 312 CWHNNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred HccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=325.94 Aligned_cols=262 Identities=19% Similarity=0.218 Sum_probs=203.6
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.|++.++||+|+||+||++.+..+++.||||++.... ....+.+|+.+++.++|++++. +...+..++..+++|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS-LAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEee-eeeeecCCCeEEEEE
Confidence 4899999999999999999998899999999875432 1234678999999998655554 444556667899999
Q ss_pred ecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 83 e~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
||+ +++|.+++... ...+++..+..++.||+.||.|||+.||+||||||+||++ ++.+.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecCCCC
Confidence 999 78999887643 3469999999999999999999999999999999999999 467899999999998654322
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
. .....|+..|+|||++.+..++.++|||||||++|||++|..||.+.......+.+...... .....
T Consensus 157 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~ 224 (285)
T cd05605 157 T--------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE----DQEEY 224 (285)
T ss_pred c--------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh----ccccc
Confidence 1 12347899999999999989999999999999999999999999875443222222211111 11123
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccccc
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILKY 295 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 295 (474)
...++..+.+|+..||..||++|| ++++| +.+ .+...++|...+.
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l---~~~-------~~~~~~~~~~~~~ 274 (285)
T cd05605 225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEV---KAH-------PFFRTANFKRLEA 274 (285)
T ss_pred CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHH---hcC-------cCccCCCHHHHhh
Confidence 356789999999999999999999 55554 222 3334567876654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=337.37 Aligned_cols=254 Identities=24% Similarity=0.338 Sum_probs=217.3
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
.+...|++.+.||.|.||.||+|+.+.+|+.||+|++..... ...+.+|+.+|+.|.+|++|..+..........
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 356689999999999999999999999999999998866543 247899999999999888888888888888899
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCC-CCeEEEEecCCcccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKRY 156 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~-~~~vkL~DFGla~~~ 156 (474)
++|||+| |+.|.+.+... .+++..+..++.||+.++.|||+.||+||||||+|||+...+. .+.+|++|||++...
T Consensus 112 ~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 9999999 89999998754 3999999999999999999999999999999999999975433 458999999999987
Q ss_pred ccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccch
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (474)
..... ....+||+.|+|||++....|+..+||||+||++|.|++|..||.+... .....++....+...
T Consensus 190 ~~~~~--------~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~---~~~~~~i~~~~~~f~ 258 (382)
T KOG0032|consen 190 KPGER--------LHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE---FEIFLAILRGDFDFT 258 (382)
T ss_pred cCCce--------EeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh---hHHHHHHHcCCCCCC
Confidence 76221 2457999999999999999999999999999999999999999988543 344456666555332
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
...+..++..++++|..|+..||..|+++.++++
T Consensus 259 -~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 259 -SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred -CCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 2334678899999999999999999999888755
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=330.56 Aligned_cols=265 Identities=22% Similarity=0.270 Sum_probs=202.9
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++|++++.||+|+||+||++.+..+++.||||++... .....+..|+.++..++| ++|..+..++..+...|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR-RWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC-CCCCceEEEEecCCeEEEE
Confidence 5799999999999999999999999999999987642 123347788999888864 5556666666778889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ +++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+....
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecCCCC
Confidence 9998 899999998666789999999999999999999999999999999999999 477899999999997654432
Q ss_pred CccccccccCCCCccCccccccccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccc
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.. ..+.+..+.......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~---~~~~~~~i~~~~~~~ 227 (331)
T cd05597 157 TV------QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHKEHF 227 (331)
T ss_pred Cc------cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC---HHHHHHHHHcCCCcc
Confidence 21 1123469999999999873 347889999999999999999999997643 334444443322222
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCC--CCCHHHHHHHHHHHHHHcCCCCCCcccccccc
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 294 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~--RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 294 (474)
..+.....+++++.++|..||..+++. |+++.++ +.+ ++...++|....
T Consensus 228 ~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~---l~h-------p~~~~~~~~~~~ 278 (331)
T cd05597 228 QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDF---KDH-------PFFEGIDWDNIR 278 (331)
T ss_pred cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHH---hcC-------CCCCCCCHHHHh
Confidence 222223457899999999988753332 5665444 443 334456777643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=331.13 Aligned_cols=256 Identities=21% Similarity=0.282 Sum_probs=196.7
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHH-HHHHhcCCCCCceeEEEeEeCCEEEEEEecC-
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAK-LYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 85 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~-il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (474)
+.||+|+||+||+|.+..+++.||||++.... ....+..|.. +++.++|+ +|..+..........++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp-~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHP-FLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCC-CCCCeeEEEEeCCEEEEEEcCCC
Confidence 47999999999999999999999999876431 1223445554 44566654 5555555566778899999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccc
Q 011945 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 165 (474)
Q Consensus 86 g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (474)
+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~---- 151 (323)
T cd05575 80 GGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSK---- 151 (323)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCCC----
Confidence 8899888874 5579999999999999999999999999999999999999 4778999999999875432211
Q ss_pred ccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCc
Q 011945 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245 (474)
Q Consensus 166 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 245 (474)
......||+.|+|||++.+..++.++|||||||++|||++|..||.... ..+.+..+..... .+...++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~-----~~~~~~~ 220 (323)
T cd05575 152 ---TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---TAEMYDNILNKPL-----RLKPNIS 220 (323)
T ss_pred ---ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC---HHHHHHHHHcCCC-----CCCCCCC
Confidence 1234579999999999999999999999999999999999999998643 3344444443322 1235678
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccccc
Q 011945 246 TEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 294 (474)
Q Consensus 246 ~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 294 (474)
.++.++|..||+.||++||++.+ .+.+++ ..++...++|....
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~---~~~~il---~~~~~~~~~~~~~~ 263 (323)
T cd05575 221 VSARHLLEGLLQKDRTKRLGAKD---DFLEIK---NHVFFSSINWDDLV 263 (323)
T ss_pred HHHHHHHHHHhhcCHHhCCCCCC---CHHHHH---cCCCcCCCCHHHHh
Confidence 99999999999999999999752 222322 12344456776654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=335.57 Aligned_cols=259 Identities=19% Similarity=0.271 Sum_probs=202.6
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-C
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 86 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (474)
+.||+|+||.||+|.+..+++.||||+++... ....+..|..++..+.+|++|..+..++......|++|||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999999999999999886432 12347789999999977777877877788888999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccc
Q 011945 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166 (474)
Q Consensus 87 ~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (474)
++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~----- 151 (329)
T cd05588 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGD----- 151 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCC-----
Confidence 899888863 4679999999999999999999999999999999999999 4778999999999975322211
Q ss_pred cccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCc------HHHHHHHHhhccccchHHHH
Q 011945 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 167 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~------~~~~~~~i~~~~~~~~~~~l 240 (474)
......||..|+|||++.+..++.++|||||||++|||++|+.||....... ....+..+..... .+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~ 224 (329)
T cd05588 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-----RI 224 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-----CC
Confidence 1234579999999999999999999999999999999999999996432111 1112222222221 23
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHH---HHHHHHHHHHHcCCCCCCcccccccc
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAY---LKRLFRDLFIREGFQFDYVFDWTILK 294 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~---l~~~L~~l~~~~~~~~~~~~dw~~~~ 294 (474)
+..++.++.++|..||..||.+|+++.. +.+++.+ ++...++|....
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h-------p~~~~~~~~~~~ 274 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH-------PFFRNIDWDLLE 274 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC-------CCCCCCCHHHHH
Confidence 4567899999999999999999998432 2233332 334456787654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=338.72 Aligned_cols=253 Identities=22% Similarity=0.266 Sum_probs=194.5
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++|+++++||+|+||.||+|++..+++.||||++... .....+.+|+.+++.+.|++++ .+......+...|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv-~~~~~~~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVV-KLYYSFQDKDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcc-eEEEEEEcCCEEEEE
Confidence 4799999999999999999999999999999987542 2234578899999999865555 445555677889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|..+....
T Consensus 80 ~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 80 MDYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCccccccc
Confidence 9999 8999999874 4568999999999999999999999999999999999999 477899999999986442110
Q ss_pred Cccc------------------------------------cccccCCCCccCccccccccccCCCCCchhhHHHHHHHHH
Q 011945 161 THQH------------------------------------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 204 (474)
Q Consensus 161 ~~~~------------------------------------~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ 204 (474)
.... .........+||+.|||||++.+..++.++|||||||+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0000 0000112457999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCC---CHHHH
Q 011945 205 YFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP---DYAYL 269 (474)
Q Consensus 205 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RP---t~~~l 269 (474)
||++|+.||.+.... ..+..+......... .....+++++.++|.+|+ .+|.+|+ ++.++
T Consensus 236 ell~G~~Pf~~~~~~---~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 236 EMLVGQPPFLADTPA---ETQLKVINWETTLHI-PSQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred ehhhCCCCCCCCCHH---HHHHHHhccCccccC-CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 999999999875432 222222211111100 012357889999999977 5999999 65555
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=338.43 Aligned_cols=253 Identities=21% Similarity=0.269 Sum_probs=193.8
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++|.++++||.|+||+||+|.+..+++.||||++.... ....+..|+++++.+.|++ |..+..++....+.|+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~-iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW-VVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCC-cceEEEEEEcCCeeEEE
Confidence 47999999999999999999999999999999875421 2245778999999998654 55555666778889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.+....
T Consensus 80 ~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~---~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 80 MEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILID---RGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC---CCCCEEEeeccccccccccc
Confidence 9999 8999999874 45799999999999999999999999999999999999994 77899999999997543211
Q ss_pred Cccc-------ccc---------------------------------ccCCCCccCccccccccccCCCCCchhhHHHHH
Q 011945 161 THQH-------IPY---------------------------------RENKNLTGTARYASMNTHLGIEQSRRDDLESLG 200 (474)
Q Consensus 161 ~~~~-------~~~---------------------------------~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlG 200 (474)
.... ... ......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 0000 000 000135799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCC---CHHHH
Q 011945 201 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP---DYAYL 269 (474)
Q Consensus 201 vil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RP---t~~~l 269 (474)
|+||||++|..||.+... ...+..+.........+ -...++.++.+||.+||. +|.+|+ ++.++
T Consensus 236 vil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p-~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 236 AIMFECLIGWPPFCSENS---HETYRKIINWRETLYFP-DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhhhcCCCCCCCCCH---HHHHHHHHccCCccCCC-CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 999999999999976433 23333333211111000 012467899999999997 777764 65554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=337.87 Aligned_cols=255 Identities=21% Similarity=0.244 Sum_probs=194.5
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
..|+++++||+|+||+||+|++..+++.||||++.... ....+..|+.+++.++|+ +|..+..+..+....++|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~-~iv~l~~~~~~~~~~~lv 79 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNE-WVVKLYYSFQDKDNLYFV 79 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCC-CeeeeEEEEecCCEEEEE
Confidence 36999999999999999999999999999999886432 123578899999999855 555555666778889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||| +..+.+||+|||+++.+....
T Consensus 80 ~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 80 MDYIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCccccccc
Confidence 9999 8899999874 4569999999999999999999999999999999999999 467899999999986542111
Q ss_pred Cccc----------------------------------------cccccCCCCccCccccccccccCCCCCchhhHHHHH
Q 011945 161 THQH----------------------------------------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLG 200 (474)
Q Consensus 161 ~~~~----------------------------------------~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlG 200 (474)
.... .........+||..|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0000 000011345799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHh--cCCCCCCCCHHHHH
Q 011945 201 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCR--SLRFDDKPDYAYLK 270 (474)
Q Consensus 201 vil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl--~~dp~~RPt~~~l~ 270 (474)
|+||||++|..||...... .....+.........+ ....+++++.+||.+|+ ..++..||++++|+
T Consensus 236 ~il~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~~~-~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPT---ETQLKVINWENTLHIP-PQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred hHHHHHHhCCCCCcCCCHH---HHHHHHHccccccCCC-CCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 9999999999999864432 2222222111111111 11247899999999854 45555699987774
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=336.47 Aligned_cols=249 Identities=21% Similarity=0.260 Sum_probs=195.9
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeE-----eC
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGV-----EG 75 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~-----~~ 75 (474)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++|++++..+..+.. ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 5689999999999999999999999999999999876432 23457789999999998777776655533 23
Q ss_pred CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 76 ~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
...|+||||++++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 102 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART 175 (364)
T ss_pred CeEEEEEeCCCCCHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEEeCCCccc
Confidence 4579999999999988875 358899999999999999999999999999999999999 4778999999999986
Q ss_pred cccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccc
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
...... .....||..|+|||++.+..++.++|||||||+||||++|+.||.+.... ..+.++.......
T Consensus 176 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~ 244 (364)
T cd07875 176 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI---DQWNKVIEQLGTP 244 (364)
T ss_pred cCCCCc--------ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCC
Confidence 543221 13357899999999999999999999999999999999999999875432 2222221100000
Q ss_pred -------------------------hHHHH------------hcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 236 -------------------------SIEAL------------CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 236 -------------------------~~~~l------------~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
....+ ....+.++.+||.+||..||.+||++.+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L 316 (364)
T cd07875 245 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316 (364)
T ss_pred CHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 00000 011245789999999999999999987663
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=336.00 Aligned_cols=252 Identities=21% Similarity=0.316 Sum_probs=197.9
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeE-----e
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGV-----E 74 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~-----~ 74 (474)
.+.++|++++.||.|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++|++++..+..+.. .
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 46789999999999999999999999999999999876432 22357789999999998777766654432 2
Q ss_pred CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 75 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 75 ~~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
....|++|++++++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 92 ~~~~~~~~~~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~---~~~~~kl~Dfg~~~ 166 (343)
T cd07878 92 FNEVYLVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVN---EDCELRILDFGLAR 166 (343)
T ss_pred cCcEEEEeecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEEC---CCCCEEEcCCccce
Confidence 24578999999999999886 45799999999999999999999999999999999999994 77899999999998
Q ss_pred ccccCCCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc-
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK- 232 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~- 232 (474)
...... ....||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+.......
T Consensus 167 ~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07878 167 QADDEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPS 236 (343)
T ss_pred ecCCCc----------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 654321 24578999999999987 568999999999999999999999997643221111111110000
Q ss_pred ----------------------ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 233 ----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 233 ----------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.......+...+++.+.+||.+||..||++||++.+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell 296 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEAL 296 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 00111222345677889999999999999999987764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=322.21 Aligned_cols=254 Identities=19% Similarity=0.237 Sum_probs=203.8
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCC------E
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD------Y 77 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~------~ 77 (474)
.|..+++||+|+||+||+|+++.+|+.||+|.+..... .....+|+.+++.|+|.++|..+..+....+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 47778899999999999999999999999998876544 2347999999999999886666666655544 7
Q ss_pred EEEEEecCCCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 78 NVLVIDLLGPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 78 ~~lv~e~~g~sL~~li~~~~---~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
.++|+||+..+|..+++... ..++...++.++.||+.||+|||++||+||||||+||||+ +.+.+||+|||+|+
T Consensus 92 l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~---~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 92 LYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLIS---SSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEEC---CCCcEeeeccchHH
Confidence 89999999999999999776 4588899999999999999999999999999999999995 78999999999999
Q ss_pred ccccCCCccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc-
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK- 232 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~- 232 (474)
.+.-+. +.....++|..|.|||++.|. .|+...||||+|||+.||++++..|.+..+.+....+..+....
T Consensus 169 a~~ip~-------~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 169 AFSIPM-------RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPN 241 (323)
T ss_pred HhcCCc-------ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCC
Confidence 655332 223456889999999999997 59999999999999999999999999876543333333332211
Q ss_pred ---cc------------------chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 233 ---VS------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 233 ---~~------------------~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
++ .......+...+...+++..||+.+|.+|.+++.+++
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~ 301 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT 301 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc
Confidence 00 0011111222357899999999999999999876643
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=323.43 Aligned_cols=236 Identities=19% Similarity=0.243 Sum_probs=187.6
Q ss_pred eeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-CCC
Q 011945 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS 88 (474)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~s 88 (474)
||+|+||+||+|.+..+++.||||++..... ...+..|+.+++.++| +++..+..++......+++|||+ +++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHS-RFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCC-CcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 7999999999999999999999998754321 2346789999999975 55555666666777889999998 889
Q ss_pred HHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccc
Q 011945 89 LEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 165 (474)
Q Consensus 89 L~~li~~---~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (474)
|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+.....
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~~~~~~~~---- 152 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLD---NDGNVRISDLGLAVELKDGQS---- 152 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEeeCccceecCCCCc----
Confidence 9887743 234699999999999999999999999999999999999994 678899999999976644322
Q ss_pred ccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHH-HHHHHHhhccccchHHHHhcCC
Q 011945 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYEKISEKKVSTSIEALCRGY 244 (474)
Q Consensus 166 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~i~~~~~~~~~~~l~~~~ 244 (474)
......||..|+|||++.+..++.++|||||||++|||++|+.||......... .....+.... ..+...+
T Consensus 153 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-----~~~~~~~ 224 (280)
T cd05608 153 ---KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS-----VTYPDKF 224 (280)
T ss_pred ---cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC-----CCCcccC
Confidence 123457999999999999999999999999999999999999999764332211 1112211111 1223568
Q ss_pred cHHHHHHHHHHhcCCCCCCCCH
Q 011945 245 PTEFASYFHYCRSLRFDDKPDY 266 (474)
Q Consensus 245 p~~l~~li~~cl~~dp~~RPt~ 266 (474)
+.++.+++..||+.||++||++
T Consensus 225 ~~~~~~li~~~l~~~P~~R~~~ 246 (280)
T cd05608 225 SPASKSFCEALLAKDPEKRLGF 246 (280)
T ss_pred CHHHHHHHHHHhcCCHHHhcCC
Confidence 8999999999999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=337.43 Aligned_cols=246 Identities=20% Similarity=0.253 Sum_probs=191.7
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.++|+++++||+|+||.||+|++..+++.||||++..... ...+.+|+++++.++|.+++. +..+...+...+++|
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVK-CHDMFDHNGEIQVLL 151 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcce-eeeEeccCCeEEEEE
Confidence 3578899999999999999999999999999998854432 245889999999998655554 445556777889999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
||+ +++|.+. ....+..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.+.....
T Consensus 152 e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~---~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 152 EFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN---SAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred ecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc---CCCCEEEcccccceecccccc
Confidence 999 6777543 2457788899999999999999999999999999999994 778999999999987643221
Q ss_pred ccccccccCCCCccCccccccccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccch
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (474)
......||..|+|||++.. ...+.++|||||||+||||++|+.||......+.......+.....
T Consensus 224 -------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--- 293 (353)
T PLN00034 224 -------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP--- 293 (353)
T ss_pred -------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCC---
Confidence 1234579999999998743 2345799999999999999999999975433333332222221111
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
......++.++.+||..||..||++||++.+|++
T Consensus 294 -~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 294 -PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred -CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1223567899999999999999999999887743
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=317.56 Aligned_cols=259 Identities=22% Similarity=0.287 Sum_probs=215.0
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
.+.+.|++.+.||+|.|+.||++.+..+|+.+|+|+++.+. ..+.+.+|++|.+.|+|++++ .+.....+..+.|
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~Iv-rL~~ti~~~~~~y 86 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV-RLHDSIQEESFHY 86 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEe-ehhhhhcccceeE
Confidence 56788999999999999999999999999999999877643 456799999999999965554 4544455677889
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
||+|++ |+.|..-|-. ..-+++..+-.++.||+++|.|+|.+||||||+||.|+|+...+..--+||+|||+|..+.+
T Consensus 87 lvFe~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred EEEecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 999999 7777554431 24588999999999999999999999999999999999998766777899999999998873
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
.. ....+.||+.|||||++...+|+..+|||+.|||||-||.|.+||.+ ++....|+.|.......+.+
T Consensus 166 g~--------~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~---~~~~rlye~I~~g~yd~~~~ 234 (355)
T KOG0033|consen 166 GE--------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD---EDQHRLYEQIKAGAYDYPSP 234 (355)
T ss_pred cc--------ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC---ccHHHHHHHHhccccCCCCc
Confidence 22 13567999999999999999999999999999999999999999988 34566777777766544432
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
.+..+.++.++|+.+||..||.+|.|+.|. |++.++.
T Consensus 235 -~w~~is~~Ak~LvrrML~~dP~kRIta~EA---L~HpWi~ 271 (355)
T KOG0033|consen 235 -EWDTVTPEAKSLIRRMLTVNPKKRITADEA---LKHPWIC 271 (355)
T ss_pred -ccCcCCHHHHHHHHHHhccChhhhccHHHH---hCCchhc
Confidence 346788999999999999999999997665 5555443
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=342.45 Aligned_cols=250 Identities=23% Similarity=0.340 Sum_probs=204.2
Q ss_pred eeeecCceEEEEEEEcCCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-CCCHH
Q 011945 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLE 90 (474)
Q Consensus 14 ~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL~ 90 (474)
+||+|.||+||-|+|..+...+|||-+..+.. .+-+..|+.+.+.|+|.|+|.++..+...+ ++-|.||-. ||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG-f~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG-FFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC-eEEEEeecCCCCcHH
Confidence 68999999999999999999999997655433 345899999999999988888887765555 556666655 99999
Q ss_pred HHHHHcCCCC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccccc
Q 011945 91 DLFNFCSRKL--SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 168 (474)
Q Consensus 91 ~li~~~~~~l--~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 168 (474)
+++...-+++ ++.++-.+..||++||.|||++.|||||||-+|+||. .-.|.+||+|||.++.+-.-..
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP------- 731 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINP------- 731 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCc-------
Confidence 9999777777 8999999999999999999999999999999999996 5679999999999987654322
Q ss_pred cCCCCccCccccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcH
Q 011945 169 ENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (474)
Q Consensus 169 ~~~~~~GT~~Y~APE~~~~~~--~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (474)
...++.||..|||||++..++ |+.++|||||||++.||.||++||..+... ...+.++..-+..+++ +..++.
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp--qAAMFkVGmyKvHP~i---Peelsa 806 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP--QAAMFKVGMYKVHPPI---PEELSA 806 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh--hHhhhhhcceecCCCC---cHHHHH
Confidence 235789999999999998765 899999999999999999999999876532 2333344433333333 345678
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011945 247 EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281 (474)
Q Consensus 247 ~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 281 (474)
+.+.||.+|+..||.+||++.+| |.+.|...+
T Consensus 807 eak~FilrcFepd~~~R~sA~~L---L~DpFlq~~ 838 (1226)
T KOG4279|consen 807 EAKNFILRCFEPDPCDRPSAKDL---LQDPFLQHN 838 (1226)
T ss_pred HHHHHHHHHcCCCcccCccHHHh---ccCcccccC
Confidence 89999999999999999997766 666665443
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=329.77 Aligned_cols=265 Identities=22% Similarity=0.287 Sum_probs=204.8
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++|++.++||+|+||+||++++..+++.||+|++.... ....+..|+.++..+.| +++..+..+.......++|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN-QWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCC-CCEeeEEEEEecCCEEEEE
Confidence 57999999999999999999999999999999875321 12236778888888764 5566666667778889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+....
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecccCC
Confidence 9998 899999998666789999999999999999999999999999999999999 477899999999997654332
Q ss_pred CccccccccCCCCccCccccccccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccc
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
.. ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||... +..+.+.++.......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~---~~~~~~~~i~~~~~~~ 227 (332)
T cd05623 157 TV------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGKIMNHKERF 227 (332)
T ss_pred cc------eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC---CHHHHHHHHhCCCccc
Confidence 21 1123579999999999863 45789999999999999999999999864 3344555554433222
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCC--CCCHHHHHHHHHHHHHHcCCCCCCcccccccc
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 294 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~--RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 294 (474)
..+.....+++++.+|+.+|+..+++. |+++++++ .+ ++...++|+...
T Consensus 228 ~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~---~h-------~~f~~~~~~~~~ 278 (332)
T cd05623 228 QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFK---QH-------PFFTGIDWDNIR 278 (332)
T ss_pred cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHh---CC-------CCcCCCCHHHHh
Confidence 223334567899999999999765544 56755553 32 334456777553
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=334.31 Aligned_cols=253 Identities=19% Similarity=0.211 Sum_probs=195.7
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEe-----
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVE----- 74 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~----- 74 (474)
.+.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++|++++..+..+...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 356899999999999999999999999999999998764322 24577899999999987777776655432
Q ss_pred CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 75 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 75 ~~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
....+++|||++++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 94 ~~~~~lv~e~~~~~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 94 FQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 167 (355)
T ss_pred cceeEEEhhhhcccHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCCEEEeeCcccc
Confidence 23579999999989888775 358999999999999999999999999999999999999 477899999999998
Q ss_pred ccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc--
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-- 232 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~-- 232 (474)
....... .....||..|+|||++.+..++.++|||||||++|+|++|+.||.+.................
T Consensus 168 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (355)
T cd07874 168 TAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239 (355)
T ss_pred cCCCccc--------cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 6543221 134578999999999999999999999999999999999999998643211111110000000
Q ss_pred -----ccc---------------hHH------------HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 233 -----VST---------------SIE------------ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 233 -----~~~---------------~~~------------~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
... ... ......+.++.+||.+||..||++||++.+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell 309 (355)
T cd07874 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL 309 (355)
T ss_pred HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHh
Confidence 000 000 00112356789999999999999999987764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=324.23 Aligned_cols=254 Identities=23% Similarity=0.326 Sum_probs=202.6
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCC-----eEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN-----EEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~-----~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
.++|++.+.||+|+||.||+|.+...+ ..||+|.+..... ...+.+|+.++..+.|++++..+ .+......
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~-~~~~~~~~ 82 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLL-GVCTKEQP 82 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEE-EEEcCCCc
Confidence 357999999999999999999976554 6899998764432 23578899999999866555544 45556677
Q ss_pred EEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCC
Q 011945 78 NVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~~---------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~ 141 (474)
.+++|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++ +
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~---~ 159 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG---E 159 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc---C
Confidence 89999998 789999987432 4588999999999999999999999999999999999994 6
Q ss_pred CCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCc
Q 011945 142 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 220 (474)
Q Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~ 220 (474)
++.+||+|||+++....... +.......++..|+|||.+.+..++.++|||||||++|||++ |..||.+...
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-- 232 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADY-----YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-- 232 (283)
T ss_pred CCcEEECCCcceeecccccc-----ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--
Confidence 78899999999976543221 111233467889999999998899999999999999999998 9999987543
Q ss_pred HHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011945 221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 275 (474)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (474)
.+.+..+..... ......+|+++.+|+..||+.||++||++.+|.+.|+.
T Consensus 233 -~~~~~~i~~~~~----~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 233 -QEVIEMIRSRQL----LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHHHHcCCc----CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 233333332222 12345789999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=333.86 Aligned_cols=267 Identities=21% Similarity=0.276 Sum_probs=203.6
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++|++.++||+|+||+||++++..+++.||||++.... ....+..|..++..+. +++|..+..+.....+.|+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEE
Confidence 57999999999999999999999999999999875421 1233677888887776 56666777777788899999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ |++|.+++......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeeccCCC
Confidence 9998 899999998666789999999999999999999999999999999999999 477889999999998765432
Q ss_pred CccccccccCCCCccCccccccccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccc
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
.. ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||.... ..+.+..+.......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~---~~~~~~~i~~~~~~~ 227 (331)
T cd05624 157 TV------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES---LVETYGKIMNHEERF 227 (331)
T ss_pred ce------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC---HHHHHHHHHcCCCcc
Confidence 21 1123579999999999876 457899999999999999999999997643 334444444322222
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccccc
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 294 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 294 (474)
..+.....+++++.+++.+||..++ +|+....+.+++.+ .+...++|+...
T Consensus 228 ~~p~~~~~~~~~~~~li~~ll~~~~-~~~~~~~~~~~~~h-------~~f~~~~~~~~~ 278 (331)
T cd05624 228 QFPSHITDVSEEAKDLIQRLICSRE-RRLGQNGIEDFKKH-------AFFEGIDWENIR 278 (331)
T ss_pred cCCCccccCCHHHHHHHHHHccCch-hhcCCCCHHHHhcC-------CCcCCCCHHHHh
Confidence 2222234578999999999998655 44322223333333 333456787653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=328.79 Aligned_cols=236 Identities=22% Similarity=0.281 Sum_probs=192.3
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-C
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 86 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (474)
+.||+|+||+||+|.+..+++.||||++... ........|..++..+.+|++|..+..+.......+++|||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999987643 223446678888887656777777777777888999999998 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccc
Q 011945 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166 (474)
Q Consensus 87 ~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (474)
++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~----- 151 (316)
T cd05619 81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD---TDGHIKIADFGMCKENMLGDA----- 151 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEEC---CCCCEEEccCCcceECCCCCC-----
Confidence 899999874 35789999999999999999999999999999999999994 778999999999975432211
Q ss_pred cccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcH
Q 011945 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (474)
Q Consensus 167 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (474)
......||..|+|||++.+..++.++|||||||++|||++|..||.+... .+.+..+..... .+...++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~i~~~~~-----~~~~~~~~ 221 (316)
T cd05619 152 --KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQSIRMDNP-----CYPRWLTR 221 (316)
T ss_pred --ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCC-----CCCccCCH
Confidence 12345799999999999999999999999999999999999999987432 333333322211 12245788
Q ss_pred HHHHHHHHHhcCCCCCCCCHH
Q 011945 247 EFASYFHYCRSLRFDDKPDYA 267 (474)
Q Consensus 247 ~l~~li~~cl~~dp~~RPt~~ 267 (474)
++.+++.+||..||++||++.
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~ 242 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVK 242 (316)
T ss_pred HHHHHHHHHhccCHhhcCCCh
Confidence 999999999999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=320.79 Aligned_cols=261 Identities=20% Similarity=0.256 Sum_probs=203.6
Q ss_pred CCCccCCcEEEeeeeeecCceEEEEEEEcCCCe----EEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeE
Q 011945 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGV 73 (474)
Q Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~----~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~ 73 (474)
|+....++|+++++||+|+||+||+|.+..+++ .||||++..... ...+..|+.+++.+.|++++..+. ++.
T Consensus 1 ~~~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~-~~~ 79 (279)
T cd05109 1 MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLG-ICL 79 (279)
T ss_pred CcccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEE-EEc
Confidence 566778899999999999999999999877766 489998765433 235778999999888665554444 444
Q ss_pred eCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCC
Q 011945 74 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (474)
Q Consensus 74 ~~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (474)
.. ..+++|+++ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ +.+.+||+|||+
T Consensus 80 ~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~---~~~~~kL~dfG~ 155 (279)
T cd05109 80 TS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK---SPNHVKITDFGL 155 (279)
T ss_pred CC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc---CCCcEEECCCCc
Confidence 33 356777777 8899999876566799999999999999999999999999999999999994 677899999999
Q ss_pred ccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhc
Q 011945 153 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEK 231 (474)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~ 231 (474)
++.+........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||........ ...+...
T Consensus 156 ~~~~~~~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~~~ 227 (279)
T cd05109 156 ARLLDIDETEYH-----ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI---PDLLEKG 227 (279)
T ss_pred eeecccccceee-----cCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHHCC
Confidence 987654322111 112245678999999999899999999999999999998 9999976543222 2222221
Q ss_pred cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 232 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
.. . .....++.++.+++..||..||++||++.++.+.|+++..
T Consensus 228 ~~-~---~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 228 ER-L---PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred Cc-C---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11 1 1124578999999999999999999999999988887753
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=329.93 Aligned_cols=235 Identities=20% Similarity=0.260 Sum_probs=194.3
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-C
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 86 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (474)
+.||+|+||+||+|.+..+++.||||++.... ....+..|..++..+.+|++|..+..+.......|+||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999876431 23346788899988877778888877778888999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccc
Q 011945 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166 (474)
Q Consensus 87 ~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (474)
++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~----- 151 (318)
T cd05570 81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGV----- 151 (318)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCC-----
Confidence 899888874 4579999999999999999999999999999999999999 4778999999999875322211
Q ss_pred cccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcH
Q 011945 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (474)
Q Consensus 167 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (474)
.....+||..|+|||++.+..++.++|||||||++|+|++|+.||.+.. ....+..+..... .+...++.
T Consensus 152 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~---~~~~~~~i~~~~~-----~~~~~~~~ 221 (318)
T cd05570 152 --TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD---EDELFQSILEDEV-----RYPRWLSK 221 (318)
T ss_pred --cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC---HHHHHHHHHcCCC-----CCCCcCCH
Confidence 1234579999999999999999999999999999999999999997643 3333343333222 12356789
Q ss_pred HHHHHHHHHhcCCCCCCCCH
Q 011945 247 EFASYFHYCRSLRFDDKPDY 266 (474)
Q Consensus 247 ~l~~li~~cl~~dp~~RPt~ 266 (474)
++.+||..||..||++||++
T Consensus 222 ~~~~li~~~l~~dP~~R~s~ 241 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGC 241 (318)
T ss_pred HHHHHHHHHccCCHHHcCCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=338.26 Aligned_cols=258 Identities=22% Similarity=0.288 Sum_probs=204.8
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCC-----CeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
.++|.++++||+|+||.||+|.+... +..||||++..... ...+.+|+++++.+..|++|..+..++.....
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 45788999999999999999987433 35799998865432 24588999999999866777777777777888
Q ss_pred EEEEEecC-CCCHHHHHHHcC-----------------------------------------------------------
Q 011945 78 NVLVIDLL-GPSLEDLFNFCS----------------------------------------------------------- 97 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~~----------------------------------------------------------- 97 (474)
.+|||||+ +++|.+++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999 889998875321
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCC
Q 011945 98 ------------------------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (474)
Q Consensus 98 ------------------------------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~ 141 (474)
..+++..++.++.||+.||.|||+++|+||||||+|||++ .
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~---~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA---Q 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe---C
Confidence 2478888999999999999999999999999999999995 6
Q ss_pred CCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCc
Q 011945 142 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 220 (474)
Q Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~ 220 (474)
++.+||+|||+++.+...... .......++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNY-----VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred CCEEEEEeCCcceeccccccc-----cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 788999999999866443221 11233457789999999999899999999999999999997 999997653321
Q ss_pred HHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
..+..+.... . ......+|.++.+++.+||..||++||++.+|.++|+.++
T Consensus 348 --~~~~~~~~~~-~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 348 --TFYNKIKSGY-R---MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred --HHHHHHhcCC-C---CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1122222211 1 1123467899999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=318.63 Aligned_cols=255 Identities=21% Similarity=0.352 Sum_probs=205.9
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
...|.+.++||.|+||.||+|.+..+++.||+|++..... ...+.+|+++++.++|.+++..+. +.......+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~~~lv~e~ 83 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG-VCTREPPFYIITEF 83 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEE-EEcCCCCcEEEEEe
Confidence 4569999999999999999999999999999998765432 346889999999998766555554 45566678899998
Q ss_pred C-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 85 L-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 85 ~-g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc---CCCcEEeCCCccccccccceee
Confidence 8 889999987543 4589999999999999999999999999999999999994 7789999999999876543221
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
......++..|+|||.+.+..++.++|||||||++|||++ |..||.+... ...+..+.... .....
T Consensus 161 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~~~~~~~~----~~~~~ 227 (263)
T cd05052 161 ------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKGY----RMERP 227 (263)
T ss_pred ------ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCCC----CCCCC
Confidence 1122345678999999999999999999999999999998 9999976432 22233332211 11234
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
..+|.++.+++.+||..+|++||++.++.+.|+.+|
T Consensus 228 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 263 (263)
T cd05052 228 EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETMF 263 (263)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhhC
Confidence 678999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=322.18 Aligned_cols=243 Identities=21% Similarity=0.196 Sum_probs=196.2
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeE---eCCEEEEEEec
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGV---EGDYNVLVIDL 84 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~---~~~~~~lv~e~ 84 (474)
..||+|++|.||+|.+ +|+.||||.+..... .+.+.+|+.++++++|++++..+..+.. ...+.+++|||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6789999999999985 789999998765432 2456799999999998765555544433 24578999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 85 ~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs-~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
+ +++|.+++.. ...+++...+.++.|++.||.|||+ .+++||||||+|||++ .++.+||+|||+++.+....
T Consensus 104 ~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~---~~~~~kl~dfg~~~~~~~~~-- 177 (283)
T PHA02988 104 CTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT---ENYKLKIICHGLEKILSSPP-- 177 (283)
T ss_pred CCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEEC---CCCcEEEcccchHhhhcccc--
Confidence 9 8899999974 4579999999999999999999998 5999999999999994 77899999999998654322
Q ss_pred cccccccCCCCccCccccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
....||..|+|||++.+ ..++.++|||||||++|||++|+.||.+... .+.+..+....... .+
T Consensus 178 --------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---~~~~~~i~~~~~~~---~~ 243 (283)
T PHA02988 178 --------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---KEIYDLIINKNNSL---KL 243 (283)
T ss_pred --------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcCCCC---CC
Confidence 12468899999999976 6799999999999999999999999987542 33334433222221 12
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
...+|+++.+++.+||+.||++||++.+|++.|+.+.
T Consensus 244 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 244 PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 3467899999999999999999999999999998764
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=337.38 Aligned_cols=271 Identities=19% Similarity=0.273 Sum_probs=205.7
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++|++++.||+|+||.||+|.+..+++.||||++... .....+..|+.++..++|++ +..+...+..+...++|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW-VVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCC-EeeEEEEEEcCCEEEEE
Confidence 4799999999999999999999999999999987642 22345778999999998655 44555556677889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ |++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.+....
T Consensus 80 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 80 MEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCccccccc
Confidence 9999 8899999874 4579999999999999999999999999999999999999 478899999999997653321
Q ss_pred Cccc----------------------------cccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 011945 161 THQH----------------------------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212 (474)
Q Consensus 161 ~~~~----------------------------~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~P 212 (474)
.... .........+||+.|+|||++.+..++.++|||||||+||||++|..|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 1000 000011245799999999999999999999999999999999999999
Q ss_pred CCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccc
Q 011945 213 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTI 292 (474)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~ 292 (474)
|.+... ...+.++.........+. ...+++++.++|.+|+ .||.+|++...+.+++.+ ++...++|..
T Consensus 236 f~~~~~---~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h-------p~f~~~~~~~ 303 (360)
T cd05627 236 FCSETP---QETYRKVMNWKETLVFPP-EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH-------PFFEGVDWGH 303 (360)
T ss_pred CCCCCH---HHHHHHHHcCCCceecCC-CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC-------CCCCCCCHHH
Confidence 987443 333344332111111110 1236789999999977 499999975444444443 4455678887
Q ss_pred cc
Q 011945 293 LK 294 (474)
Q Consensus 293 ~~ 294 (474)
..
T Consensus 304 ~~ 305 (360)
T cd05627 304 IR 305 (360)
T ss_pred Hh
Confidence 54
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=336.97 Aligned_cols=248 Identities=21% Similarity=0.280 Sum_probs=197.7
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
.++|++.++||+|+||.||+|++..+++.||||++... .....+..|+.+++.++|++ |..+..+...+...++
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~-iv~~~~~~~~~~~~~l 120 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW-IVQLHYAFQDDKYLYM 120 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCC-cceEEEEEecCCEEEE
Confidence 46799999999999999999999999999999987542 12234678999999998555 4555556677888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
||||+ |++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 121 v~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 121 VMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceeeccCC
Confidence 99999 8899999873 468999999999999999999999999999999999999 47889999999999865432
Q ss_pred CCccccccccCCCCccCccccccccccCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccc
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGI----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~----~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
... ......||+.|+|||++.+. .++.++|||||||+||||++|..||.+.. ....+.++.......
T Consensus 196 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~~~~~~ 266 (370)
T cd05596 196 GMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS---LVGTYSKIMDHKNSL 266 (370)
T ss_pred Ccc------cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC---HHHHHHHHHcCCCcC
Confidence 211 12345799999999998754 37899999999999999999999998743 234445544322111
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCC--CCCHHHH
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYL 269 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~--RPt~~~l 269 (474)
..+. ...++.++.++|..||..+|++ |++++++
T Consensus 267 ~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~el 301 (370)
T cd05596 267 TFPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEI 301 (370)
T ss_pred CCCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHH
Confidence 1111 1247899999999999999987 9997766
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=332.94 Aligned_cols=238 Identities=20% Similarity=0.275 Sum_probs=191.1
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-C
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 86 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (474)
+.||+|+||.||+|.+..+++.||||++.... ....+..|+++++.+.|+ +|..+..++......|+||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp-~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP-FLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCC-CCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999876431 123467788899888755 5555556667778899999999 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccc
Q 011945 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 165 (474)
Q Consensus 87 ~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs-~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (474)
++|.+++.. ...+++..++.++.||+.||.|||+ +||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~---- 151 (325)
T cd05594 80 GELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGA---- 151 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCc----
Confidence 889888763 4579999999999999999999997 899999999999999 4778999999999875432221
Q ss_pred ccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCc
Q 011945 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245 (474)
Q Consensus 166 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 245 (474)
......||+.|+|||++.+..++.++|||||||+||||++|..||.+... ...+..+..... .+...++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~---~~~~~~i~~~~~-----~~p~~~~ 220 (325)
T cd05594 152 ---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEEI-----RFPRTLS 220 (325)
T ss_pred ---ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH---HHHHHHHhcCCC-----CCCCCCC
Confidence 11345799999999999999999999999999999999999999976432 223333322221 1235678
Q ss_pred HHHHHHHHHHhcCCCCCCC-----CHHHHH
Q 011945 246 TEFASYFHYCRSLRFDDKP-----DYAYLK 270 (474)
Q Consensus 246 ~~l~~li~~cl~~dp~~RP-----t~~~l~ 270 (474)
+++.++|..||+.||++|+ ++.+++
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il 250 (325)
T cd05594 221 PEAKSLLSGLLKKDPKQRLGGGPDDAKEIM 250 (325)
T ss_pred HHHHHHHHHHhhcCHHHhCCCCCCCHHHHh
Confidence 9999999999999999997 666553
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=324.53 Aligned_cols=256 Identities=18% Similarity=0.224 Sum_probs=192.9
Q ss_pred eeeeeecCceEEEEEEEc--CCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeE-eCCEEEEEEecCCCC
Q 011945 12 GRKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDYNVLVIDLLGPS 88 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~--~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~-~~~~~~lv~e~~g~s 88 (474)
.++||+|+||+||+|.++ .+++.||+|.+........+.+|+.+++.++|++++..+..+.. .+...+++|||++++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHD 85 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCC
Confidence 468999999999999965 46789999998766666678999999999998887777666543 456789999999999
Q ss_pred HHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeC-CCCCeEEEEecCCccccccC
Q 011945 89 LEDLFNFCS--------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 89 L~~li~~~~--------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~-~~~~~vkL~DFGla~~~~~~ 159 (474)
|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+... +..+.+||+|||+++.+...
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~ 165 (317)
T cd07868 86 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165 (317)
T ss_pred HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCC
Confidence 999886331 248999999999999999999999999999999999999532 35578999999999876443
Q ss_pred CCccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCc------HHHHHHHHhhcc
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKYEKISEKK 232 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~------~~~~~~~i~~~~ 232 (474)
.. +........||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ....+..+....
T Consensus 166 ~~----~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 166 LK----PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred Cc----cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 21 11122456889999999999874 58999999999999999999999997533210 011111111000
Q ss_pred -------------cc--------------------chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 233 -------------VS--------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 233 -------------~~--------------------~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.. ...+......+.++.+||..||..||++|||++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 0000001123467889999999999999999888753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=336.73 Aligned_cols=255 Identities=15% Similarity=0.180 Sum_probs=199.7
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEc--CCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~--~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
.+..+|+++++||.|+||.||+|... .+++.||||.+... ..+.+|+++++.|+|++++..+. +.......|++
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---~~~~~E~~il~~l~h~~iv~~~~-~~~~~~~~~lv 164 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---KTPGREIDILKTISHRAIINLIH-AYRWKSTVCMV 164 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---ccHHHHHHHHHhcCCCCccceee-eEeeCCEEEEE
Confidence 34568999999999999999999754 35678999987543 34678999999999766665554 44566788999
Q ss_pred EecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 82 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 82 ~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
|++++++|.+++. ....+++..++.|+.||+.||.|||++|||||||||+|||+ +..+.+||+|||++..+.....
T Consensus 165 ~e~~~~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 165 MPKYKCDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred ehhcCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCccccccCcccc
Confidence 9999999999985 45679999999999999999999999999999999999999 4778999999999986654322
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc-------
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS------- 234 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~------- 234 (474)
. .......||+.|+|||++.+..++.++|||||||+||||++|..||.+.........+..+......
T Consensus 241 ~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~ 315 (392)
T PHA03207 241 T-----PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ 315 (392)
T ss_pred c-----ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence 1 1123467999999999999999999999999999999999999999876544333333322211000
Q ss_pred --------------------chHHHH--hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 235 --------------------TSIEAL--CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 235 --------------------~~~~~l--~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
...+.. ...++.++.++|.+||..||++||++.+++.
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000 1245678999999999999999999887743
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=335.28 Aligned_cols=257 Identities=19% Similarity=0.245 Sum_probs=197.8
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeC----CEEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEG----DYNV 79 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~----~~~~ 79 (474)
+|+++++||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++|++++..+..+.... ...|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4789999999999999999999999999999875432 2245788999999999777666665544332 2689
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 80 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 80 lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
++|||++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 81 lv~e~~~~~l~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 81 VVTELMQSDLHKIIV-SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEeeccccCHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccceeecccC
Confidence 999999999998886 35579999999999999999999999999999999999999 47789999999999865432
Q ss_pred CCccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc-------
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK------- 231 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~------- 231 (474)
... ......+|..|+|||++.+. .++.++|||||||++|||++|+.||.+.........+......
T Consensus 157 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 157 ESK------HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMR 230 (372)
T ss_pred ccc------cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 211 11234688999999999875 4799999999999999999999999875443222222111100
Q ss_pred -------------c-ccchHH---HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 232 -------------K-VSTSIE---ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 232 -------------~-~~~~~~---~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
. ...... .+....++++.+||.+||..||++||++.++ |.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~---l~hp~ 290 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADA---LAHPY 290 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHH---hcCHh
Confidence 0 000011 1223457899999999999999999998766 44444
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=317.65 Aligned_cols=247 Identities=21% Similarity=0.316 Sum_probs=202.5
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 85 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (474)
.+|++.+.||+|+||.||++.. .+..||+|.+......+.+..|+.+++.++|.+.+..+..+...+...+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 5799999999999999999985 4788999998766666678999999999997777776665556667789999999
Q ss_pred CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccc
Q 011945 86 GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164 (474)
Q Consensus 86 g~sL~~li~~~~~-~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (474)
+++|.+++..... .+++..++.++.||+.||+|||++||+||||||+||+++ +++.+||+|||++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~dfg~~~~~~~~~---- 156 (256)
T cd05082 84 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQ---- 156 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc---CCCcEEecCCccceeccccC----
Confidence 7899999875433 489999999999999999999999999999999999994 77899999999987654322
Q ss_pred cccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcC
Q 011945 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (474)
Q Consensus 165 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (474)
....++..|+|||++.+..++.++|||||||++|||++ |+.||..... ......+.... . ......
T Consensus 157 ------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~~~-~---~~~~~~ 223 (256)
T cd05082 157 ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEKGY-K---MDAPDG 223 (256)
T ss_pred ------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcCC-C---CCCCCC
Confidence 12345678999999999889999999999999999997 9999976432 22222222211 1 123356
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011945 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 275 (474)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (474)
+|+.+.+++.+||..+|++||++.++.+.|++
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 224 CPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 88999999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=336.81 Aligned_cols=270 Identities=21% Similarity=0.251 Sum_probs=200.6
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
.+|+++++||+|+||+||+|++..+++.||||++.... ....+..|+.+++.+.|++ |..+...+..+...|+|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~-iv~~~~~~~~~~~~~lv 79 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW-VVRLYYSFQDKDNLYFV 79 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCc-CCeEEEEEEeCCEEEEE
Confidence 36999999999999999999999999999999876432 2235788999999998655 55555556677889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++..+....
T Consensus 80 ~E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 80 MDYIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCccccccc
Confidence 9999 8899999874 3578999999999999999999999999999999999999 478899999999986432110
Q ss_pred Cccc----------------------------------------cccccCCCCccCccccccccccCCCCCchhhHHHHH
Q 011945 161 THQH----------------------------------------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLG 200 (474)
Q Consensus 161 ~~~~----------------------------------------~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlG 200 (474)
.... .........+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0000 000011235799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 201 YVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 201 vil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
|+||||++|+.||.+... .+...++.........+ ....+++++.++|.+|+ .+|++|++...+.+++++
T Consensus 236 vil~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p-~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h----- 305 (382)
T cd05625 236 VILYEMLVGQPPFLAQTP---LETQMKVINWQTSLHIP-PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH----- 305 (382)
T ss_pred HHHHHHHhCCCCCCCCCH---HHHHHHHHccCCCcCCC-CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC-----
Confidence 999999999999987433 22222322211111111 11356889999998876 599999973323333433
Q ss_pred CCCCCCccccccc
Q 011945 281 GFQFDYVFDWTIL 293 (474)
Q Consensus 281 ~~~~~~~~dw~~~ 293 (474)
++...++|...
T Consensus 306 --p~f~~~~~~~~ 316 (382)
T cd05625 306 --PFFKTIDFSSD 316 (382)
T ss_pred --CCcCCcChHHH
Confidence 23334566653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=331.99 Aligned_cols=256 Identities=21% Similarity=0.315 Sum_probs=201.4
Q ss_pred eeeeeecCceEEEEEEEc---CCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 12 GRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~---~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
++.||+|+||.||++.+. .+++.||||++.... ....+..|+++++.++|++++. +..++..+...|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK-LHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCccc-EEEEEEcCCEEEEEEcC
Confidence 367999999999999863 578999999876432 2234678999999998665554 55556677788999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 85 ~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 80 LRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCC--
Confidence 9 7899998863 4569999999999999999999999999999999999999 4778999999999976543321
Q ss_pred ccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcC
Q 011945 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (474)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ....+..+...... +...
T Consensus 154 -----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~---~~~~~~~i~~~~~~-----~p~~ 220 (318)
T cd05582 154 -----KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD---RKETMTMILKAKLG-----MPQF 220 (318)
T ss_pred -----ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC---HHHHHHHHHcCCCC-----CCCC
Confidence 1234579999999999999889999999999999999999999997643 33344444333221 2356
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHH--HHHHHHHHHHHcCCCCCCcccccccc
Q 011945 244 YPTEFASYFHYCRSLRFDDKPDYAY--LKRLFRDLFIREGFQFDYVFDWTILK 294 (474)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~--l~~~L~~l~~~~~~~~~~~~dw~~~~ 294 (474)
+++++.++|..||+.||++||++.+ +.+++.+. +...++|....
T Consensus 221 ~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~-------~~~~~~~~~~~ 266 (318)
T cd05582 221 LSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHP-------FFSTIDWNKLY 266 (318)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCC-------CcCCCCHHHHH
Confidence 7899999999999999999999776 55555433 33345676543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=339.16 Aligned_cols=238 Identities=19% Similarity=0.331 Sum_probs=197.4
Q ss_pred EeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-CCCH
Q 011945 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSL 89 (474)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL 89 (474)
-++.||+|+.|.||+|+ -.++.||||.++. .-..+++-|++|+|.|+| .+.+++.....+||+|||| .|-|
T Consensus 128 ELeWlGSGaQGAVF~Gr--l~netVAVKKV~e-----lkETdIKHLRkLkH~NII-~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGR--LHNETVAVKKVRE-----LKETDIKHLRKLKHPNII-TFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeee--ccCceehhHHHhh-----hhhhhHHHHHhccCccee-eEeeeecCCceeEEeeeccccccH
Confidence 35789999999999998 5688999997542 234578889999966555 5556677788899999999 8899
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccccccc
Q 011945 90 EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 169 (474)
Q Consensus 90 ~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 169 (474)
+.+++ ..+++.......|..+|+.||.|||.+.|||||||.-||||+ .+..|||+|||.++...+..+.
T Consensus 200 ~~VLk-a~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs---~~d~VKIsDFGTS~e~~~~STk------- 268 (904)
T KOG4721|consen 200 YEVLK-AGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS---YDDVVKISDFGTSKELSDKSTK------- 268 (904)
T ss_pred HHHHh-ccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee---ccceEEeccccchHhhhhhhhh-------
Confidence 99998 467899999999999999999999999999999999999996 6778999999999988776442
Q ss_pred CCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHH
Q 011945 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFA 249 (474)
Q Consensus 170 ~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~ 249 (474)
..|+||..|||||++.+.+.+.|+|||||||||||||||..||.+.... ..+..+....+.- ..+..||+.|+
T Consensus 269 -MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---AIIwGVGsNsL~L---pvPstcP~Gfk 341 (904)
T KOG4721|consen 269 -MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---AIIWGVGSNSLHL---PVPSTCPDGFK 341 (904)
T ss_pred -hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh---eeEEeccCCcccc---cCcccCchHHH
Confidence 3579999999999999999999999999999999999999999875432 1122222221111 23467899999
Q ss_pred HHHHHHhcCCCCCCCCHHHHHHHHH
Q 011945 250 SYFHYCRSLRFDDKPDYAYLKRLFR 274 (474)
Q Consensus 250 ~li~~cl~~dp~~RPt~~~l~~~L~ 274 (474)
-||++||+-.|..||+|.+|+..|+
T Consensus 342 lL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 342 LLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred HHHHHHHhcCCCCCccHHHHHHHHh
Confidence 9999999999999999999876653
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=316.27 Aligned_cols=254 Identities=22% Similarity=0.358 Sum_probs=201.8
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
..++|++.++||+|+||.||+|.+..+ ..||||++..... ...+.+|+.+++.+.|.+++..+. +. .....+++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~-~~-~~~~~~lv~e 80 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VV-SEEPIYIVTE 80 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEE-EE-CCCCcEEEEE
Confidence 357899999999999999999998655 4699998875333 456889999999998666555444 33 3455789999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 84 ~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
|+ +++|.+++... ...+++..++.++.|++.||.|||+.||+||||||+||+++ .++.++|+|||++..+.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~---~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc---CCCcEEeccCCceeecccccc
Confidence 98 77999999743 34589999999999999999999999999999999999994 678899999999976644321
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
. ......++..|+|||+..+..++.++|||||||++|||++ |..||.+... .+.+..+..... . ..
T Consensus 158 ~------~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~---~~~~~~~~~~~~-~---~~ 224 (262)
T cd05071 158 T------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYR-M---PC 224 (262)
T ss_pred c------cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh---HHHHHHHhcCCC-C---CC
Confidence 1 1123456778999999998899999999999999999999 8999976533 223333322111 1 11
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
...+|..+.+++.+||+.+|++||++.++.+.|++.|
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 2457899999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=321.15 Aligned_cols=259 Identities=20% Similarity=0.235 Sum_probs=197.3
Q ss_pred eeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-CCC
Q 011945 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS 88 (474)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~s 88 (474)
||+|+||.||++.+..+|+.||+|.+.... ....+..|+++++.++|++ |..+..+...+...+++|||+ |++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~-i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPF-IVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCc-EEEEEEEEecCCeEEEEEecCCCCC
Confidence 799999999999999999999999875322 2234567999999997554 555555566778899999999 889
Q ss_pred HHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccccc
Q 011945 89 LEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167 (474)
Q Consensus 89 L~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~ 167 (474)
|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++ .++.++|+|||++........
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~---~~~~~~l~Dfg~~~~~~~~~~------ 150 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLD---DQGNCRLSDLGLAVELKDGKT------ 150 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEc---CCCCEEEeeceeeeecCCCce------
Confidence 98887543 34589999999999999999999999999999999999994 678899999999986644221
Q ss_pred ccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcH-HHHHHHHhhccccchHHHHhcCCcH
Q 011945 168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVSTSIEALCRGYPT 246 (474)
Q Consensus 168 ~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (474)
.....||..|+|||++.+..++.++|||||||++|||++|..||........ .+.......... ......+++
T Consensus 151 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 224 (277)
T cd05607 151 --ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV----KFEHQNFTE 224 (277)
T ss_pred --eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccc----ccccccCCH
Confidence 1234689999999999998999999999999999999999999976543211 122222211111 111246789
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccccc
Q 011945 247 EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 295 (474)
Q Consensus 247 ~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 295 (474)
++.+++.+||+.||++||++.++. ++++. .++...++|.....
T Consensus 225 ~~~~li~~~L~~~P~~R~~~~~~~---~~~~~---h~~f~~~~~~~~~~ 267 (277)
T cd05607 225 ESKDICRLFLAKKPEDRLGSREKN---DDPRK---HEFFKTINFPRLEA 267 (277)
T ss_pred HHHHHHHHHhccCHhhCCCCccch---hhhhc---ChhhcCCCHHHHhc
Confidence 999999999999999999987653 22221 23334467765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=343.51 Aligned_cols=249 Identities=18% Similarity=0.194 Sum_probs=200.5
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCC-CeEEEEEEeccCCCc--hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVKTKH--PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~-~~~vAvK~~~~~~~~--~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
..|.+.+.||.|+||.||+|.+..+ ++.||+|.+...... ..+..|+.+++.++|++++ .+..++..+...|||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv-~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIV-KHFDDFKSDDKLLLIME 145 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEe-EEEEEEEECCEEEEEEE
Confidence 4599999999999999999998877 788999976543322 3467899999999865554 45555667788999999
Q ss_pred cC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 84 ~~-g~sL~~li~~~---~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
|+ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++ ..+.+||+|||+++.+...
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~---~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM---PTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEEC---CCCcEEEEeCcCceecCCc
Confidence 99 89999887532 34689999999999999999999999999999999999994 7789999999999876543
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+...... .
T Consensus 223 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~---~~~~~~~~~~~~~~----~ 290 (478)
T PTZ00267 223 VSL-----DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS---QREIMQQVLYGKYD----P 290 (478)
T ss_pred ccc-----ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCC----C
Confidence 211 11245679999999999999999999999999999999999999997643 23333443332221 1
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
+...++.++.++|..||..||++||++.+++.
T Consensus 291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 23467899999999999999999999988753
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=325.74 Aligned_cols=258 Identities=21% Similarity=0.276 Sum_probs=201.2
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCe----EEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~----~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
-..+|++.+.||+|+||.||+|.+..+++ .||||+++.... ...+..|+.+++.+.|++++..+. ++....
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g-~~~~~~- 82 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG-ICLTST- 82 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEE-EEcCCC-
Confidence 35679999999999999999999876665 489998764332 345788999999998776666554 444443
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
.+++++|+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.+
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~---~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVK---TPQHVKITDFGLAKLL 159 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEec---CCCcEEEccccccccc
Confidence 45666666 8999999986666799999999999999999999999999999999999994 6788999999999876
Q ss_pred ccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccc
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+.... + +..+.......
T Consensus 160 ~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~---~-~~~~~~~~~~~ 230 (316)
T cd05108 160 GADEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---E-ISSILEKGERL 230 (316)
T ss_pred cCCCcce-----eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---H-HHHHHhCCCCC
Confidence 5432211 0122345678999999999999999999999999999997 99999875332 2 22222222111
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
.....++.++.+++..||..+|++||++.+++..|.++...
T Consensus 231 ---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 231 ---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 11245778999999999999999999999999998888643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=321.26 Aligned_cols=257 Identities=20% Similarity=0.280 Sum_probs=204.0
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCe--EEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE--EVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~--~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++|++.+.||+|+||.||+|.+..++. .+++|.++.... ...+..|+.++.++.+|+++..+..+.......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 579999999999999999999877764 468887653222 245788999999996667777777777777788999
Q ss_pred EecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeE
Q 011945 82 IDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 145 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~---------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~v 145 (474)
|||+ +++|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+|||++ .++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~---~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG---ENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEEC---CCCeE
Confidence 9998 789999986422 2488999999999999999999999999999999999994 67889
Q ss_pred EEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHH
Q 011945 146 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 224 (474)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 224 (474)
||+|||++........ ......+..|+|||++.+..++.++|||||||++|||++ |..||.+... ...
T Consensus 159 kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---~~~ 227 (297)
T cd05089 159 KIADFGLSRGEEVYVK--------KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---AEL 227 (297)
T ss_pred EECCcCCCccccceec--------cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHH
Confidence 9999999864322111 111233567999999999889999999999999999997 9999977543 222
Q ss_pred HHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011945 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281 (474)
Q Consensus 225 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 281 (474)
+..+..... ......++.++.+|+.+||..+|.+||+++++.+.|..++....
T Consensus 228 ~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 228 YEKLPQGYR----MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HHHHhcCCC----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 333322111 11234678999999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=330.07 Aligned_cols=260 Identities=20% Similarity=0.301 Sum_probs=202.5
Q ss_pred CCcEEEeeeeeecCceEEEEEEE-----cCCCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCcee-EEEeEeCC
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTN-----IQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNL-RWFGVEGD 76 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~-----~~~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l-~~~~~~~~ 76 (474)
.++|++.+.||.|+||.||+|.+ ..+++.||||++...... ..+.+|+.++..+.+|++|..+ ..+...+.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46899999999999999999985 346789999998754332 3477899999999766555555 44555667
Q ss_pred EEEEEEecC-CCCHHHHHHHcC----------------------------------------------------------
Q 011945 77 YNVLVIDLL-GPSLEDLFNFCS---------------------------------------------------------- 97 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~~---------------------------------------------------------- 97 (474)
..+++|||+ +++|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 789999999 889999986421
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccccccc
Q 011945 98 --------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 169 (474)
Q Consensus 98 --------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 169 (474)
..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~---~~~~~kl~dfg~~~~~~~~~~~-----~~ 237 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDY-----VR 237 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEc---CCCcEEEEecccccccccCcch-----hh
Confidence 2367888999999999999999999999999999999994 6789999999999865432211 11
Q ss_pred CCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHH
Q 011945 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF 248 (474)
Q Consensus 170 ~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l 248 (474)
.....++..|+|||++.+..++.++|||||||++|+|++ |..||....... .....+..... ......+++++
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~~----~~~~~~~~~~~ 311 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKEGTR----MRAPDYTTPEM 311 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHHHHHhccCC----CCCCCCCCHHH
Confidence 123356778999999999899999999999999999997 999997653321 11222211111 11123467899
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 249 ASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 249 ~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
.+++..||..||++||++.+|++.|+.+++.
T Consensus 312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=322.24 Aligned_cols=261 Identities=19% Similarity=0.308 Sum_probs=206.5
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcC-------CCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeC
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEG 75 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (474)
.++|.+.+.||+|+||.||+|.+.. +...||+|++..... ...+..|+.+++.+..|+++..+..++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3789999999999999999998643 235799998875432 235778999999996567777777777777
Q ss_pred CEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeC
Q 011945 76 DYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139 (474)
Q Consensus 76 ~~~~lv~e~~-g~sL~~li~~~~---------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~ 139 (474)
...+++|||+ +++|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+|||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~-- 174 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-- 174 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc--
Confidence 8899999999 789999997532 2488999999999999999999999999999999999994
Q ss_pred CCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 011945 140 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (474)
Q Consensus 140 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~ 218 (474)
.++.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 175 -~~~~~kL~dfg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 175 -EDNVMKIADFGLARDIHHIDYYK-----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred -CCCcEEECCCcccccccccchhh-----ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 67899999999997654322111 0112234578999999999889999999999999999998 8999976432
Q ss_pred CcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011945 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281 (474)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 281 (474)
.+....+..... ......++.++.+++..||..+|++||++.++++.|++++....
T Consensus 249 ---~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~ 304 (307)
T cd05098 249 ---EELFKLLKEGHR----MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS 304 (307)
T ss_pred ---HHHHHHHHcCCC----CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence 222222222211 12334678999999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=320.08 Aligned_cols=255 Identities=18% Similarity=0.250 Sum_probs=199.4
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.++|++.++||.|+||.||+|.+..+++.||+|.+.... ....+..|+.+++.++|++++. +..+.......+++|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~-~~~~~~~~~~~~lv~ 83 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT-LHDIIHTEKSLTLVF 83 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcce-EEEEEecCCeEEEEE
Confidence 467999999999999999999999999999999876432 2235778999999998665554 445556777899999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 83 e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
||+.++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||+ +.++.+||+|||++........
T Consensus 84 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 84 EYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred eccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhccCCCCC-
Confidence 999999999988666779999999999999999999999999999999999999 4678999999999975433221
Q ss_pred cccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc--------
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------- 233 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 233 (474)
......++..|+|||++.+. .++.++|||||||++|||++|+.||...........+..+.....
T Consensus 160 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 160 ------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred ------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence 11234678999999998764 478999999999999999999999987543222211111110000
Q ss_pred --------------cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 234 --------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 234 --------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
..........+++++.+||.+||..||.+||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00111223457889999999999999999999877643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=327.42 Aligned_cols=235 Identities=21% Similarity=0.269 Sum_probs=186.8
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHH-HHHhcCCCCCceeEEEeEeCCEEEEEEecC-
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKL-YKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 85 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~i-l~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (474)
+.||+|+||+||+|.+..+|+.||||++.... ....+..|..+ ++.+.| ++|..+..+....+..+++|||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h-p~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKH-PFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCC-CCCccEEEEEecCCEEEEEEcCCC
Confidence 46999999999999999999999999876431 12334555554 455665 45555556667778899999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccc
Q 011945 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 165 (474)
Q Consensus 86 g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (474)
+++|..++. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 ~~~L~~~l~-~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~---- 151 (325)
T cd05604 80 GGELFFHLQ-RERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSD---- 151 (325)
T ss_pred CCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCC----
Confidence 788988876 35679999999999999999999999999999999999999 4778999999999875332211
Q ss_pred ccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCc
Q 011945 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245 (474)
Q Consensus 166 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 245 (474)
......||..|+|||++.+..++.++|||||||++|||++|..||.... ..+.+..+..... .+...++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~---~~~~~~~~~~~~~-----~~~~~~~ 220 (325)
T cd05604 152 ---TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD---VAEMYDNILHKPL-----VLRPGAS 220 (325)
T ss_pred ---CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC---HHHHHHHHHcCCc-----cCCCCCC
Confidence 1234579999999999999999999999999999999999999998643 3333444433221 1234678
Q ss_pred HHHHHHHHHHhcCCCCCCCCHH
Q 011945 246 TEFASYFHYCRSLRFDDKPDYA 267 (474)
Q Consensus 246 ~~l~~li~~cl~~dp~~RPt~~ 267 (474)
.++.++|..||..+|.+||++.
T Consensus 221 ~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 221 LTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred HHHHHHHHHHhccCHHhcCCCC
Confidence 8999999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=320.96 Aligned_cols=288 Identities=43% Similarity=0.701 Sum_probs=241.7
Q ss_pred ccCC-cEEEeeeeeecCceEEEEEEEcCCC-eEEEEEEeccCCC--chHHHHHHHHHHHhc---CCCCCceeEEEe-EeC
Q 011945 4 RVGN-KFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIKLENVKTK--HPQLQYEAKLYKILQ---GGTGIPNLRWFG-VEG 75 (474)
Q Consensus 4 ~i~~-~y~i~~~LG~G~fG~Vy~a~~~~~~-~~vAvK~~~~~~~--~~~l~~E~~il~~l~---~~~~i~~l~~~~-~~~ 75 (474)
.... +|++.++||+|+||.||+|.+..++ ..+|+|++..... ...+..|..++..+. +..+++.+...+ ..+
T Consensus 14 ~~~~~~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~ 93 (322)
T KOG1164|consen 14 DKVNTRYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE 93 (322)
T ss_pred cccccceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence 3345 8999999999999999999987764 6899998776433 237999999999998 467899998888 588
Q ss_pred CEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCC--CCCeEEEEecCC
Q 011945 76 DYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR--RANQVYIIDFGL 152 (474)
Q Consensus 76 ~~~~lv~e~~g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~--~~~~vkL~DFGl 152 (474)
.+.+|||+++|.+|.++..... +.|+..+++.|+.|++.+|++||+.|+|||||||+|++++... ....++|.|||+
T Consensus 94 ~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 94 DFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred ceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 8999999999999999996554 7899999999999999999999999999999999999998543 226799999999
Q ss_pred cc--ccccCCCcccccccc-CCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHh
Q 011945 153 AK--RYRDTATHQHIPYRE-NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (474)
Q Consensus 153 a~--~~~~~~~~~~~~~~~-~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (474)
|+ .+.......+.+.+. ...+.||.+|++++++.+.+.++++|+|||++++.||+.|.+||.+.........+....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 99 443333222344444 346779999999999999999999999999999999999999998877665555555554
Q ss_pred hccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccccc
Q 011945 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 294 (474)
Q Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 294 (474)
....... ++...|.++.+++..+-..++.++|++..+..+|.+.+.+.+.....++||....
T Consensus 254 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~~~ 315 (322)
T KOG1164|consen 254 RKLLTDR---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEVKL 315 (322)
T ss_pred hhhcccc---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCcccccc
Confidence 4443332 4456788999999999999999999999999999999999999999999999754
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=324.50 Aligned_cols=252 Identities=22% Similarity=0.348 Sum_probs=212.1
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc-----hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
+..+|++.+.||+|.||.|-+|.....|+.||||.+..+... -.+.+|++||..|+|+++|.++. ++...+..+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyE-VFENkdKIv 129 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYE-VFENKDKIV 129 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhh-hhcCCceEE
Confidence 346899999999999999999999899999999987655332 24789999999999776666554 455667789
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
|||||. +|.|+|++..+ +.+++.++..++.||+.|+.|+|.++++|||||.+|||+ +.++++||+||||+..+.+
T Consensus 130 ivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchhhhhcc
Confidence 999999 99999999854 579999999999999999999999999999999999999 5889999999999998876
Q ss_pred CCCccccccccCCCCccCccccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
... ..++||++.|++||++.|.+| ++.+|-|||||+||-|+.|.+||.+. +.+..+.+|.......
T Consensus 206 ~kf--------LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~---Dhk~lvrQIs~GaYrE-- 272 (668)
T KOG0611|consen 206 KKF--------LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR---DHKRLVRQISRGAYRE-- 272 (668)
T ss_pred ccH--------HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc---hHHHHHHHhhcccccC--
Confidence 543 357899999999999999997 68999999999999999999999984 4455566665544432
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 281 (474)
..-|....-||..||..+|++|.|+++|. .+.+.+.|
T Consensus 273 ----P~~PSdA~gLIRwmLmVNP~RRATieDiA---sHWWvNwg 309 (668)
T KOG0611|consen 273 ----PETPSDASGLIRWMLMVNPERRATIEDIA---SHWWVNWG 309 (668)
T ss_pred ----CCCCchHHHHHHHHHhcCcccchhHHHHh---hhheeecc
Confidence 34577889999999999999999977764 34444444
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=326.96 Aligned_cols=239 Identities=20% Similarity=0.267 Sum_probs=191.0
Q ss_pred eeeeeecCceEEEEEEEc---CCCeEEEEEEeccCC------CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 12 GRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~---~~~~~vAvK~~~~~~------~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
+++||+|+||.||++++. .+++.||||++.... ....+..|+.+++.++|++++..+. ++..+...|++|
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~-~~~~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIY-AFQTGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceee-EEecCCeEEEEE
Confidence 368999999999999864 468899999876421 2234678999999999766555554 455667889999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
||+ +++|.+++.. ...+.+..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 80 EYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred eCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCC
Confidence 998 7899998874 4568999999999999999999999999999999999999 4778999999999975433221
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
......||+.|+|||++.+..++.++|||||||+||||++|+.||.+... ...+..+..... .+.
T Consensus 156 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~---~~~~~~~~~~~~-----~~~ 220 (323)
T cd05584 156 -------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR---KKTIDKILKGKL-----NLP 220 (323)
T ss_pred -------cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCC-----CCC
Confidence 12345799999999999998899999999999999999999999987432 333444433222 234
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCC-----CHHHHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKP-----DYAYLK 270 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~ 270 (474)
..+++++.++|..||..||++|| ++++++
T Consensus 221 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~ 254 (323)
T cd05584 221 PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQ 254 (323)
T ss_pred CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHh
Confidence 56789999999999999999999 655553
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=319.64 Aligned_cols=253 Identities=23% Similarity=0.361 Sum_probs=201.8
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcC-----CCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
.++|.+.+.||+|+||.||+|.+.. +++.||||++...... ..+.+|+++++.+.|.+ +..+..++.....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~ 82 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN-IVKFYGVCTEGDP 82 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCC-chheeeEEecCCC
Confidence 3579999999999999999998743 3578999988654333 46889999999998665 4455555666678
Q ss_pred EEEEEecC-CCCHHHHHHHcC-------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCC
Q 011945 78 NVLVIDLL-GPSLEDLFNFCS-------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 143 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~~-------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~ 143 (474)
.+++|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~---~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG---YDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEc---CCC
Confidence 89999998 899999987432 3478999999999999999999999999999999999994 779
Q ss_pred eEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHH
Q 011945 144 QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKK 222 (474)
Q Consensus 144 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~ 222 (474)
.+||+|||++......... .......++..|+|||++.+..++.++|||||||++|||++ |..||.+... .
T Consensus 160 ~~kl~d~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~ 231 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---E 231 (280)
T ss_pred eEEECCcccceecccCcce-----ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---H
Confidence 9999999999765332211 11223356789999999999999999999999999999998 9999976543 2
Q ss_pred HHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011945 223 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 274 (474)
Q Consensus 223 ~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (474)
..+..+...... .....++.++.+++..||..||++||++.++++.|+
T Consensus 232 ~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 232 EVIECITQGRLL----QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 333333322221 123467899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=350.26 Aligned_cols=254 Identities=20% Similarity=0.298 Sum_probs=201.3
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeE-eCCE
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDY 77 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~-~~~~ 77 (474)
+...++|+++++||.|+||+||+|.+..+++.||+|++..... ...+..|+.+++.|.|++++..+..|.. ....
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 4556799999999999999999999999999999998765422 3458889999999998887777766543 4567
Q ss_pred EEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC-------CccccCCCCCcEEeeeC-------
Q 011945 78 NVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK-------SFLHRDIKPDNFLMGLG------- 139 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~---~~~l~~~~~~~i~~qi~~gL~yLHs~-------gIiHrDIKP~NILl~~~------- 139 (474)
+||||||+ +++|.+++... ...+++..++.|+.||+.||.|||+. +||||||||+||||+.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999 78999998643 35699999999999999999999984 49999999999999632
Q ss_pred -------CCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccC--CCCCchhhHHHHHHHHHHHHhCC
Q 011945 140 -------RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGS 210 (474)
Q Consensus 140 -------~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDIwSlGvil~elltG~ 210 (474)
+....+||+|||++..+..... .....||+.|+|||++.+ ..++.++||||||||||||++|.
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--------~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM--------AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc--------ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 1234699999999986543221 134579999999999865 34889999999999999999999
Q ss_pred CCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 211 LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 211 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.||..... ..+.+..+.... .. ....++.++.+||..||..+|++||++.+++.
T Consensus 241 ~PF~~~~~--~~qli~~lk~~p-~l----pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 241 TPFHKANN--FSQLISELKRGP-DL----PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCCcCCc--HHHHHHHHhcCC-CC----CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 99976432 222332222211 11 12456899999999999999999999887753
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=323.53 Aligned_cols=255 Identities=22% Similarity=0.276 Sum_probs=195.7
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHH-HHHHhcCCCCCceeEEEeEeCCEEEEEEecC-
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAK-LYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 85 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~-il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (474)
++||+|+||.||+|++..+++.||||++.... ....+..|.. +++.+.|++ |..+..++...+..++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~-iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPF-LVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCC-ccceeeEEEcCCEEEEEEcCCC
Confidence 47999999999999999999999999875432 1223455554 466676554 555556667778899999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccc
Q 011945 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 165 (474)
Q Consensus 86 g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (474)
+++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.......
T Consensus 80 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~---- 151 (321)
T cd05603 80 GGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEE---- 151 (321)
T ss_pred CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCCC----
Confidence 7899888763 4578999999999999999999999999999999999999 4778999999999875432221
Q ss_pred ccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCc
Q 011945 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245 (474)
Q Consensus 166 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 245 (474)
......||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ..+.+..+..... .+....+
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~-----~~~~~~~ 220 (321)
T cd05603 152 ---TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD---VSQMYDNILHKPL-----QLPGGKT 220 (321)
T ss_pred ---ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC---HHHHHHHHhcCCC-----CCCCCCC
Confidence 1234579999999999999899999999999999999999999998743 3344444443322 1234678
Q ss_pred HHHHHHHHHHhcCCCCCCCCHH-HHHHHHHHHHHHcCCCCCCcccccccc
Q 011945 246 TEFASYFHYCRSLRFDDKPDYA-YLKRLFRDLFIREGFQFDYVFDWTILK 294 (474)
Q Consensus 246 ~~l~~li~~cl~~dp~~RPt~~-~l~~~L~~l~~~~~~~~~~~~dw~~~~ 294 (474)
.++.++|..||+.||.+||+.. ++.+++++ .+....+|....
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~-------~~~~~~~~~~~~ 263 (321)
T cd05603 221 VAACDLLVGLLHKDQRRRLGAKADFLEIKNH-------VFFSPINWDDLY 263 (321)
T ss_pred HHHHHHHHHHccCCHhhcCCCCCCHHHHhCC-------CCcCCCCHHHHh
Confidence 8999999999999999999853 33333332 333445676543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=315.49 Aligned_cols=253 Identities=21% Similarity=0.363 Sum_probs=202.5
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
.++|+++++||+|+||.||+|.+ .++..||+|.+.... ..+.+..|+.+++.++|.+++. +..+.......+++||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVR-LYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeee-EEEEEcCCCCcEEEEec
Confidence 46899999999999999999996 456789999876433 3456889999999998665554 44455667778999999
Q ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 85 ~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
+ +++|.+++... ...+++..++.++.||+.||.|||+++++||||||+||+++ ..+.+||+|||++.........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEec---CCCcEEECCCccceecCCCcee
Confidence 8 88999998643 45689999999999999999999999999999999999994 7789999999999876543211
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
......++..|+|||++.+..++.++|||||||++|+|++ |..||...... .....+..... . ...
T Consensus 160 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~~~~-~---~~~ 226 (261)
T cd05072 160 ------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS---DVMSALQRGYR-M---PRM 226 (261)
T ss_pred ------ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH---HHHHHHHcCCC-C---CCC
Confidence 1123356778999999998889999999999999999998 99999764332 22233222211 1 122
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
..+|.++.+++.+||..+|++||+++++.++|+++
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 227 ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 46789999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=317.67 Aligned_cols=256 Identities=20% Similarity=0.320 Sum_probs=200.3
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcC-----CCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
.++|.+.+.||+|+||.||+|.+.. ++..||+|....... ...+..|+.+++.+.|.+ +..+..++.+...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQN-IVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCC-EeeEEEEEccCCC
Confidence 5689999999999999999999876 778899998764332 235788999999998654 4455555556667
Q ss_pred EEEEEecC-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEec
Q 011945 78 NVLVIDLL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~~------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DF 150 (474)
.+++|||+ +++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++.......+||+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df 163 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF 163 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence 78999998 899999997543 24899999999999999999999999999999999999974434457999999
Q ss_pred CCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHh
Q 011945 151 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKIS 229 (474)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~ 229 (474)
|+++........ ........+..|+|||++.+..++.++|||||||++|||++ |..||.+... ...+..+.
T Consensus 164 g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~---~~~~~~~~ 235 (277)
T cd05036 164 GMARDIYRASYY-----RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN---QEVMEFVT 235 (277)
T ss_pred ccccccCCccce-----ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH
Confidence 999876332210 11122234578999999999899999999999999999997 9999986443 22222222
Q ss_pred hccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011945 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 274 (474)
Q Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (474)
.... ......+|.++.+++.+||+.+|++||++.+|++.|.
T Consensus 236 ~~~~----~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGGR----LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCc----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 2111 1123567899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=333.93 Aligned_cols=250 Identities=20% Similarity=0.265 Sum_probs=195.4
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
..++|++.++||+|+||.||+|.+..+++.||+|++.... ....+..|+.+++.+.|++++ .+..+...+...|
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv-~~~~~~~~~~~~~ 119 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV-QLFCAFQDDKYLY 119 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEe-eEEEEEEcCCEEE
Confidence 3578999999999999999999999999999999875321 223477899999988865544 5555566778899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
+||||+ +++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+ +..+.+||+|||+|..+..
T Consensus 120 lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEecccceeccc
Confidence 999999 8899999973 468999999999999999999999999999999999999 4778999999999987643
Q ss_pred CCCccccccccCCCCccCccccccccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~----~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (474)
... .......||+.|+|||++.+.. ++.++|||||||+||||++|..||.+.. ....+..+......
T Consensus 195 ~~~------~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~---~~~~~~~i~~~~~~ 265 (370)
T cd05621 195 TGM------VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS---LVGTYSKIMDHKNS 265 (370)
T ss_pred CCc------eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCcc
Confidence 221 1123467999999999997643 7899999999999999999999998643 33444444432221
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCC--CCCHHHHH
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLK 270 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~--RPt~~~l~ 270 (474)
...+. ...++..+.+++..||..++.+ |+++.+++
T Consensus 266 ~~~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l 302 (370)
T cd05621 266 LNFPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIK 302 (370)
T ss_pred cCCCC-cccCCHHHHHHHHHHccCchhccCCCCHHHHh
Confidence 11111 1246889999999999855443 77866653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=317.52 Aligned_cols=244 Identities=20% Similarity=0.267 Sum_probs=194.0
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.|++.+.||+|+||+||+|.+..+++.||+|++..... ...+..|+++++.++|++++. +.++...++..+++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~-~~~~~~~~~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVN-LAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCcee-EEEEEecCCEEEEEE
Confidence 48889999999999999999999999999998764321 234678999999998665554 555556677889999
Q ss_pred ecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 83 e~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++ ..+.+||+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~---~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD---DYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEC---CCCCEEEecCCcceecCCCC
Confidence 988 78898887643 34699999999999999999999999999999999999994 67889999999997653321
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
. .....|+..|+|||++.+..++.++|||||||++|||++|..||.+.......+.+. .. ........
T Consensus 157 ~--------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~---~~-~~~~~~~~ 224 (285)
T cd05632 157 S--------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD---RR-VLETEEVY 224 (285)
T ss_pred c--------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---Hh-hhcccccc
Confidence 1 123578999999999999899999999999999999999999998654322111111 11 11111223
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHH
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYA 267 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~ 267 (474)
...++.++.+|+..||..||++||++.
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 225 SAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred CccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 456789999999999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=317.94 Aligned_cols=258 Identities=24% Similarity=0.337 Sum_probs=206.2
Q ss_pred CCcEEEeeeeeecCceEEEEEEEc-----CCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
.++|.+.+.||+|+||.||++.+. .++..||+|.+..... ...+..|+.+++.++|+ ++..+..++......
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~ 82 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHE-HIVKFYGVCVEGDPL 82 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCC-CcceEEEEEecCCcc
Confidence 457999999999999999999852 3456799998764432 34588999999999865 555565666777889
Q ss_pred EEEEecC-CCCHHHHHHHcC------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeE
Q 011945 79 VLVIDLL-GPSLEDLFNFCS------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 145 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~v 145 (474)
+++|||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ +++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~---~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc---cCCcE
Confidence 9999998 789999987432 2489999999999999999999999999999999999994 77899
Q ss_pred EEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHH
Q 011945 146 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 224 (474)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 224 (474)
||+|||+++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||..... ...
T Consensus 160 kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~~ 231 (288)
T cd05093 160 KIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEV 231 (288)
T ss_pred EeccCCccccccCCcee-----ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHH
Confidence 99999999865432211 11123356789999999999889999999999999999998 9999976543 223
Q ss_pred HHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 225 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
+..+...... .....++.++.+|+.+||+.||.+||++.++.+.|+++...
T Consensus 232 ~~~i~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 232 IECITQGRVL----QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHHcCCcC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 3333332221 22346789999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=317.24 Aligned_cols=255 Identities=20% Similarity=0.302 Sum_probs=199.8
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcC-----CCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeC
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEG 75 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (474)
+..++|++.+.||+|+||.||+|.+.. ++..||||++..... ...+.+|+.+++.+.|++++ .+..+...+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv-~~~~~~~~~ 81 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV-RLLGVVSQG 81 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCee-eEEEEEcCC
Confidence 457889999999999999999998642 356899998754322 23478899999999866554 455556677
Q ss_pred CEEEEEEecC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeE
Q 011945 76 DYNVLVIDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 145 (474)
Q Consensus 76 ~~~~lv~e~~-g~sL~~li~~~~---------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~v 145 (474)
...+++|||+ +++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||||+|||++ .++.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~---~~~~~ 158 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTV 158 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEc---CCCCE
Confidence 7889999998 789999986432 2357888999999999999999999999999999999994 67889
Q ss_pred EEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHH
Q 011945 146 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 224 (474)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 224 (474)
+|+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.+... ...
T Consensus 159 ~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~~ 230 (277)
T cd05062 159 KIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQV 230 (277)
T ss_pred EECCCCCccccCCccee-----ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHH
Confidence 99999999765432221 11122356788999999999899999999999999999999 7999987543 222
Q ss_pred HHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011945 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 274 (474)
Q Consensus 225 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (474)
+..+..... ..+...++..+.+++.+||+.+|++||++.++++.|+
T Consensus 231 ~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 231 LRFVMEGGL----LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHcCCc----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 332222221 1234567899999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=312.08 Aligned_cols=249 Identities=20% Similarity=0.262 Sum_probs=199.2
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 85 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (474)
++|++.+.||+|+||.||++.+. .+..||+|.+.... ....+..|+.+++.++|++++ .+..++......+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLV-QLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCce-eEEEEEccCCCEEEEEEcC
Confidence 57999999999999999999874 45689999876443 345788999999999865544 5555666777889999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccc
Q 011945 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164 (474)
Q Consensus 86 -g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (474)
+++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||+++........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~kl~d~g~~~~~~~~~~~-- 156 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS---STGVVKVSDFGMTRYVLDDEYT-- 156 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEc---CCCeEEECCCCCccccCCCcee--
Confidence 7899999875555789999999999999999999999999999999999994 6789999999999865432221
Q ss_pred cccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcC
Q 011945 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (474)
Q Consensus 165 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (474)
......++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+.+..+...... .....
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i~~~~~~----~~~~~ 225 (256)
T cd05114 157 ----SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMISRGFRL----YRPKL 225 (256)
T ss_pred ----ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHCCCCC----CCCCC
Confidence 1123346678999999998889999999999999999999 9999976432 3333333332211 11234
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011945 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLF 273 (474)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (474)
.+.++.+++.+||..+|++||++++|++.|
T Consensus 226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 678999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=311.81 Aligned_cols=255 Identities=25% Similarity=0.348 Sum_probs=203.1
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++|++.++||+|+||.||+|++..+++.||||.+..... ...+..|+.+++.++|++++..+ .+.......+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~-~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYL-DSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeee-eeEEECCeEEEE
Confidence 689999999999999999999999999999997653221 23478899999999866655554 445566788999
Q ss_pred EecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 82 IDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~---~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+|||++ .++.++|+|||++..+.
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~---~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc---CCCCEEECccccceecc
Confidence 9999 67999888632 34589999999999999999999999999999999999994 67889999999998765
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
..... .....|+..|+|||.+.+..++.++|||||||++|||++|..||..... ........+.......
T Consensus 158 ~~~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~~~~-- 227 (267)
T cd08228 158 SKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLFSLCQKIEQCDYPP-- 227 (267)
T ss_pred chhHH-------HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-cHHHHHHHHhcCCCCC--
Confidence 43211 1234688999999999988899999999999999999999999976432 2222233332222111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
.....++..+.+++.+||..+|++||++.++++.|+.+
T Consensus 228 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 -LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11235678999999999999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=316.67 Aligned_cols=260 Identities=21% Similarity=0.267 Sum_probs=198.4
Q ss_pred CCcE-EEeeeeeecCceEEEEEEE----cCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeE-eCC
Q 011945 6 GNKF-RLGRKIGSGSFGEIYLGTN----IQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGV-EGD 76 (474)
Q Consensus 6 ~~~y-~i~~~LG~G~fG~Vy~a~~----~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~-~~~ 76 (474)
.++| ++.+.||+|+||+||++.. ..++..||+|++..... ...+.+|+++++.++|++++..+..+.. ...
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 3555 9999999999999988653 35678999998865432 3457889999999987666655554433 345
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
..+++|||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~~ 156 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD---NDRLVKIGDFGLAKA 156 (283)
T ss_pred eEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEc---CCCcEEEeecccccc
Confidence 688999998 8899999874 4699999999999999999999999999999999999994 678899999999987
Q ss_pred cccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHH-----------HH
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-----------QK 224 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~-----------~~ 224 (474)
+....... .......++..|+|||++.+..++.++|||||||++|||++|..||......-.. ..
T Consensus 157 ~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05080 157 VPEGHEYY----RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVR 232 (283)
T ss_pred cCCcchhh----ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhh
Confidence 65432211 1112234667899999999888999999999999999999999998653321000 00
Q ss_pred HHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 225 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
+......... ......+|.++.+++..||+.+|++||++++|++.|+++.
T Consensus 233 ~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 233 LIELLERGMR---LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhcCCC---CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0000000000 0113457899999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=327.21 Aligned_cols=234 Identities=21% Similarity=0.245 Sum_probs=186.6
Q ss_pred eeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhc--CCCCCceeEEEeEeCCEEEEEEecC-C
Q 011945 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQ--GGTGIPNLRWFGVEGDYNVLVIDLL-G 86 (474)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~--~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (474)
||+|+||+||+|++..+++.||||++.... ....+..|..++..+. ++++|..+..........++||||+ +
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999875421 1123455666766654 6777878877778888999999998 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccc
Q 011945 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166 (474)
Q Consensus 87 ~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (474)
++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++........
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~---~~~~~kl~Dfg~a~~~~~~~~----- 151 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD---ATGHIALCDFGLSKANLTDNK----- 151 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC---CCCCEEEecCCcCcCCCCCCC-----
Confidence 899888873 56799999999999999999999999999999999999994 778999999999975432221
Q ss_pred cccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCc
Q 011945 167 YRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245 (474)
Q Consensus 167 ~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 245 (474)
.....+||..|+|||++.+. .++.++|||||||++|||++|..||.+.. ..+.+..+........ ...++
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~----~~~~~ 222 (330)
T cd05586 152 --TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED---TQQMYRNIAFGKVRFP----KNVLS 222 (330)
T ss_pred --CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC---HHHHHHHHHcCCCCCC----CccCC
Confidence 12346799999999999765 48999999999999999999999997643 3334444433322111 12468
Q ss_pred HHHHHHHHHHhcCCCCCCCCH
Q 011945 246 TEFASYFHYCRSLRFDDKPDY 266 (474)
Q Consensus 246 ~~l~~li~~cl~~dp~~RPt~ 266 (474)
+++.++|..||..||++||++
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCC
Confidence 899999999999999999954
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=315.67 Aligned_cols=254 Identities=19% Similarity=0.278 Sum_probs=198.7
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
....++|++.++||+|+||.||+|++..+++.||+|++.... ....+..|+.+++.++|++++..+ .++..+...++
T Consensus 5 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~-~~~~~~~~~~i 83 (267)
T cd06646 5 RNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYF-GSYLSREKLWI 83 (267)
T ss_pred cCchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeee-EEEEeCCEEEE
Confidence 344567999999999999999999999999999999886543 233577899999999876666554 44566778899
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
+|||+ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++..+...
T Consensus 84 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 84 CMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCccceeeccc
Confidence 99999 6799998863 4578999999999999999999999999999999999999 46788999999999866432
Q ss_pred CCccccccccCCCCccCcccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccch
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (474)
.. ......|+..|+|||.+. ...++.++|||||||++|||++|..||....... ....+........
T Consensus 160 ~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~ 229 (267)
T cd06646 160 IA-------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR---ALFLMSKSNFQPP 229 (267)
T ss_pred cc-------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh---hheeeecCCCCCC
Confidence 21 113357899999999885 3447889999999999999999999997543211 1111111111111
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.......++.++.+++..||..+|++||++++|++
T Consensus 230 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 264 (267)
T cd06646 230 KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLT 264 (267)
T ss_pred CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhc
Confidence 11122457889999999999999999999988765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=312.47 Aligned_cols=248 Identities=26% Similarity=0.432 Sum_probs=197.9
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchH----HHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~----l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
|++++.||+|+||+||++.+..+++.||+|++........ ...|+.+++.+.| ++|..+..+.......+++|++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRH-PNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTB-TTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccc-cccccccccccccccccccccc
Confidence 8999999999999999999999999999999877643332 3458999999964 5555666666668888999999
Q ss_pred CCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 85 LGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 85 ~g~-sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
+.+ +|.+++. ....+++..++.++.||+.||.+||++||+|+||||+|||+ +.++.++|+|||++........
T Consensus 80 ~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~-- 153 (260)
T PF00069_consen 80 CPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSENNE-- 153 (260)
T ss_dssp ETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTSTTS--
T ss_pred ccccccccccc-ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccc--
Confidence 955 9999998 45679999999999999999999999999999999999999 4789999999999976422111
Q ss_pred ccccccCCCCccCcccccccccc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh-
Q 011945 164 HIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC- 241 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~- 241 (474)
......++..|+|||++. +..++.++||||||+++|+|++|..||...........+.+...... .....
T Consensus 154 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 225 (260)
T PF00069_consen 154 -----NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPL---PSSSQQ 225 (260)
T ss_dssp -----EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHH---HHHTTS
T ss_pred -----ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccc---cccccc
Confidence 123457899999999998 78899999999999999999999999987532223333322222111 11111
Q ss_pred -cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 242 -RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 242 -~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
...+.++.++|..||+.||++||++.++++
T Consensus 226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 122489999999999999999999887753
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=318.38 Aligned_cols=259 Identities=23% Similarity=0.314 Sum_probs=206.6
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcC-----CCeEEEEEEeccCCCc--hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAvK~~~~~~~~--~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
..+|.+.+.||+|+||.||+|.+.. ++..|++|.+...... ..+.+|+.+++.+.|+ ++..+..++......
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~ 82 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHE-HIVKFYGVCGDGDPL 82 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCC-CcceEEEEEccCCce
Confidence 4579999999999999999998543 4567999987654332 4588999999999865 555565666777888
Q ss_pred EEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCC
Q 011945 79 VLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~---------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~ 142 (474)
++||||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ .+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~---~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---AN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc---cC
Confidence 9999998 899999986432 3489999999999999999999999999999999999994 77
Q ss_pred CeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcH
Q 011945 143 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTK 221 (474)
Q Consensus 143 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~ 221 (474)
+.++|+|||++......... .......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--- 231 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--- 231 (291)
T ss_pred CcEEECCCCcccccCCCcee-----ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---
Confidence 89999999999765433211 11233467889999999999999999999999999999998 9999976443
Q ss_pred HHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 222 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
...+..+...... .....+|.++.+++.+||..+|++||++.++.+.|+++....
T Consensus 232 ~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~ 286 (291)
T cd05094 232 TEVIECITQGRVL----ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT 286 (291)
T ss_pred HHHHHHHhCCCCC----CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence 2233333322221 223457899999999999999999999999999999996543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=317.49 Aligned_cols=242 Identities=21% Similarity=0.253 Sum_probs=193.2
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.|++.+.||+|+||.||+|.+..+++.||||.+..... ...+..|+.+++.++|++++.. ...+......+++|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~-~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-AYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeee-eEEEecCCEEEEEE
Confidence 48899999999999999999999999999998754321 2346789999999987665554 44455667889999
Q ss_pred ecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 83 e~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++ ..+.++|+|||++.......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~---~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD---DHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEEC---CCCCEEEeeccceeecCCCc
Confidence 998 88999988643 34599999999999999999999999999999999999994 67889999999987553322
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
. .....||..|+|||++.+..++.++|||||||++|+|++|..||..............+... .....
T Consensus 157 ~--------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~----~~~~~ 224 (285)
T cd05630 157 T--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----VQEEY 224 (285)
T ss_pred c--------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh----hhhhc
Confidence 1 12347899999999999999999999999999999999999999875432222222222111 11223
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCC
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPD 265 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt 265 (474)
...+++++.+|+..||+.||++||+
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~R~s 249 (285)
T cd05630 225 SEKFSPDARSLCKMLLCKDPKERLG 249 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHccC
Confidence 4568899999999999999999999
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=317.35 Aligned_cols=253 Identities=21% Similarity=0.291 Sum_probs=199.6
Q ss_pred CcEEEeeeeeecCceEEEEEEEc----CCCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNI----QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~----~~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
..|++.++||+|+||.||+|.+. .++..|++|.+...... ..+.+|+.+++.+.|++++. +..+...+...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC-LLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeee-EEEEEecCCceE
Confidence 57999999999999999999853 45678999987643322 35788999999998655554 555556677889
Q ss_pred EEEecC-CCCHHHHHHHc----------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCC
Q 011945 80 LVIDLL-GPSLEDLFNFC----------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~----------------~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~ 142 (474)
++|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ ..
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~---~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG---EQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc---CC
Confidence 999999 78999998532 12478899999999999999999999999999999999994 67
Q ss_pred CeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcH
Q 011945 143 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTK 221 (474)
Q Consensus 143 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~ 221 (474)
+.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--- 232 (283)
T cd05090 161 LHVKISDLGLSREIYSADYY-----RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--- 232 (283)
T ss_pred CcEEeccccccccccCCcce-----ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---
Confidence 88999999999876433211 11233456788999999998889999999999999999998 9999977533
Q ss_pred HHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011945 222 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 275 (474)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (474)
......+..... ...+..+++++.+++.+||+.||++||++.+|.+.|+.
T Consensus 233 ~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 233 QEVIEMVRKRQL----LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHHcCCc----CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 222233222221 12345789999999999999999999999999888763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=315.53 Aligned_cols=253 Identities=18% Similarity=0.339 Sum_probs=198.5
Q ss_pred EEEeeeeeecCceEEEEEEEcCC---CeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeEeC-----C
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEG-----D 76 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~~~-----~ 76 (474)
|++.+.||+|+||.||+|....+ +..||||++...... ..+..|+.+++.++|++++..+..+.... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67899999999999999987653 478999987654322 35788999999998776665554443322 2
Q ss_pred EEEEEEecC-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEec
Q 011945 77 YNVLVIDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~-----~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DF 150 (474)
..+++|||+ +++|..++... ...+++..++.++.||+.||.|||++||+||||||+||++ ++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEECCc
Confidence 478999988 88999888532 2358999999999999999999999999999999999999 47789999999
Q ss_pred CCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHh
Q 011945 151 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKIS 229 (474)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~ 229 (474)
|+++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+... .+.+..+.
T Consensus 158 g~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~~ 229 (273)
T cd05035 158 GLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYLR 229 (273)
T ss_pred cceeeccccccc-----cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH
Confidence 999876543321 11122345678999999998889999999999999999999 9999976543 23333333
Q ss_pred hccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
.... ......++.++.+++.+||..||++||++.++++.|+++
T Consensus 230 ~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 HGNR----LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCCC----CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 2221 123456889999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=331.84 Aligned_cols=252 Identities=21% Similarity=0.287 Sum_probs=196.2
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+..|+.+++.+.|+++ ..+......+.+.++
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~i-v~~~~~~~~~~~~~l 120 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWV-VQLFYAFQDDRYLYM 120 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCC-CeEEEEEEcCCEEEE
Confidence 478999999999999999999999999999999875321 12346788889988875554 455555667888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.....
T Consensus 121 v~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~---~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 121 VMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEC---CCCCEEEEeCCceeEcCcC
Confidence 99999 8899999873 4689999999999999999999999999999999999994 7789999999999876433
Q ss_pred CCccccccccCCCCccCccccccccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccc
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~----~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
... ......||+.|+|||++.+.. ++.++|||||||+||||++|..||... +....+.++.......
T Consensus 196 ~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~~ 266 (371)
T cd05622 196 GMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD---SLVGTYSKIMNHKNSL 266 (371)
T ss_pred Ccc------cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCcc
Confidence 211 123457999999999997643 789999999999999999999999864 3344455554332211
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCC---CCCHHHHHHHHHHHH
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDD---KPDYAYLKRLFRDLF 277 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~---RPt~~~l~~~L~~l~ 277 (474)
..+ ....++.++.++|..||. ++.. |+++++| +++.+
T Consensus 267 ~~~-~~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei---~~h~~ 306 (371)
T cd05622 267 TFP-DDNDISKEAKNLICAFLT-DREVRLGRNGVEEI---KRHLF 306 (371)
T ss_pred cCC-CcCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHH---hcCcc
Confidence 111 123578999999999998 5555 5565544 44444
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=315.09 Aligned_cols=253 Identities=19% Similarity=0.330 Sum_probs=197.0
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCe--EEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeE-----eCCE
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNE--EVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGV-----EGDY 77 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~--~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~-----~~~~ 77 (474)
|.+.++||+|+||.||+|.+..++. .||||.++... ....+..|+.+++.++|.+++..+..+.. ....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4578899999999999999877765 69999876532 22457889999999987766666544322 1234
Q ss_pred EEEEEecC-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecC
Q 011945 78 NVLVIDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~-----~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFG 151 (474)
.+++|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEECCCC
Confidence 67888888 78998887422 2348999999999999999999999999999999999999 477899999999
Q ss_pred CccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhh
Q 011945 152 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISE 230 (474)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~ 230 (474)
+++.+..... +.......++..|++||++.+..++.++|||||||++|||++ |..||.+... .+.+..+..
T Consensus 158 ~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~ 229 (272)
T cd05075 158 LSKKIYNGDY-----YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYDYLRQ 229 (272)
T ss_pred cccccCcccc-----eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHc
Confidence 9987654321 111123356788999999999999999999999999999999 8999976432 233333332
Q ss_pred ccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
... ......++..+.+++.+||+.||++||++.+|++.|+++
T Consensus 230 ~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 GNR----LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 221 112356789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=313.24 Aligned_cols=255 Identities=16% Similarity=0.265 Sum_probs=203.7
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCC---CeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
.++|++.+.||+|+||.||+|.+..+ ...||||++...... ..+..|+.+++.++|++++ .+..+.......+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~ 81 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII-RLEGVVTKSRPVM 81 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcc-eEeEEEecCCceE
Confidence 36799999999999999999998654 457999987654322 3578899999999866544 4555556677789
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
++|||+ +++|.+++......+++..++.++.|++.||.|||++||+|+||||+|||++ .++.++|+|||+++.+..
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~---~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc---CCCCEEECccchhhcccc
Confidence 999998 7899999986666899999999999999999999999999999999999994 678899999999987752
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
..... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||..... .+....+......
T Consensus 159 ~~~~~-----~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~--- 227 (266)
T cd05033 159 SEATY-----TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN---QDVIKAVEDGYRL--- 227 (266)
T ss_pred cccce-----eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH---HHHHHHHHcCCCC---
Confidence 22111 0112345678999999999899999999999999999998 9999976432 2233333222111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
.....+|+.+.+++..||+.+|++||++.+|.+.|.++
T Consensus 228 -~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 -PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11246789999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=321.72 Aligned_cols=258 Identities=20% Similarity=0.270 Sum_probs=203.7
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeE--EEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEE--VAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~--vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
-++|++.+.||+|+||.||+|.+..++.. +++|.+.... ....+.+|+.++.++.+|+++..+..++......++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 35899999999999999999998877764 5666654322 123578899999999667777777777788888999
Q ss_pred EEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCe
Q 011945 81 VIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 144 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~---------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~ 144 (474)
+|||+ +++|.+++.... ..+++.+++.++.||+.||+|||++||+||||||+|||++ .++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~---~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEec---CCCc
Confidence 99998 789999986432 2578999999999999999999999999999999999994 6788
Q ss_pred EEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHH
Q 011945 145 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQ 223 (474)
Q Consensus 145 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~ 223 (474)
+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||...... +
T Consensus 163 ~kl~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~ 231 (303)
T cd05088 163 AKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---E 231 (303)
T ss_pred EEeCccccCcccchhh--------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---H
Confidence 9999999986422110 0112234678999999988889999999999999999998 99999765432 2
Q ss_pred HHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011945 224 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281 (474)
Q Consensus 224 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 281 (474)
.+..+.... .......+++++.+|+.+||+.+|++||++++++..|..++....
T Consensus 232 ~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 232 LYEKLPQGY----RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred HHHHHhcCC----cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 222222111 111223578899999999999999999999999999998876553
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=312.89 Aligned_cols=248 Identities=21% Similarity=0.323 Sum_probs=195.5
Q ss_pred eeeecCceEEEEEEEc--CCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-CC
Q 011945 14 KIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GP 87 (474)
Q Consensus 14 ~LG~G~fG~Vy~a~~~--~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~ 87 (474)
.||+|+||.||+|.+. ..+..||||++..... .+.+.+|+.+++.+.|++++..+..+ .....++||||+ ++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~--~~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC--EAEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEE--cCCCeEEEEEeCCCC
Confidence 4899999999999865 4456799998765432 24588999999999877766665543 345678999998 88
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccccc
Q 011945 88 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167 (474)
Q Consensus 88 sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~ 167 (474)
+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+.......
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~dfg~~~~~~~~~~~~---- 152 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV---NQHYAKISDFGLSKALGADDSYY---- 152 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEc---CCCcEEeccCCccccccCCccce----
Confidence 99999876566799999999999999999999999999999999999994 67889999999998654332211
Q ss_pred ccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcH
Q 011945 168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (474)
Q Consensus 168 ~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (474)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+ ....+..... ..+...+++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~~~----~~~~~~~~~ 225 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---VMSFIEQGKR----LDCPAECPP 225 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHHCCCC----CCCCCCCCH
Confidence 11112234678999999998889999999999999999996 999998754322 2222222211 112356789
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 247 EFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 247 ~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
++.+++..||..+|++||++.+|.+.|+.++
T Consensus 226 ~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 226 EMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=315.40 Aligned_cols=260 Identities=20% Similarity=0.310 Sum_probs=206.8
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcC----CCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQ----TNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~----~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
-.++|++.+.||+|+||.||+|.+.. ++..|++|++..... ...+..|+.+++.+.|.+++..+..+...+..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45789999999999999999999865 367899998764332 23478899999999877777766655555677
Q ss_pred EEEEEecC-CCCHHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEe
Q 011945 78 NVLVIDLL-GPSLEDLFNFCS-------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~~-------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~D 149 (474)
.+++++++ +++|.+++.... ..+++..++.++.||+.||+|||+++|+||||||+|||++ .++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~---~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID---EELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEc---CCCcEEECC
Confidence 88999988 789999987532 4589999999999999999999999999999999999994 678999999
Q ss_pred cCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHH
Q 011945 150 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKI 228 (474)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i 228 (474)
||+++.+....... ......++..|+|||++.+..++.++|||||||++||+++ |+.||..... ......+
T Consensus 161 ~g~~~~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~ 232 (280)
T cd05043 161 NALSRDLFPMDYHC-----LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYL 232 (280)
T ss_pred CCCcccccCCceEE-----eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHH
Confidence 99998765433211 0122356788999999999889999999999999999998 9999976543 2222222
Q ss_pred hhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
... ... .....+|+++.+++.+||..+|++||++.++++.|.++..+
T Consensus 233 ~~~-~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 233 KDG-YRL---AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred HcC-CCC---CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 221 111 11235789999999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=337.86 Aligned_cols=253 Identities=20% Similarity=0.226 Sum_probs=196.2
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
.+..|.+.++||.|+||.||+|.+..+++.||||... ...+.+|+++++.|+|.+++.. ..++..+...+++|++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~----~~~~~~E~~iL~~L~HpnIv~l-~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW----YASSVHEARLLRRLSHPAVLAL-LDVRVVGGLTCLVLPK 241 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc----ccCHHHHHHHHHHCCCCCCCcE-EEEEEECCEEEEEEEc
Confidence 4668999999999999999999999999999999643 2346789999999986655554 4556677888999999
Q ss_pred CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccc
Q 011945 85 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164 (474)
Q Consensus 85 ~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (474)
+.++|.+++......+++..++.|+.||+.||.|||++|||||||||+||||+ ..+.+||+|||+++.+.......
T Consensus 242 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~---~~~~vkL~DFGla~~~~~~~~~~- 317 (461)
T PHA03211 242 YRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVN---GPEDICLGDFGAACFARGSWSTP- 317 (461)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEEC---CCCCEEEcccCCceecccccccc-
Confidence 99999999876556799999999999999999999999999999999999994 67889999999998664322110
Q ss_pred cccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcC-----cHHHHHHHHhhccc-----c
Q 011945 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-----TKKQKYEKISEKKV-----S 234 (474)
Q Consensus 165 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~-----~~~~~~~~i~~~~~-----~ 234 (474)
......||..|+|||++.+..++.++|||||||+||||++|..|+...... ...+....+..... .
T Consensus 318 ----~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 318 ----FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred ----cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 113457999999999999999999999999999999999988765432211 11111111111110 0
Q ss_pred c-------------------------hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 235 T-------------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 235 ~-------------------------~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
. ....+ ..++.++.+||..||..||.+||++.+|++
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRY-YKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhh-ccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 0 00000 134568999999999999999999888754
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=312.12 Aligned_cols=246 Identities=20% Similarity=0.325 Sum_probs=193.9
Q ss_pred eeeecCceEEEEEEE--cCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-C
Q 011945 14 KIGSGSFGEIYLGTN--IQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 86 (474)
Q Consensus 14 ~LG~G~fG~Vy~a~~--~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (474)
+||+|+||.||+|.+ ..++..||||+++.... ...+..|+.+++.+.|.+++..+.. .. .+..+++|||+ +
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGI-CE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEE-Ec-CCCcEEEEecCCC
Confidence 689999999999965 45678999998865433 2357889999999987666555543 33 45668899998 6
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccc
Q 011945 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166 (474)
Q Consensus 87 ~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (474)
++|.+++.. ...+++..++.++.||+.||.|||++||+||||||.|||++ .++.+||+|||++..........
T Consensus 80 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~---~~~~~kl~Dfg~~~~~~~~~~~~--- 152 (257)
T cd05116 80 GPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV---TQHYAKISDFGLSKALGADENYY--- 152 (257)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEc---CCCeEEECCCccccccCCCCCee---
Confidence 789999874 45799999999999999999999999999999999999994 67889999999998765432211
Q ss_pred cccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCc
Q 011945 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245 (474)
Q Consensus 167 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 245 (474)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||...... .....+..... ...+..++
T Consensus 153 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~i~~~~~----~~~~~~~~ 224 (257)
T cd05116 153 -KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQMIESGER----MECPQRCP 224 (257)
T ss_pred -eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHCCCC----CCCCCCCC
Confidence 11122345689999999988889999999999999999998 99999875432 23333332221 12345689
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 246 TEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 246 ~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
+++.++|..||+.||++||++++|.+.|+..
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 9999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=311.02 Aligned_cols=254 Identities=23% Similarity=0.352 Sum_probs=202.9
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
..++|++.+.||.|+||.||+|.+. .++.||||.+.... ...++.+|+.+++.++|.+.+ .+..+.......+++||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLI-QLYAVCTLEEPIYIVTE 81 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCcc-ceeEEEecCCCeeeeee
Confidence 3468999999999999999999974 55789999876543 235688999999999865544 55556667777899999
Q ss_pred cC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 84 ~~-g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
++ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||+++.+.....
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG---ENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEc---CCCCEEECCcceEEEccCCcc
Confidence 99 899999997433 4689999999999999999999999999999999999994 678899999999987753321
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
.. ......+..|+|||++.+..++.++|||||||++|||++ |+.||.+... ...+..+..... . ..
T Consensus 159 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~~-~---~~ 225 (261)
T cd05068 159 EA------REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVLQQVDQGYR-M---PC 225 (261)
T ss_pred cc------cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCC-C---CC
Confidence 11 112233568999999999899999999999999999999 9999987543 223333322211 1 12
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
...++..+.+++.+||..+|++||++.+|.+.|+++
T Consensus 226 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 226 PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 245789999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=317.21 Aligned_cols=256 Identities=17% Similarity=0.305 Sum_probs=200.6
Q ss_pred cEEEeeeeeecCceEEEEEEEcC-----CCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
+|++.+.||+|+||.||+|.+.. ....|++|.+..... ...+..|+.+++.+.|++++..+ .++......+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~-~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLY-GACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEE-EEEecCCCcE
Confidence 58899999999999999998753 235789998765433 23588899999999876655544 4556667788
Q ss_pred EEEecC-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 011945 80 LVIDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 135 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~-----------------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NIL 135 (474)
++|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 999998 789999886421 24789999999999999999999999999999999999
Q ss_pred eeeCCCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 011945 136 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQ 214 (474)
Q Consensus 136 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~ 214 (474)
++ +++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 160 l~---~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 160 VA---EGRKMKISDFGLSRDVYEEDSY-----VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred Ec---CCCcEEeccccccccccCccch-----hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 94 6789999999999865433221 11123356778999999998889999999999999999998 999997
Q ss_pred CCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 215 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 215 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
+.... .....+ ...... .....++.++.+++..||+.+|++||++.++.+.|++++.+
T Consensus 232 ~~~~~---~~~~~~-~~~~~~---~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 232 GIAPE---RLFNLL-KTGYRM---ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred CCCHH---HHHHHH-hCCCCC---CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 65432 222222 211111 12356789999999999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=312.68 Aligned_cols=253 Identities=21% Similarity=0.237 Sum_probs=195.9
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
+|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.+.|++ +..+..+...+...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN-IVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCC-EeeeEEEEeeCCeEEEEEe
Confidence 5899999999999999999998899999999875432 2346888999999998555 5555555667788899999
Q ss_pred cCCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 84 LLGPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 84 ~~g~sL~~li~~~~--~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
|+.++|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+||+|||++........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 80 FLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLID---NKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred cCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEc---CCCcEEECcccceeecCCCcc
Confidence 99889999886433 5699999999999999999999999999999999999994 778999999999975533211
Q ss_pred ccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHH------------
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI------------ 228 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i------------ 228 (474)
......++..|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+...
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (285)
T cd07861 157 -------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV 229 (285)
T ss_pred -------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc
Confidence 11233678999999998764 4789999999999999999999999864321111111000
Q ss_pred ---------hhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 229 ---------SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 229 ---------~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
...............+++++.++|.+||..||++||++.+|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000011112223457899999999999999999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=312.23 Aligned_cols=253 Identities=21% Similarity=0.360 Sum_probs=201.9
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
+..++|+++++||+|+||.||+|.+ .+++.||+|.+..... ...+..|+.+++.++|.+++..+. +. .....+++|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~-~~-~~~~~~~v~ 79 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYA-VV-TQEPIYIIT 79 (260)
T ss_pred cchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEE-EE-ccCCcEEEE
Confidence 3467899999999999999999986 4678899998765433 356889999999998766555544 33 345678999
Q ss_pred ecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 83 e~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|++ +++|.+++... ...+++..++.++.|++.||+|||+.||+||||||+||+++ .++.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEc---CCCCEEEccCcceeecCCCC
Confidence 998 88999988643 34689999999999999999999999999999999999994 77899999999997765322
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
.. ......++..|+|||++.+..++.++|||||||++|||++ |+.||.+.... ..+..+..... . .
T Consensus 157 ~~------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~~~-~---~ 223 (260)
T cd05067 157 YT------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP---EVIQNLERGYR-M---P 223 (260)
T ss_pred cc------cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH---HHHHHHHcCCC-C---C
Confidence 11 1123456788999999998889999999999999999999 99999875432 22222222111 1 1
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 275 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (474)
....+|.++.+++.+||..+|++||++++|.+.|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 235678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=325.43 Aligned_cols=249 Identities=19% Similarity=0.271 Sum_probs=213.0
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
-.|.+-|.+.+.||+|.|.+|-+|++.-+|+.||||++..... ...+.+|++.|+.++|+|+| .++.+.......
T Consensus 14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiV-RLYEViDTQTKl 92 (864)
T KOG4717|consen 14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIV-RLYEVIDTQTKL 92 (864)
T ss_pred cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCee-eeeehhcccceE
Confidence 4577889999999999999999999999999999999876543 34689999999999966555 454455566678
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
||++|+- +|+|.|+|-.....+.+..+.+++.||+.|+.|+|...+|||||||+|+++- .+-|.|||+|||++..+.
T Consensus 93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeeccccccCC
Confidence 9999988 7899999987888899999999999999999999999999999999999886 577999999999998876
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccch
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s-~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (474)
.... ..+.+|+..|-|||+++|..|+ +++||||||||||.|++|+.||+..++ .+.+-.|+..+...
T Consensus 171 PG~k--------L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND---SETLTmImDCKYtv- 238 (864)
T KOG4717|consen 171 PGKK--------LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND---SETLTMIMDCKYTV- 238 (864)
T ss_pred Ccch--------hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc---hhhhhhhhcccccC-
Confidence 5432 4578999999999999999986 688999999999999999999987554 34556666666543
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
+..++.+.++||..||..||.+|.+.++|.
T Consensus 239 ----PshvS~eCrdLI~sMLvRdPkkRAslEeI~ 268 (864)
T KOG4717|consen 239 ----PSHVSKECRDLIQSMLVRDPKKRASLEEIV 268 (864)
T ss_pred ----chhhhHHHHHHHHHHHhcCchhhccHHHHh
Confidence 345678999999999999999999988775
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=317.28 Aligned_cols=257 Identities=19% Similarity=0.320 Sum_probs=203.3
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCC-----CeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
.++|++.+.||+|+||.||++.+... ...||+|++...... ..+..|+.+++.+..++++..+..++..+..
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 46899999999999999999997643 378999987654322 3477899999999555666666666667778
Q ss_pred EEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCC
Q 011945 78 NVLVIDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~---------------~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~ 141 (474)
.+++|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~---~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT---E 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc---C
Confidence 89999988 88999998632 34689999999999999999999999999999999999994 6
Q ss_pred CCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCc
Q 011945 142 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 220 (474)
Q Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~ 220 (474)
++.+||+|||+++.+....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-- 240 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYR-----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-- 240 (293)
T ss_pred CCeEEeCcccccccccccccee-----ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH--
Confidence 7899999999998765432211 1122345678999999998899999999999999999997 9999976433
Q ss_pred HHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
.+.+..+...... .....++.++.+|+..||..+|++||++.++++.|++++
T Consensus 241 -~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 -EELFKLLKEGYRM----EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -HHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 2222222222111 123456889999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=326.45 Aligned_cols=249 Identities=19% Similarity=0.237 Sum_probs=191.1
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 85 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (474)
..+|++++.||+|+||.||+|.+..+++.||+|+.... ....|+.+++.++|++++. +..++......++||+++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----~~~~E~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----TTLIEAMLLQNVNHPSVIR-MKDTLVSGAITCMVLPHY 139 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----ccHHHHHHHHhCCCCCCcC-hhheEEeCCeeEEEEEcc
Confidence 34699999999999999999999999999999975432 3467999999999765554 445556777889999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccc
Q 011945 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 165 (474)
Q Consensus 86 g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (474)
.++|.+++......+++..++.|+.||+.||.|||++|||||||||+|||+ +..+.+||+|||+++.......
T Consensus 140 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~---- 212 (357)
T PHA03209 140 SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAPA---- 212 (357)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCccccccccCcc----
Confidence 999999987667789999999999999999999999999999999999999 4778899999999975332211
Q ss_pred ccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHH-------HHHHHHhhc-c-----
Q 011945 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK-------QKYEKISEK-K----- 232 (474)
Q Consensus 166 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~-------~~~~~i~~~-~----- 232 (474)
.....||..|+|||++.+..++.++|||||||++|||+++..|+......... ..+..+... .
T Consensus 213 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 288 (357)
T PHA03209 213 ----FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE 288 (357)
T ss_pred ----cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh
Confidence 13457999999999999999999999999999999999865554332221100 011111100 0
Q ss_pred cc-----chHH-----------------HH-hcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 233 VS-----TSIE-----------------AL-CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 233 ~~-----~~~~-----------------~l-~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
+. .... .+ ...++.++.+||.+||..||.+||++.+++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l 349 (357)
T PHA03209 289 FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEIL 349 (357)
T ss_pred cCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHh
Confidence 00 0000 00 124567788899999999999999987764
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=318.59 Aligned_cols=257 Identities=18% Similarity=0.271 Sum_probs=198.8
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCC----------------eEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCc
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN----------------EEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIP 66 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~----------------~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~ 66 (474)
.++|+++++||+|+||.||+|.+..++ ..||+|++..... ...+..|+++++.+.|++++.
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 468999999999999999999876543 5689998765432 345788999999998665554
Q ss_pred eeEEEeEeCCEEEEEEecC-CCCHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 011945 67 NLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS----------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 135 (474)
Q Consensus 67 ~l~~~~~~~~~~~lv~e~~-g~sL~~li~~~~----------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NIL 135 (474)
+..++..+...+++||++ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||+
T Consensus 84 -~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil 162 (296)
T cd05051 84 -LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL 162 (296)
T ss_pred -EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence 445555667889999988 789999987543 26899999999999999999999999999999999999
Q ss_pred eeeCCCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh--CCCCC
Q 011945 136 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR--GSLPW 213 (474)
Q Consensus 136 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt--G~~Pf 213 (474)
++ ..+.++|+|||++.......... ......++..|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 163 i~---~~~~~~l~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 234 (296)
T cd05051 163 VG---KNYTIKIADFGMSRNLYSSDYYR-----VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY 234 (296)
T ss_pred ec---CCCceEEccccceeecccCccee-----ecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCC
Confidence 95 66899999999997654332111 1223456789999999998889999999999999999998 78898
Q ss_pred CCCCcCcHHHHHHHHhhc---cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011945 214 QGLKAGTKKQKYEKISEK---KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 274 (474)
Q Consensus 214 ~~~~~~~~~~~~~~i~~~---~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (474)
...... ..+..+... ............+|.++.+++..||+.||++||++.+|.+.|+
T Consensus 235 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 235 EHLTDQ---QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCcChH---HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 764432 222222211 0000001112456789999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=312.52 Aligned_cols=251 Identities=20% Similarity=0.343 Sum_probs=196.4
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeEe------CCE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVE------GDY 77 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~~------~~~ 77 (474)
..+.|++.+.||.|+||.||+|.+..+++.||+|++.... ....+..|+.+++.+.+|+++..+..++.. ...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 3567999999999999999999999999999999886543 234688999999999655555555444332 356
Q ss_pred EEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 78 NVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
.+++|||+ +++|.+++... ...+++..++.++.||+.||.|||+++|+|+||||+||+++ .++.++|+|||++..
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~---~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEEC---CCCCEEEccCCCcee
Confidence 89999999 67999998753 34689999999999999999999999999999999999994 678899999999986
Q ss_pred cccCCCccccccccCCCCccCcccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhh
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (474)
...... ......|+..|+|||++. +..++.++|||||||++|||++|..||...... .....+..
T Consensus 161 ~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~---~~~~~~~~ 230 (272)
T cd06637 161 LDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---RALFLIPR 230 (272)
T ss_pred cccccc-------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH---HHHHHHhc
Confidence 543221 123457899999999986 335788999999999999999999999764322 11111111
Q ss_pred ccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
... .......++.++.+|+.+||..+|.+||++.++++
T Consensus 231 ~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 NPA---PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCC---CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 111 11112357889999999999999999999887753
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=316.81 Aligned_cols=257 Identities=22% Similarity=0.313 Sum_probs=202.9
Q ss_pred CCcEEEeeeeeecCceEEEEEEEc-----CCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
.++|.+.+.||+|+||.||++.+. .++..||||+++.... .+.+..|+.+++++.+|++|..+..++.....
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 458999999999999999999852 3456899998765432 23578899999999556666666666777778
Q ss_pred EEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 78 NVLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
.+++|||+ +++|.+++.... ..+++.+++.++.||+.||.|||+++|+|+||||+|||++ .++.++|+|||+++.
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT---HGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEc---CCCeEEECCCccccc
Confidence 89999998 789999987433 3389999999999999999999999999999999999994 678899999999986
Q ss_pred cccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhcccc
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS 234 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (474)
+....... ......++..|+|||++.+..++.++|||||||++|||++ |..||........ ....+.. ...
T Consensus 191 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~~~-~~~ 262 (302)
T cd05055 191 IMNDSNYV-----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLIKE-GYR 262 (302)
T ss_pred ccCCCcee-----ecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHHHc-CCc
Confidence 65432110 1123456788999999999899999999999999999998 9999987543221 1122111 111
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
. ......++++.+++.+||..+|++||++.+|++.|+++
T Consensus 263 ~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 M---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred C---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1 12235688999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=346.53 Aligned_cols=258 Identities=24% Similarity=0.351 Sum_probs=214.8
Q ss_pred CcEEEeeeeeecCceEEEEEEEcC-----CCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
.+.++.+.||+|.||+||+|+-.. ....||||.++.+.. ..+|++|++++..|+| ++|+.+.+.+.+++..
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H-~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQH-PNIVRLLGVCREGDPL 564 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccC-CCeEEEEEEEccCCee
Confidence 456788999999999999998542 345799998876544 3569999999999995 5566666777888999
Q ss_pred EEEEecC-CCCHHHHHHHcCC---------C----CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCe
Q 011945 79 VLVIDLL-GPSLEDLFNFCSR---------K----LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 144 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~---------~----l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~ 144 (474)
|+|+||| .|+|.+++..... . ++..+.+.|+.|||.||+||-++.+|||||-..|+||+ +...
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg---e~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG---ENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec---cceE
Confidence 9999999 8999999975421 2 78899999999999999999999999999999999995 8899
Q ss_pred EEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHH
Q 011945 145 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQ 223 (474)
Q Consensus 145 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~ 223 (474)
|||+||||++..-..++ |+......-..+||+||.++-.+|+.+||||||||+|||+++ |+.||.++.. .+
T Consensus 642 VKIsDfGLsRdiYssDY-----Yk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---~E 713 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDY-----YKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---QE 713 (774)
T ss_pred EEecccccchhhhhhhh-----hcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch---HH
Confidence 99999999987655444 222223345789999999999999999999999999999998 9999999765 44
Q ss_pred HHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 224 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 224 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
.++.+..... -..++.||.++.+||..||+.+|.+||+|.+|...|++.....
T Consensus 714 VIe~i~~g~l----L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 714 VIECIRAGQL----LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred HHHHHHcCCc----ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 5555555443 2345789999999999999999999999999999999886544
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=317.71 Aligned_cols=260 Identities=17% Similarity=0.302 Sum_probs=206.1
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEc-------CCCeEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEe
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNI-------QTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVE 74 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~ 74 (474)
..++|.+.+.||+|+||.||+|++. ..+..||+|+..... ....+..|+.+++.+..|++|..+..+...
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3568999999999999999999753 234579999876432 224588999999999556666666666677
Q ss_pred CCEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeee
Q 011945 75 GDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 138 (474)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~li~~~~---------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~ 138 (474)
....+++|||+ +++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||++
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~- 171 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT- 171 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc-
Confidence 77889999999 789999987532 2478889999999999999999999999999999999994
Q ss_pred CCCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 011945 139 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 217 (474)
Q Consensus 139 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~ 217 (474)
.++.+||+|||+++.+....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+..
T Consensus 172 --~~~~~kl~D~g~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 244 (304)
T cd05101 172 --ENNVMKIADFGLARDVNNIDYYK-----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 244 (304)
T ss_pred --CCCcEEECCCccceecccccccc-----cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence 67899999999998765432211 1122356778999999999889999999999999999998 889997643
Q ss_pred cCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 218 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
..+.+..+...... .....++.++.+++.+||..+|++||++.++++.|++++.-
T Consensus 245 ---~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 245 ---VEELFKLLKEGHRM----DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred ---HHHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 23333333222211 12346789999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=308.23 Aligned_cols=252 Identities=21% Similarity=0.303 Sum_probs=202.4
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
.++|++.+.||.|+||.||+|.+..+++.|++|++.... ....+..|+.+++.++|++++. +..+...+...+++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~-~~~~~~~~~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA-YFGSYLRRDKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhc-eEEEEEeCCEEEEEEe
Confidence 368999999999999999999998899999999876543 3456899999999998666555 4555667788999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
|+ +++|.+++......+++..++.++.|++.||.|||++||+|+||||+||+++ .++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT---EDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC---CCCCEEECccccchhhhhhhh-
Confidence 99 6799999876557899999999999999999999999999999999999994 678899999999976544221
Q ss_pred cccccccCCCCccCccccccccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~---~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
......++..|+|||.+.+. .++.++|||||||++|||++|..||..... ......+...........
T Consensus 157 ------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~ 227 (262)
T cd06613 157 ------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP---MRALFLISKSNFPPPKLK 227 (262)
T ss_pred ------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhccCCCcccc
Confidence 12345788999999999877 789999999999999999999999987542 222222222211111111
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
....++.++.+++.+||..+|.+||++.+|+.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 22346788999999999999999999988753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=309.01 Aligned_cols=247 Identities=21% Similarity=0.284 Sum_probs=200.5
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
.|++++.||.|+||.||++.+..+++.||||.+..... .+.+..|+++++.++|.+++..+..+.......+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 59999999999999999999999999999998765432 23578899999999877766665555445667899999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 84 ~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
++ +++|.+++... ...+++.+++.++.||+.||.|||++||+|+||||+||+++ ..+.++|+|||++..+.....
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~---~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLT---RTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEe---cCCcEEEecccceEEecccCC
Confidence 98 78999988753 34589999999999999999999999999999999999994 678999999999987643322
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||.... .......+...... .+.
T Consensus 158 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~---~~~~~~~~~~~~~~----~~~ 223 (257)
T cd08223 158 -------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD---MNSLVYRIIEGKLP----PMP 223 (257)
T ss_pred -------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhcCCC----CCc
Confidence 1234578999999999999999999999999999999999999997533 22222233222221 233
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
..+++++.+++.+||+.+|++||++.++++
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 567899999999999999999999887753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=309.60 Aligned_cols=246 Identities=21% Similarity=0.262 Sum_probs=200.1
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
+|++.++||.|+||.||++.+..+++.||+|.++... ..+.+..|+.+++.++|.+ +..+...+..+...+++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPN-IVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCC-cceEEEEEEECCEEEEEEee
Confidence 5899999999999999999999999999999875432 2345788999999998655 45555566777889999999
Q ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 85 ~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
+ +++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+|||+ +.++.++|+|||++..+.....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeeccccc-
Confidence 9 78999988643 3458999999999999999999999999999999999999 4778999999999976644322
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhc
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (474)
......|+..|+|||++.+..++.++||||||+++|+|++|..||.... ....+..+...... .+..
T Consensus 156 ------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~---~~~~~~~~~~~~~~----~~~~ 222 (255)
T cd08219 156 ------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS---WKNLILKVCQGSYK----PLPS 222 (255)
T ss_pred ------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC---HHHHHHHHhcCCCC----CCCc
Confidence 1134578999999999999889999999999999999999999997633 22333333222221 1234
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.++..+.+++.+||+.||++||++.+|+.
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 57889999999999999999999888754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=310.44 Aligned_cols=252 Identities=23% Similarity=0.388 Sum_probs=200.4
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
..++|++.++||+|+||.||+|.+..+ ..||+|.+.... ....+.+|+.+++.+.|+++++.+..+ .....+++||
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~~v~e 80 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV--SEEPIYIVTE 80 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEE--cCCCcEEEEE
Confidence 347899999999999999999997544 469999876433 335688999999999988777665544 3455789999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 84 ~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
|+ +++|.+++... ...+++..++.++.||+.||.|||+.||+|+||||+||++ ++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceEccCCcc
Confidence 98 67999999743 3358999999999999999999999999999999999999 4778999999999976543221
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
. ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.... ..+..+.... .. ..
T Consensus 158 ~------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~~~-~~---~~ 224 (260)
T cd05069 158 T------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR---EVLEQVERGY-RM---PC 224 (260)
T ss_pred c------ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCC-CC---CC
Confidence 1 1123356788999999998889999999999999999999 99999875432 2233332211 11 12
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 275 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (474)
...+|..+.+++.+||..||++||++++|.+.|++
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 PQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 34678999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=318.04 Aligned_cols=253 Identities=20% Similarity=0.237 Sum_probs=199.7
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCC-----CeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
.+|++.++||.|+||.||+|.+..+ ++.||||++...... ..+..|+.++..++|++++. +..+.......
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~-~~~~~~~~~~~ 83 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC-LLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCe-EEEEEcCCCce
Confidence 4688899999999999999987543 578999998754432 34788999999998665554 44555666678
Q ss_pred EEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCC
Q 011945 79 VLVIDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~---------------~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~ 142 (474)
+++++|+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+. ++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~---~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF---DK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec---CC
Confidence 8999988 78999988521 23488899999999999999999999999999999999994 67
Q ss_pred CeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcH
Q 011945 143 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTK 221 (474)
Q Consensus 143 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~ 221 (474)
+.+||+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--- 232 (283)
T cd05091 161 LNVKISDLGLFREVYAADYY-----KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN--- 232 (283)
T ss_pred CceEecccccccccccchhe-----eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---
Confidence 78999999998865432211 11223456789999999998889999999999999999998 8899987533
Q ss_pred HHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011945 222 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 275 (474)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (474)
.+.+..+...... .....+|.++.+++..||+.+|++||++.+|...|+.
T Consensus 233 ~~~~~~i~~~~~~----~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 233 QDVIEMIRNRQVL----PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHHHcCCcC----CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 3334444333322 2346789999999999999999999999999888763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=327.62 Aligned_cols=258 Identities=22% Similarity=0.350 Sum_probs=214.2
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 85 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (474)
+.....+||-|.||+||.|.|++-...||||.++.+.. ..+|+.|..+|+.++|+|.|..+..+. .+..+||+.|||
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT-~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-HEPPFYIITEFMC 346 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhc-cCCCeEEEEeccc
Confidence 34566899999999999999999999999998876654 367999999999999777766665554 444556677766
Q ss_pred CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccc
Q 011945 86 GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164 (474)
Q Consensus 86 g~sL~~li~~~~~~-l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (474)
.|+|.+++..|++. ++....+.++.||..||+||..+++|||||-..|+|++ .+..|||+||||++.+..+....|
T Consensus 347 yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg---EnhiVKvADFGLsRlMtgDTYTAH 423 (1157)
T KOG4278|consen 347 YGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHIVKVADFGLSRLMTGDTYTAH 423 (1157)
T ss_pred CccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc---ccceEEeeccchhhhhcCCceecc
Confidence 99999999988765 77788889999999999999999999999999999995 788999999999999988765443
Q ss_pred cccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcC
Q 011945 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (474)
Q Consensus 165 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (474)
. ...-.+.|.|||.+.-..++.|+|||+|||+|||+.| |.-||.+.+. .+.|. +.++.+ ...-+.+
T Consensus 424 A------GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl---SqVY~-LLEkgy---RM~~PeG 490 (1157)
T KOG4278|consen 424 A------GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYG-LLEKGY---RMDGPEG 490 (1157)
T ss_pred c------CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH---HHHHH-HHhccc---cccCCCC
Confidence 2 2233578999999998999999999999999999998 9999998654 33332 222222 2233578
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 011945 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGF 282 (474)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~ 282 (474)
||+.+.+||..||++.|.+||+|.++.+.|+.+|....+
T Consensus 491 CPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sSi 529 (1157)
T KOG4278|consen 491 CPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSSI 529 (1157)
T ss_pred CCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhccccc
Confidence 999999999999999999999999999999999976654
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=321.55 Aligned_cols=257 Identities=19% Similarity=0.291 Sum_probs=215.8
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-CC
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GP 87 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~ 87 (474)
|.++++||+|+||.||++.++.+|+.||||.+..+...+++..|+.|++++..+..|.++..|+... ..||||||| .|
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s-DLWIVMEYCGAG 113 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS-DLWIVMEYCGAG 113 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCC-ceEeehhhcCCC
Confidence 6788999999999999999999999999999999888899999999999999777777766666544 469999999 68
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccccc
Q 011945 88 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167 (474)
Q Consensus 88 sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~ 167 (474)
++.|+++..++++++.++..++...+.||+|||...-||||||..|||+ +.+|..||+|||.|-.+.+....
T Consensus 114 SiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTMAK----- 185 (502)
T KOG0574|consen 114 SISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTMAK----- 185 (502)
T ss_pred cHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchhhhhHHh-----
Confidence 9999999888899999999999999999999999999999999999999 58899999999999887765432
Q ss_pred ccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHH
Q 011945 168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 247 (474)
Q Consensus 168 ~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 247 (474)
.+++.||+.|||||++....|+.++||||||++..||..|++||.+..+.. .+..|..+..++. .-+..++.+
T Consensus 186 --RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---AIFMIPT~PPPTF--~KPE~WS~~ 258 (502)
T KOG0574|consen 186 --RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---AIFMIPTKPPPTF--KKPEEWSSE 258 (502)
T ss_pred --hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---eeEeccCCCCCCC--CChHhhhhH
Confidence 357899999999999999999999999999999999999999998865521 1111211111111 112456789
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCC
Q 011945 248 FASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQF 284 (474)
Q Consensus 248 l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~ 284 (474)
|.+|++.||.++|++|-|+ .+++++.|+++....
T Consensus 259 F~DFi~~CLiK~PE~R~TA---~~L~~H~FiknA~g~ 292 (502)
T KOG0574|consen 259 FNDFIRSCLIKKPEERKTA---LRLCEHTFIKNAPGC 292 (502)
T ss_pred HHHHHHHHhcCCHHHHHHH---HHHhhhhhhcCCCcc
Confidence 9999999999999999885 455778887765433
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=330.90 Aligned_cols=257 Identities=25% Similarity=0.327 Sum_probs=202.5
Q ss_pred CcEEEeeeeeecCceEEEEEEEc-----CCCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
++|.+.++||+|+||.||+|++. .+++.||||+++..... ..+..|++++..+..|++|..+..++......
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 46888999999999999999864 34578999998754332 35788999999998556666666667777788
Q ss_pred EEEEecC-CCCHHHHHHHcC------------------------------------------------------------
Q 011945 79 VLVIDLL-GPSLEDLFNFCS------------------------------------------------------------ 97 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~------------------------------------------------------------ 97 (474)
++||||+ +++|.+++....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 9999999 899999986431
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCC
Q 011945 98 -------------------------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 140 (474)
Q Consensus 98 -------------------------------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~ 140 (474)
..+++..++.|+.||+.||.|||+++|+||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~--- 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC--- 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe---
Confidence 1367778899999999999999999999999999999995
Q ss_pred CCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcC
Q 011945 141 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAG 219 (474)
Q Consensus 141 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~ 219 (474)
..+.+||+|||+++.+...... .......++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~ 348 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNY-----ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN 348 (401)
T ss_pred CCCEEEEEecCcceeccccccc-----ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence 6789999999999865432211 11223467889999999999889999999999999999998 89999765322
Q ss_pred cHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 220 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 220 ~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
. .....+.. .... .....++.++.+|+.+||..+|++||++.+|++.|+.++
T Consensus 349 ~--~~~~~~~~-~~~~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 349 E--QFYNAIKR-GYRM---AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred H--HHHHHHHc-CCCC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 1 11121211 1111 123457899999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=313.98 Aligned_cols=257 Identities=21% Similarity=0.325 Sum_probs=200.4
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcC-----CCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCC
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGD 76 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (474)
..++|++.++||+|+||.||+|.++. .+..||+|.+...... ..+..|+.+++.+.|+ ++..+..+.....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~ 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH-HVVRLLGVVSKGQ 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCC-CeeeEEEEEcCCC
Confidence 45789999999999999999997642 3558999987644322 2467899999999865 5555555566677
Q ss_pred EEEEEEecC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEE
Q 011945 77 YNVLVIDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 146 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~~---------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vk 146 (474)
..+++|||+ +++|.+++.... ..++...++.++.||+.||.|||++||+||||||+|||++ .++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~---~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEc---CCCcEE
Confidence 889999998 899999997432 2356788999999999999999999999999999999994 678999
Q ss_pred EEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHH
Q 011945 147 IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKY 225 (474)
Q Consensus 147 L~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~ 225 (474)
|+|||+++....... ........++..|+|||.+.+..++.++|||||||++|||++ |..||.+... .+.+
T Consensus 160 L~Dfg~~~~~~~~~~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---~~~~ 231 (288)
T cd05061 160 IGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---EQVL 231 (288)
T ss_pred ECcCCcccccccccc-----ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHH
Confidence 999999986543221 111223356778999999999899999999999999999998 8999976433 2222
Q ss_pred HHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 226 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
..+..... ......+++.+.+++..||+.+|++||++.++++.|++.+
T Consensus 232 ~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 232 KFVMDGGY----LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHHcCCC----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 22222211 1123467899999999999999999999999998888775
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=320.76 Aligned_cols=261 Identities=18% Similarity=0.303 Sum_probs=205.7
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCC-------CeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeC
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQT-------NEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEG 75 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-------~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (474)
..+|++++.||+|+||.||+|.+... +..||+|++..... ...+..|+.+++++..|++|..+..++...
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 45799999999999999999986432 24789998765432 245888999999996566666676666777
Q ss_pred CEEEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeC
Q 011945 76 DYNVLVIDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139 (474)
Q Consensus 76 ~~~~lv~e~~-g~sL~~li~~~---------------~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~ 139 (474)
...+++|||+ +++|.+++... ...+++.+++.++.||+.||.|||++||+||||||+|||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~-- 168 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT-- 168 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc--
Confidence 7889999999 78999998642 12478899999999999999999999999999999999994
Q ss_pred CCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 011945 140 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (474)
Q Consensus 140 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~ 218 (474)
.++.+||+|||+++........ .......++..|+|||++.+..++.++|||||||+||||++ |..||.+...
T Consensus 169 -~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 169 -EDNVMKIADFGLARDVHNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred -CCCcEEECCcccceeccccccc-----ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 6789999999999866442211 11122345678999999999999999999999999999998 8999977532
Q ss_pred CcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011945 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281 (474)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 281 (474)
...+..+...... .....++.++.+++..||..+|++||++.+|++.|+.++....
T Consensus 243 ---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 243 ---EELFKLLKEGHRM----DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred ---HHHHHHHHcCCCC----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 2333333222111 1234678899999999999999999999999999999986554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=308.82 Aligned_cols=255 Identities=24% Similarity=0.335 Sum_probs=204.0
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++|++.+.||+|+||.||+|.+..+++.||+|.++... ....+.+|+++++.+.|.+.+..+. ++......+++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~-~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA-SFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeee-eeecCCeEEEE
Confidence 68999999999999999999998899999999775321 2346889999999998655554444 45566788999
Q ss_pred EecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 82 IDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~---~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
|||+ +++|.+++... ...+++..++.++.||+.||.|||+.||+|+||||+||+++ .++.++|+|||++..+.
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~---~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT---ATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEEC---CCCcEEEeccceeeecc
Confidence 9999 78999998643 34589999999999999999999999999999999999994 67889999999987654
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
..... .....++..|+|||.+.+..++.++|||||||++|+|++|..||..... ........+.........
T Consensus 158 ~~~~~-------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~ 229 (267)
T cd08224 158 SKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEKCDYPPLP 229 (267)
T ss_pred CCCcc-------cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-cHHHHHhhhhcCCCCCCC
Confidence 43211 1234688999999999998899999999999999999999999975432 222223332222221111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
...++.++.++|.+||..+|++||++.+|++.|+++
T Consensus 230 ---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 230 ---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 125678999999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=314.40 Aligned_cols=251 Identities=20% Similarity=0.244 Sum_probs=196.2
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
+|++.+.||.|+||.||+|.+..+|+.||+|.+..... ...+..|+.+++.++|++++. +..+.......++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~-~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVR-LYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeee-HHHHhccCCceEEEEe
Confidence 58999999999999999999999999999998764322 245788999999998665554 4444566778899999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 84 ~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
|++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||+++.+.....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~---~~~~~~l~dfg~~~~~~~~~~-- 154 (284)
T cd07839 80 YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLIN---KNGELKLADFGLARAFGIPVR-- 154 (284)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEc---CCCcEEECccchhhccCCCCC--
Confidence 999999998876667799999999999999999999999999999999999994 678999999999986543221
Q ss_pred ccccccCCCCccCccccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc---------
Q 011945 164 HIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------- 233 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------- 233 (474)
......++..|+|||++.+.. ++.++|||||||++|+|++|..||..... ....+..+.....
T Consensus 155 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 227 (284)
T cd07839 155 -----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTPTEESWPG 227 (284)
T ss_pred -----CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC--HHHHHHHHHHHhCCCChHHhHH
Confidence 112346789999999988754 79999999999999999999998643222 2222222211000
Q ss_pred ---------------cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 234 ---------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 234 ---------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
..........+++++.++|.+||..||.+|||++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 228 VSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00011223456789999999999999999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=311.25 Aligned_cols=250 Identities=18% Similarity=0.267 Sum_probs=199.5
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
.++|++.+.||+|+||.||+|.+. .+..||||.+.... ....+..|+.+++.++|+ +|..+..++......+++|||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHE-KLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCC-CeeeEEEEEccCCCcEEEEEc
Confidence 357999999999999999999864 34569999876543 245689999999999855 555565566677778999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 85 ~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
+ +++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+||+|||+++.......
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~---~~~~~kl~d~g~~~~~~~~~~-- 155 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVD---DQGCVKVSDFGLSRYVLDDEY-- 155 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc---CCCCEEECCCccceecCCCce--
Confidence 8 7899999976555799999999999999999999999999999999999994 678899999999986544321
Q ss_pred ccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhc
Q 011945 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (474)
.......++..|++||++.+..++.++|||||||++|+|++ |..||..... ......+...... ....
T Consensus 156 ----~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~ 224 (256)
T cd05113 156 ----TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVEKVSQGLRL----YRPH 224 (256)
T ss_pred ----eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHhcCCCC----CCCC
Confidence 11123356788999999998889999999999999999998 9999976543 2223333332211 1123
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011945 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 273 (474)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (474)
..+.++.+++..||..+|++||++.+|++.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 4678999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=308.80 Aligned_cols=246 Identities=20% Similarity=0.301 Sum_probs=193.4
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-CCC
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS 88 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~s 88 (474)
++||+|+||.||+|.+..+++.||+|....... ...+.+|+++++.+.|.+++ .+..++......++||||+ +++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIV-RLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcc-eEEEEEcCCCCeEEEEeeccCCc
Confidence 479999999999999988999999998654322 24588999999999865554 5555566677889999998 889
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccccc
Q 011945 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 168 (474)
Q Consensus 89 L~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 168 (474)
|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..........
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~~~~~~~~----- 151 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVT---EKNVLKISDFGMSREEEDGVYAS----- 151 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEc---CCCcEEECccccCcccccccccc-----
Confidence 9999875555789999999999999999999999999999999999994 67889999999997654321100
Q ss_pred cCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHH
Q 011945 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 247 (474)
Q Consensus 169 ~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 247 (474)
......++..|+|||.+.+..++.++|||||||++|||++ |..||....... ....+.. .... .....+|.+
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---~~~~~~~-~~~~---~~~~~~~~~ 224 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---TREAIEQ-GVRL---PCPELCPDA 224 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---HHHHHHc-CCCC---CCcccCCHH
Confidence 0011123567999999999889999999999999999997 999997644321 1222211 1111 123467899
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011945 248 FASYFHYCRSLRFDDKPDYAYLKRLFR 274 (474)
Q Consensus 248 l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (474)
+.+++.+||..+|++||++.+|.+.|.
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=312.44 Aligned_cols=262 Identities=19% Similarity=0.255 Sum_probs=207.3
Q ss_pred CCCccCCcEEEeeeeeecCceEEEEEEEcCCCe----EEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeE
Q 011945 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGV 73 (474)
Q Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~----~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~ 73 (474)
|......+|++.+.||+|+||.||+|.+..+++ .||+|........ ..+.+|+.+++.+.|++++..+..+.
T Consensus 1 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~- 79 (279)
T cd05057 1 LRILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICL- 79 (279)
T ss_pred CcccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-
Confidence 345667899999999999999999999876664 5899987655432 35788999999998766666555443
Q ss_pred eCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCC
Q 011945 74 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (474)
Q Consensus 74 ~~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (474)
. ...+++|||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +..+.+||+|||+
T Consensus 80 ~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg~ 155 (279)
T cd05057 80 S-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGL 155 (279)
T ss_pred c-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCcc
Confidence 3 5678889888 889999998666679999999999999999999999999999999999999 4678899999999
Q ss_pred ccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhc
Q 011945 153 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEK 231 (474)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~ 231 (474)
++.......... .....++..|+|||.+.+..++.++|||||||++||+++ |..||.+..... ....+...
T Consensus 156 ~~~~~~~~~~~~-----~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~~ 227 (279)
T cd05057 156 AKLLDVDEKEYH-----AEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPDLLEKG 227 (279)
T ss_pred cccccCccccee-----cCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHhCC
Confidence 987653322110 112234678999999988889999999999999999998 999998754322 22222221
Q ss_pred cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 232 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
.. . .....++..+.+++.+||..+|++||++.++.+.|.+++..
T Consensus 228 ~~-~---~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 228 ER-L---PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CC-C---CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 11 1 11234678999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=317.88 Aligned_cols=259 Identities=20% Similarity=0.300 Sum_probs=196.5
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCC--------------eEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTN--------------EEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLR 69 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~--------------~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~ 69 (474)
++|++.++||+|+||.||+|.+..++ ..||||++..... ...+.+|+++++.++|++ +..+.
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~-i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPN-IIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCC-cCeEE
Confidence 58999999999999999999875432 3589998765422 235888999999998655 55555
Q ss_pred EEeEeCCEEEEEEecC-CCCHHHHHHHcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEee
Q 011945 70 WFGVEGDYNVLVIDLL-GPSLEDLFNFCS-----------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 137 (474)
Q Consensus 70 ~~~~~~~~~~lv~e~~-g~sL~~li~~~~-----------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~ 137 (474)
.++......+++|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~ 163 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence 5556677889999998 889999986422 1368899999999999999999999999999999999994
Q ss_pred eCCCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCC
Q 011945 138 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR--GSLPWQG 215 (474)
Q Consensus 138 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt--G~~Pf~~ 215 (474)
.++.+||+|||++........ ........++..|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 164 ---~~~~~kl~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 164 ---NHYTIKIADFGMSRNLYSGDY-----YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred ---CCCcEEecccccccccccCcc-----eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 677899999999976543221 111223456789999999998899999999999999999988 7788876
Q ss_pred CCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011945 216 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 274 (474)
Q Consensus 216 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (474)
...........+................+|+.+.+|+.+||..+|++||++++|.+.|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 236 LSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred cChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 54322222211111111010111123457899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=313.41 Aligned_cols=256 Identities=18% Similarity=0.213 Sum_probs=197.9
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCe----EEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~----~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
.++|++++.||+|+||+||+|.+..+++ .|++|.+...... ..+..|+.++..+.|++++..+. ++.. ...
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~-~~~~-~~~ 83 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLG-ICPG-ASL 83 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEE-EECC-Ccc
Confidence 4679999999999999999999877776 4777776543222 34566777778888766555544 4433 345
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
++++|++ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 84 ~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 84 QLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCccceecc
Confidence 5666666 899999998666789999999999999999999999999999999999999 467899999999998654
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccch
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (474)
...... ......++..|++||++.+..++.++|||||||++|||++ |..||.+..... +..+........
T Consensus 161 ~~~~~~-----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~----~~~~~~~~~~~~ 231 (279)
T cd05111 161 PDDKKY-----FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE----VPDLLEKGERLA 231 (279)
T ss_pred CCCccc-----ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHHCCCcCC
Confidence 332111 1123467789999999998899999999999999999998 999998754321 222222211111
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
....++..+.+++..||..+|++||++.++.+.|..+..
T Consensus 232 ---~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 232 ---QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 123467889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=316.80 Aligned_cols=260 Identities=18% Similarity=0.266 Sum_probs=197.0
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcC----------------CCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCc
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQ----------------TNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIP 66 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~----------------~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~ 66 (474)
.++|++.++||+|+||.||++.+.. ++..||||++..... ...+..|+.+++.++|.+ +.
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~-i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPN-II 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCC-cc
Confidence 4679999999999999999986432 345799998865432 245889999999998655 44
Q ss_pred eeEEEeEeCCEEEEEEecC-CCCHHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 011945 67 NLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCS----------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 135 (474)
Q Consensus 67 ~l~~~~~~~~~~~lv~e~~-g~sL~~li~~~~----------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NIL 135 (474)
.+..++......+++|||+ +++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil 162 (296)
T cd05095 83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL 162 (296)
T ss_pred eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence 5555666777789999998 789999987432 23778899999999999999999999999999999999
Q ss_pred eeeCCCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh--CCCCC
Q 011945 136 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR--GSLPW 213 (474)
Q Consensus 136 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt--G~~Pf 213 (474)
++ .++.++|+|||+++.+...... .......++..|++||+..+..++.++|||||||++|||++ |..||
T Consensus 163 i~---~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~ 234 (296)
T cd05095 163 VG---KNYTIKIADFGMSRNLYSGDYY-----RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPY 234 (296)
T ss_pred Ec---CCCCEEeccCcccccccCCcce-----eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCc
Confidence 94 6788999999999865433211 11122345678999999988899999999999999999998 78999
Q ss_pred CCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011945 214 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 274 (474)
Q Consensus 214 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (474)
..............................+|+.+.+|+..||..||++||++.+|.+.|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 235 SQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred cccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 7654322221111111100000001112457899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=319.23 Aligned_cols=256 Identities=18% Similarity=0.222 Sum_probs=190.7
Q ss_pred eeeeeecCceEEEEEEEcC--CCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEe-EeCCEEEEEEecCCCC
Q 011945 12 GRKIGSGSFGEIYLGTNIQ--TNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFG-VEGDYNVLVIDLLGPS 88 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~--~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~-~~~~~~~lv~e~~g~s 88 (474)
..+||+|+||+||+|.+.. ++..||+|.+........+.+|+.+++.++|++++..+..+. ..+...+++|||++++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHD 85 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCc
Confidence 4689999999999999654 568899998876655667889999999999877776666554 3456789999999999
Q ss_pred HHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeC-CCCCeEEEEecCCccccccC
Q 011945 89 LEDLFNFC--------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 89 L~~li~~~--------~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~-~~~~~vkL~DFGla~~~~~~ 159 (474)
|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+..+ +..+.+||+|||+++.+...
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~ 165 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCC
Confidence 99988532 1248899999999999999999999999999999999999432 35678999999999876543
Q ss_pred CCccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcH------HHHHHHHhhcc
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK------KQKYEKISEKK 232 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~------~~~~~~i~~~~ 232 (474)
... ........||..|+|||++.+. .++.++|||||||++|||++|+.||........ ...+..+....
T Consensus 166 ~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 166 LKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred ccc----ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 221 1122345789999999999874 589999999999999999999999975322100 00011100000
Q ss_pred c----------------c-------------chH----HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 233 V----------------S-------------TSI----EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 233 ~----------------~-------------~~~----~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
. . ... +......+..+.+|+.+||..||.+|||+.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 0 0 000 0001123457889999999999999999887753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=310.49 Aligned_cols=256 Identities=16% Similarity=0.260 Sum_probs=203.5
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCC---eEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~---~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
.++|++.+.||+|+||.||+|.+..++ ..||+|.+..... ...+..|+.+++.++|++ +..+..+...++..+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~ 81 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPN-IIHLEGVVTKSKPVM 81 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCC-cceEEEEEecCCccE
Confidence 468999999999999999999986544 3799998765332 245888999999998655 555555666778899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
++|||+ +++|.+++......+++.+++.++.||+.||.|||++||+||||||+|||++ .++.++|+|||++..+..
T Consensus 82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~---~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVN---SNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEEC---CCCeEEeCCCCccccccc
Confidence 999999 7899999986666799999999999999999999999999999999999994 678999999999987654
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
..... .......++..|++||++.+..++.++|||||||++||+++ |..||.+.... +.+..+.... ..
T Consensus 159 ~~~~~----~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~---~~~~~~~~~~-~~-- 228 (267)
T cd05066 159 DPEAA----YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ---DVIKAIEEGY-RL-- 228 (267)
T ss_pred cccee----eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH---HHHHHHhCCC-cC--
Confidence 32211 01112234678999999999899999999999999999886 99999875432 2233332221 11
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
.....+|+.+.+++.+||+.+|++||++.++.+.|.++
T Consensus 229 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 -PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 12246789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=309.98 Aligned_cols=249 Identities=22% Similarity=0.303 Sum_probs=199.1
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 85 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (474)
.+|++.+.||+|+||.||+|.+. ++..+|||++.... ....+..|+.+++.++|.+ +..+..++......+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPN-LVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCC-EEEEEEEEcCCCceEEEEecC
Confidence 46899999999999999999875 56789999876543 3346888999999998654 555555666777889999998
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccc
Q 011945 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164 (474)
Q Consensus 86 -g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (474)
+++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||+++...+....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~kl~dfg~~~~~~~~~~~-- 156 (256)
T cd05059 82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG---EDNVVKVSDFGLARYVLDDQYT-- 156 (256)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEEC---CCCcEEECCcccceeccccccc--
Confidence 8899999975556799999999999999999999999999999999999994 6788999999999765432211
Q ss_pred cccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcC
Q 011945 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (474)
Q Consensus 165 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (474)
......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+.+..+.... . ......
T Consensus 157 ----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~-~---~~~~~~ 225 (256)
T cd05059 157 ----SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SEVVESVSAGY-R---LYRPKL 225 (256)
T ss_pred ----ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HHHHHHHHcCC-c---CCCCCC
Confidence 1112234568999999999899999999999999999999 8999976543 22233332221 1 112345
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011945 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLF 273 (474)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (474)
+|.++.+++.+||..+|++||++.++++.|
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 226 APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 789999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=300.11 Aligned_cols=250 Identities=22% Similarity=0.305 Sum_probs=209.3
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
.++|++++.||.|-||.||+|+.+.++-.||+|++... ....++.+|++|...|+|+|++ .++.++.+....||
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnil-rlY~~fhd~~riyL 99 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNIL-RLYGYFHDSKRIYL 99 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHH-hhhhheeccceeEE
Confidence 46899999999999999999999999999999986543 2345789999999999965554 55556667778899
Q ss_pred EEecC-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 81 VIDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 81 v~e~~-g~sL~~li~~-~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
++||. +|.|...+.. ...+|++.....++.|++.||.|+|.++||||||||+|+|++ ..+.+||+|||.+.....
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg---~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG---SAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC---CCCCeeccCCCceeecCC
Confidence 99998 7788777763 345699999999999999999999999999999999999995 788999999999875432
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
. ...++|||..|.+||+..+..++..+|+|++|++.|||+.|..||.... ..+.|.+|.......
T Consensus 177 ~---------kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k~~~~~--- 241 (281)
T KOG0580|consen 177 N---------KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRKVDLKF--- 241 (281)
T ss_pred C---------CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHHccccC---
Confidence 1 2357899999999999999999999999999999999999999998754 556677766655433
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
+..++.+..++|.+|+.++|.+|....++ +++.++.
T Consensus 242 --p~~is~~a~dlI~~ll~~~p~~r~~l~~v---~~hpwI~ 277 (281)
T KOG0580|consen 242 --PSTISGGAADLISRLLVKNPIERLALTEV---MDHPWIV 277 (281)
T ss_pred --CcccChhHHHHHHHHhccCccccccHHHH---hhhHHHH
Confidence 36788999999999999999999995554 5555543
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=304.90 Aligned_cols=246 Identities=24% Similarity=0.309 Sum_probs=200.7
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
+|.+.+.||+|+||.||+|.+..+++.|++|.+.... ....+..|+++++.++|++++..+ .++......+++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~-~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYY-ESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehhe-eeeccCCEEEEEEE
Confidence 5889999999999999999999999999999876432 234578899999999866555544 45566778899999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 84 ~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
|+ +++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++ .++.++|+|||+++.+.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~---~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD---AYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe---CCCCEEEcccccceeccCccc
Confidence 88 88999999754 45799999999999999999999999999999999999995 678999999999987654322
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
. .....|+..|+|||++.+..++.++|||||||++|+|++|+.||.... .......+...... .+.
T Consensus 157 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~----~~~ 222 (256)
T cd08529 157 F-------ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALILKIIRGVFP----PVS 222 (256)
T ss_pred h-------hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCC----CCc
Confidence 1 133578899999999999899999999999999999999999997644 23333333332221 122
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
..++.++.+++.+||+.+|++||++.++++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 367899999999999999999999888754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=310.76 Aligned_cols=253 Identities=22% Similarity=0.364 Sum_probs=200.7
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
+..++|++.++||+|+||.||+|.+. .+..||+|.+..... ...+.+|+.+++.++|.+++..+..+ . ....+++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~-~-~~~~~lv~ 79 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV-S-EEPIYIVT 79 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEE-C-CCCcEEEE
Confidence 34578999999999999999999864 566799998765433 35688999999999977666655443 2 34568999
Q ss_pred ecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 83 e~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
||+ +++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++ +++.++|+|||++..+....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~---~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG---DGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe---CCceEEeCCceeeeeccCcc
Confidence 998 78999998743 34589999999999999999999999999999999999995 67899999999998664432
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
.. ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.... .....+.... .. .
T Consensus 157 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~~~-~~---~ 223 (260)
T cd05070 157 YT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQVERGY-RM---P 223 (260)
T ss_pred cc------cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHcCC-CC---C
Confidence 11 1122345678999999998889999999999999999999 99999775432 2233332211 11 1
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 275 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (474)
....++..+.+++.+||..+|++||++.++.+.|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 224 CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 234678999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=317.07 Aligned_cols=260 Identities=19% Similarity=0.311 Sum_probs=205.2
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcC-------CCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeC
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEG 75 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~-------~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (474)
.++|.+.++||+|+||.||+|.+.. ....||+|++...... ..+..|+.+++.+..|++|..+..++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 4689999999999999999998632 3457999987654332 34778999999997566777776666777
Q ss_pred CEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeC
Q 011945 76 DYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139 (474)
Q Consensus 76 ~~~~lv~e~~-g~sL~~li~~~~---------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~ 139 (474)
...+++|||+ +++|.+++.... ..+++.+++.++.||+.||.|||++||+||||||+|||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~-- 168 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT-- 168 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc--
Confidence 7889999998 789999996432 3488999999999999999999999999999999999994
Q ss_pred CCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 011945 140 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (474)
Q Consensus 140 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~ 218 (474)
.++.+||+|||+++......... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 169 -~~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 169 -EDNVMKIADFGLARGVHDIDYYK-----KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred -CCCcEEEcccccccccccccccc-----ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 67889999999998665322211 0112234568999999999889999999999999999999 8999976433
Q ss_pred CcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
...+..+..... ......++.++.+++.+||..+|++||++.++.+.|.++....
T Consensus 243 ---~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 243 ---EELFKLLREGHR----MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred ---HHHHHHHHcCCC----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 223333322211 1123567889999999999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=312.12 Aligned_cols=252 Identities=20% Similarity=0.251 Sum_probs=196.2
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCE-----
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY----- 77 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~----- 77 (474)
++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.+++++..+..+......
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 57999999999999999999999999999999865432 234678899999999877777766655554443
Q ss_pred EEEEEecCCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCc
Q 011945 78 NVLVIDLLGPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (474)
Q Consensus 78 ~~lv~e~~g~sL~~li~~~----~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (474)
.+++|||+.++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||+++ ..++.+||+|||++
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~--~~~~~~kl~dfg~~ 158 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLG 158 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe--cCCCeEEEeecccc
Confidence 7999999988999988643 23589999999999999999999999999999999999995 33789999999999
Q ss_pred cccccCCCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc
Q 011945 154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (474)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (474)
..+..... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... ..+.++....
T Consensus 159 ~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~---~~~~~~~~~~ 228 (295)
T cd07837 159 RAFSIPVK-------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL---QQLLHIFKLL 228 (295)
T ss_pred eecCCCcc-------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHHh
Confidence 86543211 1122356889999998875 45799999999999999999999999864332 2122111100
Q ss_pred -----------------------ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 233 -----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 233 -----------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
...........++.++.++|..||..||.+||++.+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil 289 (295)
T cd07837 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAAL 289 (295)
T ss_pred CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHh
Confidence 00111222346789999999999999999999987764
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=310.27 Aligned_cols=255 Identities=25% Similarity=0.334 Sum_probs=203.2
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++|++.+.||.|+||.||+|.+..+++.||||.+.... ....+..|+.+++.+.|.+++..+ .++..+...+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~-~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY-ASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhh-heeEeCCeEEEE
Confidence 57999999999999999999998999999999765422 123578899999999865555444 455667788999
Q ss_pred EecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 82 IDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~---~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++ .++.++|+|||++..+.
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCCEEECcchhhhccc
Confidence 9998 78999988642 34589999999999999999999999999999999999994 67889999999987664
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
..... .....|+..|+|||++.+..++.++|||||||++|+|++|..||.+... ........+.......
T Consensus 158 ~~~~~-------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~-- 227 (267)
T cd08229 158 SKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCDYPP-- 227 (267)
T ss_pred cCCcc-------cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-hHHHHhhhhhcCCCCC--
Confidence 43221 1234789999999999998899999999999999999999999976432 1222222222211111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
.....+++++.+++.+||..+|++|||+.+|.+.+.++
T Consensus 228 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 228 -LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred -CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 01234788999999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=312.44 Aligned_cols=251 Identities=22% Similarity=0.349 Sum_probs=203.8
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
..+|++.++||.|+||.||+|.+.. ++.|++|++..... ...+..|+.+++.++|.+++ .+..+.......+++||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI-SLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchh-heeeeEecCCCeEEEEe
Confidence 4579999999999999999999876 88999998866543 45688999999999865544 45555567778899999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 84 ~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
|+ +++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+||+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~---~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG---EDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc---CCceEEEccccchhhcCCccc
Confidence 99 77999999743 34689999999999999999999999999999999999994 678999999999987644321
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
. .....++..|++||++.+..++.++|||||||++|+|++ |+.||..... .+.+..+..... ...
T Consensus 160 ~-------~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~ 225 (261)
T cd05148 160 L-------SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN---HEVYDQITAGYR----MPC 225 (261)
T ss_pred c-------ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHHhCCc----CCC
Confidence 1 123356788999999998889999999999999999998 8999976542 333333332211 112
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 275 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (474)
...+++.+.+++..||..||++||++.+|.+.|+.
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 35678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=307.63 Aligned_cols=250 Identities=24% Similarity=0.344 Sum_probs=198.9
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-------chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-------~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
++|++.+.||+|+||.||+|.+..+++.||||.+..... ...+.+|+.+++.+.|+++ ..+..+.......+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i-~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI-VQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCe-eeeEEEEccCCeEE
Confidence 579999999999999999999999999999998754321 2357889999999986554 45555556677899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
+++|++ +++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+||+++ .++.++|+|||+++....
T Consensus 81 ~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~---~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 81 IFMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeecccceeccc
Confidence 999998 8899999874 35689999999999999999999999999999999999994 678899999999976543
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
..... .......|+..|+|||++.+..++.++|||||||++|||++|+.||..... ...+..+..... ..
T Consensus 157 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~---~~ 226 (263)
T cd06625 157 ICSSG----TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA---MAAIFKIATQPT---NP 226 (263)
T ss_pred ccccc----ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch---HHHHHHHhccCC---CC
Confidence 21110 001234688999999999999999999999999999999999999976432 222222222111 12
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.+...++.++.+++..||..+|++||++.++++
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 227 QLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 234567899999999999999999999888754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=346.03 Aligned_cols=263 Identities=25% Similarity=0.352 Sum_probs=203.0
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++|++.++||+|+||.||+|.+..+++.||||++..... ...+.+|+++++.++|++++. +..++..++..+++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVk-l~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVP-VYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCe-EEEEEeeCCEEEEE
Confidence 689999999999999999999999999999998764322 245888999999999655554 45556677889999
Q ss_pred EecC-CCCHHHHHHHc----------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEec
Q 011945 82 IDLL-GPSLEDLFNFC----------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~----------~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DF 150 (474)
|||+ |++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++ ..+.+||+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd---~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLG---LFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEc---CCCCEEEEec
Confidence 9999 88999998632 12356778899999999999999999999999999999994 7788999999
Q ss_pred CCccccccCCCcc-----------ccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcC
Q 011945 151 GLAKRYRDTATHQ-----------HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (474)
Q Consensus 151 Gla~~~~~~~~~~-----------~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~ 219 (474)
|+++......... ..........+||+.|||||++.+..++.++|||||||++|||++|..||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9998762211100 00011123457999999999999999999999999999999999999999764321
Q ss_pred cHHHHHHHHhhccccchHH-HHhcCCcHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHHHHH
Q 011945 220 TKKQKYEKISEKKVSTSIE-ALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRLFRDLFIR 279 (474)
Q Consensus 220 ~~~~~~~~i~~~~~~~~~~-~l~~~~p~~l~~li~~cl~~dp~~RP-t~~~l~~~L~~l~~~ 279 (474)
... ... ....+.. .....+|+.+.+++.+||..||++|| +++++.+.|+..+..
T Consensus 238 ki~--~~~----~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 238 KIS--YRD----VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hhh--hhh----hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 111 111 1111111 11246889999999999999999996 567777778777653
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=309.34 Aligned_cols=258 Identities=15% Similarity=0.247 Sum_probs=202.0
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCe---EEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
.+.|++.+.||.|+||.||+|.+..+++ .||||++..... ...+..|+.+++.+.|++++ .+..+...+...+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~-~~~~~~~~~~~~~ 81 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII-HLEGVVTKSRPVM 81 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcc-eEEEEECCCCceE
Confidence 3579999999999999999999877664 699998765422 24688899999999866555 4555556777789
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
++|||+ +++|.+++......+++.+++.++.|++.||.|||++||+|+||||+||++ +.++.+||+|||++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCcccccccc
Confidence 999998 779999998666679999999999999999999999999999999999999 4678999999999876544
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
..... .+........+..|+|||++.+..++.++|||||||++|||++ |..||...... .....+... ...
T Consensus 159 ~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~~-~~~-- 230 (269)
T cd05065 159 DTSDP--TYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQD-YRL-- 230 (269)
T ss_pred Ccccc--ccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcC-CcC--
Confidence 32211 0111111123468999999999899999999999999999886 99999765432 222333221 111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
.....+|..+.+++..||..+|++||++.+|...|+.+
T Consensus 231 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 231 -PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11246789999999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=312.65 Aligned_cols=244 Identities=20% Similarity=0.302 Sum_probs=191.6
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
++|+++++||+|+||.||+|.+..+++.||||++..... ...+..|+++++.+.|++++..+ .++......+++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~-~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY-GAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEE-EEEEECCEEEEEEe
Confidence 468999999999999999999999999999998765422 23578899999999865555544 45556778899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
|+ +++|..+ ..+++..+..++.||+.||.|||+.||+|+||||+|||++ .++.++|+|||++..+....
T Consensus 80 ~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~---~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 80 FMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN---TRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred cCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEEC---CCCCEEEeeCCcceeccccc--
Confidence 99 6666443 2578999999999999999999999999999999999994 77899999999998664332
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcH----HHHHHHHhhccccchHH
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK----KQKYEKISEKKVSTSIE 238 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~----~~~~~~i~~~~~~~~~~ 238 (474)
.....||..|+|||++.+..++.++|||||||++|+|++|+.||........ ......+.......
T Consensus 150 -------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--- 219 (279)
T cd06619 150 -------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV--- 219 (279)
T ss_pred -------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC---
Confidence 1345799999999999999999999999999999999999999975432211 11111111111100
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.....+++++.+++.+||..+|++||+++++++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 012346789999999999999999999887753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=311.84 Aligned_cols=249 Identities=18% Similarity=0.335 Sum_probs=194.8
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
++|++.+.||+|+||.||+|.+..+|+.||||.++.... ...+..|+.++.+..+++++..+..+...+...+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 479999999999999999999999999999998765432 23466677765555566666666666677778999999
Q ss_pred cCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 84 LLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 84 ~~g~sL~~li~~~---~~~l~~~~~~~i~~qi~~gL~yLHs~-gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
|+.++|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecccccccccc
Confidence 9999999888642 34689999999999999999999997 99999999999999 47789999999999866432
Q ss_pred CCccccccccCCCCccCccccccccccC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccc
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLG----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~----~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
.. .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||..... ..+.+..+......
T Consensus 158 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~- 226 (283)
T cd06617 158 VA--------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQLKQVVEEPSP- 226 (283)
T ss_pred cc--------cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHHHHHHHhcCCC-
Confidence 21 122468899999999865 4468999999999999999999999975332 12222222211111
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.. ....+|.++.++|..||..+|++||++.+|++
T Consensus 227 ~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 227 QL--PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CC--CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 11347899999999999999999999887754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=308.32 Aligned_cols=257 Identities=16% Similarity=0.235 Sum_probs=203.2
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCe---EEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
..++|+..+.||+|+||.||+|.+..++. .||||.+..... ...+..|+++++.+.|++ +..+..+.......
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~ 81 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN-IIRLEGVVTKFKPA 81 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCC-eeEEEEEEccCCCc
Confidence 34689999999999999999999876554 799998765432 345788999999998665 55555566677788
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
+++|||+ +++|.+++......+++..++.++.|++.||+|||+.||+|+||||+||+++ .++.+||+|||++....
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~---~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN---SNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEc---CCCcEEECCCccceecc
Confidence 9999998 7799999976667799999999999999999999999999999999999994 67889999999998665
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccch
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (474)
....... .......+..|+|||++.+..++.++|||||||++|||++ |..||..... ......+......
T Consensus 159 ~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~i~~~~~~-- 229 (268)
T cd05063 159 DDPEGTY----TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKAINDGFRL-- 229 (268)
T ss_pred cccccce----eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHHhcCCCC--
Confidence 4322110 0111233567999999998889999999999999999997 9999976433 2233333221111
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
.....++.++.+++.+||..+|++||++.+|.+.|+++
T Consensus 230 --~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 --PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11235789999999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=324.42 Aligned_cols=258 Identities=22% Similarity=0.326 Sum_probs=197.9
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeEeCC-EEEEEEe
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD-YNVLVID 83 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~-~~~lv~e 83 (474)
++|.-..+||+|+||.||+|.. .++..||||.+..... ..+|..|+.++.+++ |+++..+.+|+.+.. ..+||+|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~-H~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLR-HPNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred hCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCC-CcCcccEEEEEecCCceEEEEEE
Confidence 5677778999999999999995 5558999998776554 467999999999999 555555666666666 5999999
Q ss_pred cC-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 84 LL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~-~l~~~~~~~i~~qi~~gL~yLHs~---gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
|+ .|+|++.+..... .++|...+.|+.++|.||+|||.. .|||||||++|||+ |.+..+||+|||+|+....
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCCCEEccCccCcccCCc
Confidence 99 7899999985555 899999999999999999999984 39999999999999 5899999999999965543
Q ss_pred -CCCccccccccCCCC-ccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCc---HHHHH-HHHhhcc
Q 011945 159 -TATHQHIPYRENKNL-TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT---KKQKY-EKISEKK 232 (474)
Q Consensus 159 -~~~~~~~~~~~~~~~-~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~---~~~~~-~~i~~~~ 232 (474)
.... ... .||..|+|||++..+..+.|+|||||||+|+||++|+.+........ ..... ..+....
T Consensus 230 ~~~~~--------~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~ 301 (361)
T KOG1187|consen 230 GDTSV--------STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGK 301 (361)
T ss_pred cccce--------eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcc
Confidence 2111 112 79999999999999899999999999999999999998887543111 11111 1111111
Q ss_pred ccchHH-HHh-cCCc-----HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 233 VSTSIE-ALC-RGYP-----TEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 233 ~~~~~~-~l~-~~~p-----~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
....+. .+. ..++ ..+..+...|+..+|.+||++.++.+.|+.+.
T Consensus 302 ~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 302 LREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred hhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 111111 111 2233 23667788999999999999999988886553
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=334.30 Aligned_cols=241 Identities=22% Similarity=0.321 Sum_probs=203.0
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
|.-++.||.|+||.||-|++..+.+.||||.+.... .+.++..|+.+|+.|.|++.| .+.+|...+...|||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPnti-eYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTI-EYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcc-cccceeeccchHHHHHH
Confidence 566788999999999999999999999999876543 345689999999999966554 55666667777899999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 84 ~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
||-|+-.|++.-..+++-+.++..|..+.+.||.|||+.+.||||||..|||++ +.+.|||+|||.|.....
T Consensus 107 YClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs---e~g~VKLaDFGSAsi~~P----- 178 (948)
T KOG0577|consen 107 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS---EPGLVKLADFGSASIMAP----- 178 (948)
T ss_pred HHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec---CCCeeeeccccchhhcCc-----
Confidence 999999999998888999999999999999999999999999999999999995 889999999999976543
Q ss_pred ccccccCCCCccCccccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 164 HIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~---~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
.+.|+||+.|||||+++. +.|+-|+||||||+++.||...++|+.++++... +..|.....++.-
T Consensus 179 ------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA---LYHIAQNesPtLq--- 246 (948)
T KOG0577|consen 179 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHIAQNESPTLQ--- 246 (948)
T ss_pred ------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH---HHHHHhcCCCCCC---
Confidence 356899999999999874 5699999999999999999999999988765432 2233332222111
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
...++..|..|+..||.+-|.+||+.++++
T Consensus 247 s~eWS~~F~~Fvd~CLqKipqeRptse~ll 276 (948)
T KOG0577|consen 247 SNEWSDYFRNFVDSCLQKIPQERPTSEELL 276 (948)
T ss_pred CchhHHHHHHHHHHHHhhCcccCCcHHHHh
Confidence 245789999999999999999999988763
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=307.62 Aligned_cols=253 Identities=19% Similarity=0.274 Sum_probs=195.6
Q ss_pred eeeeecCceEEEEEEEcC---CCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-
Q 011945 13 RKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 85 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (474)
+.||+|+||.||+|.+.. .+..||||.+..... ...+..|+.+++.++|++++..+..+...+...+++|+|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998754 345799998754322 2457789999999987777776665555566678999988
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccc
Q 011945 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 165 (474)
Q Consensus 86 g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (474)
+++|.+++......+++..++.++.||+.||.|||+.+|+||||||+|||++ ..+.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~---~~~~~kl~dfg~~~~~~~~~~~~-- 155 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD---ESFTVKVADFGLARDIYDKEYYS-- 155 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc---CCCcEEECCccccccccCCccee--
Confidence 7899999976556678888999999999999999999999999999999994 67889999999998654322111
Q ss_pred ccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCC
Q 011945 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (474)
Q Consensus 166 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (474)
........++..|+|||.+.+..++.++|||||||++|||++ |..||..... ......+...... .....+
T Consensus 156 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~ 227 (262)
T cd05058 156 -VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYLLQGRRL----LQPEYC 227 (262)
T ss_pred -ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHhcCCCC----CCCCcC
Confidence 111123456788999999998899999999999999999999 4666765432 2222222221111 112456
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 245 PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 245 p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
|+.+.+++..||..+|++||++.+|++.|++++.
T Consensus 228 ~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 228 PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 8899999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=311.31 Aligned_cols=251 Identities=20% Similarity=0.286 Sum_probs=196.6
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
.++|++.++||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++|++++..+ .+.......+++||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~-~~~~~~~~~~lv~e 86 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYF-GSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEE-EEEEeCCEEEEEEe
Confidence 3589999999999999999999999999999998765432 23577899999999866555554 45566788899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
|+ +++|.+++.. .+.+++.+++.++.||+.||.|||++||+|+||||+||+++ ..+.+||+|||++........
T Consensus 87 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06645 87 FCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIA- 161 (267)
T ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEECcceeeeEccCccc-
Confidence 99 6799999874 45799999999999999999999999999999999999994 778899999999876543211
Q ss_pred cccccccCCCCccCcccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 163 QHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
......|+..|+|||++. +..++.++|||||||++|+|++|..||........ +..............
T Consensus 162 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~ 232 (267)
T cd06645 162 ------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA---LFLMTKSNFQPPKLK 232 (267)
T ss_pred ------ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh---HHhhhccCCCCCccc
Confidence 123457899999999975 45588999999999999999999999976433211 111111111111111
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
....++..+.+++.+||..+|++||++++|++
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 11246789999999999999999999887753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=310.92 Aligned_cols=248 Identities=23% Similarity=0.410 Sum_probs=193.3
Q ss_pred EEeeeeeecCceEEEEEEEc----CCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 10 RLGRKIGSGSFGEIYLGTNI----QTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 10 ~i~~~LG~G~fG~Vy~a~~~----~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.+.+.||.|.||.||+|.+. ..+..|+||+++.... ...+..|+++++.++| ++|..+.++.......++|+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRH-PNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSB-TTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccc-cccccccccccccccccccc
Confidence 57899999999999999987 3467899999965433 3568999999999964 55555555666666689999
Q ss_pred ecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 83 e~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
||+ +++|.+++... ...+++..++.|+.||+.||.|||+++|+|+||+++|||++ .++.+||+|||++.......
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~---~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD---SNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE---TTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccc
Confidence 999 68999999866 56799999999999999999999999999999999999995 68899999999998763322
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
.. .......+...|+|||.+.+..++.++||||||+++|||++ |+.||.+... .+....+..... ..
T Consensus 158 ~~-----~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~~~~~~~~~----~~ 225 (259)
T PF07714_consen 158 KY-----KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEIIEKLKQGQR----LP 225 (259)
T ss_dssp SE-----EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHHHHHHTTEE----TT
T ss_pred cc-----cccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccc----ce
Confidence 11 11233457789999999999889999999999999999999 7899987633 333444433222 12
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 273 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (474)
....+|..+.++|..||..+|++||++.+|.+.|
T Consensus 226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 3456899999999999999999999999998765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=308.45 Aligned_cols=246 Identities=20% Similarity=0.287 Sum_probs=199.1
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 85 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (474)
.++|++.+.||+|+||.||++. .+++.||+|+.........+.+|+.+++.++|++++..+..+. . +..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-~-~~~~~v~e~~ 80 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL-H-NGLYIVMELM 80 (254)
T ss_pred HHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEc-C-CCcEEEEECC
Confidence 4679999999999999999997 5788999999876655667899999999999777776665543 3 3368999998
Q ss_pred -CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 86 -GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 86 -g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
+++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+|||++ .++.+||+|||++.......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~---~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc---CCCcEEECCCccceeccccC---
Confidence 789999997543 3589999999999999999999999999999999999994 67899999999997643321
Q ss_pred ccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhc
Q 011945 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (474)
.....+..|+|||.+.+..++.++|||||||++|||++ |..||...... .....+... .. .....
T Consensus 155 -------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~-~~---~~~~~ 220 (254)
T cd05083 155 -------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK---EVKECVEKG-YR---MEPPE 220 (254)
T ss_pred -------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH---HHHHHHhCC-CC---CCCCC
Confidence 12244578999999998899999999999999999997 99999775432 222222221 11 11235
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011945 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 275 (474)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (474)
.+|.++.+++..||+.+|++||++++|.+.|++
T Consensus 221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 678999999999999999999999999888753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=310.91 Aligned_cols=254 Identities=21% Similarity=0.319 Sum_probs=201.1
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCC-----CeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCC
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 76 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (474)
..++|.+.+.||+|+||.||+|.+... +..||+|....... ...+.+|+.+++.+.|+ ++..+..+.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~-~i~~~~~~~~~~~ 82 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCH-HVVRLLGVVSTGQ 82 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCC-ceeEEEEEEcCCC
Confidence 356899999999999999999998644 37899998764432 23577899999999865 4555666666778
Q ss_pred EEEEEEecC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEE
Q 011945 77 YNVLVIDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 146 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~~---------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vk 146 (474)
..+++|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~---~~~~~k 159 (277)
T cd05032 83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVK 159 (277)
T ss_pred CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEc---CCCCEE
Confidence 889999998 789999986422 2368889999999999999999999999999999999994 778999
Q ss_pred EEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHH
Q 011945 147 IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKY 225 (474)
Q Consensus 147 L~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~ 225 (474)
|+|||+++....... +.......++..|+|||.+.+..++.++|||||||++|||++ |..||.+... .+..
T Consensus 160 l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~ 231 (277)
T cd05032 160 IGDFGMTRDIYETDY-----YRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVL 231 (277)
T ss_pred ECCcccchhhccCcc-----cccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHH
Confidence 999999986544322 111233467889999999998889999999999999999998 9999976433 2333
Q ss_pred HHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011945 226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 274 (474)
Q Consensus 226 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (474)
..+..... ..+...++.++.+++..||..+|++||++.+|.+.|+
T Consensus 232 ~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 232 KFVIDGGH----LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHhcCCC----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 33322211 1233557899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=301.43 Aligned_cols=265 Identities=18% Similarity=0.210 Sum_probs=202.0
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--CchHHHHHHHHHHHhcCCCCCceeEEE----eEeCCEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWF----GVEGDYNV 79 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~l~~E~~il~~l~~~~~i~~l~~~----~~~~~~~~ 79 (474)
+++|+|.++||+|||+.||++++..+++.||+|.+.... ..+...+|++..+++++++.+..+... .......|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 568999999999999999999999999999999776544 345588999999999987766655322 22445578
Q ss_pred EEEecC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEeeeCCCCCeEEEEecCCc
Q 011945 80 LVIDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~---~~l~~~~~~~i~~qi~~gL~yLHs~g--IiHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (474)
|++.|. .|+|.+.++... ..+++.+++.|+.+|+.||++||+.. +.||||||.|||++ +.+.++|.|||.+
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---DSGLPVLMDLGSA 176 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec---CCCceEEEeccCc
Confidence 888877 889999987553 35999999999999999999999998 99999999999996 5799999999998
Q ss_pred cccccCCC--ccccccccCCCCccCcccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHH
Q 011945 154 KRYRDTAT--HQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (474)
Q Consensus 154 ~~~~~~~~--~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i 228 (474)
....-... .+.....+...-..|..|.|||.+. +...+.++|||||||+||.|+.|.-||...-.... .....+
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-SlaLAv 255 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-SLALAV 255 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-eEEEee
Confidence 76543211 1111122233446799999999987 44578999999999999999999999963211000 000001
Q ss_pred hhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
....+..+. ...+++.+.++|+.||+.||.+||+..+|+..++++.
T Consensus 256 ~n~q~s~P~---~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 256 QNAQISIPN---SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred eccccccCC---CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 111111111 1237899999999999999999999999999888764
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=312.24 Aligned_cols=268 Identities=19% Similarity=0.267 Sum_probs=217.1
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
.-++|..+++||+|.||.|-+|+.+.+++.||+|+++.+.. ...-..|.++|+..+ |+.+..+.+.++..+..|
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt~drlC 244 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQTQDRLC 244 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhccCceEE
Confidence 34689999999999999999999999999999998765432 223567888888887 556666777778888999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
+||||. ||.|.-.+.. .+.|++.....+..+|+.||.|||+++||+||||.+|+|+ +++|++||+|||+++.-..
T Consensus 245 FVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 245 FVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhccc
Confidence 999999 8888777763 4579999999999999999999999999999999999999 6899999999999986443
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
... ..+++|||+.|+|||++....|++.+|+|.+||+||||++|++||.+.+. ...++-|....+
T Consensus 321 ~g~-------t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh---~kLFeLIl~ed~----- 385 (516)
T KOG0690|consen 321 YGD-------TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---EKLFELILMEDL----- 385 (516)
T ss_pred ccc-------eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---hHHHHHHHhhhc-----
Confidence 332 24678999999999999999999999999999999999999999987543 233333332222
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCC--CHHHHHHHHHHHHHHcCCCCCCccccccccccccc
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKP--DYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 299 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RP--t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~ 299 (474)
.++..++++.+.|+.-+|.+||.+|. ..++.+++.++-| ...++|+..-.....
T Consensus 386 kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~F-------F~~v~W~~~~~Kki~ 441 (516)
T KOG0690|consen 386 KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRF-------FASVDWEATYRKKIE 441 (516)
T ss_pred cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhh-------hccCCHHHHHHhccC
Confidence 23467889999999999999999996 3456666666554 445789876544443
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=319.62 Aligned_cols=258 Identities=20% Similarity=0.214 Sum_probs=197.7
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeE----eCCE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGV----EGDY 77 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~----~~~~ 77 (474)
++++|++.++||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.++|.+++..+..+.. ....
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 6789999999999999999999999999999999875322 23457789999999997766665544332 2245
Q ss_pred EEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 78 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 78 ~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
.+++||+++++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||++....
T Consensus 83 ~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 83 VYIVQELMETDLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECcccceeecc
Confidence 79999999999998886 4579999999999999999999999999999999999999 477899999999998764
Q ss_pred cCCCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc-----
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----- 231 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~----- 231 (474)
....... ......||..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.........+..+...
T Consensus 158 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 158 PEHDHTG----FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233 (336)
T ss_pred ccccccC----CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 4322111 1234578999999998765 46899999999999999999999999764321111111110000
Q ss_pred ------------------cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 232 ------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 232 ------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
........+...+++++.++|.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~ 291 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA 291 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0011112233456788999999999999999999877644
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=311.86 Aligned_cols=250 Identities=20% Similarity=0.346 Sum_probs=198.0
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeE------eCCEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGV------EGDYN 78 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~------~~~~~ 78 (474)
.+.|++.+.||.|+||.||+|.+..+++.||+|++.... ....+..|+.+++.+.+|+++..+..++. .....
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 468999999999999999999999999999999876543 33568889999999976677766655543 35678
Q ss_pred EEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 79 VLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
+++|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++ .++.++|+|||++...
T Consensus 95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~---~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQL 171 (282)
T ss_pred EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEeeCcchhhh
Confidence 9999999 66999998753 34588999999999999999999999999999999999994 6788999999998765
Q ss_pred ccCCCccccccccCCCCccCcccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (474)
..... ......|+..|+|||++. +..++.++|||||||++|||++|..||..... ...+..+...
T Consensus 172 ~~~~~-------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~---~~~~~~~~~~ 241 (282)
T cd06636 172 DRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP---MRALFLIPRN 241 (282)
T ss_pred hcccc-------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH---HhhhhhHhhC
Confidence 43221 123457899999999986 34578899999999999999999999976432 1222222211
Q ss_pred cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 232 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.. .......++.++.++|.+||..||.+||++.+|++
T Consensus 242 ~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 242 PP---PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred CC---CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 11 11123467899999999999999999999888753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=307.78 Aligned_cols=251 Identities=20% Similarity=0.220 Sum_probs=195.2
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeC--CEEEEEEe
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEG--DYNVLVID 83 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~--~~~~lv~e 83 (474)
|++.++||+|+||.||+|.+..+++.||||++..... ......|+.++..+.+|+++..+..++.+. ...+++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 7889999999999999999999999999998764321 223457888899887566666666555555 78899999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 84 ~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
|+.++|.+.+......+++..++.++.||+.||.|||++||+||||||+||+++ . +.+||+|||++........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~---~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK---D-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc---C-CCeEEEecccccccccCCC--
Confidence 998899998876556799999999999999999999999999999999999995 4 9999999999986643322
Q ss_pred ccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc----------
Q 011945 164 HIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK---------- 232 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~---------- 232 (474)
.....++..|+|||++.+ ..++.++|||||||++|||++|..||.+....+....+..+....
T Consensus 155 ------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 155 ------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred ------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence 123467899999997654 457899999999999999999999997744322111111111000
Q ss_pred -----------ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 233 -----------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 233 -----------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
....+..+...++.++.++|.+||..+|++||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 001122333467899999999999999999999887753
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=307.31 Aligned_cols=253 Identities=21% Similarity=0.264 Sum_probs=195.5
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+..|+.+++.++|.+.+ .+..+...+...+++|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~-~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLV-NLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEe-eeeeEEeeCCEEEEEE
Confidence 57999999999999999999999899999999875432 224578899999999865544 4455566778889999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 83 e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
||+.+.+.+.+......+++..++.++.||+.||.|||++||+|+||||+||+++ .++.++|+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILIT---KQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEc---CCCcEEECccccceecCCCccc
Confidence 9995554444433455799999999999999999999999999999999999994 6789999999999876543211
Q ss_pred cccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc---------
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--------- 232 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 232 (474)
.....++..|+|||++.+ ..++.++|||||||++|||++|..||.+....+....+.......
T Consensus 157 -------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 157 -------YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS 229 (286)
T ss_pred -------ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcc
Confidence 123467889999999876 457899999999999999999999998755432222211111000
Q ss_pred --------------ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 233 --------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 233 --------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
...........++..+.+|+.+||..+|++||++.+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil 281 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELL 281 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHh
Confidence 00112223356789999999999999999999988775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=306.01 Aligned_cols=245 Identities=27% Similarity=0.389 Sum_probs=200.1
Q ss_pred eeeeecCceEEEEEEEcCC---CeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-
Q 011945 13 RKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 85 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~---~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (474)
++||+|+||.||+|.+... +..|+||++..... ...+..|++++..+.| +++..+..+.......+++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGH-PNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCC-CChheeeeeecCCCceEEEEEecc
Confidence 4799999999999998765 88999999876544 3568899999999994 45555555555688889999999
Q ss_pred CCCHHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 86 GPSLEDLFNFC--------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 86 g~sL~~li~~~--------~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
+++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++ .++.+||+|||++....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~---~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEEC---CCCcEEEcccccccccc
Confidence 99999999865 46799999999999999999999999999999999999994 67899999999998765
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccch
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (474)
.... +.......++..|+|||.+.+..++.++|||||||++|||++ |..||..... .+....+....
T Consensus 157 ~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~---- 224 (262)
T cd00192 157 DDDY-----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYLRKGY---- 224 (262)
T ss_pred cccc-----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCC----
Confidence 5332 112234567899999999998889999999999999999999 6999987633 23333333211
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011945 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 273 (474)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (474)
.......+|.++.+++..||..+|++||++.++++.|
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 225 RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1122356789999999999999999999999998776
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=306.39 Aligned_cols=247 Identities=21% Similarity=0.330 Sum_probs=200.3
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
.++|++.+.||.|+||.||+|.+ .++.||||.+..... ...+..|+.+++.++|.+++..+. +.......+++||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~-~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLG-VVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEE-EEcCCCCeEEEEEe
Confidence 56899999999999999999985 488999999876544 457889999999998766555444 44457788999999
Q ss_pred C-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 85 L-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 85 ~-g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
+ +++|.+++.... ..+++..++.++.|++.||.|||++||+|+||||+||+++ .++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~---~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS---EDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEe---CCCCEEEcccccccccccccc-
Confidence 9 689999997543 2689999999999999999999999999999999999994 778999999999987633221
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
...++..|+|||++.+..++.++|||||||++|||++ |..||..... ......+..... ....
T Consensus 158 ---------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~ 221 (256)
T cd05039 158 ---------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPHVEKGYR----MEAP 221 (256)
T ss_pred ---------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHhcCCC----CCCc
Confidence 2245678999999998889999999999999999997 9999976532 222222222111 1223
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 275 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (474)
..+|+++.+++.+||..+|++||++.+|++.|+.
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 5678999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=312.37 Aligned_cols=250 Identities=18% Similarity=0.280 Sum_probs=196.9
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
..+.|+++++||.|+||.||+|.+..+++.|++|++..... ...+..|+.+++.++|.+++. +..++..+...+++|
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~ 88 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVK-LLGAFYWDGKLWIMI 88 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEee-eEEEEEeCCeEEEEE
Confidence 45679999999999999999999999999999999865432 245788999999999665544 444455667889999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
||+ +++|..++......+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++........
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT---LDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEc---CCCCEEEccCccceecccccc
Confidence 999 7788888765566799999999999999999999999999999999999994 678999999999875433211
Q ss_pred ccccccccCCCCccCcccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccch
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (474)
......++..|+|||++. ...++.++|||||||++|||++|..||..... ...+.++..... .
T Consensus 166 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~--~ 233 (292)
T cd06644 166 -------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEP--P 233 (292)
T ss_pred -------ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH---HHHHHHHhcCCC--c
Confidence 113456889999999985 34478899999999999999999999976432 222222222111 1
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.......++.++.++|.+||..+|++||++++++
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 267 (292)
T cd06644 234 TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLL 267 (292)
T ss_pred cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 1112345778999999999999999999987774
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=309.44 Aligned_cols=253 Identities=19% Similarity=0.309 Sum_probs=196.3
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEe-----EeCCE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFG-----VEGDY 77 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~-----~~~~~ 77 (474)
...++|++.+.||+|+||.||+|.+..+++.||+|+..... ....+..|+.+++.+..|+++..+..++ ..+..
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 35679999999999999999999999999999999876432 2356888999999996455555554433 24567
Q ss_pred EEEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCc
Q 011945 78 NVLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~---~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (474)
.+++|||+ +++|.+++.. ....+++..++.++.|++.||.|||+++|+||||||+||+++ ..+.+||+|||++
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~~kl~dfg~~ 171 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT---TEGGVKLVDFGVS 171 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC---CCCCEEEccCCce
Confidence 89999998 8899998753 235689999999999999999999999999999999999994 6778999999999
Q ss_pred cccccCCCccccccccCCCCccCccccccccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHH
Q 011945 154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (474)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i 228 (474)
+....... ......|+..|+|||++.. ..++.++|||||||++|||++|+.||...... ..+..+
T Consensus 172 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~---~~~~~~ 241 (286)
T cd06638 172 AQLTSTRL-------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM---RALFKI 241 (286)
T ss_pred eecccCCC-------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh---HHHhhc
Confidence 86643221 1123468999999999853 44789999999999999999999999765432 122221
Q ss_pred hhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.... .........++.++.+++.+||..||++||++.+|++
T Consensus 242 ~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 242 PRNP--PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred cccC--CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 1111 0111122346789999999999999999999888754
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=312.88 Aligned_cols=256 Identities=18% Similarity=0.174 Sum_probs=198.5
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeE-eCCEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDYNV 79 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~-~~~~~~ 79 (474)
..++|++.++||.|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++|.+++..+..+.. .....+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 35689999999999999999999999999999998764432 2246689999999998776666555433 335689
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 80 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 80 lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
+||||++++|.+++......+++..++.++.||+.||.|||++||+||||||+||+++ ..+.+||+|||++..+...
T Consensus 85 lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 85 LVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLT---DKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC---CCCCEEECccceeeecCCc
Confidence 9999999999999986667899999999999999999999999999999999999994 7789999999999876543
Q ss_pred CCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc-----
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV----- 233 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~----- 233 (474)
... .....++..|+|||++.+ ..++.++|||||||++|||++|..||.+.........+........
T Consensus 162 ~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 162 AKP-------MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred cCC-------CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhch
Confidence 211 122345788999999876 4589999999999999999999999986543222222211110000
Q ss_pred -----------------cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 234 -----------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 234 -----------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
..........+++++.++|..||..||++||++.+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il 288 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL 288 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 0001111123578899999999999999999988764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=310.82 Aligned_cols=261 Identities=21% Similarity=0.230 Sum_probs=198.6
Q ss_pred CCcEEEeeeeeecCceEEEEEE----EcCCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEe-EeCCEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFG-VEGDYN 78 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~----~~~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~-~~~~~~ 78 (474)
.++|++++.||+|+||.||+|. +..+++.||||.+..... ...+.+|+++++.++|++++..+..+. ......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 3589999999999999999997 345788999998765432 235789999999998766655554332 344568
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
+++|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTKVLP 159 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCccccccc
Confidence 8999999 899999997655679999999999999999999999999999999999999 467899999999998765
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcH------------HHHH
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK------------KQKY 225 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~------------~~~~ 225 (474)
...... .......++..|+|||++.+..++.++|||||||++|||++|..|+......-. ...+
T Consensus 160 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 160 QDKEYY----KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred CCCcce----eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 432210 001122345679999999998999999999999999999998877654221100 0000
Q ss_pred HHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 226 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
..+..... .......++.++.+|+.+||..+|++||++.+|.+.|+.+
T Consensus 236 ~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNG---RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHhcCC---cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000000 0011246789999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=305.94 Aligned_cols=247 Identities=22% Similarity=0.303 Sum_probs=195.2
Q ss_pred eeeeecCceEEEEEEEcCCC---eEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-
Q 011945 13 RKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 85 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~---~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (474)
++||+|+||.||+|.+...+ ..||+|.+..... ...+..|+.+++.+.|.+++..+. +.. ....+++|||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIG-VCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEE-EEc-CCceEEEEEeCC
Confidence 47999999999999876655 7899998765543 346888999999998766555544 333 44578999998
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccc
Q 011945 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 165 (474)
Q Consensus 86 g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (474)
+++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+||+|||+++........
T Consensus 79 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~---~~~~~kl~df~~~~~~~~~~~~--- 151 (257)
T cd05060 79 LGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV---NRHQAKISDFGMSRALGAGSDY--- 151 (257)
T ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEc---CCCcEEeccccccceeecCCcc---
Confidence 78999999743 3799999999999999999999999999999999999994 7789999999999876543321
Q ss_pred ccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCC
Q 011945 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (474)
Q Consensus 166 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (474)
+.......++..|+|||.+.+..++.++|||||||++|+|++ |..||..... .+....+..... ......+
T Consensus 152 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~~~ 223 (257)
T cd05060 152 -YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLESGER----LPRPEEC 223 (257)
T ss_pred -cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCCc----CCCCCCC
Confidence 111122334678999999999899999999999999999998 9999976543 223333322221 1223567
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 245 PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 245 p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
+..+.+++.+||..+|++||++.+|.+.|+++
T Consensus 224 ~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 224 PQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 89999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=305.90 Aligned_cols=251 Identities=24% Similarity=0.371 Sum_probs=199.8
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc-----------hHHHHHHHHHHHhcCCCCCceeEEEeEeCC
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----------PQLQYEAKLYKILQGGTGIPNLRWFGVEGD 76 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----------~~l~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (474)
+|.+...||.|+||.||+|.+..+++.||+|.+...... +.+..|+.+++.++|++ +..+..++....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN-IVQYLGSSLDAD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCC-eeeEEEEEEeCC
Confidence 588999999999999999999889999999977543211 34778999999998655 445555667778
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
+.+++|||+ +++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||++ +.++.++|+|||+++.
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGISKK 155 (267)
T ss_pred ccEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCCCcc
Confidence 889999998 7899999974 3578999999999999999999999999999999999999 4778999999999987
Q ss_pred cccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccc
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
......... .........|+..|+|||.+.+..++.++|||||||++|+|++|..||.+... ...+..+...
T Consensus 156 ~~~~~~~~~-~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~---- 227 (267)
T cd06628 156 LEANSLSTK-TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ---LQAIFKIGEN---- 227 (267)
T ss_pred cccccccCC-ccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH---HHHHHHHhcc----
Confidence 753221110 01112345689999999999998899999999999999999999999986432 2222222221
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
..+.+...++.++.++|.+||+.||++||++.+|++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 112234567899999999999999999999888754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=314.12 Aligned_cols=259 Identities=20% Similarity=0.247 Sum_probs=199.4
Q ss_pred CcEEEeeeeeecCceEEEEEEE----cCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEe-CCEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTN----IQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVE-GDYN 78 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~----~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~-~~~~ 78 (474)
.-|+++++||+|+||.||+|.. ..++..||+|.+..... ...+.+|+.+++.+.|++++..+..+... ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3479999999999999999984 45688999998764322 24588999999999876666655544443 4678
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
+++|||+ |++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.++|+|||++..+.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~---~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc---CCCCEEECCCccccccc
Confidence 9999999 8999999975555689999999999999999999999999999999999995 67889999999998765
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-----------C-cHHHHH
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA-----------G-TKKQKY 225 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~-----------~-~~~~~~ 225 (474)
...... .......++..|+|||++.+..++.++|||||||++|||+++..|+..... . ......
T Consensus 161 ~~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 161 TDKEYY----TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cCccce----eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 432211 112345678889999999988899999999999999999998776532110 0 000011
Q ss_pred HHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 226 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
..+.... .......++.++.+|+.+||+.+|++||++.++++.|+.+
T Consensus 237 ~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGK----RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCc----cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111111 0112346789999999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=303.87 Aligned_cols=250 Identities=20% Similarity=0.244 Sum_probs=213.6
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----------chHHHHHHHHHHHhcCCCCCceeEEEeEe
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------HPQLQYEAKLYKILQGGTGIPNLRWFGVE 74 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----------~~~l~~E~~il~~l~~~~~i~~l~~~~~~ 74 (474)
+-++|.-.+.||.|..++|-+|.++.++.++|+|++..... .+.-..|+.||+++.+|++|..+..+...
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 34678888999999999999999999999999998765321 12356799999999999999999999999
Q ss_pred CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCc
Q 011945 75 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (474)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (474)
+.+.++|+|+| .|.|.|++. ..-.++++....|+.|++.|++|||.++||||||||+|||+ +++.++||+|||+|
T Consensus 95 ~sF~FlVFdl~prGELFDyLt-s~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isDFGFa 170 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLT-SKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISDFGFA 170 (411)
T ss_pred cchhhhhhhhcccchHHHHhh-hheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEecccee
Confidence 99999999999 888999997 34579999999999999999999999999999999999999 58899999999999
Q ss_pred cccccCCCccccccccCCCCccCccccccccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHH
Q 011945 154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLG------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227 (474)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~------~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 227 (474)
+.+..... ...+|||+.|+|||.+.. ..|+..+|+|++|||||-||.|..||.. .....++..
T Consensus 171 ~~l~~Gek--------LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH---RkQmlMLR~ 239 (411)
T KOG0599|consen 171 CQLEPGEK--------LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH---RKQMLMLRM 239 (411)
T ss_pred eccCCchh--------HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH---HHHHHHHHH
Confidence 98766543 245799999999998863 2488999999999999999999999975 233455667
Q ss_pred HhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
|++.+.....++ +.+++...++||.+||+.||.+|.|+++++
T Consensus 240 ImeGkyqF~spe-Wadis~~~KdLIsrlLqVdp~~Ritake~L 281 (411)
T KOG0599|consen 240 IMEGKYQFRSPE-WADISATVKDLISRLLQVDPTKRITAKEAL 281 (411)
T ss_pred HHhcccccCCcc-hhhccccHHHHHHHHHeeCchhcccHHHHh
Confidence 777776554433 467889999999999999999999988764
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=305.67 Aligned_cols=249 Identities=21% Similarity=0.328 Sum_probs=201.8
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 85 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (474)
++|++.++||.|+||.||+|.+..+++.|++|.+........+.+|+++++.++|.+++ .+..+.......++++|++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~-~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIV-KYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEe-eeeeeeecCCcEEEEEecCC
Confidence 68999999999999999999998889999999987655566799999999999755554 4555556668889999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccc
Q 011945 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 165 (474)
Q Consensus 86 g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (474)
+++|.+++......+++..++.++.||+.||.|||+.||+|+||+|+||+++ .++.++|+|||++........
T Consensus 82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~---~~~~~~l~dfg~~~~~~~~~~---- 154 (256)
T cd06612 82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN---EEGQAKLADFGVSGQLTDTMA---- 154 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC---CCCcEEEcccccchhcccCcc----
Confidence 7899999986677899999999999999999999999999999999999994 678899999999987654321
Q ss_pred ccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCc
Q 011945 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245 (474)
Q Consensus 166 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 245 (474)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||....... ....+..... ........++
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~--~~~~~~~~~~ 226 (256)
T cd06612 155 ---KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR---AIFMIPNKPP--PTLSDPEKWS 226 (256)
T ss_pred ---ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh---hhhhhccCCC--CCCCchhhcC
Confidence 1123468899999999999999999999999999999999999998643321 1111111110 0011123467
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 246 TEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 246 ~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.++.+++..||+.+|++||++.++++
T Consensus 227 ~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 227 PEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred HHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 89999999999999999999887754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=305.44 Aligned_cols=254 Identities=23% Similarity=0.381 Sum_probs=203.4
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
+..++|.+.++||.|+||.||+|.+. .++.||||.+.... ....+..|+.+++.++|.+ +..+..+.......+++|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDK-LVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCC-EeeeeeeeecCCceEEEE
Confidence 45688999999999999999999974 56789999876543 3457899999999999655 555555566667789999
Q ss_pred ecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 83 e~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|++ +++|.+++... ...+++..++.++.||+.||.|||++||+|+||||+||+++ .++.+||+|||++..+....
T Consensus 81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~---~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG---ENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEc---CCCCEEECccccceeccchh
Confidence 998 78999999743 34699999999999999999999999999999999999994 67899999999998765321
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
. .......++..|+|||.+.+..++.++|||||||++|+|++ |+.||.+... ...+..+..... ..
T Consensus 158 ~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~~~~~----~~ 224 (261)
T cd05034 158 Y------TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQVERGYR----MP 224 (261)
T ss_pred h------hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCC----CC
Confidence 1 11122345678999999999889999999999999999998 9999976533 233333322111 11
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 275 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (474)
....+|.++.+++.+||..+|++||+++++.+.|+.
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 225 RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 224568999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=311.14 Aligned_cols=248 Identities=17% Similarity=0.271 Sum_probs=196.8
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
++|++++.||+|+||.||+|.+..+++.||+|.+..... ...+.+|+.+++.+.|++++..+. ++......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~-~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG-AFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhh-heecCCeEEEEEe
Confidence 478999999999999999999988999999998765322 246888999999998655555444 5556778899999
Q ss_pred cC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 84 ~~-g~sL~~li~~~--~~~l~~~~~~~i~~qi~~gL~yLHs-~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
|+ +++|..++... ...+++..+..++.||+.||.|||+ .||+|+||||+||+++ .++.+||+|||++..+...
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN---GNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC---CCCCEEEeecCCcccccCC
Confidence 99 78998888743 2369999999999999999999997 5999999999999995 6789999999999765432
Q ss_pred CCccccccccCCCCccCccccccccccCC------CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGI------EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~------~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (474)
.. ....++..|+|||++.+. .++.++|||||||++|+|++|..||...........+..+.....
T Consensus 157 ~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd06622 157 LA---------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP 227 (286)
T ss_pred cc---------ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC
Confidence 21 234688899999998654 358899999999999999999999976443332233333322221
Q ss_pred cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
..+...++.++.++|..||..+|++||+++++++
T Consensus 228 ----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 228 ----PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ----CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1233457899999999999999999999887754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=306.80 Aligned_cols=254 Identities=20% Similarity=0.258 Sum_probs=199.9
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
+|++.+.||.|+||.||+|.+..+++.||||++..... ...+..|+.+++.++|++ +..+..+...+...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~-i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY-VVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCC-CcceeeEEecCCeeEEEec
Confidence 58999999999999999999998999999998765432 346889999999998555 4455555566888999999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 84 ~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
+++++|.+++......+++..++.++.||+.||.|||++||+|+||||+||+++ ..+.++|+|||++........
T Consensus 80 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~---~~~~~~l~dfg~~~~~~~~~~-- 154 (286)
T cd07832 80 YMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEP-- 154 (286)
T ss_pred ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEc---CCCcEEEeeeeecccccCCCC--
Confidence 999999999986667799999999999999999999999999999999999994 678999999999987654321
Q ss_pred ccccccCCCCccCccccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc-----------
Q 011945 164 HIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----------- 231 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~----------- 231 (474)
.......|+..|+|||++.+.. ++.++|||||||++|||++|..||.+................
T Consensus 155 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07832 155 ----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS 230 (286)
T ss_pred ----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence 1112347899999999987654 689999999999999999998888764332111111110000
Q ss_pred -----------cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 232 -----------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 232 -----------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
........+...++.++.++|..||..+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 231 LPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred cchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0001122334567899999999999999999999887743
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=307.72 Aligned_cols=253 Identities=21% Similarity=0.266 Sum_probs=196.2
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.++|++.+.||.|+||.||+|.+..+++.||||.+..... ...+.+|+.+++.++|.+ |..+..+...+...++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHAN-IVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcc-eeeEEEEEecCCeEEEEE
Confidence 4789999999999999999999988999999998754322 234678999999998654 555656667788999999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 83 e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 83 EYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECccccccccCCCCc-
Confidence 999889999987666679999999999999999999999999999999999999 4778899999999875432111
Q ss_pred cccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhh---cc------
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE---KK------ 232 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~---~~------ 232 (474)
......++..|+|||++.+ ..++.++|||||||++|+|++|..||.+... ....+..+.. ..
T Consensus 159 ------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07844 159 ------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD--VEDQLHKIFRVLGTPTEETWP 230 (291)
T ss_pred ------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHhcCCCChhhhh
Confidence 1122356889999999876 4589999999999999999999999976432 1111111110 00
Q ss_pred ----------------ccchHHHHhcCCc--HHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 233 ----------------VSTSIEALCRGYP--TEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 233 ----------------~~~~~~~l~~~~p--~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
...........+. .++.+++.+||..+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 231 GVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0011111122334 78899999999999999999887653
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=304.89 Aligned_cols=253 Identities=20% Similarity=0.348 Sum_probs=200.5
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
+..++|++.++||+|+||.||++.+ ..+..||+|.+..... ...+.+|+.+++.++|.+++..+..+. . ...+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-~-~~~~~v~ 79 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-K-EPIYIIT 79 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEc-C-CCeEEEE
Confidence 4578999999999999999999985 4556799998765432 346889999999998766666554443 3 6678999
Q ss_pred ecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 83 DLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 83 e~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
||+ +++|.+++... ...+++..++.++.||+.||.|||+.|++|+||||+||+++ ..+.+||+|||++..+....
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc---CCCcEEECCCcceeeccCCC
Confidence 999 78999999743 34588999999999999999999999999999999999994 77899999999997664322
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
.. ......++..|+|||++.+..++.++|||||||++|++++ |..||.+.... .....+..... ..
T Consensus 157 ~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~~~~~~----~~ 223 (260)
T cd05073 157 YT------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRALERGYR----MP 223 (260)
T ss_pred cc------cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHhCCCC----CC
Confidence 11 1122356678999999998889999999999999999998 99999875432 22222222111 11
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 275 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (474)
....++.++.+++.+||..+|++||++.++.++|+.
T Consensus 224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 235678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=310.32 Aligned_cols=253 Identities=23% Similarity=0.337 Sum_probs=199.2
Q ss_pred CCcEEEeeeeeecCceEEEEEEEc-----CCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
..+|.+.++||+|+||.||++... .++..||+|.+..... ...+..|+++++.++|.+ |..+..++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~ 82 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH-IVRFYGVCTEGRPL 82 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCC-CceEEEEEecCCce
Confidence 457899999999999999999743 3466899998754332 346889999999998655 44455566777788
Q ss_pred EEEEecC-CCCHHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCC
Q 011945 79 VLVIDLL-GPSLEDLFNFCS--------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 143 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~--------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~ 143 (474)
+++|||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++ +++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~---~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG---QGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc---CCC
Confidence 9999998 889999987432 2488999999999999999999999999999999999994 678
Q ss_pred eEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHH
Q 011945 144 QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKK 222 (474)
Q Consensus 144 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~ 222 (474)
.+||+|||++........ +.......++..|+|||++.+..++.++|||||||++|||++ |..||..... .
T Consensus 160 ~~kL~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~ 231 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDY-----YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN---T 231 (280)
T ss_pred CEEECCCCceeEcCCCce-----eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH---H
Confidence 999999999976543221 111233456789999999999999999999999999999998 9999976433 2
Q ss_pred HHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011945 223 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 274 (474)
Q Consensus 223 ~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (474)
..+..+...... .....+|+.+.+++.+||..||++||++.+|.+.|.
T Consensus 232 ~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 232 EAIECITQGREL----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHHHcCccC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 223322222111 123467899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=308.58 Aligned_cols=247 Identities=20% Similarity=0.272 Sum_probs=194.8
Q ss_pred eeeeecCceEEEEEEEcCCCe--EEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-C
Q 011945 13 RKIGSGSFGEIYLGTNIQTNE--EVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 86 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~--~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (474)
+.||+|+||.||+|.+..++. .+++|.+.... ....+..|+.++.++.+|+++..+..++......+++|||+ +
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999887775 46888765322 22457889999999976777777777777777889999998 7
Q ss_pred CCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecC
Q 011945 87 PSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (474)
Q Consensus 87 ~sL~~li~~~~---------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFG 151 (474)
++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECCCC
Confidence 89999986422 247899999999999999999999999999999999999 478899999999
Q ss_pred CccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhh
Q 011945 152 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISE 230 (474)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~ 230 (474)
++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||.+... ...+..+..
T Consensus 158 l~~~~~~~~--------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~~~~ 226 (270)
T cd05047 158 LSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKLPQ 226 (270)
T ss_pred Cccccchhh--------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---HHHHHHHhC
Confidence 986322110 0112234678999999998889999999999999999997 9999976432 222332222
Q ss_pred ccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
... ......++.++.+++.+||..+|.+||++.+++..|+.++
T Consensus 227 ~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 GYR----LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCC----CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 111 1122456789999999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=310.04 Aligned_cols=248 Identities=21% Similarity=0.334 Sum_probs=198.0
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
..+|++.+.||+|+||.||+|.+..+++.|++|.+..... ...+..|+.+++.+.|.+.+..+ .++..+...++|||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~-~~~~~~~~~~lv~e 97 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYL-DSYLVGDELWVVME 97 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEE-EEEEeCCEEEEeec
Confidence 4689999999999999999999999999999998765432 34678899999998866555544 45556778999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
|+ +++|.+++. ...+++.+++.++.|++.||.|||+.||+||||||+|||++ .++.+||+|||++.........
T Consensus 98 ~~~~~~L~~~~~--~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~---~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 98 YLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred ccCCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc---CCCCEEECccccchhccccccc
Confidence 99 889999986 34689999999999999999999999999999999999994 6788999999998765432211
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhc
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (474)
.....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...... ...+. +..... . ......
T Consensus 173 -------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--~~~~~-~~~~~~-~-~~~~~~ 240 (296)
T cd06654 173 -------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYL-IATNGT-P-ELQNPE 240 (296)
T ss_pred -------cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--HhHHH-HhcCCC-C-CCCCcc
Confidence 12347899999999999988999999999999999999999999764331 11111 111111 0 111234
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.++..+.+++.+||..+|++||++.+|++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 57889999999999999999999887754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=305.91 Aligned_cols=256 Identities=21% Similarity=0.327 Sum_probs=203.0
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCC---CeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
.++|.+.++||.|+||.||+|.+... ...|+||....... .+.+..|+.+++.+.|.+++..+..+ .. ...+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~-~~~~ 82 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVI-TE-NPVW 82 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEE-cC-CCcE
Confidence 45799999999999999999997544 34689998765432 23588899999999977666655443 33 4467
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
++||++ +++|.+++......+++..++.++.||+.||.|||++|++|+||||+|||++ ..+.+||+|||+++....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~---~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS---SPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe---cCCCeEEccCceeeeccc
Confidence 899998 8899999986555799999999999999999999999999999999999995 678999999999986654
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
..... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.... .....+......
T Consensus 160 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~~~~~~~--- 227 (270)
T cd05056 160 ESYYK------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRIENGERL--- 227 (270)
T ss_pred cccee------cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHcCCcC---
Confidence 32111 122345578999999988889999999999999999986 99999875432 222333222111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
.....+|.++.+++.+||..+|++||++.++++.|+++..+
T Consensus 228 -~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 -PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 23457889999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=312.08 Aligned_cols=252 Identities=16% Similarity=0.269 Sum_probs=196.7
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
++|...++||+|+||.||++.+..+++.||||.+..... ...+..|+.++.++..++++..+..+...+...+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 467788999999999999999999999999998765432 33578899999999755666666666666778899999
Q ss_pred cCCCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 84 LLGPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 84 ~~g~sL~~li~~----~~~~l~~~~~~~i~~qi~~gL~yLHs-~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
+++.+|.++... ....+++..+..++.|++.||+|||+ .+|+||||||+|||++ ..+.+||+|||++..+..
T Consensus 84 ~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD---RNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc---cCCcEEEeecchhHHhcc
Confidence 998888776542 23569999999999999999999997 5999999999999994 678899999999976544
Q ss_pred CCCccccccccCCCCccCccccccccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccc
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~---~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
... .....|+..|+|||++.+. .++.++|||||||++|||++|+.||.... ...+.+.++.......
T Consensus 161 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~ 230 (288)
T cd06616 161 SIA--------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPI 230 (288)
T ss_pred CCc--------cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhcCCCCCc
Confidence 321 1233688999999999876 68999999999999999999999997643 1222222222211111
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
........++.++.+|+..||..+|++||++++|++
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111112357899999999999999999999887743
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=308.56 Aligned_cols=253 Identities=19% Similarity=0.220 Sum_probs=196.1
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc-------hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
+|++.+.||.|+||.||+|.+..+++.||||.+...... ..+..|+.+++.++|.+++..+. +.......++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~-~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLD-VFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhh-eeecCCEEEE
Confidence 589999999999999999999889999999987654322 34678999999999665555554 4455788999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 81 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 81 v~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
||||++++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||++ .++.++|+|||++.......
T Consensus 80 v~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~---~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 80 VFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIA---SDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred EEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEc---CCCCEEEccceeeeeccCCC
Confidence 999999999999975444799999999999999999999999999999999999994 67899999999998765432
Q ss_pred CccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc-------
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------- 232 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~------- 232 (474)
.. .....++..|+|||.+.+ ..++.++|||||||++|||++|..||.+.................
T Consensus 157 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 157 RK-------MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229 (298)
T ss_pred cc-------ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhh
Confidence 11 122356889999999865 457899999999999999999988887644322111111110000
Q ss_pred -------------ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 233 -------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 233 -------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.......+...++.++.++|..||..+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 011112223456789999999999999999999887754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=319.09 Aligned_cols=250 Identities=22% Similarity=0.281 Sum_probs=196.4
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEe-----
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVE----- 74 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~----- 74 (474)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++|.+++..+..+...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 46789999999999999999999999999999999875421 223577899999999987777766655432
Q ss_pred CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 75 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 75 ~~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
....|+||||++++|.+.+.. .+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 93 ~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 93 FQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 166 (353)
T ss_pred cCcEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCccce
Confidence 245799999999999998863 28999999999999999999999999999999999999 477899999999998
Q ss_pred ccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (474)
....... .....++..|+|||++.+..++.++|||||||++|+|++|+.||...+. ...+.++......
T Consensus 167 ~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~~~ 235 (353)
T cd07850 167 TAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH---IDQWNKIIEQLGT 235 (353)
T ss_pred eCCCCCC--------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHhcCC
Confidence 6543221 1234688999999999999999999999999999999999999976432 1112221110000
Q ss_pred -------------------------chHHHH-------------hcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 235 -------------------------TSIEAL-------------CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 235 -------------------------~~~~~l-------------~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.....+ ....+.++.++|.+||..||++||++.+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL 309 (353)
T cd07850 236 PSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDAL 309 (353)
T ss_pred CCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHh
Confidence 000000 113466789999999999999999987764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=312.07 Aligned_cols=259 Identities=19% Similarity=0.253 Sum_probs=201.7
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCe----EEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCC
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGD 76 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~----~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (474)
.-.++|++.+.||+|+||.||+|.+..+++ .||+|++...... ..+..|+.+++.+.|++++..+..+. ..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-~~- 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCL-SP- 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc-CC-
Confidence 345789999999999999999999877776 5788877654332 25778999999998766666655443 33
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
..+++++++ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~---~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK---SPNHVKITDFGLARL 158 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeec---CCCceEEcccccccc
Confidence 356777777 7899999886666799999999999999999999999999999999999994 677899999999987
Q ss_pred cccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhcccc
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS 234 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (474)
+....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+..... +..+......
T Consensus 159 ~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~----~~~~~~~~~~ 229 (303)
T cd05110 159 LEGDEKEY-----NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE----IPDLLEKGER 229 (303)
T ss_pred ccCccccc-----ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----HHHHHHCCCC
Confidence 65332210 1123346788999999999999999999999999999997 999997753221 2222221111
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
. .....++..+.+++..||..+|++||++.+|.+.|+++...
T Consensus 230 ~---~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 230 L---PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1 11245678999999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=309.96 Aligned_cols=253 Identities=23% Similarity=0.353 Sum_probs=199.3
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcC-----CCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
.++|++.+.||.|+||.||+|.+.. ++..||||++..... ...+.+|+.+++.+.|++ +..+..++..+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~-iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPN-IVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCc-hheEEEEEcCCCc
Confidence 4679999999999999999998743 578999998765432 345888999999998654 5555556666777
Q ss_pred EEEEEecC-CCCHHHHHHHcC---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 011945 78 NVLVIDLL-GPSLEDLFNFCS---------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 135 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~~---------------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NIL 135 (474)
.+++|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil 162 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL 162 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence 89999998 679999986321 24788899999999999999999999999999999999
Q ss_pred eeeCCCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 011945 136 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQ 214 (474)
Q Consensus 136 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~ 214 (474)
++ .++.++|+|||++..+..... +.......++..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 163 ~~---~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 163 VG---ENMVVKIADFGLSRNIYSADY-----YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred ec---CCCceEECccccceecccCcc-----ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 94 778999999999876543221 111122345678999999998899999999999999999997 889997
Q ss_pred CCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011945 215 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 274 (474)
Q Consensus 215 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (474)
+... .+.+..+...... .....++.++.+++.+||+.+|++||++.+|.+.|+
T Consensus 235 ~~~~---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 235 GMAH---EEVIYYVRDGNVL----SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCH---HHHHHHHhcCCCC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 6543 2333333222211 123467899999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=310.55 Aligned_cols=263 Identities=22% Similarity=0.235 Sum_probs=200.2
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeE-------
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGV------- 73 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~------- 73 (474)
..++|++.++||.|+||.||+|.+..+++.||||++..... ...+.+|+++++.++|++++..+..+..
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 35799999999999999999999999999999998754322 2357889999999998777666544432
Q ss_pred eCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCc
Q 011945 74 EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (474)
Q Consensus 74 ~~~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (474)
.....+++|+|++.+|.+.+......+++..++.++.||+.||.|||++||+|+||||+|||+ +.++.++|+|||++
T Consensus 86 ~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~ 162 (311)
T cd07866 86 KRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFGLA 162 (311)
T ss_pred cCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcCccc
Confidence 234579999999999998887556679999999999999999999999999999999999999 47889999999999
Q ss_pred cccccCCCcccc----ccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHH
Q 011945 154 KRYRDTATHQHI----PYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (474)
Q Consensus 154 ~~~~~~~~~~~~----~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i 228 (474)
............ .........++..|+|||++.+. .++.++|||||||++|||++|+.||.+.......+.+...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 866543221110 01112344678899999988764 4789999999999999999999999865443222222211
Q ss_pred hhc----------------------cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 229 SEK----------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 229 ~~~----------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
... ............+.+.+.++|.+||..||++||++.+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell 306 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDAL 306 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHh
Confidence 110 011111222234567899999999999999999987764
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=308.82 Aligned_cols=247 Identities=18% Similarity=0.275 Sum_probs=195.1
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 85 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (474)
-|++.+.||.|+||.||+|.+..++..|++|.+..... ...+..|+++++.+.|.+++.. ..++..+...+++|||+
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~-~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL-LDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeE-EEEEeeCCEEEEEEEec
Confidence 37889999999999999999999999999998765432 2357789999999986665554 44556677889999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccc
Q 011945 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164 (474)
Q Consensus 86 -g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (474)
+++|..++......+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|||++........
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~---~~~~~kl~dfg~~~~~~~~~~--- 158 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQ--- 158 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc---cCCCEEEcccccccccccccc---
Confidence 7788888765566799999999999999999999999999999999999994 678899999999976543221
Q ss_pred cccccCCCCccCcccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 165 IPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 165 ~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
......|+..|+|||++. +..++.++|||||||++|||++|..||..... ...+..+....... ..
T Consensus 159 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~~~~--~~ 229 (282)
T cd06643 159 ----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEPPT--LA 229 (282)
T ss_pred ----ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH---HHHHHHHhhcCCCC--CC
Confidence 123457899999999984 44578899999999999999999999976442 22233322211111 11
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
....++.++.++|..||+.+|++||++++++
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 260 (282)
T cd06643 230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQLL 260 (282)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 2245789999999999999999999987763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=307.28 Aligned_cols=245 Identities=22% Similarity=0.337 Sum_probs=199.6
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
++|++.+.||.|+||.||+|.+..+++.||+|++..... ...+..|+.+++.++|.+++. +..+...+...++++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITK-YYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeee-eeEEEEECCeEEEEEE
Confidence 579999999999999999999999999999998765432 235788999999999665544 4455667788999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
++ +++|.+++... .+++..++.++.|++.||.|||+++|+|+||+|+||++ +.++.++|+|||+++.+.....
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 80 YCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred eeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeeccccc-
Confidence 98 78999998743 79999999999999999999999999999999999999 4688999999999987754322
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhc
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (474)
......|+..|+|||.+.+..++.++|||||||++|+|++|..||..... ......+...... .+..
T Consensus 154 ------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~---~~~~~~~~~~~~~----~~~~ 220 (274)
T cd06609 154 ------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP---MRVLFLIPKNNPP----SLEG 220 (274)
T ss_pred ------ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch---HHHHHHhhhcCCC----CCcc
Confidence 12345788999999999998899999999999999999999999976442 2222222222111 1122
Q ss_pred C-CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 243 G-YPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 243 ~-~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
. ++.++.+++.+||..+|++||+++++++
T Consensus 221 ~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 221 NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 2 7899999999999999999999887743
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=305.68 Aligned_cols=252 Identities=21% Similarity=0.261 Sum_probs=195.6
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+.|.+ +..+..++..+...+++|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~n-i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHAN-IVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCC-EeEEEEEEecCCeEEEEE
Confidence 4689999999999999999999999999999998765432 235778999999998655 556666667778899999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 83 e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
||++++|.+.+......+++..+..++.||+.||.|||++||+|+||||+|||++ ..+.+||+|||+++.......
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~Dfg~~~~~~~~~~- 158 (291)
T cd07870 83 EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS---YLGELKLADFGLARAKSIPSQ- 158 (291)
T ss_pred ecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEc---CCCcEEEeccccccccCCCCC-
Confidence 9999999888765556688999999999999999999999999999999999994 678999999999975433221
Q ss_pred cccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc---------
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--------- 232 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 232 (474)
......++..|+|||++.+. .++.++|||||||++|||++|..||.+... ..+.+.++....
T Consensus 159 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 159 ------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD--VFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred ------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh--HHHHHHHHHHHcCCCChhhhh
Confidence 11234578999999998764 478999999999999999999999976532 122222211100
Q ss_pred ----------------ccchHHHHhc--CCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 233 ----------------VSTSIEALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 233 ----------------~~~~~~~l~~--~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.......+.. ..+.++.+++.+|+..||.+||++.+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l 286 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHh
Confidence 0000111111 1357899999999999999999988764
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=310.71 Aligned_cols=270 Identities=19% Similarity=0.260 Sum_probs=207.7
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++|++.+.||+|+||.||++.+..+++.|+||.+..... ...+..|+.+++.++|++ |..+...+..+.+.+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~-i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF-VVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCC-eeeeEEEEecCCEEEEE
Confidence 479999999999999999999999999999998765431 235778999999998654 44555666677889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ |++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++ ..+.+||+|||+++......
T Consensus 80 ~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~---~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 80 MEYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT---SMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEEC---CCCCEEEeeCCCccccCcCc
Confidence 9999 7899999974 35799999999999999999999999999999999999994 77899999999987422111
Q ss_pred Cccc--------cccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc
Q 011945 161 THQH--------IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (474)
Q Consensus 161 ~~~~--------~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (474)
.... ..........|+..|+|||.+.+..++.++|||||||++|||++|..||.+... .+.+..+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~---~~~~~~~~~~~ 232 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELFGQVISDD 232 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcc
Confidence 1000 000011234678899999999988899999999999999999999999976432 23333332221
Q ss_pred ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccc
Q 011945 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 293 (474)
Q Consensus 233 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~ 293 (474)
...+ .....+|.++.++|.+||+.+|++||+...+.++|++.+ ....+|...
T Consensus 233 ~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~-------~~~~~~~~~ 284 (305)
T cd05609 233 IEWP--EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF-------FLGLDWNGL 284 (305)
T ss_pred cCCC--CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc-------ccCCCHHHH
Confidence 1111 111257899999999999999999999887877777653 233566654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=309.99 Aligned_cols=249 Identities=20% Similarity=0.319 Sum_probs=199.2
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
.++|+++++||.|+||.||+|.+..+++.||+|++..... ...+..|+++++.++| +++..+..++..+...+++||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH-PNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCC-CceeEEEEEEecCCeEEEEee
Confidence 3679999999999999999999988999999998765432 2357889999999995 455555556667788999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
|+ +++|.+++......+++..++.++.||+.||.|||++||+|+||||+||++ +.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhhccccc-
Confidence 99 779999988666789999999999999999999999999999999999999 4778999999999876543221
Q ss_pred cccccccCCCCccCcccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 163 QHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
......|+..|+|||++. +..++.++|||||||++|||++|..||..... ...+..+.......
T Consensus 159 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~-- 227 (280)
T cd06611 159 ------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP---MRVLLKILKSEPPT-- 227 (280)
T ss_pred ------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH---HHHHHHHhcCCCCC--
Confidence 113356899999999975 34578899999999999999999999977532 22333332221111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
......++.++.++|..||..+|++||++.+++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 260 (280)
T cd06611 228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELL 260 (280)
T ss_pred cCCcccCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 111245788999999999999999999987773
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=309.64 Aligned_cols=250 Identities=18% Similarity=0.269 Sum_probs=194.5
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
++|++.++||+|+||.||++.+..++..||+|.+..... ..++.+|+++++.++|++++ .+..++..+...+++||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIV-GFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCC-eEEEEEeeCCEEEEEee
Confidence 479999999999999999999999999999998765432 23578899999999866544 44455567788999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs-~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
|+ +++|.+++... ..+++..+..++.||+.||.|||+ .+|+|+||||+|||++ .++.+||+|||++........
T Consensus 80 y~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~~~ 155 (308)
T cd06615 80 HMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMA 155 (308)
T ss_pred ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEe---cCCcEEEccCCCccccccccc
Confidence 98 78999999743 679999999999999999999998 6999999999999994 678899999999876543221
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhh-----------
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE----------- 230 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~----------- 230 (474)
....|+..|+|||++.+..++.++|||||||++|+|++|..||...........+.....
T Consensus 156 ---------~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 156 ---------NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred ---------ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence 345789999999999988899999999999999999999999965332111111100000
Q ss_pred ------------------ccccchHHHHh-cCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 231 ------------------KKVSTSIEALC-RGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 231 ------------------~~~~~~~~~l~-~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.......+.++ ..++.++.+|+.+||..+|++||++.+|+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 285 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELT 285 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 00000000001 13678899999999999999999977663
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=307.60 Aligned_cols=247 Identities=21% Similarity=0.319 Sum_probs=198.4
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
..+|++.+.||.|+||.||+|.+..+++.|+||.+.... ....+..|+.+++.++|++++.. ..+...+...++++|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~-~~~~~~~~~~~lv~e 96 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNF-LDSFLVGDELFVVME 96 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeee-eeeEecCceEEEEEE
Confidence 357999999999999999999999999999999876543 23467889999999987665554 445566778899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
|+ +++|.+++. ...+++.+++.++.|++.||.|||++||+|+||||+||+++ .++.+||+|||++.........
T Consensus 97 ~~~~~~L~~~~~--~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~---~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 97 YLAGGSLTDVVT--ETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG---MDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred ecCCCcHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEccCccchhccccccc
Confidence 99 889999886 34689999999999999999999999999999999999994 6788999999998765433211
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhc
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (474)
.....|+..|+|||.+.+..++.++|||||||++|+|++|..||...... .....+..... .......
T Consensus 172 -------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~---~~~~~~~~~~~--~~~~~~~ 239 (296)
T cd06655 172 -------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL---RALYLIATNGT--PELQNPE 239 (296)
T ss_pred -------CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcCC--cccCCcc
Confidence 12347889999999999988999999999999999999999999774331 22222211111 1111234
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 243 GYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.+++.+.++|.+||..||++||++.+|+
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il 267 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKELL 267 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 6789999999999999999999988774
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=305.73 Aligned_cols=260 Identities=23% Similarity=0.314 Sum_probs=205.5
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++|++.+.||+|+||.||++.+..+++.||||++.... ....+..|+++++.+.|+ +|..+..+...+...+++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHP-FLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCC-CccceeeEEEcCCeEEEE
Confidence 47999999999999999999999999999999875432 234578899999999955 555555566777889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+|+||+|+|||| +.++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~~ 155 (290)
T cd05580 80 MEYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGRT 155 (290)
T ss_pred EecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccCCCC
Confidence 9999 9999999874 3579999999999999999999999999999999999999 467889999999998765431
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
....|++.|+|||.+.+..++.++||||||+++|+|++|..||.... ....+..+..... .+
T Consensus 156 ----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~-----~~ 217 (290)
T cd05580 156 ----------YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN---PIQIYEKILEGKV-----RF 217 (290)
T ss_pred ----------CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCc-----cC
Confidence 23478999999999998889999999999999999999999997644 2233333332221 23
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccccc
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 294 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 294 (474)
...++..+.+++.+||..||++|++.. ...+++++ ..++...++|....
T Consensus 218 ~~~~~~~l~~li~~~l~~~p~~R~~~~--~~~~~~l~---~~~~~~~~~~~~~~ 266 (290)
T cd05580 218 PSFFSPDAKDLIRNLLQVDLTKRLGNL--KNGVNDIK---NHPWFAGIDWIALL 266 (290)
T ss_pred CccCCHHHHHHHHHHccCCHHHccCcc--cCCHHHHH---cCcccccCCHHHHh
Confidence 355689999999999999999998321 11122222 12444556777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=298.63 Aligned_cols=247 Identities=21% Similarity=0.265 Sum_probs=202.4
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
+|++++.||.|+||.||.+++..+++.|++|.+.... ....+.+|+.+++.++|. ++..+..+..+....+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~-~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP-NIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCC-CeeEEEeEEecCCeEEEEEE
Confidence 6999999999999999999999999999999866432 224588999999999755 45555555667788999999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 84 ~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
|+ +++|.+++... ...+++..++.++.|++.||.|||+.||+|+||||+||+++ .++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~---~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT---KAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe---CCCCEEECcCcceEEcccccc
Confidence 99 78999999754 45689999999999999999999999999999999999995 678899999999987654332
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
......|+..|+|||++.+..++.++|||||||++|||++|..||.... ..+.+..+....... ..
T Consensus 157 -------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~---~~~~~~~~~~~~~~~----~~ 222 (256)
T cd08221 157 -------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN---PLNLVVKIVQGNYTP----VV 222 (256)
T ss_pred -------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCCCC----Cc
Confidence 1134578999999999998889999999999999999999999997633 333444443333222 22
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRL 272 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~ 272 (474)
..++.++.+++.+||..+|++||++.++++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 223 SVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 5678999999999999999999998887653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=302.93 Aligned_cols=247 Identities=23% Similarity=0.313 Sum_probs=195.6
Q ss_pred eeeeecCceEEEEEEEcC-CC--eEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-
Q 011945 13 RKIGSGSFGEIYLGTNIQ-TN--EEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 85 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~-~~--~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (474)
++||+|+||.||+|.+.. .+ ..||||.+..... ...+..|+.+++.++|++++..+..+.. ...+++||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEecC
Confidence 468999999999999865 33 3699998876544 3468899999999997766665554443 7889999998
Q ss_pred CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccc
Q 011945 86 GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164 (474)
Q Consensus 86 g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (474)
+++|.+++.... ..+++..++.++.||+.||+|||++||+|+||||+||+++ .++.+||+|||+++.+......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~---~~~~~kl~dfg~~~~~~~~~~~-- 153 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA---SDDKVKIGDFGLMRALPQNEDH-- 153 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe---cCCEEEeccccccccccccccc--
Confidence 889999997544 5689999999999999999999999999999999999995 6689999999999876543221
Q ss_pred cccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcC
Q 011945 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (474)
Q Consensus 165 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (474)
+.......++..|+|||++.+..++.++|||||||++|||++ |..||...... +.+..+...... ......
T Consensus 154 --~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~~~~~~---~~~~~~ 225 (257)
T cd05040 154 --YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS---QILKKIDKEGER---LERPEA 225 (257)
T ss_pred --eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHhcCCc---CCCCcc
Confidence 111223467889999999999899999999999999999998 99999765432 223332221111 112346
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011945 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 274 (474)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (474)
+|..+.+++..||..+|++||++.++.+.|.
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 226 CPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 7899999999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=327.81 Aligned_cols=257 Identities=25% Similarity=0.356 Sum_probs=207.3
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCC----eEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCC
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 76 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~----~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (474)
.++..+.++||+|+||+||+|..+..+ ..||||..+.+. ....+.+|.++++.++ |++|..++++.....
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~-H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN-HPNVVRFYGVAVLEE 234 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCC
Confidence 345566799999999999999976542 238999876422 2345899999999998 556667777888889
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
..+||||+| ||+|.+++......++..+.+.++.+.+.||+|||++++|||||-.+|+|++ ..+.+||+|||+++.
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~---~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS---KKGVVKISDFGLSRA 311 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec---CCCeEEeCccccccC
Confidence 999999999 8999999997666799999999999999999999999999999999999995 667789999999875
Q ss_pred cccCCCccccccccCC-CCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccc
Q 011945 156 YRDTATHQHIPYRENK-NLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV 233 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~-~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (474)
-..-.. .. ...-..+|+|||.+....|+.++|||||||++||+++ |..||.+....... .+|.....
T Consensus 312 ~~~~~~--------~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~---~kI~~~~~ 380 (474)
T KOG0194|consen 312 GSQYVM--------KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVK---AKIVKNGY 380 (474)
T ss_pred Ccceee--------ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHH---HHHHhcCc
Confidence 431111 11 1134689999999999999999999999999999999 88999997654333 33322222
Q ss_pred cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
.. ......|.++..++..||..+|++||++.++.+.|+.+....
T Consensus 381 r~---~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 381 RM---PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred cC---CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 11 123467899999999999999999999999999999987544
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=315.12 Aligned_cols=254 Identities=18% Similarity=0.237 Sum_probs=189.3
Q ss_pred Eeeeeeec--CceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 11 LGRKIGSG--SFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 11 i~~~LG~G--~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
++++||+| +|++||++.+..+|+.||||.+..... ...+..|+.+++.++|++++. +..++..+...++||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~-~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVP-YRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeee-EEEEEEECCEEEEEEec
Confidence 57889999 789999999999999999998865432 234778999999998655554 55566777888999999
Q ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 85 ~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.++|+||+.+.........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~---~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEe---cCCcEEEcccchhhcccccccc
Confidence 9 78999998643 34599999999999999999999999999999999999994 6788999999876544322111
Q ss_pred cccccccCCCCccCccccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccc-----
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST----- 235 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~----- 235 (474)
............++..|+|||++.+ ..++.++|||||||++|||++|..||........ ....+ ......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~-~~~~~~~~~~~ 234 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKL-NGTVPCLLDTT 234 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHh-cCCcccccccc
Confidence 1000001122357788999999986 4589999999999999999999999976433211 11111 000000
Q ss_pred ------------------------------------hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 236 ------------------------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 236 ------------------------------------~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
........+++++.+|+..||+.||++||++++|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000111235678999999999999999999887743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=303.89 Aligned_cols=254 Identities=21% Similarity=0.315 Sum_probs=199.2
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--------CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--------~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
+|+..+.||+|+||.||+|.+..+++.||||++.... ....+..|+++++.++|.+++..+. +..+....+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLG-ATCEDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhc-eeccCCeEE
Confidence 5889999999999999999999999999999876432 1245888999999998766655554 455666788
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
++|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++ .....+||+|||++..+..
T Consensus 80 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~--~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 80 LFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLID--STGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccccccccccc
Confidence 889988 7899999874 45789999999999999999999999999999999999994 2334799999999987654
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
....... ......|+..|+|||++.+..++.++|||||||++|+|++|..||...........+..+..... ..
T Consensus 157 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~ 230 (268)
T cd06630 157 KGTGAGE---FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT---AP 230 (268)
T ss_pred ccccCCc---cccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC---CC
Confidence 3221110 12335789999999999988899999999999999999999999976443333332222221111 11
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.+...+++++.+++.+||..+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 233456789999999999999999999887753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=300.18 Aligned_cols=246 Identities=22% Similarity=0.281 Sum_probs=199.5
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
+|++.+.||+|+||.||+|.+..+++.||||.+.... ....+..|+.+++.++|++.+. +......+...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~-~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIE-YYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhh-eeeeEecCCEEEEEEe
Confidence 6999999999999999999999999999999876542 2345888999999998665554 4445567778899999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 84 ~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
++ +++|.+++... ...+++..++.++.|++.||.|||++||+|+||||+||+++ +..+.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccCCCceecCCCcc
Confidence 99 78999999754 34589999999999999999999999999999999999995 3456789999999987654321
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
.....|+..|+|||.+.+..++.++|||||||++|+|++|..||..... ......+..... ..+.
T Consensus 158 --------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~---~~~~~~~~~~~~----~~~~ 222 (256)
T cd08220 158 --------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL---PALVLKIMSGTF----APIS 222 (256)
T ss_pred --------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch---HHHHHHHHhcCC----CCCC
Confidence 1235788999999999988899999999999999999999999976433 222333322211 1233
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
..++.++.+++..||..+|++||++.+++.
T Consensus 223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 567899999999999999999999887753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=309.44 Aligned_cols=249 Identities=20% Similarity=0.278 Sum_probs=197.0
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++|++.+.||+|+||.||+|.+..+++.||||.+..... ...+..|+++++.+.|. +|..+..+...+...+++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP-FLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCC-CchhheeeeecCCEEEEE
Confidence 479999999999999999999988999999998765432 23578899999999855 555555666777889999
Q ss_pred EecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 82 IDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
|||+ +++|.+++... ...+++..++.++.||+.||.|||+.||+|+||||+||+|+ .++.++|+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH---ESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEc---CCCCEEEeecchhhccccc
Confidence 9988 88999998743 35699999999999999999999999999999999999994 6789999999998765432
Q ss_pred CCcccc----------------------ccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 011945 160 ATHQHI----------------------PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217 (474)
Q Consensus 160 ~~~~~~----------------------~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~ 217 (474)
...... .-.....+.||..|+|||++.+..++.++|||||||++|+|++|..||.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 211000 0001234578999999999999889999999999999999999999997643
Q ss_pred cCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCC
Q 011945 218 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 265 (474)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt 265 (474)
. ...+..+........ ....++.++.++|..||..||++||+
T Consensus 237 ~---~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~s 278 (316)
T cd05574 237 R---DETFSNILKKEVTFP---GSPPVSSSARDLIRKLLVKDPSKRLG 278 (316)
T ss_pred h---HHHHHHHhcCCccCC---CccccCHHHHHHHHHHccCCHhHCCC
Confidence 3 233333332222111 11236899999999999999999999
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=307.75 Aligned_cols=260 Identities=21% Similarity=0.287 Sum_probs=202.0
Q ss_pred CCcEEEeeeeeecCceEEEEEEEc----CCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEe--CC
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNI----QTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVE--GD 76 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~----~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~--~~ 76 (474)
...|++.+.||+|+||.||+|.+. .+++.||||++..... ...+..|+++++.+.|.+++..+ .++.. ..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~-~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYK-GVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEE-eeeecCCCC
Confidence 357899999999999999999864 3478999998876544 35689999999999866555544 44443 56
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
..+++|||+ +++|.+++......+++..++.++.||+.||+|||++||+|+||||+|||++ .++.++|+|||++..
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~ 158 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVE---SEDLVKISDFGLAKV 158 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc---CCCCEEEcccccccc
Confidence 789999999 7899999986555799999999999999999999999999999999999994 678999999999987
Q ss_pred cccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcH-----------HHH
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-----------KQK 224 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~-----------~~~ 224 (474)
....... +.......++..|++||.+.+..++.++|||||||++|||++|..||........ ...
T Consensus 159 ~~~~~~~----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05038 159 LPEDKDY----YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234 (284)
T ss_pred cccCCcc----eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH
Confidence 6533221 1111223456779999999988999999999999999999999999865332110 111
Q ss_pred HHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 225 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
+......... ......+|.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 235 ~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 235 LLELLKEGER---LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHcCCc---CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111111111 111245688999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=309.03 Aligned_cols=253 Identities=17% Similarity=0.286 Sum_probs=197.3
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.++|+++++||+|+||+||++.+..+++.||+|++..... ...+..|+++++.++|++ +..+..+.......++||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPY-IVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCC-cceEeeeEecCCEEEEEE
Confidence 3679999999999999999999999999999998754332 346889999999998554 445555556668889999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs-~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
||+ +++|.+++.. .+.+++..+..++.|++.||.|||+ .+|+||||||+||+++ .++.++|+|||++.......
T Consensus 83 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 83 EFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN---SRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred ecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEEC---CCCcEEEccCCcccchhhhc
Confidence 999 7899988874 4569999999999999999999997 6999999999999994 67899999999987553322
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCc----HHHHHHHHhhccccch
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT----KKQKYEKISEKKVSTS 236 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~----~~~~~~~i~~~~~~~~ 236 (474)
. ....|+..|+|||++.+..++.++|||||||++|+|++|..||....... ....+..+........
T Consensus 159 ~---------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd06620 159 A---------DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP 229 (284)
T ss_pred c---------CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc
Confidence 1 23578999999999998889999999999999999999999998644321 0011111111111111
Q ss_pred HHHHh-cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 011945 237 IEALC-RGYPTEFASYFHYCRSLRFDDKPDYAYLKRL 272 (474)
Q Consensus 237 ~~~l~-~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~ 272 (474)
...+. ..++.++.+|+.+||..||++||++.++.+.
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 230 PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11111 1378899999999999999999999887653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=303.11 Aligned_cols=253 Identities=21% Similarity=0.349 Sum_probs=197.5
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHhcCCCCCceeEEEeEe------CC
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVE------GD 76 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~l~~E~~il~~l~~~~~i~~l~~~~~~------~~ 76 (474)
.-.++|++.+.||.|+||.||+|.+..+++.|++|++..... ...+..|+.+++.+..|+++..+..++.. +.
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 345899999999999999999999988999999998765433 35688999999999655555555544432 44
Q ss_pred EEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCC
Q 011945 77 YNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~---~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (474)
..+++|||+ +++|.+++... +..+++..++.++.||+.||.|||++||+|+||+|+||+++ .++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~---~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEc---cCCeEEECCCcc
Confidence 689999999 67999988643 35799999999999999999999999999999999999994 678999999999
Q ss_pred ccccccCCCccccccccCCCCccCccccccccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHH
Q 011945 153 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227 (474)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 227 (474)
+......... .....|+..|+|||++.. ..++.++|||||||+||+|++|..||...... ..+..
T Consensus 160 ~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~ 229 (275)
T cd06608 160 SAQLDSTLGR-------RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM---RALFK 229 (275)
T ss_pred ceecccchhh-------hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH---HHHHH
Confidence 8765432211 133568999999998764 34678999999999999999999999764322 22222
Q ss_pred HhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
+....... . .....++.++.+++.+||..||++||++.+|++
T Consensus 230 ~~~~~~~~-~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IPRNPPPT-L-KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hhccCCCC-C-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 22211111 0 011246789999999999999999999888754
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=300.76 Aligned_cols=247 Identities=22% Similarity=0.291 Sum_probs=201.5
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeE-eCCEEEEEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDYNVLVI 82 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~-~~~~~~lv~ 82 (474)
+|++++.||.|+||.||+|.+..+++.||+|++..... ...+..|+.+++.++|++++..+..+.. .+...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 58999999999999999999999999999998764332 2357789999999997776666554433 456789999
Q ss_pred ecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHH-----HCCccccCCCCCcEEeeeCCCCCeEEEEecCCc
Q 011945 83 DLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVH-----SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (474)
Q Consensus 83 e~~-g~sL~~li~~~---~~~l~~~~~~~i~~qi~~gL~yLH-----s~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (474)
||+ +++|.+++... ...+++..++.++.||+.||.||| +.+|+|+||||+||+++ ..+.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~---~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD---ANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEe---cCCCEEEeccccc
Confidence 998 78999998754 457999999999999999999999 89999999999999995 6789999999999
Q ss_pred cccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc
Q 011945 154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (474)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (474)
......... .....|+..|+|||++.+..++.++||||||+++|+|++|..||.... .......+.....
T Consensus 158 ~~~~~~~~~-------~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~ 227 (265)
T cd08217 158 KILGHDSSF-------AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKIKEGKF 227 (265)
T ss_pred ccccCCccc-------ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHHHHhcCCC
Confidence 876543321 123478999999999999889999999999999999999999998743 2233333332222
Q ss_pred cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
..+...++.++.+++..||..+|++||++.+|++
T Consensus 228 ----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 228 ----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 2234567899999999999999999999888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=307.13 Aligned_cols=259 Identities=21% Similarity=0.252 Sum_probs=197.2
Q ss_pred cEEEeeeeeecCceEEEEEEEcC--CCeEEEEEEecc-----CCCchHHHHHHHHHHHhcCCCCCceeEEEeEeC--CEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQ--TNEEVAIKLENV-----KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEG--DYN 78 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~--~~~~vAvK~~~~-----~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~--~~~ 78 (474)
+|.+.++||+|+||.||+|.+.. +++.||||++.. ......+..|+.+++.++|++++..+..+ ... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVF-LEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEE-eCCCCceE
Confidence 58999999999999999999988 899999998776 23345688899999999976666655544 444 789
Q ss_pred EEEEecCCCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeee-CCCCCeEEEEecCCc
Q 011945 79 VLVIDLLGPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGLA 153 (474)
Q Consensus 79 ~lv~e~~g~sL~~li~~~~----~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~-~~~~~~vkL~DFGla 153 (474)
++||||++++|.+++.... ..+++..++.++.||+.||.|||+++|+||||||+|||++. ++..+.+||+|||++
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999999999998876432 26899999999999999999999999999999999999952 112789999999999
Q ss_pred cccccCCCccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCc------HHHHHH
Q 011945 154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKYE 226 (474)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~------~~~~~~ 226 (474)
......... ........++..|+|||++.+. .++.++|||||||+||+|++|..||.+..... ....+.
T Consensus 160 ~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (316)
T cd07842 160 RLFNAPLKP----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235 (316)
T ss_pred cccCCCccc----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence 876543221 1123445789999999988774 57999999999999999999999998654332 001111
Q ss_pred HHhhc----------------------------ccc-chHHH-Hh--cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 227 KISEK----------------------------KVS-TSIEA-LC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 227 ~i~~~----------------------------~~~-~~~~~-l~--~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.+... ... ..... .. ...+.++.+++..||..||++||++.++++
T Consensus 236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11000 000 00011 11 156678999999999999999999888753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=345.23 Aligned_cols=257 Identities=20% Similarity=0.271 Sum_probs=207.7
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCC-C----eEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQT-N----EEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~-~----~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
...++.+.||+|.||+||.|..... + ..||||.++.... ...|.+|..+|..++|+|++..+..+.. ....
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-~~~~ 770 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-SGPP 770 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-CCCc
Confidence 4578899999999999999987543 2 2488887765433 3459999999999998777777666555 6677
Q ss_pred EEEEecC-CCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecC
Q 011945 79 VLVIDLL-GPSLEDLFNFC------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~------~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFG 151 (474)
+|++||| ||+|..+++.. ...++..+.+.++.|||+|+.||+++++|||||-..|+||+ ....|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~---~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD---ERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec---ccCcEEEcccc
Confidence 8888888 99999999977 55699999999999999999999999999999999999995 66999999999
Q ss_pred CccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhh
Q 011945 152 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISE 230 (474)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~ 230 (474)
+|+.+-+... |+......-...|||||.+....++.|+|||||||+|||+++ |..||.+....+ .+..+..
T Consensus 848 lArDiy~~~y-----yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~---v~~~~~~ 919 (1025)
T KOG1095|consen 848 LARDIYDKDY-----YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE---VLLDVLE 919 (1025)
T ss_pred hhHhhhhchh-----eeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---HHHHHHh
Confidence 9995444332 222222344679999999999999999999999999999999 999998865432 2222222
Q ss_pred ccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
.. .-..+..||+.+.++|..||+.+|++||+|..|++.+..++..
T Consensus 920 gg----RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 920 GG----RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred CC----ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 22 1223468999999999999999999999999999988877653
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=303.81 Aligned_cols=255 Identities=21% Similarity=0.250 Sum_probs=196.1
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
++|++.+.||.|+||+||+|.+..+++.||||.+.... ....+..|+++++.+.|+ ++..+..+...+...++||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG-NIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCC-CEeeEEEEEecCCeEEEEE
Confidence 67999999999999999999999899999999875432 224578899999999865 4555555666778999999
Q ss_pred ecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 83 DLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 83 e~~g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
||++++|.+++.... ..+++..++.++.||+.||+|||++||+|+||||+||+++ ...+.+||+|||++........
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~--~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 81 EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID--RRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred ecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE--CCCCEEEEcccccccccCCCcc
Confidence 999889988886433 2368899999999999999999999999999999999996 3456899999999976533211
Q ss_pred ccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc--------
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-------- 232 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~-------- 232 (474)
......++..|+|||++.+. .++.++|||||||++|+|++|..||...........+.......
T Consensus 159 -------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 159 -------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGV 231 (294)
T ss_pred -------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccc
Confidence 11234678999999998764 57899999999999999999999997643321111111100000
Q ss_pred -------------ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 233 -------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 233 -------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
...........+++++.+++.+||+.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001111223467889999999999999999999888754
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=303.40 Aligned_cols=255 Identities=21% Similarity=0.272 Sum_probs=198.2
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
++|++.++||+|+||.||+|.+..+++.||||+++.. .....+..|+++++.+.|.+ +..+..++..+...+++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN-IVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCC-eeehhheEEECCEEEEEE
Confidence 4799999999999999999999999999999986543 22356889999999999655 444555556688899999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 83 e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
||+++++.+.+......+++..++.++.||+.||.|||++||+|+||||+||+++ +++.+||+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~---~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS---ESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEEeeecccccCCCccc
Confidence 9997777666554556799999999999999999999999999999999999994 6889999999999876544321
Q ss_pred cccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc----------
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK---------- 231 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~---------- 231 (474)
......++..|+|||++.+. .++.++|||||||++|+|++|..||.+....+.......+...
T Consensus 157 ------~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 157 ------PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred ------cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence 11345788999999999988 7899999999999999999999999764322111111111000
Q ss_pred -------------cccchHHH-HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 232 -------------KVSTSIEA-LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 232 -------------~~~~~~~~-l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
........ ....++.++.++|..||..+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00001111 12235899999999999999999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=303.74 Aligned_cols=249 Identities=24% Similarity=0.346 Sum_probs=194.2
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-------chHHHHHHHHHHHhcCCCCCceeEEEeE-eCCEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-------HPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDYN 78 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-------~~~l~~E~~il~~l~~~~~i~~l~~~~~-~~~~~ 78 (474)
.+|++.+.||+|+||.||+|.+..++..|++|++..... ...+.+|+.+++.++|++++..+..+.. .....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 479999999999999999999999999999998754321 1347889999999987666665554443 35678
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
+++||++ +++|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+||++ +.++.+||+|||++....
T Consensus 82 ~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCccccc
Confidence 8999998 7899999874 3468999999999999999999999999999999999999 467889999999997654
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
...... .......++..|+|||++.+..++.++|||||||++|||++|+.||..... .+.+..+.... ..
T Consensus 158 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~---~~~~~~~~~~~---~~ 227 (266)
T cd06651 158 TICMSG----TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA---MAAIFKIATQP---TN 227 (266)
T ss_pred cccccC----CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch---HHHHHHHhcCC---CC
Confidence 321100 011234688999999999998899999999999999999999999976432 22222221111 11
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
..+...+++.+.+++ .||..+|++||++++|+
T Consensus 228 ~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil 259 (266)
T cd06651 228 PQLPSHISEHARDFL-GCIFVEARHRPSAEELL 259 (266)
T ss_pred CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHh
Confidence 222345678889998 68889999999988874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=298.63 Aligned_cols=249 Identities=19% Similarity=0.315 Sum_probs=208.3
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCch---HHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP---QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~---~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
++.+++..||.|+.|.||+++.+.+|..+|||.+......+ .++..+.++.....++.|+...+|+..+...+|.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 34567788999999999999999999999999887654433 466667777666668888888888888888899999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 84 ~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs-~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
+|..-++.+++...+++++..+-.+...++.||.||.+ +||||||+||+|||+ |..|++||||||++-.+.+...+
T Consensus 172 lMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 172 LMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred HHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceeeccccc
Confidence 99888999998888899999999999999999999997 689999999999999 68999999999999888776543
Q ss_pred cccccccCCCCccCccccccccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~---~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
....|.+.|||||-+.-. .|+.++||||||++|+||+||..||.+.+ ...+.+.++..... +.++
T Consensus 249 --------trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~--tdFe~ltkvln~eP-P~L~- 316 (391)
T KOG0983|consen 249 --------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK--TDFEVLTKVLNEEP-PLLP- 316 (391)
T ss_pred --------ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC--ccHHHHHHHHhcCC-CCCC-
Confidence 345899999999998743 58999999999999999999999999854 34555666655332 2111
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
-..++++.|.+|+..||.+|+.+||.|.+|+
T Consensus 317 ~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll 347 (391)
T KOG0983|consen 317 GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLL 347 (391)
T ss_pred cccCcCHHHHHHHHHHhhcCcccCcchHHHh
Confidence 1245899999999999999999999998774
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=307.18 Aligned_cols=259 Identities=19% Similarity=0.217 Sum_probs=196.4
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEe-------
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVE------- 74 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~------- 74 (474)
.++|++.++||+|+||.||+|.+..+++.||||.+..... ...+.+|+.+++.++|++++..+..+...
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 4679999999999999999999999999999998754322 23457899999999987777666554332
Q ss_pred CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 75 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 75 ~~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
....+++|||++++|.+++......+++.+++.++.||+.||.|||++||+|+||||+|||+ +.++.+||+|||++.
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~ 167 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLADFGLAR 167 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcEEECcCCCcc
Confidence 24569999999999999987655579999999999999999999999999999999999999 477899999999998
Q ss_pred ccccCCCccccccccCCCCccCccccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (474)
.+........ .......++..|+|||.+.+.. ++.++|||||||++|||++|..||.+.........+..+.....
T Consensus 168 ~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 168 AFSLSKNSKP---NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred cccCCcccCC---CCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 7654322110 1112346788999999987654 78999999999999999999999987543222222222211000
Q ss_pred cc-----------------------hHHHHh-cCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 234 ST-----------------------SIEALC-RGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 234 ~~-----------------------~~~~l~-~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.. ....+. ...+..+.++|..||..||++||++++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l 305 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTAL 305 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHh
Confidence 00 000000 11246778999999999999999988775
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=301.41 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=194.5
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-------chHHHHHHHHHHHhcCCCCCceeEEEeE-eCCEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-------HPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDYN 78 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-------~~~l~~E~~il~~l~~~~~i~~l~~~~~-~~~~~ 78 (474)
.+|++.++||+|+||.||+|.+..+++.||||.+..... ...+..|+.+++.+.|++++..+..+.. .....
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 579999999999999999999999999999998653211 1247789999999987666655544333 24577
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
+++|||+ +++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+|||++ .++.++|+|||++....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRD---SVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec---CCCCEEECcCccccccc
Confidence 8999999 78999998743 4689999999999999999999999999999999999994 67899999999998654
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
..... ........|+..|+|||++.+..++.++|||||||++|||++|+.||..... ...+..+......
T Consensus 158 ~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~--- 227 (265)
T cd06652 158 TICLS----GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA---MAAIFKIATQPTN--- 227 (265)
T ss_pred ccccc----ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch---HHHHHHHhcCCCC---
Confidence 32111 0112335689999999999998899999999999999999999999976432 2222222221111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
..+...++..+.+++..|| .+|++||++++|++
T Consensus 228 ~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~ 260 (265)
T cd06652 228 PVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLR 260 (265)
T ss_pred CCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhc
Confidence 1123345678999999999 49999999887753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=300.57 Aligned_cols=254 Identities=22% Similarity=0.318 Sum_probs=201.4
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
++|++.+.||.|+||+||+|.+..++..|++|++.... ....+.+|+++++.++|.+++ .+......+...+++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV-KYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEE-EEEEEEeeCCEEEEEEe
Confidence 57999999999999999999998899999999886543 235688999999999865544 45555667788899999
Q ss_pred cC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 84 ~~-g~sL~~li~~~--~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
++ +++|.+++... ...+++..+..++.||+.||.|||++||+|+||||+||+++ +++.++|+|||++..+....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~---~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc---CCCCEEEcccchHHHhccCc
Confidence 99 88999999753 24689999999999999999999999999999999999994 67889999999998776543
Q ss_pred CccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
... ........|+..|++||++... .++.++|||||||++|+|++|+.||...... +.+.++...... ....
T Consensus 157 ~~~---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~-~~~~ 229 (267)
T cd06610 157 DRT---RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM---KVLMLTLQNDPP-SLET 229 (267)
T ss_pred ccc---ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh---hhHHHHhcCCCC-CcCC
Confidence 321 0112345789999999998877 7899999999999999999999999765432 222222222111 1111
Q ss_pred H--hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 240 L--CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 240 l--~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
. ...+++++.+++..||..||++||++.+|++
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1 1367899999999999999999999887754
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=304.07 Aligned_cols=252 Identities=19% Similarity=0.308 Sum_probs=195.9
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeEe-----CCEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVE-----GDYN 78 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~~-----~~~~ 78 (474)
..++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+..|+.+++.+.+|+++..+..++.. ....
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 3578999999999999999999999999999999876532 235678899999999555566555444432 2467
Q ss_pred EEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 79 VLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~---~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
+++|||+ +++|.++++. ....+++..++.++.|++.||.|||++||+|+||||+||+++ ..+.+||+|||++.
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~---~~~~~kl~dfg~~~ 176 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLT---TEGGVKLVDFGVSA 176 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc---CCCCEEEeecccch
Confidence 9999999 8899998863 345789999999999999999999999999999999999994 67889999999998
Q ss_pred ccccCCCccccccccCCCCccCccccccccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHh
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-----~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (474)
........ .....|+..|+|||++... .++.++|||||||++|||++|+.||..... ...+..+.
T Consensus 177 ~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~---~~~~~~~~ 246 (291)
T cd06639 177 QLTSTRLR-------RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP---VKTLFKIP 246 (291)
T ss_pred hccccccc-------ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH---HHHHHHHh
Confidence 65432211 1234688999999998643 368999999999999999999999976533 22222222
Q ss_pred hccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
....... .....++..+.++|.+||..+|++||++.+|++
T Consensus 247 ~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 247 RNPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred cCCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 2111110 112346678999999999999999999888754
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=305.70 Aligned_cols=246 Identities=21% Similarity=0.338 Sum_probs=198.9
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
...|+++++||.|+||.||+|.+..++..||||++..... ...+..|+.+++.+.| +++..+..++..+...++||
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCEEEEEE
Confidence 3568899999999999999999988999999998765432 2357889999999975 45555555667788999999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
||+ +++|.+++. ..++++..+..++.|++.||.|||+.+|+|+||+|+||+++ ..+.++|+|||++........
T Consensus 82 e~~~~~~L~~~i~--~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~---~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 82 EYLGGGSALDLLR--AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred ecCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc---CCCCEEEcccccceeccCCcc
Confidence 999 889999886 35789999999999999999999999999999999999994 678899999999976643221
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
......++..|+|||++.+..++.++|||||||++|||++|..||....... ....+.... .+.+.
T Consensus 157 -------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~~~~~----~~~~~ 222 (277)
T cd06640 157 -------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---VLFLIPKNN----PPTLT 222 (277)
T ss_pred -------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---HhhhhhcCC----CCCCc
Confidence 1123468889999999999889999999999999999999999998654321 111111111 11233
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
..++..+.+++..||..+|++||++.+++.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 223 GEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred hhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 456889999999999999999999988854
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=313.80 Aligned_cols=256 Identities=21% Similarity=0.216 Sum_probs=198.2
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC----CCchHHHHHHHHHHHhcCCCCCceeEEEeEe----CC
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVE----GD 76 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~----~~ 76 (474)
+.++|++.+.||.|+||+||+|.+..+++.||||.+... .....+..|+.+++.++|.+++..+..+... ..
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 678999999999999999999999999999999987542 1234577899999999877666655444322 13
Q ss_pred EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 77 YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 77 ~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
..+++|||++++|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+|||++ .++.+||+|||+++..
T Consensus 83 ~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~---~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 83 DVYIVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLN---ANCDLKICDFGLARTT 158 (337)
T ss_pred cEEEEEeCCCCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCCCEEECcCcccccc
Confidence 5799999999999999874 45799999999999999999999999999999999999994 6788999999999866
Q ss_pred ccCCCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhh-----
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE----- 230 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~----- 230 (474)
..... ......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+..+..
T Consensus 159 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 159 SEKGD-------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEE 231 (337)
T ss_pred CCCcc-------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChH
Confidence 44321 1133468899999998875 4589999999999999999999999976432111111111000
Q ss_pred ------------------ccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 231 ------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 231 ------------------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.............+++++.++|.+||..+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~ 290 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHc
Confidence 00011122334568899999999999999999999777643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=313.91 Aligned_cols=259 Identities=18% Similarity=0.238 Sum_probs=200.3
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeE---eCCE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGV---EGDY 77 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~---~~~~ 77 (474)
++++|++.+.||.|+||.||+|.+..+++.||||++.... ....+..|+.+++.++|++++..+..+.. ....
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 5689999999999999999999999999999999876532 23457789999999996665555444332 4457
Q ss_pred EEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 78 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 78 ~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
.+++|||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 83 ~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~---~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 83 VYVVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN---EDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEEehhhhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEecccccceeec
Confidence 899999999899998863 45699999999999999999999999999999999999994 78899999999998765
Q ss_pred cCCCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHH--------
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI-------- 228 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i-------- 228 (474)
...... ........|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.........+...
T Consensus 159 ~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 159 SSPTEH---KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred ccCcCC---CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 432211 011134578999999999876 45899999999999999999999999764332111111110
Q ss_pred ---------------hhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 229 ---------------SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 229 ---------------~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
...........+...++.++.++|..||+.+|++||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l 292 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQAL 292 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 001111122334456789999999999999999999987653
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=303.11 Aligned_cols=253 Identities=20% Similarity=0.232 Sum_probs=196.0
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
+|++++.||.|+||.||+|++..+++.||||.+..... ...+..|+++++.++|++++..+ .+...+...+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~-~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL-DVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchh-hhcccCCcEEEEee
Confidence 48999999999999999999999999999998764332 24688999999999876555544 44567778899999
Q ss_pred cCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 84 LLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 84 ~~g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
|+.++|.+++... ...+++..++.++.||+.||+|||++||+|+||+|+||++ +.++.+||+|||++..+.....
T Consensus 80 ~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 80 FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred ccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcccCcc-
Confidence 9988999988643 3568999999999999999999999999999999999999 4778999999999876543221
Q ss_pred cccccccCCCCccCccccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc---------
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--------- 232 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 232 (474)
......++..|+|||++.+.. ++.++|||||||++|||++|+.||.+.........+.......
T Consensus 156 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 156 ------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred ------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence 112235688999999987754 6889999999999999999999997643221111111100000
Q ss_pred ------------ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 233 ------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 233 ------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.......+...+++++.++|.+||..||++||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 011122233457889999999999999999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=301.25 Aligned_cols=253 Identities=22% Similarity=0.287 Sum_probs=197.4
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
+|++.++||.|++|.||+|++..+++.||||++.... ....+..|+.+++.++| +++..+..++......+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKH-ENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcC-CCEeeeeeeEeeCCcEEEEEec
Confidence 5899999999999999999999999999999876543 23457789999999975 5556666666777888999999
Q ss_pred CCCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 85 LGPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 85 ~g~sL~~li~~~~--~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
+.++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.++|+|||++........
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 80 MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred CCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCCcc-
Confidence 9889999887443 468999999999999999999999999999999999999 4678999999999976543211
Q ss_pred cccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc--------
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------- 233 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 233 (474)
......++..|++||++.+. .++.++|||||||++|+|++|+.||.+.........+........
T Consensus 156 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07836 156 ------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS 229 (284)
T ss_pred ------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence 11234678899999998764 478999999999999999999999987543222221111110000
Q ss_pred -------------cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 234 -------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 234 -------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
......+...++.++.+++..||+.||++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00112223456789999999999999999999887753
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=316.05 Aligned_cols=274 Identities=21% Similarity=0.257 Sum_probs=221.1
Q ss_pred CCccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCC
Q 011945 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 76 (474)
Q Consensus 2 ~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (474)
.|+-.+.|..-++||+||||+||-|+-..||+.||+|.+..+. ...-..+|..||.+++.. .|+.+.+.....+
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~-FiVslaYAfeTkd 258 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSP-FIVSLAYAFETKD 258 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccC-cEEEEeeeecCCC
Confidence 4666788999999999999999999999999999999754432 233467899999999854 7777777778888
Q ss_pred EEEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 77 YNVLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
..|+||.+| ||+|.-.|.+.+ ..|++..++.++.+|+.||++||..+||+|||||+|||+ |+.|+|.|+|+|||.
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAv 335 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAV 335 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEE
Confidence 899999999 889977775443 459999999999999999999999999999999999999 689999999999999
Q ss_pred ccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (474)
.+...... ...+||.+|||||++.++.|+...|+|||||+||||+.|+-||...+.....+.++ .. ..
T Consensus 336 ei~~g~~~--------~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd---rr-~~ 403 (591)
T KOG0986|consen 336 EIPEGKPI--------RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD---RR-TL 403 (591)
T ss_pred ecCCCCcc--------ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH---HH-Hh
Confidence 88775542 34589999999999999999999999999999999999999998755433332222 21 22
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHH-----HHHHHHHHHHHHcCCCCCCccccccccccccccC
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA-----YLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVS 301 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~-----~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~~~ 301 (474)
...+++...++++.++|++..|.+||.+|-... ++.+ .++...++|..+......++
T Consensus 404 ~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~----------HpfFk~lnw~rleagml~PP 465 (591)
T KOG0986|consen 404 EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE----------HPFFKDLNWRRLEAGMLEPP 465 (591)
T ss_pred cchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh----------CcccccCCHhHHhccCCCCC
Confidence 334456678999999999999999999997532 2221 34555688987765544433
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=300.72 Aligned_cols=239 Identities=18% Similarity=0.214 Sum_probs=185.4
Q ss_pred eeeeecCceEEEEEEEcCCC----------eEEEEEEeccCCC-chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 13 RKIGSGSFGEIYLGTNIQTN----------EEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~----------~~vAvK~~~~~~~-~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
+.||+|+||.||+|.+..++ ..|++|+...... ...+.+|+.+++.+.|++++..+..+ .. ...+++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVC-VR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEE-ec-CCcEEE
Confidence 47899999999999987766 4588887655433 46788999999999876665555444 33 567899
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCC----CCCeEEEEecCCcccc
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR----RANQVYIIDFGLAKRY 156 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~----~~~~vkL~DFGla~~~ 156 (474)
|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.+. ....+||+|||++...
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~ 158 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV 158 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccc
Confidence 9999 8899999875555799999999999999999999999999999999999996322 1127999999999865
Q ss_pred ccCCCccccccccCCCCccCccccccccccCC--CCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccc
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV 233 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~--~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (474)
... ....++..|+|||++.+. .++.++|||||||++|||++ |..||...........+. ....
T Consensus 159 ~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---~~~~ 224 (259)
T cd05037 159 LSR-----------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---DQHR 224 (259)
T ss_pred ccc-----------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---cCCC
Confidence 431 123567889999999877 78999999999999999999 688887754322222221 1100
Q ss_pred cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011945 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 273 (474)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (474)
........+.+++.+||..+|++||++.+|++.|
T Consensus 225 ------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 225 ------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred ------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0111237899999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=300.51 Aligned_cols=252 Identities=20% Similarity=0.322 Sum_probs=197.6
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC--------chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--------~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
+|++.+.||.|+||.||+|.+ .+++.||||++..... ...+.+|+.+++.++|.+ +..+..++.+....+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN-IVQYLGTCLDDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCC-EeeEeeEeecCCeEE
Confidence 588999999999999999986 5788999998764321 134788999999998655 445555566678999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
++|||+ +++|.+++.. ...+++..+..++.||+.||+|||+.||+|+||||+||++ +..+.++|+|||++.....
T Consensus 79 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 79 IFMEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHhhhh
Confidence 999999 8899999974 3568999999999999999999999999999999999999 4778999999999986533
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
....... ........|+..|+|||++.+..++.++|||||||++|+|++|..||...... .....+... ....+
T Consensus 155 ~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~~--~~~~~ 228 (265)
T cd06631 155 VGLHGTH-SNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL---AAMFYIGAH--RGLMP 228 (265)
T ss_pred ccccccc-cccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH---HHHHHhhhc--cCCCC
Confidence 2111000 01123457899999999999988999999999999999999999999764321 111111111 11222
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.+...++.++.++|..||..+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 229 RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 345678899999999999999999999887753
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=331.43 Aligned_cols=256 Identities=20% Similarity=0.239 Sum_probs=184.4
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCC-eEEEEE------------------Eecc-CCCchHHHHHHHHHHHhcCCCC
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIK------------------LENV-KTKHPQLQYEAKLYKILQGGTG 64 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~-~~vAvK------------------~~~~-~~~~~~l~~E~~il~~l~~~~~ 64 (474)
+.++|+++++||+|+||+||+|..+... +.+++| .+.. ......+.+|+.+++.++|+++
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 4578999999999999999998764322 222222 1111 1122357899999999986655
Q ss_pred CceeEEEeEeCCEEEEEEecCCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCC
Q 011945 65 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 140 (474)
Q Consensus 65 i~~l~~~~~~~~~~~lv~e~~g~sL~~li~~~----~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~ 140 (474)
+. +..+.......|+++++++++|.+++... ........++.|+.||+.||.|||++|||||||||+|||| +
T Consensus 226 v~-l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl---~ 301 (501)
T PHA03210 226 LK-IEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL---N 301 (501)
T ss_pred Cc-EeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---C
Confidence 54 55556677788999999998998887532 1224567788999999999999999999999999999999 4
Q ss_pred CCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCc
Q 011945 141 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220 (474)
Q Consensus 141 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~ 220 (474)
.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||+||||++|..++.......
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~ 375 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREA------FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK 375 (501)
T ss_pred CCCCEEEEeCCCceecCccccc------ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence 7789999999999876543221 1234679999999999999999999999999999999999876543322222
Q ss_pred HHHHHHHHhhc------ccc-------------------chHHHHh--cCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 221 KKQKYEKISEK------KVS-------------------TSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 221 ~~~~~~~i~~~------~~~-------------------~~~~~l~--~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
....+.++... .+. ..+..+. ..++..+.++|.+||..||++||++.+++
T Consensus 376 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL 452 (501)
T PHA03210 376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELL 452 (501)
T ss_pred HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHh
Confidence 22222211110 000 0111111 24677889999999999999999988874
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=307.25 Aligned_cols=248 Identities=22% Similarity=0.325 Sum_probs=197.2
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
.++|++.+.||+|+||.||+|.+..+++.||||.+..... ...+..|+.+++.+.|.+++ .+..++..+...+++||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~-~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV-NYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEe-eEEEEEecCCEEEEeec
Confidence 4789999999999999999999999999999998765432 34578899999998765544 44445566778899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
|+ +++|.+++. ...+++..++.++.|++.||.|||+.||+||||||+|||++ .++.++|+|||++.........
T Consensus 97 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~---~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 97 YLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred ccCCCCHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEECcCccceEccCCccC
Confidence 99 889999986 34689999999999999999999999999999999999994 6789999999999765433211
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhc
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (474)
.....+++.|+|||.+.+..++.++|||||||++|+|++|..||....... ....+.... ........
T Consensus 172 -------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~---~~~~~~~~~--~~~~~~~~ 239 (297)
T cd06656 172 -------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYLIATNG--TPELQNPE 239 (297)
T ss_pred -------cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch---heeeeccCC--CCCCCCcc
Confidence 123478899999999999889999999999999999999999997643311 111111100 00111224
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.++..+.+++.+||..+|++||++.+|++
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 57789999999999999999999887754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=318.40 Aligned_cols=254 Identities=22% Similarity=0.319 Sum_probs=210.5
Q ss_pred EEeeeeeecCceEEEEEEEcCC--C--eEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 10 RLGRKIGSGSFGEIYLGTNIQT--N--EEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 10 ~i~~~LG~G~fG~Vy~a~~~~~--~--~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.+.++||.|.||.||.|..... | --||||..+.+. ..+.|..|..+|+.+.|+++|..++.+. ....||||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~--e~P~Wivm 469 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV--EQPMWIVM 469 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee--ccceeEEE
Confidence 3457899999999999986432 2 358899876643 3456999999999999777776665543 34579999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
|++ -|-|..+++..+..++..+...++.||+.+|.|||++.+|||||-..|||+. ...+|||+|||+++.+.+...
T Consensus 470 EL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs---Sp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 470 ELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS---SPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred ecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec---Ccceeeecccchhhhccccch
Confidence 999 8899999998788899999999999999999999999999999999999995 788999999999998887654
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
|. .....-...|||||.+.-..++.++|||-|||+|||++. |..||++.+..+....+++ ......
T Consensus 547 -----Yk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn-------GeRlP~ 613 (974)
T KOG4257|consen 547 -----YK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN-------GERLPC 613 (974)
T ss_pred -----hh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC-------CCCCCC
Confidence 22 223345678999999998899999999999999999987 9999999877654333322 222334
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 281 (474)
++.||+.+..|+.+||+++|.+||++.+|...|.++++.+.
T Consensus 614 P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek 654 (974)
T KOG4257|consen 614 PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEK 654 (974)
T ss_pred CCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhh
Confidence 57899999999999999999999999999999999998554
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.54 Aligned_cols=264 Identities=24% Similarity=0.325 Sum_probs=217.6
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
.++|.|+++||+|+||+|.+++.+.+++.||+|+++... ...-|..|-.+|-.-. ...|..+++.+.++.+.|+
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n-s~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN-SEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC-cHHHHHHHHHhcCccceEE
Confidence 468999999999999999999999999999999887532 2233666777776544 6778888888899999999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
||||+ ||+|..++.... +++++.+..++..|+.||.-||+.|+|||||||+|||| +..|++||+|||.|..+..+
T Consensus 153 VMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred EEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHhcCCC
Confidence 99999 999999998666 89999999999999999999999999999999999999 58999999999999888765
Q ss_pred CCccccccccCCCCccCcccccccccc----C-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHL----G-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~----~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (474)
..-. ....+|||.|++||++. + +.|++.+|+||+||++|||+.|..||+. ......|.+|...+-.
T Consensus 229 G~V~------s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa---dslveTY~KIm~hk~~ 299 (1317)
T KOG0612|consen 229 GTVR------SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA---DSLVETYGKIMNHKES 299 (1317)
T ss_pred CcEE------eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH---HHHHHHHHHHhchhhh
Confidence 4422 34569999999999987 2 4689999999999999999999999976 4667788888877544
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCCCCC---HHHHHHHHHHHHHHcCCCCCCccccccccc
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPD---YAYLKRLFRDLFIREGFQFDYVFDWTILKY 295 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt---~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 295 (474)
..++.. ..++++.++||...+. +|+.|.. ++++.. .+|....+|...+.
T Consensus 300 l~FP~~-~~VSeeakdLI~~ll~-~~e~RLgrngiedik~----------HpFF~g~~W~~iR~ 351 (1317)
T KOG0612|consen 300 LSFPDE-TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN----------HPFFEGIDWDNIRE 351 (1317)
T ss_pred cCCCcc-cccCHHHHHHHHHHhc-ChhhhcccccHHHHHh----------CccccCCChhhhhh
Confidence 333322 3488999999999875 5888877 554432 36677789976543
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=297.53 Aligned_cols=244 Identities=20% Similarity=0.305 Sum_probs=191.9
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-CCC
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS 88 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~s 88 (474)
++||+|+||.||+|.. .++..||+|++..... ...+..|+.+++.+.|.+++. +..++......+++|||+ +++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVK-LIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCe-EEEEEecCCccEEEEECCCCCc
Confidence 4789999999999985 5688999998765432 234788999999998655554 444556667789999998 899
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccccc
Q 011945 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 168 (474)
Q Consensus 89 L~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 168 (474)
|.+++......+++..++.++.|++.+|.|||++|++||||||+||+++ .++.+||+|||++.........
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~---~~~~~~l~d~g~~~~~~~~~~~------ 149 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYS------ 149 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEc---CCCeEEECCCccceeccccccc------
Confidence 9999875556789999999999999999999999999999999999994 7789999999999754332211
Q ss_pred cCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHH
Q 011945 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 247 (474)
Q Consensus 169 ~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 247 (474)
......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.... .....+.... . ......++..
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~---~~~~~~~~~~-~---~~~~~~~~~~ 222 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ---QAREQVEKGY-R---MSCPQKCPDD 222 (250)
T ss_pred cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcCC-C---CCCCCCCCHH
Confidence 1112244678999999998889999999999999999998 99999875432 2222222211 1 1123467899
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011945 248 FASYFHYCRSLRFDDKPDYAYLKRLFR 274 (474)
Q Consensus 248 l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (474)
+.+++.+||..+|++||++.++.+.|.
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 999999999999999999999987763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=303.25 Aligned_cols=253 Identities=22% Similarity=0.258 Sum_probs=193.7
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
++|++.++||+|+||.||+|.+..+++.||+|++..... .+.+..|+++++.+.|.+++. +..++..+...+++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVN-LIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhh-HHHhcccCCeEEEEE
Confidence 579999999999999999999988999999998654322 345788999999998665554 444456778899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
||+ +++|.++.. ....+++..++.++.||+.||.|||+.||+|+||+|+||++ +.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 80 EFVDHTVLDDLEK-YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred ecCCccHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCcc
Confidence 999 455555544 34569999999999999999999999999999999999999 4778999999999986544321
Q ss_pred ccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc---------
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--------- 231 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~--------- 231 (474)
......++..|+|||++.+. .++.++|||||||++|||++|..||...........+..+...
T Consensus 156 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 156 -------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred -------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence 11235688999999998764 4788999999999999999999999754321111111110000
Q ss_pred --------------cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 232 --------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 232 --------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
............++..+.+++..||..+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0001112234567899999999999999999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=312.81 Aligned_cols=258 Identities=19% Similarity=0.229 Sum_probs=197.3
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeEe--------
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVE-------- 74 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~~-------- 74 (474)
++++|.+.+.||.|+||.||+|.+..+++.||+|++..... ...+..|+++++.++|++++..+..+...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 57899999999999999999999999999999998765432 34588899999999877766655433322
Q ss_pred -----CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEe
Q 011945 75 -----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (474)
Q Consensus 75 -----~~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~D 149 (474)
....+++|||++++|.+++. ...+++..++.++.||+.||.|||+.||+||||||+||+++ ..++.+||+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~--~~~~~~kl~d 158 (342)
T cd07854 83 GSLTELNSVYIVQEYMETDLANVLE--QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKIGD 158 (342)
T ss_pred ccccccceEEEEeecccccHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc--CCCceEEECC
Confidence 24678999999989988886 34699999999999999999999999999999999999995 3556899999
Q ss_pred cCCccccccCCCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHH
Q 011945 150 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (474)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i 228 (474)
||++.......... .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.............
T Consensus 159 fg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 159 FGLARIVDPHYSHK----GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred cccceecCCccccc----cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99997654322111 01122367889999998764 56889999999999999999999999765432111111100
Q ss_pred h----------------------hccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 229 S----------------------EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 229 ~----------------------~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
. ..........+...++.++.+|+..||..||++||++.+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell 298 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHh
Confidence 0 00111122233456788999999999999999999988774
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=297.37 Aligned_cols=249 Identities=21% Similarity=0.289 Sum_probs=197.8
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 85 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (474)
.+|++.+.||.|+||.||+|.+. .+..+|||++..... ...+..|+++++.+.|++++ .+..+.......+++|||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~-~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLV-QLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCee-eEEEEEccCCceEEEEEcC
Confidence 57999999999999999999874 467899998765433 35789999999999866554 4445556667789999998
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccc
Q 011945 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164 (474)
Q Consensus 86 -g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (474)
+++|.+++......+++..++.++.|++.||.|||++||+|+||||+||+++ .++.+||+|||++.........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~~~~~~~~-- 156 (256)
T cd05112 82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVLDDQYT-- 156 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc---CCCeEEECCCcceeecccCccc--
Confidence 7899999876566789999999999999999999999999999999999994 6788999999999765432211
Q ss_pred cccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcC
Q 011945 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (474)
Q Consensus 165 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (474)
......++..|+|||++.+..++.++|||||||++|||++ |..||..... ......+...... .....
T Consensus 157 ----~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~~ 225 (256)
T cd05112 157 ----SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVETINAGFRL----YKPRL 225 (256)
T ss_pred ----ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHhCCCCC----CCCCC
Confidence 1122345678999999998889999999999999999998 9999976432 2233332221110 11234
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011945 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLF 273 (474)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (474)
.+.++.+|+.+||+.+|++||++.++++.|
T Consensus 226 ~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 688999999999999999999999997765
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=302.73 Aligned_cols=247 Identities=19% Similarity=0.328 Sum_probs=198.8
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
++|++.+.||.|+||.||+|.+..+++.||+|.+..... ...+.+|+++++.+.|++ +..+..++......++++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~-i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY-IVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCc-hhhhheeeecCCEEEEEEE
Confidence 468899999999999999999999999999998765432 345888999999998555 4445545566688999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs-~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
++ +++|.+++......+++..+..++.||+.||.|||+ .||+|+||||+||+++ ..+.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~---~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN---SRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC---CCCCEEEeecccchhhHHHHh
Confidence 99 589999998655789999999999999999999999 9999999999999995 678899999999876643221
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--CcHHHHHHHHhhccccchHHH
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA--GTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~i~~~~~~~~~~~ 239 (474)
....++..|+|||.+.+..++.++|||||||++|+|++|..||..... ......+..+...... .
T Consensus 157 ---------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~ 223 (265)
T cd06605 157 ---------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP----R 223 (265)
T ss_pred ---------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCC----C
Confidence 125788999999999999999999999999999999999999975421 1222222222222111 1
Q ss_pred HhcC-CcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 240 LCRG-YPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 240 l~~~-~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
+... ++.++.++|..||..+|++||++.+++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 255 (265)
T cd06605 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKELL 255 (265)
T ss_pred CChhhcCHHHHHHHHHHcCCCchhCcCHHHHh
Confidence 1222 788999999999999999999988774
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=305.62 Aligned_cols=256 Identities=19% Similarity=0.223 Sum_probs=197.1
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeEeC--CEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEG--DYN 78 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~~~--~~~ 78 (474)
..++|++.+.||.|+||.||+|.+..+++.|+||.++..... ..+.+|+.+++.+.|.+++ .+..+.... ...
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~-~~~~~~~~~~~~~~ 81 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIV-TVKEVVVGSNLDKI 81 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEE-EEEEEEEecCCCcE
Confidence 346899999999999999999999989999999987654322 2467899999999965544 444444444 789
Q ss_pred EEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 79 VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 79 ~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
|++|||++++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||+ +.++.+||+|||++..+..
T Consensus 82 ~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 82 YMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREYGS 158 (293)
T ss_pred EEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceeeccC
Confidence 9999999889999998666679999999999999999999999999999999999999 4778999999999987654
Q ss_pred CCCccccccccCCCCccCccccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc---
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS--- 234 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~--- 234 (474)
... ......++..|+|||.+.+.. ++.++|||||||++|+|++|..||...........+.........
T Consensus 159 ~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (293)
T cd07843 159 PLK-------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIW 231 (293)
T ss_pred Ccc-------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHH
Confidence 321 112346788999999987654 689999999999999999999999865432222221111100000
Q ss_pred -------------------chH-HHHhcC-CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 235 -------------------TSI-EALCRG-YPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 235 -------------------~~~-~~l~~~-~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
..+ ..+... +++.+.++|..||..+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 232 PGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred HHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000 111111 4788999999999999999999888754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=301.33 Aligned_cols=253 Identities=19% Similarity=0.250 Sum_probs=197.1
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeE-eCCEEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDYNVLVI 82 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~-~~~~~~lv~ 82 (474)
++|++.++||.|++|.||+|.+..+++.||+|.+..... ...+.+|+++++.+.|++++..+..+.. .....+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 579999999999999999999999999999998765432 3458899999999987766666555533 345789999
Q ss_pred ecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 83 DLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 83 e~~-g~sL~~li~~---~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
||+ +++|.+++.. ....+++..++.++.||+.||.|||+.||+|+||+|+||+++ .++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~---~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT---RKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe---cCCeEEEeeccccccccc
Confidence 999 7899988753 245689999999999999999999999999999999999994 678899999999875543
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--CcHHHHHHHHhhccccch
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA--GTKKQKYEKISEKKVSTS 236 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~i~~~~~~~~ 236 (474)
... ....++..|+|||.+.+..++.++|||||||++|+|++|..||..... ....+....+........
T Consensus 158 ~~~---------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd06621 158 SLA---------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPEL 228 (287)
T ss_pred ccc---------ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhh
Confidence 221 234678899999999998999999999999999999999999986532 122222222222111110
Q ss_pred HHHHh--cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 237 IEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 237 ~~~l~--~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
..... ..+++++.+++.+||..+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 00000 234678999999999999999999877643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=301.27 Aligned_cols=250 Identities=20% Similarity=0.276 Sum_probs=187.5
Q ss_pred eeeeecCceEEEEEEEc--CCCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-C
Q 011945 13 RKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 86 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~--~~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (474)
+.||+|+||.||+|.+. .++..+|+|.+...... ..+.+|+.+++.++|++++.. ..++.+....++||||+ +
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~-~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC-LGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeE-EEEEcCCCCcEEEEECCCC
Confidence 46899999999999864 34568999987654322 357889999999987665554 44555667789999999 7
Q ss_pred CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 87 PSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 87 ~sL~~li~~~~----~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++ ..+.+||+|||+++.......
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~---~~~~~kL~dfg~~~~~~~~~~- 155 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLT---ADLTVKIGDYGLSHNKYKEDY- 155 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc---CCCcEEECCccccccccCcce-
Confidence 89999986432 2467788889999999999999999999999999999994 678999999999975433221
Q ss_pred cccccccCCCCccCccccccccccCC-------CCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhcccc
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGI-------EQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS 234 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~-------~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (474)
+.......++..|+|||++.+. .++.++|||||||++|||++ |..||......... ...+......
T Consensus 156 ----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~--~~~~~~~~~~ 229 (269)
T cd05087 156 ----YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL--TYTVREQQLK 229 (269)
T ss_pred ----eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH--HHHhhcccCC
Confidence 1112345678899999998643 35789999999999999996 99999765432211 1112222222
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 274 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (474)
...+.+...+++.+.+++..|| .+|++||++++|...|.
T Consensus 230 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222333457889999999999 68999999999987763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=313.17 Aligned_cols=264 Identities=18% Similarity=0.246 Sum_probs=201.9
Q ss_pred CCCccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC----CCchHHHHHHHHHHHh-cCCCCCceeEEEeE-e
Q 011945 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKIL-QGGTGIPNLRWFGV-E 74 (474)
Q Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~----~~~~~l~~E~~il~~l-~~~~~i~~l~~~~~-~ 74 (474)
+++.+.++|++.+.||+|+||.||+|.+..+++.||||.+... .....+..|+.++..+ +|.+++..+..+.. .
T Consensus 1 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~ 80 (337)
T cd07852 1 IDKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN 80 (337)
T ss_pred CCchhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC
Confidence 3678899999999999999999999999889999999976432 2234577899999999 65555555544433 3
Q ss_pred CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 75 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 75 ~~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
....++||||++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus 81 ~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~---~~~~~kl~d~g~~~ 155 (337)
T cd07852 81 DKDIYLVFEYMETDLHAVIRA--NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLN---SDCRVKLADFGLAR 155 (337)
T ss_pred CceEEEEecccccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc---CCCcEEEeeccchh
Confidence 457899999999899998873 3789999999999999999999999999999999999994 78899999999998
Q ss_pred ccccCCCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhh---
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE--- 230 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~--- 230 (474)
.+....... .......+.||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 156 ~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07852 156 SLSELEENP--ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233 (337)
T ss_pred ccccccccc--cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 765433211 0012234578999999998875 4578999999999999999999999976443222111111100
Q ss_pred --------------------ccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 231 --------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 231 --------------------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.........+...++.++.++|..||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 00111222334557899999999999999999999887754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=300.43 Aligned_cols=249 Identities=18% Similarity=0.258 Sum_probs=185.6
Q ss_pred eeeeecCceEEEEEEEcC--CCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-C
Q 011945 13 RKIGSGSFGEIYLGTNIQ--TNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 86 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~--~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (474)
+.||+|+||.||+|.... ....|++|.+..... ...+.+|+.+++.++|++++..+ ..+......+++|||+ +
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~-~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL-GQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEE-EEECCCCceEEEEEeCCC
Confidence 468999999999997533 345788887654322 23477899999999866655544 4555667789999999 7
Q ss_pred CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 87 PSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 87 ~sL~~li~~~~----~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccchhe
Confidence 89999987533 235678899999999999999999999999999999999 47789999999998754322110
Q ss_pred cccccccCCCCccCccccccccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHH-Hhhccc
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEK-ISEKKV 233 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~-------~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~-i~~~~~ 233 (474)
.......++..|+|||++.. ..++.++|||||||++|||++ |..||...... ..+.. +.....
T Consensus 157 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~~~~~~~ 228 (269)
T cd05042 157 -----ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE---QVLKQVVREQDI 228 (269)
T ss_pred -----eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHHHHHhhccCc
Confidence 01123356788999998753 357889999999999999999 88999765332 22222 222222
Q ss_pred cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011945 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 274 (474)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (474)
....+.+...++..+.+++..|| .||++||++++|.++|.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 229 KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 22223344578899999999999 59999999999988763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=302.21 Aligned_cols=234 Identities=23% Similarity=0.301 Sum_probs=182.1
Q ss_pred eeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhc--CCCCCceeEEEeEeCCEEEEEEecC-
Q 011945 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQ--GGTGIPNLRWFGVEGDYNVLVIDLL- 85 (474)
Q Consensus 14 ~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~--~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (474)
.||+|+||.||++.+..+++.||||++..... ......|..+++.+. +++++..+..+...++..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999999999999998754321 122445555555443 4566666666666777889999998
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccc
Q 011945 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 165 (474)
Q Consensus 86 g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (474)
+++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||+ +.++.++|+|||++........
T Consensus 81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~~---- 152 (279)
T cd05633 81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKP---- 152 (279)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceeccccCc----
Confidence 8899888864 4569999999999999999999999999999999999999 4778999999999975543221
Q ss_pred ccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCC
Q 011945 166 PYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (474)
Q Consensus 166 ~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (474)
....||..|+|||++.+ ..++.++|||||||++|||++|..||.......... ...... .....++..+
T Consensus 153 -----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~----~~~~~~~~~~ 222 (279)
T cd05633 153 -----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTL----TVNVELPDSF 222 (279)
T ss_pred -----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH-HHHHhh----cCCcCCcccc
Confidence 23468999999999874 568999999999999999999999998654433222 221111 1111234568
Q ss_pred cHHHHHHHHHHhcCCCCCCCC
Q 011945 245 PTEFASYFHYCRSLRFDDKPD 265 (474)
Q Consensus 245 p~~l~~li~~cl~~dp~~RPt 265 (474)
+.++.++|..||..||++||+
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~ 243 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLG 243 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcC
Confidence 899999999999999999994
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=306.65 Aligned_cols=252 Identities=19% Similarity=0.325 Sum_probs=200.2
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
-.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|+.++..+..++++..+..++......+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 35789999999999999999999988899999999865432 234666777777777677777777777888899999
Q ss_pred EecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs-~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||++++|.+++......+++..+..++.||+.||.|||+ .||+||||+|+||++ +.++.+||+|||++..+....
T Consensus 93 ~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 93 MELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred eeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccchhccCCC
Confidence 9999999999988666789999999999999999999997 699999999999999 467899999999997664432
Q ss_pred CccccccccCCCCccCccccccccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccch
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~----~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (474)
.. ....++..|+|||++.+.. ++.++|||||||++|+|++|+.||..... ..+.+..+.......
T Consensus 170 ~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~- 238 (296)
T cd06618 170 AK--------TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT--EFEVLTKILQEEPPS- 238 (296)
T ss_pred cc--------cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh--HHHHHHHHhcCCCCC-
Confidence 21 2235788999999987654 78999999999999999999999975322 122233322221111
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.+ ....++.++.+|+.+||..||++||+++++++
T Consensus 239 ~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 239 LP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred CC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 11247889999999999999999999888754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=296.55 Aligned_cols=245 Identities=22% Similarity=0.323 Sum_probs=194.4
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-CCC
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS 88 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~s 88 (474)
++||.|+||.||+|.+.. ++.||+|++..... ...+..|+++++.+.|. ++..+..++......+++||++ +++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHP-NIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCC-CeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 479999999999999876 99999998765433 24688899999999865 4555556667777889999998 889
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccccc
Q 011945 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 168 (474)
Q Consensus 89 L~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 168 (474)
|.+++......+++..++.++.|++.||.|||+++|+||||||+|||+ +.++.+||+|||++..........
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~----- 150 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTV----- 150 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCccee-----
Confidence 999997655678999999999999999999999999999999999999 477899999999997654221100
Q ss_pred cCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHH
Q 011945 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 247 (474)
Q Consensus 169 ~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 247 (474)
......++..|+|||.+.+..++.++|||||||++|||++ |..||......... ..+... ... .....+|.+
T Consensus 151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~---~~~~~~-~~~---~~~~~~~~~ 223 (251)
T cd05041 151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR---ERIESG-YRM---PAPQLCPEE 223 (251)
T ss_pred ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH---HHHhcC-CCC---CCCccCCHH
Confidence 0012234677999999998889999999999999999999 89999775432222 222111 111 123467899
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011945 248 FASYFHYCRSLRFDDKPDYAYLKRLFR 274 (474)
Q Consensus 248 l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (474)
+.+++.+||..+|++||++.+|++.|+
T Consensus 224 ~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 224 IYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=308.70 Aligned_cols=252 Identities=21% Similarity=0.242 Sum_probs=199.5
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
.+.++|++.+.||.|+||.||+|.+..+++.||||.+... .....+..|+.+++.+.|++++..+..+.......+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 3678999999999999999999999999999999976432 223567889999999998777776666655567789
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 80 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 80 lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
++||+++++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||+ +..+.++|+|||++......
T Consensus 87 lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 87 FVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred EEeehhccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCccccccccCCC
Confidence 999999999998886 4468999999999999999999999999999999999999 46789999999999754321
Q ss_pred CCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHh---------
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS--------- 229 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~--------- 229 (474)
. ....++..|+|||.+.+ ..++.++|||||||++|+|++|..||...........+.+..
T Consensus 162 ~----------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 162 M----------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred c----------CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 1 23467889999998876 568999999999999999999999997643211111111110
Q ss_pred --------------hccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 230 --------------EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 230 --------------~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
......+.......+++++.++|.+||..+|++||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell 286 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL 286 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 00011122334456789999999999999999999987763
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=297.02 Aligned_cols=248 Identities=26% Similarity=0.398 Sum_probs=198.5
Q ss_pred EEEeeeeeecCceEEEEEEEcCCC----eEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~----~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
+.+.+.||.|+||.||+|.+...+ ..||+|++..... ...+..|+.+++.+.| +++..+..+.......+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDH-PNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCC-CchheEEEEEcCCCeeEEE
Confidence 467899999999999999998766 8999999865543 3468899999999964 5555565556666788999
Q ss_pred EecC-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 82 IDLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~-l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
||++ +++|.+++...... +++..++.++.||+.||.|||+.||+|+||||+||+++ ..+.++|+|||++......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~---~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG---ENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEc---cCCeEEEcccCCceecccc
Confidence 9998 88999999754434 99999999999999999999999999999999999994 6779999999999876554
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
.... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||..... ...+..+......
T Consensus 157 ~~~~------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~---- 223 (258)
T smart00219 157 DYYK------KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYLKKGYRL---- 223 (258)
T ss_pred cccc------cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcCCCC----
Confidence 2211 112237789999999988889999999999999999998 8899976432 3333333332221
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 273 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (474)
.....++.++.+++.+||..+|++||++.++++.|
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 12345789999999999999999999999987653
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=296.51 Aligned_cols=249 Identities=24% Similarity=0.331 Sum_probs=205.0
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
++|++.+.||.|++|.||+|.+..+++.|+||++..... ...+..|+.++..++|+ ++..+..+.......+++||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESP-YVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCC-CeeeEEEEEccCCeEEEEEE
Confidence 479999999999999999999999999999998876543 45688999999999854 55556556667788999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs-~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
|+ +++|.+++... ..+++..++.++.||+.||.|||+ .|++|+||+|+||++ +.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 80 YMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceecccCCC
Confidence 99 69999999743 679999999999999999999999 999999999999999 4788999999999987654332
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
. .....++..|+|||.+.+..++.++||||||+++|+|++|..||.........+....+..... ..+.
T Consensus 156 ~-------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~ 224 (264)
T cd06623 156 Q-------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP----PSLP 224 (264)
T ss_pred c-------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC----CCCC
Confidence 1 1234688999999999998899999999999999999999999987653333444444332221 1223
Q ss_pred cC-CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 242 RG-YPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 242 ~~-~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.. ++..+.++|..||..+|++||++.++++
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 44 7899999999999999999999887754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=297.82 Aligned_cols=246 Identities=21% Similarity=0.243 Sum_probs=200.3
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
+|++.++||+|+||.||++.+..+++.||||.+.... ....+.+|+.+++.++|.+ +..+..+.......+++||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN-IVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCC-eeeeEeeecCCCeEEEEEe
Confidence 6999999999999999999999999999999876432 2346889999999998655 5555556677788999999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 84 ~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
|+ +++|.+++... ...+++..++.++.||+.||.|||++|++|+||+|+|||++ .++.++|+|||++..+.....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~---~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCCCEEEeeccceeecCcchh
Confidence 98 88999998753 33689999999999999999999999999999999999994 678899999999986644321
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
. .....|+..|+|||++.+..++.++|||||||++|+|++|+.||... .....+..+...... ...
T Consensus 157 ~-------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~---~~~~~~~~~~~~~~~----~~~ 222 (256)
T cd08218 157 L-------ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG---NMKNLVLKIIRGSYP----PVS 222 (256)
T ss_pred h-------hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC---CHHHHHHHHhcCCCC----CCc
Confidence 1 12346889999999999988999999999999999999999999753 233333333332221 223
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
..++.++.++|.+||+.+|++||++.++++
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 567899999999999999999999888754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=307.39 Aligned_cols=256 Identities=19% Similarity=0.240 Sum_probs=195.2
Q ss_pred cEEEeeeeeecCceEEEEEEEcCC--CeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEe----EeCCE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQT--NEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFG----VEGDY 77 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~--~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~----~~~~~ 77 (474)
+|++.+.||+|+||.||++.+..+ +..||||.+.... ....+..|+.+++.+.+|++|..+..+. .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999877 8899999875422 2345788999999997566666654432 22356
Q ss_pred EEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 78 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 78 ~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
.+++|++++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.+.
T Consensus 81 ~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~---~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVN---ADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEc---CCCCEEeCcCCCceecc
Confidence 789999999999999863 45799999999999999999999999999999999999994 67889999999998765
Q ss_pred cCCCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHH---------
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK--------- 227 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~--------- 227 (474)
...... ........||..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..
T Consensus 157 ~~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 157 ENPGEN---AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred cccccc---cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 432211 011234578999999998876 4689999999999999999999999976432111111110
Q ss_pred ---Hhh-----------ccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 228 ---ISE-----------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 228 ---i~~-----------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
+.. .........+...++.++.+++.+||..||++||++.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000 0001122333345678999999999999999999988763
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=301.38 Aligned_cols=245 Identities=21% Similarity=0.339 Sum_probs=196.1
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhc--CCCCCceeEEEeEeCCEEEEEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQ--GGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~--~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.|++.+.||.|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+. .++++..+..++..+...+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 58899999999999999999999999999998765422 345788999999997 2455555555667788899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+|+||+|+||+++ ..+.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT---NTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc---CCCCEEEccCCceeecCCCcc
Confidence 999 8899999863 4799999999999999999999999999999999999995 678999999999987654332
Q ss_pred ccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
. .....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.... .....+.... .+.+
T Consensus 157 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~---~~~~~~~~~~----~~~~ 222 (277)
T cd06917 157 K-------RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF---RAMMLIPKSK----PPRL 222 (277)
T ss_pred c-------cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh---hhhhccccCC----CCCC
Confidence 1 123478999999999875 44789999999999999999999999764321 1111111111 1112
Q ss_pred hc-CCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 241 CR-GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 241 ~~-~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.. .++.++.+++..||..||++||++.++++
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 EDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 22 37889999999999999999999888754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=296.89 Aligned_cols=245 Identities=25% Similarity=0.361 Sum_probs=197.6
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-------CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-------~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
+|+..+.||+|+||.||+|.+..+++.|++|.+.... ....+..|+.+++.++|.+ +..+..+...+...++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~-i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPN-IVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCC-chheeeeEecCCeEEE
Confidence 5888999999999999999998899999999875533 2245888999999998655 4455556677788899
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
+|||+ +++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+||+++ .++.+||+|||++......
T Consensus 80 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~---~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 80 FLELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVD---TNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEccCccceecccc
Confidence 99999 7899999874 34689999999999999999999999999999999999994 6789999999998865443
Q ss_pred CCccccccccCCCCccCccccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
.. .....|+..|++||.+.... ++.++|+|||||++|+|++|..||..... ......+.... ...
T Consensus 156 ~~--------~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~---~~~~~~~~~~~---~~~ 221 (258)
T cd06632 156 SF--------AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG---VAAVFKIGRSK---ELP 221 (258)
T ss_pred cc--------ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH---HHHHHHHHhcc---cCC
Confidence 21 13457899999999998776 89999999999999999999999976442 22222222111 112
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.+...+++.+.+++.+||..+|++||++.+++.
T Consensus 222 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 234567899999999999999999999887753
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=306.07 Aligned_cols=246 Identities=22% Similarity=0.311 Sum_probs=196.7
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
....|.+.++||.|+||.||+|.+..+++.||+|++..... ...+..|+.+++.++|++ +..+..++..+...+
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~n-iv~~~~~~~~~~~~~ 91 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN-TIEYKGCYLREHTAW 91 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCC-EEEEEEEEEeCCeEE
Confidence 34679999999999999999999988999999998754321 135788999999998554 555555566777889
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 80 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 80 lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
+||||+.++|.+++......+++..+..++.||+.||.|||+.||+|+||+|+||+++ .++.++|+|||++......
T Consensus 92 lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~---~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 92 LVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLT---EPGTVKLADFGSASLVSPA 168 (307)
T ss_pred EEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEC---CCCCEEEeecCcceecCCC
Confidence 9999999999998876667799999999999999999999999999999999999994 7789999999998754322
Q ss_pred CCccccccccCCCCccCcccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccch
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (474)
....++..|+|||++. ...++.++|||||||++|||++|..||.+... ......+........
T Consensus 169 -----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~ 234 (307)
T cd06607 169 -----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNDSPTL 234 (307)
T ss_pred -----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH---HHHHHHHhcCCCCCC
Confidence 2346888999999885 35588999999999999999999999976432 121222221111110
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
....++.++.++|..||..+|++||++.+|+.
T Consensus 235 ---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 235 ---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred ---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 11346789999999999999999999888754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=304.31 Aligned_cols=240 Identities=19% Similarity=0.223 Sum_probs=183.4
Q ss_pred eeeeecCceEEEEEEEcCCCe-------EEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 13 RKIGSGSFGEIYLGTNIQTNE-------EVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~-------~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
+.||.|+||.||+|.+...+. .|++|+...... .+.+..|+.+++.+.|++.+. +..++..+...++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~-~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVL-NYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhh-eeeEEEeCCCcEEEEe
Confidence 469999999999999865543 488887654322 245788999999998665554 4445556667889999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCC-----CCeEEEEecCCccccc
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-----ANQVYIIDFGLAKRYR 157 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~-----~~~vkL~DFGla~~~~ 157 (474)
|+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++. .+.++|+|||++....
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 99 78999999865667999999999999999999999999999999999999963221 1347999999987543
Q ss_pred cCCCccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCC-CCCCCCCcCcHHHHHHHHhhccccc
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGS-LPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~-~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
.. ....++..|+|||++.+. .++.++|||||||++|||++|. .||....... .. .+....
T Consensus 160 ~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~---~~-~~~~~~--- 221 (258)
T cd05078 160 PK-----------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK---KL-QFYEDR--- 221 (258)
T ss_pred Cc-----------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH---HH-HHHHcc---
Confidence 22 234688899999999874 5799999999999999999984 6665433211 11 111111
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 273 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (474)
..++...+.++.+++..||+.||++||++++|++.|
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 222 --HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred --ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 122334567899999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=305.09 Aligned_cols=259 Identities=20% Similarity=0.236 Sum_probs=199.7
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEe-----
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVE----- 74 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~----- 74 (474)
+..++|++.++||.|+||.||+|.+..+++.||||+++... ....+..|+.+++.++|++++..+..+...
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34578999999999999999999999899999999886532 223577899999999876666655443322
Q ss_pred ----CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEec
Q 011945 75 ----GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (474)
Q Consensus 75 ----~~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DF 150 (474)
....++++||++++|.+++......+++..++.++.||+.||.|||+.||+|+||||+||++ +.++.+||+||
T Consensus 84 ~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~kl~df 160 (302)
T cd07864 84 FKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQIKLADF 160 (302)
T ss_pred ccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCcEEeCcc
Confidence 23789999999889988887555579999999999999999999999999999999999999 47789999999
Q ss_pred CCccccccCCCccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHh
Q 011945 151 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (474)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (474)
|++..+...... ......++..|+|||++.+. .++.++|||||||++|||++|+.||...........+....
T Consensus 161 g~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~ 234 (302)
T cd07864 161 GLARLYNSEESR------PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC 234 (302)
T ss_pred cccccccCCccc------ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 999876543321 11223567889999988754 47899999999999999999999997643322222222221
Q ss_pred hcccc----------------------chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 230 EKKVS----------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 230 ~~~~~----------------------~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
..... .........+|..+.+++..||..+|++||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11110 0111223457899999999999999999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=299.38 Aligned_cols=252 Identities=18% Similarity=0.313 Sum_probs=199.5
Q ss_pred CcEEEeeeeeecCceEEEEEEEcC-----CCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
++|++++.||.|+||.||+|+++. ..+.|++|........ ..+..|+++++.++|.+ +..+..++......
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKN-VVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcc-eeeeEEEECCCCcc
Confidence 679999999999999999999754 3467999987654332 46889999999998655 45555566677788
Q ss_pred EEEEecC-CCCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEe
Q 011945 79 VLVIDLL-GPSLEDLFNFCS--------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~--------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~D 149 (474)
+++|||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ ..+.++|+|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~---~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS---SQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEe---CCCcEEEcc
Confidence 9999999 789999987433 1589999999999999999999999999999999999995 678899999
Q ss_pred cCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHH
Q 011945 150 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKI 228 (474)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i 228 (474)
||++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |..||..... ...+..+
T Consensus 161 ~~~~~~~~~~~~------~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~~ 231 (275)
T cd05046 161 LSLSKDVYNSEY------YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNRL 231 (275)
T ss_pred cccccccCcccc------cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHHH
Confidence 999875432211 11233466788999999998889999999999999999998 8999976433 2233333
Q ss_pred hhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011945 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 274 (474)
Q Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (474)
........ ....+|..+.+++.+||..+|++||++.+++..|.
T Consensus 232 ~~~~~~~~---~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 232 QAGKLELP---VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HcCCcCCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 22222111 23467899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=298.45 Aligned_cols=251 Identities=24% Similarity=0.398 Sum_probs=197.1
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC------------chHHHHHHHHHHHhcCCCCCceeEEEeEeC
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------------HPQLQYEAKLYKILQGGTGIPNLRWFGVEG 75 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------------~~~l~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (474)
+|.+.+.||.|+||.||+|.+..+++.||||.+..... .+.+..|+.+++.+.|.+ +..+..++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLN-IVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCC-cceEEEEeccC
Confidence 68999999999999999999988999999997653211 124678999999998655 44555566777
Q ss_pred CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 76 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 76 ~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
...++||||+ +++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||++ +.++.++|+|||+++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~~~~ 156 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFGISK 156 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeeccccc
Confidence 8889999998 88999998754 579999999999999999999999999999999999999 478899999999997
Q ss_pred ccccCCCccccccccCCCCccCccccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (474)
........ .......|+..|+|||.+.+.. ++.++||||||+++|+|++|..||..... ...+..+....
T Consensus 157 ~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~ 228 (272)
T cd06629 157 KSDDIYDN-----DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA---IAAMFKLGNKR 228 (272)
T ss_pred cccccccc-----cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch---HHHHHHhhccc
Confidence 65432111 1123456899999999988755 78999999999999999999999965322 22222222111
Q ss_pred -ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 233 -VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 233 -~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
...........++.++.+++..||..+|++||+++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 111112233567899999999999999999999888754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=298.74 Aligned_cols=248 Identities=23% Similarity=0.347 Sum_probs=196.9
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-C
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 86 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (474)
+.||.|+||.||+|.+..+++.||||++..... ...+..|..++.....++++..+..+...++..+++|||+ +
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 579999999999999988999999998764321 1234556555555545666777767777788999999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccc
Q 011945 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166 (474)
Q Consensus 87 ~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (474)
++|.+++.. ...+++..+..++.||+.||.|||+.||+|+||+|+||+++ .++.++|+|||++......
T Consensus 82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~------- 150 (260)
T cd05611 82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID---QTGHLKLTDFGLSRNGLEN------- 150 (260)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCcEEEeecccceecccc-------
Confidence 899999974 35789999999999999999999999999999999999994 6788999999998754331
Q ss_pred cccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcH
Q 011945 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (474)
Q Consensus 167 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (474)
....|+..|+|||.+.+..++.++||||||+++|+|++|..||..... ...+..+....... .......+++
T Consensus 151 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~ 222 (260)
T cd05611 151 ----KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP---DAVFDNILSRRINW-PEEVKEFCSP 222 (260)
T ss_pred ----ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHhcccCC-CCcccccCCH
Confidence 234688999999999988899999999999999999999999976433 33333333222111 1122346789
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 247 EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 247 ~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
++.+++.+||..+|++||++..+.++|.+.+.+
T Consensus 223 ~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~ 255 (260)
T cd05611 223 EAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255 (260)
T ss_pred HHHHHHHHHccCCHHHccCCCcHHHHHcChHhh
Confidence 999999999999999999988888888776653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=301.59 Aligned_cols=249 Identities=20% Similarity=0.305 Sum_probs=191.8
Q ss_pred eeeeecCceEEEEEEEcCCC------eEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 13 RKIGSGSFGEIYLGTNIQTN------EEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~------~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
+.||+|+||.||+|++.... +.||||.+.... ....+.+|+.+++.++|++++..+ .++......+++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~-~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLL-GVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEe-eeecCCCCeEEEEe
Confidence 46899999999999976544 689999765432 334688899999999876655544 44556677899999
Q ss_pred cC-CCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCC--CCCeEEEEecCCcc
Q 011945 84 LL-GPSLEDLFNFC------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR--RANQVYIIDFGLAK 154 (474)
Q Consensus 84 ~~-g~sL~~li~~~------~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~--~~~~vkL~DFGla~ 154 (474)
|+ +++|.+++... ...+++..++.++.||+.||.|||+++|+|+||||+|||++.++ ....++|+|||++.
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 88 78999998642 23478999999999999999999999999999999999996322 22389999999997
Q ss_pred ccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccc
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKV 233 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (474)
........ .......++..|+|||++.+..++.++|||||||++|||++ |..||..... .+....+....
T Consensus 160 ~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~~~~~- 230 (269)
T cd05044 160 DIYKSDYY-----RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHVTAGG- 230 (269)
T ss_pred cccccccc-----ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHHhcCC-
Confidence 65433221 11123356789999999999999999999999999999998 9999976432 22222222211
Q ss_pred cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011945 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 274 (474)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (474)
.......+|..+.+++.+||..+|++||++++|.+.|+
T Consensus 231 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 ---RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ---ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11123467899999999999999999999999988875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=298.62 Aligned_cols=251 Identities=22% Similarity=0.263 Sum_probs=193.5
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhc--CCCCCceeEEEeEeCCE-----
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQ--GGTGIPNLRWFGVEGDY----- 77 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~--~~~~i~~l~~~~~~~~~----- 77 (474)
|++.+.||.|+||.||+|++..+++.||||++..... ...+..|+.+++.+. .|+++..+..++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7899999999999999999988899999998864332 234667888888875 24555555555544444
Q ss_pred EEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 78 NVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 78 ~~lv~e~~g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
.+++||++.++|.+++.... ..+++..++.++.||+.||.|||+.+|+|+||||+||+++ .++.+||+|||++..+
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~---~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVT---SDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEc---cCCCEEEeccCcceec
Confidence 89999999889999887543 3699999999999999999999999999999999999994 6689999999999876
Q ss_pred ccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhh------
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE------ 230 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~------ 230 (474)
..... .....++..|+|||++.+..++.++|||||||++|||++|..||.+....+....+.....
T Consensus 158 ~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 158 SFEMA--------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229 (287)
T ss_pred cCCcc--------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHh
Confidence 44321 1233578899999999999999999999999999999999999987543222221111000
Q ss_pred -------------ccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 231 -------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 231 -------------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.............+++++.++|..||..||++||++.+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il 282 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEAL 282 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHh
Confidence 0001111222234568889999999999999999988775
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=305.53 Aligned_cols=245 Identities=23% Similarity=0.326 Sum_probs=197.1
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
+.|++.+.||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.+.|.+++. +..++..+...++|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITR-YYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHh-hhcccccCCceEEEEE
Confidence 457788999999999999999988999999998764432 235788999999998655544 5445566778899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
|+ +++|.+++. ...+++..++.++.||+.||.|||++||+|+||+|+||+++ .++.++|+|||++..+......
T Consensus 83 ~~~~~~L~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06642 83 YLGGGSALDLLK--PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred ccCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe---CCCCEEEccccccccccCcchh
Confidence 99 789988886 45789999999999999999999999999999999999995 6788999999999766543211
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhc
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (474)
.....|+..|+|||++.+..++.++|||||||++|||++|..||......... ..+.... ...+..
T Consensus 158 -------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~~~~~~~----~~~~~~ 223 (277)
T cd06642 158 -------RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---FLIPKNS----PPTLEG 223 (277)
T ss_pred -------hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---hhhhcCC----CCCCCc
Confidence 12346889999999999989999999999999999999999999765432211 1111111 112334
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.++.++.+++..||..+|++||++.++++
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 224 QYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 57889999999999999999999998865
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=308.86 Aligned_cols=251 Identities=22% Similarity=0.298 Sum_probs=197.2
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeC-----
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEG----- 75 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~----- 75 (474)
+.++|++.+.||+|+||.||+|.+..++..||||.+..... ...+..|+.+++.++|++++..+..+....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 67899999999999999999999999999999998754321 235788999999999777776665554332
Q ss_pred CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 76 ~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
..++++|++++++|.+++. ...+++..++.++.||+.||.|||+.||+||||||+|||++ ..+.++|+|||++..
T Consensus 93 ~~~~lv~e~~~~~l~~~~~--~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~---~~~~~kl~dfg~~~~ 167 (343)
T cd07880 93 HDFYLVMPFMGTDLGKLMK--HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQ 167 (343)
T ss_pred ceEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeecccccc
Confidence 3468999999999999886 45799999999999999999999999999999999999994 678899999999976
Q ss_pred cccCCCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc---
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--- 231 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~--- 231 (474)
..... ....++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..+...
T Consensus 168 ~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 237 (343)
T cd07880 168 TDSEM----------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK 237 (343)
T ss_pred cccCc----------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 54321 23467899999999876 45889999999999999999999999864332111111111000
Q ss_pred --------------------cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 232 --------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 232 --------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
........+...+++++.++|..||..||++||++.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 000112223356788899999999999999999987765
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=323.50 Aligned_cols=250 Identities=20% Similarity=0.374 Sum_probs=209.0
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCeEEE---EEEecc---CCCchHHHHHHHHHHHhcCCCCCceeE-EEeEeCCEEEEE
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLENV---KTKHPQLQYEAKLYKILQGGTGIPNLR-WFGVEGDYNVLV 81 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vA---vK~~~~---~~~~~~l~~E~~il~~l~~~~~i~~l~-~~~~~~~~~~lv 81 (474)
.+...+||+|+|-+||+|.|..+|.+|| ||+-+. ....+.|..|+.+|+.|+|.|+|..+. |.........+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 3566789999999999999999999887 453222 223356889999999999988888884 445566778889
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~--gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
.|++ .|+|..+++. .++++.+.+..|+.||+.||.|||++ -|||||||.+||+|+ ...|.|||+|+|||.....
T Consensus 122 TEL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 122 TELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred eecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHHhhc
Confidence 9988 9999999985 45799999999999999999999997 499999999999997 6789999999999998776
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
... +.++|||.|||||++. ..|+..+||||||++|+||+|+..||.... ...+.|.++.....+..+.
T Consensus 199 s~a---------ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~--n~AQIYKKV~SGiKP~sl~ 266 (632)
T KOG0584|consen 199 SHA---------KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT--NPAQIYKKVTSGIKPAALS 266 (632)
T ss_pred ccc---------ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC--CHHHHHHHHHcCCCHHHhh
Confidence 543 4479999999999998 689999999999999999999999998864 4578888888877766554
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
.+. .+++++||.+||.. ..+||++.+| |.+.|-..
T Consensus 267 kV~---dPevr~fIekCl~~-~~~R~sa~eL---L~d~Ff~~ 301 (632)
T KOG0584|consen 267 KVK---DPEVREFIEKCLAT-KSERLSAKEL---LKDPFFDE 301 (632)
T ss_pred ccC---CHHHHHHHHHHhcC-chhccCHHHH---hhChhhcc
Confidence 443 58999999999999 9999996665 55555443
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=298.13 Aligned_cols=242 Identities=19% Similarity=0.253 Sum_probs=190.5
Q ss_pred CCcEEEeeee--eecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 6 GNKFRLGRKI--GSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 6 ~~~y~i~~~L--G~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
.++|++.+.+ |+|+||.||++.++.+++.+|+|+....... ..|+.+...+.+++++..+...+......++|||
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e 89 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---AIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMD 89 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---hhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEE
Confidence 3567787777 9999999999999999999999987653221 1244444445557777777777777789999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCC-eEEEEecCCccccccCCC
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~-~vkL~DFGla~~~~~~~~ 161 (474)
|+ +++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++ ..+ .++|+|||++......
T Consensus 90 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~~l~dfg~~~~~~~~-- 163 (267)
T PHA03390 90 YIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD---RAKDRIYLCDYGLCKIIGTP-- 163 (267)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---CCCCeEEEecCccceecCCC--
Confidence 98 88999999754 4899999999999999999999999999999999999995 445 8999999998765432
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcH-HHHHHHHhhccccchHHHH
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~~l 240 (474)
....|+..|+|||++.+..++.++|||||||++|||++|..||........ ...+..... . ....
T Consensus 164 ---------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~-~~~~ 229 (267)
T PHA03390 164 ---------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ----K-KLPF 229 (267)
T ss_pred ---------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc----c-cCCc
Confidence 224688999999999998999999999999999999999999985433221 111111111 1 1122
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCC-HHHHH
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPD-YAYLK 270 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt-~~~l~ 270 (474)
...+++.+.++|..||+.+|++||+ +++++
T Consensus 230 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l 260 (267)
T PHA03390 230 IKNVSKNANDFVQSMLKYNINYRLTNYNEII 260 (267)
T ss_pred ccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence 3468899999999999999999995 56664
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=308.34 Aligned_cols=265 Identities=19% Similarity=0.245 Sum_probs=200.6
Q ss_pred CCCccCCcEEEe-eeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----------------hHHHHHHHHHHHhcCCC
Q 011945 1 MEPRVGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------------PQLQYEAKLYKILQGGT 63 (474)
Q Consensus 1 m~~~i~~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------------~~l~~E~~il~~l~~~~ 63 (474)
|...+.++|..+ +.||.|+||+||+|.+..+++.||||++...... ..+..|+.+++.++|.+
T Consensus 2 ~~~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 81 (335)
T PTZ00024 2 MSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHEN 81 (335)
T ss_pred CccccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcc
Confidence 677788999754 6799999999999999999999999987543221 14778999999998665
Q ss_pred CCceeEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCC
Q 011945 64 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 143 (474)
Q Consensus 64 ~i~~l~~~~~~~~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~ 143 (474)
++. +..++..+.+.+++||++.++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++ ..+
T Consensus 82 iv~-~~~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~---~~~ 156 (335)
T PTZ00024 82 IMG-LVDVYVEGDFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN---SKG 156 (335)
T ss_pred eee-eeEEEecCCcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEEC---CCC
Confidence 555 4455567788999999999999999873 45699999999999999999999999999999999999994 778
Q ss_pred eEEEEecCCccccccCCCccc-------cccccCCCCccCccccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCC
Q 011945 144 QVYIIDFGLAKRYRDTATHQH-------IPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQG 215 (474)
Q Consensus 144 ~vkL~DFGla~~~~~~~~~~~-------~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDIwSlGvil~elltG~~Pf~~ 215 (474)
.++|+|||++..+........ ..........++..|+|||.+.+.. ++.++|||||||++|||++|..||.+
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999987652211000 0000112235688999999998754 68999999999999999999999987
Q ss_pred CCcCcHHHHHHHHhhcc--------------------ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 216 LKAGTKKQKYEKISEKK--------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 216 ~~~~~~~~~~~~i~~~~--------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.........+....... ...........++.++.++|..||..+|++||++++++
T Consensus 237 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 311 (335)
T PTZ00024 237 ENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311 (335)
T ss_pred CCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence 54322111111111000 01112223345678999999999999999999987774
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=299.12 Aligned_cols=252 Identities=19% Similarity=0.227 Sum_probs=195.0
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
|++.++||.|++|.||+|.+..+|..||||++..... ...+..|+.+++.++|++.+..+ .++..+...+++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~-~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLL-DVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHh-heeccCCeEEEEEec
Confidence 6789999999999999999989999999998765432 24578899999999966555544 445667889999999
Q ss_pred CCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 85 LGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 85 ~g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
++++|.+++.... ..+++..++.++.||+.||.|||+++++|+||+|+||+++ .++.++|+|||++..+.....
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~~-- 154 (283)
T cd07835 80 LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID---REGALKLADFGLARAFGVPVR-- 154 (283)
T ss_pred cCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---CCCcEEEeecccccccCCCcc--
Confidence 9889999987433 3689999999999999999999999999999999999995 688999999999976533211
Q ss_pred ccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHh-------------
Q 011945 164 HIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS------------- 229 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~------------- 229 (474)
......++..|+|||++.+. .++.++|||||||++|+|++|+.||...........+....
T Consensus 155 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 155 -----TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred -----ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence 11223568899999988764 47899999999999999999999997643311111111000
Q ss_pred --------hccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 230 --------EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 230 --------~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
..............++.++.+++.+||+.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000011122234567889999999999999999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=296.20 Aligned_cols=247 Identities=22% Similarity=0.294 Sum_probs=198.3
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
+|.+.+.||.|+||.||+|.+..++..||+|.+... .....+.+|+.+++.++|.+.+..+ .........++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~-~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF-ASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhh-heeccCCeEEEEEe
Confidence 589999999999999999999999999999987653 2345688999999999866555544 45566778899999
Q ss_pred cC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 84 ~~-g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
|+ +++|.+++.... ..+++..++.++.||+.||.|||+++|+|+||||+||+++ ++...+||+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEc--CCCCeEEecccccchhccCCcc
Confidence 99 889999986433 3589999999999999999999999999999999999995 3335679999999987654322
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
. .....|+..|+|||++.+..++.++|||||||++|||++|..||..... .+.+..+..... ..+.
T Consensus 158 ~-------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~ 223 (257)
T cd08225 158 L-------AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL---HQLVLKICQGYF----APIS 223 (257)
T ss_pred c-------ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHhcccC----CCCC
Confidence 1 1234689999999999988899999999999999999999999976432 223333222221 1223
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
..++.++.+++.+||..+|++||++.+|++
T Consensus 224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 224 PNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 467889999999999999999999888754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.32 Aligned_cols=252 Identities=21% Similarity=0.292 Sum_probs=195.2
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEe-----
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVE----- 74 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~----- 74 (474)
.+.++|.+.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++|.+++..+..+...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 356899999999999999999999989999999998764321 24577899999999987777666554322
Q ss_pred CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 75 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 75 ~~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
....++++++++++|.+++. ...+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++.
T Consensus 94 ~~~~~lv~~~~~~~L~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~---~~~~~kl~dfg~~~ 168 (345)
T cd07877 94 FNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLAR 168 (345)
T ss_pred cccEEEEehhcccCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEc---CCCCEEEecccccc
Confidence 24578999999999999886 34699999999999999999999999999999999999994 67889999999987
Q ss_pred ccccCCCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc--
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-- 231 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~-- 231 (474)
..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+......
T Consensus 169 ~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (345)
T cd07877 169 HTDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG 238 (345)
T ss_pred ccccc----------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 54322 123578899999999877 46889999999999999999999999764332211111111000
Q ss_pred ---------------------cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 232 ---------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 232 ---------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.............++++.++|..||..||++||++.+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 298 (345)
T cd07877 239 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 298 (345)
T ss_pred HHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHh
Confidence 000011111224578899999999999999999977664
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=296.95 Aligned_cols=249 Identities=24% Similarity=0.357 Sum_probs=196.3
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-------CchHHHHHHHHHHHhcCCCCCceeEEEeE-eCCEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------KHPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDYN 78 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-------~~~~l~~E~~il~~l~~~~~i~~l~~~~~-~~~~~ 78 (474)
.+|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.+++.++|.+++..+..+.. .....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999864321 12357889999999987766665554433 34567
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
+++||++ +++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++ .++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCCCEEECccccccccc
Confidence 8999998 7899999874 34689999999999999999999999999999999999994 67889999999998654
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
...... .......|+..|+|||++.+..++.++|||||||++|+|++|+.||..... ...+..+.. ....
T Consensus 158 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~---~~~~ 227 (264)
T cd06653 158 TICMSG----TGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA---MAAIFKIAT---QPTK 227 (264)
T ss_pred cccccC----ccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH---HHHHHHHHc---CCCC
Confidence 321100 011245689999999999998899999999999999999999999976432 222222221 1122
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
+.++..+++++.+++.+||. ++..||+..+++
T Consensus 228 ~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~ 259 (264)
T cd06653 228 PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLL 259 (264)
T ss_pred CCCCcccCHHHHHHHHHHhc-CcccCccHHHHh
Confidence 33456788999999999999 579999988664
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=296.31 Aligned_cols=248 Identities=21% Similarity=0.288 Sum_probs=192.4
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 85 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (474)
+.....||+|+||.||+|.+..++..|++|.+..... ...+.+|+.+++.++|.+++. +..++..+...++++|++
T Consensus 10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~-~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQ-YLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeee-eeeeeccCCEEEEEEecCC
Confidence 3345689999999999999988999999998765432 346889999999998665554 555566778889999998
Q ss_pred CCCHHHHHHHcCCCC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 86 GPSLEDLFNFCSRKL--SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 86 g~sL~~li~~~~~~l--~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
+++|.+++......+ ++..++.++.||+.||.|||++||+||||||+||+++ ...+.++|+|||++........
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~~~~-- 164 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGINP-- 164 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc--CCCCeEEEecchhheecccCCC--
Confidence 789999987544455 8889999999999999999999999999999999995 3367899999999976543221
Q ss_pred ccccccCCCCccCccccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 164 HIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~~~--~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
......|+..|+|||++.+.. ++.++|||||||++|+|++|..||........ ... ... .......+.
T Consensus 165 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-~~~-~~~---~~~~~~~~~ 234 (268)
T cd06624 165 -----CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-AMF-KVG---MFKIHPEIP 234 (268)
T ss_pred -----ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-hHh-hhh---hhccCCCCC
Confidence 112346899999999987654 78999999999999999999999976432111 111 111 001111234
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
..+++++.+++.+||..+|++||++.++++
T Consensus 235 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 235 ESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 567889999999999999999999887753
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=306.27 Aligned_cols=247 Identities=18% Similarity=0.304 Sum_probs=194.8
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
+.|.....||.|+||.||++.+..++..||||.+.... ....+..|+.+++.++|.+++..+. .+..++..+++|||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~-~~~~~~~~~lv~e~ 100 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN-SYLVGDELWVVMEF 100 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHH-heecCCeEEEEEeC
Confidence 45666788999999999999998899999999875432 2345788999999998665555544 44567788999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 85 ~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
+ +++|.+++. ...+++..++.++.||+.||.|||++||+||||||+||+++ .++.++|+|||++........
T Consensus 101 ~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~---~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 101 LEGGALTDIVT--HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLT---SDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred CCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc---CCCCEEEccCcchhhcccccc--
Confidence 9 778988875 34689999999999999999999999999999999999994 678999999999876543221
Q ss_pred ccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcC
Q 011945 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (474)
......|+..|+|||++.+..++.++|||||||++|||++|..||..... ...+..+... ..... .....
T Consensus 174 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~-~~~~~-~~~~~ 243 (292)
T cd06658 174 -----KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP---LQAMRRIRDN-LPPRV-KDSHK 243 (292)
T ss_pred -----cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhc-CCCcc-ccccc
Confidence 12345789999999999988899999999999999999999999976432 2222222111 11111 11234
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 244 YPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
++..+.+++..||..||.+||+++++++
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 6789999999999999999999887754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=298.82 Aligned_cols=240 Identities=16% Similarity=0.188 Sum_probs=181.4
Q ss_pred eeeeecCceEEEEEEEcC------------CCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 13 RKIGSGSFGEIYLGTNIQ------------TNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~------------~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
+.||+|+||.||+|+... ....|++|++..... ...+..|+.++..++|++ |..+..++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~-iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKH-IVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCC-EeeEEEEEecCCCC
Confidence 468999999999998532 233688998654322 235778888999998655 55555556666778
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCC----CCCeEEEEecCCc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR----RANQVYIIDFGLA 153 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~----~~~~vkL~DFGla 153 (474)
+++|||+ +++|..++......+++..++.|+.||+.||.|||++||+||||||+|||++.+. ....++|+|||++
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~ 159 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP 159 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence 9999999 6788888765566799999999999999999999999999999999999996321 1124899999998
Q ss_pred cccccCCCccccccccCCCCccCcccccccccc-CCCCCchhhHHHHHHHHHHHH-hCCCCCCCCCcCcHHHHHHHHhhc
Q 011945 154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEK 231 (474)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDIwSlGvil~ell-tG~~Pf~~~~~~~~~~~~~~i~~~ 231 (474)
...... ....++..|+|||.+. +..++.++|||||||++|||+ .|..||......... .....
T Consensus 160 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~----~~~~~ 224 (262)
T cd05077 160 ITVLSR-----------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE----RFYEG 224 (262)
T ss_pred ccccCc-----------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH----HHHhc
Confidence 754321 2346788999999887 466899999999999999998 589998764322111 11111
Q ss_pred cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011945 232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 273 (474)
Q Consensus 232 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (474)
.. ......++++.+||.+||+.||++||++.+|++.|
T Consensus 225 ~~-----~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 225 QC-----MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred Cc-----cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 11 11223467899999999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=298.88 Aligned_cols=245 Identities=22% Similarity=0.341 Sum_probs=197.7
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
+-|++.++||.|+||.||+|.+..+++.||||+...... ...+.+|+.++..+.|++ +..+..+...+...++|||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY-VTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCC-EeEEEEEEEeCCeEEEEEE
Confidence 347889999999999999999988999999998754332 245788999999998655 4455555667788899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
|+ +++|.+++. ...+++..++.++.|++.||.|||++||+|+||||+||+++ .++.++|+|||++..+......
T Consensus 83 ~~~~~~l~~~i~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~---~~~~~~l~dfg~~~~~~~~~~~ 157 (277)
T cd06641 83 YLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIK 157 (277)
T ss_pred eCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEEC---CCCCEEEeecccceecccchhh
Confidence 99 778998886 35689999999999999999999999999999999999994 6788999999998765432211
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhc
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (474)
.....++..|+|||.+.+..++.++|||||||++|+|++|..||..... ......+.... .+.+..
T Consensus 158 -------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~----~~~~~~ 223 (277)
T cd06641 158 -------RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---MKVLFLIPKNN----PPTLEG 223 (277)
T ss_pred -------hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---HHHHHHHhcCC----CCCCCc
Confidence 1234688999999999988899999999999999999999999976443 22222222211 112335
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.++.++.+++..||..+|++||++.++++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 224 NYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 67899999999999999999999988866
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=298.34 Aligned_cols=242 Identities=25% Similarity=0.295 Sum_probs=197.6
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
+|++.+.||.|+||.||+|.+..+++.||+|++.... ....+..|+++++.++|+++ ..+..+...+...++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFL-VNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCCh-HHHHHhhcCCCeEEEEE
Confidence 5899999999999999999998899999999876432 23468889999999986554 44444556777899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
||+ +++|.+++... ..+++..++.|+.||+.||.|||++||+|+||||+||+++ .++.++|+|||++........
T Consensus 80 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~---~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 80 DLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLD---EQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred eCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEc---CCCCEEEeecccccccCCCcc
Confidence 999 88999998743 5799999999999999999999999999999999999994 778999999999986654321
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
.....|+..|+|||++.+..++.++|||||||++|+|++|..||................. ......
T Consensus 156 --------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~ 222 (258)
T cd05578 156 --------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-----ADVLYP 222 (258)
T ss_pred --------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-----ccccCc
Confidence 1234688999999999988899999999999999999999999987654322222222111 122234
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYA 267 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~ 267 (474)
..+|.++.++|.+||..||++||++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~~~~ 248 (258)
T cd05578 223 ATWSTEAIDAINKLLERDPQKRLGDN 248 (258)
T ss_pred ccCcHHHHHHHHHHccCChhHcCCcc
Confidence 56789999999999999999999983
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=300.87 Aligned_cols=264 Identities=18% Similarity=0.276 Sum_probs=206.7
Q ss_pred cEEEeeeeeecCceEEEEEEEc---CCCeEEEEEEeccCC------CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAvK~~~~~~------~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
+|++.+.||+|+||.||++++. .+++.||||++.... ....+..|+.++..+.+++++..+......+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 467889999875321 2245788999999998778777777777778889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
++||||+ +++|.+++.. ...+++..++.++.|++.||.|||+.|++||||||.||+++ .++.++|+|||++..+.
T Consensus 81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD---SEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC---CCCCEEEEECccccccc
Confidence 9999999 7799988863 35689999999999999999999999999999999999994 67889999999987654
Q ss_pred cCCCccccccccCCCCccCccccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHH-HHHhhcccc
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-EKISEKKVS 234 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~-~~i~~~~~~ 234 (474)
..... ......|+..|+|||.+.+.. .+.++||||||+++|||++|..||...........+ ..+....
T Consensus 157 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-- 228 (288)
T cd05583 157 AEEEE------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK-- 228 (288)
T ss_pred ccccc------ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC--
Confidence 43221 112356899999999988765 788999999999999999999999643222111111 1111111
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccc
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 293 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~ 293 (474)
......++.++.+++.+||+.||++||++.++.++|++.+ ....+|...
T Consensus 229 ---~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~-------~~~~~~~~~ 277 (288)
T cd05583 229 ---PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF-------FQGIDWDDL 277 (288)
T ss_pred ---CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc-------cccCCHHHH
Confidence 1123457889999999999999999999999988887764 334567654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=306.67 Aligned_cols=252 Identities=20% Similarity=0.249 Sum_probs=198.5
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeC----CEEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEG----DYNV 79 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~----~~~~ 79 (474)
+|++.++||.|+||.||+|++..+++.||||.+.... ..+.+..|+.+++.++|.+++..+..+.... ...|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 6999999999999999999998889999999876532 3456889999999998666555554443332 3679
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 80 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 80 lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
++|+|++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.++|+|||++......
T Consensus 81 lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~---~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 81 IVTELMETDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVN---SNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEecchhhhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEcccCceEeeccc
Confidence 9999999899998873 44899999999999999999999999999999999999994 6789999999999876554
Q ss_pred CCccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc------
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------ 232 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~------ 232 (474)
.... .......++..|+|||++.+. .++.++|||||||++|+|++|..||.+..... .+..+....
T Consensus 157 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 229 (330)
T cd07834 157 EDEK----GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID---QLNLIVEVLGTPSEE 229 (330)
T ss_pred cccc----ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHhcCCCChh
Confidence 3110 112345688999999999988 78999999999999999999999998754322 222221110
Q ss_pred --------------------ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 233 --------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 233 --------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.......+...++.++.++|..||+.+|++||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 287 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEAL 287 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 01111223345788999999999999999999988765
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=298.20 Aligned_cols=254 Identities=20% Similarity=0.257 Sum_probs=196.4
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEe-CCEEEEEEe
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVE-GDYNVLVID 83 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~-~~~~~lv~e 83 (474)
|++.++||.|+||.||+|.+..+++.||+|.+.... ....+..|+.+++.+.|.+.+..+..+... ....+++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 789999999999999999999899999999887542 224578899999999966665555444433 378999999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 84 ~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
|++++|.+++......+++..++.++.||+.||+|||+.|++|+||||+|||++ +++.+||+|||++.........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~---~~~~~~l~d~g~~~~~~~~~~~- 156 (287)
T cd07840 81 YMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILIN---NDGVLKLADFGLARPYTKRNSA- 156 (287)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEc---CCCCEEEccccceeeccCCCcc-
Confidence 998899999875556799999999999999999999999999999999999994 7889999999999876554321
Q ss_pred ccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc-----------
Q 011945 164 HIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----------- 231 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~----------- 231 (474)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||...........+......
T Consensus 157 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 157 -----DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred -----cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccccc
Confidence 11223568899999988764 5799999999999999999999999765432211111111000
Q ss_pred -----------cccchHHHHhcC-CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 232 -----------KVSTSIEALCRG-YPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 232 -----------~~~~~~~~l~~~-~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
............ ++.++.+++..||..+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000111122223 4889999999999999999999887754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=299.87 Aligned_cols=239 Identities=17% Similarity=0.227 Sum_probs=182.2
Q ss_pred eeeecCceEEEEEEEcCC------------------------CeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCce
Q 011945 14 KIGSGSFGEIYLGTNIQT------------------------NEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPN 67 (474)
Q Consensus 14 ~LG~G~fG~Vy~a~~~~~------------------------~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~ 67 (474)
+||+|+||.||+|....+ ...|++|++..... ...+..|+.+++.++| ++|..
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h-~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSH-IHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCC-CCeee
Confidence 699999999999975321 23588888754322 2346778888888886 55556
Q ss_pred eEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeC----CCC
Q 011945 68 LRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG----RRA 142 (474)
Q Consensus 68 l~~~~~~~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~----~~~ 142 (474)
+..++......++||||+ +++|..++......+++..++.++.||+.||+|||++||+||||||+|||++.. ...
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~ 160 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS 160 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence 666677788889999999 788988887656779999999999999999999999999999999999999632 123
Q ss_pred CeEEEEecCCccccccCCCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHH-hCCCCCCCCCcCc
Q 011945 143 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGT 220 (474)
Q Consensus 143 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~ell-tG~~Pf~~~~~~~ 220 (474)
..+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||.......
T Consensus 161 ~~~kl~d~g~~~~~~~~-----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 161 PFIKLSDPGVSFTALSR-----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ceeeecCCccccccccc-----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 35899999998644321 12357888999998876 56899999999999999985 6999998754322
Q ss_pred HHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011945 221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 273 (474)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (474)
....+ ..... +....++++.++|.+||+.+|++||++.+|++.|
T Consensus 230 ~~~~~----~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 KERFY----EKKHR-----LPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHH----HhccC-----CCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 21111 11111 1223457899999999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=296.73 Aligned_cols=239 Identities=22% Similarity=0.262 Sum_probs=185.8
Q ss_pred eeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhc--CCCCCceeEEEeEeCCEEEEEEecC-
Q 011945 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQ--GGTGIPNLRWFGVEGDYNVLVIDLL- 85 (474)
Q Consensus 14 ~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~--~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (474)
.||+|+||.||+|.+..+++.||||++..... ......|..+++.+. +++++..+.++....+..++||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999989999999998754321 112344555554443 3566666777777778899999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccc
Q 011945 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 165 (474)
Q Consensus 86 g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (474)
|++|.+++.. ...+++..++.|+.|++.||.|||+++|+||||||+|||++ .++.+||+|||++..+.....
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~---~~~~~kl~dfg~~~~~~~~~~---- 152 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKP---- 152 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEEC---CCCCEEEccCcCccccCccCC----
Confidence 8899988863 45799999999999999999999999999999999999994 678899999999976543221
Q ss_pred ccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCC
Q 011945 166 PYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (474)
Q Consensus 166 ~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (474)
....|+..|+|||++.+. .++.++|||||||++|||++|..||.+............+... ...+...+
T Consensus 153 -----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~ 222 (278)
T cd05606 153 -----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-----AVELPDSF 222 (278)
T ss_pred -----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhcc-----CCCCCCcC
Confidence 234789999999999754 6899999999999999999999999875433222222111111 11233456
Q ss_pred cHHHHHHHHHHhcCCCCCCC-----CHHHHH
Q 011945 245 PTEFASYFHYCRSLRFDDKP-----DYAYLK 270 (474)
Q Consensus 245 p~~l~~li~~cl~~dp~~RP-----t~~~l~ 270 (474)
+.++.+++.+||..+|.+|| ++.+++
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll 253 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 253 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHH
Confidence 89999999999999999999 776664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=306.96 Aligned_cols=252 Identities=21% Similarity=0.276 Sum_probs=194.3
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEe-----
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVE----- 74 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~----- 74 (474)
.+.++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.|.+++..+..+...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~ 91 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE 91 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence 45689999999999999999999998999999999876432 224578899999999877766665554332
Q ss_pred CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 75 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 75 ~~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
....+++++++..+|..++ ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 92 ~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~---~~~~~kL~dfg~~~ 165 (342)
T cd07879 92 FQDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN---EDCELKILDFGLAR 165 (342)
T ss_pred CceEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEeeCCCCc
Confidence 2346899999988887765 34689999999999999999999999999999999999994 77899999999997
Q ss_pred ccccCCCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc--
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-- 231 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~-- 231 (474)
...... ....++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+..+...
T Consensus 166 ~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (342)
T cd07879 166 HADAEM----------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 235 (342)
T ss_pred CCCCCC----------CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 543211 23467899999999876 45899999999999999999999999864321111111110000
Q ss_pred ---------------------cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 232 ---------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 232 ---------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
........+...++.++.++|..||+.||++||++++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0011112223456788999999999999999999888753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=299.18 Aligned_cols=249 Identities=22% Similarity=0.242 Sum_probs=198.1
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
|++.+.||.|++|.||+|.+..+++.|++|.+..... ...+..|+.+++.++|. ++..+..+...+...++++||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHP-NIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCC-CcchHHHhhccCCCEEEEEec
Confidence 6788999999999999999988999999998765432 24678899999999855 455555455566888999999
Q ss_pred CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccc
Q 011945 85 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164 (474)
Q Consensus 85 ~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (474)
+.++|.+++......+++..++.++.||+.||.|||++||+|+||||+||+++ .++.++|+|||.+........
T Consensus 80 ~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~---~~~~~~l~df~~~~~~~~~~~--- 153 (283)
T cd05118 80 MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLIN---TEGVLKLADFGLARSFGSPVR--- 153 (283)
T ss_pred cCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEEC---CCCcEEEeeeeeeEecCCCcc---
Confidence 98899999886667899999999999999999999999999999999999994 678999999999987654331
Q ss_pred cccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc-----------
Q 011945 165 IPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK----------- 232 (474)
Q Consensus 165 ~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~----------- 232 (474)
......++..|+|||.+.+. .++.++|||||||++|+|++|+.||......+ .+..+....
T Consensus 154 ----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 226 (283)
T cd05118 154 ----PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID---QLFKIFRTLGTPDPEVWPKF 226 (283)
T ss_pred ----cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCchHhcccc
Confidence 11234678899999999877 68999999999999999999999997643321 121111100
Q ss_pred --------------ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 233 --------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 233 --------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.......+...++.++.++|..||..||.+||++.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 227 TSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 011112333457889999999999999999999887753
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=295.60 Aligned_cols=255 Identities=21% Similarity=0.261 Sum_probs=209.8
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-CCCH
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSL 89 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL 89 (474)
+.||+|+|+.|--|....++.+||||++.+... ...+.+|++++..+++|.+|..+..|+.++..+|||||-+ ||.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 578999999999999999999999999877654 3568999999999999999999988899999999999999 8899
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccccccc
Q 011945 90 EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 169 (474)
Q Consensus 90 ~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 169 (474)
...|.. ...|++.++..+..+|+.||.|||.+||.||||||+|||....+.-.-||||||.|.........-......+
T Consensus 164 LshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~ 242 (463)
T KOG0607|consen 164 LSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPE 242 (463)
T ss_pred HHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCcc
Confidence 888873 4579999999999999999999999999999999999999644444568999999886544332222222223
Q ss_pred CCCCccCcccccccccc---C--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCc------------HHHHHHHHhhcc
Q 011945 170 NKNLTGTARYASMNTHL---G--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------------KKQKYEKISEKK 232 (474)
Q Consensus 170 ~~~~~GT~~Y~APE~~~---~--~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~------------~~~~~~~i~~~~ 232 (474)
..+.+|+..|||||+.. + ..|+.+.|+||||||||-||.|.+||.+....+ ....++.|++.+
T Consensus 243 L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGk 322 (463)
T KOG0607|consen 243 LLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK 322 (463)
T ss_pred ccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccC
Confidence 45568999999999764 3 248999999999999999999999998754322 345567777777
Q ss_pred ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011945 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 269 (474)
Q Consensus 233 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (474)
...+- +-+..++.+.++++..+|..|+.+|-++..+
T Consensus 323 YeFPd-kdWahIS~eakdlisnLlvrda~~rlsa~~v 358 (463)
T KOG0607|consen 323 YEFPD-KDWAHISSEAKDLISNLLVRDAKQRLSAAQV 358 (463)
T ss_pred CcCCh-hhhHHhhHHHHHHHHHHHhccHHhhhhhhhc
Confidence 75543 3456789999999999999999999886655
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=304.71 Aligned_cols=247 Identities=17% Similarity=0.288 Sum_probs=196.3
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
..|....+||.|+||.||+|.+..+++.||||++.... ....+.+|+.++..+.|++++. +..++..+...+++|||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~-~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVE-MYKSYLVGEELWVLMEF 99 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhh-hhhheeeCCeEEEEEec
Confidence 34666778999999999999998899999999875432 3346888999999998655444 44455667788999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 85 ~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
+ +++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+.....
T Consensus 100 ~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~---~~~~~kL~dfg~~~~~~~~~~-- 172 (297)
T cd06659 100 LQGGALTDIVS--QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLT---LDGRVKLSDFGFCAQISKDVP-- 172 (297)
T ss_pred CCCCCHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEc---cCCcEEEeechhHhhcccccc--
Confidence 8 788988876 35689999999999999999999999999999999999994 778999999999976543221
Q ss_pred ccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcC
Q 011945 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (474)
......|+..|+|||++.+..++.++|||||||++|||++|+.||..... ...+..+...... .......
T Consensus 173 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~--~~~~~~~ 242 (297)
T cd06659 173 -----KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKRLRDSPPP--KLKNAHK 242 (297)
T ss_pred -----cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhccCCC--CccccCC
Confidence 11345789999999999998999999999999999999999999976432 2333333221111 1112346
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 244 YPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
++.++.++|..||..+|++||++.+|++
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 7889999999999999999999887755
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=302.74 Aligned_cols=246 Identities=23% Similarity=0.320 Sum_probs=196.7
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
...|.+.+.||+|+||.||+|.+..++..||||++..... ...+..|+++++.++|++ +..+..+...+...++
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~~~~~~l 102 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN-SIEYKGCYLREHTAWL 102 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCC-EEEEEEEEeeCCeEEE
Confidence 3458899999999999999999988999999998764321 235788999999998654 4455556667778899
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 81 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 81 v~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
+|||+.++|.+++......+++..+..++.||+.||.|||++||+||||+|+||++ +.++.++|+|||++......
T Consensus 103 v~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 103 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred EEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCccccCCc-
Confidence 99999889999887666779999999999999999999999999999999999999 46789999999998754322
Q ss_pred CccccccccCCCCccCcccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
....|+..|+|||++. +..++.++|||||||++|||++|..||..... ...+..+.......
T Consensus 179 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~~~~-- 243 (317)
T cd06635 179 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNESPT-- 243 (317)
T ss_pred ----------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHHhccCCC--
Confidence 2346889999999974 45688999999999999999999999976432 22222222211111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL 272 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~ 272 (474)
.....+++.+.+++.+||..+|++||++.++++.
T Consensus 244 -~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 277 (317)
T cd06635 244 -LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKH 277 (317)
T ss_pred -CCCccccHHHHHHHHHHccCCcccCcCHHHHHhC
Confidence 1123567899999999999999999998887543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=296.19 Aligned_cols=238 Identities=21% Similarity=0.246 Sum_probs=186.9
Q ss_pred eeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-CCC
Q 011945 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS 88 (474)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~s 88 (474)
||+|+||+||+|.+..+++.||+|++.... ....+..|+++++.++| +++..+..........|++|||+ +++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS-RFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCC-CCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 699999999999999999999999875432 22346789999999985 45555555556667889999998 789
Q ss_pred HHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccccc
Q 011945 89 LEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167 (474)
Q Consensus 89 L~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~ 167 (474)
|.+++.... ..+++..++.++.||+.||.|||++||+|+||||+||++ +.++.++|+|||++........
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~------ 150 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKK------ 150 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCc------
Confidence 999887433 369999999999999999999999999999999999999 4678999999999876543211
Q ss_pred ccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHH
Q 011945 168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 247 (474)
Q Consensus 168 ~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 247 (474)
.....++..|+|||++.+..++.++|||||||++|+|++|+.||...........+.. ... .....+...++++
T Consensus 151 --~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~-~~~~~~~~~~~~~ 224 (277)
T cd05577 151 --IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR---RTL-EMAVEYPDKFSPE 224 (277)
T ss_pred --cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh---ccc-cccccCCccCCHH
Confidence 1234678899999999988899999999999999999999999976543222222211 111 1111233567899
Q ss_pred HHHHHHHHhcCCCCCCCCHHH
Q 011945 248 FASYFHYCRSLRFDDKPDYAY 268 (474)
Q Consensus 248 l~~li~~cl~~dp~~RPt~~~ 268 (474)
+.++|.+||..+|++||++.+
T Consensus 225 ~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 225 AKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred HHHHHHHHccCChhHccCCCc
Confidence 999999999999999994433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=289.38 Aligned_cols=247 Identities=25% Similarity=0.407 Sum_probs=200.0
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 85 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (474)
+|.+.+.||+|++|.||++.+..+++.|++|++.... ....+.+|+.+++.+.+ +++..+..+.......++++|++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKH-PNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCC-CCEeEEEEEEecCCeEEEEEecC
Confidence 4889999999999999999998899999999987654 44678999999999994 45555655666678889999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccc
Q 011945 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164 (474)
Q Consensus 86 -g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (474)
+++|.+++......+++..++.++.|++.||.|||++|++|+||+|+||+++ .++.++|+|||++........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc---cCCeEEEeecccccccccccc---
Confidence 5999999986556799999999999999999999999999999999999994 678999999999987654321
Q ss_pred cccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCC
Q 011945 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (474)
Q Consensus 165 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (474)
.....++..|++||.+.+..++.++||||||+++|+|++|..||...... ............... ....+
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~--~~~~~ 223 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM---KALFKIATNGPPGLR--NPEKW 223 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHHhcCCCCcC--ccccc
Confidence 13457889999999999888999999999999999999999999764322 222222111111100 01224
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 245 PTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 245 p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
+.++.+++..||..||++||++.++++
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 789999999999999999999888754
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=296.40 Aligned_cols=250 Identities=22% Similarity=0.324 Sum_probs=197.2
Q ss_pred cEEEeeeeeecCceEEEEEEEcC-CCeEEEEEEeccCC------------CchHHHHHHHHHHHhcCCCCCceeEEEeEe
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKT------------KHPQLQYEAKLYKILQGGTGIPNLRWFGVE 74 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~-~~~~vAvK~~~~~~------------~~~~l~~E~~il~~l~~~~~i~~l~~~~~~ 74 (474)
.|++.+.||+|+||.||+|.+.. .++.||||.+.... ....+..|+.++.....++++..+..+...
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999877 67899999764321 112366788877764445666666666677
Q ss_pred CCEEEEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEeeeCCCCCeEEEEe
Q 011945 75 GDYNVLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIID 149 (474)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~li~~---~~~~l~~~~~~~i~~qi~~gL~yLHs-~gIiHrDIKP~NILl~~~~~~~~vkL~D 149 (474)
+...+++|||+ +++|.+++.. ....+++..++.++.|++.||.|||+ .||+|+||||+|||++ ..+.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~---~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG---EDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEEC---CCCcEEEec
Confidence 88899999998 7899998753 34568999999999999999999996 7899999999999994 778999999
Q ss_pred cCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHh
Q 011945 150 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (474)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (474)
||++........ .....|+..|++||++.+..++.++|||||||++|+|++|..||..... ......+.
T Consensus 158 fg~~~~~~~~~~--------~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~---~~~~~~~~ 226 (269)
T cd08528 158 FGLAKQKQPESK--------LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---LSLATKIV 226 (269)
T ss_pred ccceeecccccc--------cccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH---HHHHHHHh
Confidence 999986544321 1345789999999999998899999999999999999999999975432 22223332
Q ss_pred hccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011945 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 274 (474)
Q Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (474)
....... ....+++++.+++.+||..||++||++.++.+.+.
T Consensus 227 ~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 227 EAVYEPL---PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hccCCcC---CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 2222111 11357899999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=296.51 Aligned_cols=253 Identities=18% Similarity=0.293 Sum_probs=192.8
Q ss_pred EEEeeeeeecCceEEEEEEEcC---CCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeC-----C
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEG-----D 76 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~-----~ 76 (474)
|++.+.||+|+||.||+|.+.. +++.||||++..+.. .+.+.+|+++++.+.|++++..+..+.... .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 6788999999999999998643 578999998765432 235788999999998766555554332221 1
Q ss_pred EEEEEEecC-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEec
Q 011945 77 YNVLVIDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~-----~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DF 150 (474)
..+++++|+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+||+++ .++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~---~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEc---CCCCEEECcc
Confidence 346777777 78998876422 12478999999999999999999999999999999999994 6788999999
Q ss_pred CCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHh
Q 011945 151 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKIS 229 (474)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~ 229 (474)
|+++....... +.......++..|++||.+.+..++.++|||||||++|||++ |+.||.+... ...+..+.
T Consensus 158 g~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~ 229 (273)
T cd05074 158 GLSKKIYSGDY-----YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLI 229 (273)
T ss_pred cccccccCCcc-----eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHH
Confidence 99986543221 111123356678999999998889999999999999999999 8999976533 22222222
Q ss_pred hccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
..... .....++..+.+++..||+.+|++||++.++++.|+.+
T Consensus 230 ~~~~~----~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 KGNRL----KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCCcC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 21110 11245788999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=308.80 Aligned_cols=248 Identities=22% Similarity=0.319 Sum_probs=196.6
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeC-----
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEG----- 75 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~----- 75 (474)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.|++++..+..+....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 6789999999999999999999999999999999875432 2245678999999998777666554443322
Q ss_pred CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 76 ~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
...++|+|+++++|.+++. ...+++..++.++.||+.||.|||+.||+||||||+||+++ .++.+||+|||++..
T Consensus 93 ~~~~lv~e~~~~~L~~~~~--~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~---~~~~~kL~dfg~~~~ 167 (343)
T cd07851 93 QDVYLVTHLMGADLNNIVK--CQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN---EDCELKILDFGLARH 167 (343)
T ss_pred ccEEEEEecCCCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEcccccccc
Confidence 3489999999999999987 35799999999999999999999999999999999999994 678899999999986
Q ss_pred cccCCCccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc--
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK-- 232 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~-- 232 (474)
.... .....++..|+|||.+.+. .++.++|||||||++|||++|+.||.+... ...+..+....
T Consensus 168 ~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~---~~~~~~i~~~~~~ 234 (343)
T cd07851 168 TDDE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH---IDQLKRIMNLVGT 234 (343)
T ss_pred cccc----------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHHhcCC
Confidence 5432 1234678899999998763 678999999999999999999999976433 22222221110
Q ss_pred ------------------------ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 233 ------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 233 ------------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.......+...+++++.++|..||..+|++||++.+|+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell 296 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL 296 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHh
Confidence 00111223345688999999999999999999988764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=322.67 Aligned_cols=272 Identities=22% Similarity=0.294 Sum_probs=207.2
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC---CCchHHHHHHHHHHHhcCCCCCceeEEEeE-----eCC
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK---TKHPQLQYEAKLYKILQGGTGIPNLRWFGV-----EGD 76 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~---~~~~~l~~E~~il~~l~~~~~i~~l~~~~~-----~~~ 76 (474)
....|...+.||+|+||.||+++++.+|+.||||.++.. ...+...+|+++|++|+|.|+|..+..-.. ...
T Consensus 11 ~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 11 ENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred CCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 455688889999999999999999999999999988763 345668999999999996555555432221 134
Q ss_pred EEEEEEecC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCC-CCCeEEEEecCC
Q 011945 77 YNVLVIDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGL 152 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~~--~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~-~~~~vkL~DFGl 152 (474)
..+++|||| ||+|..+++... ..+++.+++.++.+++.||.|||++|||||||||.||++-.+. .....||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 568999999 999999997443 3499999999999999999999999999999999999996544 233569999999
Q ss_pred ccccccCCCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcC-cHHHHHHHHhh
Q 011945 153 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYEKISE 230 (474)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~i~~ 230 (474)
|+.+.+... ...++||..|.+||++.. ..|+..+|.|||||++|+++||.+||...... ...+....+..
T Consensus 171 Arel~d~s~--------~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~t 242 (732)
T KOG4250|consen 171 ARELDDNSL--------FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIIT 242 (732)
T ss_pred cccCCCCCe--------eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhc
Confidence 999887653 356799999999999995 78999999999999999999999999654322 11222222222
Q ss_pred ccccch--------------------HHHHhcCCcHHHHHHHHHHhcCCCCCCC--CHHHHHHHHHHHHHHcCCCC
Q 011945 231 KKVSTS--------------------IEALCRGYPTEFASYFHYCRSLRFDDKP--DYAYLKRLFRDLFIREGFQF 284 (474)
Q Consensus 231 ~~~~~~--------------------~~~l~~~~p~~l~~li~~cl~~dp~~RP--t~~~l~~~L~~l~~~~~~~~ 284 (474)
++.... ...+...+-..+...+..+|..+|.+|- .+.+....+.+++...-...
T Consensus 243 kkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~vvhi 318 (732)
T KOG4250|consen 243 KKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKVVHI 318 (732)
T ss_pred cCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhheeEE
Confidence 221110 0011122234567778888899999998 77788888888887665433
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=291.66 Aligned_cols=246 Identities=23% Similarity=0.302 Sum_probs=201.2
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
+|.+.+.||.|+||.||++.+..+++.|++|++.... ....+..|+++++.++|++.+..+. ....+...++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~-~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE-SFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEE-EEecCCEEEEEEE
Confidence 5899999999999999999998899999999886543 2345888999999999665555444 4455588899999
Q ss_pred cC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 84 ~~-g~sL~~li~~~---~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
++ +++|.+++... ...+++..++.++.||+.||.|||++|++|+||+|+||+++ ..+.++|+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~---~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT---SNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc---CCCcEEECCccceeecccC
Confidence 98 67999999754 36799999999999999999999999999999999999994 6789999999999876543
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
.. ......|++.|+|||.+.+..++.++||||||+++|+|++|..||.... .......+.... ...
T Consensus 157 ~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~~~~----~~~ 222 (258)
T cd08215 157 VD-------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELALKILKGQ----YPP 222 (258)
T ss_pred cc-------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc---HHHHHHHHhcCC----CCC
Confidence 31 1233578999999999999889999999999999999999999997643 233333332222 222
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
+...++.++.+++..||..+|++||++.++++
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 34578899999999999999999999888754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=299.69 Aligned_cols=244 Identities=24% Similarity=0.333 Sum_probs=195.3
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
.+.|...++||+|+||+||+|++..+++.|+||++..... ...+..|+.+++.++|.+ +..+..++......++
T Consensus 20 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~l 98 (313)
T cd06633 20 EEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN-TIEYKGCYLKEHTAWL 98 (313)
T ss_pred HHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCC-CccEEEEEEeCCEEEE
Confidence 3457778899999999999999999999999998764322 135778999999998554 5555556677788999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 81 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 81 v~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
+|||+.++|.+++......+++.+++.++.||+.||.|||++||+|+||||+||+++ .++.+||+|||++.....
T Consensus 99 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~---~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 99 VMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEEC---CCCCEEEeecCCCcccCC--
Confidence 999999999999876667799999999999999999999999999999999999994 678899999999864321
Q ss_pred CccccccccCCCCccCcccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
.....|+..|+|||++. +..++.++|||||||++|+|++|..||...... .....+.......
T Consensus 174 ---------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~---~~~~~~~~~~~~~-- 239 (313)
T cd06633 174 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQNDSPT-- 239 (313)
T ss_pred ---------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHhcCCCC--
Confidence 13457899999999985 356889999999999999999999999775432 2222222211111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.....++..+.+++.+||+.+|++||++.+++
T Consensus 240 -~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l 271 (313)
T cd06633 240 -LQSNEWTDSFRGFVDYCLQKIPQERPASAELL 271 (313)
T ss_pred -CCccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 11245678899999999999999999988775
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=295.41 Aligned_cols=243 Identities=17% Similarity=0.280 Sum_probs=193.3
Q ss_pred cEEEeeeeeecCceEEEEEEEc---CCCeEEEEEEeccCC------CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAvK~~~~~~------~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
+|++.+.||.|+||.||+|.+. .+|+.||+|++.... ....+..|+.+++.+.++++|..+..+...+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999874 478999999876422 2345788999999998888888888777788889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
+++|||+ +++|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++ .++.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEC---CCCCEEEeeCccceecc
Confidence 9999999 7899998874 45689999999999999999999999999999999999994 67899999999998654
Q ss_pred cCCCccccccccCCCCccCccccccccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcH-HHHHHHHhhcccc
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVS 234 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~--~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~ 234 (474)
..... ......|+..|+|||.+.+. .++.++|||||||++|+|++|..||........ ......+....
T Consensus 157 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-- 228 (290)
T cd05613 157 EDEVE------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-- 228 (290)
T ss_pred ccccc------ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC--
Confidence 43211 11235689999999998763 467899999999999999999999975332211 11122111111
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCCCCC
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPD 265 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt 265 (474)
......+++.+.+++.+||..||++||+
T Consensus 229 ---~~~~~~~~~~~~~ll~~~l~~~p~~R~~ 256 (290)
T cd05613 229 ---PPYPQEMSALAKDIIQRLLMKDPKKRLG 256 (290)
T ss_pred ---CCCCccCCHHHHHHHHHHhcCCHHHhcC
Confidence 1123457889999999999999999983
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=299.90 Aligned_cols=247 Identities=22% Similarity=0.322 Sum_probs=196.1
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
.++|++.+.||+|+||.||++.+..++..||+|.+.... ....+..|+.+++.+.|+ ++..+..+....+..++|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp-~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHP-NIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCC-CeeehhheeeeCCcEEEEEe
Confidence 468999999999999999999998899999999875432 234578899999999854 45555555666778899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
|+ +++|.+++. ...+++..++.++.||+.||.|||++||+|+||||+||+++ .++.++|+|||++..+......
T Consensus 97 ~~~~~~L~~~~~--~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~---~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 97 YLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred cCCCCcHHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc---CCCCEEEccCcceecccccccc
Confidence 99 889999986 34689999999999999999999999999999999999994 6788999999998765443221
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhc
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (474)
.....|+..|++||.+.+..++.++|||||||++|++++|..||....... .+..+..... . ......
T Consensus 172 -------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~---~~~~~~~~~~-~-~~~~~~ 239 (293)
T cd06647 172 -------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYLIATNGT-P-ELQNPE 239 (293)
T ss_pred -------cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh---heeehhcCCC-C-CCCCcc
Confidence 123478899999999998889999999999999999999999997643211 1111111100 0 011123
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 243 GYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.++..+.+++..||..+|++||++.+++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il 267 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELL 267 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 4678899999999999999999987764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=289.65 Aligned_cols=251 Identities=24% Similarity=0.415 Sum_probs=197.7
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
+|++.+.||+|+||.||+|.+..+++.|+||++..... ...+..|+.+++.++|.+ |..+..+.......++++|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~-i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN-LVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCC-hhheeeeEecCCEEEEEEe
Confidence 69999999999999999999988999999998765533 345889999999998654 4455555667788899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
|+ +++|.+++.. ...+++..++.|+.|++.||.|||+.||+|+||||+||+++ ..+.+||+|||++.........
T Consensus 80 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~---~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 80 YCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred cCCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEcccccccccCCCCCc
Confidence 98 7899999874 34589999999999999999999999999999999999994 6789999999999876554321
Q ss_pred cccccccCCCCccCccccccccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~---~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
... ......++..|+|||++.+.. .+.++|||||||++|+|++|..||..... .......+.... ....+.
T Consensus 156 ~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~-~~~~~~ 229 (264)
T cd06626 156 MGE---EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EFQIMFHVGAGH-KPPIPD 229 (264)
T ss_pred ccc---cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc--hHHHHHHHhcCC-CCCCCc
Confidence 100 012356889999999998766 88999999999999999999999976532 111122222111 111111
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
...++..+.+++..||..+|++||++.+++
T Consensus 230 -~~~~~~~~~~li~~~l~~~p~~R~~~~~i~ 259 (264)
T cd06626 230 -SLQLSPEGKDFLDRCLESDPKKRPTASELL 259 (264)
T ss_pred -ccccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 123588999999999999999999988774
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=294.19 Aligned_cols=260 Identities=16% Similarity=0.190 Sum_probs=207.6
Q ss_pred ccCCcEEEe-eeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEe----EeCCEE
Q 011945 4 RVGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFG----VEGDYN 78 (474)
Q Consensus 4 ~i~~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~----~~~~~~ 78 (474)
.|.++|.|- ++||-|-.|.|-.|.++.+++.+|+|++. +.+...+|+++.-....|++|+.+..+. ......
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~---Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL---DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh---cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 356778776 57899999999999999999999999875 4456788999988888777777664332 245677
Q ss_pred EEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 79 VLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
.+|||++ ||.|.+.|... ...|++.++..|+.||..|+.|||+.+|.||||||+|+|.+....+-.+||+|||+|+.-
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccccc
Confidence 8999999 99999998754 446999999999999999999999999999999999999987777788999999999875
Q ss_pred ccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcH-HHHHHHHhhccccc
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVST 235 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~ 235 (474)
..... ..+-+-|+.|.|||++....|+...|+||+||+||-||+|.+||........ ...-.+|.......
T Consensus 215 ~~~~~--------L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F 286 (400)
T KOG0604|consen 215 QEPGD--------LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF 286 (400)
T ss_pred CCCcc--------ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence 54322 2345789999999999999999999999999999999999999986543221 11223343333333
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
+-+ -+..+++..+++|+.+|..+|.+|.|+.++ +++.+.
T Consensus 287 P~p-EWs~VSe~aKdlIR~LLkt~PteRlTI~~~---m~hpwi 325 (400)
T KOG0604|consen 287 PEP-EWSCVSEAAKDLIRKLLKTEPTERLTIEEV---MDHPWI 325 (400)
T ss_pred CCh-hHhHHHHHHHHHHHHHhcCCchhheeHHHh---hcCchh
Confidence 322 346678999999999999999999996655 555443
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=294.98 Aligned_cols=248 Identities=25% Similarity=0.399 Sum_probs=200.7
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++|.+.+.||.|+||.||+|.+..+++.||+|++.... ....+..|+.+++.+..+++|..+..+...+...+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 57999999999999999999999999999999876522 2345788999999998456666666566677889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
||++ +++|.+++.. ...+++..++.|+.||+.||.|||+.|++|+||||+||+++ .++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~---~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD---KDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---CCCCEEecCCccccccCCcc
Confidence 9999 9999999974 34799999999999999999999999999999999999994 67889999999998765433
Q ss_pred Ccccc-------------ccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHH
Q 011945 161 THQHI-------------PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227 (474)
Q Consensus 161 ~~~~~-------------~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 227 (474)
..... .........++..|+|||++.+..++.++|||||||++|++++|..||.... ..+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~ 233 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN---EYLTFQK 233 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHH
Confidence 21100 0122344578899999999998889999999999999999999999998643 2233333
Q ss_pred HhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 011945 228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 266 (474)
Q Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~ 266 (474)
+..... .+...+++.+.+++..||..+|++||++
T Consensus 234 ~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~ 267 (280)
T cd05581 234 ILKLEY-----SFPPNFPPDAKDLIEKLLVLDPQDRLGV 267 (280)
T ss_pred HHhcCC-----CCCCccCHHHHHHHHHHhcCCHhhCCCc
Confidence 322111 1235678999999999999999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=347.53 Aligned_cols=257 Identities=22% Similarity=0.346 Sum_probs=207.3
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
.-+|.-..+||.|.||.||.|.+..+|+..|+|-++.. ...+.+..|..++..|+|+ +++.++++.++.+..+|.
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHp-NlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHP-NLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCc-cccccCceeecHHHHHHH
Confidence 44677888999999999999999999999999965432 2345688999999999955 555666677888889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||| ||+|.+++. ..+..++.....+..|++.||.|||++|||||||||+||++ +.++.+|++|||.|..+....
T Consensus 1313 MEyC~~GsLa~ll~-~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLE-HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHhccCcHHHHHH-hcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccceeEecCch
Confidence 9999 999999998 45668888888999999999999999999999999999999 478899999999999887653
Q ss_pred CccccccccCCCCccCccccccccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~---~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
+.+| .+.....||+.|||||++.|.. ...++||||||||+.||+||+.||..++.. .+.+.++.....
T Consensus 1389 --~~~~-~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~aIMy~V~~gh~---- 1459 (1509)
T KOG4645|consen 1389 --QTMP-GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--WAIMYHVAAGHK---- 1459 (1509)
T ss_pred --hcCC-HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--hHHHhHHhccCC----
Confidence 1222 3456779999999999998743 567999999999999999999999887542 333333333222
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
+.++..++.+-.+||..||..||+.|.++.+ +|+..|-+
T Consensus 1460 Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~q---lle~~f~~ 1498 (1509)
T KOG4645|consen 1460 PQIPERLSSEGRDFLEHCLEQDPKMRWTASQ---LLEHAFGK 1498 (1509)
T ss_pred CCCchhhhHhHHHHHHHHHhcCchhhhHHHH---HHHhhccc
Confidence 2334457899999999999999999977654 45565543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=312.98 Aligned_cols=241 Identities=20% Similarity=0.318 Sum_probs=203.4
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccC----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecCCCC
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPS 88 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~g~s 88 (474)
+.||+|.||+||-|+++++|+.||||++.+. ....++..|+.||+.+. |++|+.+...++..+..++|||-+.|+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~-HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLH-HPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcC-CCCeeEEEEeecCCceEEEEehhhcch
Confidence 7899999999999999999999999987653 23467999999999997 788899999999999999999999776
Q ss_pred HHHHH-HHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccccc
Q 011945 89 LEDLF-NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167 (474)
Q Consensus 89 L~~li-~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~ 167 (474)
..++| ....+++++.....++.||+.||.|||-++|+|+||||+|||+...+.-.++||||||+|+.+.+...
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF------ 722 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF------ 722 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh------
Confidence 66655 45577899999999999999999999999999999999999998766778999999999998876543
Q ss_pred ccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHH
Q 011945 168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 247 (474)
Q Consensus 168 ~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 247 (474)
...++||+.|+|||++.++.|++.-|+||.|||+|--|.|.+||... ++...+++.....-... -+..++++
T Consensus 723 --RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~----PW~eis~~ 794 (888)
T KOG4236|consen 723 --RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPN----PWSEISPE 794 (888)
T ss_pred --hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCC----chhhcCHH
Confidence 24679999999999999999999999999999999999999999764 33344443332222222 23567899
Q ss_pred HHHHHHHHhcCCCCCCCCHHH
Q 011945 248 FASYFHYCRSLRFDDKPDYAY 268 (474)
Q Consensus 248 l~~li~~cl~~dp~~RPt~~~ 268 (474)
..+||..+|+..-.+|-+.+.
T Consensus 795 AidlIn~LLqVkm~kRysvdk 815 (888)
T KOG4236|consen 795 AIDLINNLLQVKMRKRYSVDK 815 (888)
T ss_pred HHHHHHHHHHHHHHHhcchHh
Confidence 999999999999999987543
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=296.46 Aligned_cols=250 Identities=22% Similarity=0.340 Sum_probs=201.5
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
..+.|++.+.||+|+||.||+|.+..++..|++|++..... ...+..|+++++.++|. ++..+..++......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHP-NIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCC-CeeEEEEEEEECCEEEEEEe
Confidence 45679999999999999999999988899999998875443 45688999999999865 55555556667788999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
|+ +++|.+++......+++..++.++.||+.||.|||+.||+|+||||+||+++ .++.++|+|||++........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~- 171 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS---KDGSVKLADFGFAAQLTKEKS- 171 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc---CCCCEEECccchhhhhccchh-
Confidence 99 5999999986544799999999999999999999999999999999999994 678899999999876543221
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhc
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (474)
......++..|++||++.+..++.++|||||||++|+|++|..||...... .....+....... .. ...
T Consensus 172 ------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~-~~-~~~ 240 (286)
T cd06614 172 ------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL---RALFLITTKGIPP-LK-NPE 240 (286)
T ss_pred ------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcCCCC-Cc-chh
Confidence 112346788999999999888999999999999999999999999764332 2222222221111 11 123
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 243 GYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.++.++.++|..||+.+|.+||++.+++
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il 268 (286)
T cd06614 241 KWSPEFKDFLNKCLVKDPEKRPSAEELL 268 (286)
T ss_pred hCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 4789999999999999999999988774
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=303.88 Aligned_cols=261 Identities=19% Similarity=0.266 Sum_probs=205.8
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-CCchHHHHHHHHHHHhcCC-----CCCceeEEEeEeCCE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLQYEAKLYKILQGG-----TGIPNLRWFGVEGDY 77 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-~~~~~l~~E~~il~~l~~~-----~~i~~l~~~~~~~~~ 77 (474)
.+.++|.++.+||+|.||.|-.+.+..++..||||+++.- ...+...-|+++++++.+. +-+..+..++.....
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 4678999999999999999999999999999999987643 4456678899999999533 234444555667778
Q ss_pred EEEEEecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeC---------C-------
Q 011945 78 NVLVIDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG---------R------- 140 (474)
Q Consensus 78 ~~lv~e~~g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~---------~------- 140 (474)
.|||+|.+|.|+.+++... -.+|+...+..|+.|++.+++|||+.+++|-||||+|||+... .
T Consensus 166 iCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~ 245 (415)
T KOG0671|consen 166 ICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRP 245 (415)
T ss_pred eEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceecc
Confidence 8999999999999999753 3469999999999999999999999999999999999999531 1
Q ss_pred -CCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcC
Q 011945 141 -RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (474)
Q Consensus 141 -~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~ 219 (474)
++..|+|+|||.|+...+.. ...+.|..|.|||+++|..|+.++||||+||||+|+++|...|+.-.+.
T Consensus 246 ~ks~~I~vIDFGsAtf~~e~h----------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~ 315 (415)
T KOG0671|consen 246 LKSTAIKVIDFGSATFDHEHH----------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL 315 (415)
T ss_pred CCCcceEEEecCCcceeccCc----------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence 13468999999998644322 3568899999999999999999999999999999999999999986655
Q ss_pred cHHHHHHHHhhccccchHHHH----------------------------hc-------C---CcHHHHHHHHHHhcCCCC
Q 011945 220 TKKQKYEKISEKKVSTSIEAL----------------------------CR-------G---YPTEFASYFHYCRSLRFD 261 (474)
Q Consensus 220 ~~~~~~~~i~~~~~~~~~~~l----------------------------~~-------~---~p~~l~~li~~cl~~dp~ 261 (474)
+...+++.|........+..- |. . --.+|.+||+.||.+||.
T Consensus 316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~ 395 (415)
T KOG0671|consen 316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA 395 (415)
T ss_pred HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence 555555555442211111111 00 0 013589999999999999
Q ss_pred CCCCHHHHHHHHHHHH
Q 011945 262 DKPDYAYLKRLFRDLF 277 (474)
Q Consensus 262 ~RPt~~~l~~~L~~l~ 277 (474)
+|+|+.|+ |.+.|
T Consensus 396 ~RiTl~EA---L~HpF 408 (415)
T KOG0671|consen 396 RRITLREA---LSHPF 408 (415)
T ss_pred ccccHHHH---hcCHH
Confidence 99996665 44444
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=286.43 Aligned_cols=249 Identities=24% Similarity=0.356 Sum_probs=201.6
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeC--CEEEEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEG--DYNVLV 81 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~--~~~~lv 81 (474)
+|.+.+.||+|++|.||+|.+..+++.|++|++..... ...+.+|+.+++.+.|++++..+ .+.... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~-~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY-GSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEE-EEEecCCCCeEEEE
Confidence 58899999999999999999988999999998866543 45688999999999965555544 444455 788999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
+|++ +++|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++ .++.++|+|||.+.......
T Consensus 80 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD---SDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---CCCCEEEcccccEEeccccc
Confidence 9999 899999997543 899999999999999999999999999999999999995 67899999999998776543
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
.. .......++..|++||.+.+...+.++||||||+++|+|++|..||.... ........+... .....+
T Consensus 156 ~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~---~~~~~~ 225 (260)
T cd06606 156 TG-----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG--NPMAALYKIGSS---GEPPEI 225 (260)
T ss_pred cc-----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHhcccc---CCCcCC
Confidence 21 01133578899999999998889999999999999999999999998754 222222222211 112223
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
...++.++.+++.+||..+|++||++.+++.
T Consensus 226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 226 PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 4566899999999999999999999887753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=319.02 Aligned_cols=248 Identities=19% Similarity=0.327 Sum_probs=203.2
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
+.|.|+..||-|+||.||+|.++.++-..|.|++..+.. .+.+..|+.||..+.|+.++..+..|..++ ..+|+.||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en-kLwiliEF 110 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN-KLWILIEF 110 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC-ceEEEEee
Confidence 458899999999999999999999998899998766543 356888999999999766666666555554 45777888
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 85 ~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
| ||-...++-..++.+.+.++..++.|++.||.|||+++|||||||..|||++ -+|.|+|+|||.+........
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T---ldGdirLADFGVSAKn~~t~q-- 185 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT---LDGDIRLADFGVSAKNKSTRQ-- 185 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE---ecCcEeeecccccccchhHHh--
Confidence 8 7777778777889999999999999999999999999999999999999997 678999999999865433221
Q ss_pred ccccccCCCCccCcccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 164 HIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
....+.||++|||||+.. ..+|+.++||||||++|.||..+.+|...++. ...+.+|.....++.+
T Consensus 186 -----kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp---MRVllKiaKSePPTLl- 256 (1187)
T KOG0579|consen 186 -----KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSEPPTLL- 256 (1187)
T ss_pred -----hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch---HHHHHHHhhcCCCccc-
Confidence 125689999999999865 56799999999999999999999999987654 3444444443333322
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
-+..++..|.+|+..||.+||..||++++|+
T Consensus 257 -qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll 287 (1187)
T KOG0579|consen 257 -QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLL 287 (1187)
T ss_pred -CcchhhhHHHHHHHHHHhcCCccCCCHHHHh
Confidence 2356789999999999999999999998875
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=294.36 Aligned_cols=252 Identities=23% Similarity=0.284 Sum_probs=194.4
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 85 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (474)
|.+.+.||.|+||+||+|.+..+++.|+||.+..... .....+|+..++.+.+++++..+..+...+...+++||++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 7889999999999999999988899999998755422 2235678899999984555555555555688889999999
Q ss_pred CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccc
Q 011945 86 GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164 (474)
Q Consensus 86 g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (474)
+++|.+++.... ..+++..++.++.||+.+|.|||++||+|+||||+||+++ ..+.++|+|||++........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~---~~~~~~l~d~~~~~~~~~~~~--- 154 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS---GPEVVKIADFGLAREIRSRPP--- 154 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc---CCCCEEEeecccceeccCCCC---
Confidence 999999987543 4689999999999999999999999999999999999994 788999999999986644322
Q ss_pred cccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc-----------
Q 011945 165 IPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK----------- 232 (474)
Q Consensus 165 ~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~----------- 232 (474)
.....++..|+|||++.+ ..++.++||||||+++|||++|..||......+.......+....
T Consensus 155 -----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 155 -----YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred -----cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 123568899999998864 457899999999999999999999997654322221111111000
Q ss_pred -----------ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 233 -----------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 233 -----------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
............+..+.+++..||..+|++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 001112222334688999999999999999999887753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=291.13 Aligned_cols=234 Identities=18% Similarity=0.234 Sum_probs=188.4
Q ss_pred eeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-CCC
Q 011945 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS 88 (474)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~s 88 (474)
||.|+||.||+|.+..+++.||||++.... ....+..|+.+++.+.|++++.. ..+...+...+++|||+ +++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-YRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeee-eeeEEcCCccEEEEecCCCCc
Confidence 699999999999998889999999876432 22458889999999986555554 44556777889999997 889
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccccc
Q 011945 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 168 (474)
Q Consensus 89 L~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 168 (474)
|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++ .++.++|+|||++........
T Consensus 80 L~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~---~~~~~~l~df~~~~~~~~~~~------- 148 (262)
T cd05572 80 LWTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLD---SNGYVKLVDFGFAKKLKSGQK------- 148 (262)
T ss_pred HHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEc---CCCCEEEeeCCcccccCcccc-------
Confidence 9999974 34689999999999999999999999999999999999994 678999999999987654321
Q ss_pred cCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHH
Q 011945 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF 248 (474)
Q Consensus 169 ~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l 248 (474)
.....|+..|++||.+.+..++.++|||||||++|+|++|..||..... +....+..+....... .....+++++
T Consensus 149 -~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~ 223 (262)
T cd05572 149 -TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-DPMEIYNDILKGNGKL---EFPNYIDKAA 223 (262)
T ss_pred -cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-CHHHHHHHHhccCCCC---CCCcccCHHH
Confidence 1234688999999999988899999999999999999999999987543 2333333333211111 1223457899
Q ss_pred HHHHHHHhcCCCCCCCC
Q 011945 249 ASYFHYCRSLRFDDKPD 265 (474)
Q Consensus 249 ~~li~~cl~~dp~~RPt 265 (474)
.++|.+||..+|++||+
T Consensus 224 ~~~i~~~l~~~p~~R~~ 240 (262)
T cd05572 224 KDLIKQLLRRNPEERLG 240 (262)
T ss_pred HHHHHHHccCChhhCcC
Confidence 99999999999999999
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=300.00 Aligned_cols=245 Identities=21% Similarity=0.304 Sum_probs=195.0
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
...|...+.||.|+||.||+|++..+++.||||.+.... ....+..|+++++.++|++++..+ .+.......++
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~-~~~~~~~~~~l 92 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR-GCYLREHTAWL 92 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEE-EEEEcCCeeEE
Confidence 345888899999999999999999999999999875321 123577899999999866555544 45556778899
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 81 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 81 v~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
||||+.++|.+++......+++..++.++.|++.||.|||+++++||||||+|||++ .++.++|+|||++......
T Consensus 93 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 93 VMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEEC---CCCcEEECCcccceeecCc-
Confidence 999998899988876666799999999999999999999999999999999999994 6789999999998765332
Q ss_pred CccccccccCCCCccCccccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~---~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
....|+..|+|||++.+ ..++.++|||||||++|+|++|..||....... ....+.......
T Consensus 169 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~~~~-- 233 (308)
T cd06634 169 ----------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHIAQNESPA-- 233 (308)
T ss_pred ----------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH---HHHHHhhcCCCC--
Confidence 23468899999999853 457889999999999999999999997654321 111222111111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.....++.++.++|.+||..+|++||+++++++
T Consensus 234 -~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~ 266 (308)
T cd06634 234 -LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (308)
T ss_pred -cCcccccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence 112357889999999999999999999887754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=294.12 Aligned_cols=245 Identities=20% Similarity=0.297 Sum_probs=195.1
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 85 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (474)
.|...++||+|++|.||++.+..+++.|+||.+.... ....+.+|+.+++.+.|++++. +..+...++..++++||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~-~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVE-MYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChhe-EEEEEEcCCeEEEEEecc
Confidence 5667789999999999999998899999999875432 2345788999999998655444 444556677889999998
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccc
Q 011945 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164 (474)
Q Consensus 86 -g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (474)
+++|.+++.. .++++..++.++.||+.||.|||++||+||||||+||+++ .++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~d~g~~~~~~~~~~--- 170 (285)
T cd06648 99 EGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLT---SDGRVKLSDFGFCAQVSKEVP--- 170 (285)
T ss_pred CCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEc---CCCcEEEcccccchhhccCCc---
Confidence 8899999874 5799999999999999999999999999999999999994 778999999998875543221
Q ss_pred cccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCC
Q 011945 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (474)
Q Consensus 165 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (474)
......|+..|+|||++.+..++.++|||||||++|||++|..||..... ...+..+....... . .....+
T Consensus 171 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~---~~~~~~~~~~~~~~-~-~~~~~~ 241 (285)
T cd06648 171 ----RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP---LQAMKRIRDNLPPK-L-KNLHKV 241 (285)
T ss_pred ----ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH---HHHHHHHHhcCCCC-C-cccccC
Confidence 11235689999999999988899999999999999999999999976432 23333333221111 1 112347
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 245 PTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 245 p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
+..+.+++..||..+|++||++.+++
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il 267 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELL 267 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHc
Confidence 88999999999999999999987764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=289.27 Aligned_cols=244 Identities=18% Similarity=0.289 Sum_probs=198.2
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
+|++.++||.|+||.||++.+..+++.|+||.+.... ....+..|+++++.++|. ++..+..+.......+++||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHP-NIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCC-CchhhhhhhccCCEEEEEeh
Confidence 5899999999999999999999999999999876432 223577899999999855 55555555566688999999
Q ss_pred cC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 84 ~~-g~sL~~li~~~---~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
|+ +++|.+++... ...+++..++.++.||+.||.|||+.|++|+||+|+||+++ ..+.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV---ANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe---cCCcEEEeeccchhhhccC
Confidence 98 88999988642 35689999999999999999999999999999999999995 5788999999999876543
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
.. ....++..|++||.+.+..++.++|+||||+++|+|++|+.||..... ......+...... .
T Consensus 157 ~~---------~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~~----~ 220 (256)
T cd08530 157 MA---------KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QDLRYKVQRGKYP----P 220 (256)
T ss_pred Cc---------ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCCC----C
Confidence 11 234688999999999998899999999999999999999999976543 2222222222222 2
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
+...++.++.+++.+||..+|++||++.++++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 23467889999999999999999999888754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=309.88 Aligned_cols=263 Identities=21% Similarity=0.312 Sum_probs=210.0
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC---------CchHHHHHHHHHHHhcCCCCCceeEEEeE
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---------KHPQLQYEAKLYKILQGGTGIPNLRWFGV 73 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---------~~~~l~~E~~il~~l~~~~~i~~l~~~~~ 73 (474)
|.+.++|-++.+||.|||++||+|.|...++.||||+-.... .++...+|..|.+.|.|+.+|..+++|..
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 567889999999999999999999999999999999844332 33457889999999999999999999999
Q ss_pred eCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCCCcEEeeeCCCCCeEEEEec
Q 011945 74 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (474)
Q Consensus 74 ~~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~--gIiHrDIKP~NILl~~~~~~~~vkL~DF 150 (474)
+.+.+|.|+||| |.+|.-+++ ..+-++++++..|+.||+.||.||... .|||-||||.|||+-.+...|.+||+||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLK-QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLK-QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred ccccceeeeeecCCCchhHHHH-hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 999999999999 667776666 456799999999999999999999985 5999999999999987788899999999
Q ss_pred CCccccccCCCccccccccCCCCccCccccccccccCC----CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHH
Q 011945 151 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 226 (474)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~----~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 226 (474)
||++.+.++.........-.....||.+|++||.+.-. ..+.|+||||+|||+|..+.|+.||.........-.+.
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 99999988765433333344567899999999998743 36899999999999999999999997532211111111
Q ss_pred HHhhc-cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011945 227 KISEK-KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 269 (474)
Q Consensus 227 ~i~~~-~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (474)
.|... .+.. ...+-++.+.++||.+||++.-++|.+..+|
T Consensus 698 TIlkAtEVqF---P~KPvVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 698 TILKATEVQF---PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred chhcceeccC---CCCCccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 11110 0000 0113467899999999999999999885544
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=286.35 Aligned_cols=245 Identities=23% Similarity=0.356 Sum_probs=200.0
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
+|++.+.||+|++|.||++.+..+++.|+||.+..... ...+..|++++..+.|++ +..+..+...+...+++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~-i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN-IVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCC-ccEEEEEEEeCCEEEEEEe
Confidence 58999999999999999999988999999998765532 345889999999998655 4455555666788999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
++ +++|.+++... ..+++..++.++.|++.||.|||++||+|+||||+||+++ ..+.++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 80 YAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred cCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC---CCCCEEEeccccceecCCCccc
Confidence 99 77999998743 6799999999999999999999999999999999999995 5789999999999876543321
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhc
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (474)
.....++..|+|||.+.+..++.++|||+||+++|+|++|..||..... ...+..+..... ..+..
T Consensus 156 -------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~~ 221 (254)
T cd06627 156 -------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP---MAALFRIVQDDH----PPLPE 221 (254)
T ss_pred -------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH---HHHHHHHhccCC----CCCCC
Confidence 1335789999999999888889999999999999999999999976442 222222221111 12345
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.++.++.+++..||..+|++||++.+++.
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 67899999999999999999999887753
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=292.30 Aligned_cols=252 Identities=21% Similarity=0.224 Sum_probs=196.5
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
|++.++||+|+||.||+|++..+++.||+|++.... ....+..|+.+++.+.|.+ +..+..+.......+++||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~-i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPN-IVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCC-HHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999877542 2345788999999998555 44454455566889999999
Q ss_pred CCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccc
Q 011945 85 LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164 (474)
Q Consensus 85 ~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (474)
++++|.+++......+++..++.++.|++.||.|||++||+||||+|+||+++ .++.++|+|||++........
T Consensus 80 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~---~~~~~~l~d~g~~~~~~~~~~--- 153 (282)
T cd07829 80 CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN---RDGVLKLADFGLARAFGIPLR--- 153 (282)
T ss_pred cCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEc---CCCCEEEecCCcccccCCCcc---
Confidence 99999999986556799999999999999999999999999999999999994 678999999999986644321
Q ss_pred cccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc------------
Q 011945 165 IPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK------------ 231 (474)
Q Consensus 165 ~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~------------ 231 (474)
......++..|+|||.+.+. .++.++|||||||++|||++|..||...........+......
T Consensus 154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 154 ----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred ----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccc
Confidence 11233567889999998876 7899999999999999999999999764432211111111000
Q ss_pred ---------cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 232 ---------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 232 ---------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
............++..+.++|..||..+|++||++.+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0001111222345789999999999999999999887753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=302.18 Aligned_cols=274 Identities=21% Similarity=0.252 Sum_probs=224.3
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
..+|.++.+||+|+||.|.++..+.+.+.||||+++.+.. .+--..|-++|.....++.+..+..+++.-+..|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 4578899999999999999999999999999998765432 22245678888877888888888888888889999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
||||+ |++|--.++. -++|.+..+..++.+|+-||-|||++|||+||||.+|||+ +..+++||+|||+++.-.-.
T Consensus 428 VMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeecccccccccC
Confidence 99999 8898888774 4579999999999999999999999999999999999999 68999999999999864433
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
.. ...+++||+.|+|||++.-++|+..+|+|||||+||||+.|+.||.+. +..+.+..|.+....
T Consensus 504 ~~-------TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe---DE~elF~aI~ehnvs----- 568 (683)
T KOG0696|consen 504 GV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE---DEDELFQAIMEHNVS----- 568 (683)
T ss_pred Cc-------ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHHccCc-----
Confidence 32 236789999999999999999999999999999999999999999984 445667777766653
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccccccccccCCC
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVSTP 303 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~~~~p 303 (474)
.++.++.+..+++...|.+.|.+|....---+ +++ ....+....||+.+...+.|++..
T Consensus 569 yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge--~di---~~H~FFR~iDWek~E~~eiqPPfk 627 (683)
T KOG0696|consen 569 YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGE--RDI---REHPFFRRIDWEKLERREIQPPFK 627 (683)
T ss_pred CcccccHHHHHHHHHHhhcCCccccCCCCccc--cch---hhCcchhhccHHHHhhccCCCCCC
Confidence 34678899999999999999999954211000 111 112455668999998887776653
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=289.59 Aligned_cols=248 Identities=19% Similarity=0.271 Sum_probs=182.8
Q ss_pred eeeeecCceEEEEEEEcCC--CeEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-C
Q 011945 13 RKIGSGSFGEIYLGTNIQT--NEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 86 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~--~~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (474)
+.||+|+||.||+|..... ...+++|.+.... ....+.+|+.+++.++|++++..+. ++......+++|||+ +
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~-~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG-QCVEAIPYLLVFEYCEL 79 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEE-EecCCCccEEEEecCCC
Confidence 3699999999999975433 2356677655432 2346888999999998666655554 455667789999999 7
Q ss_pred CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 87 PSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 87 ~sL~~li~~~---~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||+ +.++.+||+|||++........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~-- 154 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDY-- 154 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcchh--
Confidence 8999998743 2346777889999999999999999999999999999999 4678899999999864322111
Q ss_pred ccccccCCCCccCccccccccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhc-ccc
Q 011945 164 HIPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEK-KVS 234 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~-------~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~-~~~ 234 (474)
........++..|+|||++.. ..++.++|||||||++|||++ |..||..... ...+..+... ...
T Consensus 155 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~~~~~~~~ 228 (268)
T cd05086 155 ---IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---REVLNHVIKDQQVK 228 (268)
T ss_pred ---hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHhhcccc
Confidence 011234578899999998753 245789999999999999997 6778876433 2233332221 111
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 273 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (474)
...+.+...+++.+.+++..|| .+|++||++++|.+.|
T Consensus 229 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 229 LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 1122334457889999999999 6899999999998776
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=298.26 Aligned_cols=252 Identities=15% Similarity=0.217 Sum_probs=184.8
Q ss_pred eeeeec--CceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-
Q 011945 13 RKIGSG--SFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 85 (474)
Q Consensus 13 ~~LG~G--~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (474)
..||.| +||+||++.+..+++.||||++..... .+.+.+|+.+++.++|++ |..+..++..+...+++|||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~n-iv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPN-IMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCC-cceEeeeEecCCceEEEEeccc
Confidence 456666 999999999999999999999765432 245788899888888655 555555666677889999998
Q ss_pred CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccc
Q 011945 86 GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164 (474)
Q Consensus 86 g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (474)
+++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++ ..+.++++||+.+...........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~---~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS---GDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe---CCCcEEEechHHHhhhhccCcccc
Confidence 77999988743 34589999999999999999999999999999999999994 678899999986654332221111
Q ss_pred cccccCCCCccCccccccccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc--------
Q 011945 165 IPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS-------- 234 (474)
Q Consensus 165 ~~~~~~~~~~GT~~Y~APE~~~~~--~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-------- 234 (474)
..+.......++..|+|||++.+. .++.++|||||||++|||++|..||.+..... .....+......
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhcCCCCCCccccccc
Confidence 111111223456789999999874 47899999999999999999999997653211 111111100000
Q ss_pred ---------------------------------chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 235 ---------------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 235 ---------------------------------~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.........+++.+.+|+..||..||++||++.+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l 306 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHh
Confidence 000011123567899999999999999999988874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=289.20 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=196.4
Q ss_pred eeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-CCC
Q 011945 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS 88 (474)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~s 88 (474)
||.|+||.||+|++..+++.|++|++.... ....+..|+.+++.+.|++++. +......+...|++||++ +++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~-~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK-LYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhH-HHHheecCcEEEEEEecCCCCc
Confidence 689999999999998889999999876542 2345888999999998655544 445556778889999999 789
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc-cccc
Q 011945 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ-HIPY 167 (474)
Q Consensus 89 L~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~-~~~~ 167 (474)
|.+++.... .+++..++.++.||+.||.|||++||+|+||+|+||+++ .++.++|+|||++.......... ....
T Consensus 80 L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 80 LASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILID---SNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEc---CCCCEEEEecccchhcccCccccccccc
Confidence 999997543 799999999999999999999999999999999999994 77899999999987654321100 0000
Q ss_pred ccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHH
Q 011945 168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTE 247 (474)
Q Consensus 168 ~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 247 (474)
.......++..|++||.+.+..++.++|||||||++|+|++|..||.... ....+..+........ .. ..++..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~--~~-~~~~~~ 229 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET---PEEIFQNILNGKIEWP--ED-VEVSDE 229 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcCCcCCC--cc-ccCCHH
Confidence 11234568899999999998889999999999999999999999997643 2333333333222111 11 124899
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 248 FASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 248 l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
+.+++..||+.+|++||++..+.++|++.+
T Consensus 230 ~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~ 259 (265)
T cd05579 230 AIDLISKLLVPDPEKRLGAKSIEEIKNHPF 259 (265)
T ss_pred HHHHHHHHhcCCHhhcCCCccHHHHhcCcc
Confidence 999999999999999999977777777654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=311.28 Aligned_cols=273 Identities=19% Similarity=0.272 Sum_probs=218.0
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
..+++++..||-||||.|-++........+|+|++++.. ..+.+..|-+||..+. .+.|+.++-.+.+.++.|+
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhhhh
Confidence 356778889999999999999865555558999776532 2344778999999988 5666666666678888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
.||.| ||.|+.++. ..+.|+..++..++..+++|++|||++|||+|||||+|+|+ +.+|-+||.|||+|+.+...
T Consensus 498 LmEaClGGElWTiLr-dRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 498 LMEACLGGELWTILR-DRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hHHhhcCchhhhhhh-hcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhccC
Confidence 99988 999999998 45689999999999999999999999999999999999999 58899999999999988765
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
.. .-+++||+.|.|||++++...+..+|.||||+++||||+|++||.+.++ ...|..|....- .-.
T Consensus 574 ~K--------TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp---mktYn~ILkGid---~i~ 639 (732)
T KOG0614|consen 574 RK--------TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP---MKTYNLILKGID---KIE 639 (732)
T ss_pred Cc--------eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch---HHHHHHHHhhhh---hhh
Confidence 43 3468999999999999999999999999999999999999999998654 444554443321 223
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccccccccccCC
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVST 302 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~~~~ 302 (474)
+++.++....+||.++...+|.+|-.+. ..-+.++ ....|...|||..++..+.+++-
T Consensus 640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG~~--~~gI~DI---kkH~Wf~gfdweglr~~~L~pPi 697 (732)
T KOG0614|consen 640 FPRRITKTATDLIKKLCRDNPTERLGYQ--KGGINDI---KKHRWFEGFDWEGLRSRTLPPPI 697 (732)
T ss_pred cccccchhHHHHHHHHHhcCcHhhhccc--cCChHHH---HhhhhhhcCChhhhhhccCCCCc
Confidence 4567888999999999999999997631 1222222 11355678999999877665443
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=308.55 Aligned_cols=246 Identities=23% Similarity=0.294 Sum_probs=202.7
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
...+.|.+.+.||+|.|++|.+|++..++..||||++...... ..+.+|+++|+.|.|+++|..+ .+-......|
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~-~v~~t~~~ly 131 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLF-SVIETEATLY 131 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeee-eeeeecceeE
Confidence 4457899999999999999999999999999999998765332 3478999999999966555544 4455666789
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
+||||+ ++.+.+++...+ ...+.++..++.|++.+++|||+++|||||||.+|||| +.+..+||+|||++..+..
T Consensus 132 lV~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceeecc
Confidence 999999 999999998554 56669999999999999999999999999999999999 4777899999999998875
Q ss_pred CCCccccccccCCCCccCccccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
... ..+++|++.|+|||++.|.+| ++.+|+||+|++||-|+.|.+||.+..- +..-..+...++..
T Consensus 208 ~~~--------lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l---k~Lr~rvl~gk~rI-- 274 (596)
T KOG0586|consen 208 GLM--------LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL---KELRPRVLRGKYRI-- 274 (596)
T ss_pred ccc--------ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc---ccccchheeeeecc--
Confidence 433 356799999999999999886 6899999999999999999999987432 22223333333322
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.-.++.+..++|.++|.++|.+|++.+++.
T Consensus 275 ---p~~ms~dce~lLrk~lvl~Pskr~~~dqim 304 (596)
T KOG0586|consen 275 ---PFYMSCDCEDLLRKFLVLNPSKRGPCDQIM 304 (596)
T ss_pred ---cceeechhHHHHHHhhccCccccCCHHHhh
Confidence 234567899999999999999999987764
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=287.46 Aligned_cols=266 Identities=20% Similarity=0.245 Sum_probs=205.5
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCC----eEEEEEEeccC----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~----~~vAvK~~~~~----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
...|+++++||+|.||.||+|....++ +.+|||.++.. .......+|+.+++.|+|++.|..+..+-..+..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 357999999999999999999765553 37899988765 3345689999999999998888888777777889
Q ss_pred EEEEEecCCCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeee-CCCCCeEEEEecCC
Q 011945 78 NVLVIDLLGPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL-GRRANQVYIIDFGL 152 (474)
Q Consensus 78 ~~lv~e~~g~sL~~li~~~~----~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~-~~~~~~vkL~DFGl 152 (474)
.++++||...+|.++|+... +.++...+..|+.||+.|+.|||++=|+||||||.|||+.- +...|.|||+|||+
T Consensus 103 v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 103 VWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred EEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 99999999999999998653 35899999999999999999999999999999999999953 23458999999999
Q ss_pred ccccccCCCccccccccCCCCccCccccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcCc------HHHHH
Q 011945 153 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQKY 225 (474)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDIwSlGvil~elltG~~Pf~~~~~~~------~~~~~ 225 (474)
++.+.++-. |......++-|..|.|||.++|.. |+.+.|||++|||+.||++-++.|.+..... ....+
T Consensus 183 aR~~~~plk----pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 183 ARLFNNPLK----PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred HHHhhcccc----ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999877543 344556678899999999999865 9999999999999999999988887532210 11112
Q ss_pred HHHhh---cc----c------cc---hHHHH----------------hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011945 226 EKISE---KK----V------ST---SIEAL----------------CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLF 273 (474)
Q Consensus 226 ~~i~~---~~----~------~~---~~~~l----------------~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (474)
.+|.+ .. + +. .+..+ ...-++...+|+.++|..||.+|.|+++. |
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA---l 335 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA---L 335 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH---h
Confidence 22221 00 0 00 00000 01124457899999999999999997765 5
Q ss_pred HHHHH
Q 011945 274 RDLFI 278 (474)
Q Consensus 274 ~~l~~ 278 (474)
++.+.
T Consensus 336 eh~yF 340 (438)
T KOG0666|consen 336 EHPYF 340 (438)
T ss_pred ccccc
Confidence 55543
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=292.13 Aligned_cols=244 Identities=18% Similarity=0.281 Sum_probs=192.4
Q ss_pred EEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-C
Q 011945 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 86 (474)
Q Consensus 10 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (474)
....+||+|+||.||++.+..+++.||||.+.... ....+..|+.+++.+.|++.+ .+..++..++..+++|||+ +
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~ 101 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVV-EMYNSYLVGDELWVVMEFLEG 101 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchh-heeeEEEeCCEEEEEEecCCC
Confidence 33467999999999999999999999999875433 234588899999999865544 4445556778899999999 7
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccc
Q 011945 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166 (474)
Q Consensus 87 ~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (474)
++|.+++. ...+++..++.++.|++.||+|||+.||+|+||||+||+++ .++.++|+|||++........
T Consensus 102 ~~L~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~---~~~~~~l~dfg~~~~~~~~~~----- 171 (292)
T cd06657 102 GALTDIVT--HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVP----- 171 (292)
T ss_pred CcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC---CCCCEEEcccccceecccccc-----
Confidence 78988775 44689999999999999999999999999999999999994 678899999999876543221
Q ss_pred cccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcH
Q 011945 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (474)
Q Consensus 167 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (474)
......|+..|++||.+.+..++.++|||||||++|+|++|..||.+... ...+..+... ...... ....++.
T Consensus 172 --~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~---~~~~~~~~~~-~~~~~~-~~~~~~~ 244 (292)
T cd06657 172 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIRDN-LPPKLK-NLHKVSP 244 (292)
T ss_pred --cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhh-CCcccC-CcccCCH
Confidence 11335789999999999888899999999999999999999999976432 2222222211 111111 1245688
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 247 EFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 247 ~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.+.+++.+||..+|.+||++.++++
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhc
Confidence 9999999999999999999888754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=319.57 Aligned_cols=145 Identities=23% Similarity=0.416 Sum_probs=125.2
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
.++|.++++||+|+||.||+|.+..+++.||||++..... ...+..|+.++..++|++++ .+..++....+.||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv-~~~~~~~~~~~~~l 81 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIV-HLYYSLQSANNVYL 81 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcC-eEEEEEEECCEEEE
Confidence 3789999999999999999999999999999999865322 24578899999988865554 45566677788999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
||||+ |++|.+++.. ...+++..++.|+.||+.||.|||.+|||||||||+||||+ .++.+||+|||+++.
T Consensus 82 VmEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~---~~g~vkL~DFGls~~ 153 (669)
T cd05610 82 VMEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS---NEGHIKLTDFGLSKV 153 (669)
T ss_pred EEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEc---CCCCEEEEeCCCCcc
Confidence 99999 8999999974 35689999999999999999999999999999999999994 678999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=288.79 Aligned_cols=245 Identities=22% Similarity=0.278 Sum_probs=192.0
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-------CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-------~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
+|.+.++||+|+||.||++.+..++..+++|+.+.. .....+..|+.+++.++|++++..+. +..+....++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~-~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHA-SFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHH-HHhcCCceEE
Confidence 699999999999999999999877777777765421 12234667899999998666555444 4455667899
Q ss_pred EEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 81 VIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 81 v~e~~-g~sL~~li~~---~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
+|||+ +++|.+++.. ....+++..++.++.|++.||.|||++||+|+||||+||+++ .+.++|+|||++...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~~~~ 155 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLL 155 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCceeec
Confidence 99998 7899988863 245699999999999999999999999999999999999994 356999999999776
Q ss_pred ccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccch
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (474)
..... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.... .......+.....
T Consensus 156 ~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~---~~~~~~~~~~~~~--- 222 (260)
T cd08222 156 MGSCD-------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN---FLSVVLRIVEGPT--- 222 (260)
T ss_pred CCCcc-------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHcCCC---
Confidence 44322 1234568899999999988889999999999999999999999996532 2233333322221
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
..+...++.++.++|.+||..+|++||++.++++
T Consensus 223 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 -PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1223567889999999999999999999888754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=304.30 Aligned_cols=261 Identities=17% Similarity=0.266 Sum_probs=212.5
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.+...+.++||+|-||+|.+|+- ..+..||||+++.... ...|..|+++|.+|+ +++|..+...+..++..++++
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLK-HPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred hhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccC-CCCeeEEEeeeecCCchHHHH
Confidence 35678899999999999999984 4568999999876532 356999999999997 555666666777888889999
Q ss_pred ecC-CCCHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 83 DLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~-l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
||+ .|+|.+++.....+ +..+....|+.||+.||+||.+.+||||||.+.|+|+ +.++++||+|||+++.+-...
T Consensus 615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCcccccccccCC
Confidence 999 99999999865433 3566777899999999999999999999999999999 589999999999998655443
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh--CCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR--GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt--G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
. |+.....+-..+|||+|.+..++++.++|||+||++|||+++ ...||..+.++...+....+....-.....
T Consensus 692 y-----y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l 766 (807)
T KOG1094|consen 692 Y-----YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL 766 (807)
T ss_pred c-----eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec
Confidence 3 333445677899999999999999999999999999999765 889998876655444444444433333344
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
..+.-||.++.++|..||..|-++||++++|...|.+.
T Consensus 767 ~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 44567899999999999999999999999998887764
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=311.25 Aligned_cols=249 Identities=20% Similarity=0.244 Sum_probs=200.2
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCC---CeEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
++.++.++||+|.||.|++|.|..- ...||||++.... ....|.+|+.+|.+|+|.+.|..+..+ .+ ....|
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvV-l~-qp~mM 187 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVV-LD-QPAMM 187 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeee-cc-chhhH
Confidence 3567789999999999999999753 2479999887654 346799999999999976655554433 23 66789
Q ss_pred EEecC-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 81 VIDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 81 v~e~~-g~sL~~li~~-~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
|||++ .|+|.+.+.. ....|-......++.||+.||.||.++++|||||-..|+|+- ....||||||||.+.+..
T Consensus 188 V~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla---sprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 188 VFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA---SPRTVKICDFGLMRALGE 264 (1039)
T ss_pred HhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec---ccceeeeecccceeccCC
Confidence 99999 8999999986 445688999999999999999999999999999999999994 688999999999998876
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
....- .......-...|+|||.+....++.++|||+|||+||||++ |+.||.+..... .+++|..+..
T Consensus 265 ned~Y----vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q---IL~~iD~~er---- 333 (1039)
T KOG0199|consen 265 NEDMY----VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ---ILKNIDAGER---- 333 (1039)
T ss_pred CCcce----EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH---HHHhcccccc----
Confidence 54421 11122234578999999999999999999999999999998 899999976543 3333332211
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
..-.+.||+.+++++..||..+|++||+|..|++
T Consensus 334 LpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred CCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 1124678999999999999999999999999864
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=289.12 Aligned_cols=252 Identities=18% Similarity=0.277 Sum_probs=203.4
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
.+.+-+..||.|+||+|++..++.+|+..|||.+..... ..+|..|.....+-..+++|+.+++..-.+...||.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 344556789999999999999999999999998765443 45688899988888888887777666556666799999
Q ss_pred cCCCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 84 LLGPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 84 ~~g~sL~~li~~~----~~~l~~~~~~~i~~qi~~gL~yLHs-~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
+|.-||..+.+.. +..+++..+-.|....+.||.||-. .+||||||||+|||+ +..|.|||||||++-.+.+
T Consensus 144 LMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhHHH
Confidence 9999998887532 4569999999999999999999997 689999999999999 5899999999999987766
Q ss_pred CCCccccccccCCCCccCccccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccch
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (474)
+... +.-.|...|||||-+.. ..|+.++||||||++|||+.||.+||.+... ..+++..+.....+..
T Consensus 221 SiAk--------T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l 290 (361)
T KOG1006|consen 221 SIAK--------TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPIL 290 (361)
T ss_pred HHHh--------hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCee
Confidence 4321 23478999999999874 3489999999999999999999999987643 4455555544443322
Q ss_pred HH-HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 237 IE-ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 237 ~~-~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.. .-+-.++..+..+|..||.+|-.+||.|.+|++
T Consensus 291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred cCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 21 122357889999999999999999999998865
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=308.46 Aligned_cols=249 Identities=20% Similarity=0.363 Sum_probs=209.2
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHhcCCCCCceeEEEeE-----eCCE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGV-----EGDY 77 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~l~~E~~il~~l~~~~~i~~l~~~~~-----~~~~ 77 (474)
.-.+.|+|.+.||.|.+|.||+++++.+++.+||||...... .++++.|.++++.+.+|++++.+++++. .++.
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 345789999999999999999999999999999999876644 4668999999999999999999877654 4677
Q ss_pred EEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 78 NVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
.||||||| |||.-|+++.. +.++.|..+..|+..++.||.+||...+||||||-.|||++ .++.|||+|||++..
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT---~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQ 172 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe---ccCcEEEeeeeeeee
Confidence 89999999 89999999744 56799999999999999999999999999999999999996 889999999999987
Q ss_pred cccCCCccccccccCCCCccCccccccccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhh
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGI-----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-----~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (474)
+...-. ...+++||+.|||||++... .|+.++|+||||++..||..|.+|+.++.+. ..+..|
T Consensus 173 ldsT~g-------rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm---raLF~I-- 240 (953)
T KOG0587|consen 173 LDSTVG-------RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM---RALFLI-- 240 (953)
T ss_pred eecccc-------cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh---hhhccC--
Confidence 765332 23678999999999998754 3788999999999999999999999887652 112222
Q ss_pred ccccchHHHH--hcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011945 231 KKVSTSIEAL--CRGYPTEFASYFHYCRSLRFDDKPDYAYL 269 (474)
Q Consensus 231 ~~~~~~~~~l--~~~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (474)
...+.+.+ +..+..+|.++|..||.+|.++||...++
T Consensus 241 --pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~l 279 (953)
T KOG0587|consen 241 --PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEEL 279 (953)
T ss_pred --CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhh
Confidence 22222222 35678999999999999999999997655
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=290.98 Aligned_cols=253 Identities=19% Similarity=0.257 Sum_probs=183.0
Q ss_pred EeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-
Q 011945 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 85 (474)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (474)
+.+.+|. +|.||.+++..+++.||||++.... ....+..|+.+++.++|++++..+. +.......+++|||+
T Consensus 6 i~~~~~~--~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~-~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 6 IGKCFED--LMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT-SFIVDSELYVVSPLMA 82 (314)
T ss_pred hhHhhcC--CceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhh-eeecCCeEEEEEeccC
Confidence 3344444 4556666666799999999876542 2246889999999999766555444 556677789999999
Q ss_pred CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccc
Q 011945 86 GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164 (474)
Q Consensus 86 g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (474)
+++|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++ .++.+||+|||.+..+........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~---~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS---GDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe---cCCceEEecCccceeecccccccc
Confidence 78999998743 34689999999999999999999999999999999999995 678999999999876643322111
Q ss_pred cccccCCCCccCccccccccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc----------
Q 011945 165 IPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK---------- 232 (474)
Q Consensus 165 ~~~~~~~~~~GT~~Y~APE~~~~~--~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~---------- 232 (474)
..........++..|+|||++.+. .++.++|||||||++|||++|..||...... .....++....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 237 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTYP 237 (314)
T ss_pred ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCchh
Confidence 111122345678899999998763 5889999999999999999999999864321 11111111000
Q ss_pred -----c-------------cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 233 -----V-------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 233 -----~-------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
. ..........++.++.+++..||..||++||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0 00000011233568899999999999999999877643
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=310.56 Aligned_cols=258 Identities=16% Similarity=0.235 Sum_probs=213.7
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCC---eEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~---~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
...+|.++||.|.||+||+|+.+..+ ..||||.++.... +.+|+.|..||-++.| ++|..+.++........|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdH-PNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDH-PNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCC-CcEEEEEEEEecCceeEE
Confidence 45678999999999999999987665 4799999887543 3459999999999995 555677777778888899
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
+.||| +++|+.+++...+.|+..++..++..|+.||.||-+.++|||||-..|||+ +.+-.+||+||||++.+.++
T Consensus 708 iTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvledd 784 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDD 784 (996)
T ss_pred EhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeecccC
Confidence 99999 999999999888899999999999999999999999999999999999999 58889999999999987665
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
... +.....-.-..+|.|||.+.-.+++.++||||||++|||.+. |..||-++... +.+..|.+.-..+
T Consensus 785 ~~~----~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ---dVIkaIe~gyRLP--- 854 (996)
T KOG0196|consen 785 PEA----AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVIKAIEQGYRLP--- 854 (996)
T ss_pred CCc----cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH---HHHHHHHhccCCC---
Confidence 421 111111122579999999999999999999999999999886 99999887553 3334433322211
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
-+-+||..|..|+..||++|-.+||.|.+|+..|++++.+
T Consensus 855 -pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 855 -PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred -CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 1357999999999999999999999999999999999743
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=303.04 Aligned_cols=241 Identities=20% Similarity=0.248 Sum_probs=202.8
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
+.+.|.+...+|.|+|+.|-.+.+..+++..++|++... ..+...|+.++....+|+++..+.....++...|+|||+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~--~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR--ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc--ccccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 567899999999999999999999999999999998764 445678898999999999999999889999999999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 85 ~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
+ |+-|.+.+. ..+....++..|+.+|+.++.|||++|||||||||+|||+. +..++++|+|||.++.....-
T Consensus 398 l~g~ell~ri~--~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~~~--- 470 (612)
T KOG0603|consen 398 LDGGELLRRIR--SKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELERSC--- 470 (612)
T ss_pred ccccHHHHHHH--hcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCchhh---
Confidence 9 555555554 22333377888999999999999999999999999999995 478899999999998776541
Q ss_pred ccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcC
Q 011945 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (474)
.+-+-|..|.|||++...+|++++||||||++||+||+|+.||..-... .+.+..+...++. ..
T Consensus 471 -------~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~~~~~s-------~~ 534 (612)
T KOG0603|consen 471 -------DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQMPKFS-------EC 534 (612)
T ss_pred -------cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhcCCccc-------cc
Confidence 1235688999999999999999999999999999999999999875433 3444444443332 56
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 244 YPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
++.+.++||..||+.||.+|+++.++.
T Consensus 535 vS~~AKdLl~~LL~~dP~~Rl~~~~i~ 561 (612)
T KOG0603|consen 535 VSDEAKDLLQQLLQVDPALRLGADEIG 561 (612)
T ss_pred cCHHHHHHHHHhccCChhhCcChhhhc
Confidence 789999999999999999999988874
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=275.90 Aligned_cols=234 Identities=22% Similarity=0.296 Sum_probs=190.2
Q ss_pred eeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-CCC
Q 011945 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS 88 (474)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~s 88 (474)
||.|+||.||++.+..+++.||+|++..... ...+..|+.+++.+.|.+++ .+......+...+++||++ +++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~-~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIV-KLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHH-HHHHHeecCCeeEEEEecCCCCc
Confidence 6999999999999988899999998765432 23588899999999855544 4444556778899999999 999
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccccc
Q 011945 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 168 (474)
Q Consensus 89 L~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 168 (474)
|.+++.. ...+++..++.++.||+.||.|||+.+++|+||||+||+++ ..+.++|+|||++........
T Consensus 80 L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~---~~~~~~l~d~~~~~~~~~~~~------- 148 (250)
T cd05123 80 LFSHLSK-EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD---ADGHIKLTDFGLAKELSSEGS------- 148 (250)
T ss_pred HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc---CCCcEEEeecCcceecccCCC-------
Confidence 9999974 34689999999999999999999999999999999999994 678899999999987654321
Q ss_pred cCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHH
Q 011945 169 ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF 248 (474)
Q Consensus 169 ~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l 248 (474)
......++..|++||.+.+...+.++|+||||+++|+|++|..||..... .+.+..+..... .+...++.++
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~-----~~~~~~~~~l 220 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKILKDPL-----RFPEFLSPEA 220 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhcCCC-----CCCCCCCHHH
Confidence 11345788999999999988899999999999999999999999965432 333333333111 2344568999
Q ss_pred HHHHHHHhcCCCCCCCCHHH
Q 011945 249 ASYFHYCRSLRFDDKPDYAY 268 (474)
Q Consensus 249 ~~li~~cl~~dp~~RPt~~~ 268 (474)
.+++.+||..||++||++.+
T Consensus 221 ~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 221 RDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHhcCCHhhCCCccc
Confidence 99999999999999999855
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=319.71 Aligned_cols=257 Identities=21% Similarity=0.224 Sum_probs=188.0
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeE--------
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGV-------- 73 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~-------- 73 (474)
...+|+.++.||+||||.||+++++-+|+.||||.+..... ...+.+|+.++.+|+|+|.|.++..+..
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 45678899999999999999999999999999998876532 2348899999999998777765310000
Q ss_pred --------------------------------------------------------------------------------
Q 011945 74 -------------------------------------------------------------------------------- 73 (474)
Q Consensus 74 -------------------------------------------------------------------------------- 73 (474)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred e----------------------C--------CEEEEEEecCCCCHHHHHHHcCCCC-CHHHHHHHHHHHHHHHHHHHHC
Q 011945 74 E----------------------G--------DYNVLVIDLLGPSLEDLFNFCSRKL-SLKTVLMLADQMINRVEFVHSK 122 (474)
Q Consensus 74 ~----------------------~--------~~~~lv~e~~g~sL~~li~~~~~~l-~~~~~~~i~~qi~~gL~yLHs~ 122 (474)
+ + .+.||-||||..+|...+...+... .....|.++.||++||.|+|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 0 0 3468999999666665554333333 4788999999999999999999
Q ss_pred CccccCCCCCcEEeeeCCCCCeEEEEecCCccccc----c--C--C--Cc-cccccccCCCCccCccccccccccCCC--
Q 011945 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR----D--T--A--TH-QHIPYRENKNLTGTARYASMNTHLGIE-- 189 (474)
Q Consensus 123 gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~----~--~--~--~~-~~~~~~~~~~~~GT~~Y~APE~~~~~~-- 189 (474)
|||||||||.||++ +..+.|||+|||+|+... . . . +. ....-...+..+||..|+|||++.+..
T Consensus 717 giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred ceeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99999999999999 488999999999998722 0 0 0 00 001111345678999999999998765
Q ss_pred -CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHH
Q 011945 190 -QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY 268 (474)
Q Consensus 190 -~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~ 268 (474)
|+.|+|+||||+||+||+. ||.. ..+....+..+.....+.+ +.+...--+.-.++|+.|++.||.+|||+.+
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~T--sMERa~iL~~LR~g~iP~~-~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e 867 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGT--SMERASILTNLRKGSIPEP-ADFFDPEHPEEASLIRWLLSHDPSKRPTATE 867 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCc--hHHHHHHHHhcccCCCCCC-cccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence 9999999999999999984 5642 1222223333332222222 2222222345688999999999999999988
Q ss_pred HH
Q 011945 269 LK 270 (474)
Q Consensus 269 l~ 270 (474)
|+
T Consensus 868 LL 869 (1351)
T KOG1035|consen 868 LL 869 (1351)
T ss_pred Hh
Confidence 75
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=256.55 Aligned_cols=253 Identities=20% Similarity=0.245 Sum_probs=201.9
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.+|.-.++||+|.||+||+|++..+++.||+|.+..+... ....+|+-+++.|+|.+++..+ ..-..+...-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~-dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH-DVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehh-hhhccCceeEEeH
Confidence 3577789999999999999999999999999987665433 3589999999999976655544 4445566778999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 83 e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
|+|..+|..+++.+++.++.+.+..++.|++.||.|+|+++++||||||.|.|| +.++.+||+|||+++.+.-+.
T Consensus 81 e~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafgipv-- 155 (292)
T KOG0662|consen 81 EFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIPV-- 155 (292)
T ss_pred HHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcCCce--
Confidence 999999999999999999999999999999999999999999999999999999 589999999999999775432
Q ss_pred cccccccCCCCccCccccccccccCCC-CCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccc---h-
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST---S- 236 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~---~- 236 (474)
+.-...+-|..|.+|.++.|.. |+...|+||.|||+.|+.. |.+.|.+.+..+...++.+.....-.. .
T Consensus 156 -----rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~ 230 (292)
T KOG0662|consen 156 -----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM 230 (292)
T ss_pred -----EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence 2233446799999999999876 8999999999999999987 788888865544444444433221111 1
Q ss_pred -----------------HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 237 -----------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 237 -----------------~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
...+...+...=++++++.|.-+|.+|.+++..+
T Consensus 231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaal 281 (292)
T KOG0662|consen 231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAAL 281 (292)
T ss_pred ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHh
Confidence 1111222334458899999999999999987653
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=284.29 Aligned_cols=265 Identities=22% Similarity=0.302 Sum_probs=209.7
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHH--hcCCCCCceeEEEeEeC---CE
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKI--LQGGTGIPNLRWFGVEG---DY 77 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~--l~~~~~i~~l~~~~~~~---~~ 77 (474)
..|..+..+.+.||+|.||+||+|.+ .|+.||||++.. .....+.+|.+|++. |+|.|++.++..-..+. ..
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~s-rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSS-RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred HhhhheeEEEEEecCccccceeeccc--cCCceEEEEecc-cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 45778899999999999999999996 589999999875 345678899998886 56666555542211111 24
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH--------CCccccCCCCCcEEeeeCCCCCeEEEE
Q 011945 78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS--------KSFLHRDIKPDNFLMGLGRRANQVYII 148 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs--------~gIiHrDIKP~NILl~~~~~~~~vkL~ 148 (474)
.+||.+|- .|||.|+++. ..++.+..++++..++.||++||. -.|.|||||..|||+ .+++.+.|+
T Consensus 284 LwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~~C~IA 358 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIA 358 (513)
T ss_pred EEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCCcEEEe
Confidence 68888887 9999999984 679999999999999999999995 249999999999999 689999999
Q ss_pred ecCCccccccCCCccccccccCCCCccCccccccccccCCC------CCchhhHHHHHHHHHHHHhC----------CCC
Q 011945 149 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE------QSRRDDLESLGYVLMYFLRG----------SLP 212 (474)
Q Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~------~s~ksDIwSlGvil~elltG----------~~P 212 (474)
|||||...........++ .+..+||.+|||||++...- .-..+||||||.|+||++.. ++|
T Consensus 359 DLGLAv~h~~~t~~idi~---~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P 435 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIP---PNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP 435 (513)
T ss_pred eceeeEEecccCCcccCC---CCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence 999999887765433332 35679999999999987532 13568999999999999862 789
Q ss_pred CCCCCcCc--HHHHHHHHhhccccchHHHHhcCCc--HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 213 WQGLKAGT--KKQKYEKISEKKVSTSIEALCRGYP--TEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 213 f~~~~~~~--~~~~~~~i~~~~~~~~~~~l~~~~p--~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
|.+..+.+ ..++.+.+...+..+.++..+...| ..+.++|+.||..+|.-|-++-.|++.|.++.+
T Consensus 436 yyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 436 YYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred cccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 98765433 3444455555666666666555554 578999999999999999999999999999873
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=308.77 Aligned_cols=252 Identities=17% Similarity=0.173 Sum_probs=167.7
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCC----CeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEE----E-eEeCC
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQT----NEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRW----F-GVEGD 76 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~----~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~----~-~~~~~ 76 (474)
.++|.+.++||+|+||.||+|.+..+ +..||||.+......+....| .+ ....+..+...+.. . ...+.
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e-~l-~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE-RV-RRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH-HH-HhhchhhHHHHHHhhhcccccccCC
Confidence 46899999999999999999999888 899999987543222111111 11 11111111111111 1 24566
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCC-------------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEe
Q 011945 77 YNVLVIDLL-GPSLEDLFNFCSRK-------------------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 136 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~~~~-------------------l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl 136 (474)
..+++|+|+ +++|.+++...... .....+..|+.||+.||.|||++|||||||||+|||+
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl 288 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIF 288 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEE
Confidence 789999999 77899988643211 1234567899999999999999999999999999999
Q ss_pred eeCCCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCC----------------------CCCchh
Q 011945 137 GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI----------------------EQSRRD 194 (474)
Q Consensus 137 ~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~----------------------~~s~ks 194 (474)
+ .+.+.+||+|||+|+.+...... ....+.+|+.|||||.+... .++.++
T Consensus 289 ~--~~~~~~KL~DFGlA~~l~~~~~~------~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~ 360 (566)
T PLN03225 289 S--EGSGSFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360 (566)
T ss_pred e--CCCCcEEEEeCCCcccccccccc------CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence 5 34578999999999865433221 12456889999999976432 234567
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc-------------cchHH---HHhcCCcHHHHHHHHHHhcC
Q 011945 195 DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------------STSIE---ALCRGYPTEFASYFHYCRSL 258 (474)
Q Consensus 195 DIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------------~~~~~---~l~~~~p~~l~~li~~cl~~ 258 (474)
||||||||||||+++.+++... ..+....+..... ..... .+........++||..||.+
T Consensus 361 DVwSlGviL~el~~~~~~~~~~----~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 361 DIYSAGLIFLQMAFPNLRSDSN----LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred ccHHHHHHHHHHHhCcCCCchH----HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 9999999999999988776431 1111111111000 00000 01111233456899999999
Q ss_pred CCCCCCCHHHHHH
Q 011945 259 RFDDKPDYAYLKR 271 (474)
Q Consensus 259 dp~~RPt~~~l~~ 271 (474)
||++||++.++++
T Consensus 437 dP~kR~ta~e~L~ 449 (566)
T PLN03225 437 KGRQRISAKAALA 449 (566)
T ss_pred CcccCCCHHHHhC
Confidence 9999999777643
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=280.65 Aligned_cols=274 Identities=20% Similarity=0.283 Sum_probs=221.2
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
.++|.++++||+|+|..|.+++.+.|.+.||+|+++++ ..-...+.|..+.....+++.++-+..++..+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 46899999999999999999999999999999986543 2334578899999999888988888888888888899
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
|.||. |++|--.+. ..++++++.+..+..+|+.||.|||++|||+||||.+|+|+ +..+++||+|+|+++.-..+
T Consensus 329 vieyv~ggdlmfhmq-rqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQ-RQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred EEEEecCcceeeehh-hhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcCCCC
Confidence 99998 888876666 35689999999999999999999999999999999999999 68999999999999865544
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CcCcHHHHHHHHhhcccc
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL-----KAGTKKQKYEKISEKKVS 234 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~-----~~~~~~~~~~~i~~~~~~ 234 (474)
.. ...+++||+.|+|||++.|.+|+..+|+|+|||+|+||+.|+.||.-. ...+....++.|.++...
T Consensus 405 gd-------~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir 477 (593)
T KOG0695|consen 405 GD-------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR 477 (593)
T ss_pred Cc-------ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc
Confidence 33 236789999999999999999999999999999999999999999632 122334445556555543
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccccccccc
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 299 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~ 299 (474)
++..++-....+++.-|++||.+|....- .--|.++ .+.++..-.||+.+...|.-
T Consensus 478 -----iprslsvkas~vlkgflnkdp~erlgc~~-~~g~~di---k~h~ffr~idwd~leqk~v~ 533 (593)
T KOG0695|consen 478 -----IPRSLSVKASHVLKGFLNKDPKERLGCRP-QTGFSDI---KSHAFFRSIDWDLLEQKQVL 533 (593)
T ss_pred -----ccceeehhhHHHHHHhhcCCcHHhcCCCc-ccchhhh---hcchhhhhCCHHHHhhcccC
Confidence 34566778889999999999999954221 0123333 33455567899998765443
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=281.31 Aligned_cols=132 Identities=27% Similarity=0.520 Sum_probs=113.1
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCC-------CCcee-EEE---e
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGT-------GIPNL-RWF---G 72 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~-------~i~~l-~~~---~ 72 (474)
.+++|.+.++||.|.|++||+|.|..+.+.||+|+.+... ..+....|+++|+.+.... +|+.+ +.| +
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 3489999999999999999999999999999999987543 3455788999999987433 33333 333 4
Q ss_pred EeCCEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEe
Q 011945 73 VEGDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLM 136 (474)
Q Consensus 73 ~~~~~~~lv~e~~g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs-~gIiHrDIKP~NILl 136 (474)
..+.+.|||+|++|.+|..+|.+++ +.++...+..|+.||+.||.|||. +||||-||||+|||+
T Consensus 156 pNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 5788999999999999999998664 459999999999999999999997 799999999999999
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=277.11 Aligned_cols=259 Identities=20% Similarity=0.225 Sum_probs=199.7
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEecc---C-CCchHHHHHHHHHHHhcCCCCCceeEEEeE-------e
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV---K-TKHPQLQYEAKLYKILQGGTGIPNLRWFGV-------E 74 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~---~-~~~~~l~~E~~il~~l~~~~~i~~l~~~~~-------~ 74 (474)
.+.|+-..+||+|.||+||+|+...+|+.||+|++-. + .......+|+++|..|+|.+.+..+..+.. +
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 4678888999999999999999999999999995322 1 223457899999999998776655533321 2
Q ss_pred CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 75 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 75 ~~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
...+|+|+++|..+|..++.....+|+..++..++.+++.||.|+|...|+|||+|++|+||+ .++.+||+|||+++
T Consensus 96 r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt---~dgilklADFGlar 172 (376)
T KOG0669|consen 96 RATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLIT---KDGILKLADFGLAR 172 (376)
T ss_pred cceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEc---CCceEEeecccccc
Confidence 345899999999999999987777899999999999999999999999999999999999994 78999999999998
Q ss_pred ccccCCCccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (474)
.+.......... -+..+-|..|.+||.+.|. +|+++.|||..||||.||++|.+-|++.........+..++...-
T Consensus 173 ~fs~~~n~~kpr---ytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 173 AFSTSKNVVKPR---YTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred ceecccccCCCC---cccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 887654433221 2345669999999999985 589999999999999999999999988554333333332221110
Q ss_pred ---cchH----------------------HHHhc--CCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 234 ---STSI----------------------EALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 234 ---~~~~----------------------~~l~~--~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.+.. +...+ .-.++..+|+..++.+||.+|+++++++
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~al 313 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQAL 313 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhh
Confidence 0000 00000 1135778999999999999999988774
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=292.31 Aligned_cols=275 Identities=22% Similarity=0.257 Sum_probs=207.5
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
-|..++.||-|+||+|.++....|...||+|.+.+... ...+..|..||.... .+.|+.+++.+.+.+..|+||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD-n~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC-CcceEEEEEEeccCCceEEEE
Confidence 48889999999999999999989999999997654321 223677888888776 567778888888999999999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
||. ||++-.|+-. -+-|.+..+..++.++.+|+++.|..|+|||||||+|||| |.+|+|||+|||||.-+.-...
T Consensus 709 dYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred eccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccceeccc
Confidence 999 9999998874 4579999999999999999999999999999999999999 5899999999999986542211
Q ss_pred --------cccc-------------------ccc--------cCCCCccCccccccccccCCCCCchhhHHHHHHHHHHH
Q 011945 162 --------HQHI-------------------PYR--------ENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYF 206 (474)
Q Consensus 162 --------~~~~-------------------~~~--------~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~el 206 (474)
+... ..+ -.-.++||+.|+|||++....++.-+|+||.|||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 1000 000 12346799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCC
Q 011945 207 LRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDY 286 (474)
Q Consensus 207 ltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~ 286 (474)
+.|+.||..........++..+.... --..+..++.+..++|.++. -+++.|..-.- .+ .-....|..
T Consensus 865 ~~g~~pf~~~tp~~tq~kv~nw~~~l----~~~~~~~ls~e~~~li~kLc-~sad~RLGkng-----~d--~vKaHpfFk 932 (1034)
T KOG0608|consen 865 LVGQPPFLADTPGETQYKVINWRNFL----HIPYQGNLSKEALDLIQKLC-CSADSRLGKNG-----AD--QVKAHPFFK 932 (1034)
T ss_pred hhCCCCccCCCCCcceeeeeehhhcc----ccccccccCHHHHHHHHHHh-cChhhhhcccc-----hh--hhhcCcccc
Confidence 99999998776654333332221110 01124567888888887754 35667743211 11 123356777
Q ss_pred ccccccccccccc
Q 011945 287 VFDWTILKYQQSQ 299 (474)
Q Consensus 287 ~~dw~~~~~~~~~ 299 (474)
..||..++.+.++
T Consensus 933 gIDfsslRkq~Ap 945 (1034)
T KOG0608|consen 933 GIDFSSLRKQRAP 945 (1034)
T ss_pred ccchHhhhhccCC
Confidence 8899886655444
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=291.58 Aligned_cols=206 Identities=22% Similarity=0.281 Sum_probs=175.3
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-CCchHHHHHHHHHHHhcCC-----CCCceeEEEeEeCC
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLQYEAKLYKILQGG-----TGIPNLRWFGVEGD 76 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-~~~~~l~~E~~il~~l~~~-----~~i~~l~~~~~~~~ 76 (474)
.++.++|.+....|+|-|++|..|.+...|..|||||+... .+++.=+.|++||++|+.. .++..+.-.+...+
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 46778999999999999999999999999999999998664 4566678999999999742 23334444456778
Q ss_pred EEEEEEecCCCCHHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 77 YNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 77 ~~~lv~e~~g~sL~~li~~~~~~--l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
+.|||+|.+.-+|.++++..+.. |....+..++.|+..||..|-.+||+|.||||+||||. .....+||||||.|.
T Consensus 508 HLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~k~iLKLCDfGSA~ 585 (752)
T KOG0670|consen 508 HLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ESKNILKLCDFGSAS 585 (752)
T ss_pred eeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--cCcceeeeccCcccc
Confidence 89999999999999999866543 88899999999999999999999999999999999996 456789999999998
Q ss_pred ccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcC
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~ 219 (474)
...+... +.+.-+..|.|||+++|.+|+...|+||.||+||||.||+..|.+....
T Consensus 586 ~~~enei---------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN 641 (752)
T KOG0670|consen 586 FASENEI---------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN 641 (752)
T ss_pred ccccccc---------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH
Confidence 7655433 1234567899999999999999999999999999999999999886543
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=271.76 Aligned_cols=220 Identities=16% Similarity=0.150 Sum_probs=173.7
Q ss_pred cCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-CCCHHHHHHHc
Q 011945 18 GSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC 96 (474)
Q Consensus 18 G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL~~li~~~ 96 (474)
|.||.||++.+..+++.||+|.+.... ....|...+.... ++++..+..++......+++|||+ +++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~- 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS---EYSRERLTIIPHC-VPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK- 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh---hhhhHHHHHHhcC-CCceeehhhheecCCeEEEEEecCCCCCHHHHHHH-
Confidence 899999999999999999999886532 2344444444444 455666666667778899999999 7899999864
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccccccCCCCccC
Q 011945 97 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176 (474)
Q Consensus 97 ~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT 176 (474)
...+++..+..++.|++.||.|||++||+||||||+||+++ .++.++|+|||++....... ....++
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~~l~df~~~~~~~~~~----------~~~~~~ 145 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD---DRGHIQLTYFSRWSEVEDSC----------DGEAVE 145 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc---CCCCEEEecccchhcccccc----------ccCCcC
Confidence 34699999999999999999999999999999999999994 67889999999886554321 123567
Q ss_pred ccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHh
Q 011945 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCR 256 (474)
Q Consensus 177 ~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl 256 (474)
..|+|||.+.+..++.++|||||||++|||++|..||...... +.. .. ...+...+++.+.++|.+||
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--------~~~-~~---~~~~~~~~~~~~~~li~~~l 213 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG--------INT-HT---TLNIPEWVSEEARSLLQQLL 213 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--------ccc-cc---ccCCcccCCHHHHHHHHHHc
Confidence 7899999998888999999999999999999999888642211 000 00 01123457889999999999
Q ss_pred cCCCCCCCCHH
Q 011945 257 SLRFDDKPDYA 267 (474)
Q Consensus 257 ~~dp~~RPt~~ 267 (474)
+.||++||++.
T Consensus 214 ~~dp~~R~~~~ 224 (237)
T cd05576 214 QFNPTERLGAG 224 (237)
T ss_pred cCCHHHhcCCC
Confidence 99999999863
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=302.05 Aligned_cols=257 Identities=21% Similarity=0.320 Sum_probs=206.3
Q ss_pred cEEEeeeeeecCceEEEEEEEcC-------CCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~-------~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
+..+.+.||+|.||.||+|.-.. ....||||..+.... .+.+..|+++|+.+.+|+++..+.+++.....
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 34677799999999999997331 145799998765443 35689999999999988888888777777888
Q ss_pred EEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCC
Q 011945 78 NVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~~---------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~ 141 (474)
.++++||+ .|+|.+++..+. ..++....+.++.||+.|++||+++++|||||-..|||++ .
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~---~ 453 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT---K 453 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec---C
Confidence 88999998 899999998655 2489999999999999999999999999999999999995 7
Q ss_pred CCeEEEEecCCccccccCCCccccccccCCCCc--cCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 011945 142 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (474)
Q Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~--GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~ 218 (474)
+..+||+|||+|+....... |. .+.-. -...|||||.+....|+.++||||||++|||+++ |..||.+...
T Consensus 454 ~~~~kIaDFGlar~~~~~~~-----y~-~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 454 NKVIKIADFGLARDHYNKDY-----YR-TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred CCEEEEccccceeccCCCCc-----eE-ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 78999999999986554332 11 11112 2456999999999999999999999999999999 9999988442
Q ss_pred CcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
. ...++.+.... ....+..|++++.+++..||..+|++||++.++.+.|..++..
T Consensus 528 ~--~~l~~~l~~G~----r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 528 T--EELLEFLKEGN----RMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred H--HHHHHHHhcCC----CCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 1 22233332222 2233467799999999999999999999999999999997654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=278.36 Aligned_cols=257 Identities=22% Similarity=0.298 Sum_probs=194.8
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhc-CCCCCceeEEEeEe----CCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ-GGTGIPNLRWFGVE----GDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~-~~~~i~~l~~~~~~----~~~~~lv 81 (474)
....+.++||+|.||.||+|. -+++.||||++... ....++.|..|+.... .|++|..+...... ...++||
T Consensus 210 ~pl~l~eli~~Grfg~V~Kaq--L~~~~VAVKifp~~-~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQ--LDNRLVAVKIFPEQ-EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred CchhhHHHhhcCccceeehhh--ccCceeEEEecCHH-HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 346778999999999999998 56799999998753 4567899999988642 24444444333332 3367888
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH---------CCccccCCCCCcEEeeeCCCCCeEEEEecC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS---------KSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs---------~gIiHrDIKP~NILl~~~~~~~~vkL~DFG 151 (474)
++|. .|+|.++++ ...++|....+|+..|++||+|||+ ..|+|||||..|||| ..+.++.|+|||
T Consensus 287 t~fh~kGsL~dyL~--~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIaDFG 361 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLK--ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCIADFG 361 (534)
T ss_pred eeeccCCcHHHHHH--hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEeeccc
Confidence 8888 999999998 4579999999999999999999997 359999999999999 588999999999
Q ss_pred CccccccCCCccccccccCCCCccCccccccccccCCC-CC-----chhhHHHHHHHHHHHHhCC------------CCC
Q 011945 152 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QS-----RRDDLESLGYVLMYFLRGS------------LPW 213 (474)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s-----~ksDIwSlGvil~elltG~------------~Pf 213 (474)
||..+..... ....-..+||.+|||||++.|.- +. .+.||||+|.|||||++.- +||
T Consensus 362 LAl~~~p~~~-----~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf 436 (534)
T KOG3653|consen 362 LALRLEPGKP-----QGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF 436 (534)
T ss_pred eeEEecCCCC-----CcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence 9998874322 12233469999999999998743 22 4689999999999999842 334
Q ss_pred C---CCCcCcHHHHHHHHhhccccchHHHHhcC--CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 214 Q---GLKAGTKKQKYEKISEKKVSTSIEALCRG--YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 214 ~---~~~~~~~~~~~~~i~~~~~~~~~~~l~~~--~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
+ +.. .+..+....+..++..+.++..+.. ...-+.+.++.||..|++.|.|+.-+.+.+.++.
T Consensus 437 e~evG~h-Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 437 EAEVGNH-PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred hHHhcCC-CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 3 111 1233333444555555544443322 3467899999999999999999999988888774
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=315.10 Aligned_cols=249 Identities=14% Similarity=0.166 Sum_probs=185.4
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-C
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-G 86 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g 86 (474)
.|...+.||+|+||.||+|++..++..||||.+..... ....|++++++++|++++ .+..++......++||||+ +
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~l~~l~HpnIv-~~~~~~~~~~~~~lv~Ey~~~ 767 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--IPSSEIADMGKLQHPNIV-KLIGLCRSEKGAYLIHEYIEG 767 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--ccHHHHHHHhhCCCCCcc-eEEEEEEcCCCCEEEEeCCCC
Confidence 45667789999999999999988999999998764322 234578899999765544 5555566677889999999 8
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 87 ~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLH---s~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
++|.+++. .+++..+..|+.||+.||+||| +.+|+||||||+||+++ ..+.+++. ||........
T Consensus 768 g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~---~~~~~~~~-~~~~~~~~~~---- 835 (968)
T PLN00113 768 KNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID---GKDEPHLR-LSLPGLLCTD---- 835 (968)
T ss_pred CcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC---CCCceEEE-eccccccccC----
Confidence 99999996 4899999999999999999999 67999999999999994 55556654 6655433211
Q ss_pred ccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcC--cHHHHHHHHhhc-cc----cch
Q 011945 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG--TKKQKYEKISEK-KV----STS 236 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~--~~~~~~~~i~~~-~~----~~~ 236 (474)
....||..|+|||++.+..++.++|||||||++|||++|+.||...... ...+........ .. ...
T Consensus 836 -------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 836 -------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred -------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcc
Confidence 1236889999999999999999999999999999999999999543211 111111100000 00 000
Q ss_pred HH---HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 237 IE---ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 237 ~~---~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
.. ........++.+++..||+.||++||++.++.+.|+++..
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 00 0000112467889999999999999999999999988754
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-32 Score=255.55 Aligned_cols=236 Identities=25% Similarity=0.331 Sum_probs=187.5
Q ss_pred CceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecCCC-CHHHHHH
Q 011945 19 SFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGP-SLEDLFN 94 (474)
Q Consensus 19 ~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~g~-sL~~li~ 94 (474)
+||.||+|.+..+++.||+|++..... .+.+..|++.++.+++ +++..+..+.......++++|++++ +|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKH-PNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCC-CcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 589999999988899999999876544 4678999999999964 4555555556666788999999955 9999987
Q ss_pred HcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccccccCCCCc
Q 011945 95 FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 174 (474)
Q Consensus 95 ~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~ 174 (474)
... .+++..++.++.+++.+|.|||+.+|+|+||+|.||+++ .++.++|+|||++........ .....
T Consensus 80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~---~~~~~~l~d~~~~~~~~~~~~--------~~~~~ 147 (244)
T smart00220 80 KRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD---EDGHVKLADFGLARQLDPGGL--------LTTFV 147 (244)
T ss_pred hcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC---CCCcEEEccccceeeeccccc--------ccccc
Confidence 433 389999999999999999999999999999999999994 668999999999987655321 13457
Q ss_pred cCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHH
Q 011945 175 GTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHY 254 (474)
Q Consensus 175 GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~ 254 (474)
++..|++||.+.+..++.++|||+||+++|+|++|..||..... ....+..+....... ......++.++.+++.+
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~ 223 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIGKPKPPF--PPPEWKISPEAKDLIRK 223 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHhccCCCC--ccccccCCHHHHHHHHH
Confidence 88999999999988899999999999999999999999976322 122222222211111 11111278999999999
Q ss_pred HhcCCCCCCCCHHHHHH
Q 011945 255 CRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 255 cl~~dp~~RPt~~~l~~ 271 (474)
||..+|++||++.++++
T Consensus 224 ~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 224 LLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HccCCchhccCHHHHhh
Confidence 99999999999888764
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=288.68 Aligned_cols=255 Identities=21% Similarity=0.259 Sum_probs=208.4
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCe----EEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~----~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
.+..++||+|+||+||+|.+...++ +||||++..... ...+..|+-+|..|.|++.+..+...-... ..||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~--~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST--LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch--HHHH
Confidence 3456899999999999999976654 688898755433 456899999999999877776665443332 5567
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
.+|+ .|+|.|+++....++-.+..+.|..||++||.|||.+++|||||-..|||+ .....+||.|||+|+.+..+.
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee---cCCCeEEEEecchhhccCccc
Confidence 7777 999999999888899999999999999999999999999999999999999 588999999999999887665
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
..-+. ....-.+.|||-|.+....|+.++|||||||++||++| |..||.+....+....+++-.. ..
T Consensus 853 ~ey~~-----~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-------Ls 920 (1177)
T KOG1025|consen 853 KEYSA-----PGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-------LS 920 (1177)
T ss_pred ccccc-----cccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-------CC
Confidence 43322 12233578999999999999999999999999999999 9999999877655555443222 11
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
-+.-++-+++-++.+||..|++.||+|+++...|.++...-
T Consensus 921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 23567889999999999999999999999999998886543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=293.68 Aligned_cols=245 Identities=20% Similarity=0.231 Sum_probs=190.6
Q ss_pred eeeeeecCceE-EEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecCCCCHH
Q 011945 12 GRKIGSGSFGE-IYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLE 90 (474)
Q Consensus 12 ~~~LG~G~fG~-Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~g~sL~ 90 (474)
.+.+|.|+.|+ ||+|. ..++.||||.+-. ....-.++|+..|+.-..|++|..++....+..+.||..|+|..+|.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~-e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL~ 590 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGV--YEGREVAVKRLLE-EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSLQ 590 (903)
T ss_pred HHHcccCCCCcEEEEEe--eCCceehHHHHhh-HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhHH
Confidence 35678999885 79998 6789999996532 23456789999999999999998888888889999999999999999
Q ss_pred HHHHHcCCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCC--CCCeEEEEecCCccccccCCCcccc
Q 011945 91 DLFNFCSRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR--RANQVYIIDFGLAKRYRDTATHQHI 165 (474)
Q Consensus 91 ~li~~~~~~---l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~--~~~~vkL~DFGla~~~~~~~~~~~~ 165 (474)
++++..... ......+.++.|++.||++||+.+||||||||.||||+..+ ....++|+|||+++++.....
T Consensus 591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s---- 666 (903)
T KOG1027|consen 591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS---- 666 (903)
T ss_pred HHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc----
Confidence 999853111 11145678899999999999999999999999999997532 345789999999998876543
Q ss_pred ccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCC
Q 011945 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (474)
Q Consensus 166 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG-~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (474)
.+....+..||.+|+|||++.....+..+|||||||++|+.++| .+||.+... .-..|......- ..+...-
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~-----R~~NIl~~~~~L--~~L~~~~ 739 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE-----RQANILTGNYTL--VHLEPLP 739 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH-----hhhhhhcCccce--eeeccCc
Confidence 23345678999999999999998888999999999999999995 999965322 212222221111 0011111
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 245 PTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 245 p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
..+..+||..|++.+|..||++.+|+
T Consensus 740 d~eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 740 DCEAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred hHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 12889999999999999999988774
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=246.27 Aligned_cols=211 Identities=21% Similarity=0.281 Sum_probs=171.2
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
...-+..||+|+||.|-+.++..+|...|+|-+.... ...++.+|+.+..+...++.++.+++.-......+|.||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 3445678999999999999999999999999765543 2345778888877777777766665544455567999999
Q ss_pred CCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 85 LGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 85 ~g~sL~~li~~---~~~~l~~~~~~~i~~qi~~gL~yLHs~-gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
+..||..+... .++.+++..+-+|+..++.||.|||++ .+||||+||+|||| +..|+|||||||++-.+.++.
T Consensus 127 M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIsG~L~dSi 203 (282)
T KOG0984|consen 127 MDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGISGYLVDSI 203 (282)
T ss_pred hhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEcccccceeehhhh
Confidence 99999887653 366799999999999999999999985 89999999999999 689999999999998877654
Q ss_pred CccccccccCCCCccCccccccccccC----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLG----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~----~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (474)
.. +.-.|...|||||.+.. ..|+.|+||||||+++.||.++++||... .+..+++..+.+.
T Consensus 204 Ak--------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w--~tpF~qLkqvVee 268 (282)
T KOG0984|consen 204 AK--------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW--GTPFQQLKQVVEE 268 (282)
T ss_pred HH--------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc--CCHHHHHHHHhcC
Confidence 31 22478899999998874 35899999999999999999999999764 3456666665543
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-31 Score=275.34 Aligned_cols=253 Identities=20% Similarity=0.211 Sum_probs=174.4
Q ss_pred CCcEEEeeeeeecCceEEEEEEEc----------------CCCeEEEEEEeccCCC----------------chHHHHHH
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNI----------------QTNEEVAIKLENVKTK----------------HPQLQYEA 53 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~----------------~~~~~vAvK~~~~~~~----------------~~~l~~E~ 53 (474)
.++|++.++||+|+||+||+|.+. ..++.||||.+..... ......|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 568999999999999999999752 2356799998754321 11234467
Q ss_pred HHHHHhcCCCCCc-----eeEEEeE-------eCCEEEEEEecC-CCCHHHHHHHcC-----------------------
Q 011945 54 KLYKILQGGTGIP-----NLRWFGV-------EGDYNVLVIDLL-GPSLEDLFNFCS----------------------- 97 (474)
Q Consensus 54 ~il~~l~~~~~i~-----~l~~~~~-------~~~~~~lv~e~~-g~sL~~li~~~~----------------------- 97 (474)
.++.++++++++. .+.++.. .....+||+||+ +++|.+++....
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 7777777665422 2222211 234579999999 889999886321
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccccccCCCCccCc
Q 011945 98 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177 (474)
Q Consensus 98 ~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~ 177 (474)
..+++..++.|+.||+.||.|||+++|+||||||+|||++ .++.+||+|||++.......... .....+|+
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~---~~~~~kL~DFGla~~~~~~~~~~------~~~g~~tp 374 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVT---VDGQVKIIDFGAAVDMCTGINFN------PLYGMLDP 374 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEEC---CCCcEEEEeCcCccccccCCccC------ccccCCCc
Confidence 1246778899999999999999999999999999999994 67889999999997554321100 11224588
Q ss_pred cccccccccCCCC----------------------CchhhHHHHHHHHHHHHhCCC-CCCCCCcCcH--------HHHHH
Q 011945 178 RYASMNTHLGIEQ----------------------SRRDDLESLGYVLMYFLRGSL-PWQGLKAGTK--------KQKYE 226 (474)
Q Consensus 178 ~Y~APE~~~~~~~----------------------s~ksDIwSlGvil~elltG~~-Pf~~~~~~~~--------~~~~~ 226 (474)
.|+|||++..... ..+.||||+|||||+|++|.+ ||.+...... ...+.
T Consensus 375 ~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r 454 (507)
T PLN03224 375 RYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR 454 (507)
T ss_pred ceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH
Confidence 9999999864321 234799999999999999986 7764321111 01111
Q ss_pred HHhhccccchHHHHhcCCcHHHHHHHHHHhcCCC---CCCCCHHHHH
Q 011945 227 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRF---DDKPDYAYLK 270 (474)
Q Consensus 227 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp---~~RPt~~~l~ 270 (474)
.+...... . ......++..++|+.+||..+| .+|+++++++
T Consensus 455 ~~~~~~~~--~-~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL 498 (507)
T PLN03224 455 MYKGQKYD--F-SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQAL 498 (507)
T ss_pred hhcccCCC--c-ccccccChHHHHHHHHHhccCCCCcccCCCHHHHh
Confidence 11111111 1 1234568899999999999866 6899977763
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-33 Score=262.29 Aligned_cols=253 Identities=19% Similarity=0.285 Sum_probs=189.3
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeC----
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEG---- 75 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~---- 75 (474)
....+.+-.+.||.|+||.||.+.|..+|+.||+|.+..- ...+.+.+|+++|..++|.|.+..++......
T Consensus 50 qqq~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfF 129 (449)
T KOG0664|consen 50 QQQQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFF 129 (449)
T ss_pred cccccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHH
Confidence 3444556678899999999999999999999999975432 23456889999999999887766665443321
Q ss_pred CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 76 ~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
...|++.|++..+|..+|- ....++.+.+.-++.||+.||.|||+.+|+||||||.|.|+ +.+..+||||||+|+.
T Consensus 130 qEiYV~TELmQSDLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 130 QELYVLTELMQSDLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLART 205 (449)
T ss_pred HHHHHHHHHHHhhhhheec-cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEecccccccc
Confidence 1246778888888888775 35679999999999999999999999999999999999999 5888999999999997
Q ss_pred cccCCCccccccccCCCCccCccccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (474)
...... .++ +..+-|-.|.|||+++|.. |+...||||.|||+.||+-.+..|+...+....+.+..+.. .
T Consensus 206 ee~d~~-~hM-----TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLG---T 276 (449)
T KOG0664|consen 206 WDQRDR-LNM-----THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLG---T 276 (449)
T ss_pred cchhhh-hhh-----HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhC---C
Confidence 655432 111 2235688999999999865 89999999999999999999999987655433333333221 1
Q ss_pred chHHHH---hc--------------------------CCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011945 235 TSIEAL---CR--------------------------GYPTEFASYFHYCRSLRFDDKPDYAYL 269 (474)
Q Consensus 235 ~~~~~l---~~--------------------------~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (474)
+..+.. |+ .-.-+...++..++..||++|.+.++.
T Consensus 277 Ps~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A 340 (449)
T KOG0664|consen 277 PSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEA 340 (449)
T ss_pred CcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhh
Confidence 111111 11 012356677888889999999875544
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=251.42 Aligned_cols=266 Identities=20% Similarity=0.302 Sum_probs=203.4
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-CCchHHHHHHHHHHHhcCCCCC-ceeEEEeEeCCEEEEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLQYEAKLYKILQGGTGI-PNLRWFGVEGDYNVLV 81 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-~~~~~l~~E~~il~~l~~~~~i-~~l~~~~~~~~~~~lv 81 (474)
.+.+.|.|.+.||+|-||.+-+|+++.++..+++|.+... ....+|.+|..---.|.+|.+| ..+...+...++++++
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 3567899999999999999999999999999999977554 3446688888766667655544 4455556677799999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ .++|..-+. ...+-+.....++.|++.||.|||++++||||||.+||||-. .+...|||||||+.+......
T Consensus 101 qE~aP~gdL~snv~--~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~-~df~rvKlcDFG~t~k~g~tV 177 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVE--AAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFD-ADFYRVKLCDFGLTRKVGTTV 177 (378)
T ss_pred eccCccchhhhhcC--cccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEec-CCccEEEeeecccccccCcee
Confidence 9999 788877665 345889999999999999999999999999999999999953 345589999999987543321
Q ss_pred CccccccccCCCCccCccccccccccCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCcCc-HHHHHHHHhhcccc
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIE-----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-KKQKYEKISEKKVS 234 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-----~s~ksDIwSlGvil~elltG~~Pf~~~~~~~-~~~~~~~i~~~~~~ 234 (474)
. ...-+..|.+||...... ..+.+|||.||+++|.+|+|.+||+.....+ ....+.+....+..
T Consensus 178 ~----------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~ 247 (378)
T KOG1345|consen 178 K----------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP 247 (378)
T ss_pred h----------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc
Confidence 1 123466799999876432 4678999999999999999999998432211 12233333333332
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQ 283 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~ 283 (474)
..+....-+++.+..++++-|..+|++|--..+..+...+++.+.-+.
T Consensus 248 -~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~ 295 (378)
T KOG1345|consen 248 -ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIK 295 (378)
T ss_pred -cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhc
Confidence 445556778899999999999999999977777777777777666543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-32 Score=246.41 Aligned_cols=250 Identities=19% Similarity=0.316 Sum_probs=190.4
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeE--eCCEEEEEEe
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV--EGDYNVLVID 83 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~--~~~~~~lv~e 83 (474)
.++|++.+++|+|-|++||.|.+..+++.++||+++.- ..+.+.+|++||+.|.++++|..+..... ......|++|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 46799999999999999999999999999999998753 45679999999999997777776654433 4455678888
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
+. ..+...+.. .++...+..++.|++.||.|+|++||+|||+||.|++|+ .....++|+|+|+|..+.....
T Consensus 116 ~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAEFYHp~~e- 188 (338)
T KOG0668|consen 116 YVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKE- 188 (338)
T ss_pred hhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHhhcCCCce-
Confidence 88 455555443 688899999999999999999999999999999999996 5667899999999987765432
Q ss_pred cccccccCCCCccCccccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCC-CCcCcHHHHHHHHhhc---------
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQG-LKAGTKKQKYEKISEK--------- 231 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDIwSlGvil~elltG~~Pf~~-~~~~~~~~~~~~i~~~--------- 231 (474)
-+-.+.+..|--||.+.... |+..-|+|||||+|..|+..+-||.. ....+...++.++...
T Consensus 189 -------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 189 -------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred -------eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 12335667788899988754 88999999999999999999988853 2222222222222110
Q ss_pred ---cccchHHHHh----------------c-CCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 232 ---KVSTSIEALC----------------R-GYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 232 ---~~~~~~~~l~----------------~-~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.+.+....+. . -..++..+|+.++|..|-++|+|+.|..
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam 320 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM 320 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence 0111111111 0 1258899999999999999999988763
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=269.80 Aligned_cols=195 Identities=23% Similarity=0.361 Sum_probs=167.6
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----------CchHHHHHHHHHHHhc--CCCCCceeEEEeEeC
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----------KHPQLQYEAKLYKILQ--GGTGIPNLRWFGVEG 75 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----------~~~~l~~E~~il~~l~--~~~~i~~l~~~~~~~ 75 (474)
.|..++.||+|+||.|++|.++.+...|+||.+.+.. .-..+-.|++||..|+ .|.+|..+..|++++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 5999999999999999999999999999999765432 1123677999999998 344555666778888
Q ss_pred CEEEEEEecC--CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCc
Q 011945 76 DYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (474)
Q Consensus 76 ~~~~lv~e~~--g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (474)
+++||+||.- |-+|.++|+ ....+++.++..|+.||+.|+++||+.||||||||-+|+++ +.+|.+||+|||.|
T Consensus 642 d~yyl~te~hg~gIDLFd~IE-~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klidfgsa 717 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIE-FKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLIDFGSA 717 (772)
T ss_pred CeeEEEecCCCCCcchhhhhh-ccCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEeeccch
Confidence 9999999988 567888887 35679999999999999999999999999999999999999 58999999999999
Q ss_pred cccccCCCccccccccCCCCccCccccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCC
Q 011945 154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQG 215 (474)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDIwSlGvil~elltG~~Pf~~ 215 (474)
....... ...++||..|+|||++.|..| +..-|||+||++||.++....||.+
T Consensus 718 a~~ksgp---------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 AYTKSGP---------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhcCCC---------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 7654432 246799999999999999886 6788999999999999999999975
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=254.87 Aligned_cols=260 Identities=18% Similarity=0.247 Sum_probs=203.0
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCC-----CeEEEEEEeccCCCch---HHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKHP---QLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAvK~~~~~~~~~---~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
..++++...+-+|.||.||.|.++.. .+.|.+|.++.....- .+..|.-++..+.|++....+.....+...
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 34688888999999999999987643 3456677655433322 256677777778877777777766667777
Q ss_pred EEEEEecC-CCCHHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEe
Q 011945 78 NVLVIDLL-GPSLEDLFNFCS-------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~~-------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~D 149 (474)
.++.+.++ -++|..++..|. +.++..+...++.|++.|++|||++||||.||...|++| ++.-+|||+|
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~LqVkltD 439 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQVKLTD 439 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhheeEEecc
Confidence 77777777 678999988553 247778889999999999999999999999999999999 5779999999
Q ss_pred cCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHH
Q 011945 150 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKI 228 (474)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i 228 (474)
=.+++.+-..+.+.- ..+......||+||.+.+..|+..+|||||||+||||+| |+.||...++.+....+
T Consensus 440 saLSRDLFP~DYhcL-----GDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl--- 511 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCL-----GDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL--- 511 (563)
T ss_pred chhccccCccccccc-----CCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH---
Confidence 999987765544321 122234678999999999999999999999999999999 99999886654333222
Q ss_pred hhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
..... -.-+-+||+++..++..||...|++||+++++...|.++-...
T Consensus 512 kdGyR----laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 512 KDGYR----LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred hccce----ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 22211 1223579999999999999999999999999999999986554
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-29 Score=231.06 Aligned_cols=208 Identities=28% Similarity=0.416 Sum_probs=178.9
Q ss_pred eeecCceEEEEEEEcCCCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecCC-CCHH
Q 011945 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLG-PSLE 90 (474)
Q Consensus 15 LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~g-~sL~ 90 (474)
||+|++|.||++.+..+++.++||+....... ..+.+|+++++.+.+ .++..+..+.......++++|+++ ++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH-PNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCC-CCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 68999999999998878999999998776553 679999999999987 566666666667788999999995 9999
Q ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCC-CCeEEEEecCCccccccCCCcccccccc
Q 011945 91 DLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKRYRDTATHQHIPYRE 169 (474)
Q Consensus 91 ~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~ 169 (474)
+++......+++..++.++.+++.+|.+||++|++|+||+|.||+++ . .+.++|+|||.+........ .
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~---~~~~~~~l~d~~~~~~~~~~~~-------~ 149 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD---SDNGKVKLADFGLSKLLTSDKS-------L 149 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe---CCCCcEEEecCCceEEccCCcc-------h
Confidence 99985545799999999999999999999999999999999999995 4 68999999999987654321 1
Q ss_pred CCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHH
Q 011945 170 NKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF 248 (474)
Q Consensus 170 ~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l 248 (474)
.....+...|++||.+... ..+.+.|+|+||+++++| ..+
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------~~~ 190 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------PEL 190 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------HHH
Confidence 1234678899999999887 788999999999999999 578
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHHH
Q 011945 249 ASYFHYCRSLRFDDKPDYAYLKRL 272 (474)
Q Consensus 249 ~~li~~cl~~dp~~RPt~~~l~~~ 272 (474)
.+++..|+..+|++||++.++++.
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhhC
Confidence 999999999999999998887653
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-31 Score=258.34 Aligned_cols=262 Identities=25% Similarity=0.383 Sum_probs=200.5
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEEcC---CCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
|.+.+.|.++++||+|.|++||++.+.. ..+.||+|.+........+..|+++|..+.+..+|..+..+...++..+
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 4567889999999999999999999877 7889999998877777889999999999999999999999999999999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
+||+|+ .....+++. .++...+..++..++.||.++|.+|||||||||.|||.+ ...+.-.|+|||+|.....
T Consensus 112 ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n--~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN--RRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred EEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc--cccCCceEEechhHHHHHh
Confidence 999999 455666654 578999999999999999999999999999999999997 5667779999999983211
Q ss_pred CC------C----c------cc---------------------cccccCCCCccCccccccccccCCC-CCchhhHHHHH
Q 011945 159 TA------T----H------QH---------------------IPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLG 200 (474)
Q Consensus 159 ~~------~----~------~~---------------------~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDIwSlG 200 (474)
.. . + .. ..........||++|.|||++...+ ++.++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 10 0 0 00 0001123356999999999999765 79999999999
Q ss_pred HHHHHHHhCCCCCCCCCcCc--HHH-----------HHHHHhhc--c---------------ccch-HHH----------
Q 011945 201 YVLMYFLRGSLPWQGLKAGT--KKQ-----------KYEKISEK--K---------------VSTS-IEA---------- 239 (474)
Q Consensus 201 vil~elltG~~Pf~~~~~~~--~~~-----------~~~~i~~~--~---------------~~~~-~~~---------- 239 (474)
||++-++++.+||....+.. ..+ +....... . +... .+.
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 99999999999996432211 000 00000000 0 0000 011
Q ss_pred ---HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 240 ---LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 240 ---l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
..+.+|..+.+|+.+|++.||.+|.++++.+
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeAL 379 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDAL 379 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHh
Confidence 1123456899999999999999999988764
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=249.04 Aligned_cols=255 Identities=20% Similarity=0.222 Sum_probs=195.9
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC----CCchHHHHHHHHHHHhcCCCCCceeEEEeEe-----C
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVE-----G 75 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~-----~ 75 (474)
+..+|.-++.+|.|.- .|..+.|.-.++.||+|..... ...+...+|..++..+.|.++|..+..|... -
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 4567888899999998 8888999899999999965332 3345688999999999999888888776543 2
Q ss_pred CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 76 ~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
...|+|||++..+|.+++. -.++-+++..|+.|+++|++|||+.||+||||||+||++ +.+..+||+|||+|+.
T Consensus 94 ~e~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 94 QEVYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILDFGLART 167 (369)
T ss_pred HhHHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeeccchhhcc
Confidence 3569999999999999987 357889999999999999999999999999999999999 5889999999999985
Q ss_pred cccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc---
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--- 232 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~--- 232 (474)
.... . ..+.++.|..|.|||++.+..+.+.+||||+||++.||++|...|.+...-+...++.......
T Consensus 168 e~~~--~------~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 168 EDTD--F------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPS 239 (369)
T ss_pred cCcc--c------ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHH
Confidence 4432 1 1345688999999999999999999999999999999999999998743222111111100000
Q ss_pred -------------------ccchHHHHhcC------------CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 233 -------------------VSTSIEALCRG------------YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 233 -------------------~~~~~~~l~~~------------~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
......++.++ -.....+++.+||..||++|.+++++ |++..
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~da---L~HPY 312 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDA---LRHPY 312 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHH---hcCCe
Confidence 00111111110 12457899999999999999996554 55544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-31 Score=269.21 Aligned_cols=264 Identities=17% Similarity=0.260 Sum_probs=211.3
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
.++|+++.++|+|+||.||+++++.+++..|+|+++... ....++.|+-+++.++|++++.++..|-. .+..+++||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr-~dklwicME 92 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR-RDKLWICME 92 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh-hcCcEEEEE
Confidence 468999999999999999999999999999999877653 34568899999999999988888766543 445699999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
|| |++|++... ..+.+++.++..+....+.||+|||++|-+|||||-.|||++ +.+.+||.|||.+-.+.....
T Consensus 93 ycgggslQdiy~-~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt---d~gDvklaDfgvsaqitati~- 167 (829)
T KOG0576|consen 93 YCGGGSLQDIYH-VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT---DEGDVKLADFGVSAQITATIA- 167 (829)
T ss_pred ecCCCcccceee-ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec---ccCceeecccCchhhhhhhhh-
Confidence 99 778888765 567899999999999999999999999999999999999995 789999999999977654332
Q ss_pred cccccccCCCCccCcccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 163 QHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
..+.+.||+.|||||+.. .+.|...+|||++|++..|+-.-+.|..+.... +.+.-.....+..+..+
T Consensus 168 ------KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm---r~l~LmTkS~~qpp~lk 238 (829)
T KOG0576|consen 168 ------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM---RALFLMTKSGFQPPTLK 238 (829)
T ss_pred ------hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH---HHHHHhhccCCCCCccc
Confidence 236789999999999764 456999999999999999999888887664432 11111112222222222
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH-----------HHHHHHHHHcCCCC
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK-----------RLFRDLFIREGFQF 284 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~-----------~~L~~l~~~~~~~~ 284 (474)
-...+.+.|.+|++.||.++|.+||+++.++ .+..+++.+.+...
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l~~rl~~eLLdK~n~P~ 294 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTLSRRLAIELLDKVNNPN 294 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccchhhHHHHHHHHHccCCC
Confidence 3345788999999999999999999988764 34566777766544
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-27 Score=224.91 Aligned_cols=197 Identities=30% Similarity=0.449 Sum_probs=164.3
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 85 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (474)
|.+.+.||.|++|.||+|.+..+++.|+||.+.... ....+..|++.++.+.+. ++..+..+.......++++|++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~-~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHP-NIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCC-ChhhheeeeecCCceEEEEecc
Confidence 678899999999999999998889999999987654 345688899999999765 4444555556667888999998
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccc
Q 011945 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164 (474)
Q Consensus 86 -g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (474)
+++|.+++......+++..++.++.+++.+|.+||+++++|+||+|.||+++ ..+.++|+|||++..+......
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~---~~~~~~l~d~g~~~~~~~~~~~-- 154 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG---MDGLVKLADFGLARFIHRDLAA-- 154 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeeCceeeEecCcccc--
Confidence 5599999985433389999999999999999999999999999999999994 5689999999999877554210
Q ss_pred cccccCCCCccCccccccccc-cCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 011945 165 IPYRENKNLTGTARYASMNTH-LGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215 (474)
Q Consensus 165 ~~~~~~~~~~GT~~Y~APE~~-~~~~~s~ksDIwSlGvil~elltG~~Pf~~ 215 (474)
......++..|++||.+ ....++.++|||+||+++|+|++|+.||..
T Consensus 155 ----~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 ----LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ----cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 11335678899999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-28 Score=220.30 Aligned_cols=167 Identities=17% Similarity=0.181 Sum_probs=128.4
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccc
Q 011945 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166 (474)
Q Consensus 87 ~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (474)
|+|.+++...+..+++.+++.|+.||+.||.|||+++ ||+|||+ +.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeecccc------
Confidence 6899999866667999999999999999999999998 9999999 47788888 99997654321
Q ss_pred cccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHH--HHhcCC
Q 011945 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE--ALCRGY 244 (474)
Q Consensus 167 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~--~l~~~~ 244 (474)
..||+.|||||++.+..++.++|||||||++|||++|+.||...... ...+..+.......... .....+
T Consensus 64 ------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 135 (176)
T smart00750 64 ------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPADDPRDRSNLESV 135 (176)
T ss_pred ------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccCCccccccHHHH
Confidence 26899999999999999999999999999999999999999764321 12222222111111000 001122
Q ss_pred cH--HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 245 PT--EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 245 p~--~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
+. ++.+++..||..+|++||++.++++.+..+..
T Consensus 136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 136 SAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 33 69999999999999999999999887766543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=274.59 Aligned_cols=188 Identities=14% Similarity=0.170 Sum_probs=135.4
Q ss_pred CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeee----------------
Q 011945 75 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL---------------- 138 (474)
Q Consensus 75 ~~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~---------------- 138 (474)
...++++||+++.+|.+++......+++.+++.|+.||+.||.|||++|||||||||+||||+.
T Consensus 52 ~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~ 131 (793)
T PLN00181 52 DDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSG 131 (793)
T ss_pred cchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCccc
Confidence 3567888999999999999855667999999999999999999999999999999999999952
Q ss_pred CCCCCeEEEEecCCccccccCCC--------cccccc-ccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhC
Q 011945 139 GRRANQVYIIDFGLAKRYRDTAT--------HQHIPY-RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG 209 (474)
Q Consensus 139 ~~~~~~vkL~DFGla~~~~~~~~--------~~~~~~-~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG 209 (474)
.+..+.+||+|||+++....... ....++ .......||+.|||||++.+..++.++|||||||+||||++|
T Consensus 132 ~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~ 211 (793)
T PLN00181 132 SDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCP 211 (793)
T ss_pred ccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhC
Confidence 12344567777777764321100 000000 001124689999999999999999999999999999999999
Q ss_pred CCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 210 SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 210 ~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
..||.... ..+..+....... ..... .++...++..||..+|.+||++.++++
T Consensus 212 ~~~~~~~~-----~~~~~~~~~~~~~---~~~~~-~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 212 VSSREEKS-----RTMSSLRHRVLPP---QILLN-WPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred CCchhhHH-----HHHHHHHHhhcCh---hhhhc-CHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 88875321 1122221111111 11111 345678999999999999999998753
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.3e-26 Score=227.77 Aligned_cols=180 Identities=19% Similarity=0.213 Sum_probs=136.8
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEEcC-CCeEEEEEEeccCC-------CchHHHHHHHHHHHhcCCCCCceeEEEeEe
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKT-------KHPQLQYEAKLYKILQGGTGIPNLRWFGVE 74 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~~vAvK~~~~~~-------~~~~l~~E~~il~~l~~~~~i~~l~~~~~~ 74 (474)
+.+.++|.+.+.||+|+||+||+|.+.. +++.||||++.... ....+.+|+++|+.|.|+++++.+..+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 4567899999999999999999999876 67888999764321 123589999999999998888766543
Q ss_pred CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCcEEeeeCCCCCeEEEEecCC
Q 011945 75 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI-KPDNFLMGLGRRANQVYIIDFGL 152 (474)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDI-KP~NILl~~~~~~~~vkL~DFGl 152 (474)
...+|||||+ |++|.. +. ... ...++.|++.+|.|||++||+|||| ||+|||++ .++.+||+|||+
T Consensus 91 -~~~~LVmE~~~G~~L~~-~~----~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~---~~~~ikLiDFGl 158 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHL-AR----PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMG---PDGEAAVIDFQL 158 (365)
T ss_pred -CCcEEEEEccCCCCHHH-hC----ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEc---CCCCEEEEECcc
Confidence 3469999999 777752 21 111 1467899999999999999999999 99999994 567899999999
Q ss_pred ccccccCCCcccc-ccccCCCCccCccccccccccCCC------CCchhhHH
Q 011945 153 AKRYRDTATHQHI-PYRENKNLTGTARYASMNTHLGIE------QSRRDDLE 197 (474)
Q Consensus 153 a~~~~~~~~~~~~-~~~~~~~~~GT~~Y~APE~~~~~~------~s~ksDIw 197 (474)
|+.+........+ .+..-....+++.|+|||.+...+ .+...|-|
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9988765433222 122224678899999999987543 23446665
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-24 Score=208.36 Aligned_cols=257 Identities=30% Similarity=0.405 Sum_probs=191.9
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
|.+.+.||.|+||.||++.+. ..+++|.+..... ...+.+|+.++..+.+++.+..+..+.......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 789999999999999999976 7889998765433 34588999999999988655555555566666788999
Q ss_pred cC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCC-eEEEEecCCccccccC
Q 011945 84 LL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDT 159 (474)
Q Consensus 84 ~~-g~sL~~li~~~~--~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~-~vkL~DFGla~~~~~~ 159 (474)
++ +++|.+++.... ..+....+..++.|++.+|.|+|+.+++||||||+||+++ ..+ .++++|||++..+...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~---~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD---RDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---CCCCeEEEeccCcceecCCC
Confidence 88 788887776433 2799999999999999999999999999999999999994 455 7999999999865544
Q ss_pred CCccccccccCCCCccCccccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcC-cHHHHHHHHhhccccc
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYEKISEKKVST 235 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~---~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~i~~~~~~~ 235 (474)
....... .......||..|++||.+.+ ..++...|+|++|++++++++|..||...... ........+.......
T Consensus 156 ~~~~~~~-~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 156 GSTSSIP-ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234 (384)
T ss_pred Ccccccc-ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence 3211100 12356789999999999998 57899999999999999999999998765431 1122222222222110
Q ss_pred hHHHHhcCC----cHHHHHHHHHHhcCCCCCCCCHHHHHHH
Q 011945 236 SIEALCRGY----PTEFASYFHYCRSLRFDDKPDYAYLKRL 272 (474)
Q Consensus 236 ~~~~l~~~~----p~~l~~li~~cl~~dp~~RPt~~~l~~~ 272 (474)
......... ...+.+++..|+..+|..|.+.......
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 011111111 2578999999999999999987665443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-25 Score=234.77 Aligned_cols=252 Identities=19% Similarity=0.245 Sum_probs=186.0
Q ss_pred EEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC----CCch----HHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHP----QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 10 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~----~~~~----~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
.....+|.|++|.|+.+......+.++.|.+... .... .+..|+-+-..|.|.+++..+..+.........
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~- 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQS- 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhh-
Confidence 4567899999999998887766666666644321 1111 134455555567766666655444433333333
Q ss_pred EecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 82 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 82 ~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
||||..+|..++.. ...+...++..++.|++.||.|||+.||.||||||+|+++. ..+.+||+|||.+..+.....
T Consensus 400 mE~~~~Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~---~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 400 MEYCPYDLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT---ENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhcccHHHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe---cCCceEEeecCcceeeccCcc
Confidence 99996699888873 34799999999999999999999999999999999999995 778999999999987765433
Q ss_pred ccccccccCCCCccCccccccccccCCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCcCcHH-HHHHHHhhccccchHHH
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSR-RDDLESLGYVLMYFLRGSLPWQGLKAGTKK-QKYEKISEKKVSTSIEA 239 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~-ksDIwSlGvil~elltG~~Pf~~~~~~~~~-~~~~~i~~~~~~~~~~~ 239 (474)
.. ......++|+..|+|||++.+.+|++ ..||||.|++++.|++|+.||......+.. .................
T Consensus 476 ~~---~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~ 552 (601)
T KOG0590|consen 476 KN---IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR 552 (601)
T ss_pred hh---hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH
Confidence 21 12346789999999999999999874 689999999999999999999765443322 11111122223333455
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYL 269 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (474)
+...+|.+.+.+|-+||+.+|.+|.++++|
T Consensus 553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i 582 (601)
T KOG0590|consen 553 LLSLLPRETRIIIYRMLQLDPTKRITIEQI 582 (601)
T ss_pred HHHhchhhHHHHHHHHccCChhheecHHHH
Confidence 667789999999999999999999997766
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=220.70 Aligned_cols=255 Identities=23% Similarity=0.325 Sum_probs=184.9
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhc--CCCCCceeEEEeEeCCEEEEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ--GGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~--~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
-+..|.|.+.||.|+||.||+|.... |+.||||+.+.....+ +..=.+++.+|+ --+.|..+.......+..+||+
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-eeehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 36789999999999999999999755 9999999987655433 112223344444 1122223333334455668889
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeee----CCCCCeEEEEecCCccccc
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL----GRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~----~~~~~~vkL~DFGla~~~~ 157 (474)
+|. .|+|.++++ ..+.+++..+..++.||+.-++.||..+|||+||||+|+||.. +.+...++|+|||.+..+.
T Consensus 774 ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 774 EYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred eccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 988 899999998 6677999999999999999999999999999999999999964 2234569999999997554
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
--.... ..+..++|-.+-.+|+..|.+|+...|.|.|..+++-||.|++-= ...+.. . .....+
T Consensus 853 lfp~~~-----~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--~~~g~~----~-----~~~~~~ 916 (974)
T KOG1166|consen 853 LFPDGT-----KFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--VKNGSS----W-----MVKTNF 916 (974)
T ss_pred EcCCCc-----EEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--hcCCcc----e-----eccccc
Confidence 322221 124568899999999999999999999999999999999996431 000000 0 000001
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
..++. -+-+.+|+..+|+.|-..=|...+|+..|++.|.+.
T Consensus 917 ~Ry~~--~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 917 PRYWK--RDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred hhhhh--HHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 11111 133567888888877777788999999999888664
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=197.31 Aligned_cols=231 Identities=23% Similarity=0.262 Sum_probs=148.4
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcC----------CCCCceeEEE-
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQG----------GTGIPNLRWF- 71 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~----------~~~i~~l~~~- 71 (474)
.+...+.||.|+|+.||.+++..+|+.+|||+...... .+++.+|.-....+.+ ...+.-++..
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45678899999999999999999999999998654432 1234444433322211 0111111111
Q ss_pred -------eE---eCCE-----EEEEEecCCCCHHHHHHHc---CCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 011945 72 -------GV---EGDY-----NVLVIDLLGPSLEDLFNFC---SRK---LSLKTVLMLADQMINRVEFVHSKSFLHRDIK 130 (474)
Q Consensus 72 -------~~---~~~~-----~~lv~e~~g~sL~~li~~~---~~~---l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIK 130 (474)
.. .... .+++|+.+.++|.+++... ... +.....+.+..|++..+++||+.||||+|||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 11 1111 2677888899999987532 211 3344456777999999999999999999999
Q ss_pred CCcEEeeeCCCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccC--------CCCCchhhHHHHHHH
Q 011945 131 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--------IEQSRRDDLESLGYV 202 (474)
Q Consensus 131 P~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--------~~~s~ksDIwSlGvi 202 (474)
|+||++ +.+|.++|+||+........... ...+..|.+||.... ..++.+.|.|+||++
T Consensus 173 ~~nfll---~~~G~v~Lg~F~~~~r~g~~~~~----------~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 173 PENFLL---DQDGGVFLGDFSSLVRAGTRYRC----------SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp GGGEEE----TTS-EEE--GGGEEETTEEEEG----------GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred eeeEEE---cCCCCEEEcChHHHeecCceeec----------cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 999999 58899999999887654432210 134577999997643 247899999999999
Q ss_pred HHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCC
Q 011945 203 LMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDK 263 (474)
Q Consensus 203 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~R 263 (474)
+|.|++|.+||........... .-..|..+|+.++.||..+|+.+|++|
T Consensus 240 ly~lWC~~lPf~~~~~~~~~~~------------~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSPEADPEW------------DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHSS-STCCCGGGSTSGG------------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHccCCCCCCCccccccc------------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999999999986533211100 112466889999999999999999987
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=187.29 Aligned_cols=137 Identities=22% Similarity=0.226 Sum_probs=103.6
Q ss_pred eeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----------chH-----------------HHHHHHHHHHhcCCC
Q 011945 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----------HPQ-----------------LQYEAKLYKILQGGT 63 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----------~~~-----------------l~~E~~il~~l~~~~ 63 (474)
.+.||+|+||.||+|.+. +|+.||||+++.... ... ...|++++..+.+..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 578999999999999986 899999998764321 011 234999999997543
Q ss_pred CCceeEEEeEeCCEEEEEEecCCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCcEEeeeCCC
Q 011945 64 GIPNLRWFGVEGDYNVLVIDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFV-HSKSFLHRDIKPDNFLMGLGRR 141 (474)
Q Consensus 64 ~i~~l~~~~~~~~~~~lv~e~~g~-sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yL-Hs~gIiHrDIKP~NILl~~~~~ 141 (474)
. .....+.... .+|||||+++ +|...+. ....+++..++.++.||+.+|.|| |+.||+||||||+|||++
T Consensus 81 v-~~p~~~~~~~--~~iVmE~i~g~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~---- 152 (190)
T cd05147 81 I-PCPEPILLKS--HVLVMEFIGDDGWAAPRL-KDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH---- 152 (190)
T ss_pred C-CCCcEEEecC--CEEEEEEeCCCCCcchhh-hcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----
Confidence 2 2222222222 3899999954 4443322 245799999999999999999999 799999999999999994
Q ss_pred CCeEEEEecCCccccc
Q 011945 142 ANQVYIIDFGLAKRYR 157 (474)
Q Consensus 142 ~~~vkL~DFGla~~~~ 157 (474)
++.++|+|||+|....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 3679999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-22 Score=189.03 Aligned_cols=171 Identities=15% Similarity=0.218 Sum_probs=126.7
Q ss_pred CCccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCch-----------HHHHHHHHHHHhcCCCCCceeEE
Q 011945 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----------QLQYEAKLYKILQGGTGIPNLRW 70 (474)
Q Consensus 2 ~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-----------~l~~E~~il~~l~~~~~i~~l~~ 70 (474)
+..+.++|++++.||.|+||.||++.+ ++..||||++....... .+.+|++.+.+|.|. +++.+..
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~-GI~~~~d 102 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSE-GLASLND 102 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHC-CCCcceE
Confidence 346789999999999999999999764 56789999986443221 157888899999754 5555544
Q ss_pred EeEe--------CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCC
Q 011945 71 FGVE--------GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (474)
Q Consensus 71 ~~~~--------~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~ 141 (474)
+... ....+|+|||+ |.+|.++.. +++ ....+|+.+|..||..||+||||||+||+++ .
T Consensus 103 ~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~---~ 170 (232)
T PRK10359 103 FYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS---K 170 (232)
T ss_pred eeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe---C
Confidence 4332 23578999999 678887742 333 3456999999999999999999999999995 4
Q ss_pred CCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHH
Q 011945 142 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL 207 (474)
Q Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ell 207 (474)
++ ++|+|||........... -...+...++.++|||+|||++..+.
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~-------------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK-------------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhH-------------------HHHHHHhHhcccccccceeEeehHHH
Confidence 55 999999998765332210 11334445677899999999987654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=180.17 Aligned_cols=192 Identities=17% Similarity=0.111 Sum_probs=139.2
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCch------HHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP------QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~------~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
+.+...|++|+||+||++. ..+.+++.+-+....... .+.+|+++|++|.++++++.+..+ ...+++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~--~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVR--GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEee--cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 3467889999999999887 377788877655443311 378899999999988888888654 3358999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI-KPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDI-KP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
+|+ |.+|.+.+.. ....++.|++.+|.+||++||+|||| ||+|||++ .++.++|+|||+|.......
T Consensus 78 eyI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~---~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 78 SYLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ---EDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred eeecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc---CCCCEEEEECCCceecCCcc
Confidence 997 7777654321 12457889999999999999999999 79999994 66789999999998554332
Q ss_pred Ccc-cccccc-----CCCCccCccccccccccCC-CCC-chhhHHHHHHHHHHHHhCCCCCCCCC
Q 011945 161 THQ-HIPYRE-----NKNLTGTARYASMNTHLGI-EQS-RRDDLESLGYVLMYFLRGSLPWQGLK 217 (474)
Q Consensus 161 ~~~-~~~~~~-----~~~~~GT~~Y~APE~~~~~-~~s-~ksDIwSlGvil~elltG~~Pf~~~~ 217 (474)
... .+-++. ......++.|++|+...-. ..+ ...++++.|+.+|.|+|+.+++.+..
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 100 000000 0012357788888865433 234 56788899999999999999886544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-22 Score=216.04 Aligned_cols=238 Identities=22% Similarity=0.344 Sum_probs=161.1
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 85 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (474)
-.+|..++.|..|+||.||+++++.+.+.+|+|+-+.+. +.+. ++.... . .++|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~l----ilRn--ilt~a~-n---------------pfvv---- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNL----ILRN--ILTFAG-N---------------PFVV---- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccch----hhhc--cccccC-C---------------ccee----
Confidence 467999999999999999999999999999996532111 1111 111111 1 1111
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc--
Q 011945 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ-- 163 (474)
Q Consensus 86 g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~-- 163 (474)
++-..+++. -++++.. ++.+++|||+.||+|||+||+|.||+ .-|++|++|||+++.........
T Consensus 136 -gDc~tllk~-~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT---~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 -GDCATLLKN-IGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLIT---SMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred -chhhhhccc-CCCCcch--------hhHHhHhhccCCeecCCCCCCcceee---ecccccccchhhhhhhhhhccchhh
Confidence 333344432 2234432 37899999999999999999999995 78999999999998643221111
Q ss_pred --ccc----cccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 164 --HIP----YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 164 --~~~----~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
++. .-..+.++||+.|.|||++..+.|+..+|+|++|+|+||++-|..||.+...+. .+..+....... .
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee---lfg~visd~i~w-p 278 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFGQVISDDIEW-P 278 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH---HHhhhhhhhccc-c
Confidence 000 012356799999999999999999999999999999999999999999865533 333322222111 1
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccccc
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 294 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 294 (474)
+. ...++++.+++|.++|..+|.+|--.....++ ....+...+||..+-
T Consensus 279 E~-dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~ev-------k~h~ff~~LDw~~ll 327 (1205)
T KOG0606|consen 279 EE-DEALPPEAQDLIEQLLRQNPLCRLGTGGALEV-------KQHGFFQLLDWKSLL 327 (1205)
T ss_pred cc-CcCCCHHHHHHHHHHHHhChHhhcccchhhhh-------hhccceeecccchhh
Confidence 11 34578999999999999999999543222222 222445567777443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=178.55 Aligned_cols=138 Identities=21% Similarity=0.269 Sum_probs=105.6
Q ss_pred EeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----------------------------chHHHHHHHHHHHhcCC
Q 011945 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------------------------HPQLQYEAKLYKILQGG 62 (474)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----------------------------~~~l~~E~~il~~l~~~ 62 (474)
+.+.||+|+||.||+|.+. +|+.||||+++.... ...+..|...+.++.+.
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999986 899999998765421 01135788899998865
Q ss_pred CCCceeEEEeEeCCEEEEEEecCCCC-HH-HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEeeeC
Q 011945 63 TGIPNLRWFGVEGDYNVLVIDLLGPS-LE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLG 139 (474)
Q Consensus 63 ~~i~~l~~~~~~~~~~~lv~e~~g~s-L~-~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs-~gIiHrDIKP~NILl~~~ 139 (474)
. +.....+.... .+|||||+++. +. ..+. ...++...+..++.|++.+|.+||+ +||+||||||+|||++
T Consensus 80 ~-i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-- 152 (190)
T cd05145 80 G-VPVPEPILLKK--NVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-- 152 (190)
T ss_pred C-CCCceEEEecC--CEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE--
Confidence 4 33222222222 48999999543 33 3333 3468889999999999999999999 9999999999999994
Q ss_pred CCCCeEEEEecCCcccccc
Q 011945 140 RRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 140 ~~~~~vkL~DFGla~~~~~ 158 (474)
++.++|+|||+|.....
T Consensus 153 --~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 --DGKPYIIDVSQAVELDH 169 (190)
T ss_pred --CCCEEEEEcccceecCC
Confidence 57899999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2e-22 Score=207.38 Aligned_cols=251 Identities=19% Similarity=0.264 Sum_probs=191.8
Q ss_pred eeeecCceEEEEEEEc---CCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-
Q 011945 14 KIGSGSFGEIYLGTNI---QTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 85 (474)
Q Consensus 14 ~LG~G~fG~Vy~a~~~---~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (474)
.+|.|.||.|+++... ..+.-+|+|+.+.... ......|..++..++.++.+..+.+.+......++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 3799999999987632 3466788887654432 1245668888888888888888887777777788888888
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccc
Q 011945 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 165 (474)
Q Consensus 86 g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (474)
|+.|...+. ....+.+..+..+...++.+++++|+.+|+|||+|++||++ +..|++++.|||+++...+...
T Consensus 81 gg~lft~l~-~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~---- 152 (612)
T KOG0603|consen 81 GGDLFTRLS-KEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKI---- 152 (612)
T ss_pred cchhhhccc-cCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhh----
Confidence 667666554 34568889999999999999999999999999999999999 5889999999999987765432
Q ss_pred ccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCc
Q 011945 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245 (474)
Q Consensus 166 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 245 (474)
.+||..|||||++. .....+|.||||++++||++|..||.+ +....|...+... +..+.
T Consensus 153 -------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~Il~~~~~~-----p~~l~ 211 (612)
T KOG0603|consen 153 -------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKRILKAELEM-----PRELS 211 (612)
T ss_pred -------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHHHhhhccCC-----chhhh
Confidence 28999999999998 457789999999999999999999987 2233333323222 23445
Q ss_pred HHHHHHHHHHhcCCCCCCCCH--HHHHHHHHHHHHHcCCCCCCcccccccccccccc
Q 011945 246 TEFASYFHYCRSLRFDDKPDY--AYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300 (474)
Q Consensus 246 ~~l~~li~~cl~~dp~~RPt~--~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~~ 300 (474)
.+..+++..++..+|..|--. ..+.+..++ .+....+|+.+..++.++
T Consensus 212 ~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h-------~f~~~i~~~~l~~r~~~~ 261 (612)
T KOG0603|consen 212 AEARSLFRQLFKRNPENRLGAGPDGVDEIKQH-------EFFQSIDWNELEARSRPP 261 (612)
T ss_pred HHHHHHHHHHHhhCHHHHhccCcchhHHHhcc-------chheeeeHhhHhhcCCCC
Confidence 778999999999999999654 334444443 345667899776655443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.3e-20 Score=182.16 Aligned_cols=195 Identities=18% Similarity=0.224 Sum_probs=147.3
Q ss_pred CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCC-CCeEEEEecCCc
Q 011945 75 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLA 153 (474)
Q Consensus 75 ~~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~-~~~vkL~DFGla 153 (474)
+...|+||.-+..+|.+++. .+..+......|+.|+++|+.|||.+||.|||+|.+||||-.+++ ...+.|+|||++
T Consensus 315 ~~tlylvMkrY~~tLr~yl~--~~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCc 392 (598)
T KOG4158|consen 315 PKTLYLVMKRYRQTLREYLW--TRHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCC 392 (598)
T ss_pred CceEEEehhcchhhHHHHHh--cCCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccccee
Confidence 45679999999999999996 556888899999999999999999999999999999999976533 456789999988
Q ss_pred cccccCCCcccccccc-CCCCccCccccccccccCCC------CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcH-HHHH
Q 011945 154 KRYRDTATHQHIPYRE-NKNLTGTARYASMNTHLGIE------QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKY 225 (474)
Q Consensus 154 ~~~~~~~~~~~~~~~~-~~~~~GT~~Y~APE~~~~~~------~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~-~~~~ 225 (474)
---. ......||.. .....|....||||+....+ --.|+|.|+.|.+.||++....||........ ...|
T Consensus 393 LAd~--~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Y 470 (598)
T KOG4158|consen 393 LADD--NHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTY 470 (598)
T ss_pred eecc--ccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhh
Confidence 5322 2223344432 23346888999999987543 13589999999999999999999987321110 0112
Q ss_pred HHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 226 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
+ ...++.+...+|+.+++++..+|+.||.+|++..-..+.|+-.+...
T Consensus 471 q-------e~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~ 518 (598)
T KOG4158|consen 471 Q-------ESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRM 518 (598)
T ss_pred h-------hhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcC
Confidence 1 12334566789999999999999999999999876666665544333
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-21 Score=208.49 Aligned_cols=249 Identities=16% Similarity=0.148 Sum_probs=170.5
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC------chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
.|...+.||.+.|=.|.+|++ ..|. |+||++-.... ..+...|++ ...+++++.+++.. ..+.+...|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~-~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk-~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKD-REGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQK-VLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccC-CCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHH-HHHhhHHHHHH
Confidence 688899999999999999996 4554 99998755432 123344444 33344455554443 35566677888
Q ss_pred EecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 82 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 82 ~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
=.|...+|+|.+. ...-+...+.+.|+.||+.||..+|..||+|+|||.+||||+ .-+-+.|+||..-+..--+.+
T Consensus 100 RqyvkhnLyDRlS-TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT---SWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 100 RQYVKHNLYDRLS-TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT---SWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHhhhhhhhhc-cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe---eechhhhhcccccCCccCCCC
Confidence 8888999999886 223377889999999999999999999999999999999996 556689999986653211111
Q ss_pred -ccccccccCCCCccCccccccccccCC----------C-CCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHH
Q 011945 162 -HQHIPYRENKNLTGTARYASMNTHLGI----------E-QSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKI 228 (474)
Q Consensus 162 -~~~~~~~~~~~~~GT~~Y~APE~~~~~----------~-~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i 228 (474)
...+.|... +..--..|+|||-+... . .+++-||||+||++.||++ |++||.- ...-.|..
T Consensus 176 NPadf~fFFD-TSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~- 249 (1431)
T KOG1240|consen 176 NPADFTFFFD-TSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRS- 249 (1431)
T ss_pred CcccceEEEe-cCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhc-
Confidence 111111111 11223479999987641 1 5788999999999999998 7888842 11111111
Q ss_pred hhccccchHHHHhcCC-cHHHHHHHHHHhcCCCCCCCCHHHHHHHH
Q 011945 229 SEKKVSTSIEALCRGY-PTEFASYFHYCRSLRFDDKPDYAYLKRLF 273 (474)
Q Consensus 229 ~~~~~~~~~~~l~~~~-p~~l~~li~~cl~~dp~~RPt~~~l~~~L 273 (474)
.. ....+.+...+ ...++.+|..|++.||++|-++++.++.-
T Consensus 250 --~~-~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 250 --GN-ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred --cC-ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 11 12222233332 24689999999999999999999887653
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.5e-21 Score=176.57 Aligned_cols=243 Identities=12% Similarity=0.152 Sum_probs=181.1
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
..++-+|.+...|+.|+|++. |..+++|+++.... ...|..|.-.|+.+.|+++++.+..+....+...|...+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 446678889999999999974 45677887765432 345888888999999999888888776665554444444
Q ss_pred CCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEeeeCCCCCeEE--EEecCCccccccC
Q 011945 85 LGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVY--IIDFGLAKRYRDT 159 (474)
Q Consensus 85 ~g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~g--IiHrDIKP~NILl~~~~~~~~vk--L~DFGla~~~~~~ 159 (474)
..++|+.++.... -.++..++..++.+|+.|+.|||+.. |.---|....++|+ ++.+.+ .+|--++...
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmid---edltarismad~kfsfqe--- 343 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMID---EDLTARISMADTKFSFQE--- 343 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEec---chhhhheecccceeeeec---
Confidence 4899999997433 23778899999999999999999953 33446788889994 444444 3443333211
Q ss_pred CCccccccccCCCCccCccccccccccCCCCC---chhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccch
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQS---RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s---~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (474)
....-.+.||+||.+...+-+ +.+|+|||.++||||.|...||.+..+.+...++ .+...
T Consensus 344 -----------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki------alegl 406 (448)
T KOG0195|consen 344 -----------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI------ALEGL 406 (448)
T ss_pred -----------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh------hhccc
Confidence 123457899999999877643 5789999999999999999999987664332222 12233
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
...++.+++..+.+|+..|++.||.+||.++.|.-+|+++
T Consensus 407 rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 407 RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 3455678899999999999999999999999999988876
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=173.23 Aligned_cols=142 Identities=20% Similarity=0.224 Sum_probs=108.6
Q ss_pred cEEEeeeeeecCceEEEEEE-EcCCCeEEEEEEeccCCC--------------------------chHHHHHHHHHHHhc
Q 011945 8 KFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTK--------------------------HPQLQYEAKLYKILQ 60 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~-~~~~~~~vAvK~~~~~~~--------------------------~~~l~~E~~il~~l~ 60 (474)
-|.+.+.||+|+||.||+|. +..+|+.||||++..... ...+..|+.++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48899999999999999999 667999999998764321 012568999999997
Q ss_pred CCCCCceeEEEeEeCCEEEEEEecCCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCCCcEEeee
Q 011945 61 GGTGIPNLRWFGVEGDYNVLVIDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS-FLHRDIKPDNFLMGL 138 (474)
Q Consensus 61 ~~~~i~~l~~~~~~~~~~~lv~e~~g~-sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~g-IiHrDIKP~NILl~~ 138 (474)
+ .++.....+... ..++||||+++ +|..+.. ....+....+..++.||+.+|.+||++| |+||||||+|||++
T Consensus 109 ~-~~i~~p~~~~~~--~~~lV~E~~~g~~L~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 E-AGVPVPKPIAWR--RNVLVMEFIGGDGLPAPRL-KDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred h-cCCCCCeeeEec--CceEEEEEecCCccccccc-ccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 5 333332222222 24799999955 5555432 2345667778899999999999999999 99999999999994
Q ss_pred CCCCCeEEEEecCCccccc
Q 011945 139 GRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 139 ~~~~~~vkL~DFGla~~~~ 157 (474)
.+.++|+|||++....
T Consensus 184 ---~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 ---DGKVVIIDVSQSVELD 199 (237)
T ss_pred ---CCCEEEEEChhhhccC
Confidence 5789999999987543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-18 Score=163.50 Aligned_cols=136 Identities=16% Similarity=0.220 Sum_probs=101.2
Q ss_pred eeeeeecCceEEEEEEEcCCCeEEEEEEeccC--CCchHHHHHHHHHHHhcC----CCCCceeEEEeEeCC---E-EEEE
Q 011945 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQG----GTGIPNLRWFGVEGD---Y-NVLV 81 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~l~~E~~il~~l~~----~~~i~~l~~~~~~~~---~-~~lv 81 (474)
.+.||+|+||.||. +..++.. +||++... .....+.+|+.+++.|.+ +++|+.++.+...+. + +.+|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 46899999999995 6667666 69987653 234568999999999953 445555554444432 3 4478
Q ss_pred EecCC---CCHHHHHHHcCCCCCHHHHHHHHHHHHHHH-HHHHHCCccccCCCCCcEEeeeCC-CCCeEEEEecCCcc
Q 011945 82 IDLLG---PSLEDLFNFCSRKLSLKTVLMLADQMINRV-EFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLAK 154 (474)
Q Consensus 82 ~e~~g---~sL~~li~~~~~~l~~~~~~~i~~qi~~gL-~yLHs~gIiHrDIKP~NILl~~~~-~~~~vkL~DFGla~ 154 (474)
|||+| ++|.+++.. ..+++. ..++.|++.++ +|||+++||||||||+|||++..+ ....++|+||+.+.
T Consensus 84 ~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred ecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 99965 899999974 346665 36688888888 999999999999999999997432 34589999955443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.5e-18 Score=161.49 Aligned_cols=132 Identities=26% Similarity=0.397 Sum_probs=104.6
Q ss_pred eeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----------chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----------~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++.||+|++|.||+|.+ .+..|+||+...... ...+.+|+.++..+.+.+ ++....+.......+++
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~p~~~~~~~~~~~lv 77 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAG-VNVPAVYFVDPENFIIV 77 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCC-CCCCeEEEEeCCCCEEE
Confidence 36799999999999986 778899997654321 124678999999998554 33333344445567899
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
|||+ |.+|.+++.... . ....++.+|+.+|.+||+.||+|+|++|.|||++ .+.++|+|||++..
T Consensus 78 ~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~----~~~~~liDf~~a~~ 143 (211)
T PRK14879 78 MEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEF 143 (211)
T ss_pred EEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE----CCCEEEEECCcccC
Confidence 9998 889999987322 2 8889999999999999999999999999999994 57899999999874
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.8e-20 Score=185.99 Aligned_cols=242 Identities=19% Similarity=0.219 Sum_probs=159.7
Q ss_pred cEEEeeeeeecCceEEEEEEEcCC---CeEEEEEEeccCC--CchHHHHHHHHHHHhcCCCCCceeE-----E--E----
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLR-----W--F---- 71 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAvK~~~~~~--~~~~l~~E~~il~~l~~~~~i~~l~-----~--~---- 71 (474)
.+.+.+..+..+++.++......+ .+.++-|....+. ......+++..+....+++...... . +
T Consensus 245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~ 324 (516)
T KOG1033|consen 245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNK 324 (516)
T ss_pred cccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhccccc
Confidence 344555566666666665543322 2333333332222 1122444555555555555443332 0 0
Q ss_pred eEeCCEEEEEEecC-CCCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEE
Q 011945 72 GVEGDYNVLVIDLL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148 (474)
Q Consensus 72 ~~~~~~~~lv~e~~-g~sL~~li~~--~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~ 148 (474)
.....+.+|.|.+| ..+|++++.. .....++...+.++.|++.|++| +|.+|||+||.||++. .+.++||.
T Consensus 325 v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q~kIg 398 (516)
T KOG1033|consen 325 VGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQLKIG 398 (516)
T ss_pred cccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchhhhhh
Confidence 01234689999999 8899999962 23347888999999999999999 9999999999999995 56689999
Q ss_pred ecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHH
Q 011945 149 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEK 227 (474)
Q Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 227 (474)
|||+........+ ..-++......+||..||+||++.+..|+.++||||||+||+|++. -...|... ..+..
T Consensus 399 DFgl~ts~~~~~~-~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~------~t~~d 471 (516)
T KOG1033|consen 399 DFGLVTSQDKDET-VAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI------ATLTD 471 (516)
T ss_pred hhhheeecccCCc-ccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH------Hhhhh
Confidence 9999987665541 1111223455689999999999999999999999999999999997 33443221 11222
Q ss_pred HhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCH
Q 011945 228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDY 266 (474)
Q Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~ 266 (474)
+....++ +.+..++|. -..|+.+++...|.+||++
T Consensus 472 ~r~g~ip---~~~~~d~p~-e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 472 IRDGIIP---PEFLQDYPE-EYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred hhcCCCC---hHHhhcCcH-HHHHHHHhcCCCcccCchH
Confidence 2222222 122334443 4689999999999999943
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.2e-18 Score=177.36 Aligned_cols=212 Identities=17% Similarity=0.227 Sum_probs=160.3
Q ss_pred HhcCCCCCceeEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc-cccCCCCCcEE
Q 011945 58 ILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF-LHRDIKPDNFL 135 (474)
Q Consensus 58 ~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gI-iHrDIKP~NIL 135 (474)
.+. |.++..+.+...++...+++-+|| .++|.|.+......+++.....++.+|+.||.|||.-.| .|+.|+..|++
T Consensus 3 ~l~-h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nCl 81 (484)
T KOG1023|consen 3 QLD-HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCL 81 (484)
T ss_pred ccc-hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccce
Confidence 345 445556666666678888899999 899999998777789999999999999999999999766 99999999999
Q ss_pred eeeCCCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCC-------CCchhhHHHHHHHHHHHHh
Q 011945 136 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-------QSRRDDLESLGYVLMYFLR 208 (474)
Q Consensus 136 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-------~s~ksDIwSlGvil~ellt 208 (474)
+ +....+||+|||+.......... .......-...|.|||.+.+.. .+.+.||||||++++|+++
T Consensus 82 v---d~~w~lklt~~Gl~~~~~~~~~~-----~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 82 V---DSRWVLKLTDFGLNSLLEETAEP-----EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred e---eeeEEEEechhhhcccccccccc-----cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 9 58899999999998776431100 0011122456799999998742 3677999999999999999
Q ss_pred CCCCCCCCCcC-cHHHHHHHHhh---ccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 209 GSLPWQGLKAG-TKKQKYEKISE---KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 209 G~~Pf~~~~~~-~~~~~~~~i~~---~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
.+.||...... ...+.+..+.. ....+.+.... .+++++..++..||..+|++||+++.+...++.+...
T Consensus 154 r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 154 RSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccCccccccccCChHHHHHHHHhcCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 99999863322 22333333333 12233333222 6677999999999999999999999999988888754
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.2e-18 Score=156.24 Aligned_cols=128 Identities=24% Similarity=0.368 Sum_probs=99.9
Q ss_pred eeeecCceEEEEEEEcCCCeEEEEEEeccCCC----------chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 14 ~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----------~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
.||+|+||.||+|. .++..|++|+...... ...+.+|++++..+.+.+ +.....+.......+++||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAG-VNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCC-CCCCEEEEEECCCCEEEEE
Confidence 48999999999998 4678899998543221 134668999999998653 3333334445556689999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
++ |++|.+++.... . .++.|++.+|.+||+.||+|+||+|.|||++ .+.++|+|||++...
T Consensus 78 ~~~g~~l~~~~~~~~--~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~----~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 78 YIEGKPLKDVIEEGN--D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKYS 139 (199)
T ss_pred EECCccHHHHHhhcH--H------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE----CCcEEEEECCCCcCC
Confidence 98 889988876321 1 8899999999999999999999999999994 678999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-17 Score=155.47 Aligned_cols=136 Identities=21% Similarity=0.306 Sum_probs=103.8
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC------------------------chHHHHHHHHHHHhcCCC
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------------------------HPQLQYEAKLYKILQGGT 63 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------------------------~~~l~~E~~il~~l~~~~ 63 (474)
.|.+.+.||.|+||.||++.+ .+|+.||||++..... ......|..++..+.+..
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 488899999999999999987 4899999998654220 112567888888887542
Q ss_pred -CCceeEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCC
Q 011945 64 -GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (474)
Q Consensus 64 -~i~~l~~~~~~~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~ 141 (474)
.++... . ....+++|||+ |.+|.++.. ......++.+|+.++.++|+.||+||||||+||+++ .
T Consensus 95 i~v~~~~--~--~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~---~ 160 (198)
T cd05144 95 FPVPKPI--D--WNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVD---D 160 (198)
T ss_pred CCCCcee--e--cCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEc---C
Confidence 222222 2 23458999998 667765532 134567889999999999999999999999999994 6
Q ss_pred CCeEEEEecCCcccccc
Q 011945 142 ANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 142 ~~~vkL~DFGla~~~~~ 158 (474)
++.++|+|||++.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 78999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.3e-17 Score=173.83 Aligned_cols=133 Identities=24% Similarity=0.422 Sum_probs=102.5
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-C---------chHHHHHHHHHHHhcCCCCCceeEEEeEeCC
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-K---------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 76 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~---------~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (474)
..|...++||+|+||+||+|.+. +..+++|+...+. . ...+.+|+++++.+++++ +.....+.....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~p~~~~~~~~ 409 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAG-VPTPVIYDVDPE 409 (535)
T ss_pred cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccC-CCeeEEEEEeCC
Confidence 34566889999999999999864 3344555321111 1 134788999999998655 444444555556
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
..+++|||+ |++|.+++. ....++.|++.+|.|||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl----~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV----RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE----ECCcEEEEeCccccc
Confidence 678999999 889998875 356789999999999999999999999999999 356899999999975
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.7e-16 Score=144.81 Aligned_cols=135 Identities=24% Similarity=0.330 Sum_probs=95.1
Q ss_pred eeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hH----------------------HHHHHHHHHHhcCCC-C
Q 011945 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQ----------------------LQYEAKLYKILQGGT-G 64 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~----------------------l~~E~~il~~l~~~~-~ 64 (474)
.+.||+|+||.||+|.+. +++.||||++...... .. ...|...+..+.+.. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999975 8999999987643211 01 135666666665432 2
Q ss_pred CceeEEEeEeCCEEEEEEecCCC-CHH-HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEeeeCCC
Q 011945 65 IPNLRWFGVEGDYNVLVIDLLGP-SLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRR 141 (474)
Q Consensus 65 i~~l~~~~~~~~~~~lv~e~~g~-sL~-~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs-~gIiHrDIKP~NILl~~~~~ 141 (474)
++....+ ...+++|||+.+ .+. ..+.... .. ..+..++.+++.++.++|. +||+|+||||+||+++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~---- 149 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD---- 149 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE----
Confidence 3333222 235899999944 211 1121111 11 6788999999999999999 9999999999999994
Q ss_pred CCeEEEEecCCcccccc
Q 011945 142 ANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 142 ~~~vkL~DFGla~~~~~ 158 (474)
++.++|+|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 67899999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.2e-15 Score=132.17 Aligned_cols=132 Identities=20% Similarity=0.334 Sum_probs=106.4
Q ss_pred EeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCC-CCCceeEEEeEeCCEEEEEEecC-CCC
Q 011945 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG-TGIPNLRWFGVEGDYNVLVIDLL-GPS 88 (474)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~-~~i~~l~~~~~~~~~~~lv~e~~-g~s 88 (474)
+++.||.|.++.||++... +..++||..........+..|+.+++.+.+. ..++.+..+.......+++||++ |..
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4678999999999999963 3789999876544345789999999999876 55666666666667789999998 444
Q ss_pred HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 89 L~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~---gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
+..+ +......++.+++.+|.+||.. +++|+||+|+|||++ ..+.++|+|||++..
T Consensus 80 ~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~~ 138 (155)
T cd05120 80 LDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD---DGKILGIIDWEYAGY 138 (155)
T ss_pred cccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---CCcEEEEEecccccC
Confidence 4432 5567778899999999999984 799999999999995 468899999999863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.9e-15 Score=142.19 Aligned_cols=132 Identities=17% Similarity=0.215 Sum_probs=96.7
Q ss_pred eeee-ecCceEEEEEEEcCCCeEEEEEEeccC---------------CCchHHHHHHHHHHHhcCCCC-CceeEEEeE-e
Q 011945 13 RKIG-SGSFGEIYLGTNIQTNEEVAIKLENVK---------------TKHPQLQYEAKLYKILQGGTG-IPNLRWFGV-E 74 (474)
Q Consensus 13 ~~LG-~G~fG~Vy~a~~~~~~~~vAvK~~~~~---------------~~~~~l~~E~~il~~l~~~~~-i~~l~~~~~-~ 74 (474)
..|| .||.|+||.+.. .+..++||.+... .....+.+|+.++..|.+..+ ++....+.. .
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 899999999985 4778999976431 112357889999999986543 333333322 2
Q ss_pred CCE---EEEEEecC-C-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEe
Q 011945 75 GDY---NVLVIDLL-G-PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (474)
Q Consensus 75 ~~~---~~lv~e~~-g-~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~D 149 (474)
... .++|||++ | .+|.+++.. ..++... +.||+.+|.+||++||+||||||+|||++ .++.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~---~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLD---PDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEc---CCCCEEEEE
Confidence 222 25899988 3 589988863 3455543 57899999999999999999999999995 556899999
Q ss_pred cCCccc
Q 011945 150 FGLAKR 155 (474)
Q Consensus 150 FGla~~ 155 (474)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.5e-17 Score=176.73 Aligned_cols=253 Identities=23% Similarity=0.297 Sum_probs=188.8
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCC-CeEEEEEEeccCC-C---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVKT-K---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~~vAvK~~~~~~-~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
...|.+.+.||+|+|+.|-+.....+ ...+|+|.+.... . ......|..+-+.+..|.++..+........+.++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 35689999999999999999886433 4456777655442 1 22344577777778767777777777778888899
Q ss_pred EEecC-CCCHHHHH-HHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCcEEeeeCCCCC-eEEEEecCCcccc
Q 011945 81 VIDLL-GPSLEDLF-NFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRY 156 (474)
Q Consensus 81 v~e~~-g~sL~~li-~~~~~~l~~~~~~~i~~qi~~gL~yLH-s~gIiHrDIKP~NILl~~~~~~~-~vkL~DFGla~~~ 156 (474)
.+++. |+++.+.+ .......+...+-.++.|+..+|.|+| ..++.||||||+|.+++ ..+ .+++.|||+|..+
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~---~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD---ESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc---cCCCcccCCCchhhccc
Confidence 99988 77887777 322225777888999999999999999 99999999999999995 556 8999999999988
Q ss_pred cc-CCCccccccccCCCCcc-CccccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc
Q 011945 157 RD-TATHQHIPYRENKNLTG-TARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (474)
Q Consensus 157 ~~-~~~~~~~~~~~~~~~~G-T~~Y~APE~~~~~~-~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (474)
.. ..... .....+| ++.|+|||.+.+.. .....|+||.|+++.-+++|..||....... ..+......+.
T Consensus 176 ~~~~g~~~-----~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~~~~~~~ 248 (601)
T KOG0590|consen 176 RNKNGAER-----SLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSSWKSNKG 248 (601)
T ss_pred cccCCcce-----eeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--ccceeeccccc
Confidence 77 32211 1234567 99999999999854 5788999999999999999999997643322 12222222211
Q ss_pred cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011945 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 269 (474)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (474)
. .....+..+.....+++..++..+|..|.+.+++
T Consensus 249 ~-~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~ 283 (601)
T KOG0590|consen 249 R-FTQLPWNSISDQAHDLLHKILKENPSNRLSIEEL 283 (601)
T ss_pred c-cccCccccCChhhhhcccccccCCchhccccccc
Confidence 1 0122346678889999999999999999996655
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.2e-15 Score=154.33 Aligned_cols=254 Identities=17% Similarity=0.167 Sum_probs=190.8
Q ss_pred cCCcEEEeeeeee--cCceEEEEEEE--cCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCC
Q 011945 5 VGNKFRLGRKIGS--GSFGEIYLGTN--IQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 76 (474)
Q Consensus 5 i~~~y~i~~~LG~--G~fG~Vy~a~~--~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (474)
+.+.|-+.+.+|. |.+|.||.+.. ..++..+|+|.-+... ....-.+|..-.+.+..+.+............
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence 3456778889999 99999999987 7889999999633221 12223456666666666666666555667788
Q ss_pred EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHH----HHHHHHHCCccccCCCCCcEEeeeCCCC-CeEEEEecC
Q 011945 77 YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN----RVEFVHSKSFLHRDIKPDNFLMGLGRRA-NQVYIIDFG 151 (474)
Q Consensus 77 ~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~----gL~yLHs~gIiHrDIKP~NILl~~~~~~-~~vkL~DFG 151 (474)
..++..|+|+.+|..+......-++...++.++.+... ||.++|+.+|+|-|+||+||++. .+ ..++++|||
T Consensus 192 ~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~---~~~~s~~~~df~ 268 (524)
T KOG0601|consen 192 ILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT---SDWTSCKLTDFG 268 (524)
T ss_pred cceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc---cccceeecCCcc
Confidence 89999999999999998766666889999999999999 99999999999999999999995 45 789999999
Q ss_pred CccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc
Q 011945 152 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (474)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (474)
+...+.+...... +...+...|...|++||...+ -++..+|||+||.++.+..++..++..-..... .+.
T Consensus 269 ~v~~i~~~~~~~~--~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W-------~~~ 338 (524)
T KOG0601|consen 269 LVSKISDGNFSSV--FKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSW-------SQL 338 (524)
T ss_pred eeEEccCCccccc--eeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCc-------ccc
Confidence 9998877653221 112233467889999999876 578899999999999999998776644211110 000
Q ss_pred cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 232 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.......++|.....++...+..|+..++-.|++.+.+..
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1111234566777788888999999999999988776544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.53 E-value=5.3e-13 Score=139.00 Aligned_cols=137 Identities=20% Similarity=0.306 Sum_probs=96.0
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCCCch-------------------------------------------HH
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-------------------------------------------QL 49 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-------------------------------------------~l 49 (474)
+.||.|++|.||+|+. .+|+.||||+..... .+ ++
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i-~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGI-EKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCc-HHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 5699999999999986 589999999865431 11 13
Q ss_pred HHHHHHHHHhc----CCCCCceeEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHH-HHHHHHHCC
Q 011945 50 QYEAKLYKILQ----GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMIN-RVEFVHSKS 123 (474)
Q Consensus 50 ~~E~~il~~l~----~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~-gL~yLHs~g 123 (474)
.+|...+.++. +.+.+.....+.......+|||||+ |.+|.++.......++ ...++.+++. .+..+|..|
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 34444444443 3344443344444344569999999 8888887653222232 3456666655 478899999
Q ss_pred ccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 124 IiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
++|+|+||.||++. .++.++|+|||++..+.
T Consensus 278 ~~H~D~hPgNilv~---~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVL---KDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEEC---CCCcEEEEeCCCeeECC
Confidence 99999999999994 67899999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.9e-13 Score=120.25 Aligned_cols=126 Identities=21% Similarity=0.289 Sum_probs=96.0
Q ss_pred eeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-CCCH
Q 011945 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSL 89 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL 89 (474)
++.|+.|.++.||++.. .+..|+||+..... ....+..|+.+++.+.+...++.+..+... ..+++||++ |.++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~--~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDPE--TGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeCC--CCeEEEEecCCCcc
Confidence 46789999999999985 47889999875443 234578999999999876667776655432 347899998 5555
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----cccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 90 EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF-----LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 90 ~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gI-----iHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
.+. . .....++.+++.+|..||..++ +|+|++|.|||++ .+.++|+|||.+.
T Consensus 79 ~~~------~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~----~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTE------D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD----DGRLWLIDWEYAG 135 (170)
T ss_pred ccc------c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE----CCeEEEEeccccc
Confidence 432 0 1123457899999999999885 9999999999994 4679999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.9e-12 Score=132.10 Aligned_cols=143 Identities=17% Similarity=0.271 Sum_probs=92.9
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC------------------------------------ch----
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------------------------------------HP---- 47 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------------------------------------~~---- 47 (474)
.|+. +.||+|++|.||+|+.+.+|+.||||++..... ..
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4665 789999999999999877799999998764310 00
Q ss_pred --HHHHHHHHHHHhc----CCCCCceeEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCC-----CCHHHHHHHHHHHHHH
Q 011945 48 --QLQYEAKLYKILQ----GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRK-----LSLKTVLMLADQMINR 115 (474)
Q Consensus 48 --~l~~E~~il~~l~----~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL~~li~~~~~~-----l~~~~~~~i~~qi~~g 115 (474)
++.+|...+.++. +.+.+..-..|.......+|||||+ |..|.++....... +....+..++.||
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--- 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--- 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence 1344444444443 3333333334444455679999999 77887753211222 3333334444444
Q ss_pred HHHHHHCCccccCCCCCcEEeeeC-CCCCeEEEEecCCcccccc
Q 011945 116 VEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 116 L~yLHs~gIiHrDIKP~NILl~~~-~~~~~vkL~DFGla~~~~~ 158 (474)
+..|++|+|+||.||+++.+ ...+.++++|||++..+..
T Consensus 277 ----f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ----FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ----HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 46999999999999999622 1223899999999976643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.2e-12 Score=121.04 Aligned_cols=137 Identities=18% Similarity=0.206 Sum_probs=98.5
Q ss_pred eeeeeecCceEEEEEEEcC------CCeEEEEEEeccCC-----------------------C-chH----HHHHHHHHH
Q 011945 12 GRKIGSGSFGEIYLGTNIQ------TNEEVAIKLENVKT-----------------------K-HPQ----LQYEAKLYK 57 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~------~~~~vAvK~~~~~~-----------------------~-~~~----l~~E~~il~ 57 (474)
...||.|--+.||.|.... .+..+|||+.+... . ... ..+|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4578999999999998643 35799999743210 0 011 237999999
Q ss_pred HhcCC-CCCceeEEEeEeCCEEEEEEecCCCC-H-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCc
Q 011945 58 ILQGG-TGIPNLRWFGVEGDYNVLVIDLLGPS-L-EDLFNFCSRKLSLKTVLMLADQMINRVEFV-HSKSFLHRDIKPDN 133 (474)
Q Consensus 58 ~l~~~-~~i~~l~~~~~~~~~~~lv~e~~g~s-L-~~li~~~~~~l~~~~~~~i~~qi~~gL~yL-Hs~gIiHrDIKP~N 133 (474)
+|... -.+|....+ ...+|||||++++ + ...++ ...++...+..+..+++.+|..| |..||||+||++.|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 98743 334444433 4468999999763 2 11222 22356667788899999999999 89999999999999
Q ss_pred EEeeeCCCCCeEEEEecCCcccccc
Q 011945 134 FLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 134 ILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
||+. ++.++|+|||.+.....
T Consensus 156 IL~~----~~~v~iIDF~qav~~~h 176 (197)
T cd05146 156 MLWH----DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred EEEE----CCcEEEEECCCceeCCC
Confidence 9994 46799999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.9e-11 Score=109.34 Aligned_cols=142 Identities=19% Similarity=0.255 Sum_probs=107.5
Q ss_pred EeeeeeecCceEEEEEEEcCCCeEEEEEEe-ccCCCc---------hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLE-NVKTKH---------PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~-~~~~~~---------~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
.+..|-+|+-+.|+++. ..|+.++||.- .+.-.+ ....+|++++.++..- +|+.-..+..+.....|
T Consensus 11 ~l~likQGAEArv~~~~--~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~-GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGS--FSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRAL-GIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeec--cCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHh-CCCCceEEEEecCCCeE
Confidence 67788999999999998 57889899952 222222 3467799999988743 55555555666666789
Q ss_pred EEecCCC--CHHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 81 VIDLLGP--SLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 81 v~e~~g~--sL~~li~~~~~~-l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
+|||..+ ++.+++...-.. ........++.+|-..|.-||..+|||+||..+||++..++....+.|+|||++..
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 9999966 888888644333 33333378888899999999999999999999999997655566679999999864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=2.5e-11 Score=109.01 Aligned_cols=128 Identities=24% Similarity=0.398 Sum_probs=95.9
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccC-CCch---------HHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHP---------QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-~~~~---------~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
..|++|+-+.||.+.+ -|..+++|.-..+ -..+ ...+|.+++.++.. .+|+.-..|..+.....|+|
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~-~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKARE-AGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHH-cCCCCCeEEEEcCCCCEEEE
Confidence 4578999999999965 4556888853222 2222 35679999998874 46666666777788789999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
||. |..|.+++... . ..++..+=.-+.-||..||||+||.++||+++ .+.++++||||+..
T Consensus 79 e~I~G~~lkd~l~~~----~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~----~~~i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA----R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILS----GGRIYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc----c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEe----CCcEEEEECCcccc
Confidence 999 66677787733 2 45566666667889999999999999999994 45599999999963
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.25 E-value=2e-12 Score=140.26 Aligned_cols=274 Identities=18% Similarity=0.165 Sum_probs=185.8
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
.+.+.+++-+-+|.++.++.+.-..++...++|+...... .+....+-.++.. -+.+.+.....-.......+|
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~-p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILIT-PRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCcccc-CCCCceecccCCCCCCCCcch
Confidence 4567888899999999999998767776666664322111 1111111111110 011111111111345566789
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
+|+|+ +++|...+.. ....+.+-+...+..+..+++|||+..++|+|++|.|+|+ ...+..++.|||.......-
T Consensus 882 ~~~~~~~~~~~Skl~~-~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHN-SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---AYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred hhHHhccCCchhhhhc-CCCcccccccchhHHHHhhhhccccchhhcccccccchhh---cccCCcccCccccccccccc
Confidence 99988 7788888773 3357777788888899999999999999999999999999 47889999999844322110
Q ss_pred ---CCc------------------ccc---ccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Q 011945 160 ---ATH------------------QHI---PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215 (474)
Q Consensus 160 ---~~~------------------~~~---~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~ 215 (474)
... ... .-+......||+.|.+||...+......+|+|++|++++|.++|..||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 000 000 11224456899999999999999999999999999999999999999977
Q ss_pred CCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccccc
Q 011945 216 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 295 (474)
Q Consensus 216 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 295 (474)
... .+.++.+.......+ .-....+.+.++++...+..++.+|-.+.-- ....+..+....+|+.+..
T Consensus 1038 ~tp---q~~f~ni~~~~~~~p--~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~-------~e~k~~~~~~~~~~~~l~~ 1105 (1205)
T KOG0606|consen 1038 ETP---QQIFENILNRDIPWP--EGPEEGSYEAQDLINRLLTEEPTQRLGAKGA-------AEVKGHPFFQDVDWENLAL 1105 (1205)
T ss_pred cch---hhhhhccccCCCCCC--CCccccChhhhhhhhhhhccCchhccCcccc-------cccccCCccCCCCcccccc
Confidence 443 444455444433221 2223457889999999999999999875422 1234567778889998765
Q ss_pred c
Q 011945 296 Q 296 (474)
Q Consensus 296 ~ 296 (474)
+
T Consensus 1106 q 1106 (1205)
T KOG0606|consen 1106 Q 1106 (1205)
T ss_pred c
Confidence 4
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=8e-12 Score=129.37 Aligned_cols=240 Identities=19% Similarity=0.125 Sum_probs=165.8
Q ss_pred CCcEEEeeeeeecCceEEEEEEEc-CCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNI-QTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
..+|.++..||.|.|+.|+.+... .++..|++|-...... ...-..|+.+...+..+.++..+..-.......++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 457889999999999999998754 5778899995433221 11235577777777656555554333333444458
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
-.||| ++++...+ .....+++...+.+..|++.++.++|++.++|+|+||+||++.. +.+..++.|||+++.+.-.
T Consensus 344 p~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~--~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISN--DGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred chhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeecc--chhhhhcccccccccccee
Confidence 88999 66555444 35567899999999999999999999999999999999999962 2277899999998743221
Q ss_pred CCccccccccCCCCccCcccc--ccccccCCCCCchhhHHHHHHHHHHHHhCCC-CCCCCCcCcHHHHHHHHhhccccch
Q 011945 160 ATHQHIPYRENKNLTGTARYA--SMNTHLGIEQSRRDDLESLGYVLMYFLRGSL-PWQGLKAGTKKQKYEKISEKKVSTS 236 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~--APE~~~~~~~s~ksDIwSlGvil~elltG~~-Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (474)
. ..+.+..+++ +++......+..+.|++|||..+.+.+++.. ++.+... ..+... .
T Consensus 421 ~----------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~-------~~i~~~----~ 479 (524)
T KOG0601|consen 421 S----------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS-------LTIRSG----D 479 (524)
T ss_pred c----------ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc-------eeeecc----c
Confidence 1 1123334444 5556666778999999999999999999863 4433211 111111 1
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.+ ...+...++..+.+.+...++..||.+.++.
T Consensus 480 ~p-~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~ 512 (524)
T KOG0601|consen 480 TP-NLPGLKLQLQVLLKVMINPDRKRRPSAVELS 512 (524)
T ss_pred cc-CCCchHHhhhhhhhhhcCCccccchhhhhhc
Confidence 11 1233447888899999999999999876654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.7e-10 Score=117.58 Aligned_cols=182 Identities=17% Similarity=0.170 Sum_probs=131.6
Q ss_pred EEEeeeeeecCceEEE-EEEEcCCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC
Q 011945 9 FRLGRKIGSGSFGEIY-LGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 85 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy-~a~~~~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (474)
|.| ...+-++.+ || .|..+.++.+|.|...+.... .....+-++-|+.|+|++++.++..+..++ ..|||.|-+
T Consensus 15 Y~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~-~~ylvTErV 91 (690)
T KOG1243|consen 15 YDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEG-TLYLVTERV 91 (690)
T ss_pred ccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccC-ceEEEeecc
Confidence 555 444555554 45 466678899999998776655 345677888899999888777776665554 779999987
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccc
Q 011945 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164 (474)
Q Consensus 86 g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLH-s~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (474)
.+ |..+++. +....+...+.||+.||.||| +++++|++|.-+.|+| +..|..||++|-++.........
T Consensus 92 ~P-l~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~~-- 161 (690)
T KOG1243|consen 92 RP-LETVLKE----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKASGFNAP-- 161 (690)
T ss_pred cc-HHHHHHH----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEeccccCCcc--
Confidence 53 6666663 346778888999999999998 5789999999999999 58899999999988654432210
Q ss_pred cccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCC
Q 011945 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGS 210 (474)
Q Consensus 165 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~ 210 (474)
.....--..|..|+.+.... -..|.|-|||+++|++.|.
T Consensus 162 -----~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 162 -----AKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred -----cccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 01112223455666544322 3469999999999999993
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.7e-10 Score=106.25 Aligned_cols=138 Identities=20% Similarity=0.270 Sum_probs=99.4
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCC---CchHHHHHHHHHHHhcCCCC-CceeEEEeEeC---CEEEEEEecC
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTG-IPNLRWFGVEG---DYNVLVIDLL 85 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~-i~~l~~~~~~~---~~~~lv~e~~ 85 (474)
+.|+.|.++.||++... +|+.++||+..... ....+..|.++++.+.+... ++.+..+.... ...+++|+++
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 67899999999999863 36889999876543 24578999999999986432 55555555443 2568999998
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 011945 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS------------------------------------------- 121 (474)
Q Consensus 86 -g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs------------------------------------------- 121 (474)
|.+|.+.+. ...++......++.+++..|.+||+
T Consensus 83 ~G~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLL--RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCC--CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 555655432 1346667777777777777777773
Q ss_pred -------------CCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 122 -------------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 122 -------------~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
..++|+|+.|.|||++.+ ..+.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~ 205 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEeccccc
Confidence 236899999999999521 14668999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=7.7e-09 Score=100.69 Aligned_cols=132 Identities=18% Similarity=0.117 Sum_probs=93.3
Q ss_pred eEEEEEEEcCCCeEEEEEEeccCCC-----------c--hHHHHHHHHHHHhcCCC-CCceeEEEeEe-----CCEEEEE
Q 011945 21 GEIYLGTNIQTNEEVAIKLENVKTK-----------H--PQLQYEAKLYKILQGGT-GIPNLRWFGVE-----GDYNVLV 81 (474)
Q Consensus 21 G~Vy~a~~~~~~~~vAvK~~~~~~~-----------~--~~l~~E~~il~~l~~~~-~i~~l~~~~~~-----~~~~~lv 81 (474)
..|+++. -.|+.|.||....... . ....+|...+.+|.... .++....++.. ....+||
T Consensus 36 rrvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 36 RRTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred ceEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 3455654 4677899996533221 1 13779999998885321 12222333332 2346899
Q ss_pred EecCCC--CHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeC----CCCCeEEEEecCCcc
Q 011945 82 IDLLGP--SLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG----RRANQVYIIDFGLAK 154 (474)
Q Consensus 82 ~e~~g~--sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~----~~~~~vkL~DFGla~ 154 (474)
+|++++ +|.+++... ....+......++.+|+..+.-||..||+|+|+++.|||+..+ +....+.|+||+.+.
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 998855 799998632 3456677888999999999999999999999999999999631 235789999999885
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.9e-09 Score=105.21 Aligned_cols=255 Identities=12% Similarity=0.186 Sum_probs=157.3
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCce-eEE-----Ee-EeCCEEEEE
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPN-LRW-----FG-VEGDYNVLV 81 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~-l~~-----~~-~~~~~~~lv 81 (474)
....+-||+|+-+.+|-.-. -+ ..+.|+.....-..+ ..-+..|...-.++.+.. +.| ++ ..+....++
T Consensus 13 i~~gr~LgqGgea~ly~l~e--~~-d~VAKIYh~Pppa~~-aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGE--VR-DQVAKIYHAPPPAAQ-AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred cCCCccccCCccceeeecch--hh-chhheeecCCCchHH-HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 34567899999999997642 12 234576544322111 122223333333333322 211 12 234446677
Q ss_pred EecCCC--CHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 82 IDLLGP--SLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 82 ~e~~g~--sL~~li~~~-----~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
|....+ .+..++.-. -..+.|..+++.+..|+.+.+.||..|.+-+|+.++|||++ ++..|.|.|=..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEEEEccccee
Confidence 777622 333333211 12378999999999999999999999999999999999996 77888888843322
Q ss_pred ccccCCCccccccccCCCCccCcccccccccc-----CCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcCc----HHH-
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGT----KKQ- 223 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDIwSlGvil~elltG-~~Pf~~~~~~~----~~~- 223 (474)
...+... ...-+|...|.+||.-. +.+-+...|.|.||++++++|.| ++||.+..... ..+
T Consensus 166 i~~ng~~--------~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~ 237 (637)
T COG4248 166 INANGTL--------HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET 237 (637)
T ss_pred eccCCce--------EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence 2211111 12347899999999754 44567889999999999999996 99998753211 111
Q ss_pred HHH--------HHhhccccchHHHHhcCCcHHHHHHHHHHhcC--CCCCCCCHHHHHHHHHHHHH
Q 011945 224 KYE--------KISEKKVSTSIEALCRGYPTEFASYFHYCRSL--RFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 224 ~~~--------~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~--dp~~RPt~~~l~~~L~~l~~ 278 (474)
.+. +-.......+...-+.-+|+.+..++.+|+.. .+.-||+++.-...|..+-.
T Consensus 238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 010 00011112222222345689999999999964 36689999876666665543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.5e-09 Score=104.86 Aligned_cols=173 Identities=12% Similarity=0.142 Sum_probs=115.1
Q ss_pred EEEEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCCCcEEeeeCCCCCeEEEEec
Q 011945 77 YNVLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~---~~~~l~~~~~~~i~~qi~~gL~yLHs~--gIiHrDIKP~NILl~~~~~~~~vkL~DF 150 (474)
..+++.||+ -++|.+++++ +...+..+...+|+.||+.||.|||+. -|+|+++..+-|++. .++.+||.
T Consensus 146 rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq---~ngLIkig-- 220 (458)
T KOG1266|consen 146 RVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQ---HNGLIKIG-- 220 (458)
T ss_pred ceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeec---CCceEEec--
Confidence 456777777 8899998863 455688999999999999999999986 599999999999994 66766653
Q ss_pred CCccccccCCCccc---cccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCC-CCCcCcHHHHHH
Q 011945 151 GLAKRYRDTATHQH---IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ-GLKAGTKKQKYE 226 (474)
Q Consensus 151 Gla~~~~~~~~~~~---~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~-~~~~~~~~~~~~ 226 (474)
....- ..+.. ..-.+...-.+-+.|.+||.=.....+..+|||+||.+..||..+..--. ........+.+.
T Consensus 221 -~~ap~---s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia 296 (458)
T KOG1266|consen 221 -SVAPD---STHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIA 296 (458)
T ss_pred -ccCcc---ccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhh
Confidence 22110 01100 00112223456788999998666667789999999999999988765321 111111111111
Q ss_pred HHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011945 227 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 269 (474)
Q Consensus 227 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (474)
...+ .+. ..--+.++..|++-.|..||++.++
T Consensus 297 ---~~i~-----~le---n~lqr~~i~kcl~~eP~~rp~ar~l 328 (458)
T KOG1266|consen 297 ---NVII-----GLE---NGLQRGSITKCLEGEPNGRPDARLL 328 (458)
T ss_pred ---hhee-----ecc---CccccCcCcccccCCCCCCcchhhh
Confidence 1000 011 1223568899999999999998765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.97 E-value=2.6e-09 Score=98.41 Aligned_cols=125 Identities=24% Similarity=0.352 Sum_probs=79.8
Q ss_pred EEEEEEEcCCCeEEEEEEeccCC--------------C--------------chHHHHHHHHHHHhcCCC-CCceeEEEe
Q 011945 22 EIYLGTNIQTNEEVAIKLENVKT--------------K--------------HPQLQYEAKLYKILQGGT-GIPNLRWFG 72 (474)
Q Consensus 22 ~Vy~a~~~~~~~~vAvK~~~~~~--------------~--------------~~~l~~E~~il~~l~~~~-~i~~l~~~~ 72 (474)
.||.|.. ..|..||||+..... . .....+|.+.|.++.... .+|....+
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 4899986 678899999743210 0 013678999999998653 36655433
Q ss_pred EeCCEEEEEEecCC--CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH-HHHCCccccCCCCCcEEeeeCCCCCeEEEEe
Q 011945 73 VEGDYNVLVIDLLG--PSLEDLFNFCSRKLSLKTVLMLADQMINRVEF-VHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (474)
Q Consensus 73 ~~~~~~~lv~e~~g--~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~y-LHs~gIiHrDIKP~NILl~~~~~~~~vkL~D 149 (474)
.. .+|||||++ +.....+... .++......++.+++..+.. +|..||||+||.+.|||++ .+.++|+|
T Consensus 79 -~~--~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~----~~~~~iID 149 (188)
T PF01163_consen 79 -NR--NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD----DGKVYIID 149 (188)
T ss_dssp -ET--TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE----TTCEEE--
T ss_pred -eC--CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee----cceEEEEe
Confidence 33 479999997 4332223211 12244567778888886655 5799999999999999995 34899999
Q ss_pred cCCccccc
Q 011945 150 FGLAKRYR 157 (474)
Q Consensus 150 FGla~~~~ 157 (474)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99987544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.2e-09 Score=114.95 Aligned_cols=154 Identities=13% Similarity=0.196 Sum_probs=105.6
Q ss_pred HHHHHHHHHHHH-CCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccccccc--CCCCccCcccccccccc
Q 011945 110 DQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE--NKNLTGTARYASMNTHL 186 (474)
Q Consensus 110 ~qi~~gL~yLHs-~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~--~~~~~GT~~Y~APE~~~ 186 (474)
.+++.||.|+|. .++||++|.|++|.+ +..+.+||+.|+++.............|.. .....-...|.|||++.
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hcccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345599999997 699999999999999 588999999999987655432211111111 11123456799999999
Q ss_pred CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCC
Q 011945 187 GIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPD 265 (474)
Q Consensus 187 ~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt 265 (474)
+...+.++|+|||||++|.+.. |+.-+..... ...... ...............+|+++.+-+.+++..+..-||+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~-~~~~~~---~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~ 258 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGG-LLSYSF---SRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPT 258 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCC-cchhhh---hhcccccccccccccCcHHHHHHHHHHhcCCcccCcc
Confidence 9888999999999999999984 5554443221 111111 1111111111122578999999999999999999997
Q ss_pred HHHHH
Q 011945 266 YAYLK 270 (474)
Q Consensus 266 ~~~l~ 270 (474)
+..+.
T Consensus 259 ~~~l~ 263 (700)
T KOG2137|consen 259 LDLLL 263 (700)
T ss_pred hhhhh
Confidence 66543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.3e-07 Score=88.63 Aligned_cols=110 Identities=18% Similarity=0.255 Sum_probs=81.4
Q ss_pred chHHHHHHHHHHHhcCCC-CCceeEEEeEeC----CEEEEEEecCC--CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH
Q 011945 46 HPQLQYEAKLYKILQGGT-GIPNLRWFGVEG----DYNVLVIDLLG--PSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118 (474)
Q Consensus 46 ~~~l~~E~~il~~l~~~~-~i~~l~~~~~~~----~~~~lv~e~~g--~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~y 118 (474)
.....+|...+..|.... .++....++... ...+|++|++. .+|.+++..... .+......++.+++..+.-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence 346788999888886321 123333344331 24578888883 379999874332 6777888999999999999
Q ss_pred HHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 119 LHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
||.+||+|+|+++.|||+..++....+.|+||+.++..
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999999999974444458999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.72 E-value=9.4e-07 Score=90.62 Aligned_cols=209 Identities=18% Similarity=0.199 Sum_probs=143.6
Q ss_pred ceEEEEEEEcCCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEe---EeCCEEEEEEecC--CCCHHHH
Q 011945 20 FGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFG---VEGDYNVLVIDLL--GPSLEDL 92 (474)
Q Consensus 20 fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~---~~~~~~~lv~e~~--g~sL~~l 92 (474)
-.+.|++....+|..|++|.+..... ....-.-+++++++.|.+.|+.-..+. ..+...++|++|+ .++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35789999999999999998743221 112345578899999887776644333 3456679999998 6688887
Q ss_pred HHHc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 93 FNFC--------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 93 i~~~--------------~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
.-.. +.+.++..+|.++.|+..||.++|+.|+.-+-|.|.+||++ ....++|..-|+...+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~---G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT---GKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee---CcceEEEecccceeeecC
Confidence 5311 12477899999999999999999999999999999999995 444788877776654433
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCcCcHHHHHHHHhhccccchH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-WQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~P-f~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
+.. |.+. .-.+-|.=.||.+++.|.||..- |... .. +.. ..
T Consensus 446 d~~---------------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d--~~--~~s----------~~ 487 (655)
T KOG3741|consen 446 DPT---------------------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTD--ST--QSS----------HL 487 (655)
T ss_pred CCC---------------------cchh---HHhhhhHHHHHHHHHHHhhccccccccc--ch--HHH----------HH
Confidence 221 1111 12367999999999999998542 2211 11 111 12
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
..+...++.++++++.+....++++ -+..++.
T Consensus 488 ~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~ll 519 (655)
T KOG3741|consen 488 TRITTTYSTDLRNVVEYLESLNFRE-KSIQDLL 519 (655)
T ss_pred HHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHH
Confidence 2334566788888888888888886 3444443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.72 E-value=4.9e-07 Score=84.15 Aligned_cols=137 Identities=12% Similarity=0.081 Sum_probs=98.8
Q ss_pred eecCceEEEEEEEcCCCeEEEEEEecc--------CCCchHHHHHHHHHHHhcCCCC-CceeEEEeEe----CCEEEEEE
Q 011945 16 GSGSFGEIYLGTNIQTNEEVAIKLENV--------KTKHPQLQYEAKLYKILQGGTG-IPNLRWFGVE----GDYNVLVI 82 (474)
Q Consensus 16 G~G~fG~Vy~a~~~~~~~~vAvK~~~~--------~~~~~~l~~E~~il~~l~~~~~-i~~l~~~~~~----~~~~~lv~ 82 (474)
|.||.+-|+.... .|+.+-||.... ....+.+.+|...+..|..... ++....+... .-..+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 6689999999763 455788885431 2245679999999999874322 3333333322 22357888
Q ss_pred ecCC--CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 83 DLLG--PSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 83 e~~g--~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
|-++ .+|.+++... -.+.+......++.+|+..|.-||+.|+.|+|+-+.|||+..+ ....|+++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE-GKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC-CCeeEEEEEhhccch
Confidence 8776 7899987532 2246778888999999999999999999999999999999522 123499999987653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.1e-07 Score=86.95 Aligned_cols=136 Identities=18% Similarity=0.254 Sum_probs=90.4
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCch-----------HHHHHHHHHHHhcC--CCCCceeEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----------QLQYEAKLYKILQG--GTGIPNLRW 70 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-----------~l~~E~~il~~l~~--~~~i~~l~~ 70 (474)
.+.++|.+.+.+-......|.+.. .+|..+++|......... ...+++..+..+.. ......+..
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 467889999999888888787776 678899999765443221 12334444444432 122212111
Q ss_pred Ee-----EeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCe
Q 011945 71 FG-----VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 144 (474)
Q Consensus 71 ~~-----~~~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~ 144 (474)
.. ......+|+|||+ |..|.++.. +++ .+...|+++|.-||+.|++|+|+.|.||+++ ++.
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~----~~~ 172 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVS----NNG 172 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEE----CCc
Confidence 11 1234457899999 666665543 222 3556777889999999999999999999994 456
Q ss_pred EEEEecCCcc
Q 011945 145 VYIIDFGLAK 154 (474)
Q Consensus 145 vkL~DFGla~ 154 (474)
++++||+..+
T Consensus 173 i~iID~~~k~ 182 (229)
T PF06176_consen 173 IRIIDTQGKR 182 (229)
T ss_pred EEEEECcccc
Confidence 9999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=3.4e-07 Score=82.00 Aligned_cols=127 Identities=24% Similarity=0.392 Sum_probs=97.6
Q ss_pred EeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-CCCH
Q 011945 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSL 89 (474)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL 89 (474)
+.+.|++|.+|.||+|.+ .|..+|+|+-..+.....++.|+++|..++.....+.++.|+.+. +.|||. |..|
T Consensus 26 v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~me~i~G~~L 99 (201)
T COG2112 26 VEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDF----IRMEYIDGRPL 99 (201)
T ss_pred hhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechhh----hhhhhhcCcch
Confidence 457799999999999995 566999999998888899999999999999999999998887654 349998 6688
Q ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC--CcEEeeeCCCCCeEEEEecCCccc
Q 011945 90 EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKP--DNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 90 ~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP--~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
.++... .+.+.+ ..+++.---|-..||-|..|.- .||++ .++.+.|+||.-|+.
T Consensus 100 ~~~~~~----~~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv----~~~~~~iIDFd~At~ 155 (201)
T COG2112 100 GKLEIG----GDRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLV----NDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhc----ccHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEe----cCCcEEEEEccchhh
Confidence 877652 133333 3344444445668999999864 46666 345899999999873
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.58 E-value=1e-06 Score=83.89 Aligned_cols=71 Identities=18% Similarity=0.130 Sum_probs=56.2
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCC-CceeEEEeEeCCEEEEEEecCCC
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG-IPNLRWFGVEGDYNVLVIDLLGP 87 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~-i~~l~~~~~~~~~~~lv~e~~g~ 87 (474)
..||.|..+.||+. .+..+++|+.........+.+|.++++.+..... ++....++.......++|+++.|
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence 57899999999984 2456889987765555678999999999986555 67777787777778899999944
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=6.6e-07 Score=85.42 Aligned_cols=133 Identities=19% Similarity=0.317 Sum_probs=95.5
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC----------------C--------CchHHHHHHHHHHHhcCC-C
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----------------T--------KHPQLQYEAKLYKILQGG-T 63 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~----------------~--------~~~~l~~E~~il~~l~~~-~ 63 (474)
+.++.+||-|--+.||.|.+ ..|.++|||+-... . .....++|.++|.+|... -
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 45778999999999999996 47889999952210 0 011367899999999744 2
Q ss_pred CCceeEEEeEeCCEEEEEEecCCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCC
Q 011945 64 GIPNLRWFGVEGDYNVLVIDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142 (474)
Q Consensus 64 ~i~~l~~~~~~~~~~~lv~e~~g~-sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~ 142 (474)
.||... ..+..++|||+..+ -|..+ +++.+..-.|+..|++-+.-+-..||||+|+.+=|||++ ++
T Consensus 172 ~VP~P~----~~nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~---~d 238 (304)
T COG0478 172 KVPKPI----AWNRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT---ED 238 (304)
T ss_pred CCCCcc----ccccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe---cC
Confidence 344332 23456899999955 33221 224555666677777777777799999999999999995 77
Q ss_pred CeEEEEecCCccc
Q 011945 143 NQVYIIDFGLAKR 155 (474)
Q Consensus 143 ~~vkL~DFGla~~ 155 (474)
+.++|+||=.+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 8999999977654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1e-06 Score=83.35 Aligned_cols=136 Identities=21% Similarity=0.238 Sum_probs=92.0
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---------------------ch-----HHHHHHHHHHHhcCCCCCc
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---------------------HP-----QLQYEAKLYKILQGGTGIP 66 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---------------------~~-----~l~~E~~il~~l~~~~~i~ 66 (474)
..|.+|--+.||+|.. .++..||||+...... .. ...+|..-|+++... +|.
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eA-GVr 131 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEA-GVR 131 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHc-CCC
Confidence 3556677779999984 6788999998654321 00 135577777777532 222
Q ss_pred eeEEEeEeCCEEEEEEecCCCCHH--HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEeeeCCCCC
Q 011945 67 NLRWFGVEGDYNVLVIDLLGPSLE--DLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRAN 143 (474)
Q Consensus 67 ~l~~~~~~~~~~~lv~e~~g~sL~--~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs-~gIiHrDIKP~NILl~~~~~~~ 143 (474)
.-.-+. -...+|+|||.|.... -.++ .-.+...++..+..++++.+.-|-. .++||+||..=|||+. .+
T Consensus 132 vP~Pi~--~~~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~----~~ 203 (268)
T COG1718 132 VPEPIA--FRNNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH----DG 203 (268)
T ss_pred CCCcee--ecCCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE----CC
Confidence 221111 1235899999966410 0011 1124444788889999999999988 9999999999999993 68
Q ss_pred eEEEEecCCcccccc
Q 011945 144 QVYIIDFGLAKRYRD 158 (474)
Q Consensus 144 ~vkL~DFGla~~~~~ 158 (474)
.++|+|||-|.....
T Consensus 204 ~p~iID~~QaV~~~h 218 (268)
T COG1718 204 EPYIIDVSQAVTIDH 218 (268)
T ss_pred eEEEEECccccccCC
Confidence 899999999976543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=6.3e-07 Score=94.55 Aligned_cols=140 Identities=20% Similarity=0.314 Sum_probs=92.6
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc------------------------------------h------HHH
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------------------------------------P------QLQ 50 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------------------------------------~------~l~ 50 (474)
.-|+.++-|.||.|+. .+|+.||||+....-.. + ++.
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 4678999999999996 56999999985432100 0 133
Q ss_pred HHHHHHHHhc----CCCCCceeEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 011945 51 YEAKLYKILQ----GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125 (474)
Q Consensus 51 ~E~~il~~l~----~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIi 125 (474)
+|..-+.++. +.+.+..-..|..-....+|+|||+ |-.+.++.......++.+.+...+.++. +..+-..|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff 287 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence 4444444443 3333333344444455569999999 6677777533334566554444443332 3444458999
Q ss_pred ccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 126 HrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
|.|..|.||++ +.++.+.+.|||+...+..
T Consensus 288 HaDpHpGNi~v---~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 288 HADPHPGNILV---RSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccCCCccceEE---ecCCcEEEEcCcceecCCH
Confidence 99999999999 4779999999999876654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.42 E-value=3.1e-06 Score=79.85 Aligned_cols=139 Identities=18% Similarity=0.262 Sum_probs=81.5
Q ss_pred eeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCC-CceeEEEe---EeCCEEEEEEecC-C
Q 011945 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG-IPNLRWFG---VEGDYNVLVIDLL-G 86 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~-i~~l~~~~---~~~~~~~lv~e~~-g 86 (474)
++.|+.|..+.||++.... ..++||+.........+..|..+++.|..... ++.+..+. ......+++|+++ |
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 5789999999999999643 58999987654334568899999999985544 55655533 3444578888888 5
Q ss_pred CCHHH----------------HHH---HcC---CCCCHHH---------HHHH------------HHHHHH-HHHHHHH-
Q 011945 87 PSLED----------------LFN---FCS---RKLSLKT---------VLML------------ADQMIN-RVEFVHS- 121 (474)
Q Consensus 87 ~sL~~----------------li~---~~~---~~l~~~~---------~~~i------------~~qi~~-gL~yLHs- 121 (474)
..+.. .+. ... ..+.... .... ...+.. .+..+++
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 55555 111 110 0111000 0000 111222 2333332
Q ss_pred ------CCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 122 ------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 122 ------~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
..++|+|+.|.|||++ ..++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~--~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVD--PSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEE--SSTTEEEE--GTT-E
T ss_pred hccCCCcEEEEeccccccceee--eccceeEEEecccce
Confidence 4599999999999995 356667899998874
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.36 E-value=6.2e-06 Score=79.18 Aligned_cols=75 Identities=17% Similarity=0.274 Sum_probs=53.6
Q ss_pred eeeecCc-eEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-CCCHHH
Q 011945 14 KIGSGSF-GEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLED 91 (474)
Q Consensus 14 ~LG~G~f-G~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL~~ 91 (474)
.|-.|.. ..||++.. .+..++||+..... ...+..|+++++.+...-.++.+..++......+++|+++ |.+|.+
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~-~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSGP-TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCCc-ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 3444555 78999974 34688999875543 4568899999999986656667776666666678899988 555553
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.19 E-value=5.7e-05 Score=70.22 Aligned_cols=132 Identities=22% Similarity=0.316 Sum_probs=94.0
Q ss_pred eeeeeecCceEEEEEEEcCCCeEEEEEEeccCC------------------CchHHHHHHHHHHHhc-C----CCCCcee
Q 011945 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT------------------KHPQLQYEAKLYKILQ-G----GTGIPNL 68 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~------------------~~~~l~~E~~il~~l~-~----~~~i~~l 68 (474)
...||+|+.-.||.- ......+||+..... ...+..+|+..+..+. . ...|+.+
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 356899999999974 344567899876544 2456778888777776 2 3456666
Q ss_pred EEEeEeCCEEEEEEecC-------CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCC
Q 011945 69 RWFGVEGDYNVLVIDLL-------GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (474)
Q Consensus 69 ~~~~~~~~~~~lv~e~~-------g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~ 141 (474)
+++...+....+|+|.. ..+|.+++. ...++. .....+. .-..||-+.+|+.+||+|.||++...+.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~--~~~~~~-~~~~~L~---~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK--EGGLTE-ELRQALD---EFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH--cCCccH-HHHHHHH---HHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 66667777778888865 558899886 334665 3333333 4457888999999999999999987665
Q ss_pred CC-eEEEEe-cCC
Q 011945 142 AN-QVYIID-FGL 152 (474)
Q Consensus 142 ~~-~vkL~D-FGl 152 (474)
.. .+.|+| ||.
T Consensus 157 ~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 157 GEFRLVLIDGLGE 169 (199)
T ss_pred CceEEEEEeCCCC
Confidence 55 788999 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.8e-07 Score=97.88 Aligned_cols=257 Identities=12% Similarity=0.028 Sum_probs=167.3
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecCCCC
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPS 88 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~g~s 88 (474)
|....-+++|+++.+|+.+...+...+ .+++... ....-++++|.++++++-......-...+.+.+++|+++++.
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~ 319 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG 319 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence 444556788999999999865555444 6655432 456678899999998873333333345667889999999443
Q ss_pred --HHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccc
Q 011945 89 --LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166 (474)
Q Consensus 89 --L~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~ 166 (474)
....+......+...+...+...-+.+|++||+.--+|+| ||+. ..+..++.||+....+.....
T Consensus 320 rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~----s~~~~~~~~~~v~~~L~~~~~----- 386 (829)
T KOG0576|consen 320 RSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG----SEEEVKLLDFAVPPQLTRTMK----- 386 (829)
T ss_pred ccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc----cccccccccccCCcccCcccc-----
Confidence 3222221222355556667777788899999998779999 8887 457889999999877665431
Q ss_pred cccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcH
Q 011945 167 YRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPT 246 (474)
Q Consensus 167 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~ 246 (474)
.....+|+.++|||+..+..+..+.|+|++|+--.++.-|-.|-...... ...+....-...+..-...-+.
T Consensus 387 ---~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~-----~~~~g~~p~s~~L~~~~aw~~~ 458 (829)
T KOG0576|consen 387 ---PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAV-----LPMIGNGPNSPMLTDKSAWSPV 458 (829)
T ss_pred ---cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCccc-----cCCCCCCCCccccchhhhcCcc
Confidence 35678999999999999999999999999998877887777775431110 0000000000000000000111
Q ss_pred HHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccc
Q 011945 247 EFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTI 292 (474)
Q Consensus 247 ~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~ 292 (474)
.-.++...|+...|..++.... .+|.++|..+....-....|.-
T Consensus 459 ~~~~~~~~~~~g~P~~pkv~mg--acfsKvfngCpl~i~~aaswIh 502 (829)
T KOG0576|consen 459 FHRDFPAPCLNGLPPTPKVHMG--ACFSKVFNGCPLRIHCAASWIH 502 (829)
T ss_pred cccCCcccccCCCCCCCcchhh--HHHHHHhccCcccceecccccC
Confidence 1123666788888888877654 3688888877766666666653
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.12 E-value=4.5e-05 Score=70.59 Aligned_cols=124 Identities=19% Similarity=0.294 Sum_probs=85.2
Q ss_pred CcEEEeeeeeecCc-eEEEEEEEcCCCeEEEEEEecc---C--------------------CCchHHHHHHHHHHHhcCC
Q 011945 7 NKFRLGRKIGSGSF-GEIYLGTNIQTNEEVAIKLENV---K--------------------TKHPQLQYEAKLYKILQGG 62 (474)
Q Consensus 7 ~~y~i~~~LG~G~f-G~Vy~a~~~~~~~~vAvK~~~~---~--------------------~~~~~l~~E~~il~~l~~~ 62 (474)
.+++.++.||.|.- |.||+++ ..|+.||||++.. . .....|..|.+.+-+|+..
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~--I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVE--IDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEE--ECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 9999998 5788999998221 0 0112377899988888754
Q ss_pred CC-----CceeEEEeEe-----------------CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH
Q 011945 63 TG-----IPNLRWFGVE-----------------GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120 (474)
Q Consensus 63 ~~-----i~~l~~~~~~-----------------~~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLH 120 (474)
.. +..+.|+... .....||.||....- .+. ..-+.+|..-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHHH
Confidence 33 3333333222 112356666552211 122 233567778889999
Q ss_pred HCCccccCCCCCcEEeeeCCCCCeEEEEecCCc
Q 011945 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (474)
Q Consensus 121 s~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (474)
..||+-+|+|+.|..=+ ||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~~G--------~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYRGG--------KLVDFSSS 206 (207)
T ss_pred HCCeeeccCccccccCC--------EEEecccC
Confidence 99999999999998732 79999965
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.6e-05 Score=83.88 Aligned_cols=142 Identities=20% Similarity=0.281 Sum_probs=90.4
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---------------------------------ch------HHHHHH
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---------------------------------HP------QLQYEA 53 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---------------------------------~~------~l~~E~ 53 (474)
+-||.-+.|.||+|+- .+|+.||||+....-. .+ +|.+|.
T Consensus 167 ~piaaASlaQVhrA~L-~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARL-KNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEe-cCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 5689999999999996 4599999997543210 01 133343
Q ss_pred HHHHHh----cCCCC-----CceeEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011945 54 KLYKIL----QGGTG-----IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123 (474)
Q Consensus 54 ~il~~l----~~~~~-----i~~l~~~~~~~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~g 123 (474)
+-..++ .+-.. ||.+ |.......+|+|||+ |.-+.|+-.-....++...+..-+.++.. +-|-..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~V--y~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKV--YWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCee--hhhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcC
Confidence 333332 22221 3333 333444569999999 66565554333456777765555544432 3334578
Q ss_pred ccccCCCCCcEEeeeC-CCCCeEEEEecCCccccccC
Q 011945 124 FLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 124 IiHrDIKP~NILl~~~-~~~~~vkL~DFGla~~~~~~ 159 (474)
++|+|=.|.||++..+ .....+.+.|||+...+.+.
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~ 358 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK 358 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence 9999999999999632 24678999999999866543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.04 E-value=2.8e-05 Score=74.37 Aligned_cols=73 Identities=16% Similarity=0.182 Sum_probs=46.1
Q ss_pred eeeeeecCce-EEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCC--CCceeEEEeEeC---CEEEEEEecC
Q 011945 12 GRKIGSGSFG-EIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGT--GIPNLRWFGVEG---DYNVLVIDLL 85 (474)
Q Consensus 12 ~~~LG~G~fG-~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~--~i~~l~~~~~~~---~~~~lv~e~~ 85 (474)
++.|+.|+.. .||+.. ..+++|+.........+..|.+++..|...- -++.+...+... ...+++|+++
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 3567777777 499762 3578898655444557999999999997532 344444433332 2347788887
Q ss_pred -CCCH
Q 011945 86 -GPSL 89 (474)
Q Consensus 86 -g~sL 89 (474)
|.++
T Consensus 77 ~G~~l 81 (235)
T cd05155 77 EGETA 81 (235)
T ss_pred cCCCC
Confidence 4444
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.00017 Score=81.53 Aligned_cols=77 Identities=10% Similarity=0.163 Sum_probs=51.7
Q ss_pred EeeeeeecCceEEEEEEEcCCC--eEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCC--ceeEEEeEeC---CEEEE
Q 011945 11 LGRKIGSGSFGEIYLGTNIQTN--EEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGI--PNLRWFGVEG---DYNVL 80 (474)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~--~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i--~~l~~~~~~~---~~~~l 80 (474)
-+++|+.|.+..+|+......+ ..+++|+..... ....+.+|+++++.|..+..+ +.+.+++.+. ...++
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 3678899999999998764332 467888754322 224688999999999743334 4445554432 34689
Q ss_pred EEecCCC
Q 011945 81 VIDLLGP 87 (474)
Q Consensus 81 v~e~~g~ 87 (474)
|||++.+
T Consensus 122 VME~v~G 128 (822)
T PLN02876 122 IMEYLEG 128 (822)
T ss_pred EEEecCC
Confidence 9999844
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.0038 Score=64.24 Aligned_cols=73 Identities=19% Similarity=0.293 Sum_probs=51.7
Q ss_pred eeeeeecCceEEEEEEEcCCCeEEEEEEecc---------CCCchHHHHHHHHHHHhcC--CCCCceeEEEeEeCCEEEE
Q 011945 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENV---------KTKHPQLQYEAKLYKILQG--GTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~---------~~~~~~l~~E~~il~~l~~--~~~i~~l~~~~~~~~~~~l 80 (474)
.+.||.|.+..||++.+...++.|+||.-.. .........|.+.|+.+.. +..+|.+..+.. ...++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence 4678999999999999754446899997321 1123457888888888753 345777766644 45689
Q ss_pred EEecCC
Q 011945 81 VIDLLG 86 (474)
Q Consensus 81 v~e~~g 86 (474)
|||++.
T Consensus 109 VME~L~ 114 (401)
T PRK09550 109 VMEDLS 114 (401)
T ss_pred EEecCC
Confidence 999873
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00052 Score=65.29 Aligned_cols=73 Identities=16% Similarity=0.190 Sum_probs=49.0
Q ss_pred eeeeeecCceEEEEEEEcC-CCeEEEEEEeccCCCc-hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-CCC
Q 011945 12 GRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKTKH-PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPS 88 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~-~~~~vAvK~~~~~~~~-~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~s 88 (474)
++.|..|-...+|++.... .++.|++|+....... -...+|+.+++.+.....++.+..+.. . .++|||+ |.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~ 78 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRT 78 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCc
Confidence 4677888888999997432 3578999976543221 234689999999976666777654432 1 4788887 433
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.0027 Score=64.15 Aligned_cols=70 Identities=14% Similarity=0.231 Sum_probs=46.9
Q ss_pred eeeecCceEEEEEEEcCCCeEEEEEEe----cc-----CCCchHHHHHHHHHHHhcC--CCCCceeEEEeEeCCEEEEEE
Q 011945 14 KIGSGSFGEIYLGTNIQTNEEVAIKLE----NV-----KTKHPQLQYEAKLYKILQG--GTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 14 ~LG~G~fG~Vy~a~~~~~~~~vAvK~~----~~-----~~~~~~l~~E~~il~~l~~--~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.||-|....||++.+...++.|+||.- .. .........|...|+.... +..+|.++.| +.+..+++|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997544468999941 21 1223456778888877653 2346665544 455567888
Q ss_pred ecC
Q 011945 83 DLL 85 (474)
Q Consensus 83 e~~ 85 (474)
|++
T Consensus 80 EdL 82 (370)
T TIGR01767 80 EDL 82 (370)
T ss_pred hhC
Confidence 887
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00018 Score=71.78 Aligned_cols=140 Identities=22% Similarity=0.267 Sum_probs=97.1
Q ss_pred EeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----------------------C-----chHHHHHHHHHHHhcCC
Q 011945 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----------------------K-----HPQLQYEAKLYKILQGG 62 (474)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----------------------~-----~~~l~~E~~il~~l~~~ 62 (474)
|-..|..|--+.||.|.. .+|..+|||+.+... . .-....|++-|++|...
T Consensus 148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 445677888899999984 678889999754210 0 01256788888888743
Q ss_pred CCCceeEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEeeeCCC
Q 011945 63 TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRR 141 (474)
Q Consensus 63 ~~i~~l~~~~~~~~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs-~gIiHrDIKP~NILl~~~~~ 141 (474)
+|+.-.-... ...+|||+|+|.+-+-.=.-....++...+..+-.|++.-|.-|.. +++||.||.-=|+|+ .
T Consensus 227 -GIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly----h 299 (520)
T KOG2270|consen 227 -GIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY----H 299 (520)
T ss_pred -CCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE----E
Confidence 3443322211 2358999999754322211113457777888888888888877765 799999999999999 5
Q ss_pred CCeEEEEecCCcccccc
Q 011945 142 ANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 142 ~~~vkL~DFGla~~~~~ 158 (474)
.|.++|+|-+-+.....
T Consensus 300 dG~lyiIDVSQSVE~DH 316 (520)
T KOG2270|consen 300 DGKLYIIDVSQSVEHDH 316 (520)
T ss_pred CCEEEEEEccccccCCC
Confidence 79999999998865443
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00072 Score=67.10 Aligned_cols=77 Identities=13% Similarity=0.086 Sum_probs=54.0
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCC--CCceeEEEeEe---CCEEEEEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGT--GIPNLRWFGVE---GDYNVLVI 82 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~--~i~~l~~~~~~---~~~~~lv~ 82 (474)
...-.+.||.|..+.||.... .++ .+++|+.+.......+..|...++.|.... .++.+..++.. ....+|||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYD-SQG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hhheeeecCCccceeEEEEEc-CCC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 344567899999999999873 233 577888543224457999999999998653 45566554432 35579999
Q ss_pred ecCC
Q 011945 83 DLLG 86 (474)
Q Consensus 83 e~~g 86 (474)
|++.
T Consensus 93 E~i~ 96 (297)
T PRK10593 93 ERLR 96 (297)
T ss_pred eccC
Confidence 9983
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00051 Score=66.45 Aligned_cols=131 Identities=18% Similarity=0.190 Sum_probs=77.2
Q ss_pred eeeecCceEEEEEEEcCCCeEEEEEEeccCCCc--hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-CCCHH
Q 011945 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLE 90 (474)
Q Consensus 14 ~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL~ 90 (474)
.+..|-...+|+.. .+++.+++|+....... -....|..+++.+......+.+.+++. .+++|+++ |..+.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 35567788999987 46778999975433222 246889999999986656666655432 26888887 43332
Q ss_pred -----------HH---HHHc-C-----CCCCHH-HHHHHHHHH---------HHHHHHHHH--------CCccccCCCCC
Q 011945 91 -----------DL---FNFC-S-----RKLSLK-TVLMLADQM---------INRVEFVHS--------KSFLHRDIKPD 132 (474)
Q Consensus 91 -----------~l---i~~~-~-----~~l~~~-~~~~i~~qi---------~~gL~yLHs--------~gIiHrDIKP~ 132 (474)
.+ +... . ..++.. .+..+..++ ...+..+-. ..++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 11 1111 1 112221 111221111 111222221 25899999999
Q ss_pred cEEeeeCCCCCeEEEEecCCcc
Q 011945 133 NFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 133 NILl~~~~~~~~vkL~DFGla~ 154 (474)
|||++ .++ ++|+||..|.
T Consensus 157 Nil~~---~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 157 NLVVT---PQG-LKLIDWEYAS 174 (256)
T ss_pred cEEEe---CCC-CEEEeccccC
Confidence 99995 333 7899999875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.0022 Score=64.11 Aligned_cols=73 Identities=15% Similarity=0.147 Sum_probs=45.3
Q ss_pred eeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCC-CceeEE------EeEeCCEEEEEEec
Q 011945 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG-IPNLRW------FGVEGDYNVLVIDL 84 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~-i~~l~~------~~~~~~~~~lv~e~ 84 (474)
.+.|+.|....+|+... ..| .+++|+.. ......+..|..++..|..... ++.+.. +.......++++++
T Consensus 27 ~~~l~~G~~n~~y~v~t-~~g-~~vLK~~~-~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT-TQG-EYVLTLFE-RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred cchhccccccceEEEEe-CCC-cEEEEEec-cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 45567777789999874 333 68999876 3344567778888888863321 233221 12234556788888
Q ss_pred CCC
Q 011945 85 LGP 87 (474)
Q Consensus 85 ~g~ 87 (474)
+.|
T Consensus 104 l~G 106 (319)
T PRK05231 104 LEG 106 (319)
T ss_pred cCC
Confidence 733
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.00088 Score=75.33 Aligned_cols=202 Identities=16% Similarity=0.149 Sum_probs=125.2
Q ss_pred HHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe----cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011945 49 LQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID----LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123 (474)
Q Consensus 49 l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e----~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~g 123 (474)
...|...+..+.|.+.. .+..|+.+....-++++ +| ..++..++. .-..++..+++.+..++++||.|+|+..
T Consensus 229 ~E~e~~~l~k~~~~n~~-~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q-~v~~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLG-GYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ-SVGSIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHHhhcccccc-ceeEEeehhhcchHHHHHHHhhcCccchHHHHh-hccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 45566777777755544 44444444433333333 34 556666665 3456899999999999999999999985
Q ss_pred ccccCCCCCcEEeeeCCCCCeEEEE--ecCCccccccCCCccccccccCCCCccCccccccccccCCCCC--chhhHHHH
Q 011945 124 FLHRDIKPDNFLMGLGRRANQVYII--DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQS--RRDDLESL 199 (474)
Q Consensus 124 IiHrDIKP~NILl~~~~~~~~vkL~--DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s--~ksDIwSl 199 (474)
..|.-+...-..-...+..+.+.+. ||+..+.+.+.... ....-+..|-++|......+. ...|+|.+
T Consensus 307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--------~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--------FSDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred cceeEEecccccccccCccceeecchhhhcccccCCCcccc--------hhhcCccccccccccccccchhhhhhHHHHH
Confidence 5554443331111112345556666 88888776654321 122345567788877766554 44799999
Q ss_pred HHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 200 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 200 Gvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
|..+..+..|..+-... . ....-++..+..+..+.+..|+.-+.++|+...++ +...|.+
T Consensus 379 gll~~~~~~~~~i~~~~------~-----------~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~l---l~~~f~~ 438 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKS------A-----------VPVSLLDVLSTSELLDALPKCLDEDSEERLSALEL---LTHPFLR 438 (1351)
T ss_pred HHHHhhhhhcCcccccc------c-----------chhhhhccccchhhhhhhhhhcchhhhhccchhhh---hhchhcc
Confidence 99999998876542110 0 01111122223378889999999999999997665 5555544
Q ss_pred c
Q 011945 280 E 280 (474)
Q Consensus 280 ~ 280 (474)
.
T Consensus 439 ~ 439 (1351)
T KOG1035|consen 439 F 439 (1351)
T ss_pred c
Confidence 3
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0012 Score=65.78 Aligned_cols=140 Identities=16% Similarity=0.232 Sum_probs=79.8
Q ss_pred EEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCC-CceeEE------EeEeCCEEEEEE
Q 011945 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG-IPNLRW------FGVEGDYNVLVI 82 (474)
Q Consensus 10 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~-i~~l~~------~~~~~~~~~lv~ 82 (474)
..++.|+.|....+|++.. . +..+++|+.........+..|.+++..|..... ++.+.. +.......++++
T Consensus 25 ~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 25 LSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred eeccccCCccccceEEEEe-C-CCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 3356677777789999873 3 346888987553334567788888888863321 233211 112244568888
Q ss_pred ecCCC-C-----HHH------HH---HHcCCCC----------C-HHHHH------------HHHHHHHHHHHHHHH---
Q 011945 83 DLLGP-S-----LED------LF---NFCSRKL----------S-LKTVL------------MLADQMINRVEFVHS--- 121 (474)
Q Consensus 83 e~~g~-s-----L~~------li---~~~~~~l----------~-~~~~~------------~i~~qi~~gL~yLHs--- 121 (474)
+++.| . ..+ .+ ......+ . +.... .....+...++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 88733 2 111 11 1101111 0 00000 001123344555543
Q ss_pred ----CCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 122 ----KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 122 ----~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
.++||+|+.+.||+++ .++.+.|+||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFD---GDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEE---CCceEEEeeccccc
Confidence 6899999999999995 44556899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0011 Score=65.73 Aligned_cols=70 Identities=13% Similarity=0.068 Sum_probs=47.8
Q ss_pred eeeeeecCceEEEEEEEcC------CCeEEEEEEeccCCC-chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 12 GRKIGSGSFGEIYLGTNIQ------TNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~------~~~~vAvK~~~~~~~-~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
++.|..|-...||++.... .++.|++|+...... ......|.+++..+......+.+.++... .+++++
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 4556667777999987532 257899999765432 24578999999999866666666655532 346776
Q ss_pred C
Q 011945 85 L 85 (474)
Q Consensus 85 ~ 85 (474)
+
T Consensus 79 i 79 (302)
T cd05156 79 I 79 (302)
T ss_pred e
Confidence 5
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00071 Score=62.45 Aligned_cols=100 Identities=23% Similarity=0.280 Sum_probs=72.8
Q ss_pred HHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecCC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHH---CC
Q 011945 50 QYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLG-PSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHS---KS 123 (474)
Q Consensus 50 ~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~g-~sL~~li~~--~~~~l~~~~~~~i~~qi~~gL~yLHs---~g 123 (474)
..|.-+++.+++..+++.+.++ .+. +++.|+.+ +++...... .-...+|..+..|+.+++..+++|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~--CG~--~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGS--CGR--FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeE--CCC--EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 4588899999987766666544 343 45667765 344321000 01236899999999999999999998 45
Q ss_pred ccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 124 IiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
+.-.|++|+||-++ +++.+|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~---~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVN---DDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEe---CCCcEEEEechhcchh
Confidence 77899999999995 6788999999877544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00012 Score=71.89 Aligned_cols=132 Identities=20% Similarity=0.329 Sum_probs=91.5
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCeEEEEEEecc--------CCCc----------------hHHHHHHHHHHHhcCC-C
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--------KTKH----------------PQLQYEAKLYKILQGG-T 63 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~--------~~~~----------------~~l~~E~~il~~l~~~-~ 63 (474)
+.++++||-|--+.||.+-+ ..|.+.++|+-.. +... -...+|...|+.|..+ -
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 56789999999999999996 6788899995211 0000 1246788999988743 2
Q ss_pred CCceeEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCC
Q 011945 64 GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA 142 (474)
Q Consensus 64 ~i~~l~~~~~~~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~ 142 (474)
-|+... +....|+||++. |..|.++-+ ..+ +-.+...++.-+.-|-.+|+||+|..-=||+|. ++
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~----v~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~---dd 238 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQVRH----VED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVK---DD 238 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeeeee----cCC---hHHHHHHHHHHHHHHHHcCceecccchheeEEe---cC
Confidence 233321 334568999988 656655432 122 334455566667788899999999999999994 67
Q ss_pred CeEEEEecCCccc
Q 011945 143 NQVYIIDFGLAKR 155 (474)
Q Consensus 143 ~~vkL~DFGla~~ 155 (474)
+.++++||=-...
T Consensus 239 ~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 239 DKIVVIDFPQMVS 251 (465)
T ss_pred CCEEEeechHhhc
Confidence 8899999976543
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0023 Score=63.11 Aligned_cols=137 Identities=15% Similarity=0.184 Sum_probs=79.5
Q ss_pred eeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCC-CCceeEE------EeEeCCEEEEEEec
Q 011945 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGT-GIPNLRW------FGVEGDYNVLVIDL 84 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~-~i~~l~~------~~~~~~~~~lv~e~ 84 (474)
++.|..|....+|+... .+..+++|+... .....+..|+.++..|.... .++.+.. +...++..++++++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK-VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC-CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 56677788789999863 345789998764 34456888999999986432 1233211 12233456788888
Q ss_pred C-CCCHH-----------HHH---HHcCCCC----------CHHHH----------HHHHHHHHHHHHHHHH-------C
Q 011945 85 L-GPSLE-----------DLF---NFCSRKL----------SLKTV----------LMLADQMINRVEFVHS-------K 122 (474)
Q Consensus 85 ~-g~sL~-----------~li---~~~~~~l----------~~~~~----------~~i~~qi~~gL~yLHs-------~ 122 (474)
+ |..+. ..+ ......+ .+... ......+...+.++-. .
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 7 43321 111 1000001 11000 0011112334444443 4
Q ss_pred CccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 123 gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
++||+|+.|.|||++ .++.+.|+||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~---~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFD---GDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEe---CCceEEEeehhhhc
Confidence 799999999999994 45556899999874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.023 Score=58.20 Aligned_cols=72 Identities=18% Similarity=0.302 Sum_probs=49.2
Q ss_pred eeeeeecCceEEEEEEEcCCCeEEEEEE----eccC----CCchHHHHHHHHHHHhcC--CCCCceeEEEeEeCCEEEEE
Q 011945 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVK----TKHPQLQYEAKLYKILQG--GTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~----~~~~----~~~~~l~~E~~il~~l~~--~~~i~~l~~~~~~~~~~~lv 81 (474)
.+.||-|.-..||++.+...++.|+||. +... ....+...|.++|+.+.. +..+|.++.|. .+..++|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D--~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD--SVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC--cHHhhHH
Confidence 6788999999999999743356799994 2221 123456778888887653 34577766554 4445777
Q ss_pred EecC
Q 011945 82 IDLL 85 (474)
Q Consensus 82 ~e~~ 85 (474)
||++
T Consensus 112 MEdL 115 (409)
T PRK12396 112 MEDL 115 (409)
T ss_pred HHhC
Confidence 7776
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0011 Score=68.72 Aligned_cols=163 Identities=19% Similarity=0.187 Sum_probs=96.9
Q ss_pred CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 011945 45 KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124 (474)
Q Consensus 45 ~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gI 124 (474)
...++.-...+++.++|.+...++..........++|||+++.||++++.... +-.... + .+++
T Consensus 25 ~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~--l~~~s~----------~----~~~~ 88 (725)
T KOG1093|consen 25 NSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN--LKDESL----------L----AHGV 88 (725)
T ss_pred cHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcc--cchhhh----------c----cccc
Confidence 44567777888999997776666655555555689999999999999987432 111111 1 2222
Q ss_pred cccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHH
Q 011945 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLM 204 (474)
Q Consensus 125 iHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ 204 (474)
.| -|| ++++| -++... ....| +|+|||++|.++.
T Consensus 89 ~~-----~~~----------~~~td-~~~t~~--------------~~~~~----------------pKsdVwsl~~i~~ 122 (725)
T KOG1093|consen 89 LH-----LNI----------IYITD-HFLTKY--------------PSPIG----------------PKSDVWSLGFIIL 122 (725)
T ss_pred ce-----ehh----------hhccc-cccccC--------------CCCCC----------------cchhhhhHHHHHH
Confidence 22 222 23344 111100 00111 4999999999999
Q ss_pred HHHhCCCCCCCCCcCcHHHHHHHHhhccccc---hHH-HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011945 205 YFLRGSLPWQGLKAGTKKQKYEKISEKKVST---SIE-ALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 269 (474)
Q Consensus 205 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~---~~~-~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (474)
|+.-|..-|...........+.+........ ..+ .+.-.++..+.++...|+-..|..||...++
T Consensus 123 el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~ 191 (725)
T KOG1093|consen 123 ELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMEL 191 (725)
T ss_pred HHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHH
Confidence 9999988886644333222222221111100 011 1123467788999999999999999876654
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0026 Score=62.45 Aligned_cols=46 Identities=7% Similarity=0.047 Sum_probs=30.4
Q ss_pred eecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCC
Q 011945 16 GSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG 62 (474)
Q Consensus 16 G~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~ 62 (474)
++|-...||.+. ...|..+++|.-........+.+|.+++..|..+
T Consensus 20 ~~g~~~~v~~i~-~~~g~~~VlR~p~~~~~~~~l~rE~~vL~~L~~~ 65 (276)
T cd05152 20 ESGLDFQVVFAK-DTDGVPWVLRIPRRPDVSERAAAEKRVLALVRKH 65 (276)
T ss_pred CCcceeEEEEEE-cCCCCeEEEEecCCHHHHHHHHHHHHHHHHHHhc
Confidence 333334555553 2457889999865433445689999999999854
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.015 Score=58.98 Aligned_cols=137 Identities=12% Similarity=0.157 Sum_probs=79.7
Q ss_pred eeeeeecCceEEEEEEEcC----CCeEEEEEEeccCCC-chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-
Q 011945 12 GRKIGSGSFGEIYLGTNIQ----TNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 85 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~----~~~~vAvK~~~~~~~-~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (474)
+..|-.|-.-.+|++.... .++.|++|+...... .-....|..+++.+.....-+.+.+++..+ .+++|+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 4455557788999987432 346899998754321 123477999999998777777776655333 356665
Q ss_pred CCCHHH-----------H---HHH-cCCC------CC-HHHHHHHHHHH-----------------HHHHHHHH------
Q 011945 86 GPSLED-----------L---FNF-CSRK------LS-LKTVLMLADQM-----------------INRVEFVH------ 120 (474)
Q Consensus 86 g~sL~~-----------l---i~~-~~~~------l~-~~~~~~i~~qi-----------------~~gL~yLH------ 120 (474)
+.+|.. + +.. +... .. +..+..++.++ ...+..|.
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 334321 1 110 0101 11 22232332221 11122221
Q ss_pred --HCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 121 --SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 121 --s~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
...++|+|+++.|||++ +.++.++|+||..|.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMID--EETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEe--CCCCcEEEEeehhcc
Confidence 23589999999999996 334689999998874
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.00026 Score=81.10 Aligned_cols=130 Identities=12% Similarity=-0.018 Sum_probs=97.5
Q ss_pred eCCEEEEEEecC-CCCHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHC-----CccccCCCCCcEEeeeCCCCCe
Q 011945 74 EGDYNVLVIDLL-GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHSK-----SFLHRDIKPDNFLMGLGRRANQ 144 (474)
Q Consensus 74 ~~~~~~lv~e~~-g~sL~~li~~~~~---~l~~~~~~~i~~qi~~gL~yLHs~-----gIiHrDIKP~NILl~~~~~~~~ 144 (474)
+....+.+++++ +|.+.+.+-.... .++..-+.....+.+.+..-+|+. --+|++||+-|.+| ..+..
T Consensus 1302 ~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmI---Vtny~ 1378 (2724)
T KOG1826|consen 1302 ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMI---VTNYN 1378 (2724)
T ss_pred CChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccce---ecCCc
Confidence 444557778877 8888888753322 244445555555547777777763 27899999999999 47788
Q ss_pred EEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 011945 145 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213 (474)
Q Consensus 145 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf 213 (474)
+|+.++|+.+....... ......+++.|+++++.....++.++|+|..|+-+|+...|..+|
T Consensus 1379 v~~gk~gLdKIknp~~s-------f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1379 VKLGKGGLDKIKNPVLS-------FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred ccccccccccccCchHh-------hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 99999999983332221 124457889999999999889999999999999999999888777
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.018 Score=57.97 Aligned_cols=70 Identities=14% Similarity=0.062 Sum_probs=44.3
Q ss_pred eeeeeecCceEEEEEEEcCC---CeEEEEEEeccCCCc-hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC
Q 011945 12 GRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKH-PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 85 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~---~~~vAvK~~~~~~~~-~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (474)
++.|..|=...+|++..... +..|++|+....... -.-..|..+++.+.....-+.+.++...+ ++.+|+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi 92 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFI 92 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCCc----Eeehhh
Confidence 34444477778999874332 347999987543321 23468999999998777767766555322 356665
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.058 Score=55.62 Aligned_cols=73 Identities=15% Similarity=0.289 Sum_probs=48.5
Q ss_pred EeeeeeecCceEEEEEEEcCCCeEEEEEEec-----cCC----CchHHHHHHHHHHHhcC--CCCCceeEEEeEeCCEEE
Q 011945 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN-----VKT----KHPQLQYEAKLYKILQG--GTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~-----~~~----~~~~l~~E~~il~~l~~--~~~i~~l~~~~~~~~~~~ 79 (474)
..+.||.|....||+..+ .+..|+||.-. ... .......|...|+.+.. +..++.++.++. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 467889999999999986 34569999633 111 23345566777776653 245666666655 4467
Q ss_pred EEEecCCC
Q 011945 80 LVIDLLGP 87 (474)
Q Consensus 80 lv~e~~g~ 87 (474)
++||++.+
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88998844
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.013 Score=58.72 Aligned_cols=74 Identities=24% Similarity=0.292 Sum_probs=60.1
Q ss_pred EeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEeeeCCCCCeEEEEecC
Q 011945 73 VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (474)
Q Consensus 73 ~~~~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~-gIiHrDIKP~NILl~~~~~~~~vkL~DFG 151 (474)
.++.|.|++|++-|++|.-+- ...+++++.|+.+.+.-|.-+..+ .+=|||+.-.|||| +.|+|.|+||-
T Consensus 296 de~~y~yl~~kdhgt~is~ik-----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI----d~GnvtLIDfk 366 (488)
T COG5072 296 DETLYLYLHFKDHGTPISIIK-----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI----DEGNVTLIDFK 366 (488)
T ss_pred CCceEEEEEEecCCceeeeee-----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee----ecCceEEEEee
Confidence 567788999999998875332 246788899999888777666654 68899999999999 38999999999
Q ss_pred Cccc
Q 011945 152 LAKR 155 (474)
Q Consensus 152 la~~ 155 (474)
+++.
T Consensus 367 lsRl 370 (488)
T COG5072 367 LSRL 370 (488)
T ss_pred eeec
Confidence 9984
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.11 E-value=0.092 Score=51.79 Aligned_cols=74 Identities=18% Similarity=0.250 Sum_probs=51.7
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhc--CCCCCceeEEEeEeCCEEEEEEecC
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ--GGTGIPNLRWFGVEGDYNVLVIDLL 85 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~--~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (474)
.+-.+.|+.|....+|+.. .+++.+.||+-. ......+..|..-|+.|. ..-.++.+..++......+|+||++
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNS-ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEE-GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecC-hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 3445678889999999987 778899999876 444567999999999994 4556778888887777779999997
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.047 Score=54.44 Aligned_cols=31 Identities=23% Similarity=0.461 Sum_probs=25.6
Q ss_pred CccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 123 gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
.++|+|+.+.||+|. ..+-+=|+||+++..-
T Consensus 199 ~lvHGD~~~gNlii~---~~~~~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIID---PGRPTGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEe---CCCeeEEEeccccccC
Confidence 489999999999996 4444889999998643
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.18 Score=50.61 Aligned_cols=66 Identities=11% Similarity=0.064 Sum_probs=39.7
Q ss_pred CceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCC--CCCcee----EEEeEeCCEEEEEEecC
Q 011945 19 SFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGG--TGIPNL----RWFGVEGDYNVLVIDLL 85 (474)
Q Consensus 19 ~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~--~~i~~l----~~~~~~~~~~~lv~e~~ 85 (474)
.-..||+... .++..+++|+..... ...++..|..++..|... +.+..+ ..+...+.+.+.++++.
T Consensus 37 ~eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~ 109 (325)
T PRK11768 37 YENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRR 109 (325)
T ss_pred ccceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeee
Confidence 3446898874 456789999876433 345678899999888642 211111 01122345566777776
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.64 E-value=0.029 Score=52.51 Aligned_cols=30 Identities=37% Similarity=0.707 Sum_probs=20.3
Q ss_pred CccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 123 gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
.++|.||.|.|||+. ...+.++|+||..|.
T Consensus 144 v~cHnDl~~~Nil~~--~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILIN--NKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEET--SSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEec--cCCCeEEEecHHHHh
Confidence 488999999999993 467899999999875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.28 Score=50.45 Aligned_cols=71 Identities=14% Similarity=0.117 Sum_probs=44.4
Q ss_pred EeeeeeecCceEEEEEEEcCC-Ce-----EEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 11 LGRKIGSGSFGEIYLGTNIQT-NE-----EVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~-~~-----~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
.++.|..|-...+|++..... +. .|++++..... ..-.-.+|+++++.|....+-+.+.+.+.. ++++|
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 445665688889999974322 12 25555422111 112246799999999988888888766543 57777
Q ss_pred cC
Q 011945 84 LL 85 (474)
Q Consensus 84 ~~ 85 (474)
|+
T Consensus 130 fI 131 (383)
T PTZ00384 130 WV 131 (383)
T ss_pred Ee
Confidence 77
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.076 Score=54.19 Aligned_cols=60 Identities=23% Similarity=0.287 Sum_probs=44.1
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCcEEeee
Q 011945 77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKPDNFLMGL 138 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLH-s~gIiHrDIKP~NILl~~ 138 (474)
..+|+.+|. |-++..+++. ...+++.+..++.=.++||--|- -.+++|.|+.|.||++..
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~--~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKW--KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhc--ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 346777777 7788888873 34566667777776777765544 468999999999999964
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.41 E-value=0.1 Score=52.52 Aligned_cols=131 Identities=17% Similarity=0.200 Sum_probs=74.6
Q ss_pred CceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCce-----eE--EEeEeC--CEEEEEEecC-CCC
Q 011945 19 SFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPN-----LR--WFGVEG--DYNVLVIDLL-GPS 88 (474)
Q Consensus 19 ~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~-----l~--~~~~~~--~~~~lv~e~~-g~s 88 (474)
.-..||+... .+| .+++|+........++..|..++..|....+.+. .. ....-. .+.+-+.+++ |..
T Consensus 37 ~eN~~f~~~~-~~g-~~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~ 114 (331)
T COG2334 37 EENSNFRVQT-EDG-RYILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRP 114 (331)
T ss_pred ccCceEEEEe-cCC-CeEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcC
Confidence 4456888884 334 3499998876566778999999998874433221 11 111122 3566666666 444
Q ss_pred HHH-----HH----------HHcCCC-----------CCHHH-------------HHHHHHHHHHHHHHHHH--------
Q 011945 89 LED-----LF----------NFCSRK-----------LSLKT-------------VLMLADQMINRVEFVHS-------- 121 (474)
Q Consensus 89 L~~-----li----------~~~~~~-----------l~~~~-------------~~~i~~qi~~gL~yLHs-------- 121 (474)
+.. .+ ....+. ..|.. -.....++...+..+.+
T Consensus 115 ~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~ 194 (331)
T COG2334 115 LERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPA 194 (331)
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCc
Confidence 441 11 000011 11210 01123344445555554
Q ss_pred CC--ccccCCCCCcEEeeeCCCCC-eEEEEecCCcc
Q 011945 122 KS--FLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAK 154 (474)
Q Consensus 122 ~g--IiHrDIKP~NILl~~~~~~~-~vkL~DFGla~ 154 (474)
-+ +||+|+.|.||+++ ... .+.++||+-|.
T Consensus 195 ~~~~iIH~D~~~~NVl~d---~~~~~~g~iDFdDa~ 227 (331)
T COG2334 195 LGDQIIHGDLHPDNVLFD---DDTDVSGFIDFDDAG 227 (331)
T ss_pred ccceeeecCCCccceeEc---CCCCeeeEEEccccc
Confidence 23 99999999999995 333 47899999874
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.09 E-value=0.39 Score=55.78 Aligned_cols=47 Identities=11% Similarity=0.143 Sum_probs=33.6
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcC
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQG 61 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~ 61 (474)
+.|+ |..-.+|+... .++..+++|+.+.......+..|.+++..|..
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~ 77 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSEPRVESDFQTAALDHLAA 77 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCccchhHHHHHHHHHHHHHh
Confidence 4564 34567888874 56778999998866555567778888887764
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.76 E-value=0.47 Score=47.16 Aligned_cols=29 Identities=24% Similarity=0.462 Sum_probs=25.4
Q ss_pred CccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 123 gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
++||+|+.+.|||++ .++.+.|+||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~---~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYD---ETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEc---CCCCEEEEEhhhcc
Confidence 799999999999994 56678999998875
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.97 E-value=0.73 Score=48.37 Aligned_cols=71 Identities=14% Similarity=0.025 Sum_probs=45.7
Q ss_pred EeeeeeecCceEEEEEEEcC--------CCeEEEEEEeccCCC-chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 11 LGRKIGSGSFGEIYLGTNIQ--------TNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~--------~~~~vAvK~~~~~~~-~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
-++.|..|-.-.+|++.... .++.|++++....+. .-.-..|..+++.+....+-+.+..... .+.+
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I 184 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRI 184 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence 45666667777899987432 156899998654322 1235679999999987777677654432 2345
Q ss_pred EecC
Q 011945 82 IDLL 85 (474)
Q Consensus 82 ~e~~ 85 (474)
.+|+
T Consensus 185 ~efi 188 (442)
T PTZ00296 185 EEWL 188 (442)
T ss_pred EEee
Confidence 6666
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.60 E-value=1.2 Score=51.73 Aligned_cols=47 Identities=11% Similarity=0.137 Sum_probs=32.2
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCC
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG 62 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~ 62 (474)
..|+.+. -.+|+... ++..+++|+.+.......+..|..++..|...
T Consensus 37 ~~L~s~~-d~nf~v~t--~~~~yVLKi~~~~~~~~~l~~e~~~l~hL~~~ 83 (972)
T PRK06149 37 TELGSQQ-DRNFRVDS--DGGRFVLKICHAAYAAVELEAQHAALRHLAER 83 (972)
T ss_pred EecCCcC-cceEEEEe--cCCcEEEEeCCccCChHHHHHHHHHHHHHHhh
Confidence 4555333 36888874 23478889987655556788888888888643
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.57 E-value=0.14 Score=50.75 Aligned_cols=29 Identities=38% Similarity=0.729 Sum_probs=24.5
Q ss_pred CCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 122 ~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
.++||+|+.+.|||++ . +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEe---C-CcEEEEECcccc
Confidence 5799999999999995 3 568999999764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 474 | ||||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 0.0 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-137 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-137 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-136 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 1e-96 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 6e-96 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 1e-95 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 2e-95 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 3e-94 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 4e-94 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 5e-94 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 2e-26 | ||
| 2lav_A | 361 | Nmr Solution Structure Of Human Vaccinia-Related Ki | 5e-26 | ||
| 2kty_A | 368 | Solution Structure Of Human Vaccinia Related Kinase | 6e-26 | ||
| 3op5_A | 364 | Human Vaccinia-Related Kinase 1 Length = 364 | 6e-26 | ||
| 2jii_A | 352 | Structure Of Vaccinia Related Kinase 3 Length = 352 | 5e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 5e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 8e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-12 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-12 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 7e-12 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-11 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 8e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 9e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-09 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-09 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-09 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-09 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-08 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-08 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-08 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 5e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 5e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-08 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 6e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-08 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 9e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-07 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-07 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-07 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-07 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-07 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-07 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 6e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-07 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 6e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 7e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 7e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 7e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-07 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 8e-07 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-07 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 8e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 9e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-07 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 9e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-07 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-06 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-06 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-06 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-06 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-06 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-06 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-06 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-06 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-06 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-06 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-06 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-06 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-06 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-06 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-06 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 4e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 4e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-06 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-06 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-06 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-06 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-06 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-06 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 5e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-06 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-06 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-06 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 6e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-06 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 7e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-06 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-06 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-06 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-06 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-06 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 8e-06 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-06 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 8e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 8e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 9e-06 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-06 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-06 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 9e-06 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-06 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-06 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-06 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-06 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-06 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-05 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-05 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-05 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-05 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 1e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 2e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-05 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-05 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 4e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-05 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 4e-05 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-05 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-05 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 5e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-05 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 6e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 6e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-05 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 6e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-05 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 8e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-05 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-04 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-04 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-04 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-04 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-04 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-04 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-04 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-04 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 3e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-04 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-04 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-04 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-04 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-04 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-04 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-04 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-04 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-04 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-04 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-04 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-04 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-04 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-04 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-04 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-04 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-04 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 4e-04 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-04 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-04 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-04 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-04 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-04 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-04 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-04 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-04 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 7e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-04 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 7e-04 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-04 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-04 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 8e-04 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-04 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-04 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-04 |
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361 | Back alignment and structure |
|
| >pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368 | Back alignment and structure |
|
| >pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364 | Back alignment and structure |
|
| >pdb|2JII|A Chain A, Structure Of Vaccinia Related Kinase 3 Length = 352 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 680 bits (1757), Expect = 0.0
Identities = 374/475 (78%), Positives = 417/475 (87%), Gaps = 4/475 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL YE+K+Y+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GGTGIPN+RWFGVEGDYNVLV+DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK+YRDT+THQHIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV+TSIEAL
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300
CRGYPTEFASYFHYCRSLRFDDKPDY+YLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ+
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQI 300
Query: 301 -STPARAIGPGAGPSSGMPPAAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLS 359
S P RA+G GAGPS PPA N DRQSG +EGR +GWSS D RRR P+ + L+
Sbjct: 301 ASAPPRAVGHGAGPSGLAPPALQN-DRQSGVDEGRTSGWSSMD--RRRAPPPIASVGTLA 357
Query: 360 KQKSPMANDPAFSKDAMMSSYNLLRSSGSSRRVAVPNSREAAVVGSDTDPSRPRTTDASP 419
KQK+P+ ND +FSK+ ++S+ N L S S R +S + ++PSR R TDASP
Sbjct: 358 KQKAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSRDVMPIDTSEPSRTRATDASP 417
Query: 420 GAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 474
GAF++ S Q+SSPV S+E +H++S R +SN+KN+ES L+GIE L+F+ +ERV +
Sbjct: 418 GAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESALKGIEGLNFDGDERVQY 472
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 575 bits (1484), Expect = 0.0
Identities = 230/294 (78%), Positives = 269/294 (91%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL E+K+YK++Q
Sbjct: 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 62
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 63 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYA
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 294
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK
Sbjct: 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLK 296
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 575 bits (1485), Expect = 0.0
Identities = 172/326 (52%), Positives = 224/326 (68%), Gaps = 3/326 (0%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGT 63
VG FR+G+KIG G+FGE+ LG N+ TNE VAIKLE +K++ PQL E + YK L G
Sbjct: 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD 65
Query: 64 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
GIP + +FG G YN +V++LLGPSLEDLF+ C R SLKTVLM+A Q+I+R+E+VHSK+
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125
Query: 124 FLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
++RD+KP+NFL+G + ++IIDF LAK Y D T +HIPYRE+K+LTGTARY S
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMS 185
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241
+NTHLG EQSRRDDLE+LG++ MYFLRGSLPWQGLKA T K++Y+KI + K +T IE LC
Sbjct: 186 INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLC 245
Query: 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVS 301
+P E A+Y Y R L F +KPDY YL++LF DLF R+G+ FDY +DW + +
Sbjct: 246 ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIGKQLPTPVGA 304
Query: 302 TPARAIGPGAGPSSGMPPAAANVDRQ 327
+ Q
Sbjct: 305 VQQDPALSSNREAHQHRDKMQQSKNQ 330
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 570 bits (1470), Expect = 0.0
Identities = 175/295 (59%), Positives = 215/295 (72%), Gaps = 2/295 (0%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
VG +++GR+IG GSFG I+ GTN+ N++VAIK E ++ PQL+ E + YK+L
Sbjct: 4 QNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA 63
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
G TGIPN+ +FG EG +NVLVIDLLGPSLEDL + C RK S+KTV M A QM+ RV+ +H
Sbjct: 64 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 121 SKSFLHRDIKPDNFLMGL--GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
KS ++RDIKPDNFL+G + AN +Y++DFG+ K YRD T QHIPYRE KNL+GTAR
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 179 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238
Y S+NTHLG EQSRRDDLE+LG+V MYFLRGSLPWQGLKA T KQKYE+I EKK ST +
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243
Query: 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 293
LC G+P EF Y HY R+L FD PDY YL+ LF + R D FDW +L
Sbjct: 244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 298
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 524 bits (1351), Expect = 0.0
Identities = 83/331 (25%), Positives = 148/331 (44%), Gaps = 29/331 (8%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLG-----TNIQTNEEVAIKLENVKTKHPQLQYEAKL 55
+ +++G IG G FG IYL ++ ++ +K+E + + L E K
Sbjct: 29 ITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVE--PSDNGPLFTELKF 86
Query: 56 YKILQ--------------GGTGIPNLRWFGVEG----DYNVLVIDLLGPSLEDLFNFCS 97
Y+ G+P G+ Y +++D G L+ ++ +
Sbjct: 87 YQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA 146
Query: 98 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157
++ S KTVL L+ ++++ +E++H ++H DIK N L+ +QVY++D+GLA RY
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN-PDQVYLVDYGLAYRYC 205
Query: 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217
H+ + GT + S++ H G+ SRR DLE LGY ++ +L G LPW+
Sbjct: 206 PEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265
Query: 218 AGTKKQKYEKISEKKVSTSIEALC---RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 274
K + KI ++ S+ C P E A Y + L + +KP Y L+ +
Sbjct: 266 KDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILL 325
Query: 275 DLFIREGFQFDYVFDWTILKYQQSQVSTPAR 305
G + D D ++++ + T +
Sbjct: 326 QGLKAIGSKDDGKLDLSVVENGGLKAKTITK 356
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 501 bits (1291), Expect = e-178
Identities = 92/322 (28%), Positives = 144/322 (44%), Gaps = 30/322 (9%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLQYEAKLYKIL 59
++ GN++ LG+KIGSG FG IYL E+ A + V+ ++ L E K Y+ +
Sbjct: 31 LDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRV 90
Query: 60 QGGT--------------GIPNLRWFGV----EGDYNVLVIDLLGPSLEDLFNFCSRKLS 101
GIP G+ Y +V++ LG L+ + +
Sbjct: 91 AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG-QNGTFK 149
Query: 102 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
TVL L +M++ +E++H ++H DIK N L+G +QVY+ D+GL+ RY
Sbjct: 150 KSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKN-PDQVYLADYGLSYRYCPNGN 208
Query: 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL---KA 218
H+ K GT + S++ H G+ SRR D+E LGY ++ +L G LPW+
Sbjct: 209 HKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268
Query: 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278
+ K + E S A E A + SL +D+KP+Y LK++ I
Sbjct: 269 AVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328
Query: 279 REGFQFDYVFDWTILKYQQSQV 300
G D++ K Q V
Sbjct: 329 PLGP-----LDFST-KGQSINV 344
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 491 bits (1267), Expect = e-174
Identities = 73/316 (23%), Positives = 126/316 (39%), Gaps = 33/316 (10%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT--------NEEVAIKLENVKT------------ 44
G +++L + G +Y T ++ ++KL+
Sbjct: 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRA 99
Query: 45 -KHPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDYNVLVIDLLGPSLEDLFNFCSRK-LS 101
K Q+ KLY IP FGV + Y LV+ LG SL+ + + LS
Sbjct: 100 AKPLQVNKWKKLYST--PLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLS 157
Query: 102 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
++VL +A ++++ +EF+H ++H ++ +N + + +QV + +G A RY +
Sbjct: 158 ERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQ-SQVTLAGYGFAFRYCPS-- 214
Query: 162 HQHIPYRENKN--LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219
+H+ Y E G + SM+ H G SRR DL+SLGY ++ +L G LPW
Sbjct: 215 GKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274
Query: 220 TKKQKYEKISEKKVSTSIEALCRGY---PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276
T+ +K C + Y +L +++KP YA L+ L
Sbjct: 275 TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL 334
Query: 277 FIREGFQFDYVFDWTI 292
+
Sbjct: 335 LQDLRVSPYDPIGLPM 350
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 53/259 (20%), Positives = 93/259 (35%), Gaps = 51/259 (19%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLQYEAKLYKILQG 61
G + + ++IGSG +++ N + + AIK LE + + E LQ
Sbjct: 8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 66
Query: 62 GTGIPN---LRWFGVEGDYNVLVIDLLGPSLE----DLFNFCSRK--LSLKTVLMLADQM 112
+ +R + E + + +E DL ++ +K + M
Sbjct: 67 ----HSDKIIRLYDYEITDQYIYM-----VMECGNIDLNSWLKKKKSIDPWERKSYWKNM 117
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 172
+ V +H +H D+KP NFL+ G + +IDFG+A + + T +
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK-----DS 168
Query: 173 LTGTARYAS-----------MNTHLGIEQSRRDDLESLG---YVLMYFLRGSLPWQGLKA 218
GT Y N + S + D+ SLG Y + Y G P+Q +
Sbjct: 169 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY---GKTPFQQII- 224
Query: 219 GTKKQKYEKISEKKVSTSI 237
+ K I +
Sbjct: 225 -NQISKLHAIIDPNHEIEF 242
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 52/257 (20%), Positives = 93/257 (36%), Gaps = 47/257 (18%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLQYEAKLYKILQG 61
G + + ++IGSG +++ N + + AIK LE + + E LQ
Sbjct: 27 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 85
Query: 62 GTGIPN---LRWFGVEGDYNVLVIDLLGPSLE----DLFNFCSRK--LSLKTVLMLADQM 112
+ +R + E + + +E DL ++ +K + M
Sbjct: 86 ----HSDKIIRLYDYEITDQYIYM-----VMECGNIDLNSWLKKKKSIDPWERKSYWKNM 136
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 172
+ V +H +H D+KP NFL+ G + +IDFG+A + + T +
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK-----DS 187
Query: 173 LTGTARYAS-----------MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGT 220
GT Y N + S + D+ SLG ++Y G P+Q +
Sbjct: 188 QVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG-CILYYMTYGKTPFQQII--N 244
Query: 221 KKQKYEKISEKKVSTSI 237
+ K I +
Sbjct: 245 QISKLHAIIDPNHEIEF 261
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 52/256 (20%), Positives = 92/256 (35%), Gaps = 45/256 (17%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLQYEAKLYKILQG 61
G + + ++IGSG +++ N + + AIK LE + + E LQ
Sbjct: 55 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113
Query: 62 GTGIPN---LRWFGVEGDYNVLVIDLLGPSLE----DLFNFCSRK--LSLKTVLMLADQM 112
+ +R + E + + +E DL ++ +K + M
Sbjct: 114 ----HSDKIIRLYDYEITDQYIYM-----VMECGNIDLNSWLKKKKSIDPWERKSYWKNM 164
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 172
+ V +H +H D+KP NFL+ G + +IDFG+A + + T +
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK-----DS 215
Query: 173 LTGTARYAS-----------MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221
G Y N + S + D+ SLG +L Y G P+Q + +
Sbjct: 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQ 273
Query: 222 KQKYEKISEKKVSTSI 237
K I +
Sbjct: 274 ISKLHAIIDPNHEIEF 289
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 36/247 (14%), Positives = 72/247 (29%), Gaps = 53/247 (21%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLQYEAKLYKILQG- 61
K +L + G ++L +++ E+ A+K+ + ++ +L L G
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 62 -------------------GTGIPN-LRWFGVEGDYNV----LVIDLLGPSLEDLFNFCS 97
P + + DY V L++ LE LF+
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 98 R------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151
+ + +L Q+I + SK +H PDN + ++ + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM---PDGRLMLGDVS 239
Query: 152 LAKRYRDTATHQHIPYRENKNLTGTARYAS--MNTHLGIEQSRRDDLESLGYVLMY-FLR 208
+ + YA + + LG + +Y
Sbjct: 240 ALWKVGTRGP----------ASSVPVTYAPREFLNASTATFTHALNAWQLG-LSIYRVWC 288
Query: 209 GSLPWQG 215
LP+
Sbjct: 289 LFLPFGL 295
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 65/333 (19%), Positives = 113/333 (33%), Gaps = 65/333 (19%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLQYEAKLYKILQGGT 63
+ + L +G G+ ++ G + +T + AIK+ + E ++ K L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-- 66
Query: 64 GIPN-LRWFGVEGDYN----VLVIDLL--GPSLEDLFNFCSRK-----LSLKTVLMLADQ 111
N ++ F +E + VL+++ G L+ L L++
Sbjct: 67 --KNIVKLFAIEEETTTRHKVLIMEFCPCG----SLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKRYRDTATHQHIPYREN 170
++ + + +HR+IKP N + +G VY + DFG A+ D
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF-------- 172
Query: 171 KNLTGTARYAS--------MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAG-T 220
+L GT Y + + DL S+G V Y GSLP++ +
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFRPFEGPRR 231
Query: 221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL---F 277
K+ KI K S +I + + D P L R + L
Sbjct: 232 NKEVMYKIITGKPSGAISGVQKAENGPIDWSG---------DMPVSCSLSRGLQVLLTPV 282
Query: 278 IREGFQFD----YVFD------WTILKYQQSQV 300
+ + D + FD IL S
Sbjct: 283 LANILEADQEKCWGFDQFFAETSDILHRGNSHH 315
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 46/276 (16%), Positives = 79/276 (28%), Gaps = 47/276 (17%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHPQLQYEAKLYKILQGG 62
G +G T+ +T E + + Q++ E ++L+G
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 63 ---------------------TGIPNL-RWFGVEGDYNVLVIDLLGPS--------LEDL 92
+ R E D VL L P E L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 93 FNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150
+ S + L L L Q+I + +H +H ++P + ++ + V++ F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLTGF 250
Query: 151 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRG 209
R E L S + + D +LG +++Y
Sbjct: 251 EHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG-LVIYWIWCA 309
Query: 210 SLPWQGLKAGTKKQKYEKI--SEKKVSTSIEALCRG 243
LP E I S K + + AL G
Sbjct: 310 DLPITK---DAALGGSEWIFRSCKNIPQPVRALLEG 342
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 59/325 (18%), Positives = 104/325 (32%), Gaps = 75/325 (23%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLQYE----------- 52
+ + L +G G+ ++ G + +T + AIK+ + E
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 53 -AKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRK-----LSLKT 104
KL+ I + T + VL+++ G L+ L
Sbjct: 69 IVKLFAIEEETT-----------TRHKVLIMEFCPCG----SLYTVLEEPSNAYGLPESE 113
Query: 105 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKRYRDTATHQ 163
L++ ++ + + +HR+IKP N + +G VY + DFG A+ D
Sbjct: 114 FLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED----- 168
Query: 164 HIPYRENKNLT---GTARYAS--------MNTHLGIEQSRRDDLESLGYVLMY-FLRGSL 211
++ GT Y + + DL S+G V Y GSL
Sbjct: 169 ------DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSL 221
Query: 212 PWQGLKAG-TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270
P++ + K+ KI K S +I + + D P L
Sbjct: 222 PFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG---------DMPVSCSLS 272
Query: 271 RLFRDL---FIREGFQFDYVFDWTI 292
R + L + + D W
Sbjct: 273 RGLQVLLTPVLANILEADQEKCWGF 297
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 8e-24
Identities = 56/238 (23%), Positives = 93/238 (39%), Gaps = 47/238 (19%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKT-----KHPQLQYEA 53
E +RLG +G G FG ++ G + +VAIK+ V E
Sbjct: 27 EAFEAE-YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEV 85
Query: 54 KLYKILQGGTGIPN----LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVL--M 107
L + G G P L WF + + +LV++ P+ +DLF++ + K L
Sbjct: 86 ALLWKVGAGGGHPGVIRLLDWFETQEGF-MLVLERPLPA-QDLFDYITEKGPLGEGPSRC 143
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167
Q++ ++ HS+ +HRDIK +N L + R +IDFG D
Sbjct: 144 FFGQVVAAIQHCHSRGVVHRDIKDENIL--IDLRRGCAKLIDFGSGALLHDEPYT----- 196
Query: 168 RENKNLT--GTARYA-----SMNTHLGIEQSRRDDLESLG---YVLMYFLRGSLPWQG 215
GT Y+ S + + + + SLG Y ++ G +P++
Sbjct: 197 ------DFDGTRVYSPPEWISRHQYHALPA----TVWSLGILLYDMVC---GDIPFER 241
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 4e-23
Identities = 45/232 (19%), Positives = 86/232 (37%), Gaps = 38/232 (16%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEA--------- 53
R + F +G G+FG++ N + AIK + + + K + E
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQ 62
Query: 54 ---KLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLA 109
+ Y + + ++ +L DL + + L
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP--- 166
Q++ + ++HS+ +HRD+KP N + + V I DFGLAK + +
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFID---ESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 167 -YRENKNLT---GTARYAS--MNTHLGIEQSRRDDLE----SLG---YVLMY 205
+ NLT GTA Y + + ++ + + + SLG + ++Y
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEV-----LDGTGHYNEKIDMYSLGIIFFEMIY 226
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 97.8 bits (243), Expect = 3e-22
Identities = 42/281 (14%), Positives = 77/281 (27%), Gaps = 60/281 (21%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----ENVKTKHPQLQYEAKLYKILQG-- 61
G +G T+ +T E + + Q++ E ++L+G
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 62 -------------------GTGIPNL-RWFGVEGDYNVLVIDLLGP----SLEDLFNFCS 97
+ R E D VL L P +L+
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 98 RK------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151
L L L Q+I + +H +H ++P + ++ + V++ F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLTGFE 256
Query: 152 LAKRY-RDTATHQHIPYRENKNLTGTARYAS-----MNTHLGIEQSRRDDLESLGYVLMY 205
R + + + H + D +LG + +Y
Sbjct: 257 HLVRDGASAVSPIGRGF-------APPETTAERMLPFGQHHPTLMTFAFDTWTLG-LAIY 308
Query: 206 F-LRGSLPWQGLKAGTKKQKYEKI--SEKKVSTSIEALCRG 243
+ LP E I S K + + AL G
Sbjct: 309 WIWCADLPNTD---DAALGGSEWIFRSCKNIPQPVRALLEG 346
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 98.6 bits (245), Expect = 4e-22
Identities = 53/336 (15%), Positives = 108/336 (32%), Gaps = 79/336 (23%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------LENVKT------ 44
+ + + + ++G+G FG + + T E+VAIK E
Sbjct: 8 LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMK 67
Query: 45 --KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--- 99
HP + ++ G + D +L ++ DL + ++
Sbjct: 68 KLNHPNV---VSAREVPDGLQKLA-------PNDLPLLAMEYC--EGGDLRKYLNQFENC 115
Query: 100 --LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157
L + L + + + ++H +HRD+KP+N ++ G + IID G AK
Sbjct: 116 CGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD 175
Query: 158 DTATHQHIPYRENKNLT---GTARYAS--MNTHLGIEQSRRD---DLESLGYVLMYFL-R 208
+ T GT +Y + + +EQ + D S G L +
Sbjct: 176 Q-----------GELCTEFVGTLQYLAPEL-----LEQKKYTVTVDYWSFG-TLAFECIT 218
Query: 209 GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRF-DDKPDYA 267
G P+ + ++ +K + I Y +++F P
Sbjct: 219 GFRPFLP---NWQPVQWHGKVREKSNEHIVV-----------YDDLTGAVKFSSVLPTPN 264
Query: 268 YLKRLFRDL---FIREGFQFDYVFDWTILKYQQSQV 300
+L + +++ + T +
Sbjct: 265 HLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 9e-22
Identities = 52/239 (21%), Positives = 87/239 (36%), Gaps = 37/239 (15%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQG 61
E + N + +G GS G + VA+K E K +L
Sbjct: 10 EQSLKNLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRML-IDFCDIALMEIK---LLTE 64
Query: 62 GTGIPN-LRWFGVEGDYNV--LVIDLLGPSLEDL------FNFCSRKLSLKTVLMLADQM 112
PN +R++ E + ++L +L+DL + + + L Q+
Sbjct: 65 SDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 113 INRVEFVHSKSFLHRDIKPDNFL----------MGLGRRANQVYIIDFGLAKRYRDTATH 162
+ V +HS +HRD+KP N L G ++ I DFGL K+
Sbjct: 125 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG--- 181
Query: 163 QHIPYRENKNLTGTARYA-------SMNTHLGIEQSRRDDLESLGYVLMYFL--RGSLP 212
Q N +GT+ + S N +R D+ S+G + Y++ +G P
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG-CVFYYILSKGKHP 239
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 58/239 (24%), Positives = 96/239 (40%), Gaps = 51/239 (21%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---------HPQLQYE 52
EP +++G +GSG FG +Y G + N VAIK K + ++ E
Sbjct: 39 EPLESQ-YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPME 96
Query: 53 AKLYKILQGGTGIPN----LRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVL 106
L K + +G L WF + VL+++ P +DLF+F + + L +
Sbjct: 97 VVLLKKVS--SGFSGVIRLLDWFERPDSF-VLILERPEPV-QDLFDFITERGALQEELAR 152
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166
Q++ V H+ LHRDIK +N L + ++ +IDFG +DT
Sbjct: 153 SFFWQVLEAVRHCHNCGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKDTVYT---- 206
Query: 167 YRENKNLT--GTARYA-----SMNTHLGIEQSRRDDLESLG---YVLMYFLRGSLPWQG 215
GT Y+ + + G + SLG Y ++ G +P++
Sbjct: 207 -------DFDGTRVYSPPEWIRYHRYHGRSA----AVWSLGILLYDMVC---GDIPFEH 251
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 44/222 (19%), Positives = 80/222 (36%), Gaps = 28/222 (12%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGT 63
+ +K+G G F + L + A+K + + Q EA ++++
Sbjct: 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNH-- 85
Query: 64 GIPN----LRWFGVEGDYNVLVIDLL----GPSLEDLFNFCSRK---LSLKTVLMLADQM 112
PN + + E LL +L + K L+ +L L +
Sbjct: 86 --PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT--HQHIPYREN 170
+E +H+K + HRD+KP N L+G Q ++D G + Q + ++
Sbjct: 144 CRGLEAIHAKGYAHRDLKPTNILLG---DEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 171 KNLTGTARYAS---MNTHLGIEQSRRDDLESLG---YVLMYF 206
T Y + + R D+ SLG Y +M+
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 7e-21
Identities = 74/249 (29%), Positives = 110/249 (44%), Gaps = 53/249 (21%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQ 60
F +GR +G G FG +YL Q+ +A+K LE +H QL+ E ++ L+
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLR 67
Query: 61 GGTGIPN-LRWFGV-EGDYNVLVIDLLGPSLE-----DLFNFCSR--KLSLKTVLMLADQ 111
PN LR +G V +I LE ++ + K + +
Sbjct: 68 H----PNILRLYGYFHDATRVYLI------LEYAPLGTVYRELQKLSKFDEQRTATYITE 117
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
+ N + + HSK +HRDIKP+N L+G A ++ I DFG + H P
Sbjct: 118 LANALSYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRT 165
Query: 172 NLTGTARYAS--MNTHLGIEQSRRD---DLESLGYVLMY-FLRGSLPWQGLKAGTKKQKY 225
+L GT Y M IE D DL SLG VL Y FL G P++ A T ++ Y
Sbjct: 166 DLCGTLDYLPPEM-----IEGRMHDEKVDLWSLG-VLCYEFLVGKPPFE---ANTYQETY 216
Query: 226 EKISEKKVS 234
++IS + +
Sbjct: 217 KRISRVEFT 225
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 9e-21
Identities = 49/223 (21%), Positives = 85/223 (38%), Gaps = 21/223 (9%)
Query: 4 RVGN-KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG 62
VG F +G G+ G I + N +VA+K E + +L+
Sbjct: 20 IVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRIL-PECFSFADREVQ---LLRES 74
Query: 63 TGIPN-LRWFGVEGDYNV--LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
PN +R+F E D + I+L +L++ + L Q + + +
Sbjct: 75 DEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL 134
Query: 120 HSKSFLHRDIKPDNFL--MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTA 177
HS + +HRD+KP N L M + I DFGL K+ + + GT
Sbjct: 135 HSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS----FSRRSGVPGTE 190
Query: 178 RYAS---MNTHLGIEQSRRDDLESLGYVLMYFL--RGSLPWQG 215
+ + ++ + D+ S G + Y++ GS P+
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAG-CVFYYVISEGSHPFGK 232
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 1e-20
Identities = 55/252 (21%), Positives = 96/252 (38%), Gaps = 55/252 (21%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKL 55
+PR ++ GR +G G F + + ++ T E A K L + ++ E +
Sbjct: 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISI 68
Query: 56 YKILQGGTGIPN-LRWFGV-EGDYNVLVIDLLGPSLE-----DLFNFCSRK--LSLKTVL 106
++ L + + + G E + V V+ LE L R+ L+
Sbjct: 69 HRSLAH----QHVVGFHGFFEDNDFVFVV------LELCRRRSLLELHKRRKALTEPEAR 118
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166
Q++ +++H +HRD+K N + +V I DFGLA + +
Sbjct: 119 YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN---EDLEVKIGDFGLATK---------VE 166
Query: 167 YRENKNLT--GTARYA-----SMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKA 218
Y + GT Y S H S D+ S+G +MY L G P++
Sbjct: 167 YDGERKKVLCGTPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE---T 217
Query: 219 GTKKQKYEKISE 230
K+ Y +I +
Sbjct: 218 SCLKETYLRIKK 229
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 2e-20
Identities = 60/238 (25%), Positives = 92/238 (38%), Gaps = 38/238 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQ 60
F++G +G GSF +Y +I T EVAIK + ++Q E K++ L+
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQ-RVQNEVKIHCQLK 69
Query: 61 GGTGIPN-LRWFGV-EGDYNV-LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
P+ L + E V LV+++ + + S Q+I +
Sbjct: 70 H----PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT-- 174
++HS LHRD+ N L+ R + I DFGLA + K+ T
Sbjct: 126 LYLHSHGILHRDLTLSNLLLT---RNMNIKIADFGLA---------TQLKMPHEKHYTLC 173
Query: 175 GTARYAS--MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKAGTKKQKYEKIS 229
GT Y S + T D+ SLG + Y L G P+ T K K+
Sbjct: 174 GTPNYISPEIAT--RSAHGLESDVWSLG-CMFYTLLIGRPPFD---TDTVKNTLNKVV 225
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 9e-20
Identities = 50/202 (24%), Positives = 76/202 (37%), Gaps = 38/202 (18%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
++ R G F+ IGSG FG+++ + + IK VK + + + E K L
Sbjct: 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR--VKYNNEKAEREVKALAKLD 62
Query: 61 GGTGIPNL-----RWFGVEGDYNVLVIDLLGPSLEDLF---NFCS-------------RK 99
N+ W G + D + + LF FC K
Sbjct: 63 H----VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 100 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
L L L +Q+ V+++HSK ++RD+KP N + QV I DFGL ++
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKND 175
Query: 160 ATHQHIPYRENKNLTGTARYAS 181
GT RY S
Sbjct: 176 GKRTRS--------KGTLRYMS 189
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 56/252 (22%), Positives = 94/252 (37%), Gaps = 55/252 (21%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKL 55
+PR ++ GR +G G F + + ++ T E A K L + ++ E +
Sbjct: 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISI 94
Query: 56 YKILQGGTGIPN-LRWFGV-EGDYNVLVIDLLGPSLE-----DLFNFCSR--KLSLKTVL 106
++ L + + + G E + V V+ LE L R L+
Sbjct: 95 HRSLAH----QHVVGFHGFFEDNDFVFVV------LELCRRRSLLELHKRRKALTEPEAR 144
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166
Q++ +++H +HRD+K N L V I DFGLA + +
Sbjct: 145 YYLRQIVLGCQYLHRNRVIHRDLKLGNLF--LNEDLE-VKIGDFGLATK---------VE 192
Query: 167 YRENKNLT--GTARYA-----SMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQGLKA 218
Y + GT Y S H S D+ S+G +MY L G P++
Sbjct: 193 YDGERKKVLCGTPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE---T 243
Query: 219 GTKKQKYEKISE 230
K+ Y +I +
Sbjct: 244 SCLKETYLRIKK 255
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 33/172 (19%), Positives = 68/172 (39%), Gaps = 21/172 (12%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
+ +G G+F ++Y T + + ++ +K++ + +L + L+
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQK-PANPWEFYIGTQLMERLK 122
Query: 61 GGT--GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFN----FCSRKLSLKTVLMLADQMI 113
+ + +VLV +L +L + N + + V+ A +M+
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--------VYIIDFGLAKRYR 157
+E VH +H DIKPDNF++G G + +ID G + +
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 51/244 (20%), Positives = 92/244 (37%), Gaps = 57/244 (23%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----------HPQLQ 50
+ +GSG+FG ++ + + N+EV +K K K ++
Sbjct: 20 GEYSQK-YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVT 77
Query: 51 YEAKLYKILQGGTGIPN-LRWFGV---EGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKT 104
E + ++ N ++ + +G + LV++ G L+ LF F R L
Sbjct: 78 LEIAILSRVEH----ANIIKVLDIFENQGFF-QLVMEKHGSGLD-LFAFIDRHPRLDEPL 131
Query: 105 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164
+ Q+++ V ++ K +HRDIK +N + + + +IDFG A
Sbjct: 132 ASYIFRQLVSAVGYLRLKDIIHRDIKDENIV--IAEDFT-IKLIDFGSAAYLER------ 182
Query: 165 IPYRENKNLT---GTARYA-----SMNTHLGIEQSRRDDLESLG---YVLMYFLRGSLPW 213
K GT Y N + G E ++ SLG Y L++ P+
Sbjct: 183 -----GKLFYTFCGTIEYCAPEVLMGNPYRGPEL----EMWSLGVTLYTLVF---EENPF 230
Query: 214 QGLK 217
L+
Sbjct: 231 CELE 234
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 37/171 (21%), Positives = 61/171 (35%), Gaps = 15/171 (8%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKL 55
E F+ ++G GS+GE++ + + A+K K + +L
Sbjct: 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSH 110
Query: 56 YKILQGGTGIPNL-RWFG--VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQM 112
K+ Q P R EG L +L GPSL+ L V
Sbjct: 111 EKVGQH----PCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDT 166
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163
+ + +HS+ +H D+KP N +G + + DFGL +
Sbjct: 167 LLALAHLHSQGLVHLDVKPANIFLG---PRGRCKLGDFGLLVELGTAGAGE 214
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 34/187 (18%), Positives = 75/187 (40%), Gaps = 26/187 (13%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGG 62
+ K+ + +G G FG ++ + + K VK ++ E + I +
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH- 60
Query: 63 TGIPNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQMIN 114
N+ E + ++ + + D+F + L+ + ++ Q+
Sbjct: 61 ---RNILHLHESFESMEELVMIFEFISGL----DIFERINTSAFELNEREIVSYVHQVCE 113
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 174
++F+HS + H DI+P+N + RR++ + II+FG A++ + P + L
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIY-QTRRSSTIKIIEFGQARQLK--------PGDNFRLLF 164
Query: 175 GTARYAS 181
Y +
Sbjct: 165 TAPEYYA 171
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 2e-19
Identities = 64/250 (25%), Positives = 108/250 (43%), Gaps = 44/250 (17%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTK--HPQLQYEAKLYK 57
++++ R +G GSFGE+ L + T +E A+K VK K L E +L K
Sbjct: 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 58 ILQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFN-FCSRK-LSLKTVLMLAD 110
L PN ++ + E LV ++ G +LF+ SRK S +
Sbjct: 82 QLDH----PNIMKLYEFFEDKGYFYLVGEVYTGG----ELFDEIISRKRFSEVDAARIIR 133
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 170
Q+++ + ++H +HRD+KP+N L+ + + IIDFGL+ + +
Sbjct: 134 QVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM-------- 185
Query: 171 KNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQK 224
K+ GTA Y + E D+ S G V++Y L G P+ G +
Sbjct: 186 KDKIGTAYYIAP------EVLHGTYDEKCDVWSTG-VILYILLSGCPPFNG---ANEYDI 235
Query: 225 YEKISEKKVS 234
+K+ + K +
Sbjct: 236 LKKVEKGKYT 245
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 61/249 (24%), Positives = 102/249 (40%), Gaps = 53/249 (21%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQ 60
+ F +GR +G G FG +YL Q +A+K LE +H QL+ E ++ L+
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEH-QLRREIEIQSHLR 72
Query: 61 GGTGIPN-LRWFGV-EGDYNVLVIDLLGPSLE-----DLFNFCSR--KLSLKTVLMLADQ 111
PN LR + + ++ LE +L+ + + + ++
Sbjct: 73 H----PNILRMYNYFHDRKRIYLM------LEFAPRGELYKELQKHGRFDEQRSATFMEE 122
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
+ + + + H + +HRDIKP+N LMG ++ I DFG + H P +
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMG---YKGELKIADFGWSV---------HAPSLRRR 170
Query: 172 NLTGTARYAS--MNTHLGIEQSRRD---DLESLGYVLMY-FLRGSLPWQGLKAGTKKQKY 225
+ GT Y M IE D DL G VL Y FL G P+ + + + +
Sbjct: 171 TMCGTLDYLPPEM-----IEGKTHDEKVDLWCAG-VLCYEFLVGMPPFD---SPSHTETH 221
Query: 226 EKISEKKVS 234
+I +
Sbjct: 222 RRIVNVDLK 230
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 3e-19
Identities = 61/248 (24%), Positives = 115/248 (46%), Gaps = 43/248 (17%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTK-HPQLQYEAKLYKIL 59
+ ++ +K+GSG++GE+ L + T+ E AIK +V T + +L E + K+L
Sbjct: 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL 93
Query: 60 QGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFN-FCSRK-LSLKTVLMLADQM 112
PN ++ + E N LV++ G +LF+ R + ++ Q+
Sbjct: 94 DH----PNIMKLYDFFEDKRNYYLVMECYKGG----ELFDEIIHRMKFNEVDAAVIIKQV 145
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 172
++ V ++H + +HRD+KP+N L+ + + I+DFGL+ + + K
Sbjct: 146 LSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--------KE 197
Query: 173 LTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYE 226
GTA Y + E R+ D+ S+G V+++ L G P+ G T ++
Sbjct: 198 RLGTAYYIAP------EVLRKKYDEKCDVWSIG-VILFILLAGYPPFGG---QTDQEILR 247
Query: 227 KISEKKVS 234
K+ + K +
Sbjct: 248 KVEKGKYT 255
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 4e-19
Identities = 66/248 (26%), Positives = 115/248 (46%), Gaps = 42/248 (16%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLQYEAKLYKILQG 61
+ + F RK+GSG+FG+++L + E IK + + Q++ E ++ K L
Sbjct: 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH 79
Query: 62 GTGIPNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLF------NFCSRKLSLKTVLMLAD 110
PN+ + F V E +N+ +V++ G +L + LS V L
Sbjct: 80 ----PNIIKIFEVFEDYHNMYIVMETCEGG----ELLERIVSAQARGKALSEGYVAELMK 131
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 170
QM+N + + HS+ +H+D+KP+N L + + IIDFGLA+ ++
Sbjct: 132 QMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS-------- 183
Query: 171 KNLTGTARYAS---MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYE 226
N GTA Y + + + D+ S G V+MYF L G LP+ G + ++ +
Sbjct: 184 TNAAGTALYMAPEVFKRDVTFKC----DIWSAG-VVMYFLLTGCLPFTG---TSLEEVQQ 235
Query: 227 KISEKKVS 234
K + K+ +
Sbjct: 236 KATYKEPN 243
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 4e-19
Identities = 60/250 (24%), Positives = 108/250 (43%), Gaps = 43/250 (17%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQ-LQYEAKLYK 57
+ ++ + +G GSFGE+ + T +E A+K + K K + E +L K
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 58 ILQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFN-FCSRK-LSLKTVLMLAD 110
L PN ++ F + E + +V +L G +LF+ RK S +
Sbjct: 77 KLDH----PNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIK 128
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 170
Q+ + + ++H + +HRD+KP+N L+ + + IIDFGL+ ++
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-------- 180
Query: 171 KNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPWQGLKAGTKKQK 224
K+ GTA Y + E R D+ S G V++Y L G+ P+ G +
Sbjct: 181 KDRIGTAYYIAP------EVLRGTYDEKCDVWSAG-VILYILLSGTPPFYG---KNEYDI 230
Query: 225 YEKISEKKVS 234
+++ K +
Sbjct: 231 LKRVETGKYA 240
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 7e-19
Identities = 44/229 (19%), Positives = 82/229 (35%), Gaps = 29/229 (12%)
Query: 4 RVGN-KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQ 60
+G + R+ R + G F +Y ++ + E A+K + + E K L
Sbjct: 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLS 83
Query: 61 GGTGI-------PNLRWFGVEGDYNVLVI-DLLGPSLEDLFNFCSRK--LSLKTVLMLAD 110
G I + G L++ +L L + + LS TVL +
Sbjct: 84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143
Query: 111 QMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD-----TATHQ 163
Q V+ +H + +HRD+K +N L+ + + DFG A + +
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 164 HIPYRENKNLTGTARYAS---MNTHLGIEQSRRDDLESLG---YVLMYF 206
E T Y + ++ + + D+ +LG Y+L +
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 8e-19
Identities = 63/281 (22%), Positives = 117/281 (41%), Gaps = 29/281 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL----QYEAKLYKILQGG 62
+ +G++IGSGSFG +Y G + +VA+K+ NV PQ + E + + +
Sbjct: 24 GQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH- 79
Query: 63 TGIPNLRWF-GV--EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
N+ F G +V G SL + K +K ++ +A Q +++
Sbjct: 80 ---VNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
+H+KS +HRD+K +N + N V I DFGLA + + + L+G+
Sbjct: 136 LHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLAT-----EKSRWSGSHQFEQLSGSIL 187
Query: 179 YAS---MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235
+ + + S + D+ + G VL + G LP+ + + Q E + +S
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGRGSLSP 245
Query: 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276
+ + P C + D++P + + +L
Sbjct: 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 64/247 (25%), Positives = 110/247 (44%), Gaps = 45/247 (18%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKH---PQLQYEAKLY 56
+P +GN +RL + IG G+F ++ L +I T EVAIK ++ + +L E ++
Sbjct: 10 EQPHIGN-YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIM 68
Query: 57 KILQGGTGIPN-LRWFGV-EGDYNVLVIDLLGPSLE-----DLFNFCSR--KLSLKTVLM 107
KIL PN ++ F V E + + +I +E ++F++ ++ K
Sbjct: 69 KILNH----PNIVKLFEVIETEKTLYLI------MEYASGGEVFDYLVAHGRMKEKEARS 118
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167
Q+++ V++ H K +HRD+K +N L L N + I DFG + +
Sbjct: 119 KFRQIVSAVQYCHQKRIVHRDLKAENLL--LDADMN-IKIADFGFSNEFTV--------- 166
Query: 168 RENKNLT---GTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 223
L G YA+ G + D+ SLG +L + GSLP+ G K+
Sbjct: 167 --GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG---QNLKE 221
Query: 224 KYEKISE 230
E++
Sbjct: 222 LRERVLR 228
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 46/247 (18%), Positives = 99/247 (40%), Gaps = 44/247 (17%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYK 57
+G K+ +G +G GS+G++ + +T A+K L + ++ E +L +
Sbjct: 3 LIG-KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR 61
Query: 58 ILQGGTGIPN-LR----WFGVEGDYNVLVIDLLGPSLEDLFNF-CSRKLSLKTVLMLADQ 111
L+ N ++ + E +V++ ++++ + ++ + Q
Sbjct: 62 RLRH----KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQ 117
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
+I+ +E++HS+ +H+DIKP N L L + I G+A+ P+ +
Sbjct: 118 LIDGLEYLHSQGIVHKDIKPGNLL--LTTGGT-LKISALGVAEALH--------PFAADD 166
Query: 172 NLT---GTARYAS------MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 222
G+ + ++T G + D+ S G L G P++G
Sbjct: 167 TCRTSQGSPAFQPPEIANGLDTFSGFKV----DIWSAGVTLYNITTGLYPFEG---DNIY 219
Query: 223 QKYEKIS 229
+ +E I
Sbjct: 220 KLFENIG 226
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 41/173 (23%), Positives = 73/173 (42%), Gaps = 21/173 (12%)
Query: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGTGIPNL- 68
+G G++G +Y G ++ +AIK + L E L+K L+ N+
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH----KNIV 82
Query: 69 RWFGVEGDYNVLVIDL---LGPSLEDL--FNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
++ G + + I + G SL L + K + +T+ Q++ ++++H
Sbjct: 83 QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
+HRDIK DN L + + + I DFG +KR + TGT
Sbjct: 143 IVHRDIKGDNVL--INTYSGVLKISDFGTSKRLAGINPC-------TETFTGT 186
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 2e-18
Identities = 40/188 (21%), Positives = 82/188 (43%), Gaps = 27/188 (14%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQG 61
V + + + ++G+G+FG ++ T T A K + ++ E + +L+
Sbjct: 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH 213
Query: 62 GTGIPNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQMI 113
P L E D + ++ + + G +LF + + +S + Q+
Sbjct: 214 ----PTLVNLHDAFEDDNEMVMIYEFMSGG----ELFEKVADEHNKMSEDEAVEYMRQVC 265
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 173
+ +H +++H D+KP+N + +R+N++ +IDFGL P + K
Sbjct: 266 KGLCHMHENNYVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLD--------PKQSVKVT 316
Query: 174 TGTARYAS 181
TGTA +A+
Sbjct: 317 TGTAEFAA 324
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 3e-18
Identities = 55/229 (24%), Positives = 97/229 (42%), Gaps = 41/229 (17%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL----------QYEAK 54
+ ++++ K+G G +YL + N +VAIK + E
Sbjct: 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKA-----IFIPPREKEETLKRFEREVH 63
Query: 55 LYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMI 113
L I ++ E D LV++ + GP+L + LS+ T + +Q++
Sbjct: 64 NSSQLSH-QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQIL 121
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 173
+ ++ H +HRDIKP N L+ + I DFG+AK +T+ Q ++
Sbjct: 122 DGIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIAKALSETSLTQ------TNHV 172
Query: 174 TGTARYASMNTHLGIEQSR------RDDLESLGYVLMY-FLRGSLPWQG 215
GT +Y S EQ++ D+ S+G +++Y L G P+ G
Sbjct: 173 LGTVQYFSP------EQAKGEATDECTDIYSIG-IVLYEMLVGEPPFNG 214
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-18
Identities = 65/253 (25%), Positives = 99/253 (39%), Gaps = 46/253 (18%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYK 57
P V + L + +G G++GE+ L N T E VA+K+ + + ++ E + K
Sbjct: 3 VPFVE-DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINK 60
Query: 58 ILQGGTGIPN-LRWFGV--EGDYNVLVIDLLGPSLE-----DLFNFCSRK--LSLKTVLM 107
+L N ++++G EG+ L LE +LF+ +
Sbjct: 61 MLNH----ENVVKFYGHRREGNIQYLF-------LEYCSGGELFDRIEPDIGMPEPDAQR 109
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167
Q++ V ++H HRDIKP+N L L R N + I DFGLA +R + +
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL-- 164
Query: 168 RENKNLTGTARYA-----SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 222
+ GT Y D+ S G VL L G LPW
Sbjct: 165 ---NKMCGTLPYVAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQ--PSDSC 215
Query: 223 QKYEKISEKKVST 235
Q+Y EKK
Sbjct: 216 QEYSDWKEKKTYL 228
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 5e-18
Identities = 38/174 (21%), Positives = 67/174 (38%), Gaps = 16/174 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
+ ++G GSFGE++ + QT + A+K ++ E L P
Sbjct: 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV---FRVEELVACAGLSS----P 110
Query: 67 NL-RWFGVEGDYNVLVIDL---LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
+ +G + + I + G SL L L L Q + +E++H++
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTR 169
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
LH D+K DN L L ++ + DFG A + + + + GT
Sbjct: 170 RILHGDVKADNVL--LSSDGSRAALCDFGHALCLQPDGLGKSLLTG--DYIPGT 219
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 6e-18
Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 40/220 (18%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LQYEAKLYKIL 59
V + + + ++GSG+FG ++ T K + T +P ++ E + L
Sbjct: 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF--INTPYPLDKYTVKNEISIMNQL 105
Query: 60 QGGTGIPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRK---LSLKTVLMLADQ 111
P L + VL+++ L G +LF+ + + +S V+ Q
Sbjct: 106 HH----PKLINLHDAFEDKYEMVLILEFLSGG----ELFDRIAAEDYKMSEAEVINYMRQ 157
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
++ +H S +H DIKP+N + ++A+ V IIDFGLA + P K
Sbjct: 158 ACEGLKHMHEHSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLN--------PDEIVK 208
Query: 172 NLTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMYFL 207
T TA +A+ +G D+ ++G VL Y L
Sbjct: 209 VTTATAEFAAPEIVDREPVGFYT----DMWAIG-VLGYVL 243
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 6e-18
Identities = 44/177 (24%), Positives = 78/177 (44%), Gaps = 29/177 (16%)
Query: 4 RVGNKFRLGR-----KIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYK 57
G ++ R K+G G F ++L ++ N VA+K + K + E KL +
Sbjct: 11 FKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQ 70
Query: 58 IL-------QGGTGIPN----LRWF---GVEGDYNVLVIDLLGPSLEDL---FNFCSRKL 100
+ + G + L F G G + V+V ++LG +L L + R +
Sbjct: 71 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEH--RGI 128
Query: 101 SLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRR---ANQVYIIDFGLA 153
L V ++ Q++ ++++H + +H DIKP+N LM + Q+ I D G A
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 7e-18
Identities = 44/200 (22%), Positives = 64/200 (32%), Gaps = 25/200 (12%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQ 60
R F + +G G FG ++ N + AIK L N + ++ E K L+
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 61 ---------GGTGIPNLRWFGVEGDYNVLVIDL---LGPSLEDLFNFCSRKLSL--KTVL 106
L I + +L+D N L
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166
+ Q+ VEF+HSK +HRD+KP N + V + DFGL Q +
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 167 YRENKNLT-----GTARYAS 181
GT Y S
Sbjct: 179 TPMPAYARHTGQVGTKLYMS 198
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 36/181 (19%), Positives = 75/181 (41%), Gaps = 26/181 (14%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYK---ILQGGTGIPN 67
+++G G F + + T +E A K +K + A++ +L+ P
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAKF--LKKRRRGQDCRAEILHEIAVLELAKSCPR 90
Query: 68 L-RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRK----LSLKTVLMLADQMINRVEF 118
+ V +L+++ G ++F+ C + +S V+ L Q++ V +
Sbjct: 91 VINLHEVYENTSEIILILEYAAGG----EIFSLCLPELAEMVSENDVIRLIKQILEGVYY 146
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
+H + +H D+KP N L+ + I+DFG++++ E + + GT
Sbjct: 147 LHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG--------HACELREIMGTPE 198
Query: 179 Y 179
Y
Sbjct: 199 Y 199
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-17
Identities = 32/188 (17%), Positives = 73/188 (38%), Gaps = 29/188 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY---------EAKLYK 57
N+ ++IG G FG ++ G ++ VAIK + + + E +
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 58 ILQGGTGIPN-LRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
L PN ++ +G+ + +V++ + L + + L L +
Sbjct: 79 NLNH----PNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 116 VEFVHSKS--FLHRDIKPDNFLMGLGRRANQVY--IIDFGLAKRYRDTATHQHIPYRENK 171
+E++ +++ +HRD++ N + V + DFGL+++ + +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS---------- 184
Query: 172 NLTGTARY 179
L G ++
Sbjct: 185 GLLGNFQW 192
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 58/228 (25%), Positives = 91/228 (39%), Gaps = 30/228 (13%)
Query: 2 EPRVGNKF---RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL--------- 49
E R G +F RL R +G G G++Y + VA+KL L
Sbjct: 26 ESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKL-----MSETLSSDPVFRTR 80
Query: 50 -QYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLM 107
Q EA+ LQ + + FG + + L+ G L + L+ +
Sbjct: 81 MQREARTAGRLQE-PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP-LAPPRAVA 138
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167
+ Q+ + ++ H+ HRD+KP+N L+ + Y++DFG+A D Q
Sbjct: 139 IVRQIGSALDAAHAAGATHRDVKPENILVS---ADDFAYLVDFGIASATTDEKLTQ---- 191
Query: 168 RENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
N GT Y + + R D+ +L VL L GS P+QG
Sbjct: 192 --LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG 237
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 1e-17
Identities = 38/167 (22%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG 64
+ +++ + + +GSG+ GE+ L +T ++VAI++ + + EA ++
Sbjct: 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIE 192
Query: 65 I------PN-LRWFGVEGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQM 112
I P ++ + +V++L+ G +LF+ +L T + QM
Sbjct: 193 ILKKLNHPCIIKIKNFFDAEDYYIVLELMEGG----ELFDKVVGNKRLKEATCKLYFYQM 248
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
+ V+++H +HRD+KP+N L+ + I DFG +K +T
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 295
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 42/169 (24%), Positives = 80/169 (47%), Gaps = 19/169 (11%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQ-LQYEAKLYK 57
+ ++ + +G GSFGE+ + T +E A+K+ + K K + E +L K
Sbjct: 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76
Query: 58 ILQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFN-FCSR-KLSLKTVLMLAD 110
L PN ++ F + E + +V +L G +LF+ R + S +
Sbjct: 77 KLDH----PNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIK 128
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
Q+ + + ++H + +HRD+KP+N L+ + + IIDFGL+ ++
Sbjct: 129 QVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 46/180 (25%), Positives = 77/180 (42%), Gaps = 47/180 (26%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---------------- 45
+ +G + + +G GSFG++ L T+ +T ++VA+K + +
Sbjct: 5 KRHIGP-YIIRETLGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISY 62
Query: 46 -----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK- 99
HP + KLY ++ T I V+VI+ G +LF++ K
Sbjct: 63 LKLLRHPHI---IKLYDVITTPTDI-------------VMVIEYAG---GELFDYIVEKK 103
Query: 100 -LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
++ Q+I +E+ H +HRD+KP+N L L N V I DFGL+ D
Sbjct: 104 RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLL--LDDNLN-VKIADFGLSNIMTD 160
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 65/253 (25%), Positives = 99/253 (39%), Gaps = 46/253 (18%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYK 57
P V + L + +G G++GE+ L N T E VA+K+ + + ++ E + K
Sbjct: 3 VPFVE-DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVD-MKRAVDCPENIKKEICINK 60
Query: 58 ILQGGTGIPN-LRWFGV--EGDYNVLVIDLLGPSLE-----DLFNFCSRK--LSLKTVLM 107
+L N ++++G EG+ L LE +LF+ +
Sbjct: 61 MLNH----ENVVKFYGHRREGNIQYLF-------LEYCSGGELFDRIEPDIGMPEPDAQR 109
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167
Q++ V ++H HRDIKP+N L L R N + I DFGLA +R + +
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNNRERLL-- 164
Query: 168 RENKNLTGTARYA-----SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK 222
+ GT Y D+ S G VL L G LPW
Sbjct: 165 ---NKMCGTLPYVAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQ--PSDSC 215
Query: 223 QKYEKISEKKVST 235
Q+Y EKK
Sbjct: 216 QEYSDWKEKKTYL 228
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 48/200 (24%), Positives = 87/200 (43%), Gaps = 38/200 (19%)
Query: 1 MEP----RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQ 48
MEP +V + + +G ++GSG F + T E A K +
Sbjct: 2 MEPFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61
Query: 49 LQYEAKLYKILQGGTGIPNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRKLSL- 102
++ E + + + N+ V E +V L+++L+ G +LF+F ++K SL
Sbjct: 62 IEREVSILRQVLH----HNVITLHDVYENRTDVVLILELVSGG----ELFDFLAQKESLS 113
Query: 103 -KTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKRYRDT 159
+ Q+++ V ++H+K H D+KP+N ++ L + + +IDFGLA D
Sbjct: 114 EEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML-LDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 160 ATHQHIPYRENKNLTGTARY 179
KN+ GT +
Sbjct: 173 VEF--------KNIFGTPEF 184
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 42/227 (18%), Positives = 86/227 (37%), Gaps = 30/227 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL----QYEAKLYKILQGG 62
+ +G IG G FG++Y G + EVAI+L +++ + + E Y+ +
Sbjct: 33 EQLEIGELIGKGRFGQVYHGR---WHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRH- 88
Query: 63 TGIPNL-RWFGV--EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
N+ + G + ++ L G +L + L + +A +++ + +
Sbjct: 89 ---ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGY 145
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
+H+K LH+D+K N G+ V I DFGL + + + G
Sbjct: 146 LHAKGILHKDLKSKNVFYDNGK----VVITDFGLFSISGVLQAGRR--EDKLRIQNGWLC 199
Query: 179 Y---------ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 216
+ + + S+ D+ +LG + P++
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 38/174 (21%), Positives = 68/174 (39%), Gaps = 28/174 (16%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----------LENVKTKHPQLQY 51
+ +G G + + T +E A+K E V+
Sbjct: 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 72
Query: 52 EAKLYKILQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKT 104
E IL+ +G PN ++ E + LV DL+ G +LF++ + LS K
Sbjct: 73 EV---DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG----ELFDYLTEKVTLSEKE 125
Query: 105 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
+ ++ + +H + +HRD+KP+N L L N + + DFG + +
Sbjct: 126 TRKIMRALLEVICALHKLNIVHRDLKPENIL--LDDDMN-IKLTDFGFSCQLDP 176
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 39/167 (23%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG 64
+ +++ + + +GSG+ GE+ L +T ++VAIK+ + + EA ++
Sbjct: 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 65 I------PN-LRWFGVEGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQM 112
I P ++ + +V++L+ G +LF+ +L T + QM
Sbjct: 68 ILKKLNHPCIIKIKNFFDAEDYYIVLELMEGG----ELFDKVVGNKRLKEATCKLYFYQM 123
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
+ V+++H +HRD+KP+N L+ + I DFG +K +T
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 52/280 (18%), Positives = 98/280 (35%), Gaps = 57/280 (20%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--------------LENVKT----- 44
+ K+ L IG GS+G + + QT AIK +E +KT
Sbjct: 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLM 82
Query: 45 ---KHPQL--QYEA-----KLYKIL---QGG--------------TGIPNLRWFGVEGDY 77
HP + YE + ++ GG
Sbjct: 83 KKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 78 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 137
+ + S+ K + + Q+ + + ++H++ HRDIKP+NFL
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF- 201
Query: 138 LGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS--MNTHLGIEQSRRDD 195
++ ++ ++DFGL+K + ++ GT + + + + D
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT---KAGTPYFVAPEVLNTTNESYGPKCD 258
Query: 196 LESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEKISEKKVS 234
S G VL++ L G++P+ G ++ KK+
Sbjct: 259 AWSAG-VLLHLLLMGAVPFPG---VNDADTISQVLNKKLC 294
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 63/261 (24%), Positives = 108/261 (41%), Gaps = 54/261 (20%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---------------LENVKTKH 46
E ++G + RK+GSG++GE+ L + E AIK +N++ H
Sbjct: 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFH 90
Query: 47 PQLQYEAKLYKILQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFN-FCSRK- 99
++ E L K L PN ++ F V E LV + G +LF +R
Sbjct: 91 EEIYNEISLLKSLDH----PNIIKLFDVFEDKKYFYLVTEFYEGG----ELFEQIINRHK 142
Query: 100 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
+ Q+++ + ++H + +HRDIKP+N L+ + I+DFGL+ +
Sbjct: 143 FDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202
Query: 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYF-LRGSLPW 213
++ GTA Y + E ++ D+ S G V+MY L G P+
Sbjct: 203 YKL--------RDRLGTAYYIAP------EVLKKKYNEKCDVWSCG-VIMYILLCGYPPF 247
Query: 214 QGLKAGTKKQKYEKISEKKVS 234
G + +K+ + K
Sbjct: 248 GG---QNDQDIIKKVEKGKYY 265
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 6e-17
Identities = 41/167 (24%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQ-LQYEAKLYKI 58
+ + + + ++G G+F + + T E A K+ + + + Q L+ EA++ +
Sbjct: 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 59 LQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQ 111
LQ PN +R + + LV DL+ G +LF +R S Q
Sbjct: 62 LQH----PNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREFYSEADASHCIQQ 113
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
++ + + HS +HR++KP+N L+ + V + DFGLA D
Sbjct: 114 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 6e-17
Identities = 62/247 (25%), Positives = 100/247 (40%), Gaps = 45/247 (18%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKI 58
+ + L IG GS+GE+ + T A K +E+V + + E ++ K
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVD----RFKQEIEIMKS 62
Query: 59 LQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRK--LSLKTVLMLADQ 111
L PN +R + E + ++ LV++L G +LF K +
Sbjct: 63 LDH----PNIIRLYETFEDNTDIYLVMELCTGG----ELFERVVHKRVFRESDAARIMKD 114
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENK 171
+++ V + H + HRD+KP+NFL + + +IDFGLA R++ +
Sbjct: 115 VLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--------R 166
Query: 172 NLTGTARYAS---MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYEK 227
GT Y S + G E D S G V+MY L G P+ T + K
Sbjct: 167 TKVGTPYYVSPQVLEGLYGPEC----DEWSAG-VMMYVLLCGYPPFSA---PTDSEVMLK 218
Query: 228 ISEKKVS 234
I E +
Sbjct: 219 IREGTFT 225
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 8e-17
Identities = 39/178 (21%), Positives = 69/178 (38%), Gaps = 48/178 (26%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVK--------TKHP 47
++ + IGSG+FG L + T E VA+K ENV+ +HP
Sbjct: 18 DSD-RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHP 76
Query: 48 QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLE-----DLFNF-CSR-KL 100
+ + +++ T + ++ E +L+ C+ +
Sbjct: 77 NI---VRFKEVILTPTHL-----------AIIM---------EYASGGELYERICNAGRF 113
Query: 101 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
S Q+++ V + HS HRD+K +N L+ G A ++ I DFG +K
Sbjct: 114 SEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVL 170
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 9e-17
Identities = 44/189 (23%), Positives = 82/189 (43%), Gaps = 28/189 (14%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG 64
V + + +G ++GSG F + T +E A K +K + + ++
Sbjct: 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKF--IKKRRLSSSRRGVSREEIEREVN 60
Query: 65 I------PNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRKLSL--KTVLMLADQ 111
I PN+ + E +V L+++L+ G +LF+F + K SL Q
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGG----ELFDFLAEKESLTEDEATQFLKQ 116
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 170
+++ V ++HSK H D+KP+N ++ ++ +IDFG+A +
Sbjct: 117 ILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF-------- 168
Query: 171 KNLTGTARY 179
KN+ GT +
Sbjct: 169 KNIFGTPEF 177
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 40/172 (23%), Positives = 82/172 (47%), Gaps = 30/172 (17%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------HPQLQYEAKL 55
++G+ + LG +G G+FG++ +G + T +VA+K+ N + K +++ E +
Sbjct: 7 RVKIGH-YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQN 64
Query: 56 YKILQGGTGIPN-LRWFGV-EGDYNVLVIDLLGPSLE-----DLFNFCSRK--LSLKTVL 106
K+ + P+ ++ + V + ++ +E +LF++ + +
Sbjct: 65 LKLFRH----PHIIKLYQVISTPTDFFMV------MEYVSGGELFDYICKHGRVEEMEAR 114
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
L Q+++ V++ H +HRD+KP+N L L N I DFGL+ D
Sbjct: 115 RLFQQILSAVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLSNMMSD 163
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 39/180 (21%), Positives = 71/180 (39%), Gaps = 25/180 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
+ + +G G+FG + ++VAIK +++ E + + P
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAK--WRAKDVAIKQIESESERKAFIVELRQLSRVNH----P 61
Query: 67 N-LRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHS- 121
N ++ +G + LV++ G SL ++ + + + Q V ++HS
Sbjct: 62 NIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 122 --KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
K+ +HRD+KP N L L + I DFG A + T N G+A +
Sbjct: 122 QPKALIHRDLKPPNLL--LVAGGTVLKICDFGTACDIQTHMT----------NNKGSAAW 169
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 43/209 (20%), Positives = 69/209 (33%), Gaps = 43/209 (20%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKL 55
M+ R +F KIGSG FG ++ AIK L + L+
Sbjct: 5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAH 64
Query: 56 YKILQGGTGIPN-LRWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSL---KTVLML 108
+ Q + +R+F E D+ ++ + G SL D + R +S + L
Sbjct: 65 AVLGQ----HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYII---------------DFGL 152
Q+ + ++HS S +H DIKP N F+ D G
Sbjct: 121 LLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 153 AKRYRDTATHQHIPYRENKNLTGTARYAS 181
R G +R+ +
Sbjct: 181 VTRISSPQV-----------EEGDSRFLA 198
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 50/260 (19%), Positives = 90/260 (34%), Gaps = 46/260 (17%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
N++ L +IG GS+G + L N N A+K+ + K Q + +
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 67 NLRWFGVEGDY-------------NVL----VIDLLGPS-----LE-----DLFNFCSR- 98
++ G NV+ V+D E + +
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK 132
Query: 99 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
LS +I +E++H + +HRDIKP N L+G + I DFG++ ++
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKIADFGVSNEFKG 189
Query: 159 TATHQHIPYRENKNLTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 214
+ N GT + + T + D+ ++G L F+ G P+
Sbjct: 190 SDALLS-------NTVGTPAFMAPESLSETRKIFS-GKALDVWAMGVTLYCFVFGQCPFM 241
Query: 215 GLKAGTKKQKYEKISEKKVS 234
+ KI + +
Sbjct: 242 D---ERIMCLHSKIKSQALE 258
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 30/167 (17%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGT 63
V ++ + + IG GSFG++ + + ++ VA+K + N K H Q E + IL+
Sbjct: 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR---ILE--- 148
Query: 64 GIPNLRWFGVEGDYNV--------------LVIDLLGPSLEDLF---NFCSRKLSLKTVL 106
+LR + NV + +LL +L +L F + SL V
Sbjct: 149 ---HLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKF--QGFSLPLVR 203
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
A ++ ++ +H +H D+KP+N L+ R + + +IDFG +
Sbjct: 204 KFAHSILQCLDALHKNRIIHCDLKPENILLKQQGR-SGIKVIDFGSS 249
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 50/209 (23%), Positives = 86/209 (41%), Gaps = 33/209 (15%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
+ +G GSF + ++N+ A+K+ + K Q E K+ +G I L
Sbjct: 15 KDKPLGEGSFSICRKCVHKKSNQAFAVKIIS-KRMEANTQKEITALKLCEGHPNIVKLHE 73
Query: 71 FGVEGDYNVLVIDLL--GPSLEDLF-------NFCSRKLSLKTVLMLADQMINRVEFVHS 121
+ + LV++LL G +LF +F + S + ++++ V +H
Sbjct: 74 VFHDQLHTFLVMELLNGG----ELFERIKKKKHFSETEAS-----YIMRKLVSAVSHMHD 124
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT---GTAR 178
+HRD+KP+N L ++ IIDFG A+ +N+ L T
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP----------DNQPLKTPCFTLH 174
Query: 179 YASMNTHLGIEQSRRDDLESLGYVLMYFL 207
YA+ DL SLG V++Y +
Sbjct: 175 YAAPELLNQNGYDESCDLWSLG-VILYTM 202
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 45/193 (23%), Positives = 83/193 (43%), Gaps = 34/193 (17%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQLQYEAKL 55
+V + + +G ++GSG F + T E A K +++ E +
Sbjct: 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSI 68
Query: 56 YKILQGGTGIPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRKLSL--KTVLML 108
+ + PN+ V VL+++L+ G +LF+F ++K SL +
Sbjct: 69 LRQVLH----PNIITLHDVYENRTDVVLILELVSGG----ELFDFLAQKESLSEEEATSF 120
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKRYRDTATHQHIP 166
Q+++ V ++H+K H D+KP+N ++ L + + +IDFGLA D
Sbjct: 121 IKQILDGVNYLHTKKIAHFDLKPENIML-LDKNIPIPHIKLIDFGLAHEIEDGVEF---- 175
Query: 167 YRENKNLTGTARY 179
KN+ GT +
Sbjct: 176 ----KNIFGTPEF 184
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 46/189 (24%), Positives = 81/189 (42%), Gaps = 28/189 (14%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG 64
V + + G ++GSG F + T + A K +K + + + ++
Sbjct: 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKF--IKKRRTKSSRRGVSREDIEREVS 66
Query: 65 I------PNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRKLSL--KTVLMLADQ 111
I PN+ V E +V L+++L+ G +LF+F + K SL + Q
Sbjct: 67 ILKEIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQ 122
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMG-LGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 170
++N V ++HS H D+KP+N ++ ++ IIDFGLA +
Sbjct: 123 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF-------- 174
Query: 171 KNLTGTARY 179
KN+ GT +
Sbjct: 175 KNIFGTPEF 183
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 5e-16
Identities = 54/267 (20%), Positives = 96/267 (35%), Gaps = 41/267 (15%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLQYEAKLY 56
M R + + IG+GS+G + + K ++ L E L
Sbjct: 1 MPSRA-EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLL 59
Query: 57 KILQGGTGIPNL-----RWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRK---LSLKTVLM 107
+ L+ PN+ R +V++ G L + +++ L + VL
Sbjct: 60 RELKH----PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLR 115
Query: 108 LADQMINRVEFVHSKSF-----LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162
+ Q+ ++ H +S LHRD+KP N + V + DFGLA+ +
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTSF 172
Query: 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQG-----L 216
K GT Y S + + + D+ SLG L+Y L P+ L
Sbjct: 173 -------AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLG-CLLYELCALMPPFTAFSQKEL 224
Query: 217 KAGTKKQKYEKISEKKVSTSIEALCRG 243
++ K+ +I + S + +
Sbjct: 225 AGKIREGKFRRIPY-RYSDELNEIITR 250
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 5e-16
Identities = 42/169 (24%), Positives = 75/169 (44%), Gaps = 19/169 (11%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYK 57
+ + + + ++G G+F + + T E A K+ N K +L+ EA++ +
Sbjct: 24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 83
Query: 58 ILQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLAD 110
LQ PN +R + + LV DL+ G +LF +R S
Sbjct: 84 KLQH----PNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREFYSEADASHCIQ 135
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
Q++ + + HS +HR++KP+N L+ + V + DFGLA D+
Sbjct: 136 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 38/169 (22%), Positives = 68/169 (40%), Gaps = 21/169 (12%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLY-------K 57
K+ IG G + + T E A+K+ V + + ++
Sbjct: 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH 151
Query: 58 ILQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLAD 110
IL+ G P+ + E + LV DL+ G +LF++ + LS K +
Sbjct: 152 ILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG----ELFDYLTEKVALSEKETRSIMR 207
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
++ V F+H+ + +HRD+KP+N L L + + DFG +
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENIL--LDDNMQ-IRLSDFGFSCHLEPG 253
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 42/162 (25%), Positives = 81/162 (50%), Gaps = 8/162 (4%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGT 63
+ ++L RK+G G + E++ NI NE+V +K L+ VK K +++ E K+ + L+GG
Sbjct: 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK--KIKREIKILENLRGGP 91
Query: 64 GIPNLRWFGVEGDYNVLVIDLLGPSLEDL-FNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
I L + D L+ + + F + L+ + +++ +++ HS
Sbjct: 92 NIITL--ADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSM 149
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164
+HRD+KP N ++ R ++ +ID+GLA+ Y +
Sbjct: 150 GIMHRDVKPHNVMIDHEHR--KLRLIDWGLAEFYHPGQEYNV 189
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 6e-16
Identities = 45/170 (26%), Positives = 71/170 (41%), Gaps = 23/170 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------LENVKTKHPQLQYEAKLYKILQ 60
FR+ +KIG G F E+Y + VA+K L + K + E L K L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARA-DCIKEIDLLKQLN 90
Query: 61 GGTGIPN-LRWFGVEGDYNVLVIDL---LGPSLEDLFNFCSRKLSL---KTVLMLADQMI 113
PN ++++ + N L I L L + ++ L +TV Q+
Sbjct: 91 H----PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLC 146
Query: 114 NRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTATH 162
+ +E +HS+ +HRDIKP N F+ V + D GL + + T
Sbjct: 147 SALEHMHSRRVMHRDIKPANVFIT----ATGVVKLGDLGLGRFFSSKTTA 192
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 6e-16
Identities = 49/251 (19%), Positives = 93/251 (37%), Gaps = 49/251 (19%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-------TKHPQLQYEAKLYKILQ 60
+ L IG G F + N +T ++ A+K+ +V L+ EA + +L+
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 61 GGTGIPNL-RWFGV-EGDYNV-LVIDLL--GPSLEDLFNFCSRKLSLKTVLMLAD----- 110
P++ D + +V + + DL ++ V A
Sbjct: 85 H----PHIVELLETYSSDGMLYMVFEFMDGA----DLCFEIVKRADAGFVYSEAVASHYM 136
Query: 111 -QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 169
Q++ + + H + +HRD+KP L+ + V + FG+A + +
Sbjct: 137 RQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-------SGLV 189
Query: 170 NKNLTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLP-WQGLKAGTKKQ 223
GT + + G D+ G V+++ L G LP + GTK++
Sbjct: 190 AGGRVGTPHFMAPEVVKREPYGKPV----DVWGCG-VILFILLSGCLPFY-----GTKER 239
Query: 224 KYEKISEKKVS 234
+E I + K
Sbjct: 240 LFEGIIKGKYK 250
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 6e-16
Identities = 53/237 (22%), Positives = 99/237 (41%), Gaps = 49/237 (20%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQL----------QYEA 53
+ +++ LG +G G E++L +++ + +VA+K+ L + EA
Sbjct: 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKV-----LRADLARDPSFYLRFRREA 63
Query: 54 KLYKILQGGTGIPNL-------RWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTV 105
+ L P + G +V++ + G +L D+ + ++ K
Sbjct: 64 QNAAALNH----PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRA 118
Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 165
+ + + F H +HRD+KP N ++ N V ++DFG+A+ D+
Sbjct: 119 IEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGN---- 171
Query: 166 PYRENKNLTGTARYASMNTHLGIEQSR------RDDLESLGYVLMY-FLRGSLPWQG 215
+ + GTA+Y S EQ+R R D+ SLG ++Y L G P+ G
Sbjct: 172 SVTQTAAVIGTAQYLSP------EQARGDSVDARSDVYSLG-CVLYEVLTGEPPFTG 221
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 7e-16
Identities = 42/186 (22%), Positives = 76/186 (40%), Gaps = 18/186 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQ--LQYEAKLYKILQGGT 63
+ G +G G FG+ T+ +T E + +K L + + L+ E K+ + L+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK-EVKVMRCLEH-- 66
Query: 64 GIPN-LRWFGV---EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
PN L++ GV + N + + + G +L + + + A + + + +
Sbjct: 67 --PNVLKFIGVLYKDKRLN-FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAY 123
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
+HS + +HRD+ N L+ V + DFGLA R Q R K R
Sbjct: 124 LHSMNIIHRDLNSHNCLVR---ENKNVVVADFGLA-RLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 179 YASMNT 184
Y +
Sbjct: 180 YTVVGN 185
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 77.2 bits (191), Expect = 7e-16
Identities = 39/165 (23%), Positives = 78/165 (47%), Gaps = 17/165 (10%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQ 60
+ F +GSG+F E++L T + A+K ++ + L+ E + K ++
Sbjct: 5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK 64
Query: 61 GGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQMI 113
N + + E + LV+ L+ G +LF+ R + K ++ Q++
Sbjct: 65 H----ENIVTLEDIYESTTHYYLVMQLVSGG----ELFDRILERGVYTEKDASLVIQQVL 116
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
+ V+++H +HRD+KP+N L +++ I DFGL+K ++
Sbjct: 117 SAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 37/168 (22%), Positives = 69/168 (41%), Gaps = 26/168 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKH-PQLQYEAKLYKILQGG 62
K+ +KIG GSFG+ L + + + IK + + +K + + E + ++
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH- 82
Query: 63 TGIPN-LRWFGVEGDYNVLVIDLLGPSLE-----DLFNFCSRK----LSLKTVLMLADQM 112
PN +++ + L I ++ DLF + + +L Q+
Sbjct: 83 ---PNIVQYRESFEENGSLYI-----VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI 134
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
++ VH + LHRDIK N + + V + DFG+A+ T
Sbjct: 135 CLALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARVLNSTV 179
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 42/227 (18%), Positives = 79/227 (34%), Gaps = 40/227 (17%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNE-EVAIK-LENVKTKHPQ--LQYEAKLYKIL 59
V ++ + I G G IYL + N V +K L + Q E + +
Sbjct: 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV 136
Query: 60 QGGTGIPNLRWFGVEGDYNV-----LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMI 113
I + F D + +V++ + G SL+ +KL + + +++
Sbjct: 137 VH-PSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEIL 192
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 173
+ ++HS ++ D+KP+N ++ Q+ +ID G R L
Sbjct: 193 PALSYLHSIGLVYNDLKPENIML----TEEQLKLIDLGAVSRINSFGY-----------L 237
Query: 174 TGTARYASMNTHLGIEQSR-----RDDLESLGYVLMYFLRGSLPWQG 215
GT + + E R D+ ++G L G
Sbjct: 238 YGTPGFQAP------EIVRTGPTVATDIYTVGRTLAALTLDLPTRNG 278
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 40/167 (23%), Positives = 73/167 (43%), Gaps = 19/167 (11%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKI 58
R +++L ++G G+F + + +E A + N K H +L+ EA++ ++
Sbjct: 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66
Query: 59 LQGGTGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQ 111
L+ PN +R + + L+ DL+ G +LF +R S Q
Sbjct: 67 LKH----PNIVRLHDSISEEGHHYLIFDLVTGG----ELFEDIVAREYYSEADASHCIQQ 118
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
++ V H +HR++KP+N L+ + V + DFGLA
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 44/185 (23%), Positives = 75/185 (40%), Gaps = 29/185 (15%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPN-LR 69
L IG G FGE++ G EEVA+K+ + + + + EA++Y+ + N L
Sbjct: 46 LQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFR-EAEIYQTVMLRH--ENILG 100
Query: 70 WFGVEGDYNVLVIDLL-------GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
+ + N L SL D N ++++ ++ LA + + +H +
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHME 158
Query: 123 --------SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 174
+ HRD+K N L+ ++ I D GLA R+ I +
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIA---PNHRV 212
Query: 175 GTARY 179
GT RY
Sbjct: 213 GTKRY 217
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 50/222 (22%), Positives = 90/222 (40%), Gaps = 27/222 (12%)
Query: 3 PRVGNKFRLGRK-IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKIL 59
R + ++L +G G+ + N+ T++E A+K+ + H + + E ++
Sbjct: 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQC 67
Query: 60 QGGTGIPNLRWFGVEGDYNVLVIDLL--GPSLEDLF-------NFCSRKLSLKTVLMLAD 110
QG + L F E D LV + + G + +F + S ++
Sbjct: 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGG----SILSHIHKRRHFNELEAS-----VVVQ 118
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 170
+ + ++F+H+K HRD+KP+N L + + V I DF L + I E
Sbjct: 119 DVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 171 KNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMYFL 207
G+A Y + + DL SLG V++Y L
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG-VILYIL 219
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 46/193 (23%), Positives = 77/193 (39%), Gaps = 45/193 (23%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYK--------ILQ-- 60
+ ++IG G +GE+++G E+VA+K+ + + E ++Y+ IL
Sbjct: 41 MVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFR-ETEIYQTVLMRHENILGFI 97
Query: 61 -----GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
G L + L+ D SL D S L K++L LA ++
Sbjct: 98 AADIKGTGSWTQL-Y---------LITDYHENGSLYDYLK--STTLDAKSMLKLAYSSVS 145
Query: 115 RVEFVHSKSF--------LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIP 166
+ +H++ F HRD+K N L+ ++ I D GLA ++ IP
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIP 202
Query: 167 YRENKNLTGTARY 179
GT RY
Sbjct: 203 ---PNTRVGTKRY 212
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-15
Identities = 41/192 (21%), Positives = 68/192 (35%), Gaps = 43/192 (22%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYK--------ILQ-- 60
L +G G +GE++ G+ E VA+K+ + + + + E +LY IL
Sbjct: 12 LLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFR-ETELYNTVMLRHENILGFI 68
Query: 61 ----GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
W L+ SL D L + L + + +
Sbjct: 69 ASDMTSRHSSTQLW---------LITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASG 117
Query: 116 VEFVHSKSF--------LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167
+ +H + F HRD+K N L+ ++ Q I D GLA + + +
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVG- 173
Query: 168 RENKNLTGTARY 179
N GT RY
Sbjct: 174 --NNPRVGTKRY 183
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 43/184 (23%), Positives = 79/184 (42%), Gaps = 54/184 (29%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT----- 44
++G+ + LG +G G+FG++ +G + T +VA+K + ++
Sbjct: 12 RVKIGH-YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNL 70
Query: 45 ---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLE-----DLFNFC 96
+HP + KLY+++ + I +V +E +LF++
Sbjct: 71 KLFRHPHI---IKLYQVISTPSDI-------------FMV-------MEYVSGGELFDYI 107
Query: 97 SRK--LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ L K L Q+++ V++ H +HRD+KP+N L L N I DFGL+
Sbjct: 108 CKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLSN 164
Query: 155 RYRD 158
D
Sbjct: 165 MMSD 168
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 5e-15
Identities = 58/248 (23%), Positives = 97/248 (39%), Gaps = 40/248 (16%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG 62
+ + + + IG GS+ + TN E A+K+ + K+K + L + Q
Sbjct: 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-KSKRDPTEEIEILLRYGQH- 75
Query: 63 TGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFN--FCSRKLSLKTVLMLADQMINR 115
PN + V + V +V +L+ G +L + + S + + +
Sbjct: 76 ---PNIITLKDVYDDGKYVYVVTELMKGG----ELLDKILRQKFFSEREASAVLFTITKT 128
Query: 116 VEFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLT 174
VE++H++ +HRD+KP N L + I DFG AK+ R EN L
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA----------ENGLLM 178
Query: 175 ---GTARYAS----MNTHLGIEQSRRDDLESLGYVLMYF-LRGSLPWQGLKAGTKKQKYE 226
TA + + D+ SLG VL+Y L G P+ T ++
Sbjct: 179 TPCYTANFVAPEVLERQGYDAAC----DIWSLG-VLLYTMLTGYTPFANGPDDTPEEILA 233
Query: 227 KISEKKVS 234
+I K S
Sbjct: 234 RIGSGKFS 241
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 6e-15
Identities = 43/259 (16%), Positives = 89/259 (34%), Gaps = 49/259 (18%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGI 65
N +R+ R + G F +I L N+ A+K E + + ++ KI
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 66 --------------PN-LRWFGVEGD----YNVL-------VIDLLGPSLEDLFNFCSRK 99
L G+ + Y + ++ L +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD-EYFFVLDKNYTCF 147
Query: 100 LSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
+ ++ + + ++N ++H+ K+ HRD+KP N LM + +V + DFG ++ D
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD---KNGRVKLSDFGESEYMVD 204
Query: 159 TATHQHIPYRENKNLTGTARYAS--MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 215
GT + ++ + D+ SLG + +Y +P+
Sbjct: 205 KKIK---------GSRGTYEFMPPEFFSNESSYNGAKVDIWSLG-ICLYVMFYNVVPFSL 254
Query: 216 LKAGTKKQKYEKISEKKVS 234
+ + + I K +
Sbjct: 255 --KISLVELFNNIRTKNIE 271
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 6e-15
Identities = 46/190 (24%), Positives = 86/190 (45%), Gaps = 33/190 (17%)
Query: 4 RVGNKFRLGRK--IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LQYEAKLYK 57
V + + + + +G G FG+++ T ++A K+ +KT+ + ++ E +
Sbjct: 84 AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKI--IKTRGMKDKEEVKNEISVMN 141
Query: 58 ILQGGTGIPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRK---LSLKTVLMLA 109
L NL + + + VLV++ + G +LF+ + L+ ++
Sbjct: 142 QLDH----ANLIQLYDAFESKNDIVLVMEYVDGG----ELFDRIIDESYNLTELDTILFM 193
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 169
Q+ + +H LH D+KP+N L + R A Q+ IIDFGLA+RY+ P +
Sbjct: 194 KQICEGIRHMHQMYILHLDLKPENILC-VNRDAKQIKIIDFGLARRYK--------PREK 244
Query: 170 NKNLTGTARY 179
K GT +
Sbjct: 245 LKVNFGTPEF 254
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 6e-15
Identities = 42/192 (21%), Positives = 78/192 (40%), Gaps = 37/192 (19%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKL------ENVKTKHPQLQYEAKLYKIL 59
+ L IG G FG++Y +EVA+K E++ ++ EAKL+ +L
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 60 QGGTGIPNL-RWFGV--EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
+ PN+ GV + LV++ G L + + +++ ++ A Q+
Sbjct: 64 KH----PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARG 117
Query: 116 VEFVHSK---SFLHRDIKPDNFLMGLGRRANQVY-----IIDFGLAKRYRDTATHQHIPY 167
+ ++H + +HRD+K N L+ + I DFGLA+ + T
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-------- 169
Query: 168 RENKNLTGTARY 179
+ G +
Sbjct: 170 -TKMSAAGAYAW 180
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 8e-15
Identities = 40/229 (17%), Positives = 77/229 (33%), Gaps = 48/229 (20%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYK--------I 58
+ +L IG G +G +Y G+ VA+K+ + + E +Y+ I
Sbjct: 13 DNLKLLELIGRGRYGAVYKGS--LDERPVAVKVFSFANRQ-NFINEKNIYRVPLMEHDNI 69
Query: 59 LQ------GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQ 111
+ T + + LV++ SL + + LA
Sbjct: 70 ARFIVGDERVTADGRMEYL--------LVMEYYPNGSLXKYLS--LHTSDWVSSCRLAHS 119
Query: 112 MINRVEFVHS---------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162
+ + ++H+ + HRD+ N L+ + I DFGL+ R
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLV 176
Query: 163 QHIPY-RENKNLTGTARY-------ASMNTHLGIEQSRRDDLESLGYVL 203
+ + GT RY ++N ++ D+ +LG +
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 38/179 (21%), Positives = 67/179 (37%), Gaps = 41/179 (22%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LEN------------VKT----KHP 47
K+ KIG GS+G ++ N T + VAIK ++ KHP
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 48 QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM 107
L L ++ + + LV + ++ + R + V
Sbjct: 63 NL---VNLLEVFRRKRRL-------------HLVFEYCDHTVLHELDRYQRGVPEHLVKS 106
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQ 163
+ Q + V F H + +HRD+KP+N L+ + + + + DFG A+ D +
Sbjct: 107 ITWQTLQAVNFCHKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLTGPSDYYDDE 162
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 39/160 (24%), Positives = 68/160 (42%), Gaps = 19/160 (11%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----LQYEAKLYKILQGG 62
F R+IG GSFG +Y +++ +E VAIK + K + E + + L+
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH- 113
Query: 63 TGIPNL-RWFG--VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
PN ++ G + LV++ S DL + L + + + + ++
Sbjct: 114 ---PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG----LAKR 155
HS + +HRD+K N L+ V + DFG +A
Sbjct: 171 HSHNMIHRDVKAGNILLSE---PGLVKLGDFGSASIMAPA 207
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 45/180 (25%), Positives = 71/180 (39%), Gaps = 21/180 (11%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKIL 59
+ + L IGSG+ + E+VAIK LE +T +L E +
Sbjct: 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC 70
Query: 60 QGGTGIPN-LRWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQM--I 113
PN + ++ V D LV+ LL G S+ D+ K K+ ++ + I
Sbjct: 71 HH----PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 114 NR-----VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 168
R +E++H +HRD+K N L+G V I DFG++ R
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVSAFLATGGDITRNKVR 183
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 41/179 (22%), Positives = 77/179 (43%), Gaps = 41/179 (22%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVK-----T-----------KHP 47
K+ KIG G++G ++ N +T+E VA+K L++ + KH
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 48 QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM 107
+ +L+ +L + LV + L+ F+ C+ L + V
Sbjct: 62 NI---VRLHDVLHSDKKL-------------TLVFEFCDQDLKKYFDSCNGDLDPEIVKS 105
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TATHQ 163
Q++ + F HS++ LHRD+KP N L+ R ++ + +FGLA+ + + +
Sbjct: 106 FLFQLLKGLGFCHSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFGIPVRCYSAE 161
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 22/164 (13%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGT 63
+++ + IG GSFG++ + E VAIK ++N K Q Q E +L +++
Sbjct: 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHD 111
Query: 64 G------IPNLRWFGVEGDYN---VLVIDLLGPSLEDL---FNFCSRKLSLKTVLMLADQ 111
+ R F + LV ++L +L DL NF R +SL A Q
Sbjct: 112 TEMKYYIVHLKRHF----MFRNHLCLVFEMLSYNLYDLLRNTNF--RGVSLNLTRKFAQQ 165
Query: 112 MINRVEFVHSK--SFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
M + F+ + S +H D+KP+N L+ +R + + I+DFG +
Sbjct: 166 MCTALLFLATPELSIIHCDLKPENILLCNPKR-SAIKIVDFGSS 208
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 39/179 (21%), Positives = 66/179 (36%), Gaps = 41/179 (22%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LEN------------VKT----KHP 47
K+ +G GS+G + N T VAIK + +K +H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 48 QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM 107
L L ++ + LV + + ++ D L + V
Sbjct: 85 NL---VNLLEVCKKKKRW-------------YLVFEFVDHTILDDLELFPNGLDYQVVQK 128
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR---DTATHQ 163
Q+IN + F HS + +HRDIKP+N L+ ++ V + DFG A+ + +
Sbjct: 129 YLFQIINGIGFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYDDE 184
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 3e-14
Identities = 41/169 (24%), Positives = 74/169 (43%), Gaps = 23/169 (13%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----LENVKTKHPQLQYEAKLYKILQGGTG 64
+ +IG GSF +Y G + +T EVA + K++ + + EA++ K LQ
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH--- 84
Query: 65 IPNL-----RWFGVEGDYNVLVIDL---LGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
PN+ W +V+ +L+ + + +K + Q++ +
Sbjct: 85 -PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGL 142
Query: 117 EFVHSKS--FLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTATH 162
+F+H+++ +HRD+K DN F+ G V I D GLA R +
Sbjct: 143 QFLHTRTPPIIHRDLKCDNIFITG---PTGSVKIGDLGLATLKRASFAK 188
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 31/150 (20%), Positives = 64/150 (42%), Gaps = 9/150 (6%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
+ +G G G++ N +T E+ A+K + P+ + E +L+ I +
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREVELHWRASQCPHIVRIVD 78
Query: 71 F---GVEGDYNV-LVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
G + +V++ L G + + + + + + + ++++HS +
Sbjct: 79 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 138
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
HRD+KP+N L R + + DFG AK
Sbjct: 139 AHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 4e-14
Identities = 50/239 (20%), Positives = 80/239 (33%), Gaps = 52/239 (21%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYK--------I 58
+L G FG ++ NE VA+K+ ++ K Q E ++Y I
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQ--LLNEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENI 80
Query: 59 LQ------GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQ 111
LQ GT + W L+ SL D + +S + +A+
Sbjct: 81 LQFIGAEKRGTSVDVDLW---------LITAFHEKGSLSDFLK--ANVVSWNELCHIAET 129
Query: 112 MINRVEFVHSKSF----------LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
M + ++H HRDIK N L+ + I DFGLA ++ +
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIADFGLALKFEAGKS 186
Query: 162 HQHIPYRENKNLTGTARY-----ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+ GT RY + + R D+ ++G VL G
Sbjct: 187 AG-----DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 4e-14
Identities = 35/156 (22%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPN 67
F + K+G GS+G +Y + +T + VAIK V++ ++ E + + P+
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDS----PH 85
Query: 68 L-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
+ +++G + +V++ S+ D+ ++ L+ + + + +E++H
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
+HRDIK N L+ + DFG+A + DT
Sbjct: 146 KIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDT 178
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 6e-14
Identities = 48/231 (20%), Positives = 93/231 (40%), Gaps = 42/231 (18%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKHPQL----QYEAKLYKILQG 61
+ KIG+GSFG ++ + +VA+K+ + H + E + K L+
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH 93
Query: 62 GTGIPN-LRWFGV--EGDYNVLVIDLL-GPSLEDLF--NFCSRKLSLKTVLMLADQMINR 115
PN + + G + +V + L SL L + +L + L +A +
Sbjct: 94 ----PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 116 VEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 173
+ ++H+++ +HR++K N L+ + V + DFGL++ T + +K+
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVD---KKYTVKVCDFGLSRLKAST-------FLSSKSA 199
Query: 174 TGTARYASM------NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218
GT + M + + + D+ S G +L PW L
Sbjct: 200 AGTPEW--MAPEVLRDEPS----NEKSDVYSFGVILWELATLQQPWGNLNP 244
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 7e-14
Identities = 35/164 (21%), Positives = 68/164 (41%), Gaps = 15/164 (9%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG 62
+ + F + ++G G+ +Y T + A+K+ ++ E + L
Sbjct: 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH- 107
Query: 63 TGIPN-LRWFGV-EGDYNV-LVIDLL--GPSLEDLFNF-CSR-KLSLKTVLMLADQMINR 115
PN ++ + E + LV++L+ G +LF+ + S + Q++
Sbjct: 108 ---PNIIKLKEIFETPTEISLVLELVTGG----ELFDRIVEKGYYSERDAADAVKQILEA 160
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
V ++H +HRD+KP+N L + I DFGL+K
Sbjct: 161 VAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 8e-14
Identities = 38/178 (21%), Positives = 71/178 (39%), Gaps = 40/178 (22%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLEN-----------VKT----KHPQ 48
+ K+G G++ +Y G + T+ VA I+LE+ V KH
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 49 LQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLML 108
+ L+ I+ + LV + L L+ + C +++ V +
Sbjct: 62 I---VTLHDIIHTEKSL-------------TLVFEYLDKDLKQYLDDCGNIINMHNVKLF 105
Query: 109 ADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TATHQ 163
Q++ + + H + LHRD+KP N L+ ++ + DFGLA+ T ++
Sbjct: 106 LFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYDNE 160
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 9e-14
Identities = 43/188 (22%), Positives = 65/188 (34%), Gaps = 48/188 (25%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKT--------------- 44
++ +G G F +Y + TN+ VAIK L +
Sbjct: 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL 65
Query: 45 ----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKL 100
HP L + I LV D + LE + S L
Sbjct: 66 LQELSHP---NIIGLLDAFGHKSNI-------------SLVFDFMETDLEVIIKDNSLVL 109
Query: 101 SLKTV--LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
+ + ML + +E++H LHRD+KP+N L+ + + DFGLAK +
Sbjct: 110 TPSHIKAYML--MTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSFGS 164
Query: 159 ---TATHQ 163
THQ
Sbjct: 165 PNRAYTHQ 172
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 9e-14
Identities = 35/150 (23%), Positives = 71/150 (47%), Gaps = 9/150 (6%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPN 67
+ + ++G G+FG++Y N +T A K+ K++ +L+ +IL P
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYIVEIEILATCDH-PY 77
Query: 68 L-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
+ + G ++I+ G +++ + R L+ + ++ QM+ + F+HSK
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
+HRD+K N LM + + DFG++
Sbjct: 138 IIHRDLKAGNVLMT---LEGDIRLADFGVS 164
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 39/206 (18%), Positives = 81/206 (39%), Gaps = 14/206 (6%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQ----- 60
++ + RK+G G F ++L +IQ + VA+K +++ + E +L K ++
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96
Query: 61 --GGTGIPNLR-WF---GVEGDYNVLVIDLLGPSLEDL-FNFCSRKLSLKTVLMLADQMI 113
+ L F GV G + +V ++LG L + L L V + Q++
Sbjct: 97 DPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVL 156
Query: 114 NRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 172
++++H+K +H DIKP+N L+ + + + + +R
Sbjct: 157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216
Query: 173 LTGTARYASMNTHLGIEQSRRDDLES 198
+ + + DL +
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGN 242
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 31/154 (20%), Positives = 64/154 (41%), Gaps = 9/154 (5%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRW 70
+ +G G G++ N +T E+ A+K + P+ + E +L+ I +
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREVELHWRASQCPHIVRIVD 122
Query: 71 F---GVEGDYNV-LVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
G + +V++ L G + + + + + + + ++++HS +
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 182
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
HRD+KP+N L R + + DFG AK
Sbjct: 183 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 35/166 (21%), Positives = 75/166 (45%), Gaps = 18/166 (10%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTG 64
F L +G+G++G++Y G +++T + AIK+ +V + ++ E +L+ +
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQE---INMLKKYSH 79
Query: 65 IPN--------LRWFGVEGDYNV-LVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMI 113
N ++ D + LV++ S+ DL L + + + +++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
+ +H +HRDIK N L+ +V ++DFG++ + T
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRT 182
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 2e-13
Identities = 30/162 (18%), Positives = 69/162 (42%), Gaps = 10/162 (6%)
Query: 4 RVGNKFRLGRK-IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG 62
V + ++L ++ +G G G++ + +T ++ A+K + P+ + E + GG
Sbjct: 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK---LLYDSPKARQEVDHHWQASGG 81
Query: 63 TGIPNLRWF---GVEGDYNV-LVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
I + G + ++++ + G + + + + + + +
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
+F+HS + HRD+KP+N L + + + DFG AK
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 43/158 (27%), Positives = 78/158 (49%), Gaps = 16/158 (10%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGTGI 65
F KIG GSFGE++ G + +T + VAIK LE + + +Q E +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS---- 79
Query: 66 PNL-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
P + +++G ++ ++++ L G S DL L + + +++ ++++HS
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHS 137
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
+ +HRDIK N L+ +V + DFG+A + DT
Sbjct: 138 EKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDT 172
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 3e-13
Identities = 44/180 (24%), Positives = 70/180 (38%), Gaps = 42/180 (23%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLENVK-----T-----------KHP 47
F+ KIG G++G +Y N T E VA I+L+ T HP
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 48 QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVL 106
+ KL ++ + LV + L L+ + + + L +
Sbjct: 63 NI---VKLLDVIHTENKL-------------YLVFEFLHQDLKKFMDASALTGIPLPLIK 106
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TATHQ 163
Q++ + F HS LHRD+KP N L+ + + DFGLA+ + T TH+
Sbjct: 107 SYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHE 163
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 45/181 (24%), Positives = 78/181 (43%), Gaps = 41/181 (22%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LEN------------VKT----KHP 47
+++R K+G G++GE+Y + TNE VAIK LE+ V +H
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 48 QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM 107
+ +L ++ + L+ + L+ + +S++ +
Sbjct: 94 NI---IELKSVIHHNHRL-------------HLIFEYAENDLKKYMDKN-PDVSMRVIKS 136
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKRYRD---TATH 162
Q+IN V F HS+ LHRD+KP N L+ + + + I DFGLA+ + TH
Sbjct: 137 FLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH 196
Query: 163 Q 163
+
Sbjct: 197 E 197
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 41/173 (23%), Positives = 71/173 (41%), Gaps = 30/173 (17%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKIL 59
+ ++F++ R G G+FG + LG T VAIK +++ + ++ +LQ + +L
Sbjct: 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVL 76
Query: 60 QGGTGIPN---LRWF----GVEGD---YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA 109
PN L+ + G Y +V++ + + L C +
Sbjct: 77 HH----PNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DTLHRCCRNYYRRQVAPPPI 129
Query: 110 D------QMINRVEFVHSKSF--LHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
Q+I + +H S HRDIKP N L + + + DFG AK
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVL--VNEADGTLKLCDFGSAK 180
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 57/262 (21%), Positives = 95/262 (36%), Gaps = 74/262 (28%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT--------KH 46
+ F + R IG GSFG++ + T + A+K + NV +H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 47 P---QLQY----EAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCS 97
P L Y E ++ +V+DLL G DL
Sbjct: 75 PFLVNLWYSFQDEEDMF-----------------------MVVDLLLGG----DLRYHLQ 107
Query: 98 R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
+ +TV + +++ ++++ ++ +HRD+KPDN L+ V+I DF +A
Sbjct: 108 QNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD---EHGHVHITDFNIAAM 164
Query: 156 YRDTATHQHIPYRENKNLTGTARYAS---MNTHLGIEQSRRDDLESLGYVLMY-FLRGSL 211
+ GT Y + ++ G S D SLG V Y LRG
Sbjct: 165 LPRETQI--------TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLG-VTAYELLRGRR 215
Query: 212 PWQGLKAGTKKQKYEKISEKKV 233
P+ + + K+ V
Sbjct: 216 PYHIRSSTSSKEIVHTFETTVV 237
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 43/174 (24%), Positives = 69/174 (39%), Gaps = 32/174 (18%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY---EAKLYKI 58
+ + + IG+GSFG +Y + E VAIK K + ++ E ++ +
Sbjct: 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK----KVLQDK-RFKNRELQIMRK 103
Query: 59 LQGGTGIPN---LRWF------GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA 109
L N LR+F + Y LV+D + E ++ K L +
Sbjct: 104 LDH----CNIVRLRYFFYSSGEKKDEVYLNLVLDYVP---ETVYRVARHYSRAKQTLPVI 156
Query: 110 D------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157
Q+ + ++HS HRDIKP N L L + + DFG AK+
Sbjct: 157 YVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQLV 208
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 4e-13
Identities = 45/180 (25%), Positives = 75/180 (41%), Gaps = 30/180 (16%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVK----------------TKHP 47
+K+ KIG G+FGE++ + +T ++VA+K +EN K KH
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 76
Query: 48 QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM 107
+ L +I + N + Y LV D L L + K +L +
Sbjct: 77 NV---VNLIEICRTKASPYNRCKGSI---Y--LVFDFCEHDLAGLLSNVLVKFTLSEIKR 128
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167
+ ++N + ++H LHRD+K N L+ R + + DFGLA+ + Q Y
Sbjct: 129 VMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRY 185
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 6e-13
Identities = 41/194 (21%), Positives = 77/194 (39%), Gaps = 47/194 (24%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQ--- 60
+ N F + RK+G G+FG + L +I + A+K + N+K + EA + K +Q
Sbjct: 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDD 92
Query: 61 -GGTGIPNLR-WFGVEGDYN---VLVIDLLGPSLEDL---FNFCSRKLSLKTVLMLADQM 112
I F Y L+ + LGPSL ++ N+ ++ + + ++
Sbjct: 93 INNNNIVKYHGKF----MYYDHMCLIFEPLGPSLYEIITRNNY--NGFHIEDIKLYCIEI 146
Query: 113 INRVEFVHSKSFLHRDIKPDNFLM----------------------GLGRRANQVYIIDF 150
+ + ++ S H D+KP+N L+ ++ + +IDF
Sbjct: 147 LKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 151 GLAKRYRDTATHQH 164
G AT +
Sbjct: 207 G-------CATFKS 213
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 1e-12
Identities = 48/179 (26%), Positives = 71/179 (39%), Gaps = 42/179 (23%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVK-----T-----------KHP 47
K+ KIG G++G +Y N E A+K LE T KH
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 48 QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM 107
KLY ++ + VLV + L L+ L + C L T
Sbjct: 61 ---NIVKLYDVIHTKKRL-------------VLVFEHLDQDLKKLLDVCEGGLESVTAKS 104
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TATHQ 163
Q++N + + H + LHRD+KP N L+ R ++ I DFGLA+ + TH+
Sbjct: 105 FLLQLLNGIAYCHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAFGIPVRKYTHE 160
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 54/258 (20%), Positives = 95/258 (36%), Gaps = 73/258 (28%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT--------KHP- 47
F+ G+ +G GSF + L + T+ E AIK + V HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 48 --QLQY----EAKLYKIL---QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR 98
+L + + KLY L + G +L + +
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNG----------------------------ELLKYIRK 123
Query: 99 --KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
++++ +E++H K +HRD+KP+N L+ + I DFG AK
Sbjct: 124 IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVL 180
Query: 157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQG 215
+ + GTA+Y S + DL +LG ++Y + G P+
Sbjct: 181 SPESKQA-----RANSFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPF-- 232
Query: 216 LKAGTKKQKYEKISEKKV 233
+AG + ++KI + +
Sbjct: 233 -RAGNEYLIFQKIIKLEY 249
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 1e-12
Identities = 34/175 (19%), Positives = 65/175 (37%), Gaps = 36/175 (20%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVA---IKLENVKTKHP--------------QLQYEA--- 53
+IG G++G +Y + + VA +++ N +L+
Sbjct: 16 EIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN 75
Query: 54 --KLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLAD 110
+L + ++ LV + + L + L +T+ L
Sbjct: 76 VVRLMDVCATSRTDREIKVT--------LVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR 127
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD--TATHQ 163
Q + ++F+H+ +HRD+KP+N L+ V + DFGLA+ Y T
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVT---SGGTVKLADFGLARIYSYQMALTPV 179
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 66.4 bits (163), Expect = 3e-12
Identities = 36/179 (20%), Positives = 66/179 (36%), Gaps = 42/179 (23%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLENVK-----T-----------KHP 47
K++ K+G G++G +Y + VA I+L+ T HP
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHP 79
Query: 48 QLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLM 107
+ L ++ + LV + + L+ + + L + +
Sbjct: 80 NI---VSLIDVIHSERCL-------------TLVFEFMEKDLKKVLDENKTGLQDSQIKI 123
Query: 108 LADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TATHQ 163
Q++ V H LHRD+KP N L+ + + DFGLA+ + + TH+
Sbjct: 124 YLYQLLRGVAHCHQHRILHRDLKPQNLLIN---SDGALKLADFGLARAFGIPVRSYTHE 179
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 4e-12
Identities = 41/183 (22%), Positives = 73/183 (39%), Gaps = 45/183 (24%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVA---IKLEN-----------VKT----KHPQ 48
++F+ K+G+G++ +Y G N T VA +KL++ + KH
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHEN 64
Query: 49 LQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDL-----FNFCSRKLSLK 103
+ +LY ++ + LV + + L+ R L L
Sbjct: 65 I---VRLYDVIHTENKL-------------TLVFEFMDNDLKKYMDSRTVGNTPRGLELN 108
Query: 104 TVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD---TA 160
V Q++ + F H LHRD+KP N L+ + Q+ + DFGLA+ + T
Sbjct: 109 LVKYFQWQLLQGLAFCHENKILHRDLKPQNLLIN---KRGQLKLGDFGLARAFGIPVNTF 165
Query: 161 THQ 163
+ +
Sbjct: 166 SSE 168
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 5e-12
Identities = 41/150 (27%), Positives = 73/150 (48%), Gaps = 11/150 (7%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPN 67
K+ KIG G+ G +Y ++ T +EVAI+ N++ + P+ + +++ PN
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKN-PN 78
Query: 68 L-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
+ + + GD +V++ L G SL D+ + + + + + +EF+HS
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--ETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
+HRDIK DN L+G V + DFG
Sbjct: 137 VIHRDIKSDNILLG---MDGSVKLTDFGFC 163
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 5e-12
Identities = 21/187 (11%), Positives = 50/187 (26%), Gaps = 36/187 (19%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKHPQL----QYEAKLYKILQG 61
+ K+ GE++ G ++ +K+ V+ + E +I
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 62 GTGIPN-LRWFGV----EGDYNVLVIDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMIN 114
PN L G + L+ + SL + L + + + A M
Sbjct: 67 ----PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMAR 122
Query: 115 RVEFVHSKSF--LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 172
+ F+H+ + + ++ I + ++
Sbjct: 123 GMAFLHTLEPLIPRHALNSRSVMIDEDMT---ARISMADVKFSFQSPGR----------- 168
Query: 173 LTGTARY 179
+
Sbjct: 169 -MYAPAW 174
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 5e-12
Identities = 41/170 (24%), Positives = 78/170 (45%), Gaps = 35/170 (20%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY---EAKLYKILQ 60
+ + + IG+GSFG ++ ++++E VAIK K + ++ E ++ +I++
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIK----KVLQDK-RFKNRELQIMRIVK 90
Query: 61 GGTGIPN---LRWF-------GVEGDYNVLVIDLLGPSLEDL------FNFCSRKLSLKT 104
PN L+ F E N LV++ + E + + + + +
Sbjct: 91 H----PNVVDLKAFFYSNGDKKDEVFLN-LVLEYVP---ETVYRASRHYAKLKQTMPMLL 142
Query: 105 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ + Q++ + ++HS HRDIKP N L L + + +IDFG AK
Sbjct: 143 IKLYMYQLLRSLAYIHSIGICHRDIKPQNLL--LDPPSGVLKLIDFGSAK 190
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 35/182 (19%), Positives = 65/182 (35%), Gaps = 46/182 (25%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIK-LENVKTKHPQLQYEAKLYKILQGG 62
+ ++ + +G G+FG++ + + VA+K ++NV + E + +L+
Sbjct: 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQ---VLE-- 66
Query: 63 TGIPNLRWFGVEGDYNV--------------LVIDLLGPSLEDL---FNFCSRKLSLKTV 105
+L + +V +LLG S D F L +
Sbjct: 67 ----HLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGF--LPFRLDHI 120
Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLM----------------GLGRRANQVYIID 149
+A Q+ V F+HS H D+KP+N L + ++D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 150 FG 151
FG
Sbjct: 181 FG 182
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 43/174 (24%), Positives = 72/174 (41%), Gaps = 19/174 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQ---YEAKLYKILQGGT 63
LG +IG G+FGE++ G N VA+K EA++ K
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH-- 171
Query: 64 GIPNL-RWFGV--EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
PN+ R GV + +V++L+ G +L +KT+L + +E++
Sbjct: 172 --PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH-----IPYR 168
SK +HRD+ N L+ N + I DFG+++ D +P +
Sbjct: 230 ESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 32/182 (17%), Positives = 66/182 (36%), Gaps = 46/182 (25%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGT-NIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGG 62
+ ++ + +G G+FG++ + + +VA+K + NV + E +L+
Sbjct: 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN---VLK-- 71
Query: 63 TGIPNLRWFGVEGDYNV--------------LVIDLLGPSLEDL---FNFCSRKLSLKTV 105
++ E + + +LLG + + NF + L V
Sbjct: 72 ----KIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNF--QPYPLPHV 125
Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLM----------------GLGRRANQVYIID 149
+A Q+ + + F+H H D+KP+N L + + + D
Sbjct: 126 RHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVAD 185
Query: 150 FG 151
FG
Sbjct: 186 FG 187
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 31/150 (20%), Positives = 72/150 (48%), Gaps = 11/150 (7%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPN 67
KIG GS G + L + +VA+K+ +++ K + + I++ N
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR-KQQRRELLFNEVVIMRDYQH-FN 103
Query: 68 L-RWFG--VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
+ + + G+ ++++ L G +L D+ + +L+ + + + + ++ + ++H++
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLHAQG 161
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
+HRDIK D+ L+ +V + DFG
Sbjct: 162 VIHRDIKSDSILLT---LDGRVKLSDFGFC 188
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 38/194 (19%), Positives = 71/194 (36%), Gaps = 46/194 (23%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTK-------------- 45
K+ LG+ +G+GSFG + +I++ + A+K L++ + K
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVN 61
Query: 46 --------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV-----------LVIDLLG 86
+ E K + + +V ++++ +
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121
Query: 87 PSLEDL------FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 140
+ L F R + + + + Q+ V F+HS HRDIKP N L +
Sbjct: 122 ---DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL--VNS 176
Query: 141 RANQVYIIDFGLAK 154
+ N + + DFG AK
Sbjct: 177 KDNTLKLCDFGSAK 190
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 29/181 (16%), Positives = 62/181 (34%), Gaps = 18/181 (9%)
Query: 7 NKFRLGRKIGSG--SFGEIYLGTNIQTNEEVAIK---LENVKTKHPQ-LQYEAKLYKILQ 60
+ L IG G + L T E V ++ LE + LQ E + K+
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN 84
Query: 61 GGTGIPN-LRWFG--VEGDYNVLVIDLL-GPSLEDLF-NFCSRKLSLKTVLMLADQMINR 115
PN + + + + +V + S +DL ++ + + ++
Sbjct: 85 H----PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKA 140
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 175
++++H ++HR +K + L+ +VY+ Q + + K
Sbjct: 141 LDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 176 T 176
Sbjct: 198 V 198
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 4e-11
Identities = 32/173 (18%), Positives = 70/173 (40%), Gaps = 34/173 (19%)
Query: 14 KIGSGSFGEIYLGTNIQ-TNEEVA---IKLENVKTKHP-----------QLQYEA----- 53
+IG G++G+++ +++ VA ++++ + P L+
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 54 KLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK-LSLKTVLMLADQM 112
+L+ + + LV + + L + + +T+ + Q+
Sbjct: 78 RLFDVCTVSRTDRETKLT--------LVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 129
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD--TATHQ 163
+ ++F+HS +HRD+KP N L+ + Q+ + DFGLA+ Y T
Sbjct: 130 LRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIYSFQMALTSV 179
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 43/171 (25%), Positives = 71/171 (41%), Gaps = 21/171 (12%)
Query: 3 PRVGNKF-RLGRKIGSGSFGEIYLGTN--IQTNEEVAIKLENVKTKHPQLQYEAKLYKIL 59
RV + F G K+G G++G +Y + +++ A+K E L + L
Sbjct: 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLREL 75
Query: 60 QGGTGIPN----LRWFGVEGDYNV-LVID--------LLGPSLEDLFNFCSRKLSLKTVL 106
+ PN + F D V L+ D ++ N +L V
Sbjct: 76 KH----PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 107 MLADQMINRVEFVHSKSFLHRDIKPDNFL-MGLGRRANQVYIIDFGLAKRY 156
L Q+++ + ++H+ LHRD+KP N L MG G +V I D G A+ +
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 5e-11
Identities = 43/196 (21%), Positives = 77/196 (39%), Gaps = 48/196 (24%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLQY-EAKLYKILQG 61
+ + F+L +G G++G + T+ T E VAIK K E K+
Sbjct: 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKI------ 62
Query: 62 GTGIPNLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD---------- 110
L+ F E N++ + ++ P + FN ++ + LM D
Sbjct: 63 ------LKHFKHE---NIITIFNIQRPDSFENFN----EVYIIQELMQTDLHRVISTQML 109
Query: 111 ----------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDT 159
Q + V+ +H + +HRD+KP N L+ +N + + DFGLA+ ++
Sbjct: 110 SDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI----NSNCDLKVCDFGLARIIDES 165
Query: 160 ATHQHIPYRENKNLTG 175
A P + +
Sbjct: 166 AADNSEPTGQQSGMVE 181
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 7e-11
Identities = 39/160 (24%), Positives = 72/160 (45%), Gaps = 20/160 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLG----TNIQTNEEVAIKL--ENVKTKHPQ-LQYEAKLYKIL 59
+ R +G G FG++ L TN T E VA+K + +H + E + + L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 60 QGGTGIPNL-RWFGV---EGDYNVLVIDLLGPSLEDLFNF-CSRKLSLKTVLMLADQMIN 114
++ ++ G G ++ ++ P L L ++ + L +L+ A Q+
Sbjct: 91 YH----EHIIKYKGCCEDAGAASLQLVMEYVP-LGSLRDYLPRHSIGLAQLLLFAQQICE 145
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ ++H++ ++HRD+ N L+ V I DFGLAK
Sbjct: 146 GMAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLAK 182
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 8e-11
Identities = 57/262 (21%), Positives = 91/262 (34%), Gaps = 77/262 (29%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN--------------------VKTKHP- 47
+ + + IG G+FGE+ L + T + A+KL + P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 48 --QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR 98
QL Y + LY +++ GG DL N S
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGG----------------------------DLVNLMSN 162
Query: 99 -KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157
+ K +++ ++ +HS F+HRD+KPDN L+ ++ + + DFG +
Sbjct: 163 YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMKMN 219
Query: 158 DTATHQHIPYRENKNLTGTARYAS----MNTHLGIEQSRRDDLESLGYVLMY-FLRGSLP 212
+ GT Y S + R D S+G V +Y L G P
Sbjct: 220 KEGMVR------CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG-VFLYEMLVGDTP 272
Query: 213 WQGLKAGTKKQKYEKISEKKVS 234
+ A + Y KI K S
Sbjct: 273 F---YADSLVGTYSKIMNHKNS 291
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 42/161 (26%), Positives = 74/161 (45%), Gaps = 20/161 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKL--ENVKTKHPQ-LQYEAKLYKIL 59
+ R +G G FG++ L T E+VA+K H L+ E ++ + L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 60 QGGTGIPNL-RWFGV---EGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMI 113
N+ ++ G+ +G + +I P SL++ K++LK L A Q+
Sbjct: 81 YH----ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQIC 136
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
++++ S+ ++HRD+ N L+ +QV I DFGL K
Sbjct: 137 KGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTK 174
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 63/298 (21%), Positives = 116/298 (38%), Gaps = 55/298 (18%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGI 65
+ K+G G +GE+Y G + + VA+K L+ + + EA + K ++
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH---- 275
Query: 66 PNL-RWFGV--EGDYNVLVIDLL--GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFV 119
PNL + GV ++ + + G +L D L +++S +L +A Q+ + +E++
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 334
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD----TATHQHIPYRENKNLTG 175
K+F+HR++ N L+G + V + DFGL++ P +
Sbjct: 335 EKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW------ 385
Query: 176 TARYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKV 233
TA + S + D+ + G VL++ G P Y I +V
Sbjct: 386 TAPESLAYNKF----SIKSDVWAFG-VLLWEIATYGMSP------------YPGIDLSQV 428
Query: 234 STSIEALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQ 283
E L + Y P + C D+P +A + + F +F
Sbjct: 429 ---YELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 483
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 61.1 bits (148), Expect = 2e-10
Identities = 26/85 (30%), Positives = 34/85 (40%), Gaps = 10/85 (11%)
Query: 103 KTVLMLADQMINRVEFVHSKSFLHRDIKPDN-FLMGLGRRANQVYIIDFGLAKRYRDTAT 161
L + Q+ VEF+HSK +HRD+KP N F + V + DFGL
Sbjct: 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT----MDDVVKVGDFGLVTAMDQDEE 219
Query: 162 HQHIPYRENKNLT-----GTARYAS 181
Q + T GT Y S
Sbjct: 220 EQTVLTPMPAYATHTGQVGTKLYMS 244
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 5e-05
Identities = 12/56 (21%), Positives = 21/56 (37%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKIL 59
R F + +G G FG ++ N + AIK + + + + K L
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKAL 58
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 39/179 (21%), Positives = 72/179 (40%), Gaps = 49/179 (27%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQY-EAKLYKILQ 60
+G+++ + +G G G ++ + ++ VAIK L + + + E K+
Sbjct: 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ--SVKHALREIKI----- 61
Query: 61 GGTGIPNLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTV-----LMLAD---- 110
+R + N++ V ++LGPS L + L +V M D
Sbjct: 62 -------IRRLDHD---NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANV 111
Query: 111 ----------------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
Q++ ++++HS + LHRD+KP N + + I DFGLA
Sbjct: 112 LEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLF--INTEDLVLKIGDFGLA 168
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 3e-10
Identities = 41/169 (24%), Positives = 70/169 (41%), Gaps = 21/169 (12%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLQY-EAKLYKILQ 60
+ + +GSG++G + + ++ E+VAIK L + Y E L K +Q
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ 81
Query: 61 -------GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
P Y LV+ + DL K S + + L QM+
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFY--LVMPFMQ---TDLQKIMGLKFSEEKIQYLVYQML 136
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTAT 161
++++HS +HRD+KP N + + ++ I+DFGLA+ T
Sbjct: 137 KGLKYIHSAGVVHRDLKPGNLAV----NEDCELKILDFGLARHADAEMT 181
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 38/160 (23%), Positives = 68/160 (42%), Gaps = 19/160 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIK-LENVKTKHPQ-LQYEAKLYKILQ 60
+ ++G G+FG + L T VA+K L++ + Q E ++ K L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 61 GGTGIPNL-RWFGV---EGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMIN 114
+ ++ GV G ++ ++ P L D +L +L+ + Q+
Sbjct: 83 S----DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICK 138
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+E++ S+ +HRD+ N L+ V I DFGLAK
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAK 175
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 6e-10
Identities = 31/161 (19%), Positives = 69/161 (42%), Gaps = 15/161 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGT 63
N ++GSG+ G+++ +T +A+K K ++ ++ + ++
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMD---LDVVLKSH 81
Query: 64 GIPNL-RWFG---VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
P + + FG D + ++L+G E L + + + + ++ + ++
Sbjct: 82 DCPYIVQCFGTFITNTDV-FIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYL 140
Query: 120 HSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
K +HRD+KP N L+ Q+ + DFG++ R D
Sbjct: 141 KEKHGVIHRDVKPSNILLD---ERGQIKLCDFGISGRLVDD 178
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 39/178 (21%), Positives = 69/178 (38%), Gaps = 54/178 (30%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLQY-EAKLYKILQ 60
+ +++ + IG+GS+G + + VAIK + V + E +
Sbjct: 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAI----- 105
Query: 61 GGTGIPNLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD--------- 110
L + +V+ V+D++ P + F+ +L + + +D
Sbjct: 106 -------LNRLNHD---HVVKVLDIVIPKDVEKFD----ELYVVLEIADSDFKKLFRTPV 151
Query: 111 ------------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ---VYIIDFGLA 153
++ V++VHS LHRD+KP N L NQ V + DFGLA
Sbjct: 152 YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL------VNQDCSVKVCDFGLA 203
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-10
Identities = 40/160 (25%), Positives = 71/160 (44%), Gaps = 19/160 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQ 60
+ +++G G+FG + + T E VA+K + + + E ++ K LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 61 GGTGIPNL-RWFGV---EGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMIN 114
N+ ++ GV G N+ +I P SL D ++ +L Q+
Sbjct: 101 H----DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 156
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+E++ +K ++HRD+ N L+ N+V I DFGL K
Sbjct: 157 GMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTK 193
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 7e-10
Identities = 40/158 (25%), Positives = 75/158 (47%), Gaps = 13/158 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGI 65
+ K+G G +GE+Y G + + VA+K T + EA + K ++
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH---- 68
Query: 66 PNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
PNL + GV ++ + + G L+ L +++S +L +A Q+ + +E++
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
K+F+HRD+ N L+G + V + DFGL++
Sbjct: 129 KKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTG 163
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 7e-10
Identities = 40/160 (25%), Positives = 71/160 (44%), Gaps = 19/160 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQ 60
+ +++G G+FG + + T E VA+K + + + E ++ K LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 61 GGTGIPNL-RWFGV---EGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMIN 114
N+ ++ GV G N+ +I P SL D ++ +L Q+
Sbjct: 70 H----DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+E++ +K ++HRD+ N L+ N+V I DFGL K
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTK 162
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 64/290 (22%), Positives = 115/290 (39%), Gaps = 53/290 (18%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGI 65
RL K+G G FGE+++GT VAIK L+ EA++ K L+
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH---- 238
Query: 66 PNL-RWFGVEGDYNVLVIDLL--GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
L + + V + + ++ SL D L + L L ++ +A Q+ + + +V
Sbjct: 239 EKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 298
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD----TATHQHIPYRENKNLTGTA 177
+++HRD++ N L+G + DFGLA+ D P + TA
Sbjct: 299 MNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTA 349
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVST 235
A++ + + D+ S G +L+ +G +P Y + ++V
Sbjct: 350 PEAALYGRF----TIKSDVWSFG-ILLTELTTKGRVP------------YPGMVNREV-- 390
Query: 236 SIEALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
++ + RGY P C +++P + YL+ D F
Sbjct: 391 -LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 62/308 (20%), Positives = 99/308 (32%), Gaps = 99/308 (32%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN--------------------VKTKHP- 47
F + + IG G+F E+ + QT + A+K+ N V
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 48 --QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR 98
QL + E LY +++ GG DL S+
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGG----------------------------DLLTLLSK 154
Query: 99 ---KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
++ + +++ ++ VH ++HRDIKPDN L+ R + + DFG +
Sbjct: 155 FGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLD---RCGHIRLADFGSCLK 211
Query: 156 YRDTATHQHIPYRENKNLTGTARY-------ASMNTHLGIEQSRRDDLESLGYVLMY-FL 207
R T + + GT Y A D +LG V Y
Sbjct: 212 LRADGTVR------SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALG-VFAYEMF 264
Query: 208 RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA 267
G P+ A + + Y KI K S+ + G P E R
Sbjct: 265 YGQTPFY---ADSTAETYGKIVHYKEHLSLPLVDEGVPEE-------ARDF--------- 305
Query: 268 YLKRLFRD 275
++RL
Sbjct: 306 -IQRLLCP 312
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 59/265 (22%), Positives = 90/265 (33%), Gaps = 80/265 (30%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN--------------------VKTKHP- 47
F + + IG G+FGE+ + ++ A+K+ N V
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 48 --QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR 98
L Y + LY ++ GG DL S+
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGG----------------------------DLLTLLSK 167
Query: 99 ---KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
+L + +M+ ++ VH ++HRDIKPDN LM + + DFG +
Sbjct: 168 FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD---MNGHIRLADFGSCLK 224
Query: 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRD-----DLESLGYVLMY-FLRG 209
+ T Q + GT Y S +E + D SLG V MY L G
Sbjct: 225 LMEDGTVQ------SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLG-VCMYEMLYG 277
Query: 210 SLPWQGLKAGTKKQKYEKISEKKVS 234
P+ A + + Y KI K
Sbjct: 278 ETPFY---AESLVETYGKIMNHKER 299
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 34/156 (21%), Positives = 68/156 (43%), Gaps = 19/156 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTG 64
+++G+G FG + G + +VAIK+ + ++ EAK+ L
Sbjct: 24 KDLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIE-EAKVMMNLSH--- 78
Query: 65 IPNL-RWFGV--EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEF 118
L + +GV + ++ + + + L N+ + + +L + + +E+
Sbjct: 79 -EKLVQLYGVCTKQRPIFIITEYM--ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 135
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ SK FLHRD+ N L+ V + DFGL++
Sbjct: 136 LESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSR 168
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 34/155 (21%), Positives = 66/155 (42%), Gaps = 17/155 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQGGTGI 65
++ ++IGSG FG ++LG ++VAIK + EA++ L
Sbjct: 8 SELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH---- 62
Query: 66 PNL-RWFGV--EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFV 119
P L + +GV E LV + + L ++ + +T+L + + + ++
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFM--EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+HRD+ N L+G + + DFG+ +
Sbjct: 121 EEACVIHRDLAARNCLVG---ENQVIKVSDFGMTR 152
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 64/280 (22%), Positives = 91/280 (32%), Gaps = 84/280 (30%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------------------LENVKT 44
N F + R IG G FGE+Y T + A+K L V T
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 45 -KHP---QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLF 93
P + Y KL IL GG DL
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGG----------------------------DLH 280
Query: 94 NFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151
S+ S + A ++I +E +H++ ++RD+KP N L+ V I D G
Sbjct: 281 YHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLG 337
Query: 152 LAKRYRDTATHQHIPYRENKNLTGTARY-ASMNTHLGIEQSRRDDLESLGYVLMY-FLRG 209
LA + H GT Y A G+ D SLG +++ LRG
Sbjct: 338 LACDFSKKKPH---------ASVGTHGYMAPEVLQKGVAYDSSADWFSLG-CMLFKLLRG 387
Query: 210 SLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 243
P++ K K + V S + +L G
Sbjct: 388 HSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 427
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 2e-09
Identities = 39/161 (24%), Positives = 70/161 (43%), Gaps = 19/161 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LQYEAKLYKILQGGTG 64
+ L +++GSG FG + LG + +VA+K+ + Q EA+ L
Sbjct: 8 EEITLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQ-EAQTMMKLSH--- 62
Query: 65 IPNL-RWFGV--EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEF 118
P L +++GV + +V + + S L N+ + L +L + + + F
Sbjct: 63 -PKLVKFYGVCSKEYPIYIVTEYI--SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
+ S F+HRD+ N L+ R V + DFG+ + D
Sbjct: 120 LESHQFIHRDLAARNCLVD---RDLCVKVSDFGMTRYVLDD 157
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 40/159 (25%), Positives = 71/159 (44%), Gaps = 17/159 (10%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLQY-EAKLYKILQ 60
V +++ + IGSG+ G + + VAIK L H + Y E L K +
Sbjct: 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82
Query: 61 GGTGIPNLRWFGVEGDYNV-----LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
I L F + +V++L+ +L +L + + L QM+
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMD---ANLCQVIQMELDHERMSYLLYQMLCG 139
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 153
++ +HS +HRD+KP N ++ +++ + I+DFGLA
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLA 174
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 45/171 (26%), Positives = 74/171 (43%), Gaps = 24/171 (14%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLQY-EAKLYK--- 57
V +R + +GSG++G + + +T +VAIK L + Y E +L K
Sbjct: 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 82
Query: 58 ------ILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
+L T L F Y LV+ +G L L KL + L Q
Sbjct: 83 HENVIGLLDVFTPDETLDDF--TDFY--LVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQ 136
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTAT 161
M+ + ++H+ +HRD+KP N + + ++ I+DFGLA++ T
Sbjct: 137 MLKGLRYIHAAGIIHRDLKPGNLAV----NEDCELKILDFGLARQADSEMT 183
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 42/211 (19%), Positives = 75/211 (35%), Gaps = 55/211 (26%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLQY-EAKLYKILQ 60
V + + + IG GS+G +YL + T + VAIK + + + E +
Sbjct: 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITI----- 78
Query: 61 GGTGIPNLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD--------- 110
L + ++ + DL+ P F+ +L + + +D
Sbjct: 79 -------LNRLKSD---YIIRLYDLIIPDDLLKFD----ELYIVLEIADSDLKKLFKTPI 124
Query: 111 ------------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ---VYIIDFGLAKR 155
++ F+H +HRD+KP N L NQ V + DFGLA R
Sbjct: 125 FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCL------LNQDCSVKVCDFGLA-R 177
Query: 156 YRDTATHQHIPYRENKNLTGTARYASMNTHL 186
++ +I +N ++ L
Sbjct: 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQL 208
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 38/174 (21%), Positives = 65/174 (37%), Gaps = 48/174 (27%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLQY-EAKLYKILQG 61
VG ++ IG G++G + + VAIK + + Q E K+
Sbjct: 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKI------ 78
Query: 62 GTGIPNLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD---------- 110
L F E N++ + D++ + + + LM D
Sbjct: 79 ------LLRFRHE---NIIGINDIIRAPTIEQMK----DVYIVQDLMETDLYKLLKTQHL 125
Query: 111 ----------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 153
Q++ ++++HS + LHRD+KP N L+ + I DFGLA
Sbjct: 126 SNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTTCDLKICDFGLA 175
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 64/290 (22%), Positives = 115/290 (39%), Gaps = 53/290 (18%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGI 65
RL K+G G FGE+++GT VAIK L+ EA++ K L+
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH---- 321
Query: 66 PNL-RWFGVEGDYNVLVIDLL--GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
L + + V + + ++ SL D L + L L ++ +A Q+ + + +V
Sbjct: 322 EKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 381
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD----TATHQHIPYRENKNLTGTA 177
+++HRD++ N L+G + DFGLA+ D P + TA
Sbjct: 382 MNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTA 432
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMY--FLRGSLPWQGLKAGTKKQKYEKISEKKVST 235
A++ + + D+ S G +L+ +G +P Y + ++V
Sbjct: 433 PEAALYGRF----TIKSDVWSFG-ILLTELTTKGRVP------------YPGMVNREV-- 473
Query: 236 SIEALCRGY--------PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
++ + RGY P C +++P + YL+ D F
Sbjct: 474 -LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 25/163 (15%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLQY-EAKLYK--- 57
V +++ + IGSG+ G + + + VAIK L H + Y E L K
Sbjct: 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 119
Query: 58 ------ILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQ 111
+L T L F + Y LV++L+ +L +L + + L Q
Sbjct: 120 HKNIISLLNVFTPQKTLEEF--QDVY--LVMELMD---ANLCQVIQMELDHERMSYLLYQ 172
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 153
M+ ++ +HS +HRD+KP N ++ +++ + I+DFGLA
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLA 211
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 5e-09
Identities = 38/174 (21%), Positives = 66/174 (37%), Gaps = 27/174 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
+ +L + IG G FG++ LG +VA+K EA + L+
Sbjct: 21 KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRH----S 74
Query: 67 NL-RWFGV--EGDYNVLVIDLLGPSLE-----DLFNF----CSRKLSLKTVLMLADQMIN 114
NL + GV E + ++ E L ++ L +L + +
Sbjct: 75 NLVQLLGVIVEEKGGLYIV------TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 128
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 168
+E++ +F+HRD+ N L+ N + DFGL K T +P +
Sbjct: 129 AMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 179
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 44/159 (27%), Positives = 75/159 (47%), Gaps = 13/159 (8%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENV--KTKHPQLQY-EAKLYK 57
+ V K+ L +K+G G++G ++ + +T E VA+K + + + Q + E +
Sbjct: 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILT 63
Query: 58 ILQGGTGIPNLR-WFGVEGDYNV-LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
L G I NL + D +V LV D + L + + L + Q+I
Sbjct: 64 ELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIR--ANILEPVHKQYVVYQLIKV 121
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 153
++++HS LHRD+KP N L+ A V + DFGL+
Sbjct: 122 IKYLHSGGLLHRDMKPSNILL----NAECHVKVADFGLS 156
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 43/178 (24%), Positives = 73/178 (41%), Gaps = 38/178 (21%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-QLQYEAK--------- 54
V +++ +GSG++G + + +T VA+K K P Q AK
Sbjct: 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYRELRLL 82
Query: 55 ----------LYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKT 104
L + P Y LV L+G L ++ +KL+
Sbjct: 83 KHMKHENVIGLLDVF-----TPARSLEEFNDVY--LVTHLMGADLNNIVK--CQKLTDDH 133
Query: 105 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTAT 161
V L Q++ ++++HS +HRD+KP N + + ++ I+DFGLA+ D T
Sbjct: 134 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAV----NEDCELKILDFGLARHTADEMT 187
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 8e-09
Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 19/164 (11%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-LQYEAKLYKILQG 61
PR +L ++G+G FGE+++G + +VA+K + P EA L K LQ
Sbjct: 11 PR--ETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH 67
Query: 62 GTGIPNL-RWFGV---EGDYNVLVIDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINR 115
L R + V E Y ++ + + SL D L KL++ +L +A Q+
Sbjct: 68 ----QRLVRLYAVVTQEPIY--IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
+ F+ ++++HRD++ N L+ I DFGLA+ D
Sbjct: 122 MAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDN 162
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 35/162 (21%), Positives = 68/162 (41%), Gaps = 18/162 (11%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGTGI 65
++G G++G + ++ + + +A+K + +L + I
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMD---LDISMRTVDC 65
Query: 66 PNL-RWFG---VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLA---DQMINRVEF 118
P ++G EGD + ++L+ SL+ + K +L ++ +E
Sbjct: 66 PFTVTFYGALFREGDV-WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 119 VHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
+HSK S +HRD+KP N L+ QV + DFG++ D
Sbjct: 125 LHSKLSVIHRDVKPSNVLIN---ALGQVKMCDFGISGYLVDD 163
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 40/180 (22%), Positives = 62/180 (34%), Gaps = 49/180 (27%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG 64
+ + + + R I SGS+G + G + VAIK + + + IL
Sbjct: 20 MQSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIK------RVFNTVSDGRTVNILSDSFL 72
Query: 65 -------IPNLRWFGVEGDYNVL-VIDLLGPSLEDLFNFCSRKLSLKTVLMLAD------ 110
I L F N+L + D+ E + KL L T LM D
Sbjct: 73 CKRVLREIRLLNHFHHP---NILGLRDIFVHFEEPAMH----KLYLVTELMRTDLAQVIH 125
Query: 111 ----------------QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLA 153
++ + +H +HRD+ P N L+ N + I DF LA
Sbjct: 126 DQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL----ADNNDITICDFNLA 181
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 42/169 (24%), Positives = 69/169 (40%), Gaps = 17/169 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
+ +L + IG G FG++ LG +VA+K EA + L+
Sbjct: 193 KELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRH----S 246
Query: 67 NL-RWFGV---EGDYNVLVIDLL--GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFV 119
NL + GV E +V + + G SL D L + L +L + + +E++
Sbjct: 247 NLVQLLGVIVEEKGGLYIVTEYMAKG-SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 168
+F+HRD+ N L+ N + DFGL K T +P +
Sbjct: 306 EGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 351
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 22/217 (10%), Positives = 50/217 (23%), Gaps = 47/217 (21%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ-----LQYEAKLYKIL 59
++RL G + + + + +VA+ + + P +
Sbjct: 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI 88
Query: 60 QGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
G+ + ++V + + G SL+++ S + + +
Sbjct: 89 DK-PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAADA 144
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
H P + V + A
Sbjct: 145 AHRAGVALSIDHPSRVRVS---IDGDVVLAYPA----TMPDANP---------------- 181
Query: 179 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+DD+ +G L L P
Sbjct: 182 --------------QDDIRGIGASLYALLVNRWPLPE 204
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 28/158 (17%), Positives = 70/158 (44%), Gaps = 19/158 (12%)
Query: 14 KIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGTGIPNL-R 69
+IG G++G + + + + +A+K + + QL + ++ + P + +
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMD---LDVVMRSSDCPYIVQ 85
Query: 70 WFG---VEGDYNVLVIDLLGPSLEDL----FNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
++G EGD + ++L+ S + ++ + + + + + + +
Sbjct: 86 FYGALFREGDC-WICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 123 -SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
+HRDIKP N L+ R+ + + DFG++ + D+
Sbjct: 145 LKIIHRDIKPSNILLD---RSGNIKLCDFGISGQLVDS 179
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 54.5 bits (130), Expect = 3e-08
Identities = 34/203 (16%), Positives = 60/203 (29%), Gaps = 59/203 (29%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------------------------- 39
K + KIG G FGE++ + VAIK+
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 40 ------------------------ENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEG 75
V+ +P L +A + G+ +F +
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNF 134
+ VL + G LE ++ SL T + Q+ + + F HRD+ N
Sbjct: 137 LFIVLEFEFGGIDLE---QMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193
Query: 135 LMGLGRRANQVYIIDFGLAKRYR 157
L+ ++ + + K
Sbjct: 194 LL---KKTSLKKLHYTLNGKSST 213
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 39/169 (23%), Positives = 64/169 (37%), Gaps = 30/169 (17%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIKL--ENVKTKHPQ-LQYEAKLY 56
P R IG G FG +Y G I + AIK + + + E L
Sbjct: 17 PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76
Query: 57 KILQGGTGIPNL-RWFGV--EGDYNVLVIDLLGPSLE-----DLFNF---CSRKLSLKTV 105
+ L PN+ G+ + V+ L DL F R ++K +
Sbjct: 77 RGLNH----PNVLALIGIMLPPEGLPHVL------LPYMCHGDLLQFIRSPQRNPTVKDL 126
Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ Q+ +E++ + F+HRD+ N ++ V + DFGLA+
Sbjct: 127 ISFGLQVARGMEYLAEQKFVHRDLAARNCMLDES---FTVKVADFGLAR 172
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 3e-08
Identities = 53/275 (19%), Positives = 96/275 (34%), Gaps = 99/275 (36%)
Query: 3 PRVG-NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT----- 44
P+ F++ R +G+GSFG ++L + A+K +E+
Sbjct: 1 PKYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 60
Query: 45 ---KHP---QLQY----EAKLYKIL---QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLED 91
HP ++ +++ I+ +GG +
Sbjct: 61 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGG----------------------------E 92
Query: 92 LFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149
LF+ + + A ++ +E++HSK ++RD+KP+N L L + + + I D
Sbjct: 93 LFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL--LDKNGH-IKITD 149
Query: 150 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGY-------- 201
FG AK D L GT Y + E + + Y
Sbjct: 150 FGFAKYVPDVT----------YTLCGTPDY------IAPEV-----VSTKPYNKSIDWWS 188
Query: 202 --VLMY-FLRGSLPWQGLKAGTKKQKYEKISEKKV 233
+L+Y L G P+ + YEKI ++
Sbjct: 189 FGILIYEMLAGYTPFY---DSNTMKTYEKILNAEL 220
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 4e-08
Identities = 43/169 (25%), Positives = 73/169 (43%), Gaps = 28/169 (16%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIKLENVKTKHPQLQ---YEAKLYKILQ 60
+ LGR IG G FG+++ G + VAIK T + EA +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 61 GGTGIPNL-RWFGVEGDYNVLVIDLLGPSLE-----DLFNF---CSRKLSLKTVLMLADQ 111
P++ + GV + V +I +E +L +F L L ++++ A Q
Sbjct: 75 H----PHIVKLIGVITENPVWII------MELCTLGELRSFLQVRKYSLDLASLILYAYQ 124
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
+ + ++ SK F+HRDI N L+ + V + DFGL++ D+
Sbjct: 125 LSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDST 170
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 45/181 (24%), Positives = 77/181 (42%), Gaps = 32/181 (17%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIKLENVKTKHPQLQ---YEAKLYKILQ 60
+ LGR IG G FG+++ G + VAIK T + EA +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 61 GGTGIPNL-RWFGVEGDYNVLVIDLLGPSLE-----DLFNF---CSRKLSLKTVLMLADQ 111
P++ + GV + V +I +E +L +F L L ++++ A Q
Sbjct: 450 H----PHIVKLIGVITENPVWII------MELCTLGELRSFLQVRKFSLDLASLILYAYQ 499
Query: 112 MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD----TATHQHIPY 167
+ + ++ SK F+HRDI N L+ + V + DFGL++ D A+ +P
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 168 R 168
+
Sbjct: 557 K 557
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 38/153 (24%), Positives = 70/153 (45%), Gaps = 13/153 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGI 65
+L +K+G+G FGE+++ T + +VA+K ++ EA + K LQ
Sbjct: 188 ESLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQH---- 242
Query: 66 PNL-RWFGVEGDYNVLVIDLLGP--SLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
L + V + +I SL D L + K L ++ + Q+ + F+
Sbjct: 243 DKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
++++HRD++ N L+ + I DFGLA+
Sbjct: 303 RNYIHRDLRAANILVS---ASLVCKIADFGLAR 332
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 4e-08
Identities = 38/160 (23%), Positives = 66/160 (41%), Gaps = 21/160 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIKLENVKTKHPQLQ---YEAKLYKIL 59
+F+ + +GSG+FG +Y G I E+ VAIK T + EA + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 60 QGGTGIPNL-RWFGV-EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMIN 114
P++ R G+ L+ L+ L ++ + + +L Q+
Sbjct: 75 DN----PHVCRLLGICLTSTVQLITQLM--PFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ ++ + +HRD+ N L+ V I DFGLAK
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 6e-08
Identities = 48/185 (25%), Positives = 75/185 (40%), Gaps = 40/185 (21%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKL--ENVKTKHPQ-LQYEAK 54
PR N+ G+ +G+G+FG++ T + ++ VA+K+ + + L E K
Sbjct: 21 PR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELK 78
Query: 55 LYKILQGGTGIPNLRWFGV--EGDYNVLVI-------DLL------------GPSLEDLF 93
+ L I NL G G LVI DLL + +
Sbjct: 79 VLSYLGNHMNIVNL--LGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 94 NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
L L+ +L + Q+ + F+ SK+ +HRD+ N L+ G I DFGLA
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG---RITKICDFGLA 192
Query: 154 KRYRD 158
RD
Sbjct: 193 ---RD 194
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 7e-08
Identities = 50/181 (27%), Positives = 75/181 (41%), Gaps = 36/181 (19%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE-----VAIKLENVKTKHPQ---LQYEAK 54
PR N + G+ +G+G+FG++ T +E VA+K+ + L E K
Sbjct: 44 PR--NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 101
Query: 55 LYKILQGGTGIPNLRWFGV--EGDYNVLVI-------DLL--------GPSLEDLFNFCS 97
+ L I NL G G VLVI DLL + F +
Sbjct: 102 IMSHLGQHENIVNL--LGACTHGGP-VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 98 RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157
S + +L + Q+ + F+ SK+ +HRD+ N L+ G + I DFGLA R
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG---HVAKIGDFGLA---R 212
Query: 158 D 158
D
Sbjct: 213 D 213
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 7e-08
Identities = 43/214 (20%), Positives = 92/214 (42%), Gaps = 27/214 (12%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGTGI 65
F ++G+G+ G ++ ++ + +A K LE Q+ E ++L
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRE---LQVLHECNS- 90
Query: 66 PNL-RWFG---VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
P + ++G +G+ + ++ + G SL+ + R + + + ++ +I + ++
Sbjct: 91 PYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLR 148
Query: 121 SK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
K +HRD+KP N L+ ++ + DFG++ + D+ + + GT Y
Sbjct: 149 EKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMANSFV---------GTRSY 196
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
S G S + D+ S+G L+ G P
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 57/259 (22%), Positives = 96/259 (37%), Gaps = 80/259 (30%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT--------KHP- 47
F + +G+GSFG + L + ++ A+K +E+ P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 48 --QLQY----EAKLYKIL---QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNF--C 96
+L++ + LY ++ GG ++F+
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGG----------------------------EMFSHLRR 134
Query: 97 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
+ S A Q++ E++HS ++RD+KP+N L+ + + + DFG AKR
Sbjct: 135 IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRV 191
Query: 157 RD-TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLPWQ 214
+ T T L GT + L ++ D +LG VL+Y G P+
Sbjct: 192 KGRTWT-----------LCGTPEALAPEIILSKGYNKAVDWWALG-VLIYEMAAGYPPF- 238
Query: 215 GLKAGTKKQKYEKISEKKV 233
A Q YEKI KV
Sbjct: 239 --FADQPIQIYEKIVSGKV 255
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 9e-08
Identities = 44/183 (24%), Positives = 75/183 (40%), Gaps = 37/183 (20%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ---LQYEAK 54
PR ++ +LG+ +G G+FG++ I VA+K+ H + L E K
Sbjct: 25 PR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 82
Query: 55 LYKILQGGTGIPNLRWFGV--EGDYNVLVI-------DLL----------GPSLEDLFNF 95
+ + + NL G + ++VI +L P +
Sbjct: 83 ILIHIGHHLNVVNL--LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 140
Query: 96 CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
L+L+ ++ + Q+ +EF+ S+ +HRD+ N L+ N V I DFGLA
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK---NVVKICDFGLA-- 195
Query: 156 YRD 158
RD
Sbjct: 196 -RD 197
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 33/166 (19%), Positives = 66/166 (39%), Gaps = 24/166 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTKHPQ----LQYEAKLYKI 58
+ + IG+G FGE+Y G + + VAIK Q L EA +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG-EAGIMGQ 102
Query: 59 LQGGTGIPNL-RWFGV--EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQM 112
N+ R GV + +++ + + L F + S+ ++ + +
Sbjct: 103 FSH----HNIIRLEGVISKYKPMMIITEYM--ENGALDKFLREKDGEFSVLQLVGMLRGI 156
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
++++ + +++HRD+ N L+ + DFGL++ D
Sbjct: 157 AAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLED 199
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 34/164 (20%), Positives = 64/164 (39%), Gaps = 21/164 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT---NIQTNEEVAIKLENVKTKHPQLQ---YEAKLYKILQ 60
++ + + IGSG GE+ G Q + VAIK Q + EA +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 61 GGTGIPNL-RWFGV--EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMIN 114
PN+ R GV G ++V + + L F + ++ ++ + +
Sbjct: 109 H----PNIIRLEGVVTRGRLAMIVTEYM--ENGSLDTFLRTHDGQFTIMQLVGMLRGVGA 162
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
+ ++ ++HRD+ N L+ + DFGL++ D
Sbjct: 163 GMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRVLED 203
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 29/169 (17%), Positives = 60/169 (35%), Gaps = 28/169 (16%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-------NIQTNEEVAIK-LENVKTKHPQ--LQYEAKLY 56
+G G+F +I+ G EV +K L+ + + + A +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE-AASMM 66
Query: 57 KILQGGTGIPNL-RWFGV--EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLAD 110
L +L +GV GD N+LV + + L + +++ L +A
Sbjct: 67 SKLSH----KHLVLNYGVCVCGDENILVQEFV--KFGSLDTYLKKNKNCINILWKLEVAK 120
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFL-----MGLGRRANQVYIIDFGLAK 154
Q+ + F+ + +H ++ N L + + D G++
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 58/284 (20%), Positives = 88/284 (30%), Gaps = 92/284 (32%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------------------LENVKT 44
N FR R +G G FGE+ T + A K LE V
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN- 242
Query: 45 KHP---QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLF- 93
L Y + L +L GG DL
Sbjct: 243 -SRFVVSLAYAYETKDALCLVLTLMNGG----------------------------DLKF 273
Query: 94 ---NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYI 147
+ + A ++ +E +H + ++RD+KP+N L+ G + I
Sbjct: 274 HIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG------HIRI 327
Query: 148 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMY-F 206
D GLA + T K GT Y + + D +LG L+Y
Sbjct: 328 SDLGLAVHVPEGQT--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALG-CLLYEM 378
Query: 207 LRGSLPWQGLKAGTKKQK-YEKISEKKV----STSIEA--LCRG 243
+ G P+Q K K+++ + E S +A LC
Sbjct: 379 IAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQ 422
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 44/183 (24%), Positives = 73/183 (39%), Gaps = 45/183 (24%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIK---LENVKTKHPQ-LQYEAKL 55
R N LG+ +G G FG + G Q + VA+K L+N + + EA
Sbjct: 32 DR--NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAAC 89
Query: 56 YKILQGGTGIPN-LRWFGV------EGDYNVLVIDLLGPSLE-----DLFNF-------- 95
K PN +R GV +G +VI L DL +
Sbjct: 90 MKDFSH----PNVIRLLGVCIEMSSQGIPKPMVI------LPFMKYGDLHTYLLYSRLET 139
Query: 96 CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
+ + L+T+L + +E++ +++FLHRD+ N ++ V + DFGL+
Sbjct: 140 GPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDD---MTVCVADFGLS-- 194
Query: 156 YRD 158
+
Sbjct: 195 -KK 196
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 49/183 (26%), Positives = 86/183 (46%), Gaps = 40/183 (21%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ--LQYEAKL 55
R L R++G G+FG+++L N+ ++ VA+K T + Q EA+L
Sbjct: 13 KR--RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70
Query: 56 YKILQGGTGIPNL-RWFGV--EGDYNVLVI-------DLL------GPSLEDLFNFCSR- 98
LQ ++ +++GV +GD ++++ DL GP L + R
Sbjct: 71 LTNLQH----EHIVKFYGVCGDGD-PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 99 ---KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
+L L +L +A Q+ + + ++ S+ F+HRD+ N L+G V I DFG++
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN---LLVKIGDFGMS-- 180
Query: 156 YRD 158
RD
Sbjct: 181 -RD 182
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 44/158 (27%), Positives = 63/158 (39%), Gaps = 20/158 (12%)
Query: 9 FRLGRKIGSGSFGEIYLGT-NIQTNEE--VAIKLENVKTKHPQLQY-----EAKLYKILQ 60
RL K+G GSFG + G + + + VA+K E L
Sbjct: 20 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 79
Query: 61 GGTGIPNL-RWFGV-EGDYNVLVIDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
NL R +GV +V +L LG SL D L T+ A Q+ +
Sbjct: 80 H----RNLIRLYGVVLTPPMKMVTELAPLG-SLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
++ SK F+HRD+ N L+ + V I DFGL +
Sbjct: 135 GYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMR 169
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 44/180 (24%), Positives = 73/180 (40%), Gaps = 39/180 (21%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKL--ENVKTKHPQ-LQYEAK 54
R K + R++G GSFG +Y G + VAIK E + EA
Sbjct: 23 AR--EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 80
Query: 55 LYKILQGGTGIPNL-RWFGV--EGDYNVLVI-------DLL------GPSLEDLFNFCSR 98
+ K ++ R GV +G LVI DL P++ + N
Sbjct: 81 VMKEFNC----HHVVRLLGVVSQGQ-PTLVIMELMTRGDLKSYLRSLRPAMAN--NPVLA 133
Query: 99 KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
SL ++ +A ++ + + ++++ F+HRD+ N ++ V I DFG+ RD
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF---TVKIGDFGMT---RD 187
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 43/183 (23%), Positives = 72/183 (39%), Gaps = 35/183 (19%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTNEE---VAIKLENVKTKHPQLQ---YEAKLYKILQGGT 63
IG G FG +Y GT + + + A+K N T ++ E + K
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-- 85
Query: 64 GIPN-LRWFGV--EGDYNVLVIDLLGPSLE-----DLFNF---CSRKLSLKTVLMLADQM 112
PN L G+ + + LV+ L DL NF + ++K ++ Q+
Sbjct: 86 --PNVLSLLGICLRSEGSPLVV------LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 172
++++ SK F+HRD+ N ++ V + DFGLA RD + Y +
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEK---FTVKVADFGLA---RD--MYDKEYYSVHNK 189
Query: 173 LTG 175
Sbjct: 190 TGA 192
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 2e-07
Identities = 38/154 (24%), Positives = 74/154 (48%), Gaps = 19/154 (12%)
Query: 11 LGRKIGSGSFGEIYLGT--NIQTNEEVAIKLENVKTKHPQLQY----EAKLYKILQGGTG 64
+++GSG+FG + G + + VA+K+ + P L+ EA + + L
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN--- 77
Query: 65 IPNL-RWFGV-EGDYNVLVIDLLGPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVH 120
P + R G+ E + +LV+++ L L + +R + K ++ L Q+ ++++
Sbjct: 78 -PYIVRMIGICEAESWMLVMEMA--ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLE 134
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+F+HRD+ N L+ + I DFGL+K
Sbjct: 135 ESNFVHRDLAARNVLLV---TQHYAKISDFGLSK 165
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 51/287 (17%), Positives = 93/287 (32%), Gaps = 95/287 (33%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK----------------------LENVKT 44
+ F R +G G FGE++ T + A K L K
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA--KV 242
Query: 45 KHP---QLQY----EAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL--GPSLEDLF-- 93
L Y + L LV+ ++ G D+
Sbjct: 243 HSRFIVSLAYAFETKTDLC-----------------------LVMTIMNGG----DIRYH 275
Query: 94 ----NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVY 146
+ + + Q+++ +E +H ++ ++RD+KP+N L+ G V
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG------NVR 329
Query: 147 IIDFGLAKRYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLM 204
I D GLA + + K GT + + LG E D +LG V +
Sbjct: 330 ISDLGLAV---------ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALG-VTL 379
Query: 205 Y-FLRGSLPWQGLKAGTKKQK-YEKISEKKV----STSIEA--LCRG 243
Y + P++ + ++ +++ E+ V S + C
Sbjct: 380 YEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEA 426
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 33/162 (20%), Positives = 68/162 (41%), Gaps = 17/162 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-NIQTNEE--VAIKLENVKTKHPQLQ---YEAKLYKILQ 60
+ + +G+G FGE+ G + + +E VAIK V Q + EA +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 61 GGTGIPNL-RWFGV--EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
PN+ R GV + ++V + + SL+ + ++ ++ + + + +
Sbjct: 105 H----PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGM 160
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
+++ ++HRD+ N L+ + DFGL + D
Sbjct: 161 KYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVLED 199
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 38/160 (23%), Positives = 66/160 (41%), Gaps = 21/160 (13%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIKLENVKTKHPQLQ---YEAKLYKIL 59
+F+ + +GSG+FG +Y G I E+ VAIK T + EA + +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 60 QGGTGIPNL-RWFGV-EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMIN 114
P++ R G+ L+ L+ L ++ + + +L Q+
Sbjct: 75 DN----PHVCRLLGICLTSTVQLITQLM--PFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ ++ + +HRD+ N L+ V I DFGLAK
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 41/184 (22%), Positives = 68/184 (36%), Gaps = 46/184 (25%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIKL--ENVKTK--HPQLQYEAKL 55
P +F LGR +G G FG + Q + VA+K+ ++ + EA
Sbjct: 21 PE--QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAAC 78
Query: 56 YKILQGGTGIPN-LRWFGV-------EGDYNVLVIDLLGPSLE-----DLFNF------- 95
K P+ + GV +VI L DL F
Sbjct: 79 MKEFDH----PHVAKLVGVSLRSRAKGRLPIPMVI------LPFMKHGDLHAFLLASRIG 128
Query: 96 -CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
L L+T++ + +E++ S++F+HRD+ N ++ V + DFGL+
Sbjct: 129 ENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED---MTVCVADFGLS- 184
Query: 155 RYRD 158
R
Sbjct: 185 --RK 186
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 31/159 (19%), Positives = 59/159 (37%), Gaps = 19/159 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKL--ENVKTKHPQ--LQYEAKLYKI 58
+ R + +GSG FG ++ G V IK+ + + Q
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD-HMLAIGS 71
Query: 59 LQGGTGIPNL-RWFGVEGDYNVLVIDLLGP--SLEDLFNFCSRKLSLKTVLMLADQMINR 115
L ++ R G+ ++ ++ P SL D L + +L Q+
Sbjct: 72 LDH----AHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 127
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+ ++ +HR++ N L+ +QV + DFG+A
Sbjct: 128 MYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVAD 163
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 3e-07
Identities = 36/157 (22%), Positives = 66/157 (42%), Gaps = 16/157 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT---NIQTNEEVAIKLENVKTKHPQLQ---YEAKLYKILQ 60
L R +G G FGE+Y G + VA+K + EA + K L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 61 GGTGIPNL-RWFGV-EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE 117
P++ + G+ E + ++++L L L + T+++ + Q+ +
Sbjct: 72 H----PHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
++ S + +HRDI N L+ V + DFGL++
Sbjct: 128 YLESINCVHRDIAVRNILVA---SPECVKLGDFGLSR 161
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 44/178 (24%), Positives = 71/178 (39%), Gaps = 35/178 (19%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKL--ENVKTKHPQ-LQYEAK 54
PR L R +G G+FGE+Y G N + +VA+K E + EA
Sbjct: 28 PR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 85
Query: 55 LYKILQGGTGIPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNF---------CSRKL 100
+ N+ R GV + ++++L+ G DL +F L
Sbjct: 86 IISKFNH----QNIVRCIGVSLQSLPRFILMELMAGG----DLKSFLRETRPRPSQPSSL 137
Query: 101 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
++ +L +A + +++ F+HRDI N L+ I DFG+A RD
Sbjct: 138 AMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---RD 192
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 5e-07
Identities = 47/182 (25%), Positives = 80/182 (43%), Gaps = 39/182 (21%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ--LQYEAKL 55
R L ++G G+FG+++L N+ ++ VA+K ++ + Q EA+L
Sbjct: 39 KR--RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAEL 96
Query: 56 YKILQGGTGIPNL-RWFGV--EGDYNVLVI-------DLL---------GPSLEDLFNFC 96
+LQ ++ R+FGV EG +L++ DL L +
Sbjct: 97 LTMLQH----QHIVRFFGVCTEGR-PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 97 SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156
L L +L +A Q+ + ++ F+HRD+ N L+G G V I DFG++
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL---VVKIGDFGMS--- 205
Query: 157 RD 158
RD
Sbjct: 206 RD 207
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 7e-07
Identities = 43/176 (24%), Positives = 70/176 (39%), Gaps = 33/176 (18%)
Query: 10 RLGRKIGSGSFGEIYLGTNIQTNEE---VAIKLENVKTKHPQLQ---YEAKLYKILQGGT 63
IG G FG +Y GT + + + A+K N T ++ E + K
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-- 149
Query: 64 GIPN-LRWFGV--EGDYNVLVIDLLGPSLE-----DLFNF---CSRKLSLKTVLMLADQM 112
PN L G+ + + LV+ L DL NF + ++K ++ Q+
Sbjct: 150 --PNVLSLLGICLRSEGSPLVV------LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 201
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR 168
++F+ SK F+HRD+ N ++ V + DFGLA RD +
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLDEK---FTVKVADFGLA---RDMYDKEFDSVH 251
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 8e-07
Identities = 39/263 (14%), Positives = 78/263 (29%), Gaps = 76/263 (28%)
Query: 30 QTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI---DLLG 86
+ + L ++ + ++ + IP +L + D++
Sbjct: 354 KLTTIIESSLNVLEPAEYRKMFDR--LSVFPPSAHIP----------TILLSLIWFDVIK 401
Query: 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI--KPDNFLMGLGRRANQ 144
+ + N + SL + Q + S ++ ++ K +N L R
Sbjct: 402 SDVMVVVNKLHKY-SL-----VEKQPKESTISIPS---IYLELKVKLEN-EYALHRSIVD 451
Query: 145 VYII-----DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL-GIEQSRRDDLES 198
Y I L Y D + HI + HL IE R L
Sbjct: 452 HYNIPKTFDSDDLIPPYLDQYFYSHIGH-----------------HLKNIEHPERMTLFR 494
Query: 199 LGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSL 258
+ ++ FL +K +++ + + + L + Y Y
Sbjct: 495 MVFLDFRFLE------------QKIRHDSTAWNASGSILNTL-----QQLKFYKPYI--- 534
Query: 259 RFDDKPDYAYLKRLFRDL--FIR 279
D+ P Y +RL + F+
Sbjct: 535 -CDNDPKY---ERLVNAILDFLP 553
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.9 bits (113), Expect = 7e-06
Identities = 36/353 (10%), Positives = 98/353 (27%), Gaps = 107/353 (30%)
Query: 28 NIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEG----DYNVLV-- 81
+I + EE+ + +K + +L + ++ F VE +Y L+
Sbjct: 44 SILSKEEID---HIIMSKDAVSGTLRLFWTLLSKQEEM--VQKF-VEEVLRINYKFLMSP 97
Query: 82 --IDLLGPSLE-DLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFL-- 135
+ PS+ ++ +L + A ++R++ + L ++P +
Sbjct: 98 IKTEQRQPSMMTRMYIEQRDRLY-NDNQVFAKYNVSRLQPYLKLRQALLE-LRPAKNVLI 155
Query: 136 --M-GLG----------------RRANQVYIIDFGLAKRYRDTATH-QHIPYRENKNLTG 175
+ G G + +++ ++ Q + Y+ + N T
Sbjct: 156 DGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTS 215
Query: 176 TARYAS---MNTHLGIEQSRR--------------DDLESLGYVLMYF------------ 206
+ ++S + H + RR ++++ F
Sbjct: 216 RSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAK-AWNAFNLSCKILLTTRF 274
Query: 207 ----------LRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL----CRGYP------- 245
+ + + + K + + L P
Sbjct: 275 KQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIA 334
Query: 246 ---TEFASYFHYCRSLRFD----------DKPDYAYLKRLFRDLFIREGFQFD 285
+ + + + + D + + A +++F L + F
Sbjct: 335 ESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV---FPPS 384
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 9e-07
Identities = 44/178 (24%), Positives = 71/178 (39%), Gaps = 35/178 (19%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKL--ENVKTKHPQ-LQYEAK 54
PR L R +G G+FGE+Y G N + +VA+K E + EA
Sbjct: 69 PR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEAL 126
Query: 55 LYKILQGGTGIPNL-RWFGV--EGDYNVLVIDLL--GPSLEDLFNF---------CSRKL 100
+ N+ R GV + ++++L+ G DL +F L
Sbjct: 127 IISKFNH----QNIVRCIGVSLQSLPRFILLELMAGG----DLKSFLRETRPRPSQPSSL 178
Query: 101 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158
++ +L +A + +++ F+HRDI N L+ I DFG+A RD
Sbjct: 179 AMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---RD 233
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 9e-07
Identities = 36/152 (23%), Positives = 69/152 (45%), Gaps = 15/152 (9%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEE--VAIKL---ENVKTKHPQLQYEAKLYKILQGGTGI 65
++G G+FG + G ++ VAIK+ K ++ EA++ L
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN---- 395
Query: 66 PNL-RWFGV-EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
P + R GV + + +LV+++ G L ++ + V L Q+ ++++ K
Sbjct: 396 PYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+F+HR++ N L+ + I DFGL+K
Sbjct: 456 NFVHRNLAARNVLLV---NRHYAKISDFGLSK 484
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 1e-06
Identities = 36/158 (22%), Positives = 75/158 (47%), Gaps = 18/158 (11%)
Query: 7 NKFRLGR-KIGSGSFGEIYLGT-NIQTNE-EVAIKL--ENVKTKHPQ--LQYEAKLYKIL 59
+ + ++G G+FG + G ++ + +VAIK+ + + + ++ EA++ L
Sbjct: 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR-EAQIMHQL 67
Query: 60 QGGTGIPNL-RWFGV-EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
P + R GV + + +LV+++ G L ++ + V L Q+ +
Sbjct: 68 DN----PYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+++ K+F+HRD+ N L+ + I DFGL+K
Sbjct: 124 KYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSK 158
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 35/158 (22%), Positives = 71/158 (44%), Gaps = 19/158 (12%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTG 64
N F IG G FG++Y G ++ +VA+K ++ + + E + +
Sbjct: 39 NNFDHKFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFCRH--- 94
Query: 65 IPNL-RWFG--VEGDYNVLVIDLL--GPSLED-LF--NFCSRKLSLKTVLMLADQMINRV 116
P+L G E + +L+ + G +L+ L+ + + +S + L + +
Sbjct: 95 -PHLVSLIGFCDERNEMILIYKYMENG-NLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
++H+++ +HRD+K N L+ I DFG++K
Sbjct: 153 HYLHTRAIIHRDVKSINILLDENFVPK---ITDFGISK 187
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 40/180 (22%), Positives = 62/180 (34%), Gaps = 33/180 (18%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEEVAIKL--ENVKTKHPQ-LQYEAKLYK 57
N + IG G+FG++ + AIK E + E ++
Sbjct: 23 DW--NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 80
Query: 58 ILQGGTGIPNLRWFGV--EGDYNVLVI------DLL----------GPSLEDLFNFCSRK 99
L I NL G Y L I +LL + N +
Sbjct: 81 KLGHHPNIINL--LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 100 LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159
LS + +L A + ++++ K F+HRD+ N L+G I DFGL+ R
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN---YVAKIADFGLS---RGQ 192
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 41/184 (22%), Positives = 78/184 (42%), Gaps = 38/184 (20%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE-----VAIKL--ENVKTKHPQ-LQYE 52
PR +K LG+ +G G+FG++ + I ++ VA+K+ ++ K L E
Sbjct: 33 PR--DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 90
Query: 53 AKLYKILQGGTGIPNLRWFGV--EGDYNVLVI------DLL----------GPSLEDLFN 94
++ K++ I NL G + +++ +L D+
Sbjct: 91 MEMMKMIGKHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 148
Query: 95 FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+++ K ++ Q+ +E++ S+ +HRD+ N L+ N + I DFGLA
Sbjct: 149 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADFGLA- 204
Query: 155 RYRD 158
RD
Sbjct: 205 --RD 206
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 36/182 (19%), Positives = 67/182 (36%), Gaps = 70/182 (38%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F L R IG GS+ ++ L +T+ A+K ++ V+T HP
Sbjct: 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 48 ---QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS 97
L E++L+ +++ GG DL
Sbjct: 71 FLVGLHSCFQTESRLFFVIEYVNGG----------------------------DLMFHMQ 102
Query: 98 R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGL 152
R KL + + ++ + ++H + ++RD+K DN L+ G + + D+G+
Sbjct: 103 RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG------HIKLTDYGM 156
Query: 153 AK 154
K
Sbjct: 157 CK 158
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 38/181 (20%), Positives = 74/181 (40%), Gaps = 37/181 (20%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE-----VAIKLENVKTKHPQLQ---YE 52
PR ++ LG+ +G G+FG++ L + ++ VA+K+ L E
Sbjct: 67 PR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISE 124
Query: 53 AKLYKILQGGTGIPNL-RWFGV--EGDYNVLVI------DLL----------GPSLEDLF 93
++ K++ N+ G + +++ +L +
Sbjct: 125 MEMMKMIGKH---KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181
Query: 94 NFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
+ +LS K ++ A Q+ +E++ SK +HRD+ N L+ N + I DFGLA
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED---NVMKIADFGLA 238
Query: 154 K 154
+
Sbjct: 239 R 239
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 61/283 (21%), Positives = 96/283 (33%), Gaps = 98/283 (34%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F L + +G GSFG+++L +TN+ AIK +E +HP
Sbjct: 19 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 48 QL-------QYEAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS 97
L Q + L+ +++ GG DL
Sbjct: 79 FLTHMFCTFQTKENLFFVMEYLNGG----------------------------DLMYHIQ 110
Query: 98 R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGL 152
K L A ++I ++F+HSK ++RD+K DN L+ G + I DFG+
Sbjct: 111 SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG------HIKIADFGM 164
Query: 153 AK---RYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-F 206
K T GT Y + LG + + D S G VL+Y
Sbjct: 165 CKENMLGDAKTN------------TFCGTPDYIAPEILLGQKYNHSVDWWSFG-VLLYEM 211
Query: 207 LRGSLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 243
L G P+ G +++ + I + L
Sbjct: 212 LIGQSPFHG---QDEEELFHSIRMDNPFYPRWLEKEAKDLLVK 251
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 60/283 (21%), Positives = 96/283 (33%), Gaps = 98/283 (34%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F +G GSFG++ L T+E A+K +E K P
Sbjct: 22 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 48 ---QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS 97
QL +LY +++ GG DL
Sbjct: 82 FLTQLHSCFQTMDRLYFVMEYVNGG----------------------------DLMYHIQ 113
Query: 98 R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGL 152
+ + + A ++ + F+ SK ++RD+K DN ++ G + I DFG+
Sbjct: 114 QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG------HIKIADFGM 167
Query: 153 AK---RYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-F 206
K T T GT Y + + D + G VL+Y
Sbjct: 168 CKENIWDGVTTK------------TFCGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYEM 214
Query: 207 LRGSLPWQGLKAGTKKQKYEKISEKKV----STSIEA--LCRG 243
L G P++G + + ++ I E V S S EA +C+G
Sbjct: 215 LAGQAPFEG---EDEDELFQSIMEHNVAYPKSMSKEAVAICKG 254
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 58/283 (20%), Positives = 94/283 (33%), Gaps = 98/283 (34%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F +G GSFG++ L T+E A+K +E K P
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 48 QL-------QYEAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS 97
L Q +LY +++ GG DL
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGG----------------------------DLMYHIQ 434
Query: 98 R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGL 152
+ + + A ++ + F+ SK ++RD+K DN ++ G + I DFG+
Sbjct: 435 QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG------HIKIADFGM 488
Query: 153 AK---RYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-F 206
K T T GT Y + + D + G VL+Y
Sbjct: 489 CKENIWDGVTTK------------TFCGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYEM 535
Query: 207 LRGSLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 243
L G P++G + + ++ I E V S A+C+G
Sbjct: 536 LAGQAPFEG---EDEDELFQSIMEHNVAYPKSMSKEAVAICKG 575
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 35/182 (19%), Positives = 67/182 (36%), Gaps = 70/182 (38%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F L R IG GS+ ++ L +T+ A++ ++ V+T HP
Sbjct: 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 48 ---QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS 97
L E++L+ +++ GG DL
Sbjct: 114 FLVGLHSCFQTESRLFFVIEYVNGG----------------------------DLMFHMQ 145
Query: 98 R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGL 152
R KL + + ++ + ++H + ++RD+K DN L+ G + + D+G+
Sbjct: 146 RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG------HIKLTDYGM 199
Query: 153 AK 154
K
Sbjct: 200 CK 201
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 41/184 (22%), Positives = 77/184 (41%), Gaps = 38/184 (20%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE-----VAIKL--ENVKTKHPQ-LQYE 52
PR +K LG+ +G G FG++ + I ++ VA+K+ ++ K L E
Sbjct: 79 PR--DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 136
Query: 53 AKLYKILQGGTGIPNLRWFGV--EGDYNVLVI------DLL----------GPSLEDLFN 94
++ K++ I NL G + +++ +L D+
Sbjct: 137 MEMMKMIGKHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 194
Query: 95 FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
+++ K ++ Q+ +E++ S+ +HRD+ N L+ N + I DFGLA
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN---NVMKIADFGLA- 250
Query: 155 RYRD 158
RD
Sbjct: 251 --RD 252
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 6e-06
Identities = 59/282 (20%), Positives = 102/282 (36%), Gaps = 97/282 (34%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-----------------EN---VKTKHP- 47
F + +G G+FG++ L T A+K+ E+ T+HP
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66
Query: 48 --QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR 98
L+Y +L +++ GG +LF SR
Sbjct: 67 LTALKYAFQTHDRLCFVMEYANGG----------------------------ELFFHLSR 98
Query: 99 --KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGLA 153
+ + ++++ +E++HS+ ++RDIK +N ++ G + I DFGL
Sbjct: 99 ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG------HIKITDFGLC 152
Query: 154 K---RYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FL 207
K T T GT Y + + R D LG V+MY +
Sbjct: 153 KEGISDGATMK------------TFCGTPEYLAPEVLEDNDYGRAVDWWGLG-VVMYEMM 199
Query: 208 RGSLPWQGLKAGTKKQKYEKISEKKV----STSIEA--LCRG 243
G LP+ ++ +E I +++ + S EA L G
Sbjct: 200 CGRLPFYN---QDHERLFELILMEEIRFPRTLSPEAKSLLAG 238
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 6e-06
Identities = 42/188 (22%), Positives = 63/188 (33%), Gaps = 49/188 (26%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ---LQYEAK 54
+ R ++G FG++Y G E+ VAIK K + P ++EA
Sbjct: 7 SL--SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64
Query: 55 LYKILQGGTGIPNL-RWFGV--EGDYNVLVI-------DLL----------GPSLEDLFN 94
L LQ PN+ GV + + +I DL D
Sbjct: 65 LRARLQH----PNVVCLLGVVTKDQ-PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119
Query: 95 FCSRKLSLKTVLMLADQ----MINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150
L + L Q M E++ S +H+D+ N L+ V I D
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGM----EYLSSHHVVHKDLATRNVLVYDK---LNVKISDL 172
Query: 151 GLAKRYRD 158
GL R+
Sbjct: 173 GLF---RE 177
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 8e-06
Identities = 54/283 (19%), Positives = 91/283 (32%), Gaps = 98/283 (34%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F R +G GSFG++ L +T + A+K +E T HP
Sbjct: 25 FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 48 ---QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS 97
QL +L+ +++ GG DL
Sbjct: 85 FLTQLFCCFQTPDRLFFVMEFVNGG----------------------------DLMFHIQ 116
Query: 98 R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGL 152
+ + A ++I+ + F+H K ++RD+K DN L+ G + DFG+
Sbjct: 117 KSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG------HCKLADFGM 170
Query: 153 AK---RYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-F 206
K T T GT Y + + D ++G VL+Y
Sbjct: 171 CKEGICNGVTTA------------TFCGTPDYIAPEILQEMLYGPAVDWWAMG-VLLYEM 217
Query: 207 LRGSLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 243
L G P++ + +E I +V + +
Sbjct: 218 LCGHAPFEA---ENEDDLFEAILNDEVVYPTWLHEDATGILKS 257
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 52/262 (19%), Positives = 94/262 (35%), Gaps = 80/262 (30%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT--------KHPQ 48
F + +G G+FG++ L T A+K + + T +HP
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209
Query: 49 L-------QYEAKLYKIL---QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR 98
L Q +L ++ GG +LF SR
Sbjct: 210 LTALKYSFQTHDRLCFVMEYANGG----------------------------ELFFHLSR 241
Query: 99 --KLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
S ++++ ++++HS K+ ++RD+K +N ++ + + I DFGL K
Sbjct: 242 ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCK- 297
Query: 156 YRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLRGSLP 212
+ I T GT Y + + R D LG V+MY + G LP
Sbjct: 298 -------EGIKD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG-VVMYEMMCGRLP 348
Query: 213 WQGLKAGTKKQKYEKISEKKVS 234
+ ++ +E I +++
Sbjct: 349 FYN---QDHEKLFELILMEEIR 367
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 57/283 (20%), Positives = 93/283 (32%), Gaps = 98/283 (34%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK------------LENVKT---------KHP 47
F + IG GSFG++ L + A+K +++ + KHP
Sbjct: 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 48 ---QLQY----EAKLYKILQ---GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCS 97
L + KLY +L GG +LF
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGG----------------------------ELFYHLQ 131
Query: 98 R--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFGL 152
R A ++ + + ++HS + ++RD+KP+N L+ G + + DFGL
Sbjct: 132 RERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG------HIVLTDFGL 185
Query: 153 AK---RYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-F 206
K + T + T GT Y + R D LG ++Y
Sbjct: 186 CKENIEHNSTTS------------TFCGTPEYLAPEVLHKQPYDRTVDWWCLG-AVLYEM 232
Query: 207 LRGSLPWQGLKAGTKKQKYEKISEKKV------STSIEALCRG 243
L G P+ + Y+ I K + + S L G
Sbjct: 233 LYGLPPFYS---RNTAEMYDNILNKPLQLKPNITNSARHLLEG 272
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 1e-05
Identities = 38/197 (19%), Positives = 70/197 (35%), Gaps = 59/197 (29%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ-----LQYE 52
PR LG+ +G G FG++ T +++ VA+K+ +K L E
Sbjct: 21 PR--KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM--LKENASPSELRDLLSE 76
Query: 53 AKLYKILQGGTGIPNL-RWFGV---------------EGD-----------YNVLVIDLL 85
+ K + P++ + +G G +
Sbjct: 77 FNVLKQVNH----PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 86 GPSLEDLFNFCSRKLSLKTVLMLADQ----MINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141
+ L + R L++ ++ A Q M +++ +HRD+ N L+ G
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGM----QYLAEMKLVHRDLAARNILVAEG-- 186
Query: 142 ANQVYIIDFGLAKRYRD 158
++ I DFGL+ RD
Sbjct: 187 -RKMKISDFGLS---RD 199
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 46/197 (23%), Positives = 69/197 (35%), Gaps = 59/197 (29%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVKTKHPQ-----LQYE 52
PR N R IG G+FG ++ + E VA+K+ +K + Q E
Sbjct: 45 PR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQRE 100
Query: 53 AKLYKILQGGTGIPNL-RWFGV--EGDYNVLVI------DLL------------------ 85
A L PN+ + GV G L+ DL
Sbjct: 101 AALMAEFDN----PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 156
Query: 86 GPSLEDLFNFCSRKLSLKTVLMLADQ----MINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141
+ + + LS L +A Q M ++ + F+HRD+ N L+G
Sbjct: 157 LSTRARVSSPGPPPLSCAEQLCIARQVAAGM----AYLSERKFVHRDLATRNCLVGENM- 211
Query: 142 ANQVYIIDFGLAKRYRD 158
V I DFGL+ R+
Sbjct: 212 --VVKIADFGLS---RN 223
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 2e-05
Identities = 64/266 (24%), Positives = 105/266 (39%), Gaps = 87/266 (32%)
Query: 9 FRLGRKIGSGSFGEIYL-------GTN------------IQTNEEVAIKLEN---VKTKH 46
F L + +G GSFG+++L ++ + V K+E V+ H
Sbjct: 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85
Query: 47 P---QLQY----EAKLYKIL---QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFC 96
P +L Y E KLY IL +GG DLF
Sbjct: 86 PFIVKLHYAFQTEGKLYLILDFLRGG----------------------------DLFTRL 117
Query: 97 SR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIIDFG 151
S+ + + V ++ ++ +HS ++RD+KP+N L+ G + + DFG
Sbjct: 118 SKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG------HIKLTDFG 171
Query: 152 LAKRYRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY-FLR 208
L+K + I + E K + GT Y + ++ D S G VLM+ L
Sbjct: 172 LSK--------ESIDH-EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFG-VLMFEMLT 221
Query: 209 GSLPWQGLKAGTKKQKYEKISEKKVS 234
G+LP+QG +K+ I + K+
Sbjct: 222 GTLPFQG---KDRKETMTMILKAKLG 244
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 49/190 (25%), Positives = 70/190 (36%), Gaps = 45/190 (23%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT--NIQTNEE---VAIKL--ENVKTKHPQ-LQYEAK 54
PR G+ +GSG+FG++ T I VA+K+ E + + L E K
Sbjct: 43 PR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 55 LYKILQGGTGIPNLRWFGV--EGDYNVLVI-------DLL-----------------GPS 88
+ L I NL G + +I DLL
Sbjct: 101 MMTQLGSHENIVNL--LGACTLSG-PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157
Query: 89 LEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148
L+ + +L A Q+ +EF+ KS +HRD+ N L+ G V I
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG---KVVKIC 214
Query: 149 DFGLAKRYRD 158
DFGLA RD
Sbjct: 215 DFGLA---RD 221
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 4e-05
Identities = 64/270 (23%), Positives = 96/270 (35%), Gaps = 93/270 (34%)
Query: 9 FRLGRKIGSGSFGEIYL---GTNIQTNEEVAIK-------------LENVKT-------- 44
F L R +G G +G+++ T T + A+K + K
Sbjct: 19 FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 45 KHP---QLQY----EAKLYKIL---QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFN 94
KHP L Y KLY IL GG +LF
Sbjct: 79 KHPFIVDLIYAFQTGGKLYLILEYLSGG----------------------------ELFM 110
Query: 95 FCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYIID 149
R T ++ + +H K ++RD+KP+N ++ G V + D
Sbjct: 111 QLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG------HVKLTD 164
Query: 150 FGLAKR--YRDTATHQHIPYRENKNLT--GTARYASMNTHLGIEQSRRDDLESLGYVLMY 205
FGL K + T TH T GT Y + + +R D SLG LMY
Sbjct: 165 FGLCKESIHDGTVTH-----------TFCGTIEYMAPEILMRSGHNRAVDWWSLG-ALMY 212
Query: 206 -FLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
L G+ P+ G +K+ +KI + K++
Sbjct: 213 DMLTGAPPFTG---ENRKKTIDKILKCKLN 239
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 56/275 (20%), Positives = 103/275 (37%), Gaps = 95/275 (34%)
Query: 9 FRLGRKIGSGSFGEIYL---GTNIQTNEEVAIK-----------------------LENV 42
F L + +G+G++G+++L + T + A+K LE++
Sbjct: 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 43 KTKHP---QLQY----EAKLYKIL---QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDL 92
+ + P L Y E KL+ IL GG +L
Sbjct: 116 R-QSPFLVTLHYAFQTETKLHLILDYINGG----------------------------EL 146
Query: 93 FNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM---GLGRRANQVYI 147
F S+ + + V + +++ +E +H ++RDIK +N L+ G V +
Sbjct: 147 FTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG------HVVL 200
Query: 148 IDFGLAKRYRDTATHQHIPYRENKNLT--GTARYAS----MNTHLGIEQSRRDDLESLGY 201
DFGL+K + + + GT Y + G +++ D SLG
Sbjct: 201 TDFGLSK--------EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAV--DWWSLG- 249
Query: 202 VLMY-FLRGSLPWQGLKAG-TKKQKYEKISEKKVS 234
VLMY L G+ P+ ++ + +I + +
Sbjct: 250 VLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 284
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 21/73 (28%), Positives = 36/73 (49%), Gaps = 4/73 (5%)
Query: 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 146
E + L+L+ ++ + Q+ +EF+ S+ +HRD+ N L+ V
Sbjct: 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVK 233
Query: 147 IIDFGLAKR-YRD 158
I DFGLA+ Y+D
Sbjct: 234 ICDFGLARDIYKD 246
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 474 | |||
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.9 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.38 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.25 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.08 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.06 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.78 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.63 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.55 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.38 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.35 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.35 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.23 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.07 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.76 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.74 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.59 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.58 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.54 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.53 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.44 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.26 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.1 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.98 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.95 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.82 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.57 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.56 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.4 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.55 |
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-80 Score=653.58 Aligned_cols=470 Identities=81% Similarity=1.276 Sum_probs=278.8
Q ss_pred CCCccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
|+++++++|+++++||+|+||.||+|++..+++.||||++.......++..|+++++.|.++++++.+.+++......+|
T Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp -CCEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCCCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 89999999999999999999999999999999999999988877778899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 81 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 81 v~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
||||++++|.+++..+...+++.+++.|+.||+.||.|||++|||||||||+||||+.++..+.+||+|||+++.+....
T Consensus 81 vme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 99999999999999888899999999999999999999999999999999999999655578899999999999888777
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
...+.++.......||..|+|||++.+..++.++||||||||||||++|+.||.+.......+.+.++........++.+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH
Confidence 76677777778889999999999999999999999999999999999999999998888888889999888888888999
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccccccccccCC-CCCcCCCCCCCCCCCCC
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVST-PARAIGPGAGPSSGMPP 319 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~~~~-p~~~~~~~~~~s~~~~~ 319 (474)
+..+|+++.+||..||..||++||++.+|+++|++++.+.++++++.+||+..+..+.+.+. |++..++..++++.. +
T Consensus 241 ~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~~~~~~~~p~~~~~~~~~~s~~~-~ 319 (483)
T 3sv0_A 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQIASAPPRAVGHGAGPSGLA-P 319 (483)
T ss_dssp HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC-------------------------
T ss_pred hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhccccccccCCCCCCCCCCCCCCCCC-C
Confidence 99999999999999999999999999999999999999999999999999998887665544 444444455544443 4
Q ss_pred CcccccccCCCCCCCCCCCCCCCCCccCCCCCCCCCCCCccCCCCCCCCCCCCccccccccccc-ccCCccccccccCCC
Q 011945 320 AAANVDRQSGAEEGRHTGWSSADPSRRRNSGPLGNSANLSKQKSPMANDPAFSKDAMMSSYNLL-RSSGSSRRVAVPNSR 398 (474)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 398 (474)
+....+++++..+++.++|++.+ +|+.+++....|.++++++|+.++...++|.+.++++++ |++++||+.++|++|
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 397 (483)
T 3sv0_A 320 PALQNDRQSGVDEGRTSGWSSMD--RRRAPPPIASVGTLAKQKAPVGNDASFSKEPVISASNFLGRSSGSSRRPAVSSSR 397 (483)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccccccccCccccccccCCcccc--cccCCcccccccccccccCCCCCCccccccccccccccccccCCccccccccccc
Confidence 44556777788888888887764 677788999999999999999999999999999988877 999999999999999
Q ss_pred CcccCCCCCCCCCCCCCCCCCCCCCCCCCCcccCCcccCCCcccccccccCCccccccccccccceeccCCCccCC
Q 011945 399 EAAVVGSDTDPSRPRTTDASPGAFQKISSGQRSSPVVSSENRHTTSGRSTSNIKNFESTLRGIESLHFNNNERVHH 474 (474)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 474 (474)
.+.. +.+.+|+++|++++.+++..+.++.|+.+|..+.++|+++|+|++++++|||+||||||+|+|++|+|++|
T Consensus 398 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 472 (483)
T 3sv0_A 398 DVMP-IDTSEPSRTRATDASPGAFRRTSGPQKSSPVNSAEPKHSSSARHSSNVKNYESALKGIEGLNFDGDERVQY 472 (483)
T ss_dssp ----------------------------------------------------------------------------
T ss_pred cccC-CCCCCcccccccccCchhhhcCCCCcccCCCCccccccccccccccccccHHHHhhhhhhcccCCchHHHH
Confidence 9866 66778889999999988878999999999999999999999999999999999999999999999999987
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-56 Score=448.18 Aligned_cols=252 Identities=22% Similarity=0.250 Sum_probs=205.6
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
++|+++++||+|+||+||+|+++.+|+.||||++..... ...+.+|+++++.|+|++ |..++.++.++...||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~Hpn-IV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN-IVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTT-BCCEEEEEEETTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCC-CCcEEEEEEECCEEEEEE
Confidence 689999999999999999999999999999999875533 245889999999998655 555555667888999999
Q ss_pred ecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 83 DLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 83 e~~-g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
||| |++|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+....
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCCc
Confidence 999 889999997543 458999999999999999999999999999999999999 478899999999998765432
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
.. ....+||+.|||||++.+..|+.++||||||||||||++|+.||.+. +..+.+.++....... +
T Consensus 180 ~~-------~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~~~~~----~ 245 (350)
T 4b9d_A 180 EL-------ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG---SMKNLVLKIISGSFPP----V 245 (350)
T ss_dssp HH-------HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHTCCCC----C
T ss_pred cc-------ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHcCCCCC----C
Confidence 11 13458999999999999999999999999999999999999999874 4455556665544322 3
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
...+++++.+||..||+.||++||+++++ |++.|..
T Consensus 246 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~---l~hp~~~ 281 (350)
T 4b9d_A 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSI---LEKGFIA 281 (350)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHH---HTSHHHH
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHH---hcCHHhh
Confidence 45789999999999999999999998876 4455444
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=436.83 Aligned_cols=268 Identities=19% Similarity=0.313 Sum_probs=221.7
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
.++|+++++||+|+||+||+|+++.+++.||||+++.. .....+.+|+++|+.|+|++ |..++.++.+++..||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF-FVKLYFTFQDDEKLYF 109 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTT-BCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCC-CCeEEEEEEeCCEEEE
Confidence 35799999999999999999999999999999998642 34456899999999998555 5555556677888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
||||| |++|.+++.. .+.+++..+..|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+...
T Consensus 110 vmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecCCC
Confidence 99999 8899999975 4579999999999999999999999999999999999999 47899999999999987543
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
.... ...+++||+.|||||++.+..|+.++|||||||+||||++|+.||.+. +..+.+.++......
T Consensus 186 ~~~~-----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~~~~~----- 252 (311)
T 4aw0_A 186 SKQA-----RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEGLIFAKIIKLEYD----- 252 (311)
T ss_dssp TTCC-----CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCC-----
T ss_pred CCcc-----cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCC-----
Confidence 3211 235679999999999999999999999999999999999999999874 445566666655432
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccccc
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 295 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 295 (474)
++..+++++++||.+||..||++||+++++... ..+ ...+|...+||+.+..
T Consensus 253 ~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~-~~i---~~Hp~F~~idw~~l~~ 304 (311)
T 4aw0_A 253 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY-GPL---KAHPFFESVTWENLHQ 304 (311)
T ss_dssp CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH-HHH---HTSGGGTTCCCTTGGG
T ss_pred CCcccCHHHHHHHHHHccCCHhHCcChHHHcCC-HHH---HCCCCcCCCCHHHhcC
Confidence 245789999999999999999999998876321 111 1245556789998753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-55 Score=438.05 Aligned_cols=260 Identities=21% Similarity=0.241 Sum_probs=213.2
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 85 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (474)
+.|++.++||+|+||+||+|+++.+|+.||||+++.+.. ..+|+.+++.|+|++ |..++.++.++...|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---~~~E~~il~~l~Hpn-IV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---RVEELVACAGLSSPR-IVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CTHHHHTTTTCCCTT-BCCEEEEEEETTEEEEEECCCT
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---HHHHHHHHHhCCCCC-CCcEEEEEEECCEEEEEEeccC
Confidence 569999999999999999999999999999999876543 357999999998655 555555667888999999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCC-eEEEEecCCccccccCCCccc
Q 011945 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKRYRDTATHQH 164 (474)
Q Consensus 86 g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~-~vkL~DFGla~~~~~~~~~~~ 164 (474)
|++|.+++... +.+++..++.|+.||+.||+|||++|||||||||+||||+ .++ .+||+|||+|+.+........
T Consensus 134 gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 134 GGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS---SDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp TCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC---TTSCCEEECCCTTCEEC--------
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe---CCCCEEEEeeCCCCeEccCCCcccc
Confidence 89999999853 5799999999999999999999999999999999999995 555 699999999997765432111
Q ss_pred cccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCC
Q 011945 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (474)
Q Consensus 165 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (474)
......++||+.|||||++.+..|+.++||||||||||||++|+.||.+........ ++.... .....++..+
T Consensus 210 --~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~i~~~~--~~~~~~~~~~ 282 (336)
T 4g3f_A 210 --LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL---KIASEP--PPIREIPPSC 282 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH---HHHHSC--CGGGGSCTTS
T ss_pred --eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH---HHHcCC--CCchhcCccC
Confidence 111244689999999999999999999999999999999999999998865544333 333322 2223456789
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011945 245 PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281 (474)
Q Consensus 245 p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 281 (474)
++++.+||.+||+.||++||++.+|++.|...+...+
T Consensus 283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 9999999999999999999999999999998887654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-54 Score=423.13 Aligned_cols=293 Identities=78% Similarity=1.358 Sum_probs=258.2
Q ss_pred CCCccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
|+..++++|++.+.||+|+||.||+|++..+++.||||++........+..|+.+++.+.|++++..+..+.......++
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp --------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred cccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 56788999999999999999999999999999999999987777777899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 81 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 81 v~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
+||+++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++..+.+||+|||+++.+....
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 99999999999998777889999999999999999999999999999999999999544577889999999999887766
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
.....++.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.......+.+..+...........+
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhh
Confidence 65556666667789999999999999999999999999999999999999999987665555566666666667777778
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccc
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 293 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~ 293 (474)
+..+|+++.+++..||+.||++||++++|++.|++++.+.+..+++.+||+.+
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 4hgt_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGGC
T ss_pred hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhhc
Confidence 88999999999999999999999999999999999999999999999999865
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-54 Score=420.57 Aligned_cols=293 Identities=78% Similarity=1.358 Sum_probs=264.3
Q ss_pred CCCccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
|+..++++|++.+.||+|+||.||+|++..+++.||||++........+.+|+.+++.+.|+++++.+..+.......++
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp --CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 67788999999999999999999999999999999999988777778899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 81 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 81 v~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
+|||++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.++..+.+||+|||++.......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 99999999999998777789999999999999999999999999999999999999654567899999999999887766
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
.....++.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.......+.+..+.........+.+
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHH
Confidence 55555555667789999999999999999999999999999999999999999986655555556666666666677778
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccc
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 293 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~ 293 (474)
+..+|+++.+++..||+.||++||++.+|.+.|++++.+.+...++++||+.+
T Consensus 243 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 3uzp_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGGC
T ss_pred HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccccc
Confidence 88999999999999999999999999999999999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-55 Score=438.18 Aligned_cols=246 Identities=18% Similarity=0.260 Sum_probs=206.8
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC--CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
+.|+++++||+|+||+||+|+++.+|+.||||+++.. ...+.+.+|+.+|+.|+|+ +|..++.++..++..||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~Hp-nIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHE-NVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCT-TBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCC-CCCcEEEEEEECCEEEEEEeC
Confidence 4699999999999999999999999999999998643 3345689999999999855 555555666778889999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 85 ~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
| |++|.+++.. ..+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+.....
T Consensus 153 ~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~-- 225 (346)
T 4fih_A 153 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP-- 225 (346)
T ss_dssp CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSC--
T ss_pred CCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceecCCCCC--
Confidence 9 8899999974 569999999999999999999999999999999999999 4788999999999987765432
Q ss_pred ccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcC
Q 011945 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (474)
.....+||+.|||||++.+..|+.++||||||||||||++|+.||.+.. ..+.+..+....... ......
T Consensus 226 -----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~~~~~~--~~~~~~ 295 (346)
T 4fih_A 226 -----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMIRDNLPPR--LKNLHK 295 (346)
T ss_dssp -----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSSCCC--CSCGGG
T ss_pred -----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHcCCCCC--CCcccc
Confidence 1246799999999999999999999999999999999999999998743 344444444332111 112346
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 244 YPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
+++++.+||..||..||++||++++++
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~l 322 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAELL 322 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 889999999999999999999987763
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-54 Score=421.60 Aligned_cols=251 Identities=24% Similarity=0.325 Sum_probs=198.6
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++|++++.||+|+||+||+|+++.+|+.||||+++... ....+.+|+.+++.|+|++ |..+..++...+..|||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH-IIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTT-BCCEEEEEECSSEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCC-CCeEEEEEEECCEEEEE
Confidence 68999999999999999999999999999999986432 2346899999999998655 55555566778889999
Q ss_pred EecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 82 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 82 ~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
|||++++|.+++.. .+.+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.......
T Consensus 92 mEy~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 92 IEYAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EECCCEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSCC--------
T ss_pred EeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCCCeecCCCCc
Confidence 99999999999974 5679999999999999999999999999999999999999 4788999999999987654322
Q ss_pred ccccccccCCCCccCccccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
..+.+||+.|||||++.+..+ +.++|||||||+||||++|+.||.+. +....+..+...... +
T Consensus 168 --------~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~---~~~~~~~~i~~~~~~-----~ 231 (275)
T 3hyh_A 168 --------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE---SIPVLFKNISNGVYT-----L 231 (275)
T ss_dssp ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCC-----C
T ss_pred --------cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHcCCCC-----C
Confidence 245689999999999999886 58999999999999999999999873 344555555554432 2
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 281 (474)
+..+++++.+||.+||+.||++|||++++ |++.|.+..
T Consensus 232 p~~~s~~~~~li~~~L~~dP~~R~s~~ei---l~hpw~k~~ 269 (275)
T 3hyh_A 232 PKFLSPGAAGLIKRMLIVNPLNRISIHEI---MQDDWFKVD 269 (275)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHH---HHCHHHHTT
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHHHH---HcCcccccC
Confidence 45689999999999999999999997776 556665543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=424.50 Aligned_cols=286 Identities=60% Similarity=1.064 Sum_probs=260.0
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.+++++|++.++||+|+||.||+|.+..+++.||||++........+..|+.+++.|.++++|..+..++..+...++||
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 35788999999999999999999999999999999998877667789999999999977888888888888899999999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCe-----EEEEecCCccccc
Q 011945 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ-----VYIIDFGLAKRYR 157 (474)
Q Consensus 83 e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~-----vkL~DFGla~~~~ 157 (474)
||++++|.+++......+++..++.|+.||+.||+|||++||+||||||+|||++ .++. +||+|||+++.+.
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~---~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 85 ELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIG---RPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---CGGGTCTTSEEECCCTTCEESB
T ss_pred EeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---cCCCCCCceEEEEEcccceeee
Confidence 9999999999987777899999999999999999999999999999999999995 4444 9999999999887
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
........+++......||+.|+|||++.+..++.++|||||||+||||++|..||.+.......+.+..+.........
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI 241 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence 76665566666667889999999999999999999999999999999999999999998877788888888777777777
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccc
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTI 292 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~ 292 (474)
..++..+| ++.+++..||..||.+||++++|.++|++++.+.++..+..+||+.
T Consensus 242 ~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 295 (330)
T 2izr_A 242 EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWIG 295 (330)
T ss_dssp HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTTT
T ss_pred HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCCC
Confidence 77888888 9999999999999999999999999999999999999999999984
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-54 Score=441.13 Aligned_cols=245 Identities=18% Similarity=0.264 Sum_probs=206.4
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
+.|+++++||+|+||.||+|+++.+|+.||||++.... ..+.+.+|+.+|+.|+|++ |..++.++..++..||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~Hpn-IV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHEN-VVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTT-BCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCC-CCceEEEEEECCEEEEEEeC
Confidence 56999999999999999999999999999999986543 3456899999999998655 55555556678889999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 85 ~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
| |++|.+++.. ..+++..+..|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.+.....
T Consensus 230 ~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~~~~-- 302 (423)
T 4fie_A 230 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP-- 302 (423)
T ss_dssp CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCEECCSSCC--
T ss_pred CCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccceECCCCCc--
Confidence 9 8899999973 469999999999999999999999999999999999999 4788999999999987755432
Q ss_pred ccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcC
Q 011945 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (474)
....++||+.|||||++.+..|+.++||||||||||||++|+.||.+.. ..+.+..+....... ......
T Consensus 303 -----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~---~~~~~~~i~~~~~~~--~~~~~~ 372 (423)
T 4fie_A 303 -----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP---PLKAMKMIRDNLPPR--LKNLHK 372 (423)
T ss_dssp -----CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSCCCC--CSCTTS
T ss_pred -----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHcCCCCC--Cccccc
Confidence 1246799999999999999999999999999999999999999998743 344444444332111 112356
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011945 244 YPTEFASYFHYCRSLRFDDKPDYAYL 269 (474)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l 269 (474)
+++++.+||..||..||++||++++|
T Consensus 373 ~s~~~~dli~~~L~~dP~~R~ta~el 398 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQRATAAEL 398 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 89999999999999999999998776
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-54 Score=424.32 Aligned_cols=259 Identities=24% Similarity=0.329 Sum_probs=211.6
Q ss_pred CCcEEEeeeeeecCceEEEEEEEc-----CCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
.++|.+.++||+|+||+||+|++. .++..||||+++.... .+.|.+|+++|+.|+|+| |..+..++.+++..
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~Hpn-IV~l~g~~~~~~~~ 90 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH-IVKFYGVCVEGDPL 90 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTT-BCCEEEEECSSSSE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCC-CccEEEEEeeCCEE
Confidence 468999999999999999999875 3578999999875432 345899999999998555 55555566677788
Q ss_pred EEEEecC-CCCHHHHHHHc------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeE
Q 011945 79 VLVIDLL-GPSLEDLFNFC------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 145 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~------------~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~v 145 (474)
+|||||| +|+|.+++... ...+++.+++.|+.||+.||.|||+++||||||||+|||| +.++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl---~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---CCCCcE
Confidence 9999999 89999999753 2469999999999999999999999999999999999999 477899
Q ss_pred EEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHH
Q 011945 146 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 224 (474)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 224 (474)
||+|||+|+........ .......||+.|||||++.+..|+.++|||||||+||||+| |+.||.+... .+.
T Consensus 168 Ki~DFGla~~~~~~~~~-----~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~---~~~ 239 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEV 239 (299)
T ss_dssp EECCCSCHHHHTGGGCE-----EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHH
T ss_pred EECCcccceecCCCCce-----eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHH
Confidence 99999999876543321 11234579999999999999999999999999999999998 9999988543 444
Q ss_pred HHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 225 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
+..+...... ..+..+|+++.+||..||+.||++||++.+|.+.|+++....
T Consensus 240 ~~~i~~~~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~ 291 (299)
T 4asz_A 240 IECITQGRVL----QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS 291 (299)
T ss_dssp HHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHHHcCCCC----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 5555443322 234678999999999999999999999999999999987543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-54 Score=426.18 Aligned_cols=256 Identities=22% Similarity=0.321 Sum_probs=203.6
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
.++|++.++||+|+||+||+|++. ..||||+++..... +.|.+|+.+++.|+|+|+|..+. ++.+ +..+||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g-~~~~-~~~~iV 109 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMG-YMTK-DNLAIV 109 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEE-EECS-SSCEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEE-EEEC-CeEEEE
Confidence 357889999999999999999853 36999998654332 35889999999999777666554 4444 457899
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||| |++|.+++......+++..++.|+.||+.||+|||+++||||||||+||||+ .++.+||+|||+|+......
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~---~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLH---EGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEE---TTEEEEECCCSSCBC-----
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEEC---CCCcEEEeeccCceecccCC
Confidence 9999 8999999986677899999999999999999999999999999999999995 78899999999998765432
Q ss_pred CccccccccCCCCccCccccccccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~---~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
... .....+||+.|||||++.+. .|+.++|||||||+||||+||+.||.+.... ......+......+..
T Consensus 187 ~~~-----~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~--~~~~~~~~~~~~~p~~ 259 (307)
T 3omv_A 187 GSQ-----QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR--DQIIFMVGRGYASPDL 259 (307)
T ss_dssp ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHHHHTTCCCCCS
T ss_pred cce-----eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH--HHHHHHHhcCCCCCCc
Confidence 211 12456899999999999753 5899999999999999999999999875432 2223333333333334
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
..+...+|+++.+||..||+.||++||++.+|++.|+.+
T Consensus 260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 445678999999999999999999999999999988765
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=410.78 Aligned_cols=290 Identities=60% Similarity=1.015 Sum_probs=261.5
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.+++++|++.+.||+|+||.||+|.+..+++.||||++........+.+|+.+++.+.++++++.+..++......++||
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 45789999999999999999999999999999999998877677789999999999988888888888889999999999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeC--CCCCeEEEEecCCccccccCC
Q 011945 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 83 e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~--~~~~~vkL~DFGla~~~~~~~ 160 (474)
||++++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++.+ .....+||+|||+++......
T Consensus 86 e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~ 165 (298)
T 1csn_A 86 DLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 165 (298)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred EecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccc
Confidence 999999999998777789999999999999999999999999999999999999632 123349999999999887765
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
.....++.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.......+.+..+...........+
T Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (298)
T 1csn_A 166 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 245 (298)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred ccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHH
Confidence 55555555667788999999999999999999999999999999999999999988777777777777777777777788
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccc
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTI 292 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~ 292 (474)
+..+|+++.+++..||+.||++||++++|.+.|++++.+.+...+..+||+.
T Consensus 246 ~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~ 297 (298)
T 1csn_A 246 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNL 297 (298)
T ss_dssp TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGC
T ss_pred HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccCC
Confidence 8899999999999999999999999999999999999999999999999974
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-53 Score=417.62 Aligned_cols=247 Identities=21% Similarity=0.310 Sum_probs=202.3
Q ss_pred CCcE-EEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEe---CCE
Q 011945 6 GNKF-RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVE---GDY 77 (474)
Q Consensus 6 ~~~y-~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~---~~~ 77 (474)
.++| ++.++||+|+||+||+|.+..+++.||||++..... ...+.+|+.+++.|+|+++|..+..+... ...
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 3455 888899999999999999999999999998865432 23588999999999977777766655432 456
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~g--IiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
.||||||| |++|.+++.. ...+++..++.|+.||+.||+|||++| ||||||||+||||+ +.++.+||+|||+|+
T Consensus 104 ~~lvmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGGG
T ss_pred EEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCCE
Confidence 89999999 8999999975 457999999999999999999999998 99999999999995 346899999999998
Q ss_pred ccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (474)
...... ....+||+.|||||++.+ .|+.++||||||||||||++|+.||.+.. .....+..+......
T Consensus 181 ~~~~~~---------~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~--~~~~~~~~i~~~~~~ 248 (290)
T 3fpq_A 181 LKRASF---------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRVTSGVKP 248 (290)
T ss_dssp GCCTTS---------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHHHHTTTCCC
T ss_pred eCCCCc---------cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC--cHHHHHHHHHcCCCC
Confidence 644322 235689999999999876 69999999999999999999999997643 233444444443322
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
. .+...+++++.+||..||..||++||++++++
T Consensus 249 ~---~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l 281 (290)
T 3fpq_A 249 A---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 281 (290)
T ss_dssp G---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred C---CCCccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 2 23456789999999999999999999988764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-53 Score=424.07 Aligned_cols=256 Identities=22% Similarity=0.311 Sum_probs=203.7
Q ss_pred CcEEEeeeeeecCceEEEEEEEc-----CCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
++|.+.++||+|+||+||+|++. .+++.||||+++.... .+.|.+|+++|+.|+|+| |..+..++.+....+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~Hpn-IV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQH-IVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTT-BCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCC-CCcEEEEEEECCEEE
Confidence 57999999999999999999865 3688999999875432 345899999999998555 555555666777889
Q ss_pred EEEecC-CCCHHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCe
Q 011945 80 LVIDLL-GPSLEDLFNFCS--------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 144 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~--------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~ 144 (474)
|||||| +++|.+++.... .++++.+++.|+.||+.||+|||+++||||||||+||||+ .++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~---~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC---CCCc
Confidence 999999 899999997432 3599999999999999999999999999999999999995 7899
Q ss_pred EEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHH
Q 011945 145 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQ 223 (474)
Q Consensus 145 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~ 223 (474)
+||+|||+|+........ .......||+.|||||++.+..++.++|||||||+||||+| |+.||.+... .+
T Consensus 197 ~Ki~DFGla~~~~~~~~~-----~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~---~~ 268 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYY-----RVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TE 268 (329)
T ss_dssp EEECCCC---------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH---HH
T ss_pred EEEcccccceeccCCCcc-----eecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH---HH
Confidence 999999999876543321 12245689999999999999999999999999999999999 9999987543 34
Q ss_pred HHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 224 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 224 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
.+..+...... ..+..+|+++.+|+..||+.||++||++.+|.+.|+.+.+
T Consensus 269 ~~~~i~~g~~~----~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 269 AIDCITQGREL----ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHHHHTCCC----CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCC----CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 44444443221 2346789999999999999999999999999999998864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-54 Score=424.63 Aligned_cols=266 Identities=21% Similarity=0.327 Sum_probs=209.1
Q ss_pred CcEEEeeeeeecCceEEEEEEEc---CCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
++|++++.||+|+||+||+|++. .+++.||||+++... ....+.+|+.+++.|+|++ |..++.++.++...|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPF-IVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTT-EECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCC-CCeEEEEEEECCEEE
Confidence 57999999999999999999974 467899999876432 2335888999999998654 555555667788899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
|||||| |++|.+++.. .+.+++..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+....
T Consensus 103 ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC---
T ss_pred EEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEecccccceeccC
Confidence 999999 8999999985 4579999999999999999999999999999999999999 4788999999999986554
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+. +..+.+..+......
T Consensus 179 ~~~-------~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~~~~---- 244 (304)
T 3ubd_A 179 HEK-------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK---DRKETMTMILKAKLG---- 244 (304)
T ss_dssp --C-------CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC----
T ss_pred CCc-------cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc---CHHHHHHHHHcCCCC----
Confidence 332 124578999999999999999999999999999999999999999874 345555666554432
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCCccccccccccccc
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 299 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~--~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~ 299 (474)
++..+++++.+||.+||+.||++||++. .+.+++++. |...+||+.+..++.+
T Consensus 245 -~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp-------~f~~idw~~l~~~~~~ 299 (304)
T 3ubd_A 245 -MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHS-------FFSTIDWNKLYRREIH 299 (304)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSG-------GGTTCCHHHHHTTCSC
T ss_pred -CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCc-------cccCCCHHHHHhCCCC
Confidence 2457899999999999999999999853 233444443 3445789887654433
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-53 Score=417.48 Aligned_cols=254 Identities=20% Similarity=0.228 Sum_probs=208.1
Q ss_pred CCcEEEeeeeeecCceEEEEEEEc-----CCCeEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
..+++++++||+|+||+||+|.+. .+++.||||+++... ..+.|.+|+.++++|+|+|+|. +.+++..+..
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~-l~g~~~~~~~ 103 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC-LLGVVTKDQP 103 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCC-EEEEECSSSS
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCC-cceEEEECCE
Confidence 357899999999999999999863 467899999986543 2356999999999998665555 4455566777
Q ss_pred EEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCC
Q 011945 78 NVLVIDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~---------------~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~ 141 (474)
.+|||||| +|+|.+++... ...+++..++.|+.||+.||+|||+++||||||||+|||| ++
T Consensus 104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl---~~ 180 (308)
T 4gt4_A 104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV---YD 180 (308)
T ss_dssp CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CG
T ss_pred EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE---CC
Confidence 89999999 89999999632 1358999999999999999999999999999999999999 47
Q ss_pred CCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCc
Q 011945 142 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 220 (474)
Q Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~ 220 (474)
++.+||+|||+|+........ .......||+.|||||++.+..|+.++|||||||+||||+| |..||.+...
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~-----~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~-- 253 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYY-----KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-- 253 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCB-----CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH--
T ss_pred CCCEEECCcccceeccCCCce-----eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH--
Confidence 789999999999876543321 12345689999999999999999999999999999999998 8999988643
Q ss_pred HHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011945 221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 275 (474)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (474)
.+.+..+...... ..+..+|+++.+|+..||+.||++||++.+|.+.|+.
T Consensus 254 -~~~~~~i~~~~~~----~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 254 -QDVVEMIRNRQVL----PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp -HHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred -HHHHHHHHcCCCC----CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 4444445443322 2346789999999999999999999999999888864
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=424.05 Aligned_cols=260 Identities=20% Similarity=0.287 Sum_probs=213.9
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCC-----CeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEe-EeCCE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFG-VEGDY 77 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~-~~~~~ 77 (474)
++|+++++||+|+||+||+|.+..+ ++.||||++...... ..+.+|+++|..+.||++|..+..++ ..+..
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~ 143 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 143 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCE
Confidence 6899999999999999999997654 368999998765432 35889999999999988777766555 44567
Q ss_pred EEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCC
Q 011945 78 NVLVIDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~---------------~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~ 141 (474)
.+|||||| +|+|.+++... ...+++..++.|+.||+.||+|||+++||||||||+|||++ .
T Consensus 144 ~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~---~ 220 (353)
T 4ase_A 144 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---E 220 (353)
T ss_dssp CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---G
T ss_pred EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeC---C
Confidence 89999999 89999999743 23489999999999999999999999999999999999994 7
Q ss_pred CCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCc
Q 011945 142 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGT 220 (474)
Q Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~ 220 (474)
++.+||+|||+|+.+...... ......+||+.|||||++.+..|+.++|||||||+||||+| |..||.+.....
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~-----~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~ 295 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 295 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTS-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred CCCEEECcchhhhhcccCCCc-----eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence 789999999999876543321 12245689999999999999999999999999999999998 999998865432
Q ss_pred HHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 221 KKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
.....+..... ...+..+|+++.++|..||+.||++||++.+|++.|+++++.+
T Consensus 296 --~~~~~i~~g~~----~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~ 349 (353)
T 4ase_A 296 --EFCRRLKEGTR----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 349 (353)
T ss_dssp --HHHHHHHHTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred --HHHHHHHcCCC----CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence 22222322221 1234568999999999999999999999999999999998654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=422.57 Aligned_cols=264 Identities=21% Similarity=0.259 Sum_probs=208.2
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeE-----e
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGV-----E 74 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~-----~ 74 (474)
.++++|+++++||+|+||+||+|+++.+|+.||||+++..... ..+.+|+++|+.|+|+++|..+..+.. +
T Consensus 51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 3678999999999999999999999999999999998654332 347889999999997766666554432 3
Q ss_pred CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 75 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 75 ~~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
....|||||||+++|.+++.. .+.+++..+..|+.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+
T Consensus 131 ~~~~~ivmE~~~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 131 FKSVYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMAR 206 (398)
T ss_dssp CCCEEEEEECCSEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCB
T ss_pred CCEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEeecceee
Confidence 457899999999999999973 5679999999999999999999999999999999999999 478899999999998
Q ss_pred ccccCCCccccccccCCCCccCccccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc--
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-- 231 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~-- 231 (474)
.+....... .......+||+.|||||++.+.. ++.++||||||||||||++|+.||.+.+.......+......
T Consensus 207 ~~~~~~~~~---~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~ 283 (398)
T 4b99_A 207 GLCTSPAEH---QYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPS 283 (398)
T ss_dssp CC----------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ecccCcccc---ccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 765432211 11235679999999999998864 699999999999999999999999885443333332222111
Q ss_pred ---------------------cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 232 ---------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 232 ---------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
........+...+++++.+||.+||.+||++|||++++ |++.|
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~---L~Hp~ 347 (398)
T 4b99_A 284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAA---LRHPF 347 (398)
T ss_dssp GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHH---TTSGG
T ss_pred hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHH---hcCHh
Confidence 11122344556788999999999999999999998765 55544
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=404.92 Aligned_cols=254 Identities=22% Similarity=0.259 Sum_probs=187.8
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeC-------
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEG------- 75 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~------- 75 (474)
.++|++++.||+|+||+||+|+++.+|+.||||+++..... +.+.+|+++|+.|+|+++|..+..+...+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 35799999999999999999999999999999988654432 45889999999999777777776665433
Q ss_pred ----CEEEEEEecC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEE
Q 011945 76 ----DYNVLVIDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148 (474)
Q Consensus 76 ----~~~~lv~e~~-g~sL~~li~~~~~--~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~ 148 (474)
.+.||||||| |++|.+++..... ..++..++.|+.||+.||+|||++|||||||||+||||+ .++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~---~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC---TTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEEC---CCCcEEEc
Confidence 2579999999 8999999974321 256677899999999999999999999999999999994 77899999
Q ss_pred ecCCccccccCCCccc-----cccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHH
Q 011945 149 DFGLAKRYRDTATHQH-----IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 223 (474)
Q Consensus 149 DFGla~~~~~~~~~~~-----~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~ 223 (474)
|||+|+.+........ .........+||+.|||||++.+..|+.++||||||||||||++ ||.+.. +...
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~ 235 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ERVR 235 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHH
Confidence 9999998765432111 01112345689999999999999999999999999999999996 885421 1222
Q ss_pred HHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 224 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 224 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.+..+.....+. .....++.+.+||..||+.||++||++.+|++
T Consensus 236 ~~~~~~~~~~p~----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 236 TLTDVRNLKFPP----LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHTTCCCH----HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHhcCCCCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 333333333322 22233567889999999999999999887643
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-52 Score=409.62 Aligned_cols=267 Identities=21% Similarity=0.246 Sum_probs=199.1
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHH--HHHHHHHhcCCCCCceeEEEeEeC---CEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQY--EAKLYKILQGGTGIPNLRWFGVEG---DYNV 79 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~--E~~il~~l~~~~~i~~l~~~~~~~---~~~~ 79 (474)
|..+|.+.++||+|+||+||+|++ +|+.||||+++... ...+.. |+..+..++|+|+|..+..+...+ ...|
T Consensus 1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 457899999999999999999986 68999999986543 233444 444455677766666665555443 2679
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCcEEeeeCCCCCeEEEEec
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--------SFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~--------gIiHrDIKP~NILl~~~~~~~~vkL~DF 150 (474)
|||||| +++|.++++. ..+++..++.|+.|++.||+|||++ +||||||||+|||| +.++.+||+||
T Consensus 78 lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~DF 152 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADL 152 (303)
T ss_dssp EEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECCC
T ss_pred EEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEEeC
Confidence 999999 8999999974 4699999999999999999999987 99999999999999 57899999999
Q ss_pred CCccccccCCCccccccccCCCCccCccccccccccCC------CCCchhhHHHHHHHHHHHHhCCCCCCC---------
Q 011945 151 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI------EQSRRDDLESLGYVLMYFLRGSLPWQG--------- 215 (474)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~------~~s~ksDIwSlGvil~elltG~~Pf~~--------- 215 (474)
|+|+.......... ......+||+.|||||++.+. .++.++|||||||+||||+||..||..
T Consensus 153 Gla~~~~~~~~~~~---~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~ 229 (303)
T 3hmm_A 153 GLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229 (303)
T ss_dssp TTCEEEETTTTEES---CC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred CCCccccCCCCcee---eecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccch
Confidence 99987755432111 112346899999999999865 367899999999999999999776532
Q ss_pred -CCc--CcHHHHHHHHhhccccchHHHHhc--CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 011945 216 -LKA--GTKKQKYEKISEKKVSTSIEALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGF 282 (474)
Q Consensus 216 -~~~--~~~~~~~~~i~~~~~~~~~~~l~~--~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~ 282 (474)
... .........+........++.... .++..+.+|+..||+.||++|||+.+|.+.|+++..+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~i 301 (303)
T 3hmm_A 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301 (303)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred hcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcCC
Confidence 211 122333333333333332222222 2346799999999999999999999999999999876654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=408.35 Aligned_cols=260 Identities=22% Similarity=0.308 Sum_probs=204.8
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEEc---CCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
|.+.++|+++++||+|+||+||+|+++ .+++.||||++........+.+|+++|+.+.+|++|..+..++...++.|
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 567889999999999999999999875 46789999998776666778999999999987888888888888899999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
|||||+ |++|.++++ .+++.++..|+.||+.||+|||++|||||||||+||||+ .+.+.+||+|||+|+...+
T Consensus 97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~--~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN--RRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECTT
T ss_pred EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe--CCCCeEEECcCCCCcccCC
Confidence 999999 789999984 599999999999999999999999999999999999996 3457999999999986654
Q ss_pred CCCccc---------------------cccccCCCCccCccccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCC
Q 011945 159 TATHQH---------------------IPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGL 216 (474)
Q Consensus 159 ~~~~~~---------------------~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDIwSlGvil~elltG~~Pf~~~ 216 (474)
...... .........+||+.|||||++.+.. |+.++||||+|||+|||++|+.||...
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 321100 0001123468999999999998864 899999999999999999999999654
Q ss_pred CcCcHHHHHHHHhhccc------------------------------------c-------------chHHHHhcCCcHH
Q 011945 217 KAGTKKQKYEKISEKKV------------------------------------S-------------TSIEALCRGYPTE 247 (474)
Q Consensus 217 ~~~~~~~~~~~i~~~~~------------------------------------~-------------~~~~~l~~~~p~~ 247 (474)
.. ....+..|....- . .........++++
T Consensus 251 ~~--~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~ 328 (361)
T 4f9c_A 251 SD--DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDE 328 (361)
T ss_dssp SS--HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHH
T ss_pred CC--HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHH
Confidence 32 2222222211000 0 0000112457889
Q ss_pred HHHHHHHHhcCCCCCCCCHHHHH
Q 011945 248 FASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 248 l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
+.+||.+||.+||++|||+++++
T Consensus 329 a~DLl~~lL~~dP~~R~ta~eaL 351 (361)
T 4f9c_A 329 AYDLLDKLLDLNPASRITAEEAL 351 (361)
T ss_dssp HHHHHHHHTCSCTTTSCCHHHHH
T ss_pred HHHHHHHHCcCChhHCcCHHHHh
Confidence 99999999999999999987763
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-50 Score=405.42 Aligned_cols=285 Identities=29% Similarity=0.560 Sum_probs=223.5
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCC-----CeEEEEEEeccCCCchHHHHHHHHHHHhcC--------------CCCC
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT-----NEEVAIKLENVKTKHPQLQYEAKLYKILQG--------------GTGI 65 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~-----~~~vAvK~~~~~~~~~~l~~E~~il~~l~~--------------~~~i 65 (474)
..++|+++++||+|+||.||+|.+..+ ++.||||++... ...+..|+++++.+.+ |++|
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD--NGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETT--CHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeecc--chhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 456999999999999999999998764 588999998653 3456677777666654 5556
Q ss_pred ceeEEEeEeC----CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCC
Q 011945 66 PNLRWFGVEG----DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (474)
Q Consensus 66 ~~l~~~~~~~----~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~ 141 (474)
..+..++... .+.+|||||+|++|.+++......+++..++.|+.||+.||.|||++||+||||||+||||+. +.
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-~~ 189 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-KN 189 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-SC
T ss_pred CeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-CC
Confidence 6655554432 568999999999999999877678999999999999999999999999999999999999952 25
Q ss_pred CCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcH
Q 011945 142 ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221 (474)
Q Consensus 142 ~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~ 221 (474)
.+.+||+|||+++.+..................||+.|+|||++.+..++.++|||||||+||||++|+.||.+......
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 68999999999987765443322222223456799999999999999999999999999999999999999986433222
Q ss_pred HHHHHHHhhccccchHHHH---h---cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccccc
Q 011945 222 KQKYEKISEKKVSTSIEAL---C---RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 295 (474)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~l---~---~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 295 (474)
....... .....+..+ + ..+|+++.+++..||..||++||++.+|++.|++++.+.+...+..+||+....
T Consensus 270 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~~~~~ 346 (364)
T 3op5_A 270 YVRDSKI---RYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLSVVEN 346 (364)
T ss_dssp HHHHHHH---HHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC-----
T ss_pred HHHHHHH---HhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceEeccC
Confidence 2111111 111112222 2 578999999999999999999999999999999999999999999999997654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=426.49 Aligned_cols=270 Identities=22% Similarity=0.279 Sum_probs=220.3
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhc--CCCCCceeEEEeEeCC
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQ--GGTGIPNLRWFGVEGD 76 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~--~~~~i~~l~~~~~~~~ 76 (474)
.-.++|+++++||+|+||+||+|+++.+|+.||||+++.. .....+..|..++..+. +|++|..++.++.+..
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 3457899999999999999999999999999999998542 23334566666666554 4677777777788889
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
..||||||| ||+|.+++.. .+.|++..+..|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.
T Consensus 266 ~lylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCEE
T ss_pred EEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceeee
Confidence 999999999 8999999975 4579999999999999999999999999999999999999 5789999999999987
Q ss_pred cccCCCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (474)
+..... .+.+||+.|||||++.+ ..|+.++||||||||||||++|..||.+....+..+.+..+......
T Consensus 342 ~~~~~~---------~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~ 412 (689)
T 3v5w_A 342 FSKKKP---------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412 (689)
T ss_dssp CSSCCC---------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCC
T ss_pred cCCCCC---------CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCC
Confidence 654332 45799999999999974 57999999999999999999999999876555555555554443332
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCCccccccccccccccC
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQVS 301 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt-----~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~~~ 301 (474)
++..+++++++||..||..||.+|++ +++| ++ .+|...+||..+...+.+++
T Consensus 413 -----~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei---~~-------HpfF~~idW~~l~~~~~~pP 469 (689)
T 3v5w_A 413 -----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV---KE-------SPFFRSLDWQMVFLQKYPPP 469 (689)
T ss_dssp -----CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHH---TT-------SGGGTTCCHHHHHTTCSCCS
T ss_pred -----CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHH---hc-------CccccCCCHHHHHcCCCCcC
Confidence 34578999999999999999999998 4444 33 34556789998866655444
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=418.66 Aligned_cols=252 Identities=19% Similarity=0.281 Sum_probs=211.0
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
+.++|++++.||+|+||+||+|+++.+|+.||||++..... ...+.+|+.+|+.|+|++ |..+..++.+....||+|
T Consensus 155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT-LVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTT-BCCEEEEEECSSEEEEEE
T ss_pred CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCC-CCeEEEEEEECCEEEEEE
Confidence 34689999999999999999999999999999998865432 345889999999998655 555556667888999999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
||| |++|.+++......|++.++..|+.||+.||+|||++||+||||||+|||++. +..+.+||+|||+|+.+.....
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCSSCEECCTTSE
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC-CCCCCEEEeeccceeEccCCCc
Confidence 999 88999999755667999999999999999999999999999999999999952 2347899999999998765432
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
....+||+.|||||++.+..|+.++|||||||+||||++|..||.+.. ..+.+..+........ ....
T Consensus 313 --------~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~---~~~~~~~i~~~~~~~~-~~~~ 380 (573)
T 3uto_A 313 --------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN---DDETLRNVKSCDWNMD-DSAF 380 (573)
T ss_dssp --------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHTTCCCCC-SGGG
T ss_pred --------eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC---HHHHHHHHHhCCCCCC-cccc
Confidence 134589999999999999999999999999999999999999998743 4455555555443222 2334
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
..+++++.+||..||..||.+||++.+++
T Consensus 381 ~~~s~~~~dli~~~L~~dp~~R~t~~e~l 409 (573)
T 3uto_A 381 SGISEDGKDFIRKLLLADPNTRMTIHQAL 409 (573)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 67899999999999999999999987763
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=383.14 Aligned_cols=280 Identities=23% Similarity=0.399 Sum_probs=222.1
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcC--------CCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCc-----------
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQ--------TNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP----------- 66 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~--------~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~----------- 66 (474)
+++|++.+.||+|+||.||+|++.. .++.||||++... ..+.+|+.+++.++|++++.
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 6899999999999999999999987 4889999998743 46889999999998754433
Q ss_pred ---eeEEEeEe-CCEEEEEEecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCC
Q 011945 67 ---NLRWFGVE-GDYNVLVIDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR 141 (474)
Q Consensus 67 ---~l~~~~~~-~~~~~lv~e~~g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~ 141 (474)
.+..++.. +...++||||++++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++ .
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~---~ 194 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD---P 194 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE---T
T ss_pred CccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc---C
Confidence 24444444 7889999999999999999854 36799999999999999999999999999999999999995 5
Q ss_pred CC--eEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcC
Q 011945 142 AN--QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG 219 (474)
Q Consensus 142 ~~--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~ 219 (474)
++ .+||+|||+++.+..................||+.|+|||++.+..++.++|||||||+||||++|..||......
T Consensus 195 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 274 (352)
T 2jii_A 195 EDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPN 274 (352)
T ss_dssp TEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred CCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcC
Confidence 55 8999999999877654322211112234458999999999999999999999999999999999999999875422
Q ss_pred cHHHHHHHHh--hccccchHH--HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccc
Q 011945 220 TKKQKYEKIS--EKKVSTSIE--ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTI 292 (474)
Q Consensus 220 ~~~~~~~~i~--~~~~~~~~~--~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~ 292 (474)
. ........ ......... .....+++++.+||..||..||++||++++|++.|+.++.+.+...+..+||..
T Consensus 275 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~~~dw~~ 350 (352)
T 2jii_A 275 T-EDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYDPIGLPM 350 (352)
T ss_dssp H-HHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTSCCCCCC
T ss_pred H-HHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCccccCcC
Confidence 1 11111111 000000000 001356899999999999999999999999999999999999999999999985
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=377.60 Aligned_cols=272 Identities=18% Similarity=0.258 Sum_probs=220.7
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
.++|+++++||+|+||.||+|+++.+++.||||+++... ....+..|..++..+.+|++|..+..++......+|
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 468999999999999999999999999999999986532 234588999999998777888888888888899999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
||||+ |++|.+++.. .+.+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+.....
T Consensus 131 V~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCT
T ss_pred EEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeecccC
Confidence 99999 8899999874 3579999999999999999999999999999999999999 47899999999999864332
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcC------cHHHHHHHHhhccc
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG------TKKQKYEKISEKKV 233 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~------~~~~~~~~i~~~~~ 233 (474)
.. .....+||+.|+|||++.+..++.++|||||||+||||++|+.||...... .....+..+.....
T Consensus 207 ~~-------~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~ 279 (396)
T 4dc2_A 207 GD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 279 (396)
T ss_dssp TC-------CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC
T ss_pred CC-------ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc
Confidence 22 124578999999999999999999999999999999999999999754221 22233344443332
Q ss_pred cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHH---HHHHHHHHHHHHcCCCCCCcccccccccccccc
Q 011945 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA---YLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300 (474)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~---~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~~ 300 (474)
. ++..+++++.+||..||..||.+||++. .+.+++++ ++...+||..+...+..+
T Consensus 280 ~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H-------pff~~i~w~~l~~~~~~p 337 (396)
T 4dc2_A 280 R-----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH-------PFFRNVDWDMMEQKQVVP 337 (396)
T ss_dssp C-----CCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS-------TTTTTCCHHHHHTTCSCC
T ss_pred C-----CCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC-------ccccCCCHHHHHcCCCCC
Confidence 2 2356889999999999999999999962 34444444 445668999876554443
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=365.18 Aligned_cols=264 Identities=22% Similarity=0.359 Sum_probs=213.3
Q ss_pred CCccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeEeCC
Q 011945 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 76 (474)
Q Consensus 2 ~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (474)
...+.++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++|+ +|..+..++....
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp-~iv~~~~~~~~~~ 84 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQ-NIVSMIDVDEEDD 84 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBT-TBCCEEEEEECSS
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCC-CCceEEEeeeeCC
Confidence 45678899999999999999999999999999999998754322 23578899999999854 5555666677888
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
..++||||+ |++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~ 160 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAKA 160 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCSSSTT
T ss_pred eEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEEeCCCccc
Confidence 899999999 78999999754 479999999999999999999999999999999999999 4778999999999987
Q ss_pred cccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccc
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+... .....+........
T Consensus 161 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~ 231 (294)
T 4eqm_A 161 LSETSLT------QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA---VSIAIKHIQDSVPN 231 (294)
T ss_dssp C-------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH---HHHHHHHHSSCCCC
T ss_pred ccccccc------ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhhccCCC
Confidence 6543221 12345799999999999999999999999999999999999999987432 33333333444444
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHHHHH
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRLFRDLFIR 279 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~RP-t~~~l~~~L~~l~~~ 279 (474)
........+|+.+.++|.+||+.||++|| +++++.+.|..++.+
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 44556678999999999999999999999 888888888776543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=375.20 Aligned_cols=269 Identities=19% Similarity=0.257 Sum_probs=216.7
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
.++|+++++||+|+||.||+|+++.+++.||||++... .....+..|..++..+.+|++|..+..++......|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 47899999999999999999999999999999987642 2345578899999999778888888888888899999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
||||+ |++|.+++.. ...+++..++.|+.||+.||+|||++||+||||||+|||| +.++.+||+|||+|+.....
T Consensus 102 v~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC-
T ss_pred EEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeecccC
Confidence 99999 7899999974 3579999999999999999999999999999999999999 47889999999999854332
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+. +..+.+..+......
T Consensus 178 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~~~~----- 242 (353)
T 3txo_A 178 GV-------TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE---NEDDLFEAILNDEVV----- 242 (353)
T ss_dssp ---------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC-----
T ss_pred Cc-------cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC---CHHHHHHHHHcCCCC-----
Confidence 21 124568999999999999989999999999999999999999999874 344555555554432
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHH---HHHHHHHHHHHcCCCCCCcccccccccccccc
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAY---LKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~---l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~~ 300 (474)
+...+++++.+||..||..||++||++.+ ..+++++ ++...++|..+...+.++
T Consensus 243 ~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h-------p~f~~~~w~~l~~~~~~~ 299 (353)
T 3txo_A 243 YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH-------PFFKEIDWAQLNHRQIEP 299 (353)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS-------GGGTTCCHHHHHTTCSCC
T ss_pred CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC-------CcccCCCHHHHhcCcCCC
Confidence 23457899999999999999999999721 1333444 334557898876554443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=367.04 Aligned_cols=262 Identities=19% Similarity=0.288 Sum_probs=214.2
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
.++|++++.||+|+||.||+|++..+++.||||++... .....+..|+.+++.++| ++|..+..++......++
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCC-TTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCC-CcCcceEEEEEeCCEEEE
Confidence 46899999999999999999999999999999987542 334568899999999875 556666666777888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
||||+ |++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 83 v~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 83 VMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCT
T ss_pred EEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhcccC
Confidence 99999 7899999874 4579999999999999999999999999999999999999 47889999999999864332
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ....+..+......
T Consensus 159 ~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~----- 223 (337)
T 1o6l_A 159 GA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELILMEEIR----- 223 (337)
T ss_dssp TC-------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC-----
T ss_pred CC-------cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC---HHHHHHHHHcCCCC-----
Confidence 21 1245689999999999999999999999999999999999999998743 34444444443322
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccccccc
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQ 297 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~ 297 (474)
++..+++++.+||..||..||++|| ++++| +++ .+...++|..+....
T Consensus 224 ~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei---~~h-------~~f~~~~~~~~~~~~ 276 (337)
T 1o6l_A 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV---MEH-------RFFLSINWQDVVQKK 276 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHH---HTS-------GGGTTCCHHHHHTTC
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHH---HcC-------CCcCCCCHHHHHhCC
Confidence 2356889999999999999999999 76655 333 334457898765443
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=369.92 Aligned_cols=270 Identities=19% Similarity=0.240 Sum_probs=221.7
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
..++|++++.||+|+||.||+|++..+++.||||++... .....+..|..++..+.+|++|..+..++......|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 457899999999999999999999999999999987643 334567889999988878888988888888889999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
+||||+ |++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 98 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCccccccc
Confidence 999999 88999999743 479999999999999999999999999999999999999 4788999999999986433
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+. +..+.+..+......
T Consensus 174 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~~~~---- 239 (353)
T 2i0e_A 174 DGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIMEHNVA---- 239 (353)
T ss_dssp TTC-------CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC----
T ss_pred CCc-------ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC---CHHHHHHHHHhCCCC----
Confidence 221 124568999999999999999999999999999999999999999874 344555555554432
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCCcccccccccccccc
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~--~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~~ 300 (474)
++..+++++.+||..||..||++||++. .+.+++++ .+...++|..+...+.++
T Consensus 240 -~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h-------~~f~~~~w~~l~~~~~~~ 295 (353)
T 2i0e_A 240 -YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH-------AFFRYIDWEKLERKEIQP 295 (353)
T ss_dssp -CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS-------GGGTTCCHHHHHTTCSCC
T ss_pred -CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC-------ccccCCCHHHHHhCCCCC
Confidence 2356899999999999999999999642 23333443 334457898876554443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=368.11 Aligned_cols=275 Identities=19% Similarity=0.269 Sum_probs=220.7
Q ss_pred CCCccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeEeC
Q 011945 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEG 75 (474)
Q Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (474)
|++.-.++|++++.||+|+||.||+|++..+++.||||++..... ...+..|..+++.+.+|++|..+..++...
T Consensus 3 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~ 82 (345)
T 3a8x_A 3 MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE 82 (345)
T ss_dssp CCCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred CCCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC
Confidence 456667899999999999999999999999999999999865422 234788999999986677787887778888
Q ss_pred CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 76 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 76 ~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
...|+||||+ |++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~ 158 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCK 158 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCB
T ss_pred CEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEeccccc
Confidence 8999999999 8899999974 3579999999999999999999999999999999999999 478899999999998
Q ss_pred ccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------CcHHHHHHHH
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA------GTKKQKYEKI 228 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~------~~~~~~~~~i 228 (474)
....... .....+||+.|+|||++.+..++.++|||||||+||||++|..||..... ......+..+
T Consensus 159 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i 231 (345)
T 3a8x_A 159 EGLRPGD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 231 (345)
T ss_dssp CSCCTTC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH
T ss_pred cccCCCC-------cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH
Confidence 6433221 12456899999999999999999999999999999999999999975322 1222333344
Q ss_pred hhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHH---HHHHHHHHHHHHcCCCCCCcccccccccccc
Q 011945 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA---YLKRLFRDLFIREGFQFDYVFDWTILKYQQS 298 (474)
Q Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~---~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~ 298 (474)
...... ++..++.++.+||..||..||++||++. .+.+++.+ ++...++|..+...+.
T Consensus 232 ~~~~~~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h-------p~f~~~~w~~~~~~~~ 292 (345)
T 3a8x_A 232 LEKQIR-----IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH-------PFFRNVDWDMMEQKQV 292 (345)
T ss_dssp HHCCCC-----CCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS-------GGGTTCCHHHHHTTCS
T ss_pred HcCCCC-----CCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC-------CccCCCCHHHHHhCCC
Confidence 333322 2356889999999999999999999962 23344443 3445678987654443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=368.15 Aligned_cols=254 Identities=20% Similarity=0.282 Sum_probs=210.2
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC--------chHHHHHHHHHHHhcCCCCCceeEEEeEe
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLQYEAKLYKILQGGTGIPNLRWFGVE 74 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--------~~~l~~E~~il~~l~~~~~i~~l~~~~~~ 74 (474)
..+.++|++++.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+++.+.|+ +|..+..++..
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hp-nIv~l~~~~~~ 86 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP-NIITLHDVYEN 86 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCT-TBCCEEEEEEC
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCc-CCCcEEEEEEe
Confidence 3567889999999999999999999999999999998865432 25689999999999855 55555556677
Q ss_pred CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCC-CCeEEEEecCC
Q 011945 75 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGL 152 (474)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~-~~~vkL~DFGl 152 (474)
....++||||+ |++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. ...+||+|||+
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred CCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 88899999999 8999999973 457999999999999999999999999999999999999952111 12799999999
Q ss_pred ccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc
Q 011945 153 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (474)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (474)
++.+..... ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+. ...+.+..+....
T Consensus 166 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~ 234 (361)
T 2yab_A 166 AHEIEDGVE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANITAVS 234 (361)
T ss_dssp CEECCTTCC--------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHTTC
T ss_pred ceEcCCCCc--------cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcC
Confidence 987654322 23468999999999999999999999999999999999999999874 3344555555544
Q ss_pred ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 233 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.... ...+..+++++.+||..||..||++||++.+++
T Consensus 235 ~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l 271 (361)
T 2yab_A 235 YDFD-EEFFSQTSELAKDFIRKLLVKETRKRLTIQEAL 271 (361)
T ss_dssp CCCC-HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCC-chhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 3322 344578899999999999999999999987664
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=369.02 Aligned_cols=255 Identities=18% Similarity=0.229 Sum_probs=208.4
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-------CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCC
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 76 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-------~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (474)
.+.++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+|+.+++.++|++ |..+..+.....
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~ 99 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH-IVELLETYSSDG 99 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTT-BCCEEEEEEETT
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCC-CCcEEEEEEeCC
Confidence 4567899999999999999999999999999999987532 13456899999999998555 555555566788
Q ss_pred EEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCC
Q 011945 77 YNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~---~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (474)
..++||||+ |++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||+
T Consensus 100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 899999999 78998877532 34589999999999999999999999999999999999997544556699999999
Q ss_pred ccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc
Q 011945 153 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (474)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (474)
++.+..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+. ....+..+....
T Consensus 180 a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~----~~~~~~~i~~~~ 248 (351)
T 3c0i_A 180 AIQLGESGL-------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT----KERLFEGIIKGK 248 (351)
T ss_dssp CEECCTTSC-------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS----HHHHHHHHHHTC
T ss_pred eeEecCCCe-------eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc----HHHHHHHHHcCC
Confidence 987655322 123458999999999999999999999999999999999999999863 233444444443
Q ss_pred ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 233 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.... ......+++++.+||..||..||++||++.++++
T Consensus 249 ~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 249 YKMN-PRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CCCC-HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCC-ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 3322 2334678999999999999999999999887743
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=363.76 Aligned_cols=245 Identities=24% Similarity=0.324 Sum_probs=204.4
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
..++|++++.||+|+||.||+|.+..+|+.||||++..... ...+.+|+++++.++|+ +|..+..+.......++
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hp-nIv~l~~~~~~~~~~~l 91 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP-NIVKLFEVIETEKTLYL 91 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCT-TBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCC-CEeeEEEEEEECCEEEE
Confidence 45789999999999999999999999999999999865432 23478999999999855 45555556677888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
||||+ +++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+...
T Consensus 92 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 92 IMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp EECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSSS
T ss_pred EEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCceecCCC
Confidence 99999 88999999743 579999999999999999999999999999999999999 47889999999999866543
Q ss_pred CCccccccccCCCCccCccccccccccCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s-~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
.. ....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.. .......+......
T Consensus 168 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~---~~~~~~~i~~~~~~---- 232 (328)
T 3fe3_A 168 GK--------LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN---LKELRERVLRGKYR---- 232 (328)
T ss_dssp CG--------GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC----
T ss_pred Cc--------cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCC----
Confidence 22 2346899999999999998875 89999999999999999999998743 33444444443332
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
++..+++++.+||..||..||.+||++++++
T Consensus 233 -~p~~~s~~~~~li~~~L~~dP~~R~t~~eil 263 (328)
T 3fe3_A 233 -IPFYMSTDCENLLKRFLVLNPIKRGTLEQIM 263 (328)
T ss_dssp -CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHT
T ss_pred -CCCCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 2245789999999999999999999977764
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=359.54 Aligned_cols=255 Identities=19% Similarity=0.253 Sum_probs=206.2
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
.+.++|+++++||+|+||+||+|.+. +++.||||++..... ...+.+|+.+++.++|++ |..+..+.......+
T Consensus 18 ~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~~~~~~ 95 (311)
T 3niz_A 18 GLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN-IVSLIDVIHSERCLT 95 (311)
T ss_dssp CSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTT-BCCEEEEECCSSCEE
T ss_pred chHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCC-EeeeeeEEccCCEEE
Confidence 46789999999999999999999984 689999998865432 245889999999998554 555555566777889
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 80 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 80 lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
+||||+.++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+...
T Consensus 96 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 96 LVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEETTSC
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCcCceecCCC
Confidence 999999999999998666679999999999999999999999999999999999999 47789999999999876533
Q ss_pred CCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc-----
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV----- 233 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~----- 233 (474)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+..+.....
T Consensus 173 ~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 173 VR-------SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245 (311)
T ss_dssp CC----------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred cc-------cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence 22 1234578999999999987 4589999999999999999999999998776655555444332111
Q ss_pred -----------------cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 234 -----------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 234 -----------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
......+...+++++.+||..||..||++||++++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 299 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAM 299 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHh
Confidence 1123344566889999999999999999999987764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=360.00 Aligned_cols=257 Identities=18% Similarity=0.228 Sum_probs=201.7
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-------CchHHHHHHHHHHHhc---CCCCCceeEEEe
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------KHPQLQYEAKLYKILQ---GGTGIPNLRWFG 72 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-------~~~~l~~E~~il~~l~---~~~~i~~l~~~~ 72 (474)
..+.++|+++++||+|+||+||+|++..+++.||||++.... ....+.+|+.+++.+. |++++..+..+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 457789999999999999999999999999999999876432 2346888999998887 555555444444
Q ss_pred EeCC----EEEEEEecCCCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEE
Q 011945 73 VEGD----YNVLVIDLLGPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 147 (474)
Q Consensus 73 ~~~~----~~~lv~e~~g~sL~~li~~~~~-~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL 147 (474)
.... ..+++||+++++|.+++..... .+++..++.|+.||+.||+|||++||+||||||+|||+ +.++.+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl 161 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVKL 161 (308)
T ss_dssp ECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTTSCEEE
T ss_pred ccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEE
Confidence 3332 6799999999999999985432 39999999999999999999999999999999999999 47789999
Q ss_pred EecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHH
Q 011945 148 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227 (474)
Q Consensus 148 ~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 227 (474)
+|||+++.+..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.........+..
T Consensus 162 ~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (308)
T 3g33_A 162 ADFGLARIYSYQMA--------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 233 (308)
T ss_dssp CSCSCTTTSTTCCC--------SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred eeCccccccCCCcc--------cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999986654322 2345899999999999999999999999999999999999999987544332222222
Q ss_pred Hhhc-------------------cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 228 ISEK-------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 228 i~~~-------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.... ........+...+++++.+||..||+.||++||++.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 295 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRAL 295 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHh
Confidence 1110 111223445567899999999999999999999988764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=361.06 Aligned_cols=248 Identities=21% Similarity=0.316 Sum_probs=203.1
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC--CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
..++|++.++||+|+||+||+|.+..+++.||||++... .....+.+|+.+++.++|++ |..+..++..+...++||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN-IVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTT-BCCEEEEEEETTEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCC-CCeEeEEEEECCEEEEEE
Confidence 346899999999999999999999999999999987543 23456889999999998655 555555566778899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 97 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp ECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTC
T ss_pred ECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---CCCCCEEEeeCCCceecCCccc
Confidence 999 9999999974 369999999999999999999999999999999999999 4778999999999987654332
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
. .....||+.|+|||++.+..++.++|||||||++|||++|..||.+... ...+..+....... ....
T Consensus 172 ~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~---~~~~~~~~~~~~~~--~~~~ 239 (297)
T 3fxz_A 172 K-------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIATNGTPE--LQNP 239 (297)
T ss_dssp C-------BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHHCSCC--CSCG
T ss_pred c-------cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhCCCCC--CCCc
Confidence 1 2346899999999999999999999999999999999999999987543 22222222211111 0113
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
..+++.+.+||..||+.||++||++++++
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell 268 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELL 268 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 46789999999999999999999987764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=363.38 Aligned_cols=260 Identities=18% Similarity=0.270 Sum_probs=214.4
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++|++ |..+..++......++||
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRN-ILHLHESFESMEELVMIF 80 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTT-BCCEEEEEEETTEEEEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCC-CCeEeEEEecCCEEEEEE
Confidence 467899999999999999999999999999999999875432 235789999999998555 555555667788899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
||+ |++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++.+ .++.+||+|||+++.+.....
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~-~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-SCCCEEECCCTTCEECCTTCE
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccC-CCCCEEEEECCCCeECCCCCc
Confidence 999 789999997555679999999999999999999999999999999999999521 268999999999987654322
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ..+.+..+........ ...+
T Consensus 160 --------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~-~~~~ 227 (321)
T 1tki_A 160 --------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET---NQQIIENIMNAEYTFD-EEAF 227 (321)
T ss_dssp --------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCCCC-HHHH
T ss_pred --------cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC---HHHHHHHHHcCCCCCC-hhhh
Confidence 123578999999999999889999999999999999999999998743 3445555555444333 2345
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
..+++++.+||..||..||++||++.++ |++.+...
T Consensus 228 ~~~s~~~~~li~~~L~~dp~~Rpt~~e~---l~hp~~~~ 263 (321)
T 1tki_A 228 KEISIEAMDFVDRLLVKERKSRMTASEA---LQHPWLKQ 263 (321)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHH---HHSHHHHS
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHH---hcChhhcc
Confidence 6889999999999999999999998776 55555443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=370.46 Aligned_cols=260 Identities=17% Similarity=0.298 Sum_probs=212.8
Q ss_pred CCcEEEeeeeeecCceEEEEEEEc-------CCCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeC
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNI-------QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEG 75 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (474)
.++|++++.||+|+||.||+|++. .++..||||+++..... ..+.+|+.+++.+..|++|..+..++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 468999999999999999999975 34568999998754332 35889999999995566677776677777
Q ss_pred CEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeC
Q 011945 76 DYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139 (474)
Q Consensus 76 ~~~~lv~e~~-g~sL~~li~~~~---------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~ 139 (474)
...|+||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll--- 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV--- 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE---
Confidence 7889999999 779999997543 358999999999999999999999999999999999999
Q ss_pred CCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 011945 140 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (474)
Q Consensus 140 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~ 218 (474)
+.++.+||+|||+++.+...... .......+|+.|+|||++.+..++.++|||||||+||||++ |..||.+...
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTT-----CTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred CCCCCEEEccccCCcccCcccce-----ecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 47789999999999876543221 12234567899999999999999999999999999999999 9999988654
Q ss_pred CcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
.... ..+..... ...+..+++++.++|..||..||++||++.+|++.|+.++...
T Consensus 312 ~~~~---~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 312 EELF---KLLKEGHR----MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp GGHH---HHHHTTCC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHH---HHHhcCCC----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 3322 22222221 1123568899999999999999999999999999999998644
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=368.68 Aligned_cols=266 Identities=21% Similarity=0.289 Sum_probs=218.3
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
..++|++.+.||+|+||.||+|+++.+++.||||+++.. .....+..|..++..+.+|++|..+..++......|
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 457899999999999999999999999999999988642 334567889999998866777888877888888999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
+||||+ |++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 95 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~ 170 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENML 170 (345)
T ss_dssp EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhhccc
Confidence 999999 88999999753 579999999999999999999999999999999999999 4788999999999986433
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ....+..+......
T Consensus 171 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~---- 236 (345)
T 1xjd_A 171 GDA-------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFHSIRMDNPF---- 236 (345)
T ss_dssp TTC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC----
T ss_pred CCC-------cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHhCCCC----
Confidence 221 1245689999999999999999999999999999999999999998743 34444555443322
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHH-HHHHHHHHHHHHcCCCCCCccccccccccccc
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYA-YLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 299 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~-~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~ 299 (474)
+...+++++.+||..||..||++||++. +| ++ .++...++|..+...+.+
T Consensus 237 -~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i---~~-------hp~f~~~~w~~l~~~~~~ 287 (345)
T 1xjd_A 237 -YPRWLEKEAKDLLVKLFVREPEKRLGVRGDI---RQ-------HPLFREINWEELERKEID 287 (345)
T ss_dssp -CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCG---GG-------SGGGTTCCHHHHHTTCSC
T ss_pred -CCcccCHHHHHHHHHHhcCCHhHcCCChHHH---Hc-------CccccCCCHHHHhhCCCC
Confidence 2356789999999999999999999975 33 22 234456789877554433
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=370.36 Aligned_cols=271 Identities=29% Similarity=0.455 Sum_probs=200.2
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcC---CCeEEEEEEeccCCC-------------chHHHHHHHHHHHhcCCCCCce
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTK-------------HPQLQYEAKLYKILQGGTGIPN 67 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~-------------~~~l~~E~~il~~l~~~~~i~~ 67 (474)
..+++|++.+.||+|+||.||+|.+.. ++..||||++..... ...+.+|+.+++.+.|++++..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 456899999999999999999999987 788999998765432 1234556666666776555555
Q ss_pred eEEEeEe---CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCe
Q 011945 68 LRWFGVE---GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 144 (474)
Q Consensus 68 l~~~~~~---~~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~ 144 (474)
+..+... ....++||||++++|.+++.... .+++..++.|+.||+.||.|||++||+||||||+|||++.+ ..+.
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~~ 191 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK-NPDQ 191 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS-STTS
T ss_pred ecccccccCCCcEEEEEEeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC-CCCc
Confidence 5444332 77899999999999999987433 79999999999999999999999999999999999999632 1238
Q ss_pred EEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcH-HH
Q 011945 145 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQ 223 (474)
Q Consensus 145 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~-~~ 223 (474)
+||+|||+++.+..................||..|+|||++.+..++.++|||||||+||||++|..||.+...... ..
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 99999999987754432211111122456899999999999999999999999999999999999999965322211 11
Q ss_pred HHHHHhhccccchHHHHhc--CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 224 KYEKISEKKVSTSIEALCR--GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 224 ~~~~i~~~~~~~~~~~l~~--~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
................... .+|+++.++|..||..||++||++++|++.|+.+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 1111111122222222222 7899999999999999999999999999888765
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=358.64 Aligned_cols=246 Identities=18% Similarity=0.201 Sum_probs=201.7
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
+.++|+++++||+|+||+||+|.+..+++.||||++...... .....|+..+..+..+++|..+..++.++...++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 346899999999999999999999999999999987654322 2355666677777667778888778888999999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 81 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 81 v~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
||||++++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 135 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 135 QTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CGGGCEEECCCTTCEECC---
T ss_pred EEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEccceeeeecccCC
Confidence 99999999999998777789999999999999999999999999999999999999 477899999999998765432
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
. .....||+.|+|||++.+ .++.++|||||||++|||++|..||.+. ..+..+..... ...+
T Consensus 212 ~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~------~~~~~~~~~~~---~~~~ 273 (311)
T 3p1a_A 212 A--------GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG------EGWQQLRQGYL---PPEF 273 (311)
T ss_dssp -----------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH------HHHHHHTTTCC---CHHH
T ss_pred C--------CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc------cHHHHHhccCC---Cccc
Confidence 2 234579999999999887 7999999999999999999997666441 12233333222 2345
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
...+++++.++|..||+.||++||++++|++
T Consensus 274 ~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 274 TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 5778999999999999999999999887753
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=360.19 Aligned_cols=264 Identities=17% Similarity=0.237 Sum_probs=211.4
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
.++|++.++||+|+||+||+|.+..+++.||||++.... ....+.+|+.+++.++| ++|..+..++..+...++|||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH-PNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCC-cCcccEEEEEecCCeeEEEEE
Confidence 478999999999999999999999999999999875432 23458899999999985 455555566677888999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
|+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+......
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC-----
T ss_pred ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---CCCCCEEEeecccceeccccccc
Confidence 99 889999998777789999999999999999999999999999999999999 47889999999999876544321
Q ss_pred ccc-------ccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHH--HHHHHhhccc
Q 011945 163 QHI-------PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ--KYEKISEKKV 233 (474)
Q Consensus 163 ~~~-------~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~--~~~~i~~~~~ 233 (474)
... .........||+.|+|||++.+..++.++|||||||++|||++|..||.......... .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~----- 239 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF----- 239 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH-----
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc-----
Confidence 100 0011125689999999999999999999999999999999999999997643322110 00000
Q ss_pred cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
........+|+++.+++..||+.||++||++.+|.+.|+.+....
T Consensus 240 --~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 240 --LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp --HHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred --ccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 011123578899999999999999999999999999999987554
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=368.39 Aligned_cols=252 Identities=22% Similarity=0.277 Sum_probs=207.9
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
+.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.|+|+ +|..+..+..+....++
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hp-nIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHP-NIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCT-TBCCEEEEEECSSEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCC-CCCeEEEEEEeCCEEEE
Confidence 456899999999999999999999999999999998765432 3578999999999855 55555566677888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
||||+ |++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++..+.+||+|||++......
T Consensus 106 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp EECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 99999 7899998863 457999999999999999999999999999999999999975445567999999999876543
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ....+..+......... .
T Consensus 185 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~---~~~~~~~i~~~~~~~~~-~ 252 (362)
T 2bdw_A 185 EA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAYDYPS-P 252 (362)
T ss_dssp CS--------CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCT-T
T ss_pred cc--------cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCCc-c
Confidence 22 234689999999999999999999999999999999999999998743 34444444443332221 1
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
....+++++.+||..||..||++||++.+++
T Consensus 253 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 283 (362)
T 2bdw_A 253 EWDTVTPEAKSLIDSMLTVNPKKRITADQAL 283 (362)
T ss_dssp GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred cccCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 2356789999999999999999999987764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=376.50 Aligned_cols=255 Identities=21% Similarity=0.254 Sum_probs=209.9
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
.+.++|+++++||+|+||.||+|.+..+|+.||+|++..... ...+.+|+.+++.++|++ |..+..+..+....+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPN-IVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTT-BCCEEEEEECSSEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcC-CCeEEEEEEECCEEE
Confidence 456789999999999999999999999999999999876543 235889999999998555 555555667888899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
+||||+ |++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+..++.+||+|||+++....
T Consensus 87 lv~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp EEECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 999999 8899999874 45799999999999999999999999999999999999997544678899999999987654
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+. +....+..+.........
T Consensus 166 ~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~~~~- 234 (444)
T 3soa_A 166 EQQ-------AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE---DQHRLYQQIKAGAYDFPS- 234 (444)
T ss_dssp TCC-------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHTCCCCCT-
T ss_pred CCc-------eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc---cHHHHHHHHHhCCCCCCc-
Confidence 332 123468999999999999999999999999999999999999999774 334445555544433222
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.....+++++.+||..||..||++||++.++++
T Consensus 235 ~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 235 PEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 123578999999999999999999999887754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=377.57 Aligned_cols=266 Identities=21% Similarity=0.282 Sum_probs=215.4
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
.++|+++++||+|+||+||+|++..+++.||||++... .....+..|..++..+. |++|..+..++.+....||
T Consensus 73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCEEEE
Confidence 46899999999999999999999999999999987542 23344889999999986 5566666667778889999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
||||+ |++|.+++......+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+.....
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhhhcccC
Confidence 99999 999999998656789999999999999999999999999999999999999 57889999999999876544
Q ss_pred CCccccccccCCCCccCcccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (474)
... .....+||+.|+|||++. +..++.++|||||||+||||++|+.||.+. +..+.+.++......
T Consensus 229 ~~~------~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~~ 299 (437)
T 4aw2_A 229 GTV------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGKIMNHKER 299 (437)
T ss_dssp SCE------ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTHHHH
T ss_pred CCc------ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC---ChhHHHHhhhhcccc
Confidence 321 123468999999999997 456899999999999999999999999874 344455555432221
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCC--CCCHHHHHHHHHHHHHHcCCCCCCcccccccc
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLKRLFRDLFIREGFQFDYVFDWTILK 294 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~--RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 294 (474)
...+.....+++++.+||..||..+|++ ||++++++ ++ ++...+||+.+.
T Consensus 300 ~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil---~H-------pff~~i~w~~l~ 351 (437)
T 4aw2_A 300 FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFK---KH-------PFFSGIDWDNIR 351 (437)
T ss_dssp CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHH---TS-------GGGTTCCTTTGG
T ss_pred ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHh---CC-------CccCCCCHHHHh
Confidence 1222223458999999999999988888 89977663 33 444567898874
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=367.89 Aligned_cols=261 Identities=21% Similarity=0.247 Sum_probs=215.6
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
.+.++|++.+.||+|+||.||+|.++.+++.||||++..... ....|++++..+.+|++|..+..++.++...|+|||
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 456789999999999999999999999999999999875432 356799999999777788888888888999999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeC-CCCCeEEEEecCCccccccCCC
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~-~~~~~vkL~DFGla~~~~~~~~ 161 (474)
|+ |++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+..+ +..+.+||+|||+++.+.....
T Consensus 97 ~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (342)
T 2qr7_A 97 LMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175 (342)
T ss_dssp CCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred CCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence 99 7899999873 4579999999999999999999999999999999999998532 1224699999999987654332
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
. ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.......+.+..+........ ...+
T Consensus 176 ~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-~~~~ 247 (342)
T 2qr7_A 176 L-------LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS-GGYW 247 (342)
T ss_dssp C-------BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC-STTT
T ss_pred c-------eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC-cccc
Confidence 1 2345899999999999988899999999999999999999999987655566666666655444321 1223
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
..+++++.+||..||..||++||++.++ |++.|.
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~i---l~hp~~ 281 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALV---LRHPWI 281 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHH---TTSHHH
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHH---hcCCee
Confidence 5689999999999999999999998765 445544
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=362.19 Aligned_cols=261 Identities=17% Similarity=0.250 Sum_probs=210.3
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCe---EEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
...++|++.++||+|+||.||+|.+..+++ .||||++..... ...+.+|+.+++.++|+ +|..+..++..+..
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~ 124 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHP-NIIRLEGVVTRGRL 124 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCT-TBCCEEEEECGGGC
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCC-CCCcEEEEEEeCCc
Confidence 345789999999999999999999986554 599999875433 23588999999999855 45555556667778
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
.++||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCSSCEEC
T ss_pred cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCCCccccc
Confidence 89999999 889999998666789999999999999999999999999999999999999 47789999999999877
Q ss_pred ccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccc
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+... ...+..+......
T Consensus 202 ~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~---~~~~~~~~~~~~~- 273 (325)
T 3kul_A 202 EDDPDAAY----TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN---RDVISSVEEGYRL- 273 (325)
T ss_dssp C----CCE----ECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHHTTCCC-
T ss_pred ccCcccee----eccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcCCCC-
Confidence 55432111 1223456889999999999999999999999999999999 9999987543 3333333332211
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
.....+++++.+||..||..||++||++.+|++.|+.++..
T Consensus 274 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 274 ---PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 12356899999999999999999999999999999999754
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=354.34 Aligned_cols=251 Identities=21% Similarity=0.260 Sum_probs=202.6
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
++|+++++||+|+||+||+|.+..+++.||||++...... ..+.+|+.+++.++|+ +|..+..+...+...++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK-NIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCT-TBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCC-CEeeEEeEEEeCCEEEEEE
Confidence 6899999999999999999999999999999998654332 4578899999999855 5555556667788999999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 83 e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
||++++|.+.+......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~- 156 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCCS-
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecCCccc-
Confidence 999999999988777889999999999999999999999999999999999999 4778999999999987653322
Q ss_pred cccccccCCCCccCccccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc-------
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS------- 234 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~------- 234 (474)
......||+.|+|||++.+.. ++.++|||||||++|||++|..||.... +....+..+......
T Consensus 157 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~--~~~~~~~~i~~~~~~~~~~~~~ 228 (292)
T 3o0g_A 157 ------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp ------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCT
T ss_pred ------cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC--CHHHHHHHHHHHhCCCChhhhh
Confidence 124458899999999998866 8999999999999999999888864322 223333333221100
Q ss_pred -----------------chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 235 -----------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 235 -----------------~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.....+...+++++.+||..||+.||++||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 281 (292)
T 3o0g_A 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHh
Confidence 001112235789999999999999999999987764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=357.00 Aligned_cols=267 Identities=21% Similarity=0.252 Sum_probs=205.7
Q ss_pred CccCCcEEEe-eeeeecCceEEEEEEEcCCCeEEEEEEeccCC--CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 3 PRVGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 3 ~~i~~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
-++.++|++. +.||+|+||.||+|.+..+++.||||++.... ....+.+|+.++..+..|++|..+..+.......+
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 4577899996 78999999999999999999999999986543 34568999999999776777777777778889999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++.....
T Consensus 88 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999 78999999753 5799999999999999999999999999999999999996433334599999999986643
Q ss_pred CCCccccccccCCCCccCccccccccccC-----CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCc------------H
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLG-----IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------------K 221 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~------------~ 221 (474)
................||+.|+|||++.+ ..++.++|||||||++|||++|..||.+..... .
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 22211111112234579999999999975 457899999999999999999999998754322 2
Q ss_pred HHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 222 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
...+..+.......+. .....+++++.+||..||..||++||+++++++
T Consensus 247 ~~~~~~i~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 247 NMLFESIQEGKYEFPD-KDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHCCCCCCH-HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhccCcccCc-hhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 2333444444333222 234578999999999999999999999877743
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=373.19 Aligned_cols=264 Identities=20% Similarity=0.237 Sum_probs=193.4
Q ss_pred CCccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeE--eC
Q 011945 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGV--EG 75 (474)
Q Consensus 2 ~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~--~~ 75 (474)
+..+.++|+++++||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+.+|++|..+..+.. ..
T Consensus 4 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 4 DRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred cCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 45677899999999999999999999999999999998754322 2347789999999985556655555443 33
Q ss_pred CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 76 ~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
...|+||||++++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+|+.
T Consensus 84 ~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 84 RDVYLVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSRS 158 (388)
T ss_dssp SCEEEEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred CEEEEEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCccccc
Confidence 47899999999999999974 479999999999999999999999999999999999999 4788999999999987
Q ss_pred cccCCCcc-c-------------cccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCc
Q 011945 156 YRDTATHQ-H-------------IPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220 (474)
Q Consensus 156 ~~~~~~~~-~-------------~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~ 220 (474)
+....... . .........+||+.|+|||++.+ ..++.++||||||||||||++|+.||.+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 64321100 0 00112245689999999999987 678999999999999999999999998754332
Q ss_pred HHHHHHHHhhccccch------------------------------HH-------H--HhcCCcHHHHHHHHHHhcCCCC
Q 011945 221 KKQKYEKISEKKVSTS------------------------------IE-------A--LCRGYPTEFASYFHYCRSLRFD 261 (474)
Q Consensus 221 ~~~~~~~i~~~~~~~~------------------------------~~-------~--l~~~~p~~l~~li~~cl~~dp~ 261 (474)
....+........... .. . ....+++++.+||.+||..||+
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 2222221111000000 00 0 0126789999999999999999
Q ss_pred CCCCHHHHH
Q 011945 262 DKPDYAYLK 270 (474)
Q Consensus 262 ~RPt~~~l~ 270 (474)
+||++++++
T Consensus 319 ~R~t~~e~l 327 (388)
T 3oz6_A 319 KRISANDAL 327 (388)
T ss_dssp GSCCHHHHT
T ss_pred cCCCHHHHh
Confidence 999977663
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=363.77 Aligned_cols=263 Identities=19% Similarity=0.292 Sum_probs=216.7
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
...++|++++.||+|+||.||+|++..+++.||||++... .....+.+|+.+++.+.| ++|..+..+.......
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEcCCEE
Confidence 3457899999999999999999999999999999987542 234568889999999975 5555666667778889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
|+||||+ |++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 117 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECS
T ss_pred EEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceecc
Confidence 9999999 88999999853 469999999999999999999999999999999999999 478899999999998764
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
... ...+||+.|+|||++.+..++.++|||||||++|||++|..||.+. ...+.+..+......
T Consensus 193 ~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~~~~~--- 256 (350)
T 1rdq_E 193 GRT----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVSGKVR--- 256 (350)
T ss_dssp SCB----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC---
T ss_pred CCc----------ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC---CHHHHHHHHHcCCCC---
Confidence 321 3468999999999999999999999999999999999999999874 344555555554432
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCCccccccccccccc
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 299 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt-----~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~ 299 (474)
++..+++++.++|..||..||.+||+ +++| +++ .+....||..+...+.+
T Consensus 257 --~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei---~~h-------~~f~~~~w~~~~~~~~~ 311 (350)
T 1rdq_E 257 --FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDI---KNH-------KWFATTDWIAIYQRKVE 311 (350)
T ss_dssp --CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHH---HTS-------GGGTTCCHHHHHTTCSC
T ss_pred --CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHH---HhC-------cCcCCCCHHHHhhccCC
Confidence 23568999999999999999999998 5554 333 34456789876544433
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=362.59 Aligned_cols=255 Identities=24% Similarity=0.338 Sum_probs=205.2
Q ss_pred CCCccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
|...+.++|+++++||+|+||+||+|.+..+++.||||++..... ...+.+|+.+++.++|+ +|..+..++..+..
T Consensus 1 m~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp-nIv~~~~~~~~~~~ 79 (323)
T 3tki_A 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE-NVVKFYGHRREGNI 79 (323)
T ss_dssp -CCTTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCT-TBCCEEEEEECSSE
T ss_pred CCCcHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCC-CCCeEEEEEecCCe
Confidence 667788999999999999999999999999999999999865432 34588999999999855 45555566778888
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
.++||||+ +++|.+++. ....+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+
T Consensus 80 ~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~ 155 (323)
T 3tki_A 80 QYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVF 155 (323)
T ss_dssp EEEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---eCCCCEEEEEeecccee
Confidence 99999999 779999886 34569999999999999999999999999999999999999 47789999999999876
Q ss_pred ccCCCccccccccCCCCccCccccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccc
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
....... ......||+.|+|||++.+..+ +.++|||||||+||+|++|..||......... +..........
T Consensus 156 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~~~~~~~~~~ 228 (323)
T 3tki_A 156 RYNNRER-----LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDWKEKKTYL 228 (323)
T ss_dssp EETTEEC-----CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH--HHHHHTTCTTS
T ss_pred ccCCccc-----ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHHhcccccC
Confidence 5432211 1235689999999999998775 78999999999999999999999875543222 22222211111
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.....+++++.+||..||..||++||++.+++
T Consensus 229 ---~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil 260 (323)
T 3tki_A 229 ---NPWKKIDSAPLALLHKILVENPSARITIPDIK 260 (323)
T ss_dssp ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred ---CccccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 11356789999999999999999999977763
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=365.34 Aligned_cols=258 Identities=21% Similarity=0.274 Sum_probs=205.6
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhc----CCCCCceeEEEeEeCCE
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQ----GGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~----~~~~i~~l~~~~~~~~~ 77 (474)
..+.++|+++++||+|+||.||+|++..+++.||||++.... ....+..|+.+++.+. .|++|..+..++.....
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~ 110 (360)
T 3llt_A 31 MLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH 110 (360)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred eEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence 356889999999999999999999999999999999986432 2345788999999997 35667777777778889
Q ss_pred EEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeC-----------------
Q 011945 78 NVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG----------------- 139 (474)
Q Consensus 78 ~~lv~e~~g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~----------------- 139 (474)
.++|||+++++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+||||+..
T Consensus 111 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~ 190 (360)
T 3llt_A 111 MCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190 (360)
T ss_dssp EEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred eEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccc
Confidence 99999999999999998543 359999999999999999999999999999999999999521
Q ss_pred -----CCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCC
Q 011945 140 -----RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQ 214 (474)
Q Consensus 140 -----~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~ 214 (474)
...+.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||+||||++|+.||.
T Consensus 191 ~~~~~~~~~~~kl~DFG~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 260 (360)
T 3llt_A 191 IQIYRTKSTGIKLIDFGCATFKSDYH----------GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR 260 (360)
T ss_dssp EEEEEESCCCEEECCCTTCEETTSCC----------CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccCCCCEEEEeccCceecCCCC----------cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence 126789999999998644322 34589999999999999999999999999999999999999998
Q ss_pred CCCcCcHHHHHHHHhhccccchHH--------------------------------------HHhcCCcHHHHHHHHHHh
Q 011945 215 GLKAGTKKQKYEKISEKKVSTSIE--------------------------------------ALCRGYPTEFASYFHYCR 256 (474)
Q Consensus 215 ~~~~~~~~~~~~~i~~~~~~~~~~--------------------------------------~l~~~~p~~l~~li~~cl 256 (474)
+.........+..+.......... .+....++.+.+||..||
T Consensus 261 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 340 (360)
T 3llt_A 261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL 340 (360)
T ss_dssp CSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred CCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence 754433333332221111100000 001122478889999999
Q ss_pred cCCCCCCCCHHHHH
Q 011945 257 SLRFDDKPDYAYLK 270 (474)
Q Consensus 257 ~~dp~~RPt~~~l~ 270 (474)
+.||++||++++++
T Consensus 341 ~~dP~~Rpta~elL 354 (360)
T 3llt_A 341 QIDPTLRPSPAELL 354 (360)
T ss_dssp CSSGGGSCCHHHHT
T ss_pred cCChhhCCCHHHHh
Confidence 99999999988774
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=365.61 Aligned_cols=267 Identities=21% Similarity=0.300 Sum_probs=217.2
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
+..++|++++.||+|+||.||+|.+..+++.||||++... .....+.+|+.+++.++| ++|..+..++......
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~ 90 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH-PFLVNLWYSFQDEEDM 90 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEeCCEE
Confidence 3457899999999999999999999999999999987542 234568899999999975 5555555666777889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
|+||||+ |++|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+++.+.
T Consensus 91 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeeecc
Confidence 9999999 8899999973 5579999999999999999999999999999999999999 478899999999998765
Q ss_pred cCCCccccccccCCCCccCccccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~---~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (474)
.... ....+||+.|+|||++.+ ..++.++|||||||+||||++|..||...........+..+......
T Consensus 167 ~~~~--------~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T 4fr4_A 167 RETQ--------ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT 238 (384)
T ss_dssp TTCC--------BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC
T ss_pred CCCc--------eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccC
Confidence 4322 245689999999999974 45899999999999999999999999876655555555554433322
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCCCCC-HHHHHHHHHHHHHHcCCCCCCcccccccccccc
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPD-YAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 298 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt-~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~ 298 (474)
+...+++++.+||..||..||++||+ +++|+ ...+...++|......+.
T Consensus 239 -----~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~----------~hp~f~~~~w~~~~~~~~ 288 (384)
T 4fr4_A 239 -----YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ----------NFPYMNDINWDAVFQKRL 288 (384)
T ss_dssp -----CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH----------TSGGGTTCCHHHHHTTCS
T ss_pred -----CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH----------cChhhhcCCHHHHHhCCC
Confidence 23567899999999999999999998 44432 234556678987655443
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=365.66 Aligned_cols=262 Identities=20% Similarity=0.287 Sum_probs=210.1
Q ss_pred cCCcEEEeeeeeecCceEEEEEE-----EcCCCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeE-eC
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGV-EG 75 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~-----~~~~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~-~~ 75 (474)
..++|+++++||+|+||.||+|. +..+++.||||++...... ..+.+|++++..+.+|++|..+..++. .+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 35789999999999999999999 4556789999998765433 348899999999976666666655544 45
Q ss_pred CEEEEEEecC-CCCHHHHHHHcCC--------------------------------------------------------
Q 011945 76 DYNVLVIDLL-GPSLEDLFNFCSR-------------------------------------------------------- 98 (474)
Q Consensus 76 ~~~~lv~e~~-g~sL~~li~~~~~-------------------------------------------------------- 98 (474)
...++||||+ +++|.+++.....
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 5689999999 7899999974322
Q ss_pred ---------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccccccc
Q 011945 99 ---------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 169 (474)
Q Consensus 99 ---------~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~ 169 (474)
.+++..++.|+.||+.||.|||++||+||||||+||||+ .++.+||+|||+++.+...... ..
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~~~~~~~~-----~~ 251 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDY-----VR 251 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCGGGSCTTSCTTC-----EE
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc---CCCcEEEEeccceeeecccccc-----hh
Confidence 189999999999999999999999999999999999994 6789999999999866443221 12
Q ss_pred CCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHH
Q 011945 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEF 248 (474)
Q Consensus 170 ~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l 248 (474)
.....||+.|+|||++.+..++.++|||||||++|||++ |..||.+....... ...+..... ......+++++
T Consensus 252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~~~~~~~~----~~~~~~~~~~l 325 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLKEGTR----MRAPDYTTPEM 325 (359)
T ss_dssp C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HHHHHHTCC----CCCCTTCCHHH
T ss_pred ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HHHHHcCCC----CCCCCCCCHHH
Confidence 244578999999999999999999999999999999998 99999876543221 222222111 11235678999
Q ss_pred HHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 249 ASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 249 ~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
.+++..||..||++||++.+|++.|+.++...
T Consensus 326 ~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 326 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999998653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=357.73 Aligned_cols=254 Identities=19% Similarity=0.252 Sum_probs=207.7
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--------CchHHHHHHHHHHHhcCCCCCceeEEEeEeC
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEG 75 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--------~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (474)
.+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++|++ |..+..++...
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~~ 86 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN-VITLHEVYENK 86 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTT-BCCEEEEEECS
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCC-CCcEEEEEEeC
Confidence 35578999999999999999999999999999999876543 2356899999999998554 55555566778
Q ss_pred CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCC-CCCeEEEEecCCc
Q 011945 76 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLA 153 (474)
Q Consensus 76 ~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~-~~~~vkL~DFGla 153 (474)
...++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+. ....+||+|||++
T Consensus 87 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 87 TDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp SEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 8899999999 8899999973 45799999999999999999999999999999999999995221 1237999999999
Q ss_pred cccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc
Q 011945 154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (474)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (474)
+....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ....+..+.....
T Consensus 166 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~~~~~~~ 234 (326)
T 2y0a_A 166 HKIDFGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSAVNY 234 (326)
T ss_dssp EECCTTSC--------CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHTCC
T ss_pred eECCCCCc--------cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHHHhcCC
Confidence 87654322 234579999999999999999999999999999999999999998743 3334444443333
Q ss_pred cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.. .......++.++.+||..||..||++||++.++++
T Consensus 235 ~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 EF-EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CC-CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred Cc-CccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 22 23345678999999999999999999999887743
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=358.45 Aligned_cols=265 Identities=19% Similarity=0.215 Sum_probs=205.5
Q ss_pred ccCCcEEEeeeeeecCceEEEEEE----EcCCCeEEEEEEeccCCCc--hHHHHHHHHHHHhcCCCCCceeEEEeE-eCC
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGTGIPNLRWFGV-EGD 76 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~----~~~~~~~vAvK~~~~~~~~--~~l~~E~~il~~l~~~~~i~~l~~~~~-~~~ 76 (474)
...++|+++++||+|+||.||+|+ +..+++.||||++...... ..+.+|+.+++.++|++++..+..+.. ...
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 456899999999999999999998 5678999999998754322 458899999999997666665554432 345
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
..++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTKV 163 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCCSCC-
T ss_pred ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEc---CCCeEEEccCccccc
Confidence 678999999 8899999987666799999999999999999999999999999999999995 678999999999987
Q ss_pred cccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcC----------cHH---
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG----------TKK--- 222 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~----------~~~--- 222 (474)
+....... .......+|..|+|||++.+..++.++|||||||++|||++|..||...... ...
T Consensus 164 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 164 LPQDKEFF----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp ----------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred ccCCccee----eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 65432211 1123446788899999999999999999999999999999999998642110 000
Q ss_pred HHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 223 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 223 ~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
.....+.... .......+|+++.++|..||..||++||++.+|++.|+++..+
T Consensus 240 ~~~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 240 HLIELLKNNG----RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHTTC----CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHhccC----cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 0011111110 1112356899999999999999999999999999999998754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=358.84 Aligned_cols=260 Identities=20% Similarity=0.280 Sum_probs=214.0
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
.++|++++.||+|+||.||+|++..+|+.||||++... .....+..|..+++.+.|+ +|..+..+.......++
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP-FIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBT-TBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCC-CCceEeEEEEeCCEEEE
Confidence 46899999999999999999999999999999987642 2345678899999998754 55555566677888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
||||+ |++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 84 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 84 IMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp EECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSC
T ss_pred EEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceecCCc
Confidence 99999 7899999974 4579999999999999999999999999999999999999 47889999999999865432
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
. ...+||+.|+|||++.+..++.++|||||||++|||++|..||.+. +....+..+......
T Consensus 160 ~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~----- 221 (318)
T 1fot_A 160 T----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKILNAELR----- 221 (318)
T ss_dssp B----------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHCCCC-----
T ss_pred c----------ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCC-----
Confidence 1 3468999999999999999999999999999999999999999874 334455555544332
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCcccccccccccc
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 298 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~ 298 (474)
+...+++++.++|..||..||++|| ++++| +++ ++...++|..+.....
T Consensus 222 ~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i---~~h-------p~f~~~~~~~~~~~~~ 275 (318)
T 1fot_A 222 FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDV---KNH-------PWFKEVVWEKLLSRNI 275 (318)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHH---HTS-------GGGSSCCHHHHHTTCS
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHH---hcC-------ccccCCCHHHHHhCCC
Confidence 2356789999999999999999999 65554 333 3445678987655433
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=358.18 Aligned_cols=255 Identities=22% Similarity=0.297 Sum_probs=199.5
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
..++|++.++||+|+||+||+|++ +++.||||++...... ..+.+|+.+++.++|++ |..+..++......++
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN-IVLFMGAVTQPPNLSI 111 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTT-BCCEEEEECSTTCCEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCC-EeeEEEEEEECCceEE
Confidence 357899999999999999999985 6889999998665432 34788999999998655 5555555666777899
Q ss_pred EEecC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 81 VIDLL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~--~l~~~~~~~i~~qi~~gL~yLHs~g--IiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
||||+ +++|.+++..... .+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+|||+++.
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRL 188 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCEEECCCC----
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcEEECCCCCCcc
Confidence 99999 7899999974321 3999999999999999999999999 9999999999999 4778999999999975
Q ss_pred cccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccc
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
...... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+... .+.+..+......
T Consensus 189 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~---~~~~~~~~~~~~~- 257 (309)
T 3p86_A 189 KASTFL-------SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP---AQVVAAVGFKCKR- 257 (309)
T ss_dssp --------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHHHHSCCC-
T ss_pred cccccc-------ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCC-
Confidence 443221 12346899999999999999999999999999999999999999987543 2333333211111
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
..+...+++++.+||..||..||++||++.+|++.|+.++.
T Consensus 258 --~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 258 --LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred --CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 12345789999999999999999999999999999999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=354.11 Aligned_cols=252 Identities=22% Similarity=0.309 Sum_probs=199.1
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
++|+++++||+|+||.||+|.+ .+++.||||++.... ....+.+|+.+++.++|++ |..+..+.......++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN-IVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTT-BCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCC-EeeeeeEEccCCeEEEEE
Confidence 6899999999999999999998 788999999886543 2356889999999998655 555555566777889999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 83 e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
|++.++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC----
T ss_pred EecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccCcccc-
Confidence 999889999998767789999999999999999999999999999999999999 4778999999999986643221
Q ss_pred cccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc--------
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------- 233 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 233 (474)
......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.........+........
T Consensus 156 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 156 ------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ------ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhh
Confidence 11345789999999999864 589999999999999999999999987543322222222111100
Q ss_pred -------------cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 234 -------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 234 -------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
......+...+++++.+||..||..||++||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 279 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0011223356889999999999999999999988764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=365.52 Aligned_cols=254 Identities=19% Similarity=0.217 Sum_probs=193.2
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
.+.++|++.+.||+|+||.||+|++..+++.||||++........+.+|+.+++.+.|++ |..+..++......++|||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPN-IIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTT-BCCEEEEEECSSEEEEEEC
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCC-CcceeeeEecCCeEEEEEE
Confidence 456779999999999999999999999999999999887666667889999999998655 5555555667788999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
|+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++..+.++.+||+|||+++.......
T Consensus 129 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~- 206 (349)
T 2w4o_A 129 LVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL- 206 (349)
T ss_dssp CCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc-
Confidence 99 7899999873 45699999999999999999999999999999999999996444578999999999986644321
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhc
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (474)
.....||+.|+|||++.+..++.++|||||||+||||++|..||.+... ....+..+....... ......
T Consensus 207 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~i~~~~~~~-~~~~~~ 276 (349)
T 2w4o_A 207 -------MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG--DQFMFRRILNCEYYF-ISPWWD 276 (349)
T ss_dssp -------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC--HHHHHHHHHTTCCCC-CTTTTT
T ss_pred -------cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc--cHHHHHHHHhCCCcc-CCchhh
Confidence 1345799999999999999999999999999999999999999976433 222344444333221 122345
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 243 GYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.++.++.+||..||..||++||++.+++
T Consensus 277 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l 304 (349)
T 2w4o_A 277 EVSLNAKDLVRKLIVLDPKKRLTTFQAL 304 (349)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred hCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 7899999999999999999999987764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=373.44 Aligned_cols=266 Identities=22% Similarity=0.302 Sum_probs=212.9
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
..++|+++++||+|+||.||+|+++.+++.||||+++.. .....+..|..++..+. |++|..+..++......|
T Consensus 59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEECSSEEE
T ss_pred ChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeCCEEE
Confidence 357899999999999999999999999999999998642 12234788999999887 556666666777888999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
|||||+ |++|.+++......+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+++.+..
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCT
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhheeccC
Confidence 999999 899999998766689999999999999999999999999999999999999 5789999999999987654
Q ss_pred CCCccccccccCCCCccCcccccccccc-------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHL-------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~-------~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (474)
.... .....+||+.|+|||++. +..++.++|||||||++|||++|+.||.+.. ..+.+.++...
T Consensus 215 ~~~~------~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~~ 285 (412)
T 2vd5_A 215 DGTV------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS---TAETYGKIVHY 285 (412)
T ss_dssp TSCE------ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTH
T ss_pred CCcc------ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC---HHHHHHHHHhc
Confidence 3321 123468999999999998 3568999999999999999999999998743 34445555442
Q ss_pred cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCC---CHHHHHHHHHHHHHHcCCCCCCcccccccc
Q 011945 232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKP---DYAYLKRLFRDLFIREGFQFDYVFDWTILK 294 (474)
Q Consensus 232 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RP---t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~ 294 (474)
......+.+...+++++.+||.+||. +|++|+ ++++| +++ ++...+||+.+.
T Consensus 286 ~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei---~~H-------pff~~i~w~~l~ 340 (412)
T 2vd5_A 286 KEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDF---RTH-------PFFFGLDWDGLR 340 (412)
T ss_dssp HHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHH---HTS-------GGGTTCCSTTST
T ss_pred ccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHH---hcC-------CCcCCCCHHHHh
Confidence 22122222345789999999999999 999984 66655 333 444567898764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=362.21 Aligned_cols=265 Identities=20% Similarity=0.297 Sum_probs=216.8
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCC-------CeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEe
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT-------NEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVE 74 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~-------~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~ 74 (474)
..++|++.++||+|+||.||+|.+..+ +..||||++...... ..+.+|+++++.+..|++|..+..++..
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 357899999999999999999997543 357999998765433 4588999999999556677777777777
Q ss_pred CCEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeee
Q 011945 75 GDYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 138 (474)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~li~~~~---------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~ 138 (474)
....++||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+||||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll-- 224 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV-- 224 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE--
Confidence 78889999999 779999998543 359999999999999999999999999999999999999
Q ss_pred CCCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 011945 139 GRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 217 (474)
Q Consensus 139 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~ 217 (474)
+.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 225 -~~~~~~kL~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~ 298 (382)
T 3tt0_A 225 -TEDNVMKIADFGLARDIHHIDYY-----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 298 (382)
T ss_dssp -CTTCCEEECSCSCCCCSSCCCTT-----CCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred -cCCCcEEEcccCccccccccccc-----ccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 47789999999999876543221 12234578899999999999999999999999999999999 999998754
Q ss_pred cCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCC
Q 011945 218 AGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQF 284 (474)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~ 284 (474)
. .+....+...... .....+++++.+||..||+.||++||++.+|++.|+.++.....+.
T Consensus 299 ~---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 299 V---EELFKLLKEGHRM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp H---HHHHHHHHTTCCC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred H---HHHHHHHHcCCCC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 3 3333333332211 1235689999999999999999999999999999999987765433
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=367.41 Aligned_cols=263 Identities=17% Similarity=0.257 Sum_probs=209.7
Q ss_pred ccCCcEEEeeeeeecCceEEEEEE-----EcCCCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeC
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEG 75 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~-----~~~~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (474)
+..++|+++++||+|+||.||+|. +..+++.||||++...... ..+.+|+.+++.++|++++ .+..++...
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~~~~~~~~~ 146 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV-RCIGVSLQS 146 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBC-CEEEEECSS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCC-eEEEEEecC
Confidence 445789999999999999999999 4457889999998654322 3578899999999865554 555555666
Q ss_pred CEEEEEEecC-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEE
Q 011945 76 DYNVLVIDLL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148 (474)
Q Consensus 76 ~~~~lv~e~~-g~sL~~li~~~~------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~ 148 (474)
...++||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++....+||+
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence 7779999999 889999998543 359999999999999999999999999999999999999644455679999
Q ss_pred ecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHH
Q 011945 149 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEK 227 (474)
Q Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 227 (474)
|||+++.+...... .......||+.|+|||++.+..++.++|||||||+||||++ |..||.+.. ..+.+..
T Consensus 227 DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~---~~~~~~~ 298 (367)
T 3l9p_A 227 DFGMARDIYRAGYY-----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS---NQEVLEF 298 (367)
T ss_dssp CCHHHHHHHHHSSC-----TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC---HHHHHHH
T ss_pred CCcccccccccccc-----ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHH
Confidence 99999865432221 12234578999999999999999999999999999999998 999998743 3333444
Q ss_pred HhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
+...... .....++.++.+||..||+.||++||++.+|++.|+.+...
T Consensus 299 i~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 299 VTSGGRM----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHcCCCC----CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 3332221 12356889999999999999999999999999999888653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=372.61 Aligned_cols=260 Identities=17% Similarity=0.180 Sum_probs=198.1
Q ss_pred cCCcEEEe-eeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEe----CCEEE
Q 011945 5 VGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVE----GDYNV 79 (474)
Q Consensus 5 i~~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~----~~~~~ 79 (474)
+.++|.+. +.||.|+||+||+|.+..+++.||||++. ....+.+|+.++.++.+|++|..+..++.. ..+.|
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~---~~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEE---CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeC---cchhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 44567776 78999999999999999999999999986 345688999998777666666666544433 56789
Q ss_pred EEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
|||||+ |++|.+++.... ..+++..++.|+.||+.||.|||++|||||||||+|||++.++.++.+||+|||+++...
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~ 215 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence 999999 789999997432 359999999999999999999999999999999999999643347899999999998654
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcH-HHHHHHHhhccccch
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVSTS 236 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~~~ 236 (474)
.... ....+||+.|+|||++.+..++.++|||||||+||||++|..||.+...... ......+........
T Consensus 216 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~ 287 (400)
T 1nxk_A 216 SHNS--------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 287 (400)
T ss_dssp -------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCC
T ss_pred CCCc--------cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCC
Confidence 3221 2345899999999999999999999999999999999999999986543221 011122222222111
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
. .....+++++.+||..||..||++||++.+| |++.|..
T Consensus 288 ~-~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ei---l~hp~~~ 326 (400)
T 1nxk_A 288 N-PEWSEVSEEVKMLIRNLLKTEPTQRMTITEF---MNHPWIM 326 (400)
T ss_dssp T-TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHH---HHSHHHH
T ss_pred C-cccccCCHHHHHHHHHHCCCChhHCcCHHHH---hcCcccc
Confidence 1 1235689999999999999999999997776 5555544
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=354.81 Aligned_cols=265 Identities=20% Similarity=0.263 Sum_probs=203.8
Q ss_pred CCCccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHH--hcCCCCCceeEEEeE---eC
Q 011945 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKI--LQGGTGIPNLRWFGV---EG 75 (474)
Q Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~--l~~~~~i~~l~~~~~---~~ 75 (474)
|+..+.++|+++++||+|+||+||+|.+ +++.||||++... ....+..|.+++.. ++|++++..+..+.. ..
T Consensus 2 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 2 MQRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp --CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred ccccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 5678899999999999999999999986 7899999998653 34557778888887 566655555544332 23
Q ss_pred CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCccccCCCCCcEEeeeCCCCCeEE
Q 011945 76 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH--------SKSFLHRDIKPDNFLMGLGRRANQVY 146 (474)
Q Consensus 76 ~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLH--------s~gIiHrDIKP~NILl~~~~~~~~vk 146 (474)
...++||||+ +++|.++++ ...+++..++.|+.||+.||.||| ++||+||||||+|||+ +.++.+|
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~~~k 153 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCC 153 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTSCEE
T ss_pred ceeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCCCEE
Confidence 5679999999 779999996 457999999999999999999999 9999999999999999 4778999
Q ss_pred EEecCCccccccCCCccccccccCCCCccCccccccccccCC------CCCchhhHHHHHHHHHHHHhC----------C
Q 011945 147 IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI------EQSRRDDLESLGYVLMYFLRG----------S 210 (474)
Q Consensus 147 L~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~------~~s~ksDIwSlGvil~elltG----------~ 210 (474)
|+|||+++........... ......||+.|+|||++.+. .++.++|||||||++|||++| .
T Consensus 154 l~Dfg~a~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~ 230 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDV---GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230 (301)
T ss_dssp ECCCTTCEEEETTTTEEEC---CCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred EeeCCCeeecccccccccc---cccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence 9999999876554332111 12345899999999999887 455799999999999999999 8
Q ss_pred CCCCCCCcCc-HHHHHHHHh-hccccc--hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 211 LPWQGLKAGT-KKQKYEKIS-EKKVST--SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 211 ~Pf~~~~~~~-~~~~~~~i~-~~~~~~--~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
.||....... ....+.... ...... +.......+++++.+|+..||+.||++||++.+|++.|+++
T Consensus 231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 8997653322 122222221 111111 11112233568899999999999999999999999999875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=368.57 Aligned_cols=268 Identities=20% Similarity=0.267 Sum_probs=209.4
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHH-HHhcCCCCCceeEEEeEeCCEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLY-KILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il-~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
..++|++++.||+|+||.||+|+++.+++.||||++.... ....+..|..++ +.+. |++|..+..++......
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~-hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCC-CTTBCCEEEEEECSSEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEeCCEE
Confidence 3468999999999999999999999999999999986532 223355666653 3344 66677777777788899
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
|+||||+ |++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+++...
T Consensus 115 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGGGB
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCccccccc
Confidence 9999999 7899999874 4579999999999999999999999999999999999999 478899999999998644
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+. +..+.+..+......
T Consensus 191 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~~~~--- 257 (373)
T 2r5t_A 191 EHNS-------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR---NTAEMYDNILNKPLQ--- 257 (373)
T ss_dssp CCCC-------CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS---BHHHHHHHHHHSCCC---
T ss_pred cCCC-------ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHhcccC---
Confidence 3221 124568999999999999999999999999999999999999999874 344555555544332
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHH-HHHHHHHHHHHcCCCCCCccccccccccccc
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAY-LKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 299 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~-l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~ 299 (474)
+...++.++.+||..||..||.+||++.+ +.+++++ .+...++|..+...+.+
T Consensus 258 --~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h-------~~f~~~~w~~l~~~~~~ 311 (373)
T 2r5t_A 258 --LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH-------VFFSLINWDDLINKKIT 311 (373)
T ss_dssp --CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS-------GGGTTCCHHHHHTTCSC
T ss_pred --CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC-------ccccCCCHHHHHhCCCC
Confidence 23568899999999999999999999753 2333333 44556799887655443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=361.22 Aligned_cols=257 Identities=20% Similarity=0.303 Sum_probs=202.6
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCC-CCCceeEEEeEeCCEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGG-TGIPNLRWFGVEGDYN 78 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~-~~i~~l~~~~~~~~~~ 78 (474)
+.+++|+++++||+|+||.||+|.+ .+++.||||++...... ..+.+|+.+++.+.|+ ++|..+..++......
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 3577899999999999999999997 56889999998755433 3578899999999864 7788888888889999
Q ss_pred EEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 79 VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 79 ~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
++|||+.+++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+..
T Consensus 85 ~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~----~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 85 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEECCCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCCC--
T ss_pred EEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE----CCcEEEeecccccccCc
Confidence 99999889999999985 56799999999999999999999999999999999999994 57899999999987654
Q ss_pred CCCccccccccCCCCccCccccccccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLG-----------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----------~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 227 (474)
..... ......||+.|+|||++.+ ..++.++|||||||+||||++|..||..... ....+..
T Consensus 160 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~ 232 (343)
T 3dbq_A 160 DTTSV-----VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHA 232 (343)
T ss_dssp ---------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHH
T ss_pred ccccc-----cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh--HHHHHHH
Confidence 33211 1234589999999999875 6789999999999999999999999976432 2222333
Q ss_pred HhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
+....... .+...++.++.+||..||..||++||++.++ |++.+..
T Consensus 233 ~~~~~~~~---~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~---l~hp~~~ 278 (343)
T 3dbq_A 233 IIDPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPEL---LAHPYVQ 278 (343)
T ss_dssp HHCTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH---HTSHHHH
T ss_pred HhcCCccc---CCcccCCHHHHHHHHHHcCCChhHCCCHHHH---HhCcccc
Confidence 22221111 1234567899999999999999999998776 4555544
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=360.01 Aligned_cols=256 Identities=21% Similarity=0.269 Sum_probs=192.4
Q ss_pred cCCcEEEe---eeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 5 VGNKFRLG---RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 5 i~~~y~i~---~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
+.++|++. ++||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.+.+|++|..+..++.+....++|
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv 84 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLV 84 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEE
Confidence 34678886 7899999999999999999999999998643 3456889999999999778888888888888999999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ +++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++.++....+||+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~ 163 (325)
T 3kn6_A 85 MELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN 163 (325)
T ss_dssp ECCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred EEccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence 9999 7799999974 5679999999999999999999999999999999999999744444589999999998655432
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----CcHHHHHHHHhhccccch
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA----GTKKQKYEKISEKKVSTS 236 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~----~~~~~~~~~i~~~~~~~~ 236 (474)
.. ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ....+.+..+........
T Consensus 164 ~~-------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~ 236 (325)
T 3kn6_A 164 QP-------LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236 (325)
T ss_dssp ---------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred Cc-------ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence 21 2345789999999999999999999999999999999999999986432 223444555544443222
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
......+++++.+||..||..||++||++.+++
T Consensus 237 -~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 237 -GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp -SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred -cccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 223357899999999999999999999977763
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=369.62 Aligned_cols=267 Identities=21% Similarity=0.297 Sum_probs=213.1
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEecc-----CCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~-----~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
.++|+++++||+|+||+||+|+++.+++.||||++.. ......+..|+.+++.++| ++|..+..++.+....||
T Consensus 68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~~l 146 (410)
T 3v8s_A 68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS-PWVVQLFYAFQDDRYLYM 146 (410)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEEEE
Confidence 4689999999999999999999999999999998754 2234458899999999975 555566666778889999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
||||+ |++|.+++.. ..+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+.....
T Consensus 147 V~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 147 VMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred EEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEeeccC
Confidence 99999 8999999974 469999999999999999999999999999999999999 57889999999999876543
Q ss_pred CCccccccccCCCCccCccccccccccCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccc
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~----~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
... .....+||+.|+|||++.+.. ++.++|||||||+||||++|..||.+. +....+.++.......
T Consensus 222 ~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~~ 292 (410)
T 3v8s_A 222 GMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD---SLVGTYSKIMNHKNSL 292 (410)
T ss_dssp SEE------ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTHHHHC
T ss_pred Ccc------cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC---ChhhHHHHHHhccccc
Confidence 221 124568999999999998766 789999999999999999999999874 3444555554432111
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCC--CCCHHHHHHHHHHHHHHcCCCCCCcccccccccccc
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDD--KPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 298 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~--RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~ 298 (474)
..+ ....+++++.+||..||..+|.+ ||++++|+ ++. +....+|......+.
T Consensus 293 ~~p-~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~---~Hp-------~f~~~~w~~~~~~~~ 346 (410)
T 3v8s_A 293 TFP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIK---RHL-------FFKNDQWAWETLRDT 346 (410)
T ss_dssp CCC-TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHH---TSG-------GGCCSSCCSTTGGGS
T ss_pred cCC-CcccccHHHHHHHHHHccChhhhCCCCCHHHHh---cCc-------cccCCCHHHHhhccc
Confidence 111 12468899999999999988988 99977764 333 334456765544433
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=357.36 Aligned_cols=265 Identities=20% Similarity=0.223 Sum_probs=206.6
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEe-CCEEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVE-GDYNV 79 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~-~~~~~ 79 (474)
.+.++|++.++||+|+||+||+|.+..+++.||||++.... ....+.+|+++++.++|++++..+..+... ....+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence 46789999999999999999999999999999999986532 335678999999999966666555544333 33789
Q ss_pred EEEecC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeC-CCCCeEEEEecCCccc
Q 011945 80 LVIDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKR 155 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~--~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~-~~~~~vkL~DFGla~~ 155 (474)
+||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||+..+ +..+.+||+|||+++.
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 999999 789999997433 239999999999999999999999999999999999998432 3566799999999987
Q ss_pred cccCCCccccccccCCCCccCcccccccccc--------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcC-cHHHHHH
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHL--------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYE 226 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~--------~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~-~~~~~~~ 226 (474)
+..... .....||..|+|||++. +..++.++|||||||++|||++|..||...... ...+.+.
T Consensus 166 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 166 LEDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp CCTTCC--------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred cCCCCc--------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 655432 13457999999999987 567899999999999999999999999754432 2233333
Q ss_pred HHhhccccch--------------------HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 227 KISEKKVSTS--------------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 227 ~i~~~~~~~~--------------------~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
.+........ ...+...++..+.++|..||+.||++||+++++++...+-
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 3333221100 0011123467899999999999999999999887666554
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=372.03 Aligned_cols=252 Identities=20% Similarity=0.290 Sum_probs=211.0
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 85 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (474)
.++|++.++||+|+||.||+|.+ .++.||||+++.......+.+|+.+++.++|++++..+..+.......+|||||+
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred hHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 46899999999999999999986 4789999999877777889999999999997776666666555555789999999
Q ss_pred -CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 86 -GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 86 -g~sL~~li~~~~~-~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
+++|.+++..... .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~--- 343 (450)
T 1k9a_A 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ--- 343 (450)
T ss_dssp TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCcccccccc---
Confidence 7899999986544 37999999999999999999999999999999999999 477899999999998543221
Q ss_pred ccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhc
Q 011945 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (474)
....++..|+|||++.+..++.++|||||||+||||++ |..||.+.........+ ..... ...+.
T Consensus 344 -------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i---~~~~~----~~~p~ 409 (450)
T 1k9a_A 344 -------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---EKGYK----MDAPD 409 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH---HTTCC----CCCCT
T ss_pred -------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---HcCCC----CCCCC
Confidence 12367889999999999999999999999999999998 99999887654433332 22111 11245
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
.+|+++.+||..||..||++||++.+|++.|+++...
T Consensus 410 ~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 410 GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 7899999999999999999999999999999998753
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=363.58 Aligned_cols=255 Identities=24% Similarity=0.297 Sum_probs=207.6
Q ss_pred CCccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCC
Q 011945 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 76 (474)
Q Consensus 2 ~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (474)
.....++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+|+.+++.++|++ |..+..+.....
T Consensus 4 ~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~ 82 (336)
T 3h4j_B 4 SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH-IIKLYDVITTPT 82 (336)
T ss_dssp CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTT-BCCEEEEEECSS
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCC-CCeEEEEEEeCC
Confidence 456678999999999999999999999999999999987532 34457899999999998654 555555666778
Q ss_pred EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 77 YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 77 ~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
..++||||++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 83 ~~~lv~E~~~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~~~ 158 (336)
T 3h4j_B 83 DIVMVIEYAGGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIM 158 (336)
T ss_dssp EEEEEECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTBTT
T ss_pred EEEEEEECCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEeccceec
Confidence 8999999999999999874 3579999999999999999999999999999999999999 47789999999999876
Q ss_pred ccCCCccccccccCCCCccCccccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccc
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
..... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+...... +..+..
T Consensus 159 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---~~~i~~----- 222 (336)
T 3h4j_B 159 TDGNF--------LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL---FKKVNS----- 222 (336)
T ss_dssp TTSBT--------TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---BCCCCS-----
T ss_pred cCCcc--------cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---HHHHHc-----
Confidence 54322 234589999999999998876 7899999999999999999999976433211 111111
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
....++..+++++.+||..||..||.+||++++| +++.|.+.
T Consensus 223 ~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~ei---l~hp~~~~ 264 (336)
T 3h4j_B 223 CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEI---RRDPWFNV 264 (336)
T ss_dssp SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHH---TTCHHHHT
T ss_pred CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHH---HhChhhcc
Confidence 1112235678999999999999999999997776 45555443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=345.57 Aligned_cols=255 Identities=20% Similarity=0.278 Sum_probs=210.6
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
.++|++++.||+|+||.||+|.+. +++.||||++.... ....+.+|+.+++.++|+ +|..+..++.+....++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHP-KLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCT-TBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCC-CEeeEEEEEecCCceEEEEEe
Confidence 468999999999999999999985 67789999987644 345689999999999865 455555556667778999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 85 ~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~-- 161 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQY-- 161 (269)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---GGGCEEECCTTGGGGBCCHHH--
T ss_pred CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEc---CCCCEEecccccccccccccc--
Confidence 9 7899999986667799999999999999999999999999999999999994 678999999999986544321
Q ss_pred ccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhc
Q 011945 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (474)
.......+|..|+|||++.+..++.++|||||||++|+|++ |..||.+... ......+...... ....
T Consensus 162 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~ 230 (269)
T 4hcu_A 162 ----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN---SEVVEDISTGFRL----YKPR 230 (269)
T ss_dssp ----HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCC----CCCT
T ss_pred ----ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHhcCccC----CCCC
Confidence 11234567889999999999999999999999999999999 9999987433 3333333332111 1234
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
.+++++.+++..||..||++||++.++++.|+++..
T Consensus 231 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 231 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 578999999999999999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=345.88 Aligned_cols=260 Identities=22% Similarity=0.284 Sum_probs=211.4
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
.+.++|++.++||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++| ++|..+..+.......+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 81 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEESFHY 81 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCC-CCcCeEEEEEEcCCEEE
Confidence 5789999999999999999999999999999999998654322 457889999999985 45555556667788889
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
++|||+ +++|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++..+.+||+|||++.....
T Consensus 82 ~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 82 LVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp EEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999 7799888874 35799999999999999999999999999999999999997544556799999999976654
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ....+..+.........
T Consensus 161 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~~- 228 (284)
T 3kk8_A 161 SEA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAYDYPS- 228 (284)
T ss_dssp SCB--------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCT-
T ss_pred Ccc--------ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc---hhHHHHHHHhccccCCc-
Confidence 332 234579999999999999999999999999999999999999998743 33344444333332221
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
.....+++++.++|..||+.||++||++.++ |++.+...
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~---l~h~~~~~ 267 (284)
T 3kk8_A 229 PEWDTVTPEAKSLIDSMLTVNPKKRITADQA---LKVPWICN 267 (284)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHH---TTSHHHHS
T ss_pred hhhcccCHHHHHHHHHHcccChhhCCCHHHH---hcCccccC
Confidence 1235688999999999999999999998777 44555443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=366.74 Aligned_cols=255 Identities=20% Similarity=0.306 Sum_probs=202.4
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcC-CCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQG-GTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~-~~~i~~l~~~~~~~~~~~l 80 (474)
+.+|+++++||+|+||.||+|.+.. ++.||||++...... ..+.+|+.+++.|.+ +++|..+..++......+|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 4569999999999999999999754 899999998765432 458899999999986 6788888888888889999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 81 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 81 v~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+.+++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.+....
T Consensus 134 v~E~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~----~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 134 VMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEECCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES----SSCEEECCCSSSCCC----
T ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE----CCeEEEEecCccccccCCC
Confidence 999889999999985 45799999999999999999999999999999999999993 4789999999998765432
Q ss_pred CccccccccCCCCccCccccccccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHh
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLG-----------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~-----------~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (474)
... .....+||+.|+|||++.+ ..++.++||||||||||||++|..||..... ....+..+.
T Consensus 209 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~~~~~~~~ 281 (390)
T 2zmd_A 209 TSV-----VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHAII 281 (390)
T ss_dssp ----------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHH
T ss_pred ccc-----cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH--HHHHHHHHh
Confidence 211 1234689999999999976 3689999999999999999999999976432 223333333
Q ss_pred hccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
...... .+...++.++.+||..||..||++||++.+| |++.|..
T Consensus 282 ~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~el---l~hp~~~ 325 (390)
T 2zmd_A 282 DPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPEL---LAHPYVQ 325 (390)
T ss_dssp CTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH---HTSHHHH
T ss_pred CccccC---CCCccchHHHHHHHHHHcccChhhCCCHHHH---hhCcCcc
Confidence 222111 1224457899999999999999999998776 4555543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=350.00 Aligned_cols=259 Identities=20% Similarity=0.293 Sum_probs=200.4
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCC---CeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
+..++|++.+.||+|+||.||+|.+..+ +..||||+...... ...+.+|+.+++.++|++++..+..+ .+..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~--~~~~ 89 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI--TENP 89 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE--CSSS
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE--ccCc
Confidence 3467899999999999999999998654 45799998765432 23588999999999876666555543 3455
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
.++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYM 166 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC-------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC---CCCCEEECcccccccc
Confidence 78999999 6799999986666799999999999999999999999999999999999995 6789999999999876
Q ss_pred ccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccc
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....... ..+......
T Consensus 167 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---~~i~~~~~~- 236 (281)
T 1mp8_A 167 EDSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIENGERL- 236 (281)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHHTTCCC-
T ss_pred Cccccc------ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH---HHHHcCCCC-
Confidence 543221 1223467889999999999999999999999999999997 99999886554333 223222211
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
.+...+|+++.+++..||..||++||++.+|++.|+.++.+.
T Consensus 237 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 237 ---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 134578999999999999999999999999999999998754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=349.44 Aligned_cols=255 Identities=17% Similarity=0.259 Sum_probs=203.1
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc---------hHHHHHHHHHHHhcCCCCCceeEEEeEe
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---------PQLQYEAKLYKILQGGTGIPNLRWFGVE 74 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---------~~l~~E~~il~~l~~~~~i~~l~~~~~~ 74 (474)
...++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++|++++..+.. ...
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~-~~~ 94 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL-MHN 94 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEE-ETT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhee-ecC
Confidence 4568999999999999999999999999999999987543321 568899999999986555555444 333
Q ss_pred CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEeeeCC--CCCeEEEEe
Q 011945 75 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGR--RANQVYIID 149 (474)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~g--IiHrDIKP~NILl~~~~--~~~~vkL~D 149 (474)
.. +++|||+ +++|.+++......+++..++.++.||+.||.|||++| |+||||||+|||++.++ ....+||+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 33 6899999 68999988766678999999999999999999999999 99999999999995321 122399999
Q ss_pred cCCccccccCCCccccccccCCCCccCcccccccccc--CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHH
Q 011945 150 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL--GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227 (474)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~--~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 227 (474)
||+++..... .....||+.|+|||++. +..++.++|||||||++|||++|..||....... ......
T Consensus 173 fg~~~~~~~~----------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~ 241 (287)
T 4f0f_A 173 FGLSQQSVHS----------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-IKFINM 241 (287)
T ss_dssp CTTCBCCSSC----------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH-HHHHHH
T ss_pred CCcccccccc----------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH-HHHHHH
Confidence 9999754332 13457999999999984 4557899999999999999999999998765433 222233
Q ss_pred HhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011945 228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 275 (474)
Q Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (474)
+....... .+...+|+++.++|..||+.||++||++.+|++.|++
T Consensus 242 ~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 242 IREEGLRP---TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHSCCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HhccCCCC---CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 22222221 2345789999999999999999999999999998875
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=352.21 Aligned_cols=249 Identities=20% Similarity=0.278 Sum_probs=198.0
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----------------------------chHHHHHHHH
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------------------------HPQLQYEAKL 55 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----------------------------~~~l~~E~~i 55 (474)
...++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 345789999999999999999999999999999998765421 2458899999
Q ss_pred HHHhcCCCCCceeEEEeE-eCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 011945 56 YKILQGGTGIPNLRWFGV-EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 133 (474)
Q Consensus 56 l~~l~~~~~i~~l~~~~~-~~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~N 133 (474)
++.++|++++..+..+.. .....++||||+ +++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 999987666665555443 367889999999 678877654 4579999999999999999999999999999999999
Q ss_pred EEeeeCCCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCC---CCchhhHHHHHHHHHHHHhCC
Q 011945 134 FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGS 210 (474)
Q Consensus 134 ILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~---~s~ksDIwSlGvil~elltG~ 210 (474)
||+ +.++.+||+|||+++.+...... .....||+.|+|||++.+.. ++.++|||||||++|||++|.
T Consensus 168 il~---~~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 237 (298)
T 2zv2_A 168 LLV---GEDGHIKIADFGVSNEFKGSDAL-------LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237 (298)
T ss_dssp EEE---CTTSCEEECCCTTCEECSSSSCE-------ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSS
T ss_pred EEE---CCCCCEEEecCCCcccccccccc-------ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCC
Confidence 999 47789999999999876543221 13457999999999998765 378999999999999999999
Q ss_pred CCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 211 LPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 211 ~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.||.+.. .......+........ ....+++++.+||..||..||++||++.+|+
T Consensus 238 ~pf~~~~---~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l 291 (298)
T 2zv2_A 238 CPFMDER---IMCLHSKIKSQALEFP---DQPDIAEDLKDLITRMLDKNPESRIVVPEIK 291 (298)
T ss_dssp CSSCCSS---HHHHHHHHHHCCCCCC---SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred CCCCCcc---HHHHHHHHhcccCCCC---CccccCHHHHHHHHHHhhcChhhCCCHHHHh
Confidence 9998643 2333333333222111 1246889999999999999999999988774
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=357.65 Aligned_cols=254 Identities=22% Similarity=0.277 Sum_probs=188.0
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.++|+++++||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++|+ +|..+..+...+...++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp-~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHE-NIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBT-TBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCC-CcceEEEEEEECCeEEEEE
Confidence 578999999999999999999999999999999886543 235688999999999855 4555555666778899999
Q ss_pred ecCCCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 83 DLLGPSLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 83 e~~g~sL~~li~~~~-----~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
||+.++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 83 e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp ECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCSSCEETT
T ss_pred EecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCccceecC
Confidence 999999999987432 459999999999999999999999999999999999999 477899999999998765
Q ss_pred cCCCccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc--
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS-- 234 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-- 234 (474)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.........+.........
T Consensus 160 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 160 IPVN-------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp SCCC-------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred CCcc-------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence 3321 12345789999999999874 5899999999999999999999999875443322222222111000
Q ss_pred -------------------chH-----HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 235 -------------------TSI-----EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 235 -------------------~~~-----~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
... ......++.++.+||..||..||++||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l 292 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQAL 292 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHh
Confidence 000 011235789999999999999999999987663
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=350.64 Aligned_cols=262 Identities=21% Similarity=0.303 Sum_probs=214.2
Q ss_pred CCcEEEeeeeeecCceEEEEEEE-----cCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTN-----IQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~-----~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
.++|++.+.||+|+||.||+|.+ ..+++.||||++..... ...+.+|+.+++.+..|++|..+..++.....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 47899999999999999999985 35678999999875543 24588999999999556667777667777778
Q ss_pred EEEEEecC-CCCHHHHHHHcCC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeC
Q 011945 78 NVLVIDLL-GPSLEDLFNFCSR-----------------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~~~-----------------~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~ 139 (474)
.++||||+ +++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~-- 179 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-- 179 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE--
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEc--
Confidence 89999999 7799999975432 489999999999999999999999999999999999995
Q ss_pred CCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 011945 140 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (474)
Q Consensus 140 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~ 218 (474)
.++.+||+|||++......... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 180 -~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 180 -HGRITKICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp -TTTEEEECCCGGGSCTTSCTTS-----EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred -CCCCEEEccccccccccccccc-----eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 6789999999999876554321 11234567899999999999999999999999999999999 9999987654
Q ss_pred CcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011945 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281 (474)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 281 (474)
..... ..+.. .... .....+|.++.+++..||..||++||++.+|++.|++++.+..
T Consensus 254 ~~~~~--~~~~~-~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 254 DSKFY--KMIKE-GFRM---LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp SHHHH--HHHHH-TCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred hhHHH--HHhcc-CCCC---CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 32221 11111 1111 1134678999999999999999999999999999999987654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=347.03 Aligned_cols=257 Identities=18% Similarity=0.276 Sum_probs=209.3
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
.++|++++.||+|+||.||+|.+. ++..||||++.... ....+.+|+++++.++|++ |..+..++......++||||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEK-LVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTT-BCCEEEEECSSSSEEEEECC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCC-EeeEEEEEecCCCeEEEEec
Confidence 468999999999999999999874 77889999987654 3466899999999998554 55555556677778999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 85 ~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~-- 175 (283)
T 3gen_A 101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEY-- 175 (283)
T ss_dssp CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTSCEEECSTTGGGGBCCHHH--
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---cCCCCEEEcccccccccccccc--
Confidence 9 889999998656679999999999999999999999999999999999999 4778999999999986644321
Q ss_pred ccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhc
Q 011945 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (474)
.......+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... ......+...... ....
T Consensus 176 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~~~~~----~~~~ 244 (283)
T 3gen_A 176 ----TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHIAQGLRL----YRPH 244 (283)
T ss_dssp ----HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHHTTCCC----CCCT
T ss_pred ----ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh---hHHHHHHhcccCC----CCCC
Confidence 11234467889999999999899999999999999999998 9999987543 3333333332211 1124
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
.+++++.+++..||+.||++||++.++++.|.+++.++
T Consensus 245 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 245 LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 57899999999999999999999999999999998764
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=373.00 Aligned_cols=267 Identities=18% Similarity=0.209 Sum_probs=188.5
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeE----eC
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGV----EG 75 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~----~~ 75 (474)
.+.++|+++++||+|+||+||+|.+..+++.||||++..... ...+.+|+.+++.|+|++++..+..+.. ..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 467899999999999999999999999999999998865322 2457899999999987666666655532 23
Q ss_pred CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 76 ~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
...|+|||+++++|.+++. ....+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+.
T Consensus 130 ~~~~lv~e~~~~~L~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 130 DELYVVLEIADSDFKKLFR-TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLART 205 (458)
T ss_dssp CCEEEEECCCSEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCBC
T ss_pred ceEEEEEeccccchhhhcc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeecccccchh
Confidence 5689999999999999997 35679999999999999999999999999999999999999 4778999999999987
Q ss_pred cccCCCcccc--------------------ccccCCCCccCcccccccccc-CCCCCchhhHHHHHHHHHHHHh------
Q 011945 156 YRDTATHQHI--------------------PYRENKNLTGTARYASMNTHL-GIEQSRRDDLESLGYVLMYFLR------ 208 (474)
Q Consensus 156 ~~~~~~~~~~--------------------~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDIwSlGvil~ellt------ 208 (474)
.......... ........+||+.|+|||++. +..++.++||||||||||||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 6543211000 001234568899999999864 5669999999999999999999
Q ss_pred -----CCCCCCCCCcC-----------------cHHHHHHHHhhcc--------------------------ccchHHHH
Q 011945 209 -----GSLPWQGLKAG-----------------TKKQKYEKISEKK--------------------------VSTSIEAL 240 (474)
Q Consensus 209 -----G~~Pf~~~~~~-----------------~~~~~~~~i~~~~--------------------------~~~~~~~l 240 (474)
|..+|.+.... .....+..+.... ........
T Consensus 286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (458)
T 3rp9_A 286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER 365 (458)
T ss_dssp SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence 66777553210 0011111111100 00111122
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
...+++++.+||.+||..||++||+++++ |++.|
T Consensus 366 ~~~~s~~~~dLl~~mL~~dP~~R~t~~e~---L~Hp~ 399 (458)
T 3rp9_A 366 FPASSADAIHLLKRMLVFNPNKRITINEC---LAHPF 399 (458)
T ss_dssp STTSCHHHHHHHHHHSCSSTTTSCCHHHH---HHSGG
T ss_pred CCCCCHHHHHHHHHHhccCccccCCHHHH---hcCHh
Confidence 34568999999999999999999997766 44443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=353.48 Aligned_cols=260 Identities=22% Similarity=0.386 Sum_probs=199.4
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
.+..++|++.++||+|+||.||+|++. ..||||+++..... ..+.+|+.+++.++|++++..+. +. .....
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~-~~-~~~~~ 94 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG-YS-TAPQL 94 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEE-EE-CSSSC
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEe-ec-cCCcc
Confidence 356789999999999999999999843 35999998765433 34889999999999766665544 43 34457
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
++||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTTEEEECCCC------
T ss_pred EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC---CCCCEEEccceeccccc
Confidence 8999998 7899999976667799999999999999999999999999999999999995 67899999999998654
Q ss_pred cCCCccccccccCCCCccCcccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (474)
...... ......||+.|+|||++. +..++.++|||||||++|+|++|..||.+... .......+......
T Consensus 172 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~ 244 (289)
T 3og7_A 172 RWSGSH-----QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIEMVGRGSLS 244 (289)
T ss_dssp -----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC--HHHHHHHHHHTSCC
T ss_pred cccccc-----cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch--HHHHHHHhcccccC
Confidence 322211 123457999999999987 66789999999999999999999999987543 23334444444444
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
.....+...+|+++.+||..||..||++||++.+|++.|+++.
T Consensus 245 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 4444455678999999999999999999999999999998874
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=362.48 Aligned_cols=262 Identities=16% Similarity=0.206 Sum_probs=201.8
Q ss_pred cCCcEEEeeeeeec--CceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 5 VGNKFRLGRKIGSG--SFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 5 i~~~y~i~~~LG~G--~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
-+++|+++++||+| +||.||+|++..+++.||||++...... ..+.+|+.+++.++|++ |..+..++......
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPN-IVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTT-BCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCC-CCcEeEEEEECCEE
Confidence 35789999999999 9999999999999999999998754322 34778999999998655 44555566678889
Q ss_pred EEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 79 VLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
++||||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||++...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGGCEEC
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccccceee
Confidence 9999999 78999999754 3569999999999999999999999999999999999999 47889999999998765
Q ss_pred ccCCCccccccccCCCCccCccccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc---
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--- 231 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~--- 231 (474)
..................||..|+|||++.+ ..++.++|||||||++|||++|+.||.+................
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 258 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLL 258 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccc
Confidence 4433222111122344589999999999988 57999999999999999999999999875543322111000000
Q ss_pred -----------------------------------cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 232 -----------------------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 232 -----------------------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
............+++++.+||..||..||++||++.+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell 332 (389)
T 3gni_B 259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL 332 (389)
T ss_dssp -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence 000001123356789999999999999999999988764
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=390.65 Aligned_cols=270 Identities=19% Similarity=0.239 Sum_probs=224.9
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEecc-----CCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~-----~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
..++|+++++||+|+||.||+|++..+++.||||+++. ......+..|..++..+.++++|..+..+.......|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 35689999999999999999999999999999998764 2344568889999999988999999988888899999
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
|||||+ |++|.+++... +.+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+....
T Consensus 419 lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEECCC
T ss_pred EEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeecccc
Confidence 999999 88999999854 579999999999999999999999999999999999999 4788999999999986443
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
... .....+||+.|+|||++.+..++.++|||||||+||||++|..||.+. +..+.+..+......
T Consensus 495 ~~~-------~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~---~~~~~~~~i~~~~~~---- 560 (674)
T 3pfq_A 495 DGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIMEHNVA---- 560 (674)
T ss_dssp TTC-------CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHSSCCC----
T ss_pred CCc-------ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC---CHHHHHHHHHhCCCC----
Confidence 322 124578999999999999999999999999999999999999999874 445566666654433
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCH--HHHHHHHHHHHHHcCCCCCCcccccccccccccc
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDY--AYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQV 300 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~--~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~~ 300 (474)
++..+++++.+||..||..||++||++ ..+.++++ ..+...+||+.+...+.++
T Consensus 561 -~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~-------h~ff~~i~w~~l~~~~~~p 616 (674)
T 3pfq_A 561 -YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE-------HAFFRYIDWEKLERKEIQP 616 (674)
T ss_dssp -CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS-------SGGGSSCCHHHHTTTCSCC
T ss_pred -CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc-------CccccCCCHHHHHhCCCCC
Confidence 235789999999999999999999997 22233333 3445568999876655443
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=368.26 Aligned_cols=258 Identities=21% Similarity=0.292 Sum_probs=210.1
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.++|++.++||+|+||.||+|.+..+++.||||++...... ..+.+|+++++.++|++ |..+..++......++||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN-IVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTT-BCCEEEEECSSSSCEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCC-EEEEEEEEecCCCcEEEE
Confidence 46899999999999999999999889999999998654322 35788999999998655 455555556677789999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGCEECTTSEE
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---cCCCcEEECcCCCceecCCCce
Confidence 999 789999998666679999999999999999999999999999999999999 4778999999999986543221
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
.. ......++..|+|||++.+..++.++|||||||+||||++ |..||.+... .+....+...... ..
T Consensus 269 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~---~~~~~~~~~~~~~----~~ 336 (377)
T 3cbl_A 269 AA-----SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN---QQTREFVEKGGRL----PC 336 (377)
T ss_dssp EC-----CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH---HHHHHHHHTTCCC----CC
T ss_pred ee-----cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CC
Confidence 10 1122346788999999998899999999999999999998 9999987543 2222222222111 12
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
+..+|+++.+||..||+.||++||++.+|++.|+++..+
T Consensus 337 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 337 PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 356899999999999999999999999999999998754
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=353.94 Aligned_cols=254 Identities=21% Similarity=0.334 Sum_probs=196.8
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc-----hHHHHHHHHHHHhcCCCCCceeEEEeEeC---
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGTGIPNLRWFGVEG--- 75 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~l~~E~~il~~l~~~~~i~~l~~~~~~~--- 75 (474)
.+.++|++.++||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.++|++++..+..+....
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 88 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 88 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTE
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCC
Confidence 4678999999999999999999999999999999998764322 24788999999998776666665544332
Q ss_pred CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 76 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 76 ~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
...|+||||+ |++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---TTSCEEECCCSCC-
T ss_pred cccEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc---CCCCEEEeeccCcc
Confidence 2459999999 7899999974 35799999999999999999999999999999999999995 67889999999998
Q ss_pred ccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (474)
.+....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ............
T Consensus 165 ~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~---~~~~~~~~~~~~- 236 (311)
T 3ork_A 165 AIADSGNSV----TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---VSVAYQHVREDP- 236 (311)
T ss_dssp ---------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHHHCCC-
T ss_pred ccccccccc----ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCCC-
Confidence 765432211 122345799999999999999999999999999999999999999987543 222222222222
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 269 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (474)
.........+++++.++|..||+.||++||+..++
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~ 271 (311)
T 3ork_A 237 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAE 271 (311)
T ss_dssp CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHH
T ss_pred CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHH
Confidence 23334456799999999999999999999975543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=357.88 Aligned_cols=259 Identities=22% Similarity=0.347 Sum_probs=210.0
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEc-----CCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCC
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 76 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (474)
..++|++++.||+|+||.||+|.+. .+++.||||++..... ...+.+|+.+++.++|+ +|..+..++....
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp-~iv~~~~~~~~~~ 123 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP-NIVKLLGVCAVGK 123 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCT-TBCCEEEEECSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCC-CEEEEEEEEccCC
Confidence 3578999999999999999999987 3558999999875433 24588999999999755 4555555556677
Q ss_pred EEEEEEecC-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 011945 77 YNVLVIDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 132 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~~-----------------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~ 132 (474)
..++||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~ 203 (343)
T 1luf_A 124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203 (343)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcc
Confidence 889999999 779999997542 56999999999999999999999999999999999
Q ss_pred cEEeeeCCCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCC
Q 011945 133 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSL 211 (474)
Q Consensus 133 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~ 211 (474)
|||++ .++.+||+|||+++....... +.......||+.|+|||++.+..++.++|||||||++|||++ |..
T Consensus 204 NIl~~---~~~~~kl~Dfg~~~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 275 (343)
T 1luf_A 204 NCLVG---ENMVVKIADFGLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 275 (343)
T ss_dssp GEEEC---GGGCEEECCCSCHHHHTGGGC-----BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred eEEEC---CCCeEEEeecCCCcccccCcc-----ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCC
Confidence 99994 678999999999986644321 112234578999999999999999999999999999999999 999
Q ss_pred CCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 212 PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 212 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
||.+... .+.+..+...... .+...+|+++.++|..||..||++||++.+|.+.|+++..+
T Consensus 276 p~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 276 PYYGMAH---EEVIYYVRDGNIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp TTTTSCH---HHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred cCCCCCh---HHHHHHHhCCCcC----CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 9987533 3333444333221 23457899999999999999999999999999999988643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=358.18 Aligned_cols=257 Identities=19% Similarity=0.209 Sum_probs=206.6
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeC----CE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEG----DY 77 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~----~~ 77 (474)
++++|+++++||+|+||.||+|.+..+++.||||++...... ..+.+|+++++.++|++++..+..+.... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 468999999999999999999999999999999998654332 45789999999999777666665554332 46
Q ss_pred EEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 78 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 78 ~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
.++|||+++++|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...
T Consensus 105 ~~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 105 VYIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred EEEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE---CCCCCEEEEeCcceEecC
Confidence 899999999999999974 469999999999999999999999999999999999999 477899999999998765
Q ss_pred cCCCccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc----
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK---- 232 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~---- 232 (474)
...... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+..+....
T Consensus 180 ~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 180 PDHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp GGGCBC----CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred CCCCcc----ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 432211 112446899999999987654 58999999999999999999999998866554444433222111
Q ss_pred -------------------ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 233 -------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 233 -------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.......+...+++++.+||..||..||++||++.+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 312 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 312 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 11123344567889999999999999999999977663
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=366.99 Aligned_cols=254 Identities=19% Similarity=0.247 Sum_probs=203.5
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHhcCC-----CCCceeEEEeEeCCE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGG-----TGIPNLRWFGVEGDY 77 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~l~~E~~il~~l~~~-----~~i~~l~~~~~~~~~ 77 (474)
.+.++|+++++||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.+.+. ++|..+..++.....
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 456789999999999999999999999999999999865422 34578899999998643 356666667777889
Q ss_pred EEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCe--EEEEecCCcc
Q 011945 78 NVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ--VYIIDFGLAK 154 (474)
Q Consensus 78 ~~lv~e~~g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~--vkL~DFGla~ 154 (474)
.++|||+++++|.+++.... ..+++..++.|+.||+.||.|||++|||||||||+||||+ .++. +||+|||++.
T Consensus 174 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~---~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 174 ICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK---QQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEES---STTSCCEEECCCTTCE
T ss_pred EEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc---cCCCcceEEeecccce
Confidence 99999999999999998544 4599999999999999999999999999999999999995 4444 9999999997
Q ss_pred ccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (474)
...... ....||+.|+|||++.+..++.++|||||||+||||++|..||.+.........+.........
T Consensus 251 ~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~ 320 (429)
T 3kvw_A 251 YEHQRV----------YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ 320 (429)
T ss_dssp ETTCCC----------CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred ecCCcc----------cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 544321 3458999999999999999999999999999999999999999875443322222221110000
Q ss_pred ---------------------------------------------------chHHHHhcCCcHHHHHHHHHHhcCCCCCC
Q 011945 235 ---------------------------------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDK 263 (474)
Q Consensus 235 ---------------------------------------------------~~~~~l~~~~p~~l~~li~~cl~~dp~~R 263 (474)
.....+....++++.+||..||..||++|
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R 400 (429)
T 3kvw_A 321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR 400 (429)
T ss_dssp HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence 00111223447889999999999999999
Q ss_pred CCHHHHH
Q 011945 264 PDYAYLK 270 (474)
Q Consensus 264 Pt~~~l~ 270 (474)
||+++++
T Consensus 401 pta~e~L 407 (429)
T 3kvw_A 401 MTPGQAL 407 (429)
T ss_dssp CCHHHHH
T ss_pred CCHHHHh
Confidence 9987774
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=359.95 Aligned_cols=253 Identities=19% Similarity=0.263 Sum_probs=197.8
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
++|+++++||+|+||+||+|.+..+++.||||++...... ..+.+|+.+++.++|+ +|..+..++......++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA-NIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCT-TBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCC-CCCeeeeEEeeCCEEEEEec
Confidence 6899999999999999999999999999999988643321 2356799999999855 45555556667788899999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 84 ~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
|++++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~-- 155 (324)
T 3mtl_A 81 YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTK-- 155 (324)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---CTTCCEEECSSSEEECC-------
T ss_pred ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---CCCCCEEEccCcccccccCCcc--
Confidence 99999999998777789999999999999999999999999999999999999 4778999999999986543322
Q ss_pred ccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc---------
Q 011945 164 HIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--------- 233 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--------- 233 (474)
......||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..+.....
T Consensus 156 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 156 -----TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred -----ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhc
Confidence 1234578999999999987 5689999999999999999999999988554333333322221111
Q ss_pred -------------cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 234 -------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 234 -------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
..........+++++.+||..||+.||++||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 280 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAM 280 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHh
Confidence 1112233356789999999999999999999987764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=372.65 Aligned_cols=249 Identities=20% Similarity=0.246 Sum_probs=193.6
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEe-----C
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVE-----G 75 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~-----~ 75 (474)
+.++|+++++||+|+||+||+|.+..+++.||||++.... ....+.+|+.+++.++|++++..+..+... .
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 4578999999999999999999999999999999986432 234578999999999877777666665433 2
Q ss_pred CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 76 ~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
...||||||++++|.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||+|+.
T Consensus 140 ~~~~lv~E~~~~~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 140 QDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART 213 (464)
T ss_dssp CEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCCC--
T ss_pred CeEEEEEeCCCCCHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCEEEEEEEeeee
Confidence 4679999999888888775 359999999999999999999999999999999999999 4788999999999987
Q ss_pred cccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccc
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
...... ....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.... ..+..+.......
T Consensus 214 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~---~~~~~i~~~lg~p 282 (464)
T 3ttj_A 214 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIEQLGTP 282 (464)
T ss_dssp ---CCC--------C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCSC
T ss_pred cCCCcc--------cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcCCC
Confidence 654321 23468999999999999999999999999999999999999999875432 2233322211100
Q ss_pred -------------------------hHHHHhcC------------CcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 236 -------------------------SIEALCRG------------YPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 236 -------------------------~~~~l~~~------------~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
..+.+... .++++.+||.+||..||++|||+++++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 354 (464)
T 3ttj_A 283 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 354 (464)
T ss_dssp CHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 00111100 156799999999999999999977663
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=366.16 Aligned_cols=263 Identities=18% Similarity=0.243 Sum_probs=197.1
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeEeC----
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEG---- 75 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~~~---- 75 (474)
.+.++|++++.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++|++++..+..+....
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 4789999999999999999999999999999999998654322 45889999999999766666665554332
Q ss_pred CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 76 ~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
...|+|||+++++|.+++. ....+++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+|+.
T Consensus 103 ~~~~lv~e~~~~~L~~~~~-~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 103 DELYIVLEIADSDLKKLFK-TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLART 178 (432)
T ss_dssp CCEEEEEECCSEEHHHHHH-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred CeEEEEEecCCcCHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEccCCCccc
Confidence 5689999999999999997 34579999999999999999999999999999999999999 4778999999999987
Q ss_pred cccCCCcccc---------------ccccCCCCccCccccccccc-cCCCCCchhhHHHHHHHHHHHHhCCCCCC-----
Q 011945 156 YRDTATHQHI---------------PYRENKNLTGTARYASMNTH-LGIEQSRRDDLESLGYVLMYFLRGSLPWQ----- 214 (474)
Q Consensus 156 ~~~~~~~~~~---------------~~~~~~~~~GT~~Y~APE~~-~~~~~s~ksDIwSlGvil~elltG~~Pf~----- 214 (474)
.......... ........+||+.|+|||++ .+..++.++||||||||||||++|..||.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~ 258 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence 6543221000 00112557899999999986 45569999999999999999998544443
Q ss_pred ------CCCcC--------------cHHHHHHHHhh--------------------------ccccchHHHHhcCCcHHH
Q 011945 215 ------GLKAG--------------TKKQKYEKISE--------------------------KKVSTSIEALCRGYPTEF 248 (474)
Q Consensus 215 ------~~~~~--------------~~~~~~~~i~~--------------------------~~~~~~~~~l~~~~p~~l 248 (474)
+.... .....+..+.. .............+++++
T Consensus 259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 338 (432)
T 3n9x_A 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG 338 (432)
T ss_dssp CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence 32100 00111111111 111122333446789999
Q ss_pred HHHHHHHhcCCCCCCCCHHHHH
Q 011945 249 ASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 249 ~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.+||.+||..||++||++++++
T Consensus 339 ~dLl~~mL~~dP~~R~ta~e~L 360 (432)
T 3n9x_A 339 INLLESMLKFNPNKRITIDQAL 360 (432)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHHHHHhcCCcccCCCHHHHh
Confidence 9999999999999999977663
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=355.76 Aligned_cols=259 Identities=19% Similarity=0.241 Sum_probs=200.2
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeE----EEEEEeccC---CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCC
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIKLENVK---TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 76 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~----vAvK~~~~~---~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (474)
...++|+++++||+|+||+||+|++..+++. ||+|.+... .....+.+|+.+++.++|++++..+ .++..+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~-~~~~~~~ 90 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL-GICLTST 90 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEE-EEEESSS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEE-EEEecCC
Confidence 3457899999999999999999998877765 477765432 2345689999999999865555444 4455555
Q ss_pred EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 77 YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 77 ~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
..++++++.+++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.+
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTHHHHH
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEEC---CCCCEEEccCcceeEc
Confidence 5444444449999999987777899999999999999999999999999999999999995 6789999999999876
Q ss_pred ccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccc
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
....... ......||..|+|||++.+..++.++|||||||++|||++ |..||.+.........+. .....
T Consensus 168 ~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~---~~~~~- 238 (327)
T 3poz_A 168 GAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---KGERL- 238 (327)
T ss_dssp TTTCC------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---TTCCC-
T ss_pred cCCcccc-----cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH---cCCCC-
Confidence 5443211 1233467889999999999999999999999999999999 999998865544332222 11111
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
.....++.++.+++..||..||++||++.+|++.|+.+..
T Consensus 239 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 239 ---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ---CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred ---CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1234578999999999999999999999999999988863
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=342.19 Aligned_cols=251 Identities=21% Similarity=0.239 Sum_probs=208.4
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC--CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
+.++|++.++||+|+||.||+|.+..++..||+|++... .....+.+|+.+++.++|+ +|..+..++......++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHP-NIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCT-TBCCEEEEEECSSEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCC-CEeeEEEEEecCCeEEEEE
Confidence 567899999999999999999999999999999987653 3446789999999999754 5555656667888899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
||+ +++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+..++.++.+||+|||++..+.....
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 86 ELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp ECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred eccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 999 7899998874 45699999999999999999999999999999999999996555778999999999987654332
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
.....||+.|+|||++.+. ++.++|||||||++|+|++|..||.... ....+..+......... ...
T Consensus 165 --------~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~-~~~ 231 (277)
T 3f3z_A 165 --------MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT---DSEVMLKIREGTFTFPE-KDW 231 (277)
T ss_dssp --------BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCH-HHH
T ss_pred --------hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCCc-hhh
Confidence 2345799999999998765 8999999999999999999999998743 33444444444433322 233
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
..+++++.++|..||+.||++||++.+++
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~R~s~~~~l 260 (277)
T 3f3z_A 232 LNVSPQAESLIRRLLTKSPKQRITSLQAL 260 (277)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred hcCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 57899999999999999999999987774
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=357.62 Aligned_cols=263 Identities=19% Similarity=0.212 Sum_probs=203.3
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHhcCCCCCceeEEEeEeC---CEEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEG---DYNVLV 81 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~l~~E~~il~~l~~~~~i~~l~~~~~~~---~~~~lv 81 (474)
.++|+++++||+|+||+||+|++. ++.||||++..... ......|+.+++.++|++++..+..+.... ...++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 468999999999999999999864 89999999865432 234566888898998777666666655443 347999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC----------CccccCCCCCcEEeeeCCCCCeEEEEec
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK----------SFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~----------gIiHrDIKP~NILl~~~~~~~~vkL~DF 150 (474)
|||+ +++|.+++.. ..+++..++.|+.||+.||.|||+. ||+||||||+|||+ +..+.+||+||
T Consensus 101 ~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~kL~DF 175 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIADF 175 (322)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTTCCEEECCC
T ss_pred EecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCCCeEEEccC
Confidence 9999 7799999974 4699999999999999999999999 99999999999999 47789999999
Q ss_pred CCccccccCCCccccccccCCCCccCccccccccccCC-----CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCc-----
Q 011945 151 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-----EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT----- 220 (474)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-----~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~----- 220 (474)
|+++.+...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.....
T Consensus 176 g~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 176 GLALKFEAGKSA-----GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp TTCEEECTTSCC-----CCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred CcccccccccCc-----cccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 999876554321 112346899999999999873 45678999999999999999999997643321
Q ss_pred --------HHHHHHHHhhccccchHHHHh--cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 221 --------KKQKYEKISEKKVSTSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 221 --------~~~~~~~i~~~~~~~~~~~l~--~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
.......+............. ...++++.+||..||+.||++||++.+|++.|+++....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~ 320 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT 320 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 111122222222211111111 123467999999999999999999999999999987654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=355.81 Aligned_cols=261 Identities=20% Similarity=0.264 Sum_probs=209.2
Q ss_pred CCcEEEeeeeeecCceEEEEEEEc-----CCCeEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
.++|++.+.||+|+||.||+|.+. .+++.||||++.... ....+.+|+.+++.+..|++|..+..++.....
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 468999999999999999999973 456789999986432 345689999999999556667777667777788
Q ss_pred EEEEEecC-CCCHHHHHHHcCC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcE
Q 011945 78 NVLVIDLL-GPSLEDLFNFCSR----------------------KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNF 134 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~~~----------------------~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NI 134 (474)
.++||||+ +++|.+++..... .+++..++.|+.||+.||.|||++||+||||||+||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 203 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 203 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhE
Confidence 89999999 7899999975432 379999999999999999999999999999999999
Q ss_pred EeeeCCCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCC
Q 011945 135 LMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPW 213 (474)
Q Consensus 135 Ll~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf 213 (474)
||+ .++.+||+|||++..+....... ......||+.|+|||++.+..++.++|||||||+||||++ |..||
T Consensus 204 ll~---~~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 204 LVT---HGKVVKICDFGLARDIMSDSNYV-----VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp EEE---TTTEEEECCCGGGSCGGGCTTSE-----EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred EEc---CCCcEEeCCCccCcccccCccce-----eccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 995 77899999999998765433211 1234567889999999999999999999999999999998 99999
Q ss_pred CCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 214 QGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 214 ~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
.+....... ..+....... .....+++++.+||..||..||++||++.+|++.|+.++...
T Consensus 276 ~~~~~~~~~---~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 276 PGIPVDANF---YKLIQNGFKM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp TTCCCSHHH---HHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred ccCCcHHHH---HHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 876543222 1222211111 123467899999999999999999999999999999987543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=370.19 Aligned_cols=262 Identities=19% Similarity=0.266 Sum_probs=204.1
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
..++|+++++||+|+||.||+|.+..+++.||||++... .....+..|+.+++.++|+ +|..+..++......+
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP-FLTALKYSFQTHDRLC 224 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCT-TSCCEEEEEEETTEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCC-eEeeEEEEEeeCCEEE
Confidence 346899999999999999999999999999999987642 2234577899999888854 5556666667788899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs-~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
|||||+ +++|.+++.. ...+++..++.|+.||+.||+|||+ +|||||||||+|||| +.++.+||+|||+|+...
T Consensus 225 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp EEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCCTTC
T ss_pred EEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCceecc
Confidence 999999 7899999874 4579999999999999999999998 999999999999999 477899999999998644
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
.... .....+||+.|+|||++.+..++.++|||||||+||||++|..||.+.. ....+..+......
T Consensus 301 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~---~~~~~~~i~~~~~~--- 367 (446)
T 4ejn_A 301 KDGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HEKLFELILMEEIR--- 367 (446)
T ss_dssp C------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC---
T ss_pred CCCc-------ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC---HHHHHHHHHhCCCC---
Confidence 3322 1245689999999999999999999999999999999999999998743 33444444433322
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCcccccccccc
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 296 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 296 (474)
++..+++++.+||..||..||++|| +++++ |++. +...++|......
T Consensus 368 --~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~el---l~hp-------~f~~~~~~~~~~~ 419 (446)
T 4ejn_A 368 --FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEI---MQHR-------FFAGIVWQHVYEK 419 (446)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHH---HTSG-------GGTTCCHHHHHTT
T ss_pred --CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHH---HhCc-------cccCCCHHHHhhC
Confidence 2356889999999999999999999 87665 3333 3345678765443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=356.75 Aligned_cols=259 Identities=20% Similarity=0.223 Sum_probs=203.0
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEe-------
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVE------- 74 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~------- 74 (474)
.++|+++++||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.++|++++..+..+...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 4789999999999999999999999999999998754432 34688999999999976666666555432
Q ss_pred CCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 75 GDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 75 ~~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
....++||||++++|.+.+......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLAR 172 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCE
T ss_pred CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEccchhcc
Confidence 45789999999999999988666789999999999999999999999999999999999999 477899999999998
Q ss_pred ccccCCCccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (474)
.+........ .......||+.|+|||++.+. .++.++|||||||++|||++|..||.+.........+..+.....
T Consensus 173 ~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 173 AFSLAKNSQP---NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp ECCCCSSSSC---CCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccccc---cccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 7654322111 122456789999999999874 589999999999999999999999988554333333333222111
Q ss_pred cchHHHH------------------------hcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 234 STSIEAL------------------------CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 234 ~~~~~~l------------------------~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
....... ....++++.+||..||..||++||++++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 310 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 310 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHh
Confidence 1100000 001367899999999999999999987664
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=349.04 Aligned_cols=251 Identities=21% Similarity=0.298 Sum_probs=207.7
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC--------chHHHHHHHHHHHhcCCCCCceeEEEeEeC
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLQYEAKLYKILQGGTGIPNLRWFGVEG 75 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--------~~~l~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (474)
.+.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+.|++ |..+..++...
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~ 87 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN-VITLHDVYENR 87 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTT-BCCEEEEEECS
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCC-cceEEEEEecC
Confidence 345689999999999999999999999999999998765432 346899999999998655 44555566777
Q ss_pred CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCC----eEEEEec
Q 011945 76 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN----QVYIIDF 150 (474)
Q Consensus 76 ~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~----~vkL~DF 150 (474)
...++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++ .+||+||
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~---~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL---DKNIPIPHIKLIDF 163 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES---CTTSSSCCEEECCC
T ss_pred CEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEe---cCCCCcCCEEEccC
Confidence 8899999999 8899999973 55799999999999999999999999999999999999995 344 7999999
Q ss_pred CCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhh
Q 011945 151 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (474)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (474)
|++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ....+..+..
T Consensus 164 g~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i~~ 232 (321)
T 2a2a_A 164 GLAHEIEDGVE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANITS 232 (321)
T ss_dssp TTCEECCTTCC--------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHT
T ss_pred ccceecCcccc--------ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHh
Confidence 99987654322 234579999999999999999999999999999999999999998743 3344444444
Q ss_pred ccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
..... ...+...+++++.+||..||..||++||++.++++
T Consensus 233 ~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 233 VSYDF-DEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp TCCCC-CHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ccccc-ChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 33322 23445678999999999999999999999887753
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=351.85 Aligned_cols=265 Identities=20% Similarity=0.270 Sum_probs=202.9
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEc---CCCeEEEEEEeccCC------CchHHHHHHHHHHHhcCCCCCceeEEEeEe
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVE 74 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAvK~~~~~~------~~~~l~~E~~il~~l~~~~~i~~l~~~~~~ 74 (474)
...++|++++.||+|+||.||+|++. .+++.||||++.... ....+.+|+.+++.++|++ |..+..++..
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~ 92 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF-IVDLIYAFQT 92 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTT-BCCEEEEEEC
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCC-ccceeEEEEc
Confidence 44578999999999999999999985 689999999986532 2345788999999998655 4555555667
Q ss_pred CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCc
Q 011945 75 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (474)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (474)
....++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 93 GGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGLC 168 (327)
T ss_dssp SSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCCSCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeCCcc
Confidence 77889999999 7899999974 3569999999999999999999999999999999999999 47789999999999
Q ss_pred cccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc
Q 011945 154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (474)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (474)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ....+..+.....
T Consensus 169 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~i~~~~~ 238 (327)
T 3a62_A 169 KESIHDGT-------VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN---RKKTIDKILKCKL 238 (327)
T ss_dssp -----------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHTCC
T ss_pred cccccCCc-------cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCC
Confidence 86543222 1234689999999999999999999999999999999999999998743 3344444444332
Q ss_pred cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCCccccccccc
Q 011945 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDLFIREGFQFDYVFDWTILKY 295 (474)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~--~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 295 (474)
. +...+++++.+||..||..||++||++. .+.+++.+.| ...++|.....
T Consensus 239 ~-----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~-------f~~~~~~~~~~ 290 (327)
T 3a62_A 239 N-----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF-------FRHINWEELLA 290 (327)
T ss_dssp C-----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG-------GSSCCHHHHHT
T ss_pred C-----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc-------ccCCCHHHHhh
Confidence 2 2356789999999999999999999433 3444455544 33467876543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=342.52 Aligned_cols=255 Identities=17% Similarity=0.219 Sum_probs=209.6
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
..++|++++.||+|+||.||+|.+. ++..||||++.... ....+.+|+.+++.++|+ +|..+..++......++|||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHP-KLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCT-TBCCEEEEECSSSSEEEEEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCC-CEeeEEEEEccCCceEEEEE
Confidence 4578999999999999999999874 67789999987654 345689999999999865 45555555667777899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
|+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.........
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---CTTCCEEECCTTCEEECCTTCEE
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---CCCCCEEEccCccceecchhhhh
Confidence 99 889999998766679999999999999999999999999999999999999 47789999999999876544321
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
......+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... ......+....... ..
T Consensus 161 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~~----~~ 227 (268)
T 3sxs_A 161 ------SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN---SEVVLKVSQGHRLY----RP 227 (268)
T ss_dssp ------ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHHHHHHTTCCCC----CC
T ss_pred ------cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh---HHHHHHHHcCCCCC----CC
Confidence 1234467889999999999889999999999999999999 9999987543 23333333222111 12
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
..+++++.+++..||..||++||++.++++.|+.+.
T Consensus 228 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 228 HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 456899999999999999999999999999988764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=344.93 Aligned_cols=252 Identities=25% Similarity=0.355 Sum_probs=199.6
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
.+.++|.+.++||+|+||.||+|.+..+++.||||++.... ....+.+|+++++.++|++ |..+..++......++
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~~~~~~l 97 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPN-IIKIFEVFEDYHNMYI 97 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTT-BCCEEEEEECSSEEEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCch-HHhHHHheecCCeEEE
Confidence 45678999999999999999999999999999999876543 2367899999999998654 5555556677788999
Q ss_pred EEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 81 VIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~---~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
||||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++.++..+.+||+|||++..+
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 98 VMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp EECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred EEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 99999 77999988532 467999999999999999999999999999999999999965455688999999999866
Q ss_pred ccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccch
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (474)
..... .....||+.|+|||++. ..++.++|||||||++|||++|..||.+... ......+.......
T Consensus 178 ~~~~~--------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~---~~~~~~~~~~~~~~- 244 (285)
T 3is5_A 178 KSDEH--------STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL---EEVQQKATYKEPNY- 244 (285)
T ss_dssp -----------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCC-
T ss_pred CCccc--------CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH---HHHHhhhccCCccc-
Confidence 54322 23457999999999986 4689999999999999999999999987543 22222222222111
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
...+..+++++.+||..||..||++||++.+++
T Consensus 245 -~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l 277 (285)
T 3is5_A 245 -AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVL 277 (285)
T ss_dssp -CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHH
T ss_pred -ccccCcCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 112345789999999999999999999988774
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=357.02 Aligned_cols=260 Identities=20% Similarity=0.223 Sum_probs=197.5
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
..++|+++++||+|+||+||+|++..+++.||||++.... ....+.+|+.+++.++|++ |..+..++......++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTT-BCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCC-CCcEEEEEeeCCEEEEEEE
Confidence 3578999999999999999999999999999999886543 3567899999999998654 5555556667888999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
|+ +++|.+++.. .+.+++..++.|+.||+.||.|||++||+||||||+|||++. +..+.+||+|||+++.......
T Consensus 97 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~-~~~~~~kl~Dfg~a~~~~~~~~- 173 (361)
T 3uc3_A 97 YASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQ- 173 (361)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECS-SSSCCEEECCCCCC---------
T ss_pred eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC-CCCceEEEeecCccccccccCC-
Confidence 99 8899999874 347999999999999999999999999999999999999952 1233599999999974432221
Q ss_pred cccccccCCCCccCccccccccccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCcCc-HHHHHHHHhhccccchHHHH
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRR-DDLESLGYVLMYFLRGSLPWQGLKAGT-KKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~k-sDIwSlGvil~elltG~~Pf~~~~~~~-~~~~~~~i~~~~~~~~~~~l 240 (474)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+..... ....+..+.......+ .
T Consensus 174 -------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~---~ 243 (361)
T 3uc3_A 174 -------PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP---D 243 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCC---T
T ss_pred -------CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCC---C
Confidence 234579999999999998888655 899999999999999999998754432 2333333333322211 1
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 281 (474)
...+++++.+||.+||..||++||++.+| |++.|....
T Consensus 244 ~~~~s~~~~~li~~~L~~dP~~Rps~~el---l~hp~f~~~ 281 (361)
T 3uc3_A 244 DIRISPECCHLISRIFVADPATRISIPEI---KTHSWFLKN 281 (361)
T ss_dssp TSCCCHHHHHHHHHHSCSCTTTSCCHHHH---HTSHHHHTT
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHH---HhCcchhcC
Confidence 13578999999999999999999998776 556555443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=364.44 Aligned_cols=252 Identities=21% Similarity=0.230 Sum_probs=206.4
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
+.++|+++++||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.|+|++ |..+..++......++||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK-LINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTT-BCCEEEEEECSSEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcC-CCeEEEEEEeCCEEEEEE
Confidence 45689999999999999999999999999999999875432 335889999999998554 555555667788899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. +..+.+||+|||+++.+.....
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSC
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec-CCCCceEEEecccceecCCCcc
Confidence 999 88999998755567999999999999999999999999999999999999952 2356899999999987654322
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
. ....||+.|+|||++.+..++.++|||||||++|||++|..||.+.. ....+..+........ ....
T Consensus 207 ~--------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~i~~~~~~~~-~~~~ 274 (387)
T 1kob_A 207 V--------KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQNVKRCDWEFD-EDAF 274 (387)
T ss_dssp E--------EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHCCCCCC-SSTT
T ss_pred e--------eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCC-cccc
Confidence 1 23479999999999999999999999999999999999999998743 3334444433332211 1233
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
..+++++.+||..||..||++||++.+++
T Consensus 275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell 303 (387)
T 1kob_A 275 SSVSPEAKDFIKNLLQKEPRKRLTVHDAL 303 (387)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence 56899999999999999999999987764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=359.89 Aligned_cols=250 Identities=20% Similarity=0.292 Sum_probs=196.6
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeC----
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEG---- 75 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~---- 75 (474)
.+.++|++++.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+++.++|++++..+..+....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 356889999999999999999999999999999999855432 235789999999999776666666554432
Q ss_pred -CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 76 -DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 76 -~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
...|+||||++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 102 ~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 102 FTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLAR 176 (367)
T ss_dssp CCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred CceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---cCCCCEEEEeeeccc
Confidence 34699999999999999984 579999999999999999999999999999999999999 477899999999998
Q ss_pred ccccCCCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (474)
..... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||.+.... ..+..+.....
T Consensus 177 ~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~l~~i~~~~g 243 (367)
T 1cm8_A 177 QADSE----------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL---DQLKEIMKVTG 243 (367)
T ss_dssp ECCSS----------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHC
T ss_pred ccccc----------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHhcC
Confidence 75432 134588999999999988 67999999999999999999999999875432 22222221111
Q ss_pred c--------------------------chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 234 S--------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 234 ~--------------------------~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
. .....+...+++++.+||.+||..||++||+++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0 1112233467899999999999999999999877643
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=349.84 Aligned_cols=259 Identities=17% Similarity=0.281 Sum_probs=210.3
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEc-----CCCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCC
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGD 76 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (474)
..++|++.+.||+|+||.||+|.+. .+++.||||++...... ..+.+|+.+++.++|++ |..+..++....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~~~ 99 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH-VIKLYGACSQDG 99 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTT-BCCEEEEECSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCc-eeeEEEEEecCC
Confidence 3578999999999999999999984 45589999998754332 35788999999997554 555555566677
Q ss_pred EEEEEEecC-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 011945 77 YNVLVIDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPD 132 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~~-----------------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~ 132 (474)
..++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~ 179 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAAR 179 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchh
Confidence 789999999 789999997543 23899999999999999999999999999999999
Q ss_pred cEEeeeCCCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCC
Q 011945 133 NFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSL 211 (474)
Q Consensus 133 NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~ 211 (474)
|||++ .++.+||+|||+++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |..
T Consensus 180 NIli~---~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 251 (314)
T 2ivs_A 180 NILVA---EGRKMKISDFGLSRDVYEEDSYV-----KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 251 (314)
T ss_dssp GEEEE---TTTEEEECCCTTCEECTTTSCEE-----CSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred eEEEc---CCCCEEEccccccccccccccce-----eccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 99995 67899999999998765433211 1234567899999999999899999999999999999999 999
Q ss_pred CCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 212 PWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 212 Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
||.+........ .+..... ......+++++.++|..||+.||++||++.+|++.|++++.+
T Consensus 252 p~~~~~~~~~~~---~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 252 PYPGIPPERLFN---LLKTGHR----MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp SSTTCCGGGHHH---HHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCHHHHHH---HhhcCCc----CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 998765543322 2222211 112357899999999999999999999999999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=345.59 Aligned_cols=254 Identities=21% Similarity=0.253 Sum_probs=195.3
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
+.++|+++++||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++|++ |..+..+.......++
T Consensus 1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPN-LVNLLEVFRRKRRLHL 79 (311)
T ss_dssp --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTT-BCCEEEEEEETTEEEE
T ss_pred CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCC-ccchhheeecCCeEEE
Confidence 357899999999999999999999999999999987655433 34778999999998655 5555555677888999
Q ss_pred EEecCC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLLG-PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~g-~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
||||+. ++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 80 v~e~~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 80 VFEYCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp EEECCSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC--
T ss_pred EEEeCCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---cCCCCEEEeeCCCchhccCc
Confidence 999994 55666655 45679999999999999999999999999999999999999 47789999999999876543
Q ss_pred CCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc-----
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV----- 233 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~----- 233 (474)
... .....||..|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+........
T Consensus 156 ~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (311)
T 4agu_A 156 SDY-------YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 228 (311)
T ss_dssp -----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccc-------cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccc
Confidence 221 134578999999999987 5689999999999999999999999987654333322222211110
Q ss_pred ------------------cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 234 ------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 234 ------------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
..........+++++.+||..||..||++||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 283 (311)
T 4agu_A 229 VFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283 (311)
T ss_dssp HHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHH
T ss_pred ccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHh
Confidence 0112223356889999999999999999999987764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=346.02 Aligned_cols=260 Identities=20% Similarity=0.327 Sum_probs=215.0
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
..++|++.++||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++|++++ .+..++......++|||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~-~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV-QLLGVCTREPPFYIITE 89 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBC-CEEEEECSSSSEEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEe-eEEEEEccCCCEEEEEE
Confidence 45789999999999999999999999999999999875543 35688999999999865544 55555666777899999
Q ss_pred cC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 84 ~~-g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
++ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++........
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~~l~Dfg~~~~~~~~~~ 166 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTY 166 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEEC---GGGCEEECCCCGGGTSCSSSS
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEc---CCCCEEEccCccceeccCCcc
Confidence 99 689999998643 4599999999999999999999999999999999999994 678999999999987654332
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
. ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.........+. ..... ..
T Consensus 167 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~---~~~~~----~~ 233 (288)
T 3kfa_A 167 T------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---KDYRM----ER 233 (288)
T ss_dssp E------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---TTCCC----CC
T ss_pred c------cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh---ccCCC----CC
Confidence 1 1234467889999999999999999999999999999999 999998765443332222 21111 12
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 281 (474)
...+|+++.+|+..||..||++||++.++++.|+.++.+..
T Consensus 234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~ 274 (288)
T 3kfa_A 234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274 (288)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 35688999999999999999999999999999999998764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=354.98 Aligned_cols=243 Identities=21% Similarity=0.311 Sum_probs=201.7
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc-----hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
+.|++++.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.++|++ |..+..++......++|
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN-TIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTT-BCCEEEEEEETTEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCC-EeeEEEEEEECCeEEEE
Confidence 4699999999999999999999999999999998654322 35789999999998655 55555566778899999
Q ss_pred EecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 82 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 82 ~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
|||+.++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 133 ~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 133 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTTCBSSSSB--
T ss_pred EecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEeeccCceecCCC--
Confidence 99999999999976777899999999999999999999999999999999999995 7789999999999765432
Q ss_pred ccccccccCCCCccCcccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
....||+.|+|||++. +..++.++|||||||++|||++|..||.+... ...+..+........
T Consensus 208 ---------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~---~~~~~~~~~~~~~~~-- 273 (348)
T 1u5q_A 208 ---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQNESPAL-- 273 (348)
T ss_dssp ---------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCCC--
T ss_pred ---------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcCCCCC--
Confidence 2457999999999985 46789999999999999999999999987533 223333333222111
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
....+++.+.+||..||..||++||++++|+
T Consensus 274 -~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll 304 (348)
T 1u5q_A 274 -QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 304 (348)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred -CCCCCCHHHHHHHHHHcccChhhCcCHHHHh
Confidence 1246789999999999999999999988774
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=351.01 Aligned_cols=258 Identities=17% Similarity=0.206 Sum_probs=203.5
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEE-cCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCC-----CCceeEEEeEeC
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTN-IQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGT-----GIPNLRWFGVEG 75 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~-~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~-----~i~~l~~~~~~~ 75 (474)
.++.++|+++++||+|+||.||+|.+ ..+++.||||++.... ....+.+|+.+++.+.+.+ ++..+..+....
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred CCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 46788999999999999999999998 5688999999986432 2345889999999998654 355666667788
Q ss_pred CEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCC-------------
Q 011945 76 DYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR------------- 141 (474)
Q Consensus 76 ~~~~lv~e~~g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~------------- 141 (474)
...++|||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++..+.
T Consensus 90 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 90 GHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 8999999999999999997543 36899999999999999999999999999999999999953211
Q ss_pred ---CCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 011945 142 ---ANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (474)
Q Consensus 142 ---~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~ 218 (474)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 239 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDEHH----------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS 239 (339)
T ss_dssp EESCCCEEECCCSSCEETTSCC----------CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred cccCCCceEeeCcccccCcccc----------ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 5679999999998644321 345899999999999999999999999999999999999999987554
Q ss_pred CcHHHHHHHHhhccccchH--------------------------HHH----------hcCCcHHHHHHHHHHhcCCCCC
Q 011945 219 GTKKQKYEKISEKKVSTSI--------------------------EAL----------CRGYPTEFASYFHYCRSLRFDD 262 (474)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~--------------------------~~l----------~~~~p~~l~~li~~cl~~dp~~ 262 (474)
......+..+......... ... ...+++++.+||..||..||++
T Consensus 240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~ 319 (339)
T 1z57_A 240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319 (339)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence 3333333332211100000 000 0123578999999999999999
Q ss_pred CCCHHHHH
Q 011945 263 KPDYAYLK 270 (474)
Q Consensus 263 RPt~~~l~ 270 (474)
||++.+++
T Consensus 320 Rpt~~ell 327 (339)
T 1z57_A 320 RITLREAL 327 (339)
T ss_dssp SCCHHHHT
T ss_pred ccCHHHHh
Confidence 99988774
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=353.09 Aligned_cols=255 Identities=24% Similarity=0.245 Sum_probs=195.9
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
...++|+++++||+|+||+||+|.+..+++.||||++..... ...+.+|+.+++.++| ++|..+..+...+...+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQH-RNIIELKSVIHHNHRLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCC-TTBCCEEEEEEETTEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCC-CCcceEEEEEecCCEEE
Confidence 345789999999999999999999999999999999865432 2346789999999975 55555666667888999
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeC--CCCCeEEEEecCCccccc
Q 011945 80 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 80 lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~--~~~~~vkL~DFGla~~~~ 157 (474)
+||||+.++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++.+ +..+.+||+|||+++.+.
T Consensus 110 lv~e~~~~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAENDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCSEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9999999999999974 4569999999999999999999999999999999999999632 245679999999998765
Q ss_pred cCCCccccccccCCCCccCccccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc---
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--- 233 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--- 233 (474)
.... ......||..|+|||++.+.. ++.++|||||||++|||++|..||.+.... ..+..+.....
T Consensus 189 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~~~~~~~~~~ 258 (329)
T 3gbz_A 189 IPIR-------QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI---DQLFKIFEVLGLPD 258 (329)
T ss_dssp ------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHHHCCCC
T ss_pred Cccc-------ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH---HHHHHHHHHhCCCc
Confidence 3322 123457899999999998754 899999999999999999999999875432 22222221100
Q ss_pred ----------------------cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 234 ----------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 234 ----------------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
......+...+++++.+||..||..||++||++++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 317 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL 317 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 0011122234789999999999999999999987764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=364.28 Aligned_cols=252 Identities=20% Similarity=0.211 Sum_probs=197.6
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEe-----CCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVE-----GDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~-----~~~~~lv 81 (474)
.+|++++.||+|+||.||+|++..+++.||||++.... ....+|+++++.|+|++++..+..+... ..+.++|
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv 131 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT--TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc--hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEee
Confidence 47999999999999999999999999999999876432 2345799999999977777766555332 2356799
Q ss_pred EecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 82 IDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 82 ~e~~g~sL~~li~~---~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
|||+.++|.+++.. ....+++..++.|+.||+.||.|||++||+||||||+||||+ .+.+.+||+|||+++.+..
T Consensus 132 ~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~--~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 132 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp EECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECCT
T ss_pred hhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEe--CCCCeEEeccchhhhhccc
Confidence 99999888887753 356799999999999999999999999999999999999996 3456899999999987654
Q ss_pred CCCccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc---
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS--- 234 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~--- 234 (474)
... .....||+.|+|||++.+. .++.++||||||||||||++|+.||.+....+....+.+.......
T Consensus 210 ~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 210 GEP--------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281 (420)
T ss_dssp TCC--------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred CCC--------ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 322 2345889999999999875 6999999999999999999999999875432222222111110000
Q ss_pred ------------------chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 235 ------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 235 ------------------~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.....+...+++++.+||.+||..||++||++.+++
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l 335 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 335 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHh
Confidence 001112345789999999999999999999987764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=355.81 Aligned_cols=256 Identities=18% Similarity=0.220 Sum_probs=203.1
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeE----EEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~----vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
..++|+++++||+|+||.||+|.+..+++. ||+|++.... ....+.+|+.+++.++|++++..+. ++.. ..
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~-~~~~-~~ 88 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLG-LCPG-SS 88 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEE-EECB-SS
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEE-EEcC-Cc
Confidence 356899999999999999999999888775 7777764432 2345788999999998666555555 4443 44
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
.++||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+
T Consensus 89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGGGS
T ss_pred cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCccccc
Confidence 67788887 899999998555679999999999999999999999999999999999999 47789999999999877
Q ss_pred ccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccc
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
....... ......||..|+|||++.+..++.++|||||||++|||++ |..||.+.........+. .....
T Consensus 166 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~~~~- 236 (325)
T 3kex_A 166 PPDDKQL-----LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE---KGERL- 236 (325)
T ss_dssp CCCTTCC-----C-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH---TTCBC-
T ss_pred Ccccccc-----cccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH---cCCCC-
Confidence 5543211 1234578889999999999999999999999999999999 999998865443332222 21111
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
.....++.++.+++..||..||++||++.+|++.|+.+.
T Consensus 237 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 237 ---AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp ---CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred ---CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 112456789999999999999999999999999998874
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=355.87 Aligned_cols=254 Identities=18% Similarity=0.267 Sum_probs=207.1
Q ss_pred cCCcEEEe-eeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 5 VGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 5 i~~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
+.++|.+. ++||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.++++|..+..++......+
T Consensus 26 ~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 26 FNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 55778888 89999999999999999999999999876532 23568899999999998888888888888899999
Q ss_pred EEEecC-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 80 LVIDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~-~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
+||||+ +++|.+++.. ....+++..++.|+.||+.||.|||++||+||||||+|||++.....+.+||+|||+++...
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 999999 7799988753 23569999999999999999999999999999999999999643346899999999998765
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
.... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ...+..+....... .
T Consensus 186 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~~~-~ 253 (327)
T 3lm5_A 186 HACE--------LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN---QETYLNISQVNVDY-S 253 (327)
T ss_dssp ----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCCC-C
T ss_pred Cccc--------cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHhccccc-C
Confidence 4322 1345799999999999999999999999999999999999999987433 33333333333222 1
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
......+++.+.+||..||..||++||++++++
T Consensus 254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll 286 (327)
T 3lm5_A 254 EETFSSVSQLATDFIQSLLVKNPEKRPTAEICL 286 (327)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred chhhcccCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 223457899999999999999999999987763
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=349.06 Aligned_cols=263 Identities=20% Similarity=0.293 Sum_probs=211.2
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEc-----CCCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEE-eEeC
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWF-GVEG 75 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~-~~~~ 75 (474)
..++|++.+.||+|+||.||+|.+. .+++.||||++...... ..+.+|+.++..+.+|++|..+..+ ...+
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 104 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 104 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence 4578999999999999999999853 56789999998765432 3588999999999766666666554 4445
Q ss_pred CEEEEEEecC-CCCHHHHHHHcCCC---------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeC
Q 011945 76 DYNVLVIDLL-GPSLEDLFNFCSRK---------------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139 (474)
Q Consensus 76 ~~~~lv~e~~-g~sL~~li~~~~~~---------------l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~ 139 (474)
...+++|||+ +++|.+++...... +++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~-- 182 (316)
T 2xir_A 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-- 182 (316)
T ss_dssp SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC--
T ss_pred CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC--
Confidence 6689999999 67999999854322 89999999999999999999999999999999999994
Q ss_pred CCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 011945 140 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (474)
Q Consensus 140 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~ 218 (474)
.++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 183 -~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 256 (316)
T 2xir_A 183 -EKNVVKICDFGLARDIYKDPDYV-----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256 (316)
T ss_dssp -GGGCEEECCCGGGSCTTTCTTSE-----EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred -CCCCEEECCCccccccccCccce-----eccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccch
Confidence 67899999999998765432211 1234578899999999999999999999999999999998 9999987654
Q ss_pred CcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011945 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281 (474)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 281 (474)
... ....+..... ......+++++.++|..||..||.+||++.+|++.|+.++....
T Consensus 257 ~~~--~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 257 DEE--FCRRLKEGTR----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp SHH--HHHHHHHTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred hHH--HHHHhccCcc----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 321 2222222111 11234578999999999999999999999999999999987654
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=359.55 Aligned_cols=255 Identities=21% Similarity=0.288 Sum_probs=201.0
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeE----------
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV---------- 73 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~---------- 73 (474)
...++|+++++||+|+||+||+|.+..+++.||||++.... ....+|+.+++.++|++++..+..+..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~--~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP--RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT--TSCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc--chHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 34679999999999999999999999999999999876442 234589999999997777776665532
Q ss_pred ---------------------------eCCEEEEEEecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011945 74 ---------------------------EGDYNVLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS 123 (474)
Q Consensus 74 ---------------------------~~~~~~lv~e~~g~sL~~li~~---~~~~l~~~~~~~i~~qi~~gL~yLHs~g 123 (474)
...+.++||||+.++|.+++.. ....+++..++.|+.||+.||.|||++|
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g 161 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG 161 (383)
T ss_dssp ----------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence 3446899999999999888763 3567999999999999999999999999
Q ss_pred ccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCC-CCchhhHHHHHHH
Q 011945 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYV 202 (474)
Q Consensus 124 IiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDIwSlGvi 202 (474)
|+||||||+|||++ ..++.+||+|||+|+.+..... .....||..|+|||++.+.. ++.++|||||||+
T Consensus 162 i~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 162 ICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEP--------SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp EECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSC--------CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred CccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCC--------CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99999999999995 3578999999999987654332 23457899999999998754 8999999999999
Q ss_pred HHHHHhCCCCCCCCCcCcHHHHHHHHhhcc---------------------ccchHHHHhcCCcHHHHHHHHHHhcCCCC
Q 011945 203 LMYFLRGSLPWQGLKAGTKKQKYEKISEKK---------------------VSTSIEALCRGYPTEFASYFHYCRSLRFD 261 (474)
Q Consensus 203 l~elltG~~Pf~~~~~~~~~~~~~~i~~~~---------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~ 261 (474)
+|||++|+.||.+....+....+.++.... .......+...+|+++.+||..||..||+
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 999999999998754332222222211110 01111223456889999999999999999
Q ss_pred CCCCHHHHH
Q 011945 262 DKPDYAYLK 270 (474)
Q Consensus 262 ~RPt~~~l~ 270 (474)
+||++.+++
T Consensus 312 ~R~t~~e~l 320 (383)
T 3eb0_A 312 LRINPYEAM 320 (383)
T ss_dssp GSCCHHHHH
T ss_pred hCCCHHHHh
Confidence 999988775
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=349.98 Aligned_cols=261 Identities=20% Similarity=0.246 Sum_probs=205.9
Q ss_pred CCcEEEeeeeeecCceEEEEEE----EcCCCeEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEe-CCE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVE-GDY 77 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~----~~~~~~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~-~~~ 77 (474)
.++|+++++||+|+||.||+|+ +..+++.||||++.... ....+.+|+.+++.++|++++..+..+... ...
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 4569999999999999999999 56789999999976442 235689999999999866666555544433 366
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
.+++|||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEc---CCCCEEECcccccccc
Confidence 89999999 7799999976777899999999999999999999999999999999999995 6789999999999877
Q ss_pred ccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----------cCcH-HHH
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK-----------AGTK-KQK 224 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~-----------~~~~-~~~ 224 (474)
....... .......||..|+|||++.+..++.++|||||||++|+|++|..||.... .... ...
T Consensus 177 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 177 ETDKEYY----TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CTTCCEE----ECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cCCCcce----eccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 5543211 12344578999999999999999999999999999999999999874311 0001 111
Q ss_pred HHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 225 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
...+.... .......+++++.+||..||..||.+||++.++++.|+.++
T Consensus 253 ~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 253 VNTLKEGK----RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHTTC----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhccC----CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11111111 11123567899999999999999999999999999999886
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=348.92 Aligned_cols=246 Identities=17% Similarity=0.282 Sum_probs=201.6
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 85 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (474)
.|...++||+|+||.||+|++..+|+.||||++.... ....+.+|+.+++.++|++++ .+..+.......++||||+
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVV-EMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBC-CEEEEEEETTEEEEEECCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcc-eEEEEEEECCEEEEEEecC
Confidence 4889999999999999999998899999999986543 235688999999999865554 5555566777899999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccc
Q 011945 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164 (474)
Q Consensus 86 -g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (474)
+++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.........
T Consensus 125 ~~~~L~~~l~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~-- 197 (321)
T 2c30_A 125 QGGALTDIVS--QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPK-- 197 (321)
T ss_dssp CSCBHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSCC--
T ss_pred CCCCHHHHHH--hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCccc--
Confidence 889999986 4579999999999999999999999999999999999999 47789999999999876543221
Q ss_pred cccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCC
Q 011945 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (474)
Q Consensus 165 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (474)
.....||+.|+|||++.+..++.++|||||||++|||++|..||.+... .+.+..+........ .....+
T Consensus 198 -----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~--~~~~~~ 267 (321)
T 2c30_A 198 -----RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKRLRDSPPPKL--KNSHKV 267 (321)
T ss_dssp -----BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSSCCCC--TTGGGS
T ss_pred -----cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhcCCCCCc--CccccC
Confidence 2346899999999999999999999999999999999999999986432 333333333221111 112457
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 245 PTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 245 p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
++++.++|..||..||++||++.++++
T Consensus 268 ~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 268 SPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 899999999999999999999887743
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=344.98 Aligned_cols=262 Identities=17% Similarity=0.244 Sum_probs=208.8
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCC---eEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~---~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
..+|++.++||+|+||.||+|.+..++ ..||||.+...... ..+.+|+.+++.++|++++..+..+...+...+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 357999999999999999999975443 46899988654332 457899999999997777777776666777889
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
++|||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECcccccccccc
Confidence 999999 679999998666779999999999999999999999999999999999999 4778999999999987654
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
..... ........||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.......... ......
T Consensus 181 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~---~~~~~~--- 251 (298)
T 3f66_A 181 KEYYS---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---LQGRRL--- 251 (298)
T ss_dssp GGGCB---C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH---HTTCCC---
T ss_pred cchhc---cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH---hcCCCC---
Confidence 32211 122344578899999999999999999999999999999999 66777665544333222 221111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
.....+|+++.+++..||..||++||++.++++.|+.++...
T Consensus 252 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 252 -LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred -CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 113467899999999999999999999999999999998643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=349.76 Aligned_cols=261 Identities=17% Similarity=0.313 Sum_probs=211.9
Q ss_pred CCcEEEeeeeeecCceEEEEEEEc-------CCCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeC
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNI-------QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEG 75 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-------~~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (474)
.++|++.+.||+|+||.||+|.+. .+++.||||++...... ..+.+|+.+++.+..|++|..+..++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 578999999999999999999976 35678999998755432 35789999999996566777776777777
Q ss_pred CEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeC
Q 011945 76 DYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139 (474)
Q Consensus 76 ~~~~lv~e~~-g~sL~~li~~~~---------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~ 139 (474)
...++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll--- 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV--- 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE---
Confidence 8889999999 779999997432 248999999999999999999999999999999999999
Q ss_pred CCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 011945 140 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (474)
Q Consensus 140 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~ 218 (474)
+.++.+||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYY-----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSE-----ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cCCCCEEEccccccccccccccc-----cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 47789999999999876543321 11234567899999999999889999999999999999999 9999987543
Q ss_pred CcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011945 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281 (474)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 281 (474)
.+.+..+...... .....++.++.++|..||..||++||++.+|++.|+.++....
T Consensus 266 ---~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 266 ---EELFKLLKEGHRM----DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp ---HHHHHHHHHTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ---HHHHHHHhcCCCC----CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 3333333322211 1235688999999999999999999999999999999987543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=361.53 Aligned_cols=259 Identities=20% Similarity=0.255 Sum_probs=198.2
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcC-------CCCCceeEEEeE-
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQG-------GTGIPNLRWFGV- 73 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~-------~~~i~~l~~~~~- 73 (474)
..+.++|+++++||+|+||+||+|++..+++.||||++.... ....+.+|+.+++.+.+ +++|..+..+..
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp CEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred hhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 456789999999999999999999999999999999986432 23458899999999974 233444433333
Q ss_pred ---eCCEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEeeeCC--------
Q 011945 74 ---EGDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGR-------- 140 (474)
Q Consensus 74 ---~~~~~~lv~e~~g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~-gIiHrDIKP~NILl~~~~-------- 140 (474)
.....++|||+++++|.+.+.... ..+++..++.|+.||+.||.|||++ ||+||||||+||||+.++
T Consensus 113 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~ 192 (397)
T 1wak_A 113 SGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA 192 (397)
T ss_dssp EETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred cCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence 456789999999999988886543 5699999999999999999999998 999999999999995221
Q ss_pred --------------------------------------CCCeEEEEecCCccccccCCCccccccccCCCCccCcccccc
Q 011945 141 --------------------------------------RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182 (474)
Q Consensus 141 --------------------------------------~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP 182 (474)
....+||+|||++....... ....||..|+||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----------~~~~gt~~y~aP 262 (397)
T 1wak_A 193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----------TEDIQTRQYRSL 262 (397)
T ss_dssp HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----------CSCCSCGGGCCH
T ss_pred hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----------ccCCCCCcccCC
Confidence 11379999999998764322 345799999999
Q ss_pred ccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCc---HHHHHHHHhhccccchH----------------------
Q 011945 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT---KKQKYEKISEKKVSTSI---------------------- 237 (474)
Q Consensus 183 E~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~---~~~~~~~i~~~~~~~~~---------------------- 237 (474)
|++.+..++.++|||||||+||||++|..||....... ....+..+....-..+.
T Consensus 263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 342 (397)
T 1wak_A 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI 342 (397)
T ss_dssp HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence 99999999999999999999999999999998654332 11122221111000000
Q ss_pred ---------HHH------hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 238 ---------EAL------CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 238 ---------~~l------~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
..+ ...++.++.+||..||..||++||+++++++
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000 1123467899999999999999999887753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=353.05 Aligned_cols=258 Identities=20% Similarity=0.265 Sum_probs=199.2
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEE----EEEEeccC---CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCC
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEV----AIKLENVK---TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 76 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~v----AvK~~~~~---~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (474)
...++|+++++||+|+||.||+|.+..+++.| |+|.+... .....+.+|+.+++.++|++++..+. ++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~-~~~~~~ 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLG-ICLTST 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCE-EEESSS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEE-EEecCC
Confidence 44678999999999999999999998888755 66655432 23456899999999998665555554 444455
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
. +++++++ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 91 ~-~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 91 V-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKL 166 (327)
T ss_dssp E-EEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTC---
T ss_pred c-eEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEc---CCCCEEEccCcceeE
Confidence 4 4555555 9999999987777899999999999999999999999999999999999995 678999999999987
Q ss_pred cccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhcccc
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS 234 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (474)
+....... ......+|..|+|||++.+..++.++|||||||++|||++ |..||.+.........+. .....
T Consensus 167 ~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~---~~~~~ 238 (327)
T 3lzb_A 167 LGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---KGERL 238 (327)
T ss_dssp ------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---TTCCC
T ss_pred ccCccccc-----cccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH---cCCCC
Confidence 65433211 1233467889999999999999999999999999999999 999998865544333222 21111
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
.....++.++.++|..||..||++||++.+|++.|+.+..
T Consensus 239 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 239 ----PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred ----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1234578999999999999999999999999999999863
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=369.61 Aligned_cols=258 Identities=21% Similarity=0.322 Sum_probs=209.8
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEecc----CCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV----KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~----~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
+.++|+++++||+|+||+||+|.+..+++.||||++.. ......+.+|+.+++.++|++ |..+..+.......++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN-IMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTT-BCCEEEEEECSSEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCC-cCeEEEEEEcCCEEEE
Confidence 45789999999999999999999999999999998753 234457899999999998554 5555556677888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
||||+ +++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||++..+..+.+||+|||+++.+...
T Consensus 99 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 99999 88999988643 57999999999999999999999999999999999999965556678999999999876543
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
.. .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ....+..+.........+
T Consensus 178 ~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~~- 244 (486)
T 3mwu_A 178 TK--------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN---EYDILKRVETGKYAFDLP- 244 (486)
T ss_dssp ------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCSCSG-
T ss_pred Cc--------cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCCc-
Confidence 22 234579999999999987 59999999999999999999999998743 344445554444332222
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
.+..+++++.+||..||..||.+||++.++ |++.+.+.
T Consensus 245 ~~~~~s~~~~~li~~~L~~dp~~R~t~~~~---l~hp~~~~ 282 (486)
T 3mwu_A 245 QWRTISDDAKDLIRKMLTFHPSLRITATQC---LEHPWIQK 282 (486)
T ss_dssp GGGGSCHHHHHHHHHHTCSSTTTSCCHHHH---HHCHHHHH
T ss_pred ccCCCCHHHHHHHHHHcCCChhhCcCHHHH---hcCHhhcc
Confidence 235688999999999999999999998776 44555443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=344.15 Aligned_cols=249 Identities=18% Similarity=0.176 Sum_probs=203.1
Q ss_pred CCCccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCC
Q 011945 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 76 (474)
Q Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (474)
|...+.++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+.++..+..|++|..+..++....
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~ 84 (289)
T 1x8b_A 5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84 (289)
T ss_dssp CCCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETT
T ss_pred ccccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence 455677899999999999999999999999999999999875422 2457889999999966777777777778888
Q ss_pred EEEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCC------------
Q 011945 77 YNVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR------------ 140 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~---~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~------------ 140 (474)
..++||||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||++.+.
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---------------
T ss_pred eEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 999999999 77999999743 25699999999999999999999999999999999999996332
Q ss_pred ----CCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCC
Q 011945 141 ----RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQG 215 (474)
Q Consensus 141 ----~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~ 215 (474)
....+||+|||++....... ...||..|+|||++.+. .++.++|||||||++|+|++|..|+..
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~-----------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 233 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ-----------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN 233 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC-----------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSS
T ss_pred cccCCceEEEEcccccccccCCcc-----------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcc
Confidence 44579999999998765432 24699999999999876 567899999999999999999887754
Q ss_pred CCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 216 LKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 216 ~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
. . ....+..... ..+...+++++.++|..||..||++||++.+++
T Consensus 234 ~---~---~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 278 (289)
T 1x8b_A 234 G---D---QWHEIRQGRL----PRIPQVLSQEFTELLKVMIHPDPERRPSAMALV 278 (289)
T ss_dssp S---H---HHHHHHTTCC----CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred h---h---HHHHHHcCCC----CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHh
Confidence 2 1 1233333222 123457899999999999999999999988764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=351.64 Aligned_cols=259 Identities=17% Similarity=0.220 Sum_probs=203.5
Q ss_pred CCccCCcEEEeeeeeecCceEEEEEEEcCCC-eEEEEEEeccCC-CchHHHHHHHHHHHhcCCCC-----CceeEEEeEe
Q 011945 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTN-EEVAIKLENVKT-KHPQLQYEAKLYKILQGGTG-----IPNLRWFGVE 74 (474)
Q Consensus 2 ~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~-~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~-----i~~l~~~~~~ 74 (474)
...+.++|++++.||+|+||.||+|.+..++ +.||||++.... ....+..|+.+++.+.+.+. +..+..+...
T Consensus 14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 3467899999999999999999999998776 799999986432 23457889999999986543 5555666777
Q ss_pred CCEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeC--------------
Q 011945 75 GDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-------------- 139 (474)
Q Consensus 75 ~~~~~lv~e~~g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~-------------- 139 (474)
....++|||+++++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+||||...
T Consensus 94 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 94 HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred CCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccc
Confidence 88999999999999998887543 469999999999999999999999999999999999999422
Q ss_pred --CCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Q 011945 140 --RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217 (474)
Q Consensus 140 --~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~ 217 (474)
+..+.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||+||||++|..||....
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEHH----------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSCC----------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccCCCcEEEeecCccccccccc----------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 256889999999998644322 34589999999999999999999999999999999999999998755
Q ss_pred cCcHHHHHHHHhhccccch--------------------------HHHHh----------cCCcHHHHHHHHHHhcCCCC
Q 011945 218 AGTKKQKYEKISEKKVSTS--------------------------IEALC----------RGYPTEFASYFHYCRSLRFD 261 (474)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~--------------------------~~~l~----------~~~p~~l~~li~~cl~~dp~ 261 (474)
.......+.++........ ....+ ...+.++.+||..||..||+
T Consensus 244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 4333333333221110000 00000 01245899999999999999
Q ss_pred CCCCHHHHH
Q 011945 262 DKPDYAYLK 270 (474)
Q Consensus 262 ~RPt~~~l~ 270 (474)
+||++.+++
T Consensus 324 ~Rpt~~e~l 332 (355)
T 2eu9_A 324 QRITLAEAL 332 (355)
T ss_dssp TSCCHHHHT
T ss_pred hCcCHHHHh
Confidence 999987763
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=351.70 Aligned_cols=260 Identities=16% Similarity=0.263 Sum_probs=192.0
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCe---EEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
..++|++++.||+|+||.||+|.+..++. .||||++.... ....+.+|+.+++.++|++++..+..+ .....
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~ 99 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS-LRSRA 99 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE-ECC--
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee-ecccc
Confidence 45789999999999999999999877665 89999886542 234588999999999766555555444 33333
Q ss_pred ------EEEEEecC-CCCHHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeE
Q 011945 78 ------NVLVIDLL-GPSLEDLFNFCS-----RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 145 (474)
Q Consensus 78 ------~~lv~e~~-g~sL~~li~~~~-----~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~v 145 (474)
.+++|||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~---~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA---EDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---TTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEc---CCCCE
Confidence 38999998 779999986432 2599999999999999999999999999999999999994 77899
Q ss_pred EEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHH
Q 011945 146 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 224 (474)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 224 (474)
||+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.......
T Consensus 177 kl~Dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-- 249 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYY-----RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY-- 249 (323)
T ss_dssp EECCCCC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH--
T ss_pred EEeeccccccccccccc-----cccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH--
Confidence 99999999876543321 11234467889999999999999999999999999999999 99999886554332
Q ss_pred HHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 225 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
..+...... .....+++++.+|+..||..||++||++.++++.|++++...
T Consensus 250 -~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 250 -NYLIGGNRL----KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp -HHHHTTCCC----CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred -HHHhcCCCC----CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 222222211 123568899999999999999999999999999999998654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=349.51 Aligned_cols=256 Identities=21% Similarity=0.251 Sum_probs=196.6
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeC-----
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEG----- 75 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~----- 75 (474)
++.++|++++.||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.|+|++++..+..+....
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 345789999999999999999999999999999999865432 346889999999998777766665553322
Q ss_pred ---------------------------------------------------CEEEEEEecC-CCCHHHHHHHcC--CCCC
Q 011945 76 ---------------------------------------------------DYNVLVIDLL-GPSLEDLFNFCS--RKLS 101 (474)
Q Consensus 76 ---------------------------------------------------~~~~lv~e~~-g~sL~~li~~~~--~~l~ 101 (474)
.+.+++|||+ +++|.+++.... ...+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 2489999999 889999997432 2356
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccc-----ccccCCCCccC
Q 011945 102 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI-----PYRENKNLTGT 176 (474)
Q Consensus 102 ~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~-----~~~~~~~~~GT 176 (474)
+..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+++........... .+.......||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---TTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEe---CCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 778999999999999999999999999999999994 7789999999999877654321110 01223456899
Q ss_pred ccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHh
Q 011945 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCR 256 (474)
Q Consensus 177 ~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl 256 (474)
+.|+|||++.+..++.++|||||||++|||++|..|+.. .......+...... .....+++++.+||..||
T Consensus 240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l 310 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFP----LLFTQKYPQEHMMVQDML 310 (332)
T ss_dssp GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCC----HHHHHHCHHHHHHHHHHH
T ss_pred cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCC----cccccCChhHHHHHHHHc
Confidence 999999999999999999999999999999998776532 22222223222222 222344678899999999
Q ss_pred cCCCCCCCCHHHHHH
Q 011945 257 SLRFDDKPDYAYLKR 271 (474)
Q Consensus 257 ~~dp~~RPt~~~l~~ 271 (474)
+.||++||++.++++
T Consensus 311 ~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 311 SPSPTERPEATDIIE 325 (332)
T ss_dssp CSSGGGSCCHHHHHH
T ss_pred cCCCCcCCCHHHHhh
Confidence 999999999887753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=357.16 Aligned_cols=266 Identities=18% Similarity=0.270 Sum_probs=211.1
Q ss_pred CCcEEEeeeeeecCceEEEEEEEc---CCCeEEEEEEeccC------CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCC
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 76 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAvK~~~~~------~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (474)
.++|+++++||+|+||.||+|++. .+++.||||+++.. .....+..|+.+++.+.++++|..+..++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 378999999999999999999984 48999999987542 234557889999999987888888888888889
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
..++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCCee
Confidence 999999999 78999999743 479999999999999999999999999999999999999 4788999999999987
Q ss_pred cccCCCccccccccCCCCccCccccccccccCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcH-HHHHHHHhhcc
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGI--EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKK 232 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~--~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~i~~~~ 232 (474)
+....... .....||+.|+|||++.+. .++.++|||||||+||||++|..||........ ......+....
T Consensus 209 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 282 (355)
T 1vzo_A 209 FVADETER------AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282 (355)
T ss_dssp CCGGGGGG------GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC
T ss_pred cccCCCCc------ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC
Confidence 65432211 2345799999999999863 478999999999999999999999976543322 22222222221
Q ss_pred ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCcccccccccc
Q 011945 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 296 (474)
Q Consensus 233 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 296 (474)
. .+...++..+.+||..||..||++|| +++++ +++.| ...++|..+...
T Consensus 283 ~-----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~el---l~h~~-------f~~~~~~~l~~~ 336 (355)
T 1vzo_A 283 P-----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI---KEHLF-------FQKINWDDLAAK 336 (355)
T ss_dssp C-----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHH---HTSGG-------GTTCCHHHHHTT
T ss_pred C-----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHH---HcCcc-------hhcCChhHhhhc
Confidence 1 12356789999999999999999999 76655 44443 234578766544
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=339.27 Aligned_cols=252 Identities=22% Similarity=0.368 Sum_probs=194.9
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC------CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~------~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
-.++|++.++||+|+||.||+|.+ +++.||||++.... ....+.+|+.+++.++|+ +|..+..++......
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHP-NIIALRGVCLKEPNL 81 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCT-TBCCEEEEECCC--C
T ss_pred chhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCC-CEeeEEEEEecCCce
Confidence 457899999999999999999996 48899999875432 234688999999999855 455555566667778
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCCCcEEeeeCC-----CCCeEEEEe
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGR-----RANQVYIID 149 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~g---IiHrDIKP~NILl~~~~-----~~~~vkL~D 149 (474)
++||||+ +++|.+++. ...+++..++.++.||+.||.|||++| |+||||||+|||++... ..+.+||+|
T Consensus 82 ~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 9999999 889999986 567999999999999999999999999 89999999999996321 267899999
Q ss_pred cCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHh
Q 011945 150 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (474)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (474)
||++..+..... ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+... ......+.
T Consensus 160 fg~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~ 227 (271)
T 3dtc_A 160 FGLAREWHRTTK---------MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG---LAVAYGVA 227 (271)
T ss_dssp CCC----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH---HHHHHHHH
T ss_pred CCcccccccccc---------cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHhhh
Confidence 999986654322 235799999999999999999999999999999999999999987542 22223332
Q ss_pred hccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
...... .....+++++.+++..||..||++||++.++++.|+++
T Consensus 228 ~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 228 MNKLAL---PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp TSCCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred cCCCCC---CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 222221 12357889999999999999999999999999988753
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=349.98 Aligned_cols=261 Identities=20% Similarity=0.299 Sum_probs=211.4
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCe-----EEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~-----~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
.++|++.+.||+|+||.||+|.+..+++ .||||++..... ...+.+|+.+++.+..|++|..+..++.....
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 5789999999999999999999876654 799999876533 24588999999999556666677667777778
Q ss_pred EEEEEecC-CCCHHHHHHHc-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCC
Q 011945 78 NVLVIDLL-GPSLEDLFNFC-------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN 143 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~-------------~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~ 143 (474)
.++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~---~~~ 201 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGH 201 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE---GGG
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC---CCC
Confidence 89999999 77999998743 34689999999999999999999999999999999999995 678
Q ss_pred eEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHH
Q 011945 144 QVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKK 222 (474)
Q Consensus 144 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~ 222 (474)
.+||+|||++......... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.......
T Consensus 202 ~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 276 (333)
T 2i1m_A 202 VAKIGDFGLARDIMNDSNY-----IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276 (333)
T ss_dssp EEEBCCCGGGCCGGGCTTS-----EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred eEEECccccccccccccce-----eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence 9999999999876543321 11234567889999999999999999999999999999998 99999876543322
Q ss_pred HHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 223 QKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 223 ~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
. .+....... .....+|+++.++|..||+.||++||++.+|++.|+++..+.
T Consensus 277 ~---~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 277 Y---KLVKDGYQM---AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp H---HHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H---HHHhcCCCC---CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 2 111111111 123457899999999999999999999999999999987653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=344.90 Aligned_cols=253 Identities=20% Similarity=0.288 Sum_probs=202.6
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
..++|++.+.||+|+||.||+|.+ +++.||||++........+.+|+.+++.++|++++..+..+.......+++||+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 19 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred ChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 347899999999999999999986 588999999987767778999999999999777776666655556678999999
Q ss_pred C-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 85 L-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 85 ~-g~sL~~li~~~~~-~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
+ +++|.+++..... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeeccccccccccc--
Confidence 9 6699999975432 38999999999999999999999999999999999999 477899999999997654322
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
....++..|+|||++.+..++.++|||||||++|||++ |..||........ ...+..... ....
T Consensus 172 --------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~~~~~~~----~~~~ 236 (278)
T 1byg_A 172 --------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVEKGYK----MDAP 236 (278)
T ss_dssp ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHHHTTTCC----CCCC
T ss_pred --------cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHhcCCC----CCCc
Confidence 22367889999999999999999999999999999998 9999987544332 222222211 1233
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
..+|+++.++|..||..||++||++.++++.|+++...
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 237 DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 57899999999999999999999999999999998654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=354.66 Aligned_cols=204 Identities=26% Similarity=0.354 Sum_probs=175.4
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHhcCCCC-----CceeEEEeEeCCE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTG-----IPNLRWFGVEGDY 77 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~l~~E~~il~~l~~~~~-----i~~l~~~~~~~~~ 77 (474)
.+.++|++.++||+|+||+||+|.+..+++.||||++..... ...+..|+.+++.+.++++ +..+..++.....
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 456899999999999999999999999999999999864322 3457789999999986664 5666677778889
Q ss_pred EEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 78 NVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 78 ~~lv~e~~g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLH--s~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
.++|||+++++|.+++.... ..+++..++.++.||+.||.||| +.|||||||||+||||+. +..+.+||+|||+++
T Consensus 131 ~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~~~~kL~DFG~a~ 209 (382)
T 2vx3_A 131 LCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSSC 209 (382)
T ss_dssp EEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTSCCEEECCCTTCE
T ss_pred eEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCCCcEEEEeccCce
Confidence 99999999999999998654 56999999999999999999999 579999999999999952 246789999999998
Q ss_pred ccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~ 218 (474)
...... ....||+.|+|||++.+..++.++|||||||+||||++|+.||.+...
T Consensus 210 ~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 210 QLGQRI----------YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp ETTCCC----------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eccccc----------ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 764321 345899999999999999999999999999999999999999987543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=350.81 Aligned_cols=265 Identities=18% Similarity=0.224 Sum_probs=191.5
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEe--------EeC
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFG--------VEG 75 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~--------~~~ 75 (474)
..+|++.++||+|+||.||+|++..+++.||||++..... ...+.+|+.+++.+..|++|..+..+. ...
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 106 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ 106 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence 4589999999999999999999999999999998754332 345889999999998555555554443 344
Q ss_pred CEEEEEEecCCCCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEeeeCCCCCeEEEEecC
Q 011945 76 DYNVLVIDLLGPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (474)
Q Consensus 76 ~~~~lv~e~~g~sL~~li~~--~~~~l~~~~~~~i~~qi~~gL~yLHs~g--IiHrDIKP~NILl~~~~~~~~vkL~DFG 151 (474)
...+++|||++++|.+++.. ....+++..++.|+.||+.||.|||++| |+||||||+||||+ .++.+||+|||
T Consensus 107 ~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg 183 (337)
T 3ll6_A 107 AEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEEC---TTSCEEBCCCT
T ss_pred ceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEEC---CCCCEEEecCc
Confidence 56899999999999999864 3456999999999999999999999999 99999999999994 77899999999
Q ss_pred CccccccCCCcccc-----ccccCCCCccCccccccccc---cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHH
Q 011945 152 LAKRYRDTATHQHI-----PYRENKNLTGTARYASMNTH---LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 223 (474)
Q Consensus 152 la~~~~~~~~~~~~-----~~~~~~~~~GT~~Y~APE~~---~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~ 223 (474)
+++.+......... .........||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.... .
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~ 260 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL---R 260 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH---H
Confidence 99876543221100 00112245699999999998 5667899999999999999999999999763321 1
Q ss_pred HHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Q 011945 224 KYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQ 283 (474)
Q Consensus 224 ~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~ 283 (474)
+........ ....++..+.+||..||+.||++||++.++++.|+.+.......
T Consensus 261 ----~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 261 ----IVNGKYSIP---PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp ---------CCCC---TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred ----hhcCcccCC---cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence 111111111 12456788999999999999999999999999999998766533
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=346.73 Aligned_cols=249 Identities=18% Similarity=0.300 Sum_probs=198.7
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEe--CCEEEEEEe
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVE--GDYNVLVID 83 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~--~~~~~lv~e 83 (474)
.++|+++++||+|+||.||+|.+..+++.||||++.. .....+.+|+.+++.+.++++|..+..+... ....+++||
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc-cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 5789999999999999999999999999999999864 3456799999999999967777777666655 667899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
++ +++|.+++. .+++..++.++.||+.||.|||++||+||||||+|||++ .+...+||+|||+++.+.....
T Consensus 114 ~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~- 186 (330)
T 3nsz_A 114 HVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQE- 186 (330)
T ss_dssp CCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCC-
T ss_pred ccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCceEcCCCCc-
Confidence 99 789988875 489999999999999999999999999999999999996 3344899999999987654332
Q ss_pred cccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc-------
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS------- 234 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~------- 234 (474)
.....||..|+|||++.+ ..++.++|||||||++|+|++|..||..... ....+..+......
T Consensus 187 -------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~--~~~~l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 187 -------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD--NYDQLVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp -------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS--HHHHHHHHHHHHCHHHHHHHH
T ss_pred -------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc--hHHHHHHHHHhcCCchhhhHH
Confidence 234578999999999987 6689999999999999999999999965322 11222211111000
Q ss_pred --------chHHH-----------------HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 235 --------TSIEA-----------------LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 235 --------~~~~~-----------------l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
..... ....+++++.+||..||..||++||+++++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000 01126899999999999999999999877743
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=365.32 Aligned_cols=253 Identities=22% Similarity=0.321 Sum_probs=196.4
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----------CchHHHHHHHHHHHhcCCCCCceeEEEeEe
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----------KHPQLQYEAKLYKILQGGTGIPNLRWFGVE 74 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----------~~~~l~~E~~il~~l~~~~~i~~l~~~~~~ 74 (474)
+.++|.+.++||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++|++++..+..+ .
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~--~ 210 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF--D 210 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE--E
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE--e
Confidence 3578999999999999999999999999999999876431 122488999999999876666655543 3
Q ss_pred CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCc
Q 011945 75 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (474)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (474)
....++||||+ +++|.+++. ....+++..++.|+.||+.||.|||++||+||||||+|||++.++....+||+|||++
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred cCceEEEEEcCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 45578999999 889988876 3567999999999999999999999999999999999999975445667999999999
Q ss_pred cccccCCCccccccccCCCCccCccccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhh
Q 011945 154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (474)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~---~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (474)
+....... ....+||+.|+|||++.+ ..++.++|||||||+||+|++|..||.+....... ...+..
T Consensus 290 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--~~~i~~ 359 (419)
T 3i6u_A 290 KILGETSL--------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQITS 359 (419)
T ss_dssp TSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH--HHHHHT
T ss_pred eecCCCcc--------ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH--HHHHhc
Confidence 87654321 234689999999999864 56889999999999999999999999875433221 122222
Q ss_pred ccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
... .........+++++.+||..||..||++||+++++++
T Consensus 360 ~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 360 GKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp TCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCC-CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 222 2234455778999999999999999999999887643
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=343.90 Aligned_cols=261 Identities=20% Similarity=0.293 Sum_probs=210.9
Q ss_pred CCcEEEee-eeeecCceEEEEEEEc--CCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 6 GNKFRLGR-KIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 6 ~~~y~i~~-~LG~G~fG~Vy~a~~~--~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
.++|.+.+ .||+|+||.||+|.+. .+++.||||++..... ...+.+|+.+++.++|++++..+..+ .....+
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~--~~~~~~ 85 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC--QAEALM 85 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE--ESSSEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe--cCCCcE
Confidence 45788887 9999999999999864 4688899999876433 24588999999999866655555544 455689
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
+|||++ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEECTT
T ss_pred EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc---CCCCEEECcccceeeecc
Confidence 999999 6799999975566799999999999999999999999999999999999995 678999999999987654
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
..... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.... +....+......
T Consensus 163 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~i~~~~~~--- 232 (287)
T 1u59_A 163 DDSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQGKRM--- 232 (287)
T ss_dssp CSCEE----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHHHTTCCC---
T ss_pred Cccee----eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHhcCCcC---
Confidence 33211 11233467899999999998889999999999999999998 99999875432 233333332211
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGF 282 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~ 282 (474)
.+...+|+++.++|..||..||++||++.+|++.|+.++...+.
T Consensus 233 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 233 -ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp -CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred -CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 23457899999999999999999999999999999999877653
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=367.30 Aligned_cols=259 Identities=22% Similarity=0.323 Sum_probs=209.9
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC---------------CchHHHHHHHHHHHhcCCCCCcee
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---------------KHPQLQYEAKLYKILQGGTGIPNL 68 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---------------~~~~l~~E~~il~~l~~~~~i~~l 68 (474)
.+.++|+++++||+|+||+||+|.+..+++.||||++.... ....+.+|+.+++.|+|+ +|..+
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-niv~~ 111 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHP-NIIKL 111 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCT-TBCCE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCC-CCCeE
Confidence 46789999999999999999999999999999999876432 234688999999999854 55556
Q ss_pred EEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEE
Q 011945 69 RWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 147 (474)
Q Consensus 69 ~~~~~~~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL 147 (474)
..++......++||||+ |++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++.++....+||
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 66667888999999999 7899998874 357999999999999999999999999999999999999964433457999
Q ss_pred EecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHH
Q 011945 148 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227 (474)
Q Consensus 148 ~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 227 (474)
+|||++..+..... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ....+..
T Consensus 191 ~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~ 258 (504)
T 3q5i_A 191 VDFGLSSFFSKDYK--------LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQN---DQDIIKK 258 (504)
T ss_dssp CCCTTCEECCTTSC--------BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHH
T ss_pred EECCCCEEcCCCCc--------cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCC---HHHHHHH
Confidence 99999987654322 234579999999999875 69999999999999999999999998743 3445555
Q ss_pred HhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
+.........+ .+..+++++.+||..||..||.+||+++++ |++.+.+.
T Consensus 259 i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~t~~e~---l~h~~~~~ 307 (504)
T 3q5i_A 259 VEKGKYYFDFN-DWKNISDEAKELIKLMLTYDYNKRCTAEEA---LNSRWIKK 307 (504)
T ss_dssp HHHCCCCCCHH-HHTTSCHHHHHHHHHHTCSSTTTSCCHHHH---HTSHHHHH
T ss_pred HHcCCCCCCcc-ccCCCCHHHHHHHHHHcCCChhHCCCHHHH---hcCHhhhh
Confidence 55554433333 346789999999999999999999998776 45555443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=340.94 Aligned_cols=261 Identities=16% Similarity=0.239 Sum_probs=208.0
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCe---EEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~---~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
.|.+.++||+|+||+||+|.+..+++ .||+|++...... ..+.+|+.+++.++|++++..+..+...+...+++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 57788999999999999999765544 7999998754432 35789999999998777776666665566666888
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
||++ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEeCcCCCcccccCCc
Confidence 8888 899999998666789999999999999999999999999999999999999 477899999999998664432
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC-CCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP-WQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~P-f~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
.. .........+|..|+|||.+.+..++.++|||||||++|+|++|..| |......... ..+...... .
T Consensus 179 ~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~---~~~~~~~~~----~ 248 (298)
T 3pls_A 179 YY---SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT---HFLAQGRRL----P 248 (298)
T ss_dssp GG---CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHH---HHHHTTCCC----C
T ss_pred cc---ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHH---HHhhcCCCC----C
Confidence 11 11223455789999999999999999999999999999999995554 5443332222 222222111 1
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 281 (474)
....+++++.+++..||..||.+||++.++++.|++++....
T Consensus 249 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 249 QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 235678999999999999999999999999999999987653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=336.46 Aligned_cols=255 Identities=20% Similarity=0.278 Sum_probs=210.1
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
.++|++.+.||+|+||.||+|.+. +++.||||++.... ..+.+.+|+.+++.++|++ |..+..++......+++||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPK-LVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTT-BCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCC-EeeEEEEEccCCCeEEEEeC
Confidence 468999999999999999999985 67899999987654 3457899999999998554 55555556667778999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 85 ~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++........
T Consensus 85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~---~~~~~kl~dfg~~~~~~~~~~-- 159 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQY-- 159 (267)
T ss_dssp CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEEC---GGGCEEECCTTGGGGBCCHHH--
T ss_pred CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEC---CCCCEEEcccccccccccccc--
Confidence 9 7899999987667799999999999999999999999999999999999994 678999999999986543211
Q ss_pred ccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhc
Q 011945 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (474)
.......+|..|+|||++.+..++.++|||||||++|+|++ |..||.+.. .......+...... ....
T Consensus 160 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~i~~~~~~----~~~~ 228 (267)
T 3t9t_A 160 ----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDISTGFRL----YKPR 228 (267)
T ss_dssp ----HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTTCCC----CCCT
T ss_pred ----cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC---HHHHHHHHhcCCcC----CCCc
Confidence 11234567889999999999899999999999999999999 999998743 23333333332111 1234
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
.+++++.+++..||..||++||++.++++.|+++..
T Consensus 229 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 229 LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 578999999999999999999999999999999864
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=345.79 Aligned_cols=258 Identities=19% Similarity=0.327 Sum_probs=206.1
Q ss_pred CCcEEEee-eeeecCceEEEEEEE--cCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 6 GNKFRLGR-KIGSGSFGEIYLGTN--IQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 6 ~~~y~i~~-~LG~G~fG~Vy~a~~--~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
.++|++.+ .||+|+||.||+|.+ ..+++.||||++..... ...+.+|+.+++.++|++++..+..+ .....
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~--~~~~~ 92 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC--EAESW 92 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE--ESSSE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE--CCCCc
Confidence 45799998 999999999999954 46678999999865432 34588999999999866655555544 55667
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
++|||++ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 93 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe---CCCcEEEccCCcceeec
Confidence 8999999 7899999985 45799999999999999999999999999999999999995 67899999999998765
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccch
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (474)
...... .......+|..|+|||++.+..++.++|||||||++|+|++ |..||.+... .+....+......
T Consensus 169 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~-- 239 (291)
T 1xbb_A 169 ADENYY----KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGERM-- 239 (291)
T ss_dssp TTCSEE----EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC--
T ss_pred cCCCcc----cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCCCC--
Confidence 443211 11223457889999999999889999999999999999999 9999987543 2333333322211
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
.+...+|+++.++|..||..||++||++.+|++.|++++...
T Consensus 240 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 240 --GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 123578999999999999999999999999999999998654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=360.02 Aligned_cols=259 Identities=16% Similarity=0.261 Sum_probs=198.3
Q ss_pred CCcEEEeeeeeecCceEEEEEEEc---CCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
.++|++.+.||+|+||.||+|++. .++..||||+++.... ...+.+|+.+++.++|+ +|..+..++......+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHP-NIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCT-TBCCEEEEECSSSSCE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCC-CCCeEEEEEeeCCceE
Confidence 458999999999999999999976 4677899999875432 23588999999999855 4555555666777889
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
+||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 123 lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC--------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECcCcccccccc
Confidence 999999 889999998666679999999999999999999999999999999999999 4778999999999987654
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
...... ......+|..|+|||++.+..++.++|||||||+||||++ |+.||.+... ...+..+.......
T Consensus 200 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~---~~~~~~i~~~~~~~-- 270 (373)
T 2qol_A 200 DPEAAY----TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN---QDVIKAVDEGYRLP-- 270 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH---HHHHHHHHTTEECC--
T ss_pred CCccce----eccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCC--
Confidence 322110 1122346788999999999999999999999999999998 9999987543 33333333222111
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
....+|.++.+++..||+.||++||++.+|++.|+.++..
T Consensus 271 --~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 271 --PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp --CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred --CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 1346889999999999999999999999999999999754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=344.88 Aligned_cols=258 Identities=19% Similarity=0.300 Sum_probs=204.5
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
...++|++++.||+|+||.||+|.+..+++.||||++........+.+|+.+++.+.|++ |..+..+.......+++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPH-VVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTT-BCCEEEEEEETTEEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCC-CccEEEEEEeCCEEEEEee
Confidence 456789999999999999999999999999999999987777788999999999997555 5555555567788899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
|+ +++|.+++......+++..++.++.||+.||.|||++||+|+||||+|||++ .++.+||+|||++........
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~~~~~~~~~~- 180 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDTMA- 180 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECBTTBS-
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEEC---CCCCEEEeecccchhhhhhcc-
Confidence 99 6699999986677899999999999999999999999999999999999994 678999999999987654322
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhc
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (474)
......||..|+|||++.+..++.++|||||||++|+|++|..||..... ......+....... .....
T Consensus 181 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~--~~~~~ 249 (314)
T 3com_A 181 ------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP---MRAIFMIPTNPPPT--FRKPE 249 (314)
T ss_dssp ------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCC--CSSGG
T ss_pred ------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHhcCCCcc--cCCcc
Confidence 12345799999999999999999999999999999999999999987433 22222222211110 01124
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
.++.++.++|..||..||.+||++.++ |++.|.+.
T Consensus 250 ~~~~~l~~li~~~l~~dp~~Rpt~~~l---l~~~~~~~ 284 (314)
T 3com_A 250 LWSDNFTDFVKQCLVKSPEQRATATQL---LQHPFVRS 284 (314)
T ss_dssp GSCHHHHHHHHHHTCSCTTTSCCHHHH---TTSHHHHT
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHH---HhCHHHhc
Confidence 578999999999999999999998777 44555443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=347.06 Aligned_cols=262 Identities=16% Similarity=0.221 Sum_probs=204.2
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCC----eEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCC
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGD 76 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~----~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (474)
...++|++.+.||+|+||.||+|.+..++ ..||||++...... ..+.+|+.+++.++|++ |..+..+.....
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~ 119 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN-IIRLEGVISKYK 119 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTT-BCCEEEEECSSS
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCC-CCcEEEEEecCC
Confidence 34578999999999999999999986553 46999998754332 34788999999998655 555555566677
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
..++|||++ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC---
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE---CCCCcEEECCCCcchh
Confidence 889999999 679999998766789999999999999999999999999999999999999 4778999999999987
Q ss_pred cccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhcccc
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS 234 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (474)
........ .......+|..|+|||++.+..++.++|||||||++|||++ |..||.+... .+.+..+......
T Consensus 197 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~~~~~~~~~~~ 269 (333)
T 1mqb_A 197 LEDDPEAT----YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN---HEVMKAINDGFRL 269 (333)
T ss_dssp ------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCC
T ss_pred hccccccc----cccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHCCCcC
Confidence 65432211 01123356889999999999999999999999999999999 9999987543 3333333332211
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
.....+++++.+++..||..||++||++.+|++.|++++...
T Consensus 270 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 270 ----PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp ----CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ----CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 123468999999999999999999999999999999998643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=353.08 Aligned_cols=252 Identities=19% Similarity=0.192 Sum_probs=198.6
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-------CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-------~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
..++|++++.||+|+||.||+|.+..+|+.||||++.... ....+.+|+.+++.++|++++ .+..++.....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv-~~~~~~~~~~~ 86 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII-GLLDAFGHKSN 86 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBC-CEEEEECCTTC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCC-eEEEEEeeCCc
Confidence 3578999999999999999999999999999999876432 134688999999999865544 45455566778
Q ss_pred EEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 78 NVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 78 ~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
.++||||+.++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 87 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 87 ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFG 163 (346)
T ss_dssp CEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTT
T ss_pred eEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE---cCCCCEEEEecccceecc
Confidence 89999999889999998666679999999999999999999999999999999999999 477899999999998765
Q ss_pred cCCCccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc---
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV--- 233 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~--- 233 (474)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+... ...+..+.....
T Consensus 164 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~---~~~~~~i~~~~~~~~ 233 (346)
T 1ua2_A 164 SPNR-------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD---LDQLTRIFETLGTPT 233 (346)
T ss_dssp SCCC-------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHHHCCCC
T ss_pred CCcc-------cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH---HHHHHHHHHHcCCCC
Confidence 4322 12345789999999999765 489999999999999999999999987543 233333322110
Q ss_pred --------------------cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 234 --------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 234 --------------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
......+...+++++.+||..||..||++||++.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 290 (346)
T 1ua2_A 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290 (346)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHh
Confidence 1122334467789999999999999999999987763
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=338.58 Aligned_cols=257 Identities=19% Similarity=0.232 Sum_probs=205.4
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCC---CeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
..++|++.+.||+|+||.||+|.+... +..||||++..... ...+.+|+.+++.++|++++..+..+ .. ...
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~-~~~ 87 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII-EE-EPT 87 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEE-CS-SSC
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEE-cC-CCC
Confidence 357899999999999999999997543 45699999875432 34588999999999866666655543 33 345
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
+++||++ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---ETTEEEECCCCGGGCC-
T ss_pred EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC---CCCcEEeCccCCCcccc
Confidence 7899998 7899999987777799999999999999999999999999999999999995 67899999999998765
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccch
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (474)
..... ......+|..|+|||++.+..++.++|||||||++|||++ |+.||...........+.. ....
T Consensus 165 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~---~~~~-- 233 (281)
T 3cc6_A 165 DEDYY------KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK---GDRL-- 233 (281)
T ss_dssp --------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH---TCCC--
T ss_pred ccccc------ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc---CCCC--
Confidence 43221 1233467889999999999999999999999999999998 9999987655443332222 1111
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
.....+++.+.+++..||..||++||++.+|++.|++++..
T Consensus 234 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 234 --PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 12346789999999999999999999999999999998754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=359.41 Aligned_cols=251 Identities=21% Similarity=0.291 Sum_probs=186.2
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEe-----C
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVE-----G 75 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~-----~ 75 (474)
+.++|++++.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+++.++|++++..+..+... .
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 56899999999999999999999999999999999865432 24578999999999977766666655432 3
Q ss_pred CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 76 ~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
...+++||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 107 ~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 107 NDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH 181 (367)
T ss_dssp CCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECC------
T ss_pred CeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---CCCCCEEEeecccccc
Confidence 56799999999999999873 579999999999999999999999999999999999999 4778999999999986
Q ss_pred cccCCCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc---
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--- 231 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~--- 231 (474)
.... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+......
T Consensus 182 ~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 182 TADE----------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251 (367)
T ss_dssp -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred cccc----------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 5432 134589999999999987 67899999999999999999999999875443222222221110
Q ss_pred --------------------cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 232 --------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 232 --------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
........+...+++++.+||.+||..||++||++.+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L 310 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 310 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHh
Confidence 011223344557789999999999999999999977663
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=344.49 Aligned_cols=258 Identities=21% Similarity=0.272 Sum_probs=208.3
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
+.++|++.+.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.++|++ |..+..+.......+++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN-IVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTT-BCCEEEEEECSSEEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCC-eeehhhhcccCCEEEEEE
Confidence 5578999999999999999999999999999999986543 3346889999999998555 555555667788899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
|++ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+...+..+.+||+|||++........
T Consensus 86 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 164 (304)
T 2jam_A 86 QLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM 164 (304)
T ss_dssp CCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTT
T ss_pred EcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcc
Confidence 999 7899999874 35799999999999999999999999999999999999995445678999999999975433211
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ....+..+....... .....
T Consensus 165 ---------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~i~~~~~~~-~~~~~ 231 (304)
T 2jam_A 165 ---------STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET---ESKLFEKIKEGYYEF-ESPFW 231 (304)
T ss_dssp ---------HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHCCCCC-CTTTT
T ss_pred ---------ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCCCC-Ccccc
Confidence 23468999999999999999999999999999999999999998743 333444444433221 11234
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
..+++++.++|..||..||++||++.++ |++.+...
T Consensus 232 ~~~~~~~~~li~~~l~~dp~~Rps~~~~---l~h~~~~~ 267 (304)
T 2jam_A 232 DDISESAKDFICHLLEKDPNERYTCEKA---LSHPWIDG 267 (304)
T ss_dssp TTSCHHHHHHHHHHHCSSTTTSCCHHHH---HTSHHHHS
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHH---hcCccccC
Confidence 5789999999999999999999998776 45555443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=338.19 Aligned_cols=254 Identities=20% Similarity=0.279 Sum_probs=205.3
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--------CchHHHHHHHHHHHhcCCCCCceeEEEeEeC
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEG 75 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--------~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (474)
.+.++|++++.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++|+ +|..+..++...
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~ 80 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP-NIITLHDIFENK 80 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCT-TBCCEEEEEECS
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCC-CeeehhheecCC
Confidence 35678999999999999999999999999999999876542 235689999999999854 555555666777
Q ss_pred CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCC-CCCeEEEEecCCc
Q 011945 76 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLA 153 (474)
Q Consensus 76 ~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~-~~~~vkL~DFGla 153 (474)
...+++||++ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+. ....+||+|||++
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CeEEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 8899999999 7999999974 45799999999999999999999999999999999999995221 1238999999999
Q ss_pred cccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc
Q 011945 154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (474)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (474)
........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.. ....+..+.....
T Consensus 160 ~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~ 228 (283)
T 3bhy_A 160 HKIEAGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET---KQETLTNISAVNY 228 (283)
T ss_dssp EECC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTCC
T ss_pred eeccCCCc--------ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc---hHHHHHHhHhccc
Confidence 87654322 134579999999999999999999999999999999999999998743 3334444433332
Q ss_pred cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.. .......+++++.+++..||..||++||++.++++
T Consensus 229 ~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 DF-DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CC-CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC-cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 22 23445678999999999999999999999888754
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=369.52 Aligned_cols=270 Identities=19% Similarity=0.235 Sum_probs=216.4
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
...++|++++.||+|+||.||+|+++.+|+.||||++... .....+..|+.+++.++| ++|..+..++......
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS-RFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCC-CCEeeEEEEEeeCCEE
Confidence 4457899999999999999999999999999999987543 233568899999999975 5555566666777889
Q ss_pred EEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 79 VLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~---~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
|+||||+ |++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAV 337 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCE
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeecceee
Confidence 9999999 89999998743 2469999999999999999999999999999999999999 478899999999998
Q ss_pred ccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcC-cHHHHHHHHhhccc
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-TKKQKYEKISEKKV 233 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~-~~~~~~~~i~~~~~ 233 (474)
.+...... ....+||+.|+|||++.+..++.++|||||||+||||++|..||.+.... .....+..+.....
T Consensus 338 ~~~~~~~~-------~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~ 410 (543)
T 3c4z_A 338 ELKAGQTK-------TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV 410 (543)
T ss_dssp ECCTTCCC-------BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC
T ss_pred eccCCCcc-------cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc
Confidence 76543321 23468999999999999999999999999999999999999999875432 23344444443332
Q ss_pred cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHH--HHHHHHHHHHHcCCCCCCcccccccccc
Q 011945 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY--LKRLFRDLFIREGFQFDYVFDWTILKYQ 296 (474)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~--l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 296 (474)
. ++..+++++.+||..||..||++||++.+ +.+++.+ ++...++|..+...
T Consensus 411 ~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H-------pff~~i~w~~l~~~ 463 (543)
T 3c4z_A 411 T-----YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH-------PLFRDISWRQLEAG 463 (543)
T ss_dssp C-----CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS-------GGGTTCCHHHHHTT
T ss_pred C-----CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC-------ccccCCCHHHHHcC
Confidence 2 23568999999999999999999998632 2333433 34445789876543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=349.59 Aligned_cols=250 Identities=20% Similarity=0.242 Sum_probs=207.8
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----------chHHHHHHHHHHHhcCCCCCceeEEEeEeC
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------HPQLQYEAKLYKILQGGTGIPNLRWFGVEG 75 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----------~~~l~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (474)
.++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+++.+..+++|..+..++...
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 172 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence 3579999999999999999999988999999999865432 235788999999996677777777777888
Q ss_pred CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 76 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 76 ~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
...++||||+ |++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||++.
T Consensus 173 ~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---~~~~~ikl~DfG~~~ 248 (365)
T 2y7j_A 173 SFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFSC 248 (365)
T ss_dssp SEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCE
T ss_pred CEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEEecCccc
Confidence 9999999999 7799999974 3579999999999999999999999999999999999999 477899999999998
Q ss_pred ccccCCCccccccccCCCCccCccccccccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHH
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLG------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~------~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i 228 (474)
.+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..||.+.. ....+..+
T Consensus 249 ~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~---~~~~~~~i 317 (365)
T 2y7j_A 249 HLEPGEK--------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR---QILMLRMI 317 (365)
T ss_dssp ECCTTCC--------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHH
T ss_pred ccCCCcc--------cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC---HHHHHHHH
Confidence 7654322 234689999999999874 358899999999999999999999997643 34444444
Q ss_pred hhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.........+ ....++.++.++|..||..||++||++.++++
T Consensus 318 ~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 318 MEGQYQFSSP-EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHTCCCCCHH-HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhCCCCCCCc-ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 4444433332 34678899999999999999999999887753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=366.07 Aligned_cols=269 Identities=20% Similarity=0.230 Sum_probs=210.9
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEe-CCEEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVE-GDYNV 79 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~-~~~~~ 79 (474)
.++++|++.++||+|+||.||+|.+..+++.||||++.... ....+.+|+++++.++|++++..+..+... ....+
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 85 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV 85 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence 45789999999999999999999999999999999986532 335678999999999976666655544433 33779
Q ss_pred EEEecC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeC-CCCCeEEEEecCCccc
Q 011945 80 LVIDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAKR 155 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~--~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~-~~~~~vkL~DFGla~~ 155 (474)
+||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||+..+ +..+.+||+|||+++.
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 999999 789999997432 239999999999999999999999999999999999998432 3556799999999987
Q ss_pred cccCCCccccccccCCCCccCccccccccccC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-CcHHHHHH
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLG--------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKA-GTKKQKYE 226 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--------~~~s~ksDIwSlGvil~elltG~~Pf~~~~~-~~~~~~~~ 226 (474)
...... .....||..|+|||++.+ ..++.++|||||||++|||++|+.||..... ....+.+.
T Consensus 166 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 166 LEDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp CCCGGG--------SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred ccCCCc--------cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 654322 234579999999999875 4578899999999999999999999975433 22333344
Q ss_pred HHhhccccchH--------------------HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 227 KISEKKVSTSI--------------------EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 227 ~i~~~~~~~~~--------------------~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
++........+ ..+...++..+.++|..||+.||++||++.++.+.+.+++.+.
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 44333221100 0111234678999999999999999999999999999988553
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=350.12 Aligned_cols=263 Identities=19% Similarity=0.206 Sum_probs=202.8
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEe----C
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVE----G 75 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~----~ 75 (474)
-.+.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++|++++..+..+... .
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 3568899999999999999999999999999999999864332 23477899999999866666555544322 3
Q ss_pred CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 76 ~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
...+++||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 87 ~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 87 NEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARI 161 (353)
T ss_dssp CCEEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred ceEEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---cCCCcEEEEecccccc
Confidence 67899999999999999974 579999999999999999999999999999999999999 4778999999999987
Q ss_pred cccCCCccccc---cccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc
Q 011945 156 YRDTATHQHIP---YRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (474)
Q Consensus 156 ~~~~~~~~~~~---~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (474)
+.........+ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.........+..+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence 65432211100 011234579999999998875 67899999999999999999999999875432222221111110
Q ss_pred ------------------------cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 232 ------------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 232 ------------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
........+...+++++.+||..||..||++||++.+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 304 (353)
T 2b9h_A 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEAL 304 (353)
T ss_dssp CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 011223445567899999999999999999999987764
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=343.21 Aligned_cols=263 Identities=23% Similarity=0.310 Sum_probs=200.5
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
...++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++|++ |..+..++......
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN-VIKYYASFIEDNEL 107 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTT-BCCEEEEEEETTEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCC-EeeEEEEEEcCCcE
Confidence 345789999999999999999999999999999999865321 235788999999998554 55555566677889
Q ss_pred EEEEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 79 VLVIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~---~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
+++||++ +++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~~ 184 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGR 184 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC----
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE---cCCCCEEEEecccee
Confidence 9999999 6799999864 34569999999999999999999999999999999999999 477899999999998
Q ss_pred ccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (474)
....... ......||..|+|||++.+..++.++|||||||++|+|++|..||.+... ........+......
T Consensus 185 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~ 256 (310)
T 2wqm_A 185 FFSSKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCDYP 256 (310)
T ss_dssp ---------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-CHHHHHHHHHTTCSC
T ss_pred eecCCCc-------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-hHHHHHHHhhcccCC
Confidence 6654322 11345789999999999999999999999999999999999999976432 222333333332222
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 281 (474)
.. ....+++++.++|..||..||++||++.+|++.|+++.....
T Consensus 257 ~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 257 PL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp CC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred CC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 11 124678999999999999999999999999999999976543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-43 Score=345.09 Aligned_cols=262 Identities=18% Similarity=0.263 Sum_probs=201.3
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEe---------
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFG--------- 72 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~--------- 72 (474)
.++++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++|++++..+..+.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 568899999999999999999999999999999998765432 245789999999998777776665542
Q ss_pred ----EeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEE
Q 011945 73 ----VEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148 (474)
Q Consensus 73 ----~~~~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~ 148 (474)
......++||||++++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++ ..++.+||+
T Consensus 88 ~~~~~~~~~~~lv~e~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~ 163 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYMETDLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN--TEDLVLKIG 163 (320)
T ss_dssp ---CCSCSEEEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTTTEEEEC
T ss_pred cccccccCceeEEeeccCCCHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc--CCCCeEEEc
Confidence 3457889999999999999986 46799999999999999999999999999999999999995 356799999
Q ss_pred ecCCccccccCCCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHH
Q 011945 149 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK 227 (474)
Q Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~ 227 (474)
|||+++......... .......+|..|+|||++.+ ..++.++|||||||++|||++|+.||.+.... ..+..
T Consensus 164 Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~ 236 (320)
T 2i6l_A 164 DFGLARIMDPHYSHK----GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL---EQMQL 236 (320)
T ss_dssp CCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH
T ss_pred cCccccccCCCcccc----cccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH---HHHHH
Confidence 999998764322111 11233467999999999876 67899999999999999999999999875432 22222
Q ss_pred Hhhcc-------------------------ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 228 ISEKK-------------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 228 i~~~~-------------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
+.... .......+...++.++.+||..||+.||++||+++++ |++.|.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el---l~hp~~~ 310 (320)
T 2i6l_A 237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA---LSHPYMS 310 (320)
T ss_dssp HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHH---HTSHHHH
T ss_pred HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHH---hCCcccc
Confidence 22111 1122334456789999999999999999999998777 4454443
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=351.83 Aligned_cols=259 Identities=20% Similarity=0.298 Sum_probs=208.7
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEc-----CCCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeC
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEG 75 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (474)
+..++|++.+.||+|+||.||+|.+. .+++.||||++...... ..+.+|+.+++.+.|++ |..+..+....
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~ 100 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH-VVRLLGVVSQG 100 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTT-BCCEEEEECSS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCC-EeeeEEEEccC
Confidence 34578999999999999999999876 35788999998754332 34788999999998665 44555555667
Q ss_pred CEEEEEEecC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeE
Q 011945 76 DYNVLVIDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 145 (474)
Q Consensus 76 ~~~~lv~e~~-g~sL~~li~~~~---------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~v 145 (474)
...++|||++ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~---~~~~~ 177 (322)
T 1p4o_A 101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTV 177 (322)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEEC---TTCCE
T ss_pred CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEc---CCCeE
Confidence 7789999999 789999987432 4579999999999999999999999999999999999994 77899
Q ss_pred EEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHH
Q 011945 146 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 224 (474)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 224 (474)
||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+... .+.
T Consensus 178 kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~ 249 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQV 249 (322)
T ss_dssp EECCTTCCCGGGGGGCE-----EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHH
T ss_pred EECcCcccccccccccc-----ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH---HHH
Confidence 99999999866443221 11234467899999999999999999999999999999999 8999987533 333
Q ss_pred HHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 225 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
...+...... .....+|+++.++|..||..||++||++.++++.|++++.
T Consensus 250 ~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 250 LRFVMEGGLL----DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHcCCcC----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 3333333221 1235789999999999999999999999999998887653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=373.73 Aligned_cols=271 Identities=20% Similarity=0.213 Sum_probs=214.9
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
+...++|++++.||+|+||.||+|.+..+|+.||||++... .....+.+|+.+++.++|+ +|..+..++.....
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp-~Iv~l~~~~~~~~~ 258 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR-FVVSLAYAYETKDA 258 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCT-TBCCEEEEEECSSE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCC-CEeeEEEEEeeCCE
Confidence 34567899999999999999999999999999999987542 2345578999999999855 55555566677889
Q ss_pred EEEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 78 NVLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
.|+||||+ |++|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+++.
T Consensus 259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVH 335 (576)
T ss_dssp EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEE
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEeccccee
Confidence 99999999 899999987433 349999999999999999999999999999999999999 4788999999999987
Q ss_pred cccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcH-HHHHHHHhhcccc
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKKVS 234 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~i~~~~~~ 234 (474)
+..... ....+||+.|+|||++.+..++.++|||||||+||||++|..||.+...... ......+.....
T Consensus 336 ~~~~~~--------~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~- 406 (576)
T 2acx_A 336 VPEGQT--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPE- 406 (576)
T ss_dssp CCTTCC--------EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCC-
T ss_pred cccCcc--------ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccc-
Confidence 654322 1245899999999999998999999999999999999999999987544322 223333332221
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCCccccccccccc
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDLFIREGFQFDYVFDWTILKYQQ 297 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~--~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~ 297 (474)
.+...+++++.+||..||..||.+||++. .+.+++++. +...++|..+....
T Consensus 407 ----~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp-------fF~~i~w~~l~~~~ 460 (576)
T 2acx_A 407 ----EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHP-------LFKKLNFKRLGAGM 460 (576)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG-------GGTTCCHHHHHTTC
T ss_pred ----cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh-------hhccCCHHHHhcCC
Confidence 12356889999999999999999999421 233334443 34457898765443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=338.75 Aligned_cols=257 Identities=21% Similarity=0.372 Sum_probs=209.1
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
..++|++++.||+|+||.||+|.+ .++..||||++.... ....+.+|+++++.++|++++..+..+ . ....+++||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~-~~~~~~v~e 87 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV-T-QEPIYIITE 87 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-C-SSSCEEEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEE-cCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEE-c-CCCcEEEEe
Confidence 457899999999999999999997 467789999886543 345689999999999876666555443 3 345789999
Q ss_pred cC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 84 LL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 84 ~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
++ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCE
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---cCCCCEEECCCcccccccCccc
Confidence 99 88999998632 2369999999999999999999999999999999999999 4778999999999987654322
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
. ......+|..|+|||++.+..++.++|||||||++|||++ |..||.+... .+.+..+..... ...
T Consensus 165 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~~~~----~~~ 231 (279)
T 1qpc_A 165 T------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN---PEVIQNLERGYR----MVR 231 (279)
T ss_dssp E------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCC----CCC
T ss_pred c------cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH---HHHHHHHhcccC----CCC
Confidence 1 1234467889999999998889999999999999999999 9999987543 333333332211 112
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
...+++++.+++..||..||++||++.+|++.|++++...
T Consensus 232 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 3578999999999999999999999999999999998764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=357.58 Aligned_cols=252 Identities=21% Similarity=0.235 Sum_probs=200.8
Q ss_pred CCcEEE--eeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 6 GNKFRL--GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 6 ~~~y~i--~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
.+.|.+ .+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.|+|+ +|..+..++......+||
T Consensus 86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp-nIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHA-NLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCT-TBCCEEEEEECSSEEEEE
T ss_pred ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCC-CCCeEEEEEEECCEEEEE
Confidence 344555 678999999999999999999999999987643 234688999999999855 455555566777889999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+.. +..+.+||+|||+++.+....
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCceecCCcc
Confidence 9999 78999988765567999999999999999999999999999999999999953 246789999999998765432
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
. .....||+.|+|||++.+..++.++|||||||+||||++|..||.+.. ....+..+........ ...
T Consensus 244 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~~-~~~ 311 (373)
T 2x4f_A 244 K--------LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN---DAETLNNILACRWDLE-DEE 311 (373)
T ss_dssp B--------CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCCSC-SGG
T ss_pred c--------cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhccCCCC-hhh
Confidence 2 134579999999999999899999999999999999999999998753 3344444444333221 123
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
...+++++.+||..||..||++||++.++++
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 3578999999999999999999999887754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=339.61 Aligned_cols=251 Identities=21% Similarity=0.287 Sum_probs=207.7
Q ss_pred CCccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeE--------
Q 011945 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV-------- 73 (474)
Q Consensus 2 ~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~-------- 73 (474)
+..++++|++++.||+|+||.||+|.+..+++.||||++... ...+.+|+++++.++|++++..+..+..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN--NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC--SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc--cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 445678999999999999999999999989999999998753 3568899999999997776666654432
Q ss_pred -------eCCEEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCe
Q 011945 74 -------EGDYNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQ 144 (474)
Q Consensus 74 -------~~~~~~lv~e~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~ 144 (474)
.....+++|||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~ 160 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQ 160 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc---CCCC
Confidence 245679999999 66999999754 35799999999999999999999999999999999999995 6789
Q ss_pred EEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHH
Q 011945 145 VYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224 (474)
Q Consensus 145 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~ 224 (474)
+||+|||++........ .....||+.|+|||++.+..++.++|||||||++|||++|..||.. ....
T Consensus 161 ~kl~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-----~~~~ 227 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK--------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-----TSKF 227 (284)
T ss_dssp EEECCCTTCEESSCCSC--------CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH-----HHHH
T ss_pred EEECcchhheecccccc--------ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh-----HHHH
Confidence 99999999987654322 1345799999999999999999999999999999999999998843 1122
Q ss_pred HHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 225 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
+..+.... +...++.++.++|..||..||++||++.++++.|..+.
T Consensus 228 ~~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 228 FTDLRDGI-------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HHHHHTTC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred HHHhhccc-------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 22222211 22457899999999999999999999999998887763
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=343.96 Aligned_cols=252 Identities=19% Similarity=0.268 Sum_probs=198.3
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
-.++|++.+.||+|+||.||+|.+ .++.||||++........+.+|+++++.++|++++..+..+ . +..++||||
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~--~~~~lv~e~ 80 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC-L--NPVCLVMEY 80 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBC-T--TTTEEEEEC
T ss_pred CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEE-c--CCcEEEEEc
Confidence 346899999999999999999986 47899999987666667799999999999876655554433 2 347899999
Q ss_pred C-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 85 L-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 85 ~-g~sL~~li~~~~~--~l~~~~~~~i~~qi~~gL~yLHs---~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
+ +++|.+++..... .+++..++.++.||+.||.|||+ +||+||||||+|||++ .+...+||+|||++.....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~--~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE--TTTTEEEECCCCC------
T ss_pred CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe--CCCCEEEEccccccccccc
Confidence 9 7899999974332 47899999999999999999999 8999999999999996 3334589999999976543
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+..... .
T Consensus 159 ~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~----~ 223 (307)
T 2eva_A 159 HM----------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA-FRIMWAVHNGTR----P 223 (307)
T ss_dssp ----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH-HHHHHHHHTTCC----C
T ss_pred cc----------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH-HHHHHHHhcCCC----C
Confidence 21 23468999999999999999999999999999999999999998654322 222222222211 1
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
.+...+|+++.+++..||..||++||+++++++.|+.+..
T Consensus 224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 2345789999999999999999999999999999998853
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=369.37 Aligned_cols=255 Identities=20% Similarity=0.355 Sum_probs=207.5
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
.++|++.++||+|+||.||+|.+. .+..||||+++... ..+.+.+|+.+++.|+|++++..+..+ . ....++||||
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~-~-~~~~~lv~e~ 263 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-T-KEPIYIITEF 263 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-C-SSSCEEEECC
T ss_pred hHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEE-e-CCccEEEEee
Confidence 467999999999999999999974 57889999987543 345789999999999876666655443 3 5567899999
Q ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 85 ~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.......
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~~~- 339 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDNEY- 339 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTGGGGBCCHHH-
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCCceEcCCCce-
Confidence 9 88999999733 2368999999999999999999999999999999999999 4778999999999987643221
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
.......+|..|+|||++.+..++.++|||||||+||||++ |+.||.+... .+.+..+...... ..+
T Consensus 340 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~----~~~ 407 (454)
T 1qcf_A 340 -----TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALERGYRM----PRP 407 (454)
T ss_dssp -----HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHHHHHHTCCC----CCC
T ss_pred -----eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CCC
Confidence 11233467889999999998899999999999999999999 9999987543 3333333322111 123
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
..+|+++.+||..||..||++||++++|.+.|++++..
T Consensus 408 ~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 408 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 57899999999999999999999999999999987643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=356.65 Aligned_cols=261 Identities=18% Similarity=0.248 Sum_probs=200.9
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCC---eEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~---~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
.|++.++||+|+||.||+|.+..++ ..||||.++.... ...+.+|+.+++.++|++++..+..+...+...++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 5899999999999999999975432 4689998765433 245889999999998777666666656666778999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE---CCCCCEEEeeccccccccccc
Confidence 9999 779999998666679999999999999999999999999999999999999 477899999999998664432
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.........+ ...... .
T Consensus 247 ~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~---~~~~~~----~ 316 (373)
T 3c1x_A 247 FDS---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL---LQGRRL----L 316 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH---HTTCCC----C
T ss_pred ccc---ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH---HcCCCC----C
Confidence 211 111234567889999999999999999999999999999999 78888876554433322 222111 1
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 281 (474)
....+|+++.++|..||..||++||++.+|++.|+.++....
T Consensus 317 ~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 317 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 235689999999999999999999999999999999986543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=351.03 Aligned_cols=257 Identities=20% Similarity=0.278 Sum_probs=210.1
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEE--EEEEeccC---CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEV--AIKLENVK---TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~v--AvK~~~~~---~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++|++.+.||+|+||.||+|++..++..+ |||.+... .....+.+|+.+++.+.+|++|..+..++......++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 68999999999999999999998888865 89987642 23456899999999996677777777777888999999
Q ss_pred EecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeE
Q 011945 82 IDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 145 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~---------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~v 145 (474)
|||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~---~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---GGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEc---CCCeE
Confidence 9999 789999997432 3699999999999999999999999999999999999994 67899
Q ss_pred EEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHH
Q 011945 146 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQK 224 (474)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~ 224 (474)
||+|||+++...... ......+|..|+|||++.+..++.++|||||||++|||++ |..||.+... ...
T Consensus 182 kL~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~---~~~ 250 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AEL 250 (327)
T ss_dssp EECCTTCEESSCEEC--------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHH
T ss_pred EEcccCcCccccccc--------cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH---HHH
Confidence 999999997433211 1123467889999999999889999999999999999998 9999987532 333
Q ss_pred HHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011945 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281 (474)
Q Consensus 225 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 281 (474)
+..+...... .....+++++.+||..||..||++||+++++++.|+.++.+..
T Consensus 251 ~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 251 YEKLPQGYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp HHHGGGTCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHHhhcCCCC----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 3333332111 1234678999999999999999999999999999999987654
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=355.56 Aligned_cols=264 Identities=20% Similarity=0.218 Sum_probs=208.0
Q ss_pred CCcEEEeeeeeecCceEEEEEE----EcCCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEe-EeCCEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGT----NIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFG-VEGDYN 78 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~----~~~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~-~~~~~~ 78 (474)
.++|+++++||+|+||.||+|+ +..+++.||||++..... ...+.+|+++++.++|++++..+..+. ......
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 4689999999999999999999 467899999999875432 234889999999997666555554433 356778
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
++||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCGGGCEECC
T ss_pred EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEEC---CCCCEEEcccccceecc
Confidence 9999999 8999999986666799999999999999999999999999999999999995 67899999999998765
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcC-----------c-HHHHH
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-----------T-KKQKY 225 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~-----------~-~~~~~ 225 (474)
...... .......||..|+|||++.+..++.++|||||||++|+|++|..||...... . .....
T Consensus 179 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (327)
T 3lxl_A 179 LDKDYY----VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLL 254 (327)
T ss_dssp TTCSEE----ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHH
T ss_pred cCCccc----eeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHH
Confidence 433211 1223457899999999999989999999999999999999999999642210 0 01111
Q ss_pred HHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 226 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
..+..... ......+++++.+||..||..||++||++.+|++.|+.++...
T Consensus 255 ~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 255 ELLEEGQR----LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHhhcccC----CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 11111110 1123568899999999999999999999999999999886543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=368.78 Aligned_cols=258 Identities=23% Similarity=0.350 Sum_probs=210.9
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
.+.++|++.++||+|+||.||+|.+..+++.||||++... .....+.+|+.+++.++|+ +|..+..+.......
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-niv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP-NIMKLYEFFEDKGYF 101 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCT-TBCCEEEEEECSSEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCC-CCCcEEEEEEeCCEE
Confidence 3557899999999999999999999999999999997543 2345689999999999755 555555666778889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
++||||+ +++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+...+..+.+||+|||+++.+.
T Consensus 102 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EEEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999998 8899998873 5679999999999999999999999999999999999999654567899999999998765
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
..... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..+.+..+.........
T Consensus 181 ~~~~~--------~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~ 248 (484)
T 3nyv_A 181 ASKKM--------KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN---EYDILKKVEKGKYTFEL 248 (484)
T ss_dssp CCCSH--------HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCCS
T ss_pred ccccc--------ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHcCCCCCCC
Confidence 43321 23479999999999987 69999999999999999999999998743 34445555544433222
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
+ .+..+++++.+||..||..||.+||++.++ |++.|.+
T Consensus 249 ~-~~~~~s~~~~~li~~~L~~dp~~R~s~~e~---l~h~~~~ 286 (484)
T 3nyv_A 249 P-QWKKVSESAKDLIRKMLTYVPSMRISARDA---LDHEWIQ 286 (484)
T ss_dssp G-GGGGSCHHHHHHHHHHTCSSGGGSCCHHHH---HTSHHHH
T ss_pred c-ccccCCHHHHHHHHHHCCCChhHCcCHHHH---hhChhhc
Confidence 2 235688999999999999999999998776 4444433
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=348.27 Aligned_cols=264 Identities=18% Similarity=0.258 Sum_probs=206.4
Q ss_pred CccCCcEEEeeeeeecCceEEEEEE-----EcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEe
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVE 74 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~-----~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~ 74 (474)
.+..++|++++.||+|+||.||+|. +..+++.||||++..... ...+.+|+.+++.+.|+ +|..+..++..
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~ 104 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ-NIVRCIGVSLQ 104 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCT-TBCCEEEEECS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCC-CCCeEEEEEcC
Confidence 4567899999999999999999999 556788999999864432 23578899999999755 45555555666
Q ss_pred CCEEEEEEecC-CCCHHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEE
Q 011945 75 GDYNVLVIDLL-GPSLEDLFNFCS------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 147 (474)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~li~~~~------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL 147 (474)
....++||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++....+||
T Consensus 105 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 105 SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 77789999999 889999998643 34899999999999999999999999999999999999965445667999
Q ss_pred EecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHH
Q 011945 148 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYE 226 (474)
Q Consensus 148 ~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~ 226 (474)
+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||..... ...+.
T Consensus 185 ~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~---~~~~~ 256 (327)
T 2yfx_A 185 GDFGMARDIYRASYY-----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLE 256 (327)
T ss_dssp CCCHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HHHHH
T ss_pred Ccccccccccccccc-----ccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH---HHHHH
Confidence 999999865433221 11234568999999999999999999999999999999998 9999987432 33333
Q ss_pred HHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 227 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 227 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
.+...... .....+++++.++|..||..||.+||++.+|++.|..+...
T Consensus 257 ~~~~~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 257 FVTSGGRM----DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHhcCCCC----CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 33332221 12356899999999999999999999999999999887653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=353.90 Aligned_cols=257 Identities=16% Similarity=0.210 Sum_probs=202.9
Q ss_pred CCcEEEeeeeeecCceEEEEE-----EEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcC--CCCCceeEEEeEeCCEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLG-----TNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQG--GTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a-----~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~--~~~i~~l~~~~~~~~~~ 78 (474)
.++|.+.++||+|+||+||+| .+..+++.||||++... ....+..|+.+++.+.+ ++++..+..++......
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~ 142 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS 142 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence 567999999999999999999 46678999999998653 45678899999999873 34455666666777788
Q ss_pred EEEEecC-CCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeee--------CCCCCeE
Q 011945 79 VLVIDLL-GPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL--------GRRANQV 145 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~----~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~--------~~~~~~v 145 (474)
+|||||+ +++|.+++.. ....+++..++.|+.||+.||+|||++|||||||||+||||+. ++..+.+
T Consensus 143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~ 222 (365)
T 3e7e_A 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGL 222 (365)
T ss_dssp EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTE
T ss_pred EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCE
Confidence 9999999 8999999975 2456999999999999999999999999999999999999953 1127899
Q ss_pred EEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHH
Q 011945 146 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 225 (474)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~ 225 (474)
||+|||+|+.+....... .....+||+.|+|||++.+..++.++|||||||+||||++|+.||.......
T Consensus 223 kl~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----- 292 (365)
T 3e7e_A 223 ALIDLGQSIDMKLFPKGT-----IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----- 292 (365)
T ss_dssp EECCCTTCEEGGGSCTTE-----EECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----
T ss_pred EEeeCchhhhhhccCCCc-----eeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----
Confidence 999999997654322211 1245689999999999999999999999999999999999999996432210
Q ss_pred HHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCC-CCHHHHHHHHHHHHHHc
Q 011945 226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDK-PDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 226 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~R-Pt~~~l~~~L~~l~~~~ 280 (474)
......... ...++.+.+++..||+.+|.+| |++.++.+.|++++.+.
T Consensus 293 -----~~~~~~~~~--~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 293 -----CKPEGLFRR--LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp -----EEECSCCTT--CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -----eeechhccc--cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 000000000 1236789999999999999998 68899999999998765
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=351.06 Aligned_cols=255 Identities=20% Similarity=0.277 Sum_probs=193.4
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeC-----
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEG----- 75 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~----- 75 (474)
+.++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++|++++..+..+....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 45789999999999999999999999999999999865432 235788999999998776666665554333
Q ss_pred CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 76 ~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
...++||||+.++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 103 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 103 QDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART 176 (371)
T ss_dssp CEEEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC---
T ss_pred cceEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEEEeecccc
Confidence 3789999999999999886 459999999999999999999999999999999999999 4778999999999986
Q ss_pred cccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccc
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
...... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+... ...+..+.......
T Consensus 177 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~~ 245 (371)
T 2xrw_A 177 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH---IDQWNKVIEQLGTP 245 (371)
T ss_dssp ---------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHC-CCCC
T ss_pred cccccc--------cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCCC
Confidence 543221 2345899999999999999999999999999999999999999987543 23333332211100
Q ss_pred h-------------------------HHHHh------------cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 236 S-------------------------IEALC------------RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 236 ~-------------------------~~~l~------------~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
. ...+. ...++++.+||..||..||++||+++++ |++.|.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~---l~hp~~ 322 (371)
T 2xrw_A 246 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA---LQHPYI 322 (371)
T ss_dssp CHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHH---HHSHHH
T ss_pred CHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHH---hCCcch
Confidence 0 00000 0125789999999999999999997766 556665
Q ss_pred H
Q 011945 279 R 279 (474)
Q Consensus 279 ~ 279 (474)
+
T Consensus 323 ~ 323 (371)
T 2xrw_A 323 N 323 (371)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=343.71 Aligned_cols=253 Identities=19% Similarity=0.267 Sum_probs=201.4
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEc-CCCeEEEEEEeccCC----CchHHHHHHHHHHHhc--CCCCCceeEEEeE---
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNI-QTNEEVAIKLENVKT----KHPQLQYEAKLYKILQ--GGTGIPNLRWFGV--- 73 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~-~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~--~~~~i~~l~~~~~--- 73 (474)
...++|++++.||+|+||.||+|.+. .+++.||||++.... ....+.+|+.+++.+. .|++|..+..++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 45688999999999999999999995 678999999875432 2346788999998884 3445555444433
Q ss_pred --eCCEEEEEEecCCCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEec
Q 011945 74 --EGDYNVLVIDLLGPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (474)
Q Consensus 74 --~~~~~~lv~e~~g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DF 150 (474)
.....++|||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 88 ~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~kl~Df 164 (326)
T 1blx_A 88 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADF 164 (326)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSC
T ss_pred cCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCEEEecC
Confidence 456789999999999999998543 359999999999999999999999999999999999999 47789999999
Q ss_pred CCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhh
Q 011945 151 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (474)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (474)
|+++....... .....||..|+|||++.+..++.++|||||||++|+|++|..||.+.... ..+..+..
T Consensus 165 g~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~ 233 (326)
T 1blx_A 165 GLARIYSFQMA--------LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV---DQLGKILD 233 (326)
T ss_dssp CSCCCCCGGGG--------GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHH
T ss_pred cccccccCCCC--------ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHH
Confidence 99986543221 23457899999999999999999999999999999999999999875432 22222221
Q ss_pred cc----------------------ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 231 KK----------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 231 ~~----------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.. .......+...+++++.+||..||..||++||++.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 295 (326)
T 1blx_A 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 295 (326)
T ss_dssp HHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 10 01122334467899999999999999999999987764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=371.43 Aligned_cols=256 Identities=20% Similarity=0.336 Sum_probs=211.3
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
..+|++.++||+|+||.||+|.+..++..||||++.... ....+.+|+.+++.++|++++ .+..++......+|||||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv-~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV-QLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBC-CEEEEECSSSSCEEEEEC
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEe-eEEEEEecCCcEEEEEEc
Confidence 357999999999999999999999889999999987553 346789999999999865544 555556666778999999
Q ss_pred C-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 85 L-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 85 ~-g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
+ +++|.+++.... ..+++..++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+++.......
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~~~~~~~~- 373 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTY- 373 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---GGGCEEECCTTCEECCTTCCE-
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEC---CCCcEEEeecccceeccCCce-
Confidence 9 789999998643 4699999999999999999999999999999999999994 678999999999987654322
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
.......+|..|+|||++.+..++.++|||||||+||||++ |..||.+.......+. +.... .. ...
T Consensus 374 -----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~---~~~~~-~~---~~~ 441 (495)
T 1opk_A 374 -----TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LEKDY-RM---ERP 441 (495)
T ss_dssp -----ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH---HHTTC-CC---CCC
T ss_pred -----eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHcCC-CC---CCC
Confidence 11234467889999999999899999999999999999999 9999988655433322 22211 11 123
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
..+|+++.+||..||..||++||++.+|++.|+.++.
T Consensus 442 ~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 442 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 5789999999999999999999999999999988753
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=347.09 Aligned_cols=259 Identities=22% Similarity=0.304 Sum_probs=199.2
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
...++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++|+ +|..+..++..+...
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp-~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEP-HVVPIHDFGEIDGQL 109 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCT-TBCCEEEEEEETTEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCC-CeeEEEEEEeeCCeE
Confidence 345789999999999999999999999999999999865422 24588999999999865 555565666778889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
+++||++ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus 110 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~---~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 110 YVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS---ADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC---TTSCEEECSCCC-----
T ss_pred EEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEc---CCCCEEEecCccCcccc
Confidence 9999999 67999999753 5799999999999999999999999999999999999994 67899999999998665
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
..... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+... . .+........ ...
T Consensus 186 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---~-~~~~~~~~~~-~~~ 254 (309)
T 2h34_A 186 DEKLT------QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL---S-VMGAHINQAI-PRP 254 (309)
T ss_dssp -----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH---H-HHHHHHHSCC-CCG
T ss_pred ccccc------cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH---H-HHHHHhccCC-CCc
Confidence 43211 12345799999999999999999999999999999999999999986432 1 2222222211 112
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRLFRDLFI 278 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RP-t~~~l~~~L~~l~~ 278 (474)
..+...+|+++.++|..||..||++|| +++++.+.|+.++.
T Consensus 255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 234567899999999999999999999 99999998887753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=367.25 Aligned_cols=252 Identities=22% Similarity=0.326 Sum_probs=203.7
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
+.++|+++++||+|+||+||+|++..+++.||||++... .....+.+|+.+++.++|++ |..+..++......++
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPN-IMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTT-BCCEEEEEECSSEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCC-CCeEEEEEEeCCEEEE
Confidence 345799999999999999999999999999999987653 23456899999999998655 5555556677888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
||||+ +++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++..+..+.+||+|||++..+...
T Consensus 114 v~e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 114 VMECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred EEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 99999 7899988864 357999999999999999999999999999999999999975445677999999999876543
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
.. .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ..+.+..+......... .
T Consensus 193 ~~--------~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~-~ 259 (494)
T 3lij_A 193 KK--------MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQT---DQEILRKVEKGKYTFDS-P 259 (494)
T ss_dssp BC--------BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCCCCCS-G
T ss_pred cc--------ccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCc-h
Confidence 22 234579999999999864 69999999999999999999999998754 34444555444333222 2
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.+..+++++.+||..||..||.+||++.++++
T Consensus 260 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 260 EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 24578999999999999999999999888753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=376.40 Aligned_cols=268 Identities=19% Similarity=0.270 Sum_probs=210.1
Q ss_pred CcEEEee-eeeecCceEEEEEEEc--CCCeEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 7 NKFRLGR-KIGSGSFGEIYLGTNI--QTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 7 ~~y~i~~-~LG~G~fG~Vy~a~~~--~~~~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
++|.+.+ +||+|+||.||+|.+. .++..||||+++... ....+.+|+++++.++|++++..+..+ .. +..+|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~-~~-~~~~l 412 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA-EALML 412 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEE-ES-SSEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEe-cc-CCeEE
Confidence 4566666 8999999999999875 356789999987543 345689999999999866666555544 33 45899
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
||||+ +++|.+++......+++..++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+++.+...
T Consensus 413 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~---~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp EEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCSTTTTCC--
T ss_pred EEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEc---CCCcEEEeeccCcccccCC
Confidence 99999 8899999976666799999999999999999999999999999999999995 6789999999999876543
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
.... .......+|+.|+|||++.+..++.++|||||||+||||++ |..||.+.... +.+..+......
T Consensus 490 ~~~~----~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~---~~~~~i~~~~~~---- 558 (613)
T 2ozo_A 490 DSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQGKRM---- 558 (613)
T ss_dssp ----------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH---HHHHHHHTTCCC----
T ss_pred Ccee----eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHcCCCC----
Confidence 2211 11123356789999999999999999999999999999998 99999886543 333333332211
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccc
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDW 290 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw 290 (474)
.....+|+++.+||..||..||++||++.+|++.|++++...+...+...++
T Consensus 559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~~~~s~l 610 (613)
T 2ozo_A 559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGGSAL 610 (613)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSCCCSSSC
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccccCCccce
Confidence 1235789999999999999999999999999999999998877665544433
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=349.29 Aligned_cols=268 Identities=19% Similarity=0.219 Sum_probs=206.1
Q ss_pred ccCCcE-EEeeeeeecCceEEEEEEE----cCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEe-
Q 011945 4 RVGNKF-RLGRKIGSGSFGEIYLGTN----IQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVE- 74 (474)
Q Consensus 4 ~i~~~y-~i~~~LG~G~fG~Vy~a~~----~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~- 74 (474)
.+.++| +++++||+|+||+||++.. ..+++.||||++..... ...+.+|+.+++.++|++++..+..+...
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 456666 9999999999999988764 34789999999876543 23588999999999976666555554443
Q ss_pred CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCc
Q 011945 75 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (474)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (474)
....++||||+ +++|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFGLA 181 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGC
T ss_pred CceEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---cCCCCEEECCcccc
Confidence 57889999999 7799999973 459999999999999999999999999999999999999 47789999999999
Q ss_pred cccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcC--------cHHHHH
Q 011945 154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG--------TKKQKY 225 (474)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~--------~~~~~~ 225 (474)
..+....... .......||..|+|||++.+..++.++|||||||++|+|++|..||...... ......
T Consensus 182 ~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 257 (318)
T 3lxp_A 182 KAVPEGHEYY----RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV 257 (318)
T ss_dssp EECCTTCSEE----EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHH
T ss_pred cccccccccc----ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhH
Confidence 8775533211 1223457889999999999999999999999999999999999999652110 000000
Q ss_pred HHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 226 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
..+...............+++++.+||..||..||++||++.+|++.|+.+..+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 258 LRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 0000000000011123568899999999999999999999999999999997654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=337.56 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=203.5
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
...++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+|+.+++.++| ++|..+..++......
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH-PNILRLYGYFHDATRV 84 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCC-CCCcchhheEecCCEE
Confidence 3457899999999999999999999999999999987432 234568899999999985 5555666666778889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
+++|||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESCC-
T ss_pred EEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEeccccccCC
Confidence 9999999 68999998754 569999999999999999999999999999999999999 478899999999986544
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.... ....+..+......
T Consensus 161 ~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~--- 225 (279)
T 3fdn_A 161 SSR---------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT---YQETYKRISRVEFT--- 225 (279)
T ss_dssp ----------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCC---
T ss_pred ccc---------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc---HHHHHHHHHhCCCC---
Confidence 322 134578999999999999999999999999999999999999998643 33333433332221
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
+...+++++.+||..||..||++||++.+| |++.|..
T Consensus 226 --~~~~~~~~~~~li~~~l~~~p~~Rps~~e~---l~h~~~~ 262 (279)
T 3fdn_A 226 --FPDFVTEGARDLISRLLKHNPSQRPMLREV---LEHPWIT 262 (279)
T ss_dssp --CCTTSCHHHHHHHHHHCCSSGGGSCCHHHH---HHCHHHH
T ss_pred --CCCcCCHHHHHHHHHHhccChhhCCCHHHH---hhCcccc
Confidence 234578999999999999999999998777 4455543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=345.79 Aligned_cols=255 Identities=18% Similarity=0.234 Sum_probs=201.1
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEEcCCC-------eEEEEEEeccCC--CchHHHHHHHHHHHhcCCCCCceeEEEeE
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTN-------EEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGV 73 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~-------~~vAvK~~~~~~--~~~~l~~E~~il~~l~~~~~i~~l~~~~~ 73 (474)
.+..++|++.+.||+|+||.||+|.+..++ ..||+|++.... ....+.+|+.+++.++|++ |..+..++.
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~ 82 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH-LVLNYGVCV 82 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTT-BCCEEEEEC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCC-EeEEEEEEE
Confidence 345679999999999999999999988776 479999875432 2356889999999998555 555555566
Q ss_pred eCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCC-----CCeEEE
Q 011945 74 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRR-----ANQVYI 147 (474)
Q Consensus 74 ~~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~-----~~~vkL 147 (474)
.+...++||||+ +++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||++.+.. .+.+||
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence 677789999999 68999999866556999999999999999999999999999999999999963321 122999
Q ss_pred EecCCccccccCCCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcCcHHHHH
Q 011945 148 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGTKKQKY 225 (474)
Q Consensus 148 ~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG-~~Pf~~~~~~~~~~~~ 225 (474)
+|||++...... ....||..|+|||++.+ ..++.++|||||||++|||++| ..||..... ....
T Consensus 163 ~Dfg~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~---~~~~ 228 (289)
T 4fvq_A 163 SDPGISITVLPK-----------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS---QRKL 228 (289)
T ss_dssp CCCCSCTTTSCH-----------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH---HHHH
T ss_pred ccCcccccccCc-----------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch---HHHH
Confidence 999999755332 12368899999999998 6799999999999999999995 455544322 2222
Q ss_pred HHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 226 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
..... . ..+...+++++.+++..||+.||++||++.++++.|++++.
T Consensus 229 ~~~~~-~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 229 QFYED-R-----HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHHHT-T-----CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred HHhhc-c-----CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11111 1 11234567899999999999999999999999999988764
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=351.51 Aligned_cols=260 Identities=16% Similarity=0.216 Sum_probs=175.5
Q ss_pred ccCCcEEEee-eeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHH-HHhcCCCCCceeEEEeE---eCCEE
Q 011945 4 RVGNKFRLGR-KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLY-KILQGGTGIPNLRWFGV---EGDYN 78 (474)
Q Consensus 4 ~i~~~y~i~~-~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il-~~l~~~~~i~~l~~~~~---~~~~~ 78 (474)
.+.++|.+.+ .||+|+||.||+|.+..+++.||||++.. ......|+..+ +.+.|++++..+..+.. .....
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD---SPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEES---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecC---cHHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 4678999965 59999999999999999999999999864 23444555544 44444444444444433 14568
Q ss_pred EEEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
++||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++..+.+||+|||+++..
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 9999999 779999998543 46999999999999999999999999999999999999975555677999999999865
Q ss_pred ccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHH-HHHhhccccc
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-EKISEKKVST 235 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~-~~i~~~~~~~ 235 (474)
..... ....||+.|+|||++.+..++.++|||||||++|+|++|..||............ ..+.......
T Consensus 182 ~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (336)
T 3fhr_A 182 TQNAL---------QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252 (336)
T ss_dssp -------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CC
T ss_pred ccccc---------ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc
Confidence 53321 3457899999999999888999999999999999999999999765432211111 1111111111
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
.......+++++.+||..||..||++||++.++ |++.|.+
T Consensus 253 -~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el---l~hp~~~ 292 (336)
T 3fhr_A 253 -PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQF---MNHPWIN 292 (336)
T ss_dssp -CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH---HHSHHHH
T ss_pred -CchhhccCCHHHHHHHHHHCCCChhHCcCHHHH---hcCcccc
Confidence 111224689999999999999999999998776 4455544
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-43 Score=348.67 Aligned_cols=268 Identities=20% Similarity=0.328 Sum_probs=201.4
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhc-CCCCCceeEEEeEeC----CEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ-GGTGIPNLRWFGVEG----DYN 78 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~-~~~~i~~l~~~~~~~----~~~ 78 (474)
.+.++|+++++||+|+||.||+|++ +++.||||++... .......|.+++..+. .|++|..+..+.... ...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTT-EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred ccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEecc-ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 4567899999999999999999996 4899999998643 3344566666666552 345555555555444 788
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCcEEeeeCCCCCeEEEEe
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--------SFLHRDIKPDNFLMGLGRRANQVYIID 149 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~--------gIiHrDIKP~NILl~~~~~~~~vkL~D 149 (474)
++||||+ +++|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|
T Consensus 111 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kl~D 185 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIAD 185 (337)
T ss_dssp EEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECC
T ss_pred EEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCCCCEEEEe
Confidence 9999999 7799999974 4699999999999999999999998 99999999999999 4778999999
Q ss_pred cCCccccccCCCccccccccCCCCccCccccccccccCCCCCch------hhHHHHHHHHHHHHhC----------CCCC
Q 011945 150 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRR------DDLESLGYVLMYFLRG----------SLPW 213 (474)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~k------sDIwSlGvil~elltG----------~~Pf 213 (474)
||+++.+......... ......||+.|+|||++.+...+.. +|||||||++|||++| ..||
T Consensus 186 fg~a~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 186 LGLAVKFISDTNEVDI---PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp CTTCEECC------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred CCCceeeccccccccC---CCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 9999876554332111 1234589999999999988766554 9999999999999999 7888
Q ss_pred CCCCcCc-HHHHHHH-HhhccccchHHH--HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 011945 214 QGLKAGT-KKQKYEK-ISEKKVSTSIEA--LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGF 282 (474)
Q Consensus 214 ~~~~~~~-~~~~~~~-i~~~~~~~~~~~--l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~ 282 (474)
....... ....+.. +.........+. ....+++++.+||..||+.||++||++.+|++.|+.+......
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 335 (337)
T 3mdy_A 263 HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDI 335 (337)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTTC
T ss_pred hhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhccc
Confidence 7643322 1122222 222111111111 1134678899999999999999999999999999999876654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=364.64 Aligned_cols=253 Identities=21% Similarity=0.294 Sum_probs=208.1
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
...++|.+++.||+|+||.||+|++..+|+.||||++... .....+.+|+.+++.++|++ |..+..+.......
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~Hpn-Iv~l~~~~~~~~~~ 91 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH-IIKLYQVISTPSDI 91 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTT-BCCEEEEEECSSEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCC-CCcEEEEEEECCEE
Confidence 4567899999999999999999999999999999998543 23356889999999998655 55555566677889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
++||||+ |++|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 92 ~lv~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 92 FMVMEYVSGGELFDYIC-KNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEEEECCSSEEHHHHTT-SSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSSCEECC
T ss_pred EEEEeCCCCCcHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccchhhcc
Confidence 9999999 889999987 35579999999999999999999999999999999999999 477899999999998765
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccch
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (474)
.... ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+... ...+.++......
T Consensus 168 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~---~~~~~~i~~~~~~-- 234 (476)
T 2y94_A 168 DGEF--------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV---PTLFKKICDGIFY-- 234 (476)
T ss_dssp TTCC--------BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS---HHHHHHHHTTCCC--
T ss_pred cccc--------ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH---HHHHHHHhcCCcC--
Confidence 4322 234589999999999998775 7899999999999999999999987443 3344444443322
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
....+++++.+||..||..||++||++.+| +++.+.+.
T Consensus 235 ---~p~~~s~~~~~Li~~~L~~dP~~Rpt~~ei---l~hp~~~~ 272 (476)
T 2y94_A 235 ---TPQYLNPSVISLLKHMLQVDPMKRATIKDI---REHEWFKQ 272 (476)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHH---HTCHHHHT
T ss_pred ---CCccCCHHHHHHHHHHcCCCchhCcCHHHH---HhCHHhhh
Confidence 234578999999999999999999998776 44444443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=351.20 Aligned_cols=263 Identities=23% Similarity=0.339 Sum_probs=202.5
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-------CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-------~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
+.++|++.++||+|+||.||+|.+..+++.||||++... .....+.+|+.+++.++| ++|..+..++.....
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~ 102 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH-PNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCC-CCcceeehhhccCCe
Confidence 457899999999999999999999999999999987542 223568899999999985 455555566677889
Q ss_pred EEEEEecC-CCCHHHHHHHc---------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 011945 78 NVLVIDLL-GPSLEDLFNFC---------------------------------------SRKLSLKTVLMLADQMINRVE 117 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~---------------------------------------~~~l~~~~~~~i~~qi~~gL~ 117 (474)
.++||||+ +++|.+++... ...+++..++.|+.||+.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 99999999 89999988411 112467889999999999999
Q ss_pred HHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccC--CCCCchhh
Q 011945 118 FVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDD 195 (474)
Q Consensus 118 yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksD 195 (474)
|||++||+||||||+|||++. +....+||+|||+++.+....... ........||+.|+|||++.+ ..++.++|
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGE---YYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC-----------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHCCccccCCChhhEEEec-CCCceEEEeeccccccccccCccc---cccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999999999999999952 122389999999998765432211 112245679999999999976 67899999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011945 196 LESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 275 (474)
Q Consensus 196 IwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (474)
||||||+||||++|..||.+... ...+..+......... .....+++++.+||..||+.||++||++.++ |++
T Consensus 259 iwslG~il~el~~g~~pf~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~---l~h 331 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVND---ADTISQVLNKKLCFEN-PNYNVLSPLARDLLSNLLNRNVDERFDAMRA---LQH 331 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCTTS-GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHH---HHS
T ss_pred HHHHHHHHHHHHHCCCCCCCCCh---HHHHHHHHhcccccCC-cccccCCHHHHHHHHHHcCCChhHCCCHHHH---hcC
Confidence 99999999999999999987543 3334444433332221 1224578999999999999999999998776 555
Q ss_pred HHHH
Q 011945 276 LFIR 279 (474)
Q Consensus 276 l~~~ 279 (474)
.|.+
T Consensus 332 p~~~ 335 (345)
T 3hko_A 332 PWIS 335 (345)
T ss_dssp HHHH
T ss_pred hhhc
Confidence 5544
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=342.72 Aligned_cols=252 Identities=20% Similarity=0.348 Sum_probs=196.3
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeEe------CC
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVE------GD 76 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~~------~~ 76 (474)
...++|++++.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.+|++|..+..+... ..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 35689999999999999999999999999999999986543 456789999999999656666665555443 56
Q ss_pred EEEEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 77 YNVLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
..++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~ 177 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSA 177 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCTTTC
T ss_pred eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE---cCCCCEEEeeCcCce
Confidence 889999999 66999999754 3569999999999999999999999999999999999999 477899999999998
Q ss_pred ccccCCCccccccccCCCCccCcccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHh
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (474)
.+..... ......||+.|+|||++. +..++.++|||||||++|+|++|..||.+... ...+..+.
T Consensus 178 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~ 247 (326)
T 2x7f_A 178 QLDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP---MRALFLIP 247 (326)
T ss_dssp --------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHH
T ss_pred ecCcCcc-------ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH---HHHHHHhh
Confidence 6643221 123457999999999997 55689999999999999999999999976432 22222222
Q ss_pred hccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
...... .....++.++.+||..||..||++||++.++++
T Consensus 248 ~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 248 RNPAPR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp HSCCCC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cCcccc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 221111 113567899999999999999999999887743
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=349.35 Aligned_cols=252 Identities=23% Similarity=0.312 Sum_probs=199.3
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----------CchHHHHHHHHHHHhcCCCCCceeEEEeEe
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----------KHPQLQYEAKLYKILQGGTGIPNLRWFGVE 74 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----------~~~~l~~E~~il~~l~~~~~i~~l~~~~~~ 74 (474)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.|++++..+..+ ..
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~ 86 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DA 86 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEE-ES
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEE-cC
Confidence 4578999999999999999999999999999999876432 123478999999999876666555444 44
Q ss_pred CCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCc
Q 011945 75 GDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (474)
Q Consensus 75 ~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (474)
+. .++||||+ +++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVV-GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHS-TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred Cc-eEEEEecCCCCcHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 43 78999999 779999886 3567999999999999999999999999999999999999964444556999999999
Q ss_pred cccccCCCccccccccCCCCccCcccccccccc---CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhh
Q 011945 154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (474)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (474)
+....... .....||+.|+|||++. +..++.++|||||||++|+|++|..||......... ...+..
T Consensus 165 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~ 234 (322)
T 2ycf_A 165 KILGETSL--------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQITS 234 (322)
T ss_dssp EECCCCHH--------HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--HHHHHH
T ss_pred eecccccc--------cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--HHHHHh
Confidence 87644221 12346899999999974 456899999999999999999999999865443221 122222
Q ss_pred ccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
... ...+.....+++++.+||..||..||++||++.+++
T Consensus 235 ~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l 273 (322)
T 2ycf_A 235 GKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEAL 273 (322)
T ss_dssp TCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred Ccc-ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHh
Confidence 222 223345578899999999999999999999988775
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=349.71 Aligned_cols=255 Identities=16% Similarity=0.169 Sum_probs=195.3
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-------------chHHHHHHHHHHHhcCCCCCceeEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-------------HPQLQYEAKLYKILQGGTGIPNLRW 70 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-------------~~~l~~E~~il~~l~~~~~i~~l~~ 70 (474)
.+.++|++++.||+|+||.||+|.+. +++.||||++..... ...+.+|+.+++.++|++++..+..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 35789999999999999999999974 499999998754322 1568999999999997777666665
Q ss_pred EeE----eCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEE
Q 011945 71 FGV----EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 146 (474)
Q Consensus 71 ~~~----~~~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vk 146 (474)
+.. .....++||||++++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~~~~k 174 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDIT 174 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEE
T ss_pred EEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---cCCCCEE
Confidence 543 234789999999999999998666679999999999999999999999999999999999999 4778999
Q ss_pred EEecCCccccccCCCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHH
Q 011945 147 IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 225 (474)
Q Consensus 147 L~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~ 225 (474)
|+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+
T Consensus 175 l~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i 246 (362)
T 3pg1_A 175 ICDFNLAREDTADAN--------KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKI 246 (362)
T ss_dssp ECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred EEecCcccccccccc--------cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999975443322 234578999999999987 67899999999999999999999999875432222222
Q ss_pred HHHhhc------------------------cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 226 EKISEK------------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 226 ~~i~~~------------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
...... ............+++.+.+||..||..||++||++.+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 315 (362)
T 3pg1_A 247 VEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQAL 315 (362)
T ss_dssp HHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred HHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHH
Confidence 111110 011122334456789999999999999999999977763
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=348.53 Aligned_cols=256 Identities=23% Similarity=0.331 Sum_probs=209.4
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
+...++|.+.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.+++.+.|++ |..+..++.....
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~ 115 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH-VVGFHGFFEDNDF 115 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTT-BCCEEEEEECSSE
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCC-CCeEEEEEecCCe
Confidence 456789999999999999999999999999999999876542 2245788999999997554 5555566677888
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
.+++|||+ +++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||++...
T Consensus 116 ~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 116 VFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKV 191 (335)
T ss_dssp EEEEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---cCCCCEEEeeccCceec
Confidence 99999999 6899999874 3579999999999999999999999999999999999999 47789999999999876
Q ss_pred ccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccch
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (474)
...... .....||..|+|||++.+..++.++|||||||++|+|++|..||.... ....+..+......
T Consensus 192 ~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~-- 259 (335)
T 2owb_A 192 EYDGER-------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LKETYLRIKKNEYS-- 259 (335)
T ss_dssp CSTTCC-------BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCC--
T ss_pred ccCccc-------ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHHhcCCCC--
Confidence 533221 234579999999999999999999999999999999999999997643 23333333332221
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Q 011945 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 281 (474)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~ 281 (474)
+...+++++.+||..||..||++||++++| |++.|...+
T Consensus 260 ---~~~~~~~~~~~li~~~l~~dp~~Rps~~el---l~~~~~~~~ 298 (335)
T 2owb_A 260 ---IPKHINPVAASLIQKMLQTDPTARPTINEL---LNDEFFTSG 298 (335)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCGGGG---GGSHHHHTS
T ss_pred ---CCccCCHHHHHHHHHHccCChhHCcCHHHH---hcCccccCC
Confidence 235678999999999999999999997776 555554443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=351.90 Aligned_cols=244 Identities=19% Similarity=0.247 Sum_probs=200.4
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----------CchHHHHHHHHHHHhcCCCCCceeEEEeEe
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----------KHPQLQYEAKLYKILQGGTGIPNLRWFGVE 74 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----------~~~~l~~E~~il~~l~~~~~i~~l~~~~~~ 74 (474)
+.++|+++++||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++| ++|..+..++..
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~~~~~~~~ 100 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH-ANIIKVLDIFEN 100 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCC-TTBCCEEEEEEC
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCC-CCEeeEEEEEee
Confidence 4578999999999999999999999999999999887543 22357889999999975 455555556677
Q ss_pred CCEEEEEEecC-CC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCC
Q 011945 75 GDYNVLVIDLL-GP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (474)
Q Consensus 75 ~~~~~lv~e~~-g~-sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (474)
....++|||++ ++ +|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~Dfg~ 176 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIA---EDFTIKLIDFGS 176 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTSCEEECCCTT
T ss_pred CCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEc---CCCcEEEeeccc
Confidence 88899999988 33 99999873 45799999999999999999999999999999999999994 778999999999
Q ss_pred ccccccCCCccccccccCCCCccCccccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc
Q 011945 153 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (474)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (474)
++....... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ....
T Consensus 177 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------~~~~ 239 (335)
T 3dls_A 177 AAYLERGKL--------FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE---------TVEA 239 (335)
T ss_dssp CEECCTTCC--------BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------GTTT
T ss_pred ceECCCCCc--------eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------HHhh
Confidence 987654332 123579999999999998886 8999999999999999999999976321 1111
Q ss_pred cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 232 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
.. .....+++++.+||..||..||++||++.+| |++.|.
T Consensus 240 ~~-----~~~~~~~~~l~~li~~~L~~dP~~Rps~~el---l~hp~~ 278 (335)
T 3dls_A 240 AI-----HPPYLVSKELMSLVSGLLQPVPERRTTLEKL---VTDPWV 278 (335)
T ss_dssp CC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHH---HHCTTT
T ss_pred cc-----CCCcccCHHHHHHHHHHccCChhhCcCHHHH---hcCccc
Confidence 11 1124578999999999999999999997766 445443
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=337.03 Aligned_cols=251 Identities=18% Similarity=0.201 Sum_probs=206.8
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----------chHHHHHHHHHHHhcCCCCCceeEEEe
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----------HPQLQYEAKLYKILQGGTGIPNLRWFG 72 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----------~~~l~~E~~il~~l~~~~~i~~l~~~~ 72 (474)
.+.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+.+|++|..+..++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 356899999999999999999999999999999999865431 234778999999998677777777777
Q ss_pred EeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecC
Q 011945 73 VEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (474)
Q Consensus 73 ~~~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFG 151 (474)
......++|||++ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg 169 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFG 169 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCT
T ss_pred ccCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---cCCCcEEEeccc
Confidence 8889999999999 6899999974 3579999999999999999999999999999999999999 477899999999
Q ss_pred CccccccCCCccccccccCCCCccCcccccccccc------CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHH
Q 011945 152 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL------GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY 225 (474)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~------~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~ 225 (474)
++........ .....||+.|+|||++. ...++.++|||||||++|+|++|..||.+.. .....
T Consensus 170 ~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~ 238 (298)
T 1phk_A 170 FSCQLDPGEK--------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLML 238 (298)
T ss_dssp TCEECCTTCC--------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHH
T ss_pred chhhcCCCcc--------cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc---HHHHH
Confidence 9987654322 13457999999999986 4568999999999999999999999997743 23333
Q ss_pred HHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 226 EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 226 ~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
..+......... .....++.++.++|..||..||++||++.+++
T Consensus 239 ~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 282 (298)
T 1phk_A 239 RMIMSGNYQFGS-PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 282 (298)
T ss_dssp HHHHHTCCCCCT-TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred HHHhcCCcccCc-ccccccCHHHHHHHHHHccCCcccCCCHHHHH
Confidence 444333322211 12346789999999999999999999987764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=345.38 Aligned_cols=256 Identities=22% Similarity=0.246 Sum_probs=196.6
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
..++|++++.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.++|+ +|..+..++......++
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE-NLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCT-TBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCC-CEeeEEEEeecCCEEEE
Confidence 457899999999999999999999999999999987654432 3367899999999854 55555566678888999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 81 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 81 v~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
||||+.+.+.+.+......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+....
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC-------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCceeecCCc
Confidence 99999555444444356679999999999999999999999999999999999999 477899999999998665432
Q ss_pred CccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc--------
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK-------- 231 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~-------- 231 (474)
. ......||..|+|||++.+. .++.++|||||||++|+|++|..||.+.........+......
T Consensus 179 ~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (331)
T 4aaa_A 179 E-------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL 251 (331)
T ss_dssp ------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred c-------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhH
Confidence 2 11345789999999999876 6899999999999999999999999875432222222111110
Q ss_pred ---------------cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 232 ---------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 232 ---------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
............+++++.+||..||..||++||++.+|++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0111223334578999999999999999999999887643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=351.02 Aligned_cols=250 Identities=21% Similarity=0.288 Sum_probs=196.9
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeEeCC----
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGD---- 76 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~~~~---- 76 (474)
+.++|.+.+.||+|+||.||+|.+..+|+.||||++...... ..+.+|+.+++.++|++++..+..+.....
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 568999999999999999999999999999999998754332 457899999999997766666665544332
Q ss_pred -EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 77 -YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 77 -~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
..++||||++++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 120 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 120 YDFYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARH 193 (371)
T ss_dssp CCCEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECSTTCC--
T ss_pred eeEEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---CCCCCEEEEecCcccc
Confidence 239999999999888774 459999999999999999999999999999999999999 4778999999999986
Q ss_pred cccCCCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc---
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--- 231 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~--- 231 (474)
..... ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+......
T Consensus 194 ~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 263 (371)
T 4exu_A 194 ADAEM----------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGT 263 (371)
T ss_dssp ----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred cccCc----------CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcH
Confidence 54322 34578999999999987 67999999999999999999999999875432222222111110
Q ss_pred --------------------cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 232 --------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 232 --------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
........+...+++++.+||..||..||++||++.+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell 322 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 322 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHh
Confidence 011122334456789999999999999999999977663
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=341.27 Aligned_cols=260 Identities=18% Similarity=0.284 Sum_probs=199.1
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcC---CCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeEeCC--
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGD-- 76 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~~~~-- 76 (474)
.++|++.+.||+|+||.||+|.+.. +++.||||++...... ..+.+|+.+++.++|++++..+..+.....
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 33 RNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 4689999999999999999998765 5568999998755332 348889999999997766666655543322
Q ss_pred --EEEEEEecC-CCCHHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEE
Q 011945 77 --YNVLVIDLL-GPSLEDLFNFC-----SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148 (474)
Q Consensus 77 --~~~lv~e~~-g~sL~~li~~~-----~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~ 148 (474)
..+++|||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE---CTTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEEe
Confidence 458999999 78999998532 3569999999999999999999999999999999999999 477899999
Q ss_pred ecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHH
Q 011945 149 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEK 227 (474)
Q Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~ 227 (474)
|||+++.+...... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+....... ..
T Consensus 190 Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~ 261 (313)
T 3brb_A 190 DFGLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY---DY 261 (313)
T ss_dssp SCSCC---------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---HH
T ss_pred ecCcceeccccccc-----CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH---HH
Confidence 99999876543221 11234467889999999999999999999999999999999 99999876544332 22
Q ss_pred HhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
+..... ......+++++.++|..||..||++||++.+|++.|++++.+.
T Consensus 262 ~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 262 LLHGHR----LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp HHTTCC----CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHcCCC----CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 222211 1123578899999999999999999999999999999998653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=362.79 Aligned_cols=255 Identities=22% Similarity=0.362 Sum_probs=202.3
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
.++|++.++||+|+||.||+|.+. .+..||||+++... ..+.+.+|+.+++.|+|++++..+..+ .. ...+|||||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-~~-~~~~iv~e~ 259 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SE-EPIYIVTEY 259 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-CS-SSCEEEECC
T ss_pred hhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEE-cC-CceEEEehh
Confidence 467999999999999999999985 45679999987644 345789999999999976666655444 33 567899999
Q ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 85 ~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~---~~~~~kl~DfG~a~~~~~~~~- 335 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEY- 335 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCCTTC--------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEC---CCCCEEECCCccceecCCCce-
Confidence 9 78999999743 35699999999999999999999999999999999999994 678999999999987654321
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
.......+|..|+|||++.+..++.++|||||||+||||++ |..||.+... .+.+..+...... ...
T Consensus 336 -----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~----~~~ 403 (452)
T 1fmk_A 336 -----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYRM----PCP 403 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC----CCC
T ss_pred -----ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CCC
Confidence 11233467889999999999999999999999999999999 9999987543 3333333322111 123
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
..+|+++.+||..||..||++||++++|++.|++++..
T Consensus 404 ~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 57899999999999999999999999999999987643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=354.29 Aligned_cols=257 Identities=19% Similarity=0.288 Sum_probs=202.5
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
....++|+++++||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++| ++|..+..++..+...+
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 107 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGEIS 107 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCC-TTBCCEEEEEEETTEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCC-CCEEEEeEEEEECCEEE
Confidence 4557899999999999999999999999999999999876533 2458899999999975 45555555667788899
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~-gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
+||||+ +++|.+++... ..+++..++.|+.||+.||.|||++ ||+||||||+|||++ .++.+||+|||++....
T Consensus 108 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp EEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC---TTCCEEECCCCCCHHHH
T ss_pred EEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEEC---CCCCEEEEECCCCcccc
Confidence 999999 77999999753 4699999999999999999999996 999999999999994 77899999999997654
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHH------------
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY------------ 225 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~------------ 225 (474)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+
T Consensus 184 ~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3eqc_A 184 DSM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 254 (360)
T ss_dssp HHC-------------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------
T ss_pred ccc---------ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCC
Confidence 322 13458999999999999999999999999999999999999999764432111111
Q ss_pred ---------------------------HHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 226 ---------------------------EKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 226 ---------------------------~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
..+....... .....++.++.+||..||..||++||+++++ |++.|.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el---l~hp~~ 328 (360)
T 3eqc_A 255 PRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPK---LPSGVFSLEFQDFVNKCLIKNPAERADLKQL---MVHAFI 328 (360)
T ss_dssp -------------------CCCHHHHHHHHHHSCCCC---CCTTTSCHHHHHHHHHHHCSSTTTSCCHHHH---HTSHHH
T ss_pred CCcccCCCcccccccCCCCcccchhhhhHHhccCCCC---CCcccccHHHHHHHHHHhhcChhhCCCHHHH---hhChHh
Confidence 0000000000 0012468899999999999999999998877 444443
Q ss_pred H
Q 011945 279 R 279 (474)
Q Consensus 279 ~ 279 (474)
+
T Consensus 329 ~ 329 (360)
T 3eqc_A 329 K 329 (360)
T ss_dssp H
T ss_pred h
Confidence 3
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=339.33 Aligned_cols=256 Identities=22% Similarity=0.320 Sum_probs=209.4
Q ss_pred CCccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhcCCCCCceeEEEeEeCC
Q 011945 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 76 (474)
Q Consensus 2 ~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (474)
++...++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.+.|+ +|..+..++....
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~ 88 (294)
T 2rku_A 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ-HVVGFHGFFEDND 88 (294)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCT-TBCCEEEEEECSS
T ss_pred CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCC-CEeeeeeeeccCC
Confidence 45678899999999999999999999999999999998765421 24578899999999755 5555556667788
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
..+++||++ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATK 164 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred EEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---cCCCCEEEEeccCcee
Confidence 899999999 6899998874 3579999999999999999999999999999999999999 4778999999999987
Q ss_pred cccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccc
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+.+..+......
T Consensus 165 ~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~- 233 (294)
T 2rku_A 165 VEYDGER-------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LKETYLRIKKNEYS- 233 (294)
T ss_dssp CCSTTCC-------BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTCCC-
T ss_pred cccCccc-------cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhhccCC-
Confidence 6533221 234579999999999999899999999999999999999999998743 23333333332221
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
+...+++++.+++..||..||++||+++++ |++.+...
T Consensus 234 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l---l~~~~~~~ 271 (294)
T 2rku_A 234 ----IPKHINPVAASLIQKMLQTDPTARPTINEL---LNDEFFTS 271 (294)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCGGGG---GGSHHHHT
T ss_pred ----CccccCHHHHHHHHHHcccChhhCcCHHHH---hhChheec
Confidence 235678999999999999999999998776 44555444
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=337.05 Aligned_cols=251 Identities=18% Similarity=0.282 Sum_probs=186.3
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCch---HHHHHHHH-HHHhcCCCCCceeEEEeEeCCEEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP---QLQYEAKL-YKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~---~l~~E~~i-l~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
+..++|+++++||+|+||.||+|.+..+++.||||++....... .+..|... ++.+. |++|..+..+...+...+
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~-h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVD-CPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSSEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCC-CCeEEEEeeeeeccCCEE
Confidence 34578999999999999999999999999999999986543322 23334333 44444 566666666667778889
Q ss_pred EEEecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 80 LVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 80 lv~e~~g~sL~~li~~---~~~~l~~~~~~~i~~qi~~gL~yLHs~-gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
+||||++++|.+++.. ....+++..++.|+.||+.||.|||++ ||+||||||+|||+ +..+.+||+|||+++.
T Consensus 83 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGISGY 159 (290)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---CTTCCEEBCCC-----
T ss_pred EEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecCCccc
Confidence 9999999899888764 356799999999999999999999998 99999999999999 4678999999999987
Q ss_pred cccCCCccccccccCCCCccCccccccccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTH----LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~----~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (474)
...... .....||+.|+|||++ .+..++.++|||||||++|+|++|..||..... ....+......
T Consensus 160 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~ 229 (290)
T 3fme_A 160 LVDDVA--------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT--PFQQLKQVVEE 229 (290)
T ss_dssp ------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC--HHHHHHHHHHS
T ss_pred cccccc--------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc--hHHHHHHHhcc
Confidence 654322 1234799999999996 556789999999999999999999999976432 22223322222
Q ss_pred cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 232 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
..... ....+++++.+++..||..||++||++.++++
T Consensus 230 ~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 230 PSPQL---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCc---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 21111 12467899999999999999999999888754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=336.69 Aligned_cols=256 Identities=24% Similarity=0.340 Sum_probs=204.1
Q ss_pred CCCccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
|...+.++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++|+ +|..+..+...+..
T Consensus 1 M~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~ 79 (276)
T 2yex_A 1 MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE-NVVKFYGHRREGNI 79 (276)
T ss_dssp -CHHHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCT-TBCCEEEEEEETTE
T ss_pred CCCceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCC-CceeeeeEEEcCCE
Confidence 344456789999999999999999999999999999999864432 35688999999999755 55555566677888
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
.++|||++ +++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..+
T Consensus 80 ~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---ERDNLKISDFGLATVF 155 (276)
T ss_dssp EEEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCTTCEEC
T ss_pred EEEEEEecCCCcHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEc---cCCCEEEeeCCCcccc
Confidence 99999999 679998886 345699999999999999999999999999999999999994 7789999999999876
Q ss_pred ccCCCccccccccCCCCccCccccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccc
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
....... ......||..|+|||++.+..+ +.++|||||||++|||++|..||........ .+..+.......
T Consensus 156 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~ 228 (276)
T 2yex_A 156 RYNNRER-----LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKEKKTYL 228 (276)
T ss_dssp EETTEEC-----CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HHHHHHTTCTTS
T ss_pred CCCcchh-----cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHhhhccccc
Confidence 5432111 1234679999999999988775 7899999999999999999999987554322 122222211111
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.....+++++.++|..||..||++||++++|++
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 113467899999999999999999999877643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=336.49 Aligned_cols=246 Identities=22% Similarity=0.342 Sum_probs=204.1
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.+.|+++++||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.|+ +|..+..++......++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP-YVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCT-TBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCC-CEeEEEEEEecCCeEEEEE
Confidence 467999999999999999999999999999999986543 235689999999999754 5555555666788899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
||+ +++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..+.....
T Consensus 100 e~~~~~~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 100 EYLGGGSALDLLE--PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp ECCTTEEHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECBTTBC
T ss_pred EeCCCCcHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---CCCCCEEEeecccceecCcccc
Confidence 999 679999986 4579999999999999999999999999999999999999 4778999999999987654322
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ......+..... ..+.
T Consensus 175 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~----~~~~ 240 (303)
T 3a7i_A 175 -------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP---MKVLFLIPKNNP----PTLE 240 (303)
T ss_dssp -------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCC----CCCC
T ss_pred -------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH---HHHHHHhhcCCC----CCCc
Confidence 12345799999999999999999999999999999999999999986533 222222222221 1234
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
..++.++.+||..||..||++||++.+|++
T Consensus 241 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 241 GNYSKPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp SSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 578999999999999999999999888754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-42 Score=334.16 Aligned_cols=246 Identities=18% Similarity=0.266 Sum_probs=203.7
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
...++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+|+.+++.++|++ |..+..+.......
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN-ILRMYNYFHDRKRI 89 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTT-BCCEEEEEECSSEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCC-EeeEEEEEEcCCEE
Confidence 3457899999999999999999999999999999987532 23456889999999998554 55555566677889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
+++||++ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHAP 165 (284)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECS
T ss_pred EEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---cCCCCEEEecccccccCc
Confidence 9999999 67999999754 469999999999999999999999999999999999999 477899999999997654
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.... .......+......
T Consensus 166 ~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~~--- 230 (284)
T 2vgo_A 166 SLR---------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS---HTETHRRIVNVDLK--- 230 (284)
T ss_dssp SSC---------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTCCC---
T ss_pred ccc---------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC---HhHHHHHHhccccC---
Confidence 322 134579999999999999999999999999999999999999997643 23333333332221
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
+...++.++.++|..||..||++||+++++++
T Consensus 231 --~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 231 --FPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp --CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 23567899999999999999999999887743
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=334.06 Aligned_cols=248 Identities=21% Similarity=0.304 Sum_probs=201.3
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeE---eCCEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGV---EGDYN 78 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~---~~~~~ 78 (474)
+..|++.+.||+|+||.||+|.+..++..||+|++..... ...+.+|+.+++.++|++++..+..+.. .....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 5569999999999999999999999999999998765432 2347889999999987776666655543 35678
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~g--IiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
++||||+ +++|.+++... ..+++..++.|+.||+.||.|||++| |+||||||+|||++ ...+.+||+|||++..
T Consensus 105 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGGG
T ss_pred EEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCccc
Confidence 9999999 78999999743 57999999999999999999999999 99999999999994 3678999999999975
Q ss_pred cccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccc
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
...... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||..... ....+..+......
T Consensus 182 ~~~~~~---------~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~- 248 (290)
T 1t4h_A 182 KRASFA---------KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVKP- 248 (290)
T ss_dssp CCTTSB---------EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCCC-
T ss_pred cccccc---------ccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc--HHHHHHHHhccCCc-
Confidence 443321 23579999999998875 589999999999999999999999987432 33333333332222
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
..+...+++++.++|..||..||++||++.+|++
T Consensus 249 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 249 --ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 2234567899999999999999999999887743
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=353.36 Aligned_cols=253 Identities=18% Similarity=0.229 Sum_probs=195.6
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeC-----CEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEG-----DYNV 79 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~-----~~~~ 79 (474)
...+|+++++||+|+||.||+|++..+++ ||+|.+.... ....+|+.+++.++|++++..+..+...+ .+.+
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~--~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDK--RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCT--TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCc--chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 45689999999999999999999876665 8888664332 22357999999999777776666554332 3578
Q ss_pred EEEecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 80 LVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 80 lv~e~~g~sL~~li~~---~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
+||||+.++|.+.+.. ....+++..++.|+.||+.||.|||++||+||||||+||||+ ..++.+||+|||+|+.+
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEEC
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CCCCcEEEeeCCCcccc
Confidence 9999998887766542 356799999999999999999999999999999999999995 36789999999999876
Q ss_pred ccCCCccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc---
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--- 232 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~--- 232 (474)
..... .....||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.........+.+.....
T Consensus 193 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 264 (394)
T 4e7w_A 193 IAGEP--------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE 264 (394)
T ss_dssp CTTCC--------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cCCCC--------CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 54332 2345789999999999875 48999999999999999999999998854332222222211100
Q ss_pred ------------------ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 233 ------------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 233 ------------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.......+...+++++.+||.+||..||.+||++.+++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 320 (394)
T 4e7w_A 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEAL 320 (394)
T ss_dssp HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHh
Confidence 00111122345889999999999999999999987764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=345.09 Aligned_cols=255 Identities=18% Similarity=0.191 Sum_probs=188.4
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeEeC------CEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEG------DYN 78 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~------~~~ 78 (474)
.++|++.++||+|+||.||+|++..+++.||||++.... .......|++.+..++|++++..+..+...+ .+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 368999999999999999999999999999999875442 3456778888888898777777666654432 247
Q ss_pred EEEEecCCCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCCCcEEeeeCCCCCeEEEEecCCc
Q 011945 79 VLVIDLLGPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (474)
Q Consensus 79 ~lv~e~~g~sL~~li~~---~~~~l~~~~~~~i~~qi~~gL~yLH--s~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (474)
++||||+.++|.+.+.. ....+++..++.++.||+.||.||| ++||+||||||+||||+ ..++.+||+|||++
T Consensus 102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~--~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFGSA 179 (360)
T ss_dssp EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE--TTTTEEEECCCTTC
T ss_pred EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe--CCCCcEEEeeCCCc
Confidence 89999998888776653 3456899999999999999999999 99999999999999996 33789999999999
Q ss_pred cccccCCCccccccccCCCCccCccccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc
Q 011945 154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (474)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (474)
+.+..... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.........+.......
T Consensus 180 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 251 (360)
T 3e3p_A 180 KKLSPSEP--------NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251 (360)
T ss_dssp BCCCTTSC--------CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred eecCCCCC--------cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCC
Confidence 87654332 23457899999999997655 8999999999999999999999998754332222222211111
Q ss_pred ccch--------------------HHHHh----cCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 233 VSTS--------------------IEALC----RGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 233 ~~~~--------------------~~~l~----~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.... ..... ..+++++.+||..||+.||++||++.+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 313 (360)
T 3e3p_A 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEAL 313 (360)
T ss_dssp CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHh
Confidence 0000 11111 12578999999999999999999987764
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=340.51 Aligned_cols=256 Identities=20% Similarity=0.304 Sum_probs=200.1
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcC-CCCCceeEEEeEeCCEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQG-GTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~-~~~i~~l~~~~~~~~~~~ 79 (474)
.+++|++++.||+|+||.||+|.+. +++.||||++...... ..+.+|+.+++.+.+ +++|..+..++......+
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 4678999999999999999999974 5889999998654432 457899999999986 677888877888888999
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 80 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 80 lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
++||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+...
T Consensus 105 lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 105 MVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEECCCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE----TTEEEECCCSSSCC----
T ss_pred EEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE----CCeEEEeeccccccccCc
Confidence 9999889999999984 45799999999999999999999999999999999999994 488999999999876543
Q ss_pred CCccccccccCCCCccCccccccccccC-----------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLG-----------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----------~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i 228 (474)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||..... ....+..+
T Consensus 180 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--~~~~~~~~ 252 (313)
T 3cek_A 180 TTSV-----VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN--QISKLHAI 252 (313)
T ss_dssp ---------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHH
T ss_pred cccc-----cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH--HHHHHHHH
Confidence 2211 1234579999999999876 4689999999999999999999999976432 22222222
Q ss_pred hhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
....... .+...++.++.++|..||..||++||++.++ |++.|..
T Consensus 253 ~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~el---l~h~~~~ 297 (313)
T 3cek_A 253 IDPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPEL---LAHPYVQ 297 (313)
T ss_dssp HCTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHH---HTSHHHH
T ss_pred Hhccccc---CCcccchHHHHHHHHHHccCCcccCcCHHHH---hcCcccc
Confidence 2221111 1234568899999999999999999998776 4444443
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=359.12 Aligned_cols=263 Identities=18% Similarity=0.223 Sum_probs=188.3
Q ss_pred ccCCcEEE-eeeeeecCceEEEEEEEc--CCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeE-eCCEEE
Q 011945 4 RVGNKFRL-GRKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDYNV 79 (474)
Q Consensus 4 ~i~~~y~i-~~~LG~G~fG~Vy~a~~~--~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~-~~~~~~ 79 (474)
.+.+.|++ .++||+|+||+||+|++. .+++.||||++........+.+|+.+++.|+|++++..+..+.. .....+
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 45567888 458999999999999976 56889999999877777789999999999997766666655543 567899
Q ss_pred EEEecCCCCHHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeC-CCCCeEEEEec
Q 011945 80 LVIDLLGPSLEDLFNFCS--------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDF 150 (474)
Q Consensus 80 lv~e~~g~sL~~li~~~~--------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~-~~~~~vkL~DF 150 (474)
|||||++++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+||||... +..+.+||+||
T Consensus 97 lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 97 LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp EEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred EEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 999999999999886321 249999999999999999999999999999999999999532 35689999999
Q ss_pred CCccccccCCCccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCc------HHH
Q 011945 151 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT------KKQ 223 (474)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~------~~~ 223 (474)
|+|+.+...... .......+||+.|+|||++.+. .++.++||||||||||||++|..||.+..... ...
T Consensus 177 g~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 177 GFARLFNSPLKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp TCCC--------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred CCceecCCCCcc----cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999876543211 1123456899999999999885 48999999999999999999999997643210 011
Q ss_pred HHHHHhhcc---ccc------------------------------hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 224 KYEKISEKK---VST------------------------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 224 ~~~~i~~~~---~~~------------------------------~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.+..+.... ... .........++++.+||..||..||.+|||+++++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 122111100 000 00000112367899999999999999999977663
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=338.13 Aligned_cols=246 Identities=24% Similarity=0.325 Sum_probs=180.9
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
.++|++.+.||+|+||.||+|++..+++.||||++... .....+.+|+.+++.++|+ +|..+..+.......++
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~l 88 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP-SILELYNYFEDSNYVYL 88 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCT-TBCCEEEEEECSSEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCC-CeEeEEEEEccCCeEEE
Confidence 46799999999999999999999999999999987542 2235688999999999865 45555556677888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
+|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---CTTCCEEECCCTTCEECC--
T ss_pred EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEEeecceeeccCC
Confidence 99999 789999998655779999999999999999999999999999999999999 47789999999999876533
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
.. ......||+.|+|||++.+..++.++|||||||++|||++|..||....... .+..+..... .
T Consensus 166 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~-----~ 230 (278)
T 3cok_A 166 HE-------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN---TLNKVVLADY-----E 230 (278)
T ss_dssp ---------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------CCSSCC-----C
T ss_pred CC-------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH---HHHHHhhccc-----C
Confidence 22 1124578999999999999899999999999999999999999998754322 1222211111 1
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
+...++.++.++|..||..||++||++++++
T Consensus 231 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l 261 (278)
T 3cok_A 231 MPSFLSIEAKDLIHQLLRRNPADRLSLSSVL 261 (278)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred CccccCHHHHHHHHHHcccCHhhCCCHHHHh
Confidence 2345789999999999999999999987764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=336.67 Aligned_cols=252 Identities=21% Similarity=0.262 Sum_probs=202.3
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEe-EeCCE
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFG-VEGDY 77 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~-~~~~~ 77 (474)
|...++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++|++++..+..+. .....
T Consensus 2 p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (279)
T 2w5a_A 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTT 81 (279)
T ss_dssp -CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTE
T ss_pred CCchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCce
Confidence 3456899999999999999999999999999999999875432 235889999999998766666555443 35678
Q ss_pred EEEEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCCCcEEeeeCCCCCeEEEE
Q 011945 78 NVLVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKS-----FLHRDIKPDNFLMGLGRRANQVYII 148 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~---~~~l~~~~~~~i~~qi~~gL~yLHs~g-----IiHrDIKP~NILl~~~~~~~~vkL~ 148 (474)
.++||||+ +++|.+++... ...+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~ 158 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLG 158 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEEEC
T ss_pred EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEe
Confidence 89999999 67999999743 335999999999999999999999999 9999999999999 477899999
Q ss_pred ecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHH
Q 011945 149 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (474)
Q Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i 228 (474)
|||++......... .....||..|+|||++.+..++.++|||||||++|+|++|..||..... ......+
T Consensus 159 dfg~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~i 228 (279)
T 2w5a_A 159 DFGLARILNHDTSF-------AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKI 228 (279)
T ss_dssp CCCHHHHC---CHH-------HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH
T ss_pred cCchheeecccccc-------ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH---HHHHHHH
Confidence 99999876543211 1234689999999999999999999999999999999999999987543 3333333
Q ss_pred hhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
...... .+...+++++.++|..||..||++||++.+|++
T Consensus 229 ~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 267 (279)
T 2w5a_A 229 REGKFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267 (279)
T ss_dssp HHTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhcccc----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 333321 234568999999999999999999999887754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=359.33 Aligned_cols=250 Identities=15% Similarity=0.137 Sum_probs=186.9
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-----chHHHHHHHHHHHhc--CCCCCceeE-------EEe
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLQYEAKLYKILQ--GGTGIPNLR-------WFG 72 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~l~~E~~il~~l~--~~~~i~~l~-------~~~ 72 (474)
.+|++.++||+|+||+||+|.+..+++.||||++..... ...+..|+.+++.|. |++++..+. .+.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 359999999999999999999999999999999876543 234678877777776 555443231 221
Q ss_pred EeC----------------CEEEEEEecCCCCHHHHHHHcCCCCCHHHH------HHHHHHHHHHHHHHHHCCccccCCC
Q 011945 73 VEG----------------DYNVLVIDLLGPSLEDLFNFCSRKLSLKTV------LMLADQMINRVEFVHSKSFLHRDIK 130 (474)
Q Consensus 73 ~~~----------------~~~~lv~e~~g~sL~~li~~~~~~l~~~~~------~~i~~qi~~gL~yLHs~gIiHrDIK 130 (474)
..+ ...||||||++++|.+++......+.+..+ +.++.||+.||+|||++||||||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 111 347999999999999999865555666666 7888999999999999999999999
Q ss_pred CCcEEeeeCCCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccC--CCCCchhhHHHHHHHHHHHHh
Q 011945 131 PDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLR 208 (474)
Q Consensus 131 P~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDIwSlGvil~ellt 208 (474)
|+|||| +.++.+||+|||+|+...... ....+|+.|+|||++.+ ..++.++|||||||+||||++
T Consensus 222 p~NIll---~~~~~~kL~DFG~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 222 PDNLFI---MPDGRLMLGDVSALWKVGTRG----------PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp GGGEEE---CTTSCEEECCGGGEEETTCEE----------EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred HHHEEE---CCCCCEEEEecceeeecCCCc----------cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 999999 477899999999998664321 12367799999999987 679999999999999999999
Q ss_pred CCCCCCCCCcCcHHHHHHHHh--hccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 209 GSLPWQGLKAGTKKQKYEKIS--EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 209 G~~Pf~~~~~~~~~~~~~~i~--~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
|+.||.+....... .+..+. ...........+..+++++.+||..||..||++||++.+++
T Consensus 289 g~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l 351 (371)
T 3q60_A 289 LFLPFGLVTPGIKG-SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAM 351 (371)
T ss_dssp SSCSTTBCCTTCTT-CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHT
T ss_pred CCCCCCCcCccccc-chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 99999875332110 000000 00000111112357899999999999999999999988874
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=333.94 Aligned_cols=250 Identities=11% Similarity=0.178 Sum_probs=200.8
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeEe-CCEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVE-GDYNV 79 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~~-~~~~~ 79 (474)
..++|++.++||+|+||.||+|++ .++.||||++...... ..+.+|+.+++.++|++++..+..+... ....+
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 85 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT 85 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred CHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence 347899999999999999999997 4889999998765432 3588899999999866555555444332 26789
Q ss_pred EEEecC-CCCHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~-~l~~~~~~~i~~qi~~gL~yLHs~g--IiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
++|||+ +++|.+++..... .+++..++.|+.||+.||.|||++| |+||||||+|||+ +.++.++|+|||++..
T Consensus 86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVKFS 162 (271)
T ss_dssp EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGSCCT
T ss_pred eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEeccceee
Confidence 999999 7899999985433 5999999999999999999999999 9999999999999 4778899999988764
Q ss_pred cccCCCccccccccCCCCccCccccccccccCCCCC---chhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQS---RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s---~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (474)
... ....||+.|+|||++.+..++ .++|||||||++|||++|..||.+... ......+....
T Consensus 163 ~~~------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~ 227 (271)
T 3kmu_A 163 FQS------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN---MEIGMKVALEG 227 (271)
T ss_dssp TSC------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH---HHHHHHHHHSC
T ss_pred ecc------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh---HHHHHHHHhcC
Confidence 322 234789999999999986544 489999999999999999999987543 22223332222
Q ss_pred ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 233 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
... .+...+++++.+++..||..||++||+++++++.|+++.
T Consensus 228 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 228 LRP---TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 211 234578999999999999999999999999999998874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=343.22 Aligned_cols=243 Identities=24% Similarity=0.362 Sum_probs=202.5
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--------CchHHHHHHHHHHHhcC-CCCCceeEEEeE
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--------KHPQLQYEAKLYKILQG-GTGIPNLRWFGV 73 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--------~~~~l~~E~~il~~l~~-~~~i~~l~~~~~ 73 (474)
..+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+..|+.+++.+.+ ++++..+..+..
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 356789999999999999999999999999999999876542 22457889999999985 677777777777
Q ss_pred eCCEEEEEEecCC--CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecC
Q 011945 74 EGDYNVLVIDLLG--PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (474)
Q Consensus 74 ~~~~~~lv~e~~g--~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFG 151 (474)
.....+++||++. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ...+.+||+|||
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--~~~~~~kL~Dfg 195 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFG 195 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCT
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe--CCCCCEEEeeCc
Confidence 8888999999984 899999975 45799999999999999999999999999999999999995 356899999999
Q ss_pred CccccccCCCccccccccCCCCccCccccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhh
Q 011945 152 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230 (474)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~ 230 (474)
+++....... ....||+.|+|||++.+..+ +.++|||||||++|||++|..||.... .+..
T Consensus 196 ~~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---------~~~~ 257 (320)
T 3a99_A 196 SGALLKDTVY---------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIR 257 (320)
T ss_dssp TCEECCSSCB---------CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHHH
T ss_pred cccccccccc---------cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---------hhhc
Confidence 9987654322 34579999999999987775 789999999999999999999996521 1111
Q ss_pred ccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 231 ~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
... .+...+++++.+||..||..||++||++++|++
T Consensus 258 ~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 258 GQV-----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp CCC-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccc-----cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 123578999999999999999999999887743
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=344.97 Aligned_cols=268 Identities=19% Similarity=0.200 Sum_probs=207.0
Q ss_pred cCCcEEEeeeeeecCceEEEEEEE----cCCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeE-eCCE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTN----IQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGV-EGDY 77 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~----~~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~-~~~~ 77 (474)
..++|+++++||+|+||.||+|.+ ..+++.||||++..... ...+.+|+.+++.++|++++..+..+.. ....
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 456799999999999999999984 56899999999876433 2458899999999987666665554433 3346
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
.++|||++ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++...
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~---~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTKVL 195 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEc---CCCcEEEecCcchhhc
Confidence 78999999 7899999987667799999999999999999999999999999999999995 6789999999999876
Q ss_pred ccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---------CcHHHHHHH
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA---------GTKKQKYEK 227 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~---------~~~~~~~~~ 227 (474)
....... .......++..|+|||++.+..++.++|||||||++|||++|..||..... .........
T Consensus 196 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (326)
T 2w1i_A 196 PQDKEYY----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 271 (326)
T ss_dssp CSSCSEE----ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred ccccccc----ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence 5543211 112334678899999999998899999999999999999999999864210 000000000
Q ss_pred HhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 228 ISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 228 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
+...............+|+++.++|..||..||++||++.+|++.|+.+..+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 0000000000112356889999999999999999999999999999998654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=337.39 Aligned_cols=257 Identities=17% Similarity=0.275 Sum_probs=202.9
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC------CCchHHHHHHHHHHHhcCCCCCceeEEEe-EeCC
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFG-VEGD 76 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~------~~~~~l~~E~~il~~l~~~~~i~~l~~~~-~~~~ 76 (474)
++.++|++++.||+|+||.||+|.+..+++.||||++... .....+.+|+.+++.++|++++..+..+. ....
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 4678999999999999999999999999999999987643 22356899999999998766666655543 4556
Q ss_pred EEEEEEecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 77 YNVLVIDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 77 ~~~lv~e~~g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
..++||||+.++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~---~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 82 KMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT---TGGTLKISALGVAEA 158 (305)
T ss_dssp CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC---TTCCEEECCCTTCEE
T ss_pred eEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEc---CCCcEEeeccccccc
Confidence 78999999988888888753 45699999999999999999999999999999999999994 778999999999987
Q ss_pred cccCCCccccccccCCCCccCccccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (474)
........ ......||..|+|||++.+.. ++.++|||||||++|||++|..||.+.. ....+..+.....
T Consensus 159 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~i~~~~~ 230 (305)
T 2wtk_C 159 LHPFAADD-----TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN---IYKLFENIGKGSY 230 (305)
T ss_dssp CCTTCSSC-----EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHCCC
T ss_pred cCcccccc-----ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch---HHHHHHHHhcCCC
Confidence 65322211 113457999999999998755 3789999999999999999999998743 3344444433322
Q ss_pred cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
. +...+++++.++|..||..||++||++.++ +++.+.+
T Consensus 231 ~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l---l~~~~~~ 268 (305)
T 2wtk_C 231 A-----IPGDCGPPLSDLLKGMLEYEPAKRFSIRQI---RQHSWFR 268 (305)
T ss_dssp C-----CCSSSCHHHHHHHHHHTCSSTTTSCCHHHH---HHSHHHH
T ss_pred C-----CCCccCHHHHHHHHHHccCChhhCCCHHHH---hcCcccc
Confidence 1 235688999999999999999999998877 4444433
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=348.53 Aligned_cols=258 Identities=23% Similarity=0.334 Sum_probs=195.2
Q ss_pred CccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcC-----------CCCCceeEE
Q 011945 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQG-----------GTGIPNLRW 70 (474)
Q Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~-----------~~~i~~l~~ 70 (474)
+...++|+++++||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.+.+ ++++..+..
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 344679999999999999999999999999999999986432 23458899999999873 344444444
Q ss_pred EeEeC---CEEEEEEecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEeeeC---CCC
Q 011945 71 FGVEG---DYNVLVIDLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLG---RRA 142 (474)
Q Consensus 71 ~~~~~---~~~~lv~e~~g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~-gIiHrDIKP~NILl~~~---~~~ 142 (474)
+...+ ...+++||+++++|.+++... ...+++..++.|+.||+.||.|||++ ||+||||||+||||+.+ +..
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred hhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence 43322 378999999999999999854 34699999999999999999999998 99999999999999643 234
Q ss_pred CeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCc--
Q 011945 143 NQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-- 220 (474)
Q Consensus 143 ~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~-- 220 (474)
+.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||+||||++|..||.+.....
T Consensus 175 ~~~kl~Dfg~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEHY----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp EEEEECCCTTCEETTBCC----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ceEEEcccccccccCCCC----------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 589999999998765432 23478999999999999999999999999999999999999998643211
Q ss_pred -HHHHHHHHhhccccch------------------------------HHH-------HhcCCcHHHHHHHHHHhcCCCCC
Q 011945 221 -KKQKYEKISEKKVSTS------------------------------IEA-------LCRGYPTEFASYFHYCRSLRFDD 262 (474)
Q Consensus 221 -~~~~~~~i~~~~~~~~------------------------------~~~-------l~~~~p~~l~~li~~cl~~dp~~ 262 (474)
....+..+.......+ ... +...+++++.+||..||+.||++
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 1112222111000000 000 01234578999999999999999
Q ss_pred CCCHHHHH
Q 011945 263 KPDYAYLK 270 (474)
Q Consensus 263 RPt~~~l~ 270 (474)
||++++|+
T Consensus 325 Rpt~~ell 332 (373)
T 1q8y_A 325 RADAGGLV 332 (373)
T ss_dssp CBCHHHHH
T ss_pred cCCHHHHh
Confidence 99987763
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=334.81 Aligned_cols=252 Identities=21% Similarity=0.312 Sum_probs=204.8
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
+.++|+++++||+|+||.||+|.+..+++.||||++... .....+.+|+.+++.++|+ +|..+..+.......++
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHP-NIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCT-TBCCEEEEEECSSEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCC-CccEEEEEEeCCCeEEE
Confidence 457899999999999999999999999999999987543 2345688999999999755 55555556677788999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
+||++ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++....+||+|||++......
T Consensus 99 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~ 177 (287)
T 2wei_A 99 VGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (287)
T ss_dssp EECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred EEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence 99999 8899988864 347999999999999999999999999999999999999965444568999999999866543
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
.. .....||..|+|||++.+ .++.++|||||||++|+|++|..||.+... ......+.........+
T Consensus 178 ~~--------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~- 244 (287)
T 2wei_A 178 TK--------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILKRVETGKYAFDLP- 244 (287)
T ss_dssp SS--------CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHCCCCCCSG-
T ss_pred Cc--------cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCCCch-
Confidence 22 123468999999999876 489999999999999999999999987533 33344444433322221
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
....+++++.++|..||..||++||++.++++
T Consensus 245 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 23568999999999999999999999888754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=349.52 Aligned_cols=265 Identities=18% Similarity=0.226 Sum_probs=206.7
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
..++|++.+.||+|+||.||+|.+ .+++.||||++..... ...+.+|+.+++.++|++ |..+..++......++||
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~~~~~~~~lv~ 114 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPH-LVSLIGFCDERNEMILIY 114 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTT-BCCEEEECCCTTCCEEEE
T ss_pred HHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCC-EeeEEEEEcCCCeEEEEE
Confidence 467899999999999999999996 5789999998765433 346889999999998554 555555666777889999
Q ss_pred ecC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 83 DLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 83 e~~-g~sL~~li~~~~---~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTE 191 (321)
T ss_dssp ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEEECCCTTCEECSS
T ss_pred EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEEEeeccccccccc
Confidence 999 789999886332 358999999999999999999999999999999999999 4788999999999986543
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHH----Hhhcccc
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK----ISEKKVS 234 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~----i~~~~~~ 234 (474)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+............ .......
T Consensus 192 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 192 LDQT-----HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp SSCC-----CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred cccc-----ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 2221 112345689999999999998999999999999999999999999976543322111111 1011000
Q ss_pred c-----hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 235 T-----SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 235 ~-----~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
. ....+...++.++.+++..||..||++||++.++++.|+.++..
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 0 00111123467899999999999999999999999999998753
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=368.49 Aligned_cols=255 Identities=22% Similarity=0.362 Sum_probs=207.5
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
.++|++.++||+|+||.||+|.+. .+..||||+++... ..+.+.+|+.+|+.|+|++++..+..+ .. ...+|||||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-~~-~~~~lv~e~ 342 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SE-EPIYIVTEY 342 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEE-CS-SSCEEEECC
T ss_pred hhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEE-ee-ccceEeeeh
Confidence 467999999999999999999985 45679999987644 345799999999999977666665544 33 567899999
Q ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 85 ~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
+ +++|.+++... ...+++..++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+++.+.....
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~---~~~~~kl~DFG~a~~~~~~~~- 418 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEY- 418 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCTTSTTTCCCHHH-
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEc---CCCcEEEcccccceecCCCce-
Confidence 9 77999999743 35699999999999999999999999999999999999994 678999999999987643211
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
.......++..|+|||++.+..++.++|||||||+||||++ |..||.+... .+.+..+...... ...
T Consensus 419 -----~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~---~~~~~~i~~~~~~----~~~ 486 (535)
T 2h8h_A 419 -----TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN---REVLDQVERGYRM----PCP 486 (535)
T ss_dssp -----HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH---HHHHHHHHTTCCC----CCC
T ss_pred -----ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----CCC
Confidence 11234467889999999999999999999999999999999 9999987543 3333333322111 123
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
..+|+++.+||..||..||++||++++|++.|++++..
T Consensus 487 ~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 57899999999999999999999999999999887643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=329.80 Aligned_cols=247 Identities=21% Similarity=0.289 Sum_probs=195.5
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
...++|++.+.||+|+||.||+|.+..+++.||||++... .....+.+|+.+++.++|++ |..+..+.......
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH-IIKLYQVISTPTDF 86 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTT-BCCEEEEEECSSEE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCC-EeEEEEEEecCCeE
Confidence 4568999999999999999999999989999999987542 23456889999999998554 55555566777889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
+++||++ +++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+|||+ +.++.+||+|||++....
T Consensus 87 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---CTTSCEEECCCCGGGCCC
T ss_pred EEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---CCCCCEEEeecccccccC
Confidence 9999999 78999999753 469999999999999999999999999999999999999 477899999999998765
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccch
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (474)
.... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... ....+..+......
T Consensus 163 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~-- 229 (276)
T 2h6d_A 163 DGEF--------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH---VPTLFKKIRGGVFY-- 229 (276)
T ss_dssp C---------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC--
T ss_pred CCcc--------eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHhhcCccc--
Confidence 4321 123478999999999998775 689999999999999999999997643 33333433332221
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
+...++.++.++|..||..||++||++.+|++
T Consensus 230 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 230 ---IPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 23567899999999999999999999887744
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=358.98 Aligned_cols=239 Identities=13% Similarity=0.098 Sum_probs=184.2
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhc---CCCCCceeE------EE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQ---GGTGIPNLR------WF 71 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~---~~~~i~~l~------~~ 71 (474)
.++|++.+.||+|+||+||+|++..+|+.||||++.... ....+.+|+.+++.+. |++++..+. .+
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 578999999999999999999998899999999976431 2356889996666554 444433331 22
Q ss_pred eEeCC-----------------EEEEEEecCCCCHHHHHHHcCCCCC-------HHHHHHHHHHHHHHHHHHHHCCcccc
Q 011945 72 GVEGD-----------------YNVLVIDLLGPSLEDLFNFCSRKLS-------LKTVLMLADQMINRVEFVHSKSFLHR 127 (474)
Q Consensus 72 ~~~~~-----------------~~~lv~e~~g~sL~~li~~~~~~l~-------~~~~~~i~~qi~~gL~yLHs~gIiHr 127 (474)
..... ..||+|||++++|.+++.... .++ +..++.|+.||+.||+|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~-~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL-SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHH-HTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcc-ccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 22221 378999999999999997532 233 48888999999999999999999999
Q ss_pred CCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCC-----------CCCchhhH
Q 011945 128 DIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-----------EQSRRDDL 196 (474)
Q Consensus 128 DIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-----------~~s~ksDI 196 (474)
||||+||||+ .++.+||+|||+|+..... .....| +.|+|||++.+. .++.++||
T Consensus 231 Dikp~NIll~---~~~~~kL~DFG~a~~~~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv 296 (377)
T 3byv_A 231 YLRPVDIVLD---QRGGVFLTGFEHLVRDGAR----------VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA 296 (377)
T ss_dssp CCCGGGEEEC---TTCCEEECCGGGCEETTCE----------EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred CCCHHHEEEc---CCCCEEEEechhheecCCc----------ccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence 9999999994 6789999999999854321 124577 999999999987 89999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 197 ESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 197 wSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
|||||+||||++|+.||.+...... +.. +...+..+|+++.+||..||..||++||++.++++
T Consensus 297 wSlG~il~elltg~~Pf~~~~~~~~---~~~---------~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 297 WALGLVIYWIWCADLPITKDAALGG---SEW---------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHHHHHHSSCCC------CC---SGG---------GGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHHHHHHCCCCCcccccccc---hhh---------hhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999999999999976432111 011 11123578999999999999999999999988864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=338.02 Aligned_cols=251 Identities=20% Similarity=0.297 Sum_probs=197.9
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
...++|++++.||+|+||.||+|.+..+++.||+|++.... ....+..|+.+++.+.|+++ ..+..++......++|
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i-~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYI-VKLLGAYYHDGKLWIM 94 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTB-CCEEEEEECC-CEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCE-eeeeeeeeeCCeEEEE
Confidence 45678999999999999999999999999999999876543 34568899999999985554 4555555566788999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTSCEEECCCHHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---CCCCCEEEEECCCCccccccc
Confidence 9999 789999988767789999999999999999999999999999999999999 477899999999986433211
Q ss_pred CccccccccCCCCccCcccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccc
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
. ......||..|+|||++. +..++.++|||||||++|+|++|..||..... ...+..+.......
T Consensus 172 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~ 241 (302)
T 2j7t_A 172 Q-------KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---MRVLLKIAKSDPPT 241 (302)
T ss_dssp H-------C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHSCCCC
T ss_pred c-------ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH---HHHHHHHhccCCcc
Confidence 1 113457999999999984 66789999999999999999999999987543 22333332222111
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
. .....++.++.++|..||..||++||++.+|+
T Consensus 242 ~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 274 (302)
T 2j7t_A 242 L--LTPSKWSVEFRDFLKIALDKNPETRPSAAQLL 274 (302)
T ss_dssp C--SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHT
T ss_pred c--CCccccCHHHHHHHHHHcccChhhCCCHHHHh
Confidence 0 11245789999999999999999999988764
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=343.36 Aligned_cols=262 Identities=16% Similarity=0.204 Sum_probs=200.3
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--CchHHHHHHHHHHHhcCCCCCceeEEEeE---eCCEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGV---EGDYNV 79 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~l~~E~~il~~l~~~~~i~~l~~~~~---~~~~~~ 79 (474)
-.++|++++.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++|++++..+..+.. .....+
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 3568999999999999999999999999999999875432 23458899999999987776666655543 234778
Q ss_pred EEEecC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 80 LVIDLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~---~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
+||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEecCcchh
Confidence 999999 67999999753 5679999999999999999999999999999999999999 4778999999999876
Q ss_pred cccCCCcc--ccccccCCCCccCccccccccccCCC---CCchhhHHHHHHHHHHHHhCCCCCCCCCc--CcHHHHHHHH
Q 011945 156 YRDTATHQ--HIPYRENKNLTGTARYASMNTHLGIE---QSRRDDLESLGYVLMYFLRGSLPWQGLKA--GTKKQKYEKI 228 (474)
Q Consensus 156 ~~~~~~~~--~~~~~~~~~~~GT~~Y~APE~~~~~~---~s~ksDIwSlGvil~elltG~~Pf~~~~~--~~~~~~~~~i 228 (474)
........ ...........||+.|+|||++.+.. ++.++|||||||++|||++|..||..... ...... +
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---~ 260 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA---V 260 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH---H
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH---h
Confidence 54221100 00000011235799999999998654 68999999999999999999999954211 111111 1
Q ss_pred hhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 229 SEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
.. .... .....+++++.++|..||+.||++||++.+|++.|+.+
T Consensus 261 ~~-~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 261 QN-QLSI---PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp HC-C--C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred hc-cCCC---CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 11 1100 11246789999999999999999999999999888765
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=372.39 Aligned_cols=254 Identities=20% Similarity=0.345 Sum_probs=200.2
Q ss_pred EEEe-eeeeecCceEEEEEEE--cCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 9 FRLG-RKIGSGSFGEIYLGTN--IQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 9 y~i~-~~LG~G~fG~Vy~a~~--~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
+.+. ++||+|+||.||+|.+ ..+++.||||+++.... ...+.+|+.+++.|+|++++..+.. +. .+..+||
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~-~~-~~~~~lv 447 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI-CE-AESWMLV 447 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEE-EE-SSSEEEE
T ss_pred ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE-Ee-cCCEEEE
Confidence 4443 4899999999999965 35678999999865432 3568999999999986666655554 44 3447899
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ +++|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+++.+....
T Consensus 448 ~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~---~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp EECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCTTHHHHTTC--
T ss_pred EEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe---CCCCEEEEEcCCccccccCc
Confidence 9999 7899999974 56799999999999999999999999999999999999995 67899999999998765433
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
.. +.......+|+.|+|||++.+..++.++|||||||+||||++ |..||.+... .+....+...... .
T Consensus 524 ~~----~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~i~~~~~~----~ 592 (635)
T 4fl3_A 524 NY----YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGERM----G 592 (635)
T ss_dssp ---------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC----C
T ss_pred cc----cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCC----C
Confidence 21 111233467889999999999999999999999999999998 9999987544 2333333332211 1
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
....+|+++.+||..||..||++||++++|++.|++++.+
T Consensus 593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 2357899999999999999999999999999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=344.53 Aligned_cols=266 Identities=16% Similarity=0.222 Sum_probs=193.2
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHH--HhcCCCCCceeEEEeE----eCCEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYK--ILQGGTGIPNLRWFGV----EGDYN 78 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~--~l~~~~~i~~l~~~~~----~~~~~ 78 (474)
-.++|+++++||+|+||.||+|++ +++.||||++.... ...+..|.+++. .+.|++++..+..+.. .....
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 457899999999999999999975 78999999986532 334555555544 3666666655543322 33467
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---------CccccCCCCCcEEeeeCCCCCeEEEE
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---------SFLHRDIKPDNFLMGLGRRANQVYII 148 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~---------gIiHrDIKP~NILl~~~~~~~~vkL~ 148 (474)
++||||+ +++|.+++.. ..+++..++.|+.||+.||.|||++ ||+||||||+|||| +.++.+||+
T Consensus 88 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kL~ 162 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVIS 162 (336)
T ss_dssp EEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTSCEEEC
T ss_pred EEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE---cCCCcEEEe
Confidence 8999999 8899999974 3469999999999999999999999 99999999999999 477899999
Q ss_pred ecCCccccccCCCccc-cccccCCCCccCccccccccccC-------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCc
Q 011945 149 DFGLAKRYRDTATHQH-IPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT 220 (474)
Q Consensus 149 DFGla~~~~~~~~~~~-~~~~~~~~~~GT~~Y~APE~~~~-------~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~ 220 (474)
|||+++.+........ ..........||+.|+|||++.+ ..++.++|||||||+||||++|..||.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999987654322110 00112234579999999999987 356789999999999999999977764322111
Q ss_pred H--------------HHHHH-HHhhccccchHHHHhc---CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 221 K--------------KQKYE-KISEKKVSTSIEALCR---GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 221 ~--------------~~~~~-~i~~~~~~~~~~~l~~---~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
. ...+. .+.........+..+. .+++++.+||..||..||++||++.++++.|++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 0 00111 1111111111111111 134589999999999999999999999999999984
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=337.15 Aligned_cols=258 Identities=22% Similarity=0.270 Sum_probs=196.8
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcC-CC--eEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCC
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQ-TN--EEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 76 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~-~~--~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (474)
..++|+++++||+|+||.||+|.+.. ++ ..||||++.... ....+.+|+.+++.++|++++..+..+ ....
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 94 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV-LTPP 94 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSS
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE-ccCC
Confidence 35689999999999999999998643 33 368999876432 224588999999999866655555544 3333
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
.+++||++ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus 95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRA 170 (291)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCEE
T ss_pred -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc---CCCCEEEcccccccc
Confidence 67889988 7899999986666799999999999999999999999999999999999995 678999999999987
Q ss_pred cccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhcccc
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVS 234 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (474)
........ .......+|..|+|||++.+..++.++|||||||++|+|++ |..||.+... .+.+..+......
T Consensus 171 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~~~~~ 243 (291)
T 1u46_A 171 LPQNDDHY----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKIDKEGER 243 (291)
T ss_dssp CCC-CCEE----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTSCCC
T ss_pred ccccccch----hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH---HHHHHHHHccCCC
Confidence 65433211 11234467889999999999889999999999999999999 9999987543 3333443332221
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
. .....+|.++.+++..||..||++||++.+|++.|+++.
T Consensus 244 ~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 244 L---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred C---CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 1 123568999999999999999999999999999988874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=343.89 Aligned_cols=266 Identities=23% Similarity=0.314 Sum_probs=205.7
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHH--hcCCCCCceeEEEeEeCC----EE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKI--LQGGTGIPNLRWFGVEGD----YN 78 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~--l~~~~~i~~l~~~~~~~~----~~ 78 (474)
+.++|++.+.||+|+||.||+|++ +++.||||++... ....+.+|.+++.. ++|++++ .+..+..... ..
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~e~~~~~~~~l~h~ni~-~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-EERSWFREAEIYQTVMLRHENIL-GFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-GHHHHHHHHHHHHHSCCCCTTBC-CEEEEEECCCSSCCCE
T ss_pred ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-hHHHHHHHHHHHHHhhcCCCcEE-EEEeeecccCCcccee
Confidence 457899999999999999999996 5899999998643 34567889999988 5555444 4444444433 78
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCccccCCCCCcEEeeeCCCCCeEEEEe
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH--------SKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLH--------s~gIiHrDIKP~NILl~~~~~~~~vkL~D 149 (474)
++||||+ +++|.+++.. ..+++..++.++.||+.||.||| ++||+||||||+|||| +.++.+||+|
T Consensus 116 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~~~kL~D 190 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIAD 190 (342)
T ss_dssp EEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTSCEEECC
T ss_pred EEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCCCEEEEE
Confidence 9999999 6799999974 46999999999999999999999 8999999999999999 4778999999
Q ss_pred cCCccccccCCCccccccccCCCCccCccccccccccCCC------CCchhhHHHHHHHHHHHHhC----------CCCC
Q 011945 150 FGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE------QSRRDDLESLGYVLMYFLRG----------SLPW 213 (474)
Q Consensus 150 FGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~------~s~ksDIwSlGvil~elltG----------~~Pf 213 (474)
||++............ ......||+.|+|||++.+.. ++.++|||||||++|||++| ..||
T Consensus 191 fg~~~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 191 LGLAVRHDSATDTIDI---APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp CTTCEEEETTTTEEEE---CCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred CCCceecccccccccc---ccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 9999876554321110 124458999999999998763 34789999999999999999 8899
Q ss_pred CCCCcC--cHHHHHHHHhhccccchHHHH--hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Q 011945 214 QGLKAG--TKKQKYEKISEKKVSTSIEAL--CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGF 282 (474)
Q Consensus 214 ~~~~~~--~~~~~~~~i~~~~~~~~~~~l--~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~ 282 (474)
...... ........+.........+.. ...+++.+.+|+..||..||++||++.+|++.|+.+..+.+.
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~~ 340 (342)
T 1b6c_B 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 340 (342)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC-
T ss_pred cccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhcC
Confidence 765432 223333333332222221111 123457899999999999999999999999999999877654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=343.98 Aligned_cols=247 Identities=21% Similarity=0.295 Sum_probs=194.9
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeEeCC----
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEGD---- 76 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~~~~---- 76 (474)
+.++|.+.+.||+|+||.||+|.+..+|+.||||++...... ..+.+|+.+++.++|++++..+..+.....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 467899999999999999999999999999999998654332 357889999999997766666665544332
Q ss_pred -EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 77 -YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 77 -~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
..+++||+++++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 102 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 102 YDFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARH 175 (353)
T ss_dssp CCCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTCCEEECSTTCTTC
T ss_pred eeEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---CCCCcEEEeecccccC
Confidence 359999999988887764 469999999999999999999999999999999999999 4778999999999986
Q ss_pred cccCCCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc-
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV- 233 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~- 233 (474)
..... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.... ..+..+.....
T Consensus 176 ~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~ 242 (353)
T 3coi_A 176 ADAEM----------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL---DQLTQILKVTGV 242 (353)
T ss_dssp ------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH---HHHHHHHHHHCB
T ss_pred CCCCc----------cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHhCC
Confidence 54321 24578999999999987 67899999999999999999999999875432 22222211100
Q ss_pred -------------------------cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 234 -------------------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 234 -------------------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
......+...+++++.+||..||..||++||++++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l 304 (353)
T 3coi_A 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQAL 304 (353)
T ss_dssp CCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHH
T ss_pred CCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 0111122346789999999999999999999987663
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=333.90 Aligned_cols=250 Identities=19% Similarity=0.299 Sum_probs=183.5
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCch---HHHHHHH-HHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP---QLQYEAK-LYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~---~l~~E~~-il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
.++|++++.||+|+||.||+|.+..+++.||||++....... .+..|.. +++.+. |++|..+..++......++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~~~~~lv 102 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD-CPYIVQCFGTFITNTDVFIA 102 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTT-CTTBCCEEEEEECSSEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEEEE
Confidence 468999999999999999999999999999999987654322 2333443 444454 56666666677778899999
Q ss_pred EecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~-gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||++..+..+.......+++..++.++.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||++..+....
T Consensus 103 ~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 103 MELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp ECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---CTTSCEEECCCTTC-------
T ss_pred EeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---CCCCCEEEEECCCchhccCCc
Confidence 99998888888876677899999999999999999999995 99999999999999 477899999999997665432
Q ss_pred CccccccccCCCCccCcccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccc
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (474)
. .....||+.|+|||++. +..++.++|||||||++|||++|..||..... ....+..+.......
T Consensus 180 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~ 249 (318)
T 2dyl_A 180 A--------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT--DFEVLTKVLQEEPPL 249 (318)
T ss_dssp ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS--HHHHHHHHHHSCCCC
T ss_pred c--------ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc--cHHHHHHHhccCCCC
Confidence 2 12347999999999995 45689999999999999999999999986432 233333333322111
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
. .....+++++.++|..||..||.+||++++|++
T Consensus 250 ~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 250 L--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp C--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 012357899999999999999999999988854
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=343.61 Aligned_cols=260 Identities=18% Similarity=0.221 Sum_probs=199.2
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
..++|++.+.||+|+||.||+|.+ .+++.||||++.... ....+.+|+.+++.+.|+++ ..+..++......++|
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i-v~~~~~~~~~~~~~lv 105 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNL-LRLRGFCMTPTERLLV 105 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTB-CCCCEEECCSSCCEEE
T ss_pred HhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCc-cceEEEEecCCceEEE
Confidence 567899999999999999999985 578999999876543 23368999999999986554 4555555666777899
Q ss_pred EecC-CCCHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 82 IDLL-GPSLEDLFNFCS---RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~---~~l~~~~~~~i~~qi~~gL~yLHs~---gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
|||+ +++|.+++.... ..+++..++.|+.||+.||.|||++ ||+||||||+|||+ +.++.+||+|||+++
T Consensus 106 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 106 YPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAK 182 (326)
T ss_dssp EECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCCEEECCCSSCE
T ss_pred EEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCCEEeccCcccc
Confidence 9999 779999997432 2499999999999999999999999 99999999999999 477899999999998
Q ss_pred ccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC-----CcCcHHHHHHHHh
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL-----KAGTKKQKYEKIS 229 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~-----~~~~~~~~~~~i~ 229 (474)
......... .....||+.|+|||++.+..++.++|||||||++|+|++|..||... .............
T Consensus 183 ~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 183 LMDYKDTHV------TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp ECCSSSSCE------ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred ccCcccccc------cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 765433211 23456999999999999889999999999999999999999999521 1111111111100
Q ss_pred hcc-ccch-----HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011945 230 EKK-VSTS-----IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 275 (474)
Q Consensus 230 ~~~-~~~~-----~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (474)
... .... ........+.++.+++..||+.||++||++.+|++.|+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 000 0000 000111234789999999999999999999999888875
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=337.61 Aligned_cols=258 Identities=21% Similarity=0.263 Sum_probs=182.7
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
..++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++|++ |..+..++......++|
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN-IVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTT-BCCEEEEEESSSCEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCC-EeeEEEEEeecCCcEEE
Confidence 4678999999999999999999988899999999875432 3345788999999887555 55555556666778999
Q ss_pred EecC-CCCHHHHHHH-------cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCc
Q 011945 82 IDLL-GPSLEDLFNF-------CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (474)
Q Consensus 82 ~e~~-g~sL~~li~~-------~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (474)
|||+ +++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE---cCCCCEEEEeccch
Confidence 9999 8899999874 24569999999999999999999999999999999999999 47789999999999
Q ss_pred cccccCCCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc
Q 011945 154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (474)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (474)
........... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||.......... ......
T Consensus 169 ~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~ 243 (303)
T 2vwi_A 169 AFLATGGDITR--NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM---LTLQND 243 (303)
T ss_dssp HHCC-----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH---HHHTSS
T ss_pred heeccCCCccc--hhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH---HHhccC
Confidence 76654321110 011234579999999999876 568999999999999999999999998765432221 111111
Q ss_pred ccc-----hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 233 VST-----SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 233 ~~~-----~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
... ........++.++.++|..||..||++||++.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 111 111223568899999999999999999999887753
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=330.82 Aligned_cols=256 Identities=25% Similarity=0.326 Sum_probs=198.1
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC------CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~------~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
|...++||+|+||.||+|.+ +++.||||++.... ....+.+|+.+++.++|+ +|..+..++......+++|
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE-NLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT-TBCCEEEEECSSSSCEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC-CeEEEEEEEecCCceEEEE
Confidence 33458999999999999984 68899999876432 134688999999999855 4555555666677789999
Q ss_pred ecC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 83 DLL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 83 e~~-g~sL~~li~~~--~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKF 186 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE---cCCCcEEEeecccccccccc
Confidence 999 89999998743 3469999999999999999999999999999999999999 47789999999999876543
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+........ ..+..
T Consensus 187 ~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~ 259 (307)
T 2nru_A 187 AQTV-----MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEE-KTIED 259 (307)
T ss_dssp SSCE-----ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTS-CCHHH
T ss_pred cccc-----cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhh-hhhhh
Confidence 2211 1234579999999999876 589999999999999999999999987554332222211111111 11111
Q ss_pred H--------hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 240 L--------CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 240 l--------~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
. ...++..+.+++..||..||.+||++.+|++.|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 260 YIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp HSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred hccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 1 1123578999999999999999999999999998873
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=332.75 Aligned_cols=259 Identities=19% Similarity=0.215 Sum_probs=194.0
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeE---------
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGV--------- 73 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~--------- 73 (474)
++.++|++++.||+|+||.||+|++..+++.||||++.... ....+.+|+.+++.++|++++..+..+..
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 45678999999999999999999999999999999875432 23458899999999987766666655433
Q ss_pred ---eCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEe
Q 011945 74 ---EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIID 149 (474)
Q Consensus 74 ---~~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~D 149 (474)
.....++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~kl~d 159 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGD 159 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCEEEee
Confidence 245789999999 789999998766678999999999999999999999999999999999999 4778999999
Q ss_pred cCCccccccCCCccc-----c--ccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcH
Q 011945 150 FGLAKRYRDTATHQH-----I--PYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221 (474)
Q Consensus 150 FGla~~~~~~~~~~~-----~--~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~ 221 (474)
||++........... . .........||..|+|||++.+. .++.++|||||||++|||++ ||... ...
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--~~~ 234 (303)
T 1zy4_A 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--MER 234 (303)
T ss_dssp CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--HHH
T ss_pred CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--hhH
Confidence 999987653211000 0 01112345799999999999875 68999999999999999998 66431 112
Q ss_pred HHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 222 KQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
...+..+...... ....+...+++.+.++|..||..||++||++.++++
T Consensus 235 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 235 VNILKKLRSVSIE-FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHHSTTCC-CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhccccccc-cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 2223333222111 112234567788999999999999999999887753
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=337.95 Aligned_cols=254 Identities=16% Similarity=0.276 Sum_probs=178.6
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
..++|++++.||+|+||.||+|.+..+++.||||++...... ..+..|+..+.....|++|..+..+.......++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 357899999999999999999999999999999998765332 23555666444433466666776677778889999
Q ss_pred EecCCCCHHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 82 IDLLGPSLEDLFNF----CSRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 82 ~e~~g~sL~~li~~----~~~~l~~~~~~~i~~qi~~gL~yLHs~-gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
|||+.++|.+++.. ....+++..++.++.||+.||.|||++ ||+||||||+|||++ .++.+||+|||+++.+
T Consensus 100 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 100 MELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD---RSGNIKLCDFGISGQL 176 (327)
T ss_dssp ECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE---TTTEEEECCCSSSCC-
T ss_pred EeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEc---CCCCEEEccCCCceec
Confidence 99999899988864 256799999999999999999999998 999999999999995 7789999999999876
Q ss_pred ccCCCccccccccCCCCccCccccccccc----cCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTH----LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~----~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (474)
..... .....||..|+|||++ .+..++.++|||||||++|+|++|..||.+.... ...+..+....
T Consensus 177 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~ 246 (327)
T 3aln_A 177 VDSIA--------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--FDQLTQVVKGD 246 (327)
T ss_dssp -------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCCSC
T ss_pred ccccc--------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH--HHHHHHHhcCC
Confidence 54322 1234799999999998 4567899999999999999999999999764321 11111111111
Q ss_pred ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 233 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
...........+++++.+||..||..||++||++.+|++
T Consensus 247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 111111112458899999999999999999999888754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=333.41 Aligned_cols=241 Identities=22% Similarity=0.320 Sum_probs=189.8
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC--------chHHHHHHHHHHHhc---CCCCCceeEEEe
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------HPQLQYEAKLYKILQ---GGTGIPNLRWFG 72 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--------~~~l~~E~~il~~l~---~~~~i~~l~~~~ 72 (474)
.+.++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.++..+. .|++|..+..++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 467889999999999999999999999999999999865432 234667999999994 355566665566
Q ss_pred EeCCEEEEEEec-C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEec
Q 011945 73 VEGDYNVLVIDL-L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (474)
Q Consensus 73 ~~~~~~~lv~e~-~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DF 150 (474)
......+++||+ + +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++ ..++.+||+||
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~df 184 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID--LRRGCAKLIDF 184 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE--TTTTEEEECCC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe--CCCCeEEEEEc
Confidence 666777888887 3 8899999975 34699999999999999999999999999999999999995 36789999999
Q ss_pred CCccccccCCCccccccccCCCCccCccccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHh
Q 011945 151 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (474)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (474)
|++........ ....||..|+|||++.+..+ +.++|||||||++|||++|+.||... . .+.
T Consensus 185 g~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~----~~~ 246 (312)
T 2iwi_A 185 GSGALLHDEPY---------TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-----Q----EIL 246 (312)
T ss_dssp SSCEECCSSCB---------CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----H----HHH
T ss_pred chhhhcccCcc---------cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-----H----HHh
Confidence 99987654322 34579999999999987776 45999999999999999999999652 1 111
Q ss_pred hccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.... .+...++.++.++|..||..||++||++++++
T Consensus 247 ~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l 282 (312)
T 2iwi_A 247 EAEL-----HFPAHVSPDCCALIRRCLAPKPSSRPSLEEIL 282 (312)
T ss_dssp HTCC-----CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhcc-----CCcccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 1111 12356889999999999999999999988774
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=356.01 Aligned_cols=239 Identities=15% Similarity=0.132 Sum_probs=187.3
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCc----------eeEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIP----------NLRWF 71 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~----------~l~~~ 71 (474)
..|++.+.||+|+||+||+|++..+|+.||||++.... ..+.+.+|+.+++.+.|..++. .+...
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 35889999999999999999999999999999987332 2456889999999887633211 11110
Q ss_pred -----------eE-----eCCEEEEEEecCCCCHHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 011945 72 -----------GV-----EGDYNVLVIDLLGPSLEDLFNFC------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDI 129 (474)
Q Consensus 72 -----------~~-----~~~~~~lv~e~~g~sL~~li~~~------~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDI 129 (474)
.. .....+++|++++++|.++++.. ...+++..++.|+.||+.||+|||++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 11 12346889999999999999633 344788899999999999999999999999999
Q ss_pred CCCcEEeeeCCCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccc----------cCCCCCchhhHHHH
Q 011945 130 KPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH----------LGIEQSRRDDLESL 199 (474)
Q Consensus 130 KP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~----------~~~~~s~ksDIwSl 199 (474)
||+|||| +.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||||
T Consensus 238 Kp~NILl---~~~~~~kL~DFG~a~~~~~~----------~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 238 RPVDIVL---DQRGGVFLTGFEHLVRDGAS----------AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp CGGGEEE---CTTCCEEECCGGGCEETTEE----------ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred ccceEEE---ecCCeEEEEeccceeecCCc----------cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 9999999 47788999999999865433 134577 999999999 55568999999999
Q ss_pred HHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 200 GYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 200 Gvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
||+||||++|+.||.+...... +.. +...+..+|+++.+||..||..||++||++.++++
T Consensus 304 Gvil~elltg~~Pf~~~~~~~~---~~~---------~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALGG---SEW---------IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGSC---SGG---------GGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHCCCCCCCcchhhh---HHH---------HHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 9999999999999987533211 010 11123478999999999999999999999877743
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=364.53 Aligned_cols=257 Identities=21% Similarity=0.303 Sum_probs=207.2
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCC---CeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~---~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
.++|++.+.||+|+||.||+|.+..+ +..||||++...... ..+.+|+.+++.++|++++..+..+ . ....+
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~-~~~~~ 466 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-T-ENPVW 466 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-C-SSSCE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-e-cCceE
Confidence 46799999999999999999998643 467999987654332 4588999999999876666665544 3 34578
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
+||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++....
T Consensus 467 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~---~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp EEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCCCCCSCCC
T ss_pred EEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe---CCCCEEEEecCCCeecCC
Confidence 999999 7899999986666799999999999999999999999999999999999995 678999999999987654
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
.... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+... ...+..+......
T Consensus 544 ~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~---~~~~~~i~~~~~~--- 611 (656)
T 2j0j_A 544 STYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIENGERL--- 611 (656)
T ss_dssp ----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHHTCCC---
T ss_pred Ccce------eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHcCCCC---
Confidence 3221 1223467889999999999999999999999999999997 9999987543 3333333332221
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
.+...+|+++.++|..||..||++||++.+|++.|+.++.++
T Consensus 612 -~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 612 -PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 134578999999999999999999999999999999998764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=341.18 Aligned_cols=272 Identities=18% Similarity=0.253 Sum_probs=198.4
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
+..++|++.+.||+|+||.||+|.+.. .||||++.... ....+.+|+.+++.++|++++ .+..+.......+
T Consensus 30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~ 105 (319)
T 2y4i_B 30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVV-LFMGACMSPPHLA 105 (319)
T ss_dssp SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBC-CCCEEEECSSCEE
T ss_pred CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEe-EEEEEEecCCceE
Confidence 345789999999999999999999743 49999876532 234578899999999865555 4445556667789
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
++|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.....
T Consensus 106 iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~----~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD----NGKVVITDFGLFSISGV 181 (319)
T ss_dssp EECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC------CCEECCCSCCC----
T ss_pred EEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe----CCCEEEeecCCcccccc
Confidence 999999 7899999986556799999999999999999999999999999999999993 57899999999876533
Q ss_pred CCCccccccccCCCCccCccccccccccC---------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHh
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLG---------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~---------~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~ 229 (474)
..... .........||..|+|||++.+ ..++.++|||||||++|||++|..||..... ......+.
T Consensus 182 ~~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~ 256 (319)
T 2y4i_B 182 LQAGR--REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA---EAIIWQMG 256 (319)
T ss_dssp --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH---HHHHHHHH
T ss_pred ccccc--cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHhc
Confidence 21111 0111234569999999999875 4579999999999999999999999987433 33333333
Q ss_pred hccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccc
Q 011945 230 EKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWT 291 (474)
Q Consensus 230 ~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~ 291 (474)
....... ....+|.++.+++..||..||++||++.+|++.|+.+..+..........|.
T Consensus 257 ~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~~~~~~~~~ 315 (319)
T 2y4i_B 257 TGMKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWK 315 (319)
T ss_dssp TTCCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---------------
T ss_pred cCCCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccCCCCccccc
Confidence 2222111 1235789999999999999999999999999999998876655444444553
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=326.44 Aligned_cols=243 Identities=22% Similarity=0.289 Sum_probs=191.8
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccCC--CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-CCCH
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSL 89 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL 89 (474)
..||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++|++++ .+..+.......+++||++ +++|
T Consensus 28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv-~~~~~~~~~~~~~lv~e~~~~~~L 106 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIV-QYLGSFSENGFIKIFMEQVPGGSL 106 (295)
T ss_dssp CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBC-CEEEEEEETTEEEEEEECCSEEEH
T ss_pred EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEe-eEeeEEEeCCcEEEEEEeCCCCCH
Confidence 38999999999999999999999999876543 245688999999999865544 4555567778899999999 8899
Q ss_pred HHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccccc
Q 011945 90 EDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPY 167 (474)
Q Consensus 90 ~~li~~~~~--~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~ 167 (474)
.+++..... .+++..++.++.||+.||.|||++||+||||||+|||++ ..++.+||+|||++........
T Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~------ 178 (295)
T 2clq_A 107 SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRLAGINP------ 178 (295)
T ss_dssp HHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTCCEEECCTTTCEESCC---------
T ss_pred HHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEE--CCCCCEEEeecccccccCCCCC------
Confidence 999985433 467999999999999999999999999999999999996 3378999999999987654221
Q ss_pred ccCCCCccCccccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCc
Q 011945 168 RENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245 (474)
Q Consensus 168 ~~~~~~~GT~~Y~APE~~~~~~--~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 245 (474)
......||..|+|||++.+.. ++.++|||||||++|+|++|..||...... ............. ..+...++
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~---~~~~~~~~ 252 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP--QAAMFKVGMFKVH---PEIPESMS 252 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH--HHHHHHHHHHCCC---CCCCTTSC
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch--hHHHHhhcccccc---ccccccCC
Confidence 123457999999999998654 899999999999999999999999764321 1111111111111 12345689
Q ss_pred HHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 246 TEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 246 ~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
+++.++|..||..||++||++.+++
T Consensus 253 ~~~~~li~~~l~~dp~~Rps~~~ll 277 (295)
T 2clq_A 253 AEAKAFILKCFEPDPDKRACANDLL 277 (295)
T ss_dssp HHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHh
Confidence 9999999999999999999987764
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=335.52 Aligned_cols=251 Identities=16% Similarity=0.221 Sum_probs=199.6
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc-------------------hHHHHHHHHHHHhcCCCC
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-------------------PQLQYEAKLYKILQGGTG 64 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-------------------~~l~~E~~il~~l~~~~~ 64 (474)
...++|++++.||+|+||.||+|.+ +++.||||++...... ..+.+|+.+++.++|++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~- 104 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY- 104 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT-
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC-
Confidence 3457999999999999999999998 8999999987543111 67999999999998554
Q ss_pred CceeEEEeEeCCEEEEEEecC-CCCHHHH------HHHc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEE
Q 011945 65 IPNLRWFGVEGDYNVLVIDLL-GPSLEDL------FNFC-SRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFL 135 (474)
Q Consensus 65 i~~l~~~~~~~~~~~lv~e~~-g~sL~~l------i~~~-~~~l~~~~~~~i~~qi~~gL~yLHs-~gIiHrDIKP~NIL 135 (474)
|..+..+.......++||||+ +++|.++ +... ...+++..++.++.||+.||.|||+ +||+||||||+|||
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 555555566778899999999 6699988 5422 4579999999999999999999999 99999999999999
Q ss_pred eeeCCCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCC-CCCc-hhhHHHHHHHHHHHHhCCCCC
Q 011945 136 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSR-RDDLESLGYVLMYFLRGSLPW 213 (474)
Q Consensus 136 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~-ksDIwSlGvil~elltG~~Pf 213 (474)
+ +.++.+||+|||++....... .....||..|+|||++.+. .++. ++|||||||++|||++|..||
T Consensus 185 ~---~~~~~~kl~dfg~~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 252 (348)
T 2pml_X 185 M---DKNGRVKLSDFGESEYMVDKK---------IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252 (348)
T ss_dssp E---CTTSCEEECCCTTCEECBTTE---------ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred E---cCCCcEEEecccccccccccc---------ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCC
Confidence 9 477899999999998764431 1345799999999999987 5666 999999999999999999999
Q ss_pred CCCCcCcHHHHHHHHhhccccch--------------HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 214 QGLKAGTKKQKYEKISEKKVSTS--------------IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 214 ~~~~~~~~~~~~~~i~~~~~~~~--------------~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
...... ...+..+.......+ .......+++++.+||..||..||++||++.++++
T Consensus 253 ~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 253 SLKISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp CCSSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 875432 333444433322111 01112568899999999999999999999887743
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=345.12 Aligned_cols=259 Identities=20% Similarity=0.229 Sum_probs=190.6
Q ss_pred CCccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 2 ~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
+..+.+.|.+.++||+|+||+||.+. ..+|+.||||++... ....+.+|+.+++.+.+|++|..+..+.......+||
T Consensus 10 ~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~-~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 10 EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID-FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGG-GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHH-HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 34567888899999999999998764 478999999987653 2356789999999886677777777778888999999
Q ss_pred EecCCCCHHHHHHHcCCC------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeC----------CCCCeE
Q 011945 82 IDLLGPSLEDLFNFCSRK------LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG----------RRANQV 145 (474)
Q Consensus 82 ~e~~g~sL~~li~~~~~~------l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~----------~~~~~v 145 (474)
|||++++|.+++...... .++..++.|+.||+.||+|||++||+||||||+||||+.+ +....+
T Consensus 88 ~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 88 LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp ECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred EecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 999999999999743211 1333567899999999999999999999999999999632 245689
Q ss_pred EEEecCCccccccCCCccccccccCCCCccCccccccccccC-------CCCCchhhHHHHHHHHHHHHh-CCCCCCCCC
Q 011945 146 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG-------IEQSRRDDLESLGYVLMYFLR-GSLPWQGLK 217 (474)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-------~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~ 217 (474)
||+|||+++.+........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |..||.+..
T Consensus 168 kL~DFG~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFR---TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp EECCCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred EEcccccceecCCCCccce---eeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 9999999987755322110 01234579999999999976 568999999999999999999 999997643
Q ss_pred cCcHHHHHHHHhhccccch-HHHH-hcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 218 AGTKKQKYEKISEKKVSTS-IEAL-CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~-~~~l-~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.. .. .+........ ...+ ...+++++.+||..||..||++||++.+|+
T Consensus 245 ~~--~~---~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil 294 (434)
T 2rio_A 245 SR--ES---NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294 (434)
T ss_dssp TH--HH---HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred hh--HH---HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHH
Confidence 21 11 1111111100 0000 112468899999999999999999988775
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=345.51 Aligned_cols=253 Identities=17% Similarity=0.191 Sum_probs=188.7
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecCC
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLG 86 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~g 86 (474)
.+|.+.++||+|+||+||.. ...+++.||||++... ....+.+|+.+++.+..|++|..+..+.......|||||+++
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~-~~~~~~~vAvK~~~~~-~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~ 101 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILPE-CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA 101 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEE-EESSSSEEEEEEECTT-TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred EEEecCCeeecCcCEEEEEE-EEeCCeEEEEEEECHH-HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC
Confidence 36999999999999997643 3478999999988643 334578999999999666777777777888899999999999
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCC--CCCeEEEEecCCccccccCCCccc
Q 011945 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR--RANQVYIIDFGLAKRYRDTATHQH 164 (474)
Q Consensus 87 ~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~--~~~~vkL~DFGla~~~~~~~~~~~ 164 (474)
++|.+++......+.+..++.|+.||+.||.|||++||+||||||+||||+.++ ....+||+|||+|+.+......
T Consensus 102 g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~-- 179 (432)
T 3p23_A 102 ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS-- 179 (432)
T ss_dssp EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--------
T ss_pred CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc--
Confidence 999999986555677777889999999999999999999999999999996332 2346889999999876543211
Q ss_pred cccccCCCCccCcccccccccc---CCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 165 IPYRENKNLTGTARYASMNTHL---GIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 165 ~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
+.......||+.|+|||++. +..++.++|||||||++|||++ |..||..... .. ...+..... ......
T Consensus 180 --~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~---~~-~~~~~~~~~-~~~~~~ 252 (432)
T 3p23_A 180 --FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ---RQ-ANILLGACS-LDCLHP 252 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT---HH-HHHHTTCCC-CTTSCT
T ss_pred --eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH---HH-HHHHhccCC-ccccCc
Confidence 11224568999999999998 4567889999999999999999 9999965322 11 111111110 000000
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
....+..+.+||..||+.||++||++.+|+
T Consensus 253 ~~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 253 EKHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp TCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 112346689999999999999999988775
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=321.89 Aligned_cols=239 Identities=18% Similarity=0.216 Sum_probs=182.8
Q ss_pred cCCcEEEe-eeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEe----CCEEE
Q 011945 5 VGNKFRLG-RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVE----GDYNV 79 (474)
Q Consensus 5 i~~~y~i~-~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~----~~~~~ 79 (474)
+.++|.+. +.||+|+||.||+|.+..+++.||||++.. ...+.+|+.++.++..|++|..+..+... ....+
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc---cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 45678777 789999999999999999999999999863 45788999999666666666666555444 66789
Q ss_pred EEEecC-CCCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~-~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
+||||+ +++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++....++.+||+|||++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 171 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence 999999 779999998643 469999999999999999999999999999999999999643337899999999986432
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHH-HHHhhccccch
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-EKISEKKVSTS 236 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~-~~i~~~~~~~~ 236 (474)
+..++.++|||||||++|||++|..||.+.........+ ..+.......
T Consensus 172 -----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~- 221 (299)
T 3m2w_A 172 -----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF- 221 (299)
T ss_dssp -----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSS-
T ss_pred -----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccC-
Confidence 134678999999999999999999999764321110000 0011111111
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
.......+++++.+||..||..||++||++.++ |++.|..
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~---l~hp~~~ 261 (299)
T 3m2w_A 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF---MNHPWIM 261 (299)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH---HTSHHHH
T ss_pred CchhcccCCHHHHHHHHHHcccChhhCCCHHHH---hcChhhc
Confidence 122335789999999999999999999998777 4455443
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=318.13 Aligned_cols=231 Identities=11% Similarity=0.069 Sum_probs=186.4
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc-----hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
.++++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.++..+.|+ +|..+..++......
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp-~iv~~~~~~~~~~~~ 106 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKP-GVARVLDVVHTRAGG 106 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCT-TBCCEEEEEEETTEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCC-CcceeeEEEEECCcE
Confidence 5678999999999999999999999999999999998765432 4688999999999755 455666667778889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
|+||||+ |++|.++++. .....+++.|+.||+.||.|||++||+||||||+||||+ .++.+||+++|
T Consensus 107 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~---~~g~~kl~~~~------ 174 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS---IDGDVVLAYPA------ 174 (286)
T ss_dssp EEEEECCCEEEHHHHHTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---TTSCEEECSCC------
T ss_pred EEEEEecCCCCHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc---CCCCEEEEecc------
Confidence 9999999 7899999852 246668899999999999999999999999999999995 67888887543
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
|++ .++.++|||||||+||||++|+.||.+...........+... ......
T Consensus 175 ---------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~-~~~~~~ 225 (286)
T 3uqc_A 175 ---------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA-GQPIEP 225 (286)
T ss_dssp ---------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTT-SCBCCH
T ss_pred ---------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhc-cCCCCh
Confidence 222 368999999999999999999999987554221100000011 112233
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
..+...+|+++.++|.+||+.||++| ++.++++.|+++.
T Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 226 ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 45567899999999999999999999 9999999998875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=349.51 Aligned_cols=242 Identities=14% Similarity=0.186 Sum_probs=191.0
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcC-CCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCC---
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGD--- 76 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~-~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~--- 76 (474)
++.++|+++++||+|+||.||+|.+.. +++.||||++...... ..+..|+.+++.++|++++..+..+...+.
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 567899999999999999999999976 7899999987654322 347889999999987666666655554433
Q ss_pred -EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 77 -YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 77 -~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
..||||||+ |++|.+++. ..+++..++.|+.||+.||.|||++|||||||||+||||+ . +.+||+|||+++
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~---~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~---~-~~~kl~DFG~a~ 229 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT---E-EQLKLIDLGAVS 229 (681)
T ss_dssp EEEEEEEECCCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---S-SCEEECCCTTCE
T ss_pred ceeEEEEEeCCCCcHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe---C-CcEEEEecccch
Confidence 269999999 789988765 3799999999999999999999999999999999999994 2 489999999998
Q ss_pred ccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (474)
..... ....||+.|+|||++.+.. +.++||||||||||+|++|..||.+....... ..
T Consensus 230 ~~~~~-----------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~----------~~ 287 (681)
T 2pzi_A 230 RINSF-----------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP----------ED 287 (681)
T ss_dssp ETTCC-----------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC----------TT
T ss_pred hcccC-----------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc----------cc
Confidence 76442 2357999999999998754 89999999999999999999998753221100 00
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCCCCC-HHHHHHHHHHHHH
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPD-YAYLKRLFRDLFI 278 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt-~~~l~~~L~~l~~ 278 (474)
... ..+++.+.+||.+||..||++||+ ++++...|..++.
T Consensus 288 ~~~----~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 288 DPV----LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp CHH----HHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred ccc----cccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 001 123578999999999999999994 6667777766653
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=350.53 Aligned_cols=267 Identities=17% Similarity=0.220 Sum_probs=196.3
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeE-----eC
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGV-----EG 75 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~-----~~ 75 (474)
...++|++.++||+|+||.||+|.+..+|+.||||++..... ...+.+|+.+++.++|++++..+..+.. .+
T Consensus 11 ~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 345889999999999999999999999999999998765432 2458889999999986665555444321 26
Q ss_pred CEEEEEEecC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCC
Q 011945 76 DYNVLVIDLL-GPSLEDLFNFCS--RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (474)
Q Consensus 76 ~~~~lv~e~~-g~sL~~li~~~~--~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (474)
...++||||+ |++|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+|||++.++....+||+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 6779999999 889999998533 2599999999999999999999999999999999999997554555699999999
Q ss_pred ccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcH------HHHHH
Q 011945 153 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK------KQKYE 226 (474)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~------~~~~~ 226 (474)
+........ .....||..|+|||++.+..++.++|||||||++|+|++|..||.+...... .....
T Consensus 171 a~~~~~~~~--------~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 171 AKELDQGEL--------CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242 (676)
T ss_dssp CCBTTSCCC--------CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred ccccccccc--------cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence 987654322 2346899999999999999999999999999999999999999965311000 00000
Q ss_pred HHh-hcc------c---cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHH-----HHHHHHHHHH
Q 011945 227 KIS-EKK------V---STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAY-----LKRLFRDLFI 278 (474)
Q Consensus 227 ~i~-~~~------~---~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~-----l~~~L~~l~~ 278 (474)
.+. ... + ......+...+++.+.++|..||..||++||++.+ ..+.+++++.
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 000 000 0 00001122346789999999999999999999877 3455555553
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=319.45 Aligned_cols=241 Identities=19% Similarity=0.181 Sum_probs=178.6
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----------hHHHHHHHHHHHhc--------CCCCCce
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------PQLQYEAKLYKILQ--------GGTGIPN 67 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~l~~E~~il~~l~--------~~~~i~~ 67 (474)
.++|+++++||+|+||+||+|++ +++.||||++...... ..+.+|+.+++.|+ .|+++..
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 36799999999999999999997 7899999998754321 67899999999997 2444443
Q ss_pred e-EEEeE-----------------------------eCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHH
Q 011945 68 L-RWFGV-----------------------------EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116 (474)
Q Consensus 68 l-~~~~~-----------------------------~~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL 116 (474)
+ ..+.. .....||||||+ ++++.+.+. ...+++..++.|+.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--~~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR--TKLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT--TTCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH--hcCCCHHHHHHHHHHHHHHH
Confidence 3 33221 267899999998 665544443 35789999999999999999
Q ss_pred HHHH-HCCccccCCCCCcEEeeeCC-----------------CCCeEEEEecCCccccccCCCccccccccCCCCccCcc
Q 011945 117 EFVH-SKSFLHRDIKPDNFLMGLGR-----------------RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178 (474)
Q Consensus 117 ~yLH-s~gIiHrDIKP~NILl~~~~-----------------~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~ 178 (474)
.||| ++|||||||||+||||+.++ ....+||+|||+|+..... ..+||+.
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------------~~~gt~~ 242 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------------IVVFCDV 242 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------------EEECCCC
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------------cEEEeec
Confidence 9999 99999999999999997332 1128999999999876542 2479999
Q ss_pred ccccccccCCCCCchhhHHHHHHH-HHHHHhCCCCCCCCCcCcHHHHHHHHhhc-cc-cchHHHHhcCCcHHHHHHHHHH
Q 011945 179 YASMNTHLGIEQSRRDDLESLGYV-LMYFLRGSLPWQGLKAGTKKQKYEKISEK-KV-STSIEALCRGYPTEFASYFHYC 255 (474)
Q Consensus 179 Y~APE~~~~~~~s~ksDIwSlGvi-l~elltG~~Pf~~~~~~~~~~~~~~i~~~-~~-~~~~~~l~~~~p~~l~~li~~c 255 (474)
|+|||++.+.. +.++||||||++ .++++.|..||.+... .......+... .. ..........+++++.+||.+|
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~ 319 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTM 319 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH--HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHG
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh--hhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHH
Confidence 99999999876 999999998877 7778889999843100 01111222211 00 1111223345688999999999
Q ss_pred hcCCCCCCCCHHHHH
Q 011945 256 RSLRFDDKPDYAYLK 270 (474)
Q Consensus 256 l~~dp~~RPt~~~l~ 270 (474)
|+.| ++++++
T Consensus 320 L~~d-----sa~e~l 329 (336)
T 2vuw_A 320 LNFS-----SATDLL 329 (336)
T ss_dssp GGSS-----SHHHHH
T ss_pred hccC-----CHHHHH
Confidence 9976 766654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-32 Score=290.08 Aligned_cols=184 Identities=15% Similarity=0.133 Sum_probs=131.2
Q ss_pred eeeecCceEEEEEEEcCCCeEEEEEEeccCCC------------chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK------------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 14 ~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~------------~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
.++.|++|.+..++....|+.|+||++..... ..++.+|+++|+++.++++|+.+..++.++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45678888888878778899999998865421 235899999999999899999999999999999999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ |++|.+++.. .+.+++. .|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+......
T Consensus 321 MEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC---
T ss_pred EecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeCCCCC
Confidence 9999 8999999984 4567765 478999999999999999999999999999 478899999999998765543
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCC
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~P 212 (474)
.. ..+.+||+.|||||++.+. +..++|+||+|+++++|.++..+
T Consensus 394 ~~-------~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 SW-------PTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CC-------SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred cc-------ccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 21 2346899999999999874 67789999999998877655433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-27 Score=254.00 Aligned_cols=188 Identities=19% Similarity=0.150 Sum_probs=140.3
Q ss_pred EEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----------chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 10 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----------~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
...++||+|+||+||+|. ..++.+++|....+.. .+.+.+|+++++.++|++++ .+..++......|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv-~~~~~~~~~~~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIP-APYIFDVDLDNKR 415 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCC-CCCEEEEETTTTE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcC-ceEEEEEeCCccE
Confidence 345689999999999995 6688999997654332 12368999999999866555 3334444666679
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
|||||+ |++|.+++.. ++.|+.||+.||.|||++||+||||||+|||++ . .+||+|||+|+....
T Consensus 416 lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~---~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD---K--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES---S--SEEECCCTTCEECCC
T ss_pred EEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC---C--eEEEEECccCEECCC
Confidence 999999 7999999873 678999999999999999999999999999994 3 999999999998755
Q ss_pred CCCccccccccCCCCccCccccccccccC--CCCCchhhHHHHHHHHHHHHhCCCCCC
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQ 214 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDIwSlGvil~elltG~~Pf~ 214 (474)
........+.....+.||+.|||||++.+ ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 32211000011235689999999999987 557888999999999998888877763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-24 Score=211.56 Aligned_cols=142 Identities=16% Similarity=0.249 Sum_probs=112.0
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC--------------------chHHHHHHHHHHHhcCCCCCce
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------------------HPQLQYEAKLYKILQGGTGIPN 67 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--------------------~~~l~~E~~il~~l~~~~~i~~ 67 (474)
.|.+++.||+|+||.||+|.+ .+|+.||||++..... ...+.+|+.+++.+. + +..
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~--~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-G--LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-T--SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-C--CCc
Confidence 455669999999999999999 8899999999854321 234789999999998 2 444
Q ss_pred eEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEE
Q 011945 68 LRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVY 146 (474)
Q Consensus 68 l~~~~~~~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vk 146 (474)
+..+.. ...++||||+ |++|.+ +. ......++.||+.||.|||++||+||||||+|||++ ++.+|
T Consensus 167 ~~~~~~--~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~----~~~vk 232 (282)
T 1zar_A 167 PKVYAW--EGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIW 232 (282)
T ss_dssp CCEEEE--ETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEE
T ss_pred CeEEec--cceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE----CCcEE
Confidence 443333 3458999999 778887 32 123567999999999999999999999999999994 78999
Q ss_pred EEecCCccccccCCCccccccccCCCCccCccccccccccC
Q 011945 147 IIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG 187 (474)
Q Consensus 147 L~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~ 187 (474)
|+|||+|+. +..|+|||.+..
T Consensus 233 l~DFG~a~~--------------------~~~~~a~e~l~r 253 (282)
T 1zar_A 233 IIDFPQSVE--------------------VGEEGWREILER 253 (282)
T ss_dssp ECCCTTCEE--------------------TTSTTHHHHHHH
T ss_pred EEECCCCeE--------------------CCCCCHHHHHHH
Confidence 999999852 345788998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=9.4e-22 Score=189.64 Aligned_cols=136 Identities=19% Similarity=0.270 Sum_probs=107.2
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeE--EEEEEeccCCCc--------------------------hHHHHHHHHHHHh
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEE--VAIKLENVKTKH--------------------------PQLQYEAKLYKIL 59 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~--vAvK~~~~~~~~--------------------------~~l~~E~~il~~l 59 (474)
-|.+.+.||+|+||.||+|.+..+|+. ||||++...... ..+.+|+.++..|
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 488999999999999999998778999 999986543110 2578899999999
Q ss_pred cCCCC-CceeEEEeEeCCEEEEEEecCCC------CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCC
Q 011945 60 QGGTG-IPNLRWFGVEGDYNVLVIDLLGP------SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-SKSFLHRDIKP 131 (474)
Q Consensus 60 ~~~~~-i~~l~~~~~~~~~~~lv~e~~g~------sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLH-s~gIiHrDIKP 131 (474)
.++.. ++.+.. . ...+|||||+++ +|.++... +++..+..++.||+.||.||| ++|||||||||
T Consensus 128 ~~~~i~~p~~~~--~--~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 KEAGVSVPQPYT--Y--MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHTTCCCCCEEE--E--ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HhCCCCCCeEEE--c--CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 86532 333332 2 245899999953 77776532 235578899999999999999 99999999999
Q ss_pred CcEEeeeCCCCCeEEEEecCCcccc
Q 011945 132 DNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 132 ~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
+|||++ . .++|+|||+|...
T Consensus 200 ~NILl~---~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYI---D--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEES---S--SEEECCCTTCEET
T ss_pred HHEEEc---C--cEEEEECcccccC
Confidence 999994 3 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=8.4e-18 Score=169.99 Aligned_cols=137 Identities=18% Similarity=0.259 Sum_probs=98.9
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--------C--------ch--------HHHHHHHHHHHhcCCCC
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--------K--------HP--------QLQYEAKLYKILQGGTG 64 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--------~--------~~--------~l~~E~~il~~l~~~~~ 64 (474)
|.|+++||.|+||.||+|.+ .+|+.||||+++... . .. ...+|...|.+|. ..+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~-~~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY-EEG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH-HTT
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH-hcC
Confidence 89999999999999999997 579999999865321 0 00 1245777888885 344
Q ss_pred CceeEEEeEeCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCC-
Q 011945 65 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRA- 142 (474)
Q Consensus 65 i~~l~~~~~~~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~- 142 (474)
+.....+.... .+|||||+ |..|.++. .......++.||+.+|.|||++|||||||||.|||++.+.+.
T Consensus 175 v~vp~p~~~~~--~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~ 245 (397)
T 4gyi_A 175 FPVPEPIAQSR--HTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE 245 (397)
T ss_dssp CSCCCEEEEET--TEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred CCCCeeeeccC--ceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence 44433333333 37999999 55554332 123456788999999999999999999999999999743211
Q ss_pred ------CeEEEEecCCcccc
Q 011945 143 ------NQVYIIDFGLAKRY 156 (474)
Q Consensus 143 ------~~vkL~DFGla~~~ 156 (474)
..++|+||+-+...
T Consensus 246 d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 246 DPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CTTSEEEEEEECCCTTCEET
T ss_pred cccccccceEEEEeCCcccC
Confidence 14899999988643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.38 E-value=3e-12 Score=122.59 Aligned_cols=137 Identities=17% Similarity=0.275 Sum_probs=109.0
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC--CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
+.|++...++.|+++.||++.. .+..++||+.... .....+.+|+.+++.|..+..++.+..++......|++||+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 4699999999999999999973 4689999997642 23346999999999997666677788778888889999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 011945 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS------------------------------------------ 121 (474)
Q Consensus 85 ~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs------------------------------------------ 121 (474)
+ |.+|.+.+. +......++.+++.+|..||+
T Consensus 92 i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 92 ADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred cCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 9 777776531 122345788899999999998
Q ss_pred -----------------CCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 122 -----------------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 122 -----------------~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
..++|+|++|.|||++ +...+.|+||+.+.
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhcc
Confidence 4589999999999994 34456799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.25 E-value=3.9e-11 Score=114.02 Aligned_cols=134 Identities=16% Similarity=0.078 Sum_probs=98.1
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCC-CceeEEEeEeCCEEEEEEecC
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG-IPNLRWFGVEGDYNVLVIDLL 85 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~-i~~l~~~~~~~~~~~lv~e~~ 85 (474)
..|.+....+.|..+.||++.. .+|..|+||+.... ....+..|+.+++.+.++.. ++.+..++..+...+++||++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 4567655555666799999963 56778999987654 33568999999999987644 666767777777789999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC-----------------------------------------
Q 011945 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS----------------------------------------- 123 (474)
Q Consensus 86 -g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~g----------------------------------------- 123 (474)
|.+|. .. ..+ ...++.+++..|..||+..
T Consensus 98 ~G~~l~--~~----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 98 PGQDLL--SS----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp SSEETT--TS----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred CCcccC--cC----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 55663 11 112 2356677777788887643
Q ss_pred -----------------ccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 124 -----------------FLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 124 -----------------IiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
++|+|++|.|||++ ..+.+.|+|||.+.
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhcc
Confidence 99999999999994 44556799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.08 E-value=4.4e-10 Score=112.72 Aligned_cols=139 Identities=13% Similarity=0.207 Sum_probs=99.7
Q ss_pred EeeeeeecCceEEEEEEEcCCCeEEEEEEec--cCC---CchHHHHHHHHHHHhcCCCC-CceeEEEeEeC---CEEEEE
Q 011945 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN--VKT---KHPQLQYEAKLYKILQGGTG-IPNLRWFGVEG---DYNVLV 81 (474)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~--~~~---~~~~l~~E~~il~~l~~~~~-i~~l~~~~~~~---~~~~lv 81 (474)
-++.|+.|.++.||++.. .+..+++|+.. ... ....+.+|+.+++.|..... ++.+..++.+. ...+++
T Consensus 42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 467889999999999984 35678899765 322 23468899999999986433 56666665554 347899
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS--------------------------------------- 121 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs--------------------------------------- 121 (474)
||++ |..+.+. .-..++......++.+++..|..||+
T Consensus 120 me~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 120 MEFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 9999 4444321 12347788889999999999999997
Q ss_pred -------------------CCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 122 -------------------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 122 -------------------~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
.++||+|++|.|||++.+ ....+.|+||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~-~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPT-EPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSS-SSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCC-CCcEEEEECcccccc
Confidence 368999999999999521 113468999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.06 E-value=7.7e-11 Score=115.57 Aligned_cols=191 Identities=16% Similarity=0.170 Sum_probs=120.2
Q ss_pred eeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCC--CceeEEEeEeCC---EEEEEEecC-
Q 011945 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG--IPNLRWFGVEGD---YNVLVIDLL- 85 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~--i~~l~~~~~~~~---~~~lv~e~~- 85 (474)
++.|+.|.+..||++. ..++||+.........+..|..+++.|..... ++.+..++.... ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4568999999999864 46899986543234568999999999865433 344444433332 347889998
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 011945 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-------------------------------------------- 121 (474)
Q Consensus 86 g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs-------------------------------------------- 121 (474)
|.+|.+... ..++..+...++.|++..|..||+
T Consensus 100 G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 100 GVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 666654322 247788888889999999998886
Q ss_pred --------------CCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccccccc-------cCCCCccCcccc
Q 011945 122 --------------KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYR-------ENKNLTGTARYA 180 (474)
Q Consensus 122 --------------~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~-------~~~~~~GT~~Y~ 180 (474)
..++|+|++|.|||++.+ ....+.|+||+.+............-.. ....+.....+.
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence 136999999999999621 1456789999998753221110000000 000000000111
Q ss_pred c-cccccCCCCCchhhHHHHHHHHHHHHhCCCCC
Q 011945 181 S-MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213 (474)
Q Consensus 181 A-PE~~~~~~~s~ksDIwSlGvil~elltG~~Pf 213 (474)
. |+.... .....+.|++++++|.+.+|..+|
T Consensus 256 ~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 256 DIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 1 221111 122368999999999999998876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=2.6e-07 Score=90.61 Aligned_cols=136 Identities=24% Similarity=0.271 Sum_probs=90.9
Q ss_pred eeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCC--CceeEEEeE-eCCEEEEEEecC-CC
Q 011945 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG--IPNLRWFGV-EGDYNVLVIDLL-GP 87 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~--i~~l~~~~~-~~~~~~lv~e~~-g~ 87 (474)
++.++.|....||+. +..++||+-........+..|..+|+.|.++.. ++.+..++. .....+++|+++ |.
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 456788999999988 567899985332233568999999999986432 455555553 445568999999 65
Q ss_pred CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------------
Q 011945 88 SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK--------------------------------------------- 122 (474)
Q Consensus 88 sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~--------------------------------------------- 122 (474)
.|.+..- ..++......++.++...|..||+.
T Consensus 99 ~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 99 ILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp ECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred ECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 6655321 1345555555555555555555542
Q ss_pred ---------------CccccCCCCCcEEeeeCCCCCe-EEEEecCCccc
Q 011945 123 ---------------SFLHRDIKPDNFLMGLGRRANQ-VYIIDFGLAKR 155 (474)
Q Consensus 123 ---------------gIiHrDIKP~NILl~~~~~~~~-vkL~DFGla~~ 155 (474)
.++|+|++|.|||++.+...+. +.|+||+.+..
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3589999999999952111344 58999998853
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.55 E-value=5.5e-07 Score=86.02 Aligned_cols=132 Identities=17% Similarity=0.162 Sum_probs=94.4
Q ss_pred eeeecCce-EEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-CCCHHH
Q 011945 14 KIGSGSFG-EIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLED 91 (474)
Q Consensus 14 ~LG~G~fG-~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~sL~~ 91 (474)
.+..|..| .||+......+..++||+.... ....+..|..+|+.|...--++.+..++..+...+++|+++ |.++.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence 34445554 6999887667788999986533 23468899999999986655777888888888999999999 667766
Q ss_pred HHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-------------------------------------------------
Q 011945 92 LFNFCSRKLSLKTVLMLADQMINRVEFVHSK------------------------------------------------- 122 (474)
Q Consensus 92 li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~------------------------------------------------- 122 (474)
..... ......+..+++..|..||..
T Consensus 110 ~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 184 (272)
T 4gkh_A 110 VLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMH 184 (272)
T ss_dssp HHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHH
T ss_pred cccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHH
Confidence 55421 122334555666666666631
Q ss_pred ---------CccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 123 ---------SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 123 ---------gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
.++|+|+.+.|||++ ..+.+-|+||+.+.
T Consensus 185 ~~~~~~~~~~l~HGDl~~~Nil~~---~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 185 KLLPFSPDSVVTHGDFSLDNLIFD---EGKLIGCIDVGRVG 222 (272)
T ss_dssp TTCCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred hcccccCCcEEEcCCCCCCeEEEE---CCeEEEEEECcccc
Confidence 168999999999995 44556799999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=2.7e-06 Score=86.14 Aligned_cols=75 Identities=13% Similarity=0.152 Sum_probs=50.5
Q ss_pred EeeeeeecCceEEEEEEEcCCCeEEEEEEeccC---------CCchHHHHHHHHHHHhcCC--CCCceeEEEeEeCCEEE
Q 011945 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK---------TKHPQLQYEAKLYKILQGG--TGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~---------~~~~~l~~E~~il~~l~~~--~~i~~l~~~~~~~~~~~ 79 (474)
-.+.||.|.++.||++.....++.|+||..... .....+..|.++++.+... ..++.+..+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 356899999999999976556788999975321 1234578899999998653 345555544 344458
Q ss_pred EEEecCCC
Q 011945 80 LVIDLLGP 87 (474)
Q Consensus 80 lv~e~~g~ 87 (474)
+|||++.+
T Consensus 112 lvmE~l~g 119 (397)
T 2olc_A 112 TVMEDLSH 119 (397)
T ss_dssp EEECCCTT
T ss_pred EEEEeCCC
Confidence 99999844
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=1.3e-06 Score=87.07 Aligned_cols=77 Identities=13% Similarity=0.295 Sum_probs=52.9
Q ss_pred EEEeeee-eecCceEEEEEEEc--C----CCeEEEEEEeccCC-----CchHHHHHHHHHHHhcCC--CCCceeEEEeEe
Q 011945 9 FRLGRKI-GSGSFGEIYLGTNI--Q----TNEEVAIKLENVKT-----KHPQLQYEAKLYKILQGG--TGIPNLRWFGVE 74 (474)
Q Consensus 9 y~i~~~L-G~G~fG~Vy~a~~~--~----~~~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~--~~i~~l~~~~~~ 74 (474)
....+.| +.|....+|++... . ++..+++|+..... ....+..|+.+++.|... -.++.+..++..
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 4456778 88889999998742 1 26789999865432 124689999999999754 345666555544
Q ss_pred C---CEEEEEEecC
Q 011945 75 G---DYNVLVIDLL 85 (474)
Q Consensus 75 ~---~~~~lv~e~~ 85 (474)
. ...+++||++
T Consensus 102 ~~~~g~~~~v~e~l 115 (357)
T 3ats_A 102 GDVLGTPFFLMDYV 115 (357)
T ss_dssp STTTSSCEEEEECC
T ss_pred CCccCCceEEEEec
Confidence 3 2457899998
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.07 E-value=5.4e-05 Score=74.30 Aligned_cols=72 Identities=11% Similarity=0.137 Sum_probs=43.1
Q ss_pred eeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCC-CCceeEE------EeEeCCEEEEEEec
Q 011945 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGT-GIPNLRW------FGVEGDYNVLVIDL 84 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~-~i~~l~~------~~~~~~~~~lv~e~ 84 (474)
++.|+.|..+.||++.. .+..+++|+... ....+..|..+++.|.... .++.+.. +.......+++|++
T Consensus 37 ~~~l~gG~~n~~~~v~~--~~~~~vlk~~~~--~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT--DSGAVCLKRIHR--PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EEECC----CEEEEEEE--TTEEEEEEEECS--CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeeccccccCcEEEEEe--CCCCEEEEecCC--CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 34566677889999974 334599998865 3345667888888776321 2333321 22346677899999
Q ss_pred CCC
Q 011945 85 LGP 87 (474)
Q Consensus 85 ~g~ 87 (474)
+.|
T Consensus 113 i~G 115 (346)
T 2q83_A 113 IEG 115 (346)
T ss_dssp CCC
T ss_pred ecC
Confidence 843
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00012 Score=70.92 Aligned_cols=68 Identities=12% Similarity=0.091 Sum_probs=47.0
Q ss_pred eeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-CC
Q 011945 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GP 87 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~-g~ 87 (474)
++.|+.|....+|++ ..+++|+...... .-....|..+++.+......+.+.++. .+..+++++++ ++
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCC
Confidence 678999999999999 5689998654321 123578999999988666556665543 33346788888 44
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00011 Score=75.06 Aligned_cols=73 Identities=14% Similarity=0.281 Sum_probs=45.2
Q ss_pred EeeeeeecCceEEEEEEEcCCCeEEEEEEecc-----CC----CchHHHHHHHHHHHhc--CCCCCceeEEEeEeCCEEE
Q 011945 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KT----KHPQLQYEAKLYKILQ--GGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~-----~~----~~~~l~~E~~il~~l~--~~~~i~~l~~~~~~~~~~~ 79 (474)
-++.||.|..+.||++. .++..|+||.... .. .......|.+++..+. .+..++.+..++ ....+
T Consensus 38 ~i~~l~~G~~n~vyrv~--~~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVV--GSSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEE--CSSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEE--cCCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 35678999999999996 3567899993211 11 1123344555544442 234456665554 45568
Q ss_pred EEEecC-CC
Q 011945 80 LVIDLL-GP 87 (474)
Q Consensus 80 lv~e~~-g~ 87 (474)
+|||++ ++
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 65
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.59 E-value=0.0015 Score=60.06 Aligned_cols=123 Identities=13% Similarity=0.105 Sum_probs=80.2
Q ss_pred CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccc
Q 011945 87 PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 165 (474)
Q Consensus 87 ~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs-~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (474)
-+|.+++...+.+|+++++|.++.|.+.+|.-+-. +.-..+=+-|..|+|. .+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~---~dG~V~f~~-~~s~----------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW---RDGAVTLAP-AADD----------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE---TTSCEEECC-C--------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe---cCCceeccc-cccc-----------
Confidence 47999999889999999999999999999877621 2212333456888884 677666553 2111
Q ss_pred ccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCCc
Q 011945 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245 (474)
Q Consensus 166 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p 245 (474)
.....+.+||... ...+.+.=|||||++||..+-=.+|=. ....++
T Consensus 98 --------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~-------------------------eE~eLS 143 (229)
T 2yle_A 98 --------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKEN-------------------------EERELS 143 (229)
T ss_dssp -----------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT-------------------------EEECCC
T ss_pred --------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcc-------------------------cchhhC
Confidence 1123456787753 345788999999999999886333211 124577
Q ss_pred HHHHHHHHHHhcC
Q 011945 246 TEFASYFHYCRSL 258 (474)
Q Consensus 246 ~~l~~li~~cl~~ 258 (474)
+.|.+||..|..-
T Consensus 144 ~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 144 PPLEQLIDHMANT 156 (229)
T ss_dssp HHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHhc
Confidence 8888999888755
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.0004 Score=67.98 Aligned_cols=72 Identities=21% Similarity=0.293 Sum_probs=56.2
Q ss_pred EeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCC--CCCceeEEEeEeCCEEEEEEecC
Q 011945 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG--TGIPNLRWFGVEGDYNVLVIDLL 85 (474)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~--~~i~~l~~~~~~~~~~~lv~e~~ 85 (474)
-.+.|+.|.+..+|+... .+..++||+.... ....+..|...|+.|... ..++.+..++......+++||++
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS-YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 457789999999999973 5678999986543 345688999999999743 45666777777777899999998
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00087 Score=65.26 Aligned_cols=140 Identities=17% Similarity=0.193 Sum_probs=78.9
Q ss_pred EEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCC-CceeEEE------eEeCCEEEEEE
Q 011945 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG-IPNLRWF------GVEGDYNVLVI 82 (474)
Q Consensus 10 ~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~-i~~l~~~------~~~~~~~~lv~ 82 (474)
.-++.|+.|....+|++.. ..+ .+++|+.........+..|..+++.|..... ++.+... .......+++|
T Consensus 25 ~~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EEEEEECC---EEEEEEEE-SSC-CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred eEeeccCCCcccceEEEEe-CCc-cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 3456778888899999974 333 6889988653345578889999998875432 3333211 12345668899
Q ss_pred ecCCC-CH-----HH------H---HHHcCCCC--------C---HHHHHH------------HHHHHHHHHHHHHH---
Q 011945 83 DLLGP-SL-----ED------L---FNFCSRKL--------S---LKTVLM------------LADQMINRVEFVHS--- 121 (474)
Q Consensus 83 e~~g~-sL-----~~------l---i~~~~~~l--------~---~~~~~~------------i~~qi~~gL~yLHs--- 121 (474)
+++.| .+ .. . +......+ . +...+. +...+...+.+|..
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 98833 21 11 1 11111111 1 111000 01123445556653
Q ss_pred ----CCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 122 ----KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 122 ----~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
.++||+|+.+.|||++ .+..+.|+||+.+.
T Consensus 183 ~~~~~~liHgDl~~~Nil~~---~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFL---GDELSGLIDFYFAC 216 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred ccCCcccCCCCCCccCEEEe---CCceEEEecchhcc
Confidence 3699999999999995 34445799999874
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.0022 Score=61.54 Aligned_cols=78 Identities=14% Similarity=0.079 Sum_probs=56.7
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.+.+..-++.+|.|..+.||+++. .+|+.|+||+-.... ....+..|...|+.|.....++.-..+..... +++|
T Consensus 13 ~G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~~--~lv~ 89 (288)
T 3f7w_A 13 TGREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDDR--TLAM 89 (288)
T ss_dssp HCCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEETT--EEEE
T ss_pred cCCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccCc--eEEE
Confidence 456777889999999999999985 678999999865432 23457899999999975544444433444443 6778
Q ss_pred ecC
Q 011945 83 DLL 85 (474)
Q Consensus 83 e~~ 85 (474)
|++
T Consensus 90 e~l 92 (288)
T 3f7w_A 90 EWV 92 (288)
T ss_dssp ECC
T ss_pred Eee
Confidence 877
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00044 Score=67.89 Aligned_cols=140 Identities=19% Similarity=0.156 Sum_probs=72.4
Q ss_pred eeeeeecCceE-EEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCC-CceeEEEeEeCCEEEEEEecCC-CC
Q 011945 12 GRKIGSGSFGE-IYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG-IPNLRWFGVEGDYNVLVIDLLG-PS 88 (474)
Q Consensus 12 ~~~LG~G~fG~-Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~-i~~l~~~~~~~~~~~lv~e~~g-~s 88 (474)
++.|+.|.... +|+... .++..+++|...... ...+..|+.+++.|..... ++.+..+..... +++||.++ ..
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~-~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE-GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTT-TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC-CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 34565554444 667752 236778888654321 1456788999998875432 455555433333 67888884 45
Q ss_pred HHHHHHHc-------------------C------CCCCHHHHH-------H-H------------HHHHHHHHHHH----
Q 011945 89 LEDLFNFC-------------------S------RKLSLKTVL-------M-L------------ADQMINRVEFV---- 119 (474)
Q Consensus 89 L~~li~~~-------------------~------~~l~~~~~~-------~-i------------~~qi~~gL~yL---- 119 (474)
+.+.+... . ..++..... . + ...+...+..|
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 54433210 0 012221110 0 0 00111222333
Q ss_pred --HHCCccccCCCCCcEEeeeCCC-CCeEEEEecCCccc
Q 011945 120 --HSKSFLHRDIKPDNFLMGLGRR-ANQVYIIDFGLAKR 155 (474)
Q Consensus 120 --Hs~gIiHrDIKP~NILl~~~~~-~~~vkL~DFGla~~ 155 (474)
+...+||+|+.+.|||++.+.. .+.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 1247999999999999952100 25789999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.26 E-value=0.00095 Score=68.30 Aligned_cols=71 Identities=13% Similarity=0.089 Sum_probs=50.1
Q ss_pred EeeeeeecCceEEEEEEEcC-------CCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 11 LGRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~-------~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
-++.|+.|-...||++.... .+..|++|+.........+..|..+++.|......+.+.+.+. + .++|+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 35678888889999998642 2578999987432221567789999999986666666654432 2 37888
Q ss_pred cC
Q 011945 84 LL 85 (474)
Q Consensus 84 ~~ 85 (474)
|+
T Consensus 153 ~l 154 (429)
T 1nw1_A 153 YI 154 (429)
T ss_dssp CC
T ss_pred Ee
Confidence 87
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0042 Score=60.48 Aligned_cols=73 Identities=11% Similarity=0.069 Sum_probs=47.2
Q ss_pred eeeeecCceEEEEEEEcCCCeEEEEEEeccC-CCchHHHHHHHHHHHhcCCCC-CceeEEE-----eEeCCEEEEEEecC
Q 011945 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-TKHPQLQYEAKLYKILQGGTG-IPNLRWF-----GVEGDYNVLVIDLL 85 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-~~~~~l~~E~~il~~l~~~~~-i~~l~~~-----~~~~~~~~lv~e~~ 85 (474)
..|+ |....||++.. .+|+.+++|+.... .....+..|..+++.|..... ++.+... ...+...+++|+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3456 77789998863 45668999998643 234568889999998874322 3322221 12345667899988
Q ss_pred CC
Q 011945 86 GP 87 (474)
Q Consensus 86 g~ 87 (474)
.+
T Consensus 110 ~G 111 (328)
T 1zyl_A 110 GG 111 (328)
T ss_dssp CC
T ss_pred CC
Confidence 44
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0021 Score=64.10 Aligned_cols=71 Identities=14% Similarity=0.026 Sum_probs=43.6
Q ss_pred eeeeeecCceEEEEEEEcC--------CCeEEEEEEeccCCC-chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 12 GRKIGSGSFGEIYLGTNIQ--------TNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~--------~~~~vAvK~~~~~~~-~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
++.|+.|....+|++.... .+..|++|+...... ......|..+++.|.....++.+.... . .+++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 5677888888999998542 136899998653221 113578999999997655555554332 2 26788
Q ss_pred ecCC
Q 011945 83 DLLG 86 (474)
Q Consensus 83 e~~g 86 (474)
+++.
T Consensus 114 e~i~ 117 (369)
T 3c5i_A 114 EWLY 117 (369)
T ss_dssp ECCC
T ss_pred EEec
Confidence 8883
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0034 Score=63.04 Aligned_cols=139 Identities=17% Similarity=0.173 Sum_probs=80.9
Q ss_pred eeeeeecCceEEEEEEEcC-------CCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 12 GRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~-------~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
++.|..|-...+|++.... .++.|+||+..... ....+.+|..+++.|......+.+.+++.. .+||+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 3567778888899998532 35789999853321 234577999999999877777777655433 28888
Q ss_pred cC-CCCH-----------H---HHHHHc-C------CCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 011945 84 LL-GPSL-----------E---DLFNFC-S------RKLS--LKTVLMLADQMIN-------------------RVEFVH 120 (474)
Q Consensus 84 ~~-g~sL-----------~---~li~~~-~------~~l~--~~~~~~i~~qi~~-------------------gL~yLH 120 (474)
|+ |..| . +.+... . +... +..+..+..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 87 3222 1 111111 1 1122 3455555544422 233333
Q ss_pred H--------CCccccCCCCCcEEeeeC-CCCCeEEEEecCCcc
Q 011945 121 S--------KSFLHRDIKPDNFLMGLG-RRANQVYIIDFGLAK 154 (474)
Q Consensus 121 s--------~gIiHrDIKP~NILl~~~-~~~~~vkL~DFGla~ 154 (474)
+ ..++|+|+.+.|||+..+ +..+.+.|+||..|.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2 258999999999999632 113689999999885
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.82 E-value=0.018 Score=59.34 Aligned_cols=71 Identities=15% Similarity=0.066 Sum_probs=47.7
Q ss_pred EeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC
Q 011945 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 85 (474)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (474)
-++.|+.|-...+|++.....+..|++|+...... .-....|..+++.|......+.+.+++ .. .++|+|+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEee
Confidence 35678888889999998644458899998643221 112368999999998776667766554 22 3588887
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.56 E-value=0.11 Score=50.83 Aligned_cols=63 Identities=11% Similarity=0.122 Sum_probs=39.3
Q ss_pred ecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCC--CceeEE------EeEeCCEEEEEEecC
Q 011945 17 SGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG--IPNLRW------FGVEGDYNVLVIDLL 85 (474)
Q Consensus 17 ~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~--i~~l~~------~~~~~~~~~lv~e~~ 85 (474)
.|....||++.. .+| .+++|+..... ...|..+++.|..... ++.... +...+...+++|+++
T Consensus 33 ~g~~N~vy~v~~-~~g-~~vLK~~~~~~----~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i 103 (339)
T 3i1a_A 33 ADTNAFAYQADS-ESK-SYFIKLKYGYH----DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFI 103 (339)
T ss_dssp SCSSCEEEEEEC-SSC-EEEEEEEECSS----CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECC
T ss_pred CccccceEEEEe-CCC-CEEEEEecCcc----chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEecc
Confidence 333678999974 345 89999876543 2567888887764311 233221 123456778999988
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.40 E-value=0.055 Score=55.00 Aligned_cols=71 Identities=10% Similarity=0.113 Sum_probs=48.5
Q ss_pred EeeeeeecCceEEEEEEEcCC-------CeEEEEEEeccCCC-chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 11 LGRKIGSGSFGEIYLGTNIQT-------NEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~-------~~~vAvK~~~~~~~-~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
-++.|..|-...+|++..... ++.|++|+...... .-...+|..+++.|......+.+... ... ++||
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~--~~~--~~I~ 149 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIAD--FPE--GRIE 149 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEE--ETT--EEEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEE--cCC--CEEE
Confidence 346677788889999986421 57899998644321 12357899999999866666766543 232 6788
Q ss_pred ecC
Q 011945 83 DLL 85 (474)
Q Consensus 83 e~~ 85 (474)
+|+
T Consensus 150 efI 152 (424)
T 3mes_A 150 EFI 152 (424)
T ss_dssp ECC
T ss_pred EEe
Confidence 988
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.55 E-value=0.17 Score=50.87 Aligned_cols=31 Identities=29% Similarity=0.538 Sum_probs=25.5
Q ss_pred ccccCCCCCcEEeeeC---CCCCeEEEEecCCcc
Q 011945 124 FLHRDIKPDNFLMGLG---RRANQVYIIDFGLAK 154 (474)
Q Consensus 124 IiHrDIKP~NILl~~~---~~~~~vkL~DFGla~ 154 (474)
++|+|+.+.|||+..+ ++...++|+||-.|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6799999999999531 346779999999885
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 474 | ||||
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-98 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-95 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-31 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-31 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-30 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-30 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-30 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-30 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-30 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-29 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-29 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-28 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-28 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-27 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-27 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-27 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-27 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-27 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-27 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 6e-27 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-27 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-25 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-25 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-25 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-25 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-25 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-25 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-24 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-24 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-24 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-24 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-24 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-24 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-24 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-24 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-24 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-24 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 9e-24 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-23 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-23 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-23 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-23 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-22 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-22 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-22 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-22 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-22 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-22 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-22 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-22 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-21 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-21 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-20 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-20 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-19 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-18 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-18 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-18 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-16 |
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 294 bits (753), Expect = 7e-98
Identities = 231/299 (77%), Positives = 272/299 (90%)
Query: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQ 60
ME RVGN++RLGRKIGSGSFG+IYLGT+I EEVAIKLE VKTKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
GG GIP +RW G EGDYNV+V++LLGPSLEDLFNFCSRK SLKTVL+LADQMI+R+E++H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SK+F+HRD+KPDNFLMGLG++ N VYIIDFGLAK+YRD THQHIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
S+NTHLGIEQSRRDDLESLGYVLMYF GSLPWQGLKA TK+QKYE+ISEKK+ST IE L
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 299
C+GYP+EFA+Y ++CRSLRFDDKPDY+YL++LFR+LF R+GF +DYVFDW +LK+ S+
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFGASR 299
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 286 bits (733), Expect = 7e-95
Identities = 175/291 (60%), Positives = 215/291 (73%), Gaps = 2/291 (0%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG 64
VG +++GR+IG GSFG I+ GTN+ N++VAIK E ++ PQL+ E + YK+L G TG
Sbjct: 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG 62
Query: 65 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
IPN+ +FG EG +NVLVIDLLGPSLEDL + C RK S+KTV M A QM+ RV+ +H KS
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 122
Query: 125 LHRDIKPDNFLMGLG--RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
++RDIKPDNFL+G + AN +Y++DFG+ K YRD T QHIPYRE KNL+GTARY S+
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242
NTHLG EQSRRDDLE+LG+V MYFLRGSLPWQGLKA T KQKYE+I EKK ST + LC
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242
Query: 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 293
G+P EF Y HY R+L FD PDY YL+ LF + R D FDW +L
Sbjct: 243 GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 293
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (298), Expect = 4e-31
Identities = 62/284 (21%), Positives = 119/284 (41%), Gaps = 31/284 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ----LQYEAKLYKILQGG 62
+ +G++IGSGSFG +Y G + + +VA+K+ NV PQ + E + + +
Sbjct: 8 GQITVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH- 63
Query: 63 TGIPNL-RWFGVEGDYNV-LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
N+ + G + +V G SL + K + ++ +A Q ++++
Sbjct: 64 ---VNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
H+KS +HRD+K +N + V I DFGLA + + L+G+ +
Sbjct: 121 HAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQF-----EQLSGSILW 172
Query: 180 ASMNTHLGIEQ---SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236
+ ++ S + D+ + G VL + G LP+ + + Q + +S
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQIIFMVGRGYLSPD 230
Query: 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDY----AYLKRLFRDL 276
+ + P C + D++P + A ++ L R L
Sbjct: 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 8e-31
Identities = 47/271 (17%), Positives = 100/271 (36%), Gaps = 27/271 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGT 63
+ F ++G+G+ G ++ ++ + +A K LE Q+ E ++
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SP 64
Query: 64 GIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
I + ++ + G SL+ + + ++ + + ++ +I + ++ K
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 123 -SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
+HRD+KP N L+ ++ + DFG++ + D+ + + GT Y S
Sbjct: 124 HKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMANSFV---------GTRSYMS 171
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241
G S + D+ S+G L+ G P A + + +E
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ--------VEGDA 223
Query: 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRL 272
P + S D +P A + L
Sbjct: 224 AETPPRPRTPGRPLSSYGMDSRPPMAIFELL 254
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 119 bits (300), Expect = 1e-30
Identities = 44/212 (20%), Positives = 93/212 (43%), Gaps = 13/212 (6%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLQYEAKLYKILQGGTG 64
+ + + ++G+G+FG ++ T T A K + ++ ++ E + +L+
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HPT 84
Query: 65 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
+ NL + + V++ + + G L + K+S + Q+ + +H +
Sbjct: 85 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 144
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
++H D+KP+N + +R+N++ +IDFGL + + TGTA +A+
Sbjct: 145 YVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLDPKQSVKVT--------TGTAEFAAPE 195
Query: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
G D+ S+G + L G P+ G
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 227
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (298), Expect = 1e-30
Identities = 45/229 (19%), Positives = 97/229 (42%), Gaps = 15/229 (6%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGIP 66
K+ + +G G FG ++ + + K ++ T ++ E + I + I
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR-HRNIL 64
Query: 67 NLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
+L + V++ + + G + + N + +L+ + ++ Q+ ++F+HS +
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH 185
H DI+P+N + RR++ + II+FG A++ + + + Y + H
Sbjct: 125 HFDIRPENIIYQ-TRRSSTIKIIEFGQARQLKPGDNFRLLF--------TAPEYYAPEVH 175
Query: 186 LGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
S D+ SLG ++ L G P+ T +Q E I + +
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLA---ETNQQIIENIMNAEYT 221
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 2e-30
Identities = 48/233 (20%), Positives = 88/233 (37%), Gaps = 19/233 (8%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKILQGG 62
F+ G+ +G GSF + L + T+ E AIK + K P + E + L
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-H 67
Query: 63 TGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
L + + + + L ++++ +E++H
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHG 126
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
K +HRD+KP+N L+ + I DFG AK + + GTA+Y S
Sbjct: 127 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARA-----NSFVGTAQYVS 178
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
+ DL +LG ++ + G P++ G + ++KI + +
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA---GNEYLIFQKIIKLEYD 228
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 2e-30
Identities = 55/233 (23%), Positives = 92/233 (39%), Gaps = 21/233 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKILQG 61
F +GR +G G FG +YL Q+ +A+K QL+ E ++ L+
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 64
Query: 62 GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
I L + + L+++ K + ++ N + + HS
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
K +HRDIKP+N L+G A ++ I DFG + + GT Y
Sbjct: 125 KRVIHRDIKPENLLLG---SAGELKIADFGWSVHAPSSRRTTLC---------GTLDYLP 172
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
G + DL SLG + FL G P++ T ++ Y++IS + +
Sbjct: 173 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA---NTYQETYKRISRVEFT 222
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (291), Expect = 5e-30
Identities = 41/232 (17%), Positives = 90/232 (38%), Gaps = 22/232 (9%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLQYEAKLYKILQGGTGIP 66
+ + ++G G+FG++Y N +T+ A K+ + K++ E + I
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH-PNIV 72
Query: 67 NLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
L + ++I+ G +++ + R L+ + ++ Q ++ + ++H +
Sbjct: 73 KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKII 132
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH 185
HRD+K N L + + DFG++ + T + + GT + +
Sbjct: 133 HRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRD-------SFIGTPYWMAPEVV 182
Query: 186 LGIEQSRRD-----DLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232
+ R D+ SLG L+ P L + KI++ +
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL---NPMRVLLKIAKSE 231
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 117 bits (293), Expect = 1e-29
Identities = 51/235 (21%), Positives = 92/235 (39%), Gaps = 20/235 (8%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQ 60
V + + + ++GSG+FG ++ T K + T +P ++ E + L
Sbjct: 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKF--INTPYPLDKYTVKNEISIMNQLH 84
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
+ NL + VL+++ L G L D K+S V+ Q ++ +
Sbjct: 85 -HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 143
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
H S +H DIKP+N + ++A+ V IIDFGLA + + T TA +
Sbjct: 144 HEHSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIVKVT--------TATAEF 194
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
A+ D+ ++G + L G P+ G + + +
Sbjct: 195 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG---EDDLETLQNVKRCDWE 246
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 2e-29
Identities = 59/248 (23%), Positives = 103/248 (41%), Gaps = 27/248 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQLQYEAKLYKI 58
+++++G +GSG FG +Y G + N VAIK ++ E L K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 59 LQGG-TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINR 115
+ G +G+ L + D VL+++ P DLF+F + + L + Q++
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQ-DLFDFITERGALQEELARSFFWQVLEA 122
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 175
V H+ LHRDIK +N L + ++ +IDFG +DT G
Sbjct: 123 VRHCHNCGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKDTVYTDFD---------G 171
Query: 176 TARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
T Y+ R + SLG +L + G +P++ + + + ++VS
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH---DEEIIRGQVFFRQRVS 228
Query: 235 TSIEALCR 242
+ + L R
Sbjct: 229 SECQHLIR 236
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 1e-28
Identities = 56/247 (22%), Positives = 95/247 (38%), Gaps = 19/247 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQGGT 63
+ L + +G G++GE+ L N T E VA+K ++ ++ E + K+L
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HE 63
Query: 64 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
+ EG+ L ++ + Q++ V ++H
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
HRDIKP+N L+ + + I DFGLA +R + + + GT Y +
Sbjct: 124 ITHRDIKPENLLLD---ERDNLKISDFGLATVFRYNNRERLL-----NKMCGTLPYVAPE 175
Query: 184 THLGIE-QSRRDDLESLGYVLMYFLRGSLPWQG------LKAGTKKQKYEKISEKKVSTS 236
E + D+ S G VL L G LPW + K++K KK+ ++
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSA 235
Query: 237 IEALCRG 243
AL
Sbjct: 236 PLALLHK 242
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 110 bits (277), Expect = 3e-28
Identities = 52/225 (23%), Positives = 98/225 (43%), Gaps = 25/225 (11%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKI 58
+ +++ LG +G G E++L +++ + +VA+K L + + + + EA+
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 59 LQGGTGIPNL-RWFGV------EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLAD 110
L P + + G +V++ + G +L D+ + ++ K + +
Sbjct: 64 LNH----PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIA 118
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 170
+ F H +HRD+KP N ++ N V ++DFG+A+ D+ +
Sbjct: 119 DACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVT----QT 171
Query: 171 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+ GTA+Y S G R D+ SLG VL L G P+ G
Sbjct: 172 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 216
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 3e-28
Identities = 46/235 (19%), Positives = 93/235 (39%), Gaps = 25/235 (10%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKILQG 61
N F + +G G+FG++ L T A+K + K + E+++ + +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 62 GTGIPNL-RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEF 118
P L ++ L + + +LF SR+ + + ++++ +E+
Sbjct: 65 ----PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTAR 178
+HS+ ++RDIK +N ++ + + I DFGL K GT
Sbjct: 121 LHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMK-------TFCGTPE 170
Query: 179 YASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233
Y + + R D LG V+ + G LP+ ++ +E I +++
Sbjct: 171 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELILMEEI 222
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 110 bits (276), Expect = 1e-27
Identities = 51/287 (17%), Positives = 110/287 (38%), Gaps = 23/287 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
+ ++L RK+G G + E++ NI NE+V +K+ K +++ E K+ + L+GG I
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILK-PVKKKKIKREIKILENLRGGPNII 93
Query: 67 NLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLH 126
L + + + D + L+ + +++ +++ HS +H
Sbjct: 94 TLADIVKDPVSRTPALVFEHVNNTDFKQLY-QTLTDYDIRFYMYEILKALDYCHSMGIMH 152
Query: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHL 186
RD+KP N + + ++ +ID+GLA+ Y + + + +
Sbjct: 153 RDVKPHNVM--IDHEHRKLRLIDWGLAEFYHPGQEYNVR--------VASRYFKGPELLV 202
Query: 187 GIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYP 245
+ D+ SLG +L + P+ + +I++ + + Y
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEPFFH--GHDNYDQLVRIAKVLGTEDLYDYIDKYN 260
Query: 246 TEFASYFH-------YCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 285
E F+ R RF + + D + + ++D
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF-LDKLLRYD 306
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 1e-27
Identities = 41/211 (19%), Positives = 82/211 (38%), Gaps = 17/211 (8%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL-- 68
+ +G G G++ N +T E+ A+K + P+ + E +L+ I +
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALK---MLQDCPKARREVELHWRASQCPHIVRIVD 72
Query: 69 --RWFGVEGDYNVLVIDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
++V++ L G L + + + + + + + ++++HS +
Sbjct: 73 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINI 132
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
HRD+KP+N L R + + DFG AK + Y T Y +
Sbjct: 133 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--------TPYYVAPEV 184
Query: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+ + D+ SLG ++ L G P+
Sbjct: 185 LGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 215
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 3e-27
Identities = 66/293 (22%), Positives = 107/293 (36%), Gaps = 24/293 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHP-QLQYEAKLYKILQG- 61
+K+ KIG G+FGE++ + +T ++VA+K +EN K P E K+ ++L+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 62 ------GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
+ LV D L L + K +L + + ++N
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 175
+ ++H LHRD+K N L+ R + + DFGLA+ + Q Y N
Sbjct: 130 LYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRY---TNRVV 183
Query: 176 TARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
T Y LG DL G ++ S QG T++ + IS+ S
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG---NTEQHQLALISQLCGS 240
Query: 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR--LFRDLFIREGFQFD 285
+ E E + + K R DL I + D
Sbjct: 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDL-IDKLLVLD 292
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 108 bits (272), Expect = 4e-27
Identities = 48/248 (19%), Positives = 88/248 (35%), Gaps = 28/248 (11%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKILQGG 62
F R+IG GSFG +Y +++ +E VAIK + K + E + + L+
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH- 74
Query: 63 TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
R + LV++ S DL + L + + + + ++HS
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
+ +HRD+K N L+ V + DFG A + GT + +
Sbjct: 135 NMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPANSF-----------VGTPYWMAP 180
Query: 183 NTHLGIEQSRRD---DLESLGYVLMYFLRGSLPWQGLKAGT-----KKQKYEKISEKKVS 234
L +++ + D D+ SLG + P + A + + + + S
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240
Query: 235 TSIEALCR 242
Sbjct: 241 EYFRNFVD 248
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 107 bits (269), Expect = 4e-27
Identities = 42/238 (17%), Positives = 80/238 (33%), Gaps = 21/238 (8%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----------LENVKTKHPQLQYEAKLY 56
+ +G G + + T +E A+K E V+ E +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 57 KILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
+ + G I L+ + LV DL+ L D LS K + ++
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRALLEV 122
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 175
+ +H + +HRD+KP+N L+ + + DFG + + + + +
Sbjct: 123 ICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179
Query: 176 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233
+ + H G + D+ S G ++ L GS P+ + I
Sbjct: 180 IIECSMNDNHPGY--GKEVDMWSTGVIMYTLLAGSPPFWH---RKQMLMLRMIMSGNY 232
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 4e-27
Identities = 53/245 (21%), Positives = 96/245 (39%), Gaps = 22/245 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTG 64
K+ KIG G+ G +Y ++ T +EVAI+ N++ K + E + + +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPN 78
Query: 65 IPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
I N + GD +V++ L G SL D+ + + + + + +EF+HS
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
+HRDIK DN L+ V + DFG + + + + GT + +
Sbjct: 137 VIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRS-------TMVGTPYWMAPE 186
Query: 184 THLGIEQSRRDDLESLGYVLMYFLRGSLPWQG------LKAGTKKQKYEKISEKKVSTSI 237
+ D+ SLG + + + G P+ L E + +K+S
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 238 EALCR 242
Sbjct: 247 RDFLN 251
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 108 bits (270), Expect = 5e-27
Identities = 50/235 (21%), Positives = 100/235 (42%), Gaps = 19/235 (8%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQG 61
+ + + +G+G+F E+ L + +T + VAIK + ++ K ++ E + ++
Sbjct: 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK- 65
Query: 62 GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRK--LSLKTVLMLADQMINRVEFV 119
I L G + L++ L+ S +LF+ K + + L Q+++ V+++
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLV--SGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL 123
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
H +HRD+KP+N L +++ I DFGL+K + GT Y
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--------CGTPGY 175
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
+ S+ D S+G + L G P+ + +E+I + +
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD---ENDAKLFEQILKAEYE 227
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 6e-27
Identities = 58/277 (20%), Positives = 113/277 (40%), Gaps = 27/277 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGI 65
+L ++G+G FGE+++G + +VA+K L+ EA L K LQ
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH---- 67
Query: 66 PNL-RWFGVEGDYNV-LVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
L R + V + ++ + + G ++ L KL++ +L +A Q+ + F+
Sbjct: 68 QRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
++++HRD++ N L+ I DFGLA+ D + ++ +
Sbjct: 128 RNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAR------EGAKFPIKWTA 178
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240
+ + D+ S G +L + G +P+ G+ T + + + +
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQNLERGYRMVRPD-- 233
Query: 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
P E C R +D+P + YL+ + D F
Sbjct: 234 --NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 8e-27
Identities = 53/214 (24%), Positives = 86/214 (40%), Gaps = 15/214 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQGGTG 64
F L + +G GSFG+++L +TN+ AIK ++V ++ ++L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 65 IPNL-RWFGVEGDYNVLVIDLLGPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHS 121
P L F L + + DL K L A ++I ++F+HS
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
K ++RD+K DN L+ + + I DFG+ K + GT Y +
Sbjct: 122 KGIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDAKTN-------TFCGTPDYIA 171
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
LG + + D S G +L L G P+ G
Sbjct: 172 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 205
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 2e-25
Identities = 56/277 (20%), Positives = 92/277 (33%), Gaps = 23/277 (8%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTN---EEVAIK-----LENVKTKHPQLQYEAKLYKILQ 60
RL K+G GSFG + G + VA+K + + E L
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
+ L + ++ SL D L T+ A Q+ + ++
Sbjct: 70 H-RNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SK F+HRD+ N L+ + V I DFGL + H Y ++ +
Sbjct: 129 SKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDH----YVMQEHRKVPFAWC 181
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
+ + S D G L G PW GL Q KI ++
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQILHKIDKEGERLPRPE 238
Query: 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276
C P + + C + + +D+P + L+ +
Sbjct: 239 DC---PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 104 bits (261), Expect = 2e-25
Identities = 54/235 (22%), Positives = 86/235 (36%), Gaps = 20/235 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-----LENVKTKHPQLQYEAKLYKILQG 61
N F + R IG G FGE+Y T + A+K +K E + ++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 62 GT--GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
G I + + D ++DL+ S + A ++I +E +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
H++ ++RD+KP N L+ V I D GLA + H + GT Y
Sbjct: 124 HNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGY 171
Query: 180 ASMNTHL-GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233
+ G+ D SLG +L LRG P++ K K + V
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 226
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 103 bits (258), Expect = 3e-25
Identities = 48/233 (20%), Positives = 94/233 (40%), Gaps = 22/233 (9%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQY---EAKLYKILQG 61
F++ R +G+GSFG ++L + A+K+ + + + Q+++ E + I+
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT- 62
Query: 62 GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
I + + +++D + S++ A ++ +E++HS
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
K ++RD+KP+N L+ + + I DFG AK D L GT Y +
Sbjct: 123 KDIIYRDLKPENILLD---KNGHIKITDFGFAKYVPDVTY----------TLCGTPDYIA 169
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
++ D S G ++ L G P+ + YEKI ++
Sbjct: 170 PEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD---SNTMKTYEKILNAELR 219
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (254), Expect = 4e-25
Identities = 48/245 (19%), Positives = 96/245 (39%), Gaps = 23/245 (9%)
Query: 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQG 61
G + +IG GSF +Y G + +T EVA + K++ + + EA++ K LQ
Sbjct: 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH 67
Query: 62 GTGIPNLRWF---GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF 118
+ + VLV +L+ + + + +K + Q++ ++F
Sbjct: 68 PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 127
Query: 119 VHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGT 176
+H+++ +HRD+K DN + V I D GLA R + K + GT
Sbjct: 128 LHTRTPPIIHRDLKCDNIF--ITGPTGSVKIGDLGLATLKRASFA---------KAVIGT 176
Query: 177 ARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236
+ + + + D+ + G ++ P+ Q Y +++ S
Sbjct: 177 PEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE--CQNAAQIYRRVTSGVKPAS 233
Query: 237 IEALC 241
+ +
Sbjct: 234 FDKVA 238
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 4e-25
Identities = 57/274 (20%), Positives = 107/274 (39%), Gaps = 21/274 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGI 65
RL K+G G FGE+++GT T VAIK L+ EA++ K L+ +
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKL 74
Query: 66 PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKL-SLKTVLMLADQMINRVEFVHSKSF 124
L E ++ + SL D + K L ++ +A Q+ + + +V ++
Sbjct: 75 VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 134
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
+HRD++ N L+G + DFGLA+ D + ++ +
Sbjct: 135 VHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTAR------QGAKFPIKWTAPEA 185
Query: 185 HLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243
L + + D+ S G +L +G +P+ G+ ++ +++
Sbjct: 186 ALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVERGYRMPCPP----E 238
Query: 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
P C +++P + YL+ D F
Sbjct: 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 5e-25
Identities = 57/294 (19%), Positives = 100/294 (34%), Gaps = 30/294 (10%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK---LENVKTKHPQLQYEAKLYKILQG 61
VG ++ IG G++G + + VAIK +T + E K+ +
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65
Query: 62 GTGIPNL-RWFGV-------EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
N+ + + LV L+G L L ++ LS + Q++
Sbjct: 66 ----ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK--TQHLSNDHICYFLYQIL 119
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 173
++++HS + LHRD+KP N L+ + I DFGLA+ H
Sbjct: 120 RGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARVADPDHDHTGFLTE----Y 172
Query: 174 TGTARYASMN-THLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232
T Y + ++ D+ S+G +L L + G + I
Sbjct: 173 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG---KHYLDQLNHILGIL 229
Query: 233 VSTSIEALCRGYPTEFASY-FHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 285
S S E L + +Y + + DL + + F+
Sbjct: 230 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDL-LDKMLTFN 282
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 1e-24
Identities = 48/240 (20%), Positives = 88/240 (36%), Gaps = 27/240 (11%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQGGT 63
+ + IG+GS+G + + K + + L E L + L+
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 64 GIPNLRWFGVEGDYNV-LVIDLL-GPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEF 118
+ + + +V++ G L + +++ L + VL + Q+ ++
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 119 VHSKS-----FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 173
H +S LHRD+KP N + V + DFGLA+ + K
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFA-------KAF 174
Query: 174 TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233
GT Y S + + + D+ SLG +L P+ ++K+ KI E K
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGKIREGKF 231
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 1e-24
Identities = 54/275 (19%), Positives = 108/275 (39%), Gaps = 27/275 (9%)
Query: 13 RKIGSGSFGEIYLGTNIQTNE--EVAIK---LENVKTKHPQLQYEAKLYKILQGGTGIPN 67
++G G+FG + G + +VAIK K ++ EA++ L P
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN----PY 70
Query: 68 L-RWFGV-EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
+ R GV + + +LV+++ G L ++ + V L Q+ ++++ K+F
Sbjct: 71 IVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 130
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
+HRD+ N L+ + I DFGL+K ++ ++ +
Sbjct: 131 VHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTA----RSAGKWPLKWYAPEC 183
Query: 185 HLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243
+ S R D+ S G + L G P++ + + I + K
Sbjct: 184 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM---KGPEVMAFIEQGK----RMECPPE 236
Query: 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278
P E + C +++D+PD+ +++ R +
Sbjct: 237 CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 2e-24
Identities = 61/290 (21%), Positives = 102/290 (35%), Gaps = 34/290 (11%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNL 68
+ + IG+GSFG +Y + E VAIK V E ++ + L I L
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKRFKNRELQIMRKLD-HCNIVRL 78
Query: 69 RWFGVEGD------YNVLVIDLLGPSLEDLFNFCSRK---LSLKTVLMLADQMINRVEFV 119
R+F Y LV+D + ++ + SR L + V + Q+ + ++
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT----ATHQHIPYRENKNLTG 175
HS HRDIKP N L + + DFG AK+ + YR + + G
Sbjct: 139 HSFGICHRDIKPQNL--LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG 196
Query: 176 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235
Y + D+ S G VL L G + G + + +I + +
Sbjct: 197 ATDY-----------TSSIDVWSAGCVLAELLLGQPIFPG---DSGVDQLVEIIKVLGTP 242
Query: 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 285
+ E + P F ++ + K L ++
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPW-TKVFRPRTPPEAIAL-CSRLLEYT 290
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 2e-24
Identities = 54/295 (18%), Positives = 107/295 (36%), Gaps = 31/295 (10%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVKTKHP----QLQYEAKLYKI 58
R ++ +IG G++G+++ +++ VA+K V+T E + +
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 59 LQGGTGIPNLRWFGV--------EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLAD 110
L+ +R F V E ++ + L + +T+ +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 111 QMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYREN 170
Q++ ++F+HS +HRD+KP N L+ + Q+ + DFGLA+ Y +
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIYSFQMALTSV----- 175
Query: 171 KNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230
T Y + L + DL S+G + R ++G + + KI +
Sbjct: 176 ---VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG---SSDVDQLGKILD 229
Query: 231 KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 285
E R ++ D + L +DL + + F+
Sbjct: 230 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD---IDELGKDL-LLKCLTFN 280
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 100 bits (249), Expect = 2e-24
Identities = 54/218 (24%), Positives = 88/218 (40%), Gaps = 25/218 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQGG 62
K+ KIG G++G +Y N E A+K ++ + E + K L+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH- 59
Query: 63 TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
+ I L VLV + L L+ L + C L T Q++N + + H +
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH-----QHIPYRENKNLTGTA 177
LHRD+KP N L+ R ++ I DFGLA+ + + YR L G+
Sbjct: 120 RVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 178 RYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
+Y S D+ S+G + + G+ + G
Sbjct: 177 KY-----------STTIDIWSVGCIFAEMVNGTPLFPG 203
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.6 bits (245), Expect = 5e-24
Identities = 41/229 (17%), Positives = 88/229 (38%), Gaps = 17/229 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGI 65
+++G+G FG + G + +VAIK ++ + EAK+ L +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKL 61
Query: 66 PNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
L + ++ + + L + + + +L + + +E++ SK F
Sbjct: 62 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 121
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
LHRD+ N L+ V + DFGL++ D + R++
Sbjct: 122 LHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSV------GSKFPVRWSPPEV 172
Query: 185 HLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKK 232
+ + S + D+ + G ++ G +P++ T + E I++
Sbjct: 173 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF---TNSETAEHIAQGL 218
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.6 bits (247), Expect = 5e-24
Identities = 58/283 (20%), Positives = 97/283 (34%), Gaps = 20/283 (7%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQGGT 63
F+ KIG G++G +Y N T E VA+K + E L K L
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HP 61
Query: 64 GIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSK 122
I L + LV + L L+ + + L + Q++ + F HS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
LHRD+KP N L+ + + DFGLA+ + + A
Sbjct: 122 RVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPE 172
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242
S D+ SLG + + + G ++ + +I + + T E +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRI-FRTLGTPDEVVWP 228
Query: 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 285
G + + + R D L R L + + +D
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSL-LSQMLHYD 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.7 bits (245), Expect = 6e-24
Identities = 52/277 (18%), Positives = 96/277 (34%), Gaps = 24/277 (8%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIK---LENVKTKHPQLQYEAKLYKILQ 60
+ LGR IG G FG+++ G + VAIK + + EA +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
I L E +++ L L L ++++ A Q+ + ++
Sbjct: 67 H-PHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
SK F+HRDI N L+ + V + DFGL++ D+ ++ ++
Sbjct: 126 SKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKA------SKGKLPIKWM 176
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
+ + + D+ G + L G P+QG+ +I +
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV---KNNDVIGRIENGE----RLP 229
Query: 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276
+ P S C + +P + LK +
Sbjct: 230 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 99.0 bits (246), Expect = 7e-24
Identities = 56/275 (20%), Positives = 113/275 (41%), Gaps = 21/275 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGI 65
+ K+G G +GE+Y G + + VA+K L+ + + EA + K ++ +
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNL 75
Query: 66 PNLRWFGVEGDYNVLVIDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
L ++ + + G L+ L +++S +L +A Q+ + +E++ K+
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 135
Query: 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMN 183
F+HRD+ N L+G + V + DFGL++ H + ++ +
Sbjct: 136 FIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAK------FPIKWTAPE 186
Query: 184 THLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242
+ + S + D+ + G +L G P+ G+ Q YE + + E
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQVYELLEKDYRMERPE---- 239
Query: 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277
G P + C D+P +A + + F +F
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.3 bits (244), Expect = 9e-24
Identities = 54/281 (19%), Positives = 120/281 (42%), Gaps = 30/281 (10%)
Query: 13 RKIGSGSFGEIYLGT--NIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQGGTGIP 66
+++GSG+FG + G + + VA+K+ + P +L EA + + L P
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN----P 68
Query: 67 NL-RWFGV-EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
+ R G+ E + +LV+++ + + +R + K ++ L Q+ ++++ +F
Sbjct: 69 YIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
+HRD+ N L+ + I DFGL+K R + Y+ + ++ +
Sbjct: 129 VHRDLAARNVLLV---TQHYAKISDFGLSKALRADENY----YKAQTHGKWPVKWYAPEC 181
Query: 185 HLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243
+ S + D+ S G ++ G P++G+ + + + + G
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEVTAMLEKGERMGCPA----G 234
Query: 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF---IREG 281
P E + C + +++P +A ++ R+ + + EG
Sbjct: 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 275
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.7 bits (245), Expect = 9e-24
Identities = 48/243 (19%), Positives = 89/243 (36%), Gaps = 21/243 (8%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--------ENVKTKHPQLQYEAKLY 56
V + + G ++GSG F + T + A K ++ E +
Sbjct: 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSIL 67
Query: 57 KILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
K +Q + L +L+++L+ F L+ + Q++N V
Sbjct: 68 KEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 117 EFVHSKSFLHRDIKPDNFLM-GLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 175
++HS H D+KP+N ++ ++ IIDFGLA + ++I G
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI--------FG 178
Query: 176 TARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVST 235
T + + D+ S+G + L G+ P+ G TK++ +S
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYEF 235
Query: 236 SIE 238
E
Sbjct: 236 EDE 238
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 99.1 bits (246), Expect = 2e-23
Identities = 44/213 (20%), Positives = 90/213 (42%), Gaps = 17/213 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL--ENVKTKHPQLQYEAKLYKILQGGTG 64
++F + +G+GSFG + L + ++ A+K+ + K Q+++ +ILQ
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 65 IPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSK 122
++ D + L + + + ++F+ R + S A Q++ E++HS
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
++RD+KP+N L+ + + + DFG AKR + GT +
Sbjct: 161 DLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGRTWTLC----------GTPEALAP 207
Query: 183 NTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
L ++ D +LG ++ G P+
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 98.0 bits (243), Expect = 2e-23
Identities = 57/307 (18%), Positives = 100/307 (32%), Gaps = 51/307 (16%)
Query: 3 PRVGNKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIK---LENVKTKHPQLQYEAK 54
PR N R IG G+FG ++ + VA+K E Q EA
Sbjct: 11 PR--NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 68
Query: 55 LYKILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDL--------------------- 92
L + L G L+ + + L +
Sbjct: 69 LMAEFDNPNIVKLL-GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 127
Query: 93 --FNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDF 150
+ LS L +A Q+ + ++ + F+HRD+ N L+G V I DF
Sbjct: 128 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADF 184
Query: 151 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RG 209
GL++ Y+ + N R+ + + D+ + G VL G
Sbjct: 185 GLSRNIYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 210 SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYL 269
P+ G+ ++ + + + E P E + C S D+P + +
Sbjct: 240 LQPYYGM---AHEEVIYYVRDGNILACPE----NCPLELYNLMRLCWSKLPADRPSFCSI 292
Query: 270 KRLFRDL 276
R+ + +
Sbjct: 293 HRILQRM 299
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.3 bits (244), Expect = 2e-23
Identities = 50/267 (18%), Positives = 91/267 (34%), Gaps = 43/267 (16%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKL---ENVKTKHPQLQYEAKLYKI 58
G+ +GSG+FG++ T ++ +VA+K+ + ++ L E K+
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 59 LQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRK------------------ 99
L I NL L+ + L + K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 100 ----LSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155
L+ + +L A Q+ +EF+ KS +HRD+ N L+ V I DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLARD 213
Query: 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQ 214
+ Y N ++ + + + + D+ S G +L G P+
Sbjct: 214 IMSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268
Query: 215 GLKAGTKKQKYEKISEKKVSTSIEALC 241
G+ + K+ +
Sbjct: 269 GI---PVDANFYKLIQNGFKMDQPFYA 292
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.6 bits (242), Expect = 4e-23
Identities = 44/227 (19%), Positives = 84/227 (37%), Gaps = 17/227 (7%)
Query: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-------LENVKTKHPQLQYEAKLYKILQG 61
F+ + +GSG+FG +Y G I E+V I + ++ EA + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD- 69
Query: 62 GTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
+ L + ++ + L D + + +L Q+ + ++
Sbjct: 70 NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYAS 181
+ +HRD+ N L+ V I DFGLAK H + ++ +
Sbjct: 130 RRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHA-----EGGKVPIKWMA 181
Query: 182 MNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEK 227
+ + L + + D+ S G + + GS P+ G+ A EK
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 228
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.7 bits (242), Expect = 5e-23
Identities = 59/292 (20%), Positives = 113/292 (38%), Gaps = 30/292 (10%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKILQ 60
V +++ +GSG++G + + +T VA+K + + + E +L K ++
Sbjct: 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 61 GGTGIPNLRWF-----GVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINR 115
I L F E + LV L+G L ++ +KL+ V L Q++
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRG 133
Query: 116 VEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTG 175
++++HS +HRD+KP N + ++ I+DFGLA+ D T
Sbjct: 134 LKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGYVA---------- 180
Query: 176 TARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234
T Y + L ++ D+ S+G ++ L G + G + + I +
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG---TDHIDQLKLILRLVGT 237
Query: 235 TSIEALCRGYPTEFASYFHYCRSL-RFDDKPDYAYLKRLFRDLFIREGFQFD 285
E L + +Y + + + + L DL + + D
Sbjct: 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL-LEKMLVLD 288
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.8 bits (238), Expect = 5e-23
Identities = 54/277 (19%), Positives = 98/277 (35%), Gaps = 33/277 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIP 66
+ +L + IG G FG++ LG +VA+K EA + L+
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH----S 60
Query: 67 NL-RWFGV---EGDYNVLVIDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVH 120
NL + GV E +V + + SL D L + L +L + + +E++
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYA 180
+F+HRD+ N L+ N + DFGL K T ++
Sbjct: 121 GNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGK----------LPVKWT 167
Query: 181 SMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239
+ + S + D+ S G +L G +P+ + K ++ + + +
Sbjct: 168 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEKGYKMDAPD- 223
Query: 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276
G P C L +P + L+ +
Sbjct: 224 ---GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 97.0 bits (240), Expect = 1e-22
Identities = 53/288 (18%), Positives = 106/288 (36%), Gaps = 31/288 (10%)
Query: 2 EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQ 60
EP ++ L RK+G G F ++L ++ N VA+K + K + E KL + +
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67
Query: 61 ----------GGTGIPNLRWFGVEGDYNVLVIDLLG-----PSLEDLFNFCSRKLSLKTV 105
G I L N + + ++ L + + R + L V
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 106 LMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164
++ Q++ ++++H + +H DIKP+N L + + +I +A +H
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVL--MEIVDSPENLIQIKIADLGNACWYDEH 185
Query: 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQK 224
T Y S LG D+ S ++ + G ++ + + +
Sbjct: 186 YTNS-----IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240
Query: 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRL 272
+ I++ I L P+ Y R+ F+ + + +L
Sbjct: 241 DDHIAQ------IIELLGELPSYLLRNGKYTRTF-FNSRGLLRNISKL 281
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 95.2 bits (236), Expect = 2e-22
Identities = 36/234 (15%), Positives = 86/234 (36%), Gaps = 17/234 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE---VAIK---LENVKTKHPQLQYEAKLYKILQ 60
+ ++ + IG+G FGE+ G + VAIK + + EA +
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85
Query: 61 GGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
+ +L + +++ + + SL+ + ++ ++ + + ++++
Sbjct: 86 H-PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
+++HRD+ N L+ + DFGL++ D + Y R+
Sbjct: 145 ADMNYVHRDLAARNILVN---SNLVCKVSDFGLSRFLEDDTSDPT--YTSALGGKIPIRW 199
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKK 232
+ + + D+ S G V+ + G P+ + T + I +
Sbjct: 200 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---TNQDVINAIEQDY 250
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.4 bits (234), Expect = 2e-22
Identities = 51/273 (18%), Positives = 102/273 (37%), Gaps = 21/273 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQLQYEAKLYKILQGGTGI 65
++ ++IGSG FG ++LG + ++VAIK + EA++ L +
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKL 62
Query: 66 PNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
L +E LV + + L D + +T+L + + + ++
Sbjct: 63 VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 122
Query: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNT 184
+HRD+ N L+ + + DFG+ + D + ++AS
Sbjct: 123 IHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTK------FPVKWASPEV 173
Query: 185 HLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243
S + D+ S G ++ G +P++ + + E IS R
Sbjct: 174 FSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDISTGFR----LYKPRL 226
Query: 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276
T ++C R +D+P ++ L R ++
Sbjct: 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.8 bits (237), Expect = 2e-22
Identities = 52/253 (20%), Positives = 103/253 (40%), Gaps = 28/253 (11%)
Query: 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLQYEAKLYKIL 59
V +++ + IGSG+ G + + + VAIK + ++ + E L K +
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV 73
Query: 60 QGGTGIPNLRWFGV------EGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
I +L E LV++L+ +L + +L + + L QM+
Sbjct: 74 N-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQML 129
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 173
++ +HS +HRD+KP N ++ + + I+DFGLA+ +
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPY-------- 178
Query: 174 TGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233
T Y + LG+ D+ S+G ++ +R + + G ++ K+ E+
Sbjct: 179 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG---RDYIDQWNKVIEQLG 235
Query: 234 STSIEALCRGYPT 246
+ E + + PT
Sbjct: 236 TPCPEFMKKLQPT 248
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.2 bits (233), Expect = 4e-22
Identities = 62/283 (21%), Positives = 97/283 (34%), Gaps = 29/283 (10%)
Query: 13 RKIGSGSFGEIYLGTNIQTNEEVAIK-------LENVKTKHPQLQYEAKLYKILQGGTGI 65
+G G F +Y + TN+ VAIK E + E KL + L I
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNI 62
Query: 66 PNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125
L LV D + LE + S L+ + + +E++H L
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 122
Query: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTH 185
HRD+KP+N L+ + + DFGLAK + P R + T Y +
Sbjct: 123 HRDLKPNNLLL---DENGVLKLADFGLAKSFGS-------PNRAYTHQVVTRWYRAPELL 172
Query: 186 LGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244
G D+ ++G +L L G + + +I E + + E
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPG---DSDLDQLTRIFETLGTPTEEQW---- 225
Query: 245 PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL--FIREGFQFD 285
+ S Y F P + DL I+ F F+
Sbjct: 226 -PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFN 267
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.9 bits (232), Expect = 4e-22
Identities = 53/212 (25%), Positives = 87/212 (41%), Gaps = 16/212 (7%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQGG 62
K+ KIG G++G ++ N +T+E VA+K ++ + E L K L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-H 60
Query: 63 TGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
I L LV + L+ F+ C+ L + V Q++ + F HS+
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASM 182
+ LHRD+KP N L+ R ++ + +FGLA+ + IP R T Y
Sbjct: 121 NVLHRDLKPQNLLIN---RNGELKLANFGLARAF-------GIPVRCYSAEVVTLWYRPP 170
Query: 183 NTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPW 213
+ G + S D+ S G + P
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.7 bits (232), Expect = 7e-22
Identities = 51/246 (20%), Positives = 87/246 (35%), Gaps = 36/246 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE--EVAIK---LENVKTKHPQLQYEAKLYKILQG 61
N + IG G+FG++ + + AIK K H E ++ L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 62 GTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDL---------------FNFCSRKLSLKTV 105
I NL Y L I+ +L D N + LS + +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 165
L A + ++++ K F+HRD+ N L+G I DFGL++
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQK 224
R+ ++ + + D+ S G +L + G P+ G+ T +
Sbjct: 187 --------RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAEL 235
Query: 225 YEKISE 230
YEK+ +
Sbjct: 236 YEKLPQ 241
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.1 bits (233), Expect = 8e-22
Identities = 55/293 (18%), Positives = 110/293 (37%), Gaps = 32/293 (10%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----ENVKTKHPQLQYEAKLYKILQ 60
V +R + +GSG++G + + +T +VAIK + + E +L K ++
Sbjct: 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 75
Query: 61 GGTGIPNLRWFGVEGDYN------VLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMIN 114
+ L + LV+ +G L L KL + L QM+
Sbjct: 76 -HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK--HEKLGEDRIQFLVYQMLK 132
Query: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ--HIPYRENKN 172
+ ++H+ +HRD+KP N + ++ I+DFGLA++ T YR +
Sbjct: 133 GLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQADSEMTGYVVTRWYRAPEV 189
Query: 173 LTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232
+ RY ++ D+ S+G ++ + G ++G + ++ K++
Sbjct: 190 ILNWMRY-----------TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 238
Query: 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFD 285
+ ++ L + F A L +L + + D
Sbjct: 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNA--SPLAVNL-LEKMLVLD 288
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.6 bits (229), Expect = 1e-21
Identities = 43/233 (18%), Positives = 80/233 (34%), Gaps = 34/233 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKL---ENVKTKHPQLQYEAKLYKI 58
N+ G+ +G+G+FG++ T VA+K+ T+ L E K+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 59 LQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDL-----------------FNFCSRKL 100
L I NL G +++ + L + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 101 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
L+ +L + Q+ + F+ SK+ +HRD+ N L+ I DFGLA+ ++ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDS 199
Query: 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
+ N ++ + + + D+ S G L
Sbjct: 200 NYVV-----KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.2 bits (228), Expect = 3e-21
Identities = 43/224 (19%), Positives = 91/224 (40%), Gaps = 21/224 (9%)
Query: 4 RVG-NKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIK------LENVKTKHPQLQYEA 53
+VG F L + +G+G++G+++L I T + A+K + + E
Sbjct: 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 79
Query: 54 KLYKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
++ + ++ + L + L++D + + + V + +++
Sbjct: 80 QVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIV 139
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNL 173
+E +H ++RDIK +N L+ V + DFGL+K + T + +
Sbjct: 140 LALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFC----- 191
Query: 174 TGTARYASMNTHLGIEQ--SRRDDLESLGYVLMYFLRGSLPWQG 215
GT Y + + G + + D SLG ++ L G+ P+
Sbjct: 192 -GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 234
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.6 bits (216), Expect = 6e-20
Identities = 33/233 (14%), Positives = 80/233 (34%), Gaps = 16/233 (6%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE----VAIK---LENVKTKHPQLQYEAKLYKIL 59
+ + IG+G FGE+Y G ++ + VAIK + + EA +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 60 QGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
I ++ + +L+ + S+ ++ + + ++++
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
+ +++HRD+ N L+ + DFGL++ D + R+
Sbjct: 127 ANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDPEATYT----TSGGKIPIRW 179
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232
+ + + D+ S G V+ + + + + I++
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW--ELSNHEVMKAINDGF 230
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.6 bits (216), Expect = 6e-20
Identities = 47/253 (18%), Positives = 99/253 (39%), Gaps = 38/253 (15%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE-------VAIK---LENVKTKHPQLQYEAKLY 56
++ LG+ +G G+FG++ L I +++ VA+K + + L E ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 57 KILQGGTGIPNLRWFGVEGDYNVLVIDLL-GPSLEDLFNFC---------------SRKL 100
K++ I NL + ++++ +L + +L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 101 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160
S K ++ A Q+ +E++ SK +HRD+ N L+ N + I DFGLA+
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHID 189
Query: 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAG 219
++ N ++ + + + D+ S G +L G P+ G+
Sbjct: 190 YYKK-----TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV--- 241
Query: 220 TKKQKYEKISEKK 232
++ ++ + E
Sbjct: 242 PVEELFKLLKEGH 254
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.5 bits (208), Expect = 9e-19
Identities = 48/245 (19%), Positives = 89/245 (36%), Gaps = 29/245 (11%)
Query: 7 NKFRLGRKIGSGSFGEIYLGTN-----IQTNEEVAIK---LENVKTKHPQLQYEAKLYKI 58
K + R++G GSFG +Y G + VAIK + + EA + K
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 59 LQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSR---------KLSLKTVLMLA 109
+ L V++ + L+ SL ++ +A
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRE 169
++ + + ++++ F+HRD+ N ++ V I DFG+ + +T YR+
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDY-----YRK 191
Query: 170 NKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGLKAGTKKQKYEKI 228
R+ S + + D+ S G VL P+QGL + +Q +
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVLRFV 248
Query: 229 SEKKV 233
E +
Sbjct: 249 MEGGL 253
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 80.6 bits (198), Expect = 3e-18
Identities = 23/161 (14%), Positives = 55/161 (34%), Gaps = 31/161 (19%)
Query: 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT------------KHPQLQYEAKL--- 55
+G+ +G G ++ + + E +K V A
Sbjct: 4 IGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 56 --YKILQGGTGIPNLRWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMI 113
++ LQ G+ + + EG+ ++ E + ++ ++ + D ++
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEGNAVLM---------ELIDAKELYRVRVENPDEVLDMIL 113
Query: 114 NRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
V + + +H D+ N L+ ++IIDF +
Sbjct: 114 EEVAKFYHRGIVHGDLSQYNVLVS----EEGIWIIDFPQSV 150
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.9 bits (204), Expect = 3e-18
Identities = 42/218 (19%), Positives = 86/218 (39%), Gaps = 16/218 (7%)
Query: 8 KFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTKHPQLQY---EAKLYKILQG 61
IG G FG +Y GT + + A+K N T ++ E + K
Sbjct: 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 62 GTGIPNLRWFGVEGDYNVLVI--DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
+ +L + + + LV+ + L + + ++K ++ Q+ ++F+
Sbjct: 88 -PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 146
Query: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARY 179
SK F+HRD+ N ++ V + DFGLA+ D ++
Sbjct: 147 ASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEFDSV---HNKTGAKLPVKW 200
Query: 180 ASMNTHLGIEQSRRDDLESLGYVLMYFL-RGSLPWQGL 216
++ + + + + D+ S G +L + RG+ P+ +
Sbjct: 201 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.6 bits (203), Expect = 4e-18
Identities = 41/232 (17%), Positives = 83/232 (35%), Gaps = 33/232 (14%)
Query: 7 NKFRLGRKIGSGSFGEIYLGT-----NIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQG 61
++ +LG+ +G G+FG++ T VA+K+ H + + KIL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 62 GTGIPNLR----WFGVEGDYNVLVIDLL-GPSLEDL---------------FNFCSRKLS 101
N+ G +++++ +L + L+
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 102 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161
L+ ++ + Q+ +EF+ S+ +HRD+ N L+ N V I DFGLA+
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD 189
Query: 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
+ + ++ + T + + D+ S G +L
Sbjct: 190 YVR-----KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 236
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.0 bits (191), Expect = 1e-16
Identities = 58/274 (21%), Positives = 96/274 (35%), Gaps = 28/274 (10%)
Query: 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG-T 63
+ L IG G FGE++ G EEVA+K+ + + EA++Y+ +
Sbjct: 1 IARTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFS-SREERSWFREAEIYQTVMLRHE 57
Query: 64 GIPNLRWFGVEGDYNVLVIDLLGPSLE--DLFNFCSR---------KLSLKTVLMLADQM 112
I + + + L+ E LF++ +R KL+L T LA
Sbjct: 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 117
Query: 113 INRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKN 172
+ V + HRD+K N L+ + I D GLA R+ I +
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVK---KNGTCCIADLGLAVRHDSATDTIDIAP---NH 171
Query: 173 LTGTARY------ASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 226
GT RY E +R D+ ++G V R +
Sbjct: 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231
Query: 227 KISEKKVSTSIEALC-RGYPTEFASYFHYCRSLR 259
S+ V + +C + + + C +LR
Sbjct: 232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALR 265
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 474 | |||
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.46 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.99 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.89 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.3 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.02 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.99 |
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-61 Score=475.58 Aligned_cols=296 Identities=78% Similarity=1.353 Sum_probs=267.5
Q ss_pred CCCccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
|+.+++++|+++++||+|+||+||+|++..+|+.||||++........+..|+++++.++|+++|..+..++..+...++
T Consensus 1 ~~~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp CCCEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CCCeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 89999999999999999999999999999999999999988877778899999999999999999999999999999999
Q ss_pred EEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 81 VIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 81 v~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
||||++++|.+.+....+.+++..++.++.||+.||+|||++|||||||||+|||++..+.+..+||+|||+|+.+....
T Consensus 81 vme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 81 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 99999999999988778889999999999999999999999999999999999999765667789999999999988776
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
.....+++......||+.|||||++.+..++.++|||||||++|||++|+.||...........+..........+.+.+
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence 66666666677889999999999999999999999999999999999999999987766666666666666666777788
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCcccccccccc
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKYQ 296 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 296 (474)
+..+|+++.+||..||+.+|++||++++|.++|++++.+.++..+++|||+.++..
T Consensus 241 ~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~~~~~ 296 (299)
T d1ckia_ 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNMLKFG 296 (299)
T ss_dssp TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHHGGGT
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchhhcCC
Confidence 88999999999999999999999999999999999999999999999999988754
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.6e-59 Score=459.47 Aligned_cols=290 Identities=60% Similarity=1.020 Sum_probs=266.9
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
+++++|+++++||+|+||+||+|++..+|+.||||++........+..|+++++.|.++++++.+..++..+...++|||
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 57999999999999999999999999999999999987777777899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeC--CCCCeEEEEecCCccccccCCC
Q 011945 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG--RRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 84 ~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~--~~~~~vkL~DFGla~~~~~~~~ 161 (474)
|++++|.+++......+++.+++.++.|++.||+|||++|||||||||+||||+.. ...+.+||+|||+|+.+.....
T Consensus 82 ~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (293)
T d1csna_ 82 LLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161 (293)
T ss_dssp CCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred ecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence 99999999998777789999999999999999999999999999999999999642 2357899999999999887666
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
....+......++||+.|||||++.+..++.++|||||||++|||++|+.||.+.........+..+...+.......++
T Consensus 162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (293)
T d1csna_ 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241 (293)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHT
T ss_pred ccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhc
Confidence 56666666778899999999999999999999999999999999999999999888777777888887777777788888
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccc
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTIL 293 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~ 293 (474)
..+|+++.+++..||..+|++||+++.|.++|++++.+.++..+++|||+.+
T Consensus 242 ~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~~~ 293 (293)
T d1csna_ 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWNLL 293 (293)
T ss_dssp TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGGCC
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCCcC
Confidence 9999999999999999999999999999999999999999999999999863
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=409.17 Aligned_cols=243 Identities=23% Similarity=0.315 Sum_probs=207.0
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEecc-----CCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~-----~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
.++|++++.||+|+||+||+|+++.+++.||||++.. ......+.+|+.+++.++|++ |..+..++.++...+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN-ILRLYGYFHDATRVYL 83 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTT-BCCEEEEEECSSEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCC-CCeEEEEEEECCEEEE
Confidence 3689999999999999999999999999999998753 234456889999999998655 5556666678888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
||||| +++|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.....
T Consensus 84 vmEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 84 ILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCCCCC
T ss_pred EEeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeecCCC
Confidence 99999 7899999974 4579999999999999999999999999999999999999 47789999999999866543
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
.. ....||+.|||||++.+..++.++|||||||+||||++|+.||.+. +..+.+..+......
T Consensus 160 ~~---------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~----- 222 (263)
T d2j4za1 160 RR---------TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQETYKRISRVEFT----- 222 (263)
T ss_dssp CC---------EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTTCCC-----
T ss_pred cc---------cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC---CHHHHHHHHHcCCCC-----
Confidence 22 3458999999999999999999999999999999999999999774 344555555544432
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
++..+++++.+||..||+.||++|||+++++
T Consensus 223 ~p~~~s~~~~~li~~~L~~dp~~R~t~~eil 253 (263)
T d2j4za1 223 FPDFVTEGARDLISRLLKHNPSQRPMLREVL 253 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHHHHH
Confidence 2356899999999999999999999988774
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-53 Score=410.51 Aligned_cols=250 Identities=24% Similarity=0.338 Sum_probs=202.9
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
+.++|+++++||+|+||+||+|+++.+|+.||||++.... ..+.+.+|+.+++.++|++ |..+..+..++...|||
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~Hpn-Iv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN-VVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTT-BCCEEEEEEETTEEEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCC-EeeEeeeeccCceeEEE
Confidence 3578999999999999999999999999999999986543 2345899999999998655 55555666778899999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ |++|.+++. ....+++.+++.|+.||+.||+|||++|||||||||+|||++ .++.+||+|||+|+.+....
T Consensus 82 mEy~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~---~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 82 LEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLD---ERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp EECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC---TTCCEEECCCTTCEECEETT
T ss_pred EeccCCCcHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEEC---CCCCEEEccchhheeeccCC
Confidence 9999 789999886 345799999999999999999999999999999999999994 67899999999998765433
Q ss_pred CccccccccCCCCccCccccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
.. ......+||+.|||||++.+..+ +.++|||||||+||||++|+.||......... +..+...... ..
T Consensus 158 ~~-----~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~--~~~~~~~~~~---~~ 227 (271)
T d1nvra_ 158 RE-----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDWKEKKTY---LN 227 (271)
T ss_dssp EE-----CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH--HHHHHTTCTT---ST
T ss_pred cc-----ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH--HHHHhcCCCC---CC
Confidence 21 11245689999999999998886 67899999999999999999999765443222 2222222111 11
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYL 269 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (474)
....+++++.+||.+||+.||++|||++++
T Consensus 228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~ei 257 (271)
T d1nvra_ 228 PWKKIDSAPLALLHKILVENPSARITIPDI 257 (271)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 235678999999999999999999998876
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-53 Score=413.57 Aligned_cols=268 Identities=19% Similarity=0.306 Sum_probs=216.6
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEecc-----CCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~-----~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
.++|++++.||+|+||+||+|+++.+++.||||++.. ......+.+|+++++.++|++ |..+..++.+++..||
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF-FVKLYFTFQDDEKLYF 85 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTT-BCCEEEEEECSSEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCC-eeEEEEEEEECCEEEE
Confidence 3579999999999999999999999999999998753 233456899999999998655 4455556677788999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
||||+ |++|.+++.. .+.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.+...
T Consensus 86 vmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC--
T ss_pred EEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceecccC
Confidence 99999 7899999874 4579999999999999999999999999999999999999 47789999999999877543
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
.... .....+||+.|||||++.+..++.++|||||||+||||++|+.||.+. +..+.+.++......
T Consensus 162 ~~~~-----~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~~~~----- 228 (288)
T d1uu3a_ 162 SKQA-----RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEYLIFQKIIKLEYD----- 228 (288)
T ss_dssp -------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHTTCCC-----
T ss_pred Cccc-----ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc---CHHHHHHHHHcCCCC-----
Confidence 3211 123568999999999999999999999999999999999999999874 345555555554432
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCCCCccccccccc
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQFDYVFDWTILKY 295 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 295 (474)
++..+++++.+||.+||+.||++|||++++.+. ..+. ..++...++|..+..
T Consensus 229 ~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~-~~i~---~Hpff~~i~w~~l~~ 280 (288)
T d1uu3a_ 229 FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY-GPLK---AHPFFESVTWENLHQ 280 (288)
T ss_dssp CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH-HHHH---TSGGGTTCCCTTGGG
T ss_pred CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC-HHHH---cCCccCCCCHHHhhc
Confidence 235789999999999999999999999887542 1121 234556689987753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-53 Score=412.68 Aligned_cols=247 Identities=22% Similarity=0.330 Sum_probs=204.3
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC--CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
.++|+++++||+|+||+||+|+++.+|+.||||++... ...+.+.+|+.+++.++|++ |..+..++...+..|||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN-IVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTT-BCCEEEEEEETTEEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCC-EeeEeEEEEECCEEEEEEE
Confidence 35899999999999999999999999999999987643 23456899999999998655 4555555667788999999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
|| |++|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+.+......
T Consensus 98 y~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~---~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTCCEEECCCTTCEECCSTTCC
T ss_pred ecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEEC---CCCcEeeccchhheeecccccc
Confidence 99 8899998863 4699999999999999999999999999999999999994 6789999999999877544321
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhc
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (474)
....+||+.|||||++.+..++.++|||||||+||||++|..||.+... ...+..+....... .....
T Consensus 173 -------~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~~~~~~~~~--~~~~~ 240 (293)
T d1yhwa1 173 -------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP---LRALYLIATNGTPE--LQNPE 240 (293)
T ss_dssp -------BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH---HHHHHHHHHHCSCC--CSSGG
T ss_pred -------ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH---HHHHHHHHhCCCCC--CCCcc
Confidence 2456899999999999999999999999999999999999999987432 23333332221111 11235
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 243 GYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.+++++++||.+||..||++||++++++
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~eil 268 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKELL 268 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 6889999999999999999999988763
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=409.62 Aligned_cols=248 Identities=19% Similarity=0.288 Sum_probs=204.5
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
+.|+++++||+|+||+||+|+++.+++.||||++..... .+.+.+|+++++.|+|++ |..+..++......+|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN-IVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTT-BCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCC-CCeEEEEEeeCCeEEEEEec
Confidence 469999999999999999999999999999999865433 356899999999998655 55555566778889999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 85 ~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
| +++|.+++....+.+++..+..|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|+.......
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~---~~~~~Kl~DFG~a~~~~~~~~-- 165 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQ-- 165 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---TTSCEEECCCTTCEECHHHHH--
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeEC---CCCCEEEEechhhhccCCCcc--
Confidence 9 8899999876677899999999999999999999999999999999999994 778999999999976543221
Q ss_pred ccccccCCCCccCcccccccccc-----CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 164 HIPYRENKNLTGTARYASMNTHL-----GIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
.....+||+.|||||++. +..|+.++|||||||+||||++|+.||.+...... +.++....... .
T Consensus 166 -----~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~---~~~i~~~~~~~--~ 235 (288)
T d2jfla1 166 -----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---LLKIAKSEPPT--L 235 (288)
T ss_dssp -----HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HHHHHHSCCCC--C
T ss_pred -----cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH---HHHHHcCCCCC--C
Confidence 123468999999999985 45589999999999999999999999988654433 33333322211 1
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.....+++++.+||..||+.||++|||+++|+
T Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell 267 (288)
T d2jfla1 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLL 267 (288)
T ss_dssp SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHT
T ss_pred CccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 12346889999999999999999999988774
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-52 Score=414.34 Aligned_cols=253 Identities=20% Similarity=0.248 Sum_probs=197.1
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC---CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT---KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~---~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
.+.+.|++++.||+|+||+||+|+++.+++.||||++.... ....+.+|+.+++.|+|+ +|..+..++.++...||
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~l 84 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP-NIVALDDIYESGGHLYL 84 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCT-TBCCEEEEEECSSEEEE
T ss_pred CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCC-CCCcEEEEEEECCEEEE
Confidence 35678999999999999999999999999999999886542 234578999999999865 55555566678888999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
||||| |++|.+++.. .+.+++..+..|+.||+.||+|||++|||||||||+|||+...+.++.+||+|||+|+.....
T Consensus 85 vmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 85 IMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp EECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred EEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 99999 7999999973 567999999999999999999999999999999999999975556789999999999866543
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
.. ....+||+.|||||++.+..++.++|||||||+||||++|..||.+.. ..+.+..+......... .
T Consensus 164 ~~--------~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~~~~~~~i~~~~~~~~~-~ 231 (307)
T d1a06a_ 164 SV--------LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN---DAKLFEQILKAEYEFDS-P 231 (307)
T ss_dssp -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHTTCCCCCT-T
T ss_pred Ce--------eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHhccCCCCCC-c
Confidence 22 234689999999999999999999999999999999999999998743 34445555544433222 2
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
....+|+++.+||..||..||++||++++++
T Consensus 232 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 262 (307)
T d1a06a_ 232 YWDDISDSAKDFIRHLMEKDPEKRFTCEQAL 262 (307)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cccCCCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence 3467899999999999999999999988763
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-52 Score=407.25 Aligned_cols=248 Identities=21% Similarity=0.257 Sum_probs=196.1
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEe-EeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFG-VEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~-~~~~~~~l 80 (474)
.++|++++.||+|+||+||+|+++.+|+.||||++...... ..+.+|+++++.++|++++..+..+. ......||
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 36899999999999999999999999999999998765432 34788999999999777666665554 34566799
Q ss_pred EEecC-CCCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCCCcEEeeeCCCCCeEEEEecC
Q 011945 81 VIDLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS-----FLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (474)
Q Consensus 81 v~e~~-g~sL~~li~~---~~~~l~~~~~~~i~~qi~~gL~yLHs~g-----IiHrDIKP~NILl~~~~~~~~vkL~DFG 151 (474)
||||| +++|.+++.. ....+++..++.|+.||+.||.|||++| ||||||||+|||| +.++.+||+|||
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DFG 159 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFG 159 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEEECCHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeecc
Confidence 99999 8899999863 3567999999999999999999999976 9999999999999 477899999999
Q ss_pred CccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc
Q 011945 152 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (474)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (474)
+|+.+...... .....||+.|||||++.+..++.++|||||||+||||++|+.||.+.. ..+.+..+...
T Consensus 160 ~a~~~~~~~~~-------~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~---~~~~~~~i~~~ 229 (269)
T d2java1 160 LARILNHDTSF-------AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS---QKELAGKIREG 229 (269)
T ss_dssp HHHHC------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHT
T ss_pred ceeecccCCCc-------cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC---HHHHHHHHHcC
Confidence 99877543321 245689999999999999999999999999999999999999998743 34445555544
Q ss_pred cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 232 KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 232 ~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
... .+...+++++.+||.+||+.||++||++++|+
T Consensus 230 ~~~----~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell 264 (269)
T d2java1 230 KFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264 (269)
T ss_dssp CCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCC----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 432 23457899999999999999999999988874
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-53 Score=409.12 Aligned_cols=258 Identities=21% Similarity=0.338 Sum_probs=205.4
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
.++|+++++||+|+||+||+|+. +..||||+++.... ...+.+|+.+++.++|+++|.. ..+..+ ...+||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~---~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~-~~~~~~-~~~~lv 81 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF-MGYSTA-PQLAIV 81 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEES---SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCE-EEEECS-SSCEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEE---CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeee-eEEEec-cEEEEE
Confidence 46899999999999999999974 33699999865432 2458899999999986666554 445443 456899
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ +++|.+++......+++..++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+......
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~---~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTSSEEECCCCCSCC-----
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEc---CCCCEEEccccceeeccccC
Confidence 9999 7899999986677899999999999999999999999999999999999995 77899999999998765433
Q ss_pred CccccccccCCCCccCccccccccccCC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGI---EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~---~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
... ......||+.|||||++.+. .++.++|||||||+||||++|+.||.+... .......+.........
T Consensus 159 ~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~--~~~~~~~~~~~~~~p~~ 231 (276)
T d1uwha_ 159 GSH-----QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--RDQIIFMVGRGYLSPDL 231 (276)
T ss_dssp ------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--HHHHHHHHHHTSCCCCG
T ss_pred Ccc-----cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh--HHHHHHHHhcCCCCCcc
Confidence 211 12456899999999999753 489999999999999999999999987643 22333334444344444
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
..+...+|+++.+||..||+.||++|||+++|++.|+.+..
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 232 SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 55667899999999999999999999999999999988754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=399.34 Aligned_cols=249 Identities=20% Similarity=0.305 Sum_probs=203.3
Q ss_pred cCCcE-EEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeE---eCC
Q 011945 5 VGNKF-RLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGV---EGD 76 (474)
Q Consensus 5 i~~~y-~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~---~~~ 76 (474)
..++| ++.++||+|+||+||+|++..+++.||||++..... .+.+.+|+++++.|+|+++|..+..+.. ...
T Consensus 6 ~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence 34555 788899999999999999999999999998765432 2358899999999997777776665543 245
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCcEEeeeCCCCCeEEEEecCCc
Q 011945 77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~g--IiHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (474)
..||||||+ +++|.+++.. ...+++..++.|+.||+.||+|||+++ ||||||||+||||+ +.++.+||+|||+|
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA 162 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGG
T ss_pred EEEEEEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcc
Confidence 689999999 8899999974 357999999999999999999999998 99999999999995 35689999999999
Q ss_pred cccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc
Q 011945 154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233 (474)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~ 233 (474)
+....... ...+||+.|||||++.+ .++.++|||||||+||||++|+.||.+.. ...+.+..+.....
T Consensus 163 ~~~~~~~~---------~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~--~~~~~~~~i~~~~~ 230 (270)
T d1t4ha_ 163 TLKRASFA---------KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ--NAAQIYRRVTSGVK 230 (270)
T ss_dssp GGCCTTSB---------EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS--SHHHHHHHHTTTCC
T ss_pred eeccCCcc---------CCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc--cHHHHHHHHHcCCC
Confidence 86443221 34689999999999876 59999999999999999999999997643 33444455544332
Q ss_pred cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 234 STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 234 ~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
.. .+...+++++.+||.+||+.||++|||+++|++
T Consensus 231 ~~---~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 231 PA---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CG---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Cc---ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 22 234568899999999999999999999888743
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.5e-51 Score=413.53 Aligned_cols=252 Identities=19% Similarity=0.281 Sum_probs=209.7
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
+.++|+++++||+|+||+||+|+++.+|+.||||++..... .+.+.+|+.+++.|+|++ |..+..++.++...||||
T Consensus 24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT-LVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTT-BCCEEEEEEETTEEEEEE
T ss_pred CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCC-CCcEEEEEEECCEEEEEE
Confidence 34689999999999999999999999999999999865432 345889999999998655 555555667788999999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
||| |++|.+++....+.+++..++.|+.||+.||.|||++|||||||||+||||+. +.++.+||+|||+|+.+.....
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTSCCEEECCCTTCEECCTTSC
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc-CCCCeEEEeecchheecccccc
Confidence 999 88999999655667999999999999999999999999999999999999952 2357899999999987655432
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
.....||+.|||||++.+..++.++|||||||++|||++|+.||.+. +..+.+..+........ ....
T Consensus 182 --------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~~~-~~~~ 249 (350)
T d1koaa2 182 --------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNVKSCDWNMD-DSAF 249 (350)
T ss_dssp --------EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCCSC-CGGG
T ss_pred --------cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCC-cccc
Confidence 13458999999999999999999999999999999999999999874 33445555554443222 2234
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
..+++++.+||.+||..||++|||+++++
T Consensus 250 ~~~s~~~~~li~~~L~~dP~~R~t~~eil 278 (350)
T d1koaa2 250 SGISEDGKDFIRKLLLADPNTRMTIHQAL 278 (350)
T ss_dssp GGCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 57899999999999999999999987763
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=394.87 Aligned_cols=254 Identities=20% Similarity=0.266 Sum_probs=199.8
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 85 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (474)
++|+++++||+|+||+||+|.+. +++.||||+++... ..+.+.+|+++++.++|++ |..+..++..+...++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~Hpn-Iv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPK-LVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTT-BCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCC-cccccceeccCCceEEEEEec
Confidence 68999999999999999999974 67889999987544 3467999999999998655 555555556667789999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccc
Q 011945 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164 (474)
Q Consensus 86 -g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (474)
+++|.+++......+++..++.|+.||+.||.|||+++|+||||||+|||| +.++.+||+|||+|+.+......
T Consensus 83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~-- 157 (263)
T d1sm2a_ 83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYT-- 157 (263)
T ss_dssp TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC-------------
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---cCCCCeEecccchheeccCCCce--
Confidence 899999988666779999999999999999999999999999999999999 47789999999999876554321
Q ss_pred cccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcCcHHHHHHHHhhccccchHHHHhcC
Q 011945 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (474)
Q Consensus 165 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG-~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (474)
......||+.|+|||++.+..++.++|||||||+||||+++ .+||... ...+.+..+...... ..+..
T Consensus 158 ----~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~---~~~~~~~~i~~~~~~----~~p~~ 226 (263)
T d1sm2a_ 158 ----SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDISTGFRL----YKPRL 226 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC---CHHHHHHHHHHTCCC----CCCTT
T ss_pred ----eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC---CHHHHHHHHHhcCCC----CCccc
Confidence 12345789999999999999999999999999999999995 5556543 334444444432221 12356
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
+++++.+|+..||+.||++||++++|++.|+++.+
T Consensus 227 ~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 78999999999999999999999999999998864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.6e-52 Score=405.81 Aligned_cols=256 Identities=20% Similarity=0.293 Sum_probs=209.8
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 85 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (474)
++|++.++||+|+||+||+|++..+++.||||+++.... .+++.+|+.+++.|+|+++| .+..++.++...+|+|||+
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv-~~~~~~~~~~~~~iv~E~~ 95 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLV-QLLGVCTREPPFYIITEFM 95 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBC-CEEEEECSSSSCEEEEECC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEe-cCCccEeeCCeeEEEeecc
Confidence 479999999999999999999999999999999865543 45699999999999865555 5555556677789999999
Q ss_pred -CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 86 -GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 86 -g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
+++|.+++... ...+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.........
T Consensus 96 ~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~~~~~~~~~ 172 (287)
T d1opja_ 96 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTA 172 (287)
T ss_dssp TTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTTTCCSSSSEE
T ss_pred cCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE---CCCCcEEEccccceeecCCCCcee
Confidence 78999998743 4579999999999999999999999999999999999999 477899999999998765543211
Q ss_pred ccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcC
Q 011945 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (474)
.....||+.|+|||++.+..++.++|||||||++|||++|..||.... +..+.+..+... ... ..+..
T Consensus 173 ------~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~--~~~~~~~~i~~~-~~~---~~~~~ 240 (287)
T d1opja_ 173 ------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI--DLSQVYELLEKD-YRM---ERPEG 240 (287)
T ss_dssp ------ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC--CHHHHHHHHHTT-CCC---CCCTT
T ss_pred ------eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc--hHHHHHHHHhcC-CCC---CCCcc
Confidence 234468999999999999999999999999999999999777664422 223333333222 111 23467
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
+|+++.+||..||+.||++||++++|.+.|+.+++
T Consensus 241 ~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 89999999999999999999999999998888754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-51 Score=403.14 Aligned_cols=261 Identities=15% Similarity=0.242 Sum_probs=200.3
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCe---EEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE---EVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~---~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
.++|++.++||+|+||+||+|+++.+++ .||||.+...... +.+.+|+++|+.|+|+++| .+..++......+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~g~~~~~~~~~ 103 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI-HLEGVVTKSTPVM 103 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBC-CEEEEECSSSSCE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCc-cEEEEEeeCCEEE
Confidence 4689999999999999999999877664 5889987654332 3588999999999865555 5555666777889
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
+||||| +++|.+++......+++.+++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+.+..
T Consensus 104 iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC--------
T ss_pred EEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccceEccC
Confidence 999999 889999988666789999999999999999999999999999999999999 4788999999999987655
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
...... ........||+.|||||++.+..++.++|||||||+||||+| |+.||.+... .+.+..+.......
T Consensus 181 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~~i~~~~~~~-- 253 (299)
T d1jpaa_ 181 DTSDPT--YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVINAIEQDYRLP-- 253 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHTTCCCC--
T ss_pred CCCcce--eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCCCC--
Confidence 432111 111233468999999999999999999999999999999998 8999987543 33444444332211
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
....+|+++.+|+..||+.||++||++.+|++.|+++++.
T Consensus 254 --~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 254 --PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred --CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 2356899999999999999999999999999999998753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-52 Score=412.35 Aligned_cols=254 Identities=18% Similarity=0.262 Sum_probs=200.0
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
+..++|+++++||+|+||+||+|+++.+|+.||||+++.... ...+.+|+.+|+.++|++ |..+..++.+....||
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY-IVGFYGAFYSDGEISI 81 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTT-BCCEEEEEECSSEEEE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCC-CCcEEEEEEECCEEEE
Confidence 346789999999999999999999999999999999865432 346889999999998655 5555556667788999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEeeeCCCCCeEEEEecCCcccccc
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRD 158 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs-~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (474)
||||+ |++|.+++... +.+++..++.++.||+.||.|||+ +|||||||||+|||| +.++.+||+|||+|+.+.+
T Consensus 82 VmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHH
T ss_pred EEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCccccCC
Confidence 99998 78999999743 579999999999999999999997 599999999999999 4788999999999987654
Q ss_pred CCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc------
Q 011945 159 TATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK------ 232 (474)
Q Consensus 159 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~------ 232 (474)
.. ....+||+.|||||++.+..|+.++||||||||+|||++|+.||.+.................
T Consensus 158 ~~---------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (322)
T d1s9ja_ 158 SM---------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228 (322)
T ss_dssp HT---------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------
T ss_pred Cc---------cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCc
Confidence 32 235689999999999999999999999999999999999999998754322111100000000
Q ss_pred -----------------ccc----hHHHH--------h-cCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 233 -----------------VST----SIEAL--------C-RGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 233 -----------------~~~----~~~~l--------~-~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
... ....+ . ..++.++.+||.+||..||++|||++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000 00000 0 125789999999999999999999887744
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-51 Score=405.47 Aligned_cols=265 Identities=19% Similarity=0.276 Sum_probs=216.3
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
-++|++++.||+|+||.||+|+++.+|+.||||+++.. .....+.+|+.+|+.++ |++|..+..++.+.+..|+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeecccccccc
Confidence 36899999999999999999999999999999997642 34466889999999998 4566666667778889999
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
||||+ |++|.+++.. .+.+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+.....
T Consensus 83 v~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 83 VMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCT
T ss_pred ceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeecccccccccC
Confidence 99999 8999999874 4579999999999999999999999999999999999999 47789999999999876543
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEA 239 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (474)
.. .....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.. ..+.+..+......
T Consensus 159 ~~-------~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~---~~~~~~~i~~~~~~----- 223 (337)
T d1o6la_ 159 GA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD---HERLFELILMEEIR----- 223 (337)
T ss_dssp TC-------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC-----
T ss_pred Cc-------ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC---HHHHHHHHhcCCCC-----
Confidence 32 1245689999999999999999999999999999999999999998743 34445555444432
Q ss_pred HhcCCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCCccccccccccc
Q 011945 240 LCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDLFIREGFQFDYVFDWTILKYQQ 297 (474)
Q Consensus 240 l~~~~p~~l~~li~~cl~~dp~~RPt~~--~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~ 297 (474)
++..+++++.+||..||+.||.+|++.. .+.+++++.| ...++|..+..++
T Consensus 224 ~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~-------f~~i~~~~l~~~~ 276 (337)
T d1o6la_ 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF-------FLSINWQDVVQKK 276 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG-------GTTCCHHHHHTTC
T ss_pred CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcc-------cccCCHHHHHhCC
Confidence 3467899999999999999999999521 1223344333 3346787765443
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-51 Score=398.52 Aligned_cols=252 Identities=20% Similarity=0.259 Sum_probs=210.1
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--------CchHHHHHHHHHHHhcCCCCCceeEEEeEeCC
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--------KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGD 76 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--------~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~ 76 (474)
+.++|+++++||+|+||+||+|+++.+|+.||||+++... ..+.+.+|+.+|+.|+|++ |..+..++.+..
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~~~~~~~~~~ 86 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN-VITLHEVYENKT 86 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTT-BCCEEEEEECSS
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCC-CCcEEEEEEECC
Confidence 5678999999999999999999999999999999875432 1346899999999998655 555666667888
Q ss_pred EEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCC-CCCeEEEEecCCcc
Q 011945 77 YNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR-RANQVYIIDFGLAK 154 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~-~~~~vkL~DFGla~ 154 (474)
..||||||| |++|.+++.. .+.+++..++.|+.||+.||+|||++|||||||||+|||++.++ ....+||+|||+|+
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 899999999 7899999974 35799999999999999999999999999999999999996322 22369999999998
Q ss_pred ccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (474)
....... .....||+.|+|||++.+..++.++|||||||+||||++|+.||.+. +..+.+..+......
T Consensus 166 ~~~~~~~--------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~~~~ 234 (293)
T d1jksa_ 166 KIDFGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSAVNYE 234 (293)
T ss_dssp ECTTSCB--------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHTTCCC
T ss_pred hcCCCcc--------ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC---CHHHHHHHHHhcCCC
Confidence 7654332 23568999999999999999999999999999999999999999874 344555555554443
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.. ......+|+++.+||..||..||++||++++++
T Consensus 235 ~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 269 (293)
T d1jksa_ 235 FE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269 (293)
T ss_dssp CC-HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CC-chhcCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 32 334567899999999999999999999988764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=401.42 Aligned_cols=258 Identities=20% Similarity=0.292 Sum_probs=210.4
Q ss_pred CcEEEeee-eeecCceEEEEEEEcC--CCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 7 NKFRLGRK-IGSGSFGEIYLGTNIQ--TNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 7 ~~y~i~~~-LG~G~fG~Vy~a~~~~--~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
++|.+.+. ||+|+||+||+|.+.. ++..||||+++..... +.+.+|+++++.++|+++|..+. ++.. +..+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g-~~~~-~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG-VCQA-EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEE-EEES-SSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEee-eecc-CeEEE
Confidence 46888884 9999999999998754 4558999998755433 45889999999998766655554 4443 45789
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
||||+ +++|.+++......+++..++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+.+...
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~---~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEECTTC
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeec---cCCceeeccchhhhccccc
Confidence 99999 7899999876667899999999999999999999999999999999999995 6789999999999877554
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
.... .......||+.|||||++.+..++.++|||||||+||||+| |..||.+.... +.+..+......
T Consensus 163 ~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~i~~~~~~---- 231 (285)
T d1u59a_ 163 DSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIEQGKRM---- 231 (285)
T ss_dssp SCEE----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHHHTTCCC----
T ss_pred cccc----ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH---HHHHHHHcCCCC----
Confidence 3211 12244579999999999999999999999999999999998 99999886542 333444333221
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
.++..+|+++.+||..||+.||++||++.+|.+.|++++...
T Consensus 232 ~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 232 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 234678999999999999999999999999999999988654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.1e-51 Score=402.33 Aligned_cols=242 Identities=21% Similarity=0.324 Sum_probs=198.6
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc-----hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.|+++++||+|+||+||+|++..+++.||||++...... ..+.+|+++++.|+|+++ ..+..+..++...||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnI-v~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT-IQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTB-CCEEEEEEETTEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCE-eeEEEEEEECCEEEEEE
Confidence 599999999999999999999999999999998754432 347899999999986554 45555667788899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
||| +++|. .+......+++..++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||+|+.....
T Consensus 95 E~~~~g~l~-~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~---~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 95 EYCLGSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp ECCSEEHHH-HHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTTCBSSSSB--
T ss_pred EecCCCchH-HHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC---CCCCEEEeecccccccCCC--
Confidence 999 45554 4444567899999999999999999999999999999999999995 7889999999999865432
Q ss_pred ccccccccCCCCccCccccccccccC---CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLG---IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~---~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
....||+.|||||++.+ ..|+.++|||||||+||||++|..||.+.. ..+.+..+........
T Consensus 169 ---------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~---~~~~~~~i~~~~~~~~-- 234 (309)
T d1u5ra_ 169 ---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHIAQNESPAL-- 234 (309)
T ss_dssp ---------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHSCCCCC--
T ss_pred ---------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCC--
Confidence 34589999999999975 358999999999999999999999998743 3344444444333221
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
....+++++.+||..||+.||++|||+++|++
T Consensus 235 -~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 -QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 12467999999999999999999999888743
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-51 Score=397.35 Aligned_cols=256 Identities=20% Similarity=0.317 Sum_probs=207.3
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
.++|+++++||+|+||+||+|.+ .+++.||||+++... ..+.+.+|+.++..++|+++|..+. +..+ +..++||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g-~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VVTQ-EPIYIITEY 88 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEE-EECS-SSCEEEEEC
T ss_pred HHHeEEeEEEecCCCcEEEEEEE-CCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEe-eecc-CCeEEEEEe
Confidence 36899999999999999999997 467899999987543 3456999999999998766666554 4444 445899999
Q ss_pred C-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 85 L-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 85 ~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
+ +++|.+++... ..++++..++.|+.||+.||.|||++||+||||||+|||| +.++.+||+|||+|+.+......
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccceEEccCCccc
Confidence 9 88999877522 3369999999999999999999999999999999999999 47899999999999877543321
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhc
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (474)
......||+.|||||++.+..++.++|||||||+||||+||..||... ....+.+..+...... ..+.
T Consensus 166 ------~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~--~~~~~~~~~i~~~~~~----~~p~ 233 (272)
T d1qpca_ 166 ------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG--MTNPEVIQNLERGYRM----VRPD 233 (272)
T ss_dssp ------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHHTTCCC----CCCT
T ss_pred ------cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCC--CCHHHHHHHHHhcCCC----CCcc
Confidence 124567999999999999989999999999999999999965554332 2333444444432221 1235
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
.+|+++.+|+..||+.||++|||+++|++.|+++|..
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 7899999999999999999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.5e-51 Score=412.26 Aligned_cols=252 Identities=21% Similarity=0.224 Sum_probs=209.1
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC--chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
+.++|+++++||+|+||+||+|++..+|+.||||++..... ...+.+|+.+|+.|+|++ |..+..++.++...||||
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK-LINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTT-BCCEEEEEECSSEEEEEE
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCC-CCcEEEEEEECCEEEEEE
Confidence 34679999999999999999999999999999999875432 235788999999998655 555555667788899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
||| |++|.+++.....++++.+++.|+.||+.||.|||++|||||||||+||||+. ...+.+||+|||+|+.+.....
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~~~~~~ 184 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEI 184 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSC
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccceecCCCCc
Confidence 999 89999988755667999999999999999999999999999999999999942 2467899999999988765432
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
.....||+.|||||++.+..++.++|||||||+||||++|..||.+.. ....+..+....... .....
T Consensus 185 --------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~i~~~~~~~-~~~~~ 252 (352)
T d1koba_ 185 --------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQNVKRCDWEF-DEDAF 252 (352)
T ss_dssp --------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHCCCCC-CSSTT
T ss_pred --------eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCC-Ccccc
Confidence 123579999999999999999999999999999999999999998743 344445554443322 12234
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
..+++++.+||..||..||++||++++++
T Consensus 253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil 281 (352)
T d1koba_ 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDAL 281 (352)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 57899999999999999999999987773
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.1e-50 Score=394.44 Aligned_cols=261 Identities=20% Similarity=0.325 Sum_probs=206.6
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc-----hHHHHHHHHHHHhcCCCCCceeEEEeEeC---
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLQYEAKLYKILQGGTGIPNLRWFGVEG--- 75 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~l~~E~~il~~l~~~~~i~~l~~~~~~~--- 75 (474)
.+.++|++.+.||+|+||+||+|++..+|+.||||++...... ..+.+|+++++.++|++++..+..+....
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSS
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCC
Confidence 5778999999999999999999999999999999998654322 34789999999999888777777665543
Q ss_pred CEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcc
Q 011945 76 DYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154 (474)
Q Consensus 76 ~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~ 154 (474)
...||||||+ |++|.+++.. .+.+++.+++.|+.||+.||+|||++|||||||||+|||++ ..+.++|+|||+++
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~---~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---TTSCEEECCCTTCE
T ss_pred ceEEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC---ccccceeehhhhhh
Confidence 3579999999 7899988874 45799999999999999999999999999999999999995 78899999999997
Q ss_pred ccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc
Q 011945 155 RYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (474)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (474)
......... ......+||+.|||||++.+..++.++|||||||+||||++|+.||.+.. ..+.+..+......
T Consensus 160 ~~~~~~~~~----~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 160 AIADSGNSV----TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS---PVSVAYQHVREDPI 232 (277)
T ss_dssp ECC--------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHCCCC
T ss_pred hhccccccc----cccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC---HHHHHHHHHhcCCC
Confidence 664433211 12345689999999999999999999999999999999999999998743 23333333333222
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCCCC-CHHHHHHHHHHH
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKP-DYAYLKRLFRDL 276 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RP-t~~~l~~~L~~l 276 (474)
. .......+|+++.++|.+||+.||++|| +++++++.|..+
T Consensus 233 ~-~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 233 P-PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp C-GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred C-CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 1 2234467899999999999999999999 888887777665
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=409.85 Aligned_cols=260 Identities=17% Similarity=0.182 Sum_probs=203.5
Q ss_pred ccCCcEEEee-eeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeE----eCCEE
Q 011945 4 RVGNKFRLGR-KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV----EGDYN 78 (474)
Q Consensus 4 ~i~~~y~i~~-~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~----~~~~~ 78 (474)
.+.++|++++ .||+|+||+||+|++..+++.||||+++ ....+.+|+.++.++.+|++|..+..++. ...+.
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~---~~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEE---CSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEEC---CcHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 3457899875 5999999999999999999999999986 34678899999877755555555544433 24678
Q ss_pred EEEEecC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 79 VLVIDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
||||||| |++|.+++... ...|++.+++.|+.||+.||+|||++||+||||||+|||++..+..+.+||+|||+|+..
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeec
Confidence 9999999 78999999744 346999999999999999999999999999999999999975556778999999999876
Q ss_pred ccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHH-HHHhhccccc
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY-EKISEKKVST 235 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~-~~i~~~~~~~ 235 (474)
..... ....+||+.|||||++.+..|+.++||||||||||+|++|+.||.+.........+ ..+.......
T Consensus 165 ~~~~~--------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~ 236 (335)
T d2ozaa1 165 TSHNS--------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 236 (335)
T ss_dssp CCCCC--------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSC
T ss_pred cCCCc--------cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCC
Confidence 55432 23468999999999999999999999999999999999999999875443222211 1222222111
Q ss_pred hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
+. .....+++++.+||..||..||++||++.++ |++.|.
T Consensus 237 ~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~ei---l~hp~~ 275 (335)
T d2ozaa1 237 PN-PEWSEVSEEVKMLIRNLLKTEPTQRMTITEF---MNHPWI 275 (335)
T ss_dssp CT-THHHHSCHHHHHHHHHHSCSSTTTSCCHHHH---HHSHHH
T ss_pred CC-cccccCCHHHHHHHHHHccCChhHCcCHHHH---HcCHHh
Confidence 11 1223578999999999999999999998776 444443
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-50 Score=405.04 Aligned_cols=258 Identities=19% Similarity=0.313 Sum_probs=213.2
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++|+++++||+|+||+||+|+++.+|+.||||++... .....+.+|+++|+.++|++ |..+..++......++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpn-Iv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF-LVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTT-BCCEEEEEECSSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCc-Eeecccccccccccccc
Confidence 6899999999999999999999999999999987532 23456889999999998655 45555556677788899
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ +++|.+++.. .+.+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+.+....
T Consensus 120 ~e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~~~~ 195 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp EECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSCB
T ss_pred cccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeeccccc
Confidence 9988 8899998874 3579999999999999999999999999999999999999 477899999999998765432
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
....||+.|||||++.+..++.++|||||||+||||++|..||.+. +....+..+...... +
T Consensus 196 ----------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~~~~~-----~ 257 (350)
T d1rdqe_ 196 ----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVSGKVR-----F 257 (350)
T ss_dssp ----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC-----C
T ss_pred ----------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc---CHHHHHHHHhcCCCC-----C
Confidence 3468999999999999999999999999999999999999999874 344555555554432 2
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccccccc
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILKYQQ 297 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~ 297 (474)
+..+++++.+||..||..||.+|+ ++++|+ + .++....+|..+..++
T Consensus 258 p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell---~-------Hp~f~~~~~~~~~~~~ 309 (350)
T d1rdqe_ 258 PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIK---N-------HKWFATTDWIAIYQRK 309 (350)
T ss_dssp CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHH---T-------SGGGTTCCHHHHHTTC
T ss_pred CccCCHHHHHHHHHHhhhCHHhccccccccHHHHH---c-------CccccCCCHHHHHhcC
Confidence 357899999999999999999995 766653 2 3444556898765443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=402.46 Aligned_cols=254 Identities=21% Similarity=0.294 Sum_probs=207.2
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCe-----EEEEEEeccC---CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE-----EVAIKLENVK---TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~-----~vAvK~~~~~---~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
++|+++++||+|+||+||+|++..+++ .||||++... .....+.+|+.++..+.+|++|..+..++......
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 689999999999999999999876543 6999987543 23456889999999996677777777777788889
Q ss_pred EEEEecC-CCCHHHHHHHcC----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEE
Q 011945 79 VLVIDLL-GPSLEDLFNFCS----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFL 135 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~----------------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NIL 135 (474)
+|||||| +++|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+|||
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nil 196 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 196 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEE
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccc
Confidence 9999999 899999997432 24899999999999999999999999999999999999
Q ss_pred eeeCCCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCC
Q 011945 136 MGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQ 214 (474)
Q Consensus 136 l~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~ 214 (474)
++ .++.+||+|||+|+......... ......||+.|||||++.+..++.++|||||||+||||++ |..||.
T Consensus 197 l~---~~~~~Kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 197 VT---HGKVVKICDFGLARDIMSDSNYV-----VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp EE---TTTEEEECCCGGGSCGGGCTTSE-----EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cc---cCCeEEEeeccccccccCCCcee-----eeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 95 77899999999998766543321 1234578999999999999999999999999999999997 899998
Q ss_pred CCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHH
Q 011945 215 GLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFR 274 (474)
Q Consensus 215 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~ 274 (474)
+...... +.++....... ..+..+|+++.+||..||+.||++|||+++|++.|.
T Consensus 269 ~~~~~~~---~~~~~~~~~~~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVDAN---FYKLIQNGFKM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp TCCCSHH---HHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCHHHH---HHHHHhcCCCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 7654322 22233222221 123568999999999999999999999999988775
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=400.01 Aligned_cols=259 Identities=19% Similarity=0.278 Sum_probs=214.9
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc-hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
.+.++|++++.||+|+||+||+|.++.+++.||||+++.+... ..+.+|+++|+.++|++ |..+..++.+....||||
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~Hpn-Iv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRN-ILHLHESFESMEELVMIF 80 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTT-BCCEEEEEEETTEEEEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCC-CCeEEEEEEECCEEEEEE
Confidence 4678999999999999999999999999999999998765432 34789999999999655 555555666788899999
Q ss_pred ecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 83 e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
||| |++|.+++......+++.+++.|+.||+.||+|||++||+||||||+|||++. +....+||+|||+++.......
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~~~~~ 159 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCE
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC-CCceEEEEcccchhhccccCCc
Confidence 999 78999999755567999999999999999999999999999999999999953 2456899999999987654322
Q ss_pred ccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHh
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALC 241 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~ 241 (474)
.....||+.|+|||.+.+..++.++|||||||+||+|++|..||.+. +....+..+........ ....
T Consensus 160 --------~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~~-~~~~ 227 (321)
T d1tkia_ 160 --------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE---TNQQIIENIMNAEYTFD-EEAF 227 (321)
T ss_dssp --------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHTCCCCC-HHHH
T ss_pred --------ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCC-hhhc
Confidence 12357899999999999999999999999999999999999999874 34455566655544333 3345
Q ss_pred cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 242 RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 242 ~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
..+++++.+||..||..||++||+++++ |++.|.+
T Consensus 228 ~~~s~~~~~li~~~L~~dp~~R~s~~ei---l~hp~~~ 262 (321)
T d1tkia_ 228 KEISIEAMDFVDRLLVKERKSRMTASEA---LQHPWLK 262 (321)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHH---HHSHHHH
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHH---hcCHhhc
Confidence 6789999999999999999999998877 4454443
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=393.40 Aligned_cols=249 Identities=19% Similarity=0.337 Sum_probs=199.8
Q ss_pred eeeeecCceEEEEEEEc--CCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC-
Q 011945 13 RKIGSGSFGEIYLGTNI--QTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL- 85 (474)
Q Consensus 13 ~~LG~G~fG~Vy~a~~~--~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~- 85 (474)
++||+|+||+||+|.+. .+++.||||+++.... .+.+.+|++++++|+|++++..+. ++.. +..+|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g-~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG-ICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEE-EEES-SSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEE-Eecc-CCEEEEEEcCC
Confidence 46999999999999864 3567899999865432 245889999999998766665554 4443 4468999999
Q ss_pred CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcccc
Q 011945 86 GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQHI 165 (474)
Q Consensus 86 g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~ 165 (474)
+++|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+.+.......
T Consensus 91 ~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~---~~~~~kl~DFGla~~~~~~~~~~-- 164 (277)
T d1xbba_ 91 LGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYY-- 164 (277)
T ss_dssp TEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEECCTTCSEE--
T ss_pred CCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhccc---ccCcccccchhhhhhcccccccc--
Confidence 8899999874 56799999999999999999999999999999999999995 67899999999998765443321
Q ss_pred ccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcCC
Q 011945 166 PYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRGY 244 (474)
Q Consensus 166 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~ 244 (474)
.......||+.|||||++.+..++.++|||||||++|||++ |+.||.+... .+....+...... .++..+
T Consensus 165 --~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~~~i~~~~~~----~~p~~~ 235 (277)
T d1xbba_ 165 --KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLEKGERM----GCPAGC 235 (277)
T ss_dssp --EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHHTTCCC----CCCTTC
T ss_pred --ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH---HHHHHHHHcCCCC----CCCccc
Confidence 12234579999999999999999999999999999999998 8999987543 3334444332221 234678
Q ss_pred cHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 245 PTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 245 p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
|+++.+||..||+.||++||++++|.+.|++.|.
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 9999999999999999999999999999998874
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3e-50 Score=398.64 Aligned_cols=256 Identities=20% Similarity=0.283 Sum_probs=212.5
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEecc-----CCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~-----~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++|++++.||+|+||+||+|+++.+|+.||||++.. ....+.+.+|+.+++.++|+ +|..+..++.+....|+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~Hp-nIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP-FIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBT-TBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCc-ChhheeeeEeeCCeeeeE
Confidence 679999999999999999999999999999999753 23345688999999999865 555566666788899999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ |++|..++. ....+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+......
T Consensus 83 mE~~~gg~l~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 83 MDYIEGGELFSLLR-KSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp ECCCCSCBHHHHHH-HTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSCB
T ss_pred eeecCCcccccccc-ccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEecccc
Confidence 9999 788888887 45678999999999999999999999999999999999999 478899999999998765432
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
...+||+.|||||++.+..++.++|||||||+||||++|+.||.+. +..+.+.++...... +
T Consensus 159 ----------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~~~~~-----~ 220 (316)
T d1fota_ 159 ----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKILNAELR-----F 220 (316)
T ss_dssp ----------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHCCCC-----C
T ss_pred ----------ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc---CHHHHHHHHHcCCCC-----C
Confidence 3468999999999999999999999999999999999999999874 344555555544332 2
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCC-----CHHHHHHHHHHHHHHcCCCCCCccccccccc
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKP-----DYAYLKRLFRDLFIREGFQFDYVFDWTILKY 295 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RP-----t~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~ 295 (474)
+..+++++.++|.+||..||.+|+ ++++| |++. +...++|..+..
T Consensus 221 p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~i---l~Hp-------~f~~i~~~~l~~ 270 (316)
T d1fota_ 221 PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDV---KNHP-------WFKEVVWEKLLS 270 (316)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHH---HTSG-------GGSSCCHHHHHT
T ss_pred CCCCCHHHHHHHHHHhhhCHHhccccchhhHHHH---HcCc-------ccccCCHHHHHh
Confidence 356889999999999999999996 66655 3333 334567876543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.2e-50 Score=389.71 Aligned_cols=250 Identities=18% Similarity=0.198 Sum_probs=209.7
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc-----------hHHHHHHHHHHHhcCCCCCceeEEEeE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----------PQLQYEAKLYKILQGGTGIPNLRWFGV 73 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----------~~l~~E~~il~~l~~~~~i~~l~~~~~ 73 (474)
+.++|++++.||+|+||+||+|++..+|+.||||++...... ..+.+|+.+++.|..|++|..+..++.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 468999999999999999999999999999999998654321 247889999999997777777777788
Q ss_pred eCCEEEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCC
Q 011945 74 EGDYNVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (474)
Q Consensus 74 ~~~~~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (474)
++...||||||+ +++|.+++.. .+.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~ 156 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGF 156 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred cCcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEccchh
Confidence 899999999999 7899999975 4579999999999999999999999999999999999999 4788999999999
Q ss_pred ccccccCCCccccccccCCCCccCccccccccccC------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHH
Q 011945 153 AKRYRDTATHQHIPYRENKNLTGTARYASMNTHLG------IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 226 (474)
Q Consensus 153 a~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~------~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 226 (474)
++.+..... .....||..|+|||.+.+ ..++.++|||||||+||||++|+.||.+.. ....+.
T Consensus 157 a~~~~~~~~--------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~---~~~~~~ 225 (277)
T d1phka_ 157 SCQLDPGEK--------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QMLMLR 225 (277)
T ss_dssp CEECCTTCC--------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHH
T ss_pred eeEccCCCc--------eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC---HHHHHH
Confidence 987654322 234689999999999863 346889999999999999999999998754 344444
Q ss_pred HHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 227 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 227 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.+.........+ ....+|+++.+||.+||+.||++||++++++
T Consensus 226 ~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~~p~~R~s~~eil 268 (277)
T d1phka_ 226 MIMSGNYQFGSP-EWDDYSDTVKDLVSRFLVVQPQKRYTAEEAL 268 (277)
T ss_dssp HHHHTCCCCCTT-TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHT
T ss_pred HHHhCCCCCCCc-ccccCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence 455444332221 2357899999999999999999999988763
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.5e-50 Score=404.28 Aligned_cols=264 Identities=23% Similarity=0.297 Sum_probs=211.5
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccC-----CCchHHHHHHHHHHHhc--CCCCCceeEEEeEeCCEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK-----TKHPQLQYEAKLYKILQ--GGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~-----~~~~~l~~E~~il~~l~--~~~~i~~l~~~~~~~~~~ 78 (474)
-++|+++++||+|+||.||+|+++.+|+.||||++... .....+.+|..+++.+. +|++|..+..++...+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 36899999999999999999999999999999987532 23334666766666655 356666777777788889
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
||||||+ |++|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+|||| +..+.+||+|||+|+.+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTCEECS
T ss_pred EEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeeceeeecC
Confidence 9999999 8999999974 4579999999999999999999999999999999999999 477899999999998765
Q ss_pred cCCCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccch
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (474)
.... ...+||+.|||||++.+ ..++.++|||||||+||||++|+.||.+............+.....
T Consensus 159 ~~~~---------~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~--- 226 (364)
T d1omwa3 159 KKKP---------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV--- 226 (364)
T ss_dssp SSCC---------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCC---
T ss_pred CCcc---------cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC---
Confidence 4332 34689999999999975 5689999999999999999999999988665554443333322221
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCC-----HHHHHHHHHHHHHHcCCCCCCccccccccccc
Q 011945 237 IEALCRGYPTEFASYFHYCRSLRFDDKPD-----YAYLKRLFRDLFIREGFQFDYVFDWTILKYQQ 297 (474)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt-----~~~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~ 297 (474)
.+...+++++.+||..||..||++||+ +++| +++ ++...++|..+..++
T Consensus 227 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~ei---l~H-------p~f~~i~~~~~~~~~ 280 (364)
T d1omwa3 227 --ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEV---KES-------PFFRSLDWQMVFLQK 280 (364)
T ss_dssp --CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHH---HTS-------GGGTTCCHHHHHTTC
T ss_pred --CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHH---HcC-------ccccCCCHHHHhcCC
Confidence 234578999999999999999999999 4444 333 334457888765443
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=387.99 Aligned_cols=251 Identities=18% Similarity=0.281 Sum_probs=209.7
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 85 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (474)
++|+++++||+|+||+||+|++ .+++.||||+++... ..+.+.+|+.++..++|++++. +..++.+....++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~-~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQ-LYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCC-EEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceee-EEEEEeeCCceEEEEEcc
Confidence 6899999999999999999997 578899999987654 4467999999999998655554 445556667789999999
Q ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCccc
Q 011945 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQH 164 (474)
Q Consensus 86 -g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~ 164 (474)
+++|.+++......+++..++.|+.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.+......
T Consensus 82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~~~-- 156 (258)
T d1k2pa_ 82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYT-- 156 (258)
T ss_dssp TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSSCC--
T ss_pred CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheeccCCCce--
Confidence 789999987667789999999999999999999999999999999999999 47889999999999876554321
Q ss_pred cccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcC
Q 011945 165 IPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (474)
Q Consensus 165 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (474)
......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+... .+....+...... ..+..
T Consensus 157 ----~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~---~~~~~~i~~~~~~----~~p~~ 225 (258)
T d1k2pa_ 157 ----SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN---SETAEHIAQGLRL----YRPHL 225 (258)
T ss_dssp ----CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH---HHHHHHHHTTCCC----CCCTT
T ss_pred ----eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH---HHHHHHHHhCCCC----CCccc
Confidence 2234679999999999999999999999999999999998 8999987643 3444444443221 12357
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Q 011945 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRD 275 (474)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~ 275 (474)
+|+++.+||..||+.||++||++++|++.|.+
T Consensus 226 ~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 226 ASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 88999999999999999999999999887653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=388.72 Aligned_cols=259 Identities=15% Similarity=0.183 Sum_probs=201.0
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCC----eEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN----EEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~----~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
.+.|++.++||+|+||+||+|.+..++ ..||||++...... ..+.+|+.+++.|+|++ |..+..++......
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~n-Iv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN-IIRLEGVISKYKPM 84 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTT-BCCEEEEECSSSSE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCC-EeeeeEEEecCCce
Confidence 467999999999999999999987654 47999998654332 35789999999998655 55555556666778
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
+++|||+ +++|.+++......+++..++.|+.||+.||+|||+++||||||||+|||| +.++.+||+|||+|+.+.
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC-----
T ss_pred EEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccchhhccc
Confidence 8999998 778888887777789999999999999999999999999999999999999 478899999999998765
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI 237 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (474)
....... ......||+.|||||++.+..++.++|||||||+||||++|..||.... ...+.+..+......
T Consensus 162 ~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~--~~~~~~~~i~~~~~~--- 232 (283)
T d1mqba_ 162 DDPEATY----TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL--SNHEVMKAINDGFRL--- 232 (283)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHHTTCCC---
T ss_pred CCCccce----EeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC--CHHHHHHHHhccCCC---
Confidence 5332111 1234578999999999999999999999999999999999666654322 233444444433221
Q ss_pred HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 238 EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 238 ~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
.....+|.++.+||..||+.||++||++.+|++.|+.++.
T Consensus 233 -~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 233 -PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp -CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 1235689999999999999999999999999999998875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-50 Score=392.12 Aligned_cols=261 Identities=20% Similarity=0.274 Sum_probs=202.1
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcC-----CCeEEEEEEeccCCC---chHHHHHHHHHHHhcCCCCCceeEEEe-EeCC
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTK---HPQLQYEAKLYKILQGGTGIPNLRWFG-VEGD 76 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAvK~~~~~~~---~~~l~~E~~il~~l~~~~~i~~l~~~~-~~~~ 76 (474)
.++|+++++||+|+||.||+|.+.. +++.||||+++.... ...+..|..++.++.||++|..+..+. ..+.
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 3689999999999999999999754 357899999865433 235778889999998887777765554 4456
Q ss_pred EEEEEEecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCC
Q 011945 77 YNVLVIDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGR 140 (474)
Q Consensus 77 ~~~lv~e~~-g~sL~~li~~~---------------~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~ 140 (474)
..+++|||| +++|.+++... ...+++..++.|+.||+.||.|||++|||||||||+|||| +
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl---~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---S 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---C
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE---C
Confidence 789999999 89999999643 2348999999999999999999999999999999999999 4
Q ss_pred CCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcC
Q 011945 141 RANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAG 219 (474)
Q Consensus 141 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG-~~Pf~~~~~~ 219 (474)
.++.+||+|||+|+......... ......||+.|||||++.+..++.++|||||||++|||++| ..||.+....
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYV-----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp GGGCEEECC------CCSCTTSC-----CTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred CCCcEEEccCcchhhcccccccc-----ccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 77899999999998765443211 23456899999999999999999999999999999999986 5688765433
Q ss_pred cHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 220 TKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 220 ~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
. .....+..... ......+++++.++|..||+.||++||++++|++.|+++++.+
T Consensus 244 ~--~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 244 E--EFCRRLKEGTR----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp H--HHHHHHHHTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred H--HHHHHHhcCCC----CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence 2 22222222211 1234568999999999999999999999999999999998653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-50 Score=397.67 Aligned_cols=261 Identities=21% Similarity=0.295 Sum_probs=213.2
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEecc-----CCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~-----~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++|+++++||+|+||+||+|+++.+++.||||++.. ......+..|..++...-+|++|..+..+..++...|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 679999999999999999999999999999999853 233445778888777544566777777777888899999
Q ss_pred EecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCC
Q 011945 82 IDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTA 160 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (474)
|||+ +++|.+++.. ...+++..++.++.||+.||+|||++|||||||||+|||+ +..+.+||+|||+|+......
T Consensus 82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhccccc
Confidence 9999 8899999974 4579999999999999999999999999999999999999 478899999999998655433
Q ss_pred CccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHH
Q 011945 161 THQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEAL 240 (474)
Q Consensus 161 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (474)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.. ..+.+.++...... +
T Consensus 158 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~---~~~~~~~i~~~~~~-----~ 222 (320)
T d1xjda_ 158 A-------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD---EEELFHSIRMDNPF-----Y 222 (320)
T ss_dssp C-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCC-----C
T ss_pred c-------cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCC-----C
Confidence 2 1244689999999999999999999999999999999999999998743 44455555443322 2
Q ss_pred hcCCcHHHHHHHHHHhcCCCCCCCCHH-HHHHHHHHHHHHcCCCCCCcccccccccc
Q 011945 241 CRGYPTEFASYFHYCRSLRFDDKPDYA-YLKRLFRDLFIREGFQFDYVFDWTILKYQ 296 (474)
Q Consensus 241 ~~~~p~~l~~li~~cl~~dp~~RPt~~-~l~~~L~~l~~~~~~~~~~~~dw~~~~~~ 296 (474)
+..+|+++.+||.+||..||++||++. +|+ ++ ++...++|+.+...
T Consensus 223 p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~---~h-------pff~~~~~~~l~~~ 269 (320)
T d1xjda_ 223 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR---QH-------PLFREINWEELERK 269 (320)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG---GS-------GGGTTCCHHHHHTT
T ss_pred CccCCHHHHHHHHHhcccCCCCCcCHHHHHH---hC-------chhccCCHHHHHhc
Confidence 356899999999999999999999974 442 22 23334678765443
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-50 Score=388.85 Aligned_cols=256 Identities=21% Similarity=0.306 Sum_probs=200.0
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCC---eEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~---~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~l 80 (474)
++|++++.||+|+||+||+|++..++ ..||||.++..... ..+.+|+.+++.++|++++..+..+ . ....++
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~-~~~~~i 84 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-T-ENPVWI 84 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-C-SSSCEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-e-cCeEEE
Confidence 68999999999999999999986553 46888887644332 3588999999999876666665544 3 456789
Q ss_pred EEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 81 VIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 81 v~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
||||+ +++|.+++......+++..++.++.||+.||.|||++|||||||||+|||++ ..+.+||+|||+|+.+...
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~---~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC----------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeec---CCCcEEEccchhheeccCC
Confidence 99999 8899998877777899999999999999999999999999999999999995 6789999999999876543
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
... ......||+.|+|||++.+..++.++|||||||+||||++ |..||.+...... +..+......
T Consensus 162 ~~~------~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~---~~~i~~~~~~---- 228 (273)
T d1mp8a_ 162 TYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIENGERL---- 228 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHHTTCCC----
T ss_pred cce------eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH---HHHHHcCCCC----
Confidence 221 1234578999999999999999999999999999999998 8999988655433 3333333221
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
.++..+|+++.+||..||+.||++||++.+|++.|+.++.+.
T Consensus 229 ~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 229 PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 234678999999999999999999999999999999987654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=389.39 Aligned_cols=240 Identities=25% Similarity=0.373 Sum_probs=199.8
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--------CchHHHHHHHHHHHhcC-CCCCceeEEEeEeC
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--------KHPQLQYEAKLYKILQG-GTGIPNLRWFGVEG 75 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--------~~~~l~~E~~il~~l~~-~~~i~~l~~~~~~~ 75 (474)
+.++|++.++||+|+||+||+|++..+|+.||||++.... ....+.+|+.+++.+++ |++|..+..++...
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 4678999999999999999999999999999999876432 12346789999999984 56777777778888
Q ss_pred CEEEEEEecCC--CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCc
Q 011945 76 DYNVLVIDLLG--PSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (474)
Q Consensus 76 ~~~~lv~e~~g--~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (474)
+..++|||++. +++.+++.. ...+++.+++.|+.||+.||+|||++|||||||||+|||++ .+.+.+||+|||+|
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~--~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSG 158 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTC
T ss_pred CeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe--cCCCeEEECccccc
Confidence 89999999983 578888764 45799999999999999999999999999999999999996 34579999999999
Q ss_pred cccccCCCccccccccCCCCccCccccccccccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc
Q 011945 154 KRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (474)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (474)
+...... .....||+.|+|||++.+..+ +.++|||||||+||||++|+.||.+. ..+....
T Consensus 159 ~~~~~~~---------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---------~~i~~~~ 220 (273)
T d1xwsa_ 159 ALLKDTV---------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD---------EEIIRGQ 220 (273)
T ss_dssp EECCSSC---------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---------HHHHHCC
T ss_pred eeccccc---------ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc---------hHHhhcc
Confidence 8654432 245689999999999988765 67899999999999999999999752 1122222
Q ss_pred ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 233 VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 233 ~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
. .+...+|+++.+||.+||..||++|||+++++
T Consensus 221 ~-----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil 253 (273)
T d1xwsa_ 221 V-----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 253 (273)
T ss_dssp C-----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred c-----CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHh
Confidence 1 13357899999999999999999999988774
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=392.40 Aligned_cols=256 Identities=19% Similarity=0.246 Sum_probs=203.0
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCe----EEEEEEeccC---CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVK---TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNV 79 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~----~vAvK~~~~~---~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~ 79 (474)
.+|+++++||+|+||+||+|.+..+|+ .||||.++.. ...+.+.+|+.+++.++|++++ .+..++.++...+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv-~l~g~~~~~~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC-RLLGICLTSTVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBC-CEEEEEESSSEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEe-eEEEEEecCCeeE
Confidence 569999999999999999999988876 5888876543 2345689999999999865555 4555556666666
Q ss_pred EEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 80 LVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 80 lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
+++++++++|.+.+......+++..++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+.+...
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~---~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeC---CCCCeEeeccccceecccc
Confidence 6666669999999887778899999999999999999999999999999999999995 6789999999999876553
Q ss_pred CCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHH
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIE 238 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (474)
.... ......||+.|||||++.+..++.++|||||||+||||+| |..||.+.........+ ......
T Consensus 165 ~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i---~~~~~~---- 232 (317)
T d1xkka_ 165 EKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---EKGERL---- 232 (317)
T ss_dssp CC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH---HHTCCC----
T ss_pred cccc-----cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH---HcCCCC----
Confidence 3211 1234578999999999999999999999999999999998 89999886654433332 222211
Q ss_pred HHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 239 ALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 239 ~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
..+..+|+++.+|+..||..||++||++.+|++.|..+..
T Consensus 233 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 233 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 1235688999999999999999999999999988887653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=383.04 Aligned_cols=253 Identities=21% Similarity=0.240 Sum_probs=202.0
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
++|+++++||+|+||+||+|++..+|+.||||++.... ....+.+|+++++.++|++ |..+..+..++...|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~-Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN-IVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTT-BCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCc-EEEeccccccccceeEEE
Confidence 68999999999999999999999999999999885542 3457899999999998554 555556667888999999
Q ss_pred ecCCCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCC
Q 011945 83 DLLGPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTAT 161 (474)
Q Consensus 83 e~~g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (474)
||+++++.+++... ...+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.......
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCCSB
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceeccCCcc
Confidence 99988887777543 5569999999999999999999999999999999999999 4778999999999987654332
Q ss_pred ccccccccCCCCccCccccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhh----------
Q 011945 162 HQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE---------- 230 (474)
Q Consensus 162 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~---------- 230 (474)
......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.........+.....
T Consensus 158 -------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 158 -------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp -------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred -------cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence 124468999999999988766 58999999999999999999999987543222111111100
Q ss_pred -----------ccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 231 -----------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 231 -----------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.............+++++.+||.+||..||++|||+++|+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell 281 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 0111222334456789999999999999999999988774
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=381.79 Aligned_cols=251 Identities=20% Similarity=0.286 Sum_probs=200.9
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEecC
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDLL 85 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~~ 85 (474)
.++|+++++||+|+||.||+|.+ .|..||||+++.+...+.+.+|++++++++|++++..+..+.......++||||+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 35799999999999999999996 5789999999877777889999999999986655555554444455679999999
Q ss_pred -CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 86 -GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 86 -g~sL~~li~~~-~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
+++|.+++... ...+++..++.|+.||+.||.|||+++||||||||+|||+ +.++.+||+|||+++......
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccceecCCCC---
Confidence 89999998643 2359999999999999999999999999999999999999 478999999999998654432
Q ss_pred ccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccchHHHHhc
Q 011945 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (474)
....+|..|+|||++.+..++.++|||||||++|||++ |+.||......+ .+..+...... .+..
T Consensus 158 -------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i~~~~~~----~~~~ 223 (262)
T d1byga_ 158 -------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKGYKM----DAPD 223 (262)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHTTTCCC----CCCT
T ss_pred -------ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHcCCCC----CCCc
Confidence 23478999999999999999999999999999999998 799998754433 33444433222 2345
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
.+++++.+||..||..||++||++.+|.+.|+++-.
T Consensus 224 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 224 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 788999999999999999999999999999988754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-49 Score=387.29 Aligned_cols=249 Identities=18% Similarity=0.156 Sum_probs=196.6
Q ss_pred EeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-------chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEe
Q 011945 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-------HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVID 83 (474)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-------~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e 83 (474)
.+++||+|+||+||+|+++.+|+.||||+++.... ...+.+|+.+++.++|+++|.. ..+...+...|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~-~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL-LDAFGHKSNISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCE-EEEECCTTCCEEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEE-EeeeccCCceeehhh
Confidence 47899999999999999999999999998754321 3458899999999986655554 455566777899999
Q ss_pred cCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 84 LLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 84 ~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
|+.+.+...+...+..+++..+..|+.||+.||+|||++||+||||||+|||+ +..+.+||+|||+|+.......
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~-- 155 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNR-- 155 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCC--
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCCCcc--
Confidence 99776666665556779999999999999999999999999999999999999 4789999999999987655432
Q ss_pred ccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc-----------
Q 011945 164 HIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----------- 231 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~----------- 231 (474)
.....+||+.|+|||++.+. .++.++|||||||++|||++|..||.+....+....+.+....
T Consensus 156 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 156 -----AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp -----CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred -----cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhc
Confidence 12346899999999998754 5799999999999999999999999875443322222222110
Q ss_pred ---------cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 232 ---------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 232 ---------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
........+...+++++.+||..||..||++|||+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L 278 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 001223444567789999999999999999999988763
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=384.54 Aligned_cols=255 Identities=18% Similarity=0.251 Sum_probs=198.2
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCC-CeEEEEEEeccC----CCchHHHHHHHHHHHhc---CCCCCceeEEEeE---
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQT-NEEVAIKLENVK----TKHPQLQYEAKLYKILQ---GGTGIPNLRWFGV--- 73 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~-~~~vAvK~~~~~----~~~~~l~~E~~il~~l~---~~~~i~~l~~~~~--- 73 (474)
..++|+++++||+|+||+||+|++..+ ++.||||++... .....+.+|+.+++.|. |++++..+..+..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 457899999999999999999999765 678999987543 22345788999988874 5555555544432
Q ss_pred -eCCEEEEEEecCCCCHHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecC
Q 011945 74 -EGDYNVLVIDLLGPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151 (474)
Q Consensus 74 -~~~~~~lv~e~~g~sL~~li~-~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFG 151 (474)
.....+++||++.+.+..+.. .....+++..++.++.||+.||+|||++|||||||||+|||+ +..+.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecchh
Confidence 235779999999766655543 345669999999999999999999999999999999999999 477899999999
Q ss_pred CccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc
Q 011945 152 LAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK 231 (474)
Q Consensus 152 la~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~ 231 (474)
+++....... .....||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.........+......
T Consensus 162 ~~~~~~~~~~--------~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 162 LARIYSFQMA--------LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233 (305)
T ss_dssp SCCCCCGGGG--------GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred hhhhhccccc--------CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence 9986543322 24568999999999999999999999999999999999999999875433222222221110
Q ss_pred -------------------cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 232 -------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 232 -------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
........+...+++++.+||.+||..||++|||+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L 291 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence 111122334456789999999999999999999988763
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-49 Score=384.39 Aligned_cols=254 Identities=21% Similarity=0.295 Sum_probs=199.0
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
.++|++.++||+|+||+||+|++.. ++.||||+++.... .+.+.+|+.+++.++|++++..+.. +.++ ..++||||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~-~~~~-~~~lv~Ey 92 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VSEE-PIYIVTEY 92 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEE-ECSS-SCEEEECC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEE-EecC-CeEEEEEe
Confidence 3689999999999999999999854 46799999865543 4569999999999998776666554 4444 46789999
Q ss_pred C-CCCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 85 L-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 85 ~-g~sL~~li~~-~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
+ +++|.+++.. ....+++..++.|+.||+.||+|||++||+||||||+||||+ .++.+||+|||+|+.+......
T Consensus 93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~---~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC---GGGCEEECCCCTTC--------
T ss_pred cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEEC---CCCcEEEcccchhhhccCCCce
Confidence 8 7889888753 345699999999999999999999999999999999999994 6789999999999876543321
Q ss_pred cccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhc
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCR 242 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~ 242 (474)
......||+.|+|||++.+..++.++|||||||+||||++|..||... ....+.+..+...... ....
T Consensus 170 ------~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~--~~~~~~~~~i~~~~~~----~~~~ 237 (285)
T d1fmka3 170 ------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG--MVNREVLDQVERGYRM----PCPP 237 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT--CCHHHHHHHHHTTCCC----CCCT
T ss_pred ------eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCC--CCHHHHHHHHHhcCCC----CCCc
Confidence 123457899999999999999999999999999999999965555432 2334444444433221 1346
Q ss_pred CCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 243 GYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 243 ~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
.+|+++.+||.+||+.||++||++++|.+.|++.+
T Consensus 238 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 78999999999999999999999999998888765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-48 Score=381.63 Aligned_cols=258 Identities=20% Similarity=0.319 Sum_probs=209.5
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCC-------eEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeC
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTN-------EEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEG 75 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~-------~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~ 75 (474)
.++|++++.||+|+||.||+|++..++ ..||||+++.+... ..+..|...+.++.+|++|..+..++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 478999999999999999999976554 47999998765442 35788999999997777777777777788
Q ss_pred CEEEEEEecC-CCCHHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeC
Q 011945 76 DYNVLVIDLL-GPSLEDLFNFCS---------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139 (474)
Q Consensus 76 ~~~~lv~e~~-g~sL~~li~~~~---------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~ 139 (474)
...++||||+ +++|.+++.... ..+++.+++.++.||+.||+|||++|||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl--- 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV--- 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee---
Confidence 8899999999 899999996432 358999999999999999999999999999999999999
Q ss_pred CCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 011945 140 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (474)
Q Consensus 140 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~ 218 (474)
+.++.+||+|||+++......... ......||+.|+|||++.+..|+.++|||||||+||||++ |..||.+...
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYK-----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTC-----CCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cCCCCeEeccchhhcccccccccc-----ccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 477899999999999776544321 2345689999999999999999999999999999999998 7999977543
Q ss_pred CcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Q 011945 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFI 278 (474)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~ 278 (474)
.+.+..+...... ..+..+++++.+||..||+.||.+||++.+|++.|+.++.
T Consensus 244 ---~~~~~~i~~~~~~----~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 ---EELFKLLKEGHRM----DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ---HHHHHHHHTTCCC----CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHHHcCCCC----CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 3344444332221 2346789999999999999999999999999999998864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-49 Score=382.65 Aligned_cols=255 Identities=22% Similarity=0.275 Sum_probs=196.9
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCC-C--eEEEEEEeccCC-----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQT-N--EEVAIKLENVKT-----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYN 78 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~-~--~~vAvK~~~~~~-----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~ 78 (474)
++|++++.||+|+||+||+|++... + ..||||+++... ..+.+.+|+.+++.++|++++..+.++ .++ ..
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~-~~~-~~ 85 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV-LTP-PM 85 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSS-SC
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-eec-ch
Confidence 4699999999999999999986533 2 478999875432 124689999999999866655555544 443 45
Q ss_pred EEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccc
Q 011945 79 VLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYR 157 (474)
Q Consensus 79 ~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (474)
++||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+++.+.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~---~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCEECC
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccc---cccceeeccchhhhhcc
Confidence 7888888 8899998876667899999999999999999999999999999999999995 57899999999999876
Q ss_pred cCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCcCcHHHHHHHHhhccccch
Q 011945 158 DTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKAGTKKQKYEKISEKKVSTS 236 (474)
Q Consensus 158 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (474)
....... ......||..|+|||++.+..++.++|||||||++|||++ |..||.+.+ ..+.+..+.......
T Consensus 163 ~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~---~~~~~~~i~~~~~~~- 234 (273)
T d1u46a_ 163 QNDDHYV----MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN---GSQILHKIDKEGERL- 234 (273)
T ss_dssp C-CCEEE----C-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHHHTSCCCC-
T ss_pred cCCCcce----ecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC---HHHHHHHHHhCCCCC-
Confidence 5443221 1234568899999999999999999999999999999998 899998754 344445554433322
Q ss_pred HHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Q 011945 237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDL 276 (474)
Q Consensus 237 ~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l 276 (474)
.....+|+++.+||..||..||++|||+.+|.+.|.++
T Consensus 235 --~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 235 --PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 23467899999999999999999999999999888764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-48 Score=384.19 Aligned_cols=256 Identities=20% Similarity=0.313 Sum_probs=207.3
Q ss_pred CCcEEEeeeeeecCceEEEEEEEc-----CCCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
.++|+++++||+|+||+||+|+++ .+++.||||+++..... ..+.+|+.+++.++|++++..+. ++.....
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~-~~~~~~~ 90 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLG-VCAVGKP 90 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEE-EECSSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCccccee-eeccCCc
Confidence 357999999999999999999975 35678999998754432 45899999999998766555555 4456677
Q ss_pred EEEEEecC-CCCHHHHHHHcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 011945 78 NVLVIDLL-GPSLEDLFNFCS-----------------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 133 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~~-----------------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~N 133 (474)
.+++||++ +++|.+++.... ..+++..++.|+.||+.||+|||+++||||||||+|
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~N 170 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRN 170 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccc
Confidence 88999998 889999986432 248899999999999999999999999999999999
Q ss_pred EEeeeCCCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCC-CC
Q 011945 134 FLMGLGRRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGS-LP 212 (474)
Q Consensus 134 ILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~-~P 212 (474)
||| +.++.+||+|||+|+.+...... .......||+.|+|||.+.+..++.++|||||||+||||++|. .|
T Consensus 171 ILl---d~~~~~Kl~DFGls~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 171 CLV---GENMVVKIADFGLSRNIYSADYY-----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp EEE---CGGGCEEECCCSCHHHHTGGGCB-----C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred eEE---CCCCcEEEccchhheeccCCccc-----cccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCC
Confidence 999 47789999999999876543321 1223567899999999999999999999999999999999985 57
Q ss_pred CCCCCcCcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 213 WQGLKAGTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
|.+.. ..+.+..+...... .+...+|+++.+||..||+.||++|||+.+|.+.|+++.
T Consensus 243 ~~~~~---~~e~~~~v~~~~~~----~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 243 YYGMA---HEEVIYYVRDGNIL----ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTSC---HHHHHHHHHTTCCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCC---HHHHHHHHHcCCCC----CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 77643 34445555544432 234678999999999999999999999999999998764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=379.31 Aligned_cols=261 Identities=20% Similarity=0.308 Sum_probs=213.8
Q ss_pred CCcEEEeeeeeecCceEEEEEEEc-----CCCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
.++|+++++||+|+||.||+|++. .+++.||||+++..... ..+.+|+.+++.+.+|++|..+..++.....
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 378999999999999999999863 45679999998765432 3478999999999878888888888888888
Q ss_pred EEEEEecC-CCCHHHHHHHcC-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeC
Q 011945 78 NVLVIDLL-GPSLEDLFNFCS-----------------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG 139 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~~-----------------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~ 139 (474)
.+|+|||| +++|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+|||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~-- 179 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-- 179 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE--
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc--
Confidence 99999999 889999986432 2589999999999999999999999999999999999995
Q ss_pred CCCCeEEEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCc
Q 011945 140 RRANQVYIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLR-GSLPWQGLKA 218 (474)
Q Consensus 140 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~ellt-G~~Pf~~~~~ 218 (474)
..+.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++ |.+||.+...
T Consensus 180 -~~~~~ki~DfG~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 180 -HGRITKICDFGLARDIKNDSNY-----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp -TTTEEEECCCGGGSCTTSCTTS-----EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred -ccCcccccccchheeccCCCcc-----eEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 7889999999999876654331 12345689999999999999999999999999999999999 6666666544
Q ss_pred CcHHHHHHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 219 GTKKQKYEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
... +.++........ ....+|+++.+||..||+.||++||++++|++.|++.+.+.
T Consensus 254 ~~~---~~~~i~~~~~~~---~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~ 309 (311)
T d1t46a_ 254 DSK---FYKMIKEGFRML---SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (311)
T ss_dssp SHH---HHHHHHHTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHH---HHHHHhcCCCCC---CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccC
Confidence 322 222222222221 23467899999999999999999999999999999887653
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-48 Score=386.16 Aligned_cols=258 Identities=20% Similarity=0.218 Sum_probs=202.3
Q ss_pred ccCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEe----CC
Q 011945 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVE----GD 76 (474)
Q Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~----~~ 76 (474)
.++.+|+++++||+|+||+||+|++..+|+.||||++...... ..+.+|+.+|+.|+|++++..+..+... ..
T Consensus 5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccc
Confidence 3678999999999999999999999999999999998754332 3578899999999987777666655432 24
Q ss_pred EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 77 YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 77 ~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
+.|++|++++++|.+++.. +.+++..++.++.||+.||+|||++|||||||||+|||| +.++.+||+|||+|+..
T Consensus 85 ~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 85 DVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVA 159 (345)
T ss_dssp CEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred eEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEcccCceeec
Confidence 5788888889999999974 479999999999999999999999999999999999999 47789999999999876
Q ss_pred ccCCCccccccccCCCCccCccccccccccC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhh-----
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE----- 230 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~----- 230 (474)
....... ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||.+....+.......+..
T Consensus 160 ~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (345)
T d1pmea_ 160 DPDHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235 (345)
T ss_dssp CGGGCBC----CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH
T ss_pred cCCCccc----eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChh
Confidence 5543221 12345689999999999854 5679999999999999999999999987543222222211110
Q ss_pred ------------------ccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 231 ------------------KKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 231 ------------------~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
.........+...+++++.+||..||..||++||++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L 293 (345)
T d1pmea_ 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293 (345)
T ss_dssp HHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred hhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 0111223445567788999999999999999999988774
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=382.36 Aligned_cols=256 Identities=20% Similarity=0.253 Sum_probs=209.6
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeE--EEEEEeccC---CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEE--VAIKLENVK---TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLV 81 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~--vAvK~~~~~---~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv 81 (474)
++|++.++||+|+||+||+|+++.++.. ||||.+... ...+.+.+|+++|..+.+|++|..+..++..+...++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 5899999999999999999999888875 667765432 23446899999999996677777777777888999999
Q ss_pred EecC-CCCHHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeE
Q 011945 82 IDLL-GPSLEDLFNFC---------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQV 145 (474)
Q Consensus 82 ~e~~-g~sL~~li~~~---------------~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~v 145 (474)
|||+ +++|.+++... ...+++..++.++.||+.||.|||+++||||||||+|||+ +..+.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE---cCCCce
Confidence 9999 89999998632 3569999999999999999999999999999999999999 477899
Q ss_pred EEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCcCcHHHH
Q 011945 146 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGS-LPWQGLKAGTKKQK 224 (474)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~-~Pf~~~~~~~~~~~ 224 (474)
||+|||+|+....... .....||..|+|||.+.+..++.++|||||||++|||++|. +||.+. +..+.
T Consensus 167 kl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~---~~~~~ 235 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAEL 235 (309)
T ss_dssp EECCTTCEESSCEECC--------C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHH
T ss_pred EEcccccccccccccc--------ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC---CHHHH
Confidence 9999999986544322 23457899999999999999999999999999999999965 577664 34455
Q ss_pred HHHHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Q 011945 225 YEKISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIRE 280 (474)
Q Consensus 225 ~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~ 280 (474)
+..+...... .....+|+++.+||.+||+.||++||++.+|++.|++++.+.
T Consensus 236 ~~~i~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 236 YEKLPQGYRL----EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp HHHGGGTCCC----CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHHhcCCC----CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 5555443221 234568999999999999999999999999999999998644
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.1e-47 Score=374.77 Aligned_cols=252 Identities=22% Similarity=0.299 Sum_probs=198.1
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
++|+++++||+|+||+||+|+++ +|+.||||++.... ....+.+|+.+|+.++|++++ .+..+.......+++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv-~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV-KLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBC-CEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEE-eeeeecccCCceeEEE
Confidence 68999999999999999999984 88999999986542 245789999999999865555 5555566777789999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 83 e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
+++++.+...+....+.+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+|.........
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC----
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecccCccc
Confidence 999888888777667889999999999999999999999999999999999999 47899999999999876544321
Q ss_pred cccccccCCCCccCccccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc---------
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK--------- 232 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~--------- 232 (474)
.....|++.|+|||.+.+.. ++.++|||||||++|||++|+.||.+....+....+.......
T Consensus 157 -------~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 157 -------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred -------cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchh
Confidence 23457899999999998654 6999999999999999999999998754332222222211110
Q ss_pred ------------ccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 233 ------------VSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 233 ------------~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
...........+++++.+||.+||..||++|||+++|+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell 279 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 00111223356788999999999999999999988774
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=384.80 Aligned_cols=252 Identities=20% Similarity=0.283 Sum_probs=197.3
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeEeC-----
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGVEG----- 75 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~~~----- 75 (474)
+.++|+++++||+|+||+||+|.++.+|+.||||+++..... +.+.+|+++|+.++|+++|..+..+...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 678999999999999999999999999999999998754332 35789999999999777776666654432
Q ss_pred CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 76 ~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
...|+||||++.+|..+++. ..+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+.
T Consensus 96 ~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 96 TDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ 170 (346)
T ss_dssp CCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred ceEEEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---ccccccccccccceec
Confidence 35799999999999998873 579999999999999999999999999999999999999 5789999999999987
Q ss_pred cccCCCccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc---
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--- 231 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~--- 231 (474)
..... ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+......
T Consensus 171 ~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 171 ADSEM----------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPA 240 (346)
T ss_dssp CCSSC----------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred cCCcc----------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcH
Confidence 65432 346899999999999875 4789999999999999999999999875433222222221111
Q ss_pred --------------------cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHH
Q 011945 232 --------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKR 271 (474)
Q Consensus 232 --------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~ 271 (474)
........+...+++++.+||..||..||++|||+++|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0111112233467889999999999999999999887743
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=382.59 Aligned_cols=251 Identities=21% Similarity=0.224 Sum_probs=196.2
Q ss_pred cEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeE-----eCCEEEEEE
Q 011945 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV-----EGDYNVLVI 82 (474)
Q Consensus 8 ~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~-----~~~~~~lv~ 82 (474)
+|+.+++||+|+||+||+|++..+|+.||||++.... ....+|+.+|+.|+|++++..+..+.. ...+.+|||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~ 98 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK--RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc--hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEE
Confidence 6999999999999999999999999999999986543 234589999999998777777666533 344679999
Q ss_pred ecCCCCHHHHHH---HcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccC
Q 011945 83 DLLGPSLEDLFN---FCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDT 159 (474)
Q Consensus 83 e~~g~sL~~li~---~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (474)
||+++++.+.+. .....+++..++.|+.||+.||+|||++|||||||||+||||+ .+...+||+|||+++.+...
T Consensus 99 Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~--~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 99 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp ECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC--TTTCCEEECCCTTCEECCTT
T ss_pred eccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEe--cCCCceeEecccchhhccCC
Confidence 999887766653 2456799999999999999999999999999999999999995 23458999999999876543
Q ss_pred CCccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchH-
Q 011945 160 ATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSI- 237 (474)
Q Consensus 160 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~- 237 (474)
.. .....||..|+|||.+.+. .++.++|||||||++|||++|+.||......+....+.+..........
T Consensus 177 ~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 177 EP--------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp SC--------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cc--------cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence 32 2346899999999988764 6899999999999999999999999875432222222211111000000
Q ss_pred --------------------HHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 238 --------------------EALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 238 --------------------~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
......+++++.+||.+||..||++|||+.+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 301 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 111234688999999999999999999988764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=376.37 Aligned_cols=257 Identities=18% Similarity=0.231 Sum_probs=204.8
Q ss_pred EeeeeeecCceEEEEEEEcCCC---eEEEEEEeccCCCc---hHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 11 LGRKIGSGSFGEIYLGTNIQTN---EEVAIKLENVKTKH---PQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~---~~vAvK~~~~~~~~---~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
+.++||+|+||+||+|++..++ ..||||.++..... ..+.+|++++.+|+|++++..+..+...+...++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 4678999999999999986643 36899988643332 45899999999999766666666555556788999999
Q ss_pred C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCcc
Q 011945 85 L-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATHQ 163 (474)
Q Consensus 85 ~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~ 163 (474)
| +++|.+++......+++..++.++.||+.||.|||+++|+||||||+|||| +.++.+||+|||+++.........
T Consensus 111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTTTCCC
T ss_pred eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhcccccccc
Confidence 9 889999988666678899999999999999999999999999999999999 478899999999998776543322
Q ss_pred ccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccccchHHHHhcC
Q 011945 164 HIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVSTSIEALCRG 243 (474)
Q Consensus 164 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~ 243 (474)
........||+.|+|||.+.+..++.++|||||||+||||++|..||..... ..+....+...... ..+..
T Consensus 188 ---~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~--~~~~~~~i~~g~~~----~~p~~ 258 (311)
T d1r0pa_ 188 ---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN--TFDITVYLLQGRRL----LQPEY 258 (311)
T ss_dssp ---TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTCCC----CCCTT
T ss_pred ---ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCCCC----CCccc
Confidence 1123446799999999999999999999999999999999998888765322 22223333332221 12356
Q ss_pred CcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Q 011945 244 YPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIR 279 (474)
Q Consensus 244 ~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~ 279 (474)
+|+++.+||..||..||++||++.+|++.|+.++..
T Consensus 259 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 259 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 889999999999999999999999999999999753
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-47 Score=376.25 Aligned_cols=262 Identities=20% Similarity=0.234 Sum_probs=200.7
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC----CchHHHHHHHHHHHhcCCCCCceeEEEeE-------eC
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT----KHPQLQYEAKLYKILQGGTGIPNLRWFGV-------EG 75 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~----~~~~l~~E~~il~~l~~~~~i~~l~~~~~-------~~ 75 (474)
++|+++++||+|+||+||+|++..+|+.||||++.... ....+.+|+.+|+.++|++++..+..+.. ..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 79999999999999999999999999999999875432 33568899999999998777777665533 24
Q ss_pred CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 76 ~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
...+++||++++.+...+......+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+++.
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARA 166 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEE
T ss_pred ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEeeecceeee
Confidence 4679999999888887776667789999999999999999999999999999999999999 4788999999999987
Q ss_pred cccCCCccccccccCCCCccCccccccccccCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGI-EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (474)
+....... .......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+..+......
T Consensus 167 ~~~~~~~~---~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 167 FSLAKNSQ---PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CCC--------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccc---cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 65433211 1123456899999999999875 5899999999999999999999999875543333333332211100
Q ss_pred c----------------------hHH-HH-hcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 235 T----------------------SIE-AL-CRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 235 ~----------------------~~~-~l-~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
. ... .+ ....++++.+||.+||..||++|||++++ |++.|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~el---L~Hpf 307 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA---LNHDF 307 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHH---HHSGG
T ss_pred hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHH---HcChh
Confidence 0 000 00 01135678899999999999999998776 45544
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=375.76 Aligned_cols=272 Identities=18% Similarity=0.270 Sum_probs=215.5
Q ss_pred CcEEEeeeeeecCceEEEEEEEc---CCCeEEEEEEeccC------CCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNI---QTNEEVAIKLENVK------TKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~---~~~~~vAvK~~~~~------~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
++|+++++||+|+||+||+|++. .+|+.||||+++.. .....+.+|++++++++|+++|..+..+..+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999974 46899999987532 2345688999999999999999999888889999
Q ss_pred EEEEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 78 NVLVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
.+++|||+ +++|.+++.. .+.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+.+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccchhhh
Confidence 99999999 8899999974 4568899999999999999999999999999999999999 46789999999999876
Q ss_pred ccCCCccccccccCCCCccCccccccccccCCC--CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcccc
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIE--QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVS 234 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (474)
....... .....|++.|++||.+.+.. ++.++|||||||+||||++|+.||.+.........+.........
T Consensus 180 ~~~~~~~------~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~ 253 (322)
T d1vzoa_ 180 VADETER------AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 253 (322)
T ss_dssp CGGGGGG------GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC
T ss_pred ccccccc------ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC
Confidence 5433211 23457999999999998654 688999999999999999999999887655544444332211111
Q ss_pred chHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHH--HHHHHHHHHHHHcCCCCCCccccccccccccc
Q 011945 235 TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYA--YLKRLFRDLFIREGFQFDYVFDWTILKYQQSQ 299 (474)
Q Consensus 235 ~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~--~l~~~L~~l~~~~~~~~~~~~dw~~~~~~~~~ 299 (474)
.+...+++++.+||.+||..||++||++. .+.++|++.| ...++|..+..++.+
T Consensus 254 ----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf-------f~~i~~~~l~~~~~~ 309 (322)
T d1vzoa_ 254 ----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF-------FQKINWDDLAAKKVP 309 (322)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG-------GTTCCHHHHHTTCSC
T ss_pred ----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh-------hcCCCHHHHHhCCCC
Confidence 12356899999999999999999999531 1333344443 234577766554444
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-47 Score=372.58 Aligned_cols=268 Identities=21% Similarity=0.253 Sum_probs=200.7
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHH--HHhcCCCCCceeEEEeEeC---CEEE
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLY--KILQGGTGIPNLRWFGVEG---DYNV 79 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il--~~l~~~~~i~~l~~~~~~~---~~~~ 79 (474)
|..+|.+.++||+|+||+||+|++ +|+.||||+++... ......|.+++ ..++|+++|..+..+...+ ...+
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 456899999999999999999985 78999999986543 23444555544 4566666665555444333 3679
Q ss_pred EEEecC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH--------CCccccCCCCCcEEeeeCCCCCeEEEEec
Q 011945 80 LVIDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS--------KSFLHRDIKPDNFLMGLGRRANQVYIIDF 150 (474)
Q Consensus 80 lv~e~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs--------~gIiHrDIKP~NILl~~~~~~~~vkL~DF 150 (474)
+||||+ +++|.++++. ..+++..++.++.|++.||.|||+ +|||||||||+|||| +.++.+||+||
T Consensus 78 lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~Kl~DF 152 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADL 152 (303)
T ss_dssp EEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECCC
T ss_pred EEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeEEEec
Confidence 999999 8899999984 469999999999999999999996 599999999999999 47899999999
Q ss_pred CCccccccCCCccccccccCCCCccCccccccccccCCC------CCchhhHHHHHHHHHHHHhCCCCCCCCCc------
Q 011945 151 GLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIE------QSRRDDLESLGYVLMYFLRGSLPWQGLKA------ 218 (474)
Q Consensus 151 Gla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~------~s~ksDIwSlGvil~elltG~~Pf~~~~~------ 218 (474)
|+++.+........ .......||+.|||||++.+.. ++.++|||||||+||||++|..||.....
T Consensus 153 Gl~~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~ 229 (303)
T d1vjya_ 153 GLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229 (303)
T ss_dssp TTCEEEETTTTEEC---C----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred CccccccCCCccee---ccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh
Confidence 99998765443221 1224568999999999988653 57799999999999999999888743211
Q ss_pred ------CcHHHHHHHHhhccccchHHHHh--cCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Q 011945 219 ------GTKKQKYEKISEKKVSTSIEALC--RGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREGFQ 283 (474)
Q Consensus 219 ------~~~~~~~~~i~~~~~~~~~~~l~--~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~~~~~~~ 283 (474)
.........+........++... ...+.++.+|+..||..||++||++.+|.+.|+++..+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~~ 302 (303)
T d1vjya_ 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302 (303)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCCC
T ss_pred hcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCCC
Confidence 11222222222222222211111 123467999999999999999999999999999999888764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=371.36 Aligned_cols=256 Identities=20% Similarity=0.293 Sum_probs=207.4
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcC-----CCeEEEEEEeccCCCch---HHHHHHHHHHHhcCCCCCceeEEEeEeCCE
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQ-----TNEEVAIKLENVKTKHP---QLQYEAKLYKILQGGTGIPNLRWFGVEGDY 77 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~-----~~~~vAvK~~~~~~~~~---~l~~E~~il~~l~~~~~i~~l~~~~~~~~~ 77 (474)
.++|+++++||+|+||+||+|.+.. ++..||||+++...... .+.+|+.+++.++|++++..+ .++.....
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~-~~~~~~~~ 97 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL-GVVSQGQP 97 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE-EEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeee-eEEecCCc
Confidence 3789999999999999999998753 35789999987544332 478999999999866555554 45556667
Q ss_pred EEEEEecC-CCCHHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEE
Q 011945 78 NVLVIDLL-GPSLEDLFNFCS---------RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYI 147 (474)
Q Consensus 78 ~~lv~e~~-g~sL~~li~~~~---------~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL 147 (474)
.++||||+ +++|.+++.... ..+++..++.|+.||+.||.|||+++||||||||+|||| +.++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---cCCceEEE
Confidence 89999999 899999886431 347899999999999999999999999999999999999 57889999
Q ss_pred EecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCcCcHHHHHH
Q 011945 148 IDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRG-SLPWQGLKAGTKKQKYE 226 (474)
Q Consensus 148 ~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG-~~Pf~~~~~~~~~~~~~ 226 (474)
+|||+|+.+....... ......||+.|+|||.+.+..++.++|||||||+||||++| ..||.+. ...+.+.
T Consensus 175 ~DFGla~~~~~~~~~~-----~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~---~~~~~~~ 246 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYR-----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVLR 246 (308)
T ss_dssp CCTTCCCGGGGGGCEE-----GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS---CHHHHHH
T ss_pred eecccceeccCCccee-----eccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCC---CHHHHHH
Confidence 9999998765543211 12345789999999999999999999999999999999998 5788764 3445555
Q ss_pred HHhhccccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Q 011945 227 KISEKKVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLKRLFRDLF 277 (474)
Q Consensus 227 ~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~~~L~~l~ 277 (474)
.+....... ....+|+.+.++|..||+.||++||++.+|++.|++.+
T Consensus 247 ~i~~~~~~~----~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 247 FVMEGGLLD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp HHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHhCCCCC----CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 554433322 33578899999999999999999999999988887653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.6e-46 Score=372.14 Aligned_cols=250 Identities=18% Similarity=0.285 Sum_probs=195.9
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeE--eCCEEEEEEe
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGV--EGDYNVLVID 83 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~--~~~~~~lv~e 83 (474)
.++|+++++||+|+||+||+|+++.+|+.||||+++.. ....+.+|+.+|+.+.+|++|..+..++. .....++|||
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 46799999999999999999999999999999998653 45678999999999986667776655544 3456899999
Q ss_pred cC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 84 ~~-g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
|+ +++|.++ .+.+++..++.++.||+.||+|||++|||||||||+||||+ .+.+.+||+|||+|+.......
T Consensus 113 ~~~~~~L~~~----~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~~~~~~~~- 185 (328)
T d3bqca1 113 HVNNTDFKQL----YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQE- 185 (328)
T ss_dssp CCCSCBGGGT----TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCEECCTTCC-
T ss_pred ecCCCcHHHH----hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc--CCCCeeeecccccceeccCCCc-
Confidence 99 5676554 34799999999999999999999999999999999999996 3456799999999987654332
Q ss_pred cccccccCCCCccCccccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcH-HHHHHHHhhcc--------
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK-KQKYEKISEKK-------- 232 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~-~~~~~~i~~~~-------- 232 (474)
.....||+.|+|||++.+.. ++.++|||||||++|||++|..||........ ...+..+....
T Consensus 186 -------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 186 -------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp -------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred -------ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 24568999999999988765 79999999999999999999999976543211 11111111000
Q ss_pred ----ccc-----------------hHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 233 ----VST-----------------SIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 233 ----~~~-----------------~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
... ........+++++.+||.+||..||++|||+++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L 317 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 000 00001123678999999999999999999988774
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=376.19 Aligned_cols=251 Identities=22% Similarity=0.291 Sum_probs=198.1
Q ss_pred cCCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeE-----eC
Q 011945 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGV-----EG 75 (474)
Q Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~-----~~ 75 (474)
+.++|+++++||+|+||+||+|++..+|+.||||++...... ..+.+|+.+|+.|+|++++..+..+.. +.
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 357899999999999999999999999999999998754332 357899999999998777766666542 33
Q ss_pred CEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccc
Q 011945 76 DYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKR 155 (474)
Q Consensus 76 ~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (474)
...+++|+++|++|.+++. .+++++..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||++..
T Consensus 96 ~~~~i~~~~~gg~L~~~~~--~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH 170 (348)
T ss_dssp CCCEEEEECCSEEHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCC----C
T ss_pred ceEEEEEeecCCchhhhcc--cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---cccccccccccchhcc
Confidence 4577888888999999986 4579999999999999999999999999999999999999 4788999999999976
Q ss_pred cccCCCccccccccCCCCccCccccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhc---
Q 011945 156 YRDTATHQHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--- 231 (474)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~--- 231 (474)
..... ....||..|+|||++.+.. ++.++|||||||++|+|++|+.||.+.........+......
T Consensus 171 ~~~~~----------~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~ 240 (348)
T d2gfsa1 171 TDDEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240 (348)
T ss_dssp CTGGG----------SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred cCccc----------ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 54322 3468999999999988765 689999999999999999999999875432222222211110
Q ss_pred --------------------cccchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 232 --------------------KVSTSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 232 --------------------~~~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
............+++++.+||..||..||.+|||+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL 299 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHh
Confidence 011122333456789999999999999999999987763
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=359.62 Aligned_cols=251 Identities=21% Similarity=0.256 Sum_probs=198.3
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC----chHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEE
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVI 82 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~ 82 (474)
++|+++++||+|+||+||+|++..+++.||||+++.... ..++.+|+.+++.++|++++ .+..+.......+++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv-~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV-RLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBC-CEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEE-eeccccccccceeEEe
Confidence 689999999999999999999999999999999865432 24688999999999866544 5556667788889999
Q ss_pred ecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCccccccCCCc
Q 011945 83 DLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRYRDTATH 162 (474)
Q Consensus 83 e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~ 162 (474)
+++.+.+...+....+.+++..++.++.|++.||+|||++|||||||||+|||+ +..+.+||+|||+|+........
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCSC
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---ccCCceeeeecchhhcccCCCcc
Confidence 999544444444467789999999999999999999999999999999999999 46789999999999877654331
Q ss_pred cccccccCCCCccCccccccccccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhccc--------
Q 011945 163 QHIPYRENKNLTGTARYASMNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV-------- 233 (474)
Q Consensus 163 ~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~-------- 233 (474)
.....++..|+|||++.+.. ++.++|||||||++|||++|..||.... +..+.+.++.....
T Consensus 158 -------~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 228 (292)
T d1unla_ 158 -------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp -------CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCCCCTTTCT
T ss_pred -------ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC--CHHHHHHHHHhhcCCCChhhhh
Confidence 23456789999999988765 6999999999999999999999975432 23333333221111
Q ss_pred ----------------cchHHHHhcCCcHHHHHHHHHHhcCCCCCCCCHHHHH
Q 011945 234 ----------------STSIEALCRGYPTEFASYFHYCRSLRFDDKPDYAYLK 270 (474)
Q Consensus 234 ----------------~~~~~~l~~~~p~~l~~li~~cl~~dp~~RPt~~~l~ 270 (474)
..........+++++.+||..||+.||.+|||+++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L 281 (292)
T d1unla_ 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred hhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence 0111122345678999999999999999999988763
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=371.87 Aligned_cols=250 Identities=19% Similarity=0.216 Sum_probs=187.8
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCc----hHHHHHHHHHHHhcCCCCCceeEEEeE-----eCC
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLQYEAKLYKILQGGTGIPNLRWFGV-----EGD 76 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~l~~E~~il~~l~~~~~i~~l~~~~~-----~~~ 76 (474)
.++|+++++||+|+||+||+|+++.+|+.||||++...... ..+.+|+.+++.++|++++..+..+.. ...
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 47899999999999999999999999999999998765432 247899999999987666666666543 346
Q ss_pred EEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEEecCCcccc
Q 011945 77 YNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKRY 156 (474)
Q Consensus 77 ~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (474)
..|+||||+.++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 96 ~~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC----
T ss_pred eeEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc---ccccceeeechhhhhcc
Confidence 889999999888877664 569999999999999999999999999999999999999 47788999999998866
Q ss_pred ccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCcHHHHHHHHhhcc----
Q 011945 157 RDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK---- 232 (474)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~---- 232 (474)
..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.........+.......
T Consensus 170 ~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 241 (355)
T d2b1pa1 170 GTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_dssp -------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccc--------cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHH
Confidence 54332 245589999999999999999999999999999999999999998754322222221111000
Q ss_pred ---ccc---------------hHHH------------HhcCCcHHHHHHHHHHhcCCCCCCCCHHHH
Q 011945 233 ---VST---------------SIEA------------LCRGYPTEFASYFHYCRSLRFDDKPDYAYL 269 (474)
Q Consensus 233 ---~~~---------------~~~~------------l~~~~p~~l~~li~~cl~~dp~~RPt~~~l 269 (474)
... .... .....++++.+||.+||..||++|||+++|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~el 308 (355)
T d2b1pa1 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308 (355)
T ss_dssp HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence 000 0000 011235789999999999999999998887
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-41 Score=338.60 Aligned_cols=254 Identities=21% Similarity=0.308 Sum_probs=183.0
Q ss_pred CCcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC-chHHHHHHHHHHHhcCCC----------CCcee-EEEe-
Q 011945 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-HPQLQYEAKLYKILQGGT----------GIPNL-RWFG- 72 (474)
Q Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-~~~l~~E~~il~~l~~~~----------~i~~l-~~~~- 72 (474)
.++|+++++||+|+||+||+|+++.+|+.||||+++.... .+.+.+|+.+++.+.|.+ +|..+ ..+.
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 3579999999999999999999999999999999875432 345788999999987533 33333 3332
Q ss_pred EeCCEEEEEEecC--CCCHHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCcEEeeeCCCC---CeE
Q 011945 73 VEGDYNVLVIDLL--GPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRA---NQV 145 (474)
Q Consensus 73 ~~~~~~~lv~e~~--g~sL~~li~-~~~~~l~~~~~~~i~~qi~~gL~yLHs-~gIiHrDIKP~NILl~~~~~~---~~v 145 (474)
......+++|+++ +.+...... .....+++..++.++.||+.||+|||+ .||+||||||+||||+.++.. ..+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~ 171 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccccee
Confidence 3445556666555 444444443 334579999999999999999999998 899999999999999643221 358
Q ss_pred EEEecCCccccccCCCccccccccCCCCccCccccccccccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcCc---HH
Q 011945 146 YIIDFGLAKRYRDTATHQHIPYRENKNLTGTARYASMNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT---KK 222 (474)
Q Consensus 146 kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDIwSlGvil~elltG~~Pf~~~~~~~---~~ 222 (474)
+|+|||.+....... ...+||+.|+|||++.+..++.++|||||||++++|++|+.||....... ..
T Consensus 172 kl~dfg~s~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 172 KIADLGNACWYDEHY----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp EECCCTTCEETTBCC----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred eEeeccccccccccc----------ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence 999999998654432 34589999999999999999999999999999999999999997543211 11
Q ss_pred HHHHH---Hhhccc---------------------------cchHH----H---HhcCCcHHHHHHHHHHhcCCCCCCCC
Q 011945 223 QKYEK---ISEKKV---------------------------STSIE----A---LCRGYPTEFASYFHYCRSLRFDDKPD 265 (474)
Q Consensus 223 ~~~~~---i~~~~~---------------------------~~~~~----~---l~~~~p~~l~~li~~cl~~dp~~RPt 265 (474)
..+.. +..... ..... . +....++++.+||.+||.+||++|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence 11111 100000 00000 0 01123578999999999999999999
Q ss_pred HHHH
Q 011945 266 YAYL 269 (474)
Q Consensus 266 ~~~l 269 (474)
++++
T Consensus 322 a~e~ 325 (362)
T d1q8ya_ 322 AGGL 325 (362)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8776
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=3.6e-25 Score=201.68 Aligned_cols=164 Identities=16% Similarity=0.225 Sum_probs=114.9
Q ss_pred EEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCC--------------------chHHHHHHHHHHHhcCCCCCcee
Q 011945 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--------------------HPQLQYEAKLYKILQGGTGIPNL 68 (474)
Q Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--------------------~~~l~~E~~il~~l~~~~~i~~l 68 (474)
+.+.++||+|+||+||+|++ .+|+.||||++..... ......|...+..+.+.+.+..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 46899999999999999998 5789999998653210 01234577788888765433322
Q ss_pred EEEeEeCCEEEEEEecCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCcEEeeeCCCCCeEEEE
Q 011945 69 RWFGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYII 148 (474)
Q Consensus 69 ~~~~~~~~~~~lv~e~~g~sL~~li~~~~~~l~~~~~~~i~~qi~~gL~yLHs~gIiHrDIKP~NILl~~~~~~~~vkL~ 148 (474)
.... .+++||++++.. ...++...+..++.||+.+|.|||++||+||||||+|||++ ++.++|+
T Consensus 81 ---~~~~--~~lvme~~~~~~-------~~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~----~~~~~li 144 (191)
T d1zara2 81 ---AWEG--NAVLMELIDAKE-------LYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWII 144 (191)
T ss_dssp ---EEET--TEEEEECCCCEE-------GGGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEEEC
T ss_pred ---EecC--CEEEEEeecccc-------ccchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee----CCCEEEE
Confidence 2233 379999996532 12355666788999999999999999999999999999995 3569999
Q ss_pred ecCCccccccCCCccccccccCCCCccCcccccc--c---cccCCCCCchhhHHHHHHHHH
Q 011945 149 DFGLAKRYRDTATHQHIPYRENKNLTGTARYASM--N---THLGIEQSRRDDLESLGYVLM 204 (474)
Q Consensus 149 DFGla~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP--E---~~~~~~~s~ksDIwSlGvil~ 204 (474)
|||+|+....+.. ..|... + .+....|+.++||||+.--+.
T Consensus 145 DFG~a~~~~~~~~---------------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 145 DFPQSVEVGEEGW---------------REILERDVRNIITYFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCTTCEETTSTTH---------------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred ECCCcccCCCCCc---------------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHHh
Confidence 9999976543321 111111 0 122356788999999865443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.46 E-value=6.3e-07 Score=82.86 Aligned_cols=83 Identities=17% Similarity=0.269 Sum_probs=61.7
Q ss_pred CcEEEeeeeeecCceEEEEEEEcCCCeEEEEEEeccCC--CchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
+.|++.+..+.++.+.||+.. ..+..++||+..... ....+.+|..++..|...-.++.+..++..+...++||++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 567777776666667999986 566678889865432 2335889999999998665578888788888888999999
Q ss_pred C-CCCHHH
Q 011945 85 L-GPSLED 91 (474)
Q Consensus 85 ~-g~sL~~ 91 (474)
+ |.++.+
T Consensus 92 l~G~~~~~ 99 (263)
T d1j7la_ 92 ADGVLCSE 99 (263)
T ss_dssp CSSEEHHH
T ss_pred cccccccc
Confidence 8 555544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.99 E-value=1.2e-05 Score=79.08 Aligned_cols=74 Identities=14% Similarity=0.174 Sum_probs=48.4
Q ss_pred eeeeeecCceEEEEEEEcCCCeEEEEEEecc------C---CCchHHHHHHHHHHHhcCC--CCCceeEEEeEeCCEEEE
Q 011945 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENV------K---TKHPQLQYEAKLYKILQGG--TGIPNLRWFGVEGDYNVL 80 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~------~---~~~~~l~~E~~il~~l~~~--~~i~~l~~~~~~~~~~~l 80 (474)
.+.||.|....||++.+..+++.|+||.-.. . ........|.++|+.+... ..++.+..+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 4578999999999999777788999995321 1 1223467799999888643 345555544 4455688
Q ss_pred EEecCCC
Q 011945 81 VIDLLGP 87 (474)
Q Consensus 81 v~e~~g~ 87 (474)
+||++++
T Consensus 109 vmE~L~~ 115 (392)
T d2pula1 109 VMEDLSH 115 (392)
T ss_dssp EECCCTT
T ss_pred EEeccCC
Confidence 9999843
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.89 E-value=3.5e-05 Score=70.26 Aligned_cols=69 Identities=14% Similarity=0.019 Sum_probs=50.3
Q ss_pred eeecC-ceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCC-CceeEEEeEeCCEEEEEEecC
Q 011945 15 IGSGS-FGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTG-IPNLRWFGVEGDYNVLVIDLL 85 (474)
Q Consensus 15 LG~G~-fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~-i~~l~~~~~~~~~~~lv~e~~ 85 (474)
+..|. .+.||+... ..+..+++|+.... ....+..|..+++.|..... ++.+..+..++...+++|+++
T Consensus 18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~-~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i 88 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 88 (255)
T ss_dssp CSCTTSSCEEEEEEC-TTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred cCCcccCCeEEEEEe-CCCCEEEEEeCCcc-CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEee
Confidence 34444 468999874 56777899986543 34568999999999876544 566677777777889999998
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.30 E-value=0.00056 Score=66.69 Aligned_cols=70 Identities=13% Similarity=0.096 Sum_probs=51.5
Q ss_pred eeeeeecCceEEEEEEEcC-------CCeEEEEEEeccCCCchHHHHHHHHHHHhcCCCCCceeEEEeEeCCEEEEEEec
Q 011945 12 GRKIGSGSFGEIYLGTNIQ-------TNEEVAIKLENVKTKHPQLQYEAKLYKILQGGTGIPNLRWFGVEGDYNVLVIDL 84 (474)
Q Consensus 12 ~~~LG~G~fG~Vy~a~~~~-------~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~~~i~~l~~~~~~~~~~~lv~e~ 84 (474)
++.|+.|-.-.+|++.... ..+.|++++.......-...+|..+++.+......+.+.+++.. .+||+|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 4678888888999998643 34578888876433344577899999999887778888776542 577888
Q ss_pred C
Q 011945 85 L 85 (474)
Q Consensus 85 ~ 85 (474)
+
T Consensus 123 i 123 (395)
T d1nw1a_ 123 I 123 (395)
T ss_dssp C
T ss_pred e
Confidence 7
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.02 E-value=0.00071 Score=63.51 Aligned_cols=50 Identities=14% Similarity=0.164 Sum_probs=32.3
Q ss_pred EeeeeeecCceEEEEEEEcCCCeEEEEEEeccCCCchHHHHHHHHHHHhcCC
Q 011945 11 LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLQYEAKLYKILQGG 62 (474)
Q Consensus 11 i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~l~~E~~il~~l~~~ 62 (474)
-.+.|..|---+.|++.. ..| .+++|+.........+..|+.++..|...
T Consensus 22 ~~~~i~~G~~N~ny~v~t-~~g-~yVLri~~~~~~~~~l~~~~~~l~~L~~~ 71 (316)
T d2ppqa1 22 SYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRVEKNDLPFFLGLMQHLAAK 71 (316)
T ss_dssp EEEEECC---EEEEEEEE-SSC-CEEEEEECC---CCHHHHHHHHHHHHHHT
T ss_pred EeecCCCCcccCeEEEEE-CCC-cEEEEEcCCCCCHHHHHHHHHHHHhhhhc
Confidence 344556676678899884 334 58999987655567788899999988743
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.99 E-value=0.0026 Score=59.95 Aligned_cols=65 Identities=11% Similarity=0.102 Sum_probs=43.6
Q ss_pred eEEEEEEEcCCCeEEEEEEeccCC-CchHHHHHHHHHHHhcCCCCC-ce-e----EEEeEeCCEEEEEEecCC
Q 011945 21 GEIYLGTNIQTNEEVAIKLENVKT-KHPQLQYEAKLYKILQGGTGI-PN-L----RWFGVEGDYNVLVIDLLG 86 (474)
Q Consensus 21 G~Vy~a~~~~~~~~vAvK~~~~~~-~~~~l~~E~~il~~l~~~~~i-~~-l----~~~~~~~~~~~lv~e~~g 86 (474)
-.||++.. .+|+.|++|+..... ...++..|...+..|....+. +. + ......+...+.++++++
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 107 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence 47999984 678899999976543 346788999999998743221 11 1 122345667788888773
|